<Products xmlns="http://www.hpra.ie/xml/productsHM" xsi:schemaLocation="http://www.hpra.ie/xml/productsHM http://www.hpra.ie/xml/ProductsHM.xsd" schemaVersion="1.0" datePublished="2017-11-05T04:27:00" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Product>
    <DrugIDPK>1995029631</DrugIDPK>
    <LicenceNumber>PPA1562/001/001</LicenceNumber>
    <InterchangeableListCode>IC0008-032-033</InterchangeableListCode>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029632</DrugIDPK>
    <LicenceNumber>PPA1562/001/002</LicenceNumber>
    <InterchangeableListCode>IC0008-033-033</InterchangeableListCode>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030499</DrugIDPK>
    <LicenceNumber>PPA1562/011/003</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019918</DrugIDPK>
    <LicenceNumber>HOR0407/021/001</LicenceNumber>
    <ProductName>CALCIUM PHOSPHORICUM (CALC. PHOS.)(6C &amp; 30C)</ProductName>
    <Strength>6C &amp; 30C</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHORICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019915</DrugIDPK>
    <LicenceNumber>HOR0407/022/001</LicenceNumber>
    <ProductName>CAUSTICUM (CAUST.)(6C &amp; 30C)</ProductName>
    <Strength>6C &amp; 30C</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAUSTICUM HAHNEMANNI</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019920</DrugIDPK>
    <LicenceNumber>HOR0407/023/001</LicenceNumber>
    <ProductName>CUPRUM METALLICUM (CUPRUM. MET.) (6C &amp; 30C)</ProductName>
    <Strength>6C &amp; 30C</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CUPRUM METALLICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018659</DrugIDPK>
    <LicenceNumber>HOR0407/005/001</LicenceNumber>
    <ProductName>KALIUM BICHROMICUM (KALI. BIC.) (6C &amp; 30C)</ProductName>
    <Strength>6C &amp; 30C</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KALIUM BICHROMICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018660</DrugIDPK>
    <LicenceNumber>HOR0407/006/001</LicenceNumber>
    <ProductName>MERCUIRIUS SOLUBILIS HAHNEMANII (MERC. SOL.)</ProductName>
    <Strength>6C &amp; 30C</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MERCURIUS SOLUBILIS HAHNEMANNI</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039018</DrugIDPK>
    <LicenceNumber>PA0312/029/001</LicenceNumber>
    <ProductName>DONEPEZIL HYDROCHLORIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2014-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044870</DrugIDPK>
    <LicenceNumber>PA1968/004/001</LicenceNumber>
    <ProductName>SUPPLYELT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratoire AGUETTANT</PAHolder>
    <AuthorisedDate>2016-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC GLUCONATE</ActiveSubstance>
      <ActiveSubstance>COPPER GLUCONATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM SELENITE</ActiveSubstance>
      <ActiveSubstance>FERROUS GLUCONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM MOLYBDATE 2H2O</ActiveSubstance>
      <ActiveSubstance>CHROMIUM CHLORIDE 6H2O</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036634</DrugIDPK>
    <LicenceNumber>PA1352/020/002</LicenceNumber>
    <ProductName>AUDAVAL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2012-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036632</DrugIDPK>
    <LicenceNumber>PA1352/020/003</LicenceNumber>
    <ProductName>AUDAVAL RD</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2012-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036633</DrugIDPK>
    <LicenceNumber>PA1352/020/004</LicenceNumber>
    <ProductName>AUDAVAL RD</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2012-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE (AS BETAMETHASONE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035174</DrugIDPK>
    <LicenceNumber>PA1368/013/004</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>ATORVASTATIN PHARMATHEN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024354</DrugIDPK>
    <LicenceNumber>PPA1151/037/002</LicenceNumber>
    <InterchangeableListCode>IC0062-002-015</InterchangeableListCode>
    <ProductName>ARICEPT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023149</DrugIDPK>
    <LicenceNumber>PPA1151/037/001</LicenceNumber>
    <InterchangeableListCode>IC0062-001-015</InterchangeableListCode>
    <ProductName>ARICEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036114</DrugIDPK>
    <LicenceNumber>PA1390/042/002</LicenceNumber>
    <ProductName>APODESPAN PR</ProductName>
    <Strength>50/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2013-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022604</DrugIDPK>
    <LicenceNumber>PPA1151/022/001</LicenceNumber>
    <InterchangeableListCode>IC0021-008-024</InterchangeableListCode>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043214</DrugIDPK>
    <LicenceNumber>PPA1562/051/003</LicenceNumber>
    <InterchangeableListCode>IC0087-144-054</InterchangeableListCode>
    <ProductName>ZANTAC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>mg/10ml</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043218</DrugIDPK>
    <LicenceNumber>PPA1562/129/001</LicenceNumber>
    <InterchangeableListCode>IC0062-001-015</InterchangeableListCode>
    <ProductName>ARICEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043219</DrugIDPK>
    <LicenceNumber>PPA1562/129/002</LicenceNumber>
    <InterchangeableListCode>IC0062-002-015</InterchangeableListCode>
    <ProductName>ARICEPT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045532</DrugIDPK>
    <LicenceNumber>PA1968/005/001</LicenceNumber>
    <ProductName>SELENIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Laboratoire AGUETTANT</PAHolder>
    <AuthorisedDate>2016-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELENIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045884</DrugIDPK>
    <LicenceNumber>PA1968/008/001</LicenceNumber>
    <ProductName>ZINC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Laboratoire AGUETTANT</PAHolder>
    <AuthorisedDate>2015-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039306</DrugIDPK>
    <LicenceNumber>PA0711/225/001</LicenceNumber>
    <ProductName>BRUPRO FOR CHILDREN</ProductName>
    <Strength>100mg/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039956</DrugIDPK>
    <LicenceNumber>PA0711/194/005</LicenceNumber>
    <InterchangeableListCode>IC0071-001-015</InterchangeableListCode>
    <ProductName>ESCIPREX DISTAB</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039957</DrugIDPK>
    <LicenceNumber>PA0711/194/006</LicenceNumber>
    <InterchangeableListCode>IC0071-002-015</InterchangeableListCode>
    <ProductName>ESCIPREX DISTAB</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039958</DrugIDPK>
    <LicenceNumber>PA0711/194/007</LicenceNumber>
    <InterchangeableListCode>IC0071-032-015</InterchangeableListCode>
    <ProductName>ESCIPREX DISTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039959</DrugIDPK>
    <LicenceNumber>PA0711/194/008</LicenceNumber>
    <InterchangeableListCode>IC0071-003-015</InterchangeableListCode>
    <ProductName>ESCIPREX DISTAB</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036482</DrugIDPK>
    <LicenceNumber>PA0711/205/001</LicenceNumber>
    <ProductName>IBUPROFEN FOR CHILDREN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2013-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045971</DrugIDPK>
    <LicenceNumber>PA1809/023/001</LicenceNumber>
    <ProductName>LINEZOLID</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2016-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINEZOLID (FORM II)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription 
(see summary of product characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2017-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031541</DrugIDPK>
    <LicenceNumber>PA1422/005/001</LicenceNumber>
    <ProductName>TOPOTECAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Oncology Plc</PAHolder>
    <AuthorisedDate>2011-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2017-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038344</DrugIDPK>
    <LicenceNumber>PA1422/005/002</LicenceNumber>
    <ProductName>TOPOTECAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Oncology Plc</PAHolder>
    <AuthorisedDate>2013-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE EQUIVALENT TO TOPOTECAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2017-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008840</DrugIDPK>
    <LicenceNumber>PA0899/009/001</LicenceNumber>
    <ProductName>DYAZIDE 50MG/25MG TABLETS.</ProductName>
    <Strength>50mg/25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMTERENE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032739</DrugIDPK>
    <LicenceNumber>PPA1562/023/001</LicenceNumber>
    <ProductName>SINEMET PLUS</ProductName>
    <Strength>25/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045117</DrugIDPK>
    <LicenceNumber>PPA1562/165/001</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>200/6</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2015-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045118</DrugIDPK>
    <LicenceNumber>PPA1562/165/002</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>400/12</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2015-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022125</DrugIDPK>
    <LicenceNumber>PA1142/007/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003263</DrugIDPK>
    <LicenceNumber>PA0073/112/001</LicenceNumber>
    <ProductName>LIDOCAINE HYDROCHLORIDE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003264</DrugIDPK>
    <LicenceNumber>PA0073/112/006</LicenceNumber>
    <ProductName>LIDOCAINE HYDROCHLORIDE</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010116</DrugIDPK>
    <LicenceNumber>PA0073/112/002</LicenceNumber>
    <ProductName>LIDOCAINE HYDROCHLORIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021248</DrugIDPK>
    <LicenceNumber>PA0899/030/001</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003289</DrugIDPK>
    <LicenceNumber>PA0073/127/001</LicenceNumber>
    <ProductName>PHENYTOIN SODIUM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003180</DrugIDPK>
    <LicenceNumber>PA0073/053/004</LicenceNumber>
    <ProductName>PROMETHAZINE HYDROCHLORIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044054</DrugIDPK>
    <LicenceNumber>PPA1562/149/001</LicenceNumber>
    <ProductName>SEREVENT EVOHALER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2015-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003238</DrugIDPK>
    <LicenceNumber>PA0073/105/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011879</DrugIDPK>
    <LicenceNumber>PA0899/019/002</LicenceNumber>
    <ProductName>TRAXAM</ProductName>
    <Strength>3.17</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1996-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003248</DrugIDPK>
    <LicenceNumber>PA0073/107/001</LicenceNumber>
    <ProductName>WATER FOR INJECTIONS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003244</DrugIDPK>
    <LicenceNumber>PA0073/107/007</LicenceNumber>
    <ProductName>WATER FOR INJECTIONS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1991-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020564</DrugIDPK>
    <LicenceNumber>PA1241/015/001</LicenceNumber>
    <ProductName>ZEPHOLIN S.R.</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020565</DrugIDPK>
    <LicenceNumber>PA1241/015/002</LicenceNumber>
    <ProductName>ZEPHOLIN S.R.</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020566</DrugIDPK>
    <LicenceNumber>PA1241/015/003</LicenceNumber>
    <ProductName>ZEPHOLIN S.R.</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043549</DrugIDPK>
    <LicenceNumber>PPA1562/137/001</LicenceNumber>
    <InterchangeableListCode>IC0067-140-019</InterchangeableListCode>
    <ProductName>METFORMIN HYDROCHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2015-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995047432</DrugIDPK>
    <LicenceNumber>PPA1562/186/001</LicenceNumber>
    <InterchangeableListCode>IC0019-022-003</InterchangeableListCode>
    <ProductName>QUETIAPINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2016-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995047433</DrugIDPK>
    <LicenceNumber>PPA1562/186/002</LicenceNumber>
    <InterchangeableListCode>IC0019-067-003</InterchangeableListCode>
    <ProductName>QUETIAPINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2016-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995047434</DrugIDPK>
    <LicenceNumber>PPA1562/186/003</LicenceNumber>
    <InterchangeableListCode>IC0019-029-003</InterchangeableListCode>
    <ProductName>QUETIAPINE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2016-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995047892</DrugIDPK>
    <LicenceNumber>PPA1562/192/001</LicenceNumber>
    <ProductName>CASODEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2017-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041708</DrugIDPK>
    <LicenceNumber>PA0437/074/001</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2016-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041709</DrugIDPK>
    <LicenceNumber>PA0437/074/002</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2016-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041710</DrugIDPK>
    <LicenceNumber>PA0437/074/003</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2016-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040682</DrugIDPK>
    <LicenceNumber>PA0437/073/001</LicenceNumber>
    <ProductName>PROPOFOL HOSPIRA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003202</DrugIDPK>
    <LicenceNumber>PA0073/117/003</LicenceNumber>
    <ProductName>ATENOGEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003276</DrugIDPK>
    <LicenceNumber>PA0073/117/001</LicenceNumber>
    <ProductName>ATENOGEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003277</DrugIDPK>
    <LicenceNumber>PA0073/117/002</LicenceNumber>
    <ProductName>ATENOGEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021953</DrugIDPK>
    <LicenceNumber>PA0899/028/001</LicenceNumber>
    <ProductName>CHLOROMYCETIN 1% W/W OPHTHALMIC OINTMENT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2006-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040129</DrugIDPK>
    <LicenceNumber>PA1142/016/002</LicenceNumber>
    <ProductName>FUCITHALMIC</ProductName>
    <Strength>2mg/0.2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>2013-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036124</DrugIDPK>
    <LicenceNumber>PPA1562/041/002</LicenceNumber>
    <ProductName>PROVIGIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MODAFINIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2017-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030497</DrugIDPK>
    <LicenceNumber>PPA1562/011/001</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030498</DrugIDPK>
    <LicenceNumber>PPA1562/011/002</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029079</DrugIDPK>
    <LicenceNumber>PA0688/023/001</LicenceNumber>
    <InterchangeableListCode>IC0007-018-035</InterchangeableListCode>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029080</DrugIDPK>
    <LicenceNumber>PA0688/023/002</LicenceNumber>
    <InterchangeableListCode>IC0007-001-038</InterchangeableListCode>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029081</DrugIDPK>
    <LicenceNumber>PA0688/023/003</LicenceNumber>
    <InterchangeableListCode>IC0007-041-038</InterchangeableListCode>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029082</DrugIDPK>
    <LicenceNumber>PA0688/023/004</LicenceNumber>
    <InterchangeableListCode>IC0007-002-038</InterchangeableListCode>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029083</DrugIDPK>
    <LicenceNumber>PA0688/023/005</LicenceNumber>
    <InterchangeableListCode>IC0007-032-038</InterchangeableListCode>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029084</DrugIDPK>
    <LicenceNumber>PA0688/023/006</LicenceNumber>
    <InterchangeableListCode>IC0007-003-038</InterchangeableListCode>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017998</DrugIDPK>
    <LicenceNumber>PA0436/035/001</LicenceNumber>
    <ProductName>QVAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2004-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017999</DrugIDPK>
    <LicenceNumber>PA0436/035/002</LicenceNumber>
    <ProductName>QVAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018000</DrugIDPK>
    <LicenceNumber>PA0436/035/003</LicenceNumber>
    <ProductName>QVAR AUTOHALER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018001</DrugIDPK>
    <LicenceNumber>PA0436/035/004</LicenceNumber>
    <ProductName>QVAR AUTOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039331</DrugIDPK>
    <LicenceNumber>PA0126/252/001</LicenceNumber>
    <InterchangeableListCode>IC0015-002-005</InterchangeableListCode>
    <ProductName>RABEPRAZOLE CLONMEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039332</DrugIDPK>
    <LicenceNumber>PA0126/252/002</LicenceNumber>
    <InterchangeableListCode>IC0015-003-005</InterchangeableListCode>
    <ProductName>RABEPRAZOLE CLONMEL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034680</DrugIDPK>
    <LicenceNumber>PA0749/146/001</LicenceNumber>
    <ProductName>TEVICON</ProductName>
    <Strength>13.7</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROGEN CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038853</DrugIDPK>
    <LicenceNumber>PA0126/248/001</LicenceNumber>
    <InterchangeableListCode>IC0086-033-050</InterchangeableListCode>
    <ProductName>ZYCRON MR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030916</DrugIDPK>
    <LicenceNumber>PPA1151/127/001</LicenceNumber>
    <ProductName>DIFFLAM SPRAY</ProductName>
    <Strength>0.15</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995046950</DrugIDPK>
    <LicenceNumber>PA0678/141/001</LicenceNumber>
    <ProductName>FENILABIAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2016-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044820</DrugIDPK>
    <LicenceNumber>PA1380/192/001</LicenceNumber>
    <ProductName>IVIVERZ</ProductName>
    <Strength>600/300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2016-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMIVUDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041806</DrugIDPK>
    <LicenceNumber>PPA1562/111/001</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038888</DrugIDPK>
    <LicenceNumber>PA0437/070/001</LicenceNumber>
    <ProductName>CEFTRIAXONE HOSPIRA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2014-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTRIAXONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008086</DrugIDPK>
    <LicenceNumber>PA0566/014/001</LicenceNumber>
    <ProductName>AMINOVEN 3.5% GLUCOSE/ELECTROLYTES</ProductName>
    <Strength>3.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHIONINE, ACTIVE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TAURINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029519</DrugIDPK>
    <LicenceNumber>PPA1473/018/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030300</DrugIDPK>
    <LicenceNumber>PPA1473/018/002</LicenceNumber>
    <ProductName>CREON 10000</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028444</DrugIDPK>
    <LicenceNumber>PPA1473/007/002</LicenceNumber>
    <ProductName>IMURAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032064</DrugIDPK>
    <LicenceNumber>PPA1473/041/001</LicenceNumber>
    <InterchangeableListCode>IC0045-001-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032065</DrugIDPK>
    <LicenceNumber>PPA1473/041/002</LicenceNumber>
    <InterchangeableListCode>IC0045-002-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034708</DrugIDPK>
    <LicenceNumber>PPA1473/050/001</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034709</DrugIDPK>
    <LicenceNumber>PPA1473/050/002</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021535</DrugIDPK>
    <LicenceNumber>PA0437/056/001</LicenceNumber>
    <ProductName>OXALIPLATIN HOSPIRA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035620</DrugIDPK>
    <LicenceNumber>PPA1473/052/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029657</DrugIDPK>
    <LicenceNumber>PPA1473/013/001</LicenceNumber>
    <ProductName>XATRAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028519</DrugIDPK>
    <LicenceNumber>PPA1473/009/001</LicenceNumber>
    <InterchangeableListCode>IC0087-062-051</InterchangeableListCode>
    <ProductName>ZANTAC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028436</DrugIDPK>
    <LicenceNumber>PPA1473/004/001</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028437</DrugIDPK>
    <LicenceNumber>PPA1473/004/002</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995047598</DrugIDPK>
    <LicenceNumber>PA0678/142/001</LicenceNumber>
    <ProductName>NICOTINELL FRUITY MINT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2016-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE BITARTRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995047599</DrugIDPK>
    <LicenceNumber>PA0678/142/002</LicenceNumber>
    <ProductName>NICOTINELL FRUITY MINT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2016-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE BITARTRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044262</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/001-004</LicenceNumber>
    <ProductName>ENZEPI</ProductName>
    <Strength>5,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>2016-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044263</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/013-016</LicenceNumber>
    <ProductName>ENZEPI</ProductName>
    <Strength>40,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>2016-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044264</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/009-012</LicenceNumber>
    <ProductName>ENZEPI</ProductName>
    <Strength>25,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>2016-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044265</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/005-008</LicenceNumber>
    <ProductName>ENZEPI</ProductName>
    <Strength>10,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>2016-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022632</DrugIDPK>
    <LicenceNumber>PA0979/038/001</LicenceNumber>
    <ProductName>STREPSILS COOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMYLMETACRESOL</ActiveSubstance>
      <ActiveSubstance>DICHLOROBENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032876</DrugIDPK>
    <LicenceNumber>PA0979/062/001</LicenceNumber>
    <ProductName>STREPSILS LOZENGES FOR ADULTS AND CHILDREN OVER SIX</ProductName>
    <Strength>0.6/1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMYLMETACRESOL</ActiveSubstance>
      <ActiveSubstance>2, 4-DICHLOROBENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038552</DrugIDPK>
    <LicenceNumber>PA0979/039/002</LicenceNumber>
    <ProductName>STREPSILS WITH VITAMIN C</ProductName>
    <Strength>0.6/1.2/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2013-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMYLMETACRESOL</ActiveSubstance>
      <ActiveSubstance>2, 4-DICHLOROBENZYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031592</DrugIDPK>
    <LicenceNumber>EU/1/11/674/001-005</LicenceNumber>
    <ProductName>REPSO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>2011-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEFLUNOMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2017-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035152</DrugIDPK>
    <LicenceNumber>PA0749/145/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004009</DrugIDPK>
    <LicenceNumber>PA0808/001/001</LicenceNumber>
    <ProductName>STERILLIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>Bode Chemie GmbH</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAN-2-OL</ActiveSubstance>
      <ActiveSubstance>PROPANOL</ActiveSubstance>
      <ActiveSubstance>MECETRONIUM ETILSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040209</DrugIDPK>
    <LicenceNumber>PA1696/003/001</LicenceNumber>
    <ProductName>GLAUCOTIMA</ProductName>
    <Strength>50mcg/ml + 5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>PharmaSwiss Ceska republika s.r.o.</PAHolder>
    <AuthorisedDate>2013-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042063</DrugIDPK>
    <LicenceNumber>PA0711/238/001</LicenceNumber>
    <ProductName>IMODEX PLUS</ProductName>
    <Strength>2/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPERAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034528</DrugIDPK>
    <LicenceNumber>PA1050/003/001</LicenceNumber>
    <ProductName>LEVETIRACETAM AUROBINDO</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034529</DrugIDPK>
    <LicenceNumber>PA1050/003/002</LicenceNumber>
    <ProductName>LEVETIRACETAM AUROBINDO</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034531</DrugIDPK>
    <LicenceNumber>PA1050/003/004</LicenceNumber>
    <ProductName>LEVETIRACETAM AUROBINDO</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035053</DrugIDPK>
    <LicenceNumber>PA1050/005/001</LicenceNumber>
    <InterchangeableListCode>IC0045-001-008</InterchangeableListCode>
    <ProductName>AMLODIPINE AUROBINDO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035054</DrugIDPK>
    <LicenceNumber>PA1050/005/002</LicenceNumber>
    <InterchangeableListCode>IC0045-002-008</InterchangeableListCode>
    <ProductName>AMLODIPINE AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042821</DrugIDPK>
    <LicenceNumber>PA1050/026/001</LicenceNumber>
    <ProductName>ARIPIPRAZOLE MILPHARM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARIPIPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042822</DrugIDPK>
    <LicenceNumber>PA1050/026/002</LicenceNumber>
    <ProductName>ARIPIPRAZOLE MILPHARM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARIPIPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042823</DrugIDPK>
    <LicenceNumber>PA1050/026/003</LicenceNumber>
    <ProductName>ARIPIPRAZOLE MILPHARM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARIPIPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042824</DrugIDPK>
    <LicenceNumber>PA1050/026/004</LicenceNumber>
    <ProductName>ARIPIPRAZOLE MILPHARM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARIPIPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030708</DrugIDPK>
    <LicenceNumber>PA1311/016/001</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>CO-AMOXICLAV AUROBINDO</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma Limited</PAHolder>
    <AuthorisedDate>2009-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CLAVULANATE, DILUTED (WITH MICROCRYSTALLINE CELLULOSE IN A RATIO OF 1:1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035348</DrugIDPK>
    <LicenceNumber>PA1050/009/001</LicenceNumber>
    <ProductName>LAMOTRIGINE AUROBINDO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035349</DrugIDPK>
    <LicenceNumber>PA1050/009/002</LicenceNumber>
    <ProductName>LAMOTRIGINE AUROBINDO</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035350</DrugIDPK>
    <LicenceNumber>PA1050/009/003</LicenceNumber>
    <ProductName>LAMOTRIGINE AUROBINDO</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035351</DrugIDPK>
    <LicenceNumber>PA1050/009/004</LicenceNumber>
    <ProductName>LAMOTRIGINE AUROBINDO</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035352</DrugIDPK>
    <LicenceNumber>PA1050/009/005</LicenceNumber>
    <ProductName>LAMOTRIGINE AUROBINDO</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034530</DrugIDPK>
    <LicenceNumber>PA1050/003/003</LicenceNumber>
    <ProductName>LEVETIRACETAM AUROBINDO</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042720</DrugIDPK>
    <LicenceNumber>PA1050/025/001</LicenceNumber>
    <InterchangeableListCode>IC0003-023-003</InterchangeableListCode>
    <ProductName>LOSARTAN POTASSIUM MILPHARM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2014-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042721</DrugIDPK>
    <LicenceNumber>PA1050/025/002</LicenceNumber>
    <InterchangeableListCode>IC0003-024-003</InterchangeableListCode>
    <ProductName>LOSARTAN POTASSIUM MILPHARM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2014-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037257</DrugIDPK>
    <LicenceNumber>PA1050/004/007</LicenceNumber>
    <InterchangeableListCode>IC0007-001-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037258</DrugIDPK>
    <LicenceNumber>PA1050/004/009</LicenceNumber>
    <InterchangeableListCode>IC0007-032-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037259</DrugIDPK>
    <LicenceNumber>PA1050/004/010</LicenceNumber>
    <InterchangeableListCode>IC0007-003-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037260</DrugIDPK>
    <LicenceNumber>PA1050/004/008</LicenceNumber>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022896</DrugIDPK>
    <LicenceNumber>PA1311/002/001</LicenceNumber>
    <InterchangeableListCode>IC0076-003-003</InterchangeableListCode>
    <ProductName>PAROXETINE AUROBINDO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma Limited</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035646</DrugIDPK>
    <LicenceNumber>PA1050/011/001</LicenceNumber>
    <ProductName>PRAMIPEXOLE AUROBINDO</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035647</DrugIDPK>
    <LicenceNumber>PA1050/011/002</LicenceNumber>
    <ProductName>PRAMIPEXOLE AUROBINDO</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035648</DrugIDPK>
    <LicenceNumber>PA1050/011/003</LicenceNumber>
    <ProductName>PRAMIPEXOLE AUROBINDO</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035649</DrugIDPK>
    <LicenceNumber>PA1050/011/004</LicenceNumber>
    <ProductName>PRAMIPEXOLE AUROBINDO</ProductName>
    <Strength>1.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035550</DrugIDPK>
    <LicenceNumber>PA1050/010/001</LicenceNumber>
    <InterchangeableListCode>IC0015-002-005</InterchangeableListCode>
    <ProductName>RABEPRAZOLE AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035551</DrugIDPK>
    <LicenceNumber>PA1050/010/002</LicenceNumber>
    <InterchangeableListCode>IC0015-003-005</InterchangeableListCode>
    <ProductName>RABEPRAZOLE AUROBINDO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035345</DrugIDPK>
    <LicenceNumber>PA1050/008/001</LicenceNumber>
    <InterchangeableListCode>IC0068-001-003</InterchangeableListCode>
    <ProductName>RISEDRONATE AUROBINDO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035346</DrugIDPK>
    <LicenceNumber>PA1050/008/002</LicenceNumber>
    <InterchangeableListCode>IC0068-033-003</InterchangeableListCode>
    <ProductName>RISEDRONATE AUROBINDO</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036242</DrugIDPK>
    <LicenceNumber>PA1050/015/001</LicenceNumber>
    <InterchangeableListCode>IC0010-002-016</InterchangeableListCode>
    <ProductName>ROMEP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036243</DrugIDPK>
    <LicenceNumber>PA1050/015/002</LicenceNumber>
    <InterchangeableListCode>IC0010-003-016</InterchangeableListCode>
    <ProductName>ROMEP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036244</DrugIDPK>
    <LicenceNumber>PA1050/015/003</LicenceNumber>
    <InterchangeableListCode>IC0010-004-016</InterchangeableListCode>
    <ProductName>ROMEP</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037302</DrugIDPK>
    <LicenceNumber>PA1050/018/001</LicenceNumber>
    <InterchangeableListCode>IC0038-004-003</InterchangeableListCode>
    <ProductName>VALSARTAN AUROBINDO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037303</DrugIDPK>
    <LicenceNumber>PA1050/018/002</LicenceNumber>
    <InterchangeableListCode>IC0038-005-003</InterchangeableListCode>
    <ProductName>VALSARTAN AUROBINDO</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037304</DrugIDPK>
    <LicenceNumber>PA1050/018/003</LicenceNumber>
    <InterchangeableListCode>IC0038-082-003</InterchangeableListCode>
    <ProductName>VALSARTAN AUROBINDO</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037305</DrugIDPK>
    <LicenceNumber>PA1050/018/004</LicenceNumber>
    <InterchangeableListCode>IC0038-083-003</InterchangeableListCode>
    <ProductName>VALSARTAN AUROBINDO</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036658</DrugIDPK>
    <LicenceNumber>PA1050/016/004</LicenceNumber>
    <InterchangeableListCode>IC0040-079-003</InterchangeableListCode>
    <ProductName>VALSARTAN/HYDROCHLOROTHIAZIDE AUROBINDO</ProductName>
    <Strength>320/12.5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2013-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036659</DrugIDPK>
    <LicenceNumber>PA1050/016/005</LicenceNumber>
    <InterchangeableListCode>IC0040-080-003</InterchangeableListCode>
    <ProductName>VALSARTAN/HYDROCHLOROTHIAZIDE AUROBINDO</ProductName>
    <Strength>320/25</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2013-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039949</DrugIDPK>
    <LicenceNumber>PA0126/254/001</LicenceNumber>
    <ProductName>CARMEN</ProductName>
    <Strength>0.03/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYL ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039948</DrugIDPK>
    <LicenceNumber>PA0126/253/001</LicenceNumber>
    <ProductName>CARMENELLE</ProductName>
    <Strength>0.02/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032483</DrugIDPK>
    <LicenceNumber>PPA1562/021/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032484</DrugIDPK>
    <LicenceNumber>PPA1562/021/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015514</DrugIDPK>
    <LicenceNumber>PA0822/009/001</LicenceNumber>
    <ProductName>ANUGESIC HC CREAM</ProductName>
    <Strength>0</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BISMUTH OXIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>BALSAM PERU</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028241</DrugIDPK>
    <LicenceNumber>DPR1463/020/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028242</DrugIDPK>
    <LicenceNumber>DPR1463/020/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031385</DrugIDPK>
    <LicenceNumber>DPR1463/020/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044649</DrugIDPK>
    <LicenceNumber>PPA1562/158/001</LicenceNumber>
    <ProductName>AVELOX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040403</DrugIDPK>
    <LicenceNumber>DPR1463/043/001</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <Strength>1 000 000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2013-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN MESILATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038036</DrugIDPK>
    <LicenceNumber>PPA1463/065/001</LicenceNumber>
    <InterchangeableListCode>IC0041-012-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038037</DrugIDPK>
    <LicenceNumber>PPA1463/065/002</LicenceNumber>
    <InterchangeableListCode>IC0041-013-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038038</DrugIDPK>
    <LicenceNumber>PPA1463/065/003</LicenceNumber>
    <InterchangeableListCode>IC0041-016-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038039</DrugIDPK>
    <LicenceNumber>PPA1463/065/004</LicenceNumber>
    <InterchangeableListCode>IC0041-017-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029942</DrugIDPK>
    <LicenceNumber>PPA1463/024/001</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029943</DrugIDPK>
    <LicenceNumber>PPA1463/024/002</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038133</DrugIDPK>
    <LicenceNumber>PPA1463/039/002</LicenceNumber>
    <InterchangeableListCode>IC0039-015-003</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE PLUS</ProductName>
    <Strength>10/2.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039245</DrugIDPK>
    <LicenceNumber>PPA1463/078/001</LicenceNumber>
    <InterchangeableListCode>IC0025-006-032</InterchangeableListCode>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2013-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTARE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033077</DrugIDPK>
    <LicenceNumber>PPA1463/040/001</LicenceNumber>
    <InterchangeableListCode>IC0025-008-032</InterchangeableListCode>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029804</DrugIDPK>
    <LicenceNumber>PPA1463/022/001</LicenceNumber>
    <ProductName>DOVOBET OINTMENT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029655</DrugIDPK>
    <LicenceNumber>PPA1463/020/001</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029897</DrugIDPK>
    <LicenceNumber>PPA1463/010/001</LicenceNumber>
    <InterchangeableListCode>IC0045-001-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036452</DrugIDPK>
    <LicenceNumber>PPA1463/052/001</LicenceNumber>
    <InterchangeableListCode>IC0077-133-014</InterchangeableListCode>
    <ProductName>IXPRIM</ProductName>
    <Strength>37.5/325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031459</DrugIDPK>
    <LicenceNumber>PPA1463/026/001</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031460</DrugIDPK>
    <LicenceNumber>PPA1463/026/002</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038324</DrugIDPK>
    <LicenceNumber>PPA1463/073/001</LicenceNumber>
    <ProductName>NORIDAY</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028327</DrugIDPK>
    <LicenceNumber>PPA1463/008/001</LicenceNumber>
    <InterchangeableListCode>IC0013-003-005</InterchangeableListCode>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028328</DrugIDPK>
    <LicenceNumber>PPA1463/008/002</LicenceNumber>
    <InterchangeableListCode>IC0013-004-005</InterchangeableListCode>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037538</DrugIDPK>
    <LicenceNumber>PPA1463/061/001</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038082</DrugIDPK>
    <LicenceNumber>PPA1463/048/002</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038259</DrugIDPK>
    <LicenceNumber>PPA1463/048/003</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036199</DrugIDPK>
    <LicenceNumber>PPA1463/048/001</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029526</DrugIDPK>
    <LicenceNumber>PPA1463/016/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032221</DrugIDPK>
    <LicenceNumber>PPA1463/016/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HCI</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995046652</DrugIDPK>
    <LicenceNumber>PA1809/024/001</LicenceNumber>
    <ProductName>BIVALIRUDIN CIPLA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2016-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BIVALIRUDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2017-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030520</DrugIDPK>
    <LicenceNumber>EU/1/09/561/001-9</LicenceNumber>
    <InterchangeableListCode>IC0005-028-003</InterchangeableListCode>
    <ProductName>CLOPIDOGREL TEVA PHARMA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HCS bvba</PAHolder>
    <AuthorisedDate>2009-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038711</DrugIDPK>
    <LicenceNumber>PA1390/058/001</LicenceNumber>
    <InterchangeableListCode>IC0010-003-016</InterchangeableListCode>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038712</DrugIDPK>
    <LicenceNumber>PA1390/058/002</LicenceNumber>
    <InterchangeableListCode>IC0010-004-016</InterchangeableListCode>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030950</DrugIDPK>
    <LicenceNumber>EU/1/09/512/002</LicenceNumber>
    <ProductName>REMOVAB</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Fresenius Biotech GmbH</PAHolder>
    <AuthorisedDate>2009-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CATUMAXOMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2017-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027181</DrugIDPK>
    <LicenceNumber>EU/1/09/512/001</LicenceNumber>
    <ProductName>REMOVAB</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Fresenius Biotech GmbH</PAHolder>
    <AuthorisedDate>2009-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CATUMAXOMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2017-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009597</DrugIDPK>
    <LicenceNumber>PA0577/038/001</LicenceNumber>
    <ProductName>EMCOLOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2001-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015507</DrugIDPK>
    <LicenceNumber>PA1075/001/001</LicenceNumber>
    <ProductName>MEDICAL OXYGEN</ProductName>
    <Strength>Min 99.5</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Air Products Ireland Limited</PAHolder>
    <AuthorisedDate>2004-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Gas</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYGEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036067</DrugIDPK>
    <LicenceNumber>PA1050/013/001</LicenceNumber>
    <InterchangeableListCode>IC0014-002-014</InterchangeableListCode>
    <ProductName>PRAVASTATIN SODIUM AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036068</DrugIDPK>
    <LicenceNumber>PA1050/013/002</LicenceNumber>
    <InterchangeableListCode>IC0014-003-014</InterchangeableListCode>
    <ProductName>PRAVASTATIN SODIUM AUROBINDO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036069</DrugIDPK>
    <LicenceNumber>PA1050/013/003</LicenceNumber>
    <InterchangeableListCode>IC0014-004-014</InterchangeableListCode>
    <ProductName>PRAVASTATIN SODIUM AUROBINDO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043015</DrugIDPK>
    <LicenceNumber>PA1050/027/001</LicenceNumber>
    <ProductName>PREGABALIN MILPHARM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREGABALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043016</DrugIDPK>
    <LicenceNumber>PA1050/027/002</LicenceNumber>
    <ProductName>PREGABALIN MILPHARM</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREGABALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043017</DrugIDPK>
    <LicenceNumber>PA1050/027/003</LicenceNumber>
    <ProductName>PREGABALIN MILPHARM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREGABALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043018</DrugIDPK>
    <LicenceNumber>PA1050/027/004</LicenceNumber>
    <ProductName>PREGABALIN MILPHARM</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREGABALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043019</DrugIDPK>
    <LicenceNumber>PA1050/027/005</LicenceNumber>
    <ProductName>PREGABALIN MILPHARM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREGABALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043020</DrugIDPK>
    <LicenceNumber>PA1050/027/006</LicenceNumber>
    <ProductName>PREGABALIN MILPHARM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREGABALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029212</DrugIDPK>
    <LicenceNumber>PA1445/009/001</LicenceNumber>
    <ProductName>RAMIPRIL AUROBINDO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029213</DrugIDPK>
    <LicenceNumber>PA1445/009/002</LicenceNumber>
    <ProductName>RAMIPRIL AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035960</DrugIDPK>
    <LicenceNumber>PA1050/012/001</LicenceNumber>
    <InterchangeableListCode>IC0006-001-003</InterchangeableListCode>
    <ProductName>ROSUVASTATIN AUROBINDO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035961</DrugIDPK>
    <LicenceNumber>PA1050/012/002</LicenceNumber>
    <InterchangeableListCode>IC0006-002-003</InterchangeableListCode>
    <ProductName>ROSUVASTATIN AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035963</DrugIDPK>
    <LicenceNumber>PA1050/012/003</LicenceNumber>
    <InterchangeableListCode>IC0006-003-003</InterchangeableListCode>
    <ProductName>ROSUVASTATIN AUROBINDO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044123</DrugIDPK>
    <LicenceNumber>PA2007/001/001</LicenceNumber>
    <ProductName>BETAHECON</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BGP Products Ltd</PAHolder>
    <AuthorisedDate>2015-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044124</DrugIDPK>
    <LicenceNumber>PA2007/001/002</LicenceNumber>
    <ProductName>BETAHECON</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BGP Products Ltd</PAHolder>
    <AuthorisedDate>2015-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044121</DrugIDPK>
    <LicenceNumber>PA2007/009/001</LicenceNumber>
    <ProductName>FEMUREST-CONTI</ProductName>
    <Strength>1/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BGP Products Ltd</PAHolder>
    <AuthorisedDate>2015-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>DYDROGESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044091</DrugIDPK>
    <LicenceNumber>PA0167/088/002</LicenceNumber>
    <ProductName>EXTRANEAL CLEAR-FLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2015-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICODEXTRIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM (S)-LACTATE SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015365</DrugIDPK>
    <LicenceNumber>PA0167/086/009</LicenceNumber>
    <ProductName>NUTRINEAL PD4 1.1% AMINO ACIDS CLEAR-FLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003854</DrugIDPK>
    <LicenceNumber>PA0126/031/001</LicenceNumber>
    <ProductName>CLONAMOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1984-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003855</DrugIDPK>
    <LicenceNumber>PA0126/031/002</LicenceNumber>
    <ProductName>CLONAMOX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1984-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003857</DrugIDPK>
    <LicenceNumber>PA0126/031/003</LicenceNumber>
    <ProductName>CLONAMOX</ProductName>
    <Strength>125mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003858</DrugIDPK>
    <LicenceNumber>PA0126/031/004</LicenceNumber>
    <ProductName>CLONAMOX</ProductName>
    <Strength>250 mg/5 ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035251</DrugIDPK>
    <LicenceNumber>PPA1562/051/001</LicenceNumber>
    <InterchangeableListCode>IC0087-062-051</InterchangeableListCode>
    <ProductName>ZANTAC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>MG</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035267</DrugIDPK>
    <LicenceNumber>PPA1562/051/002</LicenceNumber>
    <InterchangeableListCode>IC0087-029-051</InterchangeableListCode>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>MG</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030444</DrugIDPK>
    <LicenceNumber>PA0577/099/003</LicenceNumber>
    <ProductName>ARIPIL OROTAB</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030445</DrugIDPK>
    <LicenceNumber>PA0577/099/004</LicenceNumber>
    <ProductName>ARIPIL OROTAB</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038319</DrugIDPK>
    <LicenceNumber>PA1380/137/001</LicenceNumber>
    <ProductName>BENIFEMA</ProductName>
    <Strength>150/30</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2013-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035446</DrugIDPK>
    <LicenceNumber>PA0577/154/001</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035447</DrugIDPK>
    <LicenceNumber>PA0577/154/002</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020135</DrugIDPK>
    <LicenceNumber>PA0749/012/001</LicenceNumber>
    <ProductName>CEFOTAXIME</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020136</DrugIDPK>
    <LicenceNumber>PA0749/012/002</LicenceNumber>
    <ProductName>CEFOTAXIME</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043719</DrugIDPK>
    <LicenceNumber>PA0405/071/001</LicenceNumber>
    <ProductName>CELECOXIB</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043720</DrugIDPK>
    <LicenceNumber>PA0405/071/002</LicenceNumber>
    <ProductName>CELECOXIB</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037122</DrugIDPK>
    <LicenceNumber>PA1352/019/002</LicenceNumber>
    <ProductName>CLOBAVATE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBETASONE BUTYRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038318</DrugIDPK>
    <LicenceNumber>PA1380/136/001</LicenceNumber>
    <ProductName>DESOGESTREL/ETHINYLESTRADIOL ACTAVIS</ProductName>
    <Strength>150/20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2014-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOGESTREL MICRONIZED</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL MICRONIZED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009598</DrugIDPK>
    <LicenceNumber>PA0577/038/002</LicenceNumber>
    <ProductName>EMCOLOL 10 MG</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2001-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043854</DrugIDPK>
    <LicenceNumber>PA0405/086/001</LicenceNumber>
    <ProductName>EPTIFIBATIDE STRIDES</ProductName>
    <Strength>0.75</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPTIFIBATIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043855</DrugIDPK>
    <LicenceNumber>PA0405/086/002</LicenceNumber>
    <ProductName>EPTIFIBATIDE STRIDES</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPTIFIBATIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005554</DrugIDPK>
    <LicenceNumber>PA0282/041/001</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005555</DrugIDPK>
    <LicenceNumber>PA0282/041/002</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021061</DrugIDPK>
    <LicenceNumber>PA0937/006/001</LicenceNumber>
    <ProductName>FLUDARABINE PHOSPHATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2007-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDARABINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042142</DrugIDPK>
    <LicenceNumber>PA1380/162/001</LicenceNumber>
    <ProductName>FLYNISE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2015-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006044</DrugIDPK>
    <LicenceNumber>PA0405/016/001</LicenceNumber>
    <ProductName>GERICARB</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006045</DrugIDPK>
    <LicenceNumber>PA0405/016/002</LicenceNumber>
    <ProductName>GERICARB</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006029</DrugIDPK>
    <LicenceNumber>PA0405/010/001</LicenceNumber>
    <ProductName>GERIFLOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040229</DrugIDPK>
    <LicenceNumber>PA0577/177/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2013-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product is not subject to medical prescription, subject to the following conditions;
Max. Dose 400mg
Max. Daily Dose 1200mg
Max. Pack Size: 50 (200mg), 25 (400mg)</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040230</DrugIDPK>
    <LicenceNumber>PA0577/177/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2013-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product is not subject to medical prescription, subject to the following conditions;
Max. Dose 400mg
Max. Daily Dose 1200mg
Max. Pack Size: 50 (200mg), 25 (400mg)</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022508</DrugIDPK>
    <LicenceNumber>PA0577/093/001</LicenceNumber>
    <ProductName>KLARIGER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020797</DrugIDPK>
    <LicenceNumber>PA0577/077/001</LicenceNumber>
    <ProductName>LAMOT</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020798</DrugIDPK>
    <LicenceNumber>PA0577/077/002</LicenceNumber>
    <ProductName>LAMOT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020799</DrugIDPK>
    <LicenceNumber>PA0577/077/003</LicenceNumber>
    <ProductName>LAMOT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042991</DrugIDPK>
    <LicenceNumber>PA0405/070/001</LicenceNumber>
    <ProductName>LATANOPROST/TIMOLOL</ProductName>
    <Strength>50mcg/ml + 5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041208</DrugIDPK>
    <LicenceNumber>PA0749/206/001</LicenceNumber>
    <ProductName>LEVODOPA/CARBIDOPA/ENTACAPONE TEVA</ProductName>
    <Strength>50/12.5/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041209</DrugIDPK>
    <LicenceNumber>PA0749/206/002</LicenceNumber>
    <ProductName>LEVODOPA/CARBIDOPA/ENTACAPONE TEVA</ProductName>
    <Strength>75/18.75/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041210</DrugIDPK>
    <LicenceNumber>PA0749/206/003</LicenceNumber>
    <ProductName>LEVODOPA/CARBIDOPA/ENTACAPONE TEVA</ProductName>
    <Strength>100/25/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041211</DrugIDPK>
    <LicenceNumber>PA0749/206/004</LicenceNumber>
    <ProductName>LEVODOPA/CARBIDOPA/ENTACAPONE TEVA</ProductName>
    <Strength>125/31.25/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041212</DrugIDPK>
    <LicenceNumber>PA0749/206/005</LicenceNumber>
    <ProductName>LEVODOPA/CARBIDOPA/ENTACAPONE TEVA</ProductName>
    <Strength>150/37.5/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041213</DrugIDPK>
    <LicenceNumber>PA0749/206/006</LicenceNumber>
    <ProductName>LEVODOPA/CARBIDOPA/ENTACAPONE TEVA</ProductName>
    <Strength>175/43.75/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041214</DrugIDPK>
    <LicenceNumber>PA0749/206/007</LicenceNumber>
    <ProductName>LEVODOPA/CARBIDOPA/ENTACAPONE TEVA</ProductName>
    <Strength>200/50/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029430</DrugIDPK>
    <LicenceNumber>PA0405/056/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>250/50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029431</DrugIDPK>
    <LicenceNumber>PA0405/056/002</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>500/100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006058</DrugIDPK>
    <LicenceNumber>PA0405/024/001</LicenceNumber>
    <ProductName>METOP</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006059</DrugIDPK>
    <LicenceNumber>PA0405/024/002</LicenceNumber>
    <ProductName>METOP</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020808</DrugIDPK>
    <LicenceNumber>PA0749/017/001</LicenceNumber>
    <InterchangeableListCode>IC0061-032-015</InterchangeableListCode>
    <ProductName>MIRTAZAPIN TEVA</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020809</DrugIDPK>
    <LicenceNumber>PA0749/017/002</LicenceNumber>
    <InterchangeableListCode>IC0061-033-015</InterchangeableListCode>
    <ProductName>MIRTAZAPIN TEVA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020810</DrugIDPK>
    <LicenceNumber>PA0749/017/003</LicenceNumber>
    <InterchangeableListCode>IC0061-110-015</InterchangeableListCode>
    <ProductName>MIRTAZAPIN TEVA</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037806</DrugIDPK>
    <LicenceNumber>PA0405/061/001</LicenceNumber>
    <ProductName>MYLAFENT</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037807</DrugIDPK>
    <LicenceNumber>PA0405/061/005</LicenceNumber>
    <ProductName>MYLAFENT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037808</DrugIDPK>
    <LicenceNumber>PA0405/061/004</LicenceNumber>
    <ProductName>MYLAFENT</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037809</DrugIDPK>
    <LicenceNumber>PA0405/061/003</LicenceNumber>
    <ProductName>MYLAFENT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037810</DrugIDPK>
    <LicenceNumber>PA0405/061/002</LicenceNumber>
    <ProductName>MYLAFENT</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037773</DrugIDPK>
    <LicenceNumber>PA0577/166/001</LicenceNumber>
    <InterchangeableListCode>IC0007-001-038</InterchangeableListCode>
    <ProductName>OLANZAPINE MYLAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037774</DrugIDPK>
    <LicenceNumber>PA0577/166/002</LicenceNumber>
    <InterchangeableListCode>IC0007-002-038</InterchangeableListCode>
    <ProductName>OLANZAPINE MYLAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037775</DrugIDPK>
    <LicenceNumber>PA0577/166/003</LicenceNumber>
    <InterchangeableListCode>IC0007-032-038</InterchangeableListCode>
    <ProductName>OLANZAPINE MYLAN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037776</DrugIDPK>
    <LicenceNumber>PA0577/166/004</LicenceNumber>
    <InterchangeableListCode>IC0007-003-038</InterchangeableListCode>
    <ProductName>OLANZAPINE MYLAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040517</DrugIDPK>
    <LicenceNumber>PA0577/175/001</LicenceNumber>
    <ProductName>OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>20mg/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2014-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040518</DrugIDPK>
    <LicenceNumber>PA0577/175/002</LicenceNumber>
    <ProductName>OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>20mg/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2014-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040519</DrugIDPK>
    <LicenceNumber>PA0577/175/003</LicenceNumber>
    <ProductName>OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>40mg/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2014-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040520</DrugIDPK>
    <LicenceNumber>PA0577/175/004</LicenceNumber>
    <ProductName>OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>40mg/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2014-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033251</DrugIDPK>
    <LicenceNumber>PA1380/095/001</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043843</DrugIDPK>
    <LicenceNumber>PA0405/078/001</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see summary of product characteristics)</SupplyComments>
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042950</DrugIDPK>
    <LicenceNumber>PA1986/001/007</LicenceNumber>
    <ProductName>PREGABALIN TEVA</ProductName>
    <Strength>225</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>2015-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREGABALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042013</DrugIDPK>
    <LicenceNumber>PA0577/179/001</LicenceNumber>
    <ProductName>RABEPRAZOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2014-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042014</DrugIDPK>
    <LicenceNumber>PA0577/179/002</LicenceNumber>
    <ProductName>RABEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2014-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036509</DrugIDPK>
    <LicenceNumber>PA0577/158/001</LicenceNumber>
    <ProductName>RABEPRAZOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036510</DrugIDPK>
    <LicenceNumber>PA0577/158/002</LicenceNumber>
    <ProductName>RABEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039135</DrugIDPK>
    <LicenceNumber>PA0577/170/001</LicenceNumber>
    <ProductName>TELMISARTAN/HYDROCHLOROTHIAZIDE MYLAN</ProductName>
    <Strength>40/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2015-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039136</DrugIDPK>
    <LicenceNumber>PA0577/170/002</LicenceNumber>
    <ProductName>TELMISARTAN/HYDROCHLOROTHIAZIDE MYLAN</ProductName>
    <Strength>80/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2015-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039137</DrugIDPK>
    <LicenceNumber>PA0577/170/003</LicenceNumber>
    <ProductName>TELMISARTAN/HYDROCHLOROTHIAZIDE MYLAN</ProductName>
    <Strength>80/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2015-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020478</DrugIDPK>
    <LicenceNumber>PA0937/005/001</LicenceNumber>
    <ProductName>VORINA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2006-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045922</DrugIDPK>
    <LicenceNumber>PA1186/018/015</LicenceNumber>
    <ProductName>NIQUITIN MINIS CHERRY FLAVOUR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chefaro Ireland DAC</PAHolder>
    <AuthorisedDate>2015-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045926</DrugIDPK>
    <LicenceNumber>PA1186/018/014</LicenceNumber>
    <ProductName>NIQUITIN MINIS CHERRY FLAVOUR</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chefaro Ireland DAC</PAHolder>
    <AuthorisedDate>2015-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038826</DrugIDPK>
    <LicenceNumber>PA0126/250/001</LicenceNumber>
    <ProductName>EXIMINE XL</ProductName>
    <Strength>4.6</Strength>
    <StrengthMeasurement>Mg/day</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038827</DrugIDPK>
    <LicenceNumber>PA0126/250/002</LicenceNumber>
    <ProductName>EXIMINE XL</ProductName>
    <Strength>9.5</Strength>
    <StrengthMeasurement>Mg/day</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008593</DrugIDPK>
    <LicenceNumber>PA0126/063/002</LicenceNumber>
    <ProductName>FLUCLON</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003906</DrugIDPK>
    <LicenceNumber>PA0126/063/001</LicenceNumber>
    <ProductName>FLUCLON</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037759</DrugIDPK>
    <LicenceNumber>PA1050/021/001</LicenceNumber>
    <ProductName>CEFUROXIME AUROBINDO</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037760</DrugIDPK>
    <LicenceNumber>PA1050/021/002</LicenceNumber>
    <ProductName>CEFUROXIME AUROBINDO</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037761</DrugIDPK>
    <LicenceNumber>PA1050/021/003</LicenceNumber>
    <ProductName>CEFUROXIME AUROBINDO</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041968</DrugIDPK>
    <LicenceNumber>PA1286/047/004</LicenceNumber>
    <ProductName>ZISPIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2014-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033234</DrugIDPK>
    <LicenceNumber>PA0964/007/003</LicenceNumber>
    <ProductName>ZISPIN</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044062</DrugIDPK>
    <LicenceNumber>PA0763/002/001</LicenceNumber>
    <ProductName>OPTIVATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bio Products Laboratory Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044063</DrugIDPK>
    <LicenceNumber>PA0763/002/002</LicenceNumber>
    <ProductName>OPTIVATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bio Products Laboratory Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044064</DrugIDPK>
    <LicenceNumber>PA0763/002/003</LicenceNumber>
    <ProductName>OPTIVATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bio Products Laboratory Limited</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042351</DrugIDPK>
    <LicenceNumber>PPA1562/118/001</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042352</DrugIDPK>
    <LicenceNumber>PPA1562/118/002</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042353</DrugIDPK>
    <LicenceNumber>PPA1562/118/003</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042354</DrugIDPK>
    <LicenceNumber>PPA1562/118/004</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039857</DrugIDPK>
    <LicenceNumber>PA1286/044/001</LicenceNumber>
    <ProductName>FINASTERIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2014-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034365</DrugIDPK>
    <LicenceNumber>EU/1/06/373/001-008</LicenceNumber>
    <InterchangeableListCode>IC0042-087-003</InterchangeableListCode>
    <ProductName>IMPRIDA</ProductName>
    <Strength>5/80</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034366</DrugIDPK>
    <LicenceNumber>EU/1/06/373/009-016</LicenceNumber>
    <InterchangeableListCode>IC0042-086-003</InterchangeableListCode>
    <ProductName>IMPRIDA</ProductName>
    <Strength>5/160</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034367</DrugIDPK>
    <LicenceNumber>EU/1/06/373/017-024</LicenceNumber>
    <InterchangeableListCode>IC0042-084-003</InterchangeableListCode>
    <ProductName>IMPRIDA</ProductName>
    <Strength>10/160</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033556</DrugIDPK>
    <LicenceNumber>PA0749/135/001</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033557</DrugIDPK>
    <LicenceNumber>PA0749/135/002</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040798</DrugIDPK>
    <LicenceNumber>PA1809/007/001</LicenceNumber>
    <ProductName>MOMETASONE FUROATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039706</DrugIDPK>
    <LicenceNumber>PPA1633/031/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>ARIMIDEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2013-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037448</DrugIDPK>
    <LicenceNumber>PPA1633/019/001</LicenceNumber>
    <ProductName>ASASANTIN RETARD</ProductName>
    <Strength>200/25</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2012-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036931</DrugIDPK>
    <LicenceNumber>PPA1633/017/001</LicenceNumber>
    <InterchangeableListCode>IC0037-076-034</InterchangeableListCode>
    <ProductName>AUGMENTIN DUO</ProductName>
    <Strength>400/57</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2012-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032561</DrugIDPK>
    <LicenceNumber>PPA1633/012/001</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032562</DrugIDPK>
    <LicenceNumber>PPA1633/012/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032559</DrugIDPK>
    <LicenceNumber>PPA1633/013/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032560</DrugIDPK>
    <LicenceNumber>PPA1633/013/002</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032378</DrugIDPK>
    <LicenceNumber>PPA1633/005/001</LicenceNumber>
    <InterchangeableListCode>IC0006-002-003</InterchangeableListCode>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032379</DrugIDPK>
    <LicenceNumber>PPA1633/005/002</LicenceNumber>
    <InterchangeableListCode>IC0006-003-003</InterchangeableListCode>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032380</DrugIDPK>
    <LicenceNumber>PPA1633/005/003</LicenceNumber>
    <InterchangeableListCode>IC0006-004-003</InterchangeableListCode>
    <ProductName>CRESTOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030560</DrugIDPK>
    <LicenceNumber>PA1339/006/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030561</DrugIDPK>
    <LicenceNumber>PA1339/006/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030860</DrugIDPK>
    <LicenceNumber>PA1339/006/004</LicenceNumber>
    <ProductName>DIAZEPAM RECTUBES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030861</DrugIDPK>
    <LicenceNumber>PA1339/006/005</LicenceNumber>
    <ProductName>DIAZEPAM RECTUBES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030862</DrugIDPK>
    <LicenceNumber>PA1339/006/003</LicenceNumber>
    <ProductName>DIAZEPAM RECTUBES</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032373</DrugIDPK>
    <LicenceNumber>PPA1633/003/001</LicenceNumber>
    <ProductName>DOVOBET</ProductName>
    <Strength>50mcg/g/0.5mg/g</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL HYDRATE</ActiveSubstance>
      <ActiveSubstance>BETAMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035148</DrugIDPK>
    <LicenceNumber>PPA1633/014/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035149</DrugIDPK>
    <LicenceNumber>PPA1633/014/002</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032416</DrugIDPK>
    <LicenceNumber>PPA1633/006/001</LicenceNumber>
    <InterchangeableListCode>IC0001-002-003</InterchangeableListCode>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032417</DrugIDPK>
    <LicenceNumber>PPA1633/006/002</LicenceNumber>
    <InterchangeableListCode>IC0001-003-003</InterchangeableListCode>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032418</DrugIDPK>
    <LicenceNumber>PPA1633/006/003</LicenceNumber>
    <InterchangeableListCode>IC0001-004-003</InterchangeableListCode>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032419</DrugIDPK>
    <LicenceNumber>PPA1633/006/004</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042628</DrugIDPK>
    <LicenceNumber>PPA1633/038/001</LicenceNumber>
    <ProductName>MALARONE</ProductName>
    <Strength>250/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOVAQUONE</ActiveSubstance>
      <ActiveSubstance>PROGUANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037971</DrugIDPK>
    <LicenceNumber>PPA1633/021/001</LicenceNumber>
    <InterchangeableListCode>IC0024-066-024</InterchangeableListCode>
    <ProductName>OMNEXEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042629</DrugIDPK>
    <LicenceNumber>PPA1633/039/001</LicenceNumber>
    <ProductName>SAFLUTAN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAFLUPROST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038086</DrugIDPK>
    <LicenceNumber>PPA1633/024/002</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038084</DrugIDPK>
    <LicenceNumber>PPA1633/024/001</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038085</DrugIDPK>
    <LicenceNumber>PPA1633/024/003</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032446</DrugIDPK>
    <LicenceNumber>PPA1633/009/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032438</DrugIDPK>
    <LicenceNumber>PPA1633/008/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032439</DrugIDPK>
    <LicenceNumber>PPA1633/008/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041639</DrugIDPK>
    <LicenceNumber>EU/1/15/1022/001</LicenceNumber>
    <ProductName>UNITUXIN</ProductName>
    <Strength>3.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>United Therapeutics Europe Ltd</PAHolder>
    <AuthorisedDate>2015-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DINUTUXIMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2017-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034458</DrugIDPK>
    <LicenceNumber>PA0408/086/001</LicenceNumber>
    <ProductName>MEROPENEM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEROPENEM TRIHYDRATE (STERILE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034459</DrugIDPK>
    <LicenceNumber>PA0408/086/002</LicenceNumber>
    <ProductName>MEROPENEM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEROPENEM TRIHYDRATE (STERILE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034538</DrugIDPK>
    <LicenceNumber>PA1450/001/001</LicenceNumber>
    <ProductName>ARKOVOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratoires ARKOPHARMA</PAHolder>
    <AuthorisedDate>2014-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IVY LEAF DRY EXTRACT (HEDERA HELIX L.) (4-6:1) EXTRACTION SOLVENT: ETHANOL 30% V/V</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034689</DrugIDPK>
    <LicenceNumber>PA2077/001/001</LicenceNumber>
    <ProductName>PREFLUCEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Nanotherapeutics Bohumil S.R.O</PAHolder>
    <AuthorisedDate>2016-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/07/2009 (H1N1)</ActiveSubstance>
      <ActiveSubstance>A/VICTORIA/361/2011 (A/H3N2)</ActiveSubstance>
      <ActiveSubstance>B/HUBEI-WUJIAGANG/158/2009 (B)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043811</DrugIDPK>
    <LicenceNumber>PA1240/013/001</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Laboratories Limited</PAHolder>
    <AuthorisedDate>2016-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043812</DrugIDPK>
    <LicenceNumber>PA1240/013/002</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Laboratories Limited</PAHolder>
    <AuthorisedDate>2016-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036794</DrugIDPK>
    <LicenceNumber>PA1462/009/001</LicenceNumber>
    <ProductName>TROSPIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2012-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROSPIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021626</DrugIDPK>
    <LicenceNumber>PPA1328/018/001</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035099</DrugIDPK>
    <LicenceNumber>PPA1328/146/001</LicenceNumber>
    <ProductName>CASODEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032514</DrugIDPK>
    <LicenceNumber>PPA1328/135/002</LicenceNumber>
    <InterchangeableListCode>IC0065-002-014</InterchangeableListCode>
    <ProductName>EMCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038116</DrugIDPK>
    <LicenceNumber>PA1809/001/001</LicenceNumber>
    <ProductName>IPRAGARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034582</DrugIDPK>
    <LicenceNumber>PPA1328/142/001</LicenceNumber>
    <ProductName>SPIRIVA</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028374</DrugIDPK>
    <LicenceNumber>PA0568/002/007</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2010-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003920</DrugIDPK>
    <LicenceNumber>PA0118/026/001</LicenceNumber>
    <ProductName>FLUORETS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUORESCEIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038206</DrugIDPK>
    <LicenceNumber>PA0568/024/001</LicenceNumber>
    <ProductName>COVERDINE</ProductName>
    <Strength>2.5/0.625/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2014-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037378</DrugIDPK>
    <LicenceNumber>PA1774/001/001</LicenceNumber>
    <ProductName>DACEPTON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>EVER Neuro Pharma GmbH</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005841</DrugIDPK>
    <LicenceNumber>PA0590/010/003</LicenceNumber>
    <ProductName>ROZEX</ProductName>
    <Strength>0.75</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030839</DrugIDPK>
    <LicenceNumber>PA0577/121/001</LicenceNumber>
    <ProductName>CANDESARTAN/HYDROCHLOROTHIAZIDE MYLAN</ProductName>
    <Strength>16/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020495</DrugIDPK>
    <LicenceNumber>PA0823/049/005</LicenceNumber>
    <ProductName>NICORETTE MINT 2MG MEDICATED CHEWING-GUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020494</DrugIDPK>
    <LicenceNumber>PA0823/049/006</LicenceNumber>
    <ProductName>NICORETTE MINT 4MG MEDICATED CHEWING-GUM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003939</DrugIDPK>
    <LicenceNumber>PA0290/073/001</LicenceNumber>
    <ProductName>VEXOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1997-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIMEXOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005087</DrugIDPK>
    <LicenceNumber>PA0013/045/004</LicenceNumber>
    <ProductName>LAMISIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005088</DrugIDPK>
    <LicenceNumber>PA0013/045/005</LicenceNumber>
    <ProductName>LAMISIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006711</DrugIDPK>
    <LicenceNumber>PA0013/045/006</LicenceNumber>
    <ProductName>LAMISIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030585</DrugIDPK>
    <LicenceNumber>EU/1/09/532/1-7</LicenceNumber>
    <InterchangeableListCode>IC0005-028-003</InterchangeableListCode>
    <ProductName>CLOPIDOGREL ACINO</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Luye Pharma AG</PAHolder>
    <AuthorisedDate>2009-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031463</DrugIDPK>
    <LicenceNumber>PA0749/031/005</LicenceNumber>
    <ProductName>CIPROFLOXACIN TEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042000</DrugIDPK>
    <LicenceNumber>EU/1/14/949/001</LicenceNumber>
    <ProductName>VYLAER SPIROMAX</ProductName>
    <Strength>160/4.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042001</DrugIDPK>
    <LicenceNumber>EU/1/14/949/002</LicenceNumber>
    <ProductName>VYLAER SPIROMAX</ProductName>
    <Strength>320/9</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029613</DrugIDPK>
    <LicenceNumber>PPA1328/095/003</LicenceNumber>
    <ProductName>HYTRIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038773</DrugIDPK>
    <LicenceNumber>PPA1328/200/001</LicenceNumber>
    <ProductName>ZINERYT</ProductName>
    <Strength>40/12</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Cut Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
      <ActiveSubstance>ZINC ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2017-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022925</DrugIDPK>
    <LicenceNumber>PPA0465/198/001</LicenceNumber>
    <ProductName>ACCOLATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZAFIRLUKAST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043449</DrugIDPK>
    <LicenceNumber>PPA0565/051/001</LicenceNumber>
    <InterchangeableListCode>IC0001-002-003</InterchangeableListCode>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043450</DrugIDPK>
    <LicenceNumber>PPA0565/051/004</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043451</DrugIDPK>
    <LicenceNumber>PPA0565/051/003</LicenceNumber>
    <InterchangeableListCode>IC0001-004-003</InterchangeableListCode>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043452</DrugIDPK>
    <LicenceNumber>PPA0565/051/002</LicenceNumber>
    <InterchangeableListCode>IC0001-003-003</InterchangeableListCode>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036230</DrugIDPK>
    <LicenceNumber>PPA0465/284/001</LicenceNumber>
    <InterchangeableListCode>IC0037-076-034</InterchangeableListCode>
    <ProductName>AUGMENTIN-DUO</ProductName>
    <Strength>400/57</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID (IN THE FORM OF POTASSIUM CLAVULANATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044646</DrugIDPK>
    <LicenceNumber>PPA0465/411/001</LicenceNumber>
    <ProductName>BENYLIN FOUR FLU</ProductName>
    <Strength>500, 12.5 &amp; 22.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2015-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 24 units per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be supplied in the course of any one retail transaction unless a valid prescription exists.</SupplyComments>
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012273</DrugIDPK>
    <LicenceNumber>PPA0465/002/001</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012278</DrugIDPK>
    <LicenceNumber>PPA0465/002/002</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015615</DrugIDPK>
    <LicenceNumber>PPA0465/095/001</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017691</DrugIDPK>
    <LicenceNumber>PPA0465/095/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034026</DrugIDPK>
    <LicenceNumber>PPA0565/031/001</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045705</DrugIDPK>
    <LicenceNumber>PPA0465/417/001</LicenceNumber>
    <ProductName>CONCERTA XL</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2015-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPHENIDATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988) as amended</SupplyComments>
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045706</DrugIDPK>
    <LicenceNumber>PPA0465/417/002</LicenceNumber>
    <ProductName>CONCERTA XL</ProductName>
    <Strength>36</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2015-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPHENIDATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988) as amended</SupplyComments>
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037521</DrugIDPK>
    <LicenceNumber>PA1077/120/002</LicenceNumber>
    <ProductName>DUAC ONCE DAILY</ProductName>
    <Strength>10 + 30</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2013-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE HYDROUS</ActiveSubstance>
      <ActiveSubstance>CLINDAMYCIN PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044357</DrugIDPK>
    <LicenceNumber>PPA0565/055/001</LicenceNumber>
    <ProductName>ESCITALPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2015-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044358</DrugIDPK>
    <LicenceNumber>PPA0565/055/002</LicenceNumber>
    <ProductName>ESCITALPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2015-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044359</DrugIDPK>
    <LicenceNumber>PPA0565/055/003</LicenceNumber>
    <ProductName>ESCITALPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2015-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043401</DrugIDPK>
    <LicenceNumber>PPA0565/053/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043402</DrugIDPK>
    <LicenceNumber>PPA0565/053/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034132</DrugIDPK>
    <LicenceNumber>PPA0565/038/001</LicenceNumber>
    <ProductName>FAMVIR</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034133</DrugIDPK>
    <LicenceNumber>PPA0565/038/002</LicenceNumber>
    <ProductName>FAMVIR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018109</DrugIDPK>
    <LicenceNumber>PPA0465/115/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALENDRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035932</DrugIDPK>
    <LicenceNumber>PPA0465/277/001</LicenceNumber>
    <ProductName>KERAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXKETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034027</DrugIDPK>
    <LicenceNumber>PPA0565/033/001</LicenceNumber>
    <InterchangeableListCode>IC0072-130-003</InterchangeableListCode>
    <ProductName>KLARAM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034028</DrugIDPK>
    <LicenceNumber>PPA0565/033/002</LicenceNumber>
    <InterchangeableListCode>IC0072-117-003</InterchangeableListCode>
    <ProductName>KLARAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044788</DrugIDPK>
    <LicenceNumber>PPA0565/057/002</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2015-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044601</DrugIDPK>
    <LicenceNumber>PPA0565/057/001</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2015-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020693</DrugIDPK>
    <LicenceNumber>PPA0465/129/003</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034144</DrugIDPK>
    <LicenceNumber>PPA0565/046/001</LicenceNumber>
    <ProductName>LISINOPRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034145</DrugIDPK>
    <LicenceNumber>PPA0565/046/002</LicenceNumber>
    <ProductName>LISINOPRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008862</DrugIDPK>
    <LicenceNumber>PA0931/003/001</LicenceNumber>
    <ProductName>MACO PHARMA METRONIDAZOLE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Maco Pharma (UK) Ltd</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035587</DrugIDPK>
    <LicenceNumber>PPA0465/272/001</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>For non-prescription, pharmacy-only sale: MS 10 mg; MDD: 30 mg; MPS: 10:  MQP: 100 mg.  Pack sizes containing more than 10 tablets are subject to prescription.</SupplyComments>
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034020</DrugIDPK>
    <LicenceNumber>PPA0565/030/001</LicenceNumber>
    <InterchangeableListCode>IC0037-074-014</InterchangeableListCode>
    <ProductName>MOXICLAV</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID (IN THE FORM OF POTASSIUM CLAVULANATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005565</DrugIDPK>
    <LicenceNumber>PA0748/024/002</LicenceNumber>
    <ProductName>ORAP 4 MG TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIMOZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043531</DrugIDPK>
    <LicenceNumber>PPA0465/403/001</LicenceNumber>
    <InterchangeableListCode>IC0013-003-005</InterchangeableListCode>
    <ProductName>PANTOPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2014-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043532</DrugIDPK>
    <LicenceNumber>PPA0465/403/002</LicenceNumber>
    <InterchangeableListCode>IC0013-004-005</InterchangeableListCode>
    <ProductName>PANTOPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2014-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034035</DrugIDPK>
    <LicenceNumber>PPA0565/034/001</LicenceNumber>
    <InterchangeableListCode>IC0013-003-005</InterchangeableListCode>
    <ProductName>PANTOPRAZOLE TEVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034036</DrugIDPK>
    <LicenceNumber>PPA0565/034/002</LicenceNumber>
    <InterchangeableListCode>IC0013-004-005</InterchangeableListCode>
    <ProductName>PANTOPRAZOLE TEVA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044787</DrugIDPK>
    <LicenceNumber>PPA0465/415/002</LicenceNumber>
    <ProductName>PROVIGIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2015-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MODAFINIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034234</DrugIDPK>
    <LicenceNumber>PPA0565/048/001</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034235</DrugIDPK>
    <LicenceNumber>PPA0565/048/002</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034138</DrugIDPK>
    <LicenceNumber>PPA0565/042/001</LicenceNumber>
    <ProductName>VENLOFEX</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034139</DrugIDPK>
    <LicenceNumber>PPA0565/042/002</LicenceNumber>
    <ProductName>VENLOFEX</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004579</DrugIDPK>
    <LicenceNumber>PA0013/087/003</LicenceNumber>
    <ProductName>VOLTAROL</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024837</DrugIDPK>
    <LicenceNumber>PPA0465/193/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022397</DrugIDPK>
    <LicenceNumber>PPA0465/193/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034137</DrugIDPK>
    <LicenceNumber>PPA0565/044/001</LicenceNumber>
    <ProductName>ZISMIRT OROTAB</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029208</DrugIDPK>
    <LicenceNumber>PA1367/002/001</LicenceNumber>
    <ProductName>KOZYLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029209</DrugIDPK>
    <LicenceNumber>PA1367/002/002</LicenceNumber>
    <ProductName>KOZYLEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029210</DrugIDPK>
    <LicenceNumber>PA1367/002/003</LicenceNumber>
    <ProductName>KOZYLEX</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029211</DrugIDPK>
    <LicenceNumber>PA1367/002/004</LicenceNumber>
    <ProductName>KOZYLEX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035009</DrugIDPK>
    <LicenceNumber>PPA1328/045/003</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021895</DrugIDPK>
    <LicenceNumber>PPA1328/046/001</LicenceNumber>
    <ProductName>ACTIVELLE</ProductName>
    <Strength>1/0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021628</DrugIDPK>
    <LicenceNumber>PPA1328/017/002</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021899</DrugIDPK>
    <LicenceNumber>PPA1328/047/004</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031843</DrugIDPK>
    <LicenceNumber>PPA1328/048/003</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021918</DrugIDPK>
    <LicenceNumber>PPA1328/050/001</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035336</DrugIDPK>
    <LicenceNumber>PPA1328/151/001</LicenceNumber>
    <ProductName>BENETOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035338</DrugIDPK>
    <LicenceNumber>PPA1328/151/002</LicenceNumber>
    <ProductName>BENETOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024926</DrugIDPK>
    <LicenceNumber>PA1217/003/001</LicenceNumber>
    <ProductName>BICALUTAMIDE HIKMA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hikma Farmaceutica (Portugal) SA</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041999</DrugIDPK>
    <LicenceNumber>EU/1/14/948/002</LicenceNumber>
    <ProductName>BIRESP SPIROMAX TEVA</ProductName>
    <Strength>320/9</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041998</DrugIDPK>
    <LicenceNumber>EU/1/14/948/001</LicenceNumber>
    <ProductName>BUDESONIDE/FORMOTEROL TEVA</ProductName>
    <Strength>160/4.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042002</DrugIDPK>
    <LicenceNumber>EU/1/14/950/001</LicenceNumber>
    <ProductName>BUDESONIDE/FORMOTEROL TEVA PHARMA B.V.</ProductName>
    <Strength>160/4.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042003</DrugIDPK>
    <LicenceNumber>EU/1/14/950/002</LicenceNumber>
    <ProductName>BUDESONIDE/FORMOTEROL TEVA PHARMA B.V.</ProductName>
    <Strength>320/9</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038568</DrugIDPK>
    <LicenceNumber>PPA1328/178/001</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>80/12.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042442</DrugIDPK>
    <LicenceNumber>PPA1328/066/002</LicenceNumber>
    <ProductName>DOVOBET</ProductName>
    <Strength>50/0.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2014-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032513</DrugIDPK>
    <LicenceNumber>PPA1328/135/001</LicenceNumber>
    <InterchangeableListCode>IC0065-001-014</InterchangeableListCode>
    <ProductName>EMCOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035702</DrugIDPK>
    <LicenceNumber>PPA1328/158/001</LicenceNumber>
    <ProductName>NOCTAMID</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORMETAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034671</DrugIDPK>
    <LicenceNumber>PA1286/036/001</LicenceNumber>
    <ProductName>DIPROBATH</ProductName>
    <Strength>46/39</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUID PARAFFIN LIGHT</ActiveSubstance>
      <ActiveSubstance>ISOPROPYL MYRISTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034672</DrugIDPK>
    <LicenceNumber>PA1286/029/002</LicenceNumber>
    <ProductName>DIPROSALIC 0.05% W/W +</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034653</DrugIDPK>
    <LicenceNumber>PA1286/027/003</LicenceNumber>
    <ProductName>DIPROSON</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034515</DrugIDPK>
    <LicenceNumber>PA1286/027/002</LicenceNumber>
    <ProductName>DIPROSONE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034516</DrugIDPK>
    <LicenceNumber>PA1286/027/001</LicenceNumber>
    <ProductName>DIPROSONE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034652</DrugIDPK>
    <LicenceNumber>PA1286/026/001</LicenceNumber>
    <ProductName>DROGENIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034700</DrugIDPK>
    <LicenceNumber>PA1050/004/001</LicenceNumber>
    <InterchangeableListCode>IC0007-018-035</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034701</DrugIDPK>
    <LicenceNumber>PA1050/004/002</LicenceNumber>
    <InterchangeableListCode>IC0007-001-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034702</DrugIDPK>
    <LicenceNumber>PA1050/004/003</LicenceNumber>
    <InterchangeableListCode>IC0007-041-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034703</DrugIDPK>
    <LicenceNumber>PA1050/004/004</LicenceNumber>
    <InterchangeableListCode>IC0007-002-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034704</DrugIDPK>
    <LicenceNumber>PA1050/004/005</LicenceNumber>
    <InterchangeableListCode>IC0007-032-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034705</DrugIDPK>
    <LicenceNumber>PA1050/004/006</LicenceNumber>
    <InterchangeableListCode>IC0007-003-038</InterchangeableListCode>
    <ProductName>OLANZAPINE AUROBINDO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020212</DrugIDPK>
    <LicenceNumber>PA0931/007/002</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE &amp; SODIUM CHLORIDE</ProductName>
    <Strength>0.2/0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Maco Pharma (UK) Ltd</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031011</DrugIDPK>
    <LicenceNumber>PA0964/005/001</LicenceNumber>
    <ProductName>PREGNYL 1500 I.U. POWDER AND SOLVENT FOR SOLUTION</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006074</DrugIDPK>
    <LicenceNumber>PA0407/003/001</LicenceNumber>
    <ProductName>AVENA SATIVA COMP.</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMULUS LUPULUS</ActiveSubstance>
      <ActiveSubstance>AVENA SATIVA</ActiveSubstance>
      <ActiveSubstance>PASSIFLORA INCARNATA</ActiveSubstance>
      <ActiveSubstance>VALERIANA OFFICINALIS</ActiveSubstance>
      <ActiveSubstance>COFFEE PREPARED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021900</DrugIDPK>
    <LicenceNumber>PPA1328/048/001</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021902</DrugIDPK>
    <LicenceNumber>PPA1328/052/001</LicenceNumber>
    <ProductName>ATACAND PLUS</ProductName>
    <Strength>16/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035337</DrugIDPK>
    <LicenceNumber>PPA1328/151/003</LicenceNumber>
    <ProductName>BENETOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031674</DrugIDPK>
    <LicenceNumber>PPA1328/127/001</LicenceNumber>
    <ProductName>ELOCON</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032644</DrugIDPK>
    <LicenceNumber>PA1368/007/001</LicenceNumber>
    <ProductName>REFAZ</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032645</DrugIDPK>
    <LicenceNumber>PA1368/007/002</LicenceNumber>
    <ProductName>REFAZ</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021897</DrugIDPK>
    <LicenceNumber>PPA1328/047/002</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034876</DrugIDPK>
    <LicenceNumber>PPA1151/146/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034877</DrugIDPK>
    <LicenceNumber>PPA1151/146/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038839</DrugIDPK>
    <LicenceNumber>PPA1328/203/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031576</DrugIDPK>
    <LicenceNumber>PPA1328/082/002</LicenceNumber>
    <InterchangeableListCode>IC0045-002-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042357</DrugIDPK>
    <LicenceNumber>PPA1328/210/001</LicenceNumber>
    <ProductName>IXPRIM</ProductName>
    <Strength>37.5/325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2014-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040850</DrugIDPK>
    <LicenceNumber>PPA1151/206/001</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040851</DrugIDPK>
    <LicenceNumber>PPA1151/206/002</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040852</DrugIDPK>
    <LicenceNumber>PPA1151/206/003</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040853</DrugIDPK>
    <LicenceNumber>PPA1151/206/004</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021608</DrugIDPK>
    <LicenceNumber>PPA1328/028/001</LicenceNumber>
    <ProductName>NEURONTIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037272</DrugIDPK>
    <LicenceNumber>PPA1328/028/004</LicenceNumber>
    <ProductName>NEURONTIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022859</DrugIDPK>
    <LicenceNumber>PPA1151/033/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029274</DrugIDPK>
    <LicenceNumber>PPA1151/033/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036181</DrugIDPK>
    <LicenceNumber>PA1638/008/001</LicenceNumber>
    <ProductName>PREDSOL RETENTION ENEMA</ProductName>
    <Strength>20mg/100ml</Strength>
    <StrengthMeasurement>Mg/Dose</StrengthMeasurement>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029938</DrugIDPK>
    <LicenceNumber>PPA1328/111/001</LicenceNumber>
    <ProductName>PREMARIN 0.625 MG PROLONGED-RELEASE TABLETS</ProductName>
    <Strength>0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029939</DrugIDPK>
    <LicenceNumber>PPA1328/111/002</LicenceNumber>
    <ProductName>PREMARIN 1.25 MG PROLONGED-RELEASE TABLETS</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031374</DrugIDPK>
    <LicenceNumber>PPA1328/119/001</LicenceNumber>
    <ProductName>PROSCAR 5MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021529</DrugIDPK>
    <LicenceNumber>PPA1151/016/001</LicenceNumber>
    <InterchangeableListCode>IC0013-003-005</InterchangeableListCode>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021530</DrugIDPK>
    <LicenceNumber>PPA1151/016/002</LicenceNumber>
    <InterchangeableListCode>IC0013-004-005</InterchangeableListCode>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039549</DrugIDPK>
    <LicenceNumber>PPA1328/207/001</LicenceNumber>
    <ProductName>REGURIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROSPIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031671</DrugIDPK>
    <LicenceNumber>PPA1328/126/001</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031672</DrugIDPK>
    <LicenceNumber>PPA1328/126/002</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031673</DrugIDPK>
    <LicenceNumber>PPA1328/126/003</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035256</DrugIDPK>
    <LicenceNumber>PPA1328/148/001</LicenceNumber>
    <ProductName>ZOFRAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035257</DrugIDPK>
    <LicenceNumber>PPA1328/148/002</LicenceNumber>
    <ProductName>ZOFRAN</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032743</DrugIDPK>
    <LicenceNumber>PPA1328/136/001</LicenceNumber>
    <ProductName>ZOLADEX</ProductName>
    <Strength>3.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GOSERELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022364</DrugIDPK>
    <LicenceNumber>PPA1151/021/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021526</DrugIDPK>
    <LicenceNumber>PPA1151/015/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039148</DrugIDPK>
    <LicenceNumber>PPA1151/034/004</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024277</DrugIDPK>
    <LicenceNumber>EU/1/09/563/001</LicenceNumber>
    <ProductName>CHONDROCELECT</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>Microlitre</StrengthMeasurement>
    <PAHolder>TiGenix nv</PAHolder>
    <AuthorisedDate>2009-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implantation suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHARACTERIZED AUTOLOGOUS CARTILAGE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015332</DrugIDPK>
    <LicenceNumber>PA0002/075/001</LicenceNumber>
    <ProductName>VIASPAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Organ Preservation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>LACTOBIONIC ACID</ActiveSubstance>
      <ActiveSubstance>POTASSIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE (40%)</ActiveSubstance>
      <ActiveSubstance>ADENOSINE</ActiveSubstance>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>RAFFINOSE</ActiveSubstance>
      <ActiveSubstance>GLUTATHIONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032580</DrugIDPK>
    <LicenceNumber>PA0126/204/001</LicenceNumber>
    <InterchangeableListCode>IC0005-028-003</InterchangeableListCode>
    <ProductName>CLOPIDOGREL CLONMEL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041814</DrugIDPK>
    <LicenceNumber>PA0126/264/001</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041815</DrugIDPK>
    <LicenceNumber>PA0126/264/002</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041816</DrugIDPK>
    <LicenceNumber>PA0126/264/003</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041817</DrugIDPK>
    <LicenceNumber>PA0126/264/004</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041818</DrugIDPK>
    <LicenceNumber>PA0126/264/005</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041819</DrugIDPK>
    <LicenceNumber>PA0126/264/006</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041820</DrugIDPK>
    <LicenceNumber>PA0126/264/007</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041821</DrugIDPK>
    <LicenceNumber>PA0126/264/008</LicenceNumber>
    <ProductName>OXIMEL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043946</DrugIDPK>
    <LicenceNumber>PA1809/020/001</LicenceNumber>
    <ProductName>ETOPOSIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETOPOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045042</DrugIDPK>
    <LicenceNumber>PA0405/096/001</LicenceNumber>
    <ProductName>FLUOROURACIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2015-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041083</DrugIDPK>
    <LicenceNumber>PA1809/004/003</LicenceNumber>
    <ProductName>MONTELUKAST</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039753</DrugIDPK>
    <LicenceNumber>PA1809/004/001</LicenceNumber>
    <ProductName>MONTELUKAST PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
      <ActiveSubstance>MONTELUKAST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039754</DrugIDPK>
    <LicenceNumber>PA1809/004/002</LicenceNumber>
    <ProductName>MONTELUKAST PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
      <ActiveSubstance>MONTELUKAST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041017</DrugIDPK>
    <LicenceNumber>PPA1328/208/001</LicenceNumber>
    <ProductName>TETRALYSAL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2014-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LYMECYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029685</DrugIDPK>
    <LicenceNumber>PPA1328/101/001</LicenceNumber>
    <ProductName>TILDIEM RETARD 90MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038698</DrugIDPK>
    <LicenceNumber>PPA1328/184/001</LicenceNumber>
    <ProductName>TRIAPIN</ProductName>
    <Strength>5/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021606</DrugIDPK>
    <LicenceNumber>PPA1328/041/001</LicenceNumber>
    <ProductName>VENTOLIN EVOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029711</DrugIDPK>
    <LicenceNumber>PPA1328/104/001</LicenceNumber>
    <ProductName>XATRAL 10MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027246</DrugIDPK>
    <LicenceNumber>EU/1/08/506/001</LicenceNumber>
    <ProductName>CELVAPAN</ProductName>
    <Strength>7.5/0.5</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Nanotherapeutics Bohumil S.R.O</PAHolder>
    <AuthorisedDate>2009-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/07/2009 (H1N1)V</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040004</DrugIDPK>
    <LicenceNumber>PPA1328/120/002</LicenceNumber>
    <ProductName>LAMISIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038699</DrugIDPK>
    <LicenceNumber>PPA1328/185/001</LicenceNumber>
    <ProductName>LIVIAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIBOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029465</DrugIDPK>
    <LicenceNumber>PPA1328/085/002</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038754</DrugIDPK>
    <LicenceNumber>PPA1328/198/001</LicenceNumber>
    <ProductName>MEZAVANT XL</ProductName>
    <Strength>1200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021466</DrugIDPK>
    <LicenceNumber>PPA1328/011/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029673</DrugIDPK>
    <LicenceNumber>PPA1328/096/001</LicenceNumber>
    <ProductName>OMNEXEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021614</DrugIDPK>
    <LicenceNumber>PPA1328/032/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033259</DrugIDPK>
    <LicenceNumber>PPA1328/138/001</LicenceNumber>
    <ProductName>ROZEX</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021607</DrugIDPK>
    <LicenceNumber>PPA1328/033/001</LicenceNumber>
    <ProductName>SCHERIPROCT</ProductName>
    <Strength>1.5/5</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE CAPROATE</ActiveSubstance>
      <ActiveSubstance>CINCHOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021613</DrugIDPK>
    <LicenceNumber>PPA1328/035/001</LicenceNumber>
    <ProductName>SERETIDE 500 DISKUS</ProductName>
    <Strength>50/500</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039460</DrugIDPK>
    <LicenceNumber>PPA1328/206/001</LicenceNumber>
    <ProductName>YASMIN</ProductName>
    <Strength>0.03/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033964</DrugIDPK>
    <LicenceNumber>PA1682/001/001</LicenceNumber>
    <ProductName>PERFAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Carinopharm GmbH</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXIMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019000</DrugIDPK>
    <LicenceNumber>PA1166/001/001</LicenceNumber>
    <ProductName>NORLEVO</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Laboratoire HRA Pharma</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003574</DrugIDPK>
    <LicenceNumber>PA0095/008/002</LicenceNumber>
    <ProductName>RUBEX ORANGE 1000 MG EFFERVESCENT TABLETS</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1987-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038479</DrugIDPK>
    <LicenceNumber>PA0568/025/001</LicenceNumber>
    <ProductName>ARPLEXAM</ProductName>
    <Strength>2.5/0.625/</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2014-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038480</DrugIDPK>
    <LicenceNumber>PA0568/025/002</LicenceNumber>
    <ProductName>ARPLEXAM</ProductName>
    <Strength>5/1.25/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2014-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038481</DrugIDPK>
    <LicenceNumber>PA0568/025/003</LicenceNumber>
    <ProductName>ARPLEXAM</ProductName>
    <Strength>5/1.25/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2014-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038482</DrugIDPK>
    <LicenceNumber>PA0568/025/004</LicenceNumber>
    <ProductName>ARPLEXAM</ProductName>
    <Strength>10/2.5/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2014-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038483</DrugIDPK>
    <LicenceNumber>PA0568/025/005</LicenceNumber>
    <ProductName>ARPLEXAM</ProductName>
    <Strength>10/2.5/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2014-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033907</DrugIDPK>
    <LicenceNumber>PPA1151/139/001</LicenceNumber>
    <ProductName>IXPRIM</ProductName>
    <Strength>37.5/325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038666</DrugIDPK>
    <LicenceNumber>PPA1562/096/001</LicenceNumber>
    <ProductName>REGURIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROSPIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027744</DrugIDPK>
    <LicenceNumber>PA0312/014/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027745</DrugIDPK>
    <LicenceNumber>PA0312/014/002</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038026</DrugIDPK>
    <LicenceNumber>EU/1/13/883/001</LicenceNumber>
    <ProductName>VITEKTA</ProductName>
    <Strength>85</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gilead Sciences International</PAHolder>
    <AuthorisedDate>2013-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ELVITEGRAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038027</DrugIDPK>
    <LicenceNumber>EU/1/13/883/002</LicenceNumber>
    <ProductName>VITEKTA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gilead Sciences International</PAHolder>
    <AuthorisedDate>2013-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ELVITEGRAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038078</DrugIDPK>
    <LicenceNumber>PA1811/002/001</LicenceNumber>
    <ProductName>RENLAUCOL</ProductName>
    <Strength>500/30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MG Pharma</PAHolder>
    <AuthorisedDate>2014-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029549</DrugIDPK>
    <LicenceNumber>PPA1328/088/001</LicenceNumber>
    <ProductName>CAPOZIDE</ProductName>
    <Strength>50/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038569</DrugIDPK>
    <LicenceNumber>PPA1328/178/002</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/12.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029451</DrugIDPK>
    <LicenceNumber>PPA1328/081/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029452</DrugIDPK>
    <LicenceNumber>PPA1328/081/002</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029709</DrugIDPK>
    <LicenceNumber>PPA1328/103/002</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035191</DrugIDPK>
    <LicenceNumber>PPA1328/147/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029460</DrugIDPK>
    <LicenceNumber>PPA1328/084/002</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029686</DrugIDPK>
    <LicenceNumber>PPA1328/101/003</LicenceNumber>
    <ProductName>TILDIEM LA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029688</DrugIDPK>
    <LicenceNumber>PPA1328/101/004</LicenceNumber>
    <ProductName>TILDIEM LA 300 MG PROLONGED-RELEASE HARD CAPSULES</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038876</DrugIDPK>
    <LicenceNumber>PA1809/002/001</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2013-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038877</DrugIDPK>
    <LicenceNumber>PA1809/002/002</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2013-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038878</DrugIDPK>
    <LicenceNumber>PA1809/002/003</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2013-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020667</DrugIDPK>
    <LicenceNumber>PA0623/007/001</LicenceNumber>
    <ProductName>METOJECT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>2006-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037355</DrugIDPK>
    <LicenceNumber>PPA1328/169/001</LicenceNumber>
    <ProductName>SEREVENT EVOHALER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038415</DrugIDPK>
    <LicenceNumber>PPA1328/176/001</LicenceNumber>
    <ProductName>SOLIAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021463</DrugIDPK>
    <LicenceNumber>PPA1328/007/001</LicenceNumber>
    <ProductName>TEGRETOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038774</DrugIDPK>
    <LicenceNumber>PPA1328/180/002</LicenceNumber>
    <ProductName>VERMOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEBENDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038632</DrugIDPK>
    <LicenceNumber>PPA1328/180/001</LicenceNumber>
    <ProductName>VERMOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEBENDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030363</DrugIDPK>
    <LicenceNumber>PPA1328/114/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029712</DrugIDPK>
    <LicenceNumber>PPA1328/105/001</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029713</DrugIDPK>
    <LicenceNumber>PPA1328/105/002</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037014</DrugIDPK>
    <LicenceNumber>PPA1328/162/001</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017760</DrugIDPK>
    <LicenceNumber>PA0030/054/001</LicenceNumber>
    <ProductName>NICOTINELL CLASSIC</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2003-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>2016-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017761</DrugIDPK>
    <LicenceNumber>PA0030/054/002</LicenceNumber>
    <ProductName>NICOTINELL CLASSIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2003-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>2016-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036559</DrugIDPK>
    <LicenceNumber>PA1750/001/001</LicenceNumber>
    <ProductName>NIQERO FRUIT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stasisport Pharma N.V.</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036560</DrugIDPK>
    <LicenceNumber>PA1750/001/002</LicenceNumber>
    <ProductName>NIQERO FRUIT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stasisport Pharma N.V.</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036561</DrugIDPK>
    <LicenceNumber>PA1750/001/003</LicenceNumber>
    <ProductName>NIQERO MINT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stasisport Pharma N.V.</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036562</DrugIDPK>
    <LicenceNumber>PA1750/001/004</LicenceNumber>
    <ProductName>NIQERO MINT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stasisport Pharma N.V.</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026363</DrugIDPK>
    <LicenceNumber>PA1421/002/001</LicenceNumber>
    <ProductName>ALVESCO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038334</DrugIDPK>
    <LicenceNumber>PA1457/007/001</LicenceNumber>
    <ProductName>CYTARABINE EBEWE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>2012-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics).</SupplyComments>
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038335</DrugIDPK>
    <LicenceNumber>PA1457/007/002</LicenceNumber>
    <ProductName>CYTARABINE EBEWE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>2012-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics).</SupplyComments>
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038336</DrugIDPK>
    <LicenceNumber>PA1457/007/003</LicenceNumber>
    <ProductName>CYTARABINE EBEWE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>2012-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics).</SupplyComments>
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038338</DrugIDPK>
    <LicenceNumber>PA1457/005/001</LicenceNumber>
    <ProductName>EPIRUBICIN "EBEWE"</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>2013-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031510</DrugIDPK>
    <LicenceNumber>PPA1328/120/001</LicenceNumber>
    <ProductName>LAMISIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037044</DrugIDPK>
    <LicenceNumber>PPA1328/165/001</LicenceNumber>
    <ProductName>LOPID</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMFIBROZIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021955</DrugIDPK>
    <LicenceNumber>PPA1328/028/002</LicenceNumber>
    <ProductName>NEURONTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038806</DrugIDPK>
    <LicenceNumber>PPA1328/201/001</LicenceNumber>
    <ProductName>OSTEOFOS D3</ProductName>
    <Strength>1200mg/800</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038337</DrugIDPK>
    <LicenceNumber>PA1457/006/001</LicenceNumber>
    <ProductName>PACLITAXEL "EBEWE"</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>2013-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030362</DrugIDPK>
    <LicenceNumber>PPA1328/113/002</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038744</DrugIDPK>
    <LicenceNumber>PPA1328/196/001</LicenceNumber>
    <ProductName>RELESTAT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINASTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031511</DrugIDPK>
    <LicenceNumber>PPA1328/121/001</LicenceNumber>
    <ProductName>RELIFEX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NABUMETONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038765</DrugIDPK>
    <LicenceNumber>PPA1328/199/001</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038766</DrugIDPK>
    <LicenceNumber>PPA1328/199/002</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038339</DrugIDPK>
    <LicenceNumber>PA1457/004/001</LicenceNumber>
    <ProductName>VINORELBINE EBEWE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>2013-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINORELBINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037159</DrugIDPK>
    <LicenceNumber>PPA1328/167/001</LicenceNumber>
    <ProductName>DOLMATIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031675</DrugIDPK>
    <LicenceNumber>PPA1328/127/002</LicenceNumber>
    <ProductName>ELOCON</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031564</DrugIDPK>
    <LicenceNumber>PPA1328/124/001</LicenceNumber>
    <ProductName>FLIXOTIDE EVOHALER</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031565</DrugIDPK>
    <LicenceNumber>PPA1328/124/002</LicenceNumber>
    <ProductName>FLIXOTIDE EVOHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021618</DrugIDPK>
    <LicenceNumber>PPA1328/024/001</LicenceNumber>
    <ProductName>FUCIDIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029611</DrugIDPK>
    <LicenceNumber>PPA1328/095/001</LicenceNumber>
    <ProductName>HYTRIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029612</DrugIDPK>
    <LicenceNumber>PPA1328/095/002</LicenceNumber>
    <ProductName>HYTRIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029456</DrugIDPK>
    <LicenceNumber>PPA1328/082/001</LicenceNumber>
    <InterchangeableListCode>IC0045-001-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031317</DrugIDPK>
    <LicenceNumber>PA1455/003/001</LicenceNumber>
    <ProductName>NUASA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Uniphar plc</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022248</DrugIDPK>
    <LicenceNumber>PPA1328/065/002</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022352</DrugIDPK>
    <LicenceNumber>PPA1328/075/001</LicenceNumber>
    <ProductName>DIPROSALIC</ProductName>
    <Strength>0.05/3</Strength>
    <StrengthMeasurement>Base %w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021474</DrugIDPK>
    <LicenceNumber>PPA1328/017/001</LicenceNumber>
    <ProductName>ACTONEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022368</DrugIDPK>
    <LicenceNumber>PPA1328/077/001</LicenceNumber>
    <ProductName>BECOTIDE EVOHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035364</DrugIDPK>
    <LicenceNumber>PPA1328/152/001</LicenceNumber>
    <ProductName>BENETOR PLUS</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022343</DrugIDPK>
    <LicenceNumber>PPA1328/072/001</LicenceNumber>
    <ProductName>BETTAMOUSSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035275</DrugIDPK>
    <LicenceNumber>PPA1328/150/001</LicenceNumber>
    <ProductName>CANESTEN HC</ProductName>
    <Strength>1.0/1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031276</DrugIDPK>
    <LicenceNumber>PPA1328/057/002</LicenceNumber>
    <ProductName>CELEBREX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034908</DrugIDPK>
    <LicenceNumber>PPA1328/145/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029609</DrugIDPK>
    <LicenceNumber>PPA1328/091/001</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029610</DrugIDPK>
    <LicenceNumber>PPA1328/091/002</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021898</DrugIDPK>
    <LicenceNumber>PPA1328/047/003</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036584</DrugIDPK>
    <LicenceNumber>PA1050/017/002</LicenceNumber>
    <ProductName>FLUCONAZOLE MILPHARM 150 MG CAPSULES, HARD</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036585</DrugIDPK>
    <LicenceNumber>PA1050/017/003</LicenceNumber>
    <ProductName>FLUCONAZOLE MILPHARM 200 MG CAPSULES, HARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036583</DrugIDPK>
    <LicenceNumber>PA1050/017/001</LicenceNumber>
    <ProductName>FLUCONAZOLE MILPHARM 50 MG CAPSULES, HARD</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045736</DrugIDPK>
    <LicenceNumber>PA1963/008/001</LicenceNumber>
    <ProductName>CARBOPLATIN CIPLA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>2015-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045510</DrugIDPK>
    <LicenceNumber>PA1963/006/001</LicenceNumber>
    <ProductName>DESLORATADINE CIPLA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>2016-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043340</DrugIDPK>
    <LicenceNumber>PA1809/019/001</LicenceNumber>
    <ProductName>FINASTERIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043546</DrugIDPK>
    <LicenceNumber>PA1410/079/001</LicenceNumber>
    <ProductName>MEGGEZONES 16MG PASTILLES.</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2014-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pastilles</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995046661</DrugIDPK>
    <LicenceNumber>PA2103/002/001</LicenceNumber>
    <ProductName>PYLERA</ProductName>
    <Strength>140/125/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>2016-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISMUTH SUBCITRATE POTASSIUM</ActiveSubstance>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043545</DrugIDPK>
    <LicenceNumber>PA1410/078/001</LicenceNumber>
    <ProductName>RINSTEAD ADULT GEL WITH BENZOCAINE</ProductName>
    <Strength>0.106 + 2.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2014-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038794</DrugIDPK>
    <LicenceNumber>PA1849/001/001</LicenceNumber>
    <ProductName>OMEGA-3-ACID-ETHYL-ESTERS EPAX</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Epax AS</PAHolder>
    <AuthorisedDate>2013-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEGA-3-ACID ETHYL ESTERS 90</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036112</DrugIDPK>
    <LicenceNumber>PPA1562/063/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE PLUS</ProductName>
    <Strength>5/1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042554</DrugIDPK>
    <LicenceNumber>PPA1562/122/001</LicenceNumber>
    <ProductName>DOLMATIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042555</DrugIDPK>
    <LicenceNumber>PPA1562/122/002</LicenceNumber>
    <ProductName>DOLMATIL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040150</DrugIDPK>
    <LicenceNumber>PA1809/006/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040151</DrugIDPK>
    <LicenceNumber>PA1809/006/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040691</DrugIDPK>
    <LicenceNumber>EU/1/09/518/002</LicenceNumber>
    <ProductName>PANTECTA CONTROL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040692</DrugIDPK>
    <LicenceNumber>EU/1/09/518/003</LicenceNumber>
    <ProductName>PANTECTA CONTROL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040693</DrugIDPK>
    <LicenceNumber>EU/1/09/518/004</LicenceNumber>
    <ProductName>PANTECTA CONTROL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030676</DrugIDPK>
    <LicenceNumber>EU/1/09/518/001</LicenceNumber>
    <ProductName>PANTECTA CONTROL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043544</DrugIDPK>
    <LicenceNumber>PA1410/077/001</LicenceNumber>
    <ProductName>RINSTEAD SUGAR FREE</ProductName>
    <Strength>0.033+0.128</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2014-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pastilles</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030508</DrugIDPK>
    <LicenceNumber>PA1569/001/001</LicenceNumber>
    <ProductName>LACTULOSE RESOLUTION</ProductName>
    <Strength>3.3</Strength>
    <StrengthMeasurement>g/5ml</StrengthMeasurement>
    <PAHolder>Resolution Chemicals Limited</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029026</DrugIDPK>
    <LicenceNumber>PPA1488/002/001</LicenceNumber>
    <InterchangeableListCode>IC0045-001-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sam McCauley Chemists Limited</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE AS AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029027</DrugIDPK>
    <LicenceNumber>PPA1488/002/002</LicenceNumber>
    <InterchangeableListCode>IC0045-002-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sam McCauley Chemists Limited</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE AS AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029021</DrugIDPK>
    <LicenceNumber>PPA1488/001/001</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sam McCauley Chemists Limited</PAHolder>
    <AuthorisedDate>2009-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029022</DrugIDPK>
    <LicenceNumber>PPA1488/001/002</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sam McCauley Chemists Limited</PAHolder>
    <AuthorisedDate>2009-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028371</DrugIDPK>
    <LicenceNumber>PA0711/163/001</LicenceNumber>
    <ProductName>PRAPEXIN</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028372</DrugIDPK>
    <LicenceNumber>PA0711/163/002</LicenceNumber>
    <ProductName>PRAPEXIN</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028373</DrugIDPK>
    <LicenceNumber>PA0711/163/003</LicenceNumber>
    <ProductName>PRAPEXIN</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034245</DrugIDPK>
    <LicenceNumber>PA0711/197/001</LicenceNumber>
    <ProductName>CLARITHYROMYCIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2012-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034246</DrugIDPK>
    <LicenceNumber>PA0711/197/002</LicenceNumber>
    <ProductName>CLARITHYROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2012-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029603</DrugIDPK>
    <LicenceNumber>PPA1328/092/001</LicenceNumber>
    <ProductName>DITROPAN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029604</DrugIDPK>
    <LicenceNumber>PPA1328/092/002</LicenceNumber>
    <ProductName>DITROPAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020568</DrugIDPK>
    <LicenceNumber>PA1241/013/001</LicenceNumber>
    <ProductName>NIVADIL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NILVADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020569</DrugIDPK>
    <LicenceNumber>PA1241/013/002</LicenceNumber>
    <ProductName>NIVADIL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NILVADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023214</DrugIDPK>
    <LicenceNumber>PA1350/004/001</LicenceNumber>
    <ProductName>OSVAREN</ProductName>
    <Strength>435 / 235</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Nephrologica Deutschland GmbH</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE HEAVY</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042056</DrugIDPK>
    <LicenceNumber>PA1809/014/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042057</DrugIDPK>
    <LicenceNumber>PA1809/014/002</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038769</DrugIDPK>
    <LicenceNumber>PA0711/220/001</LicenceNumber>
    <ProductName>DUTASTERIDE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DUTASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039110</DrugIDPK>
    <LicenceNumber>PA1547/005/002</LicenceNumber>
    <ProductName>XEFO 8 MG FILM-COATED TABLETS</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda UK Limited</PAHolder>
    <AuthorisedDate>2013-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORNOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032526</DrugIDPK>
    <LicenceNumber>PA0749/116/001</LicenceNumber>
    <ProductName>METHADONE TEVA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHADONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>‘This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.’</SupplyComments>
    <WithdrawalDate>2016-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034830</DrugIDPK>
    <LicenceNumber>PA0126/213/001</LicenceNumber>
    <ProductName>OLANZAPINE CLONMEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034831</DrugIDPK>
    <LicenceNumber>PA0126/213/004</LicenceNumber>
    <ProductName>OLANZAPINE CLONMEL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034832</DrugIDPK>
    <LicenceNumber>PA0126/213/003</LicenceNumber>
    <ProductName>OLANZAPINE CLONMEL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034833</DrugIDPK>
    <LicenceNumber>PA0126/213/002</LicenceNumber>
    <ProductName>OLANZAPINE CLONMEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035488</DrugIDPK>
    <LicenceNumber>PA0822/096/001</LicenceNumber>
    <ProductName>PREMIQUE</ProductName>
    <Strength>0.3/1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035485</DrugIDPK>
    <LicenceNumber>PA0822/096/004</LicenceNumber>
    <ProductName>PREMIQUE 5 SEPARATE</ProductName>
    <Strength>5/0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035486</DrugIDPK>
    <LicenceNumber>PA0822/096/005</LicenceNumber>
    <ProductName>PREMIQUE CYCLE 5 SEPARATE</ProductName>
    <Strength>5/0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032715</DrugIDPK>
    <LicenceNumber>PA0126/191/001</LicenceNumber>
    <ProductName>ZINATAN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032716</DrugIDPK>
    <LicenceNumber>PA0126/191/002</LicenceNumber>
    <ProductName>ZINATAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035989</DrugIDPK>
    <LicenceNumber>PA0822/098/001</LicenceNumber>
    <ProductName>TAZOCIN</ProductName>
    <Strength>2/0.25</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAZOBACTAM SODIUM</ActiveSubstance>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035990</DrugIDPK>
    <LicenceNumber>PA0822/098/002</LicenceNumber>
    <ProductName>TAZOCIN</ProductName>
    <Strength>4/0.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004490</DrugIDPK>
    <LicenceNumber>PA0176/015/003</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044260</DrugIDPK>
    <LicenceNumber>PA1963/004/001</LicenceNumber>
    <ProductName>CAPECITABINE CIPLA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>2015-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPECITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044261</DrugIDPK>
    <LicenceNumber>PA1963/004/002</LicenceNumber>
    <ProductName>CAPECITABINE CIPLA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>2015-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPECITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017919</DrugIDPK>
    <LicenceNumber>PA1125/001/001</LicenceNumber>
    <ProductName>ERTRACER</ProductName>
    <Strength>1-13</Strength>
    <StrengthMeasurement>GBq/ml</StrengthMeasurement>
    <PAHolder>M2i Limited</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDEOXYGLUCOSE (18F)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041725</DrugIDPK>
    <LicenceNumber>PA1809/009/001</LicenceNumber>
    <ProductName>LEVOCETIRIZINE DIHYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002307</DrugIDPK>
    <LicenceNumber>PA0050/073/001</LicenceNumber>
    <ProductName>LARIAM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1989-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFLOQUINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007671</DrugIDPK>
    <LicenceNumber>PA0050/068/020</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength>3miu/0.5ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007672</DrugIDPK>
    <LicenceNumber>PA0050/068/021</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.4).</SupplyComments>
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007673</DrugIDPK>
    <LicenceNumber>PA0050/068/022</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength>6miu/ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.4).</SupplyComments>
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007674</DrugIDPK>
    <LicenceNumber>PA0050/068/023</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength>9miu/0.5ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.4).</SupplyComments>
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034853</DrugIDPK>
    <LicenceNumber>PA0408/088/001</LicenceNumber>
    <ProductName>ROSUVASTATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034854</DrugIDPK>
    <LicenceNumber>PA0408/088/002</LicenceNumber>
    <ProductName>ROSUVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034855</DrugIDPK>
    <LicenceNumber>PA0408/088/003</LicenceNumber>
    <ProductName>ROSUVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034856</DrugIDPK>
    <LicenceNumber>PA0408/088/004</LicenceNumber>
    <ProductName>ROSUVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN CALCIUM</ActiveSubstance>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032547</DrugIDPK>
    <LicenceNumber>PA0654/019/004</LicenceNumber>
    <ProductName>GLUCOPHAGE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032548</DrugIDPK>
    <LicenceNumber>PA0654/019/005</LicenceNumber>
    <ProductName>GLUCOPHAGE</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032549</DrugIDPK>
    <LicenceNumber>PA0654/019/006</LicenceNumber>
    <ProductName>GLUCOPHAGE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038767</DrugIDPK>
    <LicenceNumber>PA0822/179/001</LicenceNumber>
    <ProductName>PIPERACILLIN/TAZOBACTAM</ProductName>
    <Strength>2/0.25</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2014-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM (AS SODIUM SALT)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038768</DrugIDPK>
    <LicenceNumber>PA0822/179/002</LicenceNumber>
    <ProductName>PIPERACILLIN/TAZOBACTAM</ProductName>
    <Strength>4/0.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2014-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM (AS SODIUM SALT)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009668</DrugIDPK>
    <LicenceNumber>PPA0465/066/001</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022079</DrugIDPK>
    <LicenceNumber>PA1350/001/001</LicenceNumber>
    <ProductName>FERROLOGIC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Nephrologica Deutschland GmbH</PAHolder>
    <AuthorisedDate>2008-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRON SUCROSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035898</DrugIDPK>
    <LicenceNumber>EU/1/12/810/001</LicenceNumber>
    <ProductName>KRYSTEXXA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Savient Pharma Ireland Limited</PAHolder>
    <AuthorisedDate>2013-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PEGLOTICASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020536</DrugIDPK>
    <LicenceNumber>PA0408/062/001</LicenceNumber>
    <ProductName>MOBICAM</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2005-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020537</DrugIDPK>
    <LicenceNumber>PA0408/062/002</LicenceNumber>
    <ProductName>MOBICAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2005-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022541</DrugIDPK>
    <LicenceNumber>EU/1/08/489/1</LicenceNumber>
    <ProductName>OPGENRA</ProductName>
    <Strength>3.3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Howmedica International IRL.</PAHolder>
    <AuthorisedDate>2009-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for implantation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPTOTERMIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2016-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036586</DrugIDPK>
    <LicenceNumber>PA1350/005/001</LicenceNumber>
    <ProductName>PARICALCITOL FRESENIUS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Nephrologica Deutschland GmbH</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARICALCITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036587</DrugIDPK>
    <LicenceNumber>PA1350/005/002</LicenceNumber>
    <ProductName>PARICALCITOL FRESENIUS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Nephrologica Deutschland GmbH</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARICALCITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028995</DrugIDPK>
    <LicenceNumber>PA0740/013/001</LicenceNumber>
    <ProductName>ESCITOMAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028996</DrugIDPK>
    <LicenceNumber>PA0740/013/002</LicenceNumber>
    <ProductName>ESCITOMAR</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028997</DrugIDPK>
    <LicenceNumber>PA0740/013/003</LicenceNumber>
    <ProductName>ESCITOMAR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033014</DrugIDPK>
    <LicenceNumber>PPA1463/039/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE PLUS</ProductName>
    <Strength>5/1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038903</DrugIDPK>
    <LicenceNumber>PA0577/171/001</LicenceNumber>
    <ProductName>ACARBOSE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACARBOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038904</DrugIDPK>
    <LicenceNumber>PA0577/171/002</LicenceNumber>
    <ProductName>ACARBOSE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACARBOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030257</DrugIDPK>
    <LicenceNumber>PA0577/120/004</LicenceNumber>
    <ProductName>CANDESARTAN MYLAN</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035042</DrugIDPK>
    <LicenceNumber>PA0577/144/001</LicenceNumber>
    <ProductName>DETERODINE SR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031725</DrugIDPK>
    <LicenceNumber>PA0577/124/001</LicenceNumber>
    <ProductName>DORZOLAMIDE/TIMOLOL MYLAN</ProductName>
    <Strength>20+5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035455</DrugIDPK>
    <LicenceNumber>PA0577/147/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE MYLAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035456</DrugIDPK>
    <LicenceNumber>PA0577/147/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE MYLAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006020</DrugIDPK>
    <LicenceNumber>PA0405/005/003</LicenceNumber>
    <ProductName>GERAMOX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006021</DrugIDPK>
    <LicenceNumber>PA0405/005/004</LicenceNumber>
    <ProductName>GERAMOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009274</DrugIDPK>
    <LicenceNumber>PA0577/037/001</LicenceNumber>
    <ProductName>GERICARB SR</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009275</DrugIDPK>
    <LicenceNumber>PA0577/037/002</LicenceNumber>
    <ProductName>GERICARB SR</ProductName>
    <Strength>400mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018892</DrugIDPK>
    <LicenceNumber>PA0577/056/001</LicenceNumber>
    <ProductName>GERIVENT CFC FREE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022741</DrugIDPK>
    <LicenceNumber>PA0577/095/001</LicenceNumber>
    <ProductName>LIPAPRAV</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022742</DrugIDPK>
    <LicenceNumber>PA0577/095/002</LicenceNumber>
    <ProductName>LIPAPRAV</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022743</DrugIDPK>
    <LicenceNumber>PA0577/095/003</LicenceNumber>
    <ProductName>LIPAPRAV</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023242</DrugIDPK>
    <LicenceNumber>PA0577/102/001</LicenceNumber>
    <ProductName>MYVAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034327</DrugIDPK>
    <LicenceNumber>PA0577/138/002</LicenceNumber>
    <ProductName>PRAMIPEXOLE MYLAN</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034328</DrugIDPK>
    <LicenceNumber>PA0577/138/003</LicenceNumber>
    <ProductName>PRAMIPEXOLE MYLAN</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034760</DrugIDPK>
    <LicenceNumber>PA0577/145/001</LicenceNumber>
    <ProductName>RISPERIDONE MYLAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034761</DrugIDPK>
    <LicenceNumber>PA0577/145/002</LicenceNumber>
    <ProductName>RISPERIDONE MYLAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034762</DrugIDPK>
    <LicenceNumber>PA0577/145/003</LicenceNumber>
    <ProductName>RISPERIDONE MYLAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034763</DrugIDPK>
    <LicenceNumber>PA0577/145/004</LicenceNumber>
    <ProductName>RISPERIDONE MYLAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034764</DrugIDPK>
    <LicenceNumber>PA0577/145/005</LicenceNumber>
    <ProductName>RISPERIDONE MYLAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034765</DrugIDPK>
    <LicenceNumber>PA0577/145/006</LicenceNumber>
    <ProductName>RISPERIDONE MYLAN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028480</DrugIDPK>
    <LicenceNumber>PA0577/110/001</LicenceNumber>
    <ProductName>RIVASTIGMINE MYLAN</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028481</DrugIDPK>
    <LicenceNumber>PA0577/110/004</LicenceNumber>
    <ProductName>RIVASTIGMINE MYLAN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028482</DrugIDPK>
    <LicenceNumber>PA0577/110/003</LicenceNumber>
    <ProductName>RIVASTIGMINE MYLAN</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028483</DrugIDPK>
    <LicenceNumber>PA0577/110/002</LicenceNumber>
    <ProductName>RIVASTIGMINE MYLAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002507</DrugIDPK>
    <LicenceNumber>PA0577/021/002</LicenceNumber>
    <ProductName>SOTOGER</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023226</DrugIDPK>
    <LicenceNumber>PA0577/098/001</LicenceNumber>
    <ProductName>STATEASE XL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006012</DrugIDPK>
    <LicenceNumber>PA0405/001/001</LicenceNumber>
    <ProductName>TAMOXIFEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1986-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023677</DrugIDPK>
    <LicenceNumber>PA0577/104/001</LicenceNumber>
    <ProductName>TAVAGER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006049</DrugIDPK>
    <LicenceNumber>PA0405/020/001</LicenceNumber>
    <ProductName>VERISOP</ProductName>
    <Strength>40 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006050</DrugIDPK>
    <LicenceNumber>PA0405/020/002</LicenceNumber>
    <ProductName>VERISOP</ProductName>
    <Strength>80 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006051</DrugIDPK>
    <LicenceNumber>PA0405/020/003</LicenceNumber>
    <ProductName>VERISOP</ProductName>
    <Strength>120 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038129</DrugIDPK>
    <LicenceNumber>EU/1/13/831/001</LicenceNumber>
    <ProductName>CAPECITABINE SUN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>2013-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPECITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2) .</SupplyComments>
    <WithdrawalDate>2016-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038130</DrugIDPK>
    <LicenceNumber>EU/1/13/831/002</LicenceNumber>
    <ProductName>CAPECITABINE SUN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>2013-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPECITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2) .</SupplyComments>
    <WithdrawalDate>2016-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034460</DrugIDPK>
    <LicenceNumber>PA0408/087/001</LicenceNumber>
    <ProductName>MERAPEM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEROPENEM TRIHYDRATE (STERILE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034461</DrugIDPK>
    <LicenceNumber>PA0408/087/002</LicenceNumber>
    <ProductName>MERAPEM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEROPENEM TRIHYDRATE (STERILE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035012</DrugIDPK>
    <LicenceNumber>PA0577/148/001</LicenceNumber>
    <ProductName>TACROLIMUS MYLAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2016-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035013</DrugIDPK>
    <LicenceNumber>PA0577/148/002</LicenceNumber>
    <ProductName>TACROLIMUS MYLAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2016-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035014</DrugIDPK>
    <LicenceNumber>PA0577/148/003</LicenceNumber>
    <ProductName>TACROLIMUS MYLAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2016-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041772</DrugIDPK>
    <LicenceNumber>PA1809/013/001</LicenceNumber>
    <ProductName>LATANOPROST</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030959</DrugIDPK>
    <LicenceNumber>PA0823/056/004</LicenceNumber>
    <ProductName>IMODIUM 1MG/5ML</ProductName>
    <Strength>0.2mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2009-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPERAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006280</DrugIDPK>
    <LicenceNumber>PA0455/001/004</LicenceNumber>
    <ProductName>SCHOLL ATHLETE’S FOOT SPRAY LIQUID</ProductName>
    <Strength>0.06794</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042705</DrugIDPK>
    <LicenceNumber>PA1809/018/001</LicenceNumber>
    <ProductName>AMLODIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042706</DrugIDPK>
    <LicenceNumber>PA1809/018/002</LicenceNumber>
    <ProductName>AMLODIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040322</DrugIDPK>
    <LicenceNumber>EU/1/14/942/001-005</LicenceNumber>
    <ProductName>CLOPIDOGREL / ACETYLSALICYLIC ACID TEVA</ProductName>
    <Strength>75/75</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROGEN SULPHATE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040323</DrugIDPK>
    <LicenceNumber>EU/1/14/942/006-014</LicenceNumber>
    <ProductName>CLOPIDOGREL / ACETYLSALICYLIC ACID TEVA</ProductName>
    <Strength>75/100</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROGEN SULPHATE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009378</DrugIDPK>
    <LicenceNumber>PA0970/023/001</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036178</DrugIDPK>
    <LicenceNumber>PA1380/122/001</LicenceNumber>
    <ProductName>DESLORATADINE ACTAVIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2012-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003161</DrugIDPK>
    <LicenceNumber>PA0068/004/001</LicenceNumber>
    <ProductName>LOCABIOTAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal/Oromucosal spray solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSAFUNGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041984</DrugIDPK>
    <LicenceNumber>PPA1562/112/001</LicenceNumber>
    <ProductName>CORDARONE X</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIODARONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041985</DrugIDPK>
    <LicenceNumber>PPA1562/112/002</LicenceNumber>
    <ProductName>CORDARONE X</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIODARONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043852</DrugIDPK>
    <LicenceNumber>PA0405/077/002</LicenceNumber>
    <ProductName>DOCETAXEL MYLAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>mg/2ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL (ANHYDROUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043842</DrugIDPK>
    <LicenceNumber>PA0405/077/001</LicenceNumber>
    <ProductName>DOCETAXEL MYLAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>mg/0.5ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL (ANHYDROUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045043</DrugIDPK>
    <LicenceNumber>PA0405/097/001</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2015-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045044</DrugIDPK>
    <LicenceNumber>PA0405/097/002</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2015-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045045</DrugIDPK>
    <LicenceNumber>PA0405/097/003</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2015-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see  Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043846</DrugIDPK>
    <LicenceNumber>PA0405/081/001</LicenceNumber>
    <ProductName>EPIRUBICIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043850</DrugIDPK>
    <LicenceNumber>PA0405/085/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039518</DrugIDPK>
    <LicenceNumber>PA0711/229/001</LicenceNumber>
    <ProductName>CLAVAMEL</ProductName>
    <Strength>875/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2014-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041623</DrugIDPK>
    <LicenceNumber>PA1809/011/001</LicenceNumber>
    <ProductName>CYCLIZINE HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2015-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022816</DrugIDPK>
    <LicenceNumber>PA1077/117/002</LicenceNumber>
    <ProductName>PRIORIX-TETRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIVE ATTENUATED MEASLES VIRUS (SCHWARZ STRAIN)</ActiveSubstance>
      <ActiveSubstance>LIVE ATTENUATED MUMPS VIRUS (RIT 4385 STRAIN)</ActiveSubstance>
      <ActiveSubstance>LIVE ATTENUATED RUBELLA VIRUS (WISTAR RA 27/3 STRAIN)</ActiveSubstance>
      <ActiveSubstance>LIVE ATTENUATED VARICELLA VIRUS (OKA STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043849</DrugIDPK>
    <LicenceNumber>PA0405/082/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043844</DrugIDPK>
    <LicenceNumber>PA0405/079/001</LicenceNumber>
    <ProductName>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043317</DrugIDPK>
    <LicenceNumber>PA0095/007/011</LicenceNumber>
    <ProductName>PARALINK 10MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>2014-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019599</DrugIDPK>
    <LicenceNumber>PA0785/004/001</LicenceNumber>
    <ProductName>KALILACTASOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Gambro Lundia AB</PAHolder>
    <AuthorisedDate>2004-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045010</DrugIDPK>
    <LicenceNumber>PA0879/007/005</LicenceNumber>
    <ProductName>TIMOPTOL LA</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Santen OY</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045011</DrugIDPK>
    <LicenceNumber>PA0879/007/006</LicenceNumber>
    <ProductName>TIMOPTOL LA</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Santen OY</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045008</DrugIDPK>
    <LicenceNumber>PA0879/007/004</LicenceNumber>
    <ProductName>TIMOPTOL UNIT DOSE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Santen OY</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995045009</DrugIDPK>
    <LicenceNumber>PA0879/007/003</LicenceNumber>
    <ProductName>TIMOPTOL UNIT DOSE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Santen OY</PAHolder>
    <AuthorisedDate>2015-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016076</DrugIDPK>
    <LicenceNumber>PA1063/011/001</LicenceNumber>
    <ProductName>BIOZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2001-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032436</DrugIDPK>
    <LicenceNumber>PA1063/044/002</LicenceNumber>
    <ProductName>BISOPROLOL FUMARATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032437</DrugIDPK>
    <LicenceNumber>PA1063/044/003</LicenceNumber>
    <ProductName>BISOPROLOL FUMARATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016841</DrugIDPK>
    <LicenceNumber>PA0891/005/001</LicenceNumber>
    <ProductName>UCERAX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB (Pharma) Ireland Limited</PAHolder>
    <AuthorisedDate>2001-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016842</DrugIDPK>
    <LicenceNumber>PA0891/005/002</LicenceNumber>
    <ProductName>UCERAX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>UCB (Pharma) Ireland Limited</PAHolder>
    <AuthorisedDate>2001-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009987</DrugIDPK>
    <LicenceNumber>PA0167/106/001</LicenceNumber>
    <ProductName>AERRANE (ISOFLURANE), INHALATION VAPOUR, LIQUID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005868</DrugIDPK>
    <LicenceNumber>PA0823/034/001</LicenceNumber>
    <ProductName>BENYLIN FOUR FLU</ProductName>
    <Strength>25/1000/45</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1998-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 200ml per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be supplied in the course of any one retail transaction unless a valid prescription exists.</SupplyComments>
    <WithdrawalDate>2016-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031955</DrugIDPK>
    <LicenceNumber>PA0823/051/004</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2010-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031160</DrugIDPK>
    <LicenceNumber>DPR1473/052/002</LicenceNumber>
    <ProductName>CELLUVISC EYE DROPS SOLUTION</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032259</DrugIDPK>
    <LicenceNumber>DPR1473/059/001</LicenceNumber>
    <ProductName>COLOMYCIN INJECTION</ProductName>
    <Strength>1 000 000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN MESILATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027683</DrugIDPK>
    <LicenceNumber>DPR1473/041/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030543</DrugIDPK>
    <LicenceNumber>DPR1473/051/001</LicenceNumber>
    <ProductName>DIPROBASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027820</DrugIDPK>
    <LicenceNumber>DPR1473/042/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027821</DrugIDPK>
    <LicenceNumber>DPR1473/042/003</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028854</DrugIDPK>
    <LicenceNumber>DPR1473/047/002</LicenceNumber>
    <ProductName>INSPRA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027142</DrugIDPK>
    <LicenceNumber>DPR1473/016/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032146</DrugIDPK>
    <LicenceNumber>DPR1473/056/001</LicenceNumber>
    <ProductName>QUESTRAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLESTYRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031162</DrugIDPK>
    <LicenceNumber>DPR1473/054/001</LicenceNumber>
    <ProductName>STRATTERA CAPSULES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOMOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031163</DrugIDPK>
    <LicenceNumber>DPR1473/054/002</LicenceNumber>
    <ProductName>STRATTERA CAPSULES</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOMOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031164</DrugIDPK>
    <LicenceNumber>DPR1473/054/003</LicenceNumber>
    <ProductName>STRATTERA CAPSULES</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOMOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033808</DrugIDPK>
    <LicenceNumber>PPA1596/023/001</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033809</DrugIDPK>
    <LicenceNumber>PPA1596/023/002</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029963</DrugIDPK>
    <LicenceNumber>PA1128/008/001</LicenceNumber>
    <ProductName>MOXELLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Relon Chem Limited</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027470</DrugIDPK>
    <LicenceNumber>PA1128/007/001</LicenceNumber>
    <ProductName>TAMOXIFEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Relon Chem Limited</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018931</DrugIDPK>
    <LicenceNumber>PA0019/052/006</LicenceNumber>
    <ProductName>GEODON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036732</DrugIDPK>
    <LicenceNumber>PPA1151/167/001</LicenceNumber>
    <InterchangeableListCode>IC0041-012-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036733</DrugIDPK>
    <LicenceNumber>PPA1151/167/002</LicenceNumber>
    <InterchangeableListCode>IC0041-013-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036734</DrugIDPK>
    <LicenceNumber>PPA1151/167/003</LicenceNumber>
    <InterchangeableListCode>IC0041-016-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036735</DrugIDPK>
    <LicenceNumber>PPA1151/167/004</LicenceNumber>
    <InterchangeableListCode>IC0041-017-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023377</DrugIDPK>
    <LicenceNumber>PPA1151/014/003</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023378</DrugIDPK>
    <LicenceNumber>PPA1151/014/004</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028479</DrugIDPK>
    <LicenceNumber>PPA1151/085/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE PLUS</ProductName>
    <Strength>5/1.25</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033315</DrugIDPK>
    <LicenceNumber>PPA1151/095/002</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029243</DrugIDPK>
    <LicenceNumber>PPA1151/095/001</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035442</DrugIDPK>
    <LicenceNumber>PPA1151/154/001</LicenceNumber>
    <ProductName>OMESAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026168</DrugIDPK>
    <LicenceNumber>PPA1151/054/001</LicenceNumber>
    <ProductName>PRAVITIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029304</DrugIDPK>
    <LicenceNumber>PPA1151/072/002</LicenceNumber>
    <ProductName>INNOVACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027812</DrugIDPK>
    <LicenceNumber>PPA1151/072/001</LicenceNumber>
    <ProductName>INNOVACE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028545</DrugIDPK>
    <LicenceNumber>PA0711/168/001</LicenceNumber>
    <ProductName>CIFOX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021522</DrugIDPK>
    <LicenceNumber>PPA1151/011/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021423</DrugIDPK>
    <LicenceNumber>PPA1151/011/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023104</DrugIDPK>
    <LicenceNumber>PPA1151/011/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029570</DrugIDPK>
    <LicenceNumber>PPA1151/011/004</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021520</DrugIDPK>
    <LicenceNumber>PPA1151/004/003</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018421</DrugIDPK>
    <LicenceNumber>PPA1151/004/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2004-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018422</DrugIDPK>
    <LicenceNumber>PPA1151/004/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2004-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029124</DrugIDPK>
    <LicenceNumber>PPA1151/061/002</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029125</DrugIDPK>
    <LicenceNumber>PPA1151/061/003</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026448</DrugIDPK>
    <LicenceNumber>PPA1151/061/001</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037427</DrugIDPK>
    <LicenceNumber>PPA1151/173/001</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>80/12.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2012-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037429</DrugIDPK>
    <LicenceNumber>PPA1151/173/002</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/12.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2012-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038889</DrugIDPK>
    <LicenceNumber>PA1688/015/001</LicenceNumber>
    <ProductName>LODOTRA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2013-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038890</DrugIDPK>
    <LicenceNumber>PA1688/015/002</LicenceNumber>
    <ProductName>LODOTRA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2013-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038891</DrugIDPK>
    <LicenceNumber>PA1688/015/003</LicenceNumber>
    <ProductName>LODOTRA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2013-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026183</DrugIDPK>
    <LicenceNumber>PPA1151/051/001</LicenceNumber>
    <ProductName>RAMIPRIL</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026184</DrugIDPK>
    <LicenceNumber>PPA1151/051/002</LicenceNumber>
    <ProductName>RAMIPRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026185</DrugIDPK>
    <LicenceNumber>PPA1151/051/003</LicenceNumber>
    <ProductName>RAMIPRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013457</DrugIDPK>
    <LicenceNumber>PA0740/004/002</LicenceNumber>
    <ProductName>SIMVASTATIN SY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013458</DrugIDPK>
    <LicenceNumber>PA0740/004/003</LicenceNumber>
    <ProductName>SIMVASTATIN SY</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013459</DrugIDPK>
    <LicenceNumber>PA0740/004/004</LicenceNumber>
    <ProductName>SIMVASTATIN SY</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026186</DrugIDPK>
    <LicenceNumber>PPA1151/051/004</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037428</DrugIDPK>
    <LicenceNumber>PPA1151/173/003</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/25</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2012-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028780</DrugIDPK>
    <LicenceNumber>PA1445/006/001</LicenceNumber>
    <InterchangeableListCode>IC0021-039-002</InterchangeableListCode>
    <ProductName>DOXAZOSIN AUROBINDO</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028781</DrugIDPK>
    <LicenceNumber>PA1445/006/002</LicenceNumber>
    <InterchangeableListCode>IC0021-006-002</InterchangeableListCode>
    <ProductName>DOXAZOSIN AUROBINDO</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028782</DrugIDPK>
    <LicenceNumber>PA1445/006/003</LicenceNumber>
    <InterchangeableListCode>IC0021-008-002</InterchangeableListCode>
    <ProductName>DOXAZOSIN AUROBINDO</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044052</DrugIDPK>
    <LicenceNumber>PPA1562/148/001</LicenceNumber>
    <ProductName>NASACORT</ProductName>
    <Strength>55</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2015-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037553</DrugIDPK>
    <LicenceNumber>PA0281/145/002</LicenceNumber>
    <InterchangeableListCode>IC0037-071-034</InterchangeableListCode>
    <ProductName>PINACLAV</ProductName>
    <Strength>125/31.25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2012-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID (IN THE FORM OF POTASSIUM CLAVULANATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037554</DrugIDPK>
    <LicenceNumber>PA0281/145/003</LicenceNumber>
    <InterchangeableListCode>IC0037-074-014</InterchangeableListCode>
    <ProductName>PINACLAV</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2012-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID (IN THE FORM OF POTASSIUM CLAVULANATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034064</DrugIDPK>
    <LicenceNumber>PPA1596/033/001</LicenceNumber>
    <InterchangeableListCode>IC0041-012-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034065</DrugIDPK>
    <LicenceNumber>PPA1596/033/002</LicenceNumber>
    <InterchangeableListCode>IC0041-013-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034066</DrugIDPK>
    <LicenceNumber>PPA1596/033/003</LicenceNumber>
    <InterchangeableListCode>IC0041-016-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034067</DrugIDPK>
    <LicenceNumber>PPA1596/033/004</LicenceNumber>
    <InterchangeableListCode>IC0041-017-002</InterchangeableListCode>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033679</DrugIDPK>
    <LicenceNumber>PPA1596/029/001</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>80/12.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033680</DrugIDPK>
    <LicenceNumber>PPA1596/029/002</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/12.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033681</DrugIDPK>
    <LicenceNumber>PPA1596/029/003</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/25</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034608</DrugIDPK>
    <LicenceNumber>PPA1596/038/001</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034609</DrugIDPK>
    <LicenceNumber>PPA1596/038/002</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033795</DrugIDPK>
    <LicenceNumber>PPA1596/019/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020044</DrugIDPK>
    <LicenceNumber>PA0126/144/001</LicenceNumber>
    <ProductName>HEXOPAL</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSITOL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034507</DrugIDPK>
    <LicenceNumber>PPA1596/013/003</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033216</DrugIDPK>
    <LicenceNumber>PPA1596/013/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033217</DrugIDPK>
    <LicenceNumber>PPA1596/013/002</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033208</DrugIDPK>
    <LicenceNumber>PPA1596/017/001</LicenceNumber>
    <ProductName>NEBILET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEBIVOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033799</DrugIDPK>
    <LicenceNumber>PPA1596/021/001</LicenceNumber>
    <ProductName>OMNEXEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033209</DrugIDPK>
    <LicenceNumber>PPA1596/015/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033210</DrugIDPK>
    <LicenceNumber>PPA1596/015/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034124</DrugIDPK>
    <LicenceNumber>PPA0565/037/001</LicenceNumber>
    <ProductName>PAXT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE (AS PAROXETINE HYDROCHLORIDE ANHYDRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033805</DrugIDPK>
    <LicenceNumber>PPA1596/022/001</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033806</DrugIDPK>
    <LicenceNumber>PPA1596/022/002</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033807</DrugIDPK>
    <LicenceNumber>PPA1596/022/003</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034060</DrugIDPK>
    <LicenceNumber>PPA1596/010/005</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033211</DrugIDPK>
    <LicenceNumber>PPA1596/010/001</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033212</DrugIDPK>
    <LicenceNumber>PPA1596/010/002</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033213</DrugIDPK>
    <LicenceNumber>PPA1596/010/003</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033214</DrugIDPK>
    <LicenceNumber>PPA1596/010/004</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036422</DrugIDPK>
    <LicenceNumber>PPA1596/056/001</LicenceNumber>
    <ProductName>TOBI</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036423</DrugIDPK>
    <LicenceNumber>PPA1596/055/001</LicenceNumber>
    <ProductName>VALCYTE</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALGANCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033632</DrugIDPK>
    <LicenceNumber>PPA1596/028/001</LicenceNumber>
    <ProductName>XATRAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034638</DrugIDPK>
    <LicenceNumber>PPA1500/075/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037089</DrugIDPK>
    <LicenceNumber>EU/1/13/833/001-002</LicenceNumber>
    <ProductName>NUEDEXTA</ProductName>
    <Strength>15mg/9mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Jenson Pharmaceutical Services Ltd</PAHolder>
    <AuthorisedDate>2013-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>QUINIDINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037090</DrugIDPK>
    <LicenceNumber>EU/1/13/833/003</LicenceNumber>
    <ProductName>NUEDEXTA</ProductName>
    <Strength>23mg/9mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Jenson Pharmaceutical Services Ltd</PAHolder>
    <AuthorisedDate>2013-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>QUINIDINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020002</DrugIDPK>
    <LicenceNumber>PA0281/122/001</LicenceNumber>
    <ProductName>AMLID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020003</DrugIDPK>
    <LicenceNumber>PA0281/122/002</LicenceNumber>
    <ProductName>AMLID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030276</DrugIDPK>
    <LicenceNumber>PA1329/007/001</LicenceNumber>
    <ProductName>DF 118</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2016-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033810</DrugIDPK>
    <LicenceNumber>PA0677/019/001</LicenceNumber>
    <ProductName>DOPACIS</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUORODOPA (18 F)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>2016-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029696</DrugIDPK>
    <LicenceNumber>PA1329/006/001</LicenceNumber>
    <ProductName>PARAMOL</ProductName>
    <Strength>10/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>2009-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2016-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015515</DrugIDPK>
    <LicenceNumber>PA0822/009/002</LicenceNumber>
    <ProductName>ANUGESIC HC</ProductName>
    <Strength>0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
      <ActiveSubstance>BISMUTH OXIDE</ActiveSubstance>
      <ActiveSubstance>BALSAM PERU</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>BISMUTH SUBGALLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035887</DrugIDPK>
    <LicenceNumber>PA0757/009/001</LicenceNumber>
    <ProductName>PRO-BANTHINE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPANTHELINE BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036759</DrugIDPK>
    <LicenceNumber>PA0822/154/001</LicenceNumber>
    <ProductName>ZOLEDRONIC ACID</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2013-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLEDRONIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See:Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2016-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035543</DrugIDPK>
    <LicenceNumber>PA0823/065/001</LicenceNumber>
    <ProductName>IMOGAS</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2011-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033514</DrugIDPK>
    <LicenceNumber>PA1390/034/001</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042534</DrugIDPK>
    <LicenceNumber>PA1286/049/001</LicenceNumber>
    <ProductName>CIRCLET</ProductName>
    <Strength>0.120/0.015</Strength>
    <StrengthMeasurement>mg/24 hours</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2014-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETONOGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003602</DrugIDPK>
    <LicenceNumber>PA0019/047/010</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1997-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000409</DrugIDPK>
    <LicenceNumber>PA0019/047/008</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>250mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000410</DrugIDPK>
    <LicenceNumber>PA0019/047/009</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>500mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030911</DrugIDPK>
    <LicenceNumber>PPA1151/117/002</LicenceNumber>
    <ProductName>EPILIM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030597</DrugIDPK>
    <LicenceNumber>PPA1151/117/001</LicenceNumber>
    <ProductName>EPILIM ENTERIC</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030822</DrugIDPK>
    <LicenceNumber>PA0019/093/001</LicenceNumber>
    <ProductName>AZITHROMYCIN PFIZER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2013-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030823</DrugIDPK>
    <LicenceNumber>PA0019/093/002</LicenceNumber>
    <ProductName>AZITHROMYCIN PFIZER</ProductName>
    <Strength>200/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2013-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010197</DrugIDPK>
    <LicenceNumber>PA0019/052/005</LicenceNumber>
    <ProductName>GEODON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2002-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIPRASIDONE MESILATE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036193</DrugIDPK>
    <LicenceNumber>PPA1151/157/001</LicenceNumber>
    <ProductName>HALF-INDERAL LA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038811</DrugIDPK>
    <LicenceNumber>PA0437/071/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2014-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030694</DrugIDPK>
    <LicenceNumber>PA1339/026/001</LicenceNumber>
    <ProductName>CLOPIDOGREL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033816</DrugIDPK>
    <LicenceNumber>PA0822/067/001</LicenceNumber>
    <ProductName>MICROVAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037506</DrugIDPK>
    <LicenceNumber>PA1050/019/001</LicenceNumber>
    <ProductName>ALENDRONIC ACID CEFT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2012-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALENDRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037497</DrugIDPK>
    <LicenceNumber>PA1329/009/001</LicenceNumber>
    <ProductName>DAUNOXOME</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>2012-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DAUNORUBICIN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002717</DrugIDPK>
    <LicenceNumber>PA0050/047/001</LicenceNumber>
    <ProductName>ROCALTROL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1980-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002327</DrugIDPK>
    <LicenceNumber>PA0050/083/001</LicenceNumber>
    <ProductName>VASCACE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002329</DrugIDPK>
    <LicenceNumber>PA0050/083/002</LicenceNumber>
    <ProductName>VASCACE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002330</DrugIDPK>
    <LicenceNumber>PA0050/083/003</LicenceNumber>
    <ProductName>VASCACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002332</DrugIDPK>
    <LicenceNumber>PA0050/083/004</LicenceNumber>
    <ProductName>VASCACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036872</DrugIDPK>
    <LicenceNumber>PA1390/010/003</LicenceNumber>
    <ProductName>MIDAZOLAM INJECTION BP</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036873</DrugIDPK>
    <LicenceNumber>PA1390/010/004</LicenceNumber>
    <ProductName>MIDAZOLAM INJECTION BP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041154</DrugIDPK>
    <LicenceNumber>PA0959/004/001</LicenceNumber>
    <ProductName>PARACETAMOL MAX</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aziende Chimiche Riunite Angelini Francesco</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General Sale: MAXIMUM PACK SIZE 6. Contains only paracetamol as analgesic. Maximum one pack per sale.
Pharmacy only: MAXIMUM PACK SIZE 12. Maximum two packs per sale.
Prescription only: Pack size exceeding 12 unit dosage forms. Product not supplied in blister packs
Promotion to Public: Pack size</SupplyComments>
    <WithdrawalDate>2016-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043845</DrugIDPK>
    <LicenceNumber>PA0405/080/001</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043853</DrugIDPK>
    <LicenceNumber>PA0405/080/002</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043847</DrugIDPK>
    <LicenceNumber>PA0405/078/002</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037979</DrugIDPK>
    <LicenceNumber>PPA1562/085/001</LicenceNumber>
    <ProductName>TEVETEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019719</DrugIDPK>
    <LicenceNumber>PA0281/121/001</LicenceNumber>
    <ProductName>LUSERT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2005-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019720</DrugIDPK>
    <LicenceNumber>PA0281/121/002</LicenceNumber>
    <ProductName>LUSERT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2005-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032802</DrugIDPK>
    <LicenceNumber>PA1063/046/001</LicenceNumber>
    <ProductName>DONEPEZIL NICHE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032803</DrugIDPK>
    <LicenceNumber>PA1063/046/002</LicenceNumber>
    <ProductName>DONEPEZIL NICHE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042295</DrugIDPK>
    <LicenceNumber>PPA1562/117/001</LicenceNumber>
    <ProductName>SILDENAFIL PFIZER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042296</DrugIDPK>
    <LicenceNumber>PPA1562/117/002</LicenceNumber>
    <ProductName>SILDENAFIL PFIZER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038579</DrugIDPK>
    <LicenceNumber>PPA1562/095/001</LicenceNumber>
    <ProductName>CANESTEN HC CREAM</ProductName>
    <Strength>1.0/1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042291</DrugIDPK>
    <LicenceNumber>PPA1562/116/001</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042292</DrugIDPK>
    <LicenceNumber>PPA1562/116/002</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042293</DrugIDPK>
    <LicenceNumber>PPA1562/116/003</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042294</DrugIDPK>
    <LicenceNumber>PPA1562/116/004</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038309</DrugIDPK>
    <LicenceNumber>PPA1562/090/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038516</DrugIDPK>
    <LicenceNumber>PPA1562/094/001</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2013-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038517</DrugIDPK>
    <LicenceNumber>PPA1562/094/002</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2013-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037462</DrugIDPK>
    <LicenceNumber>PPA1562/079/001</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037463</DrugIDPK>
    <LicenceNumber>PPA1562/079/002</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038316</DrugIDPK>
    <LicenceNumber>PA0568/026/001</LicenceNumber>
    <ProductName>NATRIXAM</ProductName>
    <Strength>1.5/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2013-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE AS AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038317</DrugIDPK>
    <LicenceNumber>PA0568/026/002</LicenceNumber>
    <ProductName>NATRIXAM</ProductName>
    <Strength>1.5/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2013-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE AS AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022785</DrugIDPK>
    <LicenceNumber>PA0281/135/001</LicenceNumber>
    <ProductName>OSTEOLE</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULFATE SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034201</DrugIDPK>
    <LicenceNumber>PPA1562/037/001</LicenceNumber>
    <ProductName>ACULAR</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOROLAC TROMETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035111</DrugIDPK>
    <LicenceNumber>PPA1562/047/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Base %w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038042</DrugIDPK>
    <LicenceNumber>PPA1562/048/002</LicenceNumber>
    <ProductName>SELECTOL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035101</DrugIDPK>
    <LicenceNumber>PPA1562/048/001</LicenceNumber>
    <ProductName>SELECTOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010484</DrugIDPK>
    <LicenceNumber>PA0540/028/002</LicenceNumber>
    <ProductName>AMARYL 2 MG TABLET</ProductName>
    <Strength>2.0mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2000-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010486</DrugIDPK>
    <LicenceNumber>PA0540/028/004</LicenceNumber>
    <ProductName>AMARYL 4 MG TABLET</ProductName>
    <Strength>4.0mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2000-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010502</DrugIDPK>
    <LicenceNumber>PA0540/033/002</LicenceNumber>
    <ProductName>CEFODOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1996-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPODOXIME PROXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010737</DrugIDPK>
    <LicenceNumber>PA0540/039/001</LicenceNumber>
    <ProductName>DAONIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022596</DrugIDPK>
    <LicenceNumber>PA0540/150/008</LicenceNumber>
    <ProductName>EPILIM CHRONOSPHERE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022597</DrugIDPK>
    <LicenceNumber>PA0540/150/009</LicenceNumber>
    <ProductName>EPILIM CHRONOSPHERE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033962</DrugIDPK>
    <LicenceNumber>PPA1562/033/001</LicenceNumber>
    <ProductName>IKOREL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033963</DrugIDPK>
    <LicenceNumber>PPA1562/033/002</LicenceNumber>
    <ProductName>IKOREL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010806</DrugIDPK>
    <LicenceNumber>PA0540/052/004</LicenceNumber>
    <ProductName>LASIX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010807</DrugIDPK>
    <LicenceNumber>PA0540/052/005</LicenceNumber>
    <ProductName>LASIX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020813</DrugIDPK>
    <LicenceNumber>PA0540/121/004</LicenceNumber>
    <ProductName>PHENERGAN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032426</DrugIDPK>
    <LicenceNumber>PA0540/161/003</LicenceNumber>
    <ProductName>TILDIEM 60MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025301</DrugIDPK>
    <LicenceNumber>PA0540/161/001</LicenceNumber>
    <ProductName>TILDIEM LA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025302</DrugIDPK>
    <LicenceNumber>PA0540/161/002</LicenceNumber>
    <ProductName>TILDIEM LA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032428</DrugIDPK>
    <LicenceNumber>PA0540/161/005</LicenceNumber>
    <ProductName>TILDIEM RETARD 120 MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032427</DrugIDPK>
    <LicenceNumber>PA0540/161/004</LicenceNumber>
    <ProductName>TILDIEM RETARD 90 MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2016-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033265</DrugIDPK>
    <LicenceNumber>PA1656/001/001</LicenceNumber>
    <ProductName>NANOGAM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanquin</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN NORMAL IMMUNOGLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2016-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033815</DrugIDPK>
    <LicenceNumber>PA0822/065/001</LicenceNumber>
    <ProductName>ALESSE</ProductName>
    <Strength>100, 20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017657</DrugIDPK>
    <LicenceNumber>PPA0465/108/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017658</DrugIDPK>
    <LicenceNumber>PPA0465/108/002</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034143</DrugIDPK>
    <LicenceNumber>PPA0565/047/001</LicenceNumber>
    <ProductName>BELLISIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015086</DrugIDPK>
    <LicenceNumber>PPA0465/087/001</LicenceNumber>
    <ProductName>EMCOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036485</DrugIDPK>
    <LicenceNumber>PPA0465/285/001</LicenceNumber>
    <ProductName>FLIXONASE AQUEOUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034032</DrugIDPK>
    <LicenceNumber>PPA0565/032/001</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034033</DrugIDPK>
    <LicenceNumber>PPA0565/032/002</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034034</DrugIDPK>
    <LicenceNumber>PPA0565/032/003</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037946</DrugIDPK>
    <LicenceNumber>PPA0465/291/001</LicenceNumber>
    <ProductName>GYNO-DAKTARIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033817</DrugIDPK>
    <LicenceNumber>PA0822/066/001</LicenceNumber>
    <ProductName>HARMONET</ProductName>
    <Strength>75/20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038132</DrugIDPK>
    <LicenceNumber>PPA0465/295/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009066</DrugIDPK>
    <LicenceNumber>PA0964/002/002</LicenceNumber>
    <ProductName>NORCURON 10 MG, POWDER FOR SOLUTION FOR INJECTION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>1997-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VECURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033818</DrugIDPK>
    <LicenceNumber>PA0822/068/001</LicenceNumber>
    <ProductName>OVRAN 250MCG/50MCG COATED TABLETS.</ProductName>
    <Strength>250/50mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034117</DrugIDPK>
    <LicenceNumber>PPA0565/028/001</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034118</DrugIDPK>
    <LicenceNumber>PPA0565/028/002</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034119</DrugIDPK>
    <LicenceNumber>PPA0565/028/003</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034265</DrugIDPK>
    <LicenceNumber>PPA0565/049/001</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034266</DrugIDPK>
    <LicenceNumber>PPA0565/049/002</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034267</DrugIDPK>
    <LicenceNumber>PPA0565/049/003</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035906</DrugIDPK>
    <LicenceNumber>PPA0465/153/008</LicenceNumber>
    <InterchangeableListCode>IC0019-023-024</InterchangeableListCode>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043105</DrugIDPK>
    <LicenceNumber>PPA0465/153/009</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2014-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033522</DrugIDPK>
    <LicenceNumber>PPA0465/153/006</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033523</DrugIDPK>
    <LicenceNumber>PPA0465/153/007</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034972</DrugIDPK>
    <LicenceNumber>PA0822/064/001</LicenceNumber>
    <ProductName>LANTANOPROST PFIZER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035469</DrugIDPK>
    <LicenceNumber>PA0822/092/001</LicenceNumber>
    <ProductName>LANTANOPROST/TIMOLOL</ProductName>
    <Strength>50/5.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANTANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006289</DrugIDPK>
    <LicenceNumber>PA0455/006/003</LicenceNumber>
    <ProductName>CALLOUS REMOVAL PADS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1987-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006286</DrugIDPK>
    <LicenceNumber>PA0455/006/001</LicenceNumber>
    <ProductName>CORN REMOVAL PADS</ProductName>
    <Strength>40.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1987-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006290</DrugIDPK>
    <LicenceNumber>PA0455/007/001</LicenceNumber>
    <ProductName>SCHOLL CORN REMOVAL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026193</DrugIDPK>
    <LicenceNumber>PPA1151/055/001</LicenceNumber>
    <ProductName>ATECOR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026194</DrugIDPK>
    <LicenceNumber>PPA1151/055/002</LicenceNumber>
    <ProductName>ATECOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026195</DrugIDPK>
    <LicenceNumber>PPA1151/055/003</LicenceNumber>
    <ProductName>ATECOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034941</DrugIDPK>
    <LicenceNumber>PA0019/094/001</LicenceNumber>
    <ProductName>ZIPRASIDONE PFIZER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034942</DrugIDPK>
    <LicenceNumber>PA0019/094/002</LicenceNumber>
    <ProductName>ZIPRASIDONE PFIZER</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034943</DrugIDPK>
    <LicenceNumber>PA0019/094/003</LicenceNumber>
    <ProductName>ZIPRASIDONE PFIZER</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034944</DrugIDPK>
    <LicenceNumber>PA0019/094/004</LicenceNumber>
    <ProductName>ZIPRASIDONE PFIZER</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034945</DrugIDPK>
    <LicenceNumber>PA0019/094/005</LicenceNumber>
    <ProductName>ZIPRASIDONE PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004054</DrugIDPK>
    <LicenceNumber>PA0148/026/001</LicenceNumber>
    <ProductName>LIQUIFILM TEARS OCULAR LUBRICANT</ProductName>
    <Strength>1.4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYVINYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033555</DrugIDPK>
    <LicenceNumber>PA1390/023/002</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040889</DrugIDPK>
    <LicenceNumber>PA1410/072/001</LicenceNumber>
    <ProductName>SKINOREN 20% W/W CREAM</ProductName>
    <Strength>20/2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZELAIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014948</DrugIDPK>
    <LicenceNumber>PA0544/036/002</LicenceNumber>
    <ProductName>REPEVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>ADSORBED FIMBRIAE TYPES 2 + 3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035979</DrugIDPK>
    <LicenceNumber>PPA1562/056/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043350</DrugIDPK>
    <LicenceNumber>PA0126/269/001</LicenceNumber>
    <ProductName>DULOXETINE CLONMEL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2015-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DULOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043351</DrugIDPK>
    <LicenceNumber>PA0126/269/003</LicenceNumber>
    <ProductName>DULOXETINE CLONMEL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2015-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DULOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039614</DrugIDPK>
    <LicenceNumber>PA0126/212/005</LicenceNumber>
    <ProductName>ETALOPRO MELTS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039615</DrugIDPK>
    <LicenceNumber>PA0126/212/006</LicenceNumber>
    <ProductName>ETALOPRO MELTS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039616</DrugIDPK>
    <LicenceNumber>PA0126/212/007</LicenceNumber>
    <ProductName>ETALOPRO MELTS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039617</DrugIDPK>
    <LicenceNumber>PA0126/212/008</LicenceNumber>
    <ProductName>ETALOPRO MELTS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2014-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035449</DrugIDPK>
    <LicenceNumber>PA0126/222/001</LicenceNumber>
    <ProductName>GALANTAX XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035450</DrugIDPK>
    <LicenceNumber>PA0126/222/002</LicenceNumber>
    <ProductName>GALANTAX XL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035451</DrugIDPK>
    <LicenceNumber>PA0126/222/003</LicenceNumber>
    <ProductName>GALANTAX XL</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019324</DrugIDPK>
    <LicenceNumber>PA1063/018/001</LicenceNumber>
    <ProductName>LANAFINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2005-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019325</DrugIDPK>
    <LicenceNumber>PA1063/018/002</LicenceNumber>
    <ProductName>LANAFINE AFR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2005-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 1%; maximum pack size 15g; maximum period of treatment 14 days.</SupplyComments>
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042075</DrugIDPK>
    <LicenceNumber>PA0126/262/001</LicenceNumber>
    <ProductName>METHOTREXATE CLONMEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2015-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040795</DrugIDPK>
    <LicenceNumber>PPA1463/088/001</LicenceNumber>
    <ProductName>IKOREL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040796</DrugIDPK>
    <LicenceNumber>PPA1463/088/002</LicenceNumber>
    <ProductName>IKOREL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038303</DrugIDPK>
    <LicenceNumber>PPA1463/048/004</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035328</DrugIDPK>
    <LicenceNumber>PA0540/167/001</LicenceNumber>
    <ProductName>FREESTOM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030745</DrugIDPK>
    <LicenceNumber>PA0822/025/001</LicenceNumber>
    <ProductName>SERTRALINE PFIZER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030746</DrugIDPK>
    <LicenceNumber>PA0822/025/002</LicenceNumber>
    <ProductName>SERTRALINE PFIZER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038770</DrugIDPK>
    <LicenceNumber>PA0540/171/001</LicenceNumber>
    <ProductName>SILDENAFIL ZENTIVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2013-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL BASE (AS CITRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038771</DrugIDPK>
    <LicenceNumber>PA0540/171/002</LicenceNumber>
    <ProductName>SILDENAFIL ZENTIVA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2013-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL BASE (AS CITRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038772</DrugIDPK>
    <LicenceNumber>PA0540/171/003</LicenceNumber>
    <ProductName>SILDENAFIL ZENTIVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2013-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL BASE (AS CITRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039075</DrugIDPK>
    <LicenceNumber>PA0540/172/001</LicenceNumber>
    <ProductName>ZOLMITRIPTAN SANOFI</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2014-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039076</DrugIDPK>
    <LicenceNumber>PA0540/172/002</LicenceNumber>
    <ProductName>ZOLMITRIPTAN SANOFI</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2014-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004177</DrugIDPK>
    <LicenceNumber>PA0167/055/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP, (HARTMANN’S SOLUTION)</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034946</DrugIDPK>
    <LicenceNumber>PA0126/221/001</LicenceNumber>
    <ProductName>ROPIRADE XL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034947</DrugIDPK>
    <LicenceNumber>PA0126/221/002</LicenceNumber>
    <ProductName>ROPIRADE XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034948</DrugIDPK>
    <LicenceNumber>PA0126/221/003</LicenceNumber>
    <ProductName>ROPIRADE XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2013-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031859</DrugIDPK>
    <LicenceNumber>PA1625/001/001</LicenceNumber>
    <ProductName>LATANOPROST/TIMOLOL PORTFARMA</ProductName>
    <Strength>50/5.00</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Portfarma  ehf</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029755</DrugIDPK>
    <LicenceNumber>PA1380/066/001</LicenceNumber>
    <ProductName>CEFUROXIME ACTAVIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029756</DrugIDPK>
    <LicenceNumber>PA1380/066/002</LicenceNumber>
    <ProductName>CEFUROXIME ACTAVIS</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029757</DrugIDPK>
    <LicenceNumber>PA1380/066/003</LicenceNumber>
    <ProductName>CEFUROXIME ACTAVIS</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM (STERILE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034181</DrugIDPK>
    <LicenceNumber>PA0822/071/001</LicenceNumber>
    <ProductName>EXEMESTANE PFIZER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EXEMESTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043509</DrugIDPK>
    <LicenceNumber>EU/1/15/1026/001-002</LicenceNumber>
    <ProductName>NIVOLUMAB BMS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2015-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIVOLUMAB (BMS-936558)</ActiveSubstance>
      <ActiveSubstance>NIVOLUMAB (BMS-936558)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2015-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004087</DrugIDPK>
    <LicenceNumber>PA0167/050/005</LicenceNumber>
    <ProductName>SODIUM CHLORIDE AND GLUCOSE</ProductName>
    <Strength>0.45/5.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031977</DrugIDPK>
    <LicenceNumber>PA1063/043/001</LicenceNumber>
    <ProductName>DONEPEZIL NICHE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031978</DrugIDPK>
    <LicenceNumber>PA1063/043/002</LicenceNumber>
    <ProductName>DONEPEZIL NICHE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016743</DrugIDPK>
    <LicenceNumber>PA1077/009/001</LicenceNumber>
    <ProductName>NARAMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NARATRIPTAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016133</DrugIDPK>
    <LicenceNumber>PA1077/037/002</LicenceNumber>
    <ProductName>REQUIP</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028073</DrugIDPK>
    <LicenceNumber>PA0711/160/001</LicenceNumber>
    <ProductName>VENLAFAXINE</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028074</DrugIDPK>
    <LicenceNumber>PA0711/160/002</LicenceNumber>
    <ProductName>VENLAFAXINE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029551</DrugIDPK>
    <LicenceNumber>PPA1328/090/001</LicenceNumber>
    <ProductName>ACTONEL PLUS</ProductName>
    <Strength>35mg+1000mg+880IU</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021896</DrugIDPK>
    <LicenceNumber>PPA1328/047/001</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021627</DrugIDPK>
    <LicenceNumber>PPA1328/018/002</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021934</DrugIDPK>
    <LicenceNumber>PPA1328/055/001</LicenceNumber>
    <ProductName>BRICANYL TURBOHALER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030166</DrugIDPK>
    <LicenceNumber>DPR1328/027/001</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038570</DrugIDPK>
    <LicenceNumber>PPA1328/178/003</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/25</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031275</DrugIDPK>
    <LicenceNumber>PPA1328/059/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031746</DrugIDPK>
    <LicenceNumber>PPA1328/132/001</LicenceNumber>
    <ProductName>DALACIN C</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030623</DrugIDPK>
    <LicenceNumber>PPA1328/118/003</LicenceNumber>
    <ProductName>EFEXOR XL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029708</DrugIDPK>
    <LicenceNumber>PPA1328/103/001</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035193</DrugIDPK>
    <LicenceNumber>PPA1328/147/002</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038841</DrugIDPK>
    <LicenceNumber>PPA1328/205/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030082</DrugIDPK>
    <LicenceNumber>DPR1328/012/003</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029459</DrugIDPK>
    <LicenceNumber>PPA1328/084/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032039</DrugIDPK>
    <LicenceNumber>PPA1328/015/003</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029464</DrugIDPK>
    <LicenceNumber>PPA1328/085/001</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030101</DrugIDPK>
    <LicenceNumber>DPR1328/018/002</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038237</DrugIDPK>
    <LicenceNumber>PPA1328/171/001</LicenceNumber>
    <ProductName>MYCOSTATIN</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029665</DrugIDPK>
    <LicenceNumber>PPA1328/097/001</LicenceNumber>
    <ProductName>NAPROSYN EC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029666</DrugIDPK>
    <LicenceNumber>PPA1328/097/002</LicenceNumber>
    <ProductName>NAPROSYN EC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035274</DrugIDPK>
    <LicenceNumber>PPA1328/149/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMPSPRAY</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031678</DrugIDPK>
    <LicenceNumber>PPA1328/130/001</LicenceNumber>
    <ProductName>OXIS TURBOHALER</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021609</DrugIDPK>
    <LicenceNumber>PPA1328/031/001</LicenceNumber>
    <ProductName>PHYLLOCONTIN CONTINUS</ProductName>
    <Strength>225</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038484</DrugIDPK>
    <LicenceNumber>PPA1328/177/001</LicenceNumber>
    <ProductName>PLAQUENIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYCHLOROQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037074</DrugIDPK>
    <LicenceNumber>PPA1328/113/003</LicenceNumber>
    <ProductName>PULMICORT RESPULES</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>mg/2ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021598</DrugIDPK>
    <LicenceNumber>PPA1328/037/001</LicenceNumber>
    <ProductName>SINEMET PLUS</ProductName>
    <Strength>25/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035663</DrugIDPK>
    <LicenceNumber>PPA1328/156/001</LicenceNumber>
    <ProductName>TROSYL NAIL SOLUTION</ProductName>
    <Strength>283</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021604</DrugIDPK>
    <LicenceNumber>PPA1328/041/002</LicenceNumber>
    <ProductName>VENTOLIN NEBULES</ProductName>
    <Strength>2.5/2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035381</DrugIDPK>
    <LicenceNumber>PPA1328/153/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021461</DrugIDPK>
    <LicenceNumber>PPA1328/005/001</LicenceNumber>
    <ProductName>ZOMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008625</DrugIDPK>
    <LicenceNumber>PA0281/093/001</LicenceNumber>
    <InterchangeableListCode>IC0037-071-034</InterchangeableListCode>
    <ProductName>PINACLAV</ProductName>
    <Strength>125/31.25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008626</DrugIDPK>
    <LicenceNumber>PA0281/093/002</LicenceNumber>
    <InterchangeableListCode>IC0037-074-014</InterchangeableListCode>
    <ProductName>PINACLAV</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008627</DrugIDPK>
    <LicenceNumber>PA0281/093/003</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>PINACLAV</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022337</DrugIDPK>
    <LicenceNumber>PPA1328/045/002</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029472</DrugIDPK>
    <LicenceNumber>PPA1328/087/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021903</DrugIDPK>
    <LicenceNumber>PPA1328/049/001</LicenceNumber>
    <ProductName>ARYTHMOL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021954</DrugIDPK>
    <LicenceNumber>PPA1328/018/003</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035365</DrugIDPK>
    <LicenceNumber>PPA1328/152/002</LicenceNumber>
    <ProductName>BENETOR PLUS</ProductName>
    <Strength>20/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033037</DrugIDPK>
    <LicenceNumber>PPA1328/137/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023316</DrugIDPK>
    <LicenceNumber>PA1391/001/001</LicenceNumber>
    <ProductName>BICALUTAMIDE FARMAPROJECTS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmaprojects S.A.</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021949</DrugIDPK>
    <LicenceNumber>PPA1328/056/002</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021956</DrugIDPK>
    <LicenceNumber>PPA1328/064/001</LicenceNumber>
    <ProductName>CLEXANE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXAPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030170</DrugIDPK>
    <LicenceNumber>DPR1328/028/001</LicenceNumber>
    <ProductName>COMBIGAN</ProductName>
    <Strength>2/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031494</DrugIDPK>
    <LicenceNumber>PPA1328/061/003</LicenceNumber>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038670</DrugIDPK>
    <LicenceNumber>PPA1328/182/001</LicenceNumber>
    <ProductName>DIPROBASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035192</DrugIDPK>
    <LicenceNumber>PPA1328/147/003</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030178</DrugIDPK>
    <LicenceNumber>DPR1328/030/001</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030179</DrugIDPK>
    <LicenceNumber>DPR1328/030/002</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029913</DrugIDPK>
    <LicenceNumber>PPA1328/106/001</LicenceNumber>
    <ProductName>INDERAL LA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030080</DrugIDPK>
    <LicenceNumber>DPR1328/012/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030081</DrugIDPK>
    <LicenceNumber>DPR1328/012/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038414</DrugIDPK>
    <LicenceNumber>PPA1328/175/001</LicenceNumber>
    <ProductName>NARAMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NARATRIPTAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029677</DrugIDPK>
    <LicenceNumber>PPA1328/098/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029957</DrugIDPK>
    <LicenceNumber>DPR1328/006/001</LicenceNumber>
    <ProductName>SINEMET 62.5</ProductName>
    <Strength>12.50/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029922</DrugIDPK>
    <LicenceNumber>PPA1328/110/001</LicenceNumber>
    <ProductName>TENORMIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029687</DrugIDPK>
    <LicenceNumber>PPA1328/101/002</LicenceNumber>
    <ProductName>TILDIEM RETARD 120MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034511</DrugIDPK>
    <LicenceNumber>PPA1328/143/001</LicenceNumber>
    <ProductName>TRUSOPT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036421</DrugIDPK>
    <LicenceNumber>PPA1328/161/001</LicenceNumber>
    <ProductName>VAGIFEM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029473</DrugIDPK>
    <LicenceNumber>PPA1328/087/002</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029450</DrugIDPK>
    <LicenceNumber>PPA1328/080/002</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030622</DrugIDPK>
    <LicenceNumber>PPA1328/118/002</LicenceNumber>
    <ProductName>EFEXOR XL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021472</DrugIDPK>
    <LicenceNumber>PPA1328/015/001</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029678</DrugIDPK>
    <LicenceNumber>PPA1328/098/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029958</DrugIDPK>
    <LicenceNumber>DPR1328/007/001</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029636</DrugIDPK>
    <LicenceNumber>DPR1328/002/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030087</DrugIDPK>
    <LicenceNumber>DPR1328/002/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043104</DrugIDPK>
    <LicenceNumber>PPA1328/212/001</LicenceNumber>
    <ProductName>VASTAREL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2014-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETAZIDINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035635</DrugIDPK>
    <LicenceNumber>PPA1328/155/001</LicenceNumber>
    <ProductName>ARIMIDEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022268</DrugIDPK>
    <LicenceNumber>PPA1328/050/002</LicenceNumber>
    <ProductName>AUGMENTIN-DUO</ProductName>
    <Strength>400/57</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022420</DrugIDPK>
    <LicenceNumber>PA1375/001/001</LicenceNumber>
    <ProductName>BICALUTAMIDE AVANSOR 50MG FILM-COATED TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Avansor Pharma Oy</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042379</DrugIDPK>
    <LicenceNumber>PPA1328/209/001</LicenceNumber>
    <ProductName>CALCICHEW-D3 FORTE</ProductName>
    <Strength>500/400</Strength>
    <StrengthMeasurement>mg/IU</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2014-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029447</DrugIDPK>
    <LicenceNumber>PPA1328/079/001</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029448</DrugIDPK>
    <LicenceNumber>PPA1328/079/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021917</DrugIDPK>
    <LicenceNumber>PPA1328/059/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037043</DrugIDPK>
    <LicenceNumber>PPA1328/166/001</LicenceNumber>
    <ProductName>EZETROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038671</DrugIDPK>
    <LicenceNumber>PPA1328/183/001</LicenceNumber>
    <ProductName>FUCIBET CREAM</ProductName>
    <Strength>20 + 1</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038807</DrugIDPK>
    <LicenceNumber>PPA1328/202/001</LicenceNumber>
    <ProductName>IDEOS</ProductName>
    <Strength>500mg/400</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034384</DrugIDPK>
    <LicenceNumber>PPA1328/084/003</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029457</DrugIDPK>
    <LicenceNumber>PPA1328/083/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029458</DrugIDPK>
    <LicenceNumber>PPA1328/083/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031816</DrugIDPK>
    <LicenceNumber>PPA1328/083/004</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037628</DrugIDPK>
    <LicenceNumber>PPA1328/027/002</LicenceNumber>
    <ProductName>MOVICOL</ProductName>
    <Strength>6.9</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021620</DrugIDPK>
    <LicenceNumber>PPA1328/027/001</LicenceNumber>
    <ProductName>MOVICOL</ProductName>
    <Strength>13.8</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030625</DrugIDPK>
    <LicenceNumber>PPA1328/029/002</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036208</DrugIDPK>
    <LicenceNumber>PPA1328/160/001</LicenceNumber>
    <ProductName>NORLEVO</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037013</DrugIDPK>
    <LicenceNumber>PPA1328/035/002</LicenceNumber>
    <ProductName>SERETIDE 250 DISKUS</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042714</DrugIDPK>
    <LicenceNumber>PPA1328/211/001</LicenceNumber>
    <ProductName>VERSATIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2015-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038577</DrugIDPK>
    <LicenceNumber>PPA1328/179/001</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038578</DrugIDPK>
    <LicenceNumber>PPA1328/179/002</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021599</DrugIDPK>
    <LicenceNumber>PPA1328/042/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037271</DrugIDPK>
    <LicenceNumber>PPA1328/168/001</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029270</DrugIDPK>
    <LicenceNumber>PPA1328/078/002</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021004</DrugIDPK>
    <LicenceNumber>PA0941/002/001</LicenceNumber>
    <ProductName>INFLEXAL V</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Crucell Italy S.r.l.</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)</ActiveSubstance>
      <ActiveSubstance>A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012</ActiveSubstance>
      <ActiveSubstance>B/MASSACHUSETTS/02/2012 DERIVED STRAIN USED (NYMC BX-51B)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009253</DrugIDPK>
    <LicenceNumber>PA0187/051/002</LicenceNumber>
    <ProductName>SALAZOPYRIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021894</DrugIDPK>
    <LicenceNumber>PPA1328/045/001</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037038</DrugIDPK>
    <LicenceNumber>PPA1328/163/001</LicenceNumber>
    <ProductName>ARTHROTEC</ProductName>
    <Strength>50/0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
      <ActiveSubstance>MISOPROSTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031528</DrugIDPK>
    <LicenceNumber>PPA1328/079/003</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035484</DrugIDPK>
    <LicenceNumber>PA0822/091/001</LicenceNumber>
    <ProductName>CATHATE</ProductName>
    <Strength>0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029449</DrugIDPK>
    <LicenceNumber>PPA1328/080/001</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021616</DrugIDPK>
    <LicenceNumber>PPA1328/026/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032400</DrugIDPK>
    <LicenceNumber>PPA1328/026/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037037</DrugIDPK>
    <LicenceNumber>PPA1328/164/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038840</DrugIDPK>
    <LicenceNumber>PPA1328/204/001</LicenceNumber>
    <ProductName>VOLTAROL EMULGEL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2013-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC DIETHYLAMMONIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029269</DrugIDPK>
    <LicenceNumber>PPA1328/078/001</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005990</DrugIDPK>
    <LicenceNumber>PA0739/003/001</LicenceNumber>
    <ProductName>CEPTON MEDICATED CLEAR GEL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eastern Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005989</DrugIDPK>
    <LicenceNumber>PA0739/003/002</LicenceNumber>
    <ProductName>CEPTON MEDICATED LOTION</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Eastern Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005988</DrugIDPK>
    <LicenceNumber>PA0739/003/003</LicenceNumber>
    <ProductName>CEPTON MEDICATED SKIN WASH</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Eastern Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022966</DrugIDPK>
    <LicenceNumber>PA0840/007/001</LicenceNumber>
    <ProductName>DONEPEZIL SYNTHON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022967</DrugIDPK>
    <LicenceNumber>PA0840/007/002</LicenceNumber>
    <ProductName>DONEPEZIL SYNTHON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005987</DrugIDPK>
    <LicenceNumber>PA0739/002/001</LicenceNumber>
    <ProductName>HEMOCANE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Eastern Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1995-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>BISMUTH OXIDE</ActiveSubstance>
      <ActiveSubstance>BENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>CINNAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021615</DrugIDPK>
    <LicenceNumber>PPA1328/029/001</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009812</DrugIDPK>
    <LicenceNumber>PA0849/004/001</LicenceNumber>
    <ProductName>FLEBOGAMMA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>g/l</StrengthMeasurement>
    <PAHolder>Instituto Grifols S.A.</PAHolder>
    <AuthorisedDate>2000-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN IMMUMOGLOBULINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034275</DrugIDPK>
    <LicenceNumber>PA0577/142/001</LicenceNumber>
    <ProductName>MODAFINIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MODAFINIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030184</DrugIDPK>
    <LicenceNumber>DPR1328/032/001</LicenceNumber>
    <ProductName>EZETROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031342</DrugIDPK>
    <LicenceNumber>PA1603/001/001</LicenceNumber>
    <ProductName>HAEMACCEL SOLUTION FOR INFUSION</ProductName>
    <Strength>17.5g/500m</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Piramal Healthcare UK Limited</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYGELINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027472</DrugIDPK>
    <LicenceNumber>PA0408/070/001</LicenceNumber>
    <ProductName>ALZMERAN XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LACTOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SILICA COLLOIDALIS ANHYDRICA</ActiveSubstance>
      <ActiveSubstance>POVIDONE (PVP K-30)</ActiveSubstance>
      <ActiveSubstance>TALC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036648</DrugIDPK>
    <LicenceNumber>PA0408/091/001</LicenceNumber>
    <ProductName>BELLSERT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036649</DrugIDPK>
    <LicenceNumber>PA0408/091/002</LicenceNumber>
    <ProductName>BELLSERT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032314</DrugIDPK>
    <LicenceNumber>PA0408/083/001</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032315</DrugIDPK>
    <LicenceNumber>PA0408/083/002</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031875</DrugIDPK>
    <LicenceNumber>PA0408/079/001</LicenceNumber>
    <ProductName>RISEDRONATE SODIUM ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003242</DrugIDPK>
    <LicenceNumber>PA0788/001/001</LicenceNumber>
    <ProductName>PROHANCE</ProductName>
    <Strength>279.3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bracco International B.V.</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOTERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034590</DrugIDPK>
    <LicenceNumber>PA0312/027/001</LicenceNumber>
    <ProductName>LEVETIRACETAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2012-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022470</DrugIDPK>
    <LicenceNumber>PA0281/100/003</LicenceNumber>
    <ProductName>TRAMAPINE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022471</DrugIDPK>
    <LicenceNumber>PA0281/100/004</LicenceNumber>
    <ProductName>TRAMAPINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008416</DrugIDPK>
    <LicenceNumber>PA0261/035/001</LicenceNumber>
    <ProductName>STERILISED WATER</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032872</DrugIDPK>
    <LicenceNumber>PA0711/192/001</LicenceNumber>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032873</DrugIDPK>
    <LicenceNumber>PA0711/192/002</LicenceNumber>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032874</DrugIDPK>
    <LicenceNumber>PA0711/192/003</LicenceNumber>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023713</DrugIDPK>
    <LicenceNumber>PA0711/134/004</LicenceNumber>
    <ProductName>CATASART</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038467</DrugIDPK>
    <LicenceNumber>PA0711/216/001</LicenceNumber>
    <ProductName>DEXKETOPROFEN ROWEX</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2013-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXKETOPROFEN TROMETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026468</DrugIDPK>
    <LicenceNumber>PA0711/144/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026469</DrugIDPK>
    <LicenceNumber>PA0711/144/002</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014537</DrugIDPK>
    <LicenceNumber>PA0711/011/011</LicenceNumber>
    <ProductName>NIFED RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034604</DrugIDPK>
    <LicenceNumber>PA0711/199/001</LicenceNumber>
    <ProductName>PIOGLITAZONE ROWEX</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034605</DrugIDPK>
    <LicenceNumber>PA0711/199/002</LicenceNumber>
    <ProductName>PIOGLITAZONE ROWEX</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034606</DrugIDPK>
    <LicenceNumber>PA0711/199/003</LicenceNumber>
    <ProductName>PIOGLITAZONE ROWEX</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995044746</DrugIDPK>
    <LicenceNumber>PA0840/014/001</LicenceNumber>
    <ProductName>TACAP</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2015-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005482</DrugIDPK>
    <LicenceNumber>PA0437/042/001</LicenceNumber>
    <ProductName>ATRACURIUM BESILATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATRACURIUM BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006447</DrugIDPK>
    <LicenceNumber>PA0437/042/002</LicenceNumber>
    <ProductName>ATRACURIUM BESILATE, VIAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATRACURIUM BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026330</DrugIDPK>
    <LicenceNumber>PA0437/061/001</LicenceNumber>
    <ProductName>FLUDARABINE PHOSPHATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2008-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDARABINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006184</DrugIDPK>
    <LicenceNumber>PA0437/024/002</LicenceNumber>
    <ProductName>NALOXONE HYDROCHLORIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034728</DrugIDPK>
    <LicenceNumber>PA1410/065/001</LicenceNumber>
    <ProductName>FLEXYESS</ProductName>
    <Strength>0.02/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2013-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE MICRONIZED</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL (AS BETADEX CLATHRATE MICRONIZED)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026413</DrugIDPK>
    <LicenceNumber>PA1410/019/001</LicenceNumber>
    <ProductName>LIOFORA</ProductName>
    <Strength>0.02 / 3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL (AS BETADEX-CLATHRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015074</DrugIDPK>
    <LicenceNumber>PA0111/005/001</LicenceNumber>
    <ProductName>CEFOTAXIME</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015075</DrugIDPK>
    <LicenceNumber>PA0111/005/002</LicenceNumber>
    <ProductName>CEFOTAXIME</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015076</DrugIDPK>
    <LicenceNumber>PA0111/005/003</LicenceNumber>
    <ProductName>CEFOTAXIME</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022008</DrugIDPK>
    <LicenceNumber>PA0979/015/008</LicenceNumber>
    <ProductName>GAVISCON SACHETS ORAL POWDER COOLMINT FLAVOUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROGEN CARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through: General Sale.  General sale: Maximum pack size 24 sachets</SupplyComments>
    <WithdrawalDate>2015-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031694</DrugIDPK>
    <LicenceNumber>PA1410/060/001</LicenceNumber>
    <ProductName>PALANDRA</ProductName>
    <Strength>0.03/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018725</DrugIDPK>
    <LicenceNumber>HOR0417/001/001</LicenceNumber>
    <ProductName>CALCIUM FLUORIDE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018737</DrugIDPK>
    <LicenceNumber>HOR0417/002/001</LicenceNumber>
    <ProductName>CALCIUM PHOSPHATE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018727</DrugIDPK>
    <LicenceNumber>HOR0417/003/001</LicenceNumber>
    <ProductName>CALCIUM SULPHATE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018728</DrugIDPK>
    <LicenceNumber>HOR0417/004/001</LicenceNumber>
    <ProductName>FERRUM PHOSPHORICUM</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018731</DrugIDPK>
    <LicenceNumber>HOR0417/007/001</LicenceNumber>
    <ProductName>KALIUM SULPHURICUM</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018732</DrugIDPK>
    <LicenceNumber>HOR0417/008/001</LicenceNumber>
    <ProductName>MAGNESIUM PHOSPHORICUM</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038718</DrugIDPK>
    <LicenceNumber>HOR0417/034/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION A BIOCHEMIC TISSUE SALTS</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2013-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038719</DrugIDPK>
    <LicenceNumber>HOR0417/035/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION B BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2013-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038720</DrugIDPK>
    <LicenceNumber>HOR0417/036/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION C BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2013-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM SULPHATE</ActiveSubstance>
      <ActiveSubstance>SILICON DIOXIDE, COLLOIDAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038721</DrugIDPK>
    <LicenceNumber>HOR0417/037/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION D BIOCHEMIC TISSUE SALTS</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2013-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>KALI SULPHURICUM</ActiveSubstance>
      <ActiveSubstance>SILICON DIOXIDE, COLLOIDAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038722</DrugIDPK>
    <LicenceNumber>HOR0417/038/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION E BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2013-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038723</DrugIDPK>
    <LicenceNumber>HOR0417/039/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION F BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2013-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILICON DIOXIDE, COLLOIDAL</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038724</DrugIDPK>
    <LicenceNumber>HOR0417/040/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION G BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2013-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
      <ActiveSubstance>CALCIUM FLUORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038725</DrugIDPK>
    <LicenceNumber>HOR0417/041/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION H BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
      <ActiveSubstance>SILICON DIOXIDE, COLLOIDAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038726</DrugIDPK>
    <LicenceNumber>HOR0417/042/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION I BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>KALI SULPHURICUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038727</DrugIDPK>
    <LicenceNumber>HOR0417/043/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION J BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038728</DrugIDPK>
    <LicenceNumber>HOR0417/044/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION K BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KALI SULPHURICUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
      <ActiveSubstance>SILICON DIOXIDE, COLLOIDAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038729</DrugIDPK>
    <LicenceNumber>HOR0417/045/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION L BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FLUORIDE</ActiveSubstance>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038730</DrugIDPK>
    <LicenceNumber>HOR0417/046/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION M BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038731</DrugIDPK>
    <LicenceNumber>HOR0417/047/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION N BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038732</DrugIDPK>
    <LicenceNumber>HOR0417/048/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION P BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FLUORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038733</DrugIDPK>
    <LicenceNumber>HOR0417/049/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION Q BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>KALI SULPHURICUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038734</DrugIDPK>
    <LicenceNumber>HOR0417/050/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION R BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FLUORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>FERRUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM PHOSPHORICUM</ActiveSubstance>
      <ActiveSubstance>SILICON DIOXIDE, COLLOIDAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038735</DrugIDPK>
    <LicenceNumber>HOR0417/051/001</LicenceNumber>
    <ProductName>NEW ERA COMBINATION S BIOCHEMIC TISSUE SALT</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2014-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018729</DrugIDPK>
    <LicenceNumber>HOR0417/005/001</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018730</DrugIDPK>
    <LicenceNumber>HOR0417/006/001</LicenceNumber>
    <ProductName>POTASSIUM DIHYDROGEN PHOSPHATE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018736</DrugIDPK>
    <LicenceNumber>HOR0417/012/001</LicenceNumber>
    <ProductName>SILICON DIOXIDE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILICON DIOXIDE, COLLOIDAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018733</DrugIDPK>
    <LicenceNumber>HOR0417/009/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018734</DrugIDPK>
    <LicenceNumber>HOR0417/010/001</LicenceNumber>
    <ProductName>SODIUM PHOSPHATE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018735</DrugIDPK>
    <LicenceNumber>HOR0417/011/001</LicenceNumber>
    <ProductName>SODIUM SULPHATE</ProductName>
    <Strength>6X</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039656</DrugIDPK>
    <LicenceNumber>PA1840/003/002</LicenceNumber>
    <ProductName>DOCETAXEL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Mg/4Ml</StrengthMeasurement>
    <PAHolder>Seacross Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2013-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014640</DrugIDPK>
    <LicenceNumber>PA0549/011/001</LicenceNumber>
    <ProductName>DOLFLASH</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Section 6:
General sale in blister packs containing not more than 12 unit dosage forms.   The product concerned should contain paracetamol as its only active analgesic substance and only one pack should be supplied in the course of any one retail transaction.

Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.

Packs containing more than 24 unit dosage forms may be supplied to pharmacies for use by pharmacists provided the label states that they are for dispensing purposes only.

Packs containing more than 50 unit dosage forms are prescription only.

Section 7:
Promotion to the general public for packs containing not more than 24 unit dosage forms.

Promotion to healthcare professionals only for packs containing more than 24 unit dosage forms</SupplyComments>
    <WithdrawalDate>2015-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003757</DrugIDPK>
    <LicenceNumber>PA0115/002/001</LicenceNumber>
    <ProductName>FLUANXOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003758</DrugIDPK>
    <LicenceNumber>PA0115/002/002</LicenceNumber>
    <ProductName>FLUANXOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031683</DrugIDPK>
    <LicenceNumber>PA0281/145/001</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>PINACLAV</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034375</DrugIDPK>
    <LicenceNumber>PA1271/003/001</LicenceNumber>
    <ProductName>PUGRITEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034376</DrugIDPK>
    <LicenceNumber>PA1271/003/002</LicenceNumber>
    <ProductName>PUGRITEX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023121</DrugIDPK>
    <LicenceNumber>PA0019/054/001</LicenceNumber>
    <ProductName>SAYANA 104 MG/0.65 ML SUSPENSION FOR INJECTION</ProductName>
    <Strength>104mg /0.6</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031803</DrugIDPK>
    <LicenceNumber>PA0019/054/002</LicenceNumber>
    <ProductName>SAYANA PRESS</ProductName>
    <Strength>104/0.65</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033851</DrugIDPK>
    <LicenceNumber>PA1009/024/001</LicenceNumber>
    <ProductName>SODIUM PICOSULFATE FERRING</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PICOSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033852</DrugIDPK>
    <LicenceNumber>PA1009/024/002</LicenceNumber>
    <ProductName>SODIUM PICOSULFATE FERRING</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PICOSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020383</DrugIDPK>
    <LicenceNumber>PA1226/005/002</LicenceNumber>
    <ProductName>VANCOCIN MATRIGEL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VANCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043557</DrugIDPK>
    <LicenceNumber>PA1404/004/001</LicenceNumber>
    <ProductName>VITAROS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Recordati Ireland Limited</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995043558</DrugIDPK>
    <LicenceNumber>PA1404/004/002</LicenceNumber>
    <ProductName>VITAROS</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Recordati Ireland Limited</PAHolder>
    <AuthorisedDate>2014-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022995</DrugIDPK>
    <LicenceNumber>EU/1/08/450/1-4</LicenceNumber>
    <ProductName>BIOGRASTIM</ProductName>
    <Strength>30/0.5</Strength>
    <StrengthMeasurement>MU/ml</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2008-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2015-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022996</DrugIDPK>
    <LicenceNumber>EU/1/08/450/5-8</LicenceNumber>
    <ProductName>BIOGRASTIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>MU/ml</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2008-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2015-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027924</DrugIDPK>
    <LicenceNumber>PA0979/057/001</LicenceNumber>
    <ProductName>STREPSILS ORIGINAL</ProductName>
    <Strength>0.6/1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMYLMETACRESOL</ActiveSubstance>
      <ActiveSubstance>2, 4-DICHLOROBENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040908</DrugIDPK>
    <LicenceNumber>PA0678/116/002</LicenceNumber>
    <ProductName>POLYTAR EMOLLIENT</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2013-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>CADE OIL</ActiveSubstance>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039024</DrugIDPK>
    <LicenceNumber>PA0678/116/001</LicenceNumber>
    <ProductName>POLYTAR LIQUID</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>CADE OIL</ActiveSubstance>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029602</DrugIDPK>
    <LicenceNumber>PA0979/036/001</LicenceNumber>
    <ProductName>DEQUADIN 0.25 MG LOZENGES</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038644</DrugIDPK>
    <LicenceNumber>PA0979/064/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030995</DrugIDPK>
    <LicenceNumber>PA0979/059/001</LicenceNumber>
    <ProductName>NUROFEN 200MG EFFERVESCENT TABLETS.</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription (if compliant with restrictions outlined below). 
Retail sale through pharmacies only with the following restrictions: limited indications, maximum pack size: 50 unit dosage forms, maximum strength: 200 mg, maximum dose: 400 mg, maximum daily dose: 1200 m</SupplyComments>
    <WithdrawalDate>2015-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004580</DrugIDPK>
    <LicenceNumber>PA0013/087/004</LicenceNumber>
    <ProductName>VOLTAROL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016122</DrugIDPK>
    <LicenceNumber>PA1077/029/002</LicenceNumber>
    <ProductName>INFANRIX IPV &amp; HIB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2003-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS VACCINE ADSORBED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033195</DrugIDPK>
    <LicenceNumber>PPA1328/076/002</LicenceNumber>
    <ProductName>NEBILET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEBIVOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033943</DrugIDPK>
    <LicenceNumber>PPA1562/031/001</LicenceNumber>
    <ProductName>URSOFALK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>URSODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035560</DrugIDPK>
    <LicenceNumber>PA1521/002/001</LicenceNumber>
    <ProductName>GLUSAMIN</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULPHATE SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041055</DrugIDPK>
    <LicenceNumber>PA1521/002/002</LicenceNumber>
    <ProductName>GLUSAMIN</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>2014-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULFATE SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041972</DrugIDPK>
    <LicenceNumber>PA1691/015/001</LicenceNumber>
    <ProductName>GRACIAL 25/40 AND 125/30 MICROGRAM TABLETS.</ProductName>
    <Strength>25/40 and</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Aspen Pharma Trading Limited</PAHolder>
    <AuthorisedDate>2014-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>DESOGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002672</DrugIDPK>
    <LicenceNumber>PA0050/017/002</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029016</DrugIDPK>
    <LicenceNumber>PA1391/002/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Farmaprojects S.A.</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031023</DrugIDPK>
    <LicenceNumber>PA0823/060/001</LicenceNumber>
    <ProductName>IMODIUM PLUS 2MG/125MG CHEWABLE TABLETS</ProductName>
    <Strength>2 mg/125mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPERAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022969</DrugIDPK>
    <LicenceNumber>EU/1/08/452/1</LicenceNumber>
    <ProductName>PANDEMRIX</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Biologicals S.A.</PAHolder>
    <AuthorisedDate>2008-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1)V LIKE STRAIN (X-179A)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007361</DrugIDPK>
    <LicenceNumber>PA0126/103/001</LicenceNumber>
    <ProductName>CLAVAMEL</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007362</DrugIDPK>
    <LicenceNumber>PA0126/103/002</LicenceNumber>
    <ProductName>CLAVAMEL PEDIATRIC</ProductName>
    <Strength>125/31.25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034001</DrugIDPK>
    <LicenceNumber>PA0126/103/006</LicenceNumber>
    <ProductName>CO-AMOXICLAV</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010717</DrugIDPK>
    <LicenceNumber>PA0740/002/001</LicenceNumber>
    <ProductName>MELOXAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015650</DrugIDPK>
    <LicenceNumber>PA1077/003/001</LicenceNumber>
    <ProductName>BETNOVATE-N 0.1% / 0.5% W/W CREAM</ProductName>
    <Strength>0.1/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2004-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035695</DrugIDPK>
    <LicenceNumber>PA1688/003/001</LicenceNumber>
    <ProductName>CODALAX</ProductName>
    <Strength>200mg/25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXALCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035696</DrugIDPK>
    <LicenceNumber>PA1688/003/002</LicenceNumber>
    <ProductName>CODALAX FORTE</ProductName>
    <Strength>500mg/37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXALCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038096</DrugIDPK>
    <LicenceNumber>PA1688/014/001</LicenceNumber>
    <ProductName>IFFEZA</ProductName>
    <Strength>50/5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038097</DrugIDPK>
    <LicenceNumber>PA1688/014/002</LicenceNumber>
    <ProductName>IFFEZA</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038098</DrugIDPK>
    <LicenceNumber>PA1688/014/003</LicenceNumber>
    <ProductName>IFFEZA</ProductName>
    <Strength>250/10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005602</DrugIDPK>
    <LicenceNumber>PA0282/063/004</LicenceNumber>
    <ProductName>SERENACE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028252</DrugIDPK>
    <LicenceNumber>PA1487/001/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>ANASTROZOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Welding GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038952</DrugIDPK>
    <LicenceNumber>PA0441/045/001</LicenceNumber>
    <ProductName>TEVA COLD RELIEF</ProductName>
    <Strength>200/30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>2014-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Promotion to the public subject to the following restrictions: maximum strength 200 mg, maximum pack size 50, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indications.  

For use in adults and children not under 15 years</SupplyComments>
    <WithdrawalDate>2015-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035075</DrugIDPK>
    <LicenceNumber>PA0822/084/001</LicenceNumber>
    <ProductName>KUDEQ</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035076</DrugIDPK>
    <LicenceNumber>PA0822/084/002</LicenceNumber>
    <ProductName>KUDEQ</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039010</DrugIDPK>
    <LicenceNumber>PA1864/002/001</LicenceNumber>
    <ProductName>DEXLANSOPRAZOLE TAKEDA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXLANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039011</DrugIDPK>
    <LicenceNumber>PA1864/002/002</LicenceNumber>
    <ProductName>DEXLANSOPRAZOLE TAKEDA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXLANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039008</DrugIDPK>
    <LicenceNumber>PA1864/001/001</LicenceNumber>
    <ProductName>GLADEXA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXLANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039009</DrugIDPK>
    <LicenceNumber>PA1864/001/002</LicenceNumber>
    <ProductName>GLADEXA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>2013-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXLANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022163</DrugIDPK>
    <LicenceNumber>PA0967/008/002</LicenceNumber>
    <ProductName>LIPOVAS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022164</DrugIDPK>
    <LicenceNumber>PA0967/008/003</LicenceNumber>
    <ProductName>LIPOVAS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022161</DrugIDPK>
    <LicenceNumber>PA0967/008/001</LicenceNumber>
    <ProductName>LIPOVAS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032188</DrugIDPK>
    <LicenceNumber>EU/1/11/686/043-056</LicenceNumber>
    <ProductName>RASILAMLO</ProductName>
    <Strength>300/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034173</DrugIDPK>
    <LicenceNumber>PA0749/141/001</LicenceNumber>
    <ProductName>BUDESONIDE TEVA</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mg/2ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022717</DrugIDPK>
    <LicenceNumber>PA0749/041/001</LicenceNumber>
    <ProductName>FLUCONAZOLE TEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036030</DrugIDPK>
    <LicenceNumber>PA0749/153/001</LicenceNumber>
    <ProductName>NEBRIS STERI-NEB</ProductName>
    <Strength>300/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022700</DrugIDPK>
    <LicenceNumber>PA0749/042/001</LicenceNumber>
    <ProductName>OMEPRAZOLE TEVA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016769</DrugIDPK>
    <LicenceNumber>PA0408/057/001</LicenceNumber>
    <ProductName>BELLISIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2003-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016770</DrugIDPK>
    <LicenceNumber>PA0408/057/002</LicenceNumber>
    <ProductName>BELLISIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2003-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016771</DrugIDPK>
    <LicenceNumber>PA0408/057/003</LicenceNumber>
    <ProductName>BELLISIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2003-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016772</DrugIDPK>
    <LicenceNumber>PA0408/057/004</LicenceNumber>
    <ProductName>BELLISIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2003-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027046</DrugIDPK>
    <LicenceNumber>PA0408/067/001</LicenceNumber>
    <ProductName>IRBESARTAN RANBAXY</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027047</DrugIDPK>
    <LicenceNumber>PA0408/067/002</LicenceNumber>
    <ProductName>IRBESARTAN RANBAXY</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027048</DrugIDPK>
    <LicenceNumber>PA0408/067/003</LicenceNumber>
    <ProductName>IRBESARTAN RANBAXY</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036109</DrugIDPK>
    <LicenceNumber>PPA1562/060/001</LicenceNumber>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006152</DrugIDPK>
    <LicenceNumber>PA0409/006/001</LicenceNumber>
    <ProductName>HEPARIN SODIUM</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1985-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006153</DrugIDPK>
    <LicenceNumber>PA0409/006/002</LicenceNumber>
    <ProductName>HEPARIN SODIUM</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1986-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029204</DrugIDPK>
    <LicenceNumber>PA0577/114/001</LicenceNumber>
    <InterchangeableListCode>IC0007-001-038</InterchangeableListCode>
    <ProductName>ARKOLAMYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029205</DrugIDPK>
    <LicenceNumber>PA0577/114/002</LicenceNumber>
    <InterchangeableListCode>IC0007-002-038</InterchangeableListCode>
    <ProductName>ARKOLAMYL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029206</DrugIDPK>
    <LicenceNumber>PA0577/114/003</LicenceNumber>
    <InterchangeableListCode>IC0007-032-038</InterchangeableListCode>
    <ProductName>ARKOLAMYL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029207</DrugIDPK>
    <LicenceNumber>PA0577/114/004</LicenceNumber>
    <InterchangeableListCode>IC0007-003-038</InterchangeableListCode>
    <ProductName>ARKOLAMYL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006971</DrugIDPK>
    <LicenceNumber>PA0281/076/001</LicenceNumber>
    <ProductName>CANAZOLE CLOTRIMAZOLE</ProductName>
    <Strength>1.00</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2000-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034250</DrugIDPK>
    <LicenceNumber>PA0822/076/001</LicenceNumber>
    <ProductName>DONEPEZIL PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034251</DrugIDPK>
    <LicenceNumber>PA0822/076/002</LicenceNumber>
    <ProductName>DONEPEZIL PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040315</DrugIDPK>
    <LicenceNumber>EU/1/14/912/001-005</LicenceNumber>
    <ProductName>ZOLEDRONIC ACID TEVA GENERICS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Generics B.V.</PAHolder>
    <AuthorisedDate>2014-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLEDRONIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product
Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2015-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005472</DrugIDPK>
    <LicenceNumber>PA0047/089/001</LicenceNumber>
    <ProductName>HUMULIN S KWIKPEN (SOLUBLE)</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019005</DrugIDPK>
    <LicenceNumber>PA0789/013/001</LicenceNumber>
    <ProductName>ETOPOSID "EBEWE"</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETOPOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009081</DrugIDPK>
    <LicenceNumber>PA0047/079/002</LicenceNumber>
    <ProductName>GEMZAR 1 G POWDER FOR SOLUTION FOR INFUSION.</ProductName>
    <Strength>1 g</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009080</DrugIDPK>
    <LicenceNumber>PA0047/079/001</LicenceNumber>
    <ProductName>GEMZAR 200 MG POWDER FOR SOLUTION FOR INFUSION.</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029368</DrugIDPK>
    <LicenceNumber>PA0840/010/001</LicenceNumber>
    <ProductName>RALOXIEP</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2009-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RALOXIFENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007826</DrugIDPK>
    <LicenceNumber>EU/1/99/102/002</LicenceNumber>
    <ProductName>SONATA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007827</DrugIDPK>
    <LicenceNumber>EU/1/99/102/003</LicenceNumber>
    <ProductName>SONATA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007829</DrugIDPK>
    <LicenceNumber>EU/1/99/102/005</LicenceNumber>
    <ProductName>SONATA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007830</DrugIDPK>
    <LicenceNumber>EU/1/99/102/006</LicenceNumber>
    <ProductName>SONATA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006021</DrugIDPK>
    <LicenceNumber>EU/1/99/102/001</LicenceNumber>
    <ProductName>SONATA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006022</DrugIDPK>
    <LicenceNumber>EU/1/99/102/004</LicenceNumber>
    <ProductName>SONATA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029001</DrugIDPK>
    <LicenceNumber>PA0789/017/001</LicenceNumber>
    <ProductName>DOCETAXEL EBEWE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2015-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035494</DrugIDPK>
    <LicenceNumber>PA1719/001/001</LicenceNumber>
    <ProductName>POSIJECT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Primex Pharmaceuticals Oy</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022486</DrugIDPK>
    <LicenceNumber>PA0167/127/001</LicenceNumber>
    <ProductName>FLUCONAZOLE REDIBAG</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018351</DrugIDPK>
    <LicenceNumber>PA0281/118/001</LicenceNumber>
    <ProductName>LOSEPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2004-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018353</DrugIDPK>
    <LicenceNumber>PA0281/118/002</LicenceNumber>
    <ProductName>LOSEPINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2004-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037200</DrugIDPK>
    <LicenceNumber>PA0281/150/002</LicenceNumber>
    <ProductName>TORVAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037201</DrugIDPK>
    <LicenceNumber>PA0281/150/003</LicenceNumber>
    <ProductName>TORVAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032186</DrugIDPK>
    <LicenceNumber>EU/1/11/686/015-028</LicenceNumber>
    <ProductName>RASILAMLO</ProductName>
    <Strength>150/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032187</DrugIDPK>
    <LicenceNumber>EU/1/11/686/029-042</LicenceNumber>
    <ProductName>RASILAMLO</ProductName>
    <Strength>300/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001357</DrugIDPK>
    <LicenceNumber>PA0417/007/002</LicenceNumber>
    <ProductName>MINADEX TONIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1995-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>FERRIC AMMONIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021676</DrugIDPK>
    <LicenceNumber>PA1332/011/001</LicenceNumber>
    <ProductName>ASCAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2006-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBASALATE CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032557</DrugIDPK>
    <LicenceNumber>PPA1463/036/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035561</DrugIDPK>
    <LicenceNumber>PA1521/003/001</LicenceNumber>
    <ProductName>GLUCOSAMINE SULFATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULPHATE SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031474</DrugIDPK>
    <LicenceNumber>PA0281/144/002</LicenceNumber>
    <ProductName>LOZITAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2009-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031475</DrugIDPK>
    <LicenceNumber>PA0281/144/003</LicenceNumber>
    <ProductName>LOZITAR COMP</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2009-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031749</DrugIDPK>
    <LicenceNumber>PA0281/144/001</LicenceNumber>
    <ProductName>LOZITAR COMP</ProductName>
    <Strength>100/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016199</DrugIDPK>
    <LicenceNumber>PA1077/050/005</LicenceNumber>
    <ProductName>VIANI 125 EVOHALER</ProductName>
    <Strength>25/125</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016200</DrugIDPK>
    <LicenceNumber>PA1077/050/006</LicenceNumber>
    <ProductName>VIANI 250 EVOHALER</ProductName>
    <Strength>25/250</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016198</DrugIDPK>
    <LicenceNumber>PA1077/050/004</LicenceNumber>
    <ProductName>VIANI 50 EVOHALER</ProductName>
    <Strength>25/50</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016195</DrugIDPK>
    <LicenceNumber>PA1077/050/001</LicenceNumber>
    <ProductName>VIANI DISKUS</ProductName>
    <Strength>50/100mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016196</DrugIDPK>
    <LicenceNumber>PA1077/050/002</LicenceNumber>
    <ProductName>VIANI DISKUS</ProductName>
    <Strength>50/250mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016197</DrugIDPK>
    <LicenceNumber>PA1077/050/003</LicenceNumber>
    <ProductName>VIANI DISKUS</ProductName>
    <Strength>50/500mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003459</DrugIDPK>
    <LicenceNumber>PA0789/003/001</LicenceNumber>
    <ProductName>CARBOPLATIN "EBEWE"</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011657</DrugIDPK>
    <LicenceNumber>PA0789/002/005</LicenceNumber>
    <ProductName>CISPLATIN "EBEWE"</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2001-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003447</DrugIDPK>
    <LicenceNumber>PA0789/002/001</LicenceNumber>
    <ProductName>CISPLATIN 'EBEWE'</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003351</DrugIDPK>
    <LicenceNumber>PA0789/001/001</LicenceNumber>
    <ProductName>DOXORUBICIN EBEWE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021751</DrugIDPK>
    <LicenceNumber>PA0789/014/001</LicenceNumber>
    <ProductName>EBETAXEL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005890</DrugIDPK>
    <LicenceNumber>PA0789/005/001</LicenceNumber>
    <ProductName>FLUOROURACIL "EBEWE"</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2002-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009583</DrugIDPK>
    <LicenceNumber>PA0789/011/001</LicenceNumber>
    <ProductName>FOLINIC ACID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009584</DrugIDPK>
    <LicenceNumber>PA0789/011/002</LicenceNumber>
    <ProductName>FOLINIC ACID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032290</DrugIDPK>
    <LicenceNumber>PA0789/022/001</LicenceNumber>
    <ProductName>GEMCITABINE EBEWE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2011-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037645</DrugIDPK>
    <LicenceNumber>PA0789/024/001</LicenceNumber>
    <ProductName>LEVOFOLINIC ACID EBEWE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM LEVOFOLINATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031183</DrugIDPK>
    <LicenceNumber>PA0789/020/001</LicenceNumber>
    <ProductName>METHOTREXATE EBEWE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028083</DrugIDPK>
    <LicenceNumber>PA0789/016/001</LicenceNumber>
    <ProductName>OXALIPLATIN EBEWE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031577</DrugIDPK>
    <LicenceNumber>PA0789/016/002</LicenceNumber>
    <ProductName>OXALIPLATIN EBEWE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035375</DrugIDPK>
    <LicenceNumber>PA0789/023/001</LicenceNumber>
    <ProductName>PALAT</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2011-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031182</DrugIDPK>
    <LicenceNumber>PA0789/021/001</LicenceNumber>
    <ProductName>TOPOTECAN EBEWE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2015-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029315</DrugIDPK>
    <LicenceNumber>PA0789/018/001</LicenceNumber>
    <ProductName>IRINOTECAN EBEWE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028809</DrugIDPK>
    <LicenceNumber>PA1521/001/001</LicenceNumber>
    <ProductName>ARTHRIAID</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028810</DrugIDPK>
    <LicenceNumber>PA1521/001/002</LicenceNumber>
    <ProductName>ARTHRIAID</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028811</DrugIDPK>
    <LicenceNumber>PA1521/001/003</LicenceNumber>
    <ProductName>ARTHRIAID</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028146</DrugIDPK>
    <LicenceNumber>PA1327/014/001</LicenceNumber>
    <ProductName>VANTAS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HISTRELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032886</DrugIDPK>
    <LicenceNumber>PA0126/207/001</LicenceNumber>
    <ProductName>CANDIST PLUS</ProductName>
    <Strength>8/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022873</DrugIDPK>
    <LicenceNumber>PA0979/004/003</LicenceNumber>
    <ProductName>DETTOL MED</ProductName>
    <Strength>4.8</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008873</DrugIDPK>
    <LicenceNumber>PA0258/045/001</LicenceNumber>
    <ProductName>MEDINOL OVER 6</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in child resistant packs containing not more than 70 ml of the 250mg/5ml unit dosage form.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.
Prescription only for any pack size exceeding 70ml content of the 250mg/5ml unit dosage form.</SupplyComments>
    <WithdrawalDate>2015-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005346</DrugIDPK>
    <LicenceNumber>PA0258/015/001</LicenceNumber>
    <ProductName>MEDINOL UNDER 6 PARACETAMOL ORAL SUSPENSION</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in child resistant packs containing not more than 140 ml of the 120mg/5ml unit dosage form.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.
Prescription only for any pack size exceeding 140ml content of the 120mg/5ml unit dosage form.</SupplyComments>
    <WithdrawalDate>2015-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020504</DrugIDPK>
    <LicenceNumber>PA1063/021/001</LicenceNumber>
    <ProductName>PROLOSIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011484</DrugIDPK>
    <LicenceNumber>EU/2/02/031/001</LicenceNumber>
    <ProductName>EURIFEL RCP - FELV</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Merial Animal Health Limited</PAHolder>
    <AuthorisedDate>2002-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032396</DrugIDPK>
    <LicenceNumber>PA0979/061/001</LicenceNumber>
    <ProductName>KARVOL DECONGESTANT CAPSULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2010-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>PINE OIL SYLVESTRIS BLEND</ActiveSubstance>
      <ActiveSubstance>TERPINEOL</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
      <ActiveSubstance>PUMILIO PINE OIL BLEND</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030517</DrugIDPK>
    <LicenceNumber>EU/1/09/560/001-9</LicenceNumber>
    <ProductName>CLOPIDOGREL DURA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mylan dura GmbH</PAHolder>
    <AuthorisedDate>2009-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037341</DrugIDPK>
    <LicenceNumber>EU/1/13/867/001</LicenceNumber>
    <ProductName>PROVENGE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Dendreon UK Ltd</PAHolder>
    <AuthorisedDate>2013-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR CELLS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal products on “restricted” medical prescription, reserved for use in certain specialised areas (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2015-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022862</DrugIDPK>
    <LicenceNumber>PA0577/096/001</LicenceNumber>
    <ProductName>RISPERGER</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022863</DrugIDPK>
    <LicenceNumber>PA0577/096/002</LicenceNumber>
    <ProductName>RISPERGER</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022864</DrugIDPK>
    <LicenceNumber>PA0577/096/003</LicenceNumber>
    <ProductName>RISPERGER</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022865</DrugIDPK>
    <LicenceNumber>PA0577/096/004</LicenceNumber>
    <ProductName>RISPERGER</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020270</DrugIDPK>
    <LicenceNumber>PA0823/049/009</LicenceNumber>
    <ProductName>NICORETTE INHALER 10MG</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour, Cartridge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020287</DrugIDPK>
    <LicenceNumber>PA0823/049/010</LicenceNumber>
    <ProductName>NICORETTE MICROTAB</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE B-CYCLODEXTRIN COMPLEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036425</DrugIDPK>
    <LicenceNumber>PA1107/009/001</LicenceNumber>
    <ProductName>VOLTAROL OPHTHA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Laboratoires Thea</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036428</DrugIDPK>
    <LicenceNumber>PA1107/010/002</LicenceNumber>
    <ProductName>ZADITEN</ProductName>
    <Strength>0.25/1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Laboratoires Thea</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOTIFEN FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031261</DrugIDPK>
    <LicenceNumber>PA0789/019/003</LicenceNumber>
    <ProductName>GEMCITABINE EBEWE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABIN HCL</ActiveSubstance>
      <ActiveSubstance>GEMCITABIN HCL</ActiveSubstance>
      <ActiveSubstance>GEMCITABIN HCL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027573</DrugIDPK>
    <LicenceNumber>DPR1473/033/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027574</DrugIDPK>
    <LicenceNumber>DPR1473/033/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027582</DrugIDPK>
    <LicenceNumber>DPR1473/033/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033899</DrugIDPK>
    <LicenceNumber>PA0979/041/002</LicenceNumber>
    <ProductName>STREPSILS INTENSIVE</ProductName>
    <Strength>8.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2013-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription if compliant with the following restrictions: maximum strenth: 8.75 mg, maximum pack size 16 sachets (140 mg), maximum daily dose: 43.75 mg, for use in adults and children not under 12 years.</SupplyComments>
    <WithdrawalDate>2015-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033900</DrugIDPK>
    <LicenceNumber>PA0979/041/003</LicenceNumber>
    <ProductName>STREPSILS INTENSIVE MINT</ProductName>
    <Strength>8.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2013-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription if compliant with the following restrictions: maximum strenth: 8.75 mg, maximum pack size 16 sachets (140 mg), maximum daily dose: 43.75 mg, for use in adults and children not under 12 years.</SupplyComments>
    <WithdrawalDate>2015-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028758</DrugIDPK>
    <LicenceNumber>PA0577/115/001</LicenceNumber>
    <ProductName>SIMZOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028759</DrugIDPK>
    <LicenceNumber>PA0577/115/002</LicenceNumber>
    <ProductName>SIMZOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028760</DrugIDPK>
    <LicenceNumber>PA0577/115/003</LicenceNumber>
    <ProductName>SIMZOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028761</DrugIDPK>
    <LicenceNumber>PA0577/115/004</LicenceNumber>
    <ProductName>SIMZOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027473</DrugIDPK>
    <LicenceNumber>PA0711/150/001</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027474</DrugIDPK>
    <LicenceNumber>PA0711/150/002</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027475</DrugIDPK>
    <LicenceNumber>PA0711/150/003</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035502</DrugIDPK>
    <LicenceNumber>PA0711/201/002</LicenceNumber>
    <ProductName>YOSQIERO</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2012-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034625</DrugIDPK>
    <LicenceNumber>PA1077/129/001</LicenceNumber>
    <ProductName>STIEMYCIN</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020988</DrugIDPK>
    <LicenceNumber>PA0711/095/002</LicenceNumber>
    <ProductName>AMOCLAV DUO</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006602</DrugIDPK>
    <LicenceNumber>PA0710/005/001</LicenceNumber>
    <ProductName>IODOFLEX</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Smith &amp; Nephew Pharmaceuticals</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CADEXOMER IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022345</DrugIDPK>
    <LicenceNumber>PA0711/123/001</LicenceNumber>
    <ProductName>LOTANOS</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030083</DrugIDPK>
    <LicenceNumber>PA0405/057/001</LicenceNumber>
    <ProductName>REMIFENTANIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030084</DrugIDPK>
    <LicenceNumber>PA0405/057/002</LicenceNumber>
    <ProductName>REMIFENTANIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039111</DrugIDPK>
    <LicenceNumber>PA1547/005/003</LicenceNumber>
    <ProductName>XEFO 8MG POWDER AND SOLVENT FOR SOLUTION FOR INJEC</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda UK Limited</PAHolder>
    <AuthorisedDate>2013-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORNOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031247</DrugIDPK>
    <LicenceNumber>PA0577/125/004</LicenceNumber>
    <ProductName>AMISULPRIDE MYLAN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019247</DrugIDPK>
    <LicenceNumber>PA0577/062/001</LicenceNumber>
    <ProductName>AMLIST</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019248</DrugIDPK>
    <LicenceNumber>PA0577/062/002</LicenceNumber>
    <ProductName>AMLIST</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022210</DrugIDPK>
    <LicenceNumber>PA0749/034/001</LicenceNumber>
    <ProductName>ARIPEZ</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022211</DrugIDPK>
    <LicenceNumber>PA0749/034/002</LicenceNumber>
    <ProductName>ARIPEZ</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001840</DrugIDPK>
    <LicenceNumber>PA0577/020/001</LicenceNumber>
    <ProductName>DOTHEP</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOSULEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009402</DrugIDPK>
    <LicenceNumber>PA0577/020/002</LicenceNumber>
    <ProductName>DOTHEP</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOSULEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033403</DrugIDPK>
    <LicenceNumber>PA0577/137/001</LicenceNumber>
    <ProductName>ENTACAPONE MYLAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENTACAPONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023387</DrugIDPK>
    <LicenceNumber>PA0749/055/001</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023388</DrugIDPK>
    <LicenceNumber>PA0749/055/002</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009290</DrugIDPK>
    <LicenceNumber>PA0577/008/001</LicenceNumber>
    <ProductName>GERINAP E.C.</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009292</DrugIDPK>
    <LicenceNumber>PA0577/008/002</LicenceNumber>
    <ProductName>GERINAP E.C.</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016807</DrugIDPK>
    <LicenceNumber>PA0577/046/002</LicenceNumber>
    <ProductName>HISTACLAR ALLERGY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Supply through pharmacies only and promotion to the  public subject to the following restrictions: maximum pack size 10 unit dosage forms, maximum strength: 10 mg, maximum daily dose: 10 mg.</SupplyComments>
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035617</DrugIDPK>
    <LicenceNumber>PA0577/152/001</LicenceNumber>
    <ProductName>LOSARTAN / HYDROCHLOROTHIAZIDE MYLAN</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035619</DrugIDPK>
    <LicenceNumber>PA0577/152/003</LicenceNumber>
    <ProductName>LOSARTAN / HYDROCHLOROTHIAZIDE MYLAN</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035781</DrugIDPK>
    <LicenceNumber>PA0749/026/003</LicenceNumber>
    <ProductName>LOSARTAN/HYDROCHLOROTHIAZIDE TEVA</ProductName>
    <Strength>100/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHOLOTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006053</DrugIDPK>
    <LicenceNumber>PA0405/022/001</LicenceNumber>
    <ProductName>MIANSERIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIANSERIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006054</DrugIDPK>
    <LicenceNumber>PA0405/022/003</LicenceNumber>
    <ProductName>MIANSERIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIANSERIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020940</DrugIDPK>
    <LicenceNumber>PA0577/078/001</LicenceNumber>
    <ProductName>MIGRASTAT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020970</DrugIDPK>
    <LicenceNumber>PA0577/078/002</LicenceNumber>
    <ProductName>MIGRASTAT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031722</DrugIDPK>
    <LicenceNumber>PA0577/126/001</LicenceNumber>
    <ProductName>MYCOPHENOLATE MOFETIL MYLAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MYCOPHENOLATE MOFETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022622</DrugIDPK>
    <LicenceNumber>PA0577/094/001</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022623</DrugIDPK>
    <LicenceNumber>PA0577/094/002</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022625</DrugIDPK>
    <LicenceNumber>PA0577/094/004</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028107</DrugIDPK>
    <LicenceNumber>PA0749/084/004</LicenceNumber>
    <ProductName>VALSARTAN TEVA</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021157</DrugIDPK>
    <LicenceNumber>PA0577/084/002</LicenceNumber>
    <ProductName>ZIRTENE ALLERGY 10MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription (if compliant with restrictions outlined below). 
Retail sale through pharmacies only with the following restrictions: maximum pack size: 10 unit dosage forms, maximum strength: 10 mg, maximum daily dose: 10 mg.  

Promotion to the public with the following restrictions: maximum pack size: 10 unit dosage forms, maximum strength: 10 mg, maximum daily dose: 10 mg.</SupplyComments>
    <WithdrawalDate>2015-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031942</DrugIDPK>
    <LicenceNumber>PA0405/055/003</LicenceNumber>
    <ProductName>GEMCITABINE MYLAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2010-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036835</DrugIDPK>
    <LicenceNumber>EU/1/12/804/001-010</LicenceNumber>
    <ProductName>BINDREN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mitsubishi Pharma Europe Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLESTILAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036836</DrugIDPK>
    <LicenceNumber>EU/1/12/804/011-013</LicenceNumber>
    <ProductName>BINDREN</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mitsubishi Pharma Europe Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLESTILAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036837</DrugIDPK>
    <LicenceNumber>EU/1/12/804/014-016</LicenceNumber>
    <ProductName>BINDREN</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mitsubishi Pharma Europe Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLESTILAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038056</DrugIDPK>
    <LicenceNumber>PA1390/017/003</LicenceNumber>
    <ProductName>RANITIDINE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2013-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE (FORM II)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Promotion to the public: Maximum pack size: 24.</SupplyComments>
    <WithdrawalDate>2015-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009655</DrugIDPK>
    <LicenceNumber>PA0577/039/001</LicenceNumber>
    <ProductName>GERFORMIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009656</DrugIDPK>
    <LicenceNumber>PA0577/039/002</LicenceNumber>
    <ProductName>GERFORMIN</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027969</DrugIDPK>
    <LicenceNumber>PA1504/001/001</LicenceNumber>
    <ProductName>MAGNEGITA</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>Agfa Healthcare Imaging Agents GmbH</PAHolder>
    <AuthorisedDate>2008-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOPENTETATE DIMEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034395</DrugIDPK>
    <LicenceNumber>PA1022/016/001</LicenceNumber>
    <ProductName>BARICAT</ProductName>
    <Strength>49.2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bracco UK Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cachet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>2015-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029601</DrugIDPK>
    <LicenceNumber>PA0979/035/001</LicenceNumber>
    <ProductName>DEQUACAINE LOZENGES, BENZOCAINE 10 MG, DEQUALINIUM</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010612</DrugIDPK>
    <LicenceNumber>PA0998/001/001</LicenceNumber>
    <ProductName>DR. SCHEFFLER VITAMIN C</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. B. Scheffler Nachf GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036796</DrugIDPK>
    <LicenceNumber>PA0995/010/001</LicenceNumber>
    <ProductName>ATORVASTATIN BILLEV PHARMA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Billev Pharma ApS</PAHolder>
    <AuthorisedDate>2012-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036797</DrugIDPK>
    <LicenceNumber>PA0995/010/002</LicenceNumber>
    <ProductName>ATORVASTATIN BILLEV PHARMA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Billev Pharma ApS</PAHolder>
    <AuthorisedDate>2012-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036798</DrugIDPK>
    <LicenceNumber>PA0995/010/003</LicenceNumber>
    <ProductName>ATORVASTATIN BILLEV PHARMA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Billev Pharma ApS</PAHolder>
    <AuthorisedDate>2012-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038142</DrugIDPK>
    <LicenceNumber>PA1647/009/001</LicenceNumber>
    <ProductName>LEVETIRACETAM PENSA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038143</DrugIDPK>
    <LicenceNumber>PA1647/009/002</LicenceNumber>
    <ProductName>LEVETIRACETAM PENSA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038144</DrugIDPK>
    <LicenceNumber>PA1647/009/003</LicenceNumber>
    <ProductName>LEVETIRACETAM PENSA</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037988</DrugIDPK>
    <LicenceNumber>PA1647/008/001</LicenceNumber>
    <ProductName>METFORMIN PENSA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037989</DrugIDPK>
    <LicenceNumber>PA1647/008/002</LicenceNumber>
    <ProductName>METFORMIN PENSA</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037990</DrugIDPK>
    <LicenceNumber>PA1647/008/003</LicenceNumber>
    <ProductName>METFORMIN PENSA</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037712</DrugIDPK>
    <LicenceNumber>PA1647/007/001</LicenceNumber>
    <ProductName>MONTELUKAST PENSA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2013-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037713</DrugIDPK>
    <LicenceNumber>PA1647/007/002</LicenceNumber>
    <ProductName>MONTELUKAST PENSA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2013-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037714</DrugIDPK>
    <LicenceNumber>PA1647/007/003</LicenceNumber>
    <ProductName>MONTELUKAST PENSA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2013-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037544</DrugIDPK>
    <LicenceNumber>PA1647/006/001</LicenceNumber>
    <ProductName>OLANZAPINE PENSA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037545</DrugIDPK>
    <LicenceNumber>PA1647/006/002</LicenceNumber>
    <ProductName>OLANZAPINE PENSA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037546</DrugIDPK>
    <LicenceNumber>PA1647/006/003</LicenceNumber>
    <ProductName>OLANZAPINE PENSA</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037547</DrugIDPK>
    <LicenceNumber>PA1647/006/004</LicenceNumber>
    <ProductName>OLANZAPINE PENSA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032917</DrugIDPK>
    <LicenceNumber>PA1647/001/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General Sale: MAXIMUM PACK SIZE 12. Contains only paracetamol as analgesic. Maximum one pack per sale.
Pharmacy only: MAXIMUM PACK SIZE 24. Maximum two packs per sale.
Prescription only: Pack size greater than 24. Product not supplied in blister packs.
Promotion to Public: Pack size not more than 24
Promotion to Healthcare professionals: Pack size greater than 24</SupplyComments>
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032918</DrugIDPK>
    <LicenceNumber>PA1647/001/002</LicenceNumber>
    <ProductName>PARACETAMOL MAX</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General Sale: MAXIMUM PACK SIZE 6. Contains only paracetamol as analgesic. Maximum one pack per sale.
Pharmacy only: MAXIMUM PACK SIZE 12. Maximum two packs per sale.
Prescription only: Pack size exceeding 12 unit dosage forms. Product not supplied in blister packs.
Promotion to Public: Pack size not more than 12
Promotion to Healthcare professionals: Pack size greater than 12</SupplyComments>
    <WithdrawalDate>2015-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035851</DrugIDPK>
    <LicenceNumber>PA1718/001/001</LicenceNumber>
    <ProductName>ZOLEDRONIC ACID MCM PHARMA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>MCM Pharma GmbH</PAHolder>
    <AuthorisedDate>2012-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLEDRONIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023225</DrugIDPK>
    <LicenceNumber>PA0126/171/001</LicenceNumber>
    <ProductName>LOCHOL XL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013465</DrugIDPK>
    <LicenceNumber>PA0740/006/001</LicenceNumber>
    <ProductName>SIMVASTATIN GENTHON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013466</DrugIDPK>
    <LicenceNumber>PA0740/006/002</LicenceNumber>
    <ProductName>SIMVASTATIN GENTHON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013467</DrugIDPK>
    <LicenceNumber>PA0740/006/003</LicenceNumber>
    <ProductName>SIMVASTATIN GENTHON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013468</DrugIDPK>
    <LicenceNumber>PA0740/006/004</LicenceNumber>
    <ProductName>SIMVASTATIN GENTHON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031158</DrugIDPK>
    <LicenceNumber>EU/1/10/664/001</LicenceNumber>
    <ProductName>PUMARIX</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Biologicals S.A.</PAHolder>
    <AuthorisedDate>2011-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension and Emulsion for emulsion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PURIFIED ANTIGEN FRACTIONS OF INACTIVATED SPLIT VIRIONS A/CALIFORNIA/7/2009 (H1N1) V-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Pumarix can only be marketed when there is an official WHO/EU declaration of an influenza pandemic, on the condition that the Marketing Authorisation Holder for Pumarix takes due account of the officially declared pandemic strain.</SupplyComments>
    <WithdrawalDate>2015-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027190</DrugIDPK>
    <LicenceNumber>PA0126/176/001</LicenceNumber>
    <ProductName>ROPIRADE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027191</DrugIDPK>
    <LicenceNumber>PA0126/176/002</LicenceNumber>
    <ProductName>ROPIRADE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027192</DrugIDPK>
    <LicenceNumber>PA0126/176/003</LicenceNumber>
    <ProductName>ROPIRADE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027193</DrugIDPK>
    <LicenceNumber>PA0126/176/004</LicenceNumber>
    <ProductName>ROPIRADE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035688</DrugIDPK>
    <LicenceNumber>PA0126/227/001</LicenceNumber>
    <ProductName>CLAROPT</ProductName>
    <Strength>20+5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033018</DrugIDPK>
    <LicenceNumber>PA0126/211/004</LicenceNumber>
    <ProductName>VALTAN</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027539</DrugIDPK>
    <LicenceNumber>PPA1463/005/001</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027540</DrugIDPK>
    <LicenceNumber>PPA1463/005/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038923</DrugIDPK>
    <LicenceNumber>PA1850/001/001</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <Strength>14/50</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Mallinckrodt UK Commercial Ltd</PAHolder>
    <AuthorisedDate>2013-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018885</DrugIDPK>
    <LicenceNumber>PA0521/012/003</LicenceNumber>
    <ProductName>OCTANATE 1000 IU</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2004-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMAFRAKTION (FACTOR VIII)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017958</DrugIDPK>
    <LicenceNumber>PA0521/012/002</LicenceNumber>
    <ProductName>OCTANATE 500 IU</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2004-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMAFRAKTION (FACTOR VIII)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037232</DrugIDPK>
    <LicenceNumber>PA1390/052/001</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037233</DrugIDPK>
    <LicenceNumber>PA1390/052/002</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037234</DrugIDPK>
    <LicenceNumber>PA1390/052/003</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037235</DrugIDPK>
    <LicenceNumber>PA1390/052/004</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037236</DrugIDPK>
    <LicenceNumber>PA1390/052/005</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034322</DrugIDPK>
    <LicenceNumber>PA1390/036/001</LicenceNumber>
    <ProductName>TOPOTECAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2015-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037202</DrugIDPK>
    <LicenceNumber>PA0281/150/004</LicenceNumber>
    <ProductName>TORVAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022469</DrugIDPK>
    <LicenceNumber>PA0281/100/002</LicenceNumber>
    <ProductName>TRAMAPINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033876</DrugIDPK>
    <LicenceNumber>PA0749/129/002</LicenceNumber>
    <ProductName>FOSALEN ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034158</DrugIDPK>
    <LicenceNumber>PA0577/139/001</LicenceNumber>
    <ProductName>EPROSARTAN MYLAN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034159</DrugIDPK>
    <LicenceNumber>PA0577/139/002</LicenceNumber>
    <ProductName>EPROSARTAN MYLAN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2012-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009505</DrugIDPK>
    <LicenceNumber>PA0748/033/004</LicenceNumber>
    <ProductName>RETIN-A CREAM</ProductName>
    <Strength>0.05%</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038424</DrugIDPK>
    <LicenceNumber>PA1831/001/001</LicenceNumber>
    <ProductName>BUDESITAN 0.5MG/2ML NEBULISER SUSPENSION</ProductName>
    <Strength>0.5mg/2ml</Strength>
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038425</DrugIDPK>
    <LicenceNumber>PA1831/001/002</LicenceNumber>
    <ProductName>BUDESITAN 1.0MG/2ML NEBULISER SUSPENSION</ProductName>
    <Strength>1.0mg/2ml</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038426</DrugIDPK>
    <LicenceNumber>PA1831/003/001</LicenceNumber>
    <ProductName>COMBINEB</ProductName>
    <Strength>0.5/2.5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038428</DrugIDPK>
    <LicenceNumber>PA1831/002/001</LicenceNumber>
    <ProductName>IPRAVENT</ProductName>
    <Strength>250mcg/1ml</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038429</DrugIDPK>
    <LicenceNumber>PA1831/002/002</LicenceNumber>
    <ProductName>IPRAVENT</ProductName>
    <Strength>500mcg/2ml</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038430</DrugIDPK>
    <LicenceNumber>PA1831/004/001</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>2.5/2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038431</DrugIDPK>
    <LicenceNumber>PA1831/004/002</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>5/2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>2012-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038257</DrugIDPK>
    <LicenceNumber>PPA1328/173/001</LicenceNumber>
    <ProductName>TAVANIC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025959</DrugIDPK>
    <LicenceNumber>DPR0465/012/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025960</DrugIDPK>
    <LicenceNumber>DPR0465/012/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027816</DrugIDPK>
    <LicenceNumber>DPR0465/012/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030690</DrugIDPK>
    <LicenceNumber>DPR0465/012/004</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030695</DrugIDPK>
    <LicenceNumber>DPR0465/031/001</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030696</DrugIDPK>
    <LicenceNumber>DPR0465/031/002</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025965</DrugIDPK>
    <LicenceNumber>DPR0465/013/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037501</DrugIDPK>
    <LicenceNumber>DPR0465/009/003</LicenceNumber>
    <ProductName>HALF SINEMET CR</ProductName>
    <Strength>25/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029524</DrugIDPK>
    <LicenceNumber>DPR0465/025/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030336</DrugIDPK>
    <LicenceNumber>DPR0465/025/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030336</DrugIDPK>
    <LicenceNumber>DPR0465/025/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030580</DrugIDPK>
    <LicenceNumber>DPR0465/030/001</LicenceNumber>
    <ProductName>INSPRA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030581</DrugIDPK>
    <LicenceNumber>DPR0465/030/002</LicenceNumber>
    <ProductName>INSPRA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030583</DrugIDPK>
    <LicenceNumber>DPR0465/028/003</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030434</DrugIDPK>
    <LicenceNumber>DPR0465/028/001</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030435</DrugIDPK>
    <LicenceNumber>DPR0465/028/002</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035426</DrugIDPK>
    <LicenceNumber>DPR0465/039/001</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035427</DrugIDPK>
    <LicenceNumber>DPR0465/039/002</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035428</DrugIDPK>
    <LicenceNumber>DPR0465/039/003</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024271</DrugIDPK>
    <LicenceNumber>DPR0465/009/002</LicenceNumber>
    <ProductName>SINEMET CR</ProductName>
    <Strength>50/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024269</DrugIDPK>
    <LicenceNumber>DPR0465/009/001</LicenceNumber>
    <ProductName>SINEMET PLUS</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028878</DrugIDPK>
    <LicenceNumber>DPR0465/019/002</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030089</DrugIDPK>
    <LicenceNumber>DPR0465/019/004</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028605</DrugIDPK>
    <LicenceNumber>DPR0465/019/001</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029525</DrugIDPK>
    <LicenceNumber>DPR0465/019/003</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC GRANULES</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025954</DrugIDPK>
    <LicenceNumber>DPR0465/011/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022767</DrugIDPK>
    <LicenceNumber>DPR0465/003/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035710</DrugIDPK>
    <LicenceNumber>DPR0465/040/001</LicenceNumber>
    <ProductName>VALCYTE</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALGANCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028879</DrugIDPK>
    <LicenceNumber>DPR0465/023/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028880</DrugIDPK>
    <LicenceNumber>DPR0465/023/002</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031566</DrugIDPK>
    <LicenceNumber>PPA1328/123/001</LicenceNumber>
    <ProductName>COMBIVENT UDVS</ProductName>
    <Strength>0.5/2.5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008084</DrugIDPK>
    <LicenceNumber>PA0941/001/001</LicenceNumber>
    <ProductName>EPAXAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Crucell Italy S.r.l.</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS A VIRUS (STRAIN RG-SB)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2015-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004555</DrugIDPK>
    <LicenceNumber>PA0013/090/002</LicenceNumber>
    <ProductName>AREDIA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM PENTAHYDRAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004557</DrugIDPK>
    <LicenceNumber>PA0013/090/004</LicenceNumber>
    <ProductName>AREDIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM PENTAHYDRAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009882</DrugIDPK>
    <LicenceNumber>PPA0465/047/002</LicenceNumber>
    <ProductName>AUGMENTIN DUO</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015195</DrugIDPK>
    <LicenceNumber>PPA0465/088/001</LicenceNumber>
    <ProductName>BRICANYL TURBOHALER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004585</DrugIDPK>
    <LicenceNumber>PA0013/088/001</LicenceNumber>
    <ProductName>CATAFLAM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019616</DrugIDPK>
    <LicenceNumber>PPA0465/080/004</LicenceNumber>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTARE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017535</DrugIDPK>
    <LicenceNumber>PPA0465/080/003</LicenceNumber>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028454</DrugIDPK>
    <LicenceNumber>PPA0465/213/001</LicenceNumber>
    <ProductName>DOVOBET</ProductName>
    <Strength>50/500</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039882</DrugIDPK>
    <LicenceNumber>PPA0465/319/001</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2013-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039883</DrugIDPK>
    <LicenceNumber>PPA0465/319/002</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2013-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023133</DrugIDPK>
    <LicenceNumber>PA0805/002/006</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029834</DrugIDPK>
    <LicenceNumber>PA0805/002/008</LicenceNumber>
    <ProductName>LEXAPRO MELTZ</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029835</DrugIDPK>
    <LicenceNumber>PA0805/002/009</LicenceNumber>
    <ProductName>LEXAPRO MELTZ</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007506</DrugIDPK>
    <LicenceNumber>PPA0465/059/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019147</DrugIDPK>
    <LicenceNumber>PPA0465/059/003</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015085</DrugIDPK>
    <LicenceNumber>PPA0465/086/001</LicenceNumber>
    <ProductName>OMNIC</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016097</DrugIDPK>
    <LicenceNumber>PPA0465/100/002</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER 200 MICROGRAMS INHALATION POW</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037921</DrugIDPK>
    <LicenceNumber>PPA0465/290/001</LicenceNumber>
    <ProductName>QUESTRAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLESTYRAMINE RESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019861</DrugIDPK>
    <LicenceNumber>PPA0465/153/002</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035181</DrugIDPK>
    <LicenceNumber>PPA0465/264/001</LicenceNumber>
    <ProductName>SPASMONAL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040379</DrugIDPK>
    <LicenceNumber>PPA0465/325/001</LicenceNumber>
    <ProductName>STRATTERA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2013-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOMOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040380</DrugIDPK>
    <LicenceNumber>PPA0465/325/002</LicenceNumber>
    <ProductName>STRATTERA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2013-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOMOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040381</DrugIDPK>
    <LicenceNumber>PPA0465/325/003</LicenceNumber>
    <ProductName>STRATTERA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2013-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOMOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030538</DrugIDPK>
    <LicenceNumber>PPA0465/224/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038017</DrugIDPK>
    <LicenceNumber>PPA0465/294/001</LicenceNumber>
    <ProductName>VAGIFEM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004577</DrugIDPK>
    <LicenceNumber>PA0013/087/001</LicenceNumber>
    <ProductName>VOLTAROL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004581</DrugIDPK>
    <LicenceNumber>PA0013/087/005</LicenceNumber>
    <ProductName>VOLTAROL AMPOULES</ProductName>
    <Strength>75mg/3ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030691</DrugIDPK>
    <LicenceNumber>PA0521/017/001</LicenceNumber>
    <ProductName>WILATE 450</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030692</DrugIDPK>
    <LicenceNumber>PA0521/017/002</LicenceNumber>
    <ProductName>WILATE 900</ProductName>
    <Strength>900/800</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034595</DrugIDPK>
    <LicenceNumber>PPA1562/043/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042618</DrugIDPK>
    <LicenceNumber>PPA1562/123/001</LicenceNumber>
    <ProductName>DURAPHAT</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>ppm</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038372</DrugIDPK>
    <LicenceNumber>PPA1562/092/001</LicenceNumber>
    <ProductName>ISOPTIN SR</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2013-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041690</DrugIDPK>
    <LicenceNumber>PPA1562/109/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042575</DrugIDPK>
    <LicenceNumber>PPA1562/086/003</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031492</DrugIDPK>
    <LicenceNumber>PPA1328/059/003</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017415</DrugIDPK>
    <LicenceNumber>PA1108/001/001</LicenceNumber>
    <ProductName>DICYNENE 250MG/2ML SOLUTION FOR INJECTION</ProductName>
    <Strength>250/2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>OM PHARMA SA</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029287</DrugIDPK>
    <LicenceNumber>PA1352/005/001</LicenceNumber>
    <ProductName>LAXAGOL</ProductName>
    <Strength>13.8</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032488</DrugIDPK>
    <LicenceNumber>PA0281/142/001</LicenceNumber>
    <ProductName>UNICOUGH CHESTY</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000395</DrugIDPK>
    <LicenceNumber>PA0549/001/010</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <Strength>240mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1996-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006644</DrugIDPK>
    <LicenceNumber>PA0549/001/002</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1991-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006646</DrugIDPK>
    <LicenceNumber>PA0549/001/003</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1991-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006649</DrugIDPK>
    <LicenceNumber>PA0549/001/004</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1991-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004726</DrugIDPK>
    <LicenceNumber>PA0549/001/001</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1991-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035708</DrugIDPK>
    <LicenceNumber>PA1380/116/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2013-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035708</DrugIDPK>
    <LicenceNumber>PA1380/116/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2013-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030938</DrugIDPK>
    <LicenceNumber>PA1380/079/001</LicenceNumber>
    <ProductName>TERBINAFINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028035</DrugIDPK>
    <LicenceNumber>PA1380/099/001</LicenceNumber>
    <ProductName>VANCOMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VANCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028036</DrugIDPK>
    <LicenceNumber>PA1380/099/002</LicenceNumber>
    <ProductName>VANCOMYCIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VANCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034594</DrugIDPK>
    <LicenceNumber>PA0126/219/001</LicenceNumber>
    <ProductName>VALACICLOVIR CLONMEL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015486</DrugIDPK>
    <LicenceNumber>PA0577/041/004</LicenceNumber>
    <ProductName>ZESGER 2.5 MG TABLETS.</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012301</DrugIDPK>
    <LicenceNumber>PA0126/103/005</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>CLAVAMEL</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029816</DrugIDPK>
    <LicenceNumber>PA1390/016/002</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General Sale: MAXIMUM PACK SIZE 6. Contains only paracetamol as analgesic. Maximum one pack per sale.
Pharmacy only: MAXIMUM PACK SIZE 12. Maximum two packs per sale.
Prescription only: Pack size exceeding 12 unit dosage forms. Product not supplied in blister packs.
Promotion to the public: Pack size not more than 12
Promtion to healthcare professionals: Pack size greater than 12</SupplyComments>
    <WithdrawalDate>2014-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031519</DrugIDPK>
    <LicenceNumber>PPA1328/015/002</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028284</DrugIDPK>
    <LicenceNumber>PA1380/048/001</LicenceNumber>
    <ProductName>PIPERACILLIN / TAZOBACTAM ACTAVIS 2G/0.25G POWDER</ProductName>
    <Strength>2/0.25</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028285</DrugIDPK>
    <LicenceNumber>PA1380/048/002</LicenceNumber>
    <ProductName>PIPERACILLIN / TAZOBACTAM ACTAVIS 4G/0.5G POWDER F</ProductName>
    <Strength>4/0.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034053</DrugIDPK>
    <LicenceNumber>PPA1562/036/001</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034154</DrugIDPK>
    <LicenceNumber>PPA1562/036/004</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036578</DrugIDPK>
    <LicenceNumber>PA1720/001/001</LicenceNumber>
    <ProductName>AGGRASTAT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Correvio (UK) Ltd</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIROFIBAN HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036579</DrugIDPK>
    <LicenceNumber>PA1720/001/002</LicenceNumber>
    <ProductName>AGGRASTAT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Correvio (UK) Ltd</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIROFIBAN HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023545</DrugIDPK>
    <LicenceNumber>PA0126/170/002</LicenceNumber>
    <ProductName>ESTELLE</ProductName>
    <Strength>30/75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034819</DrugIDPK>
    <LicenceNumber>PA1688/003/003</LicenceNumber>
    <ProductName>CODALAX</ProductName>
    <Strength>200mg/25mg</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXALCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034820</DrugIDPK>
    <LicenceNumber>PA1688/003/004</LicenceNumber>
    <ProductName>CODALAX FORTE 1000MG/75MG PER 5ML SUSPENSION</ProductName>
    <Strength>1000mg/75m</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXALCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030093</DrugIDPK>
    <LicenceNumber>PA0281/141/003</LicenceNumber>
    <ProductName>LOZITAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037199</DrugIDPK>
    <LicenceNumber>PA0281/150/001</LicenceNumber>
    <ProductName>TORVAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007626</DrugIDPK>
    <LicenceNumber>PA0405/032/002</LicenceNumber>
    <ProductName>CYPROTERONE ACETATE/ETHINYLESTRADIOL</ProductName>
    <Strength>2mg/35ug</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032090</DrugIDPK>
    <LicenceNumber>PA1130/028/001</LicenceNumber>
    <ProductName>LERCANIDIPINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032091</DrugIDPK>
    <LicenceNumber>PA1130/028/002</LicenceNumber>
    <ProductName>LERCANIDIPINE HYDROCHLORIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036528</DrugIDPK>
    <LicenceNumber>PA1130/031/001</LicenceNumber>
    <ProductName>MAGREZOL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036529</DrugIDPK>
    <LicenceNumber>PA1130/031/002</LicenceNumber>
    <ProductName>MAGREZOL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030203</DrugIDPK>
    <LicenceNumber>PPA1562/008/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030216</DrugIDPK>
    <LicenceNumber>PPA1562/008/002</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030094</DrugIDPK>
    <LicenceNumber>PA0281/141/004</LicenceNumber>
    <ProductName>LOZITAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041494</DrugIDPK>
    <LicenceNumber>PPA1562/107/001</LicenceNumber>
    <ProductName>TILDIEM LA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2014-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033443</DrugIDPK>
    <LicenceNumber>PA1110/012/001</LicenceNumber>
    <ProductName>SKINMAN</ProductName>
    <Strength>95.7447/10</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Ecolab Limited</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DENATURED ALCOHOL (DENATURED ETHANOL)</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>METHYL ETHYL KETONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030233</DrugIDPK>
    <LicenceNumber>PA0577/093/003</LicenceNumber>
    <ProductName>KLARIGER LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020385</DrugIDPK>
    <LicenceNumber>PA1226/004/002</LicenceNumber>
    <ProductName>AXID</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIZATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038278</DrugIDPK>
    <LicenceNumber>PPA1151/187/001</LicenceNumber>
    <ProductName>DUROGESIC DTRANS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038279</DrugIDPK>
    <LicenceNumber>PPA1151/187/002</LicenceNumber>
    <ProductName>DUROGESIC DTRANS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038280</DrugIDPK>
    <LicenceNumber>PPA1151/187/003</LicenceNumber>
    <ProductName>DUROGESIC DTRANS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038281</DrugIDPK>
    <LicenceNumber>PPA1151/187/004</LicenceNumber>
    <ProductName>DUROGESIC DTRANS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019481</DrugIDPK>
    <LicenceNumber>PA1077/030/002</LicenceNumber>
    <ProductName>INFANRIX IN A PREFILLED SYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016120</DrugIDPK>
    <LicenceNumber>PA1077/028/002</LicenceNumber>
    <ProductName>INFANRIX-HIB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030591</DrugIDPK>
    <LicenceNumber>PA0749/107/003</LicenceNumber>
    <ProductName>RAMIPRIL TEVA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030592</DrugIDPK>
    <LicenceNumber>PA0749/107/004</LicenceNumber>
    <InterchangeableListCode>IC0016-002-008</InterchangeableListCode>
    <ProductName>RAMIPRIL TEVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019275</DrugIDPK>
    <LicenceNumber>PA0736/021/001</LicenceNumber>
    <ProductName>LIPIDEM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIGLYCERIDES, MEDIUM CHAIN</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>OMEGA-3-ACID TRIGLYCERIDES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019276</DrugIDPK>
    <LicenceNumber>PA0736/021/002</LicenceNumber>
    <ProductName>LIPIDEM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIGLYCERIDES, MEDIUM CHAIN</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>OMEGA-3-ACID TRIGLYCERIDES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995042368</DrugIDPK>
    <LicenceNumber>PA0800/009/001</LicenceNumber>
    <ProductName>TETAGAM P</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>2014-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN</ActiveSubstance>
      <ActiveSubstance>HUMAN TETANUS IMMUNOGLOBULIN PH. EUR.</ActiveSubstance>
      <ActiveSubstance>IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>TETANUS ANTIBODIES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035080</DrugIDPK>
    <LicenceNumber>PA1390/019/004</LicenceNumber>
    <ProductName>TACROLIMUS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4,2)</SupplyComments>
    <WithdrawalDate>2014-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028152</DrugIDPK>
    <LicenceNumber>PA1390/019/001</LicenceNumber>
    <ProductName>TACROLIMUS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028154</DrugIDPK>
    <LicenceNumber>PA1390/019/002</LicenceNumber>
    <ProductName>TACROLIMUS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006218</DrugIDPK>
    <LicenceNumber>PA0294/018/003</LicenceNumber>
    <ProductName>AULIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIMESULIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039781</DrugIDPK>
    <LicenceNumber>PA1897/003/001</LicenceNumber>
    <ProductName>CIPROFLOXACIN AMNEAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006774</DrugIDPK>
    <LicenceNumber>PA0711/011/006</LicenceNumber>
    <ProductName>NIFED RETARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019339</DrugIDPK>
    <LicenceNumber>PA0943/010/001</LicenceNumber>
    <ProductName>PENTRAX</ProductName>
    <Strength>4.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>1995-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031986</DrugIDPK>
    <LicenceNumber>PA0408/081/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031987</DrugIDPK>
    <LicenceNumber>PA0408/081/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039782</DrugIDPK>
    <LicenceNumber>PA1897/004/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039783</DrugIDPK>
    <LicenceNumber>PA1897/004/002</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019340</DrugIDPK>
    <LicenceNumber>PA0943/011/001</LicenceNumber>
    <ProductName>METED</ProductName>
    <Strength>3 &amp; 5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2004-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLLOIDAL SULPHUR</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039788</DrugIDPK>
    <LicenceNumber>PA1897/005/001</LicenceNumber>
    <ProductName>ONDANSETRON PFIZER</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027242</DrugIDPK>
    <LicenceNumber>PA0408/069/001</LicenceNumber>
    <ProductName>VALSARTAN RANBAXY</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027243</DrugIDPK>
    <LicenceNumber>PA0408/069/002</LicenceNumber>
    <ProductName>VALSARTAN RANBAXY</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027244</DrugIDPK>
    <LicenceNumber>PA0408/069/003</LicenceNumber>
    <ProductName>VALSARTAN RANBAXY</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032238</DrugIDPK>
    <LicenceNumber>PA0408/082/001</LicenceNumber>
    <ProductName>VALSARTAN/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>80/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032239</DrugIDPK>
    <LicenceNumber>PA0408/082/002</LicenceNumber>
    <ProductName>VALSARTAN/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>160/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032240</DrugIDPK>
    <LicenceNumber>PA0408/082/003</LicenceNumber>
    <ProductName>VALSARTAN/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>160/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015368</DrugIDPK>
    <LicenceNumber>PA1070/001/001</LicenceNumber>
    <ProductName>FOLICID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Cell Pharm GmbH</PAHolder>
    <AuthorisedDate>2004-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040807</DrugIDPK>
    <LicenceNumber>PPA0074/001/001</LicenceNumber>
    <ProductName>CO-AMOXICLAV</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2013-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039779</DrugIDPK>
    <LicenceNumber>PA1897/001/001</LicenceNumber>
    <ProductName>BUPIVACAINE AMNEAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039780</DrugIDPK>
    <LicenceNumber>PA1897/001/002</LicenceNumber>
    <ProductName>BUPIVACAINE AMNEAL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031665</DrugIDPK>
    <LicenceNumber>EU/1/10/649/001-016</LicenceNumber>
    <ProductName>CLOPIDOGREL TEVA PHARMA B.V.</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012104</DrugIDPK>
    <LicenceNumber>PA0711/040/001</LicenceNumber>
    <ProductName>PAROX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2001-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020005</DrugIDPK>
    <LicenceNumber>PA0711/040/002</LicenceNumber>
    <ProductName>PAROX</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030091</DrugIDPK>
    <LicenceNumber>PA0281/141/001</LicenceNumber>
    <ProductName>LOZITAR</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030092</DrugIDPK>
    <LicenceNumber>PA0281/141/002</LicenceNumber>
    <ProductName>LOZITAR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017968</DrugIDPK>
    <LicenceNumber>PA1130/001/001</LicenceNumber>
    <ProductName>SIMATOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017969</DrugIDPK>
    <LicenceNumber>PA1130/001/003</LicenceNumber>
    <ProductName>SIMATOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017970</DrugIDPK>
    <LicenceNumber>PA1130/001/002</LicenceNumber>
    <ProductName>SIMATOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017971</DrugIDPK>
    <LicenceNumber>PA1130/001/004</LicenceNumber>
    <ProductName>SIMATOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033154</DrugIDPK>
    <LicenceNumber>PA1352/014/001</LicenceNumber>
    <ProductName>MIDAZOLAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033155</DrugIDPK>
    <LicenceNumber>PA1352/014/002</LicenceNumber>
    <ProductName>MIDAZOLAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032529</DrugIDPK>
    <LicenceNumber>PA1352/008/001</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>6. This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032530</DrugIDPK>
    <LicenceNumber>PA1352/008/002</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>6. This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032531</DrugIDPK>
    <LicenceNumber>PA1352/008/003</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>6. This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032532</DrugIDPK>
    <LicenceNumber>PA1352/008/004</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>6. This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027720</DrugIDPK>
    <LicenceNumber>PA1462/002/001</LicenceNumber>
    <ProductName>PRINDEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027721</DrugIDPK>
    <LicenceNumber>PA1462/002/002</LicenceNumber>
    <ProductName>PRINDEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027722</DrugIDPK>
    <LicenceNumber>PA1462/002/003</LicenceNumber>
    <ProductName>PRINDEX</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033258</DrugIDPK>
    <LicenceNumber>PPA1328/139/001</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>200/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036641</DrugIDPK>
    <LicenceNumber>PA0577/164/001</LicenceNumber>
    <ProductName>IRBESARTAN MYLAN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036642</DrugIDPK>
    <LicenceNumber>PA0577/164/002</LicenceNumber>
    <ProductName>IRBESARTAN MYLAN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036643</DrugIDPK>
    <LicenceNumber>PA0577/164/003</LicenceNumber>
    <ProductName>IRBESARTAN MYLAN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018888</DrugIDPK>
    <LicenceNumber>PA0577/055/001</LicenceNumber>
    <ProductName>ZESGER PLUS</ProductName>
    <Strength>10/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019414</DrugIDPK>
    <LicenceNumber>PA0436/038/001</LicenceNumber>
    <ProductName>FUNGAFINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026464</DrugIDPK>
    <LicenceNumber>PA1217/004/001</LicenceNumber>
    <ProductName>ANASTROZOLE HIKMA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hikma Farmaceutica (Portugal) SA</PAHolder>
    <AuthorisedDate>2009-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035689</DrugIDPK>
    <LicenceNumber>PA0126/229/001</LicenceNumber>
    <ProductName>RABICLON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035690</DrugIDPK>
    <LicenceNumber>PA0126/229/002</LicenceNumber>
    <ProductName>RABICLON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036630</DrugIDPK>
    <LicenceNumber>PA1747/001/001</LicenceNumber>
    <ProductName>SILDENAFIL AJANTA PHARMA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ajanta Pharma UK Limited</PAHolder>
    <AuthorisedDate>2012-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036631</DrugIDPK>
    <LicenceNumber>PA1747/001/002</LicenceNumber>
    <ProductName>SILDENAFIL AJANTA PHARMA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ajanta Pharma UK Limited</PAHolder>
    <AuthorisedDate>2012-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034217</DrugIDPK>
    <LicenceNumber>EU/1/11/744/001-002</LicenceNumber>
    <ProductName>TOPOTECAN EAGLE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Eagle Laboratories Limited c/o</PAHolder>
    <AuthorisedDate>2011-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HCL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030524</DrugIDPK>
    <LicenceNumber>EU/1/09/557/1-9</LicenceNumber>
    <ProductName>CLOPIDOGREL QUALIMED</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Qualimed</PAHolder>
    <AuthorisedDate>2009-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029540</DrugIDPK>
    <LicenceNumber>PA1533/001/001</LicenceNumber>
    <ProductName>EPOPROSTENOL DREHM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Drehm Pharma GmbH</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOPROSTENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029541</DrugIDPK>
    <LicenceNumber>PA1533/001/002</LicenceNumber>
    <ProductName>EPOPROSTENOL DREHM</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Drehm Pharma GmbH</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOPROSTENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034435</DrugIDPK>
    <LicenceNumber>EU/1/11/723/001-007</LicenceNumber>
    <ProductName>PIOGLITAZONE KRKA</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Krka d.d., Novo mesto</PAHolder>
    <AuthorisedDate>2012-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034436</DrugIDPK>
    <LicenceNumber>EU/1/11/723/008-014</LicenceNumber>
    <ProductName>PIOGLITAZONE KRKA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Krka d.d., Novo mesto</PAHolder>
    <AuthorisedDate>2012-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034437</DrugIDPK>
    <LicenceNumber>EU/1/11/723/015-045</LicenceNumber>
    <ProductName>PIOGLITAZONE KRKA</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Krka d.d., Novo mesto</PAHolder>
    <AuthorisedDate>2012-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002035</DrugIDPK>
    <LicenceNumber>EU/1/97/043/001</LicenceNumber>
    <ProductName>REVASC</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Canyon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESIRUDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007075</DrugIDPK>
    <LicenceNumber>EU/1/97/043/002</LicenceNumber>
    <ProductName>REVASC</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Canyon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2007-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESIRUDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017902</DrugIDPK>
    <LicenceNumber>PA0068/015/001</LicenceNumber>
    <ProductName>LOCABIOTAL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSAFUNGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041384</DrugIDPK>
    <LicenceNumber>EU/1/14/911/001-004</LicenceNumber>
    <ProductName>RIVASTIGMINE 3M</ProductName>
    <Strength>4.6</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>2014-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product
Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041385</DrugIDPK>
    <LicenceNumber>EU/1/14/911/005-008</LicenceNumber>
    <ProductName>RIVASTIGMINE 3M</ProductName>
    <Strength>9.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>2014-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product
Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034423</DrugIDPK>
    <LicenceNumber>PA0555/009/001</LicenceNumber>
    <ProductName>BABYLAX 1.8 G RECTAL SOLUTION</ProductName>
    <Strength>1.8</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROL 85%</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006316</DrugIDPK>
    <LicenceNumber>PA0568/008/002</LicenceNumber>
    <ProductName>BI PRETERAX</ProductName>
    <Strength>4/1.25</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>1998-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018343</DrugIDPK>
    <LicenceNumber>PA0068/016/001</LicenceNumber>
    <ProductName>TRIMETAZIDINE</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETAZIDINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034424</DrugIDPK>
    <LicenceNumber>PA0555/005/001</LicenceNumber>
    <ProductName>VIVIDRIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035371</DrugIDPK>
    <LicenceNumber>PA1647/004/001</LicenceNumber>
    <ProductName>CLOPIDOGREL PENSA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031082</DrugIDPK>
    <LicenceNumber>PPA1592/002/003</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031124</DrugIDPK>
    <LicenceNumber>PPA1592/003/002</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008637</DrugIDPK>
    <LicenceNumber>PA0568/010/001</LicenceNumber>
    <ProductName>INDAPAMIDE SR</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029793</DrugIDPK>
    <LicenceNumber>PA1462/005/001</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE/INDAPAMIDE GLENMARK</ProductName>
    <Strength>2/0.625</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029794</DrugIDPK>
    <LicenceNumber>PA1462/005/002</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE/INDAPAMIDE GLENMARK</ProductName>
    <Strength>4/1.25</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030982</DrugIDPK>
    <LicenceNumber>PPA1592/001/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031080</DrugIDPK>
    <LicenceNumber>PPA1592/002/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031081</DrugIDPK>
    <LicenceNumber>PPA1592/002/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007441</DrugIDPK>
    <LicenceNumber>PA0544/034/002</LicenceNumber>
    <ProductName>INACTIVATED INFLUENZA VACCINE (SPLIT VIRON)</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1999-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A</ActiveSubstance>
      <ActiveSubstance>A/VICTORIA/361/2011 (H3N2) - DERIVED STRAIN USED IVR-165</ActiveSubstance>
      <ActiveSubstance>B/MASSACHUSETTS/2/2012</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031345</DrugIDPK>
    <LicenceNumber>PPA1592/004/001</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031346</DrugIDPK>
    <LicenceNumber>PPA1592/004/002</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031123</DrugIDPK>
    <LicenceNumber>PPA1592/003/001</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007865</DrugIDPK>
    <LicenceNumber>PA0167/102/001</LicenceNumber>
    <ProductName>DECAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2000-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLUCONATE</ActiveSubstance>
      <ActiveSubstance>COPPER GLUCONATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>ZINC GLUCONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
      <ActiveSubstance>COBALT GLUCONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM SELENITE</ActiveSubstance>
      <ActiveSubstance>AMMONIUM MOLYBDATE</ActiveSubstance>
      <ActiveSubstance>CHROMIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029415</DrugIDPK>
    <LicenceNumber>PA0405/055/001</LicenceNumber>
    <ProductName>GEMCITABINE MYLAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030192</DrugIDPK>
    <LicenceNumber>PA0405/055/002</LicenceNumber>
    <ProductName>GEMCITABINE MYLAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030259</DrugIDPK>
    <LicenceNumber>PPA1151/108/001</LicenceNumber>
    <ProductName>CILEST</ProductName>
    <Strength>250/35</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORGESTIMATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014535</DrugIDPK>
    <LicenceNumber>PA0711/011/009</LicenceNumber>
    <ProductName>NIFED</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028016</DrugIDPK>
    <LicenceNumber>PA0126/178/001</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028017</DrugIDPK>
    <LicenceNumber>PA0126/178/002</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028018</DrugIDPK>
    <LicenceNumber>PA0126/178/003</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028019</DrugIDPK>
    <LicenceNumber>PA0126/178/004</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034611</DrugIDPK>
    <LicenceNumber>PA1286/042/001</LicenceNumber>
    <ProductName>ACOXXEL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034612</DrugIDPK>
    <LicenceNumber>PA1286/042/002</LicenceNumber>
    <ProductName>ACOXXEL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034613</DrugIDPK>
    <LicenceNumber>PA1286/042/003</LicenceNumber>
    <ProductName>ACOXXEL</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034614</DrugIDPK>
    <LicenceNumber>PA1286/042/004</LicenceNumber>
    <ProductName>ACOXXEL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006806</DrugIDPK>
    <LicenceNumber>PA0593/004/001</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006807</DrugIDPK>
    <LicenceNumber>PA0593/004/002</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006808</DrugIDPK>
    <LicenceNumber>PA0593/004/003</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032406</DrugIDPK>
    <LicenceNumber>PPA1151/135/001</LicenceNumber>
    <ProductName>KAPAKE</ProductName>
    <Strength>30/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030525</DrugIDPK>
    <LicenceNumber>PPA1151/111/001</LicenceNumber>
    <ProductName>SYNDOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL BP</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE BP</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE NF</ActiveSubstance>
      <ActiveSubstance>CAFFEINE BP</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.</SupplyComments>
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030525</DrugIDPK>
    <LicenceNumber>PPA1151/111/001</LicenceNumber>
    <ProductName>SYNDOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL BP</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE BP</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE NF</ActiveSubstance>
      <ActiveSubstance>CAFFEINE BP</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.</SupplyComments>
    <WithdrawalDate>2014-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027477</DrugIDPK>
    <LicenceNumber>PA0568/023/002</LicenceNumber>
    <ProductName>TERAXANS</ProductName>
    <Strength>10/2.5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004843</DrugIDPK>
    <LicenceNumber>PA0218/030/001</LicenceNumber>
    <ProductName>VAGIFEM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1991-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031401</DrugIDPK>
    <LicenceNumber>EU/1/08/467/002</LicenceNumber>
    <ProductName>DORIBAX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate>2010-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORIPENEM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024712</DrugIDPK>
    <LicenceNumber>EU/1/08/467/1</LicenceNumber>
    <ProductName>DORIBAX 500 MG POWDER FOR SOLUTION FOR INFUSION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate>2008-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORIPENEM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022357</DrugIDPK>
    <LicenceNumber>EU/1/07/426/1-2</LicenceNumber>
    <ProductName>OLANZAPINE CIPLA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2007-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022358</DrugIDPK>
    <LicenceNumber>EU/1/07/426/3-4</LicenceNumber>
    <ProductName>OLANZAPINE CIPLA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2007-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022359</DrugIDPK>
    <LicenceNumber>EU/1/07/426/5-6</LicenceNumber>
    <ProductName>OLANZAPINE CIPLA</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2007-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022360</DrugIDPK>
    <LicenceNumber>EU/1/07/426/7-9</LicenceNumber>
    <ProductName>OLANZAPINE CIPLA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2007-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022361</DrugIDPK>
    <LicenceNumber>EU/1/07/426/10-11</LicenceNumber>
    <ProductName>OLANZAPINE CIPLA</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>2007-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003612</DrugIDPK>
    <LicenceNumber>PA0100/001/003</LicenceNumber>
    <ProductName>COLOMYCIN UNITS/5ML</ProductName>
    <Strength>250,000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030621</DrugIDPK>
    <LicenceNumber>PPA1328/118/001</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030361</DrugIDPK>
    <LicenceNumber>PPA1328/113/001</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022419</DrugIDPK>
    <LicenceNumber>PA0840/006/001</LicenceNumber>
    <ProductName>BICALUTAMIDE SYNTHON 50MG FILM-COATED TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013456</DrugIDPK>
    <LicenceNumber>PA0740/004/001</LicenceNumber>
    <ProductName>SIMVASTATIN SY</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027432</DrugIDPK>
    <LicenceNumber>PA1380/039/001</LicenceNumber>
    <ProductName>MYCOPHENOLATE MOFETIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MYCOPHENOLATE MOFETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038949</DrugIDPK>
    <LicenceNumber>PA1380/143/001</LicenceNumber>
    <ProductName>CELECOXIB</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2014-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038950</DrugIDPK>
    <LicenceNumber>PA1380/143/002</LicenceNumber>
    <ProductName>CELECOXIB</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2014-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033565</DrugIDPK>
    <LicenceNumber>PA0237/063/001</LicenceNumber>
    <ProductName>CIPROFLOXACIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017619</DrugIDPK>
    <LicenceNumber>PA0568/012/003</LicenceNumber>
    <ProductName>PERINDOPRIL SERVIER</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009169</DrugIDPK>
    <LicenceNumber>PA0568/012/001</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE SERVIER</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004637</DrugIDPK>
    <LicenceNumber>PA0840/001/001</LicenceNumber>
    <ProductName>ZORCLONE</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029914</DrugIDPK>
    <LicenceNumber>PPA1328/107/001</LicenceNumber>
    <ProductName>TENORET</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008932</DrugIDPK>
    <LicenceNumber>PA0961/001/001</LicenceNumber>
    <ProductName>LIQUI-CHAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Oxford Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHARCOAL, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006683</DrugIDPK>
    <LicenceNumber>PA0557/002/001</LicenceNumber>
    <ProductName>AKNEMIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Surtech International Ltd</PAHolder>
    <AuthorisedDate>1994-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006685</DrugIDPK>
    <LicenceNumber>PA0557/002/002</LicenceNumber>
    <ProductName>AKNEMIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Surtech International Ltd</PAHolder>
    <AuthorisedDate>1994-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006615</DrugIDPK>
    <LicenceNumber>PA0493/003/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006616</DrugIDPK>
    <LicenceNumber>PA0493/003/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032633</DrugIDPK>
    <LicenceNumber>PA1466/002/001</LicenceNumber>
    <ProductName>NICOZONE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helm AG</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032634</DrugIDPK>
    <LicenceNumber>PA1466/002/002</LicenceNumber>
    <ProductName>NICOZONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helm AG</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013452</DrugIDPK>
    <LicenceNumber>PA0740/003/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013453</DrugIDPK>
    <LicenceNumber>PA0740/003/002</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030376</DrugIDPK>
    <LicenceNumber>PPA1328/115/001</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003768</DrugIDPK>
    <LicenceNumber>PA0115/005/009</LicenceNumber>
    <ProductName>CLOPIXOL ACUPHASE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1990-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZUCLOPENTHIXOL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003756</DrugIDPK>
    <LicenceNumber>PA0115/001/010</LicenceNumber>
    <ProductName>DEPIXOL 200 MG/ML SOLUTION FOR INJECTION</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1992-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028551</DrugIDPK>
    <LicenceNumber>PA1153/002/001</LicenceNumber>
    <ProductName>MAGNETOLUX 500 MICROMOL/ML SOLUTION FOR INJECTION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Sanochemia Pharmazeutika AG</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOPENTETATE DIMEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003778</DrugIDPK>
    <LicenceNumber>PA0805/001/001</LicenceNumber>
    <ProductName>SERDOLECT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003781</DrugIDPK>
    <LicenceNumber>PA0805/001/004</LicenceNumber>
    <ProductName>SERDOLECT</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003782</DrugIDPK>
    <LicenceNumber>PA0805/001/005</LicenceNumber>
    <ProductName>SERDOLECT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003829</DrugIDPK>
    <LicenceNumber>PA0320/005/002</LicenceNumber>
    <ProductName>COLGATE TOTAL FRESH STRIPE TOOTHPASTE</ProductName>
    <Strength>0.3/0.32</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE (EQUIVALENT TO 1450 PPM FLUORIDE)</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE (EQUIVALENT TO 1450 PPM FLUORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034157</DrugIDPK>
    <LicenceNumber>PA0749/097/004</LicenceNumber>
    <ProductName>GEMCITABINE TEVA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020086</DrugIDPK>
    <LicenceNumber>PA0937/004/001</LicenceNumber>
    <ProductName>PACLITAXEL 6 MG/ML CONCENTRATE FOR SOLUTION FOR IN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2006-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028554</DrugIDPK>
    <LicenceNumber>PA0749/087/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE TEVA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033377</DrugIDPK>
    <LicenceNumber>PA0749/126/001</LicenceNumber>
    <ProductName>PIPERACILLIN/TAZOBACTAM TEVA</ProductName>
    <Strength>2g/250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024286</DrugIDPK>
    <LicenceNumber>PA0038/090/004</LicenceNumber>
    <ProductName>ZEMPLAR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2008-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARICALCITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036962</DrugIDPK>
    <LicenceNumber>PA0749/171/001</LicenceNumber>
    <ProductName>CANDESARTAN TEVA PHARMA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036963</DrugIDPK>
    <LicenceNumber>PA0749/171/004</LicenceNumber>
    <ProductName>CANDESARTAN TEVA PHARMA</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036964</DrugIDPK>
    <LicenceNumber>PA0749/171/002</LicenceNumber>
    <ProductName>CANDESARTAN TEVA PHARMA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036965</DrugIDPK>
    <LicenceNumber>PA0749/171/003</LicenceNumber>
    <ProductName>CANDESARTAN TEVA PHARMA</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036966</DrugIDPK>
    <LicenceNumber>PA0749/172/001</LicenceNumber>
    <ProductName>CANDESARTAN/HYDROCHLOROTHIAZIDE TEVA</ProductName>
    <Strength>8/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036967</DrugIDPK>
    <LicenceNumber>PA0749/172/002</LicenceNumber>
    <ProductName>CANDESARTAN/HYDROCHLOROTHIAZIDE TEVA</ProductName>
    <Strength>16/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008834</DrugIDPK>
    <LicenceNumber>PA0281/095/001</LicenceNumber>
    <ProductName>BISOPROLOL FUMARATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008835</DrugIDPK>
    <LicenceNumber>PA0281/095/002</LicenceNumber>
    <ProductName>BISOPROLOL FUMARATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026397</DrugIDPK>
    <LicenceNumber>PA0126/171/002</LicenceNumber>
    <ProductName>LOCHOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026398</DrugIDPK>
    <LicenceNumber>PA0126/171/003</LicenceNumber>
    <ProductName>LOCHOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028495</DrugIDPK>
    <LicenceNumber>PA0126/177/001</LicenceNumber>
    <ProductName>MINODENE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2010-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028707</DrugIDPK>
    <LicenceNumber>PA0749/089/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE TEVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028708</DrugIDPK>
    <LicenceNumber>PA0749/089/002</LicenceNumber>
    <ProductName>PANTOPRAZOLE TEVA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029959</DrugIDPK>
    <LicenceNumber>PPA1328/110/002</LicenceNumber>
    <ProductName>TENORMIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034050</DrugIDPK>
    <LicenceNumber>PPA1328/125/002</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034051</DrugIDPK>
    <LicenceNumber>PPA1328/125/003</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031590</DrugIDPK>
    <LicenceNumber>PPA1328/125/001</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031491</DrugIDPK>
    <LicenceNumber>PPA1562/016/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034176</DrugIDPK>
    <LicenceNumber>PA0895/011/001</LicenceNumber>
    <ProductName>IRBESARTAN DEXCEL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dexcel-Pharma Limited</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034177</DrugIDPK>
    <LicenceNumber>PA0895/011/002</LicenceNumber>
    <ProductName>IRBESARTAN DEXCEL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dexcel-Pharma Limited</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034178</DrugIDPK>
    <LicenceNumber>PA0895/011/003</LicenceNumber>
    <ProductName>IRBESARTAN DEXCEL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dexcel-Pharma Limited</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030407</DrugIDPK>
    <LicenceNumber>PA1239/016/001</LicenceNumber>
    <ProductName>DINORTES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030408</DrugIDPK>
    <LicenceNumber>PA1239/016/002</LicenceNumber>
    <ProductName>DINORTES</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030409</DrugIDPK>
    <LicenceNumber>PA1239/016/003</LicenceNumber>
    <ProductName>DINORTES</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030404</DrugIDPK>
    <LicenceNumber>PA1239/015/001</LicenceNumber>
    <ProductName>ZANACODAR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030405</DrugIDPK>
    <LicenceNumber>PA1239/015/002</LicenceNumber>
    <ProductName>ZANACODAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030406</DrugIDPK>
    <LicenceNumber>PA1239/015/003</LicenceNumber>
    <ProductName>ZANACODAR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004971</DrugIDPK>
    <LicenceNumber>PA0282/072/001</LicenceNumber>
    <ProductName>NORZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037882</DrugIDPK>
    <LicenceNumber>DPR1633/015/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2012-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029706</DrugIDPK>
    <LicenceNumber>PPA1328/102/001</LicenceNumber>
    <ProductName>CILEST</ProductName>
    <Strength>250/35</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORGESTIMATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020188</DrugIDPK>
    <LicenceNumber>EU/1/06/339/1-2</LicenceNumber>
    <ProductName>PREOTACT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>NPS Pharma Holdings Limited</PAHolder>
    <AuthorisedDate>2006-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARATHYROID HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031660</DrugIDPK>
    <LicenceNumber>PA0126/194/001</LicenceNumber>
    <ProductName>ZANOPRO</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034729</DrugIDPK>
    <LicenceNumber>PA0237/066/001</LicenceNumber>
    <ProductName>CARBOCISTEINE TEVA</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005574</DrugIDPK>
    <LicenceNumber>PA0282/048/002</LicenceNumber>
    <ProductName>MEFENAMIC ACID</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032539</DrugIDPK>
    <LicenceNumber>PA1368/010/001</LicenceNumber>
    <ProductName>TOPIRAMATE PHARMATHEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032540</DrugIDPK>
    <LicenceNumber>PA1368/010/002</LicenceNumber>
    <ProductName>TOPIRAMATE PHARMATHEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032541</DrugIDPK>
    <LicenceNumber>PA1368/010/003</LicenceNumber>
    <ProductName>TOPIRAMATE PHARMATHEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032542</DrugIDPK>
    <LicenceNumber>PA1368/010/004</LicenceNumber>
    <ProductName>TOPIRAMATE PHARMATHEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038968</DrugIDPK>
    <LicenceNumber>PA1368/012/003</LicenceNumber>
    <ProductName>MITHEGAN XL</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2013-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039086</DrugIDPK>
    <LicenceNumber>PA1368/012/001</LicenceNumber>
    <ProductName>MITHEGAN XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2013-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039087</DrugIDPK>
    <LicenceNumber>PA1368/012/002</LicenceNumber>
    <ProductName>MITHEGAN XL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>2013-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031426</DrugIDPK>
    <LicenceNumber>PA1422/004/002</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Oncology Plc</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026954</DrugIDPK>
    <LicenceNumber>DPR1463/007/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031588</DrugIDPK>
    <LicenceNumber>PA0711/187/001</LicenceNumber>
    <ProductName>AMOXICILLIN/CLAVULANIC ACID</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029234</DrugIDPK>
    <LicenceNumber>PPA1463/015/001</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031910</DrugIDPK>
    <LicenceNumber>PPA1463/032/001</LicenceNumber>
    <ProductName>BRICANYL TURBOHALER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041535</DrugIDPK>
    <LicenceNumber>PPA1463/092/001</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2014-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041536</DrugIDPK>
    <LicenceNumber>PPA1463/092/002</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>100/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2014-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031813</DrugIDPK>
    <LicenceNumber>PPA1463/030/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037752</DrugIDPK>
    <LicenceNumber>PPA1463/030/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038264</DrugIDPK>
    <LicenceNumber>PPA1463/030/003</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031569</DrugIDPK>
    <LicenceNumber>DPR1463/029/006</LicenceNumber>
    <ProductName>HALF SINEMET CR</ProductName>
    <Strength>25/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031582</DrugIDPK>
    <LicenceNumber>PPA1463/028/001</LicenceNumber>
    <ProductName>KLACID LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028969</DrugIDPK>
    <LicenceNumber>PPA1463/012/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028970</DrugIDPK>
    <LicenceNumber>PPA1463/012/002</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031753</DrugIDPK>
    <LicenceNumber>PPA1463/012/003</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034583</DrugIDPK>
    <LicenceNumber>PPA1463/012/004</LicenceNumber>
    <ProductName>LEXAPRO 15 MG FILM-COATED TABLETS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027465</DrugIDPK>
    <LicenceNumber>PPA1463/004/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027466</DrugIDPK>
    <LicenceNumber>PPA1463/004/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027467</DrugIDPK>
    <LicenceNumber>PPA1463/004/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027468</DrugIDPK>
    <LicenceNumber>PPA1463/004/004</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038611</DrugIDPK>
    <LicenceNumber>PPA1463/076/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038612</DrugIDPK>
    <LicenceNumber>PPA1463/076/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029761</DrugIDPK>
    <LicenceNumber>PPA1463/021/002</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029762</DrugIDPK>
    <LicenceNumber>PPA1463/021/003</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031800</DrugIDPK>
    <LicenceNumber>PPA1463/027/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031801</DrugIDPK>
    <LicenceNumber>PPA1463/027/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036455</DrugIDPK>
    <LicenceNumber>PPA1463/055/001</LicenceNumber>
    <ProductName>PLAQUENIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYCHLOROQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037539</DrugIDPK>
    <LicenceNumber>PPA1463/061/002</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038304</DrugIDPK>
    <LicenceNumber>PPA1463/048/005</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029595</DrugIDPK>
    <LicenceNumber>PPA1463/018/001</LicenceNumber>
    <ProductName>SPORANOX 100MG HARD CAPSULES</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ITRACONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031852</DrugIDPK>
    <LicenceNumber>PPA1500/050/002</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029619</DrugIDPK>
    <LicenceNumber>PPA1463/019/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035987</DrugIDPK>
    <LicenceNumber>PPA1562/057/001</LicenceNumber>
    <ProductName>ZESTORETIC</ProductName>
    <Strength>10/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035988</DrugIDPK>
    <LicenceNumber>PPA1562/057/002</LicenceNumber>
    <ProductName>ZESTORETIC</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032041</DrugIDPK>
    <LicenceNumber>PPA1463/034/002</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032042</DrugIDPK>
    <LicenceNumber>PPA1463/034/003</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036454</DrugIDPK>
    <LicenceNumber>PPA1463/054/001</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036505</DrugIDPK>
    <LicenceNumber>PPA1463/057/001</LicenceNumber>
    <ProductName>ZOMIG RAPIMELT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041454</DrugIDPK>
    <LicenceNumber>PA0822/132/002</LicenceNumber>
    <ProductName>PHARMORUBICIN 2 MG/ML SOLUTION FOR INJECTION OR IN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2014-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995041455</DrugIDPK>
    <LicenceNumber>PA0822/132/005</LicenceNumber>
    <ProductName>PHARMORUBICIN 2 MG/ML SOLUTION FOR INJECTION OR IN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2014-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032703</DrugIDPK>
    <LicenceNumber>PPA1562/022/001</LicenceNumber>
    <ProductName>SEREVENT EVOHALER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029934</DrugIDPK>
    <LicenceNumber>PPA1328/112/001</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029935</DrugIDPK>
    <LicenceNumber>PPA1328/112/002</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029936</DrugIDPK>
    <LicenceNumber>PPA1328/112/003</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029937</DrugIDPK>
    <LicenceNumber>PPA1328/112/004</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029614</DrugIDPK>
    <LicenceNumber>PPA1328/025/002</LicenceNumber>
    <ProductName>IKOREL 20MG TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029915</DrugIDPK>
    <LicenceNumber>PPA1328/108/001</LicenceNumber>
    <ProductName>TENORETIC</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029669</DrugIDPK>
    <LicenceNumber>PPA1328/083/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029679</DrugIDPK>
    <LicenceNumber>PPA1328/042/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022547</DrugIDPK>
    <LicenceNumber>PA0711/117/003</LicenceNumber>
    <ProductName>FLUVAT</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026924</DrugIDPK>
    <LicenceNumber>PA0711/117/001</LicenceNumber>
    <ProductName>FLUVAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026925</DrugIDPK>
    <LicenceNumber>PA0711/117/002</LicenceNumber>
    <ProductName>FLUVAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002767</DrugIDPK>
    <LicenceNumber>PA0050/014/003</LicenceNumber>
    <ProductName>RIVOTRIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLONAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009170</DrugIDPK>
    <LicenceNumber>PA0568/012/002</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE SERVIER</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029690</DrugIDPK>
    <LicenceNumber>PPA1328/100/001</LicenceNumber>
    <ProductName>SPORANOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ITRACONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030272</DrugIDPK>
    <LicenceNumber>PA0749/099/002</LicenceNumber>
    <ProductName>ALLOPURINOL TEVA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033381</DrugIDPK>
    <LicenceNumber>PA0749/124/005</LicenceNumber>
    <ProductName>CANDESARTAN TEVA</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033307</DrugIDPK>
    <LicenceNumber>PA0749/124/001</LicenceNumber>
    <ProductName>CANDESARTAN TEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020137</DrugIDPK>
    <LicenceNumber>PA0749/012/003</LicenceNumber>
    <ProductName>CEFOTAXIME</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028216</DrugIDPK>
    <LicenceNumber>PA0749/082/001</LicenceNumber>
    <ProductName>CEFUROXIME TEVA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022101</DrugIDPK>
    <LicenceNumber>PA0749/031/004</LicenceNumber>
    <ProductName>CIPROFLOXACIN TEVA</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037018</DrugIDPK>
    <LicenceNumber>PA1332/048/001</LicenceNumber>
    <ProductName>BILENI</ProductName>
    <Strength>137/50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZELASTINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037017</DrugIDPK>
    <LicenceNumber>PA1332/047/001</LicenceNumber>
    <ProductName>DYVISTANIL</ProductName>
    <Strength>137/50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZELASTINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038040</DrugIDPK>
    <LicenceNumber>PA0749/187/001</LicenceNumber>
    <ProductName>SILDENAFIL TEVA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038041</DrugIDPK>
    <LicenceNumber>PA0749/187/002</LicenceNumber>
    <ProductName>SILDENAFIL TEVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033070</DrugIDPK>
    <LicenceNumber>PA0749/121/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033071</DrugIDPK>
    <LicenceNumber>PA0749/121/002</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033072</DrugIDPK>
    <LicenceNumber>PA0749/121/003</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033073</DrugIDPK>
    <LicenceNumber>PA0749/121/004</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033074</DrugIDPK>
    <LicenceNumber>PA0749/121/005</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023165</DrugIDPK>
    <LicenceNumber>PA0749/052/001</LicenceNumber>
    <ProductName>SIMVASTATIN TEVA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023169</DrugIDPK>
    <LicenceNumber>PA0749/052/005</LicenceNumber>
    <ProductName>SIMVASTATIN TEVA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036905</DrugIDPK>
    <LicenceNumber>PA0749/169/001</LicenceNumber>
    <ProductName>EPLERENONE TEVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2013-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036906</DrugIDPK>
    <LicenceNumber>PA0749/169/002</LicenceNumber>
    <ProductName>EPLERENONE TEVA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2013-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021702</DrugIDPK>
    <LicenceNumber>PA0749/024/001</LicenceNumber>
    <ProductName>LANSOPRAZOLE TEVA</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021703</DrugIDPK>
    <LicenceNumber>PA0749/024/002</LicenceNumber>
    <ProductName>LANSOPRAZOLE TEVA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028182</DrugIDPK>
    <LicenceNumber>PA0749/081/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN TEVA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028183</DrugIDPK>
    <LicenceNumber>PA0749/081/002</LicenceNumber>
    <ProductName>LEVOFLOXACIN TEVA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034973</DrugIDPK>
    <LicenceNumber>PA0749/149/001</LicenceNumber>
    <ProductName>OMEGA 3</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEGA-3-ACID ETHYL ESTERS 90</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036859</DrugIDPK>
    <LicenceNumber>PA0749/168/001</LicenceNumber>
    <ProductName>PERINDOPRIL TOSILATE TEVA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029670</DrugIDPK>
    <LicenceNumber>PA0749/098/001</LicenceNumber>
    <ProductName>REMIFENTANIL TEVA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029671</DrugIDPK>
    <LicenceNumber>PA0749/098/002</LicenceNumber>
    <ProductName>REMIFENTANIL TEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029672</DrugIDPK>
    <LicenceNumber>PA0749/098/003</LicenceNumber>
    <ProductName>REMIFENTANIL TEVA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032401</DrugIDPK>
    <LicenceNumber>PA1347/014/001</LicenceNumber>
    <ProductName>DONEPEZIL KRKA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Krka d.d., Novo mesto</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032402</DrugIDPK>
    <LicenceNumber>PA1347/014/002</LicenceNumber>
    <ProductName>DONEPEZIL KRKA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Krka d.d., Novo mesto</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035123</DrugIDPK>
    <LicenceNumber>DPR1633/004/002</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035124</DrugIDPK>
    <LicenceNumber>DPR1633/004/003</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035122</DrugIDPK>
    <LicenceNumber>DPR1633/004/001</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037932</DrugIDPK>
    <LicenceNumber>PA0979/063/001</LicenceNumber>
    <ProductName>LANACANE 3 % W/W CREAM</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2012-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029035</DrugIDPK>
    <LicenceNumber>PA0979/048/001</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2008-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029036</DrugIDPK>
    <LicenceNumber>PA0979/046/001</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2008-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036741</DrugIDPK>
    <LicenceNumber>PA0979/047/001</LicenceNumber>
    <ProductName>MYCIL ATHLETE'S FOOT SPRAY</ProductName>
    <Strength>0.12 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027304</DrugIDPK>
    <LicenceNumber>PA1470/001/001</LicenceNumber>
    <ProductName>DONEPEZIL HYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027305</DrugIDPK>
    <LicenceNumber>PA1470/001/002</LicenceNumber>
    <ProductName>DONEPEZIL HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026963</DrugIDPK>
    <LicenceNumber>PA0441/041/001</LicenceNumber>
    <ProductName>PARACETAMOL 1000MG, PHENYLEPHRINE HYDROCHLORIDE 12</ProductName>
    <Strength>1000/12.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>2011-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Pharmacy only: MAXIMUM PACK SIZE 12. Maximum two packs per sale.
Promotion to the public: Pack size not more than 12</SupplyComments>
    <WithdrawalDate>2014-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029904</DrugIDPK>
    <LicenceNumber>PA1380/068/001</LicenceNumber>
    <ProductName>VITILE MR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034192</DrugIDPK>
    <LicenceNumber>EU/1/10/662/001</LicenceNumber>
    <ProductName>DOCETAXEL TEVA PHARMA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2014-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034193</DrugIDPK>
    <LicenceNumber>EU/1/10/662/002</LicenceNumber>
    <ProductName>DOCETAXEL TEVA PHARMA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2014-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029164</DrugIDPK>
    <LicenceNumber>PA0789/019/001</LicenceNumber>
    <ProductName>GEMCITABINE EBEWE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029165</DrugIDPK>
    <LicenceNumber>PA0789/019/002</LicenceNumber>
    <ProductName>GEMCITABINE EBEWE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033049</DrugIDPK>
    <LicenceNumber>PA1271/004/001</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033050</DrugIDPK>
    <LicenceNumber>PA1271/004/002</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016256</DrugIDPK>
    <LicenceNumber>PA1077/073/001</LicenceNumber>
    <ProductName>OTOSPORIN EAR DROPS</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027577</DrugIDPK>
    <LicenceNumber>PA1364/002/001</LicenceNumber>
    <ProductName>TIZANIDINE DR REDDY'S</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Reddy's Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027578</DrugIDPK>
    <LicenceNumber>PA1364/002/002</LicenceNumber>
    <ProductName>TIZANIDINE DR REDDY'S</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Reddy's Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037510</DrugIDPK>
    <LicenceNumber>PA0126/239/001</LicenceNumber>
    <ProductName>CREVASTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037511</DrugIDPK>
    <LicenceNumber>PA0126/239/002</LicenceNumber>
    <ProductName>CREVASTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037512</DrugIDPK>
    <LicenceNumber>PA0126/239/003</LicenceNumber>
    <ProductName>CREVASTIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037513</DrugIDPK>
    <LicenceNumber>PA0126/239/004</LicenceNumber>
    <ProductName>CREVASTIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037514</DrugIDPK>
    <LicenceNumber>PA0126/239/005</LicenceNumber>
    <ProductName>CREVASTIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022155</DrugIDPK>
    <LicenceNumber>PA0736/025/001</LicenceNumber>
    <ProductName>FLUMAZENIL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUMAZENIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028438</DrugIDPK>
    <LicenceNumber>PPA1473/005/001</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028439</DrugIDPK>
    <LicenceNumber>PPA1473/005/002</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030851</DrugIDPK>
    <LicenceNumber>PPA1473/029/001</LicenceNumber>
    <ProductName>BRICANYL TURBOHALER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028442</DrugIDPK>
    <LicenceNumber>PPA1473/006/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035621</DrugIDPK>
    <LicenceNumber>PPA1473/053/001</LicenceNumber>
    <ProductName>CLOPIDOGREL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030301</DrugIDPK>
    <LicenceNumber>PPA1473/030/001</LicenceNumber>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033139</DrugIDPK>
    <LicenceNumber>PPA1473/047/001</LicenceNumber>
    <ProductName>DOVOBET</ProductName>
    <Strength>50/0.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL HYDRATE</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033515</DrugIDPK>
    <LicenceNumber>PPA1473/049/001</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>5 Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028523</DrugIDPK>
    <LicenceNumber>PPA1473/012/001</LicenceNumber>
    <ProductName>IKOREL 10MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028524</DrugIDPK>
    <LicenceNumber>PPA1473/012/002</LicenceNumber>
    <ProductName>IKOREL 20MG TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030304</DrugIDPK>
    <LicenceNumber>PPA1473/034/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030305</DrugIDPK>
    <LicenceNumber>PPA1473/034/002</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030974</DrugIDPK>
    <LicenceNumber>PPA1473/033/001</LicenceNumber>
    <ProductName>LIVIAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIBOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029674</DrugIDPK>
    <LicenceNumber>PPA1473/022/001</LicenceNumber>
    <ProductName>VENTOLIN EVOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035187</DrugIDPK>
    <LicenceNumber>PPA1473/048/001</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035188</DrugIDPK>
    <LicenceNumber>PPA1473/048/002</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029658</DrugIDPK>
    <LicenceNumber>PPA1473/023/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029747</DrugIDPK>
    <LicenceNumber>PPA1473/024/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035107</DrugIDPK>
    <LicenceNumber>PA1072/001/003</LicenceNumber>
    <ProductName>ANAPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Lincoln Medical Ltd</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ADRENALINE (EPINEPHRINE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020812</DrugIDPK>
    <LicenceNumber>PA0108/029/001</LicenceNumber>
    <ProductName>COEPRATENZ PLUS</ProductName>
    <Strength>600/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>2006-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESYLATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019063</DrugIDPK>
    <LicenceNumber>PA0038/089/002</LicenceNumber>
    <ProductName>TARKA</ProductName>
    <Strength>180/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037722</DrugIDPK>
    <LicenceNumber>PPA1562/043/002</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20 + 5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036487</DrugIDPK>
    <LicenceNumber>EU/1/11/729/002</LicenceNumber>
    <ProductName>ONDUARP</ProductName>
    <Strength>40/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2011-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036488</DrugIDPK>
    <LicenceNumber>EU/1/11/729/003-004</LicenceNumber>
    <ProductName>ONDUARP</ProductName>
    <Strength>80/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2011-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036489</DrugIDPK>
    <LicenceNumber>EU/1/11/729/005-006</LicenceNumber>
    <ProductName>ONDUARP</ProductName>
    <Strength>80/10</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2011-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022841</DrugIDPK>
    <LicenceNumber>PA0967/013/001</LicenceNumber>
    <ProductName>PANTOSEC CONTROL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033879</DrugIDPK>
    <LicenceNumber>PA0943/019/001</LicenceNumber>
    <ProductName>POTASSIUM IODATE</ProductName>
    <Strength>85</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2010-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM IODATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028709</DrugIDPK>
    <LicenceNumber>PA0822/023/001</LicenceNumber>
    <ProductName>FARMADURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028710</DrugIDPK>
    <LicenceNumber>PA0822/023/002</LicenceNumber>
    <ProductName>FARMADURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028287</DrugIDPK>
    <LicenceNumber>PA1063/030/001</LicenceNumber>
    <ProductName>ANASTROZOLE NICHE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2009-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034174</DrugIDPK>
    <LicenceNumber>EU/1/11/675/001-005</LicenceNumber>
    <ProductName>LEFLUNOMIDE TEVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEFLUNOMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034175</DrugIDPK>
    <LicenceNumber>EU/1/11/675/006-10</LicenceNumber>
    <ProductName>LEFLUNOMIDE TEVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEFLUNOMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031029</DrugIDPK>
    <LicenceNumber>PA1226/010/001</LicenceNumber>
    <ProductName>VINORELBINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINORELBINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026465</DrugIDPK>
    <LicenceNumber>PA1130/015/001</LicenceNumber>
    <ProductName>ANASTROZOLE ARROW</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031176</DrugIDPK>
    <LicenceNumber>PPA1562/015/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036156</DrugIDPK>
    <LicenceNumber>PA1716/001/004</LicenceNumber>
    <ProductName>RETROVIR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>ViiV Healthcare UK Ltd</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIDOVUDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031858</DrugIDPK>
    <LicenceNumber>PA1624/001/001</LicenceNumber>
    <ProductName>XALOPTIC COMBI</ProductName>
    <Strength>50/5.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmaceutical Works POLPHARMA SA</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009344</DrugIDPK>
    <LicenceNumber>PA0970/011/001</LicenceNumber>
    <ProductName>HALF-INDERAL LA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009343</DrugIDPK>
    <LicenceNumber>PA0970/011/002</LicenceNumber>
    <ProductName>INDERAL LA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1998-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038700</DrugIDPK>
    <LicenceNumber>PPA1562/085/002</LicenceNumber>
    <ProductName>TEVETEN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034252</DrugIDPK>
    <LicenceNumber>PA0822/076/003</LicenceNumber>
    <ProductName>DONEPEZIL PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034253</DrugIDPK>
    <LicenceNumber>PA0822/076/004</LicenceNumber>
    <ProductName>DONEPEZIL PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031831</DrugIDPK>
    <LicenceNumber>PA0943/016/001</LicenceNumber>
    <ProductName>BUCCASTEM</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031832</DrugIDPK>
    <LicenceNumber>PA0943/017/001</LicenceNumber>
    <ProductName>TIMODINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE (AS 50% W/V SOLUTION)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030654</DrugIDPK>
    <LicenceNumber>PPA1562/013/002</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030656</DrugIDPK>
    <LicenceNumber>PPA1562/013/004</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022253</DrugIDPK>
    <LicenceNumber>PA0711/119/001</LicenceNumber>
    <ProductName>BRIMON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020814</DrugIDPK>
    <LicenceNumber>PA0711/086/001</LicenceNumber>
    <ProductName>ONDANSETRON 4MG FILM-COATED TABLETS</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020815</DrugIDPK>
    <LicenceNumber>PA0711/086/002</LicenceNumber>
    <ProductName>ONDANSETRON 8MG FILM-COATED TABLETS</ProductName>
    <Strength>8mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020911</DrugIDPK>
    <LicenceNumber>PA0126/162/001</LicenceNumber>
    <ProductName>CANTAXEL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018337</DrugIDPK>
    <LicenceNumber>PA0126/131/003</LicenceNumber>
    <ProductName>CIPROTAN 40MG FILM-COATED TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2004-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE’</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034504</DrugIDPK>
    <LicenceNumber>PA0126/218/003</LicenceNumber>
    <ProductName>LEVETIRACETAM CLONMEL</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031073</DrugIDPK>
    <LicenceNumber>PA0126/193/001</LicenceNumber>
    <ProductName>LIPVASTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031074</DrugIDPK>
    <LicenceNumber>PA0126/193/002</LicenceNumber>
    <ProductName>LIPVASTIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031075</DrugIDPK>
    <LicenceNumber>PA0126/193/003</LicenceNumber>
    <ProductName>LIPVASTIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2012-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035233</DrugIDPK>
    <LicenceNumber>PPA1562/050/001</LicenceNumber>
    <ProductName>ABIDEC MULTIVITAMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034603</DrugIDPK>
    <LicenceNumber>PPA1562/045/001</LicenceNumber>
    <ProductName>SPASMONAL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035100</DrugIDPK>
    <LicenceNumber>PPA1562/045/002</LicenceNumber>
    <ProductName>SPASMONAL FORTE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036107</DrugIDPK>
    <LicenceNumber>PPA1562/062/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026780</DrugIDPK>
    <LicenceNumber>PA0749/068/001</LicenceNumber>
    <ProductName>ZOLMITRIPTAN TEVA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019441</DrugIDPK>
    <LicenceNumber>PA0740/009/001</LicenceNumber>
    <ProductName>SIMVASTATIN SYNTHON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019442</DrugIDPK>
    <LicenceNumber>PA0740/009/002</LicenceNumber>
    <ProductName>SIMVASTATIN SYNTHON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019443</DrugIDPK>
    <LicenceNumber>PA0740/009/003</LicenceNumber>
    <ProductName>SIMVASTATIN SYNTHON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019444</DrugIDPK>
    <LicenceNumber>PA0740/009/004</LicenceNumber>
    <ProductName>SIMVASTATIN SYNTHON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021657</DrugIDPK>
    <LicenceNumber>PA1327/004/001</LicenceNumber>
    <ProductName>ENTRYDIL 60MG MODIFIED RELEASE TABLETS.</ProductName>
    <Strength>60 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021658</DrugIDPK>
    <LicenceNumber>PA1327/004/003</LicenceNumber>
    <ProductName>ENTRYDIL S.R. 120MG PROLONGED RELEASE FILM-COATED</ProductName>
    <Strength>120 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021659</DrugIDPK>
    <LicenceNumber>PA1327/004/002</LicenceNumber>
    <ProductName>ENTRYDIL S.R. 90 MG PROLONGED-RELEASE, FILM-COATED</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001386</DrugIDPK>
    <LicenceNumber>PA0035/069/001</LicenceNumber>
    <ProductName>PEPCID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001387</DrugIDPK>
    <LicenceNumber>PA0035/069/002</LicenceNumber>
    <ProductName>PEPCID</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021663</DrugIDPK>
    <LicenceNumber>PA1327/006/001</LicenceNumber>
    <ProductName>TENOX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021664</DrugIDPK>
    <LicenceNumber>PA1327/006/002</LicenceNumber>
    <ProductName>TENOX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037092</DrugIDPK>
    <LicenceNumber>PA1773/001/001</LicenceNumber>
    <ProductName>ACARBOSE TECNIMEDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Multigeneris GmbH</PAHolder>
    <AuthorisedDate>2012-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACARBOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037093</DrugIDPK>
    <LicenceNumber>PA1773/001/002</LicenceNumber>
    <ProductName>ACARBOSE TECNIMEDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Multigeneris GmbH</PAHolder>
    <AuthorisedDate>2012-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACARBOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033034</DrugIDPK>
    <LicenceNumber>PA0566/059/001</LicenceNumber>
    <ProductName>DOCIRENA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033035</DrugIDPK>
    <LicenceNumber>PA0566/059/002</LicenceNumber>
    <ProductName>DOCIRENA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Mg/4Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033248</DrugIDPK>
    <LicenceNumber>PA0749/131/001</LicenceNumber>
    <ProductName>BYLANS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033249</DrugIDPK>
    <LicenceNumber>PA0749/131/002</LicenceNumber>
    <ProductName>BYLANS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036005</DrugIDPK>
    <LicenceNumber>PA1462/008/001</LicenceNumber>
    <ProductName>GLENTEK</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2012-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RILUZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2014-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027342</DrugIDPK>
    <LicenceNumber>PA1462/001/001</LicenceNumber>
    <ProductName>GLEPARK</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027343</DrugIDPK>
    <LicenceNumber>PA1462/001/002</LicenceNumber>
    <ProductName>GLEPARK</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027344</DrugIDPK>
    <LicenceNumber>PA1462/001/003</LicenceNumber>
    <ProductName>GLEPARK</ProductName>
    <Strength>0.35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027345</DrugIDPK>
    <LicenceNumber>PA1462/001/004</LicenceNumber>
    <ProductName>GLEPARK</ProductName>
    <Strength>0.70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028603</DrugIDPK>
    <LicenceNumber>PA0749/086/001</LicenceNumber>
    <ProductName>VINORELBINE TEVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINORELBINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020576</DrugIDPK>
    <LicenceNumber>PA1241/011/001</LicenceNumber>
    <ProductName>AFFEX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020570</DrugIDPK>
    <LicenceNumber>PA1241/012/006</LicenceNumber>
    <ProductName>DIFENE AMPOULES</ProductName>
    <Strength>75/3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2006-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006027</DrugIDPK>
    <LicenceNumber>EU/1/96/014/002</LicenceNumber>
    <ProductName>TRITANRIX HB</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Smith &amp; Nephew Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001062</DrugIDPK>
    <LicenceNumber>EU/1/96/014/001</LicenceNumber>
    <ProductName>TRITANRIX HB</ProductName>
    <Strength>3 ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Smith &amp; Nephew Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021129</DrugIDPK>
    <LicenceNumber>PA1241/001/001</LicenceNumber>
    <ProductName>ULCID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2014-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000951</DrugIDPK>
    <LicenceNumber>PA0019/044/006</LicenceNumber>
    <ProductName>DIFLUCAN 2 MG/ML SOLUTION FOR INFUSION</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022231</DrugIDPK>
    <LicenceNumber>PPA0465/192/001</LicenceNumber>
    <ProductName>SOLIAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035209</DrugIDPK>
    <LicenceNumber>PPA0465/264/002</LicenceNumber>
    <ProductName>SPASMONAL FORTE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019367</DrugIDPK>
    <LicenceNumber>PPA0465/147/001</LicenceNumber>
    <ProductName>TEVETEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020166</DrugIDPK>
    <LicenceNumber>PPA0465/163/004</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029924</DrugIDPK>
    <LicenceNumber>PPA0465/163/005</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010668</DrugIDPK>
    <LicenceNumber>PPA0465/076/001</LicenceNumber>
    <ProductName>VERMOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEBENDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035259</DrugIDPK>
    <LicenceNumber>PPA0465/269/001</LicenceNumber>
    <ProductName>XALACOM</ProductName>
    <Strength>50 + 5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003057</DrugIDPK>
    <LicenceNumber>PPA0465/053/001</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008181</DrugIDPK>
    <LicenceNumber>PPA0465/061/001</LicenceNumber>
    <ProductName>ZIRTEK</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006231</DrugIDPK>
    <LicenceNumber>PPA0465/056/001</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006232</DrugIDPK>
    <LicenceNumber>PPA0465/056/002</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006233</DrugIDPK>
    <LicenceNumber>PPA0465/056/003</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022489</DrugIDPK>
    <LicenceNumber>PPA0465/038/006</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022148</DrugIDPK>
    <LicenceNumber>PPA0465/165/002</LicenceNumber>
    <ProductName>ACTONEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026430</DrugIDPK>
    <LicenceNumber>PPA0465/210/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019160</DrugIDPK>
    <LicenceNumber>PPA0465/142/001</LicenceNumber>
    <ProductName>BETNOVATE SCALP APPLICATION</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014610</DrugIDPK>
    <LicenceNumber>PPA0465/049/001</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Pack sizes not exceeding 30 tablets: Promotion to the public. 
Pack sizes exceeding 30 tablets: Promotion to healthcare professionals.</SupplyComments>
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022439</DrugIDPK>
    <LicenceNumber>PPA0465/194/001</LicenceNumber>
    <ProductName>COPEGUS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBAVIRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019152</DrugIDPK>
    <LicenceNumber>PPA0465/140/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019153</DrugIDPK>
    <LicenceNumber>PPA0465/140/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019615</DrugIDPK>
    <LicenceNumber>PPA0465/149/001</LicenceNumber>
    <ProductName>DAONIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011548</DrugIDPK>
    <LicenceNumber>PPA0465/080/001</LicenceNumber>
    <ProductName>DETRUSITOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011550</DrugIDPK>
    <LicenceNumber>PPA0465/080/002</LicenceNumber>
    <ProductName>DETRUSITOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030733</DrugIDPK>
    <LicenceNumber>PPA0465/228/001</LicenceNumber>
    <ProductName>DIFFLAM SPRAY</ProductName>
    <Strength>0.15</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018824</DrugIDPK>
    <LicenceNumber>PPA0465/132/001</LicenceNumber>
    <ProductName>DOVONEX 50 MICROGRAMS/G CREAM</ProductName>
    <Strength>50 mcg/g</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018825</DrugIDPK>
    <LicenceNumber>PPA0465/132/003</LicenceNumber>
    <ProductName>DOVONEX 50 MICROGRAMS/ML SCALP SOLUTION</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030920</DrugIDPK>
    <LicenceNumber>PPA0465/241/001</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030921</DrugIDPK>
    <LicenceNumber>PPA0465/241/002</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018253</DrugIDPK>
    <LicenceNumber>PPA0465/120/001</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018254</DrugIDPK>
    <LicenceNumber>PPA0465/120/002</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015094</DrugIDPK>
    <LicenceNumber>PPA0465/087/002</LicenceNumber>
    <ProductName>EMCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030194</DrugIDPK>
    <LicenceNumber>PPA0465/220/001</LicenceNumber>
    <ProductName>HALF INDERAL LA 80MG PROLONGED-RELEASE CAPSULES</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007896</DrugIDPK>
    <LicenceNumber>PPA0465/060/001</LicenceNumber>
    <ProductName>IMDUR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030195</DrugIDPK>
    <LicenceNumber>PPA0465/220/002</LicenceNumber>
    <ProductName>INDERAL LA 160MG PROLONGED-RELEASE CAPSULES</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017690</DrugIDPK>
    <LicenceNumber>PPA0465/051/003</LicenceNumber>
    <ProductName>KLACID LA MODIFIED-RELEASE 500MG TABLETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007504</DrugIDPK>
    <LicenceNumber>PPA0465/059/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008914</DrugIDPK>
    <LicenceNumber>PPA0465/039/004</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008915</DrugIDPK>
    <LicenceNumber>PPA0465/039/005</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010667</DrugIDPK>
    <LicenceNumber>PPA0465/074/002</LicenceNumber>
    <ProductName>NU-SEALS</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019872</DrugIDPK>
    <LicenceNumber>PPA0465/158/001</LicenceNumber>
    <ProductName>PANADOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.

Promotion to the general public for packs containing not more than 2</SupplyComments>
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017588</DrugIDPK>
    <LicenceNumber>PPA0465/107/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017589</DrugIDPK>
    <LicenceNumber>PPA0465/107/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038474</DrugIDPK>
    <LicenceNumber>PPA0465/298/001</LicenceNumber>
    <ProductName>PHYLLOCONTIN CONTINUS</ProductName>
    <Strength>225</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037778</DrugIDPK>
    <LicenceNumber>PPA0465/100/004</LicenceNumber>
    <ProductName>PULMICORT RESPULES</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mg/2ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037779</DrugIDPK>
    <LicenceNumber>PPA0465/100/005</LicenceNumber>
    <ProductName>PULMICORT RESPULES</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>mg/2ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022177</DrugIDPK>
    <LicenceNumber>PPA0465/153/004</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019860</DrugIDPK>
    <LicenceNumber>PPA0465/153/001</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019862</DrugIDPK>
    <LicenceNumber>PPA0465/153/003</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033521</DrugIDPK>
    <LicenceNumber>PPA0465/153/005</LicenceNumber>
    <ProductName>SEROQUEL XR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035320</DrugIDPK>
    <LicenceNumber>PA1271/002/002</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035321</DrugIDPK>
    <LicenceNumber>PA1271/002/001</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035322</DrugIDPK>
    <LicenceNumber>PA1271/002/003</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038015</DrugIDPK>
    <LicenceNumber>PPA0465/293/001</LicenceNumber>
    <ProductName>COMBODART</ProductName>
    <Strength>0.5/0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DUTASTERIDE</ActiveSubstance>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015258</DrugIDPK>
    <LicenceNumber>PA1063/001/001</LicenceNumber>
    <ProductName>BIODOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2002-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037763</DrugIDPK>
    <LicenceNumber>PPA1562/082/001</LicenceNumber>
    <ProductName>AVODART</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DUTASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022300</DrugIDPK>
    <LicenceNumber>PA0931/009/002</LicenceNumber>
    <ProductName>HARTMANN'S SOLUTION - COMPOUND SODIUM LACTATE INTR</ProductName>
    <Strength>6/0.27/0.4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Maco Pharma (UK) Ltd</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE SOLUTION 60%</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022302</DrugIDPK>
    <LicenceNumber>PA0931/009/004</LicenceNumber>
    <ProductName>HARTMANN'S SOLUTION - COMPOUND SODIUM LACTATE INTR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Maco Pharma (UK) Ltd</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE SOLUTION 60%</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019891</DrugIDPK>
    <LicenceNumber>PA0943/012/001</LicenceNumber>
    <ProductName>PERIOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2005-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028653</DrugIDPK>
    <LicenceNumber>PA1226/008/001</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028654</DrugIDPK>
    <LicenceNumber>PA1226/008/002</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028103</DrugIDPK>
    <LicenceNumber>PA1226/007/001</LicenceNumber>
    <ProductName>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035942</DrugIDPK>
    <LicenceNumber>PPA1659/041/001</LicenceNumber>
    <ProductName>ACTONEL PLUS CA &amp; D</ProductName>
    <Strength>35 + 1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035939</DrugIDPK>
    <LicenceNumber>PPA1659/039/001</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035940</DrugIDPK>
    <LicenceNumber>PPA1659/039/003</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035941</DrugIDPK>
    <LicenceNumber>PPA1659/039/002</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036162</DrugIDPK>
    <LicenceNumber>PPA1659/051/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036163</DrugIDPK>
    <LicenceNumber>PPA1659/051/003</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036164</DrugIDPK>
    <LicenceNumber>PPA1659/051/002</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035556</DrugIDPK>
    <LicenceNumber>PPA1659/033/001</LicenceNumber>
    <ProductName>IMPLANON NXT</ProductName>
    <Strength>68</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETONOGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035952</DrugIDPK>
    <LicenceNumber>PPA1659/046/001</LicenceNumber>
    <ProductName>IMURAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035953</DrugIDPK>
    <LicenceNumber>PPA1659/046/002</LicenceNumber>
    <ProductName>IMURAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036302</DrugIDPK>
    <LicenceNumber>PPA1659/035/002</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035757</DrugIDPK>
    <LicenceNumber>PPA1659/036/001</LicenceNumber>
    <ProductName>TEGRETOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035758</DrugIDPK>
    <LicenceNumber>PPA1659/036/002</LicenceNumber>
    <ProductName>TEGRETOL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035557</DrugIDPK>
    <LicenceNumber>PPA1659/034/001</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035558</DrugIDPK>
    <LicenceNumber>PPA1659/034/002</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035559</DrugIDPK>
    <LicenceNumber>PPA1659/034/003</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033056</DrugIDPK>
    <LicenceNumber>PA0361/031/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE MARTINDALE PHARMA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037256</DrugIDPK>
    <LicenceNumber>PA0970/063/001</LicenceNumber>
    <ProductName>AXANUM</ProductName>
    <Strength>81/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021979</DrugIDPK>
    <LicenceNumber>PA0013/121/001</LicenceNumber>
    <ProductName>CARDIOXANE 500MG POWDER FOR CONCENTRATE FOR SOLUTI</ProductName>
    <Strength>500mg/vial</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXRAZOXANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022868</DrugIDPK>
    <LicenceNumber>PA0789/015/001</LicenceNumber>
    <ProductName>FLUDARABINE PHOSPHATE "EBEWE"</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDARABINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040011</DrugIDPK>
    <LicenceNumber>PA1330/014/003</LicenceNumber>
    <ProductName>FLUCONAZOLE 200 MG CAPSULES</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2013-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040009</DrugIDPK>
    <LicenceNumber>PA1330/014/001</LicenceNumber>
    <ProductName>FLUCONAZOLE 50 MG CAPSULES</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2013-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021785</DrugIDPK>
    <LicenceNumber>PPA0465/185/001</LicenceNumber>
    <ProductName>DIFENE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029817</DrugIDPK>
    <LicenceNumber>PPA0465/216/001</LicenceNumber>
    <ProductName>MYCOSTATIN 100,000 UNITS/ML ORAL SUSPENSION (READY</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033427</DrugIDPK>
    <LicenceNumber>PPA0465/254/001</LicenceNumber>
    <ProductName>PLAQUENIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYCHLOROQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033450</DrugIDPK>
    <LicenceNumber>PPA0465/257/001</LicenceNumber>
    <ProductName>TYLEX</ProductName>
    <Strength>30/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031580</DrugIDPK>
    <LicenceNumber>PA0749/083/002</LicenceNumber>
    <ProductName>DEBDOX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2013-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033346</DrugIDPK>
    <LicenceNumber>PA1423/009/001</LicenceNumber>
    <ProductName>VANCOMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>NRIM Limited</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VANCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033347</DrugIDPK>
    <LicenceNumber>PA1423/009/002</LicenceNumber>
    <ProductName>VANCOMYCIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>NRIM Limited</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VANCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031016</DrugIDPK>
    <LicenceNumber>EU/1/09/554/1-6</LicenceNumber>
    <ProductName>CLOPIDOGREL RATIOPHARM</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Archie Samuel s.r.o.</PAHolder>
    <AuthorisedDate>2009-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040758</DrugIDPK>
    <LicenceNumber>EU/1/09/554/002</LicenceNumber>
    <ProductName>CLOPIDOGREL RATIOPHARM</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Archie Samuel s.r.o.</PAHolder>
    <AuthorisedDate>2009-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040759</DrugIDPK>
    <LicenceNumber>EU/1/09/554/007</LicenceNumber>
    <ProductName>CLOPIDOGREL RATIOPHARM</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Archie Samuel s.r.o.</PAHolder>
    <AuthorisedDate>2009-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005047</DrugIDPK>
    <LicenceNumber>PA0623/003/001</LicenceNumber>
    <ProductName>DACARBAZINE MEDAC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACARBAZINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017576</DrugIDPK>
    <LicenceNumber>PA0281/114/001</LicenceNumber>
    <ProductName>FLUOXETINE</ProductName>
    <Strength>20mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2008-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032006</DrugIDPK>
    <LicenceNumber>PA1304/004/001</LicenceNumber>
    <ProductName>ATORVASTATIN BIOKANOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032007</DrugIDPK>
    <LicenceNumber>PA1304/004/003</LicenceNumber>
    <ProductName>ATORVASTATIN BIOKANOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032008</DrugIDPK>
    <LicenceNumber>PA1304/004/004</LicenceNumber>
    <ProductName>ATORVASTATIN BIOKANOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032009</DrugIDPK>
    <LicenceNumber>PA1304/004/002</LicenceNumber>
    <ProductName>ATORVASTATIN BIOKANOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028867</DrugIDPK>
    <LicenceNumber>PA1329/005/001</LicenceNumber>
    <ProductName>OSTEOEZE</ProductName>
    <Strength>625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031533</DrugIDPK>
    <LicenceNumber>PPA1473/032/001</LicenceNumber>
    <ProductName>DIANETTE</ProductName>
    <Strength>2mg/35mcg</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031488</DrugIDPK>
    <LicenceNumber>PPA1473/037/001</LicenceNumber>
    <ProductName>OMNEXEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035301</DrugIDPK>
    <LicenceNumber>PPA1473/051/001</LicenceNumber>
    <ProductName>RISEDRONATE SODIUM ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031949</DrugIDPK>
    <LicenceNumber>PPA1473/042/001</LicenceNumber>
    <ProductName>SERETIDE</ProductName>
    <Strength>50/500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029947</DrugIDPK>
    <LicenceNumber>PPA1473/026/001</LicenceNumber>
    <ProductName>SPIRIVA</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030865</DrugIDPK>
    <LicenceNumber>PPA1473/028/001</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>100/6</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022319</DrugIDPK>
    <LicenceNumber>PA0623/010/001</LicenceNumber>
    <ProductName>LEVOFOLINIC ACID MEDAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFOLINIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038746</DrugIDPK>
    <LicenceNumber>PPA1562/098/001</LicenceNumber>
    <ProductName>SERETIDE 100 DISKUS</ProductName>
    <Strength>50/100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038747</DrugIDPK>
    <LicenceNumber>PPA1562/098/002</LicenceNumber>
    <ProductName>SERETIDE 250 DISKUS</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030390</DrugIDPK>
    <LicenceNumber>PA0126/149/004</LicenceNumber>
    <ProductName>ARTHRIMEL ONCE DAILY</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULPHATE SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003932</DrugIDPK>
    <LicenceNumber>PA0126/077/001</LicenceNumber>
    <ProductName>CIMELDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029637</DrugIDPK>
    <LicenceNumber>PA1557/001/001</LicenceNumber>
    <ProductName>DOCETAXEL TEVA GENERICS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Generics B.V.</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for conc/solv for inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2013-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029638</DrugIDPK>
    <LicenceNumber>PA1557/001/002</LicenceNumber>
    <ProductName>DOCETAXEL TEVA GENERICS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Generics B.V.</PAHolder>
    <AuthorisedDate>2012-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for conc/solv for inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2013-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033318</DrugIDPK>
    <LicenceNumber>EU/1/10/650/001-015</LicenceNumber>
    <ProductName>CLOPIDOGREL TEVA GENERICS B.V.</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Generics B.V.</PAHolder>
    <AuthorisedDate>2010-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026586</DrugIDPK>
    <LicenceNumber>PA0568/021/001</LicenceNumber>
    <ProductName>GLYDIUM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033274</DrugIDPK>
    <LicenceNumber>PA0568/021/002</LicenceNumber>
    <ProductName>GLYDIUM</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2011-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036623</DrugIDPK>
    <LicenceNumber>PA1695/002/001</LicenceNumber>
    <ProductName>OLANZAPINE RENANTOS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Renantos Pharmavertriebsges. mbH</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036624</DrugIDPK>
    <LicenceNumber>PA1695/002/002</LicenceNumber>
    <ProductName>OLANZAPINE RENANTOS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Renantos Pharmavertriebsges. mbH</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036625</DrugIDPK>
    <LicenceNumber>PA1695/002/003</LicenceNumber>
    <ProductName>OLANZAPINE RENANTOS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Renantos Pharmavertriebsges. mbH</PAHolder>
    <AuthorisedDate>2012-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039784</DrugIDPK>
    <LicenceNumber>PA1897/002/001</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039785</DrugIDPK>
    <LicenceNumber>PA1897/002/002</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995039786</DrugIDPK>
    <LicenceNumber>PA1897/002/003</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995040232</DrugIDPK>
    <LicenceNumber>PA1897/008/001</LicenceNumber>
    <ProductName>CARBOPLATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>2013-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034629</DrugIDPK>
    <LicenceNumber>PA1077/127/002</LicenceNumber>
    <ProductName>PANOXYL ACNEGEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034624</DrugIDPK>
    <LicenceNumber>PA1077/127/001</LicenceNumber>
    <ProductName>PANOXYL ACNEGEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027723</DrugIDPK>
    <LicenceNumber>PA0167/133/001</LicenceNumber>
    <ProductName>PLASMA VOLUME REDIBAG 6 % SOLUTION FOR INFUSION</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYETHYL STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022941</DrugIDPK>
    <LicenceNumber>PA0540/097/003</LicenceNumber>
    <ProductName>CLEXANE MULTI DOSE</ProductName>
    <Strength>300/3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXAPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032301</DrugIDPK>
    <LicenceNumber>PA0540/104/001</LicenceNumber>
    <ProductName>INTAL SPINCAPS 20MG INHALATION POWDER CAPSULES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2010-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023499</DrugIDPK>
    <LicenceNumber>PA0577/101/001</LicenceNumber>
    <ProductName>MYZAAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023500</DrugIDPK>
    <LicenceNumber>PA0577/101/002</LicenceNumber>
    <ProductName>MYZAAR COMP</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027076</DrugIDPK>
    <LicenceNumber>PA1421/003/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE NYCOMED</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027077</DrugIDPK>
    <LicenceNumber>PA1421/003/002</LicenceNumber>
    <ProductName>PANTOPRAZOLE NYCOMED</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027078</DrugIDPK>
    <LicenceNumber>PA1421/003/003</LicenceNumber>
    <ProductName>PANTOPRAZOLE NYCOMED I.V.</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031127</DrugIDPK>
    <LicenceNumber>PA1390/027/003</LicenceNumber>
    <ProductName>QUETIAPINE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028282</DrugIDPK>
    <LicenceNumber>PA1050/002/001</LicenceNumber>
    <ProductName>PIPERACILLIN/TAZOBACTAM MILPHARM 2 G/0.25 G POWDER</ProductName>
    <Strength>20.25</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028283</DrugIDPK>
    <LicenceNumber>PA1050/002/002</LicenceNumber>
    <ProductName>PIPERACILLIN/TAZOBACTAM MILPHARM 4 G/0.5 G POWDER</ProductName>
    <Strength>40.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018338</DrugIDPK>
    <LicenceNumber>PA0281/117/001</LicenceNumber>
    <ProductName>CIPRAPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2004-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018339</DrugIDPK>
    <LicenceNumber>PA0281/117/002</LicenceNumber>
    <ProductName>CIPRAPINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2004-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018340</DrugIDPK>
    <LicenceNumber>PA0281/117/003</LicenceNumber>
    <ProductName>CIPRAPINE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2004-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017325</DrugIDPK>
    <LicenceNumber>PA0577/049/001</LicenceNumber>
    <ProductName>BENPH</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017326</DrugIDPK>
    <LicenceNumber>PA0577/049/002</LicenceNumber>
    <ProductName>BENPH</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017327</DrugIDPK>
    <LicenceNumber>PA0577/049/003</LicenceNumber>
    <ProductName>BENPH</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017328</DrugIDPK>
    <LicenceNumber>PA0577/049/004</LicenceNumber>
    <ProductName>BENPH</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022652</DrugIDPK>
    <LicenceNumber>PA1364/001/001</LicenceNumber>
    <ProductName>FLUOXETINE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Reddy's Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014895</DrugIDPK>
    <LicenceNumber>PA1050/001/001</LicenceNumber>
    <ProductName>GABTURE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2003-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014896</DrugIDPK>
    <LicenceNumber>PA1050/001/002</LicenceNumber>
    <ProductName>GABTURE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2003-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014897</DrugIDPK>
    <LicenceNumber>PA1050/001/003</LicenceNumber>
    <ProductName>GABTURE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2003-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022123</DrugIDPK>
    <LicenceNumber>PA1353/001/002</LicenceNumber>
    <ProductName>ESMOCARD</ProductName>
    <Strength>2500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orpha-Devel Handels und Vertriebs GmbH</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESMOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032366</DrugIDPK>
    <LicenceNumber>PA1246/002/001</LicenceNumber>
    <ProductName>TRAMADOL/PARACETAMOL</ProductName>
    <Strength>75/650</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Paladin Labs Europe Limited</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031476</DrugIDPK>
    <LicenceNumber>PA0959/003/001</LicenceNumber>
    <ProductName>CODALUX</ProductName>
    <Strength>50/5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aziende Chimiche Riunite Angelini Francesco</PAHolder>
    <AuthorisedDate>2011-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033426</DrugIDPK>
    <LicenceNumber>PPA0465/255/001</LicenceNumber>
    <ProductName>MALARONE</ProductName>
    <Strength>250/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOVAQUONE</ActiveSubstance>
      <ActiveSubstance>PROGUANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033553</DrugIDPK>
    <LicenceNumber>PA1390/035/001</LicenceNumber>
    <ProductName>ALENDRONIC ACID 10 MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036224</DrugIDPK>
    <LicenceNumber>PA1390/045/006</LicenceNumber>
    <ProductName>OLANZAPINE ACCORD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE (FORM-1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032919</DrugIDPK>
    <LicenceNumber>PA0767/001/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Millmount Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036217</DrugIDPK>
    <LicenceNumber>PA1649/002/001</LicenceNumber>
    <ProductName>RIVASTIGMINE ACINO</ProductName>
    <Strength>4.6</Strength>
    <StrengthMeasurement>mg/24 hours</StrengthMeasurement>
    <PAHolder>Luye Pharma AG</PAHolder>
    <AuthorisedDate>2013-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036218</DrugIDPK>
    <LicenceNumber>PA1649/002/002</LicenceNumber>
    <ProductName>RIVASTIGMINE ACINO</ProductName>
    <Strength>9.5</Strength>
    <StrengthMeasurement>mg/24 hours</StrengthMeasurement>
    <PAHolder>Luye Pharma AG</PAHolder>
    <AuthorisedDate>2013-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008825</DrugIDPK>
    <LicenceNumber>PA0050/068/024</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength>18miu/0.6</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>2000-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.4).</SupplyComments>
    <WithdrawalDate>2013-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003780</DrugIDPK>
    <LicenceNumber>PA0805/001/003</LicenceNumber>
    <ProductName>SERDOLECT</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037815</DrugIDPK>
    <LicenceNumber>PA0822/163/003</LicenceNumber>
    <ProductName>ADVIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037816</DrugIDPK>
    <LicenceNumber>PA0822/163/004</LicenceNumber>
    <ProductName>ADVIL MAXIMUM STRENGTH</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 400 mg, maximum pack size 25, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indications.  

For use in adults and children not under 12 years</SupplyComments>
    <WithdrawalDate>2013-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019609</DrugIDPK>
    <LicenceNumber>PA1063/018/003</LicenceNumber>
    <ProductName>LANAFINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025845</DrugIDPK>
    <LicenceNumber>PA0568/017/001</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025846</DrugIDPK>
    <LicenceNumber>PA0568/017/002</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017891</DrugIDPK>
    <LicenceNumber>PA1124/001/001</LicenceNumber>
    <ProductName>DOXEL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Clarendon Pharma Limited</PAHolder>
    <AuthorisedDate>2005-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027652</DrugIDPK>
    <LicenceNumber>PA1226/006/001</LicenceNumber>
    <ProductName>LETROZOLE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LETROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033263</DrugIDPK>
    <LicenceNumber>PA1619/003/002</LicenceNumber>
    <ProductName>RISEDRONATE 30MG FILM-COATED TABLETS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aspire Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033262</DrugIDPK>
    <LicenceNumber>PA1619/003/001</LicenceNumber>
    <ProductName>RISEDRONATE 5MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aspire Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033264</DrugIDPK>
    <LicenceNumber>PA1619/003/003</LicenceNumber>
    <ProductName>RISEDRONATE ONCE A WEEK 35MG FILM-COATED TABLET</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aspire Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM HEMIPENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030061</DrugIDPK>
    <LicenceNumber>PPA1562/006/001</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030062</DrugIDPK>
    <LicenceNumber>PPA1562/006/002</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035197</DrugIDPK>
    <LicenceNumber>PA1638/003/001</LicenceNumber>
    <ProductName>CYTAMEN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>2011-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022556</DrugIDPK>
    <LicenceNumber>PA0126/169/007</LicenceNumber>
    <ProductName>PERDAMEL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035545</DrugIDPK>
    <LicenceNumber>PA1522/006/001</LicenceNumber>
    <ProductName>IRBESARTAN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035546</DrugIDPK>
    <LicenceNumber>PA1522/006/002</LicenceNumber>
    <ProductName>IRBESARTAN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035547</DrugIDPK>
    <LicenceNumber>PA1522/006/003</LicenceNumber>
    <ProductName>IRBESARTAN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036007</DrugIDPK>
    <LicenceNumber>PA1522/007/002</LicenceNumber>
    <ProductName>IRBESARTAN/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>300/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036008</DrugIDPK>
    <LicenceNumber>PA1522/007/003</LicenceNumber>
    <ProductName>IRBESARTAN/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>300/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2012-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020653</DrugIDPK>
    <LicenceNumber>PA1130/006/005</LicenceNumber>
    <ProductName>LAMOTRIGINE 100 MG DISPERSIBLE TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020649</DrugIDPK>
    <LicenceNumber>PA1130/006/001</LicenceNumber>
    <ProductName>LAMOTRIGINE 2 MG DISPERSIBLE TABLETS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020654</DrugIDPK>
    <LicenceNumber>PA1130/006/006</LicenceNumber>
    <ProductName>LAMOTRIGINE 200 MG DISPERSIBLE TABLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020651</DrugIDPK>
    <LicenceNumber>PA1130/006/003</LicenceNumber>
    <ProductName>LAMOTRIGINE 25 MG DISPERSIBLE TABLETS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020650</DrugIDPK>
    <LicenceNumber>PA1130/006/002</LicenceNumber>
    <ProductName>LAMOTRIGINE 5 MG DISPERSIBLE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020652</DrugIDPK>
    <LicenceNumber>PA1130/006/004</LicenceNumber>
    <ProductName>LAMOTRIGINE 50 MG DISPERSIBLE TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018273</DrugIDPK>
    <LicenceNumber>PA0678/099/001</LicenceNumber>
    <ProductName>NIQUITIN CQ</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018274</DrugIDPK>
    <LicenceNumber>PA0678/099/002</LicenceNumber>
    <ProductName>NIQUITIN CQ</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018413</DrugIDPK>
    <LicenceNumber>PA0678/101/001</LicenceNumber>
    <ProductName>SOLPADEINE COLD  &amp; FLU</ProductName>
    <Strength>500/30/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2003-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Pharmacy only: MAXIMUM PACK SIZE 24. Maximum two packs per sale.
Prescription only: Pack size greater than 24. Product not supplied in blister packs.	
Promotion to the public: Pack size not more than 24
Promotion to healthcare professionals: Pack size greater than 24</SupplyComments>
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037124</DrugIDPK>
    <LicenceNumber>PA1130/033/001</LicenceNumber>
    <ProductName>TELMISARTAN ARROW</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2013-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037125</DrugIDPK>
    <LicenceNumber>PA1130/033/002</LicenceNumber>
    <ProductName>TELMISARTAN ARROW</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2013-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037126</DrugIDPK>
    <LicenceNumber>PA1130/033/003</LicenceNumber>
    <ProductName>TELMISARTAN ARROW</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2013-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022075</DrugIDPK>
    <LicenceNumber>PA1130/009/001</LicenceNumber>
    <ProductName>TOPIRAMA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022076</DrugIDPK>
    <LicenceNumber>PA1130/009/002</LicenceNumber>
    <ProductName>TOPIRAMA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022077</DrugIDPK>
    <LicenceNumber>PA1130/009/003</LicenceNumber>
    <ProductName>TOPIRAMA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022078</DrugIDPK>
    <LicenceNumber>PA1130/009/004</LicenceNumber>
    <ProductName>TOPIRAMA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032699</DrugIDPK>
    <LicenceNumber>PA1130/029/001</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032700</DrugIDPK>
    <LicenceNumber>PA1130/029/002</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032701</DrugIDPK>
    <LicenceNumber>PA1130/029/003</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032702</DrugIDPK>
    <LicenceNumber>PA1130/029/004</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011231</DrugIDPK>
    <LicenceNumber>PA0013/106/004</LicenceNumber>
    <ProductName>FAMVIR</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1996-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019217</DrugIDPK>
    <LicenceNumber>PA1063/017/001</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2005-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019218</DrugIDPK>
    <LicenceNumber>PA1063/017/002</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2005-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006185</DrugIDPK>
    <LicenceNumber>PA0437/025/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN 1G POWDER FOR CONCENTRATE FOR SOLUTIO</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1992-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
      <ActiveSubstance>LACTOBIONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021605</DrugIDPK>
    <LicenceNumber>PPA1328/030/001</LicenceNumber>
    <ProductName>NIZORAL SHAMPOO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020239</DrugIDPK>
    <LicenceNumber>PA1250/002/001</LicenceNumber>
    <ProductName>PROPOFOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Hospira Enterprises B.V.</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034467</DrugIDPK>
    <LicenceNumber>PA1638/001/002</LicenceNumber>
    <ProductName>BETNESOL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020502</DrugIDPK>
    <LicenceNumber>PA1218/004/001</LicenceNumber>
    <ProductName>HIBICET HOSPITAL CONCENTRATE</ProductName>
    <Strength>1.5, 15.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Regent Medical Overseas Limited</PAHolder>
    <AuthorisedDate>2005-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution Concentrate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028308</DrugIDPK>
    <LicenceNumber>PA0021/087/001</LicenceNumber>
    <ProductName>SOOTHELIP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006283</DrugIDPK>
    <LicenceNumber>PA0455/003/001</LicenceNumber>
    <ProductName>SCHOLL CORN AND CALLOUS REMOVAL LIQUID</ProductName>
    <Strength>11.25/2.8</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036384</DrugIDPK>
    <LicenceNumber>PPA1328/028/003</LicenceNumber>
    <ProductName>NEURONTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038049</DrugIDPK>
    <LicenceNumber>DPR1463/039/001</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038050</DrugIDPK>
    <LicenceNumber>DPR1463/039/002</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032989</DrugIDPK>
    <LicenceNumber>PA1653/001/001</LicenceNumber>
    <ProductName>TOLTERODINE TARTRATE SPECIFAR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Specifar S.A.</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032990</DrugIDPK>
    <LicenceNumber>PA1653/001/002</LicenceNumber>
    <ProductName>TOLTERODINE TARTRATE SPECIFAR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Specifar S.A.</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033551</DrugIDPK>
    <LicenceNumber>PA1668/001/001</LicenceNumber>
    <ProductName>IBANDRONIC ACID VAIA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Vaia S.A.</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONATE SODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033552</DrugIDPK>
    <LicenceNumber>PA1668/001/002</LicenceNumber>
    <ProductName>IBANDRONIC ACID VAIA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Vaia S.A.</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONATE SODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037069</DrugIDPK>
    <LicenceNumber>PA1130/035/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE ARROW</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037070</DrugIDPK>
    <LicenceNumber>PA1130/035/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE ARROW</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032885</DrugIDPK>
    <LicenceNumber>PA0126/206/004</LicenceNumber>
    <ProductName>CANDIST</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023274</DrugIDPK>
    <LicenceNumber>PA0568/020/001</LicenceNumber>
    <ProductName>REAPTAN</ProductName>
    <Strength>5/5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023275</DrugIDPK>
    <LicenceNumber>PA0568/020/002</LicenceNumber>
    <ProductName>REAPTAN</ProductName>
    <Strength>5/10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023276</DrugIDPK>
    <LicenceNumber>PA0568/020/003</LicenceNumber>
    <ProductName>REAPTAN</ProductName>
    <Strength>10/5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023277</DrugIDPK>
    <LicenceNumber>PA0568/020/004</LicenceNumber>
    <ProductName>REAPTAN</ProductName>
    <Strength>10/10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021175</DrugIDPK>
    <LicenceNumber>EU/1/06/381/1-8</LicenceNumber>
    <ProductName>DARONRIX</ProductName>
    <Strength>3.8</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Biologicals S.A.</PAHolder>
    <AuthorisedDate>2007-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WHOLE VIRON, INACTIVATED, OF PANDEMIC STRAIN (PROPAGATED IN EGGS) A/HONG KONG/1073/99(H9N2)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027041</DrugIDPK>
    <LicenceNumber>PA1287/002/001</LicenceNumber>
    <ProductName>DOMPERIDONE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PIERRE FABRE Ltd</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038231</DrugIDPK>
    <LicenceNumber>PA1504/002/001</LicenceNumber>
    <ProductName>IOPAMIGITA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Agfa Healthcare Imaging Agents GmbH</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>2013-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038232</DrugIDPK>
    <LicenceNumber>PA1504/002/002</LicenceNumber>
    <ProductName>IOPAMIGITA</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Agfa Healthcare Imaging Agents GmbH</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>2013-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033033</DrugIDPK>
    <LicenceNumber>PA1347/010/005</LicenceNumber>
    <ProductName>VALSARTAN KRKA</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Krka d.d., Novo mesto</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012303</DrugIDPK>
    <LicenceNumber>PA0167/109/002</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N4-550E</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHIONINE, ACTIVE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012305</DrugIDPK>
    <LicenceNumber>PA0167/109/004</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N5-800E</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHIONINE, ACTIVE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012307</DrugIDPK>
    <LicenceNumber>PA0167/109/006</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N6-900E</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHIONINE, ACTIVE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012308</DrugIDPK>
    <LicenceNumber>PA0167/109/007</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N7-1000</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012309</DrugIDPK>
    <LicenceNumber>PA0167/109/008</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N7-1000E</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHIONINE, ACTIVE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015670</DrugIDPK>
    <LicenceNumber>PA0167/109/009</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028538</DrugIDPK>
    <LicenceNumber>PA1130/022/001</LicenceNumber>
    <ProductName>SUMATRIPTAN ARROW</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028539</DrugIDPK>
    <LicenceNumber>PA1130/022/002</LicenceNumber>
    <ProductName>SUMATRIPTAN ARROW</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028641</DrugIDPK>
    <LicenceNumber>PA0749/090/001</LicenceNumber>
    <ProductName>LOSARTAN TEVA</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028642</DrugIDPK>
    <LicenceNumber>PA0749/090/002</LicenceNumber>
    <ProductName>LOSARTAN TEVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037897</DrugIDPK>
    <LicenceNumber>PA1130/036/001</LicenceNumber>
    <ProductName>MONTELUKAST</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037898</DrugIDPK>
    <LicenceNumber>PA1130/036/003</LicenceNumber>
    <ProductName>MONTELUKAST</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037899</DrugIDPK>
    <LicenceNumber>PA1130/036/002</LicenceNumber>
    <ProductName>MONTELUKAST</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028633</DrugIDPK>
    <LicenceNumber>PA1130/023/001</LicenceNumber>
    <ProductName>QUETIAPINE ARROW</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028634</DrugIDPK>
    <LicenceNumber>PA1130/023/002</LicenceNumber>
    <ProductName>QUETIAPINE ARROW</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028635</DrugIDPK>
    <LicenceNumber>PA1130/023/003</LicenceNumber>
    <ProductName>QUETIAPINE ARROW</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028636</DrugIDPK>
    <LicenceNumber>PA1130/023/004</LicenceNumber>
    <ProductName>QUETIAPINE ARROW</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028637</DrugIDPK>
    <LicenceNumber>PA1130/023/005</LicenceNumber>
    <ProductName>QUETIAPINE ARROW</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031599</DrugIDPK>
    <LicenceNumber>PA1595/004/001</LicenceNumber>
    <ProductName>BENEPRAV</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031600</DrugIDPK>
    <LicenceNumber>PA1595/004/002</LicenceNumber>
    <ProductName>BENEPRAV</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031601</DrugIDPK>
    <LicenceNumber>PA1595/004/003</LicenceNumber>
    <ProductName>BENEPRAV</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012142</DrugIDPK>
    <LicenceNumber>PA0623/005/001</LicenceNumber>
    <ProductName>SODIOFOLIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034730</DrugIDPK>
    <LicenceNumber>PA1312/013/001</LicenceNumber>
    <ProductName>RIVASTIGMINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Beacon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>2013-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003764</DrugIDPK>
    <LicenceNumber>PA0115/005/004</LicenceNumber>
    <ProductName>CLOPIXOL 25MG FILM-COATED TABLETS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZUCLOPENTHIXOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028574</DrugIDPK>
    <LicenceNumber>PA0441/043/001</LicenceNumber>
    <ProductName>PARACETAMOL 500MG, GUAIFENESIN 200MG, PHENYLEPHRIN</ProductName>
    <Strength>500/200/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>2012-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Pharmacy only: MAXIMUM PACK SIZE 24. Maximum two packs per sale.
Promotion to the public: Pack size not more than 24</SupplyComments>
    <WithdrawalDate>2013-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032165</DrugIDPK>
    <LicenceNumber>PA0822/029/001</LicenceNumber>
    <ProductName>PROPOFOL PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032166</DrugIDPK>
    <LicenceNumber>PA0822/029/002</LicenceNumber>
    <ProductName>PROPOFOL PFIZER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032920</DrugIDPK>
    <LicenceNumber>PA0822/030/001</LicenceNumber>
    <ProductName>SAUREV</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032921</DrugIDPK>
    <LicenceNumber>PA0822/030/002</LicenceNumber>
    <ProductName>SAUREV</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034847</DrugIDPK>
    <LicenceNumber>PA1695/001/001</LicenceNumber>
    <ProductName>ZOLMITRIPTAN RENANTOS</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Renantos Pharmavertriebsges. mbH</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034848</DrugIDPK>
    <LicenceNumber>PA1695/001/002</LicenceNumber>
    <ProductName>ZOLMITRIPTAN RENANTOS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Renantos Pharmavertriebsges. mbH</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027803</DrugIDPK>
    <LicenceNumber>PA0688/022/001</LicenceNumber>
    <ProductName>LISATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027804</DrugIDPK>
    <LicenceNumber>PA0688/022/002</LicenceNumber>
    <ProductName>LISATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027805</DrugIDPK>
    <LicenceNumber>PA0688/022/003</LicenceNumber>
    <ProductName>LISATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027806</DrugIDPK>
    <LicenceNumber>PA0688/022/004</LicenceNumber>
    <ProductName>LISATIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022824</DrugIDPK>
    <LicenceNumber>PA0688/016/001</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022825</DrugIDPK>
    <LicenceNumber>PA0688/016/002</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035379</DrugIDPK>
    <LicenceNumber>PA1312/014/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Beacon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023217</DrugIDPK>
    <LicenceNumber>PA0749/027/003</LicenceNumber>
    <ProductName>GRANISETRON TEVA 1 MG/1 ML CONCENTRATE FOR SOLUTIO</ProductName>
    <Strength>1/1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023219</DrugIDPK>
    <LicenceNumber>PA0749/027/005</LicenceNumber>
    <ProductName>GRANISETRON TEVA 3 MG/3 ML CONCENTRATE FOR SOLUTIO</ProductName>
    <Strength>3/3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023220</DrugIDPK>
    <LicenceNumber>PA0749/027/006</LicenceNumber>
    <ProductName>GRANISETRON TEVA 3 MG/3 ML CONCENTRATE FOR SOLUTIO</ProductName>
    <Strength>3/3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018030</DrugIDPK>
    <LicenceNumber>PPA0465/078/006</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034413</DrugIDPK>
    <LicenceNumber>PA1271/007/002</LicenceNumber>
    <ProductName>PANTOPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034414</DrugIDPK>
    <LicenceNumber>PA1271/007/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031210</DrugIDPK>
    <LicenceNumber>PPA1500/039/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031208</DrugIDPK>
    <LicenceNumber>PPA1500/045/001</LicenceNumber>
    <ProductName>ASASANTIN RETARD</ProductName>
    <Strength>200/25</Strength>
    <StrengthMeasurement>Mg/Dose</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031211</DrugIDPK>
    <LicenceNumber>PPA1500/040/001</LicenceNumber>
    <ProductName>BECOTIDE EVOHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034165</DrugIDPK>
    <LicenceNumber>PPA1500/036/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034166</DrugIDPK>
    <LicenceNumber>PPA1500/036/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034167</DrugIDPK>
    <LicenceNumber>PPA1500/036/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034168</DrugIDPK>
    <LicenceNumber>PPA1500/036/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034169</DrugIDPK>
    <LicenceNumber>PPA1500/036/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030572</DrugIDPK>
    <LicenceNumber>PPA1500/036/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032034</DrugIDPK>
    <LicenceNumber>PPA1500/038/001</LicenceNumber>
    <ProductName>CELEBREX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031850</DrugIDPK>
    <LicenceNumber>PPA1500/051/001</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032334</DrugIDPK>
    <LicenceNumber>PPA1500/044/001</LicenceNumber>
    <ProductName>CORDARONE X</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIODARONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036568</DrugIDPK>
    <LicenceNumber>PPA1500/027/002</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030317</DrugIDPK>
    <LicenceNumber>PPA1500/027/001</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030314</DrugIDPK>
    <LicenceNumber>PPA1500/028/001</LicenceNumber>
    <ProductName>IMDUR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030422</DrugIDPK>
    <LicenceNumber>PPA1500/031/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030048</DrugIDPK>
    <LicenceNumber>PPA1500/013/001</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031209</DrugIDPK>
    <LicenceNumber>PPA1500/041/001</LicenceNumber>
    <ProductName>NEBILET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEBIVOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030417</DrugIDPK>
    <LicenceNumber>PPA1500/029/001</LicenceNumber>
    <ProductName>NEURONTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030418</DrugIDPK>
    <LicenceNumber>PPA1500/029/002</LicenceNumber>
    <ProductName>NEURONTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032586</DrugIDPK>
    <LicenceNumber>PPA1500/049/001</LicenceNumber>
    <ProductName>PENTASA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032323</DrugIDPK>
    <LicenceNumber>PPA1500/009/002</LicenceNumber>
    <ProductName>SERETIDE 250 EVOHALER</ProductName>
    <Strength>25/250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035999</DrugIDPK>
    <LicenceNumber>PPA1500/009/004</LicenceNumber>
    <ProductName>SERETIDE EVOHALER</ProductName>
    <Strength>25mcg/125</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030282</DrugIDPK>
    <LicenceNumber>PPA1500/022/002</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030045</DrugIDPK>
    <LicenceNumber>PPA1500/016/001</LicenceNumber>
    <ProductName>TENORET</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030046</DrugIDPK>
    <LicenceNumber>PPA1500/017/001</LicenceNumber>
    <ProductName>TENORETIC</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031851</DrugIDPK>
    <LicenceNumber>PPA1500/050/001</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030320</DrugIDPK>
    <LicenceNumber>PPA1500/023/002</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030058</DrugIDPK>
    <LicenceNumber>PPA1500/018/001</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030059</DrugIDPK>
    <LicenceNumber>PPA1500/018/002</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030060</DrugIDPK>
    <LicenceNumber>PPA1500/018/003</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030414</DrugIDPK>
    <LicenceNumber>PPA1500/030/001</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030415</DrugIDPK>
    <LicenceNumber>PPA1500/030/002</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030416</DrugIDPK>
    <LicenceNumber>PPA1500/030/003</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030043</DrugIDPK>
    <LicenceNumber>PPA1500/014/001</LicenceNumber>
    <ProductName>ZOMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020281</DrugIDPK>
    <LicenceNumber>EU/1/03/266/5-6</LicenceNumber>
    <ProductName>BONDENZA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>2006-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019538</DrugIDPK>
    <LicenceNumber>EU/1/03/266/3-4</LicenceNumber>
    <ProductName>BONDENZA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>2005-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021782</DrugIDPK>
    <LicenceNumber>PA0688/011/001</LicenceNumber>
    <ProductName>SUMAGRAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021783</DrugIDPK>
    <LicenceNumber>PA0688/011/002</LicenceNumber>
    <ProductName>SUMAGRAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031094</DrugIDPK>
    <LicenceNumber>PA1063/039/001</LicenceNumber>
    <ProductName>CLOPIDOGREL NICHE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020185</DrugIDPK>
    <LicenceNumber>PA0038/079/004</LicenceNumber>
    <ProductName>ARYTHMOL SR</ProductName>
    <Strength>225</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2006-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020186</DrugIDPK>
    <LicenceNumber>PA0038/079/005</LicenceNumber>
    <ProductName>ARYTHMOL SR</ProductName>
    <Strength>325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2006-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020187</DrugIDPK>
    <LicenceNumber>PA0038/079/006</LicenceNumber>
    <ProductName>ARYTHMOL SR</ProductName>
    <Strength>425</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2006-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033804</DrugIDPK>
    <LicenceNumber>PA0931/011/001</LicenceNumber>
    <ProductName>PARACETAMOL MACOSOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Maco Pharma (UK) Ltd</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>For hospital use only</SupplyComments>
    <WithdrawalDate>2013-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028849</DrugIDPK>
    <LicenceNumber>PA0822/060/001</LicenceNumber>
    <ProductName>CLOPIDOGREL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037223</DrugIDPK>
    <LicenceNumber>PA0822/156/001</LicenceNumber>
    <ProductName>REMIFENTANIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037224</DrugIDPK>
    <LicenceNumber>PA0822/156/002</LicenceNumber>
    <ProductName>REMIFENTANIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037225</DrugIDPK>
    <LicenceNumber>PA0822/156/003</LicenceNumber>
    <ProductName>REMIFENTANIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMIFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032711</DrugIDPK>
    <LicenceNumber>PPA1500/063/001</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032712</DrugIDPK>
    <LicenceNumber>PPA1500/063/002</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034641</DrugIDPK>
    <LicenceNumber>PPA1500/074/001</LicenceNumber>
    <ProductName>ARTHROTEC</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
      <ActiveSubstance>MISOPROSTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034142</DrugIDPK>
    <LicenceNumber>PPA1500/073/001</LicenceNumber>
    <ProductName>CASODEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034979</DrugIDPK>
    <LicenceNumber>PPA1500/078/001</LicenceNumber>
    <ProductName>IKOREL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034980</DrugIDPK>
    <LicenceNumber>PPA1500/078/002</LicenceNumber>
    <ProductName>IKOREL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034688</DrugIDPK>
    <LicenceNumber>PPA1500/076/001</LicenceNumber>
    <ProductName>KYTRIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032328</DrugIDPK>
    <LicenceNumber>PPA1500/056/001</LicenceNumber>
    <ProductName>LIVIAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIBOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036457</DrugIDPK>
    <LicenceNumber>PPA1500/052/002</LicenceNumber>
    <ProductName>OMESAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034637</DrugIDPK>
    <LicenceNumber>PPA1500/077/001</LicenceNumber>
    <ProductName>PROSCAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036566</DrugIDPK>
    <LicenceNumber>PPA1500/084/001</LicenceNumber>
    <ProductName>SEREVENT EVOHALER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Base Micrograms</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033111</DrugIDPK>
    <LicenceNumber>PPA1500/065/003</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>400/12</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035280</DrugIDPK>
    <LicenceNumber>PPA1500/072/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034164</DrugIDPK>
    <LicenceNumber>PPA1500/072/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035008</DrugIDPK>
    <LicenceNumber>PPA1500/079/001</LicenceNumber>
    <ProductName>VALTREX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032725</DrugIDPK>
    <LicenceNumber>PPA1500/061/001</LicenceNumber>
    <ProductName>ZOLADEX LA</ProductName>
    <Strength>10.8</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GOSERELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035776</DrugIDPK>
    <LicenceNumber>PA1638/010/002</LicenceNumber>
    <ProductName>ASMABEC CLICKHALER 100 MICROGRAMS.  INHALATION POW</ProductName>
    <Strength>100 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035777</DrugIDPK>
    <LicenceNumber>PA1638/010/003</LicenceNumber>
    <ProductName>ASMABEC CLICKHALER 250 MICROGRAMS.  INHALATION POW</ProductName>
    <Strength>250 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035711</DrugIDPK>
    <LicenceNumber>PA1638/011/001</LicenceNumber>
    <ProductName>ASMASAL CLICKHALER</ProductName>
    <Strength>95</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>2011-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010894</DrugIDPK>
    <LicenceNumber>PA0329/002/001</LicenceNumber>
    <ProductName>TOPAAL CHEWABLE TABLETS</ProductName>
    <Strength>30/40/200/</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>1983-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE LIGHT</ActiveSubstance>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>SILICA COLLOIDAL HYDRATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021158</DrugIDPK>
    <LicenceNumber>PA0577/085/001</LicenceNumber>
    <ProductName>CETIRIZINE 10MG FILM-COATED TABLETS.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021159</DrugIDPK>
    <LicenceNumber>PA0577/085/002</LicenceNumber>
    <ProductName>CETIRIZINE MYLAN 10MG FILM-COATED TABLETS.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription (if compliant with restrictions outlined below). 
Retail sale through pharmacies only with the following restrictions: maximum pack size: 10 unit dosage forms, maximum strength: 10 mg, maximum daily dose: 10 mg.  

Promotion to the public with the following restrictions: maximum pack size: 10 unit dosage forms, maximum strength: 10 mg, maximum daily dose: 10 mg.</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005393</DrugIDPK>
    <LicenceNumber>PA0577/030/001</LicenceNumber>
    <ProductName>DIACLIDE 80MG TABLETS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022871</DrugIDPK>
    <LicenceNumber>PA0108/030/004</LicenceNumber>
    <ProductName>LIPANTIL MICRO</ProductName>
    <Strength>267</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029227</DrugIDPK>
    <LicenceNumber>PA0108/033/001</LicenceNumber>
    <ProductName>MEBECON</ProductName>
    <Strength>135</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEBEVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021877</DrugIDPK>
    <LicenceNumber>PA0577/092/001</LicenceNumber>
    <ProductName>SALBUTAMOL HFA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017705</DrugIDPK>
    <LicenceNumber>PA0577/052/001</LicenceNumber>
    <ProductName>SELIPROL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017706</DrugIDPK>
    <LicenceNumber>PA0577/052/002</LicenceNumber>
    <ProductName>SELIPROL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023279</DrugIDPK>
    <LicenceNumber>PA0577/098/002</LicenceNumber>
    <ProductName>STATEASE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023280</DrugIDPK>
    <LicenceNumber>PA0577/098/003</LicenceNumber>
    <ProductName>STATEASE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006057</DrugIDPK>
    <LicenceNumber>PA0405/023/002</LicenceNumber>
    <ProductName>TRILAM</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030887</DrugIDPK>
    <LicenceNumber>PA1189/008/001</LicenceNumber>
    <ProductName>YANTIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EQUIVALENT TO FREE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030888</DrugIDPK>
    <LicenceNumber>PA1189/008/002</LicenceNumber>
    <ProductName>YANTIL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EQUIVALENT TO FREE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030889</DrugIDPK>
    <LicenceNumber>PA1189/008/003</LicenceNumber>
    <ProductName>YANTIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EQUIVALENT TO FREE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036706</DrugIDPK>
    <LicenceNumber>PA1189/008/010</LicenceNumber>
    <ProductName>YANTIL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036707</DrugIDPK>
    <LicenceNumber>PA1189/008/011</LicenceNumber>
    <ProductName>YANTIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2012-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035849</DrugIDPK>
    <LicenceNumber>PA1189/008/009</LicenceNumber>
    <ProductName>YANTIL SR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2012-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030890</DrugIDPK>
    <LicenceNumber>PA1189/008/004</LicenceNumber>
    <ProductName>YANTIL SR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EQUIVALENT TO FREE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030891</DrugIDPK>
    <LicenceNumber>PA1189/008/005</LicenceNumber>
    <ProductName>YANTIL SR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EQUIVALENT TO FREE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030892</DrugIDPK>
    <LicenceNumber>PA1189/008/006</LicenceNumber>
    <ProductName>YANTIL SR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EQUIVALENT TO FREE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030893</DrugIDPK>
    <LicenceNumber>PA1189/008/007</LicenceNumber>
    <ProductName>YANTIL SR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAPENTADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EQUIVALENT TO FREE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended</SupplyComments>
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009669</DrugIDPK>
    <LicenceNumber>PPA0465/066/002</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019003</DrugIDPK>
    <LicenceNumber>PA0577/058/001</LicenceNumber>
    <ProductName>ZISTAP</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035874</DrugIDPK>
    <LicenceNumber>PA1380/121/001</LicenceNumber>
    <ProductName>ACTELSAR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035875</DrugIDPK>
    <LicenceNumber>PA1380/121/002</LicenceNumber>
    <ProductName>ACTELSAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035876</DrugIDPK>
    <LicenceNumber>PA1380/121/003</LicenceNumber>
    <ProductName>ACTELSAR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027914</DrugIDPK>
    <LicenceNumber>PPA1447/004/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032825</DrugIDPK>
    <LicenceNumber>PPA1447/076/001</LicenceNumber>
    <ProductName>ANADIN EXTRA</ProductName>
    <Strength>300/200/45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms. Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists. The indications should be appropriate for self-diagnosis and self-treatment.

Promotion to the general public for packs containing not more than 24 unit dosage forms.

Promotion to the general public only for indications appropriate for self diagnosis and self treatment.


Promotion to healthcare professionals only for packs containing more than 24 unit dosage forms.
Aspirin-containing medicinal products should not be administered to subjects under 16 years of age unless specifically indicated by a healthcare professional.</SupplyComments>
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030642</DrugIDPK>
    <LicenceNumber>PPA1447/038/001</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030342</DrugIDPK>
    <LicenceNumber>PPA1447/002/001</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022114</DrugIDPK>
    <LicenceNumber>PA1130/010/001</LicenceNumber>
    <ProductName>CABEREX 1 MILLIGRAM TABLETS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022115</DrugIDPK>
    <LicenceNumber>PA1130/010/002</LicenceNumber>
    <ProductName>CABEREX 2 MILLIGRAM TABLETS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022113</DrugIDPK>
    <LicenceNumber>PA1130/014/001</LicenceNumber>
    <ProductName>CABERGOLINE 0.5 MILLIGRAM TABLETS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032824</DrugIDPK>
    <LicenceNumber>PPA1447/075/001</LicenceNumber>
    <ProductName>CALPOL SUGAR FREE INFANT</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in child resistant packs containing not more than 140 ml of the 120mg/5ml unit dosage form.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.

Prescription only for any pack size exceeding 140ml content of the 120mg/5ml unit dosage form.

Promotion to the general public for packs containing not more than 140 ml of the 120mg/5ml unit dose

Promotion to healthcare professionals only for packs containing more than 140 ml of the 120mg/5ml unit dosage form.</SupplyComments>
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030339</DrugIDPK>
    <LicenceNumber>PPA1447/035/001</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033563</DrugIDPK>
    <LicenceNumber>PPA1447/035/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037751</DrugIDPK>
    <LicenceNumber>PPA1447/035/003</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2012-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030919</DrugIDPK>
    <LicenceNumber>PPA1447/040/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031482</DrugIDPK>
    <LicenceNumber>PPA1447/060/001</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031483</DrugIDPK>
    <LicenceNumber>PPA1447/060/002</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033171</DrugIDPK>
    <LicenceNumber>PPA1447/083/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033170</DrugIDPK>
    <LicenceNumber>PPA1447/080/001</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036979</DrugIDPK>
    <LicenceNumber>PPA1447/089/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036980</DrugIDPK>
    <LicenceNumber>PPA1447/089/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032442</DrugIDPK>
    <LicenceNumber>PPA1447/069/001</LicenceNumber>
    <ProductName>CYSTOPURIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034661</DrugIDPK>
    <LicenceNumber>PPA1447/088/001</LicenceNumber>
    <ProductName>MOVICOL</ProductName>
    <Strength>13.8</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031278</DrugIDPK>
    <LicenceNumber>PPA1447/051/001</LicenceNumber>
    <ProductName>NUROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 200 mg, maximum pack size 50, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indications.

For use in adults and children not under 12 years.</SupplyComments>
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031574</DrugIDPK>
    <LicenceNumber>PPA1447/064/001</LicenceNumber>
    <ProductName>NUROFEN PLUS TABLETS</ProductName>
    <Strength>200/12.8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the healthcare professionals only subject to the following restrictions: 
For ibuprofen: maximum strength 200 mg, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indications.

For use in adults</SupplyComments>
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032789</DrugIDPK>
    <LicenceNumber>PPA1447/074/001</LicenceNumber>
    <ProductName>NU-SEALS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029201</DrugIDPK>
    <LicenceNumber>PA1130/026/001</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2009-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032749</DrugIDPK>
    <LicenceNumber>PPA1447/073/001</LicenceNumber>
    <ProductName>SENOKOT</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SENNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033820</DrugIDPK>
    <LicenceNumber>PPA1447/087/002</LicenceNumber>
    <ProductName>SERETIDE 250 DISKUS</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032222</DrugIDPK>
    <LicenceNumber>PPA1447/066/001</LicenceNumber>
    <ProductName>SYNDOL</ProductName>
    <Strength>450/10/5/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>As an item for retail sale through pharmacies in child-resistant packages with a maximum pack size of 24 tablets.

Pack sizes greater than 24 may be supplied to the pharmacies for use by the pharmacists provided that the label states that they are for dispensing purposes only and must contain an appropriate patient information leaflet.

Product not subject to medical prescription supply through pharmacies only subject to the following restriction for codeine: maximum dose 20 mg.</SupplyComments>
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032222</DrugIDPK>
    <LicenceNumber>PPA1447/066/001</LicenceNumber>
    <ProductName>SYNDOL</ProductName>
    <Strength>450/10/5/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>As an item for retail sale through pharmacies in child-resistant packages with a maximum pack size of 24 tablets.

Pack sizes greater than 24 may be supplied to the pharmacies for use by the pharmacists provided that the label states that they are for dispensing purposes only and must contain an appropriate patient information leaflet.

Product not subject to medical prescription supply through pharmacies only subject to the following restriction for codeine: maximum dose 20 mg.</SupplyComments>
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038340</DrugIDPK>
    <LicenceNumber>PA1380/101/004</LicenceNumber>
    <ProductName>VALSARTAN/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>320/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038341</DrugIDPK>
    <LicenceNumber>PA1380/101/005</LicenceNumber>
    <ProductName>VALSARTAN/HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>320/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2013-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033430</DrugIDPK>
    <LicenceNumber>PPA1447/086/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033183</DrugIDPK>
    <LicenceNumber>PPA1447/027/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031948</DrugIDPK>
    <LicenceNumber>PPA1447/065/001</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032955</DrugIDPK>
    <LicenceNumber>PA0827/005/001</LicenceNumber>
    <ProductName>ABELCET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Cephalon UK Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPHOTERICIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023014</DrugIDPK>
    <LicenceNumber>PA0585/027/001</LicenceNumber>
    <ProductName>FINOCAR 5MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2007-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006321</DrugIDPK>
    <LicenceNumber>PA0436/018/004</LicenceNumber>
    <ProductName>HAY-CROM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036297</DrugIDPK>
    <LicenceNumber>PA0749/161/001</LicenceNumber>
    <ProductName>LATANOPROST/TIMOLOL TEVA 50 MICROGRAMS/ML AND 5 MG</ProductName>
    <Strength>50 + 5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2012-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANTANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020325</DrugIDPK>
    <LicenceNumber>PA0749/014/001</LicenceNumber>
    <ProductName>MELOXICAM</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020326</DrugIDPK>
    <LicenceNumber>PA0749/014/002</LicenceNumber>
    <ProductName>MELOXICAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018969</DrugIDPK>
    <LicenceNumber>PA0436/036/001</LicenceNumber>
    <ProductName>MOVOX</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2004-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018970</DrugIDPK>
    <LicenceNumber>PA0436/036/002</LicenceNumber>
    <ProductName>MOVOX</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2004-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019595</DrugIDPK>
    <LicenceNumber>PA0436/028/002</LicenceNumber>
    <ProductName>NASOBEC ALLERGY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2006-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017887</DrugIDPK>
    <LicenceNumber>PA0585/013/002</LicenceNumber>
    <ProductName>POLYFAX OPHTHALMIC OINTMENT, 10,000 IU POLYMYXIN B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017887</DrugIDPK>
    <LicenceNumber>PA0585/013/002</LicenceNumber>
    <ProductName>POLYFAX OPHTHALMIC OINTMENT, 10,000 IU POLYMYXIN B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019604</DrugIDPK>
    <LicenceNumber>PA0749/008/001</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019605</DrugIDPK>
    <LicenceNumber>PA0749/008/002</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019606</DrugIDPK>
    <LicenceNumber>PA0749/008/003</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019607</DrugIDPK>
    <LicenceNumber>PA0749/008/004</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029966</DrugIDPK>
    <LicenceNumber>PA0749/106/001</LicenceNumber>
    <ProductName>RIZATRIPTAN TEVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIZATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035771</DrugIDPK>
    <LicenceNumber>PA0749/152/001</LicenceNumber>
    <ProductName>SERTRALINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035772</DrugIDPK>
    <LicenceNumber>PA0749/152/002</LicenceNumber>
    <ProductName>SERTRALINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005596</DrugIDPK>
    <LicenceNumber>PA0282/059/002</LicenceNumber>
    <ProductName>SODIUM CROMOGLICATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032861</DrugIDPK>
    <LicenceNumber>PA0749/122/001</LicenceNumber>
    <ProductName>VENIXAF XL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032862</DrugIDPK>
    <LicenceNumber>PA0749/122/002</LicenceNumber>
    <ProductName>VENIXAF XL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032947</DrugIDPK>
    <LicenceNumber>PA0943/018/001</LicenceNumber>
    <ProductName>IMMUCYST BCG IMMUNOTHERAPEUTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BCG BACTERIA (LYOPHILISED)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033057</DrugIDPK>
    <LicenceNumber>EU/1/10/656/001-006</LicenceNumber>
    <ProductName>POSSIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca AB</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TICAGRELOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029436</DrugIDPK>
    <LicenceNumber>PA1239/009/001</LicenceNumber>
    <ProductName>CUENCA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029437</DrugIDPK>
    <LicenceNumber>PA1239/009/002</LicenceNumber>
    <ProductName>CUENCA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029438</DrugIDPK>
    <LicenceNumber>PA1239/009/003</LicenceNumber>
    <ProductName>CUENCA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029439</DrugIDPK>
    <LicenceNumber>PA1239/009/004</LicenceNumber>
    <ProductName>CUENCA</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035754</DrugIDPK>
    <LicenceNumber>PPA1562/030/002</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035130</DrugIDPK>
    <LicenceNumber>DPR1633/006/002</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016108</DrugIDPK>
    <LicenceNumber>PA0823/041/001</LicenceNumber>
    <ProductName>REACTINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2004-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in pack sizes not exceeding 10 tablets.</SupplyComments>
    <WithdrawalDate>2013-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028932</DrugIDPK>
    <LicenceNumber>PA0823/041/002</LicenceNumber>
    <ProductName>REACTINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>6. Supply through pharmicies only subject to the following restrictions: maximum strength 10mg (10mls), maximum pack size (100mls), maximum daily dose 10mg (10mls)
Pack sizes greater than 100mls are subject to medical prescription
7. Promotion to healthcare professionals for pack sizes greater than 100mls</SupplyComments>
    <WithdrawalDate>2013-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034771</DrugIDPK>
    <LicenceNumber>PPA1328/144/001</LicenceNumber>
    <ProductName>AVELOX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029825</DrugIDPK>
    <LicenceNumber>PA0408/075/001</LicenceNumber>
    <ProductName>CANDESARTAN CILEXETIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029826</DrugIDPK>
    <LicenceNumber>PA0408/075/002</LicenceNumber>
    <ProductName>CANDESARTAN CILEXETIL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029827</DrugIDPK>
    <LicenceNumber>PA0408/075/003</LicenceNumber>
    <ProductName>CANDESARTAN CILEXETIL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029828</DrugIDPK>
    <LicenceNumber>PA0408/075/004</LicenceNumber>
    <ProductName>CANDESARTAN CILEXETIL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029440</DrugIDPK>
    <LicenceNumber>PA1239/010/001</LicenceNumber>
    <ProductName>SALDANAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029441</DrugIDPK>
    <LicenceNumber>PA1239/010/002</LicenceNumber>
    <ProductName>SALDANAR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029442</DrugIDPK>
    <LicenceNumber>PA1239/010/003</LicenceNumber>
    <ProductName>SALDANAR</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029443</DrugIDPK>
    <LicenceNumber>PA1239/010/004</LicenceNumber>
    <ProductName>SALDANAR</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024801</DrugIDPK>
    <LicenceNumber>EU/1/08/460/1-11</LicenceNumber>
    <ProductName>PELZONT</ProductName>
    <Strength>1000/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>2008-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
      <ActiveSubstance>LAROPIPRANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024302</DrugIDPK>
    <LicenceNumber>EU/1/08/459/1-11</LicenceNumber>
    <ProductName>TREDAPTIVE 1000</ProductName>
    <Strength>1000/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>2008-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
      <ActiveSubstance>LAROPIPRANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035705</DrugIDPK>
    <LicenceNumber>PA1691/011/001</LicenceNumber>
    <ProductName>SILDENAFIL ASPEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aspen Pharma Trading Limited</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035706</DrugIDPK>
    <LicenceNumber>PA1691/011/002</LicenceNumber>
    <ProductName>SILDENAFIL ASPEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aspen Pharma Trading Limited</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035707</DrugIDPK>
    <LicenceNumber>PA1691/011/003</LicenceNumber>
    <ProductName>SILDENAFIL ASPEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aspen Pharma Trading Limited</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036126</DrugIDPK>
    <LicenceNumber>PA0953/008/001</LicenceNumber>
    <ProductName>GAMBROSOL TRIO 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036127</DrugIDPK>
    <LicenceNumber>PA0953/008/002</LicenceNumber>
    <ProductName>GAMBROSOL TRIO 40</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031149</DrugIDPK>
    <LicenceNumber>DPR1596/024/001</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031150</DrugIDPK>
    <LicenceNumber>DPR1596/024/002</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031151</DrugIDPK>
    <LicenceNumber>DPR1596/024/003</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031117</DrugIDPK>
    <LicenceNumber>DPR1596/006/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031118</DrugIDPK>
    <LicenceNumber>DPR1596/006/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001037</DrugIDPK>
    <LicenceNumber>PA0019/002/002</LicenceNumber>
    <ProductName>GLIBENESE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIPIZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022689</DrugIDPK>
    <LicenceNumber>PA1063/025/001</LicenceNumber>
    <ProductName>RAMIPRIL NICHE</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022690</DrugIDPK>
    <LicenceNumber>PA1063/025/002</LicenceNumber>
    <ProductName>RAMIPRIL NICHE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022691</DrugIDPK>
    <LicenceNumber>PA1063/025/003</LicenceNumber>
    <ProductName>RAMIPRIL NICHE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022692</DrugIDPK>
    <LicenceNumber>PA1063/025/004</LicenceNumber>
    <ProductName>RAMIPRIL NICHE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038635</DrugIDPK>
    <LicenceNumber>PA1837/003/001</LicenceNumber>
    <ProductName>EXMACHAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Creative Pharma Solutions s.r.o.</PAHolder>
    <AuthorisedDate>2013-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EXEMESTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002760</DrugIDPK>
    <LicenceNumber>PA0050/008/001</LicenceNumber>
    <ProductName>ROHYPNOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUNITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 3 of the Misuse of Drugs Act 1977 and 1984</SupplyComments>
    <WithdrawalDate>2013-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022102</DrugIDPK>
    <LicenceNumber>PA0167/126/001</LicenceNumber>
    <ProductName>TETABULIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN  &gt;90% GAMMA GLOBULIN</ActiveSubstance>
      <ActiveSubstance>HUMAN TETANUS IMMUNOGLOBULIN PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036148</DrugIDPK>
    <LicenceNumber>PPA1659/048/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035943</DrugIDPK>
    <LicenceNumber>PPA1659/042/001</LicenceNumber>
    <ProductName>AROMASIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EXEMESTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035938</DrugIDPK>
    <LicenceNumber>PPA1659/040/001</LicenceNumber>
    <ProductName>ARTHROTEC</ProductName>
    <Strength>50/0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
      <ActiveSubstance>MISOPROSTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035944</DrugIDPK>
    <LicenceNumber>PPA1659/043/001</LicenceNumber>
    <ProductName>BRICANYL TURBOHALER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036149</DrugIDPK>
    <LicenceNumber>PPA1659/049/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035993</DrugIDPK>
    <LicenceNumber>PPA1659/044/001</LicenceNumber>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036150</DrugIDPK>
    <LicenceNumber>PPA1659/050/001</LicenceNumber>
    <ProductName>ELANTAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036151</DrugIDPK>
    <LicenceNumber>PPA1659/050/002</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036152</DrugIDPK>
    <LicenceNumber>PPA1659/050/003</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033527</DrugIDPK>
    <LicenceNumber>PPA1659/023/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033528</DrugIDPK>
    <LicenceNumber>PPA1659/023/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033529</DrugIDPK>
    <LicenceNumber>PPA1659/023/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033530</DrugIDPK>
    <LicenceNumber>PPA1659/023/004</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033289</DrugIDPK>
    <LicenceNumber>PPA1659/001/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033290</DrugIDPK>
    <LicenceNumber>PPA1659/001/002</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033355</DrugIDPK>
    <LicenceNumber>PPA1659/015/001</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033533</DrugIDPK>
    <LicenceNumber>PPA1659/024/001</LicenceNumber>
    <ProductName>CALCICHEW-D3 FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033935</DrugIDPK>
    <LicenceNumber>PPA1659/021/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033936</DrugIDPK>
    <LicenceNumber>PPA1659/021/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033937</DrugIDPK>
    <LicenceNumber>PPA1659/021/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033938</DrugIDPK>
    <LicenceNumber>PPA1659/021/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033939</DrugIDPK>
    <LicenceNumber>PPA1659/021/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033940</DrugIDPK>
    <LicenceNumber>PPA1659/021/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033279</DrugIDPK>
    <LicenceNumber>PPA1659/012/003</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033280</DrugIDPK>
    <LicenceNumber>PPA1659/012/004</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033281</DrugIDPK>
    <LicenceNumber>PPA1659/012/001</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033282</DrugIDPK>
    <LicenceNumber>PPA1659/012/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033904</DrugIDPK>
    <LicenceNumber>PPA1659/022/002</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033287</DrugIDPK>
    <LicenceNumber>PPA1659/002/001</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033288</DrugIDPK>
    <LicenceNumber>PPA1659/002/002</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033388</DrugIDPK>
    <LicenceNumber>PPA1659/017/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033389</DrugIDPK>
    <LicenceNumber>PPA1659/017/002</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033390</DrugIDPK>
    <LicenceNumber>PPA1659/017/003</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033542</DrugIDPK>
    <LicenceNumber>PPA1659/016/001</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>100/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033543</DrugIDPK>
    <LicenceNumber>PPA1659/016/002</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033544</DrugIDPK>
    <LicenceNumber>PPA1659/016/003</LicenceNumber>
    <ProductName>COZAAR COMP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHOLOTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033283</DrugIDPK>
    <LicenceNumber>PPA1659/003/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033284</DrugIDPK>
    <LicenceNumber>PPA1659/003/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033285</DrugIDPK>
    <LicenceNumber>PPA1659/003/003</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033286</DrugIDPK>
    <LicenceNumber>PPA1659/003/004</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034880</DrugIDPK>
    <LicenceNumber>PPA1659/030/001</LicenceNumber>
    <ProductName>DIOVAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034881</DrugIDPK>
    <LicenceNumber>PPA1659/030/002</LicenceNumber>
    <ProductName>DIOVAN</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034882</DrugIDPK>
    <LicenceNumber>PPA1659/030/003</LicenceNumber>
    <ProductName>DIOVAN</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033368</DrugIDPK>
    <LicenceNumber>PPA1659/018/001</LicenceNumber>
    <ProductName>DOVOBET</ProductName>
    <Strength>50 + 0.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033291</DrugIDPK>
    <LicenceNumber>PPA1659/004/001</LicenceNumber>
    <ProductName>EFEXOR XL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033292</DrugIDPK>
    <LicenceNumber>PPA1659/004/002</LicenceNumber>
    <ProductName>EFEXOR XL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033524</DrugIDPK>
    <LicenceNumber>PPA1659/026/001</LicenceNumber>
    <ProductName>EZETROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033532</DrugIDPK>
    <LicenceNumber>PPA1659/025/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036165</DrugIDPK>
    <LicenceNumber>PPA1659/052/001</LicenceNumber>
    <ProductName>FUCIBET LIPID</ProductName>
    <Strength>20mg/g + 1</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036166</DrugIDPK>
    <LicenceNumber>PPA1659/053/001</LicenceNumber>
    <ProductName>INDERAL LA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033468</DrugIDPK>
    <LicenceNumber>PPA1659/027/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033469</DrugIDPK>
    <LicenceNumber>PPA1659/027/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033470</DrugIDPK>
    <LicenceNumber>PPA1659/027/003</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033327</DrugIDPK>
    <LicenceNumber>PPA1659/005/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033328</DrugIDPK>
    <LicenceNumber>PPA1659/005/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033329</DrugIDPK>
    <LicenceNumber>PPA1659/005/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033330</DrugIDPK>
    <LicenceNumber>PPA1659/005/004</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033322</DrugIDPK>
    <LicenceNumber>PPA1659/006/001</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033323</DrugIDPK>
    <LicenceNumber>PPA1659/006/002</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033324</DrugIDPK>
    <LicenceNumber>PPA1659/006/003</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033305</DrugIDPK>
    <LicenceNumber>PPA1659/013/001</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033306</DrugIDPK>
    <LicenceNumber>PPA1659/013/002</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034878</DrugIDPK>
    <LicenceNumber>PPA1659/031/001</LicenceNumber>
    <ProductName>OMACOR</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEGA-3-ACID ETHYL ESTERS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036167</DrugIDPK>
    <LicenceNumber>PPA1659/054/001</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033303</DrugIDPK>
    <LicenceNumber>PPA1659/007/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033304</DrugIDPK>
    <LicenceNumber>PPA1659/007/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033337</DrugIDPK>
    <LicenceNumber>PPA1659/008/001</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033526</DrugIDPK>
    <LicenceNumber>PPA1659/028/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036168</DrugIDPK>
    <LicenceNumber>PPA1659/055/001</LicenceNumber>
    <ProductName>SALAZOPYRIN EN TABS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033340</DrugIDPK>
    <LicenceNumber>PPA1659/009/002</LicenceNumber>
    <ProductName>SERETIDE DISKUS</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033341</DrugIDPK>
    <LicenceNumber>PPA1659/009/003</LicenceNumber>
    <ProductName>SERETIDE DISKUS</ProductName>
    <Strength>50/500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033342</DrugIDPK>
    <LicenceNumber>PPA1659/009/004</LicenceNumber>
    <ProductName>SERETIDE DISKUS</ProductName>
    <Strength>50/100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033343</DrugIDPK>
    <LicenceNumber>PPA1659/009/005</LicenceNumber>
    <ProductName>SERETIDE EVOHALER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033344</DrugIDPK>
    <LicenceNumber>PPA1659/009/006</LicenceNumber>
    <ProductName>SERETIDE EVOHALER</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033339</DrugIDPK>
    <LicenceNumber>PPA1659/009/001</LicenceNumber>
    <ProductName>SERETIDE EVOHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033546</DrugIDPK>
    <LicenceNumber>PPA1659/029/001</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033547</DrugIDPK>
    <LicenceNumber>PPA1659/029/003</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033895</DrugIDPK>
    <LicenceNumber>PPA1659/029/002</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033345</DrugIDPK>
    <LicenceNumber>PPA1659/010/001</LicenceNumber>
    <ProductName>SPIRIVA</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
      <ActiveSubstance>TIOTROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034883</DrugIDPK>
    <LicenceNumber>PPA1659/032/001</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>100/6</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034884</DrugIDPK>
    <LicenceNumber>PPA1659/032/002</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>200/6</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034885</DrugIDPK>
    <LicenceNumber>PPA1659/032/003</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>400/12</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036301</DrugIDPK>
    <LicenceNumber>PPA1659/035/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035954</DrugIDPK>
    <LicenceNumber>PPA1659/047/001</LicenceNumber>
    <ProductName>URSOFALK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>URSODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035759</DrugIDPK>
    <LicenceNumber>PPA1659/037/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033369</DrugIDPK>
    <LicenceNumber>PPA1659/019/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033370</DrugIDPK>
    <LicenceNumber>PPA1659/019/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033928</DrugIDPK>
    <LicenceNumber>PPA1659/020/001</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033929</DrugIDPK>
    <LicenceNumber>PPA1659/020/002</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033930</DrugIDPK>
    <LicenceNumber>PPA1659/020/003</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033931</DrugIDPK>
    <LicenceNumber>PPA1659/020/004</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035760</DrugIDPK>
    <LicenceNumber>PPA1659/038/001</LicenceNumber>
    <ProductName>ZOMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035761</DrugIDPK>
    <LicenceNumber>PPA1659/038/002</LicenceNumber>
    <ProductName>ZOMIG RAPIMELT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033349</DrugIDPK>
    <LicenceNumber>PPA1659/011/001</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033350</DrugIDPK>
    <LicenceNumber>PPA1659/011/002</LicenceNumber>
    <ProductName>ZOTON FASTTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027308</DrugIDPK>
    <LicenceNumber>PPA1447/001/001</LicenceNumber>
    <ProductName>IMDUR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033429</DrugIDPK>
    <LicenceNumber>PPA1447/034/003</LicenceNumber>
    <ProductName>KLACID LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019012</DrugIDPK>
    <LicenceNumber>PA0281/119/001</LicenceNumber>
    <ProductName>RAMIC</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2005-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026884</DrugIDPK>
    <LicenceNumber>PA0281/136/003</LicenceNumber>
    <ProductName>EFAXIL</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024369</DrugIDPK>
    <LicenceNumber>PA0281/136/001</LicenceNumber>
    <ProductName>EFAXIL XL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2008-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024370</DrugIDPK>
    <LicenceNumber>PA0281/136/002</LicenceNumber>
    <ProductName>EFAXIL XL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2008-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006197</DrugIDPK>
    <LicenceNumber>PA0441/007/002</LicenceNumber>
    <ProductName>VICKS ORIGINAL COUGH SYRUP CHESTY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1982-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023544</DrugIDPK>
    <LicenceNumber>PA0126/170/001</LicenceNumber>
    <ProductName>ESTELLE</ProductName>
    <Strength>20/75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022284</DrugIDPK>
    <LicenceNumber>PA0290/078/001</LicenceNumber>
    <ProductName>ANATERA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2007-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUORESCEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035775</DrugIDPK>
    <LicenceNumber>PA1638/010/001</LicenceNumber>
    <ProductName>ASMABEC CLICKHALER 50 MICROGRAMS.  INHALATION POWD</ProductName>
    <Strength>50 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031791</DrugIDPK>
    <LicenceNumber>PA1063/042/002</LicenceNumber>
    <ProductName>ATORVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031790</DrugIDPK>
    <LicenceNumber>PA1063/042/001</LicenceNumber>
    <ProductName>ATORVASTATIN 10 MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031792</DrugIDPK>
    <LicenceNumber>PA1063/042/003</LicenceNumber>
    <ProductName>ATORVASTATIN 40 MG FILM-COATED TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021769</DrugIDPK>
    <LicenceNumber>PA1063/024/001</LicenceNumber>
    <ProductName>NAPAMIDE PR</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031515</DrugIDPK>
    <LicenceNumber>PA1063/041/001</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031516</DrugIDPK>
    <LicenceNumber>PA1063/041/002</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031517</DrugIDPK>
    <LicenceNumber>PA1063/041/003</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036108</DrugIDPK>
    <LicenceNumber>PPA1562/061/001</LicenceNumber>
    <ProductName>PERSANTIN RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034581</DrugIDPK>
    <LicenceNumber>PPA1562/042/001</LicenceNumber>
    <ProductName>PLAQUENIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYCHLOROQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030072</DrugIDPK>
    <LicenceNumber>PPA1562/007/001</LicenceNumber>
    <ProductName>PREMPAK-C</ProductName>
    <Strength>0.625/0.15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>NORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030073</DrugIDPK>
    <LicenceNumber>PPA1562/007/002</LicenceNumber>
    <ProductName>PREMPAK-C</ProductName>
    <Strength>1.25/0.15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>NORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034580</DrugIDPK>
    <LicenceNumber>PPA1562/041/001</LicenceNumber>
    <ProductName>PROVIGIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MODAFINIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033960</DrugIDPK>
    <LicenceNumber>PPA1562/032/001</LicenceNumber>
    <ProductName>OMACOR</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEGA-3-ACID ETHYL ESTERS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036125</DrugIDPK>
    <LicenceNumber>PPA1562/064/001</LicenceNumber>
    <ProductName>OMNEXEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037228</DrugIDPK>
    <LicenceNumber>PPA1562/074/001</LicenceNumber>
    <ProductName>PENTASA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033924</DrugIDPK>
    <LicenceNumber>PPA1562/030/001</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037536</DrugIDPK>
    <LicenceNumber>PPA1562/066/002</LicenceNumber>
    <ProductName>SPIRIVA</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033561</DrugIDPK>
    <LicenceNumber>PPA1562/029/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037246</DrugIDPK>
    <LicenceNumber>PPA1562/075/001</LicenceNumber>
    <ProductName>HALF-INDERAL LA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037247</DrugIDPK>
    <LicenceNumber>PPA1562/075/002</LicenceNumber>
    <ProductName>INDERAL LA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030651</DrugIDPK>
    <LicenceNumber>PPA1562/012/001</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030652</DrugIDPK>
    <LicenceNumber>PPA1562/012/002</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035703</DrugIDPK>
    <LicenceNumber>PPA1562/054/001</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035712</DrugIDPK>
    <LicenceNumber>PPA1562/054/002</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037347</DrugIDPK>
    <LicenceNumber>PPA1562/054/003</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036569</DrugIDPK>
    <LicenceNumber>PPA1562/066/001</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033562</DrugIDPK>
    <LicenceNumber>PPA1562/028/001</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037369</DrugIDPK>
    <LicenceNumber>PPA1562/076/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037370</DrugIDPK>
    <LicenceNumber>PPA1562/076/002</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033432</DrugIDPK>
    <LicenceNumber>PPA1562/026/001</LicenceNumber>
    <ProductName>DILZEM XL</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037453</DrugIDPK>
    <LicenceNumber>PPA1562/077/001</LicenceNumber>
    <ProductName>TRUSOPT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031727</DrugIDPK>
    <LicenceNumber>PPA1562/017/001</LicenceNumber>
    <ProductName>ACUPAN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFOPAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031202</DrugIDPK>
    <LicenceNumber>PPA1500/037/001</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031203</DrugIDPK>
    <LicenceNumber>PPA1500/037/002</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031204</DrugIDPK>
    <LicenceNumber>PPA1500/037/003</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033975</DrugIDPK>
    <LicenceNumber>PPA1500/070/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033973</DrugIDPK>
    <LicenceNumber>PPA1500/069/001</LicenceNumber>
    <ProductName>ARIMIDEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034598</DrugIDPK>
    <LicenceNumber>PPA1562/044/001</LicenceNumber>
    <ProductName>ARYTHMOL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038199</DrugIDPK>
    <LicenceNumber>PPA1562/009/002</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>875/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID (IN THE FORM OF POTASSIUM CLAVULANATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030258</DrugIDPK>
    <LicenceNumber>PPA1562/009/001</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038081</DrugIDPK>
    <LicenceNumber>PPA1562/087/001</LicenceNumber>
    <ProductName>AVELOX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031847</DrugIDPK>
    <LicenceNumber>PPA1500/048/001</LicenceNumber>
    <ProductName>AVODART</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DUTASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036511</DrugIDPK>
    <LicenceNumber>PPA1562/069/001</LicenceNumber>
    <ProductName>BRICANYL TURBOHALER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032745</DrugIDPK>
    <LicenceNumber>PPA1500/060/001</LicenceNumber>
    <ProductName>BRICANYL TURBOHALER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033140</DrugIDPK>
    <LicenceNumber>PPA1562/024/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033141</DrugIDPK>
    <LicenceNumber>PPA1562/024/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030260</DrugIDPK>
    <LicenceNumber>PPA1562/003/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033431</DrugIDPK>
    <LicenceNumber>PPA1562/025/001</LicenceNumber>
    <ProductName>CASODEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032326</DrugIDPK>
    <LicenceNumber>PPA1500/059/001</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032327</DrugIDPK>
    <LicenceNumber>PPA1500/059/002</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>160/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033520</DrugIDPK>
    <LicenceNumber>PPA1500/059/003</LicenceNumber>
    <ProductName>CO-DIOVAN</ProductName>
    <Strength>80/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030139</DrugIDPK>
    <LicenceNumber>PPA1500/020/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030140</DrugIDPK>
    <LicenceNumber>PPA1500/020/002</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029594</DrugIDPK>
    <LicenceNumber>PPA1500/002/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032730</DrugIDPK>
    <LicenceNumber>PPA1500/002/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032583</DrugIDPK>
    <LicenceNumber>PPA1500/062/001</LicenceNumber>
    <ProductName>DOVOBET</ProductName>
    <Strength>50 + 0.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030566</DrugIDPK>
    <LicenceNumber>PPA1500/034/001</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030567</DrugIDPK>
    <LicenceNumber>PPA1500/034/002</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030571</DrugIDPK>
    <LicenceNumber>PPA1500/025/001</LicenceNumber>
    <ProductName>KLACID LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031214</DrugIDPK>
    <LicenceNumber>PPA1500/046/002</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031215</DrugIDPK>
    <LicenceNumber>PPA1500/046/003</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031216</DrugIDPK>
    <LicenceNumber>PPA1500/046/004</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030431</DrugIDPK>
    <LicenceNumber>PPA1500/032/002</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030432</DrugIDPK>
    <LicenceNumber>PPA1500/032/003</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029588</DrugIDPK>
    <LicenceNumber>PPA1500/003/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029589</DrugIDPK>
    <LicenceNumber>PPA1500/003/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031849</DrugIDPK>
    <LicenceNumber>PPA1500/003/004</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030423</DrugIDPK>
    <LicenceNumber>PPA1500/031/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030424</DrugIDPK>
    <LicenceNumber>PPA1500/031/003</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030049</DrugIDPK>
    <LicenceNumber>PPA1500/013/002</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030563</DrugIDPK>
    <LicenceNumber>PPA1500/035/001</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030564</DrugIDPK>
    <LicenceNumber>PPA1500/035/002</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019714</DrugIDPK>
    <LicenceNumber>PA0167/037/016</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029795</DrugIDPK>
    <LicenceNumber>PPA1500/008/001</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029796</DrugIDPK>
    <LicenceNumber>PPA1500/008/002</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032710</DrugIDPK>
    <LicenceNumber>PPA1500/064/001</LicenceNumber>
    <ProductName>OMACOR</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEGA-3-ACID ETHYL ESTERS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036458</DrugIDPK>
    <LicenceNumber>PPA1500/052/003</LicenceNumber>
    <ProductName>OMESAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035279</DrugIDPK>
    <LicenceNumber>PPA1500/080/001</LicenceNumber>
    <ProductName>OMNEXEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030142</DrugIDPK>
    <LicenceNumber>PPA1500/019/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029787</DrugIDPK>
    <LicenceNumber>PPA1500/007/001</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029788</DrugIDPK>
    <LicenceNumber>PPA1500/007/002</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032329</DrugIDPK>
    <LicenceNumber>PPA1500/042/001</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016835</DrugIDPK>
    <LicenceNumber>PA0111/003/003</LicenceNumber>
    <ProductName>RIMACTAZID 150/75</ProductName>
    <Strength>150/75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016850</DrugIDPK>
    <LicenceNumber>PA0111/007/001</LicenceNumber>
    <ProductName>RIMSTAR</ProductName>
    <Strength>150/75/400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
      <ActiveSubstance>PYRAZINAMIDE</ActiveSubstance>
      <ActiveSubstance>ETHAMBUTOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032597</DrugIDPK>
    <LicenceNumber>PPA1500/009/003</LicenceNumber>
    <ProductName>SERETIDE 250 DISKUS</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033260</DrugIDPK>
    <LicenceNumber>PPA1500/068/001</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034441</DrugIDPK>
    <LicenceNumber>PPA1500/068/002</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036567</DrugIDPK>
    <LicenceNumber>PPA1500/083/001</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035846</DrugIDPK>
    <LicenceNumber>PPA1500/043/002</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033110</DrugIDPK>
    <LicenceNumber>PPA1500/065/002</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>200/6</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038134</DrugIDPK>
    <LicenceNumber>PPA1562/088/001</LicenceNumber>
    <ProductName>TYLEX</ProductName>
    <Strength>30/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036565</DrugIDPK>
    <LicenceNumber>PPA1500/085/001</LicenceNumber>
    <ProductName>URSOFALK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>URSODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038048</DrugIDPK>
    <LicenceNumber>PPA1562/086/002</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029593</DrugIDPK>
    <LicenceNumber>PPA1500/004/001</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033997</DrugIDPK>
    <LicenceNumber>PPA1500/004/002</LicenceNumber>
    <ProductName>ZANIDIP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030044</DrugIDPK>
    <LicenceNumber>PPA1500/014/002</LicenceNumber>
    <ProductName>ZOMIG RAPIMELT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029586</DrugIDPK>
    <LicenceNumber>PPA1500/005/001</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE HSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029587</DrugIDPK>
    <LicenceNumber>PPA1500/005/002</LicenceNumber>
    <ProductName>ZOTON FASTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE HSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003830</DrugIDPK>
    <LicenceNumber>EU/1/97/040/001</LicenceNumber>
    <ProductName>TESLASCAN</ProductName>
    <Strength>0.01</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1997-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRISODIUM MANGAFODIPIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006967</DrugIDPK>
    <LicenceNumber>EU/1/97/040/002</LicenceNumber>
    <ProductName>TESLASCAN</ProductName>
    <Strength>0.01</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1997-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRISODIUM MANGAFODIPIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007020</DrugIDPK>
    <LicenceNumber>EU/1/97/054/003</LicenceNumber>
    <ProductName>VIRACEPT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1998-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESYLATE NELFINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004721</DrugIDPK>
    <LicenceNumber>EU/1/97/054/001</LicenceNumber>
    <ProductName>VIRACEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1998-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESYLATE NELFINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2013-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004722</DrugIDPK>
    <LicenceNumber>EU/1/97/054/002</LicenceNumber>
    <ProductName>VIRACEPT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1998-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESYLATE NELFINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015912</DrugIDPK>
    <LicenceNumber>EU/1/97/054/005</LicenceNumber>
    <ProductName>VIRACEPT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>2001-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESYLATE NELFINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010180</DrugIDPK>
    <LicenceNumber>EU/1/97/054/004</LicenceNumber>
    <ProductName>VIRACEPT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>2001-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESYLATE NELFINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030967</DrugIDPK>
    <LicenceNumber>PPA1447/034/001</LicenceNumber>
    <ProductName>KLACID FORTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031257</DrugIDPK>
    <LicenceNumber>PPA1447/042/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030575</DrugIDPK>
    <LicenceNumber>PPA1447/036/001</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030576</DrugIDPK>
    <LicenceNumber>PPA1447/036/002</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033819</DrugIDPK>
    <LicenceNumber>PPA1447/087/001</LicenceNumber>
    <ProductName>SERETIDE 100 DISKUS</ProductName>
    <Strength>50/100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031472</DrugIDPK>
    <LicenceNumber>PPA1447/054/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031473</DrugIDPK>
    <LicenceNumber>PPA1447/054/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027354</DrugIDPK>
    <LicenceNumber>PPA1447/003/001</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031259</DrugIDPK>
    <LicenceNumber>PPA1447/003/002</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031503</DrugIDPK>
    <LicenceNumber>PPA1447/058/001</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032679</DrugIDPK>
    <LicenceNumber>PPA1447/070/001</LicenceNumber>
    <ProductName>ANTHISAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031469</DrugIDPK>
    <LicenceNumber>PPA1447/059/001</LicenceNumber>
    <ProductName>BETNOVATE SCALP APPLICATION</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%v/w</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030844</DrugIDPK>
    <LicenceNumber>PPA1447/039/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033229</DrugIDPK>
    <LicenceNumber>PPA1447/082/001</LicenceNumber>
    <ProductName>CANESTEN COMBI PESSARY &amp; CREAM</ProductName>
    <Strength>500 mg/2%w</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessaries and Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000459</DrugIDPK>
    <LicenceNumber>PA0007/014/002</LicenceNumber>
    <ProductName>CATAPRES TABLETS 300 MICROGRAMS.</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLONIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031455</DrugIDPK>
    <LicenceNumber>PPA1447/052/001</LicenceNumber>
    <ProductName>CORDARONE X</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIODARONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000423</DrugIDPK>
    <LicenceNumber>PA0007/034/004</LicenceNumber>
    <ProductName>DUOVENT UNIT DOSE VIALS</ProductName>
    <Strength>0.5mg/1.25</Strength>
    <StrengthMeasurement>Mg/Dose</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1993-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031908</DrugIDPK>
    <LicenceNumber>PPA1328/133/001</LicenceNumber>
    <ProductName>DONA</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULFATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036973</DrugIDPK>
    <LicenceNumber>PA1130/032/001</LicenceNumber>
    <ProductName>SILDENAFIL ARROW</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036974</DrugIDPK>
    <LicenceNumber>PA1130/032/002</LicenceNumber>
    <ProductName>SILDENAFIL ARROW</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036975</DrugIDPK>
    <LicenceNumber>PA1130/032/003</LicenceNumber>
    <ProductName>SILDENAFIL ARROW</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2013-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007924</DrugIDPK>
    <LicenceNumber>PA0566/007/001</LicenceNumber>
    <ProductName>INTRAFUSIN 22</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1994-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE-L-GLUTAMATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>N-ACETYLTYROSINE PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038194</DrugIDPK>
    <LicenceNumber>PPA1562/002/002</LicenceNumber>
    <ProductName>VENTOLIN DISKUS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033867</DrugIDPK>
    <LicenceNumber>PA0126/111/002</LicenceNumber>
    <ProductName>ZYCRON MR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030945</DrugIDPK>
    <LicenceNumber>PA1130/027/001</LicenceNumber>
    <ProductName>ONDATAB</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030946</DrugIDPK>
    <LicenceNumber>PA1130/027/002</LicenceNumber>
    <ProductName>ONDATAB</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030394</DrugIDPK>
    <LicenceNumber>PPA1562/010/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005276</DrugIDPK>
    <LicenceNumber>PA0281/007/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005278</DrugIDPK>
    <LicenceNumber>PA0281/008/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035382</DrugIDPK>
    <LicenceNumber>PPA1562/052/001</LicenceNumber>
    <ProductName>TIMOPTOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Base %w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035383</DrugIDPK>
    <LicenceNumber>PPA1562/052/002</LicenceNumber>
    <ProductName>TIMOPTOL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Base %w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028885</DrugIDPK>
    <LicenceNumber>PA1532/002/001</LicenceNumber>
    <ProductName>ALIPZA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Kowa Pharmaceutical Europe Co. Ltd</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PITAVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028886</DrugIDPK>
    <LicenceNumber>PA1532/002/002</LicenceNumber>
    <ProductName>ALIPZA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Kowa Pharmaceutical Europe Co. Ltd</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PITAVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032727</DrugIDPK>
    <LicenceNumber>PA1532/002/003</LicenceNumber>
    <ProductName>ALIPZA 1MG FILM-COATED TABLETS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Kowa Pharmaceutical Europe Co. Ltd</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PITAVASTATIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037454</DrugIDPK>
    <LicenceNumber>PPA1562/070/003</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036512</DrugIDPK>
    <LicenceNumber>PPA1562/070/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036513</DrugIDPK>
    <LicenceNumber>PPA1562/070/002</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028398</DrugIDPK>
    <LicenceNumber>PA0408/072/006</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028399</DrugIDPK>
    <LicenceNumber>PA0408/072/007</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028400</DrugIDPK>
    <LicenceNumber>PA0408/072/008</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028401</DrugIDPK>
    <LicenceNumber>PA0408/072/009</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034002</DrugIDPK>
    <LicenceNumber>PPA1562/035/001</LicenceNumber>
    <ProductName>ARTHROTEC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
      <ActiveSubstance>MISOPROSTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034003</DrugIDPK>
    <LicenceNumber>PPA1562/035/002</LicenceNumber>
    <ProductName>ARTHROTEC</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
      <ActiveSubstance>MISOPROSTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026943</DrugIDPK>
    <LicenceNumber>DPR1463/003/001</LicenceNumber>
    <ProductName>NASACORT</ProductName>
    <Strength>55</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026956</DrugIDPK>
    <LicenceNumber>DPR1463/008/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>140 dose</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030047</DrugIDPK>
    <LicenceNumber>PPA1500/015/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033976</DrugIDPK>
    <LicenceNumber>PPA1500/070/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029591</DrugIDPK>
    <LicenceNumber>PPA1500/001/001</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029592</DrugIDPK>
    <LicenceNumber>PPA1500/001/002</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029800</DrugIDPK>
    <LicenceNumber>PPA1500/011/001</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029801</DrugIDPK>
    <LicenceNumber>PPA1500/011/002</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029803</DrugIDPK>
    <LicenceNumber>PPA1500/012/001</LicenceNumber>
    <ProductName>COVERSYL ARGININE PLUS 5MG/1.25MG FILM-COATED TABL</ProductName>
    <Strength>5/1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035278</DrugIDPK>
    <LicenceNumber>PPA1500/081/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030138</DrugIDPK>
    <LicenceNumber>PPA1500/021/001</LicenceNumber>
    <ProductName>DETRUSITOL SR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
      <ActiveSubstance>TOLTERODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033261</DrugIDPK>
    <LicenceNumber>PPA1500/067/001</LicenceNumber>
    <ProductName>DIOVAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032558</DrugIDPK>
    <LicenceNumber>PPA1500/053/001</LicenceNumber>
    <ProductName>IMURAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036564</DrugIDPK>
    <LicenceNumber>PPA1500/086/001</LicenceNumber>
    <ProductName>IXPRIM</ProductName>
    <Strength>37.5/325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030430</DrugIDPK>
    <LicenceNumber>PPA1500/032/001</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029590</DrugIDPK>
    <LicenceNumber>PPA1500/003/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030050</DrugIDPK>
    <LicenceNumber>PPA1500/013/003</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030316</DrugIDPK>
    <LicenceNumber>PPA1500/026/001</LicenceNumber>
    <ProductName>MOVICOL</ProductName>
    <Strength>13.8</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL/POLYETHYLENE GLYCOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031848</DrugIDPK>
    <LicenceNumber>PPA1500/052/001</LicenceNumber>
    <ProductName>OMESAR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLMESARTAN MEDOXOMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030141</DrugIDPK>
    <LicenceNumber>PPA1500/019/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029798</DrugIDPK>
    <LicenceNumber>PPA1500/009/001</LicenceNumber>
    <ProductName>SERETIDE 500 DISKUS</ProductName>
    <Strength>50/500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030281</DrugIDPK>
    <LicenceNumber>PPA1500/022/001</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032322</DrugIDPK>
    <LicenceNumber>PPA1500/043/001</LicenceNumber>
    <ProductName>SPIRIVA</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
      <ActiveSubstance>TIOTROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029797</DrugIDPK>
    <LicenceNumber>PPA1500/010/001</LicenceNumber>
    <ProductName>VENTOLIN EVOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035924</DrugIDPK>
    <LicenceNumber>PPA1500/082/001</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035925</DrugIDPK>
    <LicenceNumber>PPA1500/082/002</LicenceNumber>
    <ProductName>VESITIRIM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030321</DrugIDPK>
    <LicenceNumber>PPA1500/024/001</LicenceNumber>
    <ProductName>XATRAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032349</DrugIDPK>
    <LicenceNumber>PPA1500/055/001</LicenceNumber>
    <ProductName>XYZAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030319</DrugIDPK>
    <LicenceNumber>PPA1500/023/001</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030039</DrugIDPK>
    <LicenceNumber>PPA1500/006/001</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033112</DrugIDPK>
    <LicenceNumber>PPA1500/066/001</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033113</DrugIDPK>
    <LicenceNumber>PPA1500/066/002</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007242</DrugIDPK>
    <LicenceNumber>PA0913/021/001</LicenceNumber>
    <ProductName>ZYDOL XL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007243</DrugIDPK>
    <LicenceNumber>PA0913/021/002</LicenceNumber>
    <ProductName>ZYDOL XL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007244</DrugIDPK>
    <LicenceNumber>PA0913/021/003</LicenceNumber>
    <ProductName>ZYDOL XL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007245</DrugIDPK>
    <LicenceNumber>PA0913/021/004</LicenceNumber>
    <ProductName>ZYDOL XL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1999-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020803</DrugIDPK>
    <LicenceNumber>PA0436/043/001</LicenceNumber>
    <ProductName>SIMVASTATIN 10MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020804</DrugIDPK>
    <LicenceNumber>PA0436/043/002</LicenceNumber>
    <ProductName>SIMVASTATIN 20MG FILM-COATED TABLET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020805</DrugIDPK>
    <LicenceNumber>PA0436/043/003</LicenceNumber>
    <ProductName>SIMVASTATIN 40MG FILM-COATED TABLET</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021882</DrugIDPK>
    <LicenceNumber>PA0577/087/001</LicenceNumber>
    <ProductName>MYZAAR</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022186</DrugIDPK>
    <LicenceNumber>PA1286/022/005</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2006-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019715</DrugIDPK>
    <LicenceNumber>PA1063/019/001</LicenceNumber>
    <ProductName>SERTRANICHE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2005-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019716</DrugIDPK>
    <LicenceNumber>PA1063/019/002</LicenceNumber>
    <ProductName>SERTRANICHE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2005-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032892</DrugIDPK>
    <LicenceNumber>PA1189/010/001</LicenceNumber>
    <ProductName>LIDOCAINE 5% MEDICATED PLASTER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016820</DrugIDPK>
    <LicenceNumber>PA0966/007/001</LicenceNumber>
    <ProductName>BYZESTRA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016821</DrugIDPK>
    <LicenceNumber>PA0966/007/002</LicenceNumber>
    <ProductName>BYZESTRA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016822</DrugIDPK>
    <LicenceNumber>PA0966/007/003</LicenceNumber>
    <ProductName>BYZESTRA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016823</DrugIDPK>
    <LicenceNumber>PA0966/007/004</LicenceNumber>
    <ProductName>BYZESTRA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025092</DrugIDPK>
    <LicenceNumber>PA1390/012/001</LicenceNumber>
    <ProductName>TERAZOSIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030653</DrugIDPK>
    <LicenceNumber>PPA1562/013/001</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030655</DrugIDPK>
    <LicenceNumber>PPA1562/013/003</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033796</DrugIDPK>
    <LicenceNumber>PPA1596/030/001</LicenceNumber>
    <ProductName>KLACID LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003822</DrugIDPK>
    <LicenceNumber>PA0126/015/001</LicenceNumber>
    <ProductName>CLONAMP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003897</DrugIDPK>
    <LicenceNumber>PA0126/056/001</LicenceNumber>
    <ProductName>METRONIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027930</DrugIDPK>
    <LicenceNumber>PA1445/004/001</LicenceNumber>
    <ProductName>CETIRIZINE AUROBINDO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029608</DrugIDPK>
    <LicenceNumber>PPA1328/094/001</LicenceNumber>
    <ProductName>GOPTEN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031518</DrugIDPK>
    <LicenceNumber>PPA1328/014/002</LicenceNumber>
    <ProductName>KLACID</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037156</DrugIDPK>
    <LicenceNumber>PPA1328/084/004</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2012-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034195</DrugIDPK>
    <LicenceNumber>PPA1328/141/001</LicenceNumber>
    <ProductName>OMACOR</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEGA-3-ACID ETHYL ESTERS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029691</DrugIDPK>
    <LicenceNumber>PPA1328/099/001</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029692</DrugIDPK>
    <LicenceNumber>PPA1328/099/002</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995038838</DrugIDPK>
    <LicenceNumber>PA1466/003/001</LicenceNumber>
    <ProductName>EXEMESTANE HELM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helm AG</PAHolder>
    <AuthorisedDate>2013-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EXEMESTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022793</DrugIDPK>
    <LicenceNumber>PA1332/020/001</LicenceNumber>
    <ProductName>NUELIN SA</ProductName>
    <Strength>175</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022794</DrugIDPK>
    <LicenceNumber>PA1332/020/002</LicenceNumber>
    <ProductName>NUELIN SA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2013-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026787</DrugIDPK>
    <LicenceNumber>PA1453/001/001</LicenceNumber>
    <ProductName>IMIPENEM/CILASTATIN MEDREG</ProductName>
    <Strength>500/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MEDREG s.r.o.</PAHolder>
    <AuthorisedDate>2010-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPENEM ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CILASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020221</DrugIDPK>
    <LicenceNumber>PA0329/010/002</LicenceNumber>
    <ProductName>NICOPASS FRESH MINT</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031185</DrugIDPK>
    <LicenceNumber>PA0329/010/004</LicenceNumber>
    <ProductName>NICOPASS FRESH MINT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031184</DrugIDPK>
    <LicenceNumber>PA0329/010/003</LicenceNumber>
    <ProductName>NICOPASS LIQUORICE MINT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020220</DrugIDPK>
    <LicenceNumber>PA0329/010/001</LicenceNumber>
    <ProductName>NICOPASS LIQUORICE MINT</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033896</DrugIDPK>
    <LicenceNumber>PA1663/001/001</LicenceNumber>
    <ProductName>SILDENAFIL ADAIR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galenicum Health, S.L.</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033897</DrugIDPK>
    <LicenceNumber>PA1663/001/002</LicenceNumber>
    <ProductName>SILDENAFIL ADAIR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galenicum Health, S.L.</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033898</DrugIDPK>
    <LicenceNumber>PA1663/001/003</LicenceNumber>
    <ProductName>SILDENAFIL ADAIR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galenicum Health, S.L.</PAHolder>
    <AuthorisedDate>2011-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003626</DrugIDPK>
    <LicenceNumber>PA0100/033/003</LicenceNumber>
    <ProductName>SUSCARD BUCCAL</ProductName>
    <Strength>2.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003628</DrugIDPK>
    <LicenceNumber>PA0100/033/005</LicenceNumber>
    <ProductName>SUSCARD BUCCAL</ProductName>
    <Strength>3.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003629</DrugIDPK>
    <LicenceNumber>PA0100/033/006</LicenceNumber>
    <ProductName>SUSCARD BUCCAL</ProductName>
    <Strength>5.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029530</DrugIDPK>
    <LicenceNumber>PPA0465/214/001</LicenceNumber>
    <ProductName>ASASANTIN RETARD</ProductName>
    <Strength>200/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023959</DrugIDPK>
    <LicenceNumber>PPA0465/204/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023960</DrugIDPK>
    <LicenceNumber>PPA0465/204/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030252</DrugIDPK>
    <LicenceNumber>PPA0465/204/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030253</DrugIDPK>
    <LicenceNumber>PPA0465/204/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019154</DrugIDPK>
    <LicenceNumber>PPA0465/140/003</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032764</DrugIDPK>
    <LicenceNumber>PPA0465/140/004</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029819</DrugIDPK>
    <LicenceNumber>PPA0465/093/002</LicenceNumber>
    <ProductName>DIFLUCAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015613</DrugIDPK>
    <LicenceNumber>PPA0465/093/001</LicenceNumber>
    <ProductName>DIFLUCAN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022178</DrugIDPK>
    <LicenceNumber>PPA0465/191/001</LicenceNumber>
    <ProductName>DONA</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSAMINE SULFATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030747</DrugIDPK>
    <LicenceNumber>PPA0465/229/001</LicenceNumber>
    <ProductName>LIPANTIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008918</DrugIDPK>
    <LicenceNumber>PPA0465/039/006A</LicenceNumber>
    <ProductName>LOSEC MUPS 40 MG GASTRO-RESISTANT, FILM-COATED TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030939</DrugIDPK>
    <LicenceNumber>PPA0465/242/001</LicenceNumber>
    <ProductName>MACRODANTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023929</DrugIDPK>
    <LicenceNumber>PPA0465/202/001</LicenceNumber>
    <ProductName>MAXOLON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030901</DrugIDPK>
    <LicenceNumber>PPA0465/239/001</LicenceNumber>
    <ProductName>NEBILET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEBIVOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032922</DrugIDPK>
    <LicenceNumber>PPA0465/248/001</LicenceNumber>
    <ProductName>OMACOR</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEGA-3-ACID ETHYL ESTERS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030917</DrugIDPK>
    <LicenceNumber>PPA0465/240/001</LicenceNumber>
    <ProductName>SCHERIPROCT</ProductName>
    <Strength>1.5/5</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE CAPROATE</ActiveSubstance>
      <ActiveSubstance>CINCHOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023738</DrugIDPK>
    <LicenceNumber>PPA0465/201/001</LicenceNumber>
    <ProductName>TEGRETOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031480</DrugIDPK>
    <LicenceNumber>PPA0465/201/002</LicenceNumber>
    <ProductName>TEGRETOL RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031481</DrugIDPK>
    <LicenceNumber>PPA0465/201/003</LicenceNumber>
    <ProductName>TEGRETOL RETARD</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031538</DrugIDPK>
    <LicenceNumber>PPA0465/245/001</LicenceNumber>
    <ProductName>TENORET</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002253</DrugIDPK>
    <LicenceNumber>PPA0465/046/001</LicenceNumber>
    <ProductName>TENORETIC</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016095</DrugIDPK>
    <LicenceNumber>PPA0465/101/001</LicenceNumber>
    <ProductName>VALTREX 500MG FILM-COATED TABLETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026623</DrugIDPK>
    <LicenceNumber>PA1380/026/001</LicenceNumber>
    <ProductName>KLARAM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2007-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026624</DrugIDPK>
    <LicenceNumber>PA1380/026/002</LicenceNumber>
    <ProductName>KLARAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2007-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035985</DrugIDPK>
    <LicenceNumber>PA0030/044/005</LicenceNumber>
    <ProductName>LAMISIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2012-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009067</DrugIDPK>
    <LicenceNumber>PA0035/083/001</LicenceNumber>
    <ProductName>FOSAMAX</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032624</DrugIDPK>
    <LicenceNumber>PA1031/004/001</LicenceNumber>
    <ProductName>ROSUVASTATIN DISPHAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Disphar International B.V.</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032625</DrugIDPK>
    <LicenceNumber>PA1031/004/002</LicenceNumber>
    <ProductName>ROSUVASTATIN DISPHAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Disphar International B.V.</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032626</DrugIDPK>
    <LicenceNumber>PA1031/004/003</LicenceNumber>
    <ProductName>ROSUVASTATIN DISPHAR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Disphar International B.V.</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032627</DrugIDPK>
    <LicenceNumber>PA1031/004/004</LicenceNumber>
    <ProductName>ROSUVASTATIN DISPHAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Disphar International B.V.</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019890</DrugIDPK>
    <LicenceNumber>PA0061/014/001</LicenceNumber>
    <ProductName>TESTOSTERONE 100 MG IMPLANT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028383</DrugIDPK>
    <LicenceNumber>PA0568/007/003</LicenceNumber>
    <ProductName>DIADEON MR 60 MG MODIFIED RELEASE TABLETS</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034517</DrugIDPK>
    <LicenceNumber>PA1286/040/001</LicenceNumber>
    <ProductName>NITRO-DUR 0.1 MG/H TRANSDERMAL PATCH</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034518</DrugIDPK>
    <LicenceNumber>PA1286/040/002</LicenceNumber>
    <ProductName>NITRO-DUR 0.2 MG/H TRANSDERMAL PATCH</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034519</DrugIDPK>
    <LicenceNumber>PA1286/040/003</LicenceNumber>
    <ProductName>NITRO-DUR 0.4 MG/H TRANSDERMAL PATCH</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034520</DrugIDPK>
    <LicenceNumber>PA1286/040/004</LicenceNumber>
    <ProductName>NITRO-DUR 0.6 MG/H TRANSDERMAL PATCH</ProductName>
    <Strength>0.6</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003580</DrugIDPK>
    <LicenceNumber>PA0095/008/006</LicenceNumber>
    <ProductName>RUBEX 500 MG CHEWABLE TABLETS</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID, SILICON COATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030206</DrugIDPK>
    <LicenceNumber>PA1312/004/001</LicenceNumber>
    <ProductName>CAMRATA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Beacon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017762</DrugIDPK>
    <LicenceNumber>PA0915/010/001</LicenceNumber>
    <ProductName>TRUOXIN 100 MG FILM-COATED TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017765</DrugIDPK>
    <LicenceNumber>PA0915/010/004</LicenceNumber>
    <ProductName>TRUOXIN 750 MG FILM-COATED TABLETS</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021978</DrugIDPK>
    <LicenceNumber>PA0943/015/001</LicenceNumber>
    <ProductName>DERMAMIST DRY SKIN SPRAY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WHITE SOFT PARAFFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033860</DrugIDPK>
    <LicenceNumber>PA0749/134/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE TEVA PHARMA BV</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033861</DrugIDPK>
    <LicenceNumber>PA0749/134/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE TEVA PHARMA BV</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003611</DrugIDPK>
    <LicenceNumber>PA0100/001/002</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <Strength>1,500,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032924</DrugIDPK>
    <LicenceNumber>PA1410/046/001</LicenceNumber>
    <ProductName>GERMOLENE OINTMENT</ProductName>
    <Strength>6.55/3/0.3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>OCTAFONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028625</DrugIDPK>
    <LicenceNumber>EU/1/09/582/001</LicenceNumber>
    <ProductName>RILONACEPT REGENERON</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Regeneron UK Limited</PAHolder>
    <AuthorisedDate>2009-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RILONACEPT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028291</DrugIDPK>
    <LicenceNumber>PA1506/001/001</LicenceNumber>
    <ProductName>ANASTROZOLE DOCPHARMA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Docpharma BVBA</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027546</DrugIDPK>
    <LicenceNumber>PA1380/035/001</LicenceNumber>
    <ProductName>ZOLMITRIPTAN ACTAVIS</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035877</DrugIDPK>
    <LicenceNumber>PA1679/001/001</LicenceNumber>
    <ProductName>OPTIRAY 160</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Covidien (UK) Commerical Limited</PAHolder>
    <AuthorisedDate>2012-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOVERSOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037082</DrugIDPK>
    <LicenceNumber>PA1668/003/001</LicenceNumber>
    <ProductName>SILPEMAR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Vaia S.A.</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037083</DrugIDPK>
    <LicenceNumber>PA1668/003/003</LicenceNumber>
    <ProductName>SILPEMAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Vaia S.A.</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037084</DrugIDPK>
    <LicenceNumber>PA1668/003/002</LicenceNumber>
    <ProductName>SILPEMAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Vaia S.A.</PAHolder>
    <AuthorisedDate>2012-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030515</DrugIDPK>
    <LicenceNumber>PA1380/077/001</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035420</DrugIDPK>
    <LicenceNumber>PA0408/089/001</LicenceNumber>
    <ProductName>RABEPRAZOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035421</DrugIDPK>
    <LicenceNumber>PA0408/089/002</LicenceNumber>
    <ProductName>RABEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028406</DrugIDPK>
    <LicenceNumber>PA0585/046/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2012-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021990</DrugIDPK>
    <LicenceNumber>PA1130/007/001</LicenceNumber>
    <ProductName>TRANDOPIL 0.5 MG CAPSULES</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021992</DrugIDPK>
    <LicenceNumber>PA1130/007/002</LicenceNumber>
    <ProductName>TRANDOPIL 1 MG CAPSULES</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021993</DrugIDPK>
    <LicenceNumber>PA1130/007/003</LicenceNumber>
    <ProductName>TRANDOPIL 2 MG CAPSULES</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021991</DrugIDPK>
    <LicenceNumber>PA1130/007/004</LicenceNumber>
    <ProductName>TRANDOPIL 4 MG CAPSULES</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029478</DrugIDPK>
    <LicenceNumber>PA1063/036/001</LicenceNumber>
    <ProductName>ARIZIME</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029479</DrugIDPK>
    <LicenceNumber>PA1063/036/002</LicenceNumber>
    <ProductName>ARIZIME</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029832</DrugIDPK>
    <LicenceNumber>PA0749/091/001</LicenceNumber>
    <ProductName>LINEZOLID TEVA</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINEZOLID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022167</DrugIDPK>
    <LicenceNumber>PA0437/058/001</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022168</DrugIDPK>
    <LicenceNumber>PA0437/058/002</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022169</DrugIDPK>
    <LicenceNumber>PA0437/058/003</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036514</DrugIDPK>
    <LicenceNumber>PPA1562/068/003</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036461</DrugIDPK>
    <LicenceNumber>PPA1562/068/001</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036462</DrugIDPK>
    <LicenceNumber>PPA1562/068/002</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012267</DrugIDPK>
    <LicenceNumber>PA0007/062/001</LicenceNumber>
    <ProductName>GINSANA G115</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1999-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANAX GINSENG</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012268</DrugIDPK>
    <LicenceNumber>PA0007/062/002</LicenceNumber>
    <ProductName>GINSANA G115 TONIC</ProductName>
    <Strength>140/15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1999-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANAX GINSENG</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031736</DrugIDPK>
    <LicenceNumber>PA1367/005/001</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031737</DrugIDPK>
    <LicenceNumber>PA1367/005/002</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031738</DrugIDPK>
    <LicenceNumber>PA1367/005/003</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031739</DrugIDPK>
    <LicenceNumber>PA1367/005/004</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031740</DrugIDPK>
    <LicenceNumber>PA1367/005/005</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031741</DrugIDPK>
    <LicenceNumber>PA1367/005/006</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031742</DrugIDPK>
    <LicenceNumber>PA1367/005/007</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031743</DrugIDPK>
    <LicenceNumber>PA1367/005/008</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031744</DrugIDPK>
    <LicenceNumber>PA1367/005/009</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031745</DrugIDPK>
    <LicenceNumber>PA1367/005/010</LicenceNumber>
    <ProductName>ONEZYP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IWA Consulting ApS</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029932</DrugIDPK>
    <LicenceNumber>PA0711/179/001</LicenceNumber>
    <ProductName>SITRANE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029933</DrugIDPK>
    <LicenceNumber>PA0711/179/002</LicenceNumber>
    <ProductName>SITRANE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031067</DrugIDPK>
    <LicenceNumber>PA1380/088/004</LicenceNumber>
    <ProductName>BUPLEX RX</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024337</DrugIDPK>
    <LicenceNumber>PA1380/009/001</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035067</DrugIDPK>
    <LicenceNumber>PA1380/110/001</LicenceNumber>
    <ProductName>RAPONER</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035068</DrugIDPK>
    <LicenceNumber>PA1380/110/002</LicenceNumber>
    <ProductName>RAPONER</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035069</DrugIDPK>
    <LicenceNumber>PA1380/110/003</LicenceNumber>
    <ProductName>RAPONER</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2012-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034928</DrugIDPK>
    <LicenceNumber>PA1050/006/001</LicenceNumber>
    <ProductName>FLUOXETINE AUROBINDO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>2011-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007833</DrugIDPK>
    <LicenceNumber>EU/1/99/099/002</LicenceNumber>
    <ProductName>ZERENE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007834</DrugIDPK>
    <LicenceNumber>EU/1/99/099/003</LicenceNumber>
    <ProductName>ZERENE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007835</DrugIDPK>
    <LicenceNumber>EU/1/99/099/005</LicenceNumber>
    <ProductName>ZERENE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007836</DrugIDPK>
    <LicenceNumber>EU/1/99/099/006</LicenceNumber>
    <ProductName>ZERENE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006023</DrugIDPK>
    <LicenceNumber>EU/1/99/099/001</LicenceNumber>
    <ProductName>ZERENE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006024</DrugIDPK>
    <LicenceNumber>EU/1/99/099/004</LicenceNumber>
    <ProductName>ZERENE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda AB</PAHolder>
    <AuthorisedDate>1999-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALEPLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004125</DrugIDPK>
    <LicenceNumber>PA0167/051/005A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE &amp; GLUCOSE BP</ProductName>
    <Strength>0.15/5.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004158</DrugIDPK>
    <LicenceNumber>PA0167/052/009A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE 0.3% W/V AND SODIUM CHLORIDE 0.</ProductName>
    <Strength>0.3/0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026858</DrugIDPK>
    <LicenceNumber>PA0167/004/007</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE AND SODIUM CHLORIDE IN GLUCOSE</ProductName>
    <Strength>0.15/0.18/</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004094</DrugIDPK>
    <LicenceNumber>PA0167/004/001A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE, SODIUM CHLORIDE AND GLUCOSE BP</ProductName>
    <Strength>0.15/0.18/4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004126</DrugIDPK>
    <LicenceNumber>PA0167/008/009A</LicenceNumber>
    <ProductName>SODIUM CHLORIDE INTRAVENOUS INFUSION BP</ProductName>
    <Strength>0.45</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000360</DrugIDPK>
    <LicenceNumber>PA0002/039/004</LicenceNumber>
    <ProductName>CAPOTEN 12.5 MG TABLETS</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036736</DrugIDPK>
    <LicenceNumber>PA1063/054/001</LicenceNumber>
    <ProductName>MIREXEL</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2012-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036737</DrugIDPK>
    <LicenceNumber>PA1063/054/002</LicenceNumber>
    <ProductName>MIREXEL</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2012-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>PRAMIPEXOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036738</DrugIDPK>
    <LicenceNumber>PA1063/054/003</LicenceNumber>
    <ProductName>MIROLE</ProductName>
    <Strength>0.35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2012-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>PRAMIPEXOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025462</DrugIDPK>
    <LicenceNumber>PA0218/054/001</LicenceNumber>
    <ProductName>NOVIANA</ProductName>
    <Strength>0.5/0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2010-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028075</DrugIDPK>
    <LicenceNumber>PA1327/013/001</LicenceNumber>
    <ProductName>RIVASTIGMINE ORION</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028076</DrugIDPK>
    <LicenceNumber>PA1327/013/002</LicenceNumber>
    <ProductName>RIVASTIGMINE ORION</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028078</DrugIDPK>
    <LicenceNumber>PA1327/013/003</LicenceNumber>
    <ProductName>RIVASTIGMINE ORION</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031370</DrugIDPK>
    <LicenceNumber>PA0408/078/001</LicenceNumber>
    <ProductName>ANASTROZOLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004354</DrugIDPK>
    <LicenceNumber>PA0408/053/001</LicenceNumber>
    <ProductName>BELLVIRAX</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1999-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004355</DrugIDPK>
    <LicenceNumber>PA0408/053/002</LicenceNumber>
    <ProductName>BELLVIRAX</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1999-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004356</DrugIDPK>
    <LicenceNumber>PA0408/053/003</LicenceNumber>
    <ProductName>BELLVIRAX</ProductName>
    <Strength>800 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1999-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030541</DrugIDPK>
    <LicenceNumber>PA0408/077/001</LicenceNumber>
    <ProductName>DONEPEZIL HYDROCHLORIDE RANBAXY</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030542</DrugIDPK>
    <LicenceNumber>PA0408/077/002</LicenceNumber>
    <ProductName>DONEPEZIL HYDROCHLORIDE RANBAXY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002102</DrugIDPK>
    <LicenceNumber>PA0775/001/003</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032138</DrugIDPK>
    <LicenceNumber>PA0544/041/001</LicenceNumber>
    <ProductName>PEDIACEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2011-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID ADSORBED</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID ADSORBED</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID ADSORBED (PT)</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ ADSORBED (FHA)</ActiveSubstance>
      <ActiveSubstance>FIMBRIAE TYPES 2 AND 3 ADSORBED (FIM)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN ADSORBED (PRN)</ActiveSubstance>
      <ActiveSubstance>INACTIVATED POLIOMYELITIS VACCINE TYPE 1 (MAHONEY)</ActiveSubstance>
      <ActiveSubstance>INACTIVATED POLIOMYELITIS VACCINE TYPE 2 (MEF-1)</ActiveSubstance>
      <ActiveSubstance>INACTIVATED POLIOMYELITIS VACCINE TYPE 3 (SAUKETT)</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE B CONJUGATE VACCINE (PRP-T)</ActiveSubstance>
      <ActiveSubstance>CONJUGATED TO TENANUS PROTEIN</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE (A1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029584</DrugIDPK>
    <LicenceNumber>PA1063/038/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE NICHE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029585</DrugIDPK>
    <LicenceNumber>PA1063/038/002</LicenceNumber>
    <ProductName>PANTOPRAZOLE NICHE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029497</DrugIDPK>
    <LicenceNumber>PA0408/074/001</LicenceNumber>
    <ProductName>LOSARTAN RANBAXY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029498</DrugIDPK>
    <LicenceNumber>PA0408/074/002</LicenceNumber>
    <ProductName>LOSARTAN RANBAXY</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005545</DrugIDPK>
    <LicenceNumber>PA0095/008/003</LicenceNumber>
    <ProductName>RUBEX CHEWABLE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1987-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID, SILICON COATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029219</DrugIDPK>
    <LicenceNumber>PA1513/004/001</LicenceNumber>
    <ProductName>ALENDRONIC ACID APOTEX ONCE WEEKLY 70 MG TABLETS</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019216</DrugIDPK>
    <LicenceNumber>PA1177/001/001</LicenceNumber>
    <ProductName>ICG-PULSION</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PULSION Medical Systems AG</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOCYANINE GREEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019732</DrugIDPK>
    <LicenceNumber>PA1177/001/002</LicenceNumber>
    <ProductName>ICG-PULSION</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PULSION Medical Systems AG</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOCYANINE GREEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034682</DrugIDPK>
    <LicenceNumber>PPA0465/189/002</LicenceNumber>
    <ProductName>ZYDOL SR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034683</DrugIDPK>
    <LicenceNumber>PPA0465/189/003</LicenceNumber>
    <ProductName>ZYDOL SR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034684</DrugIDPK>
    <LicenceNumber>PPA0465/189/004</LicenceNumber>
    <ProductName>ZYDOL SR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018110</DrugIDPK>
    <LicenceNumber>PA0577/053/001</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>3.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018111</DrugIDPK>
    <LicenceNumber>PA0577/053/002</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>6.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018112</DrugIDPK>
    <LicenceNumber>PA0577/053/003</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>12.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018113</DrugIDPK>
    <LicenceNumber>PA0577/053/004</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020194</DrugIDPK>
    <LicenceNumber>PA0711/076/001</LicenceNumber>
    <ProductName>KETOZOL 2% W/W SHAMPOO</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%v/w</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This has been the case since authorisation of this PA and the labelling states this.
although the dandruff shampoo is thru pharmacy, the MAH have not requested this to be changed.</SupplyComments>
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019508</DrugIDPK>
    <LicenceNumber>PA0436/039/001</LicenceNumber>
    <ProductName>MYOSTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019509</DrugIDPK>
    <LicenceNumber>PA0436/039/002</LicenceNumber>
    <ProductName>MYOSTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022866</DrugIDPK>
    <LicenceNumber>PA0577/096/005</LicenceNumber>
    <ProductName>RISPERGER</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022867</DrugIDPK>
    <LicenceNumber>PA0577/096/006</LicenceNumber>
    <ProductName>RISPERGER</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018944</DrugIDPK>
    <LicenceNumber>EU/1/01/193/002</LicenceNumber>
    <ProductName>MABCAMPATH</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>ILEX Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALEMTUZUMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034738</DrugIDPK>
    <LicenceNumber>EU/1/11/680/001-020</LicenceNumber>
    <ProductName>RIPRAZO HCT</ProductName>
    <Strength>150/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034739</DrugIDPK>
    <LicenceNumber>EU/1/11/680/021-040</LicenceNumber>
    <ProductName>RIPRAZO HCT</ProductName>
    <Strength>150/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034740</DrugIDPK>
    <LicenceNumber>EU/1/11/680/041-060</LicenceNumber>
    <ProductName>RIPRAZO HCT</ProductName>
    <Strength>300/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034741</DrugIDPK>
    <LicenceNumber>EU/1/11/680/061-080</LicenceNumber>
    <ProductName>RIPRAZO HCT</ProductName>
    <Strength>300/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028591</DrugIDPK>
    <LicenceNumber>EU/1/09/513/1-5</LicenceNumber>
    <ProductName>RIVASTIGMINE TEVA</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028592</DrugIDPK>
    <LicenceNumber>EU/1/09/513/6-10</LicenceNumber>
    <ProductName>RIVASTIGMINE TEVA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028593</DrugIDPK>
    <LicenceNumber>EU/1/09/513/11-15</LicenceNumber>
    <ProductName>RIVASTIGMINE TEVA</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028594</DrugIDPK>
    <LicenceNumber>EU/1/09/513/16-20</LicenceNumber>
    <ProductName>RIVASTIGMINE TEVA</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE HYDROGEN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023048</DrugIDPK>
    <LicenceNumber>PA1380/004/001</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023049</DrugIDPK>
    <LicenceNumber>PA1380/004/002</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023050</DrugIDPK>
    <LicenceNumber>PA1380/004/003</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023051</DrugIDPK>
    <LicenceNumber>PA1380/004/004</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023053</DrugIDPK>
    <LicenceNumber>PA1380/004/006</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023054</DrugIDPK>
    <LicenceNumber>PA1380/004/007</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006915</DrugIDPK>
    <LicenceNumber>PA0405/035/001</LicenceNumber>
    <ProductName>PROSTAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006070</DrugIDPK>
    <LicenceNumber>PA0405/030/001</LicenceNumber>
    <ProductName>DILTIAZEM HYDROCHLORIDE TABLETS 60 MG (PROLONGED R</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1990-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029117</DrugIDPK>
    <LicenceNumber>PA0577/112/001</LicenceNumber>
    <ProductName>GERFORMIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029118</DrugIDPK>
    <LicenceNumber>PA0577/112/002</LicenceNumber>
    <ProductName>GERFORMIN</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029119</DrugIDPK>
    <LicenceNumber>PA0577/112/003</LicenceNumber>
    <ProductName>GERFORMIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017498</DrugIDPK>
    <LicenceNumber>PA0915/009/003</LicenceNumber>
    <ProductName>BYTRITE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017497</DrugIDPK>
    <LicenceNumber>PA0915/009/002</LicenceNumber>
    <ProductName>BYTRITE 2.5MG CAPSULES</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036491</DrugIDPK>
    <LicenceNumber>PA1751/001/001</LicenceNumber>
    <ProductName>FER-IN-SOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mead Johnson Nutrition</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031055</DrugIDPK>
    <LicenceNumber>PA0979/044/001</LicenceNumber>
    <ProductName>ITCH RELIEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAUROMACROGOL 400</ActiveSubstance>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022647</DrugIDPK>
    <LicenceNumber>PA1333/001/001</LicenceNumber>
    <ProductName>METFORMIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Morningside Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022648</DrugIDPK>
    <LicenceNumber>PA1333/001/002</LicenceNumber>
    <ProductName>METFORMIN</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Morningside Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021977</DrugIDPK>
    <LicenceNumber>PPA0465/189/001</LicenceNumber>
    <ProductName>ZYDOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002292</DrugIDPK>
    <LicenceNumber>PA0048/001/006</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029075</DrugIDPK>
    <LicenceNumber>PA1063/034/001</LicenceNumber>
    <ProductName>FLUCONAZOLE NICHE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028796</DrugIDPK>
    <LicenceNumber>PA0408/073/001</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM /HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028796</DrugIDPK>
    <LicenceNumber>PA0408/073/001</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM /HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028797</DrugIDPK>
    <LicenceNumber>PA0408/073/002</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM /HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028797</DrugIDPK>
    <LicenceNumber>PA0408/073/002</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM /HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004540</DrugIDPK>
    <LicenceNumber>PA0179/001/027</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004543</DrugIDPK>
    <LicenceNumber>PA0179/001/030</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION BP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004549</DrugIDPK>
    <LicenceNumber>PA0179/001/036</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION BP</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007751</DrugIDPK>
    <LicenceNumber>PA0179/001/038</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION BP</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027557</DrugIDPK>
    <LicenceNumber>PA1330/003/002</LicenceNumber>
    <ProductName>SCIPPA 10 MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027558</DrugIDPK>
    <LicenceNumber>PA1330/003/003</LicenceNumber>
    <ProductName>SCIPPA 15 MG FILM-COATED TABLETS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027559</DrugIDPK>
    <LicenceNumber>PA1330/003/004</LicenceNumber>
    <ProductName>SCIPPA 20 MG FILM-COATED TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027556</DrugIDPK>
    <LicenceNumber>PA1330/003/001</LicenceNumber>
    <ProductName>SCIPPA 5 MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021209</DrugIDPK>
    <LicenceNumber>PA0566/033/002</LicenceNumber>
    <ProductName>STRUCTOKABIVEN, BIOFINE CONTAINER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYCINE ACETATE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TAURINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE HEPTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021210</DrugIDPK>
    <LicenceNumber>PA0566/034/002</LicenceNumber>
    <ProductName>STRUCTOKABIVEN, BIOFINE CONTAINER, ELECTROLYTE FRE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TAURINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017536</DrugIDPK>
    <LicenceNumber>PA0566/033/001</LicenceNumber>
    <ProductName>STRUCTOKABIVEN, EXCEL CONTAINER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2003-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYCINE ACETATE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TAURINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017537</DrugIDPK>
    <LicenceNumber>PA0566/034/001</LicenceNumber>
    <ProductName>STRUCTOKABIVEN, EXCEL CONTAINER, ELECTOLYTE FREE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2003-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TAURINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026788</DrugIDPK>
    <LicenceNumber>PA0937/010/001</LicenceNumber>
    <ProductName>EPIRUBICINE HCL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033564</DrugIDPK>
    <LicenceNumber>PA0237/064/001</LicenceNumber>
    <ProductName>FLUCONAZOLE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>2010-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028113</DrugIDPK>
    <LicenceNumber>PA1130/020/001</LicenceNumber>
    <ProductName>ALENDROMAX 10MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALENDRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028114</DrugIDPK>
    <LicenceNumber>PA1130/020/002</LicenceNumber>
    <ProductName>ALENDROMAX ONCE WEEKLY 70MG TABLETS</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALENDRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010453</DrugIDPK>
    <LicenceNumber>PA0013/100/001</LicenceNumber>
    <ProductName>NYOGEL 0.1% W/W EYE GEL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2002-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eyegel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011295</DrugIDPK>
    <LicenceNumber>PA1009/001/004</LicenceNumber>
    <ProductName>DDAVP DESMOPRESSIN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019094</DrugIDPK>
    <LicenceNumber>PA1009/017/003</LicenceNumber>
    <ProductName>NORDURINE MELT</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019095</DrugIDPK>
    <LicenceNumber>PA1009/017/004</LicenceNumber>
    <ProductName>NORDURINE MELT</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019096</DrugIDPK>
    <LicenceNumber>PA1009/017/005</LicenceNumber>
    <ProductName>NORDURINE MELT</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021920</DrugIDPK>
    <LicenceNumber>PA1130/008/002</LicenceNumber>
    <ProductName>RISDONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021921</DrugIDPK>
    <LicenceNumber>PA1130/008/003</LicenceNumber>
    <ProductName>RISDONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021922</DrugIDPK>
    <LicenceNumber>PA1130/008/004</LicenceNumber>
    <ProductName>RISDONE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021923</DrugIDPK>
    <LicenceNumber>PA1130/008/005</LicenceNumber>
    <ProductName>RISDONE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005850</DrugIDPK>
    <LicenceNumber>EU/1/99/101/001</LicenceNumber>
    <ProductName>REGRANEX</ProductName>
    <Strength>0.01</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1999-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECAPLERMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029366</DrugIDPK>
    <LicenceNumber>PA1130/025/001</LicenceNumber>
    <ProductName>VALACICLOVIR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024504</DrugIDPK>
    <LicenceNumber>PA1130/013/001</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024504</DrugIDPK>
    <LicenceNumber>PA1130/013/001</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024506</DrugIDPK>
    <LicenceNumber>PA1130/013/003</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024506</DrugIDPK>
    <LicenceNumber>PA1130/013/003</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024507</DrugIDPK>
    <LicenceNumber>PA1130/013/002</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024507</DrugIDPK>
    <LicenceNumber>PA1130/013/002</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026683</DrugIDPK>
    <LicenceNumber>PA1130/017/001</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026684</DrugIDPK>
    <LicenceNumber>PA1130/017/002</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026685</DrugIDPK>
    <LicenceNumber>PA1130/017/003</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026686</DrugIDPK>
    <LicenceNumber>PA1130/017/004</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009964</DrugIDPK>
    <LicenceNumber>PA0593/024/001</LicenceNumber>
    <ProductName>ENAPRIL STADA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009965</DrugIDPK>
    <LicenceNumber>PA0593/024/002</LicenceNumber>
    <ProductName>ENAPRIL STADA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009966</DrugIDPK>
    <LicenceNumber>PA0593/024/003</LicenceNumber>
    <ProductName>ENAPRIL STADA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009967</DrugIDPK>
    <LicenceNumber>PA0593/024/004</LicenceNumber>
    <ProductName>ENAPRIL STADA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017345</DrugIDPK>
    <LicenceNumber>PA0966/010/001</LicenceNumber>
    <ProductName>RUSTIN</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017346</DrugIDPK>
    <LicenceNumber>PA0966/010/002</LicenceNumber>
    <ProductName>RUSTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017344</DrugIDPK>
    <LicenceNumber>PA0915/008/001</LicenceNumber>
    <ProductName>BIRAVID</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030125</DrugIDPK>
    <LicenceNumber>PA0915/026/001</LicenceNumber>
    <ProductName>BY-MADOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030613</DrugIDPK>
    <LicenceNumber>PA0915/025/001</LicenceNumber>
    <ProductName>CALMAX</ProductName>
    <Strength>0.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030614</DrugIDPK>
    <LicenceNumber>PA0915/025/002</LicenceNumber>
    <ProductName>CALMAX</ProductName>
    <Strength>0.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030615</DrugIDPK>
    <LicenceNumber>PA0915/025/003</LicenceNumber>
    <ProductName>CALMAX</ProductName>
    <Strength>1.0mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013126</DrugIDPK>
    <LicenceNumber>PA0943/003/001</LicenceNumber>
    <ProductName>DISTAMINE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2000-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013127</DrugIDPK>
    <LicenceNumber>PA0943/003/002</LicenceNumber>
    <ProductName>DISTAMINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2000-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023573</DrugIDPK>
    <LicenceNumber>PA0915/016/001</LicenceNumber>
    <ProductName>FINTEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033458</DrugIDPK>
    <LicenceNumber>PA1676/001/001</LicenceNumber>
    <ProductName>MYTANYL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Lavipharm S.A.</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033459</DrugIDPK>
    <LicenceNumber>PA1676/001/002</LicenceNumber>
    <ProductName>MYTANYL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Lavipharm S.A.</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033460</DrugIDPK>
    <LicenceNumber>PA1676/001/003</LicenceNumber>
    <ProductName>MYTANYL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Lavipharm S.A.</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033461</DrugIDPK>
    <LicenceNumber>PA1676/001/004</LicenceNumber>
    <ProductName>MYTANYL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram per hour</StrengthMeasurement>
    <PAHolder>Lavipharm S.A.</PAHolder>
    <AuthorisedDate>2010-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027887</DrugIDPK>
    <LicenceNumber>PA1130/019/001</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027888</DrugIDPK>
    <LicenceNumber>PA1130/019/002</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027889</DrugIDPK>
    <LicenceNumber>PA1130/019/003</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027890</DrugIDPK>
    <LicenceNumber>PA1130/019/004</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027891</DrugIDPK>
    <LicenceNumber>PA1130/019/005</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023758</DrugIDPK>
    <LicenceNumber>PA0915/017/001</LicenceNumber>
    <ProductName>SOLVATAN</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023759</DrugIDPK>
    <LicenceNumber>PA0915/017/004</LicenceNumber>
    <ProductName>SOLVATAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023760</DrugIDPK>
    <LicenceNumber>PA0915/017/003</LicenceNumber>
    <ProductName>SOLVATAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023761</DrugIDPK>
    <LicenceNumber>PA0915/017/002</LicenceNumber>
    <ProductName>SOLVATAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032903</DrugIDPK>
    <LicenceNumber>PA0970/061/001</LicenceNumber>
    <ProductName>BUDFOR</ProductName>
    <Strength>100/6</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032904</DrugIDPK>
    <LicenceNumber>PA0970/061/002</LicenceNumber>
    <ProductName>BUDFOR</ProductName>
    <Strength>200/6</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032905</DrugIDPK>
    <LicenceNumber>PA0970/061/003</LicenceNumber>
    <ProductName>BUDFOR</ProductName>
    <Strength>400/12</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026854</DrugIDPK>
    <LicenceNumber>PA1327/011/001</LicenceNumber>
    <ProductName>DONEPEZIL HYDROCHORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2009-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026855</DrugIDPK>
    <LicenceNumber>PA1327/011/002</LicenceNumber>
    <ProductName>DONEPEZIL HYDROCHORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2009-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032906</DrugIDPK>
    <LicenceNumber>PA0970/062/001</LicenceNumber>
    <ProductName>EDOFLO</ProductName>
    <Strength>100/6</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032907</DrugIDPK>
    <LicenceNumber>PA0970/062/002</LicenceNumber>
    <ProductName>EDOFLO</ProductName>
    <Strength>200/6</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032908</DrugIDPK>
    <LicenceNumber>PA0970/062/003</LicenceNumber>
    <ProductName>EDOFLO</ProductName>
    <Strength>400/12</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022852</DrugIDPK>
    <LicenceNumber>PA0167/129/002</LicenceNumber>
    <ProductName>TISSEEL KIT</ProductName>
    <Strength>1.0ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR I (FIBRINOGEN)</ActiveSubstance>
      <ActiveSubstance>PLASMAFIBRONECTIN</ActiveSubstance>
      <ActiveSubstance>FACTOR XIII</ActiveSubstance>
      <ActiveSubstance>PROFIBRINOLYSIN</ActiveSubstance>
      <ActiveSubstance>APROTININ</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022853</DrugIDPK>
    <LicenceNumber>PA0167/129/003</LicenceNumber>
    <ProductName>TISSEEL KIT</ProductName>
    <Strength>2.0ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR I (FIBRINOGEN)</ActiveSubstance>
      <ActiveSubstance>PLASMAFIBRONECTIN</ActiveSubstance>
      <ActiveSubstance>FACTOR XIII</ActiveSubstance>
      <ActiveSubstance>PROFIBRINOLYSIN</ActiveSubstance>
      <ActiveSubstance>APROTININ</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022854</DrugIDPK>
    <LicenceNumber>PA0167/129/004</LicenceNumber>
    <ProductName>TISSEEL KIT</ProductName>
    <Strength>5.0ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR I (FIBRINOGEN)</ActiveSubstance>
      <ActiveSubstance>PLASMAFIBRONECTIN</ActiveSubstance>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
      <ActiveSubstance>PROFIBRINOLYSIN</ActiveSubstance>
      <ActiveSubstance>APROTININ</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010663</DrugIDPK>
    <LicenceNumber>EU/1/00/147/006</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036644</DrugIDPK>
    <LicenceNumber>PA0408/092/001</LicenceNumber>
    <ProductName>BELLRAMIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036645</DrugIDPK>
    <LicenceNumber>PA0408/092/002</LicenceNumber>
    <ProductName>BELLRAMIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036646</DrugIDPK>
    <LicenceNumber>PA0408/092/003</LicenceNumber>
    <ProductName>BELLRAMIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029453</DrugIDPK>
    <LicenceNumber>PA1063/037/001</LicenceNumber>
    <ProductName>CIPROFLOXACIN NICHE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028393</DrugIDPK>
    <LicenceNumber>PA0408/072/001</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028394</DrugIDPK>
    <LicenceNumber>PA0408/072/002</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028395</DrugIDPK>
    <LicenceNumber>PA0408/072/003</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028396</DrugIDPK>
    <LicenceNumber>PA0408/072/004</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008334</DrugIDPK>
    <LicenceNumber>EU/1/00/147/001</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pasteur Merieux MSD</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010660</DrugIDPK>
    <LicenceNumber>EU/1/00/147/004</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010661</DrugIDPK>
    <LicenceNumber>EU/1/00/147/005</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010665</DrugIDPK>
    <LicenceNumber>EU/1/00/147/007</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010666</DrugIDPK>
    <LicenceNumber>EU/1/00/147/008</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010558</DrugIDPK>
    <LicenceNumber>EU/1/00/147/002</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pasteur Merieux MSD</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010560</DrugIDPK>
    <LicenceNumber>EU/1/00/147/003</LicenceNumber>
    <ProductName>HEXAVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pasteur Merieux MSD</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023076</DrugIDPK>
    <LicenceNumber>EU/1/07/407/1-10,21-30</LicenceNumber>
    <ProductName>SPRIMEO</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023077</DrugIDPK>
    <LicenceNumber>EU/1/07/407/11-20,31-40</LicenceNumber>
    <ProductName>SPRIMEO</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028005</DrugIDPK>
    <LicenceNumber>PA1493/002/001</LicenceNumber>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028006</DrugIDPK>
    <LicenceNumber>PA1493/002/002</LicenceNumber>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028007</DrugIDPK>
    <LicenceNumber>PA1493/002/003</LicenceNumber>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028008</DrugIDPK>
    <LicenceNumber>PA1493/002/004</LicenceNumber>
    <ProductName>OLANZAPINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005074</DrugIDPK>
    <LicenceNumber>PA0857/001/003</LicenceNumber>
    <ProductName>ROBINUL SOLUTION FOR IONTOPHORESIS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>MercuryPharm Ltd</PAHolder>
    <AuthorisedDate>1993-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOPYRRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009385</DrugIDPK>
    <LicenceNumber>PA0970/026/002</LicenceNumber>
    <ProductName>ZOMIG 5 MG TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004828</DrugIDPK>
    <LicenceNumber>PA0823/016/001</LicenceNumber>
    <ProductName>BENADRYL SKIN ALLERGY RELIEF</ProductName>
    <Strength>1/8/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004828</DrugIDPK>
    <LicenceNumber>PA0823/016/001</LicenceNumber>
    <ProductName>BENADRYL SKIN ALLERGY RELIEF</ProductName>
    <Strength>1/8/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033893</DrugIDPK>
    <LicenceNumber>PA0749/137/001</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033894</DrugIDPK>
    <LicenceNumber>PA0749/137/002</LicenceNumber>
    <ProductName>ESOMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE MAGNESIUM (AMORPHOUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022256</DrugIDPK>
    <LicenceNumber>PA0823/049/016</LicenceNumber>
    <ProductName>NICORETTE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028818</DrugIDPK>
    <LicenceNumber>PA1522/002/001</LicenceNumber>
    <ProductName>REPAGLINIDE ARROW</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REPAGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028819</DrugIDPK>
    <LicenceNumber>PA1522/002/002</LicenceNumber>
    <ProductName>REPAGLINIDE ARROW</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REPAGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028820</DrugIDPK>
    <LicenceNumber>PA1522/002/003</LicenceNumber>
    <ProductName>REPAGLINIDE ARROW</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REPAGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036255</DrugIDPK>
    <LicenceNumber>PA1739/001/001</LicenceNumber>
    <ProductName>PERISOM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Strandhaven Ltd trading as Somex Pharma</PAHolder>
    <AuthorisedDate>2011-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036256</DrugIDPK>
    <LicenceNumber>PA1739/001/002</LicenceNumber>
    <ProductName>PERISOM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Strandhaven Ltd trading as Somex Pharma</PAHolder>
    <AuthorisedDate>2011-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995036257</DrugIDPK>
    <LicenceNumber>PA1739/001/003</LicenceNumber>
    <ProductName>PERISOM</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Strandhaven Ltd trading as Somex Pharma</PAHolder>
    <AuthorisedDate>2011-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028471</DrugIDPK>
    <LicenceNumber>PA1130/009/008</LicenceNumber>
    <ProductName>TOPIRAMA 15MG CAPSULES, HARD</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028472</DrugIDPK>
    <LicenceNumber>PA1130/009/009</LicenceNumber>
    <ProductName>TOPIRAMA 25MG CAPSULES, HARD</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022725</DrugIDPK>
    <LicenceNumber>PA1130/009/007</LicenceNumber>
    <ProductName>TOPIRAMA CAPSULES</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033230</DrugIDPK>
    <LicenceNumber>PA0964/008/001</LicenceNumber>
    <ProductName>DECA DURABOLIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022009</DrugIDPK>
    <LicenceNumber>PA0979/015/009</LicenceNumber>
    <ProductName>GAVISCON SACHETS FRESH TROPICAL FLAVOUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through: General Sale.  General sale: Maximum pack size 24 sachets</SupplyComments>
    <WithdrawalDate>2012-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019236</DrugIDPK>
    <LicenceNumber>PA0408/061/001</LicenceNumber>
    <ProductName>BELLCITAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019237</DrugIDPK>
    <LicenceNumber>PA0408/061/003</LicenceNumber>
    <ProductName>BELLCITAL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019238</DrugIDPK>
    <LicenceNumber>PA0408/061/002</LicenceNumber>
    <ProductName>BELLCITAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995037805</DrugIDPK>
    <LicenceNumber>PPA1562/083/001</LicenceNumber>
    <ProductName>ZOMIG RAPIMELT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2012-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030922</DrugIDPK>
    <LicenceNumber>PPA1562/014/001</LicenceNumber>
    <ProductName>ZOMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025491</DrugIDPK>
    <LicenceNumber>PA1410/026/001</LicenceNumber>
    <ProductName>BETA-ADALAT</ProductName>
    <Strength>20mg/50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030644</DrugIDPK>
    <LicenceNumber>PA0915/028/001</LicenceNumber>
    <ProductName>BYFLUC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030645</DrugIDPK>
    <LicenceNumber>PA0915/028/002</LicenceNumber>
    <ProductName>BYFLUC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030646</DrugIDPK>
    <LicenceNumber>PA0915/028/003</LicenceNumber>
    <ProductName>BYFLUC</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020032</DrugIDPK>
    <LicenceNumber>PA0966/015/001</LicenceNumber>
    <ProductName>BYSEC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020033</DrugIDPK>
    <LicenceNumber>PA0966/015/002</LicenceNumber>
    <ProductName>BYSEC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007912</DrugIDPK>
    <LicenceNumber>PA0592/004/004</LicenceNumber>
    <ProductName>MEGALOTECT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>IMMUNOGLOBULIN CYTOMEGALOVIRUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007909</DrugIDPK>
    <LicenceNumber>PA0592/004/002</LicenceNumber>
    <ProductName>MEGALOTECT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>IMMUNOGLOBULIN CYTOMEGALOVIRUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030553</DrugIDPK>
    <LicenceNumber>PA1547/003/002</LicenceNumber>
    <ProductName>PROSTAP 3, 11.25 MG, POWDER AND SOLVENT FOR PROLON</ProductName>
    <Strength>11.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda UK Limited</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUPRORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032066</DrugIDPK>
    <LicenceNumber>PA1522/005/001</LicenceNumber>
    <ProductName>PRAMIPEXOLE ARROW</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032067</DrugIDPK>
    <LicenceNumber>PA1522/005/002</LicenceNumber>
    <ProductName>PRAMIPEXOLE ARROW</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032068</DrugIDPK>
    <LicenceNumber>PA1522/005/003</LicenceNumber>
    <ProductName>PRAMIPEXOLE ARROW</ProductName>
    <Strength>0.35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032069</DrugIDPK>
    <LicenceNumber>PA1522/005/004</LicenceNumber>
    <ProductName>PRAMIPEXOLE ARROW</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE BASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031540</DrugIDPK>
    <LicenceNumber>PA1522/004/002</LicenceNumber>
    <ProductName>IBANDRONIC ACID ARROW 150 MG TABLETS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2010-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IBANDRONATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030236</DrugIDPK>
    <LicenceNumber>PA1522/003/001</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030237</DrugIDPK>
    <LicenceNumber>PA1522/003/002</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030238</DrugIDPK>
    <LicenceNumber>PA1522/003/003</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030239</DrugIDPK>
    <LicenceNumber>PA1522/003/004</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030240</DrugIDPK>
    <LicenceNumber>PA1522/003/005</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030241</DrugIDPK>
    <LicenceNumber>PA1522/003/006</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030242</DrugIDPK>
    <LicenceNumber>PA1522/003/007</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030243</DrugIDPK>
    <LicenceNumber>PA1522/003/008</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030244</DrugIDPK>
    <LicenceNumber>PA1522/003/009</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030245</DrugIDPK>
    <LicenceNumber>PA1522/003/010</LicenceNumber>
    <ProductName>OLANZAPINE ARROW</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow ApS</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028397</DrugIDPK>
    <LicenceNumber>PA0408/072/005</LicenceNumber>
    <ProductName>OLANZAPINE RANBAXY</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023332</DrugIDPK>
    <LicenceNumber>PA1175/002/015</LicenceNumber>
    <ProductName>BETADINE ANTISEPTIC TULLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2007-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019926</DrugIDPK>
    <LicenceNumber>PA1218/003/001</LicenceNumber>
    <ProductName>HIBITANE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Regent Medical Overseas Limited</PAHolder>
    <AuthorisedDate>2005-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution Concentrate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIGLUCONATE (AS CHLORHEXIDINE DIGLUCONATE SOLUTION (20% W/V) PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021569</DrugIDPK>
    <LicenceNumber>PA1175/009/001</LicenceNumber>
    <ProductName>STERETS PRE-INJECTION SWABS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2006-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022354</DrugIDPK>
    <LicenceNumber>PA1175/012/001</LicenceNumber>
    <ProductName>STERIPASTE MEDICATED PASTE BANDAGE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011213</DrugIDPK>
    <LicenceNumber>PA0967/002/001</LicenceNumber>
    <ProductName>MOXICLAV</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011214</DrugIDPK>
    <LicenceNumber>PA0967/002/002</LicenceNumber>
    <ProductName>MOXICLAV</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID (IN THE FORM OF POTASSIUM CLAVULANATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026544</DrugIDPK>
    <LicenceNumber>PA1311/009/001</LicenceNumber>
    <ProductName>QUINAPRIL/HYDROCHLOROTHIAZIDE AUROBINDO 10MG/12.5M</ProductName>
    <Strength>10/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026545</DrugIDPK>
    <LicenceNumber>PA1311/009/002</LicenceNumber>
    <ProductName>QUINAPRIL/HYDROCHLOROTHIAZIDE AUROBINDO 20MG/12.5M</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026546</DrugIDPK>
    <LicenceNumber>PA1311/009/003</LicenceNumber>
    <ProductName>QUINAPRIL/HYDROCHLOROTHIAZIDE AUROBINDO 20MG/25MG</ProductName>
    <Strength>20/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aurobindo Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004599</DrugIDPK>
    <LicenceNumber>PA0179/003/008</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE INTRAVENOUS BP</ProductName>
    <Strength>0.45/2.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032900</DrugIDPK>
    <LicenceNumber>PA0237/062/001</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029065</DrugIDPK>
    <LicenceNumber>EU/1/10/630/002</LicenceNumber>
    <ProductName>DOCEFREZ</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>2010-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL (ANHYDROUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029064</DrugIDPK>
    <LicenceNumber>EU/1/10/630/001</LicenceNumber>
    <ProductName>DOCEFREZ</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>2010-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCETAXEL (ANHYDROUS)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035838</DrugIDPK>
    <LicenceNumber>DPR1633/013/001</LicenceNumber>
    <ProductName>FINASTERIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007941</DrugIDPK>
    <LicenceNumber>PA0736/014/001</LicenceNumber>
    <ProductName>NUTRIFLEX LIPID PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC ACETATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>MEDIUM CHAIN TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE HYPROCHLORIDE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>GLYCINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM ACETATE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007942</DrugIDPK>
    <LicenceNumber>PA0736/015/001</LicenceNumber>
    <ProductName>NUTRIFLEX LIPID SPECIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC ACETATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>MEDIUM CHAIN TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE HYPROCHLORIDE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>GLYCINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM ACETATE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE (= 2H2O)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035833</DrugIDPK>
    <LicenceNumber>DPR1633/012/001</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035834</DrugIDPK>
    <LicenceNumber>DPR1633/012/002</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035835</DrugIDPK>
    <LicenceNumber>DPR1633/012/003</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035836</DrugIDPK>
    <LicenceNumber>DPR1633/012/004</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035837</DrugIDPK>
    <LicenceNumber>DPR1633/012/005</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010577</DrugIDPK>
    <LicenceNumber>PA0540/033/001</LicenceNumber>
    <ProductName>CEFODOX PAEDIATRIC 40MG/5ML GRANULES FOR ORAL SUSP</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Base mg/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPODOXIME PROXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011060</DrugIDPK>
    <LicenceNumber>PA0540/074/002</LicenceNumber>
    <ProductName>SUPREFACT DEPOT 6.3 MG IMPLANT</ProductName>
    <Strength>6.3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSERELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022874</DrugIDPK>
    <LicenceNumber>PA0540/130/002</LicenceNumber>
    <ProductName>TILADE CFC-FREE</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEDOCROMIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035831</DrugIDPK>
    <LicenceNumber>DPR1633/011/001</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035832</DrugIDPK>
    <LicenceNumber>DPR1633/011/002</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027497</DrugIDPK>
    <LicenceNumber>PA0749/073/002</LicenceNumber>
    <ProductName>OXCARBAZEPINE TEVA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXCARBAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027498</DrugIDPK>
    <LicenceNumber>PA0749/073/003</LicenceNumber>
    <ProductName>OXCARBAZEPINE TEVA</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXCARBAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026589</DrugIDPK>
    <LicenceNumber>PA0749/062/001</LicenceNumber>
    <ProductName>PAROXETINE TEVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026590</DrugIDPK>
    <LicenceNumber>PA0749/062/002</LicenceNumber>
    <ProductName>PAROXETINE TEVA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026689</DrugIDPK>
    <LicenceNumber>PA0749/066/001</LicenceNumber>
    <ProductName>TOPIRAMATE TEVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026690</DrugIDPK>
    <LicenceNumber>PA0749/066/002</LicenceNumber>
    <ProductName>TOPIRAMATE TEVA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026691</DrugIDPK>
    <LicenceNumber>PA0749/066/003</LicenceNumber>
    <ProductName>TOPIRAMATE TEVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026692</DrugIDPK>
    <LicenceNumber>PA0749/066/004</LicenceNumber>
    <ProductName>TOPIRAMATE TEVA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026693</DrugIDPK>
    <LicenceNumber>PA0749/066/005</LicenceNumber>
    <ProductName>TOPIRAMATE TEVA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026694</DrugIDPK>
    <LicenceNumber>PA0749/066/006</LicenceNumber>
    <ProductName>TOPIRAMATE TEVA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029161</DrugIDPK>
    <LicenceNumber>PA0749/034/003</LicenceNumber>
    <ProductName>ARIPEZ</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029162</DrugIDPK>
    <LicenceNumber>PA0749/034/004</LicenceNumber>
    <ProductName>ARIPEZ</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022426</DrugIDPK>
    <LicenceNumber>PA0749/039/001</LicenceNumber>
    <ProductName>AZITHROMYCIN TEVA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021890</DrugIDPK>
    <LicenceNumber>PA0436/045/001</LicenceNumber>
    <ProductName>DALZIOR</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028214</DrugIDPK>
    <LicenceNumber>PA0749/079/001</LicenceNumber>
    <ProductName>DORTIM</ProductName>
    <Strength>20 + 5</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002236</DrugIDPK>
    <LicenceNumber>PA0047/073/001</LicenceNumber>
    <ProductName>CELANCE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERGOLIDE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002237</DrugIDPK>
    <LicenceNumber>PA0047/073/002</LicenceNumber>
    <ProductName>CELANCE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERGOLIDE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002238</DrugIDPK>
    <LicenceNumber>PA0047/073/003</LicenceNumber>
    <ProductName>CELANCE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERGOLIDE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018304</DrugIDPK>
    <LicenceNumber>PA1146/001/001</LicenceNumber>
    <ProductName>GABAPENTIN MASTERFARM</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Masterfarm SL</PAHolder>
    <AuthorisedDate>2004-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018306</DrugIDPK>
    <LicenceNumber>PA1146/001/002</LicenceNumber>
    <ProductName>GABAPENTIN MASTERFARM</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Masterfarm SL</PAHolder>
    <AuthorisedDate>2004-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018307</DrugIDPK>
    <LicenceNumber>PA1146/001/003</LicenceNumber>
    <ProductName>GABAPENTIN MASTERFARM</ProductName>
    <Strength>400mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Masterfarm SL</PAHolder>
    <AuthorisedDate>2004-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009431</DrugIDPK>
    <LicenceNumber>PA0030/043/001</LicenceNumber>
    <ProductName>LACTULOSE LIQUID PH. EUR.</ProductName>
    <Strength>67</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1998-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004938</DrugIDPK>
    <LicenceNumber>PA0030/026/003</LicenceNumber>
    <ProductName>OTRIVINE CHILD NASAL DROPS</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1994-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Drops Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XYLOMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004930</DrugIDPK>
    <LicenceNumber>PA0030/022/001</LicenceNumber>
    <ProductName>TIXYLIX CHESTY COUGH</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1996-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031277</DrugIDPK>
    <LicenceNumber>PPA1447/053/001</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027814</DrugIDPK>
    <LicenceNumber>PA0540/146/001</LicenceNumber>
    <ProductName>DITROPAN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011395</DrugIDPK>
    <LicenceNumber>PA0540/132/001</LicenceNumber>
    <ProductName>VALLERGAN</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMEPRAZINE TARTARE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011396</DrugIDPK>
    <LicenceNumber>PA0540/132/002</LicenceNumber>
    <ProductName>VALLERGAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMEPRAZINE TARTARE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011394</DrugIDPK>
    <LicenceNumber>PA0540/131/001</LicenceNumber>
    <ProductName>VALLERGAN FORTE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMEPRAZINE TARTARE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021554</DrugIDPK>
    <LicenceNumber>PA1319/001/001</LicenceNumber>
    <ProductName>TAMSULOSIN</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stichting Registratiebeheer</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031729</DrugIDPK>
    <LicenceNumber>PA0312/019/001</LicenceNumber>
    <ProductName>SALAZOPYRIN 250MG/5ML ORAL SUSPENSION.</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034171</DrugIDPK>
    <LicenceNumber>PPA1447/077/001</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032680</DrugIDPK>
    <LicenceNumber>PPA1447/072/001</LicenceNumber>
    <ProductName>DIORALYTE BLACKCURRANT</ProductName>
    <Strength>0.47/0.3/3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032410</DrugIDPK>
    <LicenceNumber>PPA1447/068/001</LicenceNumber>
    <ProductName>EURAX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROTAMITON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006751</DrugIDPK>
    <LicenceNumber>PA0167/099/001</LicenceNumber>
    <ProductName>BREVIBLOC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1994-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESMOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015489</DrugIDPK>
    <LicenceNumber>PA0167/063/005</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE &amp; GLUCOSE 5%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2003-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004120</DrugIDPK>
    <LicenceNumber>PA0167/051/001A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE &amp; GLUCOSE BP</ProductName>
    <Strength>0.3/5.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004137</DrugIDPK>
    <LicenceNumber>PA0167/052/001A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE 0.15% W/V AND SODIUM CHLORIDE 0</ProductName>
    <Strength>0.15/0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004100</DrugIDPK>
    <LicenceNumber>PA0167/004/005A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE, SODIUM CHLORIDE AND GLUCOSE</ProductName>
    <Strength>0.3/0.18/4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028871</DrugIDPK>
    <LicenceNumber>PA1513/003/001</LicenceNumber>
    <ProductName>PRAMIPEXOLE APOTEX</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028872</DrugIDPK>
    <LicenceNumber>PA1513/003/002</LicenceNumber>
    <ProductName>PRAMIPEXOLE APOTEX</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028873</DrugIDPK>
    <LicenceNumber>PA1513/003/003</LicenceNumber>
    <ProductName>PRAMIPEXOLE APOTEX</ProductName>
    <Strength>0.35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028874</DrugIDPK>
    <LicenceNumber>PA1513/003/004</LicenceNumber>
    <ProductName>PRAMIPEXOLE APOTEX</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022611</DrugIDPK>
    <LicenceNumber>PPA1151/024/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004091</DrugIDPK>
    <LicenceNumber>PA0167/050/009A</LicenceNumber>
    <ProductName>SODIUM CHLORIDE AND GLUCOSE</ProductName>
    <Strength>0.9/5.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027522</DrugIDPK>
    <LicenceNumber>PA0038/093/001</LicenceNumber>
    <ProductName>NIASPAN</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027523</DrugIDPK>
    <LicenceNumber>PA0038/093/002</LicenceNumber>
    <ProductName>NIASPAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027524</DrugIDPK>
    <LicenceNumber>PA0038/093/003</LicenceNumber>
    <ProductName>NIASPAN</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027525</DrugIDPK>
    <LicenceNumber>PA0038/093/004</LicenceNumber>
    <ProductName>NIASPAN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005704</DrugIDPK>
    <LicenceNumber>PA0748/020/003</LicenceNumber>
    <ProductName>GYNO-DAKTARIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005327</DrugIDPK>
    <LicenceNumber>PA0748/017/003</LicenceNumber>
    <ProductName>GYNO-PEVARYL 150 MG VAGINAL PESSARIES</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033457</DrugIDPK>
    <LicenceNumber>PPA1562/027/001</LicenceNumber>
    <ProductName>PREMARIN</ProductName>
    <Strength>0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033968</DrugIDPK>
    <LicenceNumber>PPA1562/034/001</LicenceNumber>
    <ProductName>RHINOLAST</ProductName>
    <Strength>140</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZELASTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027623</DrugIDPK>
    <LicenceNumber>PPA1447/018/002</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028095</DrugIDPK>
    <LicenceNumber>PPA1447/005/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028096</DrugIDPK>
    <LicenceNumber>PPA1447/005/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027958</DrugIDPK>
    <LicenceNumber>PPA1447/029/001</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027959</DrugIDPK>
    <LicenceNumber>PPA1447/029/002</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018213</DrugIDPK>
    <LicenceNumber>PA0654/015/001</LicenceNumber>
    <ProductName>FEMSEVEN CONTI</ProductName>
    <Strength>50/7</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>2004-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033044</DrugIDPK>
    <LicenceNumber>PA1271/006/001</LicenceNumber>
    <ProductName>ALENDRONIC ACID ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE MONOSODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024086</DrugIDPK>
    <LicenceNumber>PA0167/132/002</LicenceNumber>
    <ProductName>IMMUNINE</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for inf/inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN COAGULATION FACTOR IX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024087</DrugIDPK>
    <LicenceNumber>PA0167/132/003</LicenceNumber>
    <ProductName>IMMUNINE</ProductName>
    <Strength>1200</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for inf/inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN COAGULATION FACTOR IX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005511</DrugIDPK>
    <LicenceNumber>PA0282/026/001</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005512</DrugIDPK>
    <LicenceNumber>PA0282/026/002</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034399</DrugIDPK>
    <LicenceNumber>PA0749/042/002</LicenceNumber>
    <ProductName>OMEPRAZOLE TEVA 10MG GASTRO-RESISTANT CAPSULES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034397</DrugIDPK>
    <LicenceNumber>PA0749/042/003</LicenceNumber>
    <ProductName>OMEPRAZOLE TEVA 20MG, GASTRO-RESISTANT CAPSULES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034398</DrugIDPK>
    <LicenceNumber>PA0749/042/004</LicenceNumber>
    <ProductName>OMEPRAZOLE TEVA 40MG, GASTRO-RESISTANT CAPSULES</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034377</DrugIDPK>
    <LicenceNumber>PA1271/003/003</LicenceNumber>
    <ProductName>PUGRITEX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030204</DrugIDPK>
    <LicenceNumber>PA0749/107/001</LicenceNumber>
    <ProductName>RAMIPRIL TEVA</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030205</DrugIDPK>
    <LicenceNumber>PA0749/107/002</LicenceNumber>
    <ProductName>RAMIPRIL TEVA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022704</DrugIDPK>
    <LicenceNumber>PA0749/045/001</LicenceNumber>
    <ProductName>TIBOLONE TEVA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIBOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007893</DrugIDPK>
    <LicenceNumber>EU/1/97/035/003</LicenceNumber>
    <ProductName>REFLUDAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmion Limited</PAHolder>
    <AuthorisedDate>1999-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEPIRUDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007894</DrugIDPK>
    <LicenceNumber>EU/1/97/035/004</LicenceNumber>
    <ProductName>REFLUDAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmion Limited</PAHolder>
    <AuthorisedDate>1999-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEPIRUDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2012-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035266</DrugIDPK>
    <LicenceNumber>PA0822/079/001</LicenceNumber>
    <ProductName>ALENDRONIC ACID PFIZER 70 MG TABLETS</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALENDRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027252</DrugIDPK>
    <LicenceNumber>PA0749/075/001</LicenceNumber>
    <ProductName>AMISULPRIDE TEVA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027253</DrugIDPK>
    <LicenceNumber>PA0749/075/002</LicenceNumber>
    <ProductName>AMISULPRIDE TEVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027254</DrugIDPK>
    <LicenceNumber>PA0749/075/003</LicenceNumber>
    <ProductName>AMISULPRIDE TEVA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027255</DrugIDPK>
    <LicenceNumber>PA0749/075/004</LicenceNumber>
    <ProductName>AMISULPRIDE TEVA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029223</DrugIDPK>
    <LicenceNumber>PA0749/093/001</LicenceNumber>
    <ProductName>ATORVASTATIN 10 MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029224</DrugIDPK>
    <LicenceNumber>PA0749/093/002</LicenceNumber>
    <ProductName>ATORVASTATIN 20 MG FILM-COATED TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029225</DrugIDPK>
    <LicenceNumber>PA0749/093/003</LicenceNumber>
    <ProductName>ATORVASTATIN 40 MG FILM-COATED TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029226</DrugIDPK>
    <LicenceNumber>PA0749/093/004</LicenceNumber>
    <ProductName>ATORVASTATIN 80 MG FILM-COATED TABLETS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033383</DrugIDPK>
    <LicenceNumber>PA0822/058/001</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033384</DrugIDPK>
    <LicenceNumber>PA0822/058/002</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033954</DrugIDPK>
    <LicenceNumber>PA0822/062/001</LicenceNumber>
    <ProductName>BISPROLOL PFIZER</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033955</DrugIDPK>
    <LicenceNumber>PA0822/062/002</LicenceNumber>
    <ProductName>BISPROLOL PFIZER</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033956</DrugIDPK>
    <LicenceNumber>PA0822/062/003</LicenceNumber>
    <ProductName>BISPROLOL PFIZER</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033957</DrugIDPK>
    <LicenceNumber>PA0822/062/004</LicenceNumber>
    <ProductName>BISPROLOL PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033958</DrugIDPK>
    <LicenceNumber>PA0822/062/006</LicenceNumber>
    <ProductName>BISPROLOL PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033959</DrugIDPK>
    <LicenceNumber>PA0822/062/005</LicenceNumber>
    <ProductName>BISPROLOL PFIZER</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032606</DrugIDPK>
    <LicenceNumber>PA0822/044/001</LicenceNumber>
    <ProductName>CARVEDILOL PFIZER</ProductName>
    <Strength>3.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032607</DrugIDPK>
    <LicenceNumber>PA0822/044/002</LicenceNumber>
    <ProductName>CARVEDILOL PFIZER</ProductName>
    <Strength>6.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032608</DrugIDPK>
    <LicenceNumber>PA0822/044/003</LicenceNumber>
    <ProductName>CARVEDILOL PFIZER</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032609</DrugIDPK>
    <LicenceNumber>PA0822/044/004</LicenceNumber>
    <ProductName>CARVEDILOL PFIZER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019954</DrugIDPK>
    <LicenceNumber>PA0013/088/003</LicenceNumber>
    <ProductName>CATAFLAM SACHETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2006-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031392</DrugIDPK>
    <LicenceNumber>PA0822/028/001</LicenceNumber>
    <ProductName>CIPROFLOXACIN PFIZER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031393</DrugIDPK>
    <LicenceNumber>PA0822/028/002</LicenceNumber>
    <ProductName>CIPROFLOXACIN PFIZER 500 MG FILM-COATED TABLETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031394</DrugIDPK>
    <LicenceNumber>PA0822/028/003</LicenceNumber>
    <ProductName>CIPROFLOXACIN PFIZER 750 MG FILM-COATED TABLETS</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032057</DrugIDPK>
    <LicenceNumber>PA0822/034/001</LicenceNumber>
    <ProductName>CITALOPRAM PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032058</DrugIDPK>
    <LicenceNumber>PA0822/034/002</LicenceNumber>
    <ProductName>CITALOPRAM PFIZER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032059</DrugIDPK>
    <LicenceNumber>PA0822/034/003</LicenceNumber>
    <ProductName>CITALOPRAM PFIZER</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035342</DrugIDPK>
    <LicenceNumber>PA0822/103/001</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035343</DrugIDPK>
    <LicenceNumber>PA0822/103/002</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035037</DrugIDPK>
    <LicenceNumber>PA0822/085/001</LicenceNumber>
    <ProductName>CO-AMOXICLAV PFIZER</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CLAVULANATE, DILUTED (WITH MICROCRYSTALLINE CELLULOSE IN A RATIO OF 1:1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035038</DrugIDPK>
    <LicenceNumber>PA0822/085/002</LicenceNumber>
    <ProductName>CO-AMOXICLAV PFIZER</ProductName>
    <Strength>875/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CLAVULANATE, DILUTED (WITH MICROCRYSTALLINE CELLULOSE IN A RATIO OF 1:1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033104</DrugIDPK>
    <LicenceNumber>PA0822/054/001</LicenceNumber>
    <ProductName>ESCITALOPRAM PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033105</DrugIDPK>
    <LicenceNumber>PA0822/054/002</LicenceNumber>
    <ProductName>ESCITALOPRAM PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033106</DrugIDPK>
    <LicenceNumber>PA0822/054/003</LicenceNumber>
    <ProductName>ESCITALOPRAM PFIZER</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033107</DrugIDPK>
    <LicenceNumber>PA0822/054/004</LicenceNumber>
    <ProductName>ESCITALOPRAM PFIZER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031896</DrugIDPK>
    <LicenceNumber>PA0822/033/001</LicenceNumber>
    <ProductName>FINASTERIDE PFIZER 5 MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005553</DrugIDPK>
    <LicenceNumber>PA0282/041/003</LicenceNumber>
    <ProductName>FLUCLOXACILLIN ORAL SOLUTION BP 125 MG/5ML</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009012</DrugIDPK>
    <LicenceNumber>PA0282/074/001</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2001-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009013</DrugIDPK>
    <LicenceNumber>PA0282/074/002</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2001-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009014</DrugIDPK>
    <LicenceNumber>PA0282/074/003</LicenceNumber>
    <ProductName>GABAPENTIN TEVA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2001-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033064</DrugIDPK>
    <LicenceNumber>PA0822/042/001</LicenceNumber>
    <ProductName>IRBESARTAN PFIZER</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033065</DrugIDPK>
    <LicenceNumber>PA0822/042/002</LicenceNumber>
    <ProductName>IRBESARTAN PFIZER</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033066</DrugIDPK>
    <LicenceNumber>PA0822/042/003</LicenceNumber>
    <ProductName>IRBESARTAN PFIZER</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034524</DrugIDPK>
    <LicenceNumber>PA0822/078/001</LicenceNumber>
    <ProductName>LEVETIRACETAM PFIZER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034525</DrugIDPK>
    <LicenceNumber>PA0822/078/002</LicenceNumber>
    <ProductName>LEVETIRACETAM PFIZER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034526</DrugIDPK>
    <LicenceNumber>PA0822/078/003</LicenceNumber>
    <ProductName>LEVETIRACETAM PFIZER</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034527</DrugIDPK>
    <LicenceNumber>PA0822/078/004</LicenceNumber>
    <ProductName>LEVETIRACETAM PFIZER</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034720</DrugIDPK>
    <LicenceNumber>PA0822/078/005</LicenceNumber>
    <ProductName>LEVETIRACETAM PFIZER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVETIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034111</DrugIDPK>
    <LicenceNumber>PA0822/061/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN PFIZER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034112</DrugIDPK>
    <LicenceNumber>PA0822/061/002</LicenceNumber>
    <ProductName>LEVOFLOXACIN PFIZER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033148</DrugIDPK>
    <LicenceNumber>PA0822/050/001</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM / HYDROCHLORTHIAZIDE PFIZER</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033149</DrugIDPK>
    <LicenceNumber>PA0822/050/002</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM / HYDROCHLORTHIAZIDE PFIZER</ProductName>
    <Strength>100/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033150</DrugIDPK>
    <LicenceNumber>PA0822/050/003</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM / HYDROCHLORTHIAZIDE PFIZER</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032331</DrugIDPK>
    <LicenceNumber>PA0822/040/001</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM PFIZER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032332</DrugIDPK>
    <LicenceNumber>PA0822/040/002</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM PFIZER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032333</DrugIDPK>
    <LicenceNumber>PA0822/040/003</LicenceNumber>
    <ProductName>LOSARTAN POTASSIUM PFIZER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032051</DrugIDPK>
    <LicenceNumber>PA0822/035/001</LicenceNumber>
    <ProductName>METFORMIN PFIZER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032052</DrugIDPK>
    <LicenceNumber>PA0822/035/002</LicenceNumber>
    <ProductName>METFORMIN PFIZER</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032053</DrugIDPK>
    <LicenceNumber>PA0822/035/003</LicenceNumber>
    <ProductName>METFORMIN PFIZER</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032821</DrugIDPK>
    <LicenceNumber>PA0822/047/001</LicenceNumber>
    <ProductName>MIRTAZAPINE PFIZER</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032822</DrugIDPK>
    <LicenceNumber>PA0822/047/002</LicenceNumber>
    <ProductName>MIRTAZAPINE PFIZER</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032823</DrugIDPK>
    <LicenceNumber>PA0822/047/003</LicenceNumber>
    <ProductName>MIRTAZAPINE PFIZER</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034694</DrugIDPK>
    <LicenceNumber>PA0822/077/001</LicenceNumber>
    <ProductName>OLANZAPINE PFIZER</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034695</DrugIDPK>
    <LicenceNumber>PA0822/077/002</LicenceNumber>
    <ProductName>OLANZAPINE PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034696</DrugIDPK>
    <LicenceNumber>PA0822/077/003</LicenceNumber>
    <ProductName>OLANZAPINE PFIZER</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034697</DrugIDPK>
    <LicenceNumber>PA0822/077/004</LicenceNumber>
    <ProductName>OLANZAPINE PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034698</DrugIDPK>
    <LicenceNumber>PA0822/077/005</LicenceNumber>
    <ProductName>OLANZAPINE PFIZER</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034699</DrugIDPK>
    <LicenceNumber>PA0822/077/006</LicenceNumber>
    <ProductName>OLANZAPINE PFIZER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032829</DrugIDPK>
    <LicenceNumber>PA0822/045/001</LicenceNumber>
    <ProductName>OMEPRAZOLE PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032830</DrugIDPK>
    <LicenceNumber>PA0822/045/002</LicenceNumber>
    <ProductName>OMEPRAZOLE PFIZER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032831</DrugIDPK>
    <LicenceNumber>PA0822/045/003</LicenceNumber>
    <ProductName>OMEPRAZOLE PFIZER</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032741</DrugIDPK>
    <LicenceNumber>PA0822/041/002</LicenceNumber>
    <ProductName>PERINDOPRIL PFIZER</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032740</DrugIDPK>
    <LicenceNumber>PA0822/041/001</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE PFIZER 4 MG TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033198</DrugIDPK>
    <LicenceNumber>PA0822/053/001</LicenceNumber>
    <ProductName>QUETIAPINE PFIZER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033199</DrugIDPK>
    <LicenceNumber>PA0822/053/002</LicenceNumber>
    <ProductName>QUETIAPINE PFIZER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033200</DrugIDPK>
    <LicenceNumber>PA0822/053/003</LicenceNumber>
    <ProductName>QUETIAPINE PFIZER</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033201</DrugIDPK>
    <LicenceNumber>PA0822/053/004</LicenceNumber>
    <ProductName>QUETIAPINE PFIZER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033202</DrugIDPK>
    <LicenceNumber>PA0822/053/005</LicenceNumber>
    <ProductName>QUETIAPINE PFIZER</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030792</DrugIDPK>
    <LicenceNumber>PA0822/024/001</LicenceNumber>
    <ProductName>RAMIPRIL PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030793</DrugIDPK>
    <LicenceNumber>PA0822/024/002</LicenceNumber>
    <ProductName>RAMIPRIL PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033003</DrugIDPK>
    <LicenceNumber>PA0822/049/001</LicenceNumber>
    <ProductName>RISEDRONATE SODIUM PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM (HEMIPENTAHYDRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033004</DrugIDPK>
    <LicenceNumber>PA0822/049/002</LicenceNumber>
    <ProductName>RISEDRONATE SODIUM PFIZER</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM (HEMIPENTAHYDRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033005</DrugIDPK>
    <LicenceNumber>PA0822/049/003</LicenceNumber>
    <ProductName>RISEDRONATE SODIUM PFIZER ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM (HEMIPENTAHYDRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021540</DrugIDPK>
    <LicenceNumber>PA0281/129/001</LicenceNumber>
    <ProductName>RISPAL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021541</DrugIDPK>
    <LicenceNumber>PA0281/129/002</LicenceNumber>
    <ProductName>RISPAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021542</DrugIDPK>
    <LicenceNumber>PA0281/129/003</LicenceNumber>
    <ProductName>RISPAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021543</DrugIDPK>
    <LicenceNumber>PA0281/129/004</LicenceNumber>
    <ProductName>RISPAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021544</DrugIDPK>
    <LicenceNumber>PA0281/129/005</LicenceNumber>
    <ProductName>RISPAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021545</DrugIDPK>
    <LicenceNumber>PA0281/129/006</LicenceNumber>
    <ProductName>RISPAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021546</DrugIDPK>
    <LicenceNumber>PA0281/129/007</LicenceNumber>
    <ProductName>RISPAL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032591</DrugIDPK>
    <LicenceNumber>PA0822/038/001</LicenceNumber>
    <ProductName>RISPERIDONE PFIZER</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032592</DrugIDPK>
    <LicenceNumber>PA0822/038/002</LicenceNumber>
    <ProductName>RISPERIDONE PFIZER</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032593</DrugIDPK>
    <LicenceNumber>PA0822/038/003</LicenceNumber>
    <ProductName>RISPERIDONE PFIZER</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032594</DrugIDPK>
    <LicenceNumber>PA0822/038/004</LicenceNumber>
    <ProductName>RISPERIDONE PFIZER</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032595</DrugIDPK>
    <LicenceNumber>PA0822/038/005</LicenceNumber>
    <ProductName>RISPERIDONE PFIZER</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032596</DrugIDPK>
    <LicenceNumber>PA0822/038/006</LicenceNumber>
    <ProductName>RISPERIDONE PFIZER</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005599</DrugIDPK>
    <LicenceNumber>PA0282/063/001</LicenceNumber>
    <ProductName>SERENACE 5 MG/ML AMPOULE SOLUTION FOR INJECTION.</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031923</DrugIDPK>
    <LicenceNumber>PA0822/032/001</LicenceNumber>
    <ProductName>SIMVASTATIN PFIZER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031924</DrugIDPK>
    <LicenceNumber>PA0822/032/002</LicenceNumber>
    <ProductName>SIMVASTATIN PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031925</DrugIDPK>
    <LicenceNumber>PA0822/032/003</LicenceNumber>
    <ProductName>SIMVASTATIN PFIZER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031926</DrugIDPK>
    <LicenceNumber>PA0822/032/004</LicenceNumber>
    <ProductName>SIMVASTATIN PFIZER</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031927</DrugIDPK>
    <LicenceNumber>PA0822/032/005</LicenceNumber>
    <ProductName>SIMVASTATIN PFIZER</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032767</DrugIDPK>
    <LicenceNumber>PA0822/048/001</LicenceNumber>
    <ProductName>SUMATRIPTAN PFIZER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032768</DrugIDPK>
    <LicenceNumber>PA0822/048/002</LicenceNumber>
    <ProductName>SUMATRIPTAN PFIZER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032602</DrugIDPK>
    <LicenceNumber>PA0822/039/001</LicenceNumber>
    <ProductName>TERBINAFINE PFIZER</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032603</DrugIDPK>
    <LicenceNumber>PA0822/039/002</LicenceNumber>
    <ProductName>TERBINAFINE PFIZER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035528</DrugIDPK>
    <LicenceNumber>PA0822/057/001</LicenceNumber>
    <ProductName>VALACICLOVIR PFIZER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034206</DrugIDPK>
    <LicenceNumber>PA0822/074/001</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034208</DrugIDPK>
    <LicenceNumber>PA0822/074/003</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034209</DrugIDPK>
    <LicenceNumber>PA0822/074/004</LicenceNumber>
    <ProductName>VALSARTAN</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034207</DrugIDPK>
    <LicenceNumber>PA0822/074/002</LicenceNumber>
    <ProductName>VALSARTAN PFIZER</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2012-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019851</DrugIDPK>
    <LicenceNumber>PA0030/057/001</LicenceNumber>
    <ProductName>BOOTS NICASSIST</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2003-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015364</DrugIDPK>
    <LicenceNumber>PA0030/052/001</LicenceNumber>
    <ProductName>NCH MINT</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Supply through pharmacies and promotion to the public subject to the following restrictions: oral dosage form, maximum dose 4mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>2012-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027364</DrugIDPK>
    <LicenceNumber>PA0711/152/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027514</DrugIDPK>
    <LicenceNumber>EU/1/09/520/7-11</LicenceNumber>
    <ProductName>EXALIEF</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BIAL - Portela &amp; Cª, S.A.</PAHolder>
    <AuthorisedDate>2009-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESLICARBAZEPINE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027515</DrugIDPK>
    <LicenceNumber>EU/1/09/520/12-20</LicenceNumber>
    <ProductName>EXALIEF</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BIAL - Portela &amp; Cª, S.A.</PAHolder>
    <AuthorisedDate>2009-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESLICARBAZEPINE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006212</DrugIDPK>
    <LicenceNumber>PA0441/034/002</LicenceNumber>
    <ProductName>ORANGE FLAVOUR REGULAN 3.4G PER SACHET POWDER FOR</ProductName>
    <Strength>3.4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1990-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISPAGHULA HUSKS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006211</DrugIDPK>
    <LicenceNumber>PA0441/034/001</LicenceNumber>
    <ProductName>REGULAN LEMON/LIME FLAVOUR 3.4G PER SACHET POWDER</ProductName>
    <Strength>49</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1990-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISPAGHULA HUSKS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028290</DrugIDPK>
    <LicenceNumber>PA1063/032/001</LicenceNumber>
    <ProductName>ANASTROZOLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2009-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029342</DrugIDPK>
    <LicenceNumber>PA1380/063/002</LicenceNumber>
    <ProductName>VELEXOR</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029344</DrugIDPK>
    <LicenceNumber>PA1380/063/004</LicenceNumber>
    <ProductName>VELEXOR</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033045</DrugIDPK>
    <LicenceNumber>PA1271/005/001</LicenceNumber>
    <ProductName>SIMVASTATIN 10 MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033046</DrugIDPK>
    <LicenceNumber>PA1271/005/002</LicenceNumber>
    <ProductName>SIMVASTATIN 20 MG FILM-COATED TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033047</DrugIDPK>
    <LicenceNumber>PA1271/005/003</LicenceNumber>
    <ProductName>SIMVASTATIN 40 MG FILM-COATED TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033048</DrugIDPK>
    <LicenceNumber>PA1271/005/004</LicenceNumber>
    <ProductName>SIMVASTATIN 80 MG FILM-COATED TABLETS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>2010-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027275</DrugIDPK>
    <LicenceNumber>PPA1447/015/001</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027276</DrugIDPK>
    <LicenceNumber>PPA1447/015/002</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027277</DrugIDPK>
    <LicenceNumber>PPA1447/015/003</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027278</DrugIDPK>
    <LicenceNumber>PPA1447/015/004</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032604</DrugIDPK>
    <LicenceNumber>PA0822/027/002</LicenceNumber>
    <ProductName>ONDANSETRON PFIZER</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032605</DrugIDPK>
    <LicenceNumber>PA0822/027/003</LicenceNumber>
    <ProductName>ONDANSETRON PFIZER</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026946</DrugIDPK>
    <LicenceNumber>PA0915/020/002</LicenceNumber>
    <ProductName>DONELINN 10 MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026945</DrugIDPK>
    <LicenceNumber>PA0915/020/001</LicenceNumber>
    <ProductName>DONELINN 5 MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005728</DrugIDPK>
    <LicenceNumber>PA0336/001/001</LicenceNumber>
    <ProductName>ISOPRINOSINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Newport Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSINE ACEDOBEN DIMEPRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021754</DrugIDPK>
    <LicenceNumber>PA1301/003/001</LicenceNumber>
    <ProductName>COSMEGEN LYOVAC POWDER FOR SOLUTION FOR INJECTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>2006-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACTINOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004212</DrugIDPK>
    <LicenceNumber>PA0167/017/011</LicenceNumber>
    <ProductName>DIANEAL PD1 GLUCOSE 2.27% W/V (22.7 MG/ML) SOLUTIO</ProductName>
    <Strength>2.27</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022500</DrugIDPK>
    <LicenceNumber>PA0840/005/001</LicenceNumber>
    <ProductName>OLANZAPINE SYNTHON</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2008-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022501</DrugIDPK>
    <LicenceNumber>PA0840/005/002</LicenceNumber>
    <ProductName>OLANZAPINE SYNTHON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2008-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022502</DrugIDPK>
    <LicenceNumber>PA0840/005/003</LicenceNumber>
    <ProductName>OLANZAPINE SYNTHON</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2008-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022503</DrugIDPK>
    <LicenceNumber>PA0840/005/004</LicenceNumber>
    <ProductName>OLANZAPINE SYNTHON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>2008-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031228</DrugIDPK>
    <LicenceNumber>PA0757/008/001</LicenceNumber>
    <ProductName>APOMORPHINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024753</DrugIDPK>
    <LicenceNumber>PA1063/027/001</LicenceNumber>
    <ProductName>MIRZATEN 15 MG ORODISPERSIBLE TABLETS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024754</DrugIDPK>
    <LicenceNumber>PA1063/027/002</LicenceNumber>
    <ProductName>MIRZATEN 30 MG ORODISPERSIBLE TABLETS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024755</DrugIDPK>
    <LicenceNumber>PA1063/027/003</LicenceNumber>
    <ProductName>MIRZATEN 45 MG ORODISPERSIBLE TABLETS</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027627</DrugIDPK>
    <LicenceNumber>PA1380/023/001</LicenceNumber>
    <ProductName>ATORVASTATIN ACTAVIS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTASTIN MAGNESIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027628</DrugIDPK>
    <LicenceNumber>PA1380/023/002</LicenceNumber>
    <ProductName>ATORVASTATIN ACTAVIS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTASTIN MAGNESIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027629</DrugIDPK>
    <LicenceNumber>PA1380/023/003</LicenceNumber>
    <ProductName>ATORVASTATIN ACTAVIS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTASTIN MAGNESIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020697</DrugIDPK>
    <LicenceNumber>PPA0465/078/008</LicenceNumber>
    <ProductName>RISPERDAL QUICKLET</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003900</DrugIDPK>
    <LicenceNumber>PA0126/058/001</LicenceNumber>
    <ProductName>FERROUS GLUCONATE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023771</DrugIDPK>
    <LicenceNumber>PA0967/017/003</LicenceNumber>
    <ProductName>VELEXOR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023772</DrugIDPK>
    <LicenceNumber>PA0967/017/002</LicenceNumber>
    <ProductName>VELEXOR</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028289</DrugIDPK>
    <LicenceNumber>PA1063/031/001</LicenceNumber>
    <ProductName>ANASTROZOLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2009-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006659</DrugIDPK>
    <LicenceNumber>PA0549/003/001</LicenceNumber>
    <ProductName>CARDOX SR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006660</DrugIDPK>
    <LicenceNumber>PA0549/003/002</LicenceNumber>
    <ProductName>CARDOX SR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006661</DrugIDPK>
    <LicenceNumber>PA0549/003/003</LicenceNumber>
    <ProductName>CARDOX SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032942</DrugIDPK>
    <LicenceNumber>PA0822/046/001</LicenceNumber>
    <ProductName>DOBUTAMINE PFIZER</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026533</DrugIDPK>
    <LicenceNumber>PA1448/001/001</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wockpharma Ireland Limited</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010334</DrugIDPK>
    <LicenceNumber>PA0408/054/001</LicenceNumber>
    <ProductName>BELLIMCOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010335</DrugIDPK>
    <LicenceNumber>PA0408/054/002</LicenceNumber>
    <ProductName>BELLIMCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033019</DrugIDPK>
    <LicenceNumber>PPA1328/059/004</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN (AS CALCIUM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029046</DrugIDPK>
    <LicenceNumber>PPA1447/032/001</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030395</DrugIDPK>
    <LicenceNumber>PPA1562/010/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030396</DrugIDPK>
    <LicenceNumber>PPA1562/010/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030397</DrugIDPK>
    <LicenceNumber>PPA1562/010/004</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009023</DrugIDPK>
    <LicenceNumber>PA0960/001/001</LicenceNumber>
    <ProductName>PHOTOFRIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Axcan Pharma International B.V.</PAHolder>
    <AuthorisedDate>2000-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PORFIMER SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027200</DrugIDPK>
    <LicenceNumber>PPA1447/019/001</LicenceNumber>
    <ProductName>ACULAR</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOROLAC TROMETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034306</DrugIDPK>
    <LicenceNumber>PPA1447/085/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008150</DrugIDPK>
    <LicenceNumber>PA0167/103/001</LicenceNumber>
    <ProductName>MONOSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Haemofiltration</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008153</DrugIDPK>
    <LicenceNumber>PA0167/104/001</LicenceNumber>
    <ProductName>MONOSOL-K WITH 2 MEQ/L POTASSIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Haemofiltration</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008154</DrugIDPK>
    <LicenceNumber>PA0167/104/002</LicenceNumber>
    <ProductName>MONOSOL-K WITH 4 MEQ/L POTASSIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Haemofiltration</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031471</DrugIDPK>
    <LicenceNumber>PPA1447/056/001</LicenceNumber>
    <ProductName>NEURONTIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028087</DrugIDPK>
    <LicenceNumber>PPA1447/016/002</LicenceNumber>
    <ProductName>SINEMET CR</ProductName>
    <Strength>50/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027332</DrugIDPK>
    <LicenceNumber>PPA1447/022/001</LicenceNumber>
    <ProductName>SPORANOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ITRACONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031819</DrugIDPK>
    <LicenceNumber>PPA1447/046/001</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031820</DrugIDPK>
    <LicenceNumber>PPA1447/046/002</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031821</DrugIDPK>
    <LicenceNumber>PPA1447/046/003</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030968</DrugIDPK>
    <LicenceNumber>PPA1447/043/001</LicenceNumber>
    <ProductName>TROSYL</ProductName>
    <Strength>283</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Nail Lacquer</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027459</DrugIDPK>
    <LicenceNumber>PPA1447/007/001</LicenceNumber>
    <ProductName>VASCACE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027460</DrugIDPK>
    <LicenceNumber>PPA1447/007/002</LicenceNumber>
    <ProductName>VASCACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027461</DrugIDPK>
    <LicenceNumber>PPA1447/007/003</LicenceNumber>
    <ProductName>VASCACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027915</DrugIDPK>
    <LicenceNumber>PPA1447/026/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027916</DrugIDPK>
    <LicenceNumber>PPA1447/026/002</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028314</DrugIDPK>
    <LicenceNumber>PPA1447/008/001</LicenceNumber>
    <ProductName>ZISPIN SOLTABS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028315</DrugIDPK>
    <LicenceNumber>PPA1447/008/003</LicenceNumber>
    <ProductName>ZISPIN SOLTABS</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028316</DrugIDPK>
    <LicenceNumber>PPA1447/008/002</LicenceNumber>
    <ProductName>ZISPIN SOLTABS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027778</DrugIDPK>
    <LicenceNumber>PPA1447/009/001</LicenceNumber>
    <ProductName>ZOMIG RAPIMELT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031218</DrugIDPK>
    <LicenceNumber>PPA1447/055/001</LicenceNumber>
    <ProductName>ZYLORIC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031219</DrugIDPK>
    <LicenceNumber>PPA1447/055/002</LicenceNumber>
    <ProductName>ZYLORIC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995033451</DrugIDPK>
    <LicenceNumber>PPA1328/140/001</LicenceNumber>
    <ProductName>FLAMAZINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFADIAZINE SILVER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031679</DrugIDPK>
    <LicenceNumber>PPA1328/131/001</LicenceNumber>
    <ProductName>LESCOL XL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029684</DrugIDPK>
    <LicenceNumber>PPA1328/001/002</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031676</DrugIDPK>
    <LicenceNumber>PPA1328/129/001</LicenceNumber>
    <ProductName>SALAZOPYRIN EN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035261</DrugIDPK>
    <LicenceNumber>DPR1473/060/002</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035262</DrugIDPK>
    <LicenceNumber>DPR1473/060/003</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035263</DrugIDPK>
    <LicenceNumber>DPR1473/060/004</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035264</DrugIDPK>
    <LicenceNumber>DPR1473/060/005</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035529</DrugIDPK>
    <LicenceNumber>PA0822/051/001</LicenceNumber>
    <ProductName>TOPIRAMATE PFIZER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035530</DrugIDPK>
    <LicenceNumber>PA0822/051/002</LicenceNumber>
    <ProductName>TOPIRAMATE PFIZER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035531</DrugIDPK>
    <LicenceNumber>PA0822/051/003</LicenceNumber>
    <ProductName>TOPIRAMATE PFIZER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035532</DrugIDPK>
    <LicenceNumber>PA0822/051/004</LicenceNumber>
    <ProductName>TOPIRAMATE PFIZER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995035060</DrugIDPK>
    <LicenceNumber>PA1704/001/001</LicenceNumber>
    <ProductName>LATANOPROST/TIMOLOL NORMON</ProductName>
    <Strength>50 /5.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratorios Normon S.A.</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019116</DrugIDPK>
    <LicenceNumber>PA0540/138/005</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019117</DrugIDPK>
    <LicenceNumber>PA0540/138/006</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019118</DrugIDPK>
    <LicenceNumber>PA0540/138/007</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019119</DrugIDPK>
    <LicenceNumber>PA0540/138/008</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024976</DrugIDPK>
    <LicenceNumber>PA0408/065/001</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024976</DrugIDPK>
    <LicenceNumber>PA0408/065/001</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024977</DrugIDPK>
    <LicenceNumber>PA0408/065/002</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024977</DrugIDPK>
    <LicenceNumber>PA0408/065/002</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024978</DrugIDPK>
    <LicenceNumber>PA0408/065/003</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024978</DrugIDPK>
    <LicenceNumber>PA0408/065/003</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024979</DrugIDPK>
    <LicenceNumber>PA0408/065/004</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024979</DrugIDPK>
    <LicenceNumber>PA0408/065/004</LicenceNumber>
    <ProductName>RANGABAX</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021755</DrugIDPK>
    <LicenceNumber>PA1301/002/001</LicenceNumber>
    <ProductName>INDOCID PDA 1 MG POWDER FOR SOLUTION FOR INJECTION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>2006-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN SODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032793</DrugIDPK>
    <LicenceNumber>PA0312/021/001</LicenceNumber>
    <ProductName>MAXOLON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032794</DrugIDPK>
    <LicenceNumber>PA0312/021/002</LicenceNumber>
    <ProductName>MAXOLON PAEDIATRIC LIQUID</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027714</DrugIDPK>
    <LicenceNumber>PPA1447/025/001</LicenceNumber>
    <ProductName>OXIS TURBOHALER</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027715</DrugIDPK>
    <LicenceNumber>PPA1447/025/002</LicenceNumber>
    <ProductName>OXIS TURBOHALER</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMATRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022415</DrugIDPK>
    <LicenceNumber>PA0711/124/006</LicenceNumber>
    <ProductName>ROLYPREXA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011110</DrugIDPK>
    <LicenceNumber>PA0540/080/003</LicenceNumber>
    <ProductName>TRENTAL 400 MG MODIFIED-RELEASE, COATED TABLETS.</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1977-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006175</DrugIDPK>
    <LicenceNumber>PA0414/001/002</LicenceNumber>
    <ProductName>TRILOBAL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Intersan GmbH</PAHolder>
    <AuthorisedDate>1984-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GINKGO BILOBA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022795</DrugIDPK>
    <LicenceNumber>PA1332/019/001</LicenceNumber>
    <ProductName>ACUPAN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFOPAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031245</DrugIDPK>
    <LicenceNumber>PA0577/125/002</LicenceNumber>
    <ProductName>AMISULPRIDE MYLAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001102</DrugIDPK>
    <LicenceNumber>PA0172/004/007</LicenceNumber>
    <ProductName>ANIALL 500 / 50 MG TABLETS</ProductName>
    <Strength>500/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031757</DrugIDPK>
    <LicenceNumber>PA0822/026/001</LicenceNumber>
    <ProductName>FUROSEMIDE PFIZER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2011-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030531</DrugIDPK>
    <LicenceNumber>PA0623/012/003</LicenceNumber>
    <ProductName>GEMCITABINE MEDAC</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029909</DrugIDPK>
    <LicenceNumber>PA0623/012/002</LicenceNumber>
    <ProductName>GEMCITABINE MEDAC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027303</DrugIDPK>
    <LicenceNumber>PA0623/012/001</LicenceNumber>
    <ProductName>GEMCITABINE MEDAC</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023205</DrugIDPK>
    <LicenceNumber>PA0915/015/001</LicenceNumber>
    <ProductName>BICALINN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017499</DrugIDPK>
    <LicenceNumber>PA0915/009/004</LicenceNumber>
    <ProductName>BYTRITE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017494</DrugIDPK>
    <LicenceNumber>PA0915/009/001</LicenceNumber>
    <ProductName>BYTRITE 1.25MG CAPSULES</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015809</DrugIDPK>
    <LicenceNumber>PA0030/018/001</LicenceNumber>
    <ProductName>EURAX HC</ProductName>
    <Strength>10/0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROTAMITON</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Following conditions apply: Hydrocortisone maximum strength 1%; maximum pack size: 15 g; Limited indications: contact dermatitis, irritant dermatitis, insect bite reactions and mild to moderate eczema</SupplyComments>
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001733</DrugIDPK>
    <LicenceNumber>PA0030/014/001</LicenceNumber>
    <ProductName>EURAX HYDROCORTISONE CREAM</ProductName>
    <Strength>10/0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1988-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROTAMITON</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019347</DrugIDPK>
    <LicenceNumber>PA0577/064/002</LicenceNumber>
    <ProductName>ISOTRETINOIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019348</DrugIDPK>
    <LicenceNumber>PA0577/064/003</LicenceNumber>
    <ProductName>ISOTRETINOIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019388</DrugIDPK>
    <LicenceNumber>PA0577/064/001</LicenceNumber>
    <ProductName>ISOTRETINOIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030552</DrugIDPK>
    <LicenceNumber>PA1547/003/001</LicenceNumber>
    <ProductName>PROSTAP SR 3.75 MG POWDER AND SOLVENT FOR PROLONGE</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda UK Limited</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUPRORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029488</DrugIDPK>
    <LicenceNumber>PA0915/022/001</LicenceNumber>
    <ProductName>TOPIRAXE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029489</DrugIDPK>
    <LicenceNumber>PA0915/022/002</LicenceNumber>
    <ProductName>TOPIRAXE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029490</DrugIDPK>
    <LicenceNumber>PA0915/022/003</LicenceNumber>
    <ProductName>TOPIRAXE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029491</DrugIDPK>
    <LicenceNumber>PA0915/022/004</LicenceNumber>
    <ProductName>TOPIRAXE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2011-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027006</DrugIDPK>
    <LicenceNumber>PA0915/019/001</LicenceNumber>
    <ProductName>VALHERP</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021052</DrugIDPK>
    <LicenceNumber>PA0577/079/001</LicenceNumber>
    <ProductName>XATGER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022844</DrugIDPK>
    <LicenceNumber>PPA1151/032/001</LicenceNumber>
    <ProductName>COMBIVENT METERED AERSOL</ProductName>
    <Strength>20/100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE/SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023103</DrugIDPK>
    <LicenceNumber>PPA1151/045/002</LicenceNumber>
    <ProductName>DULCOLAX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027411</DrugIDPK>
    <LicenceNumber>PPA0565/006/001</LicenceNumber>
    <ProductName>RANITIDINE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027412</DrugIDPK>
    <LicenceNumber>PPA0565/006/002</LicenceNumber>
    <ProductName>RANITIDINE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022340</DrugIDPK>
    <LicenceNumber>PPA1328/070/001</LicenceNumber>
    <ProductName>ATROVENT 250 UDVS</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>anhyd mg/ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022341</DrugIDPK>
    <LicenceNumber>PPA1328/070/002</LicenceNumber>
    <ProductName>ATROVENT 500 UDVS</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>anhyd mg/ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020828</DrugIDPK>
    <LicenceNumber>PA0540/119/004</LicenceNumber>
    <ProductName>ORUVAIL 2.5% W/W GEL.</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029089</DrugIDPK>
    <LicenceNumber>PA1506/002/001</LicenceNumber>
    <ProductName>PARACETAMOL DOCPHARMA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Docpharma BVBA</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010738</DrugIDPK>
    <LicenceNumber>PA0540/040/001</LicenceNumber>
    <ProductName>SEMI-DAONIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022070</DrugIDPK>
    <LicenceNumber>PA0540/100/006</LicenceNumber>
    <ProductName>FLAGYL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011363</DrugIDPK>
    <LicenceNumber>PA0540/120/001</LicenceNumber>
    <ProductName>PENTACARINAT READY-TO-USE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAMIDINE ISETHIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029550</DrugIDPK>
    <LicenceNumber>PPA1328/089/001</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022342</DrugIDPK>
    <LicenceNumber>PPA1328/071/001</LicenceNumber>
    <ProductName>AXID</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIZATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022260</DrugIDPK>
    <LicenceNumber>PPA1328/067/002</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2012-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008843</DrugIDPK>
    <LicenceNumber>PA0240/022/001</LicenceNumber>
    <ProductName>AMERSCAN MEDRONATE II AGENT 6.25 MILLIGRAMS KIT FO</ProductName>
    <Strength>6.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLENE DIPHOSPHONIC ACID DI- AND TRISODIUM SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing.</SupplyComments>
    <WithdrawalDate>2012-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003051</DrugIDPK>
    <LicenceNumber>PPA0465/051/001A</LicenceNumber>
    <ProductName>KLACID</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010527</DrugIDPK>
    <LicenceNumber>EU/1/00/153/002</LicenceNumber>
    <ProductName>INFANRIX PENTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010528</DrugIDPK>
    <LicenceNumber>EU/1/00/153/003</LicenceNumber>
    <ProductName>INFANRIX PENTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010530</DrugIDPK>
    <LicenceNumber>EU/1/00/153/004</LicenceNumber>
    <ProductName>INFANRIX PENTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010531</DrugIDPK>
    <LicenceNumber>EU/1/00/153/005</LicenceNumber>
    <ProductName>INFANRIX PENTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010533</DrugIDPK>
    <LicenceNumber>EU/1/00/153/006</LicenceNumber>
    <ProductName>INFANRIX PENTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010534</DrugIDPK>
    <LicenceNumber>EU/1/00/153/007</LicenceNumber>
    <ProductName>INFANRIX PENTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008180</DrugIDPK>
    <LicenceNumber>EU/1/00/153/001</LicenceNumber>
    <ProductName>INFANRIX PENTA</ProductName>
    <Strength>5 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010535</DrugIDPK>
    <LicenceNumber>EU/1/00/153/008</LicenceNumber>
    <ProductName>INFANRIX-PENTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>2000-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028325</DrugIDPK>
    <LicenceNumber>PA1399/002/001</LicenceNumber>
    <ProductName>LETROZOLE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Caduceus Pharma Ltd</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LETROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995034712</DrugIDPK>
    <LicenceNumber>PA0361/034/001</LicenceNumber>
    <ProductName>NORADRENALINE (NOREPINEPHRINE)</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NORADRENALINE ACID TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024378</DrugIDPK>
    <LicenceNumber>PA1380/013/001</LicenceNumber>
    <ProductName>VALACICLOVIR ACTAVIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024380</DrugIDPK>
    <LicenceNumber>PA1380/013/003</LicenceNumber>
    <ProductName>VALACICLOVIR ACTAVIS</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020053</DrugIDPK>
    <LicenceNumber>PA0030/056/001</LicenceNumber>
    <ProductName>LAMISIL AT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027818</DrugIDPK>
    <LicenceNumber>EU/1/08/474/1-3</LicenceNumber>
    <ProductName>ALISADE 27.5 MICROGRAMS/SPRAY</ProductName>
    <Strength>27.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2008-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE FUROATE (MICRONISED)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028059</DrugIDPK>
    <LicenceNumber>EU/1/08/478/1</LicenceNumber>
    <ProductName>PREPANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Biologicals</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PURIFIED ANTIGEN FRACTIONS OF INACTIVATED SPLIT VIRIONS A/VIETNAM/1194/2004 NIBRG-14 (H5N1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021475</DrugIDPK>
    <LicenceNumber>PPA0465/181/001</LicenceNumber>
    <ProductName>SOLPADEINE SOLUBLE</ProductName>
    <Strength>500/8/30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021475</DrugIDPK>
    <LicenceNumber>PPA0465/181/001</LicenceNumber>
    <ProductName>SOLPADEINE SOLUBLE</ProductName>
    <Strength>500/8/30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021962</DrugIDPK>
    <LicenceNumber>PPA1328/013/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020958</DrugIDPK>
    <LicenceNumber>PA0749/020/001</LicenceNumber>
    <ProductName>LAMEUTRAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020959</DrugIDPK>
    <LicenceNumber>PA0749/020/002</LicenceNumber>
    <ProductName>LAMEUTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020960</DrugIDPK>
    <LicenceNumber>PA0749/020/003</LicenceNumber>
    <ProductName>LAMEUTRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020961</DrugIDPK>
    <LicenceNumber>PA0749/020/004</LicenceNumber>
    <ProductName>LAMEUTRAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027348</DrugIDPK>
    <LicenceNumber>PA1128/006/001</LicenceNumber>
    <ProductName>MIRTAZAPINE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Relon Chem Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020874</DrugIDPK>
    <LicenceNumber>PA0437/053/001</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020467</DrugIDPK>
    <LicenceNumber>PA0577/075/001</LicenceNumber>
    <ProductName>GLYCEMAGER 1 MG TABLETS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020468</DrugIDPK>
    <LicenceNumber>PA0577/075/002</LicenceNumber>
    <ProductName>GLYCEMAGER 2 MG TABLETS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020469</DrugIDPK>
    <LicenceNumber>PA0577/075/003</LicenceNumber>
    <ProductName>GLYCEMAGER 3 MG TABLETS</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020470</DrugIDPK>
    <LicenceNumber>PA0577/075/004</LicenceNumber>
    <ProductName>GLYCEMAGER 4 MG TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030983</DrugIDPK>
    <LicenceNumber>EU/1/10/629/001</LicenceNumber>
    <ProductName>HUMENZA (PANDEMIC INFLUENZA VACCINE H1N1)</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD</PAHolder>
    <AuthorisedDate>2010-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension and Emulsion for emulsion for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022999</DrugIDPK>
    <LicenceNumber>EU/1/08/449/1-4</LicenceNumber>
    <ProductName>FILGRASTIM RATIOPHARM 30 MU/0.5 ML SOLUTION FOR I</ProductName>
    <Strength>30/0.5</Strength>
    <StrengthMeasurement>MU/ml</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2008-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2011-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023000</DrugIDPK>
    <LicenceNumber>EU/1/08/449/5-8</LicenceNumber>
    <ProductName>FILGRASTIM RATIOPHARM 48 MIU/0.8 ML SOLUTION FOR I</ProductName>
    <Strength>48/0.8</Strength>
    <StrengthMeasurement>MU/ml</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2008-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>2011-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004653</DrugIDPK>
    <LicenceNumber>PA0179/031/001</LicenceNumber>
    <ProductName>LIPOFUNDIN MCT/LCT 10%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1991-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004656</DrugIDPK>
    <LicenceNumber>PA0179/031/004</LicenceNumber>
    <ProductName>LIPOFUNDIN MCT/LCT 20%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1991-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022915</DrugIDPK>
    <LicenceNumber>PA0540/144/001</LicenceNumber>
    <ProductName>DIASTABOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIGLITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022916</DrugIDPK>
    <LicenceNumber>PA0540/144/002</LicenceNumber>
    <ProductName>DIASTABOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIGLITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023768</DrugIDPK>
    <LicenceNumber>PA0967/009/004</LicenceNumber>
    <ProductName>VENLIFT XL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023769</DrugIDPK>
    <LicenceNumber>PA0967/009/005</LicenceNumber>
    <ProductName>VENLIFT XL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024204</DrugIDPK>
    <LicenceNumber>PA0167/130/001</LicenceNumber>
    <ProductName>CIPROFLOXACIN REDIBAG</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000040</DrugIDPK>
    <LicenceNumber>PA0677/013/001</LicenceNumber>
    <ProductName>YTTRIUM  COLLOID</ProductName>
    <Strength>37-370</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YTTRIUM [Y-90] CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>2011-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004781</DrugIDPK>
    <LicenceNumber>PA0206/029/001</LicenceNumber>
    <ProductName>AIDEX FIRST AID ANTISEPTIC</ProductName>
    <Strength>0.1,0.1,1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1993-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOACRIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>PHENOXYETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017739</DrugIDPK>
    <LicenceNumber>PA0521/008/001</LicenceNumber>
    <ProductName>ALBUMINATIV</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>1999-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017740</DrugIDPK>
    <LicenceNumber>PA0521/008/002</LicenceNumber>
    <ProductName>ALBUMINATIV</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018895</DrugIDPK>
    <LicenceNumber>PA0100/048/001</LicenceNumber>
    <ProductName>BISODOL HEARTBURN</ProductName>
    <Strength>400/200/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>2002-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGALDRATE</ActiveSubstance>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004198</DrugIDPK>
    <LicenceNumber>PA0167/017/001</LicenceNumber>
    <ProductName>DIANEAL PD1 GLUCOSE 1.36% W/V (13.6MG/ML) SOLUTION</ProductName>
    <Strength>1.36</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004199</DrugIDPK>
    <LicenceNumber>PA0167/017/002</LicenceNumber>
    <ProductName>DIANEAL PD1 GLUCOSE 3.86% W/V (38.6 MG/ML) SOLUTIO</ProductName>
    <Strength>3.86</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018926</DrugIDPK>
    <LicenceNumber>PA0108/028/001</LicenceNumber>
    <ProductName>INVIVAC 2005/2006</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>2004-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/7/2004 (H3N2) – LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>A/NEW CALEDONIA/20/99 (H1H1)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/SHANGHAI/361/2002 – LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020582</DrugIDPK>
    <LicenceNumber>PA1241/004/001</LicenceNumber>
    <ProductName>LOCOID C</ProductName>
    <Strength>0.1 %w/w,</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE BUTYRATE</ActiveSubstance>
      <ActiveSubstance>CHLORQUINALDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020583</DrugIDPK>
    <LicenceNumber>PA1241/004/002</LicenceNumber>
    <ProductName>LOCOID C</ProductName>
    <Strength>0.1/3.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE BUTYRATE</ActiveSubstance>
      <ActiveSubstance>CHLORQUINALDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006728</DrugIDPK>
    <LicenceNumber>PA0521/002/007</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 200G/L</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>g/l</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALBUMIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017787</DrugIDPK>
    <LicenceNumber>PA0585/011/002</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <Strength>500mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2006-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017791</DrugIDPK>
    <LicenceNumber>PA0585/011/001</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <Strength>250mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2006-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004138</DrugIDPK>
    <LicenceNumber>PA0167/009/018</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION BP 10% W/V</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031220</DrugIDPK>
    <LicenceNumber>PPA1447/034/002</LicenceNumber>
    <ProductName>KLACID</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027622</DrugIDPK>
    <LicenceNumber>PPA1447/018/001</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027624</DrugIDPK>
    <LicenceNumber>PPA1447/018/003</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014687</DrugIDPK>
    <LicenceNumber>EU/1/03/259/1-6</LicenceNumber>
    <ProductName>ONSENAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia-Pfizer EEIG</PAHolder>
    <AuthorisedDate>2003-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031486</DrugIDPK>
    <LicenceNumber>PPA1447/049/001</LicenceNumber>
    <ProductName>SAVLON ANTISEPTIC</ProductName>
    <Strength>0.5/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031507</DrugIDPK>
    <LicenceNumber>PPA1447/062/002</LicenceNumber>
    <ProductName>VOLTAROL RETARD</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031504</DrugIDPK>
    <LicenceNumber>PPA1447/061/001</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031505</DrugIDPK>
    <LicenceNumber>PPA1447/061/002</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020696</DrugIDPK>
    <LicenceNumber>PPA0465/078/007</LicenceNumber>
    <ProductName>RISPERDAL QUICKLET</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006720</DrugIDPK>
    <LicenceNumber>PA0521/002/001</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 50G/L</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>g/l</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALBUMIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021889</DrugIDPK>
    <LicenceNumber>PPA1328/044/001</LicenceNumber>
    <ProductName>ACCOLATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZAFIRLUKAST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021901</DrugIDPK>
    <LicenceNumber>PPA1328/048/002</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021625</DrugIDPK>
    <LicenceNumber>PPA1328/019/001</LicenceNumber>
    <ProductName>BECONASE AQUEOUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022246</DrugIDPK>
    <LicenceNumber>PPA1328/020/002</LicenceNumber>
    <ProductName>BETALOC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021928</DrugIDPK>
    <LicenceNumber>PPA1328/053/001</LicenceNumber>
    <ProductName>BETALOC</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021948</DrugIDPK>
    <LicenceNumber>PPA1328/056/001</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021943</DrugIDPK>
    <LicenceNumber>PPA1328/057/001</LicenceNumber>
    <ProductName>CELEBREX 100 MG CAPSULES.</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021621</DrugIDPK>
    <LicenceNumber>PPA1328/022/001</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021951</DrugIDPK>
    <LicenceNumber>PPA1328/060/001</LicenceNumber>
    <ProductName>DAONIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021939</DrugIDPK>
    <LicenceNumber>PPA1328/061/001</LicenceNumber>
    <ProductName>DETRUSITOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021940</DrugIDPK>
    <LicenceNumber>PPA1328/061/002</LicenceNumber>
    <ProductName>DETRUSITOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021925</DrugIDPK>
    <LicenceNumber>PPA1328/010/002</LicenceNumber>
    <ProductName>DIAMICRON MR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021464</DrugIDPK>
    <LicenceNumber>PPA1328/009/001</LicenceNumber>
    <ProductName>IMDUR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021462</DrugIDPK>
    <LicenceNumber>PPA1328/006/001</LicenceNumber>
    <ProductName>LIVIAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIBOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021947</DrugIDPK>
    <LicenceNumber>PPA1328/062/001</LicenceNumber>
    <ProductName>SOLARAZE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021460</DrugIDPK>
    <LicenceNumber>PPA1328/008/001</LicenceNumber>
    <ProductName>ZYDOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003920</DrugIDPK>
    <LicenceNumber>PA0618/020/001</LicenceNumber>
    <ProductName>WOODWARDS GRIPE WATER ALCOHOL FREE</ProductName>
    <Strength>0.69mg/5ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>DILL SEED OIL TERPENELESS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031260</DrugIDPK>
    <LicenceNumber>PPA1447/048/001</LicenceNumber>
    <ProductName>GERMOLENE FIRST AID</ProductName>
    <Strength>1.2/0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE DIGLUCONATE (AS CHLORHEXIDINE DIGLUCONATE SOLUTION (20% W/V) PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007156</DrugIDPK>
    <LicenceNumber>PA0913/005/005</LicenceNumber>
    <ProductName>MST CONTINUS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1995-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. 328 of 1988)</SupplyComments>
    <WithdrawalDate>2011-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028417</DrugIDPK>
    <LicenceNumber>PPA1473/002/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028418</DrugIDPK>
    <LicenceNumber>PPA1473/002/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028419</DrugIDPK>
    <LicenceNumber>PPA1473/002/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022542</DrugIDPK>
    <LicenceNumber>PA1350/002/001</LicenceNumber>
    <ProductName>SORBISTERIT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Nephrologica Deutschland GmbH</PAHolder>
    <AuthorisedDate>2007-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM POLYSTYRENE SULFONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011760</DrugIDPK>
    <LicenceNumber>PA0913/014/008</LicenceNumber>
    <ProductName>ADIZEM-XL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2002-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021432</DrugIDPK>
    <LicenceNumber>PA0585/023/001</LicenceNumber>
    <ProductName>IMITAG</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021433</DrugIDPK>
    <LicenceNumber>PA0585/023/002</LicenceNumber>
    <ProductName>IMITAG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020854</DrugIDPK>
    <LicenceNumber>PA0749/018/001</LicenceNumber>
    <ProductName>MODAFINIL TEVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MODAFINIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005442</DrugIDPK>
    <LicenceNumber>PA0261/029/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022921</DrugIDPK>
    <LicenceNumber>PA0521/010/001</LicenceNumber>
    <ProductName>NANOTIV</ProductName>
    <Strength>500IU</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022922</DrugIDPK>
    <LicenceNumber>PA0521/010/002</LicenceNumber>
    <ProductName>NANOTIV</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032299</DrugIDPK>
    <LicenceNumber>PPA1328/131/002</LicenceNumber>
    <ProductName>LESCOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032300</DrugIDPK>
    <LicenceNumber>PPA1328/131/003</LicenceNumber>
    <ProductName>LESCOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021622</DrugIDPK>
    <LicenceNumber>PPA1328/021/001</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE’</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024505</DrugIDPK>
    <LicenceNumber>PA1130/013/004</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024505</DrugIDPK>
    <LicenceNumber>PA1130/013/004</LicenceNumber>
    <ProductName>FAMLOV</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023317</DrugIDPK>
    <LicenceNumber>PA0863/007/001</LicenceNumber>
    <ProductName>MOOV HEAD LICE</ProductName>
    <Strength>11.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>2008-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EUCALYPTUS GLOBULUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021624</DrugIDPK>
    <LicenceNumber>PPA1328/020/001</LicenceNumber>
    <ProductName>BETALOC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021623</DrugIDPK>
    <LicenceNumber>PPA1328/021/002</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021619</DrugIDPK>
    <LicenceNumber>PPA1328/023/001</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021617</DrugIDPK>
    <LicenceNumber>PPA1328/025/001</LicenceNumber>
    <ProductName>IKOREL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICORANDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021469</DrugIDPK>
    <LicenceNumber>PPA1328/001/001</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024376</DrugIDPK>
    <LicenceNumber>PA0749/058/001</LicenceNumber>
    <ProductName>TEVARYL 4MG TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024377</DrugIDPK>
    <LicenceNumber>PA0749/058/002</LicenceNumber>
    <ProductName>TEVARYL 8MG TABLETS</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ERBUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011204</DrugIDPK>
    <LicenceNumber>PA0936/011/002</LicenceNumber>
    <ProductName>ZYVOX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINEZOLID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020304</DrugIDPK>
    <LicenceNumber>PA1058/008/006</LicenceNumber>
    <ProductName>ZAMADOL</ProductName>
    <Strength>100mg/2ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>MEDA Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2011-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031512</DrugIDPK>
    <LicenceNumber>PPA0465/173/003</LicenceNumber>
    <ProductName>ATROVENT 250 UDVS 250 MICROGRAMS/ 1ML NEBULISER SOLUTION</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010518</DrugIDPK>
    <LicenceNumber>PPA0465/072/001A</LicenceNumber>
    <ProductName>BECONASE 50 MICROGRAMS AQUEOUS NASAL SPRAY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002204</DrugIDPK>
    <LicenceNumber>PPA0465/043/001A</LicenceNumber>
    <ProductName>CAPOZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021403</DrugIDPK>
    <LicenceNumber>PPA0465/179/002</LicenceNumber>
    <ProductName>DELTACORTRIL ENTERIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015193</DrugIDPK>
    <LicenceNumber>PPA0465/045/002A</LicenceNumber>
    <ProductName>DIAMICRON MR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014827</DrugIDPK>
    <LicenceNumber>PPA0465/085/002A</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003530</DrugIDPK>
    <LicenceNumber>PPA0465/054/001A</LicenceNumber>
    <ProductName>LIORESAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1994-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BACLOFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017835</DrugIDPK>
    <LicenceNumber>PPA0465/112/002A</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003053</DrugIDPK>
    <LicenceNumber>PPA0465/031/004A</LicenceNumber>
    <ProductName>NAPROSYN EC 500MG TABLETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030117</DrugIDPK>
    <LicenceNumber>PPA0465/219/001</LicenceNumber>
    <ProductName>NATRILIX SR</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018868</DrugIDPK>
    <LicenceNumber>PPA0465/133/001A</LicenceNumber>
    <ProductName>NOLVADEX D</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025453</DrugIDPK>
    <LicenceNumber>PPA0465/208/001</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025454</DrugIDPK>
    <LicenceNumber>PPA0465/208/002</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020933</DrugIDPK>
    <LicenceNumber>PPA0465/174/001</LicenceNumber>
    <ProductName>REQUIP</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020934</DrugIDPK>
    <LicenceNumber>PPA0465/174/002</LicenceNumber>
    <ProductName>REQUIP</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020935</DrugIDPK>
    <LicenceNumber>PPA0465/174/003</LicenceNumber>
    <ProductName>REQUIP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018207</DrugIDPK>
    <LicenceNumber>PPA0465/121/002A</LicenceNumber>
    <ProductName>SELECTOL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018209</DrugIDPK>
    <LicenceNumber>PPA0465/121/001A</LicenceNumber>
    <ProductName>SELECTOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020431</DrugIDPK>
    <LicenceNumber>PPA0465/005/002</LicenceNumber>
    <ProductName>SERC</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012292</DrugIDPK>
    <LicenceNumber>PPA0465/005/001A</LicenceNumber>
    <ProductName>SERC</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030897</DrugIDPK>
    <LicenceNumber>PPA0465/055/003</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030898</DrugIDPK>
    <LicenceNumber>PPA0465/238/001</LicenceNumber>
    <ProductName>STEMETIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022417</DrugIDPK>
    <LicenceNumber>PPA0465/064/002</LicenceNumber>
    <ProductName>VENTOLIN NEBULES</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018208</DrugIDPK>
    <LicenceNumber>PPA0465/123/001A</LicenceNumber>
    <ProductName>ZINNAT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020364</DrugIDPK>
    <LicenceNumber>PPA0465/123/002</LicenceNumber>
    <ProductName>ZINNAT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020168</DrugIDPK>
    <LicenceNumber>PPA0465/113/003</LicenceNumber>
    <ProductName>ZOFRAN ZYDIS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020169</DrugIDPK>
    <LicenceNumber>PPA0465/113/004</LicenceNumber>
    <ProductName>ZOFRAN ZYDIS</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015194</DrugIDPK>
    <LicenceNumber>PPA0465/089/001A</LicenceNumber>
    <ProductName>ZYBAN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMFEBUTAMONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000462</DrugIDPK>
    <LicenceNumber>PA0007/015/004</LicenceNumber>
    <ProductName>ALUPENT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027552</DrugIDPK>
    <LicenceNumber>PA0585/037/001</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027553</DrugIDPK>
    <LicenceNumber>PA0585/037/002</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027554</DrugIDPK>
    <LicenceNumber>PA0585/037/003</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027555</DrugIDPK>
    <LicenceNumber>PA0585/037/004</LicenceNumber>
    <ProductName>ESCITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020362</DrugIDPK>
    <LicenceNumber>PPA0465/167/001</LicenceNumber>
    <ProductName>FLIXONASE AQUEOUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030103</DrugIDPK>
    <LicenceNumber>PA1380/075/001</LicenceNumber>
    <ProductName>GLICLAZIDE ACTAVIS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029903</DrugIDPK>
    <LicenceNumber>PA1505/003/001</LicenceNumber>
    <ProductName>SEGLICOL MR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>ESP Pharma Limited</PAHolder>
    <AuthorisedDate>2010-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027357</DrugIDPK>
    <LicenceNumber>PA1161/006/001</LicenceNumber>
    <ProductName>SUSTAC</ProductName>
    <Strength>2.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chemidex Pharma Limited</PAHolder>
    <AuthorisedDate>2008-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027358</DrugIDPK>
    <LicenceNumber>PA1161/006/002</LicenceNumber>
    <ProductName>SUSTAC</ProductName>
    <Strength>6.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chemidex Pharma Limited</PAHolder>
    <AuthorisedDate>2008-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012097</DrugIDPK>
    <LicenceNumber>PA0577/045/001</LicenceNumber>
    <ProductName>CEFAGER</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2002-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012098</DrugIDPK>
    <LicenceNumber>PA0577/045/002</LicenceNumber>
    <ProductName>CEFAGER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2002-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026867</DrugIDPK>
    <LicenceNumber>PA0585/036/001</LicenceNumber>
    <ProductName>ANASTROZOLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020060</DrugIDPK>
    <LicenceNumber>PA0585/018/001</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020061</DrugIDPK>
    <LicenceNumber>PA0585/018/002</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020062</DrugIDPK>
    <LicenceNumber>PA0585/018/003</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022715</DrugIDPK>
    <LicenceNumber>PA0749/043/001</LicenceNumber>
    <ProductName>FLUVASTATIN TEVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022716</DrugIDPK>
    <LicenceNumber>PA0749/043/002</LicenceNumber>
    <ProductName>FLUVASTATIN TEVA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026366</DrugIDPK>
    <LicenceNumber>PA0585/034/001</LicenceNumber>
    <ProductName>GABAPENTIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026367</DrugIDPK>
    <LicenceNumber>PA0585/034/002</LicenceNumber>
    <ProductName>GABAPENTIN</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019464</DrugIDPK>
    <LicenceNumber>PA1077/106/001</LicenceNumber>
    <ProductName>ADARTREL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019465</DrugIDPK>
    <LicenceNumber>PA1077/106/002</LicenceNumber>
    <ProductName>ADARTREL</ProductName>
    <Strength>0.50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019467</DrugIDPK>
    <LicenceNumber>PA1077/106/004</LicenceNumber>
    <ProductName>ADARTREL</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010498</DrugIDPK>
    <LicenceNumber>PA0540/032/001</LicenceNumber>
    <ProductName>BATRAFEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX OLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029416</DrugIDPK>
    <LicenceNumber>PA0540/032/006</LicenceNumber>
    <ProductName>BATRAFEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX OLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016186</DrugIDPK>
    <LicenceNumber>PA1077/049/013</LicenceNumber>
    <ProductName>VENTOLIN</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016187</DrugIDPK>
    <LicenceNumber>PA1077/049/014</LicenceNumber>
    <ProductName>VENTOLIN</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016189</DrugIDPK>
    <LicenceNumber>PA1077/049/006</LicenceNumber>
    <ProductName>VENTOLIN RESPIRATOR SOLUTION</ProductName>
    <Strength>5mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006538</DrugIDPK>
    <LicenceNumber>PA0471/011/001</LicenceNumber>
    <ProductName>POTTER’S SKIN CLEAR OINTMENT</ProductName>
    <Strength>17/5/23%w/</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Potters (Herbal Supplies) Ltd</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STARCH</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013848</DrugIDPK>
    <LicenceNumber>PA0970/030/001</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2002-04-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019121</DrugIDPK>
    <LicenceNumber>PA0970/030/005</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016206</DrugIDPK>
    <LicenceNumber>PA1077/054/001</LicenceNumber>
    <ProductName>CICATRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016208</DrugIDPK>
    <LicenceNumber>PA1077/054/002</LicenceNumber>
    <ProductName>CICATRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013876</DrugIDPK>
    <LicenceNumber>PA0970/041/001</LicenceNumber>
    <ProductName>IMDUR PROLONGED-RELEASE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011660</DrugIDPK>
    <LicenceNumber>PA0970/018/006</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2002-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030514</DrugIDPK>
    <LicenceNumber>PA1380/077/003</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030516</DrugIDPK>
    <LicenceNumber>PA1380/077/002</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027551</DrugIDPK>
    <LicenceNumber>PA1380/035/004</LicenceNumber>
    <ProductName>ZOLMILES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002536</DrugIDPK>
    <LicenceNumber>PA0054/064/002</LicenceNumber>
    <ProductName>NUTRIZYM 10,000</ProductName>
    <Strength>155</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002537</DrugIDPK>
    <LicenceNumber>PA0054/064/003</LicenceNumber>
    <ProductName>NUTRIZYM 22,000</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017821</DrugIDPK>
    <LicenceNumber>PA0329/009/001</LicenceNumber>
    <ProductName>PECTODRILL FOR CHESTY COUGHS</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017827</DrugIDPK>
    <LicenceNumber>PA0329/009/003</LicenceNumber>
    <ProductName>TUSSIDRILL SUGAR-FREE FOR DRY COUGHS</ProductName>
    <Strength>15mg/5ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018886</DrugIDPK>
    <LicenceNumber>PA0805/002/005</LicenceNumber>
    <ProductName>LEXAPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001913</DrugIDPK>
    <LicenceNumber>PA0007/052/001</LicenceNumber>
    <ProductName>COMBIVENT METERED AEROSOL 20 MICROGRAMS/100 MICROG</ProductName>
    <Strength>20/100</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1994-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026578</DrugIDPK>
    <LicenceNumber>PA1441/002/001</LicenceNumber>
    <ProductName>MONURIL</ProductName>
    <Strength>2g</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Zambon S.p.A.</PAHolder>
    <AuthorisedDate>2007-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOSFOMYCIN TROMETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028509</DrugIDPK>
    <LicenceNumber>PA0711/167/001</LicenceNumber>
    <ProductName>CLOPIDOGREL ROWEX</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019871</DrugIDPK>
    <LicenceNumber>PPA0465/157/001</LicenceNumber>
    <ProductName>PANADOL EXTRA</ProductName>
    <Strength>500/65</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in blister packs containing not more than 12 unit dosage forms.   The product concerned should contain paracetamol as its only active analgesic substance and only one pack should be supplied in the course of any one retail transaction.

Promotion to the general public for packs containing not more than 24 unit dosage forms.</SupplyComments>
    <WithdrawalDate>2010-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019671</DrugIDPK>
    <LicenceNumber>PA0100/047/003</LicenceNumber>
    <ProductName>BISODOL ANTACID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM HYDROGEN CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE LIGHT</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE HEAVY</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021944</DrugIDPK>
    <LicenceNumber>PA0585/025/001</LicenceNumber>
    <ProductName>FOSALEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2006-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029916</DrugIDPK>
    <LicenceNumber>PPA1328/109/001</LicenceNumber>
    <ProductName>NOLVADEX D</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028972</DrugIDPK>
    <LicenceNumber>PPA1463/013/001</LicenceNumber>
    <ProductName>PROSCAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022236</DrugIDPK>
    <LicenceNumber>PA0967/009/001</LicenceNumber>
    <ProductName>VENLIFT</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022237</DrugIDPK>
    <LicenceNumber>PA0967/009/002</LicenceNumber>
    <ProductName>VENLIFT</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017996</DrugIDPK>
    <LicenceNumber>PA0436/034/001</LicenceNumber>
    <ProductName>AEROLIN AUTOHALER CFC-FREE 100 MICROGRAMS PER METE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2002-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017995</DrugIDPK>
    <LicenceNumber>PA0436/033/002</LicenceNumber>
    <ProductName>AIROMIR AUTOHALER 100 MICROGRAMS PER METERED DOSE,</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2002-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007993</DrugIDPK>
    <LicenceNumber>PA0007/033/005</LicenceNumber>
    <ProductName>BEROTEC 100 INHALER CFC-FREE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008362</DrugIDPK>
    <LicenceNumber>PA0915/001/003</LicenceNumber>
    <ProductName>MESULID</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIMESULIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020723</DrugIDPK>
    <LicenceNumber>PA1267/001/001</LicenceNumber>
    <ProductName>KETAMINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>hameln pharma r&amp;d gmbh</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020725</DrugIDPK>
    <LicenceNumber>PA1267/001/003</LicenceNumber>
    <ProductName>KETAMINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>hameln pharma r&amp;d gmbh</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020726</DrugIDPK>
    <LicenceNumber>PA1267/001/004</LicenceNumber>
    <ProductName>KETAMINE MULTIDOSE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>hameln pharma r&amp;d gmbh</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020724</DrugIDPK>
    <LicenceNumber>PA1267/001/002</LicenceNumber>
    <ProductName>KETAMINE MULTIDOSE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>hameln pharma r&amp;d gmbh</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005254</DrugIDPK>
    <LicenceNumber>PA0167/096/003</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION BP</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023889</DrugIDPK>
    <LicenceNumber>PA1410/014/001</LicenceNumber>
    <ProductName>ALLURENE</ProductName>
    <Strength>1, 2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029520</DrugIDPK>
    <LicenceNumber>PPA1473/015/001</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CO-AMOXICLAV</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029599</DrugIDPK>
    <LicenceNumber>PPA1473/017/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030855</DrugIDPK>
    <LicenceNumber>PPA1473/031/001</LicenceNumber>
    <ProductName>DIAMICRON MR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028522</DrugIDPK>
    <LicenceNumber>PPA1473/010/001</LicenceNumber>
    <ProductName>NIZORAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028445</DrugIDPK>
    <LicenceNumber>PPA1473/008/001</LicenceNumber>
    <ProductName>PROSCAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028434</DrugIDPK>
    <LicenceNumber>PPA1473/003/001</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028435</DrugIDPK>
    <LicenceNumber>PPA1473/003/002</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030852</DrugIDPK>
    <LicenceNumber>PPA1473/036/001</LicenceNumber>
    <ProductName>ZYDOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000311</DrugIDPK>
    <LicenceNumber>PA0002/023/001</LicenceNumber>
    <ProductName>KENALOG</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017666</DrugIDPK>
    <LicenceNumber>PPA1071/011/001A</LicenceNumber>
    <ProductName>BECONASE AQUEOUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015427</DrugIDPK>
    <LicenceNumber>PPA1071/003/001A</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2002-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015464</DrugIDPK>
    <LicenceNumber>PPA1071/005/001A</LicenceNumber>
    <ProductName>IMDUR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2002-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015456</DrugIDPK>
    <LicenceNumber>PPA1071/004/001A</LicenceNumber>
    <ProductName>SEREVENT INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017609</DrugIDPK>
    <LicenceNumber>PPA1071/007/001A</LicenceNumber>
    <ProductName>VENTOLIN EVOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017646</DrugIDPK>
    <LicenceNumber>PPA1071/009/002A</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017645</DrugIDPK>
    <LicenceNumber>PPA1071/009/001A</LicenceNumber>
    <ProductName>ZANTAC TABLETS 150 MG</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015394</DrugIDPK>
    <LicenceNumber>PPA1071/002/001A</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015395</DrugIDPK>
    <LicenceNumber>PPA1071/002/001B</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015396</DrugIDPK>
    <LicenceNumber>PPA1071/002/002A</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021766</DrugIDPK>
    <LicenceNumber>PA1260/004/001</LicenceNumber>
    <ProductName>DOPACARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Cephalon Limited</PAHolder>
    <AuthorisedDate>2006-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOPEXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029760</DrugIDPK>
    <LicenceNumber>PPA1463/021/001</LicenceNumber>
    <ProductName>LOSEC MUPS 10MG GASTRO-RESISTANT TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029598</DrugIDPK>
    <LicenceNumber>PPA1473/019/001</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031950</DrugIDPK>
    <LicenceNumber>PPA1473/019/003</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030975</DrugIDPK>
    <LicenceNumber>PPA1473/019/002</LicenceNumber>
    <ProductName>LOSEC MUPS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021222</DrugIDPK>
    <LicenceNumber>PA0030/021/011</LicenceNumber>
    <ProductName>NCH 14 MG/24 HOURS TRANSDERMAL PATCH</ProductName>
    <Strength>14</Strength>
    <StrengthMeasurement>mg/24 hours</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021223</DrugIDPK>
    <LicenceNumber>PA0030/021/012</LicenceNumber>
    <ProductName>NCH 21 MG/24 HOURS TRANSDERMAL PATCH</ProductName>
    <Strength>21</Strength>
    <StrengthMeasurement>mg/24 hours</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021221</DrugIDPK>
    <LicenceNumber>PA0030/021/010</LicenceNumber>
    <ProductName>NCH 7 MG/24 HOURS TRANSDERMAL PATCH</ProductName>
    <Strength>7</Strength>
    <StrengthMeasurement>mg/24 hours</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023770</DrugIDPK>
    <LicenceNumber>PA0967/017/001</LicenceNumber>
    <ProductName>VELEXOR</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023767</DrugIDPK>
    <LicenceNumber>PA0967/009/003</LicenceNumber>
    <ProductName>VENLIFT XL</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017994</DrugIDPK>
    <LicenceNumber>PA0436/033/001</LicenceNumber>
    <ProductName>AIROMIR INHALER 100 MICROGRAMS PER METERED DOSE PR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2000-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009257</DrugIDPK>
    <LicenceNumber>PPA0465/063/002A</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024641</DrugIDPK>
    <LicenceNumber>PA0585/032/001</LicenceNumber>
    <ProductName>EIRONIL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024642</DrugIDPK>
    <LicenceNumber>PA0585/032/002</LicenceNumber>
    <ProductName>EIRONIL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024643</DrugIDPK>
    <LicenceNumber>PA0585/032/003</LicenceNumber>
    <ProductName>EIRONIL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024644</DrugIDPK>
    <LicenceNumber>PA0585/032/004</LicenceNumber>
    <ProductName>EIRONIL</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024645</DrugIDPK>
    <LicenceNumber>PA0585/032/005</LicenceNumber>
    <ProductName>EIRONIL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027171</DrugIDPK>
    <LicenceNumber>PA0749/074/001</LicenceNumber>
    <ProductName>ROPINIROLE TEVA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027172</DrugIDPK>
    <LicenceNumber>PA0749/074/002</LicenceNumber>
    <ProductName>ROPINIROLE TEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027173</DrugIDPK>
    <LicenceNumber>PA0749/074/003</LicenceNumber>
    <ProductName>ROPINIROLE TEVA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011133</DrugIDPK>
    <LicenceNumber>PA0540/085/001</LicenceNumber>
    <ProductName>TRITAZIDE</ProductName>
    <Strength>2.5/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2000-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011133</DrugIDPK>
    <LicenceNumber>PA0540/085/001</LicenceNumber>
    <ProductName>TRITAZIDE</ProductName>
    <Strength>2.5/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2000-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006269</DrugIDPK>
    <LicenceNumber>PA0417/001/001</LicenceNumber>
    <ProductName>MAXEPA</ProductName>
    <Strength>170/115</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EICOSAPENTAENOIC ACID</ActiveSubstance>
      <ActiveSubstance>DOCOSAHEXANOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006270</DrugIDPK>
    <LicenceNumber>PA0417/001/002</LicenceNumber>
    <ProductName>MAXEPA LIQUID</ProductName>
    <Strength>780/530</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EICOSAPENTAENOIC ACID</ActiveSubstance>
      <ActiveSubstance>DOCOSAHEXANOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023124</DrugIDPK>
    <LicenceNumber>PA0966/017/001</LicenceNumber>
    <ProductName>BEXMIRT</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023125</DrugIDPK>
    <LicenceNumber>PA0966/017/002</LicenceNumber>
    <ProductName>BEXMIRT</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023126</DrugIDPK>
    <LicenceNumber>PA0966/017/003</LicenceNumber>
    <ProductName>BEXMIRT</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020190</DrugIDPK>
    <LicenceNumber>PA0590/022/001</LicenceNumber>
    <ProductName>ETRIVEX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>2005-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBETASOL PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003784</DrugIDPK>
    <LicenceNumber>PA0118/012/002</LicenceNumber>
    <ProductName>MINIMS CYCLOPENTOLATE HYDROCHLORIDE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTOLATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013283</DrugIDPK>
    <LicenceNumber>PA0899/017/002</LicenceNumber>
    <ProductName>BECLO-RHINO ALLERGY</ProductName>
    <Strength>50mcg/dose</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004258</DrugIDPK>
    <LicenceNumber>PA0282/070/001</LicenceNumber>
    <ProductName>CARDILATE 10MG</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004259</DrugIDPK>
    <LicenceNumber>PA0282/070/002</LicenceNumber>
    <ProductName>CARDILATE 20MG</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004333</DrugIDPK>
    <LicenceNumber>PA0282/070/003</LicenceNumber>
    <ProductName>CARDILATE XL 40MG</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020560</DrugIDPK>
    <LicenceNumber>PA0899/029/001</LicenceNumber>
    <ProductName>FENTAZIN 2MG COATED TABLETS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021792</DrugIDPK>
    <LicenceNumber>PA0749/027/001</LicenceNumber>
    <ProductName>GRANISETRON TEVA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021793</DrugIDPK>
    <LicenceNumber>PA0749/027/002</LicenceNumber>
    <ProductName>GRANISETRON TEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013893</DrugIDPK>
    <LicenceNumber>PA0970/047/001</LicenceNumber>
    <ProductName>NAROPIN</ProductName>
    <Strength>200/100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017950</DrugIDPK>
    <LicenceNumber>PA0970/047/009</LicenceNumber>
    <ProductName>NAROPIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2004-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019174</DrugIDPK>
    <LicenceNumber>PA0237/061/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>2005-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022449</DrugIDPK>
    <LicenceNumber>PA0749/037/001</LicenceNumber>
    <ProductName>SUMATRIPTAN TEVA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022450</DrugIDPK>
    <LicenceNumber>PA0749/037/002</LicenceNumber>
    <ProductName>SUMATRIPTAN TEVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020816</DrugIDPK>
    <LicenceNumber>PA0654/017/001</LicenceNumber>
    <ProductName>UFT</ProductName>
    <Strength>100/224</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEGAFUR</ActiveSubstance>
      <ActiveSubstance>URACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022296</DrugIDPK>
    <LicenceNumber>PA0540/163/001</LicenceNumber>
    <ProductName>ALFUZOSIN WINTHROP 10MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006110</DrugIDPK>
    <LicenceNumber>PA0408/013/001</LicenceNumber>
    <ProductName>ALLOPURINOL TABLETS BP 100MG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006111</DrugIDPK>
    <LicenceNumber>PA0408/013/002</LicenceNumber>
    <ProductName>ALLOPURINOL TABLETS BP 300MG</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017018</DrugIDPK>
    <LicenceNumber>PA0408/058/001</LicenceNumber>
    <ProductName>CELIPROLOL HYDROCHLORIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2003-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017019</DrugIDPK>
    <LicenceNumber>PA0408/058/002</LicenceNumber>
    <ProductName>CELIPROLOL HYDROCHLORIDE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2003-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELIPROLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006139</DrugIDPK>
    <LicenceNumber>PA0408/042/001</LicenceNumber>
    <ProductName>CODEINE PHOSPHATE TABLETS BP 15 MG</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006140</DrugIDPK>
    <LicenceNumber>PA0408/042/002</LicenceNumber>
    <ProductName>CODEINE PHOSPHATE TABLETS BP 30 MG</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006141</DrugIDPK>
    <LicenceNumber>PA0408/042/003</LicenceNumber>
    <ProductName>CODEINE PHOSPHATE TABLETS BP 60 MG</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022620</DrugIDPK>
    <LicenceNumber>PA0540/148/002</LicenceNumber>
    <ProductName>ELOXATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026599</DrugIDPK>
    <LicenceNumber>PA0540/149/001</LicenceNumber>
    <ProductName>EPI-CHRONO 200 MG PROLONGED-RELEASE TABLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026600</DrugIDPK>
    <LicenceNumber>PA0540/149/002</LicenceNumber>
    <ProductName>EPI-CHRONO 300 MG PROLONGED-RELEASE TABLETS</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026601</DrugIDPK>
    <LicenceNumber>PA0540/149/003</LicenceNumber>
    <ProductName>EPI-CHRONO 500 MG PROLONGED-RELEASE TABLETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022592</DrugIDPK>
    <LicenceNumber>PA0540/150/004</LicenceNumber>
    <ProductName>EPILIM CHRONOSPHERE 50MG PROLONGED-RELEASE GRANULE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006123</DrugIDPK>
    <LicenceNumber>PA0408/026/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1992-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022618</DrugIDPK>
    <LicenceNumber>PA0540/153/001</LicenceNumber>
    <ProductName>OXALIPLATIN WINTHROP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022619</DrugIDPK>
    <LicenceNumber>PA0540/153/002</LicenceNumber>
    <ProductName>OXALIPLATIN WINTHROP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006084</DrugIDPK>
    <LicenceNumber>PA0408/002/001</LicenceNumber>
    <ProductName>RIMA 10 CHLORDIAZEPOXIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1986-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006083</DrugIDPK>
    <LicenceNumber>PA0408/001/004</LicenceNumber>
    <ProductName>RIMACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1987-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006080</DrugIDPK>
    <LicenceNumber>PA0408/001/001</LicenceNumber>
    <ProductName>RIMACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1985-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006081</DrugIDPK>
    <LicenceNumber>PA0408/001/002</LicenceNumber>
    <ProductName>RIMACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1987-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006085</DrugIDPK>
    <LicenceNumber>PA0408/004/001</LicenceNumber>
    <ProductName>RIMADOL PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in blister packs containing not more than 12 unit dosage forms.  The product concerned should contain paracetamol as its only active substance and only one pack should be supplied in the course of any one retail transaction.

Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.</SupplyComments>
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006087</DrugIDPK>
    <LicenceNumber>PA0408/006/001</LicenceNumber>
    <ProductName>RIMAPAM DIAZEPAM BP</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1986-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006088</DrugIDPK>
    <LicenceNumber>PA0408/006/002</LicenceNumber>
    <ProductName>RIMAPAM DIAZEPAM BP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1986-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006090</DrugIDPK>
    <LicenceNumber>PA0408/006/003</LicenceNumber>
    <ProductName>RIMAPAM DIAZEPAM BP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1986-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006124</DrugIDPK>
    <LicenceNumber>PA0408/029/001</LicenceNumber>
    <ProductName>RIMATIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006125</DrugIDPK>
    <LicenceNumber>PA0408/029/002</LicenceNumber>
    <ProductName>RIMATIDINE</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006108</DrugIDPK>
    <LicenceNumber>PA0408/012/003</LicenceNumber>
    <ProductName>RIMOXALLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006109</DrugIDPK>
    <LicenceNumber>PA0408/012/004</LicenceNumber>
    <ProductName>RIMOXALLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018407</DrugIDPK>
    <LicenceNumber>PA0408/059/001</LicenceNumber>
    <ProductName>SERTRALINE RANBAXY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018408</DrugIDPK>
    <LicenceNumber>PA0408/059/002</LicenceNumber>
    <ProductName>SERTRALINE RANBAXY</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000297</DrugIDPK>
    <LicenceNumber>PA0002/014/009</LicenceNumber>
    <ProductName>VELOSEF</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000298</DrugIDPK>
    <LicenceNumber>PA0002/014/010</LicenceNumber>
    <ProductName>VELOSEF</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000177</DrugIDPK>
    <LicenceNumber>PA0002/014/001</LicenceNumber>
    <ProductName>VELOSEF 250 MG HARD CAPSULES</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000294</DrugIDPK>
    <LicenceNumber>PA0002/014/002</LicenceNumber>
    <ProductName>VELOSEF 500 MG HARD CAPSULES</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000295</DrugIDPK>
    <LicenceNumber>PA0002/014/004</LicenceNumber>
    <ProductName>VELOSEF SYRUP</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021802</DrugIDPK>
    <LicenceNumber>PA0711/112/001</LicenceNumber>
    <ProductName>GEMABIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2007-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021803</DrugIDPK>
    <LicenceNumber>PA0711/112/002</LicenceNumber>
    <ProductName>GEMABIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2007-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029103</DrugIDPK>
    <LicenceNumber>PA1410/043/001</LicenceNumber>
    <ProductName>DELSYM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Supply through pharmacies only with the following restrictions: maximum dose: equivalent of 30 mg dextromethorphan, maximum daily dose: equivalent of 75 mg dextromethorphan.</SupplyComments>
    <WithdrawalDate>2010-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016849</DrugIDPK>
    <LicenceNumber>PA0111/006/001</LicenceNumber>
    <ProductName>RIMCURE</ProductName>
    <Strength>150/75/400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
      <ActiveSubstance>PYRAZINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008986</DrugIDPK>
    <LicenceNumber>PA0290/063/002</LicenceNumber>
    <ProductName>ALOMIDE ALLERGY 0.1% W/V EYE DROPS, SOLUTION</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2003-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LODOXAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015164</DrugIDPK>
    <LicenceNumber>PA0610/011/001</LicenceNumber>
    <ProductName>TRANSVASIN HEAT RUB</ProductName>
    <Strength>2/2/14</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2001-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>HEXYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>THURFYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014547</DrugIDPK>
    <LicenceNumber>PA0566/028/001</LicenceNumber>
    <ProductName>VAMINOVEN 18</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014549</DrugIDPK>
    <LicenceNumber>PA0566/029/001</LicenceNumber>
    <ProductName>VAMINOVEN 18 ELECTROLYTE FREE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032040</DrugIDPK>
    <LicenceNumber>PPA1463/034/001</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000082</DrugIDPK>
    <LicenceNumber>PA0441/038/001</LicenceNumber>
    <ProductName>VICKS ACTION</ProductName>
    <Strength>200mg/30mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1997-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001829</DrugIDPK>
    <LicenceNumber>PA0437/040/001</LicenceNumber>
    <ProductName>DACARBAZINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACARBAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001830</DrugIDPK>
    <LicenceNumber>PA0437/040/002</LicenceNumber>
    <ProductName>DACARBAZINE FOR INJECTION BP</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACARBAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019766</DrugIDPK>
    <LicenceNumber>PA0540/032/005</LicenceNumber>
    <ProductName>BATRAFEN 10MG/G</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020241</DrugIDPK>
    <LicenceNumber>PPA0465/164/001</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020242</DrugIDPK>
    <LicenceNumber>PPA0465/164/002</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005920</DrugIDPK>
    <LicenceNumber>PA0256/005/001</LicenceNumber>
    <ProductName>PREGNACARE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Vitabiotics Limited</PAHolder>
    <AuthorisedDate>2002-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETACAROTENE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACID SUCCINATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>PHYTOMENADIONE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>COPPER SULPHATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027421</DrugIDPK>
    <LicenceNumber>PA1483/001/001</LicenceNumber>
    <ProductName>BENTOME</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medana Pharma SA</PAHolder>
    <AuthorisedDate>2008-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027422</DrugIDPK>
    <LicenceNumber>PA1483/001/002</LicenceNumber>
    <ProductName>BENTOME</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medana Pharma SA</PAHolder>
    <AuthorisedDate>2008-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027423</DrugIDPK>
    <LicenceNumber>PA1483/001/003</LicenceNumber>
    <ProductName>BENTOME</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medana Pharma SA</PAHolder>
    <AuthorisedDate>2008-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021431</DrugIDPK>
    <LicenceNumber>PA0126/164/002</LicenceNumber>
    <ProductName>SUMALIEVE 100 MG TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021430</DrugIDPK>
    <LicenceNumber>PA0126/164/001</LicenceNumber>
    <ProductName>SUMALIEVE 50 MG TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007276</DrugIDPK>
    <LicenceNumber>PA0290/002/001</LicenceNumber>
    <ProductName>MYDRIACYL 0.5% EYE DROPS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROPICAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007250</DrugIDPK>
    <LicenceNumber>PA0290/002/002</LicenceNumber>
    <ProductName>MYDRIACYL 1% EYE DROPS</ProductName>
    <Strength>1%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROPICAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005685</DrugIDPK>
    <LicenceNumber>PA0290/064/001</LicenceNumber>
    <ProductName>PILOGEL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eyegel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008562</DrugIDPK>
    <LicenceNumber>PA0022/065/002</LicenceNumber>
    <ProductName>EFEXOR 37.5 MG TABLETS</ProductName>
    <Strength>37.5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008567</DrugIDPK>
    <LicenceNumber>PA0022/065/004</LicenceNumber>
    <ProductName>EFEXOR 75 MG TABLETS</ProductName>
    <Strength>75 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031698</DrugIDPK>
    <LicenceNumber>PA0365/088/002</LicenceNumber>
    <ProductName>DEPONIT 10MG/24 HOURS TRANSDERMAL PATCH</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/day</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031697</DrugIDPK>
    <LicenceNumber>PA0365/088/001</LicenceNumber>
    <ProductName>DEPONIT 5MG/24 HOURS TRANSDERMAL PATCH</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/day</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010572</DrugIDPK>
    <LicenceNumber>PA0013/104/001</LicenceNumber>
    <ProductName>OCULOTECT</ProductName>
    <Strength>50/mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2001-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYVIDONE 25</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010573</DrugIDPK>
    <LicenceNumber>PA0013/104/002</LicenceNumber>
    <ProductName>OCULOTECT</ProductName>
    <Strength>50mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2001-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYVIDONE 25</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018494</DrugIDPK>
    <LicenceNumber>PPA1151/001/002A</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>10/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2004-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015748</DrugIDPK>
    <LicenceNumber>PA0148/061/001</LicenceNumber>
    <ProductName>ZORAC</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAZAROTENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015749</DrugIDPK>
    <LicenceNumber>PA0148/061/002</LicenceNumber>
    <ProductName>ZORAC</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAZAROTENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020393</DrugIDPK>
    <LicenceNumber>PA1255/002/002</LicenceNumber>
    <ProductName>EPIPEN</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Mg/Dose</StrengthMeasurement>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020394</DrugIDPK>
    <LicenceNumber>PA1255/002/001</LicenceNumber>
    <ProductName>EPIPEN JUNIOR</ProductName>
    <Strength>0.15</Strength>
    <StrengthMeasurement>Mg/Dose</StrengthMeasurement>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004293</DrugIDPK>
    <LicenceNumber>PA0218/050/002</LicenceNumber>
    <ProductName>ESTROFEM</ProductName>
    <Strength>1 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1998-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017313</DrugIDPK>
    <LicenceNumber>PA1103/001/001</LicenceNumber>
    <ProductName>MELOXICAM FAL</ProductName>
    <Strength>7.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>F.A.L. Duiven BV</PAHolder>
    <AuthorisedDate>2006-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017314</DrugIDPK>
    <LicenceNumber>PA1103/001/002</LicenceNumber>
    <ProductName>MELOXICAM FAL</ProductName>
    <Strength>15mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>F.A.L. Duiven BV</PAHolder>
    <AuthorisedDate>2006-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003647</DrugIDPK>
    <LicenceNumber>PA0102/017/001</LicenceNumber>
    <ProductName>POSALFILIN</ProductName>
    <Strength>20/25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PODOPHYLLUM RESIN</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription subject to the following restrictions: maximum strength: 20.0%, external use only.</SupplyComments>
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020544</DrugIDPK>
    <LicenceNumber>PA0688/007/001</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020545</DrugIDPK>
    <LicenceNumber>PA0688/007/002</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020546</DrugIDPK>
    <LicenceNumber>PA0688/007/003</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020547</DrugIDPK>
    <LicenceNumber>PA0688/007/004</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020548</DrugIDPK>
    <LicenceNumber>PA0688/007/006</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020549</DrugIDPK>
    <LicenceNumber>PA0688/007/007</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020550</DrugIDPK>
    <LicenceNumber>PA0688/007/005</LicenceNumber>
    <ProductName>RISPATAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006273</DrugIDPK>
    <LicenceNumber>PA0417/004/001</LicenceNumber>
    <ProductName>SEVEN SEAS FIZZIES MULTIVITAMIN TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027444</DrugIDPK>
    <LicenceNumber>PA1484/001/001</LicenceNumber>
    <ProductName>LOSAPOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Heumann Pharma GmbH &amp; Co. Generica KG</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027445</DrugIDPK>
    <LicenceNumber>PA1484/001/002</LicenceNumber>
    <ProductName>LOSAPOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Heumann Pharma GmbH &amp; Co. Generica KG</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027446</DrugIDPK>
    <LicenceNumber>PA1484/001/003</LicenceNumber>
    <ProductName>LOSAPOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Heumann Pharma GmbH &amp; Co. Generica KG</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019666</DrugIDPK>
    <LicenceNumber>PA0915/011/001</LicenceNumber>
    <ProductName>RAPOLYTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2004-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019670</DrugIDPK>
    <LicenceNumber>PA0915/011/005</LicenceNumber>
    <ProductName>RAPOLYTE - NATURAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2004-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019669</DrugIDPK>
    <LicenceNumber>PA0915/011/004</LicenceNumber>
    <ProductName>RAPOLYTE - TUTTI FRUITTI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2004-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019668</DrugIDPK>
    <LicenceNumber>PA0915/011/003</LicenceNumber>
    <ProductName>RAPOLYTE- BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2004-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019667</DrugIDPK>
    <LicenceNumber>PA0915/011/002</LicenceNumber>
    <ProductName>RAPOLYTE-ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2004-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015802</DrugIDPK>
    <LicenceNumber>PA0727/001/001</LicenceNumber>
    <ProductName>IBULEVE</ProductName>
    <Strength>5%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Diomed Developments</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020962</DrugIDPK>
    <LicenceNumber>PA0966/016/001</LicenceNumber>
    <ProductName>BYMOT DISPERSIBLE TABLETS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020963</DrugIDPK>
    <LicenceNumber>PA0966/016/002</LicenceNumber>
    <ProductName>BYMOT DISPERSIBLE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020964</DrugIDPK>
    <LicenceNumber>PA0966/016/003</LicenceNumber>
    <ProductName>BYMOT DISPERSIBLE TABLETS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020965</DrugIDPK>
    <LicenceNumber>PA0966/016/004</LicenceNumber>
    <ProductName>BYMOT DISPERSIBLE TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020966</DrugIDPK>
    <LicenceNumber>PA0966/016/005</LicenceNumber>
    <ProductName>BYMOT DISPERSIBLE TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020967</DrugIDPK>
    <LicenceNumber>PA0966/016/006</LicenceNumber>
    <ProductName>BYMOT DISPERSIBLE TABLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009871</DrugIDPK>
    <LicenceNumber>PA0915/005/001</LicenceNumber>
    <ProductName>DTZ</ProductName>
    <Strength>120 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009872</DrugIDPK>
    <LicenceNumber>PA0915/005/002</LicenceNumber>
    <ProductName>DTZ</ProductName>
    <Strength>180 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009873</DrugIDPK>
    <LicenceNumber>PA0915/005/003</LicenceNumber>
    <ProductName>DTZ</ProductName>
    <Strength>240mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021294</DrugIDPK>
    <LicenceNumber>PA0711/101/001</LicenceNumber>
    <ProductName>CEFTAL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027853</DrugIDPK>
    <LicenceNumber>PA1499/001/001</LicenceNumber>
    <ProductName>DAVLIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Volkspharma GmbH</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027854</DrugIDPK>
    <LicenceNumber>PA1499/001/002</LicenceNumber>
    <ProductName>DAVLIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Volkspharma GmbH</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027855</DrugIDPK>
    <LicenceNumber>PA1499/001/003</LicenceNumber>
    <ProductName>DAVLIET</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Volkspharma GmbH</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009761</DrugIDPK>
    <LicenceNumber>PA0568/007/002</LicenceNumber>
    <ProductName>GLICLAZIDE SERVIER</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020492</DrugIDPK>
    <LicenceNumber>PA0823/049/008</LicenceNumber>
    <ProductName>NICORETTE CITRUS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020493</DrugIDPK>
    <LicenceNumber>PA0823/049/007</LicenceNumber>
    <ProductName>NICORETTE CITRUS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013883</DrugIDPK>
    <LicenceNumber>PA0970/044/004</LicenceNumber>
    <ProductName>LOSEC IV</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005680</DrugIDPK>
    <LicenceNumber>PA0290/061/002</LicenceNumber>
    <ProductName>BETOPTIC 0.25% EYEDROPS</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1993-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007780</DrugIDPK>
    <LicenceNumber>PA0290/069/001</LicenceNumber>
    <ProductName>CILOXAN 0.3 % W/V EYE DROPS, SOLUTION.</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009866</DrugIDPK>
    <LicenceNumber>PA0290/069/002</LicenceNumber>
    <ProductName>CILOXAN 3 MG/G EYE OINTMENT.</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2004-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014489</DrugIDPK>
    <LicenceNumber>PA0290/075/001</LicenceNumber>
    <ProductName>PHYSIOTEARS</ProductName>
    <Strength>1.0/3.0</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2004-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
      <ActiveSubstance>DEXTRAN 70</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001708</DrugIDPK>
    <LicenceNumber>PA0290/072/002</LicenceNumber>
    <ProductName>TIMOLOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001684</DrugIDPK>
    <LicenceNumber>PA0290/072/001</LicenceNumber>
    <ProductName>TIMOLOL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019230</DrugIDPK>
    <LicenceNumber>PA0290/077/001</LicenceNumber>
    <ProductName>TOBRAVISC 3.0MG/ML EYE DROPS, SOLUTION</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008799</DrugIDPK>
    <LicenceNumber>PA0240/008/001</LicenceNumber>
    <ProductName>META-IODOBENZYLGUANIDINE</ProductName>
    <Strength>0.185-0.74</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOBENGUANE CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>2010-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020027</DrugIDPK>
    <LicenceNumber>PPA0465/104/004</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007430</DrugIDPK>
    <LicenceNumber>PA0281/052/001</LicenceNumber>
    <ProductName>LIQUID PARAFFIN BP</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020164</DrugIDPK>
    <LicenceNumber>PPA0465/163/002</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020178</DrugIDPK>
    <LicenceNumber>PA1236/001/001</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>RMR Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020179</DrugIDPK>
    <LicenceNumber>PA1236/001/002</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>RMR Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021780</DrugIDPK>
    <LicenceNumber>PA0688/010/001</LicenceNumber>
    <ProductName>SUMATRIPTAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021781</DrugIDPK>
    <LicenceNumber>PA0688/010/002</LicenceNumber>
    <ProductName>SUMATRIPTAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028812</DrugIDPK>
    <LicenceNumber>PA1380/061/001</LicenceNumber>
    <ProductName>VINORELBINE CADUCEUS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINORELBINE DITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008374</DrugIDPK>
    <LicenceNumber>PA0417/007/001</LicenceNumber>
    <ProductName>MINADEX TONIC HALF STRENGTH ORAL EMULSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1995-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>FERRIC AMMONIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032564</DrugIDPK>
    <LicenceNumber>PA1640/001/001</LicenceNumber>
    <ProductName>SODIUM CROMOGLICATE EYEDROPS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Freynes &amp; Co Limited</PAHolder>
    <AuthorisedDate>2010-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear/Eye Drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022174</DrugIDPK>
    <LicenceNumber>PA0868/007/001</LicenceNumber>
    <ProductName>EPIESTROL-SEPTEM</ProductName>
    <Strength>25 mg/24ho</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022175</DrugIDPK>
    <LicenceNumber>PA0868/007/002</LicenceNumber>
    <ProductName>EPIESTROL-SEPTEM</ProductName>
    <Strength>50 mg/24 h</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022176</DrugIDPK>
    <LicenceNumber>PA0868/007/003</LicenceNumber>
    <ProductName>EPIESTROL-SEPTEM</ProductName>
    <Strength>75mg/24 ho</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022804</DrugIDPK>
    <LicenceNumber>PA1350/003/001</LicenceNumber>
    <ProductName>EVEROSE</ProductName>
    <Strength>660</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Nephrologica Deutschland GmbH</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002167</DrugIDPK>
    <LicenceNumber>PA0046/018/001</LicenceNumber>
    <ProductName>CENTYL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002168</DrugIDPK>
    <LicenceNumber>PA0046/018/002</LicenceNumber>
    <ProductName>CENTYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003210</DrugIDPK>
    <LicenceNumber>PA0073/090/001</LicenceNumber>
    <ProductName>GENOXEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003211</DrugIDPK>
    <LicenceNumber>PA0073/090/002</LicenceNumber>
    <ProductName>GENOXEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022851</DrugIDPK>
    <LicenceNumber>PA0167/129/001</LicenceNumber>
    <ProductName>TISSEEL KIT</ProductName>
    <Strength>0.5ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR I (FIBRINOGEN)</ActiveSubstance>
      <ActiveSubstance>PLASMAFIBRONECTIN</ActiveSubstance>
      <ActiveSubstance>FACTOR XIII</ActiveSubstance>
      <ActiveSubstance>PROFIBRINOLYSIN</ActiveSubstance>
      <ActiveSubstance>APROTININ</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
      <ActiveSubstance>PROTEIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009867</DrugIDPK>
    <LicenceNumber>PA0968/002/001</LicenceNumber>
    <ProductName>KESTINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Almirall, S.A.</PAHolder>
    <AuthorisedDate>2000-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EBASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017875</DrugIDPK>
    <LicenceNumber>PA0968/002/003</LicenceNumber>
    <ProductName>KESTINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Almirall, S.A.</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EBASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017876</DrugIDPK>
    <LicenceNumber>PA0968/002/004</LicenceNumber>
    <ProductName>KESTINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Almirall, S.A.</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EBASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031954</DrugIDPK>
    <LicenceNumber>PA0823/051/003</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031956</DrugIDPK>
    <LicenceNumber>PA0823/051/005</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026449</DrugIDPK>
    <LicenceNumber>PA0623/011/001</LicenceNumber>
    <ProductName>OXAMED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022425</DrugIDPK>
    <LicenceNumber>PA1363/003/002</LicenceNumber>
    <ProductName>FELODIPINE 10 MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Selana Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022424</DrugIDPK>
    <LicenceNumber>PA1363/003/001</LicenceNumber>
    <ProductName>FELODIPINE 5 MG, PROLONGED RELEASE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Selana Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006287</DrugIDPK>
    <LicenceNumber>PA0455/006/002</LicenceNumber>
    <ProductName>SOFT-CORN REMOVAL PADS</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1987-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021556</DrugIDPK>
    <LicenceNumber>PA0281/130/002</LicenceNumber>
    <ProductName>CAPRIN 300 MG TABLETS</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007875</DrugIDPK>
    <LicenceNumber>PA0437/045/001</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007878</DrugIDPK>
    <LicenceNumber>PA0437/045/004</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007879</DrugIDPK>
    <LicenceNumber>PA0437/045/005</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006790</DrugIDPK>
    <LicenceNumber>PA0590/007/002</LicenceNumber>
    <ProductName>ACNECIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002960</DrugIDPK>
    <LicenceNumber>PA0590/007/004</LicenceNumber>
    <ProductName>ACNECIDE WASH</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE HYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019345</DrugIDPK>
    <LicenceNumber>PA1190/001/001</LicenceNumber>
    <ProductName>SIMVASTATIN IREX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires Irex - Groupe Sanofi-Synthelabo</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019346</DrugIDPK>
    <LicenceNumber>PA1190/001/002</LicenceNumber>
    <ProductName>SIMVASTATIN IREX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires Irex - Groupe Sanofi-Synthelabo</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019357</DrugIDPK>
    <LicenceNumber>PA1190/001/003</LicenceNumber>
    <ProductName>SIMVASTATIN IREX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires Irex - Groupe Sanofi-Synthelabo</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019358</DrugIDPK>
    <LicenceNumber>PA1190/001/004</LicenceNumber>
    <ProductName>SIMVASTATIN IREX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires Irex - Groupe Sanofi-Synthelabo</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024218</DrugIDPK>
    <LicenceNumber>PA0711/137/002</LicenceNumber>
    <ProductName>FETANEX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2010-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024220</DrugIDPK>
    <LicenceNumber>PA0711/137/004</LicenceNumber>
    <ProductName>FETANEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2010-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024221</DrugIDPK>
    <LicenceNumber>PA0711/137/005</LicenceNumber>
    <ProductName>FETANEX</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2010-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024222</DrugIDPK>
    <LicenceNumber>PA0711/137/006</LicenceNumber>
    <ProductName>FETANEX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2010-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001205</DrugIDPK>
    <LicenceNumber>PA0417/009/001</LicenceNumber>
    <ProductName>SEVEN SEAS FOLIC ACID CAPSULES</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1997-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006263</DrugIDPK>
    <LicenceNumber>PA0416/001/001</LicenceNumber>
    <ProductName>SEVEN SEAS SUPER VITAMIN E</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008859</DrugIDPK>
    <LicenceNumber>PA0030/040/001</LicenceNumber>
    <ProductName>BOOTS NICOTINE CHEWING GUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>2010-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008860</DrugIDPK>
    <LicenceNumber>PA0030/040/002</LicenceNumber>
    <ProductName>BOOTS NICOTINE CHEWING GUM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>2010-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017394</DrugIDPK>
    <LicenceNumber>PA0030/040/004</LicenceNumber>
    <ProductName>BOOTS NICOTINE TRANSDERMAL PATCH 24HOUR</ProductName>
    <Strength>7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017395</DrugIDPK>
    <LicenceNumber>PA0030/040/005</LicenceNumber>
    <ProductName>BOOTS NICOTINE TRANSDERMAL PATCH 24HOUR</ProductName>
    <Strength>14mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017396</DrugIDPK>
    <LicenceNumber>PA0030/040/006</LicenceNumber>
    <ProductName>BOOTS NICOTINE TRANSDERMAL PATCH 24HOUR</ProductName>
    <Strength>21mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019961</DrugIDPK>
    <LicenceNumber>PA0966/013/001</LicenceNumber>
    <ProductName>BEXZIS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002284</DrugIDPK>
    <LicenceNumber>PA0050/062/007</LicenceNumber>
    <ProductName>ROCEPHIN</ProductName>
    <Strength>2 g</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTRIAXONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022106</DrugIDPK>
    <LicenceNumber>PA0967/006/001</LicenceNumber>
    <ProductName>BELLRAMIL</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022522</DrugIDPK>
    <LicenceNumber>PA0967/010/001</LicenceNumber>
    <ProductName>VENLAFAXINE</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022523</DrugIDPK>
    <LicenceNumber>PA0967/010/002</LicenceNumber>
    <ProductName>VENLAFAXINE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029660</DrugIDPK>
    <LicenceNumber>PPA1473/025/001</LicenceNumber>
    <ProductName>ZISPIN SOLTABS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013862</DrugIDPK>
    <LicenceNumber>PA0970/036/004</LicenceNumber>
    <ProductName>BRICANYL RESPULES</ProductName>
    <Strength>5mg/2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013576</DrugIDPK>
    <LicenceNumber>PA1032/002/001</LicenceNumber>
    <ProductName>CENTRADOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Grunenthal GmbH</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPRENORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013577</DrugIDPK>
    <LicenceNumber>PA1032/002/002</LicenceNumber>
    <ProductName>CENTRADOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Grunenthal GmbH</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPRENORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013578</DrugIDPK>
    <LicenceNumber>PA1032/002/003</LicenceNumber>
    <ProductName>CENTRADOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Grunenthal GmbH</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPRENORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005005</DrugIDPK>
    <LicenceNumber>PA0035/082/002</LicenceNumber>
    <ProductName>COZAAR INITIATION PACK FOR HEART FAILURE</ProductName>
    <Strength>12.5 &amp; 50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009328</DrugIDPK>
    <LicenceNumber>PA0970/005/001</LicenceNumber>
    <ProductName>DIPRIVAN 1% W/V EMULSION FOR INTRAVENOUS INJECTION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012202</DrugIDPK>
    <LicenceNumber>PA0038/084/001</LicenceNumber>
    <ProductName>GOPTEN 0.5 MG HARD CAPSULES</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012203</DrugIDPK>
    <LicenceNumber>PA0038/084/002</LicenceNumber>
    <ProductName>GOPTEN 1.0 MG HARD CAPSULES</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012204</DrugIDPK>
    <LicenceNumber>PA0038/084/003</LicenceNumber>
    <ProductName>GOPTEN 2 MG HARD CAPSULES</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013884</DrugIDPK>
    <LicenceNumber>PA0970/044/005</LicenceNumber>
    <ProductName>LOSEC 40 MG POWDER FOR SOLUTION FOR INFUSION.</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028206</DrugIDPK>
    <LicenceNumber>PA1509/001/001</LicenceNumber>
    <ProductName>MYLCER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Flexopharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028207</DrugIDPK>
    <LicenceNumber>PA1509/001/002</LicenceNumber>
    <ProductName>MYLCER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Flexopharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028208</DrugIDPK>
    <LicenceNumber>PA1509/001/003</LicenceNumber>
    <ProductName>MYLCER</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Flexopharm GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002857</DrugIDPK>
    <LicenceNumber>PA0230/006/003</LicenceNumber>
    <ProductName>PULMOCLASE PAEDIATRIC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>UCB S.A.</PAHolder>
    <AuthorisedDate>1993-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019925</DrugIDPK>
    <LicenceNumber>PA1218/002/001</LicenceNumber>
    <ProductName>HIBISOL</ProductName>
    <Strength>0.5%</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Regent Medical Overseas Limited</PAHolder>
    <AuthorisedDate>2005-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIGLUCONATE (AS CHLORHEXIDINE DIGLUCONATE SOLUTION (20% W/V) PH.EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031654</DrugIDPK>
    <LicenceNumber>PPA1593/001/001</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>S.C.A.C Limited</PAHolder>
    <AuthorisedDate>2010-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031655</DrugIDPK>
    <LicenceNumber>PPA1593/001/002</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>S.C.A.C Limited</PAHolder>
    <AuthorisedDate>2010-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032193</DrugIDPK>
    <LicenceNumber>PA0167/141/001</LicenceNumber>
    <ProductName>CLINOLEIC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REFINED OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>SOYA BEAN OIL, REFINED PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995032194</DrugIDPK>
    <LicenceNumber>PA0167/141/002</LicenceNumber>
    <ProductName>CLINOLEIC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REFINED OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>SOYA BEAN OIL, REFINED PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010361</DrugIDPK>
    <LicenceNumber>PA0030/050/001</LicenceNumber>
    <ProductName>NICOTINELL LIQUORICE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>2010-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010362</DrugIDPK>
    <LicenceNumber>PA0030/050/002</LicenceNumber>
    <ProductName>NICOTINELL LIQUORICE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>2010-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010487</DrugIDPK>
    <LicenceNumber>PA0540/028/005</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>6.0mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2000-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030447</DrugIDPK>
    <LicenceNumber>PPA1328/116/001</LicenceNumber>
    <ProductName>DYAZIDE</ProductName>
    <Strength>50/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMTERENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027765</DrugIDPK>
    <LicenceNumber>PA1495/001/001</LicenceNumber>
    <ProductName>KALGRIFF</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>KSK-Pharma Vertriebs AG</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027766</DrugIDPK>
    <LicenceNumber>PA1495/001/002</LicenceNumber>
    <ProductName>KALGRIFF</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>KSK-Pharma Vertriebs AG</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027767</DrugIDPK>
    <LicenceNumber>PA1495/001/003</LicenceNumber>
    <ProductName>KALGRIFF</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>KSK-Pharma Vertriebs AG</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009962</DrugIDPK>
    <LicenceNumber>PA0568/014/001</LicenceNumber>
    <ProductName>AERODIOL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009961</DrugIDPK>
    <LicenceNumber>PA0568/015/001</LicenceNumber>
    <ProductName>ESTRADIOL SERVIER</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011623</DrugIDPK>
    <LicenceNumber>PA0566/027/001</LicenceNumber>
    <ProductName>HYPERHAES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011789</DrugIDPK>
    <LicenceNumber>PA0688/002/001</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>300 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>1998-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 50 dose units.</SupplyComments>
    <WithdrawalDate>2010-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031728</DrugIDPK>
    <LicenceNumber>PPA1562/018/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016080</DrugIDPK>
    <LicenceNumber>PA0167/109/010</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004627</DrugIDPK>
    <LicenceNumber>PA0775/001/006</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012302</DrugIDPK>
    <LicenceNumber>PA0167/109/001</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N4-550</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012304</DrugIDPK>
    <LicenceNumber>PA0167/109/003</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N5-800</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012306</DrugIDPK>
    <LicenceNumber>PA0167/109/005</LicenceNumber>
    <ProductName>OLICLINOMEL</ProductName>
    <Strength>N6-900</Strength>
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLIVE OIL</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005235</DrugIDPK>
    <LicenceNumber>PA0167/092/004</LicenceNumber>
    <ProductName>SYNTHAMIN 14 WITHOUT ELECTROLYTES</ProductName>
    <Strength>8.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1997-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005238</DrugIDPK>
    <LicenceNumber>PA0167/092/007</LicenceNumber>
    <ProductName>SYNTHAMIN 17 WITHOUT ELECTROLYTES</ProductName>
    <Strength>10%</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1997-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005232</DrugIDPK>
    <LicenceNumber>PA0167/092/001</LicenceNumber>
    <ProductName>SYNTHAMIN 9 WITHOUT ELECTROLYTES</ProductName>
    <Strength>5.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1997-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022538</DrugIDPK>
    <LicenceNumber>PA0583/006/002</LicenceNumber>
    <ProductName>IDROLAX</ProductName>
    <Strength>4g</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>2007-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 4000</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014860</DrugIDPK>
    <LicenceNumber>PA1046/001/001</LicenceNumber>
    <ProductName>GABAPENTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014861</DrugIDPK>
    <LicenceNumber>PA1046/001/002</LicenceNumber>
    <ProductName>GABAPENTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014862</DrugIDPK>
    <LicenceNumber>PA1046/001/003</LicenceNumber>
    <ProductName>GABAPENTIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008898</DrugIDPK>
    <LicenceNumber>PA0690/006/001</LicenceNumber>
    <ProductName>SODIUM IODIDE (I131) D</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Mallinckrodt Medical B.V.</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IODIDE (131 I)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Shall only be dispensed in a hospital</SupplyComments>
    <WithdrawalDate>2010-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024910</DrugIDPK>
    <LicenceNumber>PA0540/140/001</LicenceNumber>
    <ProductName>ADENOSCAN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ADENOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019239</DrugIDPK>
    <LicenceNumber>PA0540/103/002</LicenceNumber>
    <ProductName>INTAL CFC-FREE INHALER 5MG PRESSURISED INHALATION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CROMOGLICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017547</DrugIDPK>
    <LicenceNumber>PA0540/137/001</LicenceNumber>
    <ProductName>RAMIPRIL 1.25MG CAPSULES</ProductName>
    <Strength>1.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019112</DrugIDPK>
    <LicenceNumber>PA0540/137/005</LicenceNumber>
    <ProductName>RAMIPRIL 1.25MG TABLETS</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017550</DrugIDPK>
    <LicenceNumber>PA0540/137/004</LicenceNumber>
    <ProductName>RAMIPRIL 10MG CAPSULES</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019115</DrugIDPK>
    <LicenceNumber>PA0540/137/008</LicenceNumber>
    <ProductName>RAMIPRIL 10MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017548</DrugIDPK>
    <LicenceNumber>PA0540/137/002</LicenceNumber>
    <ProductName>RAMIPRIL 2.5MG CAPSULES</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019113</DrugIDPK>
    <LicenceNumber>PA0540/137/006</LicenceNumber>
    <ProductName>RAMIPRIL 2.5MG TABLETS</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017549</DrugIDPK>
    <LicenceNumber>PA0540/137/003</LicenceNumber>
    <ProductName>RAMIPRIL 5MG CAPSULES</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019114</DrugIDPK>
    <LicenceNumber>PA0540/137/007</LicenceNumber>
    <ProductName>RAMIPRIL 5MG TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011393</DrugIDPK>
    <LicenceNumber>PA0540/130/001</LicenceNumber>
    <ProductName>TILADE AEROSOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Dose</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEDOCROMIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022850</DrugIDPK>
    <LicenceNumber>PA0540/162/002</LicenceNumber>
    <ProductName>XATRAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011816</DrugIDPK>
    <LicenceNumber>PA0258/047/001</LicenceNumber>
    <ProductName>MELTUS DECONGESTANT</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1996-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017723</DrugIDPK>
    <LicenceNumber>PA1117/001/001</LicenceNumber>
    <ProductName>NITROMIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>EGIS UK Ltd</PAHolder>
    <AuthorisedDate>1999-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Spray, Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005668</DrugIDPK>
    <LicenceNumber>PA0876/002/001</LicenceNumber>
    <ProductName>HERPETAD COLD SORE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028846</DrugIDPK>
    <LicenceNumber>PA1410/055/002</LicenceNumber>
    <ProductName>TRANSIPEG IN SACHET</ProductName>
    <Strength>5.9</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030804</DrugIDPK>
    <LicenceNumber>PA1138/005/001</LicenceNumber>
    <ProductName>FULL MARKS LOTION</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>SSL International plc</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOTHRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028845</DrugIDPK>
    <LicenceNumber>PA1410/055/001</LicenceNumber>
    <ProductName>TRANSIPEG IN SACHET</ProductName>
    <Strength>2.95</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020455</DrugIDPK>
    <LicenceNumber>PA0167/097/002</LicenceNumber>
    <ProductName>CERNEVIT BIO-SET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>DL-ALFA-TOCOFEROL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>COCARBOXYLASE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>DEXPANTHENOL</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021849</DrugIDPK>
    <LicenceNumber>PA0749/029/001</LicenceNumber>
    <ProductName>ENALAPRIL MALEATE HYDROCHLOROTHIAZIDE TEVA</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022249</DrugIDPK>
    <LicenceNumber>PA0749/033/001</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022250</DrugIDPK>
    <LicenceNumber>PA0749/033/002</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022251</DrugIDPK>
    <LicenceNumber>PA0749/033/003</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022252</DrugIDPK>
    <LicenceNumber>PA0749/033/004</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020159</DrugIDPK>
    <LicenceNumber>PA1233/001/001</LicenceNumber>
    <ProductName>PAMIDRONATE DISODIUM TEVA 3MG/ML CONCENTRATE FOR S</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharmaceuticals Europe B.V.</PAHolder>
    <AuthorisedDate>2007-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028124</DrugIDPK>
    <LicenceNumber>PA0585/047/005</LicenceNumber>
    <ProductName>RIVASTIGMINE PLIVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2009-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027703</DrugIDPK>
    <LicenceNumber>PPA1151/076/001</LicenceNumber>
    <ProductName>EFEXOR 37.5 MG TABLETS</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027704</DrugIDPK>
    <LicenceNumber>PPA1151/076/002</LicenceNumber>
    <ProductName>EFEXOR 75 MG TABLETS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000018</DrugIDPK>
    <LicenceNumber>PA0002/064/001</LicenceNumber>
    <ProductName>ETOPOPHOS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETOPOSIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006278</DrugIDPK>
    <LicenceNumber>PA0455/001/003</LicenceNumber>
    <ProductName>SCHOLL ATHLETE’S FOOT SOLUTION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030399</DrugIDPK>
    <LicenceNumber>PPA1151/034/002</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013920</DrugIDPK>
    <LicenceNumber>PA0970/054/001</LicenceNumber>
    <ProductName>XYLOCAINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019104</DrugIDPK>
    <LicenceNumber>PA0126/136/003</LicenceNumber>
    <ProductName>CLONOCID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019105</DrugIDPK>
    <LicenceNumber>PA0126/136/004</LicenceNumber>
    <ProductName>CLONOCID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010452</DrugIDPK>
    <LicenceNumber>PA0654/010/001</LicenceNumber>
    <ProductName>FEMSEVEN SEQUI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015031</DrugIDPK>
    <LicenceNumber>PA0968/002/002</LicenceNumber>
    <ProductName>KESTINE</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Almirall, S.A.</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EBASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020670</DrugIDPK>
    <LicenceNumber>PA0711/061/003</LicenceNumber>
    <ProductName>CLOROM</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020671</DrugIDPK>
    <LicenceNumber>PA0711/061/004</LicenceNumber>
    <ProductName>CLOROM</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001659</DrugIDPK>
    <LicenceNumber>PA0618/016/002</LicenceNumber>
    <ProductName>MALATHION LOTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1992-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001658</DrugIDPK>
    <LicenceNumber>PA0618/016/001</LicenceNumber>
    <ProductName>PRIODERM 1% W/W CREAM SHAMPOO</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1995-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004959</DrugIDPK>
    <LicenceNumber>PA0618/025/001</LicenceNumber>
    <ProductName>RALGEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1997-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
      <ActiveSubstance>ETHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012614</DrugIDPK>
    <LicenceNumber>PA0167/110/002</LicenceNumber>
    <ProductName>PENTASTARCH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008889</DrugIDPK>
    <LicenceNumber>PA0686/001/001</LicenceNumber>
    <ProductName>ENDOREM</ProductName>
    <Strength>11.2</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>GUERBET</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Susp for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRON OXIDE SUPERPAROMAGNETIC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020678</DrugIDPK>
    <LicenceNumber>PA1241/007/001</LicenceNumber>
    <ProductName>OMNIC</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020752</DrugIDPK>
    <LicenceNumber>PA1241/008/001</LicenceNumber>
    <ProductName>VESIKUR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020753</DrugIDPK>
    <LicenceNumber>PA1241/008/002</LicenceNumber>
    <ProductName>VESIKUR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Co. Ltd</PAHolder>
    <AuthorisedDate>2005-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOLIFENACIN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004530</DrugIDPK>
    <LicenceNumber>PA0013/070/002</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024278</DrugIDPK>
    <LicenceNumber>PA0585/029/001</LicenceNumber>
    <ProductName>PACLITAXEL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2007-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027049</DrugIDPK>
    <LicenceNumber>PA0585/038/001</LicenceNumber>
    <ProductName>TOPOTECAN PLIVA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002054</DrugIDPK>
    <LicenceNumber>PA0046/005/003</LicenceNumber>
    <ProductName>FUCIDIN H</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDATE SODIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022235</DrugIDPK>
    <LicenceNumber>PA0937/008/001</LicenceNumber>
    <ProductName>BLEOMYCIN</ProductName>
    <Strength>15 U (USP)/vial</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BLEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023721</DrugIDPK>
    <LicenceNumber>PA0585/030/001</LicenceNumber>
    <ProductName>OXALIPLATIN 5 MG/ML POWDER FOR SOLUTION FOR INFUSI</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001050</DrugIDPK>
    <LicenceNumber>PA0019/013/006</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1985-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004529</DrugIDPK>
    <LicenceNumber>PA0013/070/001</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009988</DrugIDPK>
    <LicenceNumber>PA0985/001/001</LicenceNumber>
    <ProductName>PLETAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Otsuka Pharmaceutical Europe Ltd</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILOSTAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009989</DrugIDPK>
    <LicenceNumber>PA0985/001/002</LicenceNumber>
    <ProductName>PLETAL</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Otsuka Pharmaceutical Europe Ltd</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILOSTAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001637</DrugIDPK>
    <LicenceNumber>PA0577/013/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001638</DrugIDPK>
    <LicenceNumber>PA0577/013/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009958</DrugIDPK>
    <LicenceNumber>PA0219/003/001</LicenceNumber>
    <ProductName>NYSTAFORM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Typharm Limited</PAHolder>
    <AuthorisedDate>2000-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009959</DrugIDPK>
    <LicenceNumber>PA0219/004/001</LicenceNumber>
    <ProductName>NYSTAFORM H.C. CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Typharm Limited</PAHolder>
    <AuthorisedDate>2000-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>OCTYLDODECANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009960</DrugIDPK>
    <LicenceNumber>PA0219/004/002</LicenceNumber>
    <ProductName>NYSTAFORM H.C. OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Typharm Limited</PAHolder>
    <AuthorisedDate>2000-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016776</DrugIDPK>
    <LicenceNumber>PA0980/002/001</LicenceNumber>
    <ProductName>XEPIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cambridge Healthcare Supplies Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002728</DrugIDPK>
    <LicenceNumber>PA0050/053/002</LicenceNumber>
    <ProductName>ROACCUTANE</ProductName>
    <Strength>5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004452</DrugIDPK>
    <LicenceNumber>PA0170/015/001</LicenceNumber>
    <ProductName>CACIT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1990-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004453</DrugIDPK>
    <LicenceNumber>PA0170/015/002</LicenceNumber>
    <ProductName>CACIT</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1990-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002384</DrugIDPK>
    <LicenceNumber>PA0170/018/002</LicenceNumber>
    <ProductName>CACIT D3</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002383</DrugIDPK>
    <LicenceNumber>PA0170/018/001</LicenceNumber>
    <ProductName>CACIT D3 500MG/440 IU EFFERVESCENT GRANULES FOR OR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009220</DrugIDPK>
    <LicenceNumber>PA0170/017/001</LicenceNumber>
    <ProductName>DIDRONEL PMO</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1996-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETIDRONATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028838</DrugIDPK>
    <LicenceNumber>PA1410/049/002</LicenceNumber>
    <ProductName>MYCOSPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BIFONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028839</DrugIDPK>
    <LicenceNumber>PA1410/049/001</LicenceNumber>
    <ProductName>MYCOSPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BIFONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028840</DrugIDPK>
    <LicenceNumber>PA1410/049/003</LicenceNumber>
    <ProductName>MYCOSPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BIFONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028841</DrugIDPK>
    <LicenceNumber>PA1410/049/004</LicenceNumber>
    <ProductName>MYCOSPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BIFONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021686</DrugIDPK>
    <LicenceNumber>PA1326/001/003</LicenceNumber>
    <ProductName>HALLS MENTHOLYPTUS BLACKCURRANT LOZENGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cadbury Trebor Bassett</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>EUCALYPTUS GLOBULUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021685</DrugIDPK>
    <LicenceNumber>PA1326/001/002</LicenceNumber>
    <ProductName>HALLS MENTHOLYPTUS EXTRA STRONG LOZENGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cadbury Trebor Bassett</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>EUCALYPTUS GLOBULUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021687</DrugIDPK>
    <LicenceNumber>PA1326/001/004</LicenceNumber>
    <ProductName>HALLS MENTHOLYPTUS HONEY AND LEMON LOZENGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cadbury Trebor Bassett</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>EUCALYPTUS GLOBULUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021684</DrugIDPK>
    <LicenceNumber>PA1326/001/001</LicenceNumber>
    <ProductName>HALLS MENTHOLYPTUS ORIGINAL LOZENGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cadbury Trebor Bassett</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>EUCALYPTUS GLOBULUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003157</DrugIDPK>
    <LicenceNumber>PA0068/001/001</LicenceNumber>
    <ProductName>NATRILIX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1975-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008797</DrugIDPK>
    <LicenceNumber>PA0240/005/003</LicenceNumber>
    <ProductName>INDIUM CHLORIDE STERILE</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Radio-Pharm Precursor</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDIUM (111 IN) CHLORIDE SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020165</DrugIDPK>
    <LicenceNumber>PPA0465/163/003</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000194</DrugIDPK>
    <LicenceNumber>PA0002/059/001A</LicenceNumber>
    <ProductName>TAXOL</ProductName>
    <Strength>6mg/ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002373</DrugIDPK>
    <LicenceNumber>PA0048/022/005</LicenceNumber>
    <ProductName>VEPESID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base mg/unit</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETOPOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020375</DrugIDPK>
    <LicenceNumber>PA0047/095/001</LicenceNumber>
    <ProductName>STRATTERA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2006-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATOMOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029518</DrugIDPK>
    <LicenceNumber>PPA1473/016/001</LicenceNumber>
    <ProductName>BECONASE AQUEOUS NASAL SPRAY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019314</DrugIDPK>
    <LicenceNumber>PA0577/063/001</LicenceNumber>
    <ProductName>PERGOLIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERGOLIDE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019315</DrugIDPK>
    <LicenceNumber>PA0577/063/002</LicenceNumber>
    <ProductName>PERGOLIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERGOLIDE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019316</DrugIDPK>
    <LicenceNumber>PA0577/063/003</LicenceNumber>
    <ProductName>PERGOLIDE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERGOLIDE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002723</DrugIDPK>
    <LicenceNumber>PA0050/051/001</LicenceNumber>
    <ProductName>KONAKION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHYTOMENADIONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009518</DrugIDPK>
    <LicenceNumber>PA0973/001/001</LicenceNumber>
    <ProductName>ADDIFLU SUSPENSION FOR INJECTION</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD S.p.A.</PAHolder>
    <AuthorisedDate>2000-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/BRISBANE/59/2007 (H1N1) - LIKE STRAIN (A/BRISBANE/59/2007, IVR-148) PH.EUR</ActiveSubstance>
      <ActiveSubstance>A/BRISBANE/10/2007 (H3N2) - LIKE STRAIN (A/URUGUAY/716/2007,NYMC X-175-C)</ActiveSubstance>
      <ActiveSubstance>B/BRISBANE/60/2008 - LIKE STRAIN (B/BRISBANE/60/2008)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021317</DrugIDPK>
    <LicenceNumber>PA0800/006/001</LicenceNumber>
    <ProductName>RHOPHYLAC</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN HUMAN NORMAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012620</DrugIDPK>
    <LicenceNumber>PA0936/015/001</LicenceNumber>
    <ProductName>ALDACTIDE 25 FILM-COATED TABLETS</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1998-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
      <ActiveSubstance>HYDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012621</DrugIDPK>
    <LicenceNumber>PA0936/015/002</LicenceNumber>
    <ProductName>ALDACTIDE 50 FILM-COATED TABLETS</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1998-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
      <ActiveSubstance>HYDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020556</DrugIDPK>
    <LicenceNumber>PA0953/006/001</LicenceNumber>
    <ProductName>BALANCE 1.5% GLUCOSE, 1.25MMOL/L CALCIUM</ProductName>
    <Strength>1.5%/1.25mmol/l</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2005-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014672</DrugIDPK>
    <LicenceNumber>PA0953/005/001</LicenceNumber>
    <ProductName>BALANCE 1.5% GLUCOSE, 1.75MMOL/L CALCIUM</ProductName>
    <Strength>1.5%/1.75mmol/l</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020558</DrugIDPK>
    <LicenceNumber>PA0953/006/002</LicenceNumber>
    <ProductName>BALANCE 2.3% GLUCOSE, 1.25MMOL/L CALCIUM</ProductName>
    <Strength>2.3%/1.25mmol/l</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2005-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014674</DrugIDPK>
    <LicenceNumber>PA0953/005/003</LicenceNumber>
    <ProductName>BALANCE 2.3% GLUCOSE, 1.75MMOL/L CALCIUM</ProductName>
    <Strength>2.3%/1.75mmol/l</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020557</DrugIDPK>
    <LicenceNumber>PA0953/006/003</LicenceNumber>
    <ProductName>BALANCE 4.25% GLUCOSE, 1.25MMOL/L CALCIUM</ProductName>
    <Strength>4.25%/1.25mmol/l</Strength>
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2005-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014673</DrugIDPK>
    <LicenceNumber>PA0953/005/002</LicenceNumber>
    <ProductName>BALANCE 4.25% GLUCOSE, 1.75MMOL/L CALCIUM</ProductName>
    <Strength>4.25%/1.75mmol/l</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2003-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012615</DrugIDPK>
    <LicenceNumber>PA0953/004/001</LicenceNumber>
    <ProductName>BICAVERA</ProductName>
    <Strength>1.5%</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2003-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012616</DrugIDPK>
    <LicenceNumber>PA0953/004/002</LicenceNumber>
    <ProductName>BICAVERA</ProductName>
    <Strength>4.25%</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2003-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012617</DrugIDPK>
    <LicenceNumber>PA0953/004/003</LicenceNumber>
    <ProductName>BICAVERA</ProductName>
    <Strength>2.3%</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2003-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008376</DrugIDPK>
    <LicenceNumber>PA0953/001/001</LicenceNumber>
    <ProductName>CAPD/DPCA 17</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008382</DrugIDPK>
    <LicenceNumber>PA0953/002/001</LicenceNumber>
    <ProductName>CAPD/DPCA 18</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008383</DrugIDPK>
    <LicenceNumber>PA0953/003/001</LicenceNumber>
    <ProductName>CAPD/DPCA 19</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029327</DrugIDPK>
    <LicenceNumber>PA0711/178/001</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029328</DrugIDPK>
    <LicenceNumber>PA0711/178/002</LicenceNumber>
    <ProductName>GEMCITABINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022870</DrugIDPK>
    <LicenceNumber>PA0108/030/002</LicenceNumber>
    <ProductName>LIPANTIL MICRO</ProductName>
    <Strength>140</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019466</DrugIDPK>
    <LicenceNumber>PA1077/106/003</LicenceNumber>
    <ProductName>ADARTREL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024846</DrugIDPK>
    <LicenceNumber>PA1077/037/007</LicenceNumber>
    <ProductName>REQUIP-MODUTAB</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010967</DrugIDPK>
    <LicenceNumber>PA1005/001/002</LicenceNumber>
    <ProductName>ALMIRID 20MG TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Polichem S.A.</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOTAMINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010966</DrugIDPK>
    <LicenceNumber>PA1005/001/001</LicenceNumber>
    <ProductName>ALMIRID 5MG CAPSULES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Polichem S.A.</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOCRYPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006623</DrugIDPK>
    <LicenceNumber>PA0863/006/001</LicenceNumber>
    <ProductName>PINETARSOL</ProductName>
    <Strength>2.30</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026476</DrugIDPK>
    <LicenceNumber>PA1288/004/001</LicenceNumber>
    <ProductName>AGIOLAX PICO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Madaus GmbH</PAHolder>
    <AuthorisedDate>2007-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PICOSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027490</DrugIDPK>
    <LicenceNumber>PA1474/007/001</LicenceNumber>
    <ProductName>ETHINYLESTRADIOL/DROSPIRENONE LEON FARMA &amp; PLACEBO</ProductName>
    <Strength>0.02 / 3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Leon Farma, S.A.</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027491</DrugIDPK>
    <LicenceNumber>PA1474/007/002</LicenceNumber>
    <ProductName>ETHINYLESTRADIOL/DROSPIRENONE LEON FARMA &amp; PLACEBO</ProductName>
    <Strength>0.03 / 3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Leon Farma, S.A.</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002403</DrugIDPK>
    <LicenceNumber>PA0048/041/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1988-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002406</DrugIDPK>
    <LicenceNumber>PA0048/041/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1988-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019730</DrugIDPK>
    <LicenceNumber>PA0585/021/001</LicenceNumber>
    <ProductName>EMITAL 4MG FILM-COATED TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019731</DrugIDPK>
    <LicenceNumber>PA0585/021/002</LicenceNumber>
    <ProductName>EMITAL 8MG FILM-COATED TABLETS</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031570</DrugIDPK>
    <LicenceNumber>PA0819/030/001</LicenceNumber>
    <ProductName>PRAVALO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031571</DrugIDPK>
    <LicenceNumber>PA0819/030/002</LicenceNumber>
    <ProductName>PRAVALO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031572</DrugIDPK>
    <LicenceNumber>PA0819/030/003</LicenceNumber>
    <ProductName>PRAVALO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001026</DrugIDPK>
    <LicenceNumber>PA0018/040/001</LicenceNumber>
    <ProductName>INTAL 5</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1985-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022507</DrugIDPK>
    <LicenceNumber>PA1038/002/002</LicenceNumber>
    <ProductName>TARDCAPS XL 150 MG</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IXL Pharma Limited</PAHolder>
    <AuthorisedDate>2008-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022506</DrugIDPK>
    <LicenceNumber>PA1038/002/001</LicenceNumber>
    <ProductName>TARDCAPS XL 75 MG</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IXL Pharma Limited</PAHolder>
    <AuthorisedDate>2008-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010251</DrugIDPK>
    <LicenceNumber>PA0111/004/001</LicenceNumber>
    <ProductName>AMOXICILLIN SANDOZ</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010252</DrugIDPK>
    <LicenceNumber>PA0111/004/002</LicenceNumber>
    <ProductName>AMOXICILLIN SANDOZ</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008888</DrugIDPK>
    <LicenceNumber>PA0899/011/001</LicenceNumber>
    <ProductName>RIDAURA TILTAB 3MG FILM-COATED TABLETS</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2000-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AURANOFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009079</DrugIDPK>
    <LicenceNumber>PA0401/003/001</LicenceNumber>
    <ProductName>MACROTEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Amersham Health Srl</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN MACRO AGGREGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021907</DrugIDPK>
    <LicenceNumber>PA0126/168/001</LicenceNumber>
    <ProductName>ISTAMEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021908</DrugIDPK>
    <LicenceNumber>PA0126/168/002</LicenceNumber>
    <ProductName>ISTAMEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028743</DrugIDPK>
    <LicenceNumber>PA0126/181/001</LicenceNumber>
    <ProductName>LOSAMEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE (I.N.N.)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028744</DrugIDPK>
    <LicenceNumber>PA0126/181/002</LicenceNumber>
    <ProductName>LOSAMEL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE (I.N.N.)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028745</DrugIDPK>
    <LicenceNumber>PA0126/181/003</LicenceNumber>
    <ProductName>LOSAMEL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE (I.N.N.)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003861</DrugIDPK>
    <LicenceNumber>PA0126/032/001</LicenceNumber>
    <ProductName>OXYTETRACYCLINE 250 MILLIGRAM TABLETS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019761</DrugIDPK>
    <LicenceNumber>PA0126/142/001</LicenceNumber>
    <ProductName>ONDANSETRON 2 MG/ML. SOLUTION FOR INJECTION</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995031499</DrugIDPK>
    <LicenceNumber>PA1410/052/002</LicenceNumber>
    <ProductName>RENNIE LIQUID RELIEF, ORAL SUSPENSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2009-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>LIGHT MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028505</DrugIDPK>
    <LicenceNumber>PA1498/001/001</LicenceNumber>
    <ProductName>TRADOREC XL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HGH Regulatory Sciences Limited</PAHolder>
    <AuthorisedDate>2009-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028506</DrugIDPK>
    <LicenceNumber>PA1498/001/002</LicenceNumber>
    <ProductName>TRADOREC XL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HGH Regulatory Sciences Limited</PAHolder>
    <AuthorisedDate>2009-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027438</DrugIDPK>
    <LicenceNumber>PA1486/001/001</LicenceNumber>
    <ProductName>LEMOWAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>acis Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2008-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027439</DrugIDPK>
    <LicenceNumber>PA1486/001/002</LicenceNumber>
    <ProductName>LEMOWAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>acis Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2008-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027440</DrugIDPK>
    <LicenceNumber>PA1486/001/003</LicenceNumber>
    <ProductName>LEMOWAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>acis Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2008-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027441</DrugIDPK>
    <LicenceNumber>PA1485/001/001</LicenceNumber>
    <ProductName>SOOTHOME</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>mibe GmbH Arzneimittel</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027442</DrugIDPK>
    <LicenceNumber>PA1485/001/002</LicenceNumber>
    <ProductName>SOOTHOME</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>mibe GmbH Arzneimittel</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027443</DrugIDPK>
    <LicenceNumber>PA1485/001/003</LicenceNumber>
    <ProductName>SOOTHOME</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>mibe GmbH Arzneimittel</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006076</DrugIDPK>
    <LicenceNumber>PA0407/007/001</LicenceNumber>
    <ProductName>COMBUDORON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>1994-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARNICA MONTANA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020982</DrugIDPK>
    <LicenceNumber>PA0711/096/001</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020983</DrugIDPK>
    <LicenceNumber>PA0711/096/002</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020984</DrugIDPK>
    <LicenceNumber>PA0711/096/003</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020985</DrugIDPK>
    <LicenceNumber>PA0711/096/004</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004531</DrugIDPK>
    <LicenceNumber>PA0013/070/003</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007246</DrugIDPK>
    <LicenceNumber>PA0258/038/001</LicenceNumber>
    <ProductName>HONEY &amp; LEMON MELTUS COUGH LICTUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1990-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020055</DrugIDPK>
    <LicenceNumber>PA0740/010/001</LicenceNumber>
    <ProductName>PROPOFOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020056</DrugIDPK>
    <LicenceNumber>PA0740/010/002</LicenceNumber>
    <ProductName>PROPOFOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020057</DrugIDPK>
    <LicenceNumber>PA0740/010/003</LicenceNumber>
    <ProductName>PROPOFOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020058</DrugIDPK>
    <LicenceNumber>PA0740/010/004</LicenceNumber>
    <ProductName>PROPOFOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Genthon BV</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011628</DrugIDPK>
    <LicenceNumber>PA0012/093/001</LicenceNumber>
    <ProductName>RESOVIST</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol.</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERUCARBOTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020352</DrugIDPK>
    <LicenceNumber>PA1261/001/001</LicenceNumber>
    <ProductName>BOCASAN</ProductName>
    <Strength>68.635/29.415</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Gillette Group UK Ltd</PAHolder>
    <AuthorisedDate>2005-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PERBORATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005774</DrugIDPK>
    <LicenceNumber>PA0748/031/001</LicenceNumber>
    <ProductName>SIBELIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-04-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUNARIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009178</DrugIDPK>
    <LicenceNumber>PA0074/049/001</LicenceNumber>
    <ProductName>SILCOCK'S BASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1997-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2010-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020603</DrugIDPK>
    <LicenceNumber>PPA0465/172/001</LicenceNumber>
    <ProductName>CALPOL 120MG/5ML SUGAR FREE INFANT ORAL SUSPENSION</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011546</DrugIDPK>
    <LicenceNumber>PPA0465/079/001A</LicenceNumber>
    <ProductName>CATAFLAM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>mg/tablet</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC POTASSIUM</ActiveSubstance>
      <ActiveSubstance>TITANIUM DIOXIDE (E171)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008842</DrugIDPK>
    <LicenceNumber>PA0240/020/001</LicenceNumber>
    <ProductName>CHROMIUM [51CR] EDTA INJECTION ,CHROMIUM [51CR] ED</ProductName>
    <Strength>3.7</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHROMIUM [CR-51] EDTA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Hospital use only radiopharmaceutical agent</SupplyComments>
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021402</DrugIDPK>
    <LicenceNumber>PPA0465/179/001</LicenceNumber>
    <ProductName>DELTACORTRIL ENTERIC</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020991</DrugIDPK>
    <LicenceNumber>PPA0465/175/001</LicenceNumber>
    <ProductName>DEPO-PROVERA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014826</DrugIDPK>
    <LicenceNumber>PPA0465/085/001A</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007562</DrugIDPK>
    <LicenceNumber>PA0748/025/010</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>40000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1999-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022061</DrugIDPK>
    <LicenceNumber>PA0735/010/001</LicenceNumber>
    <ProductName>HEXVIX</ProductName>
    <Strength>85</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>2007-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv/Soln/Intravesical Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEXAMINOLEVULINATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019182</DrugIDPK>
    <LicenceNumber>PPA0465/145/001A</LicenceNumber>
    <ProductName>LEVONELLE</ProductName>
    <Strength>750mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021194</DrugIDPK>
    <LicenceNumber>PPA0465/177/001</LicenceNumber>
    <ProductName>LOCOID</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE BUTYRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021195</DrugIDPK>
    <LicenceNumber>PPA0465/177/002</LicenceNumber>
    <ProductName>LOCOID LIPOCREAM</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE BUTYRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019876</DrugIDPK>
    <LicenceNumber>PPA0465/154/001</LicenceNumber>
    <ProductName>MERCILON</ProductName>
    <Strength>150/20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019988</DrugIDPK>
    <LicenceNumber>PPA0465/127/002</LicenceNumber>
    <ProductName>SEREVENT DISKUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021561</DrugIDPK>
    <LicenceNumber>PPA0465/182/001</LicenceNumber>
    <ProductName>XANAX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021562</DrugIDPK>
    <LicenceNumber>PPA0465/182/002</LicenceNumber>
    <ProductName>XANAX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021563</DrugIDPK>
    <LicenceNumber>PPA0465/182/003</LicenceNumber>
    <ProductName>XANAX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021031</DrugIDPK>
    <LicenceNumber>PA1287/001/003</LicenceNumber>
    <ProductName>NAVELBINE 40 MG SOFT CAPSULE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PIERRE FABRE Ltd</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINORELBINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029051</DrugIDPK>
    <LicenceNumber>PA0126/180/001</LicenceNumber>
    <ProductName>PIPERACILLIN/TAZOBACTAM STRAGEN</ProductName>
    <Strength>2/0.250</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003230</DrugIDPK>
    <LicenceNumber>PA0073/102/001</LicenceNumber>
    <ProductName>AGELAN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003188</DrugIDPK>
    <LicenceNumber>PA0073/060/001</LicenceNumber>
    <ProductName>ANTIMET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003183</DrugIDPK>
    <LicenceNumber>PA0073/057/001</LicenceNumber>
    <ProductName>FOLIC ACID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018884</DrugIDPK>
    <LicenceNumber>PA0736/001/004</LicenceNumber>
    <ProductName>HEMOHES 10%</ProductName>
    <Strength>10%</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018883</DrugIDPK>
    <LicenceNumber>PA0736/001/003</LicenceNumber>
    <ProductName>HEMOHES 6%</ProductName>
    <Strength>6%</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2005-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003898</DrugIDPK>
    <LicenceNumber>PA0126/056/002</LicenceNumber>
    <ProductName>METRONIDE 400MG TABLETS</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016278</DrugIDPK>
    <LicenceNumber>PA1077/082/003</LicenceNumber>
    <ProductName>VALTREX</ProductName>
    <Strength>1000mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALACICLOVIR HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029417</DrugIDPK>
    <LicenceNumber>PA0540/037/004</LicenceNumber>
    <ProductName>CLAFORAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013424</DrugIDPK>
    <LicenceNumber>PA0022/069/011</LicenceNumber>
    <ProductName>PREMIQUE LD</ProductName>
    <Strength>0.45/1.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019664</DrugIDPK>
    <LicenceNumber>PA0678/106/002</LicenceNumber>
    <ProductName>BEECHAMS COLD &amp; FLU BLACKCURRANT POWDER</ProductName>
    <Strength>600/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in a maximum pack size of 10 sachets. Only one pack should be supplied on each occasion of purchase.</SupplyComments>
    <WithdrawalDate>2009-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019663</DrugIDPK>
    <LicenceNumber>PA0678/106/003</LicenceNumber>
    <ProductName>BEECHAMS COLD &amp; FLU LEMON WITH HONEY</ProductName>
    <Strength>600/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in a maximum pack size of 10 sachets.</SupplyComments>
    <WithdrawalDate>2009-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019228</DrugIDPK>
    <LicenceNumber>PA0678/104/001</LicenceNumber>
    <ProductName>BEECHAMS MAX STRENGTH COLD AND FLU</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028041</DrugIDPK>
    <LicenceNumber>PA1469/001/001</LicenceNumber>
    <ProductName>LERCANIDIPINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPNE HCI, ANHYDR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028042</DrugIDPK>
    <LicenceNumber>PA1469/001/002</LicenceNumber>
    <ProductName>LERCANIDIPINE HYDROCHLORIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPNE HCI, ANHYDR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005279</DrugIDPK>
    <LicenceNumber>PA0167/098/006</LicenceNumber>
    <ProductName>CLINIMIX N12G20</ProductName>
    <Strength>7/20</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005276</DrugIDPK>
    <LicenceNumber>PA0167/098/003</LicenceNumber>
    <ProductName>CLINIMIX N12G20E</ProductName>
    <Strength>7/20</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005280</DrugIDPK>
    <LicenceNumber>PA0167/098/007</LicenceNumber>
    <ProductName>CLINIMIX N14G30</ProductName>
    <Strength>8.5/30</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005281</DrugIDPK>
    <LicenceNumber>PA0167/098/008</LicenceNumber>
    <ProductName>CLINIMIX N17G35</ProductName>
    <Strength>10/35</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005278</DrugIDPK>
    <LicenceNumber>PA0167/098/005</LicenceNumber>
    <ProductName>CLINIMIX N17G35E</ProductName>
    <Strength>10/35</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005274</DrugIDPK>
    <LicenceNumber>PA0167/098/001</LicenceNumber>
    <ProductName>CLINIMIX N9G15E</ProductName>
    <Strength>5.5/15</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023097</DrugIDPK>
    <LicenceNumber>PA0915/014/001</LicenceNumber>
    <ProductName>RADLINN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023098</DrugIDPK>
    <LicenceNumber>PA0915/014/002</LicenceNumber>
    <ProductName>RADLINN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023099</DrugIDPK>
    <LicenceNumber>PA0915/014/003</LicenceNumber>
    <ProductName>RADLINN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023100</DrugIDPK>
    <LicenceNumber>PA0915/014/004</LicenceNumber>
    <ProductName>RADLINN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023101</DrugIDPK>
    <LicenceNumber>PA0915/014/005</LicenceNumber>
    <ProductName>RADLINN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023102</DrugIDPK>
    <LicenceNumber>PA0915/014/006</LicenceNumber>
    <ProductName>RADLINN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003896</DrugIDPK>
    <LicenceNumber>PA0126/055/004</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>20 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003943</DrugIDPK>
    <LicenceNumber>PA0126/081/001</LicenceNumber>
    <ProductName>PONMEL 250</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003944</DrugIDPK>
    <LicenceNumber>PA0126/081/002</LicenceNumber>
    <ProductName>PONMEL 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022438</DrugIDPK>
    <LicenceNumber>PA1294/003/001</LicenceNumber>
    <ProductName>PACLITAXEL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Stragen UK Limited</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014466</DrugIDPK>
    <LicenceNumber>PA0711/044/001</LicenceNumber>
    <ProductName>CEDINE 200 MG FILM-COATED TABLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2001-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005120</DrugIDPK>
    <LicenceNumber>PA0251/011/001</LicenceNumber>
    <ProductName>LIMCLAIR CONCENTRATE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1991-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRISODIUM EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018435</DrugIDPK>
    <LicenceNumber>PA0748/052/003</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>2004-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007136</DrugIDPK>
    <LicenceNumber>PA0251/010/001</LicenceNumber>
    <ProductName>LEDCLAIR STERILE SODIUM CALCIUM EDETATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CALCIUM EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012229</DrugIDPK>
    <LicenceNumber>PA0408/055/001</LicenceNumber>
    <ProductName>BELLZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020995</DrugIDPK>
    <LicenceNumber>PA0711/098/002</LicenceNumber>
    <ProductName>DOXANE</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008871</DrugIDPK>
    <LicenceNumber>PA0013/095/001</LicenceNumber>
    <ProductName>ESTALIS 50/250</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008872</DrugIDPK>
    <LicenceNumber>PA0013/096/001</LicenceNumber>
    <ProductName>ESTALIS SEQUI</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022117</DrugIDPK>
    <LicenceNumber>PA0013/096/002</LicenceNumber>
    <ProductName>SEQUIDOT</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018239</DrugIDPK>
    <LicenceNumber>PA0126/130/001</LicenceNumber>
    <ProductName>ORATAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2004-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018240</DrugIDPK>
    <LicenceNumber>PA0126/130/002</LicenceNumber>
    <ProductName>ORATAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2004-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021206</DrugIDPK>
    <LicenceNumber>PA1304/001/001</LicenceNumber>
    <ProductName>TAMSULAS</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003166</DrugIDPK>
    <LicenceNumber>PA0068/011/001</LicenceNumber>
    <ProductName>VECTARION</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1984-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALMITRINE BISMESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016326</DrugIDPK>
    <LicenceNumber>PA1077/093/008</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000270</DrugIDPK>
    <LicenceNumber>PA0002/007/009</LicenceNumber>
    <ProductName>MYCOSTATIN</ProductName>
    <Strength>25,000</Strength>
    <StrengthMeasurement>Units/Gram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000264</DrugIDPK>
    <LicenceNumber>PA0002/007/002</LicenceNumber>
    <ProductName>MYCOSTATIN</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009813</DrugIDPK>
    <LicenceNumber>PA0736/019/001</LicenceNumber>
    <ProductName>TRACUTIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRON (III) CHLORIDE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CHLORIDE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>CUPRIC CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CHROMIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM SELENITE PENTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM MOLYBDATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002323</DrugIDPK>
    <LicenceNumber>PA0048/004/006</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1976-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000372</DrugIDPK>
    <LicenceNumber>PA0002/052/001</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1985-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019231</DrugIDPK>
    <LicenceNumber>PA0022/089/002</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1994-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022869</DrugIDPK>
    <LicenceNumber>PA0108/030/006</LicenceNumber>
    <ProductName>LIPANTIL SUPRA</ProductName>
    <Strength>160mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003798</DrugIDPK>
    <LicenceNumber>PA0126/027/003</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1992-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008844</DrugIDPK>
    <LicenceNumber>PA0240/023/001</LicenceNumber>
    <ProductName>AMERSCAN HEPTONATE II AGENT</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STANNOUS FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003343</DrugIDPK>
    <LicenceNumber>PA0076/001/001</LicenceNumber>
    <ProductName>DEEP FREEZE CUTANEOUS SPRAY SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>The Mentholatum Company Ltd.</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTANE</ActiveSubstance>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012619</DrugIDPK>
    <LicenceNumber>PA0219/003/002</LicenceNumber>
    <ProductName>NYSTAFORM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Typharm Limited</PAHolder>
    <AuthorisedDate>2000-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026627</DrugIDPK>
    <LicenceNumber>PA1380/027/003</LicenceNumber>
    <ProductName>CIPRALAM 40 MG FILM-COATED TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2007-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE’</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027414</DrugIDPK>
    <LicenceNumber>PA1380/046/001</LicenceNumber>
    <ProductName>COSARTAL</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027417</DrugIDPK>
    <LicenceNumber>PA1380/046/002</LicenceNumber>
    <ProductName>COSARTAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995030595</DrugIDPK>
    <LicenceNumber>PA1380/078/001</LicenceNumber>
    <ProductName>KYFLAM</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024338</DrugIDPK>
    <LicenceNumber>PA1380/009/002</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026616</DrugIDPK>
    <LicenceNumber>PA1380/024/001</LicenceNumber>
    <ProductName>RAMYTE</ProductName>
    <Strength>1.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2007-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029341</DrugIDPK>
    <LicenceNumber>PA1380/063/001</LicenceNumber>
    <ProductName>VELEXOR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029343</DrugIDPK>
    <LicenceNumber>PA1380/063/003</LicenceNumber>
    <ProductName>VELEXOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020161</DrugIDPK>
    <LicenceNumber>PA0540/118/001</LicenceNumber>
    <ProductName>ORUGESIC 2.5% W/W GEL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022786</DrugIDPK>
    <LicenceNumber>PA1380/001/001</LicenceNumber>
    <ProductName>GRANISETRON</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022787</DrugIDPK>
    <LicenceNumber>PA1380/001/002</LicenceNumber>
    <ProductName>GRANISETRON</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002709</DrugIDPK>
    <LicenceNumber>PA0050/043/001</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002711</DrugIDPK>
    <LicenceNumber>PA0050/043/003</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002715</DrugIDPK>
    <LicenceNumber>PA0050/043/007</LicenceNumber>
    <ProductName>MADOPAR CR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1988-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006291</DrugIDPK>
    <LicenceNumber>PA0748/034/001</LicenceNumber>
    <ProductName>ORTHO-GYNEST 0.5MG PESSARIES.</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021322</DrugIDPK>
    <LicenceNumber>PA0711/104/001</LicenceNumber>
    <ProductName>CALCIL 50 MICROGRAM/G CREAM</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2007-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020994</DrugIDPK>
    <LicenceNumber>PA0711/098/001</LicenceNumber>
    <ProductName>DOXANE</ProductName>
    <Strength>1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020996</DrugIDPK>
    <LicenceNumber>PA0711/098/003</LicenceNumber>
    <ProductName>DOXANE</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022346</DrugIDPK>
    <LicenceNumber>PA0711/123/002</LicenceNumber>
    <ProductName>LOSARTAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022348</DrugIDPK>
    <LicenceNumber>PA0711/123/004</LicenceNumber>
    <ProductName>LOSARTAN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014534</DrugIDPK>
    <LicenceNumber>PA0711/011/008</LicenceNumber>
    <ProductName>NIFED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020893</DrugIDPK>
    <LicenceNumber>PA0711/090/001</LicenceNumber>
    <ProductName>OMEPRAZOLE 20MG GASTRO-RESISTANT CAPSULES</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027042</DrugIDPK>
    <LicenceNumber>PA0408/068/001</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027043</DrugIDPK>
    <LicenceNumber>PA0408/068/002</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027044</DrugIDPK>
    <LicenceNumber>PA0408/068/003</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027045</DrugIDPK>
    <LicenceNumber>PA0408/068/004</LicenceNumber>
    <ProductName>QUINAPRIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020017</DrugIDPK>
    <LicenceNumber>PA1046/014/001</LicenceNumber>
    <ProductName>PRAVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020018</DrugIDPK>
    <LicenceNumber>PA1046/014/003</LicenceNumber>
    <ProductName>PRAVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020019</DrugIDPK>
    <LicenceNumber>PA1046/014/002</LicenceNumber>
    <ProductName>PRAVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2005-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026466</DrugIDPK>
    <LicenceNumber>PA1443/001/001</LicenceNumber>
    <ProductName>BALMOSA CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Consumer Ltd.</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015009</DrugIDPK>
    <LicenceNumber>PA0936/089/001</LicenceNumber>
    <ProductName>EDRONAX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2002-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REBOXETINE MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000589</DrugIDPK>
    <LicenceNumber>PA0013/026/001</LicenceNumber>
    <ProductName>VISKALDIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1980-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINDOLOL</ActiveSubstance>
      <ActiveSubstance>CLOPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000554</DrugIDPK>
    <LicenceNumber>PA0013/001/002</LicenceNumber>
    <ProductName>VISKEN</ProductName>
    <Strength>5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINDOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020476</DrugIDPK>
    <LicenceNumber>PA1262/001/001</LicenceNumber>
    <ProductName>NOCUTIL 0.1 MG TABLETS</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gebro Pharma GmbH</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020477</DrugIDPK>
    <LicenceNumber>PA1262/001/002</LicenceNumber>
    <ProductName>NOCUTIL 0.2 MG TABLETS</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gebro Pharma GmbH</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022083</DrugIDPK>
    <LicenceNumber>PA1049/006/001</LicenceNumber>
    <ProductName>ABSTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Kyowa Kirin Ltd</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010003</DrugIDPK>
    <LicenceNumber>PA0986/001/001</LicenceNumber>
    <ProductName>QUIXIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Omrix Biopharmaceuticals S.A.</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Sealant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN CLOTTABLE PROTEIN</ActiveSubstance>
      <ActiveSubstance>HUMAN ALPHA THROMBIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>TRANEXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007363</DrugIDPK>
    <LicenceNumber>PA0126/103/003</LicenceNumber>
    <ProductName>CLAVAMEL 125MG/62.5MG PER 5ML JUNIOR POWDER FOR OR</ProductName>
    <Strength>125/62.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002837</DrugIDPK>
    <LicenceNumber>PA0230/006/001</LicenceNumber>
    <ProductName>PULMOCLASE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB S.A.</PAHolder>
    <AuthorisedDate>1992-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015211</DrugIDPK>
    <LicenceNumber>PA0282/081/001</LicenceNumber>
    <ProductName>EMVASC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015211</DrugIDPK>
    <LicenceNumber>PA0282/081/001</LicenceNumber>
    <ProductName>EMVASC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015212</DrugIDPK>
    <LicenceNumber>PA0282/081/002</LicenceNumber>
    <ProductName>EMVASC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005501</DrugIDPK>
    <LicenceNumber>PA0282/021/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005502</DrugIDPK>
    <LicenceNumber>PA0282/021/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003687</DrugIDPK>
    <LicenceNumber>PA0577/024/001</LicenceNumber>
    <ProductName>GEROTEN</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003688</DrugIDPK>
    <LicenceNumber>PA0577/024/002</LicenceNumber>
    <ProductName>GEROTEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003689</DrugIDPK>
    <LicenceNumber>PA0577/024/003</LicenceNumber>
    <ProductName>GEROTEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022316</DrugIDPK>
    <LicenceNumber>PA0937/009/001</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2007-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010454</DrugIDPK>
    <LicenceNumber>PA0937/002/001</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010455</DrugIDPK>
    <LicenceNumber>PA0937/002/002</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010456</DrugIDPK>
    <LicenceNumber>PA0937/002/003</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010457</DrugIDPK>
    <LicenceNumber>PA0937/002/004</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULPHATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023691</DrugIDPK>
    <LicenceNumber>PA0126/169/008</LicenceNumber>
    <ProductName>PERDAMEL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003312</DrugIDPK>
    <LicenceNumber>PA0074/010/002</LicenceNumber>
    <ProductName>METOCYL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1986-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010698</DrugIDPK>
    <LicenceNumber>PA0970/029/001</LicenceNumber>
    <ProductName>AVLOCLOR TABLETS 250 MG</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROQUINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009329</DrugIDPK>
    <LicenceNumber>PA0970/005/002</LicenceNumber>
    <ProductName>DIPRIVAN 1% W/V EMULSION FOR INJECTION OR INFUSION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008825</DrugIDPK>
    <LicenceNumber>PA0240/016/001</LicenceNumber>
    <ProductName>CYANOCOBALAMIN</ProductName>
    <Strength>18.5 KBq</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYANOCOBALAMIN (57 CO)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007185</DrugIDPK>
    <LicenceNumber>PA0913/008/001</LicenceNumber>
    <ProductName>DHC CONTINUS</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1997-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004542</DrugIDPK>
    <LicenceNumber>PA0013/075/001</LicenceNumber>
    <ProductName>ESTRACOMBI TTS</ProductName>
    <Strength>50/50/250</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004495</DrugIDPK>
    <LicenceNumber>PA0013/083/003</LicenceNumber>
    <ProductName>LOPRESOR SR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005879</DrugIDPK>
    <LicenceNumber>PA0187/061/003</LicenceNumber>
    <ProductName>CABASER 4MG TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028843</DrugIDPK>
    <LicenceNumber>PA1410/036/001</LicenceNumber>
    <ProductName>ASPRO C EFFERVESCENT TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments>General sale in blister packs containing not more than 24 unit dosage forms.    
Retail sale through pharmacies only in blister packs containing not more than 50 unit dosage forms.

The indications should be appropriate for self-diagnosis and self-treatment.  

Promotion to the general public o</SupplyComments>
    <WithdrawalDate>2009-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007783</DrugIDPK>
    <LicenceNumber>PA0937/001/001</LicenceNumber>
    <ProductName>FLUTAPLEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018229</DrugIDPK>
    <LicenceNumber>PA0819/028/001</LicenceNumber>
    <ProductName>SIMVASTATIN SH</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018230</DrugIDPK>
    <LicenceNumber>PA0819/028/002</LicenceNumber>
    <ProductName>SIMVASTATIN SH</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018231</DrugIDPK>
    <LicenceNumber>PA0819/028/003</LicenceNumber>
    <ProductName>SIMVASTATIN SH</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018232</DrugIDPK>
    <LicenceNumber>PA0819/028/004</LicenceNumber>
    <ProductName>SIMVASTATIN SH</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020987</DrugIDPK>
    <LicenceNumber>PA0711/095/001</LicenceNumber>
    <ProductName>AMOXICILLIN/CLAVULANIC ACID 250/125MG FILM-COATED</ProductName>
    <Strength>250/125mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018332</DrugIDPK>
    <LicenceNumber>PA0074/054/003</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>4mg/2ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018333</DrugIDPK>
    <LicenceNumber>PA0074/054/004</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>8mg/4ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019194</DrugIDPK>
    <LicenceNumber>PA0074/061/001</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003750</DrugIDPK>
    <LicenceNumber>PA0409/003/008</LicenceNumber>
    <ProductName>DIAZEPAM RECTUBES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015604</DrugIDPK>
    <LicenceNumber>PA1081/001/001</LicenceNumber>
    <ProductName>SIMVASTATIN CT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CT Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015605</DrugIDPK>
    <LicenceNumber>PA1081/001/002</LicenceNumber>
    <ProductName>SIMVASTATIN CT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CT Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015606</DrugIDPK>
    <LicenceNumber>PA1081/001/003</LicenceNumber>
    <ProductName>SIMVASTATIN CT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CT Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015607</DrugIDPK>
    <LicenceNumber>PA1081/001/004</LicenceNumber>
    <ProductName>SIMVASTATIN CT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CT Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027717</DrugIDPK>
    <LicenceNumber>PA1380/045/001</LicenceNumber>
    <ProductName>PERCARNIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028544</DrugIDPK>
    <LicenceNumber>PA1161/005/001</LicenceNumber>
    <ProductName>PREDENEMA</ProductName>
    <Strength>20 mg, in</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chemidex Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE SODIUM SULFOBENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023145</DrugIDPK>
    <LicenceNumber>PA1380/003/001</LicenceNumber>
    <ProductName>FLUDARABINE PHOSPHATE ACTAVIS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lyophilisate for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDARABINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027350</DrugIDPK>
    <LicenceNumber>PA1380/019/001</LicenceNumber>
    <ProductName>GLEMIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027351</DrugIDPK>
    <LicenceNumber>PA1380/019/002</LicenceNumber>
    <ProductName>GLEMIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027352</DrugIDPK>
    <LicenceNumber>PA1380/019/003</LicenceNumber>
    <ProductName>GLEMIDE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027353</DrugIDPK>
    <LicenceNumber>PA1380/019/004</LicenceNumber>
    <ProductName>GLEMIDE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022833</DrugIDPK>
    <LicenceNumber>PA1384/001/001</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>2008-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023052</DrugIDPK>
    <LicenceNumber>PA1380/004/005</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004162</DrugIDPK>
    <LicenceNumber>PA0007/053/001</LicenceNumber>
    <ProductName>DEXA-RHINASPRAY DUO</ProductName>
    <Strength>120/20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXAMETHASONE ISONICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028754</DrugIDPK>
    <LicenceNumber>PA0405/054/001</LicenceNumber>
    <ProductName>TOPAMAT FILM COATED TABLETS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028755</DrugIDPK>
    <LicenceNumber>PA0405/054/002</LicenceNumber>
    <ProductName>TOPAMAT FILM COATED TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028756</DrugIDPK>
    <LicenceNumber>PA0405/054/003</LicenceNumber>
    <ProductName>TOPAMAT FILM COATED TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028757</DrugIDPK>
    <LicenceNumber>PA0405/054/004</LicenceNumber>
    <ProductName>TOPAMAT FILM COATED TABLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2008-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021805</DrugIDPK>
    <LicenceNumber>PA0688/012/001</LicenceNumber>
    <ProductName>RESPINTEL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021806</DrugIDPK>
    <LicenceNumber>PA0688/012/002</LicenceNumber>
    <ProductName>RESPINTEL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021807</DrugIDPK>
    <LicenceNumber>PA0688/012/007</LicenceNumber>
    <ProductName>RESPINTEL</ProductName>
    <Strength>6.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021808</DrugIDPK>
    <LicenceNumber>PA0688/012/006</LicenceNumber>
    <ProductName>RESPINTEL</ProductName>
    <Strength>4.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021809</DrugIDPK>
    <LicenceNumber>PA0688/012/005</LicenceNumber>
    <ProductName>RESPINTEL</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021810</DrugIDPK>
    <LicenceNumber>PA0688/012/004</LicenceNumber>
    <ProductName>RESPINTEL</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021811</DrugIDPK>
    <LicenceNumber>PA0688/012/003</LicenceNumber>
    <ProductName>RESPINTEL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020446</DrugIDPK>
    <LicenceNumber>PA0688/006/001</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020447</DrugIDPK>
    <LicenceNumber>PA0688/006/002</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020448</DrugIDPK>
    <LicenceNumber>PA0688/006/003</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020449</DrugIDPK>
    <LicenceNumber>PA0688/006/004</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020450</DrugIDPK>
    <LicenceNumber>PA0688/006/005</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020451</DrugIDPK>
    <LicenceNumber>PA0688/006/006</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020452</DrugIDPK>
    <LicenceNumber>PA0688/006/007</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021987</DrugIDPK>
    <LicenceNumber>PA0711/114/001</LicenceNumber>
    <ProductName>GALTAM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021988</DrugIDPK>
    <LicenceNumber>PA0711/114/002</LicenceNumber>
    <ProductName>GALTAM</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021989</DrugIDPK>
    <LicenceNumber>PA0711/114/003</LicenceNumber>
    <ProductName>GALTAM</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020257</DrugIDPK>
    <LicenceNumber>PA0915/012/001</LicenceNumber>
    <ProductName>DOXAZOSIN DISPHAR</ProductName>
    <Strength>1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2005-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020258</DrugIDPK>
    <LicenceNumber>PA0915/012/002</LicenceNumber>
    <ProductName>DOXAZOSIN DISPHAR</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2005-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020259</DrugIDPK>
    <LicenceNumber>PA0915/012/003</LicenceNumber>
    <ProductName>DOXAZOSIN DISPHAR</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2005-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020250</DrugIDPK>
    <LicenceNumber>PA0966/009/005</LicenceNumber>
    <ProductName>HYRAZ 1 MG AND 2 MG TABLETS. TITRATION PACK.</ProductName>
    <Strength>1/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019074</DrugIDPK>
    <LicenceNumber>PA0966/009/004</LicenceNumber>
    <ProductName>HYRAZ 1 MG TABLETS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017324</DrugIDPK>
    <LicenceNumber>PA0966/009/003</LicenceNumber>
    <ProductName>HYRAZ 10 MG TABLETS</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017322</DrugIDPK>
    <LicenceNumber>PA0966/009/001</LicenceNumber>
    <ProductName>HYRAZ 2 MG TABLETS</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017323</DrugIDPK>
    <LicenceNumber>PA0966/009/002</LicenceNumber>
    <ProductName>HYRAZ 5 MG TABLETS</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017801</DrugIDPK>
    <LicenceNumber>PA0966/012/001</LicenceNumber>
    <ProductName>QUINAPRO</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017802</DrugIDPK>
    <LicenceNumber>PA0966/012/002</LicenceNumber>
    <ProductName>QUINAPRO</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017803</DrugIDPK>
    <LicenceNumber>PA0966/012/003</LicenceNumber>
    <ProductName>QUINAPRO</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017804</DrugIDPK>
    <LicenceNumber>PA0966/012/004</LicenceNumber>
    <ProductName>QUINAPRO</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008852</DrugIDPK>
    <LicenceNumber>PA0240/026/001</LicenceNumber>
    <ProductName>INDIUM OXINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Radio-Pharm Precursor</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDIUM OXINE (IN-111)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019318</DrugIDPK>
    <LicenceNumber>PA0100/001/007</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <Strength>500000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN MESILATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021610</DrugIDPK>
    <LicenceNumber>PPA1328/038/001</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER 100/6 INHALATION POWDER</ProductName>
    <Strength>100/4.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020616</DrugIDPK>
    <LicenceNumber>PA1272/001/001</LicenceNumber>
    <ProductName>SYNERCID</ProductName>
    <Strength>150mg/350m</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monarch Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINUPRISTIN</ActiveSubstance>
      <ActiveSubstance>DALFOPRISTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019356</DrugIDPK>
    <LicenceNumber>PA1077/105/001</LicenceNumber>
    <ProductName>DUAGEN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DUTASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021612</DrugIDPK>
    <LicenceNumber>PPA1328/034/001</LicenceNumber>
    <ProductName>SERC</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019432</DrugIDPK>
    <LicenceNumber>PA1027/002/002</LicenceNumber>
    <ProductName>WINRHO SDF</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Cangene Europe Limited</PAHolder>
    <AuthorisedDate>2005-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTI-D IMMUNOGLOBULIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019433</DrugIDPK>
    <LicenceNumber>PA1027/002/003</LicenceNumber>
    <ProductName>WINRHO SDF</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Cangene Europe Limited</PAHolder>
    <AuthorisedDate>2005-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTI-D IMMUNOGLOBULIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014852</DrugIDPK>
    <LicenceNumber>PA0002/074/001</LicenceNumber>
    <ProductName>REVIA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALTREXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017555</DrugIDPK>
    <LicenceNumber>PA1081/002/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CT Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017556</DrugIDPK>
    <LicenceNumber>PA1081/002/002</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CT Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017557</DrugIDPK>
    <LicenceNumber>PA1081/002/003</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CT Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020621</DrugIDPK>
    <LicenceNumber>PA1063/022/001</LicenceNumber>
    <ProductName>SUMATRIPTAN NICHE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2006-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020622</DrugIDPK>
    <LicenceNumber>PA1063/022/002</LicenceNumber>
    <ProductName>SUMATRIPTAN NICHE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2006-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020333</DrugIDPK>
    <LicenceNumber>PA0372/010/001</LicenceNumber>
    <ProductName>MELOXICAM</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>2007-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020334</DrugIDPK>
    <LicenceNumber>PA0372/010/002</LicenceNumber>
    <ProductName>MELOXICAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>2007-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005733</DrugIDPK>
    <LicenceNumber>PA0678/061/001</LicenceNumber>
    <ProductName>SOLPAFLEX SUSTAINED RELEASE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019814</DrugIDPK>
    <LicenceNumber>PA0585/019/002</LicenceNumber>
    <ProductName>CHOLSTAT 20MG TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019812</DrugIDPK>
    <LicenceNumber>PA0585/019/003</LicenceNumber>
    <ProductName>CHOLSTAT 40MG TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018909</DrugIDPK>
    <LicenceNumber>PA0118/048/001</LicenceNumber>
    <ProductName>FORTINOL LA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Prolonged Rel.</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARTEOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018910</DrugIDPK>
    <LicenceNumber>PA0118/048/002</LicenceNumber>
    <ProductName>FORTINOL LA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Prolonged Rel.</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARTEOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009017</DrugIDPK>
    <LicenceNumber>PA0022/078/001</LicenceNumber>
    <ProductName>MENINGITEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2000-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENINGOCOCCAL POLYSACCHARIDE GROUP C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015035</DrugIDPK>
    <LicenceNumber>PA0050/068/025</LicenceNumber>
    <ProductName>ROFERON-A PRE-FILLED SYRINGE 18MIU/0.5ML</ProductName>
    <Strength>18 MIU/0.5</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017295</DrugIDPK>
    <LicenceNumber>PA0988/002/001</LicenceNumber>
    <ProductName>GAMMADERM 200MG/G CREAM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Dr. August Wolff GmbH &amp; Co.</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003482</DrugIDPK>
    <LicenceNumber>PA0593/012/002</LicenceNumber>
    <ProductName>RANITISTAD 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010075</DrugIDPK>
    <LicenceNumber>PA0988/001/001</LicenceNumber>
    <ProductName>PSORIMED</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dr. August Wolff GmbH &amp; Co.</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019255</DrugIDPK>
    <LicenceNumber>PA0535/006/008</LicenceNumber>
    <ProductName>REMINYL XL (STARTER PACK)</ProductName>
    <Strength>8&amp;16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2004-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027981</DrugIDPK>
    <LicenceNumber>PA0711/161/005</LicenceNumber>
    <ProductName>VEDIXAL 150 MG TABLETS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027977</DrugIDPK>
    <LicenceNumber>PA0711/161/001</LicenceNumber>
    <ProductName>VEDIXAL 25 MG TABLETS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027979</DrugIDPK>
    <LicenceNumber>PA0711/161/003</LicenceNumber>
    <ProductName>VEDIXAL 50 MG TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011755</DrugIDPK>
    <LicenceNumber>PA0282/078/001</LicenceNumber>
    <ProductName>EQUORAL</ProductName>
    <Strength>100mg/mL</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016289</DrugIDPK>
    <LicenceNumber>PA0282/078/002</LicenceNumber>
    <ProductName>EQUORAL</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016290</DrugIDPK>
    <LicenceNumber>PA0282/078/003</LicenceNumber>
    <ProductName>EQUORAL</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016291</DrugIDPK>
    <LicenceNumber>PA0282/078/004</LicenceNumber>
    <ProductName>EQUORAL</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018717</DrugIDPK>
    <LicenceNumber>PA0521/014/001</LicenceNumber>
    <ProductName>GAMMANORM</ProductName>
    <Strength>165</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>2004-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN G</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018823</DrugIDPK>
    <LicenceNumber>PPA0465/132/002A</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <Strength>50 mcg/g</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002127</DrugIDPK>
    <LicenceNumber>PA0043/006/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000287</DrugIDPK>
    <LicenceNumber>PA0002/008/002</LicenceNumber>
    <ProductName>GRANEODIN OINTMENT</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000334</DrugIDPK>
    <LicenceNumber>PA0002/034/002</LicenceNumber>
    <ProductName>PRONESTYL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCAINAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019641</DrugIDPK>
    <LicenceNumber>PA0372/009/001</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>2006-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019642</DrugIDPK>
    <LicenceNumber>PA0372/009/002</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>2006-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022514</DrugIDPK>
    <LicenceNumber>PA1332/008/001</LicenceNumber>
    <ProductName>ZOPICLONE</ProductName>
    <Strength>3.75 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021654</DrugIDPK>
    <LicenceNumber>PA1327/001/001</LicenceNumber>
    <ProductName>ALPROX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008800</DrugIDPK>
    <LicenceNumber>PA0240/008/002</LicenceNumber>
    <ProductName>META-IODOBENZYLGUANIDINE</ProductName>
    <Strength>9.25-18.5</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOBENGUANE CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008832</DrugIDPK>
    <LicenceNumber>PA0240/018/002</LicenceNumber>
    <ProductName>SODIUM IODIDE</ProductName>
    <Strength>925 MBq/ml</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IODIDE (131 I)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008834</DrugIDPK>
    <LicenceNumber>PA0240/018/003</LicenceNumber>
    <ProductName>SODIUM IODIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IODIDE (131 I)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008830</DrugIDPK>
    <LicenceNumber>PA0240/018/001</LicenceNumber>
    <ProductName>SODIUM IODIDE</ProductName>
    <Strength>37 MBq/ml</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IODIDE (131 I)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002751</DrugIDPK>
    <LicenceNumber>PA0240/031/001</LicenceNumber>
    <ProductName>THERACAP</ProductName>
    <Strength>37-5500 MBq</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IODIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000302</DrugIDPK>
    <LicenceNumber>PA0002/018/001</LicenceNumber>
    <ProductName>ADCORTYL IN ORABASE 0.1% W/W OROMUCOSAL PASTE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006625</DrugIDPK>
    <LicenceNumber>PA0501/001/001</LicenceNumber>
    <ProductName>AYRTONS ANTISEPTIC OINTMENT</ProductName>
    <Strength>5/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ayrton Saunders Ltd</PAHolder>
    <AuthorisedDate>1991-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>DICHLOROBENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000290</DrugIDPK>
    <LicenceNumber>PA0002/009/002</LicenceNumber>
    <ProductName>KENACOMB CREAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000289</DrugIDPK>
    <LicenceNumber>PA0002/009/001</LicenceNumber>
    <ProductName>KENACOMB OINTMENT</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000332</DrugIDPK>
    <LicenceNumber>PA0002/033/001</LicenceNumber>
    <ProductName>KENACOMB OTIC OINTMENT.</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021848</DrugIDPK>
    <LicenceNumber>PA1330/002/001</LicenceNumber>
    <ProductName>ALENDRONIC ACID 70MG 'ONCE WEEKLY'</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018949</DrugIDPK>
    <LicenceNumber>PA0943/007/001</LicenceNumber>
    <ProductName>OCCLUSAL LS</ProductName>
    <Strength>17</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2004-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011153</DrugIDPK>
    <LicenceNumber>PA0289/009/001</LicenceNumber>
    <ProductName>DIABEX</ProductName>
    <Strength>1000mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009358</DrugIDPK>
    <LicenceNumber>PA0970/016/001</LicenceNumber>
    <ProductName>PALUDRINE TABLETS 100MG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROGUANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001735</DrugIDPK>
    <LicenceNumber>PA0030/015/002</LicenceNumber>
    <ProductName>VIOFORM HYDROCORTISONE</ProductName>
    <Strength>3/1 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1988-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001734</DrugIDPK>
    <LicenceNumber>PA0030/015/001</LicenceNumber>
    <ProductName>VIOFORM-HYDOCORTISONE</ProductName>
    <Strength>3/1 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1988-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020686</DrugIDPK>
    <LicenceNumber>PA0126/160/002</LicenceNumber>
    <ProductName>BENPROTAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021913</DrugIDPK>
    <LicenceNumber>PPA1328/022/002</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003481</DrugIDPK>
    <LicenceNumber>PA0593/012/001</LicenceNumber>
    <ProductName>RANITISTAD 150</ProductName>
    <Strength>150.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018418</DrugIDPK>
    <LicenceNumber>PPA1151/003/001A</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2004-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018420</DrugIDPK>
    <LicenceNumber>PPA1151/003/002A</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2004-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022351</DrugIDPK>
    <LicenceNumber>PPA1328/074/001</LicenceNumber>
    <ProductName>CIPROXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021459</DrugIDPK>
    <LicenceNumber>PPA1328/004/001</LicenceNumber>
    <ProductName>ZINNAT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026036</DrugIDPK>
    <LicenceNumber>PA1410/015/003</LicenceNumber>
    <ProductName>CLIMARA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026414</DrugIDPK>
    <LicenceNumber>PA1410/017/001</LicenceNumber>
    <ProductName>FLUDARABINE PHOSPHATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDARABINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009579</DrugIDPK>
    <LicenceNumber>PA0899/017/001</LicenceNumber>
    <ProductName>BECLO-RHINO AQUEOUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1999-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022640</DrugIDPK>
    <LicenceNumber>PA0979/032/004</LicenceNumber>
    <ProductName>NUROFEN 200 MG MELTLETS</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2007-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003988</DrugIDPK>
    <LicenceNumber>PA0144/010/001</LicenceNumber>
    <ProductName>ACETOXYL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003990</DrugIDPK>
    <LicenceNumber>PA0144/010/003</LicenceNumber>
    <ProductName>ACETOXYL 10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003989</DrugIDPK>
    <LicenceNumber>PA0144/010/002</LicenceNumber>
    <ProductName>ACETOXYL 5</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004056</DrugIDPK>
    <LicenceNumber>PA0144/028/001</LicenceNumber>
    <ProductName>ACNEGEL</ProductName>
    <Strength>5.3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004000</DrugIDPK>
    <LicenceNumber>PA0144/017/004</LicenceNumber>
    <ProductName>ANTHRANOL 0.4</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003997</DrugIDPK>
    <LicenceNumber>PA0144/017/001</LicenceNumber>
    <ProductName>ANTHRANOL 1.0</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1990-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003998</DrugIDPK>
    <LicenceNumber>PA0144/017/002</LicenceNumber>
    <ProductName>ANTHRANOL 2.0</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1990-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004012</DrugIDPK>
    <LicenceNumber>PA0144/025/001</LicenceNumber>
    <ProductName>BRASIVOL FINE</ProductName>
    <Strength>38</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004013</DrugIDPK>
    <LicenceNumber>PA0144/025/002</LicenceNumber>
    <ProductName>BRASIVOL MEDIUM</ProductName>
    <Strength>52</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004015</DrugIDPK>
    <LicenceNumber>PA0144/012/002</LicenceNumber>
    <ProductName>DRICLOR</ProductName>
    <Strength>0.20</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALDIOXA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006839</DrugIDPK>
    <LicenceNumber>PA0144/022/005</LicenceNumber>
    <ProductName>OILATUM FRAGRANCE FREE</ProductName>
    <Strength>63.4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUID PARAFFIN LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003983</DrugIDPK>
    <LicenceNumber>PA0144/011/008</LicenceNumber>
    <ProductName>PANOXLY 5</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003984</DrugIDPK>
    <LicenceNumber>PA0144/011/009</LicenceNumber>
    <ProductName>PANOXYL 5</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004057</DrugIDPK>
    <LicenceNumber>PA0144/030/001</LicenceNumber>
    <ProductName>POLYTAR ANTI-FUNGAL</ProductName>
    <Strength>1/1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>PYRITHIONE ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016418</DrugIDPK>
    <LicenceNumber>PA0144/035/001</LicenceNumber>
    <ProductName>ROSAC METRONIDAZOLE GEL</ProductName>
    <Strength>0.75</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004004</DrugIDPK>
    <LicenceNumber>PA0144/021/001</LicenceNumber>
    <ProductName>SPECTRABAN 4</ProductName>
    <Strength>3.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PADIMATE O</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004016</DrugIDPK>
    <LicenceNumber>PA0144/027/001</LicenceNumber>
    <ProductName>STIEFEL ACNE</ProductName>
    <Strength>6.37</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soap</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPHONATED OIL</ActiveSubstance>
      <ActiveSubstance>MINERAL OIL EMULSION</ActiveSubstance>
      <ActiveSubstance>SORBITAN MONO-OLETAE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008672</DrugIDPK>
    <LicenceNumber>PA0144/041/001</LicenceNumber>
    <ProductName>STIEFEL ANTI-PERSPIRANT SOLUTION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1990-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004009</DrugIDPK>
    <LicenceNumber>PA0144/023/002</LicenceNumber>
    <ProductName>STIEFEL DRY SKIN</ProductName>
    <Strength>21</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014645</DrugIDPK>
    <LicenceNumber>PA0144/044/001</LicenceNumber>
    <ProductName>STIEFEL EMOLLIENT</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soap</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010146</DrugIDPK>
    <LicenceNumber>PA0144/043/001</LicenceNumber>
    <ProductName>STIEFEL SUNBLOCK LOTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PADIMATE O</ActiveSubstance>
      <ActiveSubstance>AVOBENZONE</ActiveSubstance>
      <ActiveSubstance>ETHYLHEXYL P-METHOXYCINNAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000111</DrugIDPK>
    <LicenceNumber>PA0144/016/002</LicenceNumber>
    <ProductName>STIEMYCIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010347</DrugIDPK>
    <LicenceNumber>PA0566/019/012</LicenceNumber>
    <ProductName>INTRALIPID</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020170</DrugIDPK>
    <LicenceNumber>PA0544/024/002</LicenceNumber>
    <ProductName>M-M-R ™ II POWDER AND SOLVENT FOR SOLUTION FOR INJ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2005-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS LIVE ATTENUATED DERIVED FROM THE EDMONSTON B STRAIN</ActiveSubstance>
      <ActiveSubstance>MUMPS VIRUS - JERYLYNN STRAIN</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (WISTAR RA 27/3 STRAIN) LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002867</DrugIDPK>
    <LicenceNumber>PA0544/024/001</LicenceNumber>
    <ProductName>M-M-RTM II POWDER AND SOLVENT FOR SOLUTION FOR INJ</ProductName>
    <Strength>0.5ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - ENDERS EDMONSTON STRAIN</ActiveSubstance>
      <ActiveSubstance>MUMPS VIRUS - JERYLYNN STRAIN</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS - WISTAR RA27/3 STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009294</DrugIDPK>
    <LicenceNumber>PA0566/023/001</LicenceNumber>
    <ProductName>VAMIN 14 ELECTROLYTE - FREE SOLUTION FOR INFUSION,</ProductName>
    <Strength>500ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009295</DrugIDPK>
    <LicenceNumber>PA0566/023/002</LicenceNumber>
    <ProductName>VAMIN 14 ELECTROLYTE - FREE SOLUTION FOR INFUSION,</ProductName>
    <Strength>1000ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009293</DrugIDPK>
    <LicenceNumber>PA0566/022/002</LicenceNumber>
    <ProductName>VAMIN 14 SOLUTION FOR INFUSION, 1000ML</ProductName>
    <Strength>1000ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLUCONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009292</DrugIDPK>
    <LicenceNumber>PA0566/022/001</LicenceNumber>
    <ProductName>VAMIN 14 SOLUTION FOR INFUSION, 500ML</ProductName>
    <Strength>500ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLUCONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009296</DrugIDPK>
    <LicenceNumber>PA0566/024/001</LicenceNumber>
    <ProductName>VAMIN 18 ELECTROLYTE - FREE SOLUTION FOR INFUSION,</ProductName>
    <Strength>500ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009297</DrugIDPK>
    <LicenceNumber>PA0566/024/002</LicenceNumber>
    <ProductName>VAMIN 18 ELECTROLYTE - FREE SOLUTION FOR INFUSION,</ProductName>
    <Strength>1000ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007935</DrugIDPK>
    <LicenceNumber>PA0566/012/002</LicenceNumber>
    <ProductName>VAMIN 9 GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1997-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007936</DrugIDPK>
    <LicenceNumber>PA0566/012/003</LicenceNumber>
    <ProductName>VAMIN 9 GLUCOSE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1997-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014844</DrugIDPK>
    <LicenceNumber>PA0002/072/001</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014845</DrugIDPK>
    <LicenceNumber>PA0002/072/002</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014846</DrugIDPK>
    <LicenceNumber>PA0002/072/003</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014850</DrugIDPK>
    <LicenceNumber>PA0002/073/001</LicenceNumber>
    <ProductName>CARACE 10 PLUS</ProductName>
    <Strength>10/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2000-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014851</DrugIDPK>
    <LicenceNumber>PA0002/073/002</LicenceNumber>
    <ProductName>CARACE 20 PLUS</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2000-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004450</DrugIDPK>
    <LicenceNumber>PA0170/014/001</LicenceNumber>
    <ProductName>DIDRONEL</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1985-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017465</DrugIDPK>
    <LicenceNumber>PA0818/004/001</LicenceNumber>
    <ProductName>LEVONELLE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>Medimpex (UK) Limited</PAHolder>
    <AuthorisedDate>2003-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008703</DrugIDPK>
    <LicenceNumber>PA0566/019/001</LicenceNumber>
    <ProductName>INTRALIPID 10%,100ML  EMULSION FOR INFUSION</ProductName>
    <Strength>10%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008704</DrugIDPK>
    <LicenceNumber>PA0566/019/002</LicenceNumber>
    <ProductName>INTRALIPID 10%,500ML  EMULSION FOR INFUSION</ProductName>
    <Strength>10%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008705</DrugIDPK>
    <LicenceNumber>PA0566/019/003</LicenceNumber>
    <ProductName>INTRALIPID 20%,100ML  EMULSION FOR INFUSION</ProductName>
    <Strength>20%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008706</DrugIDPK>
    <LicenceNumber>PA0566/019/004</LicenceNumber>
    <ProductName>INTRALIPID 20%,250ML  EMULSION FOR INFUSION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009288</DrugIDPK>
    <LicenceNumber>PA0566/019/007</LicenceNumber>
    <ProductName>INTRALIPID 30%, 333ML  EMULSION FOR INFUSION</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010499</DrugIDPK>
    <LicenceNumber>PA0540/032/002</LicenceNumber>
    <ProductName>BATRAFEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX OLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017911</DrugIDPK>
    <LicenceNumber>PA0013/113/001</LicenceNumber>
    <ProductName>BENTIFEN</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2005-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOTIFEN FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017913</DrugIDPK>
    <LicenceNumber>PA0013/113/002</LicenceNumber>
    <ProductName>BENTIFEN SINGLE DOSE UNIT</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2005-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOTIFEN FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023755</DrugIDPK>
    <LicenceNumber>PA0013/118/004</LicenceNumber>
    <ProductName>CO-TAREG</ProductName>
    <Strength>320/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE, MICRONIZED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023756</DrugIDPK>
    <LicenceNumber>PA0013/118/005</LicenceNumber>
    <ProductName>CO-TAREG</ProductName>
    <Strength>320/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE, MICRONIZED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020222</DrugIDPK>
    <LicenceNumber>PA0013/118/001</LicenceNumber>
    <ProductName>CO-TAREG</ProductName>
    <Strength>80/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2005-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020223</DrugIDPK>
    <LicenceNumber>PA0013/118/002</LicenceNumber>
    <ProductName>CO-TAREG</ProductName>
    <Strength>160/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2005-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020224</DrugIDPK>
    <LicenceNumber>PA0013/118/003</LicenceNumber>
    <ProductName>CO-TAREG</ProductName>
    <Strength>160/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2005-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001102</DrugIDPK>
    <LicenceNumber>PA0021/004/005</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1978-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009826</DrugIDPK>
    <LicenceNumber>PA0979/003/001</LicenceNumber>
    <ProductName>CODIS DISPERSIBLE TABLETS, 500MG ASPIRIN, 8MG CODE</ProductName>
    <Strength>500/8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>6. Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms and subject to the following restrictions: aspirin - maximum dose: 650 mg, aspirin maximum daily dose: 4.0 g; codeine: maximum dose: 20 mg.  

The indications should be appropriate for self-diagno</SupplyComments>
    <WithdrawalDate>2009-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009828</DrugIDPK>
    <LicenceNumber>PA0979/004/001</LicenceNumber>
    <ProductName>DETTOL ANTISEPTIC</ProductName>
    <Strength>0.3/0.3/0.2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>EDETATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009834</DrugIDPK>
    <LicenceNumber>PA0979/008/001</LicenceNumber>
    <ProductName>DISPROL PARACETAMOL ORAL SUSPENSION</ProductName>
    <Strength>120mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009835</DrugIDPK>
    <LicenceNumber>PA0979/008/002</LicenceNumber>
    <ProductName>DISPROL SOLUBLE PARACETAMOL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020460</DrugIDPK>
    <LicenceNumber>PA1249/001/001</LicenceNumber>
    <ProductName>NALCROM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Italchimici S.p.A.</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018711</DrugIDPK>
    <LicenceNumber>PA0013/089/002</LicenceNumber>
    <ProductName>FORADIL CERTIHALER</ProductName>
    <Strength>10mcg</Strength>
    <StrengthMeasurement>Units/Gram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005889</DrugIDPK>
    <LicenceNumber>PA0540/013/001</LicenceNumber>
    <ProductName>ANTHISAN PLUS STING RELIEF (SPRAY)</ProductName>
    <Strength>2/2 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2000-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025663</DrugIDPK>
    <LicenceNumber>PA0585/033/001</LicenceNumber>
    <ProductName>BICALUTAMIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025664</DrugIDPK>
    <LicenceNumber>PA0585/033/002</LicenceNumber>
    <ProductName>BICALUTAMIDE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019813</DrugIDPK>
    <LicenceNumber>PA0585/019/001</LicenceNumber>
    <ProductName>CHOLSTAT 10MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995029115</DrugIDPK>
    <LicenceNumber>PA0540/145/001</LicenceNumber>
    <ProductName>DILTIAZEM HYDROCHLORIDE 60MG PROLONGED - RELEASE T</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017551</DrugIDPK>
    <LicenceNumber>PA0540/138/001</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>1.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017552</DrugIDPK>
    <LicenceNumber>PA0540/138/002</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017554</DrugIDPK>
    <LicenceNumber>PA0540/138/004</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023376</DrugIDPK>
    <LicenceNumber>PA0540/151/001</LicenceNumber>
    <ProductName>MIZOLLEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIZOLASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023346</DrugIDPK>
    <LicenceNumber>PA0585/028/001</LicenceNumber>
    <ProductName>VENLAFAXINE</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023347</DrugIDPK>
    <LicenceNumber>PA0585/028/002</LicenceNumber>
    <ProductName>VENLAFAXINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023348</DrugIDPK>
    <LicenceNumber>PA0585/028/003</LicenceNumber>
    <ProductName>VENLAFAXINE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020390</DrugIDPK>
    <LicenceNumber>PA1255/001/001</LicenceNumber>
    <ProductName>ALUTARD AVANZ</ProductName>
    <Strength>1,000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALLERGAN PHLEUM PRATENSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020391</DrugIDPK>
    <LicenceNumber>PA1255/001/002</LicenceNumber>
    <ProductName>ALUTARD AVANZ</ProductName>
    <Strength>10,000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLERGAN PHLEUM PRATENSE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020392</DrugIDPK>
    <LicenceNumber>PA1255/001/003</LicenceNumber>
    <ProductName>ALUTARD AVANZ</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>2006-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLERGAN PHLEUM PRATENSE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017553</DrugIDPK>
    <LicenceNumber>PA0540/138/003</LicenceNumber>
    <ProductName>LOAVEL</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010655</DrugIDPK>
    <LicenceNumber>PA0968/003/001</LicenceNumber>
    <ProductName>AIRTAL 100MG FILM-COATED TABLETS.</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Almirall, S.A.</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACECLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005645</DrugIDPK>
    <LicenceNumber>PA0289/005/003</LicenceNumber>
    <ProductName>NITRONAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005642</DrugIDPK>
    <LicenceNumber>PA0289/005/001</LicenceNumber>
    <ProductName>NITRONAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005643</DrugIDPK>
    <LicenceNumber>PA0289/005/002</LicenceNumber>
    <ProductName>NITRONAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028949</DrugIDPK>
    <LicenceNumber>PA0540/159/002</LicenceNumber>
    <ProductName>SOLPADOL</ProductName>
    <Strength>500/30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2008-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005312</DrugIDPK>
    <LicenceNumber>PA0748/019/001</LicenceNumber>
    <ProductName>ACI-JEL THERAPEUTIC VAGINAL JELLY</ProductName>
    <Strength>0.93865</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000449</DrugIDPK>
    <LicenceNumber>PA0007/015/002</LicenceNumber>
    <ProductName>ALUPENT EXPECTORANT</ProductName>
    <Strength>10/4 MG/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016330</DrugIDPK>
    <LicenceNumber>PA1077/093/006</LicenceNumber>
    <ProductName>AUGMENTION JUNIOR</ProductName>
    <Strength>125/62.5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026703</DrugIDPK>
    <LicenceNumber>PA1380/028/001</LicenceNumber>
    <ProductName>CICLOSPORIN DUMEX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026704</DrugIDPK>
    <LicenceNumber>PA1380/028/002</LicenceNumber>
    <ProductName>CICLOSPORIN DUMEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026705</DrugIDPK>
    <LicenceNumber>PA1380/028/003</LicenceNumber>
    <ProductName>CICLOSPORIN DUMEX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026700</DrugIDPK>
    <LicenceNumber>PA1380/029/001</LicenceNumber>
    <ProductName>CICLOSPORIN PHARMACHEMIE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026701</DrugIDPK>
    <LicenceNumber>PA1380/029/002</LicenceNumber>
    <ProductName>CICLOSPORIN PHARMACHEMIE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026702</DrugIDPK>
    <LicenceNumber>PA1380/029/003</LicenceNumber>
    <ProductName>CICLOSPORIN PHARMACHEMIE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007054</DrugIDPK>
    <LicenceNumber>PA0868/002/001</LicenceNumber>
    <ProductName>DERMESTRIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007055</DrugIDPK>
    <LicenceNumber>PA0868/002/002</LicenceNumber>
    <ProductName>DERMESTRIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007059</DrugIDPK>
    <LicenceNumber>PA0868/002/003</LicenceNumber>
    <ProductName>DERMESTRIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006037</DrugIDPK>
    <LicenceNumber>PA0417/012/004</LicenceNumber>
    <ProductName>ILIADIN</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006035</DrugIDPK>
    <LicenceNumber>PA0417/012/001</LicenceNumber>
    <ProductName>ILIADIN</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Drops Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006034</DrugIDPK>
    <LicenceNumber>PA0417/012/002</LicenceNumber>
    <ProductName>ILIADIN MINI</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Drops Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006036</DrugIDPK>
    <LicenceNumber>PA0417/012/003</LicenceNumber>
    <ProductName>ILIADIN MINI PAEDIATRIC</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Drops Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005656</DrugIDPK>
    <LicenceNumber>PA0290/013/001</LicenceNumber>
    <ProductName>ISOPTO ALKALINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005655</DrugIDPK>
    <LicenceNumber>PA0290/012/001</LicenceNumber>
    <ProductName>ISOPTO PLAIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000271</DrugIDPK>
    <LicenceNumber>PA0002/007/010</LicenceNumber>
    <ProductName>MYCOSTATIN PASTILLES</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001823</DrugIDPK>
    <LicenceNumber>PA0035/045/001</LicenceNumber>
    <ProductName>PERIACTIN</ProductName>
    <Strength>4 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROHEPTADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995028842</DrugIDPK>
    <LicenceNumber>PA1410/033/001</LicenceNumber>
    <ProductName>ALKA ANTACID</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004926</DrugIDPK>
    <LicenceNumber>PA0030/021/004</LicenceNumber>
    <ProductName>NCH FRUIT G</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1997-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004927</DrugIDPK>
    <LicenceNumber>PA0030/021/005</LicenceNumber>
    <ProductName>NCH FRUIT G</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1997-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004928</DrugIDPK>
    <LicenceNumber>PA0030/021/006</LicenceNumber>
    <ProductName>NCH MINT G</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1997-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004929</DrugIDPK>
    <LicenceNumber>PA0030/021/007</LicenceNumber>
    <ProductName>NCH MINT G</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1997-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009849</DrugIDPK>
    <LicenceNumber>PA0979/013/002</LicenceNumber>
    <ProductName>LEMSIP PHARMACY WITH PHENYLEPHRINE</ProductName>
    <Strength>650/50/10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006791</DrugIDPK>
    <LicenceNumber>PA0043/006/007</LicenceNumber>
    <ProductName>NUROFEN CAPLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006092</DrugIDPK>
    <LicenceNumber>PA0408/012/001</LicenceNumber>
    <ProductName>RIMOXALLIN (AMOXICILLIN ORAL SUSPENSION BP)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1987-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006093</DrugIDPK>
    <LicenceNumber>PA0408/012/002</LicenceNumber>
    <ProductName>RIMOXALLIN (AMOXICILLIN ORAL SUSPENSION BP)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1987-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027155</DrugIDPK>
    <LicenceNumber>PA0585/031/010</LicenceNumber>
    <ProductName>OLANZAPINE PLIVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027261</DrugIDPK>
    <LicenceNumber>PA0540/158/005</LicenceNumber>
    <ProductName>SOLIAN 100MG/ML ORAL SOLUTION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020037</DrugIDPK>
    <LicenceNumber>PA1228/001/001</LicenceNumber>
    <ProductName>STRIANT SR MUCOADHESIVE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ardana Bioscience Limited</PAHolder>
    <AuthorisedDate>2005-04-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021600</DrugIDPK>
    <LicenceNumber>PPA1328/036/001</LicenceNumber>
    <ProductName>SEREVENT INHALER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011119</DrugIDPK>
    <LicenceNumber>PA0540/084/001</LicenceNumber>
    <ProductName>TRITACE 1.25MG CAPSULES</ProductName>
    <Strength>1.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011128</DrugIDPK>
    <LicenceNumber>PA0540/084/004</LicenceNumber>
    <ProductName>TRITACE 10MG CAPSULES</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011124</DrugIDPK>
    <LicenceNumber>PA0540/084/002</LicenceNumber>
    <ProductName>TRITACE 2.5MG CAPSULES</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011125</DrugIDPK>
    <LicenceNumber>PA0540/084/003</LicenceNumber>
    <ProductName>TRITACE 5MG CAPSULES</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1999-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013854</DrugIDPK>
    <LicenceNumber>PA0970/033/001</LicenceNumber>
    <ProductName>BETALOC 200MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013875</DrugIDPK>
    <LicenceNumber>PA0970/040/003</LicenceNumber>
    <ProductName>HEMINEVRIN</ProductName>
    <Strength>31.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMETHIAZOLE EDISILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013874</DrugIDPK>
    <LicenceNumber>PA0970/040/002</LicenceNumber>
    <ProductName>HEMINEVRIN 192 MG CAPSULES</ProductName>
    <Strength>192</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMETHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003895</DrugIDPK>
    <LicenceNumber>PA0809/003/001</LicenceNumber>
    <ProductName>NEOSTIGMINE BROMIDE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lifehealth Limited</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOSTIGMINE BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013925</DrugIDPK>
    <LicenceNumber>PA0970/056/001</LicenceNumber>
    <ProductName>XYLOPROCT</ProductName>
    <Strength>5/0.275</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022116</DrugIDPK>
    <LicenceNumber>PA1130/010/003</LicenceNumber>
    <ProductName>CABEREX 4 MILLIGRAM TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2008-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006410</DrugIDPK>
    <LicenceNumber>PA0876/003/001</LicenceNumber>
    <ProductName>NORFLOCUX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>1998-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020463</DrugIDPK>
    <LicenceNumber>PA0021/055/001</LicenceNumber>
    <ProductName>ALEVE</ProductName>
    <Strength>220.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024304</DrugIDPK>
    <LicenceNumber>PA0585/031/001</LicenceNumber>
    <ProductName>OLANZAPINE PLIVA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024305</DrugIDPK>
    <LicenceNumber>PA0585/031/002</LicenceNumber>
    <ProductName>OLANZAPINE PLIVA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024306</DrugIDPK>
    <LicenceNumber>PA0585/031/003</LicenceNumber>
    <ProductName>OLANZAPINE PLIVA</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024307</DrugIDPK>
    <LicenceNumber>PA0585/031/004</LicenceNumber>
    <ProductName>OLANZAPINE PLIVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027154</DrugIDPK>
    <LicenceNumber>PA0585/031/009</LicenceNumber>
    <ProductName>OLANZAPINE PLIVA</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019643</DrugIDPK>
    <LicenceNumber>PA0372/007/001</LicenceNumber>
    <ProductName>CEFUROXIME SODIUM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019644</DrugIDPK>
    <LicenceNumber>PA0372/007/003</LicenceNumber>
    <ProductName>CEFUROXIME SODIUM</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019645</DrugIDPK>
    <LicenceNumber>PA0372/007/002</LicenceNumber>
    <ProductName>CEFUROXIME SODIUM</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026359</DrugIDPK>
    <LicenceNumber>PA0540/152/001</LicenceNumber>
    <ProductName>NEGRAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALIDIXIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026471</DrugIDPK>
    <LicenceNumber>PA0540/156/003</LicenceNumber>
    <ProductName>PRIADEL</ProductName>
    <Strength>10.4% w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LITHIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019695</DrugIDPK>
    <LicenceNumber>PA0540/123/002</LicenceNumber>
    <ProductName>RYNACROM</ProductName>
    <Strength>2 %w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003996</DrugIDPK>
    <LicenceNumber>PA0818/001/001</LicenceNumber>
    <ProductName>TENSOPRIL</ProductName>
    <Strength>12.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medimpex (UK) Limited</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003997</DrugIDPK>
    <LicenceNumber>PA0818/001/002</LicenceNumber>
    <ProductName>TENSOPRIL</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medimpex (UK) Limited</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003998</DrugIDPK>
    <LicenceNumber>PA0818/001/003</LicenceNumber>
    <ProductName>TENSOPRIL</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medimpex (UK) Limited</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010310</DrugIDPK>
    <LicenceNumber>PA0577/040/002</LicenceNumber>
    <ProductName>GEROTIDE</ProductName>
    <Strength>50/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010309</DrugIDPK>
    <LicenceNumber>PA0577/040/001</LicenceNumber>
    <ProductName>HALF-GEROTIDE</ProductName>
    <Strength>25/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022678</DrugIDPK>
    <LicenceNumber>PA0967/011/001</LicenceNumber>
    <ProductName>LAMIDUS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022679</DrugIDPK>
    <LicenceNumber>PA0967/011/002</LicenceNumber>
    <ProductName>LAMIDUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022680</DrugIDPK>
    <LicenceNumber>PA0967/011/003</LicenceNumber>
    <ProductName>LAMIDUS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022681</DrugIDPK>
    <LicenceNumber>PA0967/011/004</LicenceNumber>
    <ProductName>LAMIDUS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022674</DrugIDPK>
    <LicenceNumber>PA0967/012/001</LicenceNumber>
    <ProductName>LAMOTRIGINE RANBAXY</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022675</DrugIDPK>
    <LicenceNumber>PA0967/012/002</LicenceNumber>
    <ProductName>LAMOTRIGINE RANBAXY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022676</DrugIDPK>
    <LicenceNumber>PA0967/012/003</LicenceNumber>
    <ProductName>LAMOTRIGINE RANBAXY</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022677</DrugIDPK>
    <LicenceNumber>PA0967/012/004</LicenceNumber>
    <ProductName>LAMOTRIGINE RANBAXY</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027090</DrugIDPK>
    <LicenceNumber>PA1471/001/001</LicenceNumber>
    <ProductName>VOMLEZ</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>biomo pharma GmbH</PAHolder>
    <AuthorisedDate>2008-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027091</DrugIDPK>
    <LicenceNumber>PA1471/001/002</LicenceNumber>
    <ProductName>VOMLEZ</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>biomo pharma GmbH</PAHolder>
    <AuthorisedDate>2008-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027092</DrugIDPK>
    <LicenceNumber>PA1471/001/003</LicenceNumber>
    <ProductName>VOMLEZ</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>biomo pharma GmbH</PAHolder>
    <AuthorisedDate>2008-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005974</DrugIDPK>
    <LicenceNumber>PA0577/031/001</LicenceNumber>
    <ProductName>GERAMIL</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1999-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOFEPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013657</DrugIDPK>
    <LicenceNumber>PA0021/052/001</LicenceNumber>
    <ProductName>ALKA RAPID CRYSTALS</ProductName>
    <Strength>500mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2004-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002482</DrugIDPK>
    <LicenceNumber>PA0048/016/001</LicenceNumber>
    <ProductName>BICNU 100 MG POWDER AND SOLVENT FOR SOLUTION FOR I</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1979-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020617</DrugIDPK>
    <LicenceNumber>PA1272/001/002</LicenceNumber>
    <ProductName>SYNERCID</ProductName>
    <Strength>180mg/420m</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monarch Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINUPRISTIN</ActiveSubstance>
      <ActiveSubstance>DALFOPRISTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010190</DrugIDPK>
    <LicenceNumber>PA0172/029/004</LicenceNumber>
    <ProductName>ADVIL JUNIOR</ProductName>
    <Strength>100/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>2002-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020683</DrugIDPK>
    <LicenceNumber>PA1244/002/001</LicenceNumber>
    <ProductName>HYSTREAM</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Europe BV</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020684</DrugIDPK>
    <LicenceNumber>PA1244/001/001</LicenceNumber>
    <ProductName>TAMSULOSIN HYDROCHLORIDE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Europe BV</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007943</DrugIDPK>
    <LicenceNumber>PA0736/016/001</LicenceNumber>
    <ProductName>NUTRIFLEX LIPID PLUS WITHOUT ELECTROLYTES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE HYPROCHLORIDE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003995</DrugIDPK>
    <LicenceNumber>PA0144/014/001</LicenceNumber>
    <ProductName>SARNOL</ProductName>
    <Strength>0.5 0.5 1%w/v</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1989-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015251</DrugIDPK>
    <LicenceNumber>PA0876/005/001</LicenceNumber>
    <ProductName>FLUTAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017805</DrugIDPK>
    <LicenceNumber>PA0876/006/001</LicenceNumber>
    <ProductName>SIMVACUX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>2004-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017806</DrugIDPK>
    <LicenceNumber>PA0876/006/002</LicenceNumber>
    <ProductName>SIMVACUX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>2004-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017807</DrugIDPK>
    <LicenceNumber>PA0876/006/003</LicenceNumber>
    <ProductName>SIMVACUX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>2004-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017808</DrugIDPK>
    <LicenceNumber>PA0876/006/004</LicenceNumber>
    <ProductName>SIMVACUX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>2004-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019206</DrugIDPK>
    <LicenceNumber>PA1178/001/001</LicenceNumber>
    <ProductName>VASTATIFIX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alfred E Tiefenbacher (GmbH &amp; Co. KG)</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019207</DrugIDPK>
    <LicenceNumber>PA1178/001/002</LicenceNumber>
    <ProductName>VASTATIFIX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alfred E Tiefenbacher (GmbH &amp; Co. KG)</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019208</DrugIDPK>
    <LicenceNumber>PA1178/001/003</LicenceNumber>
    <ProductName>VASTATIFIX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alfred E Tiefenbacher (GmbH &amp; Co. KG)</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000407</DrugIDPK>
    <LicenceNumber>PA0007/001/001</LicenceNumber>
    <ProductName>MEXITIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1975-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEXILETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000409</DrugIDPK>
    <LicenceNumber>PA0007/001/003</LicenceNumber>
    <ProductName>MEXITIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1975-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEXILETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000410</DrugIDPK>
    <LicenceNumber>PA0007/001/004</LicenceNumber>
    <ProductName>MEXITIL</ProductName>
    <Strength>250/10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1975-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEXILETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013906</DrugIDPK>
    <LicenceNumber>PA0970/050/001</LicenceNumber>
    <ProductName>PULMICORT INHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013907</DrugIDPK>
    <LicenceNumber>PA0970/050/002</LicenceNumber>
    <ProductName>PULMICORT LS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021381</DrugIDPK>
    <LicenceNumber>PA1285/016/001</LicenceNumber>
    <ProductName>GLIMEPIRIDE 1 MG TABLETS</ProductName>
    <Strength>1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021382</DrugIDPK>
    <LicenceNumber>PA1285/016/002</LicenceNumber>
    <ProductName>GLIMEPIRIDE 2 MG TABLETS</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021383</DrugIDPK>
    <LicenceNumber>PA1285/016/003</LicenceNumber>
    <ProductName>GLIMEPIRIDE 3 MG TABLETS</ProductName>
    <Strength>3mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021384</DrugIDPK>
    <LicenceNumber>PA1285/016/004</LicenceNumber>
    <ProductName>GLIMEPIRIDE 4 MG TABLETS</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017834</DrugIDPK>
    <LicenceNumber>PPA0465/112/001A</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021076</DrugIDPK>
    <LicenceNumber>PA0711/093/001</LicenceNumber>
    <ProductName>CALCIL</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008892</DrugIDPK>
    <LicenceNumber>PA0690/002/001</LicenceNumber>
    <ProductName>NORCHOLESTEROL (131I)</ProductName>
    <Strength>37 MBq</Strength>
    <StrengthMeasurement>M.Bequerel</StrengthMeasurement>
    <PAHolder>Mallinckrodt Medical B.V.</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODOMETHYLNORCHOLESTEROL (I-131)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004497</DrugIDPK>
    <LicenceNumber>PA0013/083/002</LicenceNumber>
    <ProductName>LOPRESOR 100 MG FILM-COATED TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006789</DrugIDPK>
    <LicenceNumber>PA0544/003/001</LicenceNumber>
    <ProductName>MEASAVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023424</DrugIDPK>
    <LicenceNumber>PA1161/003/001</LicenceNumber>
    <ProductName>MEBEVERINE 50MG/5ML SUGAR FREE ORAL SUSPENSION</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Chemidex Pharma Limited</PAHolder>
    <AuthorisedDate>2007-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEBEVERINE PAMOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006787</DrugIDPK>
    <LicenceNumber>PA0544/002/001</LicenceNumber>
    <ProductName>RUBAVAX</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>TCID 50</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020761</DrugIDPK>
    <LicenceNumber>PA0544/002/004</LicenceNumber>
    <ProductName>RUBAVAX VACCINE LIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2006-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015403</DrugIDPK>
    <LicenceNumber>PA1044/004/002</LicenceNumber>
    <ProductName>XYMEL</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kellpharm Limited</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005377</DrugIDPK>
    <LicenceNumber>PA0711/002/004</LicenceNumber>
    <ProductName>CAPTOR</ProductName>
    <Strength>6.25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020718</DrugIDPK>
    <LicenceNumber>PA0711/085/001</LicenceNumber>
    <ProductName>LARIG 5 MG DISPERSIBLE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000300</DrugIDPK>
    <LicenceNumber>PA0002/015/001</LicenceNumber>
    <ProductName>MOTIVAL</ProductName>
    <Strength>10 mg/0.5mg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>FLUPHENAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004059</DrugIDPK>
    <LicenceNumber>PA0144/032/001</LicenceNumber>
    <ProductName>SOLABAN A + B</ProductName>
    <Strength>8/3/2 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PADIMATE O</ActiveSubstance>
      <ActiveSubstance>AVOBENZONE</ActiveSubstance>
      <ActiveSubstance>OXYBENZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020203</DrugIDPK>
    <LicenceNumber>PA1077/093/009</LicenceNumber>
    <ProductName>AUGMENTIN ES</ProductName>
    <Strength>600/42.9</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008256</DrugIDPK>
    <LicenceNumber>PA0281/085/002</LicenceNumber>
    <ProductName>DICLO (ENTERIC-COATED)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1999-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010568</DrugIDPK>
    <LicenceNumber>PA0013/102/001</LicenceNumber>
    <ProductName>TEOPTIC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2001-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARTEOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010569</DrugIDPK>
    <LicenceNumber>PA0013/102/002</LicenceNumber>
    <ProductName>TEOPTIC</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2001-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARTEOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2009-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020695</DrugIDPK>
    <LicenceNumber>PPA0465/173/001</LicenceNumber>
    <ProductName>ATROVENT  UDV'S</ProductName>
    <Strength>250/1</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020694</DrugIDPK>
    <LicenceNumber>PPA0465/173/002</LicenceNumber>
    <ProductName>ATROVENT UDV'S</ProductName>
    <Strength>500/2</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023122</DrugIDPK>
    <LicenceNumber>PPA0465/200/001</LicenceNumber>
    <ProductName>BETALOC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015018</DrugIDPK>
    <LicenceNumber>PA1052/001/001</LicenceNumber>
    <ProductName>CARDIOLITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma Belgium SPRL</PAHolder>
    <AuthorisedDate>2001-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Kit for radiopharmaceutical preparation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STANNOUS CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>TETRAKIS (2-METHOXY ISOBUTYL ISONITRILE) COPPER (I) TETRAFLUOROLBORATE</ActiveSubstance>
      <ActiveSubstance>CYSTEINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010077</DrugIDPK>
    <LicenceNumber>PPA0465/067/001A</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020082</DrugIDPK>
    <LicenceNumber>PPA0465/067/002</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023017</DrugIDPK>
    <LicenceNumber>PPA0465/067/003</LicenceNumber>
    <ProductName>COVERSYL PLUS</ProductName>
    <Strength>4/1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002201</DrugIDPK>
    <LicenceNumber>PPA0465/045/001A</LicenceNumber>
    <ProductName>DIAMICRON</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018226</DrugIDPK>
    <LicenceNumber>PPA0465/126/001A</LicenceNumber>
    <ProductName>DYAZIDE</ProductName>
    <Strength>50/25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMTERENE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014604</DrugIDPK>
    <LicenceNumber>PPA0465/044/002B</LicenceNumber>
    <ProductName>ESTRADERM TTS 50 MICROGRAMS/24HOURS TRANSDERMAL PA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018214</DrugIDPK>
    <LicenceNumber>PPA0465/124/001A</LicenceNumber>
    <ProductName>KLIOGEST</ProductName>
    <Strength>2/1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019858</DrugIDPK>
    <LicenceNumber>PPA0465/152/001</LicenceNumber>
    <ProductName>LEXOTAN</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019859</DrugIDPK>
    <LicenceNumber>PPA0465/152/002</LicenceNumber>
    <ProductName>LEXOTAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003052</DrugIDPK>
    <LicenceNumber>PPA0465/031/003A</LicenceNumber>
    <ProductName>NAPROSYN EC 250 MG TABLETS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021839</DrugIDPK>
    <LicenceNumber>PPA0465/187/001</LicenceNumber>
    <ProductName>NICORETTE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021840</DrugIDPK>
    <LicenceNumber>PPA0465/187/002</LicenceNumber>
    <ProductName>NICORETTE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021841</DrugIDPK>
    <LicenceNumber>PPA0465/187/003</LicenceNumber>
    <ProductName>NICORETTE MINT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021842</DrugIDPK>
    <LicenceNumber>PPA0465/187/004</LicenceNumber>
    <ProductName>NICORETTE MINT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022857</DrugIDPK>
    <LicenceNumber>PPA0465/040/002</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021185</DrugIDPK>
    <LicenceNumber>PPA0465/174/004</LicenceNumber>
    <ProductName>REQUIP</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005967</DrugIDPK>
    <LicenceNumber>PA0748/003/008</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1999-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011544</DrugIDPK>
    <LicenceNumber>PPA0465/078/005A</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019377</DrugIDPK>
    <LicenceNumber>PPA0465/148/002</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>275</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019378</DrugIDPK>
    <LicenceNumber>PPA0465/148/001</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>110</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016559</DrugIDPK>
    <LicenceNumber>PPA0465/102/001A</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>80mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016560</DrugIDPK>
    <LicenceNumber>PPA0465/102/002A</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>160mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019149</DrugIDPK>
    <LicenceNumber>PPA0465/138/001A</LicenceNumber>
    <ProductName>XATRAL 2.5MG TABLETS</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012290</DrugIDPK>
    <LicenceNumber>PPA0465/017/001A</LicenceNumber>
    <ProductName>ZYLORIC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019797</DrugIDPK>
    <LicenceNumber>PA1189/002/001</LicenceNumber>
    <ProductName>CLAROSIP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019798</DrugIDPK>
    <LicenceNumber>PA1189/002/002</LicenceNumber>
    <ProductName>CLAROSIP</ProductName>
    <Strength>187.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019799</DrugIDPK>
    <LicenceNumber>PA1189/002/003</LicenceNumber>
    <ProductName>CLAROSIP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010931</DrugIDPK>
    <LicenceNumber>PA1001/005/001</LicenceNumber>
    <ProductName>FLUVIRIN (INACTIVATED INFLUENZA VACCINE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1998-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/SINGAPORE\6\86 - LIKE STRAIN (H1N1)</ActiveSubstance>
      <ActiveSubstance>A/WUHAN /359/95 (H3N2)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020103</DrugIDPK>
    <LicenceNumber>PA0899/026/001</LicenceNumber>
    <ProductName>LEDERFEN 300 MG TABLETS</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020104</DrugIDPK>
    <LicenceNumber>PA0899/026/002</LicenceNumber>
    <ProductName>LEDERFEN 450 MG TABLETS</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009253</DrugIDPK>
    <LicenceNumber>PA0967/001/001</LicenceNumber>
    <ProductName>BELLRAN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2000-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012108</DrugIDPK>
    <LicenceNumber>PA0437/016/008</LicenceNumber>
    <ProductName>GENTAMICIN INJECTION BP</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2004-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025497</DrugIDPK>
    <LicenceNumber>PA1410/028/001</LicenceNumber>
    <ProductName>CIPROXIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009414</DrugIDPK>
    <LicenceNumber>PA0701/003/001</LicenceNumber>
    <ProductName>TERTROXIN 20 MICROGRAM TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Mercury Pharma Group Limited</PAHolder>
    <AuthorisedDate>1993-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIOTHYRONINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007735</DrugIDPK>
    <LicenceNumber>PA0486/002/001</LicenceNumber>
    <ProductName>CLICKHALER BECLOMETASONE</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007736</DrugIDPK>
    <LicenceNumber>PA0486/002/002</LicenceNumber>
    <ProductName>CLICKHALER BECLOMETASONE</ProductName>
    <Strength>100 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007737</DrugIDPK>
    <LicenceNumber>PA0486/002/003</LicenceNumber>
    <ProductName>CLICKHALER BECLOMETASONE</ProductName>
    <Strength>250 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005619</DrugIDPK>
    <LicenceNumber>PA0486/001/001</LicenceNumber>
    <ProductName>CLICKHALER SALBUTAMOL</ProductName>
    <Strength>95mcg/actu</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>1998-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005370</DrugIDPK>
    <LicenceNumber>PA0261/003/002</LicenceNumber>
    <ProductName>DECA DURABOLIN 25 MG / ML SOLUTION FOR INJECTION (</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005373</DrugIDPK>
    <LicenceNumber>PA0261/003/005</LicenceNumber>
    <ProductName>DECA DURABOLIN 50 MG/ML SOLUTION FOR INJECTION (AM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017411</DrugIDPK>
    <LicenceNumber>PA1044/005/001</LicenceNumber>
    <ProductName>FLUCOMEL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kellpharm Limited</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017412</DrugIDPK>
    <LicenceNumber>PA1044/005/002</LicenceNumber>
    <ProductName>FLUCOMEL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kellpharm Limited</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017413</DrugIDPK>
    <LicenceNumber>PA1044/005/003</LicenceNumber>
    <ProductName>FLUCOMEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kellpharm Limited</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020088</DrugIDPK>
    <LicenceNumber>PA0126/148/001</LicenceNumber>
    <ProductName>OSTEOMEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015147</DrugIDPK>
    <LicenceNumber>PA1044/002/003</LicenceNumber>
    <ProductName>PROFLOXIN 750 MG FILM-COATED TABLETS</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kellpharm Limited</PAHolder>
    <AuthorisedDate>2005-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015404</DrugIDPK>
    <LicenceNumber>PA1044/004/003</LicenceNumber>
    <ProductName>XYMEL</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kellpharm Limited</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003595</DrugIDPK>
    <LicenceNumber>PA0299/014/001</LicenceNumber>
    <ProductName>FLEET MICRO ENEMA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate>1996-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LAURYL SULFOACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022146</DrugIDPK>
    <LicenceNumber>PA0585/024/001</LicenceNumber>
    <ProductName>CARBOPLATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005056</DrugIDPK>
    <LicenceNumber>PA0144/011/011</LicenceNumber>
    <ProductName>PANOXYL AQUACREAM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019697</DrugIDPK>
    <LicenceNumber>PA1189/001/002</LicenceNumber>
    <ProductName>ZYDOL</ProductName>
    <Strength>100mg/ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2004-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005726</DrugIDPK>
    <LicenceNumber>PA0334/001/001</LicenceNumber>
    <ProductName>PHARMATEX OVULE</ProductName>
    <Strength>18.9</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Innothera Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026474</DrugIDPK>
    <LicenceNumber>PA1288/003/001</LicenceNumber>
    <ProductName>COLOFIBRE</ProductName>
    <Strength>65/2.2 %w/</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Madaus GmbH</PAHolder>
    <AuthorisedDate>2007-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISPAGHULA HUSKS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005369</DrugIDPK>
    <LicenceNumber>PA0261/003/001</LicenceNumber>
    <ProductName>DECA DURABOLIN 100MG/ML, SOLUTION FOR INJECTION (A</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1975-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008110</DrugIDPK>
    <LicenceNumber>PA0061/006/001</LicenceNumber>
    <ProductName>NOVIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Unknown</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008111</DrugIDPK>
    <LicenceNumber>PA0061/006/002</LicenceNumber>
    <ProductName>NOVIAL 28</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/w</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005420</DrugIDPK>
    <LicenceNumber>PA0261/009/001</LicenceNumber>
    <ProductName>SUSTANON 100 AMPOULES</ProductName>
    <Strength>20/40/40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE PROPIONATE</ActiveSubstance>
      <ActiveSubstance>TESTOSTERONE PHENYLPROPIONATE</ActiveSubstance>
      <ActiveSubstance>TESTOSTERONE ISOCAPROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005421</DrugIDPK>
    <LicenceNumber>PA0261/009/003</LicenceNumber>
    <ProductName>SUSTANON 250 AMPOULES</ProductName>
    <Strength>30/60/60/1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE PROPIONATE</ActiveSubstance>
      <ActiveSubstance>TESTOSTERONE PHENYLPROPIONATE</ActiveSubstance>
      <ActiveSubstance>TESTOSTERONE ISOCAPROATE</ActiveSubstance>
      <ActiveSubstance>TESTOSTERONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021893</DrugIDPK>
    <LicenceNumber>PA0436/044/003</LicenceNumber>
    <ProductName>EFLAVEX 4 MG TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004922</DrugIDPK>
    <LicenceNumber>PA0030/020/003</LicenceNumber>
    <ProductName>PROFLEX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1996-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027035</DrugIDPK>
    <LicenceNumber>PA1238/002/001</LicenceNumber>
    <ProductName>TUMELIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hennig Arzneimittel GmbH &amp; Co KG</PAHolder>
    <AuthorisedDate>2008-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027036</DrugIDPK>
    <LicenceNumber>PA1238/002/002</LicenceNumber>
    <ProductName>TUMELIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hennig Arzneimittel GmbH &amp; Co KG</PAHolder>
    <AuthorisedDate>2008-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027037</DrugIDPK>
    <LicenceNumber>PA1238/002/003</LicenceNumber>
    <ProductName>TUMELIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hennig Arzneimittel GmbH &amp; Co KG</PAHolder>
    <AuthorisedDate>2008-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016130</DrugIDPK>
    <LicenceNumber>PA1077/035/001</LicenceNumber>
    <ProductName>POLIOMYELITIS LIVE ATTENUATED (ORAL) MONODOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 2</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005731</DrugIDPK>
    <LicenceNumber>PA0334/001/002</LicenceNumber>
    <ProductName>PHARMATEX</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Innothera Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008096</DrugIDPK>
    <LicenceNumber>PA0577/033/001</LicenceNumber>
    <ProductName>GERCOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008097</DrugIDPK>
    <LicenceNumber>PA0577/033/002</LicenceNumber>
    <ProductName>GERCOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008098</DrugIDPK>
    <LicenceNumber>PA0577/033/003</LicenceNumber>
    <ProductName>GERCOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008099</DrugIDPK>
    <LicenceNumber>PA0577/033/004</LicenceNumber>
    <ProductName>GERCOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008100</DrugIDPK>
    <LicenceNumber>PA0577/033/005</LicenceNumber>
    <ProductName>GERCOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008101</DrugIDPK>
    <LicenceNumber>PA0577/033/006</LicenceNumber>
    <ProductName>GERCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025502</DrugIDPK>
    <LicenceNumber>PA1410/028/008</LicenceNumber>
    <ProductName>CIPROXIN ORAL SUSPENSION 250MG/5ML</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995025503</DrugIDPK>
    <LicenceNumber>PA1410/028/009</LicenceNumber>
    <ProductName>CIPROXIN ORAL SUSPENSION FORTE 500 MG/5ML</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2007-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007563</DrugIDPK>
    <LicenceNumber>PA0929/001/001</LicenceNumber>
    <ProductName>METFORMIN GERMANIA</ProductName>
    <Strength>850mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Germania Pharmazeutika GesmbH</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009331</DrugIDPK>
    <LicenceNumber>PA0618/007/001</LicenceNumber>
    <ProductName>CODELLA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1990-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WOOL ALCOHOLS</ActiveSubstance>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005283</DrugIDPK>
    <LicenceNumber>PA0858/001/002</LicenceNumber>
    <ProductName>QUELLADA-M CREAM</ProductName>
    <Strength>1.0 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ultra Chemicals Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006116</DrugIDPK>
    <LicenceNumber>PA0408/020/001</LicenceNumber>
    <ProductName>RIMOXYN NAPROXEN</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006117</DrugIDPK>
    <LicenceNumber>PA0408/020/002</LicenceNumber>
    <ProductName>RIMOXYN NAPROXEN</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006760</DrugIDPK>
    <LicenceNumber>PA0144/040/001</LicenceNumber>
    <ProductName>WARTICON</ProductName>
    <Strength>0.5%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1993-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PODOPHYLLOTOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008067</DrugIDPK>
    <LicenceNumber>PA0593/019/001</LicenceNumber>
    <ProductName>FAMULCO FILM-COATED</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008068</DrugIDPK>
    <LicenceNumber>PA0593/019/002</LicenceNumber>
    <ProductName>FAMULCO FILM-COATED</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006417</DrugIDPK>
    <LicenceNumber>PA0022/069/009</LicenceNumber>
    <ProductName>PREMIQUE CYCLE 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2000-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004829</DrugIDPK>
    <LicenceNumber>PA0823/016/002</LicenceNumber>
    <ProductName>BENADRYL SKIN ALLERGY RELIEF LOTION</ProductName>
    <Strength>1/8/0.1%w/</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019495</DrugIDPK>
    <LicenceNumber>PA0711/070/004</LicenceNumber>
    <ProductName>FENTANYL 100 MICROGRAMS/HOUR TRANSDERMAL PATCH</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019492</DrugIDPK>
    <LicenceNumber>PA0711/070/001</LicenceNumber>
    <ProductName>FENTANYL 25 MICROGRAMS/HOUR TRANSDERMAL PATCH</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019493</DrugIDPK>
    <LicenceNumber>PA0711/070/002</LicenceNumber>
    <ProductName>FENTANYL 50 MICROGRAMS/HOUR TRANSDERMAL PATCH</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019494</DrugIDPK>
    <LicenceNumber>PA0711/070/003</LicenceNumber>
    <ProductName>FENTANYL 75 MICROGRAMS/HOUR TRANSDERMAL PATCH</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011346</DrugIDPK>
    <LicenceNumber>PA0013/107/001</LicenceNumber>
    <ProductName>SALAGEN 5MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2000-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017545</DrugIDPK>
    <LicenceNumber>PA0980/003/001</LicenceNumber>
    <ProductName>ANABACT</ProductName>
    <Strength>0.75%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cambridge Healthcare Supplies Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006244</DrugIDPK>
    <LicenceNumber>PA0043/027/001</LicenceNumber>
    <ProductName>CURATODERM</ProductName>
    <Strength>4 mcg/gr</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACALCITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005147</DrugIDPK>
    <LicenceNumber>PA0858/001/001</LicenceNumber>
    <ProductName>QUELLADA-M</ProductName>
    <Strength>0.5 %w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Ultra Chemicals Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003603</DrugIDPK>
    <LicenceNumber>PA0095/020/001</LicenceNumber>
    <ProductName>LIQUID PARAFFIN BP</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1993-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011429</DrugIDPK>
    <LicenceNumber>PA0971/002/004</LicenceNumber>
    <ProductName>DOBUTAMINE-HAMELN 250 MG/ 5 ML AMPOULE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011427</DrugIDPK>
    <LicenceNumber>PA0971/002/002</LicenceNumber>
    <ProductName>DOBUTAMINE-HAMELN 250 MG/ 50 ML VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011428</DrugIDPK>
    <LicenceNumber>PA0971/002/003</LicenceNumber>
    <ProductName>DOBUTAMINE-HAMELN 250 MG/20 ML AMPOULE</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011426</DrugIDPK>
    <LicenceNumber>PA0971/002/001</LicenceNumber>
    <ProductName>DOBUTAMINE-HAMELN 250 MG/50 ML AMPOULE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>2003-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003766</DrugIDPK>
    <LicenceNumber>PA0115/005/006</LicenceNumber>
    <ProductName>CLOPIXOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZUCLOPENTHIXOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003769</DrugIDPK>
    <LicenceNumber>PA0115/005/010</LicenceNumber>
    <ProductName>CLOPIXOL ACUPHASE 100 MG/2ML SOLUTION FOR INJECTIO</ProductName>
    <Strength>100/2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1990-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZUCLOPENTHIXOL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001828</DrugIDPK>
    <LicenceNumber>PA0035/046/002</LicenceNumber>
    <ProductName>COGENTIN</ProductName>
    <Strength>1 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZATROPINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003741</DrugIDPK>
    <LicenceNumber>PA0115/001/002</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <Strength>40/2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1976-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005650</DrugIDPK>
    <LicenceNumber>PA0748/025/001</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>2000IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005651</DrugIDPK>
    <LicenceNumber>PA0748/025/002</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>4000 iu/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005652</DrugIDPK>
    <LicenceNumber>PA0748/025/003</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>10000IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017745</DrugIDPK>
    <LicenceNumber>PA0521/011/001</LicenceNumber>
    <ProductName>RHESONATIV</ProductName>
    <Strength>1250 IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTI-D IMMUNOGLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019431</DrugIDPK>
    <LicenceNumber>PA1027/002/001</LicenceNumber>
    <ProductName>WINRHO SDF</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Cangene Europe Limited</PAHolder>
    <AuthorisedDate>2005-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTI-D IMMUNOGLOBULIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995026215</DrugIDPK>
    <LicenceNumber>PA1142/012/001</LicenceNumber>
    <ProductName>TOPICYCLINE</ProductName>
    <Strength>0.22 % w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011636</DrugIDPK>
    <LicenceNumber>PA1014/001/001</LicenceNumber>
    <ProductName>COPAXONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLATIRAMER ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001635</DrugIDPK>
    <LicenceNumber>PA0037/063/002</LicenceNumber>
    <ProductName>LEDERFOLIN 350 MG/35ML SOLUTION FOR INJECTION OR I</ProductName>
    <Strength>350 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018492</DrugIDPK>
    <LicenceNumber>PA0408/060/001</LicenceNumber>
    <ProductName>CLINDAMYCIN</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2006-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009415</DrugIDPK>
    <LicenceNumber>PA0701/004/001</LicenceNumber>
    <ProductName>FERSADAY</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharma Group Limited</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005661</DrugIDPK>
    <LicenceNumber>PA0876/001/001</LicenceNumber>
    <ProductName>ACICLOVIR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003789</DrugIDPK>
    <LicenceNumber>PA0320/006/001</LicenceNumber>
    <ProductName>PEROXYL 1.5% MOUTHWASH</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROGEN PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006419</DrugIDPK>
    <LicenceNumber>PA0282/073/001</LicenceNumber>
    <ProductName>NORACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006420</DrugIDPK>
    <LicenceNumber>PA0282/073/002</LicenceNumber>
    <ProductName>NORACE</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006421</DrugIDPK>
    <LicenceNumber>PA0282/073/003</LicenceNumber>
    <ProductName>NORACE</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006422</DrugIDPK>
    <LicenceNumber>PA0282/073/004</LicenceNumber>
    <ProductName>NORACE</ProductName>
    <Strength>20.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010646</DrugIDPK>
    <LicenceNumber>PA0678/012/008</LicenceNumber>
    <ProductName>AUGMENTIN 1000/62.5 MG PROLONGED RELEASE FILM-COAT</ProductName>
    <Strength>562.5/437</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023626</DrugIDPK>
    <LicenceNumber>PA0711/135/001</LicenceNumber>
    <ProductName>FELODIPINE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019264</DrugIDPK>
    <LicenceNumber>PA0711/050/004</LicenceNumber>
    <ProductName>SIVATIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019511</DrugIDPK>
    <LicenceNumber>PA0711/071/001</LicenceNumber>
    <ProductName>TERNAF</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009560</DrugIDPK>
    <LicenceNumber>PA0282/075/001</LicenceNumber>
    <ProductName>ZYNOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011765</DrugIDPK>
    <LicenceNumber>PA0282/075/002</LicenceNumber>
    <ProductName>ZYNOR ALLERGY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015019</DrugIDPK>
    <LicenceNumber>PA1052/002/001</LicenceNumber>
    <ProductName>NEUROLITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma Belgium SPRL</PAHolder>
    <AuthorisedDate>1998-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Radionuclide Generator</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICISATE DIHYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>STANNOUS CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020540</DrugIDPK>
    <LicenceNumber>PA0021/061/001</LicenceNumber>
    <ProductName>BAYER MULTIVITAMIN &amp; MINERAL EFFERVESCENT TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>ZINC CITRATE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027951</DrugIDPK>
    <LicenceNumber>PA1230/002/001</LicenceNumber>
    <ProductName>FUNGSTER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PIERRE FABRE DERMATOLOGIE</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009844</DrugIDPK>
    <LicenceNumber>PA0979/011/003</LicenceNumber>
    <ProductName>GAVISCON LEMON FLAVOUR</ProductName>
    <Strength>500/170/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005158</DrugIDPK>
    <LicenceNumber>PA0057/068/001</LicenceNumber>
    <ProductName>HFA-134A BECLOMETASONE DIPROPIONATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005159</DrugIDPK>
    <LicenceNumber>PA0057/068/002</LicenceNumber>
    <ProductName>HFA-134A BECLOMETASONE DIPROPIONATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005160</DrugIDPK>
    <LicenceNumber>PA0057/068/003</LicenceNumber>
    <ProductName>HFA-134A BECLOMETASONE DIPROPIONATE AUTOHALER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005161</DrugIDPK>
    <LicenceNumber>PA0057/068/004</LicenceNumber>
    <ProductName>HFA-134A BECLOMETASONE DIPROPIONATE AUTOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003990</DrugIDPK>
    <LicenceNumber>PA0144/031/002</LicenceNumber>
    <ProductName>ISOTREX CREAM 0.05%</ProductName>
    <Strength>0.05% w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1998-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003991</DrugIDPK>
    <LicenceNumber>PA0144/031/003</LicenceNumber>
    <ProductName>ISOTREX CREAM 0.10%</ProductName>
    <Strength>0.1% w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1998-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006234</DrugIDPK>
    <LicenceNumber>PA0285/005/005</LicenceNumber>
    <ProductName>SAIZEN  USE WITH SYRINGE &amp; BACTERIOSTATIC SOLVENT</ProductName>
    <Strength>8 mg 0.3%</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1998-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GROWTH HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014467</DrugIDPK>
    <LicenceNumber>PA0711/044/002</LicenceNumber>
    <ProductName>CEDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2001-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004763</DrugIDPK>
    <LicenceNumber>PA0711/009/004</LicenceNumber>
    <ProductName>DICLAC 150 MG PROLONGED-RELEASE TABLETS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018721</DrugIDPK>
    <LicenceNumber>PA0711/057/005</LicenceNumber>
    <ProductName>FLUCOL</ProductName>
    <Strength>100mg/50ml</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018723</DrugIDPK>
    <LicenceNumber>PA0711/057/007</LicenceNumber>
    <ProductName>FLUCOL</ProductName>
    <Strength>400/200</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018218</DrugIDPK>
    <LicenceNumber>PA0711/057/002</LicenceNumber>
    <ProductName>FLUCOL</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2004-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008821</DrugIDPK>
    <LicenceNumber>PA0240/014/001</LicenceNumber>
    <ProductName>GALLIUM CITRATE</ProductName>
    <Strength>37</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALLIUM (67 GA) CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016027</DrugIDPK>
    <LicenceNumber>PA0711/047/001</LicenceNumber>
    <ProductName>LISPRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2003-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017837</DrugIDPK>
    <LicenceNumber>PA0711/052/002</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020894</DrugIDPK>
    <LicenceNumber>PA0711/091/001</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020895</DrugIDPK>
    <LicenceNumber>PA0711/091/002</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020896</DrugIDPK>
    <LicenceNumber>PA0711/091/003</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020897</DrugIDPK>
    <LicenceNumber>PA0711/091/004</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003577</DrugIDPK>
    <LicenceNumber>PA0095/008/004</LicenceNumber>
    <ProductName>RUBEX 100 MG TABLETS</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID, SILICON COATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003578</DrugIDPK>
    <LicenceNumber>PA0095/008/005</LicenceNumber>
    <ProductName>RUBEX 200 MG TABLETS</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID, SILICON COATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003573</DrugIDPK>
    <LicenceNumber>PA0095/008/001</LicenceNumber>
    <ProductName>RUBEX LEMON</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006344</DrugIDPK>
    <LicenceNumber>PA0437/002/001</LicenceNumber>
    <ProductName>SODIUM NITROPRUSSIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1987-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROPRUSSIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019608</DrugIDPK>
    <LicenceNumber>PA0969/007/001</LicenceNumber>
    <ProductName>TERBINAFINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medimpex France S.A.</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008849</DrugIDPK>
    <LicenceNumber>PA0240/025/001</LicenceNumber>
    <ProductName>THALLOUS CHLORIDE</ProductName>
    <Strength>37</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THALLIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003516</DrugIDPK>
    <LicenceNumber>PA0711/016/001</LicenceNumber>
    <ProductName>VERAP</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2001-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003517</DrugIDPK>
    <LicenceNumber>PA0711/016/002</LicenceNumber>
    <ProductName>VERAP</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2001-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005392</DrugIDPK>
    <LicenceNumber>PA0320/008/001</LicenceNumber>
    <ProductName>DURAPHAT 2800 PPM FLUORIDE</ProductName>
    <Strength>0.619</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020094</DrugIDPK>
    <LicenceNumber>PA0043/027/002</LicenceNumber>
    <ProductName>CURATODERM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACALCITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010651</DrugIDPK>
    <LicenceNumber>PA0979/009/003</LicenceNumber>
    <ProductName>FYBOGEL LEMON</ProductName>
    <Strength>3.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISPAGHULA HUSKS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020337</DrugIDPK>
    <LicenceNumber>PA0043/043/001</LicenceNumber>
    <ProductName>GALOXIWAY</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020338</DrugIDPK>
    <LicenceNumber>PA0043/043/002</LicenceNumber>
    <ProductName>GALOXIWAY</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019336</DrugIDPK>
    <LicenceNumber>PA0979/015/007</LicenceNumber>
    <ProductName>GAVISCON LEMON TABLETS 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2004-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019334</DrugIDPK>
    <LicenceNumber>PA0979/015/006</LicenceNumber>
    <ProductName>GAVISCON PEPPERMINT TABLETS 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2004-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004963</DrugIDPK>
    <LicenceNumber>PA0043/004/002</LicenceNumber>
    <ProductName>KARVOL DECONGESTANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>PINE OIL</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
      <ActiveSubstance>PINUS SYLVESTRIS</ActiveSubstance>
      <ActiveSubstance>TERPINEOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000115</DrugIDPK>
    <LicenceNumber>PA0043/006/004</LicenceNumber>
    <ProductName>NUROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2001-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018654</DrugIDPK>
    <LicenceNumber>PA0043/042/001</LicenceNumber>
    <ProductName>STREPSILS CHESTY COUGH</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027686</DrugIDPK>
    <LicenceNumber>PA1332/026/001</LicenceNumber>
    <ProductName>LORAMET</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORMETAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027685</DrugIDPK>
    <LicenceNumber>PA1332/025/001</LicenceNumber>
    <ProductName>NORMISON</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2008-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027687</DrugIDPK>
    <LicenceNumber>PA1332/025/002</LicenceNumber>
    <ProductName>NORMISON</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2008-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027684</DrugIDPK>
    <LicenceNumber>PA1332/024/001</LicenceNumber>
    <ProductName>NOVANTRONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2008-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MITOXANTRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021150</DrugIDPK>
    <LicenceNumber>PA0711/099/001</LicenceNumber>
    <ProductName>VALPROAT</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021151</DrugIDPK>
    <LicenceNumber>PA0711/099/002</LicenceNumber>
    <ProductName>VALPROAT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
      <ActiveSubstance>VALPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021268</DrugIDPK>
    <LicenceNumber>PA1317/001/001</LicenceNumber>
    <ProductName>METRONIDAZOLE/METROVEX</ProductName>
    <Strength>500/100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Gambro Northern Ireland Limited</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008244</DrugIDPK>
    <LicenceNumber>PA0108/023/002</LicenceNumber>
    <ProductName>TEVETEN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001472</DrugIDPK>
    <LicenceNumber>PA0258/046/001</LicenceNumber>
    <ProductName>MEBENDAZOLE TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>2003-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEBENDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022074</DrugIDPK>
    <LicenceNumber>PA1189/004/001</LicenceNumber>
    <ProductName>CONTRAMAL RETARD</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2007-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008318</DrugIDPK>
    <LicenceNumber>PA0549/009/001</LicenceNumber>
    <ProductName>ETHYPHARM KETOPROFEN SR</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008319</DrugIDPK>
    <LicenceNumber>PA0549/009/002</LicenceNumber>
    <ProductName>ETHYPHARM KETOPROFEN SR</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003519</DrugIDPK>
    <LicenceNumber>PA0087/002/004</LicenceNumber>
    <ProductName>SLO-PHYLLIN</ProductName>
    <Strength>60 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003521</DrugIDPK>
    <LicenceNumber>PA0087/002/005</LicenceNumber>
    <ProductName>SLO-PHYLLIN</ProductName>
    <Strength>125 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003523</DrugIDPK>
    <LicenceNumber>PA0087/002/006</LicenceNumber>
    <ProductName>SLO-PHYLLIN</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006038</DrugIDPK>
    <LicenceNumber>PA0417/013/001</LicenceNumber>
    <ProductName>ACTAL</ProductName>
    <Strength>360</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1998-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALEXITOL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007905</DrugIDPK>
    <LicenceNumber>PA0592/003/003</LicenceNumber>
    <ProductName>VARITECT</ProductName>
    <Strength>5g/1250IU/50 ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>IMMUNOGLOBULIN VARICELLA-ZOSTER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007902</DrugIDPK>
    <LicenceNumber>PA0592/003/001</LicenceNumber>
    <ProductName>VARITECT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>IMMUNOGLOBULIN VARICELLA-ZOSTER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001349</DrugIDPK>
    <LicenceNumber>PA0749/003/002</LicenceNumber>
    <ProductName>METHOTREXATE TEVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001345</DrugIDPK>
    <LicenceNumber>PA0749/003/003</LicenceNumber>
    <ProductName>METHOTREXATE TEVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003985</DrugIDPK>
    <LicenceNumber>PA0144/003/001</LicenceNumber>
    <ProductName>LACTICARE</ProductName>
    <Strength>2.5/5.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1977-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PYRROLIDONE CARBOXYLATE</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003434</DrugIDPK>
    <LicenceNumber>PA0144/036/001</LicenceNumber>
    <ProductName>TARMED AF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1998-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>CICLOPIROX OLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020243</DrugIDPK>
    <LicenceNumber>PPA0465/164/003</LicenceNumber>
    <ProductName>DILZEM XL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020244</DrugIDPK>
    <LicenceNumber>PPA0465/164/004</LicenceNumber>
    <ProductName>DILZEM XL</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020867</DrugIDPK>
    <LicenceNumber>PA0021/070/001</LicenceNumber>
    <ProductName>JUNIOR KWELLS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020236</DrugIDPK>
    <LicenceNumber>PA0021/078/002</LicenceNumber>
    <ProductName>RENNIE RAP-EZE ORANGE FLAVOUR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008722</DrugIDPK>
    <LicenceNumber>PA0073/112/015</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006737</DrugIDPK>
    <LicenceNumber>PA0535/001/001</LicenceNumber>
    <ProductName>CALCICHEW D3</ProductName>
    <Strength>500mg/200I</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1993-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020465</DrugIDPK>
    <LicenceNumber>PA0021/076/001</LicenceNumber>
    <ProductName>RENNIE DUO</ProductName>
    <Strength>300/1250/147</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020687</DrugIDPK>
    <LicenceNumber>PA0711/083/001</LicenceNumber>
    <ProductName>ALFU</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020716</DrugIDPK>
    <LicenceNumber>PA1161/001/003</LicenceNumber>
    <ProductName>PONSTAN PAEDIATRIC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Chemidex Pharma Limited</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003826</DrugIDPK>
    <LicenceNumber>PA0271/002/007</LicenceNumber>
    <ProductName>ISOKET RETARD 20MG TABLET PROLONGED RELEASE</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1984-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005487</DrugIDPK>
    <LicenceNumber>PA0271/002/009</LicenceNumber>
    <ProductName>ISOKET RETARD 40</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005111</DrugIDPK>
    <LicenceNumber>PA0251/001/001</LicenceNumber>
    <ProductName>VISCLAIR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1978-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MECYSTEINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014800</DrugIDPK>
    <LicenceNumber>PA0593/035/001</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002483</DrugIDPK>
    <LicenceNumber>PA0048/044/004A</LicenceNumber>
    <ProductName>PARAPLATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1991-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009474</DrugIDPK>
    <LicenceNumber>PA0971/001/001</LicenceNumber>
    <ProductName>FENTANYL-HAMELN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>2000-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021202</DrugIDPK>
    <LicenceNumber>PA0437/055/001</LicenceNumber>
    <ProductName>VINORELBINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2006-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINORELBINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003982</DrugIDPK>
    <LicenceNumber>PA0144/011/010</LicenceNumber>
    <ProductName>PANOXYL 10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1978-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006115</DrugIDPK>
    <LicenceNumber>PA0408/019/001</LicenceNumber>
    <ProductName>RIMARIN CHLORPHENIRAMINE</ProductName>
    <Strength>4 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020009</DrugIDPK>
    <LicenceNumber>PA0711/050/005</LicenceNumber>
    <ProductName>SIVATIN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006781</DrugIDPK>
    <LicenceNumber>PA0855/037/002</LicenceNumber>
    <ProductName>RYTHMODAN</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1999-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001660</DrugIDPK>
    <LicenceNumber>PA0618/017/002</LicenceNumber>
    <ProductName>CARYLDERM</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1993-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBARIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001661</DrugIDPK>
    <LicenceNumber>PA0618/017/001</LicenceNumber>
    <ProductName>CARYLDERM LOTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1993-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBARIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001662</DrugIDPK>
    <LicenceNumber>PA0618/018/001</LicenceNumber>
    <ProductName>SULEO-M</ProductName>
    <Strength>0.5%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1993-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023070</DrugIDPK>
    <LicenceNumber>PA1329/001/001</LicenceNumber>
    <ProductName>DICLOMAX</ProductName>
    <Strength>75mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023071</DrugIDPK>
    <LicenceNumber>PA1329/001/002</LicenceNumber>
    <ProductName>DICLOMAX RETARD</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003987</DrugIDPK>
    <LicenceNumber>PA0144/007/001</LicenceNumber>
    <ProductName>SPECTRABAN 15</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1978-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>P-AMINOBENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>PADIMATE O</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001062</DrugIDPK>
    <LicenceNumber>PA0019/023/002</LicenceNumber>
    <ProductName>HYPOVASE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAZOSIN HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PRAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006048</DrugIDPK>
    <LicenceNumber>PA0892/001/001</LicenceNumber>
    <ProductName>MITOMYCIN-C KYOWA 2 MG, POWDER FOR SOLUTION FOR IN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kyowa Hakko Kirin UK Ltd</PAHolder>
    <AuthorisedDate>2003-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MITOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006050</DrugIDPK>
    <LicenceNumber>PA0892/001/003</LicenceNumber>
    <ProductName>MITOMYCIN-C KYOWA 20 MG, POWDER FOR SOLUTION FOR I</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Kyowa Hakko Kirin UK Ltd</PAHolder>
    <AuthorisedDate>2003-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MITOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004466</DrugIDPK>
    <LicenceNumber>PA0172/011/001</LicenceNumber>
    <ProductName>PREPARATION H</ProductName>
    <Strength>1/3%w/w</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIVE YEAST CELL DERIVATIVE</ActiveSubstance>
      <ActiveSubstance>SHARK-LIVER OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009507</DrugIDPK>
    <LicenceNumber>PA0047/077/005</LicenceNumber>
    <ProductName>PROZAC WEEKLY</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2001-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003601</DrugIDPK>
    <LicenceNumber>PA0748/009/003</LicenceNumber>
    <ProductName>SPORANOX PULSE</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ITRACONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015658</DrugIDPK>
    <LicenceNumber>PA0271/012/001</LicenceNumber>
    <ProductName>BENZAMYCIN</ProductName>
    <Strength>3/5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>2001-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE HYDROUS</ActiveSubstance>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023334</DrugIDPK>
    <LicenceNumber>PA0167/124/003</LicenceNumber>
    <ProductName>HUMAN ALBUMIN 20%</ProductName>
    <Strength>10/50</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002718</DrugIDPK>
    <LicenceNumber>PA0050/047/002</LicenceNumber>
    <ProductName>ROCALTROL 0.5 MICROGRAM CAPSULES</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1980-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017297</DrugIDPK>
    <LicenceNumber>PPA0465/104/001A</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017298</DrugIDPK>
    <LicenceNumber>PPA0465/104/002A</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017299</DrugIDPK>
    <LicenceNumber>PPA0465/104/003A</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003274</DrugIDPK>
    <LicenceNumber>PA0073/115/001</LicenceNumber>
    <ProductName>CALCIUM GLUCONATE</ProductName>
    <Strength>10 %w/v, 1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000049</DrugIDPK>
    <LicenceNumber>PA0686/003/001</LicenceNumber>
    <ProductName>DOTAREM (VIAL)</ProductName>
    <Strength>1396.5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>GUERBET</PAHolder>
    <AuthorisedDate>1996-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOTERIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006007</DrugIDPK>
    <LicenceNumber>PA0385/001/001</LicenceNumber>
    <ProductName>PARACETAMOL TABLETS BP 500 MG</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Wallis Laboratory Ltd</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>As an item for general sale in safety containers with the number of unit dose forms not exceeding 12 per pack. Only one pack should be supplied on each occasion of purchase.     As an item for retail sale through pharmacies only in safety containers with the number of unit dose forms not exceeding 24 per pack. Packs containing more than 24 tablets may be supplied to pharmacies for use by pharmacists, provided the label states that are for dispensing purposes only.     As a prescription-only item in packs containing more than 50 tablets.</SupplyComments>
    <WithdrawalDate>2008-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022558</DrugIDPK>
    <LicenceNumber>PA0899/025/001</LicenceNumber>
    <ProductName>THIOTEPA</ProductName>
    <Strength>15 mg/vial</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2007-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOTEPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995027291</DrugIDPK>
    <LicenceNumber>PA1161/007/001</LicenceNumber>
    <ProductName>FLETCHERS' PHOSPATE</ProductName>
    <Strength>10%w/v, 8%</Strength>
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>Chemidex Pharma Limited</PAHolder>
    <AuthorisedDate>2008-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Enema</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017630</DrugIDPK>
    <LicenceNumber>PA0549/013/001</LicenceNumber>
    <ProductName>SLO-MORPH</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1998-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017631</DrugIDPK>
    <LicenceNumber>PA0549/013/002</LicenceNumber>
    <ProductName>SLO-MORPH</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1998-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017632</DrugIDPK>
    <LicenceNumber>PA0549/013/003</LicenceNumber>
    <ProductName>SLO-MORPH</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1998-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017633</DrugIDPK>
    <LicenceNumber>PA0549/013/004</LicenceNumber>
    <ProductName>SLO-MORPH</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1998-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019800</DrugIDPK>
    <LicenceNumber>PA1189/003/001</LicenceNumber>
    <ProductName>CLARITHROMYCIN GRUNENTHAL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019801</DrugIDPK>
    <LicenceNumber>PA1189/003/003</LicenceNumber>
    <ProductName>CLARITHROMYCIN GRUNENTHAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019802</DrugIDPK>
    <LicenceNumber>PA1189/003/002</LicenceNumber>
    <ProductName>CLARITHROMYCIN GRUNENTHAL</ProductName>
    <Strength>187.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009424</DrugIDPK>
    <LicenceNumber>PA0705/001/001</LicenceNumber>
    <ProductName>ENDOXANA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009426</DrugIDPK>
    <LicenceNumber>PA0705/001/002</LicenceNumber>
    <ProductName>ENDOXANA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018932</DrugIDPK>
    <LicenceNumber>PA0711/059/001</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2004-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018933</DrugIDPK>
    <LicenceNumber>PA0711/059/002</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2004-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014312</DrugIDPK>
    <LicenceNumber>PA1035/001/001</LicenceNumber>
    <ProductName>DURAGLAN</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Jacobsen Pharma &amp; MedTech Advice A/S</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021591</DrugIDPK>
    <LicenceNumber>PA0711/109/001</LicenceNumber>
    <ProductName>PANTOZOL 40MG POWDER FOR SOLUTION FOR INJECTION</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018509</DrugIDPK>
    <LicenceNumber>PA0678/100/002</LicenceNumber>
    <ProductName>DAY NURSE LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2003-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018510</DrugIDPK>
    <LicenceNumber>PA0678/101/002</LicenceNumber>
    <ProductName>SOLPADEINE COLD &amp; FLU LIQUID</ProductName>
    <Strength>1000/60/10 mg /30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2003-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005166</DrugIDPK>
    <LicenceNumber>PA0678/039/004</LicenceNumber>
    <ProductName>PANADOL COLD AND FLU CITRUS 500MG SOLUBLE TABLETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1993-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments>As an item for general sale in a maximum pack size of 12 tablets supplied in blister packs only. Only one pack should be supplied on each occasion of purchase.     As an item for retail sale through pharmacies only in blister packs containing not more than 24 tablets. Not more than two such packs should be supplied to a single patient unless a valid prescription exists.     Packs containing more than 24 tablets may be supplied to pharmacies for use by pharmacists provided the label states that they are for dispensing purposes only.     As a prescription-only item in packs containing more than 50 tablets</SupplyComments>
    <WithdrawalDate>2008-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014746</DrugIDPK>
    <LicenceNumber>PA0144/045/001</LicenceNumber>
    <ProductName>PRURICALM</ProductName>
    <Strength>0.5/0.5/1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>2003-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000083</DrugIDPK>
    <LicenceNumber>PA0437/038/001</LicenceNumber>
    <ProductName>BLEOMYCIN SULPHATE</ProductName>
    <Strength>15000IU/vi</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BLEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003799</DrugIDPK>
    <LicenceNumber>PA0118/032/001</LicenceNumber>
    <ProductName>MINIMS GENTAMICIM SULPHATE</ProductName>
    <Strength>0.3 % w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003793</DrugIDPK>
    <LicenceNumber>PA0118/017/004</LicenceNumber>
    <ProductName>MINIMS PILOCARPINE NITRATE</ProductName>
    <Strength>4.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004496</DrugIDPK>
    <LicenceNumber>PA0013/083/001</LicenceNumber>
    <ProductName>LOPRESOR 50 MG FILM-COATED TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003644</DrugIDPK>
    <LicenceNumber>PA0035/055/001</LicenceNumber>
    <ProductName>MODUCREN</ProductName>
    <Strength>25/2.5/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995024878</DrugIDPK>
    <LicenceNumber>PA1424/001/001</LicenceNumber>
    <ProductName>SITAMIC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BioAlliance Pharma</PAHolder>
    <AuthorisedDate>2008-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006446</DrugIDPK>
    <LicenceNumber>PA0590/016/001</LicenceNumber>
    <ProductName>SILKIS</ProductName>
    <Strength>0.003</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1998-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020871</DrugIDPK>
    <LicenceNumber>PA0021/061/002</LicenceNumber>
    <ProductName>BAYER MULTIVITAMIN &amp; MINERAL FILM COATED TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>ZINC CITRATE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003290</DrugIDPK>
    <LicenceNumber>PA0593/011/002</LicenceNumber>
    <ProductName>ACTOPRIL</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003289</DrugIDPK>
    <LicenceNumber>PA0593/011/001</LicenceNumber>
    <ProductName>ACTOPRIL TABLETS 12.5MG.</ProductName>
    <Strength>12.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003291</DrugIDPK>
    <LicenceNumber>PA0593/011/003</LicenceNumber>
    <ProductName>ACTOPRIL TABLETS 50MG</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021495</DrugIDPK>
    <LicenceNumber>PA1284/008/001</LicenceNumber>
    <ProductName>HENTOM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bentley Pharmaceuticals Ireland Limited</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021496</DrugIDPK>
    <LicenceNumber>PA1284/008/002</LicenceNumber>
    <ProductName>HENTOM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bentley Pharmaceuticals Ireland Limited</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021497</DrugIDPK>
    <LicenceNumber>PA1284/008/003</LicenceNumber>
    <ProductName>HENTOM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bentley Pharmaceuticals Ireland Limited</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009452</DrugIDPK>
    <LicenceNumber>PA0919/004/001</LicenceNumber>
    <ProductName>MENJUGATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>2000-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENINGOCOCCAL POLYSACCHARIDE GROUP C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004565</DrugIDPK>
    <LicenceNumber>PA0013/082/001</LicenceNumber>
    <ProductName>SYMMETREL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1996-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMANTADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000902</DrugIDPK>
    <LicenceNumber>PA0126/097/001</LicenceNumber>
    <ProductName>XANOMEL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1996-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003604</DrugIDPK>
    <LicenceNumber>PA0095/021/001</LicenceNumber>
    <ProductName>CALAMINE B.P.</ProductName>
    <Strength>15, 5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1993-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011392</DrugIDPK>
    <LicenceNumber>PA0775/001/007</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>15/1.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019169</DrugIDPK>
    <LicenceNumber>PA0126/139/001</LicenceNumber>
    <ProductName>MELOXICAM</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019170</DrugIDPK>
    <LicenceNumber>PA0126/139/002</LicenceNumber>
    <ProductName>MELOXICAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006604</DrugIDPK>
    <LicenceNumber>PA0863/005/001</LicenceNumber>
    <ProductName>Q.V. Bath Oil Bath Additive</ProductName>
    <Strength>85</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUID PARAFFIN LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006126</DrugIDPK>
    <LicenceNumber>PA0408/029/003</LicenceNumber>
    <ProductName>RIMATIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008701</DrugIDPK>
    <LicenceNumber>PA0038/071/001</LicenceNumber>
    <ProductName>CHIROCAINE</ProductName>
    <Strength>2.5mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUPIVACAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008702</DrugIDPK>
    <LicenceNumber>PA0038/071/002</LicenceNumber>
    <ProductName>CHIROCAINE</ProductName>
    <Strength>5.0mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUPIVACAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008707</DrugIDPK>
    <LicenceNumber>PA0038/071/003</LicenceNumber>
    <ProductName>CHIROCAINE</ProductName>
    <Strength>7.5mg</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUPIVACAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018275</DrugIDPK>
    <LicenceNumber>PA0002/077/001</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018276</DrugIDPK>
    <LicenceNumber>PA0002/077/002</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018277</DrugIDPK>
    <LicenceNumber>PA0002/077/003</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003587</DrugIDPK>
    <LicenceNumber>PA0618/015/002</LicenceNumber>
    <ProductName>FULL MARKS MOUSSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1998-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOTHRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006731</DrugIDPK>
    <LicenceNumber>PA0593/015/001</LicenceNumber>
    <ProductName>ACYCLOSTAD</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005111</DrugIDPK>
    <LicenceNumber>PA0618/027/002</LicenceNumber>
    <ProductName>MEROCET</ProductName>
    <Strength>0.05/0.045</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1993-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouth Wash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005792</DrugIDPK>
    <LicenceNumber>PA0298/010/005</LicenceNumber>
    <ProductName>AMOXYCILLIN SACHET SUGAR FREE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1993-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002252</DrugIDPK>
    <LicenceNumber>PA0361/009/001</LicenceNumber>
    <ProductName>OMNOPON</ProductName>
    <Strength>15.4, 1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIHYDROCODEINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009399</DrugIDPK>
    <LicenceNumber>PA0710/002/001</LicenceNumber>
    <ProductName>CUPLEX</ProductName>
    <Strength>11+4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Smith &amp; Nephew Pharmaceuticals</PAHolder>
    <AuthorisedDate>1991-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002949</DrugIDPK>
    <LicenceNumber>PA0409/019/001</LicenceNumber>
    <ProductName>METHADONE</ProductName>
    <Strength>1ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHADONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006091</DrugIDPK>
    <LicenceNumber>PA0408/009/001</LicenceNumber>
    <ProductName>RIMAPEN PENICILLIN VK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001787</DrugIDPK>
    <LicenceNumber>PA0035/016/001</LicenceNumber>
    <ProductName>DECADRON 500 MICROGRAM TABLETS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009501</DrugIDPK>
    <LicenceNumber>PA0281/099/002</LicenceNumber>
    <ProductName>CAPRILL</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009502</DrugIDPK>
    <LicenceNumber>PA0281/099/003</LicenceNumber>
    <ProductName>CAPRILL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009503</DrugIDPK>
    <LicenceNumber>PA0281/099/004</LicenceNumber>
    <ProductName>CAPRILL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006346</DrugIDPK>
    <LicenceNumber>PA0863/003/002</LicenceNumber>
    <ProductName>EGODERM</ProductName>
    <Strength>1.0/ 15.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICHTHAMMOL</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005696</DrugIDPK>
    <LicenceNumber>PA0863/003/001</LicenceNumber>
    <ProductName>EGODERM</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>1999-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICHTHAMMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007934</DrugIDPK>
    <LicenceNumber>PA0566/012/001</LicenceNumber>
    <ProductName>VAMIN 9 GLUCOSE, SOLUTION FOR INFUSION 100MLS</ProductName>
    <Strength>100ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE HEPTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004157</DrugIDPK>
    <LicenceNumber>PA0167/010/009A</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE BP 0.02% W/V IRRIGATION SOLU</ProductName>
    <Strength>0.02</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017534</DrugIDPK>
    <LicenceNumber>PPA0465/105/001A</LicenceNumber>
    <ProductName>COMBIVENT METERED</ProductName>
    <Strength>20/100</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006780</DrugIDPK>
    <LicenceNumber>PA0590/006/001</LicenceNumber>
    <ProductName>DIFFERIN CUTANEOUS SOLUTION 0.1% W/W</ProductName>
    <Strength>0.1%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1993-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ADAPALENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004131</DrugIDPK>
    <LicenceNumber>PA0167/009/001A</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION BP 5% W/V. (VIAFLEX C</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004190</DrugIDPK>
    <LicenceNumber>PA0167/055/005A</LicenceNumber>
    <ProductName>HALF STRENGTH COMPOUND SODIUM LACTATE IV INFUSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001793</DrugIDPK>
    <LicenceNumber>PA0035/021/002</LicenceNumber>
    <ProductName>HYDROCORTONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001644</DrugIDPK>
    <LicenceNumber>PA0696/009/002</LicenceNumber>
    <ProductName>OROVITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004310</DrugIDPK>
    <LicenceNumber>PA0167/039/001A</LicenceNumber>
    <ProductName>PLASMA-LYTE M (ELECTROLYTE SOLUTION) WITH 5 % W/V</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003986</DrugIDPK>
    <LicenceNumber>PA0144/004/001</LicenceNumber>
    <ProductName>POLYTAR PLUS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>CADE OIL</ActiveSubstance>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004146</DrugIDPK>
    <LicenceNumber>PA0167/052/005A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE AND SODIUM CHLORIDE</ProductName>
    <Strength>0.2/0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004132</DrugIDPK>
    <LicenceNumber>PA0167/051/007A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE GLUCOSE</ProductName>
    <Strength>0.2/5.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002181</DrugIDPK>
    <LicenceNumber>PA0046/033/001</LicenceNumber>
    <ProductName>PROTAMINE SULPHATE LEO</ProductName>
    <Strength>10 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTAMINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007455</DrugIDPK>
    <LicenceNumber>PA0047/077/003</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>60mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1994-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003646</DrugIDPK>
    <LicenceNumber>PA0102/015/001</LicenceNumber>
    <ProductName>PYRALVEX OROMUCOSAL SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004257</DrugIDPK>
    <LicenceNumber>PA0167/054/001A</LicenceNumber>
    <ProductName>RINGERS INTRAVENOUS INFUSION</ProductName>
    <Strength>8600/ 330/300 mg/l</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004080</DrugIDPK>
    <LicenceNumber>PA0167/050/001A</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.18% W/V AND 4.0% W/V GLUCOSE INT</ProductName>
    <Strength>0.18/4.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004114</DrugIDPK>
    <LicenceNumber>PA0167/008/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9% W/V.</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005573</DrugIDPK>
    <LicenceNumber>PA0590/013/003</LicenceNumber>
    <ProductName>STERAX</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005571</DrugIDPK>
    <LicenceNumber>PA0590/013/001</LicenceNumber>
    <ProductName>STERAX CREAM 0.05% W/W</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005572</DrugIDPK>
    <LicenceNumber>PA0590/013/002</LicenceNumber>
    <ProductName>STERAX CUTANEOUS EMULSION 0.05% W/W</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005497</DrugIDPK>
    <LicenceNumber>PA0590/012/001</LicenceNumber>
    <ProductName>TETRALYSAL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LYMECYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010220</DrugIDPK>
    <LicenceNumber>PA0654/009/001</LicenceNumber>
    <ProductName>NEUROBION</ProductName>
    <Strength>100mg, 1mg</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005568</DrugIDPK>
    <LicenceNumber>PA0308/012/001</LicenceNumber>
    <ProductName>GELCOTAR</ProductName>
    <Strength>1.25/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Quinoderm Ltd</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION STRONG</ActiveSubstance>
      <ActiveSubstance>CADE OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020251</DrugIDPK>
    <LicenceNumber>PA1155/005/001</LicenceNumber>
    <ProductName>HIOXYL</ProductName>
    <Strength>1.5%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROGEN PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003156</DrugIDPK>
    <LicenceNumber>PA0073/039/001</LicenceNumber>
    <ProductName>BOESTROL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIETHYLSTILBESTROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003158</DrugIDPK>
    <LicenceNumber>PA0073/039/002</LicenceNumber>
    <ProductName>BOESTROL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIETHYLSTILBESTROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007872</DrugIDPK>
    <LicenceNumber>PA0566/004/001</LicenceNumber>
    <ProductName>COMPLEVEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>TAURINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>MALIC ACID</ActiveSubstance>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>POTASSIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SOYA BEAN OIL EPOXIDISED</ActiveSubstance>
      <ActiveSubstance>LECITHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003138</DrugIDPK>
    <LicenceNumber>PA0073/019/001</LicenceNumber>
    <ProductName>PALFIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMORAMIDE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003235</DrugIDPK>
    <LicenceNumber>PA0073/104/003</LicenceNumber>
    <ProductName>CHLORPROMAZINE BP</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003236</DrugIDPK>
    <LicenceNumber>PA0073/104/004</LicenceNumber>
    <ProductName>CHLORPROMAZINE BP</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003237</DrugIDPK>
    <LicenceNumber>PA0073/104/005</LicenceNumber>
    <ProductName>CHLORPROMAZINE BP</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005831</DrugIDPK>
    <LicenceNumber>PA0299/010/001</LicenceNumber>
    <ProductName>CLINICIDE LOTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate>1987-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBARIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005832</DrugIDPK>
    <LicenceNumber>PA0299/011/001</LicenceNumber>
    <ProductName>CLINIMAL LOTION</ProductName>
    <Strength>0.5%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate>1993-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006757</DrugIDPK>
    <LicenceNumber>PA0073/150/001</LicenceNumber>
    <ProductName>TRAMEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018271</DrugIDPK>
    <LicenceNumber>PA0711/058/003</LicenceNumber>
    <ProductName>PRAVITIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2004-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003891</DrugIDPK>
    <LicenceNumber>PA0126/051/002</LicenceNumber>
    <ProductName>TETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020604</DrugIDPK>
    <LicenceNumber>PA0711/078/001</LicenceNumber>
    <ProductName>AMLODIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020605</DrugIDPK>
    <LicenceNumber>PA0711/078/003</LicenceNumber>
    <ProductName>AMLODIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009018</DrugIDPK>
    <LicenceNumber>PA0144/042/001</LicenceNumber>
    <ProductName>ISOTREXOL CREAM 0.05 %</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009019</DrugIDPK>
    <LicenceNumber>PA0144/042/002</LicenceNumber>
    <ProductName>ISOTREXOL CREAM 0.10 %</ProductName>
    <Strength>0.10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011210</DrugIDPK>
    <LicenceNumber>PA0050/067/002</LicenceNumber>
    <ProductName>MOBIFLEX TABLETS 20 MG</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1988-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002295</DrugIDPK>
    <LicenceNumber>PA0050/067/005</LicenceNumber>
    <ProductName>MOBIFLEX VIALS 20MG POWDER AND SOLVENT FOR SOLUTI</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1994-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002671</DrugIDPK>
    <LicenceNumber>PA0050/017/001</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005186</DrugIDPK>
    <LicenceNumber>PA0678/048/001</LicenceNumber>
    <ProductName>ANDREWS ANTACID (ORANGE)</ProductName>
    <Strength>600/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005187</DrugIDPK>
    <LicenceNumber>PA0678/048/002</LicenceNumber>
    <ProductName>ANDREWS ANTACID FRUIT FLAVOURS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>HEAVY MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011112</DrugIDPK>
    <LicenceNumber>PA0540/080/002</LicenceNumber>
    <ProductName>TRENTAL</ProductName>
    <Strength>100/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018210</DrugIDPK>
    <LicenceNumber>PA0126/129/001</LicenceNumber>
    <ProductName>TAZAMEL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2004-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018212</DrugIDPK>
    <LicenceNumber>PA0126/129/003</LicenceNumber>
    <ProductName>TAZAMEL</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2004-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003301</DrugIDPK>
    <LicenceNumber>PA0073/133/002</LicenceNumber>
    <ProductName>VOLOGEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002083</DrugIDPK>
    <LicenceNumber>PA0073/133/004</LicenceNumber>
    <ProductName>VOLOGEN RETARD</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003137</DrugIDPK>
    <LicenceNumber>PA0073/018/001</LicenceNumber>
    <ProductName>PHOLCOLIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001654</DrugIDPK>
    <LicenceNumber>PA0618/013/001</LicenceNumber>
    <ProductName>DERBAC C</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1998-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBARIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001655</DrugIDPK>
    <LicenceNumber>PA0618/013/002</LicenceNumber>
    <ProductName>DERBAC C SHAMPOO</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1998-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBARIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001100</DrugIDPK>
    <LicenceNumber>PA0021/004/003</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001103</DrugIDPK>
    <LicenceNumber>PA0021/004/006</LicenceNumber>
    <ProductName>CANESTEN DERMATOLOGICAL</ProductName>
    <Strength>1%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1978-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010394</DrugIDPK>
    <LicenceNumber>PA0815/003/001</LicenceNumber>
    <ProductName>ORFIRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Desitin Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2000-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020462</DrugIDPK>
    <LicenceNumber>PA0021/074/004</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005621</DrugIDPK>
    <LicenceNumber>PA0285/003/001</LicenceNumber>
    <ProductName>SEROPHENE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1983-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMIFENE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020440</DrugIDPK>
    <LicenceNumber>PA0126/155/001</LicenceNumber>
    <ProductName>SULPROMEL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020441</DrugIDPK>
    <LicenceNumber>PA0126/155/002</LicenceNumber>
    <ProductName>SULPROMEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020442</DrugIDPK>
    <LicenceNumber>PA0126/155/003</LicenceNumber>
    <ProductName>SULPROMEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020443</DrugIDPK>
    <LicenceNumber>PA0126/155/004</LicenceNumber>
    <ProductName>SULPROMEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003190</DrugIDPK>
    <LicenceNumber>PA0073/063/001</LicenceNumber>
    <ProductName>BUFIGEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003191</DrugIDPK>
    <LicenceNumber>PA0073/063/002</LicenceNumber>
    <ProductName>BUFIGEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003192</DrugIDPK>
    <LicenceNumber>PA0073/063/003</LicenceNumber>
    <ProductName>BUFIGEN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001853</DrugIDPK>
    <LicenceNumber>PA0654/003/001</LicenceNumber>
    <ProductName>ESTRADIOL TTS</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009727</DrugIDPK>
    <LicenceNumber>PA0899/018/001</LicenceNumber>
    <ProductName>FORTIPINE LA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004477</DrugIDPK>
    <LicenceNumber>PA0172/023/001</LicenceNumber>
    <ProductName>DENOREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017012</DrugIDPK>
    <LicenceNumber>PA0172/033/001</LicenceNumber>
    <ProductName>ROBITUSSIN JUNIOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017858</DrugIDPK>
    <LicenceNumber>PA0172/033/003</LicenceNumber>
    <ProductName>ROBITUSSIN SOFT PASTILLES FOR DRY COUGH</ProductName>
    <Strength>7.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005734</DrugIDPK>
    <LicenceNumber>PA0336/001/002</LicenceNumber>
    <ProductName>ISOPRINOSINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Newport Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSINE ACEDOBEN DIMEPRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019520</DrugIDPK>
    <LicenceNumber>PA0577/066/001</LicenceNumber>
    <ProductName>AZROMAX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019521</DrugIDPK>
    <LicenceNumber>PA0577/066/002</LicenceNumber>
    <ProductName>AZROMAX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001653</DrugIDPK>
    <LicenceNumber>PA0618/012/001</LicenceNumber>
    <ProductName>COMPLOMENT</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1993-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020264</DrugIDPK>
    <LicenceNumber>PA0985/002/001</LicenceNumber>
    <ProductName>UBIT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Otsuka Pharmaceutical Europe Ltd</PAHolder>
    <AuthorisedDate>2006-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>13C-UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019491</DrugIDPK>
    <LicenceNumber>PA1077/018/001</LicenceNumber>
    <ProductName>ANDROPATCH</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/day</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016791</DrugIDPK>
    <LicenceNumber>PA1046/004/001</LicenceNumber>
    <ProductName>ACICLOVIR</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016793</DrugIDPK>
    <LicenceNumber>PA1046/004/003</LicenceNumber>
    <ProductName>ACICLOVIR DISPERSIBLE BP</ProductName>
    <Strength>800mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1999-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016789</DrugIDPK>
    <LicenceNumber>PA1046/003/001</LicenceNumber>
    <ProductName>AMIODARONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2000-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIODARONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016790</DrugIDPK>
    <LicenceNumber>PA1046/003/002</LicenceNumber>
    <ProductName>AMIODARONE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2000-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIODARONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019620</DrugIDPK>
    <LicenceNumber>PA1046/013/001</LicenceNumber>
    <ProductName>AMISULPRIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019621</DrugIDPK>
    <LicenceNumber>PA1046/013/002</LicenceNumber>
    <ProductName>AMISULPRIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019622</DrugIDPK>
    <LicenceNumber>PA1046/013/003</LicenceNumber>
    <ProductName>AMISULPRIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019623</DrugIDPK>
    <LicenceNumber>PA1046/013/004</LicenceNumber>
    <ProductName>AMISULPRIDE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2004-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016815</DrugIDPK>
    <LicenceNumber>PA1046/009/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2000-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016816</DrugIDPK>
    <LicenceNumber>PA1046/009/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2000-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016817</DrugIDPK>
    <LicenceNumber>PA1046/009/003</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2000-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016813</DrugIDPK>
    <LicenceNumber>PA1046/007/001</LicenceNumber>
    <ProductName>DICLOFENAC SODIUM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016814</DrugIDPK>
    <LicenceNumber>PA1046/007/002</LicenceNumber>
    <ProductName>DICLOFENAC SODIUM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002303</DrugIDPK>
    <LicenceNumber>PA0050/071/001</LicenceNumber>
    <ProductName>FANSIDAR</ProductName>
    <Strength>500/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFADOXINE</ActiveSubstance>
      <ActiveSubstance>PYRIMETHAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020471</DrugIDPK>
    <LicenceNumber>PA0711/080/001</LicenceNumber>
    <ProductName>GLEPID</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020472</DrugIDPK>
    <LicenceNumber>PA0711/080/002</LicenceNumber>
    <ProductName>GLEPID</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020473</DrugIDPK>
    <LicenceNumber>PA0711/080/003</LicenceNumber>
    <ProductName>GLEPID</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020474</DrugIDPK>
    <LicenceNumber>PA0711/080/004</LicenceNumber>
    <ProductName>GLEPID</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020475</DrugIDPK>
    <LicenceNumber>PA0711/080/005</LicenceNumber>
    <ProductName>GLEPID</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020290</DrugIDPK>
    <LicenceNumber>PA1046/015/001</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2006-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020291</DrugIDPK>
    <LicenceNumber>PA1046/015/002</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2006-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020292</DrugIDPK>
    <LicenceNumber>PA1046/015/003</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2006-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020293</DrugIDPK>
    <LicenceNumber>PA1046/015/004</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2006-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020294</DrugIDPK>
    <LicenceNumber>PA1046/015/005</LicenceNumber>
    <ProductName>GLIMEPIRIDE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2006-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016836</DrugIDPK>
    <LicenceNumber>PA1046/011/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2001-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017350</DrugIDPK>
    <LicenceNumber>PA1046/012/001</LicenceNumber>
    <ProductName>RANITIDINE</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017352</DrugIDPK>
    <LicenceNumber>PA1046/012/002</LicenceNumber>
    <ProductName>RANITIDINE</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016810</DrugIDPK>
    <LicenceNumber>PA1046/008/001</LicenceNumber>
    <ProductName>SODIUM VALPROATE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2001-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016811</DrugIDPK>
    <LicenceNumber>PA1046/008/002</LicenceNumber>
    <ProductName>SODIUM VALPROATE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2001-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016812</DrugIDPK>
    <LicenceNumber>PA1046/008/003</LicenceNumber>
    <ProductName>SODIUM VALPROATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2001-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016805</DrugIDPK>
    <LicenceNumber>PA1046/006/001</LicenceNumber>
    <ProductName>TRAMADOL HYDROCHLORIDE</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000314</DrugIDPK>
    <LicenceNumber>PA0002/024/001</LicenceNumber>
    <ProductName>ECOSTATIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000315</DrugIDPK>
    <LicenceNumber>PA0002/024/002</LicenceNumber>
    <ProductName>ECOSTATIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009193</DrugIDPK>
    <LicenceNumber>PA0004/056/001</LicenceNumber>
    <ProductName>ANTISEPTIC THROAT DROPS MENTHOL AND EUCALYPTUS</ProductName>
    <Strength>0.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>2001-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMYLMETACRESOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006292</DrugIDPK>
    <LicenceNumber>PA0748/035/001</LicenceNumber>
    <ProductName>ORTHO-CREME CONTRACEPTIVE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016270</DrugIDPK>
    <LicenceNumber>PA0678/096/001</LicenceNumber>
    <ProductName>SEMPREX</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACRIVASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016002</DrugIDPK>
    <LicenceNumber>PA0437/011/004A</LicenceNumber>
    <ProductName>FLOUROURACIL GLASS VIAL</ProductName>
    <Strength>50mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015633</DrugIDPK>
    <LicenceNumber>PA0506/017/001</LicenceNumber>
    <ProductName>RADIAN B MUSCLE LOTION</ProductName>
    <Strength>1.4%w/w,0.</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>AMMONIUM SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015631</DrugIDPK>
    <LicenceNumber>PA0506/015/001</LicenceNumber>
    <ProductName>RADIAN B MUSCLE RUB CREAM</ProductName>
    <Strength>2.54%w/w,1</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate>1998-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008692</DrugIDPK>
    <LicenceNumber>PA0675/002/001</LicenceNumber>
    <ProductName>DEXEMEL 4%</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Innovata plc</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICODEXTRIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
      <ActiveSubstance>S(+) SODIUM LACTATE 960%W/W SOLUTION</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019483</DrugIDPK>
    <LicenceNumber>PA1077/060/002</LicenceNumber>
    <ProductName>KEMADRIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCYCLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020346</DrugIDPK>
    <LicenceNumber>PA1077/110/001</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020347</DrugIDPK>
    <LicenceNumber>PA1077/110/002</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020348</DrugIDPK>
    <LicenceNumber>PA1077/110/003</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020349</DrugIDPK>
    <LicenceNumber>PA1077/110/004</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020350</DrugIDPK>
    <LicenceNumber>PA1077/110/005</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020351</DrugIDPK>
    <LicenceNumber>PA1077/110/006</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020344</DrugIDPK>
    <LicenceNumber>PA1077/109/001</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020345</DrugIDPK>
    <LicenceNumber>PA1077/109/002</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009259</DrugIDPK>
    <LicenceNumber>PA0863/002/001</LicenceNumber>
    <ProductName>Q.V. SKIN</ProductName>
    <Strength>10/10/5%w/</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>LIQUID PARAFFIN LIGHT</ActiveSubstance>
      <ActiveSubstance>WHITE SOFT PARAFFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009261</DrugIDPK>
    <LicenceNumber>PA0863/001/001</LicenceNumber>
    <ProductName>Q.V.SKIN</ProductName>
    <Strength>5%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WHITE SOFT PARAFFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019460</DrugIDPK>
    <LicenceNumber>PA1077/107/001</LicenceNumber>
    <ProductName>VUNEXIN</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019461</DrugIDPK>
    <LicenceNumber>PA1077/107/002</LicenceNumber>
    <ProductName>VUNEXIN</ProductName>
    <Strength>0.50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019462</DrugIDPK>
    <LicenceNumber>PA1077/107/003</LicenceNumber>
    <ProductName>VUNEXIN</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019463</DrugIDPK>
    <LicenceNumber>PA1077/107/004</LicenceNumber>
    <ProductName>VUNEXIN</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017880</DrugIDPK>
    <LicenceNumber>PA0585/012/001</LicenceNumber>
    <ProductName>PRESINEX</ProductName>
    <Strength>10mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>2004-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021050</DrugIDPK>
    <LicenceNumber>PA1300/001/001</LicenceNumber>
    <ProductName>GABAPENTIN 600 MG FILM COATED TABLETS</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2006-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021051</DrugIDPK>
    <LicenceNumber>PA1300/001/002</LicenceNumber>
    <ProductName>GABAPENTIN 800 MG FILM COATED TABLETS</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2006-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015632</DrugIDPK>
    <LicenceNumber>PA0506/016/001</LicenceNumber>
    <ProductName>RADIAN B PAIN RELIEF SPRAY</ProductName>
    <Strength>1.4%w/w,0.</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>RACEMIC CAMPHOR</ActiveSubstance>
      <ActiveSubstance>AMMONIUM SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016005</DrugIDPK>
    <LicenceNumber>PA0144/034/001</LicenceNumber>
    <ProductName>TARMED</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011749</DrugIDPK>
    <LicenceNumber>PA0320/009/001</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>1998-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003794</DrugIDPK>
    <LicenceNumber>PA0118/018/001</LicenceNumber>
    <ProductName>MINIMS ROSE BENGAL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSE BENGAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2008-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014810</DrugIDPK>
    <LicenceNumber>PPA0465/008/002C</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017788</DrugIDPK>
    <LicenceNumber>PPA0465/110/001A</LicenceNumber>
    <ProductName>AULIN</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIMESULIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009254</DrugIDPK>
    <LicenceNumber>PPA0465/041/002A</LicenceNumber>
    <ProductName>BECOTIDE INHALER 100 MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009252</DrugIDPK>
    <LicenceNumber>PPA0465/041/001A</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006705</DrugIDPK>
    <LicenceNumber>PA0535/005/002</LicenceNumber>
    <ProductName>CALCORT</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1997-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEFLAZACORT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007202</DrugIDPK>
    <LicenceNumber>PPA0465/029/001A</LicenceNumber>
    <ProductName>CALPOL INFANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017459</DrugIDPK>
    <LicenceNumber>PPA0465/044/001C</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017460</DrugIDPK>
    <LicenceNumber>PPA0465/044/003C</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014607</DrugIDPK>
    <LicenceNumber>PPA0465/044/003B</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014601</DrugIDPK>
    <LicenceNumber>PPA0465/044/001B</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010507</DrugIDPK>
    <LicenceNumber>PPA0465/070/001A</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010508</DrugIDPK>
    <LicenceNumber>PPA0465/070/001B</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010509</DrugIDPK>
    <LicenceNumber>PPA0465/070/001C</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010510</DrugIDPK>
    <LicenceNumber>PPA0465/070/001D</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010511</DrugIDPK>
    <LicenceNumber>PPA0465/070/002A</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010512</DrugIDPK>
    <LicenceNumber>PPA0465/070/002B</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010513</DrugIDPK>
    <LicenceNumber>PPA0465/070/002C</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUMATRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011838</DrugIDPK>
    <LicenceNumber>PPA0465/039/001D</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1995-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011840</DrugIDPK>
    <LicenceNumber>PPA0465/039/001B</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1995-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011841</DrugIDPK>
    <LicenceNumber>PPA0465/039/001C</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1995-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009247</DrugIDPK>
    <LicenceNumber>PPA0465/039/001A</LicenceNumber>
    <ProductName>LOSEC 20 MG GASTRO-RESISTANT HARD CAPSULES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1995-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007891</DrugIDPK>
    <LicenceNumber>PA0735/008/004</LicenceNumber>
    <ProductName>OMNISCAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>2001-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADODIAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008957</DrugIDPK>
    <LicenceNumber>PA0735/008/005</LicenceNumber>
    <ProductName>OMNISCAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>2000-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADODIAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006535</DrugIDPK>
    <LicenceNumber>PA0735/008/001</LicenceNumber>
    <ProductName>OMNISCAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADODIAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020246</DrugIDPK>
    <LicenceNumber>PPA0465/166/001</LicenceNumber>
    <ProductName>REMINYL</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019617</DrugIDPK>
    <LicenceNumber>PPA0465/150/001</LicenceNumber>
    <ProductName>ROGAINE REGULAR STRENGTH</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOXIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018228</DrugIDPK>
    <LicenceNumber>PPA0465/127/001A</LicenceNumber>
    <ProductName>SEREVENT INHALER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020594</DrugIDPK>
    <LicenceNumber>PPA0465/170/001</LicenceNumber>
    <ProductName>SURMONTIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMIPRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019370</DrugIDPK>
    <LicenceNumber>PPA0465/015/002</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007871</DrugIDPK>
    <LicenceNumber>PA0593/018/001</LicenceNumber>
    <ProductName>ZOPICALM</ProductName>
    <Strength>7.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006703</DrugIDPK>
    <LicenceNumber>PPA0465/058/002A</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007333</DrugIDPK>
    <LicenceNumber>PPA0465/058/002B</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007335</DrugIDPK>
    <LicenceNumber>PPA0465/058/002C</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010617</DrugIDPK>
    <LicenceNumber>PA0043/037/001</LicenceNumber>
    <ProductName>CROOKES IBUPROFEN LIQUID</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2001-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010036</DrugIDPK>
    <LicenceNumber>PA0979/018/001</LicenceNumber>
    <ProductName>DETTOL ANTISEPTIC PAIN RELIEF SPRAY</ProductName>
    <Strength>2.2/0.395</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005952</DrugIDPK>
    <LicenceNumber>PA0888/001/001</LicenceNumber>
    <ProductName>FLUTAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PH &amp; T S.p.A.</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009843</DrugIDPK>
    <LicenceNumber>PA0979/011/002</LicenceNumber>
    <ProductName>GAVISCON</ProductName>
    <Strength>500/25/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004390</DrugIDPK>
    <LicenceNumber>PA0022/069/007</LicenceNumber>
    <ProductName>PREMIQUE CYCLE</ProductName>
    <Strength>5/0.625 mg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017385</DrugIDPK>
    <LicenceNumber>PA0043/025/002</LicenceNumber>
    <ProductName>STREPSILS INTENSIVE SUGAR FREE ORANGE</ProductName>
    <Strength>8.75mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2004-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006266</DrugIDPK>
    <LicenceNumber>PA0416/009/001</LicenceNumber>
    <ProductName>FEMIN-9</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate>1992-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>POTASSIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>EPANOIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014476</DrugIDPK>
    <LicenceNumber>PA1037/001/001</LicenceNumber>
    <ProductName>BARICOL</ProductName>
    <Strength>1.05</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>E-Z-EM Nederland B.V.</PAHolder>
    <AuthorisedDate>2002-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003225</DrugIDPK>
    <LicenceNumber>PA0073/098/001</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003226</DrugIDPK>
    <LicenceNumber>PA0073/098/002</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003219</DrugIDPK>
    <LicenceNumber>PA0073/093/001</LicenceNumber>
    <ProductName>NOLGEN TABLETS 10 MG (TAMOXIFEN TABLETS BP 10 MG)</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019053</DrugIDPK>
    <LicenceNumber>PA0577/046/003</LicenceNumber>
    <ProductName>HISTACLAR SYRUP</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002179</DrugIDPK>
    <LicenceNumber>PA0046/029/001</LicenceNumber>
    <ProductName>SELEXIDIN INJECTION</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MECILLINAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013918</DrugIDPK>
    <LicenceNumber>PA0970/053/002</LicenceNumber>
    <ProductName>XYLOCAINE 1% WITH ADRENALINE (EPINEPHRINE)</ProductName>
    <Strength>(1:200,000)</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003630</DrugIDPK>
    <LicenceNumber>PA0711/017/003</LicenceNumber>
    <ProductName>ACIC LYOPHILISATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2003-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010219</DrugIDPK>
    <LicenceNumber>PA0654/008/001</LicenceNumber>
    <ProductName>EMCORETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>1997-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006310</DrugIDPK>
    <LicenceNumber>PA0436/009/001</LicenceNumber>
    <ProductName>DICLOFENAC SODIUM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006311</DrugIDPK>
    <LicenceNumber>PA0436/009/002</LicenceNumber>
    <ProductName>DICLOFENAC SODIUM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004065</DrugIDPK>
    <LicenceNumber>PA0148/002/001</LicenceNumber>
    <ProductName>PROPINE STERILE OPHTHALMIC</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1979-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPIVEFRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002338</DrugIDPK>
    <LicenceNumber>PA0050/086/002</LicenceNumber>
    <ProductName>ROCEPHIN 1M</ProductName>
    <Strength>3.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004468</DrugIDPK>
    <LicenceNumber>PA0185/035/002</LicenceNumber>
    <ProductName>TRAMAKE INSTS/TRAMADOL HYDROCHLORIDE</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004469</DrugIDPK>
    <LicenceNumber>PA0185/035/003</LicenceNumber>
    <ProductName>TRAMAKE INSTS/TRAMADOL HYDROCHLORIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000236</DrugIDPK>
    <LicenceNumber>PA0004/026/001</LicenceNumber>
    <ProductName>DAY COLD COMFORT</ProductName>
    <Strength>600/10/40</Strength>
    <StrengthMeasurement>mg/30ml</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017010</DrugIDPK>
    <LicenceNumber>PA0172/032/001</LicenceNumber>
    <ProductName>DIMOTANE CO</ProductName>
    <Strength>2/30/10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>2001-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017011</DrugIDPK>
    <LicenceNumber>PA0172/032/002</LicenceNumber>
    <ProductName>DIMOTANE CO PAEDIATRIC</ProductName>
    <Strength>2/15/3</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>2001-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016414</DrugIDPK>
    <LicenceNumber>PA1091/002/001</LicenceNumber>
    <ProductName>EZETIMIBE 10MG TABLETS</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MSD-SP Limited</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000237</DrugIDPK>
    <LicenceNumber>PA0004/027/001</LicenceNumber>
    <ProductName>NIGHT COLD COMFORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009540</DrugIDPK>
    <LicenceNumber>PA0004/058/001</LicenceNumber>
    <ProductName>PARACETAMOL CAPLETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>2003-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019256</DrugIDPK>
    <LicenceNumber>PA1091/003/001</LicenceNumber>
    <ProductName>VYTORIN</ProductName>
    <Strength>10/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MSD-SP Limited</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019257</DrugIDPK>
    <LicenceNumber>PA1091/003/002</LicenceNumber>
    <ProductName>VYTORIN</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MSD-SP Limited</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019258</DrugIDPK>
    <LicenceNumber>PA1091/003/003</LicenceNumber>
    <ProductName>VYTORIN</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MSD-SP Limited</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019259</DrugIDPK>
    <LicenceNumber>PA1091/003/004</LicenceNumber>
    <ProductName>VYTORIN</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MSD-SP Limited</PAHolder>
    <AuthorisedDate>2004-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001981</DrugIDPK>
    <LicenceNumber>PA0040/068/005</LicenceNumber>
    <ProductName>MYOCRISIN</ProductName>
    <Strength>50mg/0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AUROTHIOMALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022550</DrugIDPK>
    <LicenceNumber>PA0126/169/001</LicenceNumber>
    <ProductName>PERDAMEL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2007-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020306</DrugIDPK>
    <LicenceNumber>PA1155/007/001</LicenceNumber>
    <ProductName>BENZOYL PEROXIDE</ProductName>
    <Strength>5%</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020307</DrugIDPK>
    <LicenceNumber>PA1155/007/002</LicenceNumber>
    <ProductName>BENZOYL PEROXIDE</ProductName>
    <Strength>10%</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019505</DrugIDPK>
    <LicenceNumber>PA0711/069/001</LicenceNumber>
    <ProductName>ONTON 2MG/ML SOLUTION FOR INJECTION OR INFUSION</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2005-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009829</DrugIDPK>
    <LicenceNumber>PA0979/005/001</LicenceNumber>
    <ProductName>DETTOL FRESH</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020341</DrugIDPK>
    <LicenceNumber>PA0021/068/002</LicenceNumber>
    <ProductName>EPHYNAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020342</DrugIDPK>
    <LicenceNumber>PA0021/068/001</LicenceNumber>
    <ProductName>EPHYNAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002188</DrugIDPK>
    <LicenceNumber>PA0047/038/003</LicenceNumber>
    <ProductName>KEFADOL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAMANDOLE NAFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002189</DrugIDPK>
    <LicenceNumber>PA0047/038/004</LicenceNumber>
    <ProductName>KEFADOL</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAMANDOLE NAFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002185</DrugIDPK>
    <LicenceNumber>PA0047/038/001</LicenceNumber>
    <ProductName>KEFADOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAMANDOLE NAFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004097</DrugIDPK>
    <LicenceNumber>PA0167/004/003A</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE SODIUM CHLORIDE AND GLUCOSE</ProductName>
    <Strength>0.2/0.18/4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003194</DrugIDPK>
    <LicenceNumber>PA0073/073/001</LicenceNumber>
    <ProductName>ANTAROL</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003195</DrugIDPK>
    <LicenceNumber>PA0073/073/002</LicenceNumber>
    <ProductName>ANTAROL</ProductName>
    <Strength>40 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003196</DrugIDPK>
    <LicenceNumber>PA0073/073/003</LicenceNumber>
    <ProductName>ANTAROL</ProductName>
    <Strength>80 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006704</DrugIDPK>
    <LicenceNumber>PA0535/005/001</LicenceNumber>
    <ProductName>CALCORT</ProductName>
    <Strength>1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEFLAZACORT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006706</DrugIDPK>
    <LicenceNumber>PA0535/005/003</LicenceNumber>
    <ProductName>CALCORT</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1997-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEFLAZACORT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007232</DrugIDPK>
    <LicenceNumber>PA0913/017/001</LicenceNumber>
    <ProductName>MXL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007233</DrugIDPK>
    <LicenceNumber>PA0913/017/002</LicenceNumber>
    <ProductName>MXL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007234</DrugIDPK>
    <LicenceNumber>PA0913/017/003</LicenceNumber>
    <ProductName>MXL</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007235</DrugIDPK>
    <LicenceNumber>PA0913/017/004</LicenceNumber>
    <ProductName>MXL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007236</DrugIDPK>
    <LicenceNumber>PA0913/017/005</LicenceNumber>
    <ProductName>MXL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007237</DrugIDPK>
    <LicenceNumber>PA0913/017/006</LicenceNumber>
    <ProductName>MXL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022515</DrugIDPK>
    <LicenceNumber>PA0061/010/001</LicenceNumber>
    <ProductName>DEXAMETHASONE</ProductName>
    <Strength>500 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006086</DrugIDPK>
    <LicenceNumber>PA0408/004/002</LicenceNumber>
    <ProductName>RIMADOL PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1992-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000258</DrugIDPK>
    <LicenceNumber>PA0006/010/002</LicenceNumber>
    <ProductName>SOFRADEX EYE/EAR</ProductName>
    <Strength>0.5/0.05/0</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005174</DrugIDPK>
    <LicenceNumber>PA0257/034/001</LicenceNumber>
    <ProductName>LANEPA</ProductName>
    <Strength>180/120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate>1992-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EICOSAPENTAENOIC ACID</ActiveSubstance>
      <ActiveSubstance>DOCOSAHEXANOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016177</DrugIDPK>
    <LicenceNumber>PA1077/047/002</LicenceNumber>
    <ProductName>SEREVENT ROTADISKS</ProductName>
    <Strength>50mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016176</DrugIDPK>
    <LicenceNumber>PA1077/047/001</LicenceNumber>
    <ProductName>SEREVENT INHALER</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002791</DrugIDPK>
    <LicenceNumber>PA0618/019/002</LicenceNumber>
    <ProductName>ASILONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM OXIDUM LEVE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002792</DrugIDPK>
    <LicenceNumber>PA0618/019/003</LicenceNumber>
    <ProductName>ASILONE ANTACID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002790</DrugIDPK>
    <LicenceNumber>PA0618/019/001</LicenceNumber>
    <ProductName>ASILONE ANTACID LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM OXIDUM LEVE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006271</DrugIDPK>
    <LicenceNumber>PA0417/002/001</LicenceNumber>
    <ProductName>SEVEN SEAS CHERRY FLAVOUR VITAMIN C CAPSULES</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1992-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022686</DrugIDPK>
    <LicenceNumber>PA1332/021/005</LicenceNumber>
    <ProductName>ZAMADOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022683</DrugIDPK>
    <LicenceNumber>PA1332/021/002</LicenceNumber>
    <ProductName>ZAMADOL SR 100 MG PROLONGED-RELEASE CAPSULES</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022684</DrugIDPK>
    <LicenceNumber>PA1332/021/003</LicenceNumber>
    <ProductName>ZAMADOL SR 150 MG PROLONGED-RELEASE CAPSULES</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022685</DrugIDPK>
    <LicenceNumber>PA1332/021/004</LicenceNumber>
    <ProductName>ZAMADOL SR 200MG PROLONGED-RELEASE CAPSULES</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022682</DrugIDPK>
    <LicenceNumber>PA1332/021/001</LicenceNumber>
    <ProductName>ZAMADOL SR 50MG PROLONGED-RELEASE CAPSULES</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2007-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009036</DrugIDPK>
    <LicenceNumber>PA0022/068/002</LicenceNumber>
    <ProductName>CATHATE</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001277</DrugIDPK>
    <LicenceNumber>PA0022/058/005</LicenceNumber>
    <ProductName>PREMARIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001271</DrugIDPK>
    <LicenceNumber>PA0022/058/001</LicenceNumber>
    <ProductName>PREMARIN VAGINAL</ProductName>
    <Strength>0.0625</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004253</DrugIDPK>
    <LicenceNumber>PA0167/026/001A</LicenceNumber>
    <ProductName>DEXTRAN 40</ProductName>
    <Strength>10/5 %w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 40</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004258</DrugIDPK>
    <LicenceNumber>PA0167/028/001A</LicenceNumber>
    <ProductName>DEXTRAN 70</ProductName>
    <Strength>6/5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 70</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004251</DrugIDPK>
    <LicenceNumber>PA0167/025/001A</LicenceNumber>
    <ProductName>GENTRAN 40 (DEXTRAN 40 INTRAVENOUS INFUSION BP 10%</ProductName>
    <Strength>10/0.9 %w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 40</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004255</DrugIDPK>
    <LicenceNumber>PA0167/027/001A</LicenceNumber>
    <ProductName>GENTRAN 70 (DEXTRAN 70 INTRAVENOUS INFUSION BP 6.0</ProductName>
    <Strength>6/0.9 %w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 70</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003946</DrugIDPK>
    <LicenceNumber>PA0126/082/001</LicenceNumber>
    <ProductName>DICLOMEL 25</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003947</DrugIDPK>
    <LicenceNumber>PA0126/082/002</LicenceNumber>
    <ProductName>DICLOMEL 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001978</DrugIDPK>
    <LicenceNumber>PA0040/068/003</LicenceNumber>
    <ProductName>MYOCRISIN</ProductName>
    <Strength>10mg/0.5 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AUROTHIOMALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001979</DrugIDPK>
    <LicenceNumber>PA0040/068/004</LicenceNumber>
    <ProductName>MYOCRISIN</ProductName>
    <Strength>20 mg/0.5 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AUROTHIOMALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003975</DrugIDPK>
    <LicenceNumber>PA0143/011/001</LicenceNumber>
    <ProductName>NOXYFLEX S</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Cutaneous Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOXYTIOLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008378</DrugIDPK>
    <LicenceNumber>PA0437/008/006</LicenceNumber>
    <ProductName>VINCRISTINE SULPHATE INJECTION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1996-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008221</DrugIDPK>
    <LicenceNumber>PA0743/010/003</LicenceNumber>
    <ProductName>BREXIDOL</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>2002-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM BETADEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005141</DrugIDPK>
    <LicenceNumber>PA0255/003/003</LicenceNumber>
    <ProductName>ISOPRENALINE HYDROCHLORIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013857</DrugIDPK>
    <LicenceNumber>PA0970/034/001</LicenceNumber>
    <ProductName>BETAZOK 100 MG PROLONGED-RELEASE FILM-COATED TABLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1998-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>--Unknown--</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013879</DrugIDPK>
    <LicenceNumber>PA0970/043/001</LicenceNumber>
    <ProductName>KINIDIN DURULES</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINIDINE SULFATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010284</DrugIDPK>
    <LicenceNumber>PA0540/019/002</LicenceNumber>
    <ProductName>MERBENTYL</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015196</DrugIDPK>
    <LicenceNumber>PA0677/017/001</LicenceNumber>
    <ProductName>FLUCIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>mBg/ml</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>2003-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDEOXYGLUCOSE (18F)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005252</DrugIDPK>
    <LicenceNumber>PA0167/096/011</LicenceNumber>
    <ProductName>GLUCOSE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020868</DrugIDPK>
    <LicenceNumber>PA0021/060/001</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020869</DrugIDPK>
    <LicenceNumber>PA0021/060/002</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020231</DrugIDPK>
    <LicenceNumber>PA0021/058/001</LicenceNumber>
    <ProductName>ASPRO</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001109</DrugIDPK>
    <LicenceNumber>PA0021/006/001</LicenceNumber>
    <ProductName>BAYER ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001164</DrugIDPK>
    <LicenceNumber>PA0021/038/001</LicenceNumber>
    <ProductName>BAYTHROM</ProductName>
    <Strength>324</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1987-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020870</DrugIDPK>
    <LicenceNumber>PA0021/059/001</LicenceNumber>
    <ProductName>BECOSYM FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001133</DrugIDPK>
    <LicenceNumber>PA0021/016/001</LicenceNumber>
    <ProductName>LASONIL</ProductName>
    <Strength>5000/15000</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARINOID</ActiveSubstance>
      <ActiveSubstance>HYALURONIDASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020541</DrugIDPK>
    <LicenceNumber>PA0021/071/001</LicenceNumber>
    <ProductName>PARACODOL</ProductName>
    <Strength>500/8</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020542</DrugIDPK>
    <LicenceNumber>PA0021/071/002</LicenceNumber>
    <ProductName>PARACODOL</ProductName>
    <Strength>500/8</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020646</DrugIDPK>
    <LicenceNumber>PA0021/072/001</LicenceNumber>
    <ProductName>REDOXON C</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020647</DrugIDPK>
    <LicenceNumber>PA0021/072/002</LicenceNumber>
    <ProductName>REDOXON C</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020644</DrugIDPK>
    <LicenceNumber>PA0021/074/001</LicenceNumber>
    <ProductName>REDOXON PLAIN EFFERVESCENT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019759</DrugIDPK>
    <LicenceNumber>PA0022/090/003</LicenceNumber>
    <ProductName>TAZOCIN</ProductName>
    <Strength>4.5 g</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2005-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>TAZOBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002861</DrugIDPK>
    <LicenceNumber>PA0320/004/001</LicenceNumber>
    <ProductName>FLUORIGARD GEL-KAM</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STANNOUS FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009912</DrugIDPK>
    <LicenceNumber>PA0913/023/001</LicenceNumber>
    <ProductName>ZEROPAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009913</DrugIDPK>
    <LicenceNumber>PA0913/023/002</LicenceNumber>
    <ProductName>ZEROPAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009914</DrugIDPK>
    <LicenceNumber>PA0913/023/003</LicenceNumber>
    <ProductName>ZEROPAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009915</DrugIDPK>
    <LicenceNumber>PA0913/023/004</LicenceNumber>
    <ProductName>ZEROPAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007246</DrugIDPK>
    <LicenceNumber>PA0913/021/005</LicenceNumber>
    <ProductName>ZYTRAM-SR</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2000-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007247</DrugIDPK>
    <LicenceNumber>PA0913/021/006</LicenceNumber>
    <ProductName>ZYTRAM-SR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2000-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007248</DrugIDPK>
    <LicenceNumber>PA0913/021/007</LicenceNumber>
    <ProductName>ZYTRAM-SR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2000-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007249</DrugIDPK>
    <LicenceNumber>PA0913/021/008</LicenceNumber>
    <ProductName>ZYTRAM-SR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2000-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009356</DrugIDPK>
    <LicenceNumber>PA0970/015/001</LicenceNumber>
    <ProductName>NOLVADEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001650</DrugIDPK>
    <LicenceNumber>PA0618/010/002</LicenceNumber>
    <ProductName>SULEO-C</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1997-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBARIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019821</DrugIDPK>
    <LicenceNumber>PA1217/001/001</LicenceNumber>
    <ProductName>DOBUTAMIN HIKMA 250 MG/ 50 ML AMPOULE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hikma Farmaceutica (Portugal) SA</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019822</DrugIDPK>
    <LicenceNumber>PA1217/001/002</LicenceNumber>
    <ProductName>DOBUTAMIN HIKMA 250 MG/50 ML VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hikma Farmaceutica (Portugal) SA</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019823</DrugIDPK>
    <LicenceNumber>PA1217/001/003</LicenceNumber>
    <ProductName>DOBUTAMIN HIKMA 250/20 ML AMPOULE</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hikma Farmaceutica (Portugal) SA</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005180</DrugIDPK>
    <LicenceNumber>PA0678/031/004</LicenceNumber>
    <ProductName>MILK OF MAGNESIA (NEW FORMULA PEPPERMINT)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003746</DrugIDPK>
    <LicenceNumber>PA0277/053/003</LicenceNumber>
    <ProductName>CLARITYN RAPIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008636</DrugIDPK>
    <LicenceNumber>PA0043/006/003</LicenceNumber>
    <ProductName>NUROFEN MICRO-GRANULES</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>2002-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015575</DrugIDPK>
    <LicenceNumber>PA1078/001/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dumex Ltd</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015577</DrugIDPK>
    <LicenceNumber>PA1078/001/002</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dumex Ltd</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015579</DrugIDPK>
    <LicenceNumber>PA1078/001/003</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dumex Ltd</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015593</DrugIDPK>
    <LicenceNumber>PA0176/071/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015594</DrugIDPK>
    <LicenceNumber>PA0176/071/002</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015595</DrugIDPK>
    <LicenceNumber>PA0176/071/003</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007484</DrugIDPK>
    <LicenceNumber>PA0743/010/002</LicenceNumber>
    <ProductName>BREXIDOL TABLETS</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1997-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM BETADEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020796</DrugIDPK>
    <LicenceNumber>PA1226/003/001</LicenceNumber>
    <ProductName>DOBUTREX</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Flynn Pharma Ltd</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016276</DrugIDPK>
    <LicenceNumber>PA0437/037/001</LicenceNumber>
    <ProductName>DORYX</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016277</DrugIDPK>
    <LicenceNumber>PA0437/037/002</LicenceNumber>
    <ProductName>DORYX</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001736</DrugIDPK>
    <LicenceNumber>PA0030/017/001</LicenceNumber>
    <ProductName>LACTITOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1991-04-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTITOL MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004103</DrugIDPK>
    <LicenceNumber>PA0167/005/001</LicenceNumber>
    <ProductName>LIDOCAINE HCL/GLUCOSE</ProductName>
    <Strength>0.1 / 5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004105</DrugIDPK>
    <LicenceNumber>PA0167/005/002</LicenceNumber>
    <ProductName>LIDOCAINE HCL/GLUCOSE</ProductName>
    <Strength>0.2 /5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008564</DrugIDPK>
    <LicenceNumber>PA0043/036/001</LicenceNumber>
    <ProductName>IBUPROFEN 200 MG/CODEINE PHOSPHATE 12.8 MG TABLETS</ProductName>
    <Strength>200/12.8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006676</DrugIDPK>
    <LicenceNumber>PA0043/035/001</LicenceNumber>
    <ProductName>MYCORTIN</ProductName>
    <Strength>2/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022318</DrugIDPK>
    <LicenceNumber>PA0899/027/001</LicenceNumber>
    <ProductName>TRIPTAFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2007-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019824</DrugIDPK>
    <LicenceNumber>PA1217/001/004</LicenceNumber>
    <ProductName>DOBUTAMIN HIKMA 250 MG/ 5 ML AMPOULE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hikma Farmaceutica (Portugal) SA</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009042</DrugIDPK>
    <LicenceNumber>PA0022/069/004</LicenceNumber>
    <ProductName>PREMIQUE CYCLE 10 SEPARATE</ProductName>
    <Strength>10/0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019232</DrugIDPK>
    <LicenceNumber>PA0022/089/001</LicenceNumber>
    <ProductName>ZOTON 15MG GASTRO-RESISTANT CAPSULES</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2004-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005833</DrugIDPK>
    <LicenceNumber>PA0037/069/003</LicenceNumber>
    <ProductName>ZOTON 30MG GASTRO-RESISTANT GRANULES FOR ORAL SUSP</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020252</DrugIDPK>
    <LicenceNumber>PA1155/004/001</LicenceNumber>
    <ProductName>CEANEL CONCENTRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLETHYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>UNDECYLENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011387</DrugIDPK>
    <LicenceNumber>PA0540/128/004</LicenceNumber>
    <ProductName>SURMONTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2003-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMIPRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021557</DrugIDPK>
    <LicenceNumber>PA1244/006/001</LicenceNumber>
    <ProductName>MILDISON LIPOCREAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Astellas Pharma Europe BV</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010480</DrugIDPK>
    <LicenceNumber>PA0021/051/001</LicenceNumber>
    <ProductName>ASPIRIN MIGRAINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008796</DrugIDPK>
    <LicenceNumber>PA0593/006/002</LicenceNumber>
    <ProductName>METOPROLOL 100 STADA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008801</DrugIDPK>
    <LicenceNumber>PA0593/006/003</LicenceNumber>
    <ProductName>METOPROLOL 200 STADA RETARD PROLONGED RELEASE TABL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008795</DrugIDPK>
    <LicenceNumber>PA0593/006/001</LicenceNumber>
    <ProductName>METOPROLOL 50 STADA</ProductName>
    <Strength>50.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008496</DrugIDPK>
    <LicenceNumber>PA0593/003/002</LicenceNumber>
    <ProductName>NIFEDIPINE 10 STADA NIFEDIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1997-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008494</DrugIDPK>
    <LicenceNumber>PA0593/003/001</LicenceNumber>
    <ProductName>NIFEDIPINE 5 STADA NIFEDIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1997-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005058</DrugIDPK>
    <LicenceNumber>PA0593/010/002</LicenceNumber>
    <ProductName>NIFELEASE</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003183</DrugIDPK>
    <LicenceNumber>PA0593/010/001</LicenceNumber>
    <ProductName>NIFELEASE MR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1997-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016774</DrugIDPK>
    <LicenceNumber>PA1046/002/001</LicenceNumber>
    <ProductName>MEFENAMIC ACID BP</ProductName>
    <Strength>250mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1997-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016775</DrugIDPK>
    <LicenceNumber>PA1046/002/002</LicenceNumber>
    <ProductName>MEFENAMIC ACID BP</ProductName>
    <Strength>500mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1997-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014841</DrugIDPK>
    <LicenceNumber>PA0002/071/001</LicenceNumber>
    <ProductName>NARCAN NEONATAL</ProductName>
    <Strength>20/1</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004006</DrugIDPK>
    <LicenceNumber>PA0281/061/002</LicenceNumber>
    <ProductName>PINADONE METHADONE MIXTURE</ProductName>
    <Strength>5mg/5ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHADONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001170</DrugIDPK>
    <LicenceNumber>PA0022/001/001</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <Strength>1 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001172</DrugIDPK>
    <LicenceNumber>PA0022/001/002</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <Strength>2.5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005632</DrugIDPK>
    <LicenceNumber>PA0285/006/001</LicenceNumber>
    <ProductName>GEREF 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1991-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERMORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008977</DrugIDPK>
    <LicenceNumber>PA0111/002/001</LicenceNumber>
    <ProductName>RIMACTANE</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>1997-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001775</DrugIDPK>
    <LicenceNumber>PA0035/004/001</LicenceNumber>
    <ProductName>CLINORIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULINDAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001776</DrugIDPK>
    <LicenceNumber>PA0035/004/002</LicenceNumber>
    <ProductName>CLINORIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULINDAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005142</DrugIDPK>
    <LicenceNumber>PA0748/014/001</LicenceNumber>
    <ProductName>PANCREASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTEASE</ActiveSubstance>
      <ActiveSubstance>AMYLASE</ActiveSubstance>
      <ActiveSubstance>LIPASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006112</DrugIDPK>
    <LicenceNumber>PA0408/015/001</LicenceNumber>
    <ProductName>RIMATASE CHLORPROPAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002186</DrugIDPK>
    <LicenceNumber>PA0046/036/001</LicenceNumber>
    <ProductName>HEPARIN (MUCOUS) INJECTION B.P. 1000 UNITS/ML</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017922</DrugIDPK>
    <LicenceNumber>PA0061/018/002</LicenceNumber>
    <ProductName>LIVIAL 1.25 MG CAPSULES</ProductName>
    <Strength>1.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>2007-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIBOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006752</DrugIDPK>
    <LicenceNumber>PA0167/099/002</LicenceNumber>
    <ProductName>BREVIBLOC CONCENTRATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESMOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006284</DrugIDPK>
    <LicenceNumber>PA0455/005/001</LicenceNumber>
    <ProductName>SCHOLL ANTISEPTIC FOOT BALM</ProductName>
    <Strength>.5/.4/.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>HALQUINOL</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008802</DrugIDPK>
    <LicenceNumber>PA0593/007/001</LicenceNumber>
    <ProductName>CIMETIDINE 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008803</DrugIDPK>
    <LicenceNumber>PA0593/007/002</LicenceNumber>
    <ProductName>CIMETIDINE 400</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008804</DrugIDPK>
    <LicenceNumber>PA0593/007/003</LicenceNumber>
    <ProductName>CIMETIDINE 800</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007852</DrugIDPK>
    <LicenceNumber>PA0757/005/001</LicenceNumber>
    <ProductName>OPILON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>1995-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXISYLYTE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002192</DrugIDPK>
    <LicenceNumber>PA0046/036/003</LicenceNumber>
    <ProductName>HEPARIN (MUCOUS) INJECTION B.P. 25000 UNITS/ML</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002190</DrugIDPK>
    <LicenceNumber>PA0046/036/002</LicenceNumber>
    <ProductName>HEPARIN (MUCOUS) INJECTION B.P. 5000 UNITS/ML</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006254</DrugIDPK>
    <LicenceNumber>PA0405/033/001</LicenceNumber>
    <ProductName>OXYBUTYNIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006255</DrugIDPK>
    <LicenceNumber>PA0405/033/002</LicenceNumber>
    <ProductName>OXYBUTYNIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010576</DrugIDPK>
    <LicenceNumber>PA0281/105/001</LicenceNumber>
    <ProductName>ZEPHROL ADULT COUGH SUPPRESSANT</ProductName>
    <Strength>3.6/5/20</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014842</DrugIDPK>
    <LicenceNumber>PA0002/071/002</LicenceNumber>
    <ProductName>NARCAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014843</DrugIDPK>
    <LicenceNumber>PA0002/071/003</LicenceNumber>
    <ProductName>NARCAN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995023333</DrugIDPK>
    <LicenceNumber>PA0167/124/002</LicenceNumber>
    <ProductName>HUMAN ALBUMIN 4.5%</ProductName>
    <Strength>2.25/50</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2007-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PLASMA PROTEIN FRACTION (HUMAN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021315</DrugIDPK>
    <LicenceNumber>PA1315/001/001</LicenceNumber>
    <ProductName>SLOKET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurand S.p.A.</PAHolder>
    <AuthorisedDate>2006-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000014</DrugIDPK>
    <LicenceNumber>PA0711/007/003</LicenceNumber>
    <ProductName>ACC</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007327</DrugIDPK>
    <LicenceNumber>PA0019/044/009</LicenceNumber>
    <ProductName>DIFLUCAN SOLUTION FOR INFUSION 2 MG/ML (400MG/200M</ProductName>
    <Strength>2 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001053</DrugIDPK>
    <LicenceNumber>PA0019/015/001</LicenceNumber>
    <ProductName>SINEQUAN</ProductName>
    <Strength>75 mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001054</DrugIDPK>
    <LicenceNumber>PA0019/015/002</LicenceNumber>
    <ProductName>SINEQUAN</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001055</DrugIDPK>
    <LicenceNumber>PA0019/015/003</LicenceNumber>
    <ProductName>SINEQUAN</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001056</DrugIDPK>
    <LicenceNumber>PA0019/015/004</LicenceNumber>
    <ProductName>SINEQUAN</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001651</DrugIDPK>
    <LicenceNumber>PA0618/010/001</LicenceNumber>
    <ProductName>SULEO-C LOTION</ProductName>
    <Strength>0.5%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1997-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBARIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015535</DrugIDPK>
    <LicenceNumber>PA0822/017/001</LicenceNumber>
    <ProductName>ZARONTIN</ProductName>
    <Strength>250mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHOSUXIMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008559</DrugIDPK>
    <LicenceNumber>PA0022/065/001</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008565</DrugIDPK>
    <LicenceNumber>PA0022/065/003</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018432</DrugIDPK>
    <LicenceNumber>PA0022/088/001</LicenceNumber>
    <ProductName>JOLLET COATED TABLETS</ProductName>
    <Strength>0.075/0.20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2004-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018495</DrugIDPK>
    <LicenceNumber>PA0022/088/002</LicenceNumber>
    <ProductName>JOLLET ED COATED TABLETS</ProductName>
    <Strength>0.075/0.20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2004-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008510</DrugIDPK>
    <LicenceNumber>PA0566/018/001</LicenceNumber>
    <ProductName>VITRIMIX K.V. EMULSION FOR INFUSION</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020609</DrugIDPK>
    <LicenceNumber>PA0436/042/001</LicenceNumber>
    <ProductName>TAMNIC</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009642</DrugIDPK>
    <LicenceNumber>PA0975/001/001</LicenceNumber>
    <ProductName>UBIT</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Otsuka Pharma GmbH</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>13C-UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015221</DrugIDPK>
    <LicenceNumber>PA0540/135/001</LicenceNumber>
    <ProductName>NORITATE</ProductName>
    <Strength>1% w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005487</DrugIDPK>
    <LicenceNumber>PA0593/013/001</LicenceNumber>
    <ProductName>PROZATAN</ProductName>
    <Strength>20 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000016</DrugIDPK>
    <LicenceNumber>PA0711/007/005</LicenceNumber>
    <ProductName>ACC</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000017</DrugIDPK>
    <LicenceNumber>PA0711/007/006</LicenceNumber>
    <ProductName>ACC</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021027</DrugIDPK>
    <LicenceNumber>PA0711/089/001</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021028</DrugIDPK>
    <LicenceNumber>PA0711/089/002</LicenceNumber>
    <ProductName>LANSOPRAZOLE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021411</DrugIDPK>
    <LicenceNumber>PA0711/108/001</LicenceNumber>
    <ProductName>PRAVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021412</DrugIDPK>
    <LicenceNumber>PA0711/108/002</LicenceNumber>
    <ProductName>PRAVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021413</DrugIDPK>
    <LicenceNumber>PA0711/108/003</LicenceNumber>
    <ProductName>PRAVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021171</DrugIDPK>
    <LicenceNumber>PA0711/105/001</LicenceNumber>
    <ProductName>RAMIPRIL</ProductName>
    <Strength>1.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021172</DrugIDPK>
    <LicenceNumber>PA0711/105/002</LicenceNumber>
    <ProductName>RAMIPRIL</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021173</DrugIDPK>
    <LicenceNumber>PA0711/105/003</LicenceNumber>
    <ProductName>RAMIPRIL</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021174</DrugIDPK>
    <LicenceNumber>PA0711/105/004</LicenceNumber>
    <ProductName>RAMIPRIL</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020714</DrugIDPK>
    <LicenceNumber>PA0711/084/001</LicenceNumber>
    <ProductName>SERTRALINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020715</DrugIDPK>
    <LicenceNumber>PA0711/084/002</LicenceNumber>
    <ProductName>SERTRALINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020822</DrugIDPK>
    <LicenceNumber>PA0711/087/001</LicenceNumber>
    <ProductName>TAMSULOSIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2006-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMSULOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003518</DrugIDPK>
    <LicenceNumber>PA0711/016/003</LicenceNumber>
    <ProductName>VERAP</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2001-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005250</DrugIDPK>
    <LicenceNumber>PA0167/096/001</LicenceNumber>
    <ProductName>GLUCOSE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005258</DrugIDPK>
    <LicenceNumber>PA0167/096/007</LicenceNumber>
    <ProductName>GLUCOSE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015490</DrugIDPK>
    <LicenceNumber>PA0167/112/001</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2003-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE, MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015491</DrugIDPK>
    <LicenceNumber>PA0167/112/002</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2003-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE, MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001484</DrugIDPK>
    <LicenceNumber>PA0037/023/011</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>50 mg/2 ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001490</DrugIDPK>
    <LicenceNumber>PA0037/023/015</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>1g/40 ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001189</DrugIDPK>
    <LicenceNumber>PA0022/014/001</LicenceNumber>
    <ProductName>ALGIPAN RUB</ProductName>
    <Strength>10/1/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019551</DrugIDPK>
    <LicenceNumber>PA0038/080/001</LicenceNumber>
    <ProductName>BRUFEN</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2004-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007325</DrugIDPK>
    <LicenceNumber>PA0019/044/007</LicenceNumber>
    <ProductName>DIFLUCAN SOLUTION FOR INFUSION 2 MG/ML (100MG/50ML</ProductName>
    <Strength>2 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006026</DrugIDPK>
    <LicenceNumber>PA0405/008/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005245</DrugIDPK>
    <LicenceNumber>PA0167/094/001</LicenceNumber>
    <ProductName>NUTRACEL 400</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC ACETATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CHLORIDE TETRAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005246</DrugIDPK>
    <LicenceNumber>PA0167/094/002</LicenceNumber>
    <ProductName>NUTRACEL 800</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC ACETATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CHLORIDE TETRAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003598</DrugIDPK>
    <LicenceNumber>PA0185/036/001</LicenceNumber>
    <ProductName>DIARREST RF</ProductName>
    <Strength>1/40/50/50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPERAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004571</DrugIDPK>
    <LicenceNumber>PA0185/007/001</LicenceNumber>
    <ProductName>GIVITOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1980-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995022278</DrugIDPK>
    <LicenceNumber>PA1175/005/001</LicenceNumber>
    <ProductName>MANUSEPT</ProductName>
    <Strength>0.5/70</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005209</DrugIDPK>
    <LicenceNumber>PA0277/062/001</LicenceNumber>
    <ProductName>TINADERM PLUS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005210</DrugIDPK>
    <LicenceNumber>PA0277/062/002</LicenceNumber>
    <ProductName>TINADERM PLUS</ProductName>
    <Strength>0.09</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000809</DrugIDPK>
    <LicenceNumber>PA0012/005/001</LicenceNumber>
    <ProductName>ANDROCUR 50 MG TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003212</DrugIDPK>
    <LicenceNumber>PA0012/080/001</LicenceNumber>
    <ProductName>MINERVA</ProductName>
    <Strength>2.0/.035</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004052</DrugIDPK>
    <LicenceNumber>PA0800/002/002</LicenceNumber>
    <ProductName>HAEMATE P</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>1994-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004053</DrugIDPK>
    <LicenceNumber>PA0800/002/003</LicenceNumber>
    <ProductName>HAEMATE P</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>1994-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005407</DrugIDPK>
    <LicenceNumber>PA0855/007/001</LicenceNumber>
    <ProductName>LASIX PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1998-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001009</DrugIDPK>
    <LicenceNumber>PA0018/003/005</LicenceNumber>
    <ProductName>RYNACROM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001005</DrugIDPK>
    <LicenceNumber>PA0018/003/001</LicenceNumber>
    <ProductName>RYNACROM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1976-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Drops Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006780</DrugIDPK>
    <LicenceNumber>PA0855/037/001</LicenceNumber>
    <ProductName>RYTHMODAN</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>2004-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011375</DrugIDPK>
    <LicenceNumber>PA0540/125/003</LicenceNumber>
    <ProductName>SECTRAL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2003-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEBUTOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011065</DrugIDPK>
    <LicenceNumber>PA0540/075/003</LicenceNumber>
    <ProductName>SURGAM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2002-04-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008542</DrugIDPK>
    <LicenceNumber>PA0018/050/001</LicenceNumber>
    <ProductName>TILAVIST</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEDOCROMIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011107</DrugIDPK>
    <LicenceNumber>PA0540/079/001</LicenceNumber>
    <ProductName>TOPISOLON</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOXIMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011111</DrugIDPK>
    <LicenceNumber>PA0540/080/001</LicenceNumber>
    <ProductName>TRENTAL</ProductName>
    <Strength>300/15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003287</DrugIDPK>
    <LicenceNumber>PA0073/126/001A</LicenceNumber>
    <ProductName>GLYCOPYRROLATE U.S.P.</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOPYRRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010501</DrugIDPK>
    <LicenceNumber>PA0540/032/004</LicenceNumber>
    <ProductName>BATRAFEN NAIL LACQUER</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2002-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019817</DrugIDPK>
    <LicenceNumber>PA0577/069/003</LicenceNumber>
    <ProductName>CIFLOXAGER</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021677</DrugIDPK>
    <LicenceNumber>PA1332/012/001</LicenceNumber>
    <ProductName>ASCAL</ProductName>
    <Strength>650</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>2006-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBASALATE CALCIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000540</DrugIDPK>
    <LicenceNumber>PA0012/063/001</LicenceNumber>
    <ProductName>FEMODENE</ProductName>
    <Strength>75/30mcg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1988-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012613</DrugIDPK>
    <LicenceNumber>PA0167/110/001</LicenceNumber>
    <ProductName>PENTASTARCH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021558</DrugIDPK>
    <LicenceNumber>PA1244/005/001</LicenceNumber>
    <ProductName>LOCOID CRELO</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Astellas Pharma Europe BV</PAHolder>
    <AuthorisedDate>2006-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE BUTYRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001961</DrugIDPK>
    <LicenceNumber>PA0040/062/001</LicenceNumber>
    <ProductName>ASCABIOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007603</DrugIDPK>
    <LicenceNumber>PA0593/016/001</LicenceNumber>
    <ProductName>FLUTAMID STADA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007913</DrugIDPK>
    <LicenceNumber>PA0592/005/001</LicenceNumber>
    <ProductName>HEPATECT</ProductName>
    <Strength>200mg/100IU/2 ml</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>IMMUNOGLOBULIN ANTIHEPATITIS B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017809</DrugIDPK>
    <LicenceNumber>PA1121/001/001</LicenceNumber>
    <ProductName>IBUCAPS IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Banner Pharmacaps Europe B.V.</PAHolder>
    <AuthorisedDate>2005-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005750</DrugIDPK>
    <LicenceNumber>PA0590/014/001</LicenceNumber>
    <ProductName>MISTAMINE MODIFIED RELEASE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIZOLASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008782</DrugIDPK>
    <LicenceNumber>PA0593/022/001</LicenceNumber>
    <ProductName>OXYBUTYNIN STADA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2000-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008139</DrugIDPK>
    <LicenceNumber>PA0943/001/001</LicenceNumber>
    <ProductName>PRAGMATAR</ProductName>
    <Strength>4/3/3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000259</DrugIDPK>
    <LicenceNumber>PA0006/011/001</LicenceNumber>
    <ProductName>SOFRAMYCIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000260</DrugIDPK>
    <LicenceNumber>PA0006/011/002</LicenceNumber>
    <ProductName>SOFRAMYCIN EYE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006378</DrugIDPK>
    <LicenceNumber>PA0748/038/001</LicenceNumber>
    <ProductName>SULTRIN TRIPLE SULFA</ProductName>
    <Strength>3.42/2.86/3.7</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFATHIAZOLE</ActiveSubstance>
      <ActiveSubstance>SULFACETAMIDE</ActiveSubstance>
      <ActiveSubstance>SULFABENZAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004049</DrugIDPK>
    <LicenceNumber>PA0148/021/001</LicenceNumber>
    <ProductName>BLEPHAMIDE LIQUIFILM</ProductName>
    <Strength>0.22/10.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE ACETATE</ActiveSubstance>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005018</DrugIDPK>
    <LicenceNumber>PA0236/005/001</LicenceNumber>
    <ProductName>KELFIZINE W</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFALENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008979</DrugIDPK>
    <LicenceNumber>PA0111/003/001</LicenceNumber>
    <ProductName>RIMACTAZID</ProductName>
    <Strength>300/150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006357</DrugIDPK>
    <LicenceNumber>PA0899/003/003</LicenceNumber>
    <ProductName>STELAZINE SPANSULE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIFLUOPERAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006358</DrugIDPK>
    <LicenceNumber>PA0899/003/004</LicenceNumber>
    <ProductName>STELAZINE SPANSULE</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIFLUOPERAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006359</DrugIDPK>
    <LicenceNumber>PA0899/003/005</LicenceNumber>
    <ProductName>STELAZINE SPANSULE</ProductName>
    <Strength>15 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIFLUOPERAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011380</DrugIDPK>
    <LicenceNumber>PA0540/127/004</LicenceNumber>
    <ProductName>STEMETIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011381</DrugIDPK>
    <LicenceNumber>PA0540/127/003</LicenceNumber>
    <ProductName>STEMETIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018400</DrugIDPK>
    <LicenceNumber>PA0891/007/001</LicenceNumber>
    <ProductName>SITOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB (Pharma) Ireland Limited</PAHolder>
    <AuthorisedDate>2004-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006025</DrugIDPK>
    <LicenceNumber>PA0405/008/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006800</DrugIDPK>
    <LicenceNumber>PA0544/005/001</LicenceNumber>
    <ProductName>MENGIVAC (A+C) SINGLE DOSE</ProductName>
    <Strength>50/50mcg/0</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-09-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEISSERIA MENINGITIDIS A</ActiveSubstance>
      <ActiveSubstance>NEISSERIA MENINGITIDIS C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014905</DrugIDPK>
    <LicenceNumber>PA0805/003/001</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014906</DrugIDPK>
    <LicenceNumber>PA0805/003/002</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014907</DrugIDPK>
    <LicenceNumber>PA0805/003/003</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014908</DrugIDPK>
    <LicenceNumber>PA0805/003/004</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018887</DrugIDPK>
    <LicenceNumber>PA0805/003/005</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2005-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007749</DrugIDPK>
    <LicenceNumber>PA0593/017/001</LicenceNumber>
    <ProductName>UROFLOX</ProductName>
    <Strength>400mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008927</DrugIDPK>
    <LicenceNumber>PA0812/003/001</LicenceNumber>
    <ProductName>FENTICONAZOLE NITRATE VAGINAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Recordati Industria Chimica e Farmaceutica SpA</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013873</DrugIDPK>
    <LicenceNumber>PA0970/040/001</LicenceNumber>
    <ProductName>HEMINEVRIN 0.8% INFUSION</ProductName>
    <Strength>8mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMETHIAZOLE EDISILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020685</DrugIDPK>
    <LicenceNumber>PA0126/160/001</LicenceNumber>
    <ProductName>BENPROTAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFUZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020910</DrugIDPK>
    <LicenceNumber>PA1262/001/003</LicenceNumber>
    <ProductName>NOCUTIL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Gebro Pharma GmbH</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003306</DrugIDPK>
    <LicenceNumber>PA0074/007/001</LicenceNumber>
    <ProductName>MIGRANAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>PIPOXOLAN HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001308</DrugIDPK>
    <LicenceNumber>PA0024/001/003</LicenceNumber>
    <ProductName>VENTOLIN ROTACAP</ProductName>
    <Strength>200 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001309</DrugIDPK>
    <LicenceNumber>PA0024/001/004</LicenceNumber>
    <ProductName>VENTOLIN ROTACAP</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006259</DrugIDPK>
    <LicenceNumber>PA0417/015/001</LicenceNumber>
    <ProductName>ACTAL PASTILS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002051</DrugIDPK>
    <LicenceNumber>PA0046/004/015</LicenceNumber>
    <ProductName>FUCIDIN FOR IV INFUSION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005414</DrugIDPK>
    <LicenceNumber>PA0855/014/001</LicenceNumber>
    <ProductName>STREPTASE</ProductName>
    <Strength>250,000IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005415</DrugIDPK>
    <LicenceNumber>PA0855/014/002</LicenceNumber>
    <ProductName>STREPTASE</ProductName>
    <Strength>750,000IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005416</DrugIDPK>
    <LicenceNumber>PA0855/014/003</LicenceNumber>
    <ProductName>STREPTASE</ProductName>
    <Strength>1500000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007378</DrugIDPK>
    <LicenceNumber>PA0711/027/001</LicenceNumber>
    <ProductName>AMBROL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMBROXOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002245</DrugIDPK>
    <LicenceNumber>PA0046/059/001</LicenceNumber>
    <ProductName>BURAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006823</DrugIDPK>
    <LicenceNumber>PA0544/018/002</LicenceNumber>
    <ProductName>DIFTAVAX SYRINGE</ProductName>
    <Strength>4/40IU/0.5ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003528</DrugIDPK>
    <LicenceNumber>PA0038/051/006</LicenceNumber>
    <ProductName>KLACID ADULT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018211</DrugIDPK>
    <LicenceNumber>PA0126/129/002</LicenceNumber>
    <ProductName>TAZAMEL 30MG FILM-COATED TABLETS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2004-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003568</DrugIDPK>
    <LicenceNumber>PA0050/128/004</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003570</DrugIDPK>
    <LicenceNumber>PA0050/128/005</LicenceNumber>
    <ProductName>NAPROSYN  500MG TABLETS</ProductName>
    <Strength>500mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1995-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003572</DrugIDPK>
    <LicenceNumber>PA0050/128/007</LicenceNumber>
    <ProductName>NAPROSYN EC</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1995-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003541</DrugIDPK>
    <LicenceNumber>PA0050/129/001</LicenceNumber>
    <ProductName>SYNFLEX TABLETS 275 MG</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003295</DrugIDPK>
    <LicenceNumber>PA0073/130/001</LicenceNumber>
    <ProductName>PANCURONIUM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006127</DrugIDPK>
    <LicenceNumber>PA0408/030/001</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001962</DrugIDPK>
    <LicenceNumber>PA0040/063/001</LicenceNumber>
    <ProductName>PIPORTIL DEPOT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1982-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPOTIAZINE PALMITATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001963</DrugIDPK>
    <LicenceNumber>PA0040/063/002</LicenceNumber>
    <ProductName>PIPORTIL DEPOT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1982-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPOTIAZINE PALMITATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017872</DrugIDPK>
    <LicenceNumber>PA0167/116/002</LicenceNumber>
    <ProductName>GAMMABULIN</ProductName>
    <Strength>0.8g/5ml</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN  &gt;90% GAMMA GLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017873</DrugIDPK>
    <LicenceNumber>PA0167/116/003</LicenceNumber>
    <ProductName>GAMMABULIN S/D 10ML HUMAN NORMAL IMMUNOGLOBULIN</ProductName>
    <Strength>1.6g/10ml</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN  &gt;90% GAMMA GLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002100</DrugIDPK>
    <LicenceNumber>PA0775/001/001</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002101</DrugIDPK>
    <LicenceNumber>PA0775/001/002</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013580</DrugIDPK>
    <LicenceNumber>PA0775/001/008</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019476</DrugIDPK>
    <LicenceNumber>PA1046/010/001</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2004-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019477</DrugIDPK>
    <LicenceNumber>PA1046/010/002</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2004-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019051</DrugIDPK>
    <LicenceNumber>PA0436/037/001</LicenceNumber>
    <ProductName>SALBUTAMOL CFC - FREE INHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2003-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003568</DrugIDPK>
    <LicenceNumber>PA0095/006/001</LicenceNumber>
    <ProductName>RESPRIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ADEPS SOLIDUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003569</DrugIDPK>
    <LicenceNumber>PA0095/006/002</LicenceNumber>
    <ProductName>RESPRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008810</DrugIDPK>
    <LicenceNumber>PA0593/008/004</LicenceNumber>
    <ProductName>DICLOFENAC 25</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008816</DrugIDPK>
    <LicenceNumber>PA0593/008/005</LicenceNumber>
    <ProductName>DICLOFENAC 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015273</DrugIDPK>
    <LicenceNumber>PA1064/001/001</LicenceNumber>
    <ProductName>PAMIDRONATE DISODIUM</ProductName>
    <Strength>3mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Neomed Technology Ltd</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015274</DrugIDPK>
    <LicenceNumber>PA1064/001/002</LicenceNumber>
    <ProductName>PAMIDRONATE DISODIUM</ProductName>
    <Strength>9mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Neomed Technology Ltd</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004468</DrugIDPK>
    <LicenceNumber>PA0172/011/002</LicenceNumber>
    <ProductName>PREPARATION H</ProductName>
    <Strength>1/3%w/w</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIVE YEAST CELL DERIVATIVE</ActiveSubstance>
      <ActiveSubstance>SHARK-LIVER OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013915</DrugIDPK>
    <LicenceNumber>PA0970/052/001</LicenceNumber>
    <ProductName>UNIMAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013916</DrugIDPK>
    <LicenceNumber>PA0970/052/002</LicenceNumber>
    <ProductName>UNIMAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010325</DrugIDPK>
    <LicenceNumber>PA0022/079/001</LicenceNumber>
    <ProductName>TOTELLE CYCLE</ProductName>
    <Strength>2/0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>TRIMEGESTONE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006574</DrugIDPK>
    <LicenceNumber>PA0484/005/001</LicenceNumber>
    <ProductName>FORANS COUGH MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUORICE LIQUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>MARRUBIUM VULGARE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008730</DrugIDPK>
    <LicenceNumber>PA0074/047/001</LicenceNumber>
    <ProductName>CALAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008693</DrugIDPK>
    <LicenceNumber>PA0946/001/001</LicenceNumber>
    <ProductName>KOLANTICON GEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Peckforton Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDUM LEVE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004505</DrugIDPK>
    <LicenceNumber>PA0176/034/001</LicenceNumber>
    <ProductName>COSALGESIC</ProductName>
    <Strength>32.5/325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003261</DrugIDPK>
    <LicenceNumber>PA0751/002/001</LicenceNumber>
    <ProductName>GLUCOSE 4.3% AND SODIUM CHLORIDE 0.18%</ProductName>
    <Strength>0.9g/21.5g</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003262</DrugIDPK>
    <LicenceNumber>PA0751/002/002</LicenceNumber>
    <ProductName>GLUCOSE 4.3% AND SODIUM CHLORIDE 0.18%</ProductName>
    <Strength>1.8/43</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003255</DrugIDPK>
    <LicenceNumber>PA0751/003/001</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003263</DrugIDPK>
    <LicenceNumber>PA0751/004/001</LicenceNumber>
    <ProductName>RINGER LACTATE (HARTMANNS SOLUTION)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003264</DrugIDPK>
    <LicenceNumber>PA0751/004/002</LicenceNumber>
    <ProductName>RINGER LACTATE (HARTMANNS SOLUTION)</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017668</DrugIDPK>
    <LicenceNumber>PA0838/005/001</LicenceNumber>
    <ProductName>SIMVASTATIN PHARMA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Danmark A/S</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017669</DrugIDPK>
    <LicenceNumber>PA0838/005/002</LicenceNumber>
    <ProductName>SIMVASTATIN PHARMA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Danmark A/S</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017670</DrugIDPK>
    <LicenceNumber>PA0838/005/003</LicenceNumber>
    <ProductName>SIMVASTATIN PHARMA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Danmark A/S</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010343</DrugIDPK>
    <LicenceNumber>PA0979/021/002</LicenceNumber>
    <ProductName>Children’s Lemsip Cold &amp; Flu Blackcurrant</ProductName>
    <Strength>240mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>As an item for general sale, in pack sizes of not more than 12 sachets.</SupplyComments>
    <WithdrawalDate>2007-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019185</DrugIDPK>
    <LicenceNumber>PA1136/001/002</LicenceNumber>
    <ProductName>INFUKOLL N</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Serumwerk Bernburg AG</PAHolder>
    <AuthorisedDate>2004-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018171</DrugIDPK>
    <LicenceNumber>PA1136/001/001</LicenceNumber>
    <ProductName>INFUKOLL N</ProductName>
    <Strength>6%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Serumwerk Bernburg AG</PAHolder>
    <AuthorisedDate>2004-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010100</DrugIDPK>
    <LicenceNumber>PA0022/066/001</LicenceNumber>
    <ProductName>NORDETTE COATED TABLETS</ProductName>
    <Strength>150/30mcg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006113</DrugIDPK>
    <LicenceNumber>PA0408/018/001</LicenceNumber>
    <ProductName>RIMASAL SALBUTAMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006114</DrugIDPK>
    <LicenceNumber>PA0408/018/002</LicenceNumber>
    <ProductName>RIMASAL SALBUTAMOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1988-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003201</DrugIDPK>
    <LicenceNumber>PA0727/002/001</LicenceNumber>
    <ProductName>OTEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Diomed Developments</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UREA HYDROGEN PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019884</DrugIDPK>
    <LicenceNumber>PA0290/076/001</LicenceNumber>
    <ProductName>MIOSTAT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>2005-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBACHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004151</DrugIDPK>
    <LicenceNumber>PA0167/009/026</LicenceNumber>
    <ProductName>GLUCOSE</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004153</DrugIDPK>
    <LicenceNumber>PA0167/009/027</LicenceNumber>
    <ProductName>GLUCOSE 0.3%</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010821</DrugIDPK>
    <LicenceNumber>PA0540/056/003</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>50mg/5ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001899</DrugIDPK>
    <LicenceNumber>PA0040/018/009</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011319</DrugIDPK>
    <LicenceNumber>PA0540/108/005</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011321</DrugIDPK>
    <LicenceNumber>PA0540/108/003</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011322</DrugIDPK>
    <LicenceNumber>PA0540/108/004</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020524</DrugIDPK>
    <LicenceNumber>PA0126/156/001</LicenceNumber>
    <ProductName>RAMITACE</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020525</DrugIDPK>
    <LicenceNumber>PA0126/156/002</LicenceNumber>
    <ProductName>RAMITACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020526</DrugIDPK>
    <LicenceNumber>PA0126/156/003</LicenceNumber>
    <ProductName>RAMITACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020527</DrugIDPK>
    <LicenceNumber>PA0126/156/004</LicenceNumber>
    <ProductName>RAMITACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002379</DrugIDPK>
    <LicenceNumber>PA0048/027/001</LicenceNumber>
    <ProductName>MEGACE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEGESTROL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003777</DrugIDPK>
    <LicenceNumber>PA0118/003/001</LicenceNumber>
    <ProductName>MINIMS NEOMYCIN SULPHATE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000505</DrugIDPK>
    <LicenceNumber>PA0012/051/001</LicenceNumber>
    <ProductName>NOCTAMID</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORMETAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015600</DrugIDPK>
    <LicenceNumber>PA0848/002/001</LicenceNumber>
    <ProductName>SIMVASTATIN REAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dolorgiet GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015601</DrugIDPK>
    <LicenceNumber>PA0848/002/002</LicenceNumber>
    <ProductName>SIMVASTATIN REAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dolorgiet GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015602</DrugIDPK>
    <LicenceNumber>PA0848/002/003</LicenceNumber>
    <ProductName>SIMVASTATIN REAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dolorgiet GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015603</DrugIDPK>
    <LicenceNumber>PA0848/002/004</LicenceNumber>
    <ProductName>SIMVASTATIN REAL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dolorgiet GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>2002-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015155</DrugIDPK>
    <LicenceNumber>PA0610/002/001</LicenceNumber>
    <ProductName>DERMIDEX</ProductName>
    <Strength>1.2/0.5/0.</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2002-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>ALCLOXA</ActiveSubstance>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015206</DrugIDPK>
    <LicenceNumber>PA0610/014/001</LicenceNumber>
    <ProductName>GALPSEUD</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1999-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2007-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012287</DrugIDPK>
    <LicenceNumber>PPA0465/002/003B</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003609</DrugIDPK>
    <LicenceNumber>PA0100/001/001</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <Strength>500000IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN MESILATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003614</DrugIDPK>
    <LicenceNumber>PA0100/001/005</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <Strength>1000000</Strength>
    <StrengthMeasurement>MU/ml</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN MESILATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015482</DrugIDPK>
    <LicenceNumber>PPA0465/092/004A</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020081</DrugIDPK>
    <LicenceNumber>PPA0465/162/001</LicenceNumber>
    <ProductName>MINOCIN SA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017464</DrugIDPK>
    <LicenceNumber>PA0013/112/001</LicenceNumber>
    <ProductName>RESCULA</ProductName>
    <Strength>0.15</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2004-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UNOPROSTONE ISOPROPYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008864</DrugIDPK>
    <LicenceNumber>PA0240/030/001</LicenceNumber>
    <ProductName>SODIUM PHOSPHATE [32P]</ProductName>
    <Strength>185 MBq/ml</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PHOSPHATE (32 P)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008808</DrugIDPK>
    <LicenceNumber>PA0240/009/001</LicenceNumber>
    <ProductName>XENON GAS FOR INHALATION</ProductName>
    <Strength>92.5</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Gas</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XENON (133 XE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008814</DrugIDPK>
    <LicenceNumber>PA0240/011/001</LicenceNumber>
    <ProductName>YTTRIUM [90Y] SILICATE</ProductName>
    <Strength>37-92.5</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YTTRIUM (90 Y) SILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006702</DrugIDPK>
    <LicenceNumber>PPA0465/058/001A</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016303</DrugIDPK>
    <LicenceNumber>PA1077/091/004</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016306</DrugIDPK>
    <LicenceNumber>PA1077/091/005</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014680</DrugIDPK>
    <LicenceNumber>PA0218/026/007</LicenceNumber>
    <ProductName>INSULATARD FLEXPEN</ProductName>
    <Strength>100IU/ml</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2002-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009210</DrugIDPK>
    <LicenceNumber>PA0218/026/006</LicenceNumber>
    <ProductName>INSULATARD INNOLET</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009211</DrugIDPK>
    <LicenceNumber>PA0218/029/006</LicenceNumber>
    <ProductName>MIXTARD 30 INNOLET</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004826</DrugIDPK>
    <LicenceNumber>PA0218/008/002</LicenceNumber>
    <ProductName>TRISEQUENS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1987-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018989</DrugIDPK>
    <LicenceNumber>PA1077/042/008</LicenceNumber>
    <ProductName>BECOTIDE EVOHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015845</DrugIDPK>
    <LicenceNumber>PA1077/021/004</LicenceNumber>
    <ProductName>CO-AMOXICLAV</ProductName>
    <Strength>250, 125</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016111</DrugIDPK>
    <LicenceNumber>PA1077/022/002</LicenceNumber>
    <ProductName>CO-AMOXICLAV DUO 400 MG / 57 MG PER 5 ML POWDER FO</ProductName>
    <Strength>400/57</Strength>
    <StrengthMeasurement>Base mg/5ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016113</DrugIDPK>
    <LicenceNumber>PA1077/022/003</LicenceNumber>
    <ProductName>CO-AMOXICLAV DUO 500 MG / 125 MG FILM-COATED TABLE</ProductName>
    <Strength>500/125</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016018</DrugIDPK>
    <LicenceNumber>PA1077/021/002</LicenceNumber>
    <ProductName>CO-AMOXICLAV JUNIOR SUSPENSION</ProductName>
    <Strength>125/62</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016017</DrugIDPK>
    <LicenceNumber>PA1077/021/001</LicenceNumber>
    <ProductName>CO-AMOXICLAV PAEDIATRIC</ProductName>
    <Strength>25/31</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016299</DrugIDPK>
    <LicenceNumber>PA1077/023/003</LicenceNumber>
    <ProductName>ENGERIX B VACCINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2004-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN (HBS AG)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016151</DrugIDPK>
    <LicenceNumber>PA1077/043/002</LicenceNumber>
    <ProductName>FLIXONASE NASULE</ProductName>
    <Strength>400mcg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Drops Susp</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020735</DrugIDPK>
    <LicenceNumber>PA1077/112/001</LicenceNumber>
    <ProductName>FRAXIPARINE</ProductName>
    <Strength>0.2 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADROPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020736</DrugIDPK>
    <LicenceNumber>PA1077/112/002</LicenceNumber>
    <ProductName>FRAXIPARINE</ProductName>
    <Strength>2850IU ant</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADROPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020737</DrugIDPK>
    <LicenceNumber>PA1077/112/003</LicenceNumber>
    <ProductName>FRAXIPARINE</ProductName>
    <Strength>3800IU ant</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADROPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020738</DrugIDPK>
    <LicenceNumber>PA1077/112/004</LicenceNumber>
    <ProductName>FRAXIPARINE</ProductName>
    <Strength>5700IU ant</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADROPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020739</DrugIDPK>
    <LicenceNumber>PA1077/112/005</LicenceNumber>
    <ProductName>FRAXIPARINE</ProductName>
    <Strength>7600IU ant</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADROPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020740</DrugIDPK>
    <LicenceNumber>PA1077/112/006</LicenceNumber>
    <ProductName>FRAXIPARINE</ProductName>
    <Strength>9500IU ant</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADROPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016311</DrugIDPK>
    <LicenceNumber>PA1077/026/003</LicenceNumber>
    <ProductName>HAVRIX MONODOSE VACCINE</ProductName>
    <Strength>NLT720 Eli</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATIT A VIRUS ANTIGEN</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019762</DrugIDPK>
    <LicenceNumber>PA1077/008/005</LicenceNumber>
    <ProductName>IMIGRAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2004-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016121</DrugIDPK>
    <LicenceNumber>PA1077/029/001</LicenceNumber>
    <ProductName>INFANRIX IPV &amp; HIB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016128</DrugIDPK>
    <LicenceNumber>PA1077/034/001</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018025</DrugIDPK>
    <LicenceNumber>PA1077/036/002</LicenceNumber>
    <ProductName>PRIORIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019286</DrugIDPK>
    <LicenceNumber>PA1077/102/001</LicenceNumber>
    <ProductName>ROPINIROLE PAUCOURT</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019287</DrugIDPK>
    <LicenceNumber>PA1077/102/002</LicenceNumber>
    <ProductName>ROPINIROLE PAUCOURT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019288</DrugIDPK>
    <LicenceNumber>PA1077/102/005</LicenceNumber>
    <ProductName>ROPINIROLE PAUCOURT</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019289</DrugIDPK>
    <LicenceNumber>PA1077/102/004</LicenceNumber>
    <ProductName>ROPINIROLE PAUCOURT</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019290</DrugIDPK>
    <LicenceNumber>PA1077/102/003</LicenceNumber>
    <ProductName>ROPINIROLE PAUCOURT</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019291</DrugIDPK>
    <LicenceNumber>PA1077/103/001</LicenceNumber>
    <ProductName>ROPINIROLE SAINT-GERMAIN</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019292</DrugIDPK>
    <LicenceNumber>PA1077/103/002</LicenceNumber>
    <ProductName>ROPINIROLE SAINT-GERMAIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019293</DrugIDPK>
    <LicenceNumber>PA1077/103/003</LicenceNumber>
    <ProductName>ROPINIROLE SAINT-GERMAIN</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019294</DrugIDPK>
    <LicenceNumber>PA1077/103/004</LicenceNumber>
    <ProductName>ROPINIROLE SAINT-GERMAIN</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019295</DrugIDPK>
    <LicenceNumber>PA1077/103/005</LicenceNumber>
    <ProductName>ROPINIROLE SAINT-GERMAIN</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995021342</DrugIDPK>
    <LicenceNumber>PA1077/113/001</LicenceNumber>
    <ProductName>SALMETEROL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016125</DrugIDPK>
    <LicenceNumber>PA1077/031/001</LicenceNumber>
    <ProductName>STERILE SALINE SOLUTION (0.9%) 1ML AMPOULE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sterile Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016127</DrugIDPK>
    <LicenceNumber>PA1077/031/003</LicenceNumber>
    <ProductName>STERILE SALINE SOLUTION (0.9%) 1ML SYRINGE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sterile Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016126</DrugIDPK>
    <LicenceNumber>PA1077/031/002</LicenceNumber>
    <ProductName>STERILE SALINE SOLUTION (0.9%) 3ML VIAL</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sterile Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016349</DrugIDPK>
    <LicenceNumber>PA1077/098/001</LicenceNumber>
    <ProductName>TIMENTIN 1.6</ProductName>
    <Strength>1.5/0.1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TICARCILLIN DISODIUM</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016350</DrugIDPK>
    <LicenceNumber>PA1077/098/002</LicenceNumber>
    <ProductName>TIMENTIN 3.2</ProductName>
    <Strength>3/0.2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TICARCILLIN DISODIUM</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016138</DrugIDPK>
    <LicenceNumber>PA1077/039/001</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016139</DrugIDPK>
    <LicenceNumber>PA1077/039/002</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016140</DrugIDPK>
    <LicenceNumber>PA1077/039/003</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016744</DrugIDPK>
    <LicenceNumber>PA1077/012/001</LicenceNumber>
    <ProductName>ZANDINE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015696</DrugIDPK>
    <LicenceNumber>PA1077/012/002</LicenceNumber>
    <ProductName>ZANDINE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015799</DrugIDPK>
    <LicenceNumber>PA1077/013/006</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019487</DrugIDPK>
    <LicenceNumber>PA1077/084/004</LicenceNumber>
    <ProductName>ZOVIRAX I.V.</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005572</DrugIDPK>
    <LicenceNumber>PA0282/047/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1988-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005561</DrugIDPK>
    <LicenceNumber>PA0282/047/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1988-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005540</DrugIDPK>
    <LicenceNumber>PA0282/038/002</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005535</DrugIDPK>
    <LicenceNumber>PA0282/038/001</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004271</DrugIDPK>
    <LicenceNumber>PA0282/071/001</LicenceNumber>
    <ProductName>RANITIDINE BP</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004272</DrugIDPK>
    <LicenceNumber>PA0282/071/002</LicenceNumber>
    <ProductName>RANITIDINE BP</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010387</DrugIDPK>
    <LicenceNumber>PA0979/023/001</LicenceNumber>
    <ProductName>IBUPROFEN FROM THE MAKERS OF DISPRIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008913</DrugIDPK>
    <LicenceNumber>PA0690/014/001</LicenceNumber>
    <ProductName>TECHNESCAN HSA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Mallinckrodt Medical B.V.</PAHolder>
    <AuthorisedDate>2001-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALBUMIN NORMAL HUMAN SERUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020635</DrugIDPK>
    <LicenceNumber>PA0126/157/001</LicenceNumber>
    <ProductName>TULPIN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020636</DrugIDPK>
    <LicenceNumber>PA0126/157/003</LicenceNumber>
    <ProductName>TULPIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020637</DrugIDPK>
    <LicenceNumber>PA0126/157/002</LicenceNumber>
    <ProductName>TULPIN</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2006-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016295</DrugIDPK>
    <LicenceNumber>PA1077/084/008</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003284</DrugIDPK>
    <LicenceNumber>PA0073/123/001</LicenceNumber>
    <ProductName>ISOSORBIDE DINITRATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1991-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005051</DrugIDPK>
    <LicenceNumber>PA0167/089/001</LicenceNumber>
    <ProductName>HETASTARCH IN 0.9% W/V SODIUM CHLORIDE INTRAVENOUS</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HETASTARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000418</DrugIDPK>
    <LicenceNumber>PA0007/004/003</LicenceNumber>
    <ProductName>TRANXENE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLORAZEPATE DIPOTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010620</DrugIDPK>
    <LicenceNumber>PA0540/036/001</LicenceNumber>
    <ProductName>CIDOMYCIN ADULT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2002-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010621</DrugIDPK>
    <LicenceNumber>PA0540/036/002</LicenceNumber>
    <ProductName>CIDOMYCIN ADULT</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2003-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003949</DrugIDPK>
    <LicenceNumber>PA0126/082/003</LicenceNumber>
    <ProductName>DICLOMEL SR</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1994-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001717</DrugIDPK>
    <LicenceNumber>PA0040/003/005</LicenceNumber>
    <ProductName>FLAGYL</ProductName>
    <Strength>1 g</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010699</DrugIDPK>
    <LicenceNumber>PA0126/111/001</LicenceNumber>
    <ProductName>GLICLAZIDE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009198</DrugIDPK>
    <LicenceNumber>PA0436/022/003</LicenceNumber>
    <ProductName>CROMOGEN EASI-BREATHE INHALER</ProductName>
    <Strength>5mg/actuat</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1995-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006335</DrugIDPK>
    <LicenceNumber>PA0436/022/002</LicenceNumber>
    <ProductName>CROMOGEN INHALER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004955</DrugIDPK>
    <LicenceNumber>PA0030/037/001</LicenceNumber>
    <ProductName>BRADOSOL PLUS</ProductName>
    <Strength>0.5mg/5mg</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1994-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMIPHEN BROMIDE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001560</DrugIDPK>
    <LicenceNumber>PA0037/045/001</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>15 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004933</DrugIDPK>
    <LicenceNumber>PA0030/024/001</LicenceNumber>
    <ProductName>MU-CRON</ProductName>
    <Strength>25/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004051</DrugIDPK>
    <LicenceNumber>PA0800/002/001</LicenceNumber>
    <ProductName>HAEMATE P</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>1994-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
      <ActiveSubstance>VON WILLEBRAND FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001390</DrugIDPK>
    <LicenceNumber>PA0035/073/001</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1989-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010503</DrugIDPK>
    <LicenceNumber>PPA0465/069/001A</LicenceNumber>
    <ProductName>PREMARIN</ProductName>
    <Strength>0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010505</DrugIDPK>
    <LicenceNumber>PPA0465/069/002A</LicenceNumber>
    <ProductName>PREMARIN</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010506</DrugIDPK>
    <LicenceNumber>PPA0465/069/002B</LicenceNumber>
    <ProductName>PREMARIN</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018367</DrugIDPK>
    <LicenceNumber>PPA0465/069/002C</LicenceNumber>
    <ProductName>PREMARIN</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003299</DrugIDPK>
    <LicenceNumber>PA0073/132/001</LicenceNumber>
    <ProductName>DULAX (LACTULOSE SOLUTION B.P.)</ProductName>
    <Strength>3350</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1991-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016345</DrugIDPK>
    <LicenceNumber>PA1077/096/004</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012199</DrugIDPK>
    <LicenceNumber>PA0038/083/004</LicenceNumber>
    <ProductName>FROBEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1976-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012200</DrugIDPK>
    <LicenceNumber>PA0038/083/005</LicenceNumber>
    <ProductName>FROBEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012201</DrugIDPK>
    <LicenceNumber>PA0038/083/006</LicenceNumber>
    <ProductName>FROBEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012195</DrugIDPK>
    <LicenceNumber>PA0038/083/001</LicenceNumber>
    <ProductName>FROBEN SR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003175</DrugIDPK>
    <LicenceNumber>PA0073/051/001</LicenceNumber>
    <ProductName>DOPAGEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003176</DrugIDPK>
    <LicenceNumber>PA0073/051/002</LicenceNumber>
    <ProductName>DOPAGEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015952</DrugIDPK>
    <LicenceNumber>PA0593/036/001</LicenceNumber>
    <ProductName>SIMVASTAD</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2004-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015953</DrugIDPK>
    <LicenceNumber>PA0593/036/002</LicenceNumber>
    <ProductName>SIMVASTAD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2004-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015954</DrugIDPK>
    <LicenceNumber>PA0593/036/003</LicenceNumber>
    <ProductName>SIMVASTAD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2004-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015955</DrugIDPK>
    <LicenceNumber>PA0593/036/004</LicenceNumber>
    <ProductName>SIMVASTAD</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>2004-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020645</DrugIDPK>
    <LicenceNumber>PA0021/073/002</LicenceNumber>
    <ProductName>REDOXON DOUBLE ACTION</ProductName>
    <Strength>500/5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>ZINC CITRATE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006674</DrugIDPK>
    <LicenceNumber>PA0043/033/001</LicenceNumber>
    <ProductName>AKNEMYCIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000179</DrugIDPK>
    <LicenceNumber>PA0002/007/001</LicenceNumber>
    <ProductName>MYCOSTATIN</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>Units/Gram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005842</DrugIDPK>
    <LicenceNumber>PA0046/062/001</LicenceNumber>
    <ProductName>BOCATRIOL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005843</DrugIDPK>
    <LicenceNumber>PA0046/062/002</LicenceNumber>
    <ProductName>BOCATRIOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016698</DrugIDPK>
    <LicenceNumber>PA0282/087/001</LicenceNumber>
    <ProductName>FLUCAZOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016699</DrugIDPK>
    <LicenceNumber>PA0282/087/002</LicenceNumber>
    <ProductName>FLUCAZOL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016700</DrugIDPK>
    <LicenceNumber>PA0282/087/003</LicenceNumber>
    <ProductName>FLUCAZOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015714</DrugIDPK>
    <LicenceNumber>PA0282/086/001</LicenceNumber>
    <ProductName>HAY-RITE 10MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010614</DrugIDPK>
    <LicenceNumber>PA0046/063/001</LicenceNumber>
    <ProductName>HEPARIN SODIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010615</DrugIDPK>
    <LicenceNumber>PA0046/063/002</LicenceNumber>
    <ProductName>HEPARIN SODIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020201</DrugIDPK>
    <LicenceNumber>PA0002/078/001</LicenceNumber>
    <ProductName>PRAVAGETTES</ProductName>
    <Strength>40/81</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009728</DrugIDPK>
    <LicenceNumber>PA0771/004/003</LicenceNumber>
    <ProductName>RECOFOL</ProductName>
    <Strength>20mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007965</DrugIDPK>
    <LicenceNumber>PA0522/005/001</LicenceNumber>
    <ProductName>SURE-LAX SENNA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Peter Black Healthcare Ltd</PAHolder>
    <AuthorisedDate>2003-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SENNOSIDE B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000183</DrugIDPK>
    <LicenceNumber>PA0002/057/014</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>150 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000180</DrugIDPK>
    <LicenceNumber>PA0002/057/012</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000181</DrugIDPK>
    <LicenceNumber>PA0002/057/013</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000403</DrugIDPK>
    <LicenceNumber>PA0002/057/011</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008284</DrugIDPK>
    <LicenceNumber>PA0002/057/015</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015438</DrugIDPK>
    <LicenceNumber>PA0678/085/001</LicenceNumber>
    <ProductName>SETLERS WIND-EZE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017614</DrugIDPK>
    <LicenceNumber>PA0610/015/003</LicenceNumber>
    <ProductName>ELECTROLADE BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2002-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017614</DrugIDPK>
    <LicenceNumber>PA0610/015/003</LicenceNumber>
    <ProductName>ELECTROLADE BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2002-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017614</DrugIDPK>
    <LicenceNumber>PA0610/015/003</LicenceNumber>
    <ProductName>ELECTROLADE BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2002-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017613</DrugIDPK>
    <LicenceNumber>PA0610/015/002</LicenceNumber>
    <ProductName>ELECTROLADE MELON</ProductName>
    <Strength>236/300/50</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2002-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017613</DrugIDPK>
    <LicenceNumber>PA0610/015/002</LicenceNumber>
    <ProductName>ELECTROLADE MELON</ProductName>
    <Strength>236/300/50</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2002-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017613</DrugIDPK>
    <LicenceNumber>PA0610/015/002</LicenceNumber>
    <ProductName>ELECTROLADE MELON</ProductName>
    <Strength>236/300/50</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2002-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017615</DrugIDPK>
    <LicenceNumber>PA0610/015/004</LicenceNumber>
    <ProductName>ELECTROLADE ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017615</DrugIDPK>
    <LicenceNumber>PA0610/015/004</LicenceNumber>
    <ProductName>ELECTROLADE ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017615</DrugIDPK>
    <LicenceNumber>PA0610/015/004</LicenceNumber>
    <ProductName>ELECTROLADE ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006373</DrugIDPK>
    <LicenceNumber>PA0819/001/001</LicenceNumber>
    <ProductName>FLUOXETINE</ProductName>
    <Strength>20 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005173</DrugIDPK>
    <LicenceNumber>PA0678/042/001</LicenceNumber>
    <ProductName>ACTIPROFEN</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1997-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006666</DrugIDPK>
    <LicenceNumber>PA0043/028/001</LicenceNumber>
    <ProductName>BALNEUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006670</DrugIDPK>
    <LicenceNumber>PA0043/030/001</LicenceNumber>
    <ProductName>BALNEUM PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1994-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>MACROGOL FATTY ACIDS ETHERS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013865</DrugIDPK>
    <LicenceNumber>PA0970/036/006</LicenceNumber>
    <ProductName>BRICANYL</ProductName>
    <Strength>1.5mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013858</DrugIDPK>
    <LicenceNumber>PA0970/035/001</LicenceNumber>
    <ProductName>BRICANYL EXPECTORANT</ProductName>
    <Strength>1.5/66.65m</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013859</DrugIDPK>
    <LicenceNumber>PA0970/036/001</LicenceNumber>
    <ProductName>BRICANYL INHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013863</DrugIDPK>
    <LicenceNumber>PA0970/037/001</LicenceNumber>
    <ProductName>BRICANYL SA</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2002-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006672</DrugIDPK>
    <LicenceNumber>PA0043/032/001</LicenceNumber>
    <ProductName>UNGUENTUM M</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017612</DrugIDPK>
    <LicenceNumber>PA0610/015/001</LicenceNumber>
    <ProductName>ELECTROLADE BANANA</ProductName>
    <Strength>236/300/50</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2001-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002753</DrugIDPK>
    <LicenceNumber>PA0271/010/002</LicenceNumber>
    <ProductName>TYLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1996-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014519</DrugIDPK>
    <LicenceNumber>PA1022/009/001</LicenceNumber>
    <ProductName>NIOPAM 200</ProductName>
    <Strength>200/10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bracco UK Limited</PAHolder>
    <AuthorisedDate>1998-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014521</DrugIDPK>
    <LicenceNumber>PA1022/010/001</LicenceNumber>
    <ProductName>NIOPAM 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bracco UK Limited</PAHolder>
    <AuthorisedDate>1998-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014524</DrugIDPK>
    <LicenceNumber>PA1022/012/001</LicenceNumber>
    <ProductName>NIOPAM 370</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bracco UK Limited</PAHolder>
    <AuthorisedDate>1998-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005619</DrugIDPK>
    <LicenceNumber>PA0285/002/005</LicenceNumber>
    <ProductName>PROFASI</ProductName>
    <Strength>10000IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1986-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019966</DrugIDPK>
    <LicenceNumber>PA1175/002/013</LicenceNumber>
    <ProductName>BETADINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003247</DrugIDPK>
    <LicenceNumber>PA0073/106/002</LicenceNumber>
    <ProductName>STERILE POTASSIUM CHLORIDE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019965</DrugIDPK>
    <LicenceNumber>PA1175/002/016</LicenceNumber>
    <ProductName>BETADINE ANTISEPTIC SWAB</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019967</DrugIDPK>
    <LicenceNumber>PA1175/002/018</LicenceNumber>
    <ProductName>BETADINE MISTETTE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019968</DrugIDPK>
    <LicenceNumber>PA1175/002/017</LicenceNumber>
    <ProductName>BETADINE SWABSTICKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Stick</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019969</DrugIDPK>
    <LicenceNumber>PA1175/002/009</LicenceNumber>
    <ProductName>BETADINE VAGINAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019972</DrugIDPK>
    <LicenceNumber>PA1175/004/001</LicenceNumber>
    <ProductName>EPADERM</ProductName>
    <Strength>30%/30%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMULSIFYING WAX</ActiveSubstance>
      <ActiveSubstance>PETROLATUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019971</DrugIDPK>
    <LicenceNumber>PA1175/013/001</LicenceNumber>
    <ProductName>STER-ZAC</ProductName>
    <Strength>0.33</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>2005-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEXACHLOROPHENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007133</DrugIDPK>
    <LicenceNumber>PA0329/001/002</LicenceNumber>
    <ProductName>ELUDRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>1991-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Spray, Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>TETRACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010803</DrugIDPK>
    <LicenceNumber>PA0540/049/001</LicenceNumber>
    <ProductName>IDARAC</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2002-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLOCTAFENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004166</DrugIDPK>
    <LicenceNumber>PA0167/010/015</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE</ProductName>
    <Strength>0.02</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004168</DrugIDPK>
    <LicenceNumber>PA0167/010/016</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010285</DrugIDPK>
    <LicenceNumber>PA0540/019/003</LicenceNumber>
    <ProductName>MERBENTYL</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008575</DrugIDPK>
    <LicenceNumber>PA0077/127/001</LicenceNumber>
    <ProductName>SKELID</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TILUDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011096</DrugIDPK>
    <LicenceNumber>PA0540/075/001</LicenceNumber>
    <ProductName>SURGAM SA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2004-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007362</DrugIDPK>
    <LicenceNumber>PA0102/025/001</LicenceNumber>
    <ProductName>NORGALAX</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009859</DrugIDPK>
    <LicenceNumber>PA0735/007/012</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009861</DrugIDPK>
    <LicenceNumber>PA0735/007/014</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009862</DrugIDPK>
    <LicenceNumber>PA0735/007/015</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001900</DrugIDPK>
    <LicenceNumber>PA0040/021/003</LicenceNumber>
    <ProductName>NEULACTIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERICIAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009852</DrugIDPK>
    <LicenceNumber>PA0979/016/001</LicenceNumber>
    <ProductName>SENOKOT 7.5 MG/5ML ORAL SOLUTION</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SENNOSIDE B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009342</DrugIDPK>
    <LicenceNumber>PA0970/010/001</LicenceNumber>
    <ProductName>INDERAL INJECTION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009340</DrugIDPK>
    <LicenceNumber>PA0970/010/003</LicenceNumber>
    <ProductName>INDERAL TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009341</DrugIDPK>
    <LicenceNumber>PA0970/010/004</LicenceNumber>
    <ProductName>INDERAL TABLETS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010030</DrugIDPK>
    <LicenceNumber>PA0970/018/005</LicenceNumber>
    <ProductName>SEROQUEL 4-DAY STARTER PACK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016231</DrugIDPK>
    <LicenceNumber>PA0711/048/001</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2003-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001965</DrugIDPK>
    <LicenceNumber>PA0044/023/002</LicenceNumber>
    <ProductName>BETNOVATE N</ProductName>
    <Strength>0.1/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001932</DrugIDPK>
    <LicenceNumber>PA0044/009/004</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <Strength>125 mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001935</DrugIDPK>
    <LicenceNumber>PA0044/009/005</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <Strength>250 mg/5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002866</DrugIDPK>
    <LicenceNumber>PA0060/006/002</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009371</DrugIDPK>
    <LicenceNumber>PA0970/019/001</LicenceNumber>
    <ProductName>TENORMIN INJECTION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008826</DrugIDPK>
    <LicenceNumber>PA0862/001/001</LicenceNumber>
    <ProductName>SMART DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pro-Med AG</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006627</DrugIDPK>
    <LicenceNumber>PA0540/016/003</LicenceNumber>
    <ProductName>SUPRAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1994-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFIXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004472</DrugIDPK>
    <LicenceNumber>PA0172/014/001</LicenceNumber>
    <ProductName>FREEZONE</ProductName>
    <Strength>17.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011863</DrugIDPK>
    <LicenceNumber>PA0172/031/004</LicenceNumber>
    <ProductName>GEVRAL INSTANT PROTEIN CHOCOLATE FLAVOUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PHOSPHORUS</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>CHOLINE</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>MILK POWDER</ActiveSubstance>
      <ActiveSubstance>SOYA PROTEIN</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>MANGANESE DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011862</DrugIDPK>
    <LicenceNumber>PA0172/031/003</LicenceNumber>
    <ProductName>GEVRAL INSTANT PROTEIN CUSTARD FLAVOUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PHOSPHORUS</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>CHOLINE</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>MILK POWDER</ActiveSubstance>
      <ActiveSubstance>SOYA PROTEIN</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>MANGANESE DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011860</DrugIDPK>
    <LicenceNumber>PA0172/031/001</LicenceNumber>
    <ProductName>GEVRAL INSTANT PROTEIN ORANGE FLAVOUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PHOSPHORUS</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>CHOLINE</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>MILK POWDER</ActiveSubstance>
      <ActiveSubstance>SOYA PROTEIN</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>MANGANESE DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011861</DrugIDPK>
    <LicenceNumber>PA0172/031/002</LicenceNumber>
    <ProductName>GEVRAL INSTANT PROTEIN STRAWBERRY FLAVOUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PHOSPHORUS</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>CHOLINE</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>MILK POWDER</ActiveSubstance>
      <ActiveSubstance>SOYA PROTEIN</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>MANGANESE DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004474</DrugIDPK>
    <LicenceNumber>PA0172/020/001</LicenceNumber>
    <ProductName>JUNIOR PARACETAMOL</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1987-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003179</DrugIDPK>
    <LicenceNumber>PA0073/053/002</LicenceNumber>
    <ProductName>PROMETHAZINE HYDROCHLORIDE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007857</DrugIDPK>
    <LicenceNumber>PA0057/069/001</LicenceNumber>
    <ProductName>EPAQ</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003178</DrugIDPK>
    <LicenceNumber>PA0073/053/001</LicenceNumber>
    <ProductName>PROMETHAZINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007918</DrugIDPK>
    <LicenceNumber>PA0329/008/001</LicenceNumber>
    <ProductName>PRIMALAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>1995-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEQUITAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011185</DrugIDPK>
    <LicenceNumber>PA0678/071/004</LicenceNumber>
    <ProductName>NIQUITIN</ProductName>
    <Strength>7mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011186</DrugIDPK>
    <LicenceNumber>PA0678/071/005</LicenceNumber>
    <ProductName>NIQUITIN</ProductName>
    <Strength>14</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011187</DrugIDPK>
    <LicenceNumber>PA0678/071/006</LicenceNumber>
    <ProductName>NIQUITIN</ProductName>
    <Strength>21</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016266</DrugIDPK>
    <LicenceNumber>PA1077/078/002</LicenceNumber>
    <ProductName>RETROVIR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIDOVUDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009454</DrugIDPK>
    <LicenceNumber>PA0894/002/001</LicenceNumber>
    <ProductName>R.B.C.</ProductName>
    <Strength>1.8/8/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Strides Shasun (UK) Ltd</PAHolder>
    <AuthorisedDate>1996-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008080</DrugIDPK>
    <LicenceNumber>PA0711/034/001</LicenceNumber>
    <ProductName>SOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008083</DrugIDPK>
    <LicenceNumber>PA0711/034/002</LicenceNumber>
    <ProductName>SOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009591</DrugIDPK>
    <LicenceNumber>PA0006/038/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009593</DrugIDPK>
    <LicenceNumber>PA0006/038/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>300 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000342</DrugIDPK>
    <LicenceNumber>PA0006/033/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000344</DrugIDPK>
    <LicenceNumber>PA0006/033/003</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>600mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003206</DrugIDPK>
    <LicenceNumber>PA0073/088/001</LicenceNumber>
    <ProductName>LUBORANT SALIVA REPLACEMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003218</DrugIDPK>
    <LicenceNumber>PA0073/092/001</LicenceNumber>
    <ProductName>MUCOGEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012875</DrugIDPK>
    <LicenceNumber>PA0936/031/001</LicenceNumber>
    <ProductName>SOLEXA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012878</DrugIDPK>
    <LicenceNumber>PA0936/031/002</LicenceNumber>
    <ProductName>SOLEXA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CELECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006432</DrugIDPK>
    <LicenceNumber>PA0437/016/001A</LicenceNumber>
    <ProductName>GENTAMICIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016343</DrugIDPK>
    <LicenceNumber>PA1077/096/005</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>1 G</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006509</DrugIDPK>
    <LicenceNumber>PA0476/005/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1989-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006510</DrugIDPK>
    <LicenceNumber>PA0476/005/003</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1989-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014751</DrugIDPK>
    <LicenceNumber>PA0775/003/001</LicenceNumber>
    <ProductName>FAVINT</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2002-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003211</DrugIDPK>
    <LicenceNumber>PA0012/081/001</LicenceNumber>
    <ProductName>CURANDRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009996</DrugIDPK>
    <LicenceNumber>PA0987/001/001</LicenceNumber>
    <ProductName>SOLVAZINC</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Provalis Healthcare Limited</PAHolder>
    <AuthorisedDate>1997-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006204</DrugIDPK>
    <LicenceNumber>PA0441/026/001</LicenceNumber>
    <ProductName>VICKS COLDCARE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1986-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008897</DrugIDPK>
    <LicenceNumber>PA0271/007/003</LicenceNumber>
    <ProductName>DEPONIT 15</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1996-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005478</DrugIDPK>
    <LicenceNumber>PA0271/002/005</LicenceNumber>
    <ProductName>ISOKET</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1983-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001417</DrugIDPK>
    <LicenceNumber>PA0037/007/004</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1980-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006521</DrugIDPK>
    <LicenceNumber>PA0735/007/001A</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>7.5g/50ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1996-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006523</DrugIDPK>
    <LicenceNumber>PA0735/007/003A</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>4g/20ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1996-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006528</DrugIDPK>
    <LicenceNumber>PA0735/007/005A</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>5g/20ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1996-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006530</DrugIDPK>
    <LicenceNumber>PA0735/007/007A</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>6g/20ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1996-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006533</DrugIDPK>
    <LicenceNumber>PA0735/007/010A</LicenceNumber>
    <ProductName>IMAGOPAQUE</ProductName>
    <Strength>17.5g/50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1996-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPENTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016261</DrugIDPK>
    <LicenceNumber>PA1077/075/001</LicenceNumber>
    <ProductName>PHYSEPTONE</ProductName>
    <Strength>10mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2003-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHADONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001415</DrugIDPK>
    <LicenceNumber>PA0037/007/002</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009068</DrugIDPK>
    <LicenceNumber>PA0037/072/001</LicenceNumber>
    <ProductName>MINOCYCLINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1997-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009070</DrugIDPK>
    <LicenceNumber>PA0037/072/002</LicenceNumber>
    <ProductName>MINOCYCLINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1997-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001445</DrugIDPK>
    <LicenceNumber>PA0037/018/001</LicenceNumber>
    <ProductName>VARIDASE TOPICAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
      <ActiveSubstance>STREPTODORNASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001561</DrugIDPK>
    <LicenceNumber>PA0037/045/003</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004260</DrugIDPK>
    <LicenceNumber>PA0623/002/001</LicenceNumber>
    <ProductName>CCNU</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>1992-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006909</DrugIDPK>
    <LicenceNumber>PA0623/001/001</LicenceNumber>
    <ProductName>TREOSULFAN CAPSULE 250 MG</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medac Gesellschaft fur Klinische Spezialpraparate mbH</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TREOSULFAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010489</DrugIDPK>
    <LicenceNumber>PA0688/001/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chanelle Medical</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006412</DrugIDPK>
    <LicenceNumber>PA0437/008/004</LicenceNumber>
    <ProductName>VINCRISTINE SULPHATE</ProductName>
    <Strength>1mg/1ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1987-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001927</DrugIDPK>
    <LicenceNumber>PA0040/033/003</LicenceNumber>
    <ProductName>ORUDIS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1981-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001924</DrugIDPK>
    <LicenceNumber>PA0040/033/001</LicenceNumber>
    <ProductName>ORUDIS 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008731</DrugIDPK>
    <LicenceNumber>PA0076/004/001</LicenceNumber>
    <ProductName>MENTHOLAIR EXTRA GENTLE VAPOUR RUB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>The Mentholatum Company Ltd.</PAHolder>
    <AuthorisedDate>1996-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour, Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>OIL OF EUCALIPTUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009395</DrugIDPK>
    <LicenceNumber>PA0696/002/019</LicenceNumber>
    <ProductName>BETADINE VAGINAL</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009396</DrugIDPK>
    <LicenceNumber>PA0696/002/020</LicenceNumber>
    <ProductName>BETADINE VAGINAL CLEANSING KIT</ProductName>
    <Strength>10%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009403</DrugIDPK>
    <LicenceNumber>PA0696/005/001</LicenceNumber>
    <ProductName>BRUSH-OFF COLD SORE TREATMENT</ProductName>
    <Strength>10%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1993-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009398</DrugIDPK>
    <LicenceNumber>PA0696/004/001</LicenceNumber>
    <ProductName>CALABAND</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008483</DrugIDPK>
    <LicenceNumber>PA0711/036/001</LicenceNumber>
    <ProductName>ESTRAMON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008484</DrugIDPK>
    <LicenceNumber>PA0711/036/002</LicenceNumber>
    <ProductName>ESTRAMON</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010141</DrugIDPK>
    <LicenceNumber>PA0696/001/001</LicenceNumber>
    <ProductName>SEROTULLE CHLORHEXIDINE GAUZE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1994-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002348</DrugIDPK>
    <LicenceNumber>PA0007/008/001</LicenceNumber>
    <ProductName>PERSANTIN</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000460</DrugIDPK>
    <LicenceNumber>PA0007/008/002</LicenceNumber>
    <ProductName>PERSANTIN</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1981-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006069</DrugIDPK>
    <LicenceNumber>PA0405/029/002</LicenceNumber>
    <ProductName>BACLOPAR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BACLOFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006046</DrugIDPK>
    <LicenceNumber>PA0405/016/003</LicenceNumber>
    <ProductName>GERICARB</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006031</DrugIDPK>
    <LicenceNumber>PA0405/011/001</LicenceNumber>
    <ProductName>GERINAP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1985-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006033</DrugIDPK>
    <LicenceNumber>PA0405/011/002</LicenceNumber>
    <ProductName>GERINAP</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1985-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007048</DrugIDPK>
    <LicenceNumber>PA0405/001/003</LicenceNumber>
    <ProductName>TAMOXIFEN CITRATE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1999-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005364</DrugIDPK>
    <LicenceNumber>PA0261/001/001</LicenceNumber>
    <ProductName>TOLVON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1975-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIANSERIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005366</DrugIDPK>
    <LicenceNumber>PA0261/001/003</LicenceNumber>
    <ProductName>TOLVON</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIANSERIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000391</DrugIDPK>
    <LicenceNumber>PA0743/002/001</LicenceNumber>
    <ProductName>ANGITIL SR</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007150</DrugIDPK>
    <LicenceNumber>PA0913/004/001</LicenceNumber>
    <ProductName>DIUMIDE-K</ProductName>
    <Strength>40/600</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003965</DrugIDPK>
    <LicenceNumber>PA0118/033/001</LicenceNumber>
    <ProductName>SNO TEARS</ProductName>
    <Strength>1.4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYVINYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005883</DrugIDPK>
    <LicenceNumber>PA0705/013/001</LicenceNumber>
    <ProductName>ONKOTRONE</ProductName>
    <Strength>2.328mg/1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MITOXANTRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019416</DrugIDPK>
    <LicenceNumber>PA0038/091/001</LicenceNumber>
    <ProductName>ZIAXEL</ProductName>
    <Strength>180/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2004-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016016</DrugIDPK>
    <LicenceNumber>PA0030/020/002</LicenceNumber>
    <ProductName>PROFLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1996-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016015</DrugIDPK>
    <LicenceNumber>PA0030/020/001</LicenceNumber>
    <ProductName>PROFLEX PAIN RELIEF</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1996-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000297</DrugIDPK>
    <LicenceNumber>PA0751/001/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1996-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000241</DrugIDPK>
    <LicenceNumber>PA0006/003/001</LicenceNumber>
    <ProductName>CIDOMYCIN INTRATHECAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009333</DrugIDPK>
    <LicenceNumber>PA0970/005/006</LicenceNumber>
    <ProductName>DIPRIVAN 2% PRE-FILLED SYRINGE</ProductName>
    <Strength>20mg/ml, 1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1995-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009334</DrugIDPK>
    <LicenceNumber>PA0970/005/007</LicenceNumber>
    <ProductName>DIPRIVAN 2% PRE-FILLED SYRINGE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1995-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006295</DrugIDPK>
    <LicenceNumber>PA0456/002/001</LicenceNumber>
    <ProductName>TORBETOL ACNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Torbet Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006418</DrugIDPK>
    <LicenceNumber>PA0437/010/002</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001645</DrugIDPK>
    <LicenceNumber>PA0185/035/001</LicenceNumber>
    <ProductName>TRAMAKE/TRAMADOL HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001633</DrugIDPK>
    <LicenceNumber>PA0577/018/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001634</DrugIDPK>
    <LicenceNumber>PA0577/018/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001635</DrugIDPK>
    <LicenceNumber>PA0577/018/003</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010336</DrugIDPK>
    <LicenceNumber>PA0993/001/001</LicenceNumber>
    <ProductName>VIAZEM SR</ProductName>
    <Strength>120mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biovail Technologies (Ireland)</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010337</DrugIDPK>
    <LicenceNumber>PA0993/001/002</LicenceNumber>
    <ProductName>VIAZEM SR</ProductName>
    <Strength>180mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biovail Technologies (Ireland)</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010338</DrugIDPK>
    <LicenceNumber>PA0993/001/003</LicenceNumber>
    <ProductName>VIAZEM SR</ProductName>
    <Strength>240mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biovail Technologies (Ireland)</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010339</DrugIDPK>
    <LicenceNumber>PA0993/001/004</LicenceNumber>
    <ProductName>VIAZEM SR</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biovail Technologies (Ireland)</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010340</DrugIDPK>
    <LicenceNumber>PA0993/001/005</LicenceNumber>
    <ProductName>VIAZEM SR</ProductName>
    <Strength>360 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biovail Technologies (Ireland)</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014957</DrugIDPK>
    <LicenceNumber>PA0731/002/001</LicenceNumber>
    <ProductName>OMNICEF 300 MG CAPSULE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma GmbH</PAHolder>
    <AuthorisedDate>2000-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFDINIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014958</DrugIDPK>
    <LicenceNumber>PA0731/002/002</LicenceNumber>
    <ProductName>OMNICEF SUSPENSION</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Astellas Pharma GmbH</PAHolder>
    <AuthorisedDate>2000-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFDINIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006621</DrugIDPK>
    <LicenceNumber>PA0590/017/001</LicenceNumber>
    <ProductName>ZOSTRUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1996-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IDOXURIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000015</DrugIDPK>
    <LicenceNumber>PA0711/007/004</LicenceNumber>
    <ProductName>ACC HARD GELATIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009415</DrugIDPK>
    <LicenceNumber>PA0584/002/001</LicenceNumber>
    <ProductName>BUTOVENT PULVINAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Chiesi Farmaceutici S.p.A.</PAHolder>
    <AuthorisedDate>2001-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011438</DrugIDPK>
    <LicenceNumber>PA0050/149/001</LicenceNumber>
    <ProductName>KYTRIL PAEDIATRIC</ProductName>
    <Strength>224mcg/ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003625</DrugIDPK>
    <LicenceNumber>PA0748/005/001</LicenceNumber>
    <ProductName>GYNOL II CONTRACEPTIVE JELLY</ProductName>
    <Strength>1.62g/81g</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1991-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012040</DrugIDPK>
    <LicenceNumber>EU/1/01/180/002</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012046</DrugIDPK>
    <LicenceNumber>EU/1/01/180/008</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006745</DrugIDPK>
    <LicenceNumber>PA0577/002/001</LicenceNumber>
    <ProductName>GERELAX</ProductName>
    <Strength>3.35g/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009500</DrugIDPK>
    <LicenceNumber>PA0281/099/001</LicenceNumber>
    <ProductName>CAPRILL</ProductName>
    <Strength>6.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009504</DrugIDPK>
    <LicenceNumber>PA0281/099/005</LicenceNumber>
    <ProductName>CAPRILL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009380</DrugIDPK>
    <LicenceNumber>PA0696/002/009</LicenceNumber>
    <ProductName>BETADINE EAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1990-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010992</DrugIDPK>
    <LicenceNumber>PA0997/002/002</LicenceNumber>
    <ProductName>HYPAQUE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Intrapharm Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010993</DrugIDPK>
    <LicenceNumber>PA0997/002/003</LicenceNumber>
    <ProductName>HYPAQUE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Intrapharm Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010991</DrugIDPK>
    <LicenceNumber>PA0997/002/001</LicenceNumber>
    <ProductName>HYPAQUE 25%</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Intrapharm Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010994</DrugIDPK>
    <LicenceNumber>PA0997/003/001</LicenceNumber>
    <ProductName>HYPAQUE 45%</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Intrapharm Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008769</DrugIDPK>
    <LicenceNumber>PA0544/016/001</LicenceNumber>
    <ProductName>MENOMUNE A/C/Y/W-135</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENINGOCCAL POLYSACCHARIDE GROUP A</ActiveSubstance>
      <ActiveSubstance>MENINGOCOCCAL POLYSACCHARIDE GROUP C</ActiveSubstance>
      <ActiveSubstance>MENINGOCOCCAL POLYSACCHARIDE GROUP Y</ActiveSubstance>
      <ActiveSubstance>MENINGOCOCCAL POLYSACCHARIDE GROU W-135</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006569</DrugIDPK>
    <LicenceNumber>PA0483/006/001</LicenceNumber>
    <ProductName>STERETS CHLORASOL</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seton Prebbles Ltd</PAHolder>
    <AuthorisedDate>1991-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM HYPOCHLORITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007523</DrugIDPK>
    <LicenceNumber>PA0448/001/001</LicenceNumber>
    <ProductName>INDOCOLLYRE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Laboratoires Chauvin</PAHolder>
    <AuthorisedDate>1996-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Pdr &amp; Solv for Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010183</DrugIDPK>
    <LicenceNumber>PA0544/021/002</LicenceNumber>
    <ProductName>PNEUMOVAX II PREFILLED SYRINGE</ProductName>
    <Strength>25mcg/0.5m</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019717</DrugIDPK>
    <LicenceNumber>PA1155/003/001</LicenceNumber>
    <ProductName>QUINODERM LOTIO-GEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM HYDROXYQUINOLIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008229</DrugIDPK>
    <LicenceNumber>PA0696/010/001</LicenceNumber>
    <ProductName>RALGEX IBUPROFEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008950</DrugIDPK>
    <LicenceNumber>PA0035/083/002</LicenceNumber>
    <ProductName>FOSAMAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>2001-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009374</DrugIDPK>
    <LicenceNumber>PA0696/002/006</LicenceNumber>
    <ProductName>BETADINE ANTISEPTIC WIPES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009386</DrugIDPK>
    <LicenceNumber>PA0696/002/013</LicenceNumber>
    <ProductName>BETADINE SCALP &amp; SKIN CLEANSER</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007401</DrugIDPK>
    <LicenceNumber>PA0618/035/001</LicenceNumber>
    <ProductName>WOODWARDS TEETHING</ProductName>
    <Strength>8.70/0.01</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CETALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005782</DrugIDPK>
    <LicenceNumber>PA0298/008/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005784</DrugIDPK>
    <LicenceNumber>PA0298/008/002</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005751</DrugIDPK>
    <LicenceNumber>PA0345/002/001</LicenceNumber>
    <ProductName>CALCIFORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Laboratoires Grimberg</PAHolder>
    <AuthorisedDate>1991-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLUCONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLUCEPTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SACCHAROMYCES CEREVISIAE MEYEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001866</DrugIDPK>
    <LicenceNumber>PA0035/003/001</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001867</DrugIDPK>
    <LicenceNumber>PA0035/003/002</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001869</DrugIDPK>
    <LicenceNumber>PA0035/003/004</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002063</DrugIDPK>
    <LicenceNumber>PA0035/003/005</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001773</DrugIDPK>
    <LicenceNumber>PA0035/003/006</LicenceNumber>
    <ProductName>INDOCID-R</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005658</DrugIDPK>
    <LicenceNumber>PA0290/034/001</LicenceNumber>
    <ProductName>TOBREX</ProductName>
    <Strength>0.3%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1983-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018894</DrugIDPK>
    <LicenceNumber>PA0100/047/002</LicenceNumber>
    <ProductName>BISODOL SPEARMINT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>2001-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>LIGHT MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005703</DrugIDPK>
    <LicenceNumber>PA0294/005/002</LicenceNumber>
    <ProductName>CUNIL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1986-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008440</DrugIDPK>
    <LicenceNumber>PA0466/004/001</LicenceNumber>
    <ProductName>VITAMIN C</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Quest Vitamins (UK) Ltd</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008448</DrugIDPK>
    <LicenceNumber>PA0466/005/001</LicenceNumber>
    <ProductName>MULTI B COMPLEX PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Quest Vitamins (UK) Ltd</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRODOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>CHOLINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>P-AMINOBENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001392</DrugIDPK>
    <LicenceNumber>PA0476/009/001</LicenceNumber>
    <ProductName>LACTOLAX</ProductName>
    <Strength>3350</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006511</DrugIDPK>
    <LicenceNumber>PA0476/007/005</LicenceNumber>
    <ProductName>NAPROXEN EC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006512</DrugIDPK>
    <LicenceNumber>PA0476/007/006</LicenceNumber>
    <ProductName>NAPROXEN EC</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006513</DrugIDPK>
    <LicenceNumber>PA0476/007/007</LicenceNumber>
    <ProductName>NAPROXEN EC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000407</DrugIDPK>
    <LicenceNumber>PA0755/001/002</LicenceNumber>
    <ProductName>PEPCID AC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Limited</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005360</DrugIDPK>
    <LicenceNumber>PA0258/040/001</LicenceNumber>
    <ProductName>PRIPSEN WORM ELIXIR</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1991-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERAZINE HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015446</DrugIDPK>
    <LicenceNumber>PA0678/091/001</LicenceNumber>
    <ProductName>JOY-RIDES</ProductName>
    <Strength>150 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005206</DrugIDPK>
    <LicenceNumber>PA0678/059/001</LicenceNumber>
    <ProductName>Macleans Sensitive</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1997-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STRONTIUM ACETATE HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018120</DrugIDPK>
    <LicenceNumber>PA0678/098/001</LicenceNumber>
    <ProductName>QUELLADA APPLICATION PC</ProductName>
    <Strength>1.00</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINDANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018119</DrugIDPK>
    <LicenceNumber>PA0678/097/001</LicenceNumber>
    <ProductName>QUELLADA LOTION</ProductName>
    <Strength>1.00</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINDANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018392</DrugIDPK>
    <LicenceNumber>PA1112/002/002</LicenceNumber>
    <ProductName>ALBUREX</ProductName>
    <Strength>20% w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>ZLB GmbH</PAHolder>
    <AuthorisedDate>2004-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006347</DrugIDPK>
    <LicenceNumber>PA0437/003/003</LicenceNumber>
    <ProductName>DOPAMINE 160 MG/ML STERILE CONCENTRATE</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000084</DrugIDPK>
    <LicenceNumber>PA0437/039/001</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000085</DrugIDPK>
    <LicenceNumber>PA0437/039/002</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010311</DrugIDPK>
    <LicenceNumber>PA0992/001/001</LicenceNumber>
    <ProductName>BICAFLAC BUFFER SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Edwards Lifesciences Germany</PAHolder>
    <AuthorisedDate>2001-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Haemofiltration</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010315</DrugIDPK>
    <LicenceNumber>PA0992/003/001</LicenceNumber>
    <ProductName>BICAFLAC ELECTROLYTE SOLUTION WITH</ProductName>
    <Strength>2 mmol/1 P</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Edwards Lifesciences Germany</PAHolder>
    <AuthorisedDate>2001-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Haemofiltration</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010314</DrugIDPK>
    <LicenceNumber>PA0992/002/001</LicenceNumber>
    <ProductName>BICAFLAC ELECTROLYTE SOLUTION WITHOUT POTASSIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Edwards Lifesciences Germany</PAHolder>
    <AuthorisedDate>2001-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013871</DrugIDPK>
    <LicenceNumber>PA0970/039/003</LicenceNumber>
    <ProductName>ENTOCORT</ProductName>
    <Strength>0.02mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Enema</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016271</DrugIDPK>
    <LicenceNumber>EU/1/96/007/003</LicenceNumber>
    <ProductName>HUMALOG CARTRIDGES</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006236</DrugIDPK>
    <LicenceNumber>EU/1/96/007/007</LicenceNumber>
    <ProductName>HUMALOG NPL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>1998-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016269</DrugIDPK>
    <LicenceNumber>EU/1/96/007/001</LicenceNumber>
    <ProductName>HUMALOG VIALS</ProductName>
    <Strength>40IU/ml</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009037</DrugIDPK>
    <LicenceNumber>PA0022/069/001</LicenceNumber>
    <ProductName>PREMIQUE 2.5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006449</DrugIDPK>
    <LicenceNumber>PA0468/003/001</LicenceNumber>
    <ProductName>ALGICON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009839</DrugIDPK>
    <LicenceNumber>PA0979/011/004</LicenceNumber>
    <ProductName>GAVISCON 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009840</DrugIDPK>
    <LicenceNumber>PA0979/011/005</LicenceNumber>
    <ProductName>GAVISCON 250 - LEMON FLAVOUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003111</DrugIDPK>
    <LicenceNumber>PA0047/082/001</LicenceNumber>
    <ProductName>HUMAJECT I (ISOPHANE)</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003112</DrugIDPK>
    <LicenceNumber>PA0047/083/001</LicenceNumber>
    <ProductName>HUMAJECT M3 (MIXTURE 3)</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003110</DrugIDPK>
    <LicenceNumber>PA0047/081/001</LicenceNumber>
    <ProductName>HUMAJECT S (SOLUBLE)</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003452</DrugIDPK>
    <LicenceNumber>PA0047/066/004</LicenceNumber>
    <ProductName>HUMULIN (MIXTURE 2)</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007685</DrugIDPK>
    <LicenceNumber>PA0047/075/001</LicenceNumber>
    <ProductName>HUMULIN LENTE</ProductName>
    <Strength>100 IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1995-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005475</DrugIDPK>
    <LicenceNumber>PA0047/091/001</LicenceNumber>
    <ProductName>HUMULIN M2 PEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007683</DrugIDPK>
    <LicenceNumber>PA0047/074/001</LicenceNumber>
    <ProductName>HUMULIN M5 (MIXTURE 5)</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1994-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002207</DrugIDPK>
    <LicenceNumber>PA0047/061/001</LicenceNumber>
    <ProductName>HUMULIN ZN (ZINC)</ProductName>
    <Strength>100 iu</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1990-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019729</DrugIDPK>
    <LicenceNumber>PA0261/048/001</LicenceNumber>
    <ProductName>ORADEXON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004083</DrugIDPK>
    <LicenceNumber>PA0167/001/001</LicenceNumber>
    <ProductName>ALBUMIN 20%W/V (BUMINATE 20%W/V)</ProductName>
    <Strength>20 %w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003311</DrugIDPK>
    <LicenceNumber>PA0074/010/001</LicenceNumber>
    <ProductName>METOCYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1986-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007760</DrugIDPK>
    <LicenceNumber>PA0936/003/002</LicenceNumber>
    <ProductName>REGAINE TOPICAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1996-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOXIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015207</DrugIDPK>
    <LicenceNumber>PA0282/080/001</LicenceNumber>
    <ProductName>VASODUR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015208</DrugIDPK>
    <LicenceNumber>PA0282/080/002</LicenceNumber>
    <ProductName>VASODUR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015209</DrugIDPK>
    <LicenceNumber>PA0282/080/003</LicenceNumber>
    <ProductName>VASODUR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006806</DrugIDPK>
    <LicenceNumber>PA0073/091/015</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006807</DrugIDPK>
    <LicenceNumber>PA0073/091/016</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005283</DrugIDPK>
    <LicenceNumber>PA0281/009/005</LicenceNumber>
    <ProductName>NOVAPEN AMPICILLIN SYRUP BP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020642</DrugIDPK>
    <LicenceNumber>PA0021/074/003</LicenceNumber>
    <ProductName>REDOXON LEMON</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017634</DrugIDPK>
    <LicenceNumber>PA0549/013/005</LicenceNumber>
    <ProductName>SLO-MORPH</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2001-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018724</DrugIDPK>
    <LicenceNumber>PA0610/017/001</LicenceNumber>
    <ProductName>VIRASORB</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2001-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001393</DrugIDPK>
    <LicenceNumber>PA0476/010/001</LicenceNumber>
    <ProductName>DICLOFENAC 100 MG PROLONGED RELEASE TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019557</DrugIDPK>
    <LicenceNumber>PA1202/001/001</LicenceNumber>
    <ProductName>GLYCERINE LEMON &amp; HONEY</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Colet Products Ltd</PAHolder>
    <AuthorisedDate>2004-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019558</DrugIDPK>
    <LicenceNumber>PA1202/002/001</LicenceNumber>
    <ProductName>LIQUID PARAFFIN PH EUR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Colet Products Ltd</PAHolder>
    <AuthorisedDate>2004-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008854</DrugIDPK>
    <LicenceNumber>PA0240/027/001</LicenceNumber>
    <ProductName>AMERSCAN DMSA AGENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCCIMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008859</DrugIDPK>
    <LicenceNumber>PA0240/028/001</LicenceNumber>
    <ProductName>AMERSCAN PENTETATE II AGENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM TRISODIUM PENTETATE</ActiveSubstance>
      <ActiveSubstance>STANNOUS CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000678</DrugIDPK>
    <LicenceNumber>PA0010/032/003</LicenceNumber>
    <ProductName>MONONINE FREEZE DRIED HUMAN COAG. FACTOR IX</ProductName>
    <Strength>1000 IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000677</DrugIDPK>
    <LicenceNumber>PA0010/032/002</LicenceNumber>
    <ProductName>MONONINE FREEZE DRIED HUMAN COAG.FACTOR</ProductName>
    <Strength>500 IU/10ml</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016067</DrugIDPK>
    <LicenceNumber>PA1063/006/001</LicenceNumber>
    <ProductName>RENAMEL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1998-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016068</DrugIDPK>
    <LicenceNumber>PA1063/006/002</LicenceNumber>
    <ProductName>RENAMEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1998-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019284</DrugIDPK>
    <LicenceNumber>PA0800/004/001</LicenceNumber>
    <ProductName>VIVAGLOBIN</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN IMMUMOGLOBULINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016758</DrugIDPK>
    <LicenceNumber>PA1096/002/001</LicenceNumber>
    <ProductName>BETIM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Valeant Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002570</DrugIDPK>
    <LicenceNumber>PA0073/091/013</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE B.P. 0.75% W/V</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002568</DrugIDPK>
    <LicenceNumber>PA0073/091/011</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE BP 0.375%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015439</DrugIDPK>
    <LicenceNumber>PA0678/085/002</LicenceNumber>
    <ProductName>SETLERS WIND-EZE SOFT GEL</ProductName>
    <Strength>125mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003233</DrugIDPK>
    <LicenceNumber>PA0073/104/001A</LicenceNumber>
    <ProductName>CHLORPROMAZINE 1 ML</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008640</DrugIDPK>
    <LicenceNumber>PA0047/068/003</LicenceNumber>
    <ProductName>HUMATROPE</ProductName>
    <Strength>18 iu</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008641</DrugIDPK>
    <LicenceNumber>PA0047/068/004</LicenceNumber>
    <ProductName>HUMATROPE</ProductName>
    <Strength>36 iu</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008642</DrugIDPK>
    <LicenceNumber>PA0047/068/005</LicenceNumber>
    <ProductName>HUMATROPE</ProductName>
    <Strength>72 iu</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002225</DrugIDPK>
    <LicenceNumber>PA0047/068/001</LicenceNumber>
    <ProductName>HUMATROPE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002227</DrugIDPK>
    <LicenceNumber>PA0047/068/002</LicenceNumber>
    <ProductName>HUMATROPE</ProductName>
    <Strength>16 iu</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007894</DrugIDPK>
    <LicenceNumber>PA0592/001/003</LicenceNumber>
    <ProductName>INTRAGLOBIN F (FLUID)</ProductName>
    <Strength>1000/20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007895</DrugIDPK>
    <LicenceNumber>PA0592/001/004A</LicenceNumber>
    <ProductName>INTRAGLOBIN F (FLUID)</ProductName>
    <Strength>2500/50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000810</DrugIDPK>
    <LicenceNumber>PA0016/038/001</LicenceNumber>
    <ProductName>ATGAM STERILE</ProductName>
    <Strength>50 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1986-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EQUINE GAMMA GLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001065</DrugIDPK>
    <LicenceNumber>PA0019/024/001</LicenceNumber>
    <ProductName>FELDENE 5 MG CAPSULES</ProductName>
    <Strength>5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005627</DrugIDPK>
    <LicenceNumber>PA0312/003/001</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>5mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1987-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005630</DrugIDPK>
    <LicenceNumber>PA0312/003/002</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>10mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1987-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005636</DrugIDPK>
    <LicenceNumber>PA0312/004/002</LicenceNumber>
    <ProductName>LI-LIQUID/LITHIUM CITRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LITHIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005634</DrugIDPK>
    <LicenceNumber>PA0312/004/001</LicenceNumber>
    <ProductName>LI-LIQUID/LITHIUM CITRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LITHIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009729</DrugIDPK>
    <LicenceNumber>PA0771/004/004</LicenceNumber>
    <ProductName>RECOFOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009233</DrugIDPK>
    <LicenceNumber>PA0771/004/002</LicenceNumber>
    <ProductName>RECOFOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007892</DrugIDPK>
    <LicenceNumber>PA0771/004/001</LicenceNumber>
    <ProductName>RECOFOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020643</DrugIDPK>
    <LicenceNumber>PA0021/074/002</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004575</DrugIDPK>
    <LicenceNumber>PA0013/086/002</LicenceNumber>
    <ProductName>TOFRANIL</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002414</DrugIDPK>
    <LicenceNumber>PA0022/076/001</LicenceNumber>
    <ProductName>ISOVORIN</ProductName>
    <Strength>20mg/2ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015320</DrugIDPK>
    <LicenceNumber>PA0573/003/003</LicenceNumber>
    <ProductName>SALOFALK GRANU-BOX</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Falk Pharma GmbH</PAHolder>
    <AuthorisedDate>2003-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002376</DrugIDPK>
    <LicenceNumber>PA0048/023/001</LicenceNumber>
    <ProductName>VUMON</ProductName>
    <Strength>10 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENIPOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005248</DrugIDPK>
    <LicenceNumber>PA0167/095/001</LicenceNumber>
    <ProductName>IVELIP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005249</DrugIDPK>
    <LicenceNumber>PA0167/095/002</LicenceNumber>
    <ProductName>IVELIP</ProductName>
    <Strength>20%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016514</DrugIDPK>
    <LicenceNumber>PA0705/005/003</LicenceNumber>
    <ProductName>MITOXANA LYOPHILISATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>1996-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016515</DrugIDPK>
    <LicenceNumber>PA0705/005/004</LicenceNumber>
    <ProductName>MITOXANA LYOPHILISATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>1996-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016516</DrugIDPK>
    <LicenceNumber>PA0705/005/005</LicenceNumber>
    <ProductName>MITOXANA LYOPHILISATE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>1996-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016517</DrugIDPK>
    <LicenceNumber>PA0705/005/006</LicenceNumber>
    <ProductName>MITOXANA LYOPHILISATE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>1996-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009397</DrugIDPK>
    <LicenceNumber>PA0696/003/001</LicenceNumber>
    <ProductName>QUINABAND</ProductName>
    <Strength>9.25/5.75/1%w/w</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>1997-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000443</DrugIDPK>
    <LicenceNumber>PA0436/030/001</LicenceNumber>
    <ProductName>CO-TENIDONE BP</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000444</DrugIDPK>
    <LicenceNumber>PA0436/030/002</LicenceNumber>
    <ProductName>CO-TENIDONE BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005285</DrugIDPK>
    <LicenceNumber>PA0281/011/001</LicenceNumber>
    <ProductName>THIOZINE</ProductName>
    <Strength>25mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1983-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018962</DrugIDPK>
    <LicenceNumber>PA0675/001/003</LicenceNumber>
    <ProductName>ICODIAL</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Innovata plc</PAHolder>
    <AuthorisedDate>2004-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICODEXTRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008863</DrugIDPK>
    <LicenceNumber>PA0675/001/001</LicenceNumber>
    <ProductName>ICODIAL 7.5%</ProductName>
    <Strength>112.5 /150</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Innovata plc</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001010</DrugIDPK>
    <LicenceNumber>PA0018/004/001</LicenceNumber>
    <ProductName>INTAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1976-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002254</DrugIDPK>
    <LicenceNumber>PA0047/005/001</LicenceNumber>
    <ProductName>NEBCIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002255</DrugIDPK>
    <LicenceNumber>PA0047/005/002</LicenceNumber>
    <ProductName>NEBCIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002256</DrugIDPK>
    <LicenceNumber>PA0047/005/003</LicenceNumber>
    <ProductName>NEBCIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005404</DrugIDPK>
    <LicenceNumber>PA0277/007/001</LicenceNumber>
    <ProductName>NETILLIN AMPOULE</ProductName>
    <Strength>15mg/1.5ml</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008679</DrugIDPK>
    <LicenceNumber>PA0185/028/001</LicenceNumber>
    <ProductName>GALENAMOX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1994-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008681</DrugIDPK>
    <LicenceNumber>PA0185/028/002</LicenceNumber>
    <ProductName>GALENAMOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1994-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008683</DrugIDPK>
    <LicenceNumber>PA0185/028/004</LicenceNumber>
    <ProductName>GALENAMOX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1994-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008653</DrugIDPK>
    <LicenceNumber>PA0185/028/003</LicenceNumber>
    <ProductName>GALENAMOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1994-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015338</DrugIDPK>
    <LicenceNumber>PA0891/004/001</LicenceNumber>
    <ProductName>BUTENAFINE HYDROCHLORIDE 10 MG/G</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>UCB (Pharma) Ireland Limited</PAHolder>
    <AuthorisedDate>2003-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTENAFINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007387</DrugIDPK>
    <LicenceNumber>PA0167/080/001</LicenceNumber>
    <ProductName>HEMOFIL M ANTIHAEMOPHILIC</ProductName>
    <Strength>250IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007390</DrugIDPK>
    <LicenceNumber>PA0167/080/002</LicenceNumber>
    <ProductName>HEMOFIL M ANTIHAEMOPHILIC</ProductName>
    <Strength>500IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007392</DrugIDPK>
    <LicenceNumber>PA0167/080/003</LicenceNumber>
    <ProductName>HEMOFIL M ANTIHAEMOPHILIC</ProductName>
    <Strength>1000IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013773</DrugIDPK>
    <LicenceNumber>PA0711/042/001</LicenceNumber>
    <ProductName>LUVASED MONO</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALERIANA OFFICINALIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000688</DrugIDPK>
    <LicenceNumber>PA0016/001/001</LicenceNumber>
    <ProductName>PROSTIN E2 ORAL</ProductName>
    <Strength>0.5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1974-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DINOPROST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008655</DrugIDPK>
    <LicenceNumber>PA0522/007/001</LicenceNumber>
    <ProductName>SUPER VITAMIN C</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Peter Black Healthcare Ltd</PAHolder>
    <AuthorisedDate>1996-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018391</DrugIDPK>
    <LicenceNumber>PA1112/002/001</LicenceNumber>
    <ProductName>ALBUREX</ProductName>
    <Strength>5%w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>ZLB GmbH</PAHolder>
    <AuthorisedDate>2004-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011758</DrugIDPK>
    <LicenceNumber>PA0167/108/001</LicenceNumber>
    <ProductName>LIDOCAINE HYDROCHLORIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2003-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010296</DrugIDPK>
    <LicenceNumber>PA0823/039/001</LicenceNumber>
    <ProductName>PANCREOLAURYL TEST</ProductName>
    <Strength>174.25/188</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1998-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUORESCEIN DILAURATE</ActiveSubstance>
      <ActiveSubstance>FLUORESCEIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005407</DrugIDPK>
    <LicenceNumber>PA0277/007/004</LicenceNumber>
    <ProductName>NETILLIN</ProductName>
    <Strength>100mg/1ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005408</DrugIDPK>
    <LicenceNumber>PA0277/007/006</LicenceNumber>
    <ProductName>NETILLIN</ProductName>
    <Strength>150mg/1.5ml</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005406</DrugIDPK>
    <LicenceNumber>PA0277/007/003</LicenceNumber>
    <ProductName>NETILLIN AMPOULE</ProductName>
    <Strength>50mg/1ml</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005409</DrugIDPK>
    <LicenceNumber>PA0277/007/008</LicenceNumber>
    <ProductName>NETILLIN VIAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005395</DrugIDPK>
    <LicenceNumber>PA0277/001/002</LicenceNumber>
    <ProductName>OPTIMINE</ProductName>
    <Strength>500mcg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005400</DrugIDPK>
    <LicenceNumber>PA0277/003/001</LicenceNumber>
    <ProductName>TINADERM-M</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1978-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008425</DrugIDPK>
    <LicenceNumber>PA0277/069/001</LicenceNumber>
    <ProductName>UNI-DUR SUSTAINED RELEASE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008426</DrugIDPK>
    <LicenceNumber>PA0277/069/002</LicenceNumber>
    <ProductName>UNI-DUR SUSTAINED RELEASE</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005221</DrugIDPK>
    <LicenceNumber>PA0277/065/001</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007927</DrugIDPK>
    <LicenceNumber>PA0566/008/002</LicenceNumber>
    <ProductName>KABIMIX 14</ProductName>
    <Strength>2580</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007926</DrugIDPK>
    <LicenceNumber>PA0566/008/001</LicenceNumber>
    <ProductName>KABIMIX 9</ProductName>
    <Strength>2580</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009713</DrugIDPK>
    <LicenceNumber>PA0282/077/001</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009714</DrugIDPK>
    <LicenceNumber>PA0282/077/002</LicenceNumber>
    <ProductName>PAROXETINE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003290</DrugIDPK>
    <LicenceNumber>PA0073/128/001</LicenceNumber>
    <ProductName>CIMAGEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003291</DrugIDPK>
    <LicenceNumber>PA0073/128/002</LicenceNumber>
    <ProductName>CIMAGEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003292</DrugIDPK>
    <LicenceNumber>PA0073/128/003</LicenceNumber>
    <ProductName>CIMAGEN</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003278</DrugIDPK>
    <LicenceNumber>PA0073/118/001</LicenceNumber>
    <ProductName>DEXTROSE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003273</DrugIDPK>
    <LicenceNumber>PA0073/114/001</LicenceNumber>
    <ProductName>FERROTAB</ProductName>
    <Strength>200/2.2/2.5</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003141</DrugIDPK>
    <LicenceNumber>PA0073/020/002</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008201</DrugIDPK>
    <LicenceNumber>PA0073/020/005</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008202</DrugIDPK>
    <LicenceNumber>PA0073/020/006</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003241</DrugIDPK>
    <LicenceNumber>PA0073/105/004</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003252</DrugIDPK>
    <LicenceNumber>PA0073/107/005</LicenceNumber>
    <ProductName>WATER FOR INJECTIONS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006122</DrugIDPK>
    <LicenceNumber>PA0408/024/001</LicenceNumber>
    <ProductName>RIMAPRIN ASPIRIN BP</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1991-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018776</DrugIDPK>
    <LicenceNumber>PPA0465/130/001A</LicenceNumber>
    <ProductName>ZISPIN</ProductName>
    <Strength>30mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005423</DrugIDPK>
    <LicenceNumber>PA0261/012/001</LicenceNumber>
    <ProductName>PREGNYL 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020866</DrugIDPK>
    <LicenceNumber>PA0021/079/001</LicenceNumber>
    <ProductName>RENNIE RELIEVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>LIGHT MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020863</DrugIDPK>
    <LicenceNumber>PA0021/081/001</LicenceNumber>
    <ProductName>VALDERMA CARE ANTISEPTIC SKIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2005-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001728</DrugIDPK>
    <LicenceNumber>PA0743/004/001</LicenceNumber>
    <ProductName>SLOMON SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011497</DrugIDPK>
    <LicenceNumber>PA0833/004/001</LicenceNumber>
    <ProductName>ZOLGEN</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Genthon GmbH</PAHolder>
    <AuthorisedDate>2002-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLPIDEM TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011498</DrugIDPK>
    <LicenceNumber>PA0833/004/002</LicenceNumber>
    <ProductName>ZOLGEN</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Genthon GmbH</PAHolder>
    <AuthorisedDate>2002-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLPIDEM TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008556</DrugIDPK>
    <LicenceNumber>PA0022/001/004</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <Strength>0.5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1995-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008558</DrugIDPK>
    <LicenceNumber>PA0022/001/005</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <Strength>2.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1995-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006012</DrugIDPK>
    <LicenceNumber>PA0062/037/001</LicenceNumber>
    <ProductName>CARDENE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1997-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006013</DrugIDPK>
    <LicenceNumber>PA0062/037/002</LicenceNumber>
    <ProductName>CARDENE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1997-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006014</DrugIDPK>
    <LicenceNumber>PA0062/037/003</LicenceNumber>
    <ProductName>CARDENE SR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1997-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006015</DrugIDPK>
    <LicenceNumber>PA0062/037/004</LicenceNumber>
    <ProductName>CARDENE SR</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1997-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015008</DrugIDPK>
    <LicenceNumber>PA0936/088/001</LicenceNumber>
    <ProductName>CORVERT</ProductName>
    <Strength>0.1mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUTILIDE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013003</DrugIDPK>
    <LicenceNumber>PA0936/036/001</LicenceNumber>
    <ProductName>ESTRACYT</ProductName>
    <Strength>140</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRAMUSTINE PHOSPHATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003150</DrugIDPK>
    <LicenceNumber>PA0062/029/001</LicenceNumber>
    <ProductName>LIPOBASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004567</DrugIDPK>
    <LicenceNumber>PA0185/002/001</LicenceNumber>
    <ProductName>PARAKE</ProductName>
    <Strength>500/8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1976-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016081</DrugIDPK>
    <LicenceNumber>PA0118/047/001</LicenceNumber>
    <ProductName>TIMOLOL CHAUVIN</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2003-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016082</DrugIDPK>
    <LicenceNumber>PA0118/047/002</LicenceNumber>
    <ProductName>TIMOLOL CHAUVIN</ProductName>
    <Strength>0.50</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2003-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006060</DrugIDPK>
    <LicenceNumber>PA0405/025/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006061</DrugIDPK>
    <LicenceNumber>PA0405/025/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006062</DrugIDPK>
    <LicenceNumber>PA0405/025/003</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016278</DrugIDPK>
    <LicenceNumber>PA0405/032/001</LicenceNumber>
    <ProductName>CYPROTERONE ACETATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001687</DrugIDPK>
    <LicenceNumber>PA0577/019/001</LicenceNumber>
    <ProductName>DICLOFENAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1995-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001688</DrugIDPK>
    <LicenceNumber>PA0577/019/002</LicenceNumber>
    <ProductName>DICLOFENAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1995-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006063</DrugIDPK>
    <LicenceNumber>PA0405/026/001</LicenceNumber>
    <ProductName>GEROXICAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006064</DrugIDPK>
    <LicenceNumber>PA0405/026/002</LicenceNumber>
    <ProductName>GEROXICAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015829</DrugIDPK>
    <LicenceNumber>PA0577/012/002</LicenceNumber>
    <ProductName>GEROXICAM DISPERSIBLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1995-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015831</DrugIDPK>
    <LicenceNumber>PA0577/012/001</LicenceNumber>
    <ProductName>GEROXICAM DISPERSIBLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1995-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001639</DrugIDPK>
    <LicenceNumber>PA0577/015/001</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005481</DrugIDPK>
    <LicenceNumber>PA0282/010/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1981-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005483</DrugIDPK>
    <LicenceNumber>PA0282/010/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1981-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005485</DrugIDPK>
    <LicenceNumber>PA0282/010/003</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>600 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007241</DrugIDPK>
    <LicenceNumber>PA0913/020/001</LicenceNumber>
    <ProductName>DISTALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006118</DrugIDPK>
    <LicenceNumber>PA0408/021/001</LicenceNumber>
    <ProductName>RIMAZINE CHLORPROMAZINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006119</DrugIDPK>
    <LicenceNumber>PA0408/021/002</LicenceNumber>
    <ProductName>RIMAZINE CHLORPROMAZINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006120</DrugIDPK>
    <LicenceNumber>PA0408/021/003</LicenceNumber>
    <ProductName>RIMAZINE CHLORPROMAZINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015630</DrugIDPK>
    <LicenceNumber>PA0506/014/001</LicenceNumber>
    <ProductName>VALDERMA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate>2001-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM HYDROXYQUINOLIN SULFATE</ActiveSubstance>
      <ActiveSubstance>CHLOROCRESOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007178</DrugIDPK>
    <LicenceNumber>PA0913/007/001</LicenceNumber>
    <ProductName>GASTROBID CONTINUS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009231</DrugIDPK>
    <LicenceNumber>PA0185/034/001</LicenceNumber>
    <ProductName>NITEDRI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1997-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015512</DrugIDPK>
    <LicenceNumber>PA0822/008/001</LicenceNumber>
    <ProductName>ACCURETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017874</DrugIDPK>
    <LicenceNumber>PA0167/116/001</LicenceNumber>
    <ProductName>GAMMABULIN</ProductName>
    <Strength>0.32g/2ml</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN  &gt;90% GAMMA GLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011222</DrugIDPK>
    <LicenceNumber>PA0050/148/002</LicenceNumber>
    <ProductName>LORON 520</ProductName>
    <Strength>520</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>2000-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLODRONATE DISODIUM TETRAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002894</DrugIDPK>
    <LicenceNumber>PA0057/054/006</LicenceNumber>
    <ProductName>AEROLIN AUTOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1986-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015435</DrugIDPK>
    <LicenceNumber>PA0678/083/001</LicenceNumber>
    <ProductName>EARCALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Spray Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015430</DrugIDPK>
    <LicenceNumber>PA0678/079/001</LicenceNumber>
    <ProductName>OTOMIZE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Spray Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002202</DrugIDPK>
    <LicenceNumber>PA0422/006/001</LicenceNumber>
    <ProductName>LOWASA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1996-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006149</DrugIDPK>
    <LicenceNumber>PA0409/004/001</LicenceNumber>
    <ProductName>CHENDOL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1985-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHENODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006150</DrugIDPK>
    <LicenceNumber>PA0409/004/002</LicenceNumber>
    <ProductName>CHENDOL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1990-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHENODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006017</DrugIDPK>
    <LicenceNumber>PA0405/003/001</LicenceNumber>
    <ProductName>GERIVENT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1986-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013861</DrugIDPK>
    <LicenceNumber>PA0970/036/003</LicenceNumber>
    <ProductName>BRICANYL</ProductName>
    <Strength>0.5mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008933</DrugIDPK>
    <LicenceNumber>PA0126/107/001</LicenceNumber>
    <ProductName>INNOMEL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008934</DrugIDPK>
    <LicenceNumber>PA0126/107/002</LicenceNumber>
    <ProductName>INNOMEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008935</DrugIDPK>
    <LicenceNumber>PA0126/107/003</LicenceNumber>
    <ProductName>INNOMEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008936</DrugIDPK>
    <LicenceNumber>PA0126/107/004</LicenceNumber>
    <ProductName>INNOMEL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018568</DrugIDPK>
    <LicenceNumber>PA0819/029/001</LicenceNumber>
    <ProductName>OMEPRAZOLE-RATIOPHARM</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2004-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018569</DrugIDPK>
    <LicenceNumber>PA0819/029/002</LicenceNumber>
    <ProductName>OMEPRAZOLE-RATIOPHARM</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2004-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015892</DrugIDPK>
    <LicenceNumber>PA0819/021/001</LicenceNumber>
    <ProductName>ULCID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2003-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005249</DrugIDPK>
    <LicenceNumber>PA0278/007/002</LicenceNumber>
    <ProductName>ANHYDROL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005257</DrugIDPK>
    <LicenceNumber>PA0278/018/001</LicenceNumber>
    <ProductName>DITHROGEL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005258</DrugIDPK>
    <LicenceNumber>PA0278/018/002</LicenceNumber>
    <ProductName>DITHROGEL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005259</DrugIDPK>
    <LicenceNumber>PA0278/018/003</LicenceNumber>
    <ProductName>DITHROGEL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005260</DrugIDPK>
    <LicenceNumber>PA0278/018/004</LicenceNumber>
    <ProductName>DITHROGEL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005261</DrugIDPK>
    <LicenceNumber>PA0278/018/005</LicenceNumber>
    <ProductName>DITHROGEL</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005262</DrugIDPK>
    <LicenceNumber>PA0278/018/006</LicenceNumber>
    <ProductName>DITHROGEL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020035</DrugIDPK>
    <LicenceNumber>PA0849/005/002</LicenceNumber>
    <ProductName>ALBUTEIN 20%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Instituto Grifols S.A.</PAHolder>
    <AuthorisedDate>2005-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020036</DrugIDPK>
    <LicenceNumber>PA0849/005/003</LicenceNumber>
    <ProductName>ALBUTEIN 25%</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Instituto Grifols S.A.</PAHolder>
    <AuthorisedDate>2005-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020034</DrugIDPK>
    <LicenceNumber>PA0849/005/001</LicenceNumber>
    <ProductName>ALBUTEIN 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Instituto Grifols S.A.</PAHolder>
    <AuthorisedDate>2005-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007605</DrugIDPK>
    <LicenceNumber>PA0012/073/001</LicenceNumber>
    <ProductName>NUVELLE</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007655</DrugIDPK>
    <LicenceNumber>PA0748/040/002</LicenceNumber>
    <ProductName>RAPIFEN TM</ProductName>
    <Strength>0.544mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFENTANIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015113</DrugIDPK>
    <LicenceNumber>PA1058/001/001</LicenceNumber>
    <ProductName>ASCAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>MEDA Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2001-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBASALATE CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009257</DrugIDPK>
    <LicenceNumber>PA0469/016/001</LicenceNumber>
    <ProductName>CRYSTACIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROGEN PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010973</DrugIDPK>
    <LicenceNumber>PA0007/059/001</LicenceNumber>
    <ProductName>PHARMATON VIT-AL PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>2003-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANAX GINSENG</ActiveSubstance>
      <ActiveSubstance>BETACAROTENE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE</ActiveSubstance>
      <ActiveSubstance>SODIUM SELENITE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULPHATE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE HEAVY</ActiveSubstance>
      <ActiveSubstance>FERROUS SULFATE EXSICCATED</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE DIBASIC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2006-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000456</DrugIDPK>
    <LicenceNumber>PA0007/047/001</LicenceNumber>
    <ProductName>BONEFOS</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLODRONATE DISODIUM TETRAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000457</DrugIDPK>
    <LicenceNumber>PA0007/047/002</LicenceNumber>
    <ProductName>BONEFOS</ProductName>
    <Strength>60mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLODRONATE DISODIUM TETRAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007147</DrugIDPK>
    <LicenceNumber>PA0913/003/001</LicenceNumber>
    <ProductName>PHYLLOCONTIN PAEDIATRIC CONTINUS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000416</DrugIDPK>
    <LicenceNumber>PA0007/004/001</LicenceNumber>
    <ProductName>TRANXENE</ProductName>
    <Strength>15 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLORAZEPATE DIPOTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004830</DrugIDPK>
    <LicenceNumber>PA0218/025/001</LicenceNumber>
    <ProductName>ACTRAPID</ProductName>
    <Strength>1000/10</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004834</DrugIDPK>
    <LicenceNumber>PA0218/025/005</LicenceNumber>
    <ProductName>ACTRAPID NOVOLET</ProductName>
    <Strength>300/3</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004833</DrugIDPK>
    <LicenceNumber>PA0218/025/004</LicenceNumber>
    <ProductName>ACTRAPID PENFILL</ProductName>
    <Strength>300IU/3 ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004835</DrugIDPK>
    <LicenceNumber>PA0218/026/001</LicenceNumber>
    <ProductName>INSULATARD 100IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009288</DrugIDPK>
    <LicenceNumber>PA0218/026/005</LicenceNumber>
    <ProductName>INSULATARD NOVOLET 3 ML</ProductName>
    <Strength>100IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009286</DrugIDPK>
    <LicenceNumber>PA0218/026/004</LicenceNumber>
    <ProductName>INSULATARD PENFILL 100IU</ProductName>
    <Strength>3ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016440</DrugIDPK>
    <LicenceNumber>PA0218/033/005</LicenceNumber>
    <ProductName>MIXTARD 10 NOVOLET 3ML</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016438</DrugIDPK>
    <LicenceNumber>PA0218/034/005</LicenceNumber>
    <ProductName>MIXTARD 20 NOVOLET 100IU/ML</ProductName>
    <Strength>3ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016439</DrugIDPK>
    <LicenceNumber>PA0218/034/004</LicenceNumber>
    <ProductName>MIXTARD 20 PENFILL 3ML</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009296</DrugIDPK>
    <LicenceNumber>PA0218/029/005</LicenceNumber>
    <ProductName>MIXTARD 30 NOVOLET 100IU/ML</ProductName>
    <Strength>3ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009295</DrugIDPK>
    <LicenceNumber>PA0218/029/004</LicenceNumber>
    <ProductName>MIXTARD 30 PENFILL 3ML</ProductName>
    <Strength>100IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016435</DrugIDPK>
    <LicenceNumber>PA0218/035/005</LicenceNumber>
    <ProductName>MIXTARD 40 NOVOLET 3ML</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016436</DrugIDPK>
    <LicenceNumber>PA0218/035/004</LicenceNumber>
    <ProductName>MIXTARD 40 PENFILL 3ML</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009111</DrugIDPK>
    <LicenceNumber>PA0218/036/005</LicenceNumber>
    <ProductName>MIXTARD 50 NOVOLET 3ML</ProductName>
    <Strength>100IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004828</DrugIDPK>
    <LicenceNumber>PA0218/024/001</LicenceNumber>
    <ProductName>MONOTARD INSULIN</ProductName>
    <Strength>1000/10</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004838</DrugIDPK>
    <LicenceNumber>PA0218/027/001</LicenceNumber>
    <ProductName>ULTRATARD 100IU/ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020063</DrugIDPK>
    <LicenceNumber>PA0126/145/001</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020064</DrugIDPK>
    <LicenceNumber>PA0126/145/003</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020065</DrugIDPK>
    <LicenceNumber>PA0126/145/002</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010937</DrugIDPK>
    <LicenceNumber>PA0126/082/005</LicenceNumber>
    <ProductName>DICLOMEL 100</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010936</DrugIDPK>
    <LicenceNumber>PA0126/082/004</LicenceNumber>
    <ProductName>DICLOMEL 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009484</DrugIDPK>
    <LicenceNumber>PA0126/109/001</LicenceNumber>
    <ProductName>VIAZEM XL</ProductName>
    <Strength>120mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009485</DrugIDPK>
    <LicenceNumber>PA0126/109/002</LicenceNumber>
    <ProductName>VIAZEM XL</ProductName>
    <Strength>180mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009486</DrugIDPK>
    <LicenceNumber>PA0126/109/003</LicenceNumber>
    <ProductName>VIAZEM XL</ProductName>
    <Strength>240mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009487</DrugIDPK>
    <LicenceNumber>PA0126/109/004</LicenceNumber>
    <ProductName>VIAZEM XL</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009488</DrugIDPK>
    <LicenceNumber>PA0126/109/005</LicenceNumber>
    <ProductName>VIAZEM XL</ProductName>
    <Strength>360mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007727</DrugIDPK>
    <LicenceNumber>PA0711/024/003</LicenceNumber>
    <ProductName>RANITIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006082</DrugIDPK>
    <LicenceNumber>PA0408/001/003</LicenceNumber>
    <ProductName>RIMACILIN AMPICILLIN MIXTURE BP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1985-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008558</DrugIDPK>
    <LicenceNumber>PPA0465/041/004A</LicenceNumber>
    <ProductName>BECOTIDE 250 INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005589</DrugIDPK>
    <LicenceNumber>PA0282/057/001</LicenceNumber>
    <ProductName>TAMOXIFEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Heumann PCS GmbH</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005590</DrugIDPK>
    <LicenceNumber>PA0282/057/002</LicenceNumber>
    <ProductName>TAMOXIFEN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005591</DrugIDPK>
    <LicenceNumber>PA0282/057/003</LicenceNumber>
    <ProductName>TAMOXIFEN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003960</DrugIDPK>
    <LicenceNumber>PA0126/090/002</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003958</DrugIDPK>
    <LicenceNumber>PA0126/090/001</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003849</DrugIDPK>
    <LicenceNumber>PA0126/029/001</LicenceNumber>
    <ProductName>CIDOMEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003839</DrugIDPK>
    <LicenceNumber>PA0126/025/003</LicenceNumber>
    <ProductName>MELZINE</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000903</DrugIDPK>
    <LicenceNumber>PA0126/097/002</LicenceNumber>
    <ProductName>XANOMEL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1996-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009294</DrugIDPK>
    <LicenceNumber>PA0577/009/001</LicenceNumber>
    <ProductName>INAMIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006186</DrugIDPK>
    <LicenceNumber>PA0437/026/001</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE FOR INJECTION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020163</DrugIDPK>
    <LicenceNumber>PPA0465/163/001</LicenceNumber>
    <ProductName>TRITACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004511</DrugIDPK>
    <LicenceNumber>PA0013/064/001</LicenceNumber>
    <ProductName>APRESOLINE</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002343</DrugIDPK>
    <LicenceNumber>PA0050/089/001</LicenceNumber>
    <ProductName>HIVID</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1994-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002344</DrugIDPK>
    <LicenceNumber>PA0050/089/002</LicenceNumber>
    <ProductName>HIVID</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1994-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZALCITABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008186</DrugIDPK>
    <LicenceNumber>PA0947/001/001</LicenceNumber>
    <ProductName>TICINAN SUSTAINED RELEASE</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lannacher Heilmittel Ges.m.b.H</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008187</DrugIDPK>
    <LicenceNumber>PA0947/001/002</LicenceNumber>
    <ProductName>TICINAN SUSTAINED RELEASE</ProductName>
    <Strength>30mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lannacher Heilmittel Ges.m.b.H</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008188</DrugIDPK>
    <LicenceNumber>PA0947/001/003</LicenceNumber>
    <ProductName>TICINAN SUSTAINED RELEASE</ProductName>
    <Strength>60mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lannacher Heilmittel Ges.m.b.H</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008189</DrugIDPK>
    <LicenceNumber>PA0947/001/004</LicenceNumber>
    <ProductName>TICINAN SUSTAINED RELEASE</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lannacher Heilmittel Ges.m.b.H</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008190</DrugIDPK>
    <LicenceNumber>PA0947/001/005</LicenceNumber>
    <ProductName>TICINAN SUSTAINED RELEASE</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lannacher Heilmittel Ges.m.b.H</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001901</DrugIDPK>
    <LicenceNumber>PA0040/021/004</LicenceNumber>
    <ProductName>NEULACTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERICIAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012175</DrugIDPK>
    <LicenceNumber>PA0038/079/001</LicenceNumber>
    <ProductName>ARYTHMOL</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001816</DrugIDPK>
    <LicenceNumber>PA0736/001/002</LicenceNumber>
    <ProductName>HEMOHES 10%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HETASTARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001815</DrugIDPK>
    <LicenceNumber>PA0736/001/001</LicenceNumber>
    <ProductName>HEMOHES 6%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Microlitre</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004023</DrugIDPK>
    <LicenceNumber>PA0148/034/001</LicenceNumber>
    <ProductName>PREFERIN - A TOPICAL OPHTHALMIC</ProductName>
    <Strength>0.12/0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015020</DrugIDPK>
    <LicenceNumber>PA0073/133/005</LicenceNumber>
    <ProductName>VOLOGEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006299</DrugIDPK>
    <LicenceNumber>PA0436/007/001</LicenceNumber>
    <ProductName>SALOMOL INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-04-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005774</DrugIDPK>
    <LicenceNumber>PA0298/004/001</LicenceNumber>
    <ProductName>TETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1985-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016318</DrugIDPK>
    <LicenceNumber>PA1077/033/003</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005556</DrugIDPK>
    <LicenceNumber>PA0282/042/001</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1985-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005557</DrugIDPK>
    <LicenceNumber>PA0282/042/002</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1985-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002450</DrugIDPK>
    <LicenceNumber>PA0054/009/002</LicenceNumber>
    <ProductName>OPTIMAX WITHOUT VITAMINS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003471</DrugIDPK>
    <LicenceNumber>PA0086/008/005</LicenceNumber>
    <ProductName>ROBINUL</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOPYRRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017909</DrugIDPK>
    <LicenceNumber>PA1077/015/006</LicenceNumber>
    <ProductName>ZINNAT</ProductName>
    <Strength>250mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012765</DrugIDPK>
    <LicenceNumber>PA0936/021/001</LicenceNumber>
    <ProductName>CO-BETALOC</ProductName>
    <Strength>100/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008482</DrugIDPK>
    <LicenceNumber>PA0566/001/001</LicenceNumber>
    <ProductName>HAES STERIL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTASTARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008483</DrugIDPK>
    <LicenceNumber>PA0566/001/002</LicenceNumber>
    <ProductName>HAES STERIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTASTARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002184</DrugIDPK>
    <LicenceNumber>PA0046/035/002</LicenceNumber>
    <ProductName>MINIHEP SODIUM</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008849</DrugIDPK>
    <LicenceNumber>PA0062/038/001</LicenceNumber>
    <ProductName>CONOTRANE</ProductName>
    <Strength>0.1/22</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1997-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000561</DrugIDPK>
    <LicenceNumber>PA0013/004/001</LicenceNumber>
    <ProductName>MELLERIL</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000562</DrugIDPK>
    <LicenceNumber>PA0013/004/002</LicenceNumber>
    <ProductName>MELLERIL</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000563</DrugIDPK>
    <LicenceNumber>PA0013/004/003</LicenceNumber>
    <ProductName>MELLERIL</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000564</DrugIDPK>
    <LicenceNumber>PA0013/004/004</LicenceNumber>
    <ProductName>MELLERIL</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000565</DrugIDPK>
    <LicenceNumber>PA0013/004/005</LicenceNumber>
    <ProductName>MELLERIL</ProductName>
    <Strength>25mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007926</DrugIDPK>
    <LicenceNumber>PA0388/006/001</LicenceNumber>
    <ProductName>EPSOM SALTS PH. EUR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>East Wall Manufacturing</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007542</DrugIDPK>
    <LicenceNumber>PA0484/013/001</LicenceNumber>
    <ProductName>CUREA</ProductName>
    <Strength>10/10 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006590</DrugIDPK>
    <LicenceNumber>PA0484/026/001</LicenceNumber>
    <ProductName>TAR POMADE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000542</DrugIDPK>
    <LicenceNumber>PA0012/065/001</LicenceNumber>
    <ProductName>TRIODENE</ProductName>
    <Strength>30/50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1990-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004841</DrugIDPK>
    <LicenceNumber>PA0218/029/001</LicenceNumber>
    <ProductName>MIXTARD 30 INSULIN</ProductName>
    <Strength>1000/10</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000331</DrugIDPK>
    <LicenceNumber>PA0002/031/007</LicenceNumber>
    <ProductName>MODECATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005633</DrugIDPK>
    <LicenceNumber>PA0050/139/002</LicenceNumber>
    <ProductName>BIOVITAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1995-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRIC SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>MANGANESE CITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001657</DrugIDPK>
    <LicenceNumber>PA0038/018/001</LicenceNumber>
    <ProductName>ETHRANE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1980-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Gas</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002173</DrugIDPK>
    <LicenceNumber>PA0046/024/006A</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001983</DrugIDPK>
    <LicenceNumber>PA0040/070/001</LicenceNumber>
    <ProductName>ORUVAIL-100 SR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1982-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005891</DrugIDPK>
    <LicenceNumber>PA0372/001/001</LicenceNumber>
    <ProductName>METROLYL</ProductName>
    <Strength>500/100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1985-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005892</DrugIDPK>
    <LicenceNumber>PA0372/001/002</LicenceNumber>
    <ProductName>METROLYL</ProductName>
    <Strength>500/100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005525</DrugIDPK>
    <LicenceNumber>PA0748/023/003</LicenceNumber>
    <ProductName>STUGERON FORTE</ProductName>
    <Strength>75 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1995-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINNARIZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017665</DrugIDPK>
    <LicenceNumber>PPA1071/010/002A</LicenceNumber>
    <ProductName>BECOTIDE 100 INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017664</DrugIDPK>
    <LicenceNumber>PPA1071/010/001A</LicenceNumber>
    <ProductName>BECOTIDE 50 INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017712</DrugIDPK>
    <LicenceNumber>PPA1071/013/001A</LicenceNumber>
    <ProductName>BRUFEN RETARD</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017644</DrugIDPK>
    <LicenceNumber>PPA1071/008/001A</LicenceNumber>
    <ProductName>PROTHIADEN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOSULEPIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017559</DrugIDPK>
    <LicenceNumber>PPA1071/006/001A</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017560</DrugIDPK>
    <LicenceNumber>PPA1071/006/002A</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017701</DrugIDPK>
    <LicenceNumber>PPA1071/012/001A</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010038</DrugIDPK>
    <LicenceNumber>PA0007/043/004</LicenceNumber>
    <ProductName>ACTILYSE</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALTEPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006742</DrugIDPK>
    <LicenceNumber>PA0541/001/001</LicenceNumber>
    <ProductName>NICOBREVIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicobrevin UK Limited</PAHolder>
    <AuthorisedDate>1990-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUININE</ActiveSubstance>
      <ActiveSubstance>MENTHYL VALERATE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>OIL OF EUCALIPTUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007764</DrugIDPK>
    <LicenceNumber>PA0179/008/004</LicenceNumber>
    <ProductName>OSMOFUNDIN</ProductName>
    <Strength>15%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000045</DrugIDPK>
    <LicenceNumber>PA0002/065/001</LicenceNumber>
    <ProductName>CEFZIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPROZIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000046</DrugIDPK>
    <LicenceNumber>PA0002/065/002</LicenceNumber>
    <ProductName>CEFZIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPROZIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000047</DrugIDPK>
    <LicenceNumber>PA0002/065/003</LicenceNumber>
    <ProductName>CEFZIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPROZIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000048</DrugIDPK>
    <LicenceNumber>PA0002/065/004</LicenceNumber>
    <ProductName>CEFZIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPROZIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013308</DrugIDPK>
    <LicenceNumber>PA0936/043/005</LicenceNumber>
    <ProductName>PHARMORUBICIN</ProductName>
    <Strength>200/100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013305</DrugIDPK>
    <LicenceNumber>PA0936/043/001</LicenceNumber>
    <ProductName>PHARMORUBICIN 10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013306</DrugIDPK>
    <LicenceNumber>PA0936/043/002</LicenceNumber>
    <ProductName>PHARMORUBICIN 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006665</DrugIDPK>
    <LicenceNumber>PA0516/007/001</LicenceNumber>
    <ProductName>VERELAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006666</DrugIDPK>
    <LicenceNumber>PA0516/007/002</LicenceNumber>
    <ProductName>VERELAN</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006668</DrugIDPK>
    <LicenceNumber>PA0516/007/003</LicenceNumber>
    <ProductName>VERELAN</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015844</DrugIDPK>
    <LicenceNumber>PA1077/020/002</LicenceNumber>
    <ProductName>BOOSTRIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019124</DrugIDPK>
    <LicenceNumber>PA1077/101/002</LicenceNumber>
    <ProductName>BOOSTRIX POLIO (GLASS VIALS)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2004-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN (PRN, OR 69KDA OMP)</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 1 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 2 INACTIVATED</ActiveSubstance>
      <ActiveSubstance>POLIO VIRUS TYPE 3 INACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019480</DrugIDPK>
    <LicenceNumber>PA1077/030/001</LicenceNumber>
    <ProductName>INFANRIX SINGLE-DOSE VIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016119</DrugIDPK>
    <LicenceNumber>PA1077/028/001</LicenceNumber>
    <ProductName>INFANRIX-HIB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B, CONJUGATE WITH TETANUS PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019698</DrugIDPK>
    <LicenceNumber>PA1189/001/003</LicenceNumber>
    <ProductName>ZYDOL</ProductName>
    <Strength>50mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2004-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995019703</DrugIDPK>
    <LicenceNumber>PA1189/001/005</LicenceNumber>
    <ProductName>ZYDOL SOLUBLE</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>2004-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008485</DrugIDPK>
    <LicenceNumber>PA0903/002/001</LicenceNumber>
    <ProductName>AVOMINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Manx Pharma Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE TEOCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006340</DrugIDPK>
    <LicenceNumber>PA0903/001/001</LicenceNumber>
    <ProductName>BRULIDINE</ProductName>
    <Strength>0.15</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Manx Pharma Limited</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIBROMPROPAMIDINE ISETIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008486</DrugIDPK>
    <LicenceNumber>PA0903/003/001</LicenceNumber>
    <ProductName>CEPLAC</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Manx Pharma Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007188</DrugIDPK>
    <LicenceNumber>PA0913/009/001</LicenceNumber>
    <ProductName>CODAFEN CONTINUS</ProductName>
    <Strength>300/20</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1997-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013880</DrugIDPK>
    <LicenceNumber>PA0970/044/001</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013881</DrugIDPK>
    <LicenceNumber>PA0970/044/002</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013882</DrugIDPK>
    <LicenceNumber>PA0970/044/003</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2002-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003833</DrugIDPK>
    <LicenceNumber>PA0126/022/001</LicenceNumber>
    <ProductName>MELDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003834</DrugIDPK>
    <LicenceNumber>PA0126/022/002</LicenceNumber>
    <ProductName>MELDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008587</DrugIDPK>
    <LicenceNumber>PA0126/106/001</LicenceNumber>
    <ProductName>MORSTEL SR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008588</DrugIDPK>
    <LicenceNumber>PA0126/106/002</LicenceNumber>
    <ProductName>MORSTEL SR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008589</DrugIDPK>
    <LicenceNumber>PA0126/106/003</LicenceNumber>
    <ProductName>MORSTEL SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008590</DrugIDPK>
    <LicenceNumber>PA0126/106/004</LicenceNumber>
    <ProductName>MORSTEL SR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003878</DrugIDPK>
    <LicenceNumber>PA0126/044/003</LicenceNumber>
    <ProductName>NAPMEL  EC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003880</DrugIDPK>
    <LicenceNumber>PA0126/044/005</LicenceNumber>
    <ProductName>NAPMEL EC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006207</DrugIDPK>
    <LicenceNumber>PA0126/101/001</LicenceNumber>
    <ProductName>VERTAMEL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006208</DrugIDPK>
    <LicenceNumber>PA0126/101/002</LicenceNumber>
    <ProductName>VERTAMEL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007186</DrugIDPK>
    <LicenceNumber>PA0913/008/002</LicenceNumber>
    <ProductName>DHC CONTINUS</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1995-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007187</DrugIDPK>
    <LicenceNumber>PA0913/008/003</LicenceNumber>
    <ProductName>DHC CONTINUS</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1995-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003779</DrugIDPK>
    <LicenceNumber>PA0805/001/002</LicenceNumber>
    <ProductName>SERDOLECT</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003783</DrugIDPK>
    <LicenceNumber>PA0805/001/006</LicenceNumber>
    <ProductName>SERDOLECT</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007122</DrugIDPK>
    <LicenceNumber>PA0408/008/001</LicenceNumber>
    <ProductName>ASCORBIC ACID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1995-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008708</DrugIDPK>
    <LicenceNumber>PA0073/091/007</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008712</DrugIDPK>
    <LicenceNumber>PA0073/091/009</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006968</DrugIDPK>
    <LicenceNumber>PA0735/009/011</LicenceNumber>
    <ProductName>VISIPAQUE</ProductName>
    <Strength>305</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODIXANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006538</DrugIDPK>
    <LicenceNumber>PA0735/009/001</LicenceNumber>
    <ProductName>VISIPAQUE</ProductName>
    <Strength>150 I</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODIXANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006835</DrugIDPK>
    <LicenceNumber>PA0899/006/001</LicenceNumber>
    <ProductName>RHEUMOX</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZAPROPAZONE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002272</DrugIDPK>
    <LicenceNumber>PA0047/028/001</LicenceNumber>
    <ProductName>DOLOXENE</ProductName>
    <Strength>60 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE NAPSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009228</DrugIDPK>
    <LicenceNumber>PA0185/032/001</LicenceNumber>
    <ProductName>TRICLORYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRICLOFOS SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007023</DrugIDPK>
    <LicenceNumber>PA0022/037/001</LicenceNumber>
    <ProductName>LORAMET</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1995-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORMETAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009307</DrugIDPK>
    <LicenceNumber>PA0585/006/001</LicenceNumber>
    <ProductName>SODIUM CROMOGLYCATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007577</DrugIDPK>
    <LicenceNumber>PA0743/009/002</LicenceNumber>
    <ProductName>URIMIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009101</DrugIDPK>
    <LicenceNumber>PA0437/035/001</LicenceNumber>
    <ProductName>MORCAP SR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009102</DrugIDPK>
    <LicenceNumber>PA0437/035/002</LicenceNumber>
    <ProductName>MORCAP SR</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009103</DrugIDPK>
    <LicenceNumber>PA0437/035/003</LicenceNumber>
    <ProductName>MORCAP SR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002918</DrugIDPK>
    <LicenceNumber>PA0057/061/001</LicenceNumber>
    <ProductName>ACUPAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1981-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFOPAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008380</DrugIDPK>
    <LicenceNumber>PA0437/032/001</LicenceNumber>
    <ProductName>AMIKACIN</ProductName>
    <Strength>250mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1997-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011633</DrugIDPK>
    <LicenceNumber>PA0437/047/001</LicenceNumber>
    <ProductName>ETOPOSIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2002-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETOPOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010037</DrugIDPK>
    <LicenceNumber>PA0979/019/001</LicenceNumber>
    <ProductName>DISPRIN EXTRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005581</DrugIDPK>
    <LicenceNumber>PA0282/052/001</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005582</DrugIDPK>
    <LicenceNumber>PA0282/052/002</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006690</DrugIDPK>
    <LicenceNumber>PA0516/016/001</LicenceNumber>
    <ProductName>DILZEM ONCE DAILY</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1990-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015806</DrugIDPK>
    <LicenceNumber>PA0187/051/005</LicenceNumber>
    <ProductName>SALAZOPYRIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016792</DrugIDPK>
    <LicenceNumber>PA1046/004/002</LicenceNumber>
    <ProductName>ACICLOVIR</ProductName>
    <Strength>400mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000703</DrugIDPK>
    <LicenceNumber>PA0016/004/001</LicenceNumber>
    <ProductName>COLESTID</ProductName>
    <Strength>5g</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLESTIPOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009099</DrugIDPK>
    <LicenceNumber>PA0437/034/001</LicenceNumber>
    <ProductName>PHENYTOIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1995-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006774</DrugIDPK>
    <LicenceNumber>PA0590/001/001</LicenceNumber>
    <ProductName>ALCODERM</ProductName>
    <Strength>13</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006775</DrugIDPK>
    <LicenceNumber>PA0590/001/002</LicenceNumber>
    <ProductName>ALCODERM LOTION</ProductName>
    <Strength>13.7</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006776</DrugIDPK>
    <LicenceNumber>PA0590/002/001</LicenceNumber>
    <ProductName>IONAX SCRUB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
      <ActiveSubstance>POLYETHYLENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006777</DrugIDPK>
    <LicenceNumber>PA0590/003/001</LicenceNumber>
    <ProductName>IONIL T</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>POLYETHYLENE GLYCOL 4  LAURYL ETHA</ActiveSubstance>
      <ActiveSubstance>POLYETHYLENE GLYCOL 24 LAURYL ETHA</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006779</DrugIDPK>
    <LicenceNumber>PA0590/005/001</LicenceNumber>
    <ProductName>PSORIGEL</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006101</DrugIDPK>
    <LicenceNumber>PA0437/020/001</LicenceNumber>
    <ProductName>FENTANYL CITRATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006102</DrugIDPK>
    <LicenceNumber>PA0437/020/002</LicenceNumber>
    <ProductName>FENTANYL CITRATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004809</DrugIDPK>
    <LicenceNumber>PA0823/025/002</LicenceNumber>
    <ProductName>MUCOLEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000717</DrugIDPK>
    <LicenceNumber>PA0016/013/001</LicenceNumber>
    <ProductName>NEO-MEDRONE ACNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE ACETATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM CHLORHYDROXIDE-COMPLEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004827</DrugIDPK>
    <LicenceNumber>PA0823/015/001</LicenceNumber>
    <ProductName>BENADRYL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017525</DrugIDPK>
    <LicenceNumber>PA1110/007/001</LicenceNumber>
    <ProductName>GELCOTAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Ecolab Limited</PAHolder>
    <AuthorisedDate>2000-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION STRONG</ActiveSubstance>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006582</DrugIDPK>
    <LicenceNumber>PA0469/034/001</LicenceNumber>
    <ProductName>EXELDERM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1995-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001785</DrugIDPK>
    <LicenceNumber>PA0035/014/004</LicenceNumber>
    <ProductName>DOLOBID</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1980-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUNISAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009229</DrugIDPK>
    <LicenceNumber>PA0185/033/001</LicenceNumber>
    <ProductName>CLINIMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009222</DrugIDPK>
    <LicenceNumber>PA0185/030/001</LicenceNumber>
    <ProductName>DF 118</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004575</DrugIDPK>
    <LicenceNumber>PA0185/015/001</LicenceNumber>
    <ProductName>DYNESE ANTACID</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1986-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGALDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001989</DrugIDPK>
    <LicenceNumber>PA0185/021/002</LicenceNumber>
    <ProductName>EXPULIN DRY COUGH</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001122</DrugIDPK>
    <LicenceNumber>PA0185/021/001</LicenceNumber>
    <ProductName>EXPULIN DRY COUGH PAEDIATRIC</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004581</DrugIDPK>
    <LicenceNumber>PA0185/023/001</LicenceNumber>
    <ProductName>GALENAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1992-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004585</DrugIDPK>
    <LicenceNumber>PA0185/023/003</LicenceNumber>
    <ProductName>GALENAMET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1992-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008698</DrugIDPK>
    <LicenceNumber>PA0185/023/002</LicenceNumber>
    <ProductName>GALENAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1992-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008685</DrugIDPK>
    <LicenceNumber>PA0185/029/001</LicenceNumber>
    <ProductName>MINOGAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1994-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008687</DrugIDPK>
    <LicenceNumber>PA0185/029/002</LicenceNumber>
    <ProductName>MINOGAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1994-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004574</DrugIDPK>
    <LicenceNumber>PA0185/013/001</LicenceNumber>
    <ProductName>VERUCASEP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1981-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUTARAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006836</DrugIDPK>
    <LicenceNumber>PA0899/006/002</LicenceNumber>
    <ProductName>RHEUMOX</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZAPROPAZONE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002146</DrugIDPK>
    <LicenceNumber>PA0040/086/001</LicenceNumber>
    <ProductName>PENTACARINAT</ProductName>
    <Strength>300 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1990-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAMIDINE ISETHIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012151</DrugIDPK>
    <LicenceNumber>PA0549/010/001</LicenceNumber>
    <ProductName>FENOFIBRATE ETHYPHARM</ProductName>
    <Strength>67</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004822</DrugIDPK>
    <LicenceNumber>PA0212/008/001</LicenceNumber>
    <ProductName>TETABULIN</ProductName>
    <Strength>1 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GAMMA GLOBULIN</ActiveSubstance>
      <ActiveSubstance>TETANUS ANTIBODIES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005324</DrugIDPK>
    <LicenceNumber>PA0281/044/002</LicenceNumber>
    <ProductName>PINALGESIC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008543</DrugIDPK>
    <LicenceNumber>PA0281/092/001</LicenceNumber>
    <ProductName>PINAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003922</DrugIDPK>
    <LicenceNumber>PA0185/037/001</LicenceNumber>
    <ProductName>AILAX</ProductName>
    <Strength>1.5/12g/30</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXALCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003924</DrugIDPK>
    <LicenceNumber>PA0185/037/002</LicenceNumber>
    <ProductName>AILAX FORTE</ProductName>
    <Strength>4.5/60g/30</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXAMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014394</DrugIDPK>
    <LicenceNumber>PA0167/111/001</LicenceNumber>
    <ProductName>BAXTER PROPOFOL</ProductName>
    <Strength>1%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2002-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014396</DrugIDPK>
    <LicenceNumber>PA0167/111/002</LicenceNumber>
    <ProductName>BAXTER PROPOFOL</ProductName>
    <Strength>2%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2002-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005288</DrugIDPK>
    <LicenceNumber>PA0172/030/001</LicenceNumber>
    <ProductName>FIBERCON</ProductName>
    <Strength>625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYCARBOPHIL CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000883</DrugIDPK>
    <LicenceNumber>PA0019/033/004</LicenceNumber>
    <ProductName>GYNO TROSYL VAGINAL OVULES</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000884</DrugIDPK>
    <LicenceNumber>PA0019/033/005</LicenceNumber>
    <ProductName>GYNO-TROSYL VAGINAL OVULES</ProductName>
    <Strength>300 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017382</DrugIDPK>
    <LicenceNumber>PA0002/076/001</LicenceNumber>
    <ProductName>PACLITAXEL INJECTION CONCENTRATE</ProductName>
    <Strength>6mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2004-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003940</DrugIDPK>
    <LicenceNumber>PA0126/080/001</LicenceNumber>
    <ProductName>PERICAM 10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003942</DrugIDPK>
    <LicenceNumber>PA0126/080/002</LicenceNumber>
    <ProductName>PERICAM 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008759</DrugIDPK>
    <LicenceNumber>PA0281/094/001</LicenceNumber>
    <ProductName>TRIMOPAN (SUSPENSION)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006183</DrugIDPK>
    <LicenceNumber>PA0437/024/001</LicenceNumber>
    <ProductName>NALOXONE HYDROCHLORIDE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1990-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003625</DrugIDPK>
    <LicenceNumber>PA0100/033/001</LicenceNumber>
    <ProductName>SUSCARD BUCCAL</ProductName>
    <Strength>1.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003627</DrugIDPK>
    <LicenceNumber>PA0100/033/004</LicenceNumber>
    <ProductName>SUSCARD BUCCAL</ProductName>
    <Strength>2.5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007189</DrugIDPK>
    <LicenceNumber>PA0913/010/001</LicenceNumber>
    <ProductName>FLEXIN CONTINUS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007190</DrugIDPK>
    <LicenceNumber>PA0913/010/002</LicenceNumber>
    <ProductName>FLEXIN CONTINUS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1995-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007191</DrugIDPK>
    <LicenceNumber>PA0913/010/003</LicenceNumber>
    <ProductName>FLEXIN CONTINUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1995-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007858</DrugIDPK>
    <LicenceNumber>PA0789/008/001</LicenceNumber>
    <ProductName>ALPHARUBICIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2000-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007859</DrugIDPK>
    <LicenceNumber>PA0789/009/001</LicenceNumber>
    <ProductName>BETARUBICIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2000-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007860</DrugIDPK>
    <LicenceNumber>PA0789/010/001</LicenceNumber>
    <ProductName>EBEDOX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002400</DrugIDPK>
    <LicenceNumber>PA0002/056/002</LicenceNumber>
    <ProductName>STARIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOSINOPRIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007820</DrugIDPK>
    <LicenceNumber>PA0002/056/003</LicenceNumber>
    <ProductName>STARIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOSINOPRIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008887</DrugIDPK>
    <LicenceNumber>PA0677/012/001</LicenceNumber>
    <ProductName>GALLIUM CITRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALLIUM (67 GA) CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000380</DrugIDPK>
    <LicenceNumber>PA0002/066/001</LicenceNumber>
    <ProductName>STADOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000198</DrugIDPK>
    <LicenceNumber>PA0003/004/001</LicenceNumber>
    <ProductName>FOLEX-350</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004040</DrugIDPK>
    <LicenceNumber>PA0757/002/001</LicenceNumber>
    <ProductName>PLESMET</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>1995-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLYCINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000333</DrugIDPK>
    <LicenceNumber>PA0002/034/001</LicenceNumber>
    <ProductName>PRONESTYL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCAINAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006206</DrugIDPK>
    <LicenceNumber>PA0894/001/001</LicenceNumber>
    <ProductName>CREMALGIN BALM</ProductName>
    <Strength>0.1/1/10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Strides Shasun (UK) Ltd</PAHolder>
    <AuthorisedDate>2000-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>CAPSICUM FRUTESCENS</ActiveSubstance>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003182</DrugIDPK>
    <LicenceNumber>PA0073/056/001</LicenceNumber>
    <ProductName>DIGOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002535</DrugIDPK>
    <LicenceNumber>PA0054/064/001</LicenceNumber>
    <ProductName>NUTRIZYM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1989-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013285</DrugIDPK>
    <LicenceNumber>PA1027/001/001</LicenceNumber>
    <ProductName>WINRHO SDF</ProductName>
    <Strength>120mcg</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>Cangene Europe Limited</PAHolder>
    <AuthorisedDate>1999-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for inf/inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTI-D IMMUNOGLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013286</DrugIDPK>
    <LicenceNumber>PA1027/001/002</LicenceNumber>
    <ProductName>WINRHO SDF</ProductName>
    <Strength>300mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Cangene Europe Limited</PAHolder>
    <AuthorisedDate>2000-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for inf/inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTI-D IMMUNOGLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003215</DrugIDPK>
    <LicenceNumber>PA0073/091/004</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLOIDE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003214</DrugIDPK>
    <LicenceNumber>PA0073/091/003</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004844</DrugIDPK>
    <LicenceNumber>PA0823/028/001</LicenceNumber>
    <ProductName>SINUTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004843</DrugIDPK>
    <LicenceNumber>PA0823/027/001</LicenceNumber>
    <ProductName>VEGANIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005600</DrugIDPK>
    <LicenceNumber>PA0282/063/002</LicenceNumber>
    <ProductName>SERENACE AMPOULES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000422</DrugIDPK>
    <LicenceNumber>PA0179/039/001</LicenceNumber>
    <ProductName>AMINOPLASMAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>ASPARAGINE</ActiveSubstance>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>ORNITHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ACETYLTYROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000425</DrugIDPK>
    <LicenceNumber>PA0179/040/001</LicenceNumber>
    <ProductName>AMINOPLASMAL - E</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>2000-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>ASPARAGINE</ActiveSubstance>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>ORNITHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM ACETATE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MALIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013366</DrugIDPK>
    <LicenceNumber>PA0936/054/001</LicenceNumber>
    <ProductName>EUHYPNOS ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1997-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002042</DrugIDPK>
    <LicenceNumber>PA0046/004/004</LicenceNumber>
    <ProductName>FUCIDIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001337</DrugIDPK>
    <LicenceNumber>PA0024/019/003</LicenceNumber>
    <ProductName>BECODISKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1992-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001613</DrugIDPK>
    <LicenceNumber>PA0037/062/001</LicenceNumber>
    <ProductName>AUDICORT EAR</ProductName>
    <Strength>1/3.5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1990-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN UNDECYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008996</DrugIDPK>
    <LicenceNumber>PA0007/047/003</LicenceNumber>
    <ProductName>BONEFOS</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLODRONATE DISODIUM TETRAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015442</DrugIDPK>
    <LicenceNumber>PA0678/087/001</LicenceNumber>
    <ProductName>ALPHOSYL HC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012172</DrugIDPK>
    <LicenceNumber>PA0038/078/001</LicenceNumber>
    <ProductName>CO-BRUFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015163</DrugIDPK>
    <LicenceNumber>PA0610/010/001</LicenceNumber>
    <ProductName>GASTROCOTE</ProductName>
    <Strength>20/80/40/7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001347</DrugIDPK>
    <LicenceNumber>PA0024/023/005</LicenceNumber>
    <ProductName>FLIXOTIDE ROTADISKS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001348</DrugIDPK>
    <LicenceNumber>PA0024/023/006</LicenceNumber>
    <ProductName>FLIXOTIDE ROTADISKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001349</DrugIDPK>
    <LicenceNumber>PA0024/023/007</LicenceNumber>
    <ProductName>FLIXOTIDE ROTADISKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001350</DrugIDPK>
    <LicenceNumber>PA0024/023/008</LicenceNumber>
    <ProductName>FLIXOTIDE ROTADISKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006919</DrugIDPK>
    <LicenceNumber>PA0692/001/002</LicenceNumber>
    <ProductName>HACKS BLACKCURRANT</ProductName>
    <Strength>0.06</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Trebor Ireland Limited</PAHolder>
    <AuthorisedDate>1994-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006920</DrugIDPK>
    <LicenceNumber>PA0692/001/003</LicenceNumber>
    <ProductName>HACKS HONEY &amp; LEMON</ProductName>
    <Strength>0.06</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Trebor Ireland Limited</PAHolder>
    <AuthorisedDate>1994-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006918</DrugIDPK>
    <LicenceNumber>PA0692/001/001</LicenceNumber>
    <ProductName>HACKS ORIGINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Trebor Ireland Limited</PAHolder>
    <AuthorisedDate>1994-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009323</DrugIDPK>
    <LicenceNumber>PA0970/001/002</LicenceNumber>
    <ProductName>ACCOLATE</ProductName>
    <Strength>40 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZAFIRLUKAST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004554</DrugIDPK>
    <LicenceNumber>PA0013/090/001</LicenceNumber>
    <ProductName>AREDIA DRY POWDER</ProductName>
    <Strength>15 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003892</DrugIDPK>
    <LicenceNumber>PA0809/001/001</LicenceNumber>
    <ProductName>FLUORO-URACIL ROCHE AMPOULES</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lifehealth Limited</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009270</DrugIDPK>
    <LicenceNumber>PA0187/055/002</LicenceNumber>
    <ProductName>OCTONATIV M</ProductName>
    <Strength>500 IU/5ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009268</DrugIDPK>
    <LicenceNumber>PA0187/055/001</LicenceNumber>
    <ProductName>OCTONATIV-M</ProductName>
    <Strength>250/2.5</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000656</DrugIDPK>
    <LicenceNumber>PA0013/043/004</LicenceNumber>
    <ProductName>SANDOSTATIN MULTI-DOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1990-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OCTREOTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002345</DrugIDPK>
    <LicenceNumber>PA0048/014/002</LicenceNumber>
    <ProductName>ULTRACEF</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFADROXIL MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008248</DrugIDPK>
    <LicenceNumber>PA0281/081/002</LicenceNumber>
    <ProductName>AMOXICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008247</DrugIDPK>
    <LicenceNumber>PA0281/081/001</LicenceNumber>
    <ProductName>AMOXICILLIN  MIXTURE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000412</DrugIDPK>
    <LicenceNumber>PA0007/002/001</LicenceNumber>
    <ProductName>ATROVENT METERED DOSE INHALER</ProductName>
    <Strength>20 mcg/act</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1976-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002861</DrugIDPK>
    <LicenceNumber>PA0057/005/003</LicenceNumber>
    <ProductName>NUELIN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1980-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE SODIUM AMINOACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003281</DrugIDPK>
    <LicenceNumber>PA0073/121/003</LicenceNumber>
    <ProductName>VASOFED RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009222</DrugIDPK>
    <LicenceNumber>PA0111/002/003</LicenceNumber>
    <ProductName>RIMACTANE</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>1997-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004034</DrugIDPK>
    <LicenceNumber>PA0148/044/001</LicenceNumber>
    <ProductName>VISTALBALON</ProductName>
    <Strength>0.05/0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1992-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTAZOLINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>NAPHAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005332</DrugIDPK>
    <LicenceNumber>PA0281/054/001</LicenceNumber>
    <ProductName>PINAMET CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1990-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000137</DrugIDPK>
    <LicenceNumber>PA0544/020/003</LicenceNumber>
    <ProductName>MEASLES RUBELLA VACCINE LIVE - SYRINGE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1995-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010278</DrugIDPK>
    <LicenceNumber>PA0540/019/001</LicenceNumber>
    <ProductName>MERBENTYL SYRUP</ProductName>
    <Strength>10mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008926</DrugIDPK>
    <LicenceNumber>PA0282/066/001</LicenceNumber>
    <ProductName>SULPIRIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010229</DrugIDPK>
    <LicenceNumber>PA0522/009/001</LicenceNumber>
    <ProductName>HIGH POTENCY VITAMIN C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Peter Black Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRUS BIOFLAVANOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001343</DrugIDPK>
    <LicenceNumber>PA0749/003/001</LicenceNumber>
    <ProductName>METHOTREXATE INJ  AMPOULES</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001350</DrugIDPK>
    <LicenceNumber>PA0749/003/004</LicenceNumber>
    <ProductName>METHOTREXATE INJ VIAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001346</DrugIDPK>
    <LicenceNumber>PA0749/003/004</LicenceNumber>
    <ProductName>METHOTREXATE INJ VIALS</ProductName>
    <Strength>100mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008328</DrugIDPK>
    <LicenceNumber>PA0950/001/002</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chugai Pharma UK Ltd</PAHolder>
    <AuthorisedDate>2000-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000876</DrugIDPK>
    <LicenceNumber>PA0012/032/002</LicenceNumber>
    <ProductName>ULTRAPROCT</ProductName>
    <Strength>0.612/0.63/1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE PIVALATE</ActiveSubstance>
      <ActiveSubstance>FLUOCORTOLONE CAPROATE</ActiveSubstance>
      <ActiveSubstance>CINCHOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001732</DrugIDPK>
    <LicenceNumber>PA0030/013/001</LicenceNumber>
    <ProductName>FABROL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1985-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016843</DrugIDPK>
    <LicenceNumber>PA0936/090/001</LicenceNumber>
    <ProductName>REBOXETINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REBOXETINE MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016844</DrugIDPK>
    <LicenceNumber>PA0936/090/002</LicenceNumber>
    <ProductName>REBOXETINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REBOXETINE MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012143</DrugIDPK>
    <LicenceNumber>PA0711/041/001</LicenceNumber>
    <ProductName>FENOR</ProductName>
    <Strength>67</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012144</DrugIDPK>
    <LicenceNumber>PA0711/041/002</LicenceNumber>
    <ProductName>FENOR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006505</DrugIDPK>
    <LicenceNumber>PA0476/001/001</LicenceNumber>
    <ProductName>EXARTIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1990-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009192</DrugIDPK>
    <LicenceNumber>PA0436/021/006</LicenceNumber>
    <ProductName>BECLAZONE EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1995-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009194</DrugIDPK>
    <LicenceNumber>PA0436/021/007</LicenceNumber>
    <ProductName>BECLAZONE EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1995-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009196</DrugIDPK>
    <LicenceNumber>PA0436/021/008</LicenceNumber>
    <ProductName>BECLAZONE EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1995-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001325</DrugIDPK>
    <LicenceNumber>PA0024/005/005</LicenceNumber>
    <ProductName>BECOTIDE 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1989-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003501</DrugIDPK>
    <LicenceNumber>PA0024/005/004</LicenceNumber>
    <ProductName>BECOTIDE 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1985-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001321</DrugIDPK>
    <LicenceNumber>PA0024/005/001</LicenceNumber>
    <ProductName>BECOTIDE INHALER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015216</DrugIDPK>
    <LicenceNumber>PA0711/045/001</LicenceNumber>
    <ProductName>ORABET</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015217</DrugIDPK>
    <LicenceNumber>PA0711/045/002</LicenceNumber>
    <ProductName>ORABET</ProductName>
    <Strength>850mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2002-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010961</DrugIDPK>
    <LicenceNumber>PA1003/001/001</LicenceNumber>
    <ProductName>SMECTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Beaufour Ipsen Pharma</PAHolder>
    <AuthorisedDate>2000-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SMECTITE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000200</DrugIDPK>
    <LicenceNumber>PA0003/006/001</LicenceNumber>
    <ProductName>GUAREM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate>1985-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAR GUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000256</DrugIDPK>
    <LicenceNumber>PA0006/009/001</LicenceNumber>
    <ProductName>SOFRA - TULLE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005382</DrugIDPK>
    <LicenceNumber>PA0258/017/002</LicenceNumber>
    <ProductName>ADULT KAO-C DIARRHOEA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1983-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005357</DrugIDPK>
    <LicenceNumber>PA0258/036/001</LicenceNumber>
    <ProductName>COLD SORE LOTION</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1991-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005355</DrugIDPK>
    <LicenceNumber>PA0258/034/001</LicenceNumber>
    <ProductName>CYSTOLEVE SACHETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1990-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005352</DrugIDPK>
    <LicenceNumber>PA0258/031/001</LicenceNumber>
    <ProductName>GLUCO-LYTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1990-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005363</DrugIDPK>
    <LicenceNumber>PA0258/043/001</LicenceNumber>
    <ProductName>GLYCERIN LEMON &amp; HONEY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1991-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005878</DrugIDPK>
    <LicenceNumber>PA0258/017/001</LicenceNumber>
    <ProductName>JUNIOR KAO-C DIARRHOEA</ProductName>
    <Strength>0.5/0.25g/</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1983-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005362</DrugIDPK>
    <LicenceNumber>PA0258/042/001</LicenceNumber>
    <ProductName>NOVASIL PLUS ANTACID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1991-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008113</DrugIDPK>
    <LicenceNumber>PA0669/004/001</LicenceNumber>
    <ProductName>OCTEGRA</ProductName>
    <Strength>400mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015357</DrugIDPK>
    <LicenceNumber>PA0669/004/002</LicenceNumber>
    <ProductName>OCTEGRA</ProductName>
    <Strength>400mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017389</DrugIDPK>
    <LicenceNumber>PA0669/004/003</LicenceNumber>
    <ProductName>OCTEGRA</ProductName>
    <Strength>400mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>2003-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005229</DrugIDPK>
    <LicenceNumber>PA0258/005/001</LicenceNumber>
    <ProductName>PARACETAMOL B.P.</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005354</DrugIDPK>
    <LicenceNumber>PA0258/033/001</LicenceNumber>
    <ProductName>TYROCANE JUNIOR ANTISEPTIC</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1990-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005186</DrugIDPK>
    <LicenceNumber>PA0258/004/001</LicenceNumber>
    <ProductName>TYROCANE THROAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005181</DrugIDPK>
    <LicenceNumber>PA0258/001/001</LicenceNumber>
    <ProductName>ULC-AID MOUTH ULCER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1977-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005181</DrugIDPK>
    <LicenceNumber>PA0258/001/001</LicenceNumber>
    <ProductName>ULC-AID MOUTH ULCER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1977-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005183</DrugIDPK>
    <LicenceNumber>PA0258/003/001</LicenceNumber>
    <ProductName>ULC-AID MOUTH ULCER THROAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005381</DrugIDPK>
    <LicenceNumber>PA0258/013/001</LicenceNumber>
    <ProductName>VERRUCA TREATMENT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1980-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005356</DrugIDPK>
    <LicenceNumber>PA0258/035/001</LicenceNumber>
    <ProductName>WAPEZE INSECT BITE</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003781</DrugIDPK>
    <LicenceNumber>PA0118/010/003</LicenceNumber>
    <ProductName>GANDA (3+0.5)</ProductName>
    <Strength>3.0/0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE SULFATE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003660</DrugIDPK>
    <LicenceNumber>PA0736/010/001</LicenceNumber>
    <ProductName>NUTRIFLEX SPECIAL WITHOUT ELECTROLYTES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE GLUTAMATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ASPARAGINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005970</DrugIDPK>
    <LicenceNumber>PA0073/121/005</LicenceNumber>
    <ProductName>VASOFED RETARD</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2000-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000134</DrugIDPK>
    <LicenceNumber>PA0436/029/001</LicenceNumber>
    <ProductName>SALAMOL EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1995-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005700</DrugIDPK>
    <LicenceNumber>PA0748/011/007</LicenceNumber>
    <ProductName>PREPULSID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISAPRIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005701</DrugIDPK>
    <LicenceNumber>PA0748/011/008</LicenceNumber>
    <ProductName>PREPULSID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISAPRIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005702</DrugIDPK>
    <LicenceNumber>PA0748/011/005</LicenceNumber>
    <ProductName>PREPULSID</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>anhyd mg/ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISAPRIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005703</DrugIDPK>
    <LicenceNumber>PA0748/011/006</LicenceNumber>
    <ProductName>PREPULSID PAEDIATRIC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>anhyd mg/ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISAPRIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002869</DrugIDPK>
    <LicenceNumber>PA0060/006/005</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1985-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003659</DrugIDPK>
    <LicenceNumber>PA0736/009/001</LicenceNumber>
    <ProductName>NUTRIFLEX PLUS WITHOUT ELECTROLYTES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2000-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE GLUTAMATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ASPARAGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003032</DrugIDPK>
    <LicenceNumber>PA0060/046/002</LicenceNumber>
    <ProductName>ALGITEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2005-01-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006557</DrugIDPK>
    <LicenceNumber>PA0473/003/004</LicenceNumber>
    <ProductName>ZEPHOLIN S.R.</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003967</DrugIDPK>
    <LicenceNumber>PA0141/020/001</LicenceNumber>
    <ProductName>VIVIOPTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1993-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>RUTOSIDE</ActiveSubstance>
      <ActiveSubstance>DEXPANTHENOL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>ETHYL LINOLEATE</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>OROTIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM MOLYBDATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>CHOLINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>ADENOSINE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER SULPHATE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>COBALT SULPHATE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULPHATE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>FERROUS SULFATE EXSICCATED</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>LECITHIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003358</DrugIDPK>
    <LicenceNumber>PA0077/010/002</LicenceNumber>
    <ProductName>NEGRAM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALIDIXIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000427</DrugIDPK>
    <LicenceNumber>PA0007/008/003</LicenceNumber>
    <ProductName>PERSANTIN - AMPOULES</ProductName>
    <Strength>10mg/2ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1981-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006348</DrugIDPK>
    <LicenceNumber>PPA0465/004/001A</LicenceNumber>
    <ProductName>DAKTACORT</ProductName>
    <Strength>2/1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006338</DrugIDPK>
    <LicenceNumber>PPA0465/001/001A</LicenceNumber>
    <ProductName>IMODIUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPERAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005350</DrugIDPK>
    <LicenceNumber>PA0258/026/002</LicenceNumber>
    <ProductName>JUNIOR MELTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1989-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SUCROSE</ActiveSubstance>
      <ActiveSubstance>HONEY</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008830</DrugIDPK>
    <LicenceNumber>PA0012/088/001</LicenceNumber>
    <ProductName>MIRELLE</ProductName>
    <Strength>0.060mg/0. 015</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014536</DrugIDPK>
    <LicenceNumber>PA0711/011/010</LicenceNumber>
    <ProductName>NIFED</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005279</DrugIDPK>
    <LicenceNumber>PA0281/009/001</LicenceNumber>
    <ProductName>NOVAPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005282</DrugIDPK>
    <LicenceNumber>PA0281/009/003</LicenceNumber>
    <ProductName>NOVAPEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005281</DrugIDPK>
    <LicenceNumber>PA0281/009/002</LicenceNumber>
    <ProductName>NOVAPEN AMPICILLIN BP</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002195</DrugIDPK>
    <LicenceNumber>PA0711/012/001</LicenceNumber>
    <ProductName>PENTOFYL (PENTOXIFYLLINE)</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002196</DrugIDPK>
    <LicenceNumber>PA0711/012/002</LicenceNumber>
    <ProductName>PENTOFYL (PENTOXIFYLLINE)</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005333</DrugIDPK>
    <LicenceNumber>PA0281/054/002</LicenceNumber>
    <ProductName>PINAMET CIMETIDINE</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1990-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008437</DrugIDPK>
    <LicenceNumber>PA0466/003/001</LicenceNumber>
    <ProductName>VITAMIN C &amp; B BIOFLAVONOIDS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Quest Vitamins (UK) Ltd</PAHolder>
    <AuthorisedDate>1994-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRUS BIOFLAVANOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005672</DrugIDPK>
    <LicenceNumber>PA0290/058/002</LicenceNumber>
    <ProductName>ISOPTO CARPINE 1.0%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005673</DrugIDPK>
    <LicenceNumber>PA0290/058/003</LicenceNumber>
    <ProductName>ISOPTO CARPINE 2.0%</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005676</DrugIDPK>
    <LicenceNumber>PA0290/058/005</LicenceNumber>
    <ProductName>ISOPTO CARPINE 4.0%</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017962</DrugIDPK>
    <LicenceNumber>PA0771/006/001</LicenceNumber>
    <ProductName>TAMOFEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2001-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017963</DrugIDPK>
    <LicenceNumber>PA0771/006/002</LicenceNumber>
    <ProductName>TAMOFEN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2001-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012219</DrugIDPK>
    <LicenceNumber>PA0038/089/001</LicenceNumber>
    <ProductName>TARKA</ProductName>
    <Strength>180/2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TRANDOLAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007533</DrugIDPK>
    <LicenceNumber>PA0476/006/001</LicenceNumber>
    <ProductName>PARACETAMOL INFANT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1989-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007763</DrugIDPK>
    <LicenceNumber>PA0179/008/003</LicenceNumber>
    <ProductName>OSMOFUNDIN</ProductName>
    <Strength>10 %</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015312</DrugIDPK>
    <LicenceNumber>PA0936/008/003</LicenceNumber>
    <ProductName>CYKLOKAPRON</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANEXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007764</DrugIDPK>
    <LicenceNumber>PA0936/005/001</LicenceNumber>
    <ProductName>DRAMAMINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1996-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMENHYDRINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002344</DrugIDPK>
    <LicenceNumber>PA0748/004/001</LicenceNumber>
    <ProductName>EVOREL PATCH</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002345</DrugIDPK>
    <LicenceNumber>PA0748/004/002</LicenceNumber>
    <ProductName>EVOREL PATCH</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002347</DrugIDPK>
    <LicenceNumber>PA0748/004/003</LicenceNumber>
    <ProductName>EVOREL PATCH</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015230</DrugIDPK>
    <LicenceNumber>PA0185/041/001</LicenceNumber>
    <ProductName>MENORING 50</ProductName>
    <Strength>12.4 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>2003-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016304</DrugIDPK>
    <LicenceNumber>PA0748/010/001</LicenceNumber>
    <ProductName>MICRONOR HRT</ProductName>
    <Strength>1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005892</DrugIDPK>
    <LicenceNumber>PA0748/033/002</LicenceNumber>
    <ProductName>RETIN A</ProductName>
    <Strength>0.025%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005891</DrugIDPK>
    <LicenceNumber>PA0748/033/001</LicenceNumber>
    <ProductName>RETIN-A</ProductName>
    <Strength>0.01%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003645</DrugIDPK>
    <LicenceNumber>PA0102/014/001</LicenceNumber>
    <ProductName>SPASMONAL FIBRE</ProductName>
    <Strength>62</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
      <ActiveSubstance>STERCULIA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008668</DrugIDPK>
    <LicenceNumber>PA0172/025/001</LicenceNumber>
    <ProductName>WHITE HAEMORRHOIDAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008672</DrugIDPK>
    <LicenceNumber>PA0172/025/002</LicenceNumber>
    <ProductName>WHITE HAEMORRHOIDAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004807</DrugIDPK>
    <LicenceNumber>PA0856/008/001</LicenceNumber>
    <ProductName>LENTIZOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>1995-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004808</DrugIDPK>
    <LicenceNumber>PA0856/008/002</LicenceNumber>
    <ProductName>LENTIZOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>1995-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000676</DrugIDPK>
    <LicenceNumber>PA0010/032/001</LicenceNumber>
    <ProductName>MONONINE FREEZE DRIED HUMAN COAG. FACTOR IX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007615</DrugIDPK>
    <LicenceNumber>PA0877/002/001</LicenceNumber>
    <ProductName>DTP VACCINE BEHRING SINGLE DOSE AMPOULE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate>1995-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM TIMERFONATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007619</DrugIDPK>
    <LicenceNumber>PA0877/002/002</LicenceNumber>
    <ProductName>DTP VACCINE BEHRING VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate>1995-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM TIMERFONATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007620</DrugIDPK>
    <LicenceNumber>PA0877/002/003</LicenceNumber>
    <ProductName>DTP VACCINE BEHRING VIAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate>1995-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM TIMERFONATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001784</DrugIDPK>
    <LicenceNumber>PA0035/014/002</LicenceNumber>
    <ProductName>DOLOBID</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUNISAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008285</DrugIDPK>
    <LicenceNumber>PA0913/011/007</LicenceNumber>
    <ProductName>SEVREDOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008286</DrugIDPK>
    <LicenceNumber>PA0913/011/008</LicenceNumber>
    <ProductName>SEVREDOL CONCENTRATED</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1999-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015160</DrugIDPK>
    <LicenceNumber>PA0610/007/001</LicenceNumber>
    <ProductName>PRIPSEN</ProductName>
    <Strength>4000/15.3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1998-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERAZINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SENNOSIDE B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005359</DrugIDPK>
    <LicenceNumber>PA0258/039/001</LicenceNumber>
    <ProductName>CUPAL DECONGESTANT INHALENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003633</DrugIDPK>
    <LicenceNumber>PA0100/037/001</LicenceNumber>
    <ProductName>FLETCHERS ENEMETTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1984-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004173</DrugIDPK>
    <LicenceNumber>PA0167/053/001</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004953</DrugIDPK>
    <LicenceNumber>PA0030/035/001</LicenceNumber>
    <ProductName>ALLEREZE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1994-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLEMASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003777</DrugIDPK>
    <LicenceNumber>PA0711/004/001</LicenceNumber>
    <ProductName>DILTAM</ProductName>
    <Strength>60mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1994-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013878</DrugIDPK>
    <LicenceNumber>PA0970/042/001</LicenceNumber>
    <ProductName>JECTOFER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRON SORBITEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013917</DrugIDPK>
    <LicenceNumber>PA0970/053/001</LicenceNumber>
    <ProductName>XYLOCAINE 0.5% WITH ADRENALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2001-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013922</DrugIDPK>
    <LicenceNumber>PA0970/054/003</LicenceNumber>
    <ProductName>XYLOCAINE PLAIN</ProductName>
    <Strength>2.0%</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001383</DrugIDPK>
    <LicenceNumber>PA0035/067/004</LicenceNumber>
    <ProductName>INNOVACE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1985-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008212</DrugIDPK>
    <LicenceNumber>PA0282/064/001</LicenceNumber>
    <ProductName>TERFENADINE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1994-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014507</DrugIDPK>
    <LicenceNumber>PA0819/017/001</LicenceNumber>
    <ProductName>ZOLPIDEM-RATIOPHARM</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLPIDEM TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014508</DrugIDPK>
    <LicenceNumber>PA0819/017/002</LicenceNumber>
    <ProductName>ZOLPIDEM-RATIOPHARM</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLPIDEM TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009426</DrugIDPK>
    <LicenceNumber>PA0969/001/001</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Medimpex France S.A.</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009427</DrugIDPK>
    <LicenceNumber>PA0969/001/002</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medimpex France S.A.</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009428</DrugIDPK>
    <LicenceNumber>PA0969/001/003</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medimpex France S.A.</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009429</DrugIDPK>
    <LicenceNumber>PA0969/001/004</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Medimpex France S.A.</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010112</DrugIDPK>
    <LicenceNumber>EU/1/00/139/012</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010104</DrugIDPK>
    <LicenceNumber>EU/1/00/138/010</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010105</DrugIDPK>
    <LicenceNumber>EU/1/00/138/011</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010106</DrugIDPK>
    <LicenceNumber>EU/1/00/138/012</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010095</DrugIDPK>
    <LicenceNumber>EU/1/00/138/003</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010096</DrugIDPK>
    <LicenceNumber>EU/1/00/138/004</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010097</DrugIDPK>
    <LicenceNumber>EU/1/00/138/005</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010098</DrugIDPK>
    <LicenceNumber>EU/1/00/138/006</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010099</DrugIDPK>
    <LicenceNumber>EU/1/00/138/007</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010100</DrugIDPK>
    <LicenceNumber>EU/1/00/138/008</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010101</DrugIDPK>
    <LicenceNumber>EU/1/00/138/009</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007535</DrugIDPK>
    <LicenceNumber>EU/1/00/138/001</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010107</DrugIDPK>
    <LicenceNumber>EU/1/00/139/007</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010108</DrugIDPK>
    <LicenceNumber>EU/1/00/139/008</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010109</DrugIDPK>
    <LicenceNumber>EU/1/00/139/009</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010110</DrugIDPK>
    <LicenceNumber>EU/1/00/139/010</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010111</DrugIDPK>
    <LicenceNumber>EU/1/00/139/011</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010091</DrugIDPK>
    <LicenceNumber>EU/1/00/139/002</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010092</DrugIDPK>
    <LicenceNumber>EU/1/00/139/003</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010093</DrugIDPK>
    <LicenceNumber>EU/1/00/139/004</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010102</DrugIDPK>
    <LicenceNumber>EU/1/00/139/005</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010103</DrugIDPK>
    <LicenceNumber>EU/1/00/139/006</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007536</DrugIDPK>
    <LicenceNumber>EU/1/00/139/001</LicenceNumber>
    <ProductName>VENVIA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018964</DrugIDPK>
    <LicenceNumber>PPA0465/084/002B</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018020</DrugIDPK>
    <LicenceNumber>PPA0465/084/001B</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>12.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014824</DrugIDPK>
    <LicenceNumber>PPA0465/084/001A</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014825</DrugIDPK>
    <LicenceNumber>PPA0465/084/002A</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008720</DrugIDPK>
    <LicenceNumber>PA0073/112/014</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE 2.0%</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016309</DrugIDPK>
    <LicenceNumber>PA1077/092/001</LicenceNumber>
    <ProductName>PYLORID</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE BISMUTREX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016803</DrugIDPK>
    <LicenceNumber>PA1046/005/001</LicenceNumber>
    <ProductName>BENORILATE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2001-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016804</DrugIDPK>
    <LicenceNumber>PA1046/005/002</LicenceNumber>
    <ProductName>BENORILATE MIXTURE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2001-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004320</DrugIDPK>
    <LicenceNumber>PA0167/041/001</LicenceNumber>
    <ProductName>PLASMA-LYTE 148/WATER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCONATE SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004275</DrugIDPK>
    <LicenceNumber>PA0167/035/001</LicenceNumber>
    <ProductName>PLASMA-LYTE 50/30</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010094</DrugIDPK>
    <LicenceNumber>EU/1/00/138/002</LicenceNumber>
    <ProductName>NYRACTA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2000-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016308</DrugIDPK>
    <LicenceNumber>PA1077/091/001</LicenceNumber>
    <ProductName>TAGAMET INFUSION</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000938</DrugIDPK>
    <LicenceNumber>PA0678/013/001</LicenceNumber>
    <ProductName>DAY NURSE</ProductName>
    <Strength>500/12.5/7</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1995-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005212</DrugIDPK>
    <LicenceNumber>PA0167/090/001</LicenceNumber>
    <ProductName>PRIMENE 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>ORNITHINE</ActiveSubstance>
      <ActiveSubstance>TAURINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002497</DrugIDPK>
    <LicenceNumber>PA0049/007/001</LicenceNumber>
    <ProductName>AMPICLOX</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002498</DrugIDPK>
    <LicenceNumber>PA0049/007/003</LicenceNumber>
    <ProductName>AMPICLOX</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002500</DrugIDPK>
    <LicenceNumber>PA0049/007/005</LicenceNumber>
    <ProductName>AMPICLOX NEONATAL</ProductName>
    <Strength>60 mg, 30 mg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002501</DrugIDPK>
    <LicenceNumber>PA0049/007/006</LicenceNumber>
    <ProductName>AMPLICOX</ProductName>
    <Strength>125/125mg/5 ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000814</DrugIDPK>
    <LicenceNumber>PA0012/011/001</LicenceNumber>
    <ProductName>MICROGYNON 30</ProductName>
    <Strength>150/30</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003877</DrugIDPK>
    <LicenceNumber>PA0126/044/002</LicenceNumber>
    <ProductName>NAPMEL 250</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003876</DrugIDPK>
    <LicenceNumber>PA0126/044/001</LicenceNumber>
    <ProductName>NAPMEL 250 (500)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007387</DrugIDPK>
    <LicenceNumber>PA0167/100/001</LicenceNumber>
    <ProductName>CLINOMEL N4-550</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SOYBEAN OIL</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007388</DrugIDPK>
    <LicenceNumber>PA0167/100/002</LicenceNumber>
    <ProductName>CLINOMEL N5-800</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SOYBEAN OIL</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007389</DrugIDPK>
    <LicenceNumber>PA0167/100/003</LicenceNumber>
    <ProductName>CLINOMEL N6-900</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SOYBEAN OIL</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007390</DrugIDPK>
    <LicenceNumber>PA0167/100/004</LicenceNumber>
    <ProductName>CLINOMEL N7-1000</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>SOYBEAN OIL</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005256</DrugIDPK>
    <LicenceNumber>PA0167/096/005</LicenceNumber>
    <ProductName>GLUCOSE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008216</DrugIDPK>
    <LicenceNumber>PA0282/065/001</LicenceNumber>
    <ProductName>TERFENOR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014679</DrugIDPK>
    <LicenceNumber>PA0218/025/007</LicenceNumber>
    <ProductName>ACTRAPID FLEXPEN</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2002-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009209</DrugIDPK>
    <LicenceNumber>PA0218/025/006</LicenceNumber>
    <ProductName>ACTRAPID INNOLET</ProductName>
    <Strength>100 IU/ml</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014681</DrugIDPK>
    <LicenceNumber>PA0218/029/007</LicenceNumber>
    <ProductName>MIXTARD 30 FLEXPEN</ProductName>
    <Strength>100IU/ml</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2002-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013586</DrugIDPK>
    <LicenceNumber>PA0035/092/001</LicenceNumber>
    <ProductName>CEOXX</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013587</DrugIDPK>
    <LicenceNumber>PA0035/092/002</LicenceNumber>
    <ProductName>CEOXX</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008062</DrugIDPK>
    <LicenceNumber>PA0035/091/001</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>12.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008063</DrugIDPK>
    <LicenceNumber>PA0035/091/002</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008064</DrugIDPK>
    <LicenceNumber>PA0035/091/003</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>12.5mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008065</DrugIDPK>
    <LicenceNumber>PA0035/091/004</LicenceNumber>
    <ProductName>VIOXX</ProductName>
    <Strength>25mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROFECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003202</DrugIDPK>
    <LicenceNumber>PA0073/083/001</LicenceNumber>
    <ProductName>HEXOGEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1984-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSITOL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009379</DrugIDPK>
    <LicenceNumber>PA0970/023/005</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009090</DrugIDPK>
    <LicenceNumber>PA0077/148/002</LicenceNumber>
    <ProductName>DICYNENE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010125</DrugIDPK>
    <LicenceNumber>PA0819/007/001</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010127</DrugIDPK>
    <LicenceNumber>PA0819/007/002</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009723</DrugIDPK>
    <LicenceNumber>PA0819/006/001</LicenceNumber>
    <ProductName>CAPTOHCT-RATIOPHARM</ProductName>
    <Strength>25/12.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009724</DrugIDPK>
    <LicenceNumber>PA0819/006/002</LicenceNumber>
    <ProductName>CAPTOHCT-RATIOPHARM</ProductName>
    <Strength>50/25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010321</DrugIDPK>
    <LicenceNumber>PA0819/010/001</LicenceNumber>
    <ProductName>CAPTOPRIL</ProductName>
    <Strength>12.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010322</DrugIDPK>
    <LicenceNumber>PA0819/010/002</LicenceNumber>
    <ProductName>CAPTOPRIL</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010323</DrugIDPK>
    <LicenceNumber>PA0819/010/003</LicenceNumber>
    <ProductName>CAPTOPRIL</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010318</DrugIDPK>
    <LicenceNumber>PA0819/011/001</LicenceNumber>
    <ProductName>CAPTOPRIL-RATIOPHARM</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010319</DrugIDPK>
    <LicenceNumber>PA0819/011/002</LicenceNumber>
    <ProductName>CAPTOPRIL-RATIOPHARM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010320</DrugIDPK>
    <LicenceNumber>PA0819/011/003</LicenceNumber>
    <ProductName>CAPTOPRIL-RATIOPHARM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014766</DrugIDPK>
    <LicenceNumber>PA0819/018/001</LicenceNumber>
    <ProductName>CETIRIZINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2003-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008998</DrugIDPK>
    <LicenceNumber>PA0819/003/001</LicenceNumber>
    <ProductName>DOXAZIN</ProductName>
    <Strength>1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008999</DrugIDPK>
    <LicenceNumber>PA0819/003/002</LicenceNumber>
    <ProductName>DOXAZIN</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009001</DrugIDPK>
    <LicenceNumber>PA0819/003/003</LicenceNumber>
    <ProductName>DOXAZIN</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008992</DrugIDPK>
    <LicenceNumber>PA0819/002/001</LicenceNumber>
    <ProductName>DOXAZOSIN-RATIOPHARM</ProductName>
    <Strength>1mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008993</DrugIDPK>
    <LicenceNumber>PA0819/002/002</LicenceNumber>
    <ProductName>DOXAZOSIN-RATIOPHARM</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008995</DrugIDPK>
    <LicenceNumber>PA0819/002/003</LicenceNumber>
    <ProductName>DOXAZOSIN-RATIOPHARM</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009129</DrugIDPK>
    <LicenceNumber>PA0819/005/001</LicenceNumber>
    <ProductName>ENALAPRIL</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009130</DrugIDPK>
    <LicenceNumber>PA0819/005/002</LicenceNumber>
    <ProductName>ENALAPRIL</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009131</DrugIDPK>
    <LicenceNumber>PA0819/005/003</LicenceNumber>
    <ProductName>ENALAPRIL</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011152</DrugIDPK>
    <LicenceNumber>PA0819/013/001</LicenceNumber>
    <ProductName>ENALAPRIL HCT</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011150</DrugIDPK>
    <LicenceNumber>PA0819/012/001</LicenceNumber>
    <ProductName>ENALAPRIL HCT-RATIOPHARM</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009123</DrugIDPK>
    <LicenceNumber>PA0819/004/001</LicenceNumber>
    <ProductName>ENALAPRIL-RATIOPHARM</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009126</DrugIDPK>
    <LicenceNumber>PA0819/004/002</LicenceNumber>
    <ProductName>ENALAPRIL-RATIOPHARM</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009127</DrugIDPK>
    <LicenceNumber>PA0819/004/003</LicenceNumber>
    <ProductName>ENALAPRIL-RATIOPHARM</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009128</DrugIDPK>
    <LicenceNumber>PA0819/004/004</LicenceNumber>
    <ProductName>ENALAPRIL-RATIOPHARM</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014768</DrugIDPK>
    <LicenceNumber>PA0819/019/002</LicenceNumber>
    <ProductName>FELODIPINE XL</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2003-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014769</DrugIDPK>
    <LicenceNumber>PA0819/019/003</LicenceNumber>
    <ProductName>FELODIPINE XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2003-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017819</DrugIDPK>
    <LicenceNumber>PA0819/027/001</LicenceNumber>
    <ProductName>LISINOPRIL HYDROCHLOROTHIAZIDE 10 MG/12.5 MG</ProductName>
    <Strength>10/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2004-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017820</DrugIDPK>
    <LicenceNumber>PA0819/027/002</LicenceNumber>
    <ProductName>LISINOPRIL HYDROCHLOROTHIAZIDE 20 MG/12.5 MG</ProductName>
    <Strength>20/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2004-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010301</DrugIDPK>
    <LicenceNumber>PA0819/008/001</LicenceNumber>
    <ProductName>LISINOPRIL-RATIOPHARM</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010302</DrugIDPK>
    <LicenceNumber>PA0819/008/002</LicenceNumber>
    <ProductName>LISINOPRIL-RATIOPHARM</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010303</DrugIDPK>
    <LicenceNumber>PA0819/008/003</LicenceNumber>
    <ProductName>LISINOPRIL-RATIOPHARM</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010304</DrugIDPK>
    <LicenceNumber>PA0819/008/004</LicenceNumber>
    <ProductName>LISINOPRIL-RATIOPHARM</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006801</DrugIDPK>
    <LicenceNumber>PA0544/005/002</LicenceNumber>
    <ProductName>MENGIVAC (A+C) 10 DOSE</ProductName>
    <Strength>500/500mcg/5ml</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-09-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEISSERIA MENINGITIDIS A</ActiveSubstance>
      <ActiveSubstance>NEISSERIA MENINGITIDIS C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011207</DrugIDPK>
    <LicenceNumber>PA0819/014/001</LicenceNumber>
    <ProductName>RANITIDINE-RATIOPHARM</ProductName>
    <Strength>150mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011209</DrugIDPK>
    <LicenceNumber>PA0819/014/002</LicenceNumber>
    <ProductName>RANITIDINE-RATIOPHARM</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008944</DrugIDPK>
    <LicenceNumber>PA0488/010/001</LicenceNumber>
    <ProductName>EXPULIN CHILDRENS COUGH LINCTUS-SUGAR FREE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008948</DrugIDPK>
    <LicenceNumber>PA0488/013/001</LicenceNumber>
    <ProductName>EXPULIN COUGH LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008947</DrugIDPK>
    <LicenceNumber>PA0488/012/001</LicenceNumber>
    <ProductName>EXPULIN DECONGESTANT SUGAR FREE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008946</DrugIDPK>
    <LicenceNumber>PA0488/011/001</LicenceNumber>
    <ProductName>EXPULIN DRY COUGH STRONG</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006793</DrugIDPK>
    <LicenceNumber>PA0544/004/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE BP AMPOULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002891</DrugIDPK>
    <LicenceNumber>PA0785/001/003</LicenceNumber>
    <ProductName>GAMBROSOL 40 H WITH GLUCOSE 4%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Gambro Lundia AB</PAHolder>
    <AuthorisedDate>1996-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002889</DrugIDPK>
    <LicenceNumber>PA0785/001/001</LicenceNumber>
    <ProductName>GAMBROSOL 40L WITH GLUCOSE 1.5%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Gambro Lundia AB</PAHolder>
    <AuthorisedDate>1996-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002890</DrugIDPK>
    <LicenceNumber>PA0785/001/002</LicenceNumber>
    <ProductName>GAMBROSOL 40M WITH GLUCOSE 2.5%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Gambro Lundia AB</PAHolder>
    <AuthorisedDate>1996-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000835</DrugIDPK>
    <LicenceNumber>PA0017/005/001</LicenceNumber>
    <ProductName>NEOSPORIN</ProductName>
    <Strength>5000/1700/</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007486</DrugIDPK>
    <LicenceNumber>PA0484/025/001</LicenceNumber>
    <ProductName>GLYCERIN LEMON &amp; HONEY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>HONEY</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009291</DrugIDPK>
    <LicenceNumber>PA0566/008/003</LicenceNumber>
    <ProductName>KABIMIX 11</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYCINE ACETATE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005573</DrugIDPK>
    <LicenceNumber>PA0282/048/001</LicenceNumber>
    <ProductName>MEFENAMIC ACID</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005760</DrugIDPK>
    <LicenceNumber>PA0295/006/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>AU</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1983-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005750</DrugIDPK>
    <LicenceNumber>PA0295/003/005</LicenceNumber>
    <ProductName>GLUCOSE 10%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005746</DrugIDPK>
    <LicenceNumber>PA0295/003/001</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006279</DrugIDPK>
    <LicenceNumber>PA0423/002/001A</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Ivex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005762</DrugIDPK>
    <LicenceNumber>PA0295/007/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.18%/DEXTROSE 4.0%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1983-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005741</DrugIDPK>
    <LicenceNumber>PA0295/002/005</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.45%</ProductName>
    <Strength>0.45</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005732</DrugIDPK>
    <LicenceNumber>PA0295/002/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005766</DrugIDPK>
    <LicenceNumber>PA0295/007/003</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%/DEXTROSE 5.0%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1983-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005757</DrugIDPK>
    <LicenceNumber>PA0295/005/001A</LicenceNumber>
    <ProductName>SODIUM LACTATE</ProductName>
    <Strength>1.85</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1983-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005756</DrugIDPK>
    <LicenceNumber>PA0295/004/001</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate>1980-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006276</DrugIDPK>
    <LicenceNumber>PA0423/001/001A</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ivex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004251</DrugIDPK>
    <LicenceNumber>PA0016/055/001</LicenceNumber>
    <ProductName>ALPRAZOLAM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>2000-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004252</DrugIDPK>
    <LicenceNumber>PA0016/055/002</LicenceNumber>
    <ProductName>ALPRAZOLAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>2000-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004253</DrugIDPK>
    <LicenceNumber>PA0016/055/003</LicenceNumber>
    <ProductName>ALPRAZOLAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>2000-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003425</DrugIDPK>
    <LicenceNumber>PA0077/115/001</LicenceNumber>
    <ProductName>CALCIPARINE</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010923</DrugIDPK>
    <LicenceNumber>PA0936/009/001</LicenceNumber>
    <ProductName>CAVERJECT DUAL CHAMBER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010924</DrugIDPK>
    <LicenceNumber>PA0936/009/002</LicenceNumber>
    <ProductName>CAVERJECT DUAL CHAMBER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012608</DrugIDPK>
    <LicenceNumber>PA0936/034/002</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2002-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012609</DrugIDPK>
    <LicenceNumber>PA0936/034/003</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2002-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012610</DrugIDPK>
    <LicenceNumber>PA0936/034/004</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2002-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012083</DrugIDPK>
    <LicenceNumber>PA0936/014/001</LicenceNumber>
    <ProductName>EPOGAM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012085</DrugIDPK>
    <LicenceNumber>PA0936/014/003</LicenceNumber>
    <ProductName>EPOGAM</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009161</DrugIDPK>
    <LicenceNumber>PA0012/089/001</LicenceNumber>
    <ProductName>GADOVIST</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>2000-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOBUTROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009162</DrugIDPK>
    <LicenceNumber>PA0012/089/002</LicenceNumber>
    <ProductName>GADOVIST</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOBUTROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009163</DrugIDPK>
    <LicenceNumber>PA0012/089/003</LicenceNumber>
    <ProductName>GADOVIST</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>2000-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOBUTROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007744</DrugIDPK>
    <LicenceNumber>PA0935/001/001</LicenceNumber>
    <ProductName>FSME-IMMUN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter AG</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TBE VIRUS ANTIGEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014969</DrugIDPK>
    <LicenceNumber>PA0936/071/005</LicenceNumber>
    <ProductName>SOLU-MEDRONE</ProductName>
    <Strength>62.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003100</DrugIDPK>
    <LicenceNumber>PA0778/014/001</LicenceNumber>
    <ProductName>SYNPHASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1996-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004350</DrugIDPK>
    <LicenceNumber>PA0823/010/001</LicenceNumber>
    <ProductName>CALPOL SIX PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005032</DrugIDPK>
    <LicenceNumber>PA0236/010/001</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012084</DrugIDPK>
    <LicenceNumber>PA0936/014/002</LicenceNumber>
    <ProductName>EPOGAM PAEDIATRIC</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001377</DrugIDPK>
    <LicenceNumber>PA0035/065/003</LicenceNumber>
    <ProductName>UTINOR</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1984-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016179</DrugIDPK>
    <LicenceNumber>PA1077/048/001</LicenceNumber>
    <ProductName>VENTODISKS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016180</DrugIDPK>
    <LicenceNumber>PA1077/048/002</LicenceNumber>
    <ProductName>VENTODISKS</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005609</DrugIDPK>
    <LicenceNumber>PA0285/001/001</LicenceNumber>
    <ProductName>PERGONAL</ProductName>
    <Strength>75/75 IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLICLE-STIMULATING HORMONE, HUMAN</ActiveSubstance>
      <ActiveSubstance>LUTEINISING HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009367</DrugIDPK>
    <LicenceNumber>PA0970/018/004</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016141</DrugIDPK>
    <LicenceNumber>PA1077/040/001</LicenceNumber>
    <ProductName>BECODISKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016142</DrugIDPK>
    <LicenceNumber>PA1077/040/002</LicenceNumber>
    <ProductName>BECODISKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013101</DrugIDPK>
    <LicenceNumber>PA0936/034/007</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>10mg/5ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013102</DrugIDPK>
    <LicenceNumber>PA0936/034/008</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>50mg/25ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012607</DrugIDPK>
    <LicenceNumber>PA0936/034/001</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2002-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013089</DrugIDPK>
    <LicenceNumber>PA0936/034/005</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013095</DrugIDPK>
    <LicenceNumber>PA0936/034/006</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014982</DrugIDPK>
    <LicenceNumber>PA0936/076/001</LicenceNumber>
    <ProductName>LONITEN</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOXIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014984</DrugIDPK>
    <LicenceNumber>PA0936/076/003</LicenceNumber>
    <ProductName>LONITEN</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOXIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013416</DrugIDPK>
    <LicenceNumber>PA0936/058/003</LicenceNumber>
    <ProductName>ZAVEDOS</ProductName>
    <Strength>25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2000-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IDARUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011417</DrugIDPK>
    <LicenceNumber>PA0936/013/001</LicenceNumber>
    <ProductName>DETSEL SR</ProductName>
    <Strength>2mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011418</DrugIDPK>
    <LicenceNumber>PA0936/013/002</LicenceNumber>
    <ProductName>DETSEL SR</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLTERODINE L-TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001069</DrugIDPK>
    <LicenceNumber>PA0019/024/005</LicenceNumber>
    <ProductName>FELDENE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1984-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009444</DrugIDPK>
    <LicenceNumber>PA0187/032/024</LicenceNumber>
    <ProductName>GENOTROPIN</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GROWTH HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004741</DrugIDPK>
    <LicenceNumber>PA0187/032/001</LicenceNumber>
    <ProductName>GENOTROPIN 1.3 MG</ProductName>
    <Strength>4 IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009445</DrugIDPK>
    <LicenceNumber>PA0187/032/025</LicenceNumber>
    <ProductName>GENOTROPIN KABI VIAL</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GROWTH HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000673</DrugIDPK>
    <LicenceNumber>PA0010/031/001</LicenceNumber>
    <ProductName>MONOCLATE P</ProductName>
    <Strength>250 IU/10ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1990-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000674</DrugIDPK>
    <LicenceNumber>PA0010/031/002</LicenceNumber>
    <ProductName>MONOCLATE P</ProductName>
    <Strength>500 IU/10ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1990-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000675</DrugIDPK>
    <LicenceNumber>PA0010/031/003</LicenceNumber>
    <ProductName>MONOCLATE P</ProductName>
    <Strength>1000 IU/10ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1990-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001000</DrugIDPK>
    <LicenceNumber>PA0017/101/001</LicenceNumber>
    <ProductName>EXOSURF NEONATAL</ProductName>
    <Strength>13.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1991-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv/Susp/EPulmInst</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLFOSCERIL PALMITATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001317</DrugIDPK>
    <LicenceNumber>PA0024/001/012</LicenceNumber>
    <ProductName>VENTOLIN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1989-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005768</DrugIDPK>
    <LicenceNumber>PA0185/025/002</LicenceNumber>
    <ProductName>KAPAKE INSTS 30/500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005769</DrugIDPK>
    <LicenceNumber>PA0185/025/003</LicenceNumber>
    <ProductName>KAPAKE INSTS 60/1000</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015162</DrugIDPK>
    <LicenceNumber>PA0610/009/001</LicenceNumber>
    <ProductName>VITATHONE CHILBLAIN</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1999-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004029</DrugIDPK>
    <LicenceNumber>PA0148/040/003</LicenceNumber>
    <ProductName>BETAGAN OPHTHALMIC</ProductName>
    <Strength>0.25 %w/v</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1990-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004044</DrugIDPK>
    <LicenceNumber>PA0148/015/001</LicenceNumber>
    <ProductName>PREFRIN</ProductName>
    <Strength>0.12</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1985-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016094</DrugIDPK>
    <LicenceNumber>PA0281/112/001</LicenceNumber>
    <ProductName>ACIDOPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002903</DrugIDPK>
    <LicenceNumber>PA0050/125/001</LicenceNumber>
    <ProductName>CYMEVENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GANCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004264</DrugIDPK>
    <LicenceNumber>PA0167/032/018</LicenceNumber>
    <ProductName>TRAVASEPT 100</ProductName>
    <Strength>.015/.15</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004262</DrugIDPK>
    <LicenceNumber>PA0167/032/016</LicenceNumber>
    <ProductName>TRAVASEPT 15</ProductName>
    <Strength>0.1/1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004263</DrugIDPK>
    <LicenceNumber>PA0167/032/017</LicenceNumber>
    <ProductName>TRAVASEPT 30</ProductName>
    <Strength>0.05/0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001078</DrugIDPK>
    <LicenceNumber>PA0019/030/001</LicenceNumber>
    <ProductName>TROSYL DERMAL</ProductName>
    <Strength>1 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1981-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001080</DrugIDPK>
    <LicenceNumber>PA0019/030/004</LicenceNumber>
    <ProductName>TROSYL DERMAL LOTION</ProductName>
    <Strength>1 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000878</DrugIDPK>
    <LicenceNumber>PA0019/030/005</LicenceNumber>
    <ProductName>TROSYL DERMAL PUMP SPRAY</ProductName>
    <Strength>1 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001079</DrugIDPK>
    <LicenceNumber>PA0019/030/003</LicenceNumber>
    <ProductName>TROSYL DUSTING POWER</ProductName>
    <Strength>1 %w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004391</DrugIDPK>
    <LicenceNumber>PA0281/071/001</LicenceNumber>
    <ProductName>CORTOPIN HYDROCORTISONE B.P.</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1994-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005212</DrugIDPK>
    <LicenceNumber>PA0277/063/002</LicenceNumber>
    <ProductName>LEUCOMAX</ProductName>
    <Strength>150 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005213</DrugIDPK>
    <LicenceNumber>PA0277/063/003</LicenceNumber>
    <ProductName>LEUCOMAX</ProductName>
    <Strength>400 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005217</DrugIDPK>
    <LicenceNumber>PA0277/063/006</LicenceNumber>
    <ProductName>LEUCOMAX</ProductName>
    <Strength>300 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003462</DrugIDPK>
    <LicenceNumber>PA0086/001/003</LicenceNumber>
    <ProductName>ALLBEE WITH C 300</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1984-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008273</DrugIDPK>
    <LicenceNumber>PA0711/035/001</LicenceNumber>
    <ProductName>OXYBASE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008274</DrugIDPK>
    <LicenceNumber>PA0711/035/002</LicenceNumber>
    <ProductName>OXYBASE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005794</DrugIDPK>
    <LicenceNumber>PA0544/030/001</LicenceNumber>
    <ProductName>PNEUMO 23</ProductName>
    <Strength>0.5ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1999-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 1 (1)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 2 (2)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 3 (3)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 4 (4)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 5 (5)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 26 (6B)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 51 (7F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 8 (8)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 9N</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 9V</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 34 (10A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 43 (11A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 12 (12F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 14 (14)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 54 (15B)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 17 (17F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 56 (18C)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 57 (19A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 19 (19F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 20 (20)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 22 (22F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 23 (23F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 70 (33F)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008638</DrugIDPK>
    <LicenceNumber>PA0126/103/004</LicenceNumber>
    <ProductName>CLAVAMEL PAEDIATRIC SACHETS</ProductName>
    <Strength>125/31</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016020</DrugIDPK>
    <LicenceNumber>PA1077/022/001</LicenceNumber>
    <ProductName>CO-AMOXICLAV DUO SACHETS</ProductName>
    <Strength>200, 28</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016019</DrugIDPK>
    <LicenceNumber>PA1077/021/003</LicenceNumber>
    <ProductName>CO-AMOXICLAV PAEDIATRIC SACHET</ProductName>
    <Strength>125/31</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001887</DrugIDPK>
    <LicenceNumber>PA0040/017/001</LicenceNumber>
    <ProductName>INTRAVAL SODIUM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPENTAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001705</DrugIDPK>
    <LicenceNumber>PA0040/001/002</LicenceNumber>
    <ProductName>SECTRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1975-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEBUTOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001707</DrugIDPK>
    <LicenceNumber>PA0040/001/003</LicenceNumber>
    <ProductName>SECTRAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1976-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEBUTOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002908</DrugIDPK>
    <LicenceNumber>PA0060/023/002</LicenceNumber>
    <ProductName>POLIOMYELITIS VACCINE LIVE (ORAL)</ProductName>
    <Strength>6.0/5.0/5.5</Strength>
    <StrengthMeasurement>Log10 TCID50</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1978-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 2</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017964</DrugIDPK>
    <LicenceNumber>PA0771/006/003</LicenceNumber>
    <ProductName>TAMOFEN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2001-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017965</DrugIDPK>
    <LicenceNumber>PA0771/006/004</LicenceNumber>
    <ProductName>TAMOFEN</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate>2001-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005287</DrugIDPK>
    <LicenceNumber>PA0281/015/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005288</DrugIDPK>
    <LicenceNumber>PA0281/015/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004294</DrugIDPK>
    <LicenceNumber>PA0167/037/005</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006128</DrugIDPK>
    <LicenceNumber>PA0408/032/001</LicenceNumber>
    <ProductName>RIMAFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006129</DrugIDPK>
    <LicenceNumber>PA0408/032/002</LicenceNumber>
    <ProductName>RIMAFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006136</DrugIDPK>
    <LicenceNumber>PA0408/037/001</LicenceNumber>
    <ProductName>RIMAFLOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006137</DrugIDPK>
    <LicenceNumber>PA0408/037/002</LicenceNumber>
    <ProductName>RIMAFLOX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004289</DrugIDPK>
    <LicenceNumber>PA0167/037/001</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006572</DrugIDPK>
    <LicenceNumber>PA0484/001/001</LicenceNumber>
    <ProductName>BONFIELDS HYDROCORTISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1989-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007535</DrugIDPK>
    <LicenceNumber>PA0483/004/001</LicenceNumber>
    <ProductName>STERETS CHLORHEXIDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seton Prebbles Ltd</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004654</DrugIDPK>
    <LicenceNumber>PA0748/012/005</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>300 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1997-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004655</DrugIDPK>
    <LicenceNumber>PA0748/012/006</LicenceNumber>
    <ProductName>TOPAMAX</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1997-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002770</DrugIDPK>
    <LicenceNumber>PA0038/058/002</LicenceNumber>
    <ProductName>CALCIJEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001881</DrugIDPK>
    <LicenceNumber>PA0038/058/001</LicenceNumber>
    <ProductName>CALCIJEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006783</DrugIDPK>
    <LicenceNumber>PA0544/001/001</LicenceNumber>
    <ProductName>ADSORBED TETANUS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005513</DrugIDPK>
    <LicenceNumber>PA0282/027/001</LicenceNumber>
    <ProductName>AMILCO</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006471</DrugIDPK>
    <LicenceNumber>PA0468/016/003</LicenceNumber>
    <ProductName>MAALOX TC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006784</DrugIDPK>
    <LicenceNumber>PA0544/001/002</LicenceNumber>
    <ProductName>ADSORBED TETANUS SYRINGE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010174</DrugIDPK>
    <LicenceNumber>PA0484/022/001</LicenceNumber>
    <ProductName>EPSOM SALTS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015825</DrugIDPK>
    <LicenceNumber>PA1077/016/007</LicenceNumber>
    <ProductName>ZOFRAN</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003477</DrugIDPK>
    <LicenceNumber>PA0086/013/001</LicenceNumber>
    <ProductName>DIMOTANE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003478</DrugIDPK>
    <LicenceNumber>PA0086/013/002</LicenceNumber>
    <ProductName>DIMOTANE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004397</DrugIDPK>
    <LicenceNumber>PA0167/067/009</LicenceNumber>
    <ProductName>HEPARIN SODIUM BP 20000</ProductName>
    <Strength>20000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004393</DrugIDPK>
    <LicenceNumber>PA0167/067/005</LicenceNumber>
    <ProductName>HEPARIN SODIUM BP 2500</ProductName>
    <Strength>2500000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004399</DrugIDPK>
    <LicenceNumber>PA0167/067/011</LicenceNumber>
    <ProductName>HEPARIN SODIUM BP 25000</ProductName>
    <Strength>25000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004401</DrugIDPK>
    <LicenceNumber>PA0167/067/013</LicenceNumber>
    <ProductName>HEPARIN SODIUM BP 75000</ProductName>
    <Strength>75000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004395</DrugIDPK>
    <LicenceNumber>PA0167/067/007</LicenceNumber>
    <ProductName>HEPARIN SODIUM BP 5000</ProductName>
    <Strength>5000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011248</DrugIDPK>
    <LicenceNumber>PA0540/095/001</LicenceNumber>
    <ProductName>CALSYNAR</ProductName>
    <Strength>100IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011249</DrugIDPK>
    <LicenceNumber>PA0540/095/002</LicenceNumber>
    <ProductName>CALSYNAR</ProductName>
    <Strength>200IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004640</DrugIDPK>
    <LicenceNumber>PA0187/014/002</LicenceNumber>
    <ProductName>CETIPRIN NOVUM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM CARRAGEENATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005419</DrugIDPK>
    <LicenceNumber>PA0277/018/005</LicenceNumber>
    <ProductName>PILOCARPINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014974</DrugIDPK>
    <LicenceNumber>PA0936/072/006</LicenceNumber>
    <ProductName>PROVERA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-12-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010945</DrugIDPK>
    <LicenceNumber>PA0540/065/001</LicenceNumber>
    <ProductName>RELEFACT LH-RH</ProductName>
    <Strength>0/1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GONADORELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007863</DrugIDPK>
    <LicenceNumber>PA0748/033/003</LicenceNumber>
    <ProductName>RETIN-A LOTION</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001322</DrugIDPK>
    <LicenceNumber>PA0024/005/002</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001323</DrugIDPK>
    <LicenceNumber>PA0024/005/003</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010098</DrugIDPK>
    <LicenceNumber>PA0016/004/003</LicenceNumber>
    <ProductName>COLESTID</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010167</DrugIDPK>
    <LicenceNumber>PA0016/004/002</LicenceNumber>
    <ProductName>COLESTID ORANGE</ProductName>
    <Strength>5g</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLESTIPOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006775</DrugIDPK>
    <LicenceNumber>PA0711/011/007</LicenceNumber>
    <ProductName>NIFED RETARD</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006453</DrugIDPK>
    <LicenceNumber>PA0468/004/003</LicenceNumber>
    <ProductName>FRUMIL DOUBLE STRENGTH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001991</DrugIDPK>
    <LicenceNumber>PA0040/070/006</LicenceNumber>
    <ProductName>ORUVAIL 150</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1994-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004514</DrugIDPK>
    <LicenceNumber>PA0178/006/001</LicenceNumber>
    <ProductName>GYNOFLOR E</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRIOL</ActiveSubstance>
      <ActiveSubstance>LACTOBACILLUS ACIDOPHILUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006528</DrugIDPK>
    <LicenceNumber>PA0469/002/001</LicenceNumber>
    <ProductName>HYDROCAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1989-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016305</DrugIDPK>
    <LicenceNumber>PA1077/091/002</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005287</DrugIDPK>
    <LicenceNumber>PA0050/137/002</LicenceNumber>
    <ProductName>CAL-D-VITA CHEWABLE</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005286</DrugIDPK>
    <LicenceNumber>PA0050/137/001</LicenceNumber>
    <ProductName>CAL-D-VITA EFFERVESCENT</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002922</DrugIDPK>
    <LicenceNumber>PA0057/062/002</LicenceNumber>
    <ProductName>MINITRAN 10</ProductName>
    <Strength>36</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1994-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002923</DrugIDPK>
    <LicenceNumber>PA0057/062/003</LicenceNumber>
    <ProductName>MINITRAN 15</ProductName>
    <Strength>54</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1994-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002920</DrugIDPK>
    <LicenceNumber>PA0057/062/001</LicenceNumber>
    <ProductName>MINITRAN 5</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1994-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010920</DrugIDPK>
    <LicenceNumber>PA0437/046/001</LicenceNumber>
    <ProductName>MIDAZOLAM INJECTION</ProductName>
    <Strength>1mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010921</DrugIDPK>
    <LicenceNumber>PA0437/046/002</LicenceNumber>
    <ProductName>MIDAZOLAM INJECTION</ProductName>
    <Strength>1mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010922</DrugIDPK>
    <LicenceNumber>PA0437/046/003</LicenceNumber>
    <ProductName>MIDAZOLAM INJECTION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009287</DrugIDPK>
    <LicenceNumber>PA0566/019/006</LicenceNumber>
    <ProductName>INTRALIPID 30%</ProductName>
    <Strength>75g/250ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009289</DrugIDPK>
    <LicenceNumber>PA0566/019/008</LicenceNumber>
    <ProductName>INTRALIPID 30%</ProductName>
    <Strength>150g/500ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009290</DrugIDPK>
    <LicenceNumber>PA0566/019/009</LicenceNumber>
    <ProductName>INTRALIPID 30%</ProductName>
    <Strength>300/1000</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014035</DrugIDPK>
    <LicenceNumber>PA0934/001/001</LicenceNumber>
    <ProductName>NALTREXIN</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AOP Orphan Pharmaceuticals AG</PAHolder>
    <AuthorisedDate>2004-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALTREXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017017</DrugIDPK>
    <LicenceNumber>PA0172/036/002</LicenceNumber>
    <ProductName>INFRA-RUB</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004454</DrugIDPK>
    <LicenceNumber>PA0172/004/004</LicenceNumber>
    <ProductName>SOLUBLE ANADIN</ProductName>
    <Strength>325/30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1980-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003846</DrugIDPK>
    <LicenceNumber>PA0126/028/001</LicenceNumber>
    <ProductName>TIPERAL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008841</DrugIDPK>
    <LicenceNumber>PA0899/010/001</LicenceNumber>
    <ProductName>DYSPAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1999-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003449</DrugIDPK>
    <LicenceNumber>PA0077/003/002</LicenceNumber>
    <ProductName>HEXOPAL FORTE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSITOL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000940</DrugIDPK>
    <LicenceNumber>PA0019/044/003</LicenceNumber>
    <ProductName>DIFLUCAN</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001070</DrugIDPK>
    <LicenceNumber>PA0019/024/006</LicenceNumber>
    <ProductName>FELDENE DISPERSIBLE</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1985-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001071</DrugIDPK>
    <LicenceNumber>PA0019/024/007</LicenceNumber>
    <ProductName>FELDENE DISPERSIBLE</ProductName>
    <Strength>20 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1985-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001073</DrugIDPK>
    <LicenceNumber>PA0019/024/009</LicenceNumber>
    <ProductName>FELDENE IM</ProductName>
    <Strength>20 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008180</DrugIDPK>
    <LicenceNumber>PA0019/024/011</LicenceNumber>
    <ProductName>FELDENE MELT</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008182</DrugIDPK>
    <LicenceNumber>PA0019/024/012</LicenceNumber>
    <ProductName>FELDENE MELT</ProductName>
    <Strength>20 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007814</DrugIDPK>
    <LicenceNumber>PA0822/001/007</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>20 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000076</DrugIDPK>
    <LicenceNumber>PA0019/013/008</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1994-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000077</DrugIDPK>
    <LicenceNumber>PA0019/013/009</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1994-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006440</DrugIDPK>
    <LicenceNumber>PA0437/018/001</LicenceNumber>
    <ProductName>METHYLPREDNISOLONE SODIUM SUCCINATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1989-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006441</DrugIDPK>
    <LicenceNumber>PA0437/018/002</LicenceNumber>
    <ProductName>METHYLPREDNISOLONE SODIUM SUCCINATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1989-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000772</DrugIDPK>
    <LicenceNumber>PA0016/025/003</LicenceNumber>
    <ProductName>CYTOSAR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015120</DrugIDPK>
    <LicenceNumber>PA0936/009/006</LicenceNumber>
    <ProductName>CAVERJECT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005318</DrugIDPK>
    <LicenceNumber>PA0281/036/003</LicenceNumber>
    <ProductName>PINAMOX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1988-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008078</DrugIDPK>
    <LicenceNumber>PA0050/143/001</LicenceNumber>
    <ProductName>BEROCCA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>2000-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006121</DrugIDPK>
    <LicenceNumber>PA0408/023/001</LicenceNumber>
    <ProductName>COMPOUND MAGNESIUM TRISILICATE</ProductName>
    <Strength>250/120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1994-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002875</DrugIDPK>
    <LicenceNumber>PA0778/004/003</LicenceNumber>
    <ProductName>CYTOTEC</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1994-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MISOPROSTOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010034</DrugIDPK>
    <LicenceNumber>PA0013/098/001</LicenceNumber>
    <ProductName>RIAMET</ProductName>
    <Strength>20mg/120mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2002-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARTEMETHER</ActiveSubstance>
      <ActiveSubstance>LUMEFANTRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016202</DrugIDPK>
    <LicenceNumber>PA1077/051/003</LicenceNumber>
    <ProductName>ALKERAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPHALAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005291</DrugIDPK>
    <LicenceNumber>PA0743/008/001</LicenceNumber>
    <ProductName>IOPAMIDOL IODINE/ML</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005292</DrugIDPK>
    <LicenceNumber>PA0743/008/002</LicenceNumber>
    <ProductName>IOPAMIDOL IODINE/ML</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005293</DrugIDPK>
    <LicenceNumber>PA0743/008/003</LicenceNumber>
    <ProductName>IOPAMIDOL IODINE/ML</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005294</DrugIDPK>
    <LicenceNumber>PA0743/008/004</LicenceNumber>
    <ProductName>IOPAMIDOL IODINE/ML</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001839</DrugIDPK>
    <LicenceNumber>PA0035/051/001</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016203</DrugIDPK>
    <LicenceNumber>PA1077/051/001</LicenceNumber>
    <ProductName>ALKERAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPHALAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001568</DrugIDPK>
    <LicenceNumber>PA0037/050/001</LicenceNumber>
    <ProductName>ARTANE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIHEXYPHENIDYL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001569</DrugIDPK>
    <LicenceNumber>PA0037/050/002</LicenceNumber>
    <ProductName>ARTANE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIHEXYPHENIDYL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001822</DrugIDPK>
    <LicenceNumber>PA0035/044/005</LicenceNumber>
    <ProductName>BLOCADREN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013866</DrugIDPK>
    <LicenceNumber>PA0970/036/007</LicenceNumber>
    <ProductName>BRICANYL</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013864</DrugIDPK>
    <LicenceNumber>PA0970/036/005</LicenceNumber>
    <ProductName>BRICANYL SPACER INHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001826</DrugIDPK>
    <LicenceNumber>PA0035/046/001</LicenceNumber>
    <ProductName>COGENTIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZATROPINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000770</DrugIDPK>
    <LicenceNumber>PA0016/025/001</LicenceNumber>
    <ProductName>CYTOSAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003894</DrugIDPK>
    <LicenceNumber>PA0809/002/001</LicenceNumber>
    <ProductName>DEBRISOQUINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lifehealth Limited</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEBRISOQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004460</DrugIDPK>
    <LicenceNumber>PA0172/007/001</LicenceNumber>
    <ProductName>DRISTAN NASAL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005650</DrugIDPK>
    <LicenceNumber>PA0290/004/001</LicenceNumber>
    <ProductName>ISOPTO ATROPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005649</DrugIDPK>
    <LicenceNumber>PA0290/003/001</LicenceNumber>
    <ProductName>ISOPTO CARBACHOL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBACHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005648</DrugIDPK>
    <LicenceNumber>PA0290/001/001</LicenceNumber>
    <ProductName>ISOPTO FRIN</ProductName>
    <Strength>0.12</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016245</DrugIDPK>
    <LicenceNumber>PA1077/065/002</LicenceNumber>
    <ProductName>LEUKERAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMBUCIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003788</DrugIDPK>
    <LicenceNumber>PA0118/014/002</LicenceNumber>
    <ProductName>MINIMS HOMATROPINE HYDROBROMIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HOMATROPINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003791</DrugIDPK>
    <LicenceNumber>PA0118/017/001</LicenceNumber>
    <ProductName>MINIMS PILOCARPINE NITRATE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001190</DrugIDPK>
    <LicenceNumber>PA0022/020/001</LicenceNumber>
    <ProductName>MUCAINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1974-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXETACAINE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016250</DrugIDPK>
    <LicenceNumber>PA1077/070/001</LicenceNumber>
    <ProductName>MYLERAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSULFAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014920</DrugIDPK>
    <LicenceNumber>PA0936/062/004</LicenceNumber>
    <ProductName>PROSTIN E2</ProductName>
    <Strength>10 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DINOPROSTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004173</DrugIDPK>
    <LicenceNumber>PA0017/055/001</LicenceNumber>
    <ProductName>VASOXINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995018135</DrugIDPK>
    <LicenceNumber>PA0844/003/001</LicenceNumber>
    <ProductName>ANAPOLON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cambridge Laboratories Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETHOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011314</DrugIDPK>
    <LicenceNumber>PA1009/011/002</LicenceNumber>
    <ProductName>CHORAGON 5000 U AND CHORAGON SOLVENT</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013869</DrugIDPK>
    <LicenceNumber>PA0970/039/001</LicenceNumber>
    <ProductName>ENTOCORT CR</ProductName>
    <Strength>2.25mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2001-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012159</DrugIDPK>
    <LicenceNumber>PA1022/003/002</LicenceNumber>
    <ProductName>IOMERON 250</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bracco UK Limited</PAHolder>
    <AuthorisedDate>1999-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOMEPROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000021</DrugIDPK>
    <LicenceNumber>PA0281/028/003</LicenceNumber>
    <ProductName>NAPREX ENTERIC COATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000022</DrugIDPK>
    <LicenceNumber>PA0281/028/004</LicenceNumber>
    <ProductName>NAPREX ENTERIC COATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008546</DrugIDPK>
    <LicenceNumber>PA0281/092/003</LicenceNumber>
    <ProductName>PINAMET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005316</DrugIDPK>
    <LicenceNumber>PA0281/036/001</LicenceNumber>
    <ProductName>PINAMOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1985-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005317</DrugIDPK>
    <LicenceNumber>PA0281/036/002</LicenceNumber>
    <ProductName>PINAMOX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1985-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009142</DrugIDPK>
    <LicenceNumber>PA0281/060/001</LicenceNumber>
    <ProductName>TEMAZINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009144</DrugIDPK>
    <LicenceNumber>PA0281/060/002</LicenceNumber>
    <ProductName>TEMAZINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008253</DrugIDPK>
    <LicenceNumber>PA0281/084/001</LicenceNumber>
    <ProductName>TENCHLOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008254</DrugIDPK>
    <LicenceNumber>PA0281/084/002</LicenceNumber>
    <ProductName>TENCHLOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003094</DrugIDPK>
    <LicenceNumber>PA0062/026/011</LicenceNumber>
    <ProductName>FLEMOXIN SOLUTABS</ProductName>
    <Strength>125 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003095</DrugIDPK>
    <LicenceNumber>PA0062/026/012</LicenceNumber>
    <ProductName>FLEMOXIN SOLUTABS</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003126</DrugIDPK>
    <LicenceNumber>PA0062/026/013</LicenceNumber>
    <ProductName>FLEMOXIN SOLUTABS</ProductName>
    <Strength>375 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003128</DrugIDPK>
    <LicenceNumber>PA0062/026/014</LicenceNumber>
    <ProductName>FLEMOXIN SOLUTABS</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003130</DrugIDPK>
    <LicenceNumber>PA0062/026/015</LicenceNumber>
    <ProductName>FLEMOXIN SOLUTABS</ProductName>
    <Strength>750 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003134</DrugIDPK>
    <LicenceNumber>PA0062/026/016</LicenceNumber>
    <ProductName>FLEMOXIN SOLUTABS</ProductName>
    <Strength>1000 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002182</DrugIDPK>
    <LicenceNumber>PA0046/035/001</LicenceNumber>
    <ProductName>MINIHEP SYRINGES</ProductName>
    <Strength>2500</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003346</DrugIDPK>
    <LicenceNumber>PA0077/002/001</LicenceNumber>
    <ProductName>DANOL</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003347</DrugIDPK>
    <LicenceNumber>PA0077/002/002</LicenceNumber>
    <ProductName>DANOL</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005170</DrugIDPK>
    <LicenceNumber>PA0257/012/001</LicenceNumber>
    <ProductName>TOP C</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005068</DrugIDPK>
    <LicenceNumber>PA0013/087/009</LicenceNumber>
    <ProductName>VOLTAROL OPHTHA</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015840</DrugIDPK>
    <LicenceNumber>PA1077/019/001</LicenceNumber>
    <ProductName>AUGMENTIN DUO SACHETS</ProductName>
    <Strength>228.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003827</DrugIDPK>
    <LicenceNumber>PA0711/021/001</LicenceNumber>
    <ProductName>CEC</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003828</DrugIDPK>
    <LicenceNumber>PA0711/021/002</LicenceNumber>
    <ProductName>CEC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008877</DrugIDPK>
    <LicenceNumber>PA0677/004/001</LicenceNumber>
    <ProductName>HEMATOCIS KIT FOR LABELLING RED BLOOD CELLS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PYROPHOSPHATE DECAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000392</DrugIDPK>
    <LicenceNumber>PA0677/014/001</LicenceNumber>
    <ProductName>PHYTACIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PHYTATE</ActiveSubstance>
      <ActiveSubstance>STANNOUS CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016169</DrugIDPK>
    <LicenceNumber>PA1077/045/001</LicenceNumber>
    <ProductName>RESPIRONTIN NEBULES</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008886</DrugIDPK>
    <LicenceNumber>PA0677/011/001</LicenceNumber>
    <ProductName>THALLIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THALLOUS CHLORIDE (201 TL)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004324</DrugIDPK>
    <LicenceNumber>PA0167/042/001</LicenceNumber>
    <ProductName>DIANEAL WITH GLUCOSE 1.36 %</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007930</DrugIDPK>
    <LicenceNumber>PA0566/011/001</LicenceNumber>
    <ProductName>VAMIN 9</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1996-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE HEPTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004810</DrugIDPK>
    <LicenceNumber>PA0212/003/004</LicenceNumber>
    <ProductName>GAMMABULIN LYOPHILISED</ProductName>
    <Strength>320mg/2ml</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN  &gt;90% GAMMA GLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014973</DrugIDPK>
    <LicenceNumber>PA0936/072/005</LicenceNumber>
    <ProductName>PROVERA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002415</DrugIDPK>
    <LicenceNumber>PA0172/027/001</LicenceNumber>
    <ProductName>AXID AP</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIZATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016794</DrugIDPK>
    <LicenceNumber>PA0970/058/001</LicenceNumber>
    <ProductName>ROSUVASTATIN ASTRAZENECA</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2003-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016795</DrugIDPK>
    <LicenceNumber>PA0970/058/002</LicenceNumber>
    <ProductName>ROSUVASTATIN ASTRAZENECA</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2003-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016796</DrugIDPK>
    <LicenceNumber>PA0970/058/003</LicenceNumber>
    <ProductName>ROSUVASTATIN ASTRAZENECA</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2003-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010305</DrugIDPK>
    <LicenceNumber>PA0819/009/001</LicenceNumber>
    <ProductName>LISINOPRIL-RATIO</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010306</DrugIDPK>
    <LicenceNumber>PA0819/009/002</LicenceNumber>
    <ProductName>LISINOPRIL-RATIO</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010307</DrugIDPK>
    <LicenceNumber>PA0819/009/003</LicenceNumber>
    <ProductName>LISINOPRIL-RATIO</ProductName>
    <Strength>10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013924</DrugIDPK>
    <LicenceNumber>PA0970/055/001</LicenceNumber>
    <ProductName>XYLOCARD</ProductName>
    <Strength>100/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003256</DrugIDPK>
    <LicenceNumber>PA0073/109/001</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>Mg/Ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1989-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003260</DrugIDPK>
    <LicenceNumber>PA0073/109/002</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1989-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005302</DrugIDPK>
    <LicenceNumber>PA0281/026/001</LicenceNumber>
    <ProductName>PRIMACINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016344</DrugIDPK>
    <LicenceNumber>PA1077/096/003</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004550</DrugIDPK>
    <LicenceNumber>PA0013/079/001</LicenceNumber>
    <ProductName>DIOVAN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1996-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004551</DrugIDPK>
    <LicenceNumber>PA0013/079/002</LicenceNumber>
    <ProductName>DIOVAN</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1996-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004532</DrugIDPK>
    <LicenceNumber>PA0013/070/004</LicenceNumber>
    <ProductName>ESTRADERM MX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004533</DrugIDPK>
    <LicenceNumber>PA0013/070/005</LicenceNumber>
    <ProductName>ESTRADERM MX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004534</DrugIDPK>
    <LicenceNumber>PA0013/070/006</LicenceNumber>
    <ProductName>ESTRADERM MX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006338</DrugIDPK>
    <LicenceNumber>PA0904/001/001</LicenceNumber>
    <ProductName>PRIMEDOL PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Murphy Healthcare Ireland Ltd.,</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001397</DrugIDPK>
    <LicenceNumber>PA0035/077/001</LicenceNumber>
    <ProductName>NOROXIN</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1994-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001994</DrugIDPK>
    <LicenceNumber>PA0040/071/002</LicenceNumber>
    <ProductName>NOZINAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1989-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTRIMEPRAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016341</DrugIDPK>
    <LicenceNumber>PA1077/096/001</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016342</DrugIDPK>
    <LicenceNumber>PA1077/096/002</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006675</DrugIDPK>
    <LicenceNumber>PA0043/034/001</LicenceNumber>
    <ProductName>EMZOL</ProductName>
    <Strength>2 % w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003027</DrugIDPK>
    <LicenceNumber>PA0060/042/001</LicenceNumber>
    <ProductName>ERVEVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1985-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003483</DrugIDPK>
    <LicenceNumber>PA0590/011/001</LicenceNumber>
    <ProductName>ERYACNE 2</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003484</DrugIDPK>
    <LicenceNumber>PA0590/011/002</LicenceNumber>
    <ProductName>ERYACNE 4</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011061</DrugIDPK>
    <LicenceNumber>PA0540/074/003</LicenceNumber>
    <ProductName>SUPREFACT DEPOT 3 MONTHS</ProductName>
    <Strength>9.9</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSERELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008360</DrugIDPK>
    <LicenceNumber>PA0872/003/001</LicenceNumber>
    <ProductName>CORLOPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Elan Pharma International Ltd</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOLDOPAM MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005651</DrugIDPK>
    <LicenceNumber>PA0290/005/001</LicenceNumber>
    <ProductName>BSS (BALANCED SALT SOLUTION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010998</DrugIDPK>
    <LicenceNumber>PA0785/003/003</LicenceNumber>
    <ProductName>GAMBROSOL 10H/4.0% GLUCOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Gambro Lundia AB</PAHolder>
    <AuthorisedDate>1999-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010996</DrugIDPK>
    <LicenceNumber>PA0785/003/001</LicenceNumber>
    <ProductName>GAMBROSOL 10L/1.5% GLUCOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Gambro Lundia AB</PAHolder>
    <AuthorisedDate>1999-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010997</DrugIDPK>
    <LicenceNumber>PA0785/003/002</LicenceNumber>
    <ProductName>GAMBROSOL 10M/2.5% GLUCOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Gambro Lundia AB</PAHolder>
    <AuthorisedDate>1999-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004832</DrugIDPK>
    <LicenceNumber>PA0218/025/003</LicenceNumber>
    <ProductName>ACTRAPID NOVOLET</ProductName>
    <Strength>150/1.5</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004831</DrugIDPK>
    <LicenceNumber>PA0218/025/002</LicenceNumber>
    <ProductName>ACTRAPID PENFILL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004837</DrugIDPK>
    <LicenceNumber>PA0218/026/003</LicenceNumber>
    <ProductName>INSULATARD NOVOLET</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004836</DrugIDPK>
    <LicenceNumber>PA0218/026/002</LicenceNumber>
    <ProductName>INSULATARD PENFILL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009300</DrugIDPK>
    <LicenceNumber>PA0218/033/002</LicenceNumber>
    <ProductName>MIXTARD 10 PENFILL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1990-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009117</DrugIDPK>
    <LicenceNumber>PA0218/034/002</LicenceNumber>
    <ProductName>MIXTARD 20 PENFILL 1.5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1990-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009293</DrugIDPK>
    <LicenceNumber>PA0218/029/003</LicenceNumber>
    <ProductName>MIXTARD 30 NOVOLET 1.5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009291</DrugIDPK>
    <LicenceNumber>PA0218/029/002</LicenceNumber>
    <ProductName>MIXTARD 30 PENFILL 1.5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1989-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016437</DrugIDPK>
    <LicenceNumber>PA0218/035/002</LicenceNumber>
    <ProductName>MIXTARD 40 PENFILL 1.5ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1990-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004869</DrugIDPK>
    <LicenceNumber>PA0218/036/001</LicenceNumber>
    <ProductName>MIXTARD 50</ProductName>
    <Strength>1000/10</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1996-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016434</DrugIDPK>
    <LicenceNumber>PA0218/036/002</LicenceNumber>
    <ProductName>MIXTARD 50 PENFILL 1.5ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1996-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006387</DrugIDPK>
    <LicenceNumber>PPA0465/017/002A</LicenceNumber>
    <ProductName>ZYLORIC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007195</DrugIDPK>
    <LicenceNumber>PA0436/012/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007196</DrugIDPK>
    <LicenceNumber>PA0436/012/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007197</DrugIDPK>
    <LicenceNumber>PA0436/012/003</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001656</DrugIDPK>
    <LicenceNumber>PA0038/016/001</LicenceNumber>
    <ProductName>HARMOGEN</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROPIPATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012213</DrugIDPK>
    <LicenceNumber>PA0038/086/001</LicenceNumber>
    <ProductName>NIAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000411</DrugIDPK>
    <LicenceNumber>PA0007/001/005</LicenceNumber>
    <ProductName>MEXITIL PL PERLONGETS</ProductName>
    <Strength>360</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1981-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEXILETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003302</DrugIDPK>
    <LicenceNumber>PA0073/133/003</LicenceNumber>
    <ProductName>VOLOGEN RETARD</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003231</DrugIDPK>
    <LicenceNumber>PA0073/103/001</LicenceNumber>
    <ProductName>BUPIVACAINE &amp; ADRENALINE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1989-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE, MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003374</DrugIDPK>
    <LicenceNumber>PA0077/046/001</LicenceNumber>
    <ProductName>PYROGASTRONE</ProductName>
    <Strength>20/240/60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBENOXOLONE SODIUM</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014811</DrugIDPK>
    <LicenceNumber>PPA0465/008/001B</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010244</DrugIDPK>
    <LicenceNumber>PPA0465/068/003A</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010245</DrugIDPK>
    <LicenceNumber>PPA0465/068/003B</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015479</DrugIDPK>
    <LicenceNumber>PPA0465/092/001A</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015480</DrugIDPK>
    <LicenceNumber>PPA0465/092/002A</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015481</DrugIDPK>
    <LicenceNumber>PPA0465/092/003A</LicenceNumber>
    <ProductName>LAMICTAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012100</DrugIDPK>
    <LicenceNumber>EU/1/02/242/1-24</LicenceNumber>
    <ProductName>VALDYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Enterprises S.A.</PAHolder>
    <AuthorisedDate>2003-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VALDECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010354</DrugIDPK>
    <LicenceNumber>EU/1/02/208/001</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARECOXIB SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015580</DrugIDPK>
    <LicenceNumber>EU/1/02/208/002</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015581</DrugIDPK>
    <LicenceNumber>EU/1/02/208/003</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015582</DrugIDPK>
    <LicenceNumber>EU/1/02/208/004</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015583</DrugIDPK>
    <LicenceNumber>EU/1/02/208/005</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015584</DrugIDPK>
    <LicenceNumber>EU/1/02/208/006</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015585</DrugIDPK>
    <LicenceNumber>EU/1/02/208/007</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015586</DrugIDPK>
    <LicenceNumber>EU/1/02/208/008</LicenceNumber>
    <ProductName>XAPIT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003838</DrugIDPK>
    <LicenceNumber>PA0126/025/002</LicenceNumber>
    <ProductName>MELZINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003840</DrugIDPK>
    <LicenceNumber>PA0126/025/004</LicenceNumber>
    <ProductName>MELZINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001401</DrugIDPK>
    <LicenceNumber>PA0073/138/001</LicenceNumber>
    <ProductName>FEMPLAN - MA .</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017016</DrugIDPK>
    <LicenceNumber>PA0172/036/001</LicenceNumber>
    <ProductName>INFRA-RUB PAIN RELIEVING</ProductName>
    <Strength>3.17%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1999-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005394</DrugIDPK>
    <LicenceNumber>PA0277/001/001</LicenceNumber>
    <ProductName>OPTIMINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005964</DrugIDPK>
    <LicenceNumber>PA0743/009/001</LicenceNumber>
    <ProductName>URIMIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1999-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007014</DrugIDPK>
    <LicenceNumber>PA0549/008/001</LicenceNumber>
    <ProductName>ETIPROFEN SR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2004-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006260</DrugIDPK>
    <LicenceNumber>PA0454/001/001</LicenceNumber>
    <ProductName>OSPEXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Biochem Ltd</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006267</DrugIDPK>
    <LicenceNumber>PA0454/001/004</LicenceNumber>
    <ProductName>OSPEXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forum Products Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006268</DrugIDPK>
    <LicenceNumber>PA0454/001/005</LicenceNumber>
    <ProductName>OSPEXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forum Products Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006264</DrugIDPK>
    <LicenceNumber>PA0454/001/003</LicenceNumber>
    <ProductName>OSPEXIN GRANULES FOR CEPHALEXIN MIXTURE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Forum Products Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006262</DrugIDPK>
    <LicenceNumber>PA0454/001/002</LicenceNumber>
    <ProductName>OSPEXIN GRANULES FOR CEPHALEXIN MIXTURE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Forum Products Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005576</DrugIDPK>
    <LicenceNumber>PA0795/001/001</LicenceNumber>
    <ProductName>BECLOMET EASYHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>1998-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009204</DrugIDPK>
    <LicenceNumber>PA0795/001/002</LicenceNumber>
    <ProductName>BECLOMET EASYHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009205</DrugIDPK>
    <LicenceNumber>PA0795/001/003</LicenceNumber>
    <ProductName>BECLOMET EASYHALER</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2001-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003956</DrugIDPK>
    <LicenceNumber>PA0126/088/001</LicenceNumber>
    <ProductName>CLONILIX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1994-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005681</DrugIDPK>
    <LicenceNumber>PA0290/062/001</LicenceNumber>
    <ProductName>FLAREX</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1989-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROMETHOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008473</DrugIDPK>
    <LicenceNumber>PA0002/062/001</LicenceNumber>
    <ProductName>MAXIPIME</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFEPIME DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008475</DrugIDPK>
    <LicenceNumber>PA0002/062/002</LicenceNumber>
    <ProductName>MAXIPIME</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFEPIME DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008478</DrugIDPK>
    <LicenceNumber>PA0002/062/003</LicenceNumber>
    <ProductName>MAXIPIME</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFEPIME DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005007</DrugIDPK>
    <LicenceNumber>PA0848/001/001</LicenceNumber>
    <ProductName>IBUTOP</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Dolorgiet GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016205</DrugIDPK>
    <LicenceNumber>PA1077/053/001</LicenceNumber>
    <ProductName>BRETYLATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRETYLIUM TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016442</DrugIDPK>
    <LicenceNumber>PA0303/025/002</LicenceNumber>
    <ProductName>ALPROX</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1995-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000598</DrugIDPK>
    <LicenceNumber>PA0303/032/001</LicenceNumber>
    <ProductName>BUVENTOL EASYHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000599</DrugIDPK>
    <LicenceNumber>PA0303/032/002</LicenceNumber>
    <ProductName>BUVENTOL EASYHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004562</DrugIDPK>
    <LicenceNumber>PA0184/007/001</LicenceNumber>
    <ProductName>MRS CULLENS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cullen and Davison Limited</PAHolder>
    <AuthorisedDate>1993-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009441</DrugIDPK>
    <LicenceNumber>PA0795/003/001</LicenceNumber>
    <ProductName>DIVISEQ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001482</DrugIDPK>
    <LicenceNumber>PA0037/023/010</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002347</DrugIDPK>
    <LicenceNumber>PA0048/014/003</LicenceNumber>
    <ProductName>ULTRACEF</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Base mg/5ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFADROXIL MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002348</DrugIDPK>
    <LicenceNumber>PA0048/014/004</LicenceNumber>
    <ProductName>ULTRACEF</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base mg/5ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFADROXIL MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011645</DrugIDPK>
    <LicenceNumber>PA0013/108/001</LicenceNumber>
    <ProductName>PENCICLOVIR INTRAVENOUS</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011646</DrugIDPK>
    <LicenceNumber>PA0013/108/002</LicenceNumber>
    <ProductName>PENCICLOVIR INTRAVENOUS</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005624</DrugIDPK>
    <LicenceNumber>PA0285/004/002</LicenceNumber>
    <ProductName>METRODIN HIGH PURITY /0.9% NACL</ProductName>
    <Strength>75 iu</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1993-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UROFOLLITROPIN</ActiveSubstance>
      <ActiveSubstance>FOLLICLE-STIMULATING HORMONE, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005626</DrugIDPK>
    <LicenceNumber>PA0285/004/003</LicenceNumber>
    <ProductName>METRODIN HIGH PURITY/0.9% NACL</ProductName>
    <Strength>150 iu</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1993-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UROFOLLITROPIN</ActiveSubstance>
      <ActiveSubstance>FOLLICLE-STIMULATING HORMONE, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008480</DrugIDPK>
    <LicenceNumber>PA0551/002/002</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abdine Ltd.</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003640</DrugIDPK>
    <LicenceNumber>PA0102/004/002</LicenceNumber>
    <ProductName>SOMNITE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000671</DrugIDPK>
    <LicenceNumber>PA0010/022/010</LicenceNumber>
    <ProductName>ALBUMINAR-5</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1984-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004456</DrugIDPK>
    <LicenceNumber>PA0303/028/002</LicenceNumber>
    <ProductName>ELDEPRYL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010348</DrugIDPK>
    <LicenceNumber>PA0540/022/001</LicenceNumber>
    <ProductName>ONDEVA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>TRIMEGESTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017369</DrugIDPK>
    <LicenceNumber>PA0281/113/001</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2003-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017370</DrugIDPK>
    <LicenceNumber>PA0281/113/002</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2003-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017371</DrugIDPK>
    <LicenceNumber>PA0281/113/003</LicenceNumber>
    <ProductName>SIMVASTATIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2003-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014590</DrugIDPK>
    <LicenceNumber>PPA0465/033/002B</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014591</DrugIDPK>
    <LicenceNumber>PPA0465/033/002C</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014593</DrugIDPK>
    <LicenceNumber>PPA0465/033/002E</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014620</DrugIDPK>
    <LicenceNumber>PPA0465/053/001C</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014622</DrugIDPK>
    <LicenceNumber>PPA0465/053/001E</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015429</DrugIDPK>
    <LicenceNumber>PA0678/078/001</LicenceNumber>
    <ProductName>Alphosyl Conditioning Shampoo</ProductName>
    <Strength>5% w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALCOHOLIC COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015433</DrugIDPK>
    <LicenceNumber>PA0678/081/002</LicenceNumber>
    <ProductName>ALPHOSYL LOTION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALCOHOLIC COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005348</DrugIDPK>
    <LicenceNumber>PA0258/020/001</LicenceNumber>
    <ProductName>BRONALIN EXPECTORANT</ProductName>
    <Strength>14/135/57  MG/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001929</DrugIDPK>
    <LicenceNumber>PA0044/009/003</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001926</DrugIDPK>
    <LicenceNumber>PA0044/009/002</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004110</DrugIDPK>
    <LicenceNumber>PA0167/005/005</LicenceNumber>
    <ProductName>LIGNOCAINE HCL/GLUCOSE</ProductName>
    <Strength>0.4/5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004111</DrugIDPK>
    <LicenceNumber>PA0167/005/006</LicenceNumber>
    <ProductName>LIGNOCAINE HCL/GLUCOSE</ProductName>
    <Strength>0.4/5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004113</DrugIDPK>
    <LicenceNumber>PA0167/005/007</LicenceNumber>
    <ProductName>LIGNOCAINE HCL/GLUCOSE</ProductName>
    <Strength>0.4/5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005754</DrugIDPK>
    <LicenceNumber>PA0345/002/002</LicenceNumber>
    <ProductName>CALCIFORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Laboratoires Grimberg</PAHolder>
    <AuthorisedDate>1993-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLUCONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLUCEPTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SACCHAROMYCES CEREVISIAE MEYEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006794</DrugIDPK>
    <LicenceNumber>PA0590/008/002</LicenceNumber>
    <ProductName>CALMURID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UREA</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016152</DrugIDPK>
    <LicenceNumber>PA1077/044/001</LicenceNumber>
    <ProductName>FLIXOTIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016154</DrugIDPK>
    <LicenceNumber>PA1077/044/003</LicenceNumber>
    <ProductName>FLIXOTIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016155</DrugIDPK>
    <LicenceNumber>PA1077/044/004</LicenceNumber>
    <ProductName>FLIXOTIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001344</DrugIDPK>
    <LicenceNumber>PA0024/023/002</LicenceNumber>
    <ProductName>FLIXOTIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002875</DrugIDPK>
    <LicenceNumber>PA0057/009/001</LicenceNumber>
    <ProductName>HIPREX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1988-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHENAMINE HIPPURATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003840</DrugIDPK>
    <LicenceNumber>PA0577/025/001</LicenceNumber>
    <ProductName>LAXOL</ProductName>
    <Strength>660</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006652</DrugIDPK>
    <LicenceNumber>PA0654/006/001</LicenceNumber>
    <ProductName>OSTEOCUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006651</DrugIDPK>
    <LicenceNumber>PA0654/005/001</LicenceNumber>
    <ProductName>OSTRAM D3</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014792</DrugIDPK>
    <LicenceNumber>PPA0465/013/004C</LicenceNumber>
    <ProductName>VOLTAROL RETARD</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014793</DrugIDPK>
    <LicenceNumber>PPA0465/013/004D</LicenceNumber>
    <ProductName>VOLTAROL RETARD</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014791</DrugIDPK>
    <LicenceNumber>PPA0465/013/004B</LicenceNumber>
    <ProductName>VOLTROL RETARD</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006681</DrugIDPK>
    <LicenceNumber>PA0516/012/004</LicenceNumber>
    <ProductName>DILZEM SR 180</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001722</DrugIDPK>
    <LicenceNumber>PA0040/003/009</LicenceNumber>
    <ProductName>FLAGYL</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006404</DrugIDPK>
    <LicenceNumber>PA0751/005/001</LicenceNumber>
    <ProductName>PERITONEAL DIALYSIS COD 55</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006405</DrugIDPK>
    <LicenceNumber>PA0751/005/002</LicenceNumber>
    <ProductName>PERITONEAL DIALYSIS COD 55</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006406</DrugIDPK>
    <LicenceNumber>PA0751/005/003</LicenceNumber>
    <ProductName>PERITONEAL DIALYSIS COD AA</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006407</DrugIDPK>
    <LicenceNumber>PA0751/005/004</LicenceNumber>
    <ProductName>PERITONEAL DIALYSIS COD AA</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006408</DrugIDPK>
    <LicenceNumber>PA0751/005/005</LicenceNumber>
    <ProductName>PERITONEAL DIALYSIS COD AC</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006409</DrugIDPK>
    <LicenceNumber>PA0751/005/006</LicenceNumber>
    <ProductName>PERITONEAL DIALYSIS COD AC</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soln for Peritoneal Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003189</DrugIDPK>
    <LicenceNumber>PA0073/060/002</LicenceNumber>
    <ProductName>ANTIMET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006651</DrugIDPK>
    <LicenceNumber>PA0549/001/005</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1993-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008907</DrugIDPK>
    <LicenceNumber>PA0856/021/001</LicenceNumber>
    <ProductName>FEMHRT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>2000-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013410</DrugIDPK>
    <LicenceNumber>PA0936/056/001</LicenceNumber>
    <ProductName>MINODIAB</ProductName>
    <Strength>5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1998-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIPIZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008144</DrugIDPK>
    <LicenceNumber>PA0002/060/001</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008145</DrugIDPK>
    <LicenceNumber>PA0002/060/002</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008147</DrugIDPK>
    <LicenceNumber>PA0002/060/003</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008148</DrugIDPK>
    <LicenceNumber>PA0002/060/004</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001819</DrugIDPK>
    <LicenceNumber>PA0035/042/001</LicenceNumber>
    <ProductName>MEFOXIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOXITIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016360</DrugIDPK>
    <LicenceNumber>PA0035/042/002</LicenceNumber>
    <ProductName>MEFOXIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOXITIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015432</DrugIDPK>
    <LicenceNumber>PA0678/081/001</LicenceNumber>
    <ProductName>ALPHOSYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003200</DrugIDPK>
    <LicenceNumber>PA0073/081/001</LicenceNumber>
    <ProductName>VITAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003201</DrugIDPK>
    <LicenceNumber>PA0073/081/002</LicenceNumber>
    <ProductName>VITAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000995</DrugIDPK>
    <LicenceNumber>PA0019/047/003</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>100 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000996</DrugIDPK>
    <LicenceNumber>PA0019/047/004</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>150 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000997</DrugIDPK>
    <LicenceNumber>PA0019/047/005</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>200 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001007</DrugIDPK>
    <LicenceNumber>PA0019/047/007</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>400 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001002</DrugIDPK>
    <LicenceNumber>PA0019/047/006</LicenceNumber>
    <ProductName>ZITHROMAX</ProductName>
    <Strength>300 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016734</DrugIDPK>
    <LicenceNumber>PA0073/152/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1998-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016735</DrugIDPK>
    <LicenceNumber>PA0073/152/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1998-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003303</DrugIDPK>
    <LicenceNumber>PA0073/134/001</LicenceNumber>
    <ProductName>GLYCOPYRROLATE &amp; NEOSTIGMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOPYRRONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>NEOSTIGMINE METILSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007154</DrugIDPK>
    <LicenceNumber>PA0035/070/003</LicenceNumber>
    <ProductName>TIENAM I.V. 13ML</ProductName>
    <Strength>250/250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPENEM</ActiveSubstance>
      <ActiveSubstance>CILASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017904</DrugIDPK>
    <LicenceNumber>PA0282/088/001</LicenceNumber>
    <ProductName>SYNTARIS NASAL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>2000-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUNISOLIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000352</DrugIDPK>
    <LicenceNumber>PA0002/036/001</LicenceNumber>
    <ProductName>IPRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000353</DrugIDPK>
    <LicenceNumber>PA0002/036/003</LicenceNumber>
    <ProductName>IPRAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001616</DrugIDPK>
    <LicenceNumber>PA0037/063/001</LicenceNumber>
    <ProductName>LEDERFOLIN</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012503</DrugIDPK>
    <LicenceNumber>PA1026/001/003</LicenceNumber>
    <ProductName>NEUPOGEN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>1998-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012504</DrugIDPK>
    <LicenceNumber>PA1026/001/004</LicenceNumber>
    <ProductName>NEUPOGEN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>1998-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012505</DrugIDPK>
    <LicenceNumber>PA1026/001/005</LicenceNumber>
    <ProductName>NEUPOGEN</ProductName>
    <Strength>30, 0.5</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012511</DrugIDPK>
    <LicenceNumber>PA1026/001/006</LicenceNumber>
    <ProductName>NEUPOGEN</ProductName>
    <Strength>48, 0.5</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>1999-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006551</DrugIDPK>
    <LicenceNumber>PA0473/002/001</LicenceNumber>
    <ProductName>SYSTEPIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006552</DrugIDPK>
    <LicenceNumber>PA0473/002/002</LicenceNumber>
    <ProductName>SYSTEPIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006553</DrugIDPK>
    <LicenceNumber>PA0473/002/003</LicenceNumber>
    <ProductName>SYSTEPIN RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002267</DrugIDPK>
    <LicenceNumber>PA0047/014/002</LicenceNumber>
    <ProductName>DOBUTREX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004330</DrugIDPK>
    <LicenceNumber>EU/1/98/083/001</LicenceNumber>
    <ProductName>HUMASPECT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>KS Biomedix Limited</PAHolder>
    <AuthorisedDate>1998-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VOTUMUMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005349</DrugIDPK>
    <LicenceNumber>PA0258/026/001</LicenceNumber>
    <ProductName>ADULT MELTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1987-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SUCROSE</ActiveSubstance>
      <ActiveSubstance>HONEY</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006366</DrugIDPK>
    <LicenceNumber>PA0907/001/001</LicenceNumber>
    <ProductName>LANSINOH FOR BREASTFEEDING MOTHERS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Egnell Ameda Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WOOL FAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004993</DrugIDPK>
    <LicenceNumber>PA0046/016/010</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009106</DrugIDPK>
    <LicenceNumber>PA0077/154/001</LicenceNumber>
    <ProductName>KERLONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007667</DrugIDPK>
    <LicenceNumber>PA0050/068/019</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1999-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003360</DrugIDPK>
    <LicenceNumber>PA0077/017/004</LicenceNumber>
    <ProductName>FRANOL EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001718</DrugIDPK>
    <LicenceNumber>PA0016/050/001</LicenceNumber>
    <ProductName>LOMEXIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005759</DrugIDPK>
    <LicenceNumber>PA0345/003/001</LicenceNumber>
    <ProductName>MOXYDAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratoires Grimberg</PAHolder>
    <AuthorisedDate>1993-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>GUAR GUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008404</DrugIDPK>
    <LicenceNumber>PA0240/007/001</LicenceNumber>
    <ProductName>MYOVIEW</ProductName>
    <Strength>0.23</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETROFOSMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003220</DrugIDPK>
    <LicenceNumber>PA0073/093/002</LicenceNumber>
    <ProductName>NOLGEN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008369</DrugIDPK>
    <LicenceNumber>PA0952/004/001</LicenceNumber>
    <ProductName>CALCIUM PLUS D3 HERMES</ProductName>
    <Strength>0.6g/400</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hermes Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008368</DrugIDPK>
    <LicenceNumber>PA0952/003/001</LicenceNumber>
    <ProductName>CALCIUM PLUS VITAMIN D3 HERMES</ProductName>
    <Strength>0.6g/400</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hermes Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008357</DrugIDPK>
    <LicenceNumber>PA0952/001/001</LicenceNumber>
    <ProductName>CALCIUM VITAMIN D3 HERMES</ProductName>
    <Strength>0.6g/400</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hermes Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000484</DrugIDPK>
    <LicenceNumber>PA0007/034/001</LicenceNumber>
    <ProductName>DUOVENT MDI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001875</DrugIDPK>
    <LicenceNumber>PA0007/048/002</LicenceNumber>
    <ProductName>OXIVENT AUTOHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXITROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000458</DrugIDPK>
    <LicenceNumber>PA0007/048/001</LicenceNumber>
    <ProductName>OXIVENT INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXITROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005312</DrugIDPK>
    <LicenceNumber>PA0281/030/003</LicenceNumber>
    <ProductName>VENTAMOL SALBUTAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1988-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008356</DrugIDPK>
    <LicenceNumber>PA0363/007/001</LicenceNumber>
    <ProductName>DUMICOAT DENTURE LACQUER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alpharma ApS</PAHolder>
    <AuthorisedDate>1995-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006575</DrugIDPK>
    <LicenceNumber>PA0484/006/001</LicenceNumber>
    <ProductName>ZINC &amp; CASTOR OIL</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>CASTOR OIL</ActiveSubstance>
      <ActiveSubstance>CETOSTEARYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>BEESWAX</ActiveSubstance>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004403</DrugIDPK>
    <LicenceNumber>PA0828/001/001</LicenceNumber>
    <ProductName>MEDICOAL CHARCOAL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Concord Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHARCOAL, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006394</DrugIDPK>
    <LicenceNumber>PA0748/039/001</LicenceNumber>
    <ProductName>RETINOVA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008380</DrugIDPK>
    <LicenceNumber>PA0007/058/001</LicenceNumber>
    <ProductName>DILOSPIR</ProductName>
    <Strength>20mg/2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>2000-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008161</DrugIDPK>
    <LicenceNumber>PA0009/035/002</LicenceNumber>
    <ProductName>EMLA PATCH</ProductName>
    <Strength>25/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003075</DrugIDPK>
    <LicenceNumber>PA0062/024/001</LicenceNumber>
    <ProductName>STAFOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1984-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003076</DrugIDPK>
    <LicenceNumber>PA0062/024/002</LicenceNumber>
    <ProductName>STAFOXIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1984-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001913</DrugIDPK>
    <LicenceNumber>PA0040/026/008</LicenceNumber>
    <ProductName>STEMETIL E.F.F.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1988-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001088</DrugIDPK>
    <LicenceNumber>PA0019/025/001</LicenceNumber>
    <ProductName>DIABINESE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001076</DrugIDPK>
    <LicenceNumber>PA0019/025/002</LicenceNumber>
    <ProductName>DIABINESE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001063</DrugIDPK>
    <LicenceNumber>PA0019/023/003</LicenceNumber>
    <ProductName>HYPOVASE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000888</DrugIDPK>
    <LicenceNumber>PA0019/036/001</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1984-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000889</DrugIDPK>
    <LicenceNumber>PA0019/036/002</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1984-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000890</DrugIDPK>
    <LicenceNumber>PA0019/036/003</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1986-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000891</DrugIDPK>
    <LicenceNumber>PA0019/036/004</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1986-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000668</DrugIDPK>
    <LicenceNumber>PA0013/049/001</LicenceNumber>
    <ProductName>CLIMAVAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000669</DrugIDPK>
    <LicenceNumber>PA0013/049/002</LicenceNumber>
    <ProductName>CLIMAVAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016057</DrugIDPK>
    <LicenceNumber>PA1063/004/002</LicenceNumber>
    <ProductName>ISOTRATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1999-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016058</DrugIDPK>
    <LicenceNumber>PA1063/004/001</LicenceNumber>
    <ProductName>ISOTRATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2000-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016059</DrugIDPK>
    <LicenceNumber>PA1063/004/003</LicenceNumber>
    <ProductName>ISOTRATE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2000-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004004</DrugIDPK>
    <LicenceNumber>PA0447/005/006</LicenceNumber>
    <ProductName>PROZAC DISPERSIBLE</ProductName>
    <Strength>20.00</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016060</DrugIDPK>
    <LicenceNumber>PA1063/005/001</LicenceNumber>
    <ProductName>SELEGILINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016066</DrugIDPK>
    <LicenceNumber>PA1063/005/002</LicenceNumber>
    <ProductName>SELEGILINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000585</DrugIDPK>
    <LicenceNumber>PA0013/021/001</LicenceNumber>
    <ProductName>TAVEGIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLEMASTINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016069</DrugIDPK>
    <LicenceNumber>PA1063/007/001</LicenceNumber>
    <ProductName>TRAMADOL HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1998-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006230</DrugIDPK>
    <LicenceNumber>PA0009/016/022</LicenceNumber>
    <ProductName>XYLOCAINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008046</DrugIDPK>
    <LicenceNumber>PA0838/003/001</LicenceNumber>
    <ProductName>NYCOPREN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Danmark A/S</PAHolder>
    <AuthorisedDate>1998-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008047</DrugIDPK>
    <LicenceNumber>PA0838/003/002</LicenceNumber>
    <ProductName>NYCOPREN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Danmark A/S</PAHolder>
    <AuthorisedDate>1998-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000664</DrugIDPK>
    <LicenceNumber>PA0013/047/001</LicenceNumber>
    <ProductName>WATER FOR INJECTION PH.EUR.</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016074</DrugIDPK>
    <LicenceNumber>PA1063/010/001</LicenceNumber>
    <ProductName>FAMOTIDINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016075</DrugIDPK>
    <LicenceNumber>PA1063/010/002</LicenceNumber>
    <ProductName>FAMOTIDINE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001314</DrugIDPK>
    <LicenceNumber>PA0024/001/009</LicenceNumber>
    <ProductName>VENTOLIN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000881</DrugIDPK>
    <LicenceNumber>PA0019/033/002</LicenceNumber>
    <ProductName>GYNO-TROSYL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1983-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000882</DrugIDPK>
    <LicenceNumber>PA0019/033/003</LicenceNumber>
    <ProductName>GYNO-TROSYL</ProductName>
    <Strength>65</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1983-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005494</DrugIDPK>
    <LicenceNumber>PA0282/015/001</LicenceNumber>
    <ProductName>OXYTETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003372</DrugIDPK>
    <LicenceNumber>PA0077/045/001</LicenceNumber>
    <ProductName>STROMBA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STANOZOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016327</DrugIDPK>
    <LicenceNumber>PA1077/093/003</LicenceNumber>
    <ProductName>AUGMENTIN JUNIOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016329</DrugIDPK>
    <LicenceNumber>PA1077/093/005</LicenceNumber>
    <ProductName>AUGMENTIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003716</DrugIDPK>
    <LicenceNumber>PA0073/142/001</LicenceNumber>
    <ProductName>HYPERBARIC BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005960</DrugIDPK>
    <LicenceNumber>PA0697/003/003</LicenceNumber>
    <ProductName>LIPOVENOS</ProductName>
    <Strength>30%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Fresenius AG</PAHolder>
    <AuthorisedDate>1998-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYBEAN OIL</ActiveSubstance>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>PHOSPHOLIPIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003619</DrugIDPK>
    <LicenceNumber>PA0100/016/002</LicenceNumber>
    <ProductName>SAVENTRINE I.V.</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003315</DrugIDPK>
    <LicenceNumber>PA0074/014/001</LicenceNumber>
    <ProductName>DECAVIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>DL-ALFA-TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007899</DrugIDPK>
    <LicenceNumber>PA0812/002/002</LicenceNumber>
    <ProductName>LOMEXIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Recordati Industria Chimica e Farmaceutica SpA</PAHolder>
    <AuthorisedDate>1998-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007900</DrugIDPK>
    <LicenceNumber>PA0812/002/003</LicenceNumber>
    <ProductName>LOMEXIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Recordati Industria Chimica e Farmaceutica SpA</PAHolder>
    <AuthorisedDate>1998-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008458</DrugIDPK>
    <LicenceNumber>PA0473/009/003</LicenceNumber>
    <ProductName>PENTOXIFYLLINE 600 MG SR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008457</DrugIDPK>
    <LicenceNumber>PA0473/009/001</LicenceNumber>
    <ProductName>PENTOXIFYLLINE AMPOULES</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002742</DrugIDPK>
    <LicenceNumber>PA0473/009/002</LicenceNumber>
    <ProductName>PENTOXIFYLLINE S.R.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004033</DrugIDPK>
    <LicenceNumber>PA0148/043/002</LicenceNumber>
    <ProductName>PRED G LIQUIFILM STERILE OPHTHALMIC</ProductName>
    <Strength>1.0/0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE ACETATE</ActiveSubstance>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003428</DrugIDPK>
    <LicenceNumber>PA0077/116/001</LicenceNumber>
    <ProductName>TRIFYBA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTA TRITICUM TRICUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006558</DrugIDPK>
    <LicenceNumber>PA0473/003/009</LicenceNumber>
    <ProductName>ZEPHOLIN AMPOULE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1989-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE SODIUM AMINOACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006191</DrugIDPK>
    <LicenceNumber>PA0437/030/001</LicenceNumber>
    <ProductName>TOBRAMYCIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOBRAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006203</DrugIDPK>
    <LicenceNumber>PA0540/007/002</LicenceNumber>
    <ProductName>ZOLERIM</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011356</DrugIDPK>
    <LicenceNumber>PA0540/117/003</LicenceNumber>
    <ProductName>ORUDIS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002515</DrugIDPK>
    <LicenceNumber>PA0054/041/001</LicenceNumber>
    <ProductName>SEPTOPAL</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002516</DrugIDPK>
    <LicenceNumber>PA0054/041/002</LicenceNumber>
    <ProductName>SEPTOPAL</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implantation Chain</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009869</DrugIDPK>
    <LicenceNumber>PA0980/001/001</LicenceNumber>
    <ProductName>CLINITAR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cambridge Healthcare Supplies Limited</PAHolder>
    <AuthorisedDate>1998-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009870</DrugIDPK>
    <LicenceNumber>PA0980/001/002</LicenceNumber>
    <ProductName>CLINITAR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cambridge Healthcare Supplies Limited</PAHolder>
    <AuthorisedDate>1998-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002162</DrugIDPK>
    <LicenceNumber>PA0046/016/007</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001402</DrugIDPK>
    <LicenceNumber>PA0037/004/001</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001403</DrugIDPK>
    <LicenceNumber>PA0037/004/002</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001404</DrugIDPK>
    <LicenceNumber>PA0037/004/003</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001406</DrugIDPK>
    <LicenceNumber>PA0037/004/006</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001407</DrugIDPK>
    <LicenceNumber>PA0037/004/007</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001408</DrugIDPK>
    <LicenceNumber>PA0037/004/008</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010624</DrugIDPK>
    <LicenceNumber>PA0540/037/001</LicenceNumber>
    <ProductName>CLAFORAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008114</DrugIDPK>
    <LicenceNumber>PA0669/005/001</LicenceNumber>
    <ProductName>ACTIRA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003626</DrugIDPK>
    <LicenceNumber>PA0748/006/001</LicenceNumber>
    <ProductName>DELFEN CONTRACEPTIVE</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003221</DrugIDPK>
    <LicenceNumber>PA0073/096/001</LicenceNumber>
    <ProductName>DANAZANT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003222</DrugIDPK>
    <LicenceNumber>PA0073/096/002</LicenceNumber>
    <ProductName>DANAZANT</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015156</DrugIDPK>
    <LicenceNumber>PA0610/003/001</LicenceNumber>
    <ProductName>MENTHOL AND WINTERGREEN HEAT RUB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MUSTARD OIL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016070</DrugIDPK>
    <LicenceNumber>PA1063/008/001</LicenceNumber>
    <ProductName>ZACTOLINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016071</DrugIDPK>
    <LicenceNumber>PA1063/008/002</LicenceNumber>
    <ProductName>ZACTOLINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>1998-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003623</DrugIDPK>
    <LicenceNumber>PA0100/027/001</LicenceNumber>
    <ProductName>FLETCHERS ARACHIS OIL RETENTION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005844</DrugIDPK>
    <LicenceNumber>PA0046/062/003</LicenceNumber>
    <ProductName>BOCATRIOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005834</DrugIDPK>
    <LicenceNumber>PA0046/024/008</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1999-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017899</DrugIDPK>
    <LicenceNumber>PPA0465/049/001E</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014611</DrugIDPK>
    <LicenceNumber>PPA0465/049/001C</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003049</DrugIDPK>
    <LicenceNumber>PPA0465/049/001A</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017526</DrugIDPK>
    <LicenceNumber>PA1110/008/001</LicenceNumber>
    <ProductName>QUINOCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ecolab Limited</PAHolder>
    <AuthorisedDate>1998-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM HYDROXYQUINOLIN SULFATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001243</DrugIDPK>
    <LicenceNumber>PA0022/043/002</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001244</DrugIDPK>
    <LicenceNumber>PA0022/043/003</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004536</DrugIDPK>
    <LicenceNumber>PA0013/071/002</LicenceNumber>
    <ProductName>ESTRAPAK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch+Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003177</DrugIDPK>
    <LicenceNumber>PA0073/051/003</LicenceNumber>
    <ProductName>DOPAGEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003764</DrugIDPK>
    <LicenceNumber>PA0544/023/004</LicenceNumber>
    <ProductName>H-B VAX II PREFILLED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1996-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003765</DrugIDPK>
    <LicenceNumber>PA0544/023/005</LicenceNumber>
    <ProductName>H-B VAX II PREFILLED</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1996-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002870</DrugIDPK>
    <LicenceNumber>PA0544/023/003</LicenceNumber>
    <ProductName>HB-VAX II</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005893</DrugIDPK>
    <LicenceNumber>PA0372/001/003</LicenceNumber>
    <ProductName>METROLYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1988-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006032</DrugIDPK>
    <LicenceNumber>PA0372/001/004</LicenceNumber>
    <ProductName>METROLYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1988-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007617</DrugIDPK>
    <LicenceNumber>PA0017/097/001</LicenceNumber>
    <ProductName>DUACT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACRIVASTINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007618</DrugIDPK>
    <LicenceNumber>PA0017/097/002</LicenceNumber>
    <ProductName>DUACT LA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ACRIVASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005177</DrugIDPK>
    <LicenceNumber>PA0257/041/001</LicenceNumber>
    <ProductName>HALIBUT LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate>1993-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003348</DrugIDPK>
    <LicenceNumber>PA0077/003/001</LicenceNumber>
    <ProductName>HEXOPAL</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSITOL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002436</DrugIDPK>
    <LicenceNumber>PA0289/008/002</LicenceNumber>
    <ProductName>PRAXILENE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAFTIDROFURYL OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012865</DrugIDPK>
    <LicenceNumber>PA0936/024/001</LicenceNumber>
    <ProductName>FEMULEN</ProductName>
    <Strength>0.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1998-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETYNODIOL DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001263</DrugIDPK>
    <LicenceNumber>PA0022/053/001</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001265</DrugIDPK>
    <LicenceNumber>PA0022/053/002</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001267</DrugIDPK>
    <LicenceNumber>PA0022/053/003</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001268</DrugIDPK>
    <LicenceNumber>PA0022/055/001</LicenceNumber>
    <ProductName>BC 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004413</DrugIDPK>
    <LicenceNumber>PA0167/068/011</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004416</DrugIDPK>
    <LicenceNumber>PA0167/068/014</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007670</DrugIDPK>
    <LicenceNumber>PA0009/016/006</LicenceNumber>
    <ProductName>XYLOCAINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007673</DrugIDPK>
    <LicenceNumber>PA0009/016/009</LicenceNumber>
    <ProductName>XYLOCAINE PLAIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007674</DrugIDPK>
    <LicenceNumber>PA0009/016/013</LicenceNumber>
    <ProductName>XYLOCAINE PLAIN</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009324</DrugIDPK>
    <LicenceNumber>PA0970/002/001</LicenceNumber>
    <ProductName>ZAFIRLUKAST ZENECA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2001-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZAFIRLUKAST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009325</DrugIDPK>
    <LicenceNumber>PA0970/002/002</LicenceNumber>
    <ProductName>ZAFIRLUKAST ZENECA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2001-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZAFIRLUKAST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000696</DrugIDPK>
    <LicenceNumber>PA0016/002/001</LicenceNumber>
    <ProductName>DALACIN C PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1975-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN PALMITATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004748</DrugIDPK>
    <LicenceNumber>PA0187/032/004</LicenceNumber>
    <ProductName>GENOTROPIN 0.7MG KABIQUICK</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004752</DrugIDPK>
    <LicenceNumber>PA0187/032/006</LicenceNumber>
    <ProductName>GENOTROPIN 1.3MG KABIQUICK</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004750</DrugIDPK>
    <LicenceNumber>PA0187/032/005</LicenceNumber>
    <ProductName>GENOTROPIN 1MG KABIQUICK</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002810</DrugIDPK>
    <LicenceNumber>PA0778/008/001</LicenceNumber>
    <ProductName>MAXAQUIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1991-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMEFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003102</DrugIDPK>
    <LicenceNumber>PA0778/016/001</LicenceNumber>
    <ProductName>MENOPHASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1995-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000820</DrugIDPK>
    <LicenceNumber>PA0016/043/001</LicenceNumber>
    <ProductName>PREPIDIL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DINOPROSTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003377</DrugIDPK>
    <LicenceNumber>PA0077/051/001</LicenceNumber>
    <ProductName>MICTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1981-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALIDIXIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014617</DrugIDPK>
    <LicenceNumber>PPA0465/051/001C</LicenceNumber>
    <ProductName>KLACID</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995017814</DrugIDPK>
    <LicenceNumber>PPA0465/051/001F</LicenceNumber>
    <ProductName>KLACID</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009067</DrugIDPK>
    <LicenceNumber>PA0964/003/001</LicenceNumber>
    <ProductName>PAVULON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005415</DrugIDPK>
    <LicenceNumber>PA0277/018/001</LicenceNumber>
    <ProductName>PILOCARPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005416</DrugIDPK>
    <LicenceNumber>PA0277/018/002</LicenceNumber>
    <ProductName>PILOCARPINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005417</DrugIDPK>
    <LicenceNumber>PA0277/018/003</LicenceNumber>
    <ProductName>PILOCARPINE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005418</DrugIDPK>
    <LicenceNumber>PA0277/018/004</LicenceNumber>
    <ProductName>PILOCARPINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005411</DrugIDPK>
    <LicenceNumber>PA0277/011/001</LicenceNumber>
    <ProductName>CHLORAMPHENICOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001563</DrugIDPK>
    <LicenceNumber>PA0037/045/004</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001565</DrugIDPK>
    <LicenceNumber>PA0037/045/005</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001246</DrugIDPK>
    <LicenceNumber>PA0022/044/001</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>1.0 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1993-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001247</DrugIDPK>
    <LicenceNumber>PA0022/044/002</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>2.5 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1993-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005412</DrugIDPK>
    <LicenceNumber>PA0277/012/001</LicenceNumber>
    <ProductName>HOMATROPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HOMATROPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005413</DrugIDPK>
    <LicenceNumber>PA0277/012/002</LicenceNumber>
    <ProductName>HOMATROPINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HOMATROPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005410</DrugIDPK>
    <LicenceNumber>PA0277/010/001</LicenceNumber>
    <ProductName>ATROPINE SULPHATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006469</DrugIDPK>
    <LicenceNumber>PA0468/016/001</LicenceNumber>
    <ProductName>MAALOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009418</DrugIDPK>
    <LicenceNumber>PA0872/005/003</LicenceNumber>
    <ProductName>FEMATRIX 7 DAY 80</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma International Ltd</PAHolder>
    <AuthorisedDate>1998-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005328</DrugIDPK>
    <LicenceNumber>PA0281/047/001</LicenceNumber>
    <ProductName>AZOPINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1989-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005274</DrugIDPK>
    <LicenceNumber>PA0281/006/002</LicenceNumber>
    <ProductName>FUROSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008899</DrugIDPK>
    <LicenceNumber>PA0271/008/001</LicenceNumber>
    <ProductName>PERDIX</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1996-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOEXIPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008901</DrugIDPK>
    <LicenceNumber>PA0271/008/002</LicenceNumber>
    <ProductName>PERDIX</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1996-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOEXIPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005334</DrugIDPK>
    <LicenceNumber>PA0281/054/003</LicenceNumber>
    <ProductName>PINAMET CIMETIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1990-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005319</DrugIDPK>
    <LicenceNumber>PA0281/036/004</LicenceNumber>
    <ProductName>PINAMOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1988-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006436</DrugIDPK>
    <LicenceNumber>PA0437/017/001</LicenceNumber>
    <ProductName>CARBOPLATIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007514</DrugIDPK>
    <LicenceNumber>PA0439/001/001</LicenceNumber>
    <ProductName>GOLYTELY</ProductName>
    <Strength>4000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Golytely Limited name changed</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM SULFATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001551</DrugIDPK>
    <LicenceNumber>PA0037/039/001</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001554</DrugIDPK>
    <LicenceNumber>PA0037/039/002</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001555</DrugIDPK>
    <LicenceNumber>PA0037/039/003</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005414</DrugIDPK>
    <LicenceNumber>PA0277/014/001</LicenceNumber>
    <ProductName>HYPROMELLOSE</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006840</DrugIDPK>
    <LicenceNumber>PA0621/002/001</LicenceNumber>
    <ProductName>STERINEB SODIUM CROMOGLYCATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Steripak Ltd</PAHolder>
    <AuthorisedDate>1994-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005318</DrugIDPK>
    <LicenceNumber>PA0437/041/001</LicenceNumber>
    <ProductName>ASTRIX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016806</DrugIDPK>
    <LicenceNumber>PA1046/006/002</LicenceNumber>
    <ProductName>TRAMADOL HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004846</DrugIDPK>
    <LicenceNumber>PA0823/030/001</LicenceNumber>
    <ProductName>ABIDEC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006477</DrugIDPK>
    <LicenceNumber>PA0468/021/003</LicenceNumber>
    <ProductName>ACTHAR GEL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003142</DrugIDPK>
    <LicenceNumber>PA0073/025/001</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002864</DrugIDPK>
    <LicenceNumber>PA0544/022/001</LicenceNumber>
    <ProductName>ATTENUVAX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - ENDERS EDMONSTON STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004740</DrugIDPK>
    <LicenceNumber>PA0206/011/001</LicenceNumber>
    <ProductName>BELLADONNA POROUS PLASTER ON RED FLANNELETTE</ProductName>
    <Strength>0.25%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001782</DrugIDPK>
    <LicenceNumber>PA0035/012/001</LicenceNumber>
    <ProductName>BENEMID</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROBENECID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000877</DrugIDPK>
    <LicenceNumber>PA0012/035/001</LicenceNumber>
    <ProductName>BILOPTIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IOPODATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000235</DrugIDPK>
    <LicenceNumber>PA0004/025/001</LicenceNumber>
    <ProductName>BOOTS HEALTHCARE HOT LEMON COLD RELIEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004945</DrugIDPK>
    <LicenceNumber>PA0030/031/001</LicenceNumber>
    <ProductName>BRADOSOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMIPHEN BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002166</DrugIDPK>
    <LicenceNumber>PA0046/017/001</LicenceNumber>
    <ProductName>BURINEX K</ProductName>
    <Strength>0.5/573</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005194</DrugIDPK>
    <LicenceNumber>PA0258/009/001</LicenceNumber>
    <ProductName>BURNAID</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOACRIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004346</DrugIDPK>
    <LicenceNumber>PA0823/010/007</LicenceNumber>
    <ProductName>CALPOL</ProductName>
    <Strength>500 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001857</DrugIDPK>
    <LicenceNumber>PA0035/041/002</LicenceNumber>
    <ProductName>CONCORDIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001817</DrugIDPK>
    <LicenceNumber>PA0035/041/001</LicenceNumber>
    <ProductName>CONCORDIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005190</DrugIDPK>
    <LicenceNumber>PA0258/007/001</LicenceNumber>
    <ProductName>CUPAL</ProductName>
    <Strength>400/30/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005197</DrugIDPK>
    <LicenceNumber>PA0258/011/001</LicenceNumber>
    <ProductName>CUPAL COLD/FLU WITH COUGH SUPPRESSANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001788</DrugIDPK>
    <LicenceNumber>PA0035/016/003</LicenceNumber>
    <ProductName>DECADRON</ProductName>
    <Strength>3.3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001790</DrugIDPK>
    <LicenceNumber>PA0035/016/004</LicenceNumber>
    <ProductName>DECADRON SHOCK PAK</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004326</DrugIDPK>
    <LicenceNumber>PA0167/043/001</LicenceNumber>
    <ProductName>DIANEAL 130/GLUCOSE 1.36 % W/V/13.6 MG/ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004329</DrugIDPK>
    <LicenceNumber>PA0167/045/001</LicenceNumber>
    <ProductName>DIANEAL 130/GLUCOSE 1.36%/POTASSIUM 2.5MMOL/L</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004328</DrugIDPK>
    <LicenceNumber>PA0167/044/001</LicenceNumber>
    <ProductName>DIANEAL/GLUCOSE 3.86%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000861</DrugIDPK>
    <LicenceNumber>PA0017/017/001</LicenceNumber>
    <ProductName>DICONAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPIPANONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYCLIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001795</DrugIDPK>
    <LicenceNumber>PA0035/024/001</LicenceNumber>
    <ProductName>EDECRIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETACRYNATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003228</DrugIDPK>
    <LicenceNumber>PA0073/100/001</LicenceNumber>
    <ProductName>ERGOMETRINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOMETRINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001719</DrugIDPK>
    <LicenceNumber>PA0040/003/006</LicenceNumber>
    <ProductName>FLAGYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001798</DrugIDPK>
    <LicenceNumber>PA0035/026/001</LicenceNumber>
    <ProductName>HYDROSALURIC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003148</DrugIDPK>
    <LicenceNumber>PA0073/034/001</LicenceNumber>
    <ProductName>ISONIAZID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003149</DrugIDPK>
    <LicenceNumber>PA0073/034/002</LicenceNumber>
    <ProductName>ISONIAZID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995016091</DrugIDPK>
    <LicenceNumber>PA0506/018/001</LicenceNumber>
    <ProductName>METANIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TITANIUM DIOXIDE</ActiveSubstance>
      <ActiveSubstance>TITANIUM PEROXIDE</ActiveSubstance>
      <ActiveSubstance>TITANIUM SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001802</DrugIDPK>
    <LicenceNumber>PA0035/028/001</LicenceNumber>
    <ProductName>MIDAMOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001356</DrugIDPK>
    <LicenceNumber>PA0035/057/001</LicenceNumber>
    <ProductName>MINTEZOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIABENDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002524</DrugIDPK>
    <LicenceNumber>PA0054/053/001</LicenceNumber>
    <ProductName>MULTIBIONTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXPANTHENOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002869</DrugIDPK>
    <LicenceNumber>PA0544/026/001</LicenceNumber>
    <ProductName>MUMPSVAX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MUMPS VIRUS - JERYLYNN STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010221</DrugIDPK>
    <LicenceNumber>PA0654/009/002</LicenceNumber>
    <ProductName>NEUROBION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002879</DrugIDPK>
    <LicenceNumber>PA0057/012/001</LicenceNumber>
    <ProductName>NORGESIC</ProductName>
    <Strength>35/450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORPHENADRINE CITRATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>GELATINE HYDROLYSATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015158</DrugIDPK>
    <LicenceNumber>PA0610/005/001</LicenceNumber>
    <ProductName>OROVITE</ProductName>
    <Strength>5/5/33.3/10/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003144</DrugIDPK>
    <LicenceNumber>PA0073/031/001</LicenceNumber>
    <ProductName>PAPAVERETUM B.P.</ProductName>
    <Strength>15.4</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAPAVERETUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003146</DrugIDPK>
    <LicenceNumber>PA0073/033/001</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003147</DrugIDPK>
    <LicenceNumber>PA0073/033/002</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003389</DrugIDPK>
    <LicenceNumber>PA0077/077/001</LicenceNumber>
    <ProductName>RESONIUM A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM POLYSTYRENE SULFONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004099</DrugIDPK>
    <LicenceNumber>PA0167/050/013A</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>0.225/5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001059</DrugIDPK>
    <LicenceNumber>PA0019/021/001</LicenceNumber>
    <ProductName>TERRACORTRIL NYSTATIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004265</DrugIDPK>
    <LicenceNumber>PA0167/032/019A</LicenceNumber>
    <ProductName>TRAVASEPT 15</ProductName>
    <Strength>0.1/1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004268</DrugIDPK>
    <LicenceNumber>PA0167/032/022A</LicenceNumber>
    <ProductName>TRAVASEPT 30</ProductName>
    <Strength>0.05/0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001861</DrugIDPK>
    <LicenceNumber>PA0035/002/002</LicenceNumber>
    <ProductName>TRYPTIZOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001862</DrugIDPK>
    <LicenceNumber>PA0035/002/003</LicenceNumber>
    <ProductName>TRYPTIZOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001863</DrugIDPK>
    <LicenceNumber>PA0035/002/004</LicenceNumber>
    <ProductName>TRYPTIZOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001865</DrugIDPK>
    <LicenceNumber>PA0035/002/006</LicenceNumber>
    <ProductName>TRYPTIZOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001996</DrugIDPK>
    <LicenceNumber>PA0040/074/001</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001997</DrugIDPK>
    <LicenceNumber>PA0040/074/002</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001998</DrugIDPK>
    <LicenceNumber>PA0040/074/003</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007658</DrugIDPK>
    <LicenceNumber>PA0009/007/002</LicenceNumber>
    <ProductName>XYLOPROCT</ProductName>
    <Strength>60/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008235</DrugIDPK>
    <LicenceNumber>PA0365/080/001</LicenceNumber>
    <ProductName>ZAROXOLYN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOLAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008236</DrugIDPK>
    <LicenceNumber>PA0365/080/002</LicenceNumber>
    <ProductName>ZAROXOLYN</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOLAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006585</DrugIDPK>
    <LicenceNumber>PA0469/030/001</LicenceNumber>
    <ProductName>CETAVLEX ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006583</DrugIDPK>
    <LicenceNumber>PA0469/031/001</LicenceNumber>
    <ProductName>HIBITANE OBSTETRIC</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006580</DrugIDPK>
    <LicenceNumber>PA0469/029/001</LicenceNumber>
    <ProductName>METOSYN</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006584</DrugIDPK>
    <LicenceNumber>PA0469/033/001</LicenceNumber>
    <ProductName>SIOPEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004104</DrugIDPK>
    <LicenceNumber>PA0167/050/015A</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>0.45/2.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006589</DrugIDPK>
    <LicenceNumber>PA0469/026/003</LicenceNumber>
    <ProductName>SYNALAR</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006592</DrugIDPK>
    <LicenceNumber>PA0469/026/001</LicenceNumber>
    <ProductName>SYNALAR</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006590</DrugIDPK>
    <LicenceNumber>PA0469/028/001</LicenceNumber>
    <ProductName>SYNALAR C</ProductName>
    <Strength>0.025/3.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006591</DrugIDPK>
    <LicenceNumber>PA0469/028/002</LicenceNumber>
    <ProductName>SYNALAR C</ProductName>
    <Strength>0.025/3.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006588</DrugIDPK>
    <LicenceNumber>PA0469/027/002</LicenceNumber>
    <ProductName>SYNALAR N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006587</DrugIDPK>
    <LicenceNumber>PA0469/027/001</LicenceNumber>
    <ProductName>SYNLAR N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011221</DrugIDPK>
    <LicenceNumber>PA0050/148/001</LicenceNumber>
    <ProductName>LORON FOR INFUSION</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLODRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006573</DrugIDPK>
    <LicenceNumber>PA0484/002/001</LicenceNumber>
    <ProductName>BENZYL BENZOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004141</DrugIDPK>
    <LicenceNumber>PA0050/135/001</LicenceNumber>
    <ProductName>ETHYL CHLORIDE BP</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1993-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHYL CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005325</DrugIDPK>
    <LicenceNumber>PA0281/045/001</LicenceNumber>
    <ProductName>TRANTALOL ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1988-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005326</DrugIDPK>
    <LicenceNumber>PA0281/045/002</LicenceNumber>
    <ProductName>TRANTALOL ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1988-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004556</DrugIDPK>
    <LicenceNumber>PA0013/090/003</LicenceNumber>
    <ProductName>AREDIA DRY POWDER</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004548</DrugIDPK>
    <LicenceNumber>PA0013/078/003</LicenceNumber>
    <ProductName>CIBACEN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENAZEPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003667</DrugIDPK>
    <LicenceNumber>PA0769/009/001</LicenceNumber>
    <ProductName>DILAUDID</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011230</DrugIDPK>
    <LicenceNumber>PA0013/106/003</LicenceNumber>
    <ProductName>FAMVIR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008823</DrugIDPK>
    <LicenceNumber>PA0240/015/001</LicenceNumber>
    <ProductName>FERRIC CITRATE</ProductName>
    <Strength>3.7</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRIC (59 FE) CITRATE INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007611</DrugIDPK>
    <LicenceNumber>PA0013/045/002</LicenceNumber>
    <ProductName>LAMISIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005734</DrugIDPK>
    <LicenceNumber>PA0013/054/005</LicenceNumber>
    <ProductName>NEORAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006950</DrugIDPK>
    <LicenceNumber>PA0656/001/001</LicenceNumber>
    <ProductName>OSTRAM</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Laboratoires Merck-Clevenot</PAHolder>
    <AuthorisedDate>1993-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000635</DrugIDPK>
    <LicenceNumber>PA0013/033/002</LicenceNumber>
    <ProductName>SANDIMMUN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1984-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000584</DrugIDPK>
    <LicenceNumber>PA0013/019/001</LicenceNumber>
    <ProductName>SYNTOPRESSIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LYPRESSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003900</DrugIDPK>
    <LicenceNumber>PA0711/022/003</LicenceNumber>
    <ProductName>TAMOX</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1993-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000573</DrugIDPK>
    <LicenceNumber>PA0013/013/001</LicenceNumber>
    <ProductName>ZADITEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1978-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOTIFEN FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004882</DrugIDPK>
    <LicenceNumber>PA0218/040/003</LicenceNumber>
    <ProductName>NORDITROPIN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004883</DrugIDPK>
    <LicenceNumber>PA0218/040/004</LicenceNumber>
    <ProductName>NORDITROPIN</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004880</DrugIDPK>
    <LicenceNumber>PA0218/040/001</LicenceNumber>
    <ProductName>NORDITROPIN PENSET</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1991-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
      <ActiveSubstance>R-DNA (E.COLI EXPRESSION SYSTEM)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004881</DrugIDPK>
    <LicenceNumber>PA0218/040/002</LicenceNumber>
    <ProductName>NORDITROPIN PENSET</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1991-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011883</DrugIDPK>
    <LicenceNumber>PA0013/109/001</LicenceNumber>
    <ProductName>TAREG</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2001-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011884</DrugIDPK>
    <LicenceNumber>PA0013/109/002</LicenceNumber>
    <ProductName>TAREG</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2001-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002760</DrugIDPK>
    <LicenceNumber>EU/1/96/021/001</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002761</DrugIDPK>
    <LicenceNumber>EU/1/96/021/003</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002762</DrugIDPK>
    <LicenceNumber>EU/1/96/021/005</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002763</DrugIDPK>
    <LicenceNumber>EU/1/96/021/007</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007179</DrugIDPK>
    <LicenceNumber>EU/1/96/021/002</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007180</DrugIDPK>
    <LicenceNumber>EU/1/96/021/004</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007181</DrugIDPK>
    <LicenceNumber>EU/1/96/021/006</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007182</DrugIDPK>
    <LicenceNumber>EU/1/96/021/008</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007183</DrugIDPK>
    <LicenceNumber>EU/1/96/021/009</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007184</DrugIDPK>
    <LicenceNumber>EU/1/96/021/010</LicenceNumber>
    <ProductName>OLANSEK</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1996-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002120</DrugIDPK>
    <LicenceNumber>PA0769/001/001</LicenceNumber>
    <ProductName>CHYMODIACTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1996-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOPAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003565</DrugIDPK>
    <LicenceNumber>PA0050/128/002</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1993-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003566</DrugIDPK>
    <LicenceNumber>PA0050/128/003</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000967</DrugIDPK>
    <LicenceNumber>PA0017/084/001</LicenceNumber>
    <ProductName>MALOPRIM</ProductName>
    <Strength>12.5/100mg</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIMETHAMINE</ActiveSubstance>
      <ActiveSubstance>DAPSONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014831</DrugIDPK>
    <LicenceNumber>PA1047/002/001</LicenceNumber>
    <ProductName>PLASMATEIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alpha Therapeutic Europe Limited</PAHolder>
    <AuthorisedDate>1998-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016342</DrugIDPK>
    <LicenceNumber>PA0582/014/001</LicenceNumber>
    <ProductName>MIOCHOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Pdr &amp; Solv for Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCHOLINE CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003300</DrugIDPK>
    <LicenceNumber>PA0073/133/001</LicenceNumber>
    <ProductName>VOLOGEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005289</DrugIDPK>
    <LicenceNumber>PA0281/015/003</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015108</DrugIDPK>
    <LicenceNumber>PA1056/002/001</LicenceNumber>
    <ProductName>PSORIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>LPC Medical (UK) Ltd</PAHolder>
    <AuthorisedDate>2002-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015107</DrugIDPK>
    <LicenceNumber>PA1056/001/001</LicenceNumber>
    <ProductName>PSORIN SCALP</ProductName>
    <Strength>0.25/1.6</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>LPC Medical (UK) Ltd</PAHolder>
    <AuthorisedDate>1998-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006770</DrugIDPK>
    <LicenceNumber>PA0585/004/001</LicenceNumber>
    <ProductName>TIMOLOL EYE DROPS</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006771</DrugIDPK>
    <LicenceNumber>PA0585/004/002</LicenceNumber>
    <ProductName>TIMOLOL EYE DROPS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013132</DrugIDPK>
    <LicenceNumber>PA0997/005/002</LicenceNumber>
    <ProductName>HRF (GONADORELIN)</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Intrapharm Laboratories Limited</PAHolder>
    <AuthorisedDate>1998-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GONADORELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000619</DrugIDPK>
    <LicenceNumber>PA0009/050/001</LicenceNumber>
    <ProductName>IMTACK</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Mg/Dose</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015998</DrugIDPK>
    <LicenceNumber>PA0437/011/008</LicenceNumber>
    <ProductName>FLOUROURACIL ONCO-VIAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010133</DrugIDPK>
    <LicenceNumber>PA0365/055/001</LicenceNumber>
    <ProductName>VIVOTIF</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1994-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VIABLE SALMONELLA TYPHI TY21A BERNA CELLS</ActiveSubstance>
      <ActiveSubstance>SALMONELLA TYPHI TY21A BERNA CELLS INACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007933</DrugIDPK>
    <LicenceNumber>PA0566/011/002</LicenceNumber>
    <ProductName>VAMIN 9</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1998-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>L-GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE HEPTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004042</DrugIDPK>
    <LicenceNumber>PA0148/010/001</LicenceNumber>
    <ProductName>HMS LIQUIFILM</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1983-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDRYSONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002198</DrugIDPK>
    <LicenceNumber>PPA0465/044/001A</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002199</DrugIDPK>
    <LicenceNumber>PPA0465/044/002A</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002200</DrugIDPK>
    <LicenceNumber>PPA0465/044/003A</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006478</DrugIDPK>
    <LicenceNumber>PA0778/018/004</LicenceNumber>
    <ProductName>ELLESTE DUET</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1998-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011929</DrugIDPK>
    <LicenceNumber>PA0778/018/005</LicenceNumber>
    <ProductName>ELLESTE DUET CONTI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004423</DrugIDPK>
    <LicenceNumber>PA0778/018/003</LicenceNumber>
    <ProductName>ELLESTE-DUET</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004421</DrugIDPK>
    <LicenceNumber>PA0778/018/001</LicenceNumber>
    <ProductName>ELLESTE-SOLO</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004422</DrugIDPK>
    <LicenceNumber>PA0778/018/002</LicenceNumber>
    <ProductName>ELLESTE-SOLO</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001451</DrugIDPK>
    <LicenceNumber>PA0037/020/001</LicenceNumber>
    <ProductName>ZADSTAT</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001455</DrugIDPK>
    <LicenceNumber>PA0037/020/005</LicenceNumber>
    <ProductName>ZADSTAT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011310</DrugIDPK>
    <LicenceNumber>PA1009/009/001</LicenceNumber>
    <ProductName>MENOGON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLICLE-STIMULATING HORMONE, HUMAN</ActiveSubstance>
      <ActiveSubstance>LUTEINISING HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005207</DrugIDPK>
    <LicenceNumber>PA0678/060/001</LicenceNumber>
    <ProductName>BEECHAMS COLD RELIEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1996-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005201</DrugIDPK>
    <LicenceNumber>PA0678/053/001</LicenceNumber>
    <ProductName>BEECHAMS HOT LEMON DECONGESTANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1993-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008829</DrugIDPK>
    <LicenceNumber>PA0620/001/003</LicenceNumber>
    <ProductName>HAVRIX JUNIOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATIT A VIRUS ANTIGEN</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008831</DrugIDPK>
    <LicenceNumber>PA0620/001/004</LicenceNumber>
    <ProductName>HAVRIX JUNIOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATIT A VIRUS ANTIGEN</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005475</DrugIDPK>
    <LicenceNumber>PA0271/002/004</LicenceNumber>
    <ProductName>ISOKET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1983-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005472</DrugIDPK>
    <LicenceNumber>PA0271/002/003</LicenceNumber>
    <ProductName>ISOKET</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1983-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005480</DrugIDPK>
    <LicenceNumber>PA0271/002/006</LicenceNumber>
    <ProductName>ISOKET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1983-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006606</DrugIDPK>
    <LicenceNumber>PA0488/007/003</LicenceNumber>
    <ProductName>ISORDIL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005204</DrugIDPK>
    <LicenceNumber>PA0678/057/001</LicenceNumber>
    <ProductName>TUMS ASSORTED FLAVOUR</ProductName>
    <Strength>mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1996-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005184</DrugIDPK>
    <LicenceNumber>PA0678/046/001</LicenceNumber>
    <ProductName>VALDA PASTILLES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1997-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
      <ActiveSubstance>EXTRACT OF PINEWOOD, COMPOUND</ActiveSubstance>
      <ActiveSubstance>GUAIACOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001630</DrugIDPK>
    <LicenceNumber>PA0271/009/001</LicenceNumber>
    <ProductName>VIRIDAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1996-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001631</DrugIDPK>
    <LicenceNumber>PA0271/009/002</LicenceNumber>
    <ProductName>VIRIDAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1996-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001632</DrugIDPK>
    <LicenceNumber>PA0271/009/003</LicenceNumber>
    <ProductName>VIRIDAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1996-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004422</DrugIDPK>
    <LicenceNumber>PA0167/069/014</LicenceNumber>
    <ProductName>CHLORASEPT 2000 ANTISEPTIC</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004420</DrugIDPK>
    <LicenceNumber>PA0167/069/012</LicenceNumber>
    <ProductName>CHLORASEPT 2000 ANTISEPTIC SOLUTION</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016315</DrugIDPK>
    <LicenceNumber>PA0037/074/001</LicenceNumber>
    <ProductName>PNU-IMUNE VACCINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/BAYERN/7/95 (HINI) - LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009935</DrugIDPK>
    <LicenceNumber>PA0037/074/002</LicenceNumber>
    <ProductName>PNU-IMUNE VACCINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 1 (1)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 2 (2)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 3 (3)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 4 (4)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 5 (5)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 26 (6B)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 51 (7F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 8 (8)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 9N</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 9V</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 34 (10A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 43 (11A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 12 (12F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 14 (14)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 54 (15B)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 17 (17F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 56 (18C)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 57 (19A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 19 (19F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 20 (20)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 22 (22F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 23 (23F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 70 (33F)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005275</DrugIDPK>
    <LicenceNumber>PA0281/007/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005277</DrugIDPK>
    <LicenceNumber>PA0281/007/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011159</DrugIDPK>
    <LicenceNumber>PA0748/033/005</LicenceNumber>
    <ProductName>RETIN-A</ProductName>
    <Strength>0.025%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005612</DrugIDPK>
    <LicenceNumber>PA0285/002/001</LicenceNumber>
    <ProductName>PROFASI</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1983-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005614</DrugIDPK>
    <LicenceNumber>PA0285/002/002</LicenceNumber>
    <ProductName>PROFASI</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1983-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005616</DrugIDPK>
    <LicenceNumber>PA0285/002/003</LicenceNumber>
    <ProductName>PROFASI</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1983-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005617</DrugIDPK>
    <LicenceNumber>PA0285/002/004</LicenceNumber>
    <ProductName>PROFASI</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1983-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012871</DrugIDPK>
    <LicenceNumber>PA0936/030/001</LicenceNumber>
    <ProductName>REHIDRAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SUCROSE</ActiveSubstance>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004120</DrugIDPK>
    <LicenceNumber>PA0013/055/001</LicenceNumber>
    <ProductName>CLIMESSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003993</DrugIDPK>
    <LicenceNumber>PA0810/002/001</LicenceNumber>
    <ProductName>OESCLIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fournier Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003994</DrugIDPK>
    <LicenceNumber>PA0810/002/002</LicenceNumber>
    <ProductName>OESCLIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fournier Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003995</DrugIDPK>
    <LicenceNumber>PA0810/002/003</LicenceNumber>
    <ProductName>OESCLIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fournier Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007854</DrugIDPK>
    <LicenceNumber>PA0810/002/004</LicenceNumber>
    <ProductName>OESCLIM</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Fournier Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007855</DrugIDPK>
    <LicenceNumber>PA0810/002/005</LicenceNumber>
    <ProductName>OESCLIM</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Fournier Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003927</DrugIDPK>
    <LicenceNumber>PA0118/029/001</LicenceNumber>
    <ProductName>EPPY MULTIDOSE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010139</DrugIDPK>
    <LicenceNumber>PA0667/001/001</LicenceNumber>
    <ProductName>REPLENS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Columbia Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1994-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2003-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016331</DrugIDPK>
    <LicenceNumber>PA0669/002/003</LicenceNumber>
    <ProductName>HELIXATE 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016329</DrugIDPK>
    <LicenceNumber>PA0669/002/001</LicenceNumber>
    <ProductName>HELIXATE 250</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016330</DrugIDPK>
    <LicenceNumber>PA0669/002/002</LicenceNumber>
    <ProductName>HELIXATE 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>1999-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010095</DrugIDPK>
    <LicenceNumber>PA0021/041/003</LicenceNumber>
    <ProductName>KOGENATE 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010097</DrugIDPK>
    <LicenceNumber>PA0021/041/001</LicenceNumber>
    <ProductName>KOGENATE 250</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010096</DrugIDPK>
    <LicenceNumber>PA0021/041/002</LicenceNumber>
    <ProductName>KOGENATE 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005693</DrugIDPK>
    <LicenceNumber>PA0271/008/003</LicenceNumber>
    <ProductName>PERDIX PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1998-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOEXIPRIL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005694</DrugIDPK>
    <LicenceNumber>PA0271/008/004</LicenceNumber>
    <ProductName>PERDIX PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1998-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOEXIPRIL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001166</DrugIDPK>
    <LicenceNumber>PA0021/039/001</LicenceNumber>
    <ProductName>TABCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000924</DrugIDPK>
    <LicenceNumber>PA0019/043/003</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>4 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000930</DrugIDPK>
    <LicenceNumber>PA0019/043/004</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>8 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009715</DrugIDPK>
    <LicenceNumber>PA0975/002/001</LicenceNumber>
    <ProductName>RAXAR</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Otsuka Pharma GmbH</PAHolder>
    <AuthorisedDate>1997-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GREPAFLOXACIN HYDROCHLORIDE SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009716</DrugIDPK>
    <LicenceNumber>PA0975/002/002</LicenceNumber>
    <ProductName>RAXAR</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Otsuka Pharma GmbH</PAHolder>
    <AuthorisedDate>1997-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GREPAFLOXACIN HYDROCHLORIDE SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006531</DrugIDPK>
    <LicenceNumber>PA0469/005/001</LicenceNumber>
    <ProductName>MINOXIDIL BIOGLAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1992-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOXIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007658</DrugIDPK>
    <LicenceNumber>PA0271/002/011</LicenceNumber>
    <ProductName>ISOKET 0.05% I.C. 10ML PREFILLED SYRINGE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006244</DrugIDPK>
    <LicenceNumber>PA0415/008/001</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005389</DrugIDPK>
    <LicenceNumber>PA0271/004/002</LicenceNumber>
    <ProductName>PHASONIT 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1988-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005388</DrugIDPK>
    <LicenceNumber>PA0271/004/001</LicenceNumber>
    <ProductName>PHASONIT 5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1986-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011296</DrugIDPK>
    <LicenceNumber>PA1009/002/001</LicenceNumber>
    <ProductName>CARBEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005736</DrugIDPK>
    <LicenceNumber>PA0337/006/001</LicenceNumber>
    <ProductName>KIDDI PHARMATON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PANTHENOL</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009043</DrugIDPK>
    <LicenceNumber>PA0013/097/001</LicenceNumber>
    <ProductName>MENOREST</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009044</DrugIDPK>
    <LicenceNumber>PA0013/097/002</LicenceNumber>
    <ProductName>MENOREST</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009045</DrugIDPK>
    <LicenceNumber>PA0013/097/003</LicenceNumber>
    <ProductName>MENOREST</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009046</DrugIDPK>
    <LicenceNumber>PA0013/097/004</LicenceNumber>
    <ProductName>MENOREST</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001667</DrugIDPK>
    <LicenceNumber>PA0690/019/001</LicenceNumber>
    <ProductName>TECHNESCAN Q12</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mallinckrodt Medical B.V.</PAHolder>
    <AuthorisedDate>1998-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIFOSMIN</ActiveSubstance>
      <ActiveSubstance>FUROMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003695</DrugIDPK>
    <LicenceNumber>PA0729/001/001</LicenceNumber>
    <ProductName>FERRISELTZ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bracco SPA</PAHolder>
    <AuthorisedDate>1997-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRIC AMMONIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008539</DrugIDPK>
    <LicenceNumber>PPA0465/012/004B</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006375</DrugIDPK>
    <LicenceNumber>PPA0465/011/001A</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006376</DrugIDPK>
    <LicenceNumber>PPA0465/011/002A</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014808</DrugIDPK>
    <LicenceNumber>PPA0465/011/001B</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007962</DrugIDPK>
    <LicenceNumber>PPA0465/011/002B</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003046</DrugIDPK>
    <LicenceNumber>PPA0465/041/003A</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014599</DrugIDPK>
    <LicenceNumber>PPA0465/041/003B</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014600</DrugIDPK>
    <LicenceNumber>PPA0465/041/003C</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007203</DrugIDPK>
    <LicenceNumber>PPA0465/029/002A</LicenceNumber>
    <ProductName>CALPOL SIX PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009255</DrugIDPK>
    <LicenceNumber>PPA0465/063/001A</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009261</DrugIDPK>
    <LicenceNumber>PPA0465/063/003A</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009262</DrugIDPK>
    <LicenceNumber>PPA0465/063/003D</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009263</DrugIDPK>
    <LicenceNumber>PPA0465/063/003B</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009264</DrugIDPK>
    <LicenceNumber>PPA0465/063/003C</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014596</DrugIDPK>
    <LicenceNumber>PPA0465/037/002B</LicenceNumber>
    <ProductName>FELDENDE DISPERSIBLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009237</DrugIDPK>
    <LicenceNumber>PPA0465/037/001A</LicenceNumber>
    <ProductName>FELDENE DISPERSIBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009239</DrugIDPK>
    <LicenceNumber>PPA0465/037/002A</LicenceNumber>
    <ProductName>FELDENE DISPERSIBLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014597</DrugIDPK>
    <LicenceNumber>PPA0465/037/002C</LicenceNumber>
    <ProductName>FELDENE DISPERSIBLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014598</DrugIDPK>
    <LicenceNumber>PPA0465/037/002D</LicenceNumber>
    <ProductName>FELDENE DISPERSIBLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014595</DrugIDPK>
    <LicenceNumber>PPA0465/037/001B</LicenceNumber>
    <ProductName>FELDENE DISPERSIBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007500</DrugIDPK>
    <LicenceNumber>PPA0465/039/002A</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007501</DrugIDPK>
    <LicenceNumber>PPA0465/039/002B</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009235</DrugIDPK>
    <LicenceNumber>PPA0465/036/001A</LicenceNumber>
    <ProductName>OPTICROM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014594</DrugIDPK>
    <LicenceNumber>PPA0465/036/001B</LicenceNumber>
    <ProductName>OPTICROM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008115</DrugIDPK>
    <LicenceNumber>PA0936/007/001</LicenceNumber>
    <ProductName>KAOPECTATE</ProductName>
    <Strength>1.03</Strength>
    <StrengthMeasurement>g/5ml</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007527</DrugIDPK>
    <LicenceNumber>PA0736/012/001</LicenceNumber>
    <ProductName>FENTANYL B. BRAUN</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007528</DrugIDPK>
    <LicenceNumber>PA0736/012/002</LicenceNumber>
    <ProductName>FENTANYL B. BRAUN</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007529</DrugIDPK>
    <LicenceNumber>PA0736/012/003</LicenceNumber>
    <ProductName>FENTANYL B. BRAUN</ProductName>
    <Strength>0.50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008069</DrugIDPK>
    <LicenceNumber>PA0936/001/002</LicenceNumber>
    <ProductName>CYKLO Q</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANEXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004636</DrugIDPK>
    <LicenceNumber>PA0187/013/004</LicenceNumber>
    <ProductName>KABIKINASE IV MI</ProductName>
    <Strength>750,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004638</DrugIDPK>
    <LicenceNumber>PA0187/013/005</LicenceNumber>
    <ProductName>KABIKINASE IV MI</ProductName>
    <Strength>1,500,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004052</DrugIDPK>
    <LicenceNumber>PA0148/023/001</LicenceNumber>
    <ProductName>CHLOROPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001947</DrugIDPK>
    <LicenceNumber>PA0073/121/004</LicenceNumber>
    <ProductName>VASOFED RETARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005044</DrugIDPK>
    <LicenceNumber>PA0236/013/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005046</DrugIDPK>
    <LicenceNumber>PA0236/013/003</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000451</DrugIDPK>
    <LicenceNumber>PA0236/013/002</LicenceNumber>
    <ProductName>CISPLATIN VIALS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002280</DrugIDPK>
    <LicenceNumber>PA0016/047/003</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009016</DrugIDPK>
    <LicenceNumber>PA0016/047/001</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000730</DrugIDPK>
    <LicenceNumber>PA0016/020/002</LicenceNumber>
    <ProductName>MEDRONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003821</DrugIDPK>
    <LicenceNumber>PA0126/012/003</LicenceNumber>
    <ProductName>MELFEN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005023</DrugIDPK>
    <LicenceNumber>PA0236/020/001</LicenceNumber>
    <ProductName>OLBETAM</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACIPIMOX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004196</DrugIDPK>
    <LicenceNumber>PA0016/054/001</LicenceNumber>
    <ProductName>VERYL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1998-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005004</DrugIDPK>
    <LicenceNumber>PA0016/054/003</LicenceNumber>
    <ProductName>VERYL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1998-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002165</DrugIDPK>
    <LicenceNumber>PA0046/016/008</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001492</DrugIDPK>
    <LicenceNumber>PA0037/023/016</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001481</DrugIDPK>
    <LicenceNumber>PA0037/023/009</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001486</DrugIDPK>
    <LicenceNumber>PA0037/023/012</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001487</DrugIDPK>
    <LicenceNumber>PA0037/023/013</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001489</DrugIDPK>
    <LicenceNumber>PA0037/023/014</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001467</DrugIDPK>
    <LicenceNumber>PA0037/023/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001468</DrugIDPK>
    <LicenceNumber>PA0037/023/002</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001470</DrugIDPK>
    <LicenceNumber>PA0037/023/004</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001471</DrugIDPK>
    <LicenceNumber>PA0037/023/005</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001473</DrugIDPK>
    <LicenceNumber>PA0037/023/006</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001474</DrugIDPK>
    <LicenceNumber>PA0037/023/007</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001476</DrugIDPK>
    <LicenceNumber>PA0037/023/008</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1980-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006674</DrugIDPK>
    <LicenceNumber>PA0516/010/002</LicenceNumber>
    <ProductName>NAPRELAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1990-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002818</DrugIDPK>
    <LicenceNumber>PA0046/039/004</LicenceNumber>
    <ProductName>UNIHEP LEO</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002198</DrugIDPK>
    <LicenceNumber>PA0046/039/001</LicenceNumber>
    <ProductName>UNIHEP LEO 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002202</DrugIDPK>
    <LicenceNumber>PA0046/039/003</LicenceNumber>
    <ProductName>UNIHEP LEO 10000</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002205</DrugIDPK>
    <LicenceNumber>PA0046/039/002</LicenceNumber>
    <ProductName>UNIHEP LEO 5000</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000731</DrugIDPK>
    <LicenceNumber>PA0016/020/003</LicenceNumber>
    <ProductName>MEDRONE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003592</DrugIDPK>
    <LicenceNumber>PA0016/052/001</LicenceNumber>
    <ProductName>VINCRISOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1997-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004032</DrugIDPK>
    <LicenceNumber>PA0148/042/001</LicenceNumber>
    <ProductName>OCUFEN LIQUIFILM OPHTHALMIC</ProductName>
    <Strength>0.03</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1987-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN SODIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001084</DrugIDPK>
    <LicenceNumber>PA0021/001/001</LicenceNumber>
    <ProductName>TRASYLOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APROTININ</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001085</DrugIDPK>
    <LicenceNumber>PA0021/001/002</LicenceNumber>
    <ProductName>TRASYLOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APROTININ</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010932</DrugIDPK>
    <LicenceNumber>PA1001/006/001</LicenceNumber>
    <ProductName>TUBERCULIN PPD</ProductName>
    <Strength>1000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1997-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TUBERCULIN PPD</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003129</DrugIDPK>
    <LicenceNumber>PA0073/007/001</LicenceNumber>
    <ProductName>CHENOFALK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHENODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003073</DrugIDPK>
    <LicenceNumber>PA0062/022/002</LicenceNumber>
    <ProductName>DE-NOLTAB</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPOTASSIUM DICITRATO BISMUTHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005896</DrugIDPK>
    <LicenceNumber>PA0372/003/001</LicenceNumber>
    <ProductName>LUGACIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1987-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005897</DrugIDPK>
    <LicenceNumber>PA0372/003/002</LicenceNumber>
    <ProductName>LUGACIN PAEDIATRIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1987-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010716</DrugIDPK>
    <LicenceNumber>PA0828/006/001</LicenceNumber>
    <ProductName>BENPERIDOL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Concord Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003673</DrugIDPK>
    <LicenceNumber>PA0108/012/001</LicenceNumber>
    <ProductName>DUVADILAN RETARD</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003397</DrugIDPK>
    <LicenceNumber>PA0077/092/001</LicenceNumber>
    <ProductName>GASTRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1988-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE DRIED</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001517</DrugIDPK>
    <LicenceNumber>PA0037/026/001</LicenceNumber>
    <ProductName>LEDERFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001519</DrugIDPK>
    <LicenceNumber>PA0037/026/002</LicenceNumber>
    <ProductName>LEDERFEN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003674</DrugIDPK>
    <LicenceNumber>PA0108/013/003</LicenceNumber>
    <ProductName>YUTOPAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RITODRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000138</DrugIDPK>
    <LicenceNumber>PA0072/006/001</LicenceNumber>
    <ProductName>DELSYM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001188</DrugIDPK>
    <LicenceNumber>PA0022/013/001</LicenceNumber>
    <ProductName>OVRAN 30</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1978-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004598</DrugIDPK>
    <LicenceNumber>PA0711/026/001</LicenceNumber>
    <ProductName>ATE-NIFE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003634</DrugIDPK>
    <LicenceNumber>PA0711/018/001</LicenceNumber>
    <ProductName>BROMOX</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMOCRIPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003635</DrugIDPK>
    <LicenceNumber>PA0711/018/002</LicenceNumber>
    <ProductName>BROMOX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMOCRIPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003636</DrugIDPK>
    <LicenceNumber>PA0711/018/003</LicenceNumber>
    <ProductName>BROMOX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMOCRIPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005378</DrugIDPK>
    <LicenceNumber>PA0711/002/005</LicenceNumber>
    <ProductName>CAPTOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014847</DrugIDPK>
    <LicenceNumber>PA0002/072/004</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014848</DrugIDPK>
    <LicenceNumber>PA0002/072/005</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014468</DrugIDPK>
    <LicenceNumber>PA0711/044/003</LicenceNumber>
    <ProductName>CEDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2001-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016335</DrugIDPK>
    <LicenceNumber>PA0711/006/001</LicenceNumber>
    <ProductName>FRUDEX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002886</DrugIDPK>
    <LicenceNumber>PA0057/051/001</LicenceNumber>
    <ProductName>SUPER PLENAMINS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>DEXPANTHENOL</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>FERROUS SULFATE EXSICCATED</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>POTASSIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE PENTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SULFATE DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002914</DrugIDPK>
    <LicenceNumber>PA0711/015/001</LicenceNumber>
    <ProductName>TERFEN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2000-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003645</DrugIDPK>
    <LicenceNumber>PA0711/019/001</LicenceNumber>
    <ProductName>TIMOLOL MALEATE OPHTHALMIC</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1991-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003646</DrugIDPK>
    <LicenceNumber>PA0711/019/002</LicenceNumber>
    <ProductName>TIMOLOL MALEATE OPHTHALMIC</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1991-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003647</DrugIDPK>
    <LicenceNumber>PA0711/019/003</LicenceNumber>
    <ProductName>TIMOLOL MALEATE OPHTHALMIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1991-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015333</DrugIDPK>
    <LicenceNumber>PA0549/012/001</LicenceNumber>
    <ProductName>TOPFEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1997-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015334</DrugIDPK>
    <LicenceNumber>PA0549/012/002</LicenceNumber>
    <ProductName>TOPFEN CR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1997-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015335</DrugIDPK>
    <LicenceNumber>PA0549/012/003</LicenceNumber>
    <ProductName>TOPFEN CR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1997-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000892</DrugIDPK>
    <LicenceNumber>PA0019/037/001</LicenceNumber>
    <ProductName>FASIGYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TINIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000880</DrugIDPK>
    <LicenceNumber>PA0019/033/001</LicenceNumber>
    <ProductName>GYNO-TROSYL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010925</DrugIDPK>
    <LicenceNumber>PA1001/001/002</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1999-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010926</DrugIDPK>
    <LicenceNumber>PA1001/001/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1999-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010929</DrugIDPK>
    <LicenceNumber>PA1001/003/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA VACCINE BP (CHILD)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1999-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010927</DrugIDPK>
    <LicenceNumber>PA1001/002/002</LicenceNumber>
    <ProductName>ADSORBED TETANUS VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1999-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010928</DrugIDPK>
    <LicenceNumber>PA1001/002/001</LicenceNumber>
    <ProductName>ADSORBED TETANUS VACCINE BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1999-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010930</DrugIDPK>
    <LicenceNumber>PA1001/004/001</LicenceNumber>
    <ProductName>ARILVAX YELLOW FEVER VACCINE LIVE B.P.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>1999-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YELLOW FEVER VIRUS STRAIN 17D</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010933</DrugIDPK>
    <LicenceNumber>PA1001/007/001</LicenceNumber>
    <ProductName>BCG VACCINE INTRADERMAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>2000-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BCG VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008940</DrugIDPK>
    <LicenceNumber>PA0303/027/001</LicenceNumber>
    <ProductName>BUSORIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008945</DrugIDPK>
    <LicenceNumber>PA0303/027/002</LicenceNumber>
    <ProductName>BUSORIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008581</DrugIDPK>
    <LicenceNumber>PA0108/021/002</LicenceNumber>
    <ProductName>FEMOSTON 2/20</ProductName>
    <Strength>2 mg, 20 m</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>DYDROGESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005425</DrugIDPK>
    <LicenceNumber>PA0855/018/001</LicenceNumber>
    <ProductName>LASORIDE</ProductName>
    <Strength>40/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009417</DrugIDPK>
    <LicenceNumber>PA0872/005/002</LicenceNumber>
    <ProductName>FEMATRIX 80</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma International Ltd</PAHolder>
    <AuthorisedDate>2000-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004159</DrugIDPK>
    <LicenceNumber>PA0577/027/001</LicenceNumber>
    <ProductName>MEFENAMIC ACID</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008721</DrugIDPK>
    <LicenceNumber>PA0199/004/002</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009077</DrugIDPK>
    <LicenceNumber>PA0077/142/001</LicenceNumber>
    <ProductName>ASPEGIC 100</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLATE LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009079</DrugIDPK>
    <LicenceNumber>PA0077/142/003</LicenceNumber>
    <ProductName>ASPEGIC 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLATE LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009078</DrugIDPK>
    <LicenceNumber>PA0077/142/002</LicenceNumber>
    <ProductName>ASPEGIC 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>2000-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLATE LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006600</DrugIDPK>
    <LicenceNumber>PA0488/005/001</LicenceNumber>
    <ProductName>BARATOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDORAMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006601</DrugIDPK>
    <LicenceNumber>PA0488/005/002</LicenceNumber>
    <ProductName>BARATOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDORAMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009273</DrugIDPK>
    <LicenceNumber>PA0516/022/001</LicenceNumber>
    <ProductName>ERYMIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1998-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003376</DrugIDPK>
    <LicenceNumber>PA0077/050/001</LicenceNumber>
    <ProductName>FERGON</ProductName>
    <Strength>310</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006604</DrugIDPK>
    <LicenceNumber>PA0488/007/001</LicenceNumber>
    <ProductName>ISORDIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006605</DrugIDPK>
    <LicenceNumber>PA0488/007/002</LicenceNumber>
    <ProductName>ISORDIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004660</DrugIDPK>
    <LicenceNumber>PA0179/032/002</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001848</DrugIDPK>
    <LicenceNumber>PA0516/023/001</LicenceNumber>
    <ProductName>UNIVER</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1993-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001849</DrugIDPK>
    <LicenceNumber>PA0516/023/002</LicenceNumber>
    <ProductName>UNIVER</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1993-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004635</DrugIDPK>
    <LicenceNumber>PA0179/009/008</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016299</DrugIDPK>
    <LicenceNumber>PA0678/006/001</LicenceNumber>
    <ProductName>EOLARIX VACCINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011305</DrugIDPK>
    <LicenceNumber>PA1009/006/004</LicenceNumber>
    <ProductName>PENTASA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003026</DrugIDPK>
    <LicenceNumber>PA0060/036/001</LicenceNumber>
    <ProductName>RIMEVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1984-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002055</DrugIDPK>
    <LicenceNumber>PA0773/001/001</LicenceNumber>
    <ProductName>HESPAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Austria GmbH</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HETASTARCH</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006530</DrugIDPK>
    <LicenceNumber>PA0469/004/001</LicenceNumber>
    <ProductName>METAZEM</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005143</DrugIDPK>
    <LicenceNumber>PA0748/014/002</LicenceNumber>
    <ProductName>PANCREASE HI LIPASE</ProductName>
    <Strength>387.45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003257</DrugIDPK>
    <LicenceNumber>PA0073/109/004</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003258</DrugIDPK>
    <LicenceNumber>PA0073/109/005</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007716</DrugIDPK>
    <LicenceNumber>PA0073/109/003</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008943</DrugIDPK>
    <LicenceNumber>PA0488/009/001</LicenceNumber>
    <ProductName>EXPULIN CHESTY COUGH LINCTUS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009182</DrugIDPK>
    <LicenceNumber>PA0363/008/001</LicenceNumber>
    <ProductName>ANTABUSE EFFERVESCENT</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alpharma ApS</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISULFIRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005300</DrugIDPK>
    <LicenceNumber>PA0281/024/001</LicenceNumber>
    <ProductName>PURINOL - ALLOPURINOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1982-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005301</DrugIDPK>
    <LicenceNumber>PA0281/024/002</LicenceNumber>
    <ProductName>PURINOL - ALLOPURINOL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1982-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005671</DrugIDPK>
    <LicenceNumber>PA0290/058/001</LicenceNumber>
    <ProductName>ISOPTO CARPINE 0.5%</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005674</DrugIDPK>
    <LicenceNumber>PA0290/058/004</LicenceNumber>
    <ProductName>ISOPTO CARPINE 3.0%</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005856</DrugIDPK>
    <LicenceNumber>PA0697/005/001</LicenceNumber>
    <ProductName>ENFLURANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fresenius AG</PAHolder>
    <AuthorisedDate>1997-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002044</DrugIDPK>
    <LicenceNumber>PA0046/004/006</LicenceNumber>
    <ProductName>FUCIDIN INTERTULLE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003532</DrugIDPK>
    <LicenceNumber>PA0793/001/001</LicenceNumber>
    <ProductName>ISOFLURANE MEDEVA EUROPE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Celltech Pharma Europe Limited</PAHolder>
    <AuthorisedDate>1997-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009201</DrugIDPK>
    <LicenceNumber>PA0437/005/011</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009203</DrugIDPK>
    <LicenceNumber>PA0437/005/012</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009205</DrugIDPK>
    <LicenceNumber>PA0437/005/013</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1997-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004688</DrugIDPK>
    <LicenceNumber>PA0499/001/002</LicenceNumber>
    <ProductName>PROLEUKIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Chiron B.V.</PAHolder>
    <AuthorisedDate>1998-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALDESLEUKIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006579</DrugIDPK>
    <LicenceNumber>PA0484/011/001</LicenceNumber>
    <ProductName>SURGICAL SPIRIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1992-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>ETHYL PHTHALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000524</DrugIDPK>
    <LicenceNumber>PA0016/054/002</LicenceNumber>
    <ProductName>VERYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1997-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011045</DrugIDPK>
    <LicenceNumber>PA0540/073/001</LicenceNumber>
    <ProductName>SUPRECUR DEPOT</ProductName>
    <Strength>3.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSERELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001719</DrugIDPK>
    <LicenceNumber>PA0016/050/002</LicenceNumber>
    <ProductName>LOMEXIN PESSARY</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001720</DrugIDPK>
    <LicenceNumber>PA0016/050/003</LicenceNumber>
    <ProductName>LOMEXIN VAGINAL CREAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005839</DrugIDPK>
    <LicenceNumber>PA0303/034/001</LicenceNumber>
    <ProductName>ELDOPAR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1999-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005840</DrugIDPK>
    <LicenceNumber>PA0303/034/002</LicenceNumber>
    <ProductName>ELDOPAR</ProductName>
    <Strength>250/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1999-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004018</DrugIDPK>
    <LicenceNumber>PA0148/030/001</LicenceNumber>
    <ProductName>OPHTHETIC STERILE OPTHALMIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPARACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005323</DrugIDPK>
    <LicenceNumber>PA0281/044/001</LicenceNumber>
    <ProductName>PINALGESIC</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1987-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011420</DrugIDPK>
    <LicenceNumber>EU/1/01/171/003</LicenceNumber>
    <ProductName>RAPAMUNE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate>2001-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011421</DrugIDPK>
    <LicenceNumber>EU/1/01/171/004</LicenceNumber>
    <ProductName>RAPAMUNE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate>2001-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005191</DrugIDPK>
    <LicenceNumber>PA0678/047/001</LicenceNumber>
    <ProductName>CONTAC 400</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009416</DrugIDPK>
    <LicenceNumber>PA0872/005/001</LicenceNumber>
    <ProductName>FEMATRIX 40</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma International Ltd</PAHolder>
    <AuthorisedDate>1996-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011833</DrugIDPK>
    <LicenceNumber>PA0757/007/002</LicenceNumber>
    <ProductName>PABRINEX IMHP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>1997-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005192</DrugIDPK>
    <LicenceNumber>PA0678/041/001</LicenceNumber>
    <ProductName>ENOS FRUIT SALTS</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1997-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>TARTARIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005192</DrugIDPK>
    <LicenceNumber>PA0678/041/001</LicenceNumber>
    <ProductName>ENOS FRUIT SALTS</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1997-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>TARTARIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007483</DrugIDPK>
    <LicenceNumber>PA0743/010/001</LicenceNumber>
    <ProductName>BREXIDOL SACHETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1997-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM BETADEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003035</DrugIDPK>
    <LicenceNumber>PA0060/048/002</LicenceNumber>
    <ProductName>CORACTEN SPANSULE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014585</DrugIDPK>
    <LicenceNumber>PPA0465/020/001B</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014586</DrugIDPK>
    <LicenceNumber>PPA0465/020/002B</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006390</DrugIDPK>
    <LicenceNumber>PPA0465/020/001A</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006391</DrugIDPK>
    <LicenceNumber>PPA0465/020/002A</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006392</DrugIDPK>
    <LicenceNumber>PPA0465/020/003A</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001118</DrugIDPK>
    <LicenceNumber>PA0021/013/001</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001120</DrugIDPK>
    <LicenceNumber>PA0021/013/002</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001121</DrugIDPK>
    <LicenceNumber>PA0021/013/003</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001122</DrugIDPK>
    <LicenceNumber>PA0021/013/004</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>20.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001123</DrugIDPK>
    <LicenceNumber>PA0021/013/005</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1993-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001125</DrugIDPK>
    <LicenceNumber>PA0021/013/006</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001126</DrugIDPK>
    <LicenceNumber>PA0021/013/007</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014801</DrugIDPK>
    <LicenceNumber>PPA0465/012/003B</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014802</DrugIDPK>
    <LicenceNumber>PPA0465/012/003C</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995014803</DrugIDPK>
    <LicenceNumber>PPA0465/012/003D</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006379</DrugIDPK>
    <LicenceNumber>PPA0465/012/003A</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006364</DrugIDPK>
    <LicenceNumber>PPA0465/008/001A</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006366</DrugIDPK>
    <LicenceNumber>PPA0465/008/002A</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005313</DrugIDPK>
    <LicenceNumber>PA0748/017/001</LicenceNumber>
    <ProductName>GYNO-PEVARYL 150 COMBIPACK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002575</DrugIDPK>
    <LicenceNumber>PA0544/021/001</LicenceNumber>
    <ProductName>PNEUMOVAX II</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1995-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 1 (1)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 2 (2)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 3 (3)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 4 (4)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 5 (5)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 8 (8)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 9 (9)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 12 (12F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 14 (14)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 17 (17F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 19 (19F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 20 (20)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 22 (22F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 23 (23F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 26 (6B)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 34 (10A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 43 (11A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 51 (7F)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 54 (15B)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 56 (18C)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 57 (19A)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 68 (9L)</ActiveSubstance>
      <ActiveSubstance>PNEUMOCOCCAL POLYSACCHARIDE TYPE 70 (33F)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003893</DrugIDPK>
    <LicenceNumber>PA0809/001/002</LicenceNumber>
    <ProductName>FLUORO-URACIL ROCHE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lifehealth Limited</PAHolder>
    <AuthorisedDate>1992-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006620</DrugIDPK>
    <LicenceNumber>EU/1/99/115/001</LicenceNumber>
    <ProductName>VITRAVENE</ProductName>
    <Strength>6.6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Ophthalmics Europe Ltd</PAHolder>
    <AuthorisedDate>1999-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOMIVIRSEN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003865</DrugIDPK>
    <LicenceNumber>PA0126/034/001</LicenceNumber>
    <ProductName>ANTI-HIST</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012285</DrugIDPK>
    <LicenceNumber>PPA0465/002/003A</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000514</DrugIDPK>
    <LicenceNumber>PA0549/006/001</LicenceNumber>
    <ProductName>ETHYPHARM PARACETAMOL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000517</DrugIDPK>
    <LicenceNumber>PA0549/006/003</LicenceNumber>
    <ProductName>ETHYPHARM PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000528</DrugIDPK>
    <LicenceNumber>PA0549/006/002</LicenceNumber>
    <ProductName>ETHYPHARM PARACETAMOL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010405</DrugIDPK>
    <LicenceNumber>PPA0465/046/001B</LicenceNumber>
    <ProductName>TENORETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010406</DrugIDPK>
    <LicenceNumber>PPA0465/046/001C</LicenceNumber>
    <ProductName>TENORETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010407</DrugIDPK>
    <LicenceNumber>PPA0465/046/001D</LicenceNumber>
    <ProductName>TENORETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995015115</DrugIDPK>
    <LicenceNumber>PA1058/003/001</LicenceNumber>
    <ProductName>DIUREXAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MEDA Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XIPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005852</DrugIDPK>
    <LicenceNumber>PA0303/017/001</LicenceNumber>
    <ProductName>KEFEXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005853</DrugIDPK>
    <LicenceNumber>PA0303/017/002</LicenceNumber>
    <ProductName>KEFEXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001982</DrugIDPK>
    <LicenceNumber>PA0040/069/001</LicenceNumber>
    <ProductName>SECADREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEBUTOLOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLORTHIAZIDE VENALE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003353</DrugIDPK>
    <LicenceNumber>PA0077/008/002</LicenceNumber>
    <ProductName>BENORAL</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007295</DrugIDPK>
    <LicenceNumber>EU/1/96/027/002</LicenceNumber>
    <ProductName>HYCAMTIN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012872</DrugIDPK>
    <LicenceNumber>PA0936/030/002</LicenceNumber>
    <ProductName>REHIDRAT ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1997-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SUCROSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006720</DrugIDPK>
    <LicenceNumber>PA0170/019/001</LicenceNumber>
    <ProductName>ALORA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006721</DrugIDPK>
    <LicenceNumber>PA0170/019/002</LicenceNumber>
    <ProductName>ALORA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006722</DrugIDPK>
    <LicenceNumber>PA0170/019/003</LicenceNumber>
    <ProductName>ALORA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006292</DrugIDPK>
    <LicenceNumber>PA0456/001/001</LicenceNumber>
    <ProductName>CALSALETTES</ProductName>
    <Strength>38</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Torbet Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009271</DrugIDPK>
    <LicenceNumber>PA0111/002/004</LicenceNumber>
    <ProductName>RIMACTANE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>1997-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006470</DrugIDPK>
    <LicenceNumber>PA0468/016/002</LicenceNumber>
    <ProductName>MAALOX TC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE GEL 30 %</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005351</DrugIDPK>
    <LicenceNumber>PA0258/029/001</LicenceNumber>
    <ProductName>REGULETT</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1987-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN YELLOW</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006341</DrugIDPK>
    <LicenceNumber>PA0437/001/001</LicenceNumber>
    <ProductName>STERILE CO-TRIMOXAZOLE CONCENTRATE BP</ProductName>
    <Strength>400/80</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1987-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001850</DrugIDPK>
    <LicenceNumber>PA0038/064/001</LicenceNumber>
    <ProductName>ATRACURIUM BESYLATE 2.5ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATRACURIUM BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001851</DrugIDPK>
    <LicenceNumber>PA0038/064/002</LicenceNumber>
    <ProductName>ATRACURIUM BESYLATE 5.0ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ATRACURIUM BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001566</DrugIDPK>
    <LicenceNumber>PA0037/045/006</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1987-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008757</DrugIDPK>
    <LicenceNumber>PA0012/087/001</LicenceNumber>
    <ProductName>CLIMARA DUO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1999-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006607</DrugIDPK>
    <LicenceNumber>PA0488/007/004</LicenceNumber>
    <ProductName>ISORDIL TEMBIDS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007947</DrugIDPK>
    <LicenceNumber>PA0488/020/001</LicenceNumber>
    <ProductName>RAMODAR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETODOLAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007948</DrugIDPK>
    <LicenceNumber>PA0488/020/002</LicenceNumber>
    <ProductName>RAMODAR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETODOLAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007949</DrugIDPK>
    <LicenceNumber>PA0488/020/003</LicenceNumber>
    <ProductName>RAMODAR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETODOLAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002075</DrugIDPK>
    <LicenceNumber>PA0041/016/001</LicenceNumber>
    <ProductName>KOLANTICON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE LIGHT</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003437</DrugIDPK>
    <LicenceNumber>PA0540/007/001</LicenceNumber>
    <ProductName>ZOLERIM</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1998-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005855</DrugIDPK>
    <LicenceNumber>PA0540/012/002</LicenceNumber>
    <ProductName>ZOPICLONE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000660</DrugIDPK>
    <LicenceNumber>PA0010/022/005A</LicenceNumber>
    <ProductName>ALBUMINAR 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000667</DrugIDPK>
    <LicenceNumber>PA0010/022/008A</LicenceNumber>
    <ProductName>ALBUMINAR 25</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000653</DrugIDPK>
    <LicenceNumber>PA0010/022/002A</LicenceNumber>
    <ProductName>ALBUMINAR 5</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016537</DrugIDPK>
    <LicenceNumber>EU/1/97/41/001</LicenceNumber>
    <ProductName>ORLAAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sipaco Internacional LDA</PAHolder>
    <AuthorisedDate>1997-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVACETYL METHADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006000</DrugIDPK>
    <LicenceNumber>EU/1/98/079/001</LicenceNumber>
    <ProductName>ZARTRA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Laboratories 3M Sante</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIQUIMOD</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006698</DrugIDPK>
    <LicenceNumber>PA0516/018/002</LicenceNumber>
    <ProductName>NICONIL 11</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1992-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007847</DrugIDPK>
    <LicenceNumber>PA0757/004/002</LicenceNumber>
    <ProductName>THIOPENTONE SODIUM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>1997-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPENTAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008266</DrugIDPK>
    <LicenceNumber>PA0281/091/001</LicenceNumber>
    <ProductName>BERKMYCEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1998-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008263</DrugIDPK>
    <LicenceNumber>PA0281/089/001</LicenceNumber>
    <ProductName>IMBRILON</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1998-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008265</DrugIDPK>
    <LicenceNumber>PA0281/090/001</LicenceNumber>
    <ProductName>TETRACHEL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1998-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008760</DrugIDPK>
    <LicenceNumber>PA0281/094/002</LicenceNumber>
    <ProductName>TRIMOPAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008761</DrugIDPK>
    <LicenceNumber>PA0281/094/003</LicenceNumber>
    <ProductName>TRIMOPAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000604</DrugIDPK>
    <LicenceNumber>PA0077/132/001</LicenceNumber>
    <ProductName>TERFENADINE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008722</DrugIDPK>
    <LicenceNumber>EU/1/99/119/004</LicenceNumber>
    <ProductName>NOVORAPID NOVOLET</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN ASPART</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008720</DrugIDPK>
    <LicenceNumber>EU/1/99/119/002</LicenceNumber>
    <ProductName>NOVORAPID PENFILL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1999-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN ASPART</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002881</DrugIDPK>
    <LicenceNumber>PA0062/035/001</LicenceNumber>
    <ProductName>DERMAMIST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WHITE SOFT PARAFFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006300</DrugIDPK>
    <LicenceNumber>PA0436/007/002</LicenceNumber>
    <ProductName>SALOMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1987-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001653</DrugIDPK>
    <LicenceNumber>PA0038/009/005</LicenceNumber>
    <ProductName>ERYTHROPED ADULT SINGLE DOSE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1986-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009476</DrugIDPK>
    <LicenceNumber>PA0231/008/001</LicenceNumber>
    <ProductName>ALUDROX LIQUID</ProductName>
    <Strength>4.16</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1997-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007497</DrugIDPK>
    <LicenceNumber>PA0231/006/001</LicenceNumber>
    <ProductName>ALUDROX MH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE MAGNESIUM CARBONATE CO-DRIED GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008255</DrugIDPK>
    <LicenceNumber>PA0281/085/001</LicenceNumber>
    <ProductName>DICLO (ENTERIC-COATED)</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1999-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009475</DrugIDPK>
    <LicenceNumber>PA0231/007/001</LicenceNumber>
    <ProductName>ISOGEL</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1997-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISPAGHULA HUSKS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002856</DrugIDPK>
    <LicenceNumber>PA0230/006/002</LicenceNumber>
    <ProductName>PULMOCLASE</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB S.A.</PAHolder>
    <AuthorisedDate>1995-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002858</DrugIDPK>
    <LicenceNumber>PA0230/006/004</LicenceNumber>
    <ProductName>PULMOCLASE ADULT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>UCB S.A.</PAHolder>
    <AuthorisedDate>1993-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005098</DrugIDPK>
    <LicenceNumber>PA0240/003/001</LicenceNumber>
    <ProductName>SEHCAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004940</DrugIDPK>
    <LicenceNumber>PA0231/003/002</LicenceNumber>
    <ProductName>TCP BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1986-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
      <ActiveSubstance>HALOGENATED PHENOLS</ActiveSubstance>
      <ActiveSubstance>SODIUM SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004944</DrugIDPK>
    <LicenceNumber>PA0231/003/004</LicenceNumber>
    <ProductName>TCP HONEY &amp; MENTHOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1994-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
      <ActiveSubstance>HALOGENATED PHENOLS</ActiveSubstance>
      <ActiveSubstance>SODIUM SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004945</DrugIDPK>
    <LicenceNumber>PA0231/003/005</LicenceNumber>
    <ProductName>TCP ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1993-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
      <ActiveSubstance>SODIUM SALICYLATE</ActiveSubstance>
      <ActiveSubstance>HALOGENATED PHENOLS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004942</DrugIDPK>
    <LicenceNumber>PA0231/003/003</LicenceNumber>
    <ProductName>TCP THROAT PASTILLES - LEMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1986-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
      <ActiveSubstance>HALOGENATED PHENOLS</ActiveSubstance>
      <ActiveSubstance>SODIUM SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004302</DrugIDPK>
    <LicenceNumber>PA0167/037/013</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>40g/200 ml</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004303</DrugIDPK>
    <LicenceNumber>PA0167/037/014</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>50g/250 ml</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000647</DrugIDPK>
    <LicenceNumber>PA0013/040/003</LicenceNumber>
    <ProductName>MIACALCIC MULTIDOSE VIALS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000276</DrugIDPK>
    <LicenceNumber>PA0006/023/003</LicenceNumber>
    <ProductName>SURGAM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-04-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
      <ActiveSubstance>TALC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006657</DrugIDPK>
    <LicenceNumber>PA0549/002/002</LicenceNumber>
    <ProductName>ETHYPHARM IBUPROFEN SPARKLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1992-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006653</DrugIDPK>
    <LicenceNumber>PA0549/002/001</LicenceNumber>
    <ProductName>ETHYPHARM IBUPROFEN SPARKLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1992-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006830</DrugIDPK>
    <LicenceNumber>PA0620/001/002</LicenceNumber>
    <ProductName>HAVRIX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATIT A VIRUS ANTIGEN</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006827</DrugIDPK>
    <LicenceNumber>PA0620/001/001</LicenceNumber>
    <ProductName>HAVRIX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>1992-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATIT A VIRUS ANTIGEN</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003717</DrugIDPK>
    <LicenceNumber>PA0114/057/003</LicenceNumber>
    <ProductName>SEVREDOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003718</DrugIDPK>
    <LicenceNumber>PA0114/057/004</LicenceNumber>
    <ProductName>SEVREDOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003719</DrugIDPK>
    <LicenceNumber>PA0114/057/005</LicenceNumber>
    <ProductName>SEVREDOL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005047</DrugIDPK>
    <LicenceNumber>PA0236/013/004</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005049</DrugIDPK>
    <LicenceNumber>PA0236/013/006</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000343</DrugIDPK>
    <LicenceNumber>PA0006/033/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000362</DrugIDPK>
    <LicenceNumber>PA0006/036/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000356</DrugIDPK>
    <LicenceNumber>PA0006/036/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000358</DrugIDPK>
    <LicenceNumber>PA0006/036/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004857</DrugIDPK>
    <LicenceNumber>PA0856/004/002</LicenceNumber>
    <ProductName>THROMBOSTAT 10000 IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>1997-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004798</DrugIDPK>
    <LicenceNumber>PA0856/004/003</LicenceNumber>
    <ProductName>THROMBOSTAT 20000 IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>1997-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004796</DrugIDPK>
    <LicenceNumber>PA0856/004/001</LicenceNumber>
    <ProductName>THROMBOSTAT 5000 IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>1997-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003031</DrugIDPK>
    <LicenceNumber>PA0060/046/001</LicenceNumber>
    <ProductName>ALGITEC CHEWTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1987-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002172</DrugIDPK>
    <LicenceNumber>PA0046/024/005</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001692</DrugIDPK>
    <LicenceNumber>PA0038/050/001</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001693</DrugIDPK>
    <LicenceNumber>PA0038/050/002</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001694</DrugIDPK>
    <LicenceNumber>PA0038/050/003</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001691</DrugIDPK>
    <LicenceNumber>PA0038/044/003</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001058</DrugIDPK>
    <LicenceNumber>PA0019/017/001</LicenceNumber>
    <ProductName>NEPHRIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002487</DrugIDPK>
    <LicenceNumber>PA0049/006/004</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005685</DrugIDPK>
    <LicenceNumber>EU/1/97/034/001</LicenceNumber>
    <ProductName>VITRASERT IMPLANT</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Gerhard Mann, Chem.-Pharm,</PAHolder>
    <AuthorisedDate>1997-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GANCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001428</DrugIDPK>
    <LicenceNumber>PA0037/010/001</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001433</DrugIDPK>
    <LicenceNumber>PA0037/010/006</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001436</DrugIDPK>
    <LicenceNumber>PA0037/010/008</LicenceNumber>
    <ProductName>ACHROMYCIN IV</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001038</DrugIDPK>
    <LicenceNumber>PA0019/003/001</LicenceNumber>
    <ProductName>ATARAX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001039</DrugIDPK>
    <LicenceNumber>PA0019/003/002</LicenceNumber>
    <ProductName>ATARAX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001438</DrugIDPK>
    <LicenceNumber>PA0037/012/001</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001439</DrugIDPK>
    <LicenceNumber>PA0037/012/002</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001412</DrugIDPK>
    <LicenceNumber>PA0037/006/001</LicenceNumber>
    <ProductName>DETECLO</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002052</DrugIDPK>
    <LicenceNumber>PA0046/005/001</LicenceNumber>
    <ProductName>FUCIDIN H</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009160</DrugIDPK>
    <LicenceNumber>PA0899/013/003</LicenceNumber>
    <ProductName>FURADANTIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001888</DrugIDPK>
    <LicenceNumber>PA0040/017/003</LicenceNumber>
    <ProductName>INTRAVAL SODIUM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPENTAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001889</DrugIDPK>
    <LicenceNumber>PA0040/017/004</LicenceNumber>
    <ProductName>INTRAVAL SODIUM</ProductName>
    <Strength>5 %w/v, 10 ml</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPENTAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001890</DrugIDPK>
    <LicenceNumber>PA0040/017/005</LicenceNumber>
    <ProductName>INTRAVAL SODIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPENTAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001891</DrugIDPK>
    <LicenceNumber>PA0040/017/007</LicenceNumber>
    <ProductName>INTRAVAL SODIUM</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>g/20ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPENTAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001443</DrugIDPK>
    <LicenceNumber>PA0037/013/006</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000330</DrugIDPK>
    <LicenceNumber>PA0002/031/006</LicenceNumber>
    <ProductName>MODECATE INJECTION</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000710</DrugIDPK>
    <LicenceNumber>PA0016/010/002</LicenceNumber>
    <ProductName>MYCIFRADIN SULPHATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000714</DrugIDPK>
    <LicenceNumber>PA0016/012/001</LicenceNumber>
    <ProductName>NEO-CORTEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear/Eye Drops, Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000716</DrugIDPK>
    <LicenceNumber>PA0016/012/002</LicenceNumber>
    <ProductName>NEO-CORTEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002502</DrugIDPK>
    <LicenceNumber>PA0049/009/001</LicenceNumber>
    <ProductName>ORBENIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002504</DrugIDPK>
    <LicenceNumber>PA0049/009/003</LicenceNumber>
    <ProductName>ORBENIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002507</DrugIDPK>
    <LicenceNumber>PA0049/009/006</LicenceNumber>
    <ProductName>ORBENIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002508</DrugIDPK>
    <LicenceNumber>PA0049/009/007</LicenceNumber>
    <ProductName>ORBENIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002509</DrugIDPK>
    <LicenceNumber>PA0049/009/008</LicenceNumber>
    <ProductName>ORBENIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002618</DrugIDPK>
    <LicenceNumber>PA0049/010/018</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002620</DrugIDPK>
    <LicenceNumber>PA0049/010/020</LicenceNumber>
    <ProductName>PENBRITIN FORTE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006613</DrugIDPK>
    <LicenceNumber>PA0493/001/001</LicenceNumber>
    <ProductName>QUINIDINE SULPHATE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINIDINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006614</DrugIDPK>
    <LicenceNumber>PA0493/001/002</LicenceNumber>
    <ProductName>QUINIDINE SULPHATE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINIDINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009272</DrugIDPK>
    <LicenceNumber>PA0111/003/002</LicenceNumber>
    <ProductName>RIMACTAZID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001184</DrugIDPK>
    <LicenceNumber>PA0022/010/001</LicenceNumber>
    <ProductName>SPARINE</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001186</DrugIDPK>
    <LicenceNumber>PA0022/010/006</LicenceNumber>
    <ProductName>SPARINE</ProductName>
    <Strength>5.000</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001910</DrugIDPK>
    <LicenceNumber>PA0040/026/006</LicenceNumber>
    <ProductName>STEMETIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001040</DrugIDPK>
    <LicenceNumber>PA0019/007/001</LicenceNumber>
    <ProductName>TERRACORTRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001042</DrugIDPK>
    <LicenceNumber>PA0019/008/001</LicenceNumber>
    <ProductName>TERRACORTRIL</ProductName>
    <Strength>5/15/1.25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001045</DrugIDPK>
    <LicenceNumber>PA0019/009/001</LicenceNumber>
    <ProductName>TERRAMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001046</DrugIDPK>
    <LicenceNumber>PA0019/009/007</LicenceNumber>
    <ProductName>TERRAMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001374</DrugIDPK>
    <LicenceNumber>PA0035/060/001</LicenceNumber>
    <ProductName>ZINAMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRAZINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001654</DrugIDPK>
    <LicenceNumber>PA0038/009/009</LicenceNumber>
    <ProductName>ERYTHROPED</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001655</DrugIDPK>
    <LicenceNumber>PA0038/009/010</LicenceNumber>
    <ProductName>ERYTHROPED</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001650</DrugIDPK>
    <LicenceNumber>PA0038/009/001</LicenceNumber>
    <ProductName>ERYTHROPED FORTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014778</DrugIDPK>
    <LicenceNumber>PA0038/009/011</LicenceNumber>
    <ProductName>ERYTHROPED P.I. SINGLE DOSE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008191</DrugIDPK>
    <LicenceNumber>PA0038/009/012</LicenceNumber>
    <ProductName>ERYTHROPED SINGLE DOSE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000340</DrugIDPK>
    <LicenceNumber>PA0006/031/002</LicenceNumber>
    <ProductName>CHLORAMPHENICOL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004127</DrugIDPK>
    <LicenceNumber>PA0822/001/003</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>1996-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004133</DrugIDPK>
    <LicenceNumber>PA0822/001/001</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>1996-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004134</DrugIDPK>
    <LicenceNumber>PA0822/001/002</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>1996-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004137</DrugIDPK>
    <LicenceNumber>PA0822/001/006</LicenceNumber>
    <ProductName>LUSTRAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>1996-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015823</DrugIDPK>
    <LicenceNumber>PA0061/005/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.45</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1996-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009097</DrugIDPK>
    <LicenceNumber>PA0965/001/001</LicenceNumber>
    <ProductName>OMEPRAZOLE-RATIOPHARM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm Espana S.A.</PAHolder>
    <AuthorisedDate>2001-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009419</DrugIDPK>
    <LicenceNumber>PA0872/006/001</LicenceNumber>
    <ProductName>FEMAPAK 40 (PATCH AND TABLETS)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma International Ltd</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch+Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>DYDROGESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011311</DrugIDPK>
    <LicenceNumber>PA1009/010/001</LicenceNumber>
    <ProductName>GHRH FERRING</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001647</DrugIDPK>
    <LicenceNumber>PA0038/002/007</LicenceNumber>
    <ProductName>ERYTHROCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN LACTOBIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001648</DrugIDPK>
    <LicenceNumber>PA0038/002/008</LicenceNumber>
    <ProductName>ERYTHROCIN</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN LACTOBIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005321</DrugIDPK>
    <LicenceNumber>PA0281/038/002</LicenceNumber>
    <ProductName>PINIFED</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1987-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000413</DrugIDPK>
    <LicenceNumber>PA0007/002/003</LicenceNumber>
    <ProductName>ATROVENT FORTE</ProductName>
    <Strength>40.0</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006303</DrugIDPK>
    <LicenceNumber>PA0436/008/001</LicenceNumber>
    <ProductName>SALBUTAMOL EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001689</DrugIDPK>
    <LicenceNumber>PA0038/044/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001690</DrugIDPK>
    <LicenceNumber>PA0038/044/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007600</DrugIDPK>
    <LicenceNumber>EU/1/97/031/018</LicenceNumber>
    <ProductName>NEORECORMON</ProductName>
    <Strength>10,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006866</DrugIDPK>
    <LicenceNumber>EU/1/97/031/014</LicenceNumber>
    <ProductName>NEORECORMON WITH SYRINGE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006868</DrugIDPK>
    <LicenceNumber>EU/1/97/031/015</LicenceNumber>
    <ProductName>NEORECORMON WITH SYRINGE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006870</DrugIDPK>
    <LicenceNumber>EU/1/97/031/016</LicenceNumber>
    <ProductName>NEORECORMON WITH SYRINGE</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006872</DrugIDPK>
    <LicenceNumber>EU/1/97/031/017</LicenceNumber>
    <ProductName>NEORECORMON WITH SYRINGE</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003355</DrugIDPK>
    <LicenceNumber>PA0077/009/001</LicenceNumber>
    <ProductName>OXYPERTINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPERTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003743</DrugIDPK>
    <LicenceNumber>PA0115/001/004</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1977-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001864</DrugIDPK>
    <LicenceNumber>PA0035/002/005</LicenceNumber>
    <ProductName>TRYPTIZOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE PAMOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002431</DrugIDPK>
    <LicenceNumber>PA0591/001/001</LicenceNumber>
    <ProductName>EPIESTROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rottapharm B.V.</PAHolder>
    <AuthorisedDate>1997-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002432</DrugIDPK>
    <LicenceNumber>PA0591/001/002</LicenceNumber>
    <ProductName>EPIESTROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rottapharm B.V.</PAHolder>
    <AuthorisedDate>1997-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002433</DrugIDPK>
    <LicenceNumber>PA0591/001/003</LicenceNumber>
    <ProductName>EPIESTROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rottapharm B.V.</PAHolder>
    <AuthorisedDate>1997-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002056</DrugIDPK>
    <LicenceNumber>PA0773/002/001</LicenceNumber>
    <ProductName>PENTASPAN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Austria GmbH</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTASTARCH</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003901</DrugIDPK>
    <LicenceNumber>PA0711/022/004</LicenceNumber>
    <ProductName>TAMOX</ProductName>
    <Strength>40mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005443</DrugIDPK>
    <LicenceNumber>PA0261/030/001</LicenceNumber>
    <ProductName>GYNOXIN</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005320</DrugIDPK>
    <LicenceNumber>PA0281/038/001</LicenceNumber>
    <ProductName>PINIFED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006171</DrugIDPK>
    <LicenceNumber>PA0410/002/001</LicenceNumber>
    <ProductName>VALDISPERT</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Products GmbH</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006173</DrugIDPK>
    <LicenceNumber>PA0410/002/002</LicenceNumber>
    <ProductName>VALDISPERT FORTE</ProductName>
    <Strength>135</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Products GmbH</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003759</DrugIDPK>
    <LicenceNumber>PA0115/004/002</LicenceNumber>
    <ProductName>BLEOMYCIN LUNDBECK INJECTION</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1977-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BLEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008909</DrugIDPK>
    <LicenceNumber>PA0281/058/001</LicenceNumber>
    <ProductName>DICLO-DICLOFENAC ENTERIC COATED</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1994-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008914</DrugIDPK>
    <LicenceNumber>PA0281/058/002</LicenceNumber>
    <ProductName>DICLO-DICLOFENAC ENTERIC COATED</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1994-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016339</DrugIDPK>
    <LicenceNumber>PA0436/027/002</LicenceNumber>
    <ProductName>EPIMAZ</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016340</DrugIDPK>
    <LicenceNumber>PA0436/027/001</LicenceNumber>
    <ProductName>EPIMAZ</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016341</DrugIDPK>
    <LicenceNumber>PA0436/027/003</LicenceNumber>
    <ProductName>EPIMAZ</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001842</DrugIDPK>
    <LicenceNumber>PA0035/051/005</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013620</DrugIDPK>
    <LicenceNumber>PPA0465/038/001D</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013621</DrugIDPK>
    <LicenceNumber>PPA0465/038/001E</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013622</DrugIDPK>
    <LicenceNumber>PPA0465/038/001F</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013623</DrugIDPK>
    <LicenceNumber>PPA0465/038/001G</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013624</DrugIDPK>
    <LicenceNumber>PPA0465/038/001H</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009083</DrugIDPK>
    <LicenceNumber>PA0077/144/001</LicenceNumber>
    <ProductName>MIGRAMAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLATE LYSINE</ActiveSubstance>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005286</DrugIDPK>
    <LicenceNumber>PA0281/013/001</LicenceNumber>
    <ProductName>PREDNISOLONE B.P.</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005307</DrugIDPK>
    <LicenceNumber>PA0748/018/001</LicenceNumber>
    <ProductName>DROLEPTAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005631</DrugIDPK>
    <LicenceNumber>PA0285/005/003</LicenceNumber>
    <ProductName>SAIZEN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003099</DrugIDPK>
    <LicenceNumber>PA0778/013/001</LicenceNumber>
    <ProductName>NORIMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003101</DrugIDPK>
    <LicenceNumber>PA0778/015/001</LicenceNumber>
    <ProductName>NORINYL - 1</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003941</DrugIDPK>
    <LicenceNumber>PA0041/051/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>40 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000393</DrugIDPK>
    <LicenceNumber>PA0002/057/001</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000396</DrugIDPK>
    <LicenceNumber>PA0002/057/002</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>67</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000397</DrugIDPK>
    <LicenceNumber>PA0002/057/003</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000398</DrugIDPK>
    <LicenceNumber>PA0002/057/004</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>167</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000399</DrugIDPK>
    <LicenceNumber>PA0002/057/005</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000400</DrugIDPK>
    <LicenceNumber>PA0002/057/006</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004941</DrugIDPK>
    <LicenceNumber>PA0236/020/002</LicenceNumber>
    <ProductName>OLBETAM</ProductName>
    <Strength>250mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACIPIMOX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004596</DrugIDPK>
    <LicenceNumber>PA0022/074/001</LicenceNumber>
    <ProductName>LYRELLE 50</ProductName>
    <Strength>24.22</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004597</DrugIDPK>
    <LicenceNumber>PA0022/074/002</LicenceNumber>
    <ProductName>LYRELLE 80</ProductName>
    <Strength>38.74</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009107</DrugIDPK>
    <LicenceNumber>PA0077/155/001</LicenceNumber>
    <ProductName>DOLMATIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009108</DrugIDPK>
    <LicenceNumber>PA0077/155/002</LicenceNumber>
    <ProductName>DOLMATIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003676</DrugIDPK>
    <LicenceNumber>PA0769/014/001</LicenceNumber>
    <ProductName>CLIVARINE</ProductName>
    <Strength>1750/0.25ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1992-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REVIPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000834</DrugIDPK>
    <LicenceNumber>PA0017/004/001</LicenceNumber>
    <ProductName>DARAPRIM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIMETHAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001911</DrugIDPK>
    <LicenceNumber>PA0040/026/007</LicenceNumber>
    <ProductName>STEMETIL</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001579</DrugIDPK>
    <LicenceNumber>PA0037/053/001</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001580</DrugIDPK>
    <LicenceNumber>PA0037/053/002</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001582</DrugIDPK>
    <LicenceNumber>PA0037/053/003</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001583</DrugIDPK>
    <LicenceNumber>PA0037/053/004</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001584</DrugIDPK>
    <LicenceNumber>PA0037/053/005</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001586</DrugIDPK>
    <LicenceNumber>PA0037/053/006</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001587</DrugIDPK>
    <LicenceNumber>PA0037/053/007</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001589</DrugIDPK>
    <LicenceNumber>PA0037/053/008</LicenceNumber>
    <ProductName>PIPRIL</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005595</DrugIDPK>
    <LicenceNumber>PA0282/059/001</LicenceNumber>
    <ProductName>CROMOGEN STERI-NEB</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1992-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003432</DrugIDPK>
    <LicenceNumber>PA0126/098/001</LicenceNumber>
    <ProductName>CO-TENOMEL</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003433</DrugIDPK>
    <LicenceNumber>PA0126/098/002</LicenceNumber>
    <ProductName>CO-TENOMEL</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003351</DrugIDPK>
    <LicenceNumber>PA0077/004/001</LicenceNumber>
    <ProductName>FORTAGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008545</DrugIDPK>
    <LicenceNumber>PA0077/122/002</LicenceNumber>
    <ProductName>FRANOL SR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008548</DrugIDPK>
    <LicenceNumber>PA0077/122/003</LicenceNumber>
    <ProductName>FRANOL SR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008543</DrugIDPK>
    <LicenceNumber>PA0077/122/001</LicenceNumber>
    <ProductName>FRANOL SR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004619</DrugIDPK>
    <LicenceNumber>PA0568/006/001</LicenceNumber>
    <ProductName>PREVILEX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009101</DrugIDPK>
    <LicenceNumber>PA0077/153/003</LicenceNumber>
    <ProductName>TILDIEM INJECTABLE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009102</DrugIDPK>
    <LicenceNumber>PA0077/153/004</LicenceNumber>
    <ProductName>TILDIEM INJECTABLE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003847</DrugIDPK>
    <LicenceNumber>PA0126/028/002</LicenceNumber>
    <ProductName>TIPERAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003875</DrugIDPK>
    <LicenceNumber>PA0126/042/001</LicenceNumber>
    <ProductName>TIPROCIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003866</DrugIDPK>
    <LicenceNumber>PA0126/037/001</LicenceNumber>
    <ProductName>TIPROCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009421</DrugIDPK>
    <LicenceNumber>PA0021/045/004</LicenceNumber>
    <ProductName>LIPOBAY</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2000-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CERIVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004634</DrugIDPK>
    <LicenceNumber>PA0021/045/001</LicenceNumber>
    <ProductName>LIPOBAY</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CERIVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004635</DrugIDPK>
    <LicenceNumber>PA0021/045/002</LicenceNumber>
    <ProductName>LIPOBAY</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CERIVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004636</DrugIDPK>
    <LicenceNumber>PA0021/045/003</LicenceNumber>
    <ProductName>LIPOBAY</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1997-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CERIVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009065</DrugIDPK>
    <LicenceNumber>PA0964/002/001</LicenceNumber>
    <ProductName>NORCURON</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>1999-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VECURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2002-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008853</DrugIDPK>
    <LicenceNumber>PA0646/002/001</LicenceNumber>
    <ProductName>NEUTREXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ipsen Biotech</PAHolder>
    <AuthorisedDate>1995-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004954</DrugIDPK>
    <LicenceNumber>PA0030/036/001</LicenceNumber>
    <ProductName>ALLEREZE PLUS</ProductName>
    <Strength>0.5/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1997-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLEMASTINE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004950</DrugIDPK>
    <LicenceNumber>PA0030/033/002</LicenceNumber>
    <ProductName>TRIOGESIC</ProductName>
    <Strength>12.5/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004950</DrugIDPK>
    <LicenceNumber>PA0030/033/002</LicenceNumber>
    <ProductName>TRIOGESIC</ProductName>
    <Strength>12.5/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004949</DrugIDPK>
    <LicenceNumber>PA0030/033/001</LicenceNumber>
    <ProductName>TRIOGESIC ELIXIR</ProductName>
    <Strength>3/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004949</DrugIDPK>
    <LicenceNumber>PA0030/033/001</LicenceNumber>
    <ProductName>TRIOGESIC ELIXIR</ProductName>
    <Strength>3/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004951</DrugIDPK>
    <LicenceNumber>PA0030/034/001</LicenceNumber>
    <ProductName>TRIOMINIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004951</DrugIDPK>
    <LicenceNumber>PA0030/034/001</LicenceNumber>
    <ProductName>TRIOMINIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004952</DrugIDPK>
    <LicenceNumber>PA0030/034/002</LicenceNumber>
    <ProductName>TRIOMINIC</ProductName>
    <Strength>25/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004952</DrugIDPK>
    <LicenceNumber>PA0030/034/002</LicenceNumber>
    <ProductName>TRIOMINIC</ProductName>
    <Strength>25/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000307</DrugIDPK>
    <LicenceNumber>PA0006/031/001</LicenceNumber>
    <ProductName>CHLORAMPHENICOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000599</DrugIDPK>
    <LicenceNumber>PA0009/041/001</LicenceNumber>
    <ProductName>THEODUR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1986-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000600</DrugIDPK>
    <LicenceNumber>PA0009/041/002</LicenceNumber>
    <ProductName>THEODUR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1986-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011308</DrugIDPK>
    <LicenceNumber>PA1009/008/001</LicenceNumber>
    <ProductName>ZOMACTON</ProductName>
    <Strength>4.0</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006474</DrugIDPK>
    <LicenceNumber>PA0468/019/001</LicenceNumber>
    <ProductName>AAA MOUTH &amp; THROAT</ProductName>
    <Strength>1.5/.0413</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000402</DrugIDPK>
    <LicenceNumber>PA0006/032/001</LicenceNumber>
    <ProductName>ATROPINE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1989-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009420</DrugIDPK>
    <LicenceNumber>PA0872/006/002</LicenceNumber>
    <ProductName>FEMAPAK 80 (PATCH AND TABLETS)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma International Ltd</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch+Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>DYDROGESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005411</DrugIDPK>
    <LicenceNumber>PA0855/011/001</LicenceNumber>
    <ProductName>DANERAL SA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003837</DrugIDPK>
    <LicenceNumber>PA0126/025/001</LicenceNumber>
    <ProductName>MELZINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000269</DrugIDPK>
    <LicenceNumber>PA0006/017/002</LicenceNumber>
    <ProductName>PRECORTISYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005409</DrugIDPK>
    <LicenceNumber>PA0855/009/001</LicenceNumber>
    <ProductName>RASTINON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLBUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002892</DrugIDPK>
    <LicenceNumber>PA0060/014/001</LicenceNumber>
    <ProductName>STELABID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPROPAMIDE IODIDE</ActiveSubstance>
      <ActiveSubstance>TRIFLUOPERAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005403</DrugIDPK>
    <LicenceNumber>PA0855/004/002</LicenceNumber>
    <ProductName>TOPISOLON</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1998-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DESOXIMETASONE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005404</DrugIDPK>
    <LicenceNumber>PA0855/004/003</LicenceNumber>
    <ProductName>TOPISOLON</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1998-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DESOXIMETASONE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000388</DrugIDPK>
    <LicenceNumber>PA0006/041/001</LicenceNumber>
    <ProductName>HYPROMELLOSE</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005406</DrugIDPK>
    <LicenceNumber>PA0855/006/001</LicenceNumber>
    <ProductName>LASIKAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005401</DrugIDPK>
    <LicenceNumber>PA0855/003/004</LicenceNumber>
    <ProductName>LASIX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002091</DrugIDPK>
    <LicenceNumber>PA0041/031/001</LicenceNumber>
    <ProductName>LURSELLE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROBUCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001907</DrugIDPK>
    <LicenceNumber>PA0040/026/004</LicenceNumber>
    <ProductName>STEMETIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011317</DrugIDPK>
    <LicenceNumber>PA1009/013/001</LicenceNumber>
    <ProductName>TESTOSTERONE FERRING</ProductName>
    <Strength>328</Strength>
    <StrengthMeasurement>Mg/day</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011315</DrugIDPK>
    <LicenceNumber>PA1009/012/001</LicenceNumber>
    <ProductName>TESTOTOP 10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011316</DrugIDPK>
    <LicenceNumber>PA1009/012/002</LicenceNumber>
    <ProductName>TESTOTOP 15</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>1999-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003661</DrugIDPK>
    <LicenceNumber>PA0798/001/001</LicenceNumber>
    <ProductName>TUBERCULIN PPD RT23 SSI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Statens Serum Institute</PAHolder>
    <AuthorisedDate>1997-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TUBERCULIN PPD</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003663</DrugIDPK>
    <LicenceNumber>PA0798/001/003</LicenceNumber>
    <ProductName>TUBERCULIN PPD RT23 SSI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Statens Serum Institute</PAHolder>
    <AuthorisedDate>1997-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TUBERCULIN PPD</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007747</DrugIDPK>
    <LicenceNumber>PA0936/001/001</LicenceNumber>
    <ProductName>CYKLO-F</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANEXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005991</DrugIDPK>
    <LicenceNumber>PA0863/004/001</LicenceNumber>
    <ProductName>DERMAZOLE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006334</DrugIDPK>
    <LicenceNumber>PA0436/022/001</LicenceNumber>
    <ProductName>CROMOGEN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000760</DrugIDPK>
    <LicenceNumber>PA0016/024/004</LicenceNumber>
    <ProductName>DEPO-PROVERA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1981-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007853</DrugIDPK>
    <LicenceNumber>PA0757/006/001</LicenceNumber>
    <ProductName>NARDIL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>1996-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENELZINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010392</DrugIDPK>
    <LicenceNumber>PA0815/002/001</LicenceNumber>
    <ProductName>TIMONIL RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Desitin Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010393</DrugIDPK>
    <LicenceNumber>PA0815/002/002</LicenceNumber>
    <ProductName>TIMONIL RETARD</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Desitin Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>2000-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005417</DrugIDPK>
    <LicenceNumber>PA0855/015/001</LicenceNumber>
    <ProductName>ARELIX</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1998-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005418</DrugIDPK>
    <LicenceNumber>PA0855/015/002</LicenceNumber>
    <ProductName>ARELIX</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1998-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000039</DrugIDPK>
    <LicenceNumber>PA0006/014/001</LicenceNumber>
    <ProductName>DECORTISYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000244</DrugIDPK>
    <LicenceNumber>PA0006/014/002</LicenceNumber>
    <ProductName>DECORTISYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005405</DrugIDPK>
    <LicenceNumber>PA0855/005/001</LicenceNumber>
    <ProductName>HOSTACYCLINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1998-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008605</DrugIDPK>
    <LicenceNumber>PA0167/085/001A</LicenceNumber>
    <ProductName>NUTRINEAL PD2 1.1%</ProductName>
    <Strength>1.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1994-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005429</DrugIDPK>
    <LicenceNumber>PA0855/019/004</LicenceNumber>
    <ProductName>TARIVID</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1996-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005426</DrugIDPK>
    <LicenceNumber>PA0855/019/001</LicenceNumber>
    <ProductName>TARIVID IV INFUSION</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1994-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001641</DrugIDPK>
    <LicenceNumber>PA0577/017/001</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001642</DrugIDPK>
    <LicenceNumber>PA0577/017/002</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006378</DrugIDPK>
    <LicenceNumber>PPA0465/012/002</LicenceNumber>
    <ProductName>ADALAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012286</DrugIDPK>
    <LicenceNumber>PPA0465/014/002A</LicenceNumber>
    <ProductName>ALDACTONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012288</DrugIDPK>
    <LicenceNumber>PPA0465/014/002B</LicenceNumber>
    <ProductName>ALDACTONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>P.B.S Sales  Limited</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012282</DrugIDPK>
    <LicenceNumber>PPA0465/014/001A</LicenceNumber>
    <ProductName>ALDACTONE TABLETS 25 MG</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012284</DrugIDPK>
    <LicenceNumber>PPA0465/014/001B</LicenceNumber>
    <ProductName>ALDACTONE TABLETS 25 MG</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012294</DrugIDPK>
    <LicenceNumber>PPA0465/007/001A</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012295</DrugIDPK>
    <LicenceNumber>PPA0465/007/001B</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012296</DrugIDPK>
    <LicenceNumber>PPA0465/007/001C</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012297</DrugIDPK>
    <LicenceNumber>PPA0465/007/002A</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012298</DrugIDPK>
    <LicenceNumber>PPA0465/007/002B</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012299</DrugIDPK>
    <LicenceNumber>PPA0465/007/002C</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012300</DrugIDPK>
    <LicenceNumber>PPA0465/007/003A</LicenceNumber>
    <ProductName>INDOCID R</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007502</DrugIDPK>
    <LicenceNumber>PPA0465/039/003A</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007503</DrugIDPK>
    <LicenceNumber>PPA0465/039/003B</LicenceNumber>
    <ProductName>LOSEC</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009232</DrugIDPK>
    <LicenceNumber>PPA0465/035/001</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009233</DrugIDPK>
    <LicenceNumber>PPA0465/035/002</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006385</DrugIDPK>
    <LicenceNumber>PPA0465/016/001</LicenceNumber>
    <ProductName>NATRILIX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009230</DrugIDPK>
    <LicenceNumber>PPA0465/034/002A</LicenceNumber>
    <ProductName>PERSANTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009227</DrugIDPK>
    <LicenceNumber>PPA0465/034/001A</LicenceNumber>
    <ProductName>PERSANTIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006442</DrugIDPK>
    <LicenceNumber>PPA0465/019/001</LicenceNumber>
    <ProductName>VENTOLIN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006380</DrugIDPK>
    <LicenceNumber>PPA0465/013/001</LicenceNumber>
    <ProductName>VOLTAROL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006381</DrugIDPK>
    <LicenceNumber>PPA0465/013/002</LicenceNumber>
    <ProductName>VOLTAROL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010476</DrugIDPK>
    <LicenceNumber>PA0946/002/001</LicenceNumber>
    <ProductName>ACTINAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Peckforton Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>BUTOXYETHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>ALLANTOIN</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001894</DrugIDPK>
    <LicenceNumber>PA0040/018/004</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001895</DrugIDPK>
    <LicenceNumber>PA0040/018/005</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000367</DrugIDPK>
    <LicenceNumber>PA0006/037/001</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000376</DrugIDPK>
    <LicenceNumber>PA0006/037/003</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000371</DrugIDPK>
    <LicenceNumber>PA0006/037/002</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000379</DrugIDPK>
    <LicenceNumber>PA0006/037/004</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000265</DrugIDPK>
    <LicenceNumber>PA0006/017/001</LicenceNumber>
    <ProductName>PRECORTISYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000345</DrugIDPK>
    <LicenceNumber>PA0006/034/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000346</DrugIDPK>
    <LicenceNumber>PA0006/034/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000350</DrugIDPK>
    <LicenceNumber>PA0006/034/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001139</DrugIDPK>
    <LicenceNumber>PA0023/008/007</LicenceNumber>
    <ProductName>LASIX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1993-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001873</DrugIDPK>
    <LicenceNumber>PA0007/002/006</LicenceNumber>
    <ProductName>ATROVENT AUTOHALER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001874</DrugIDPK>
    <LicenceNumber>PA0007/034/005</LicenceNumber>
    <ProductName>DUOVENT AUTOHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000535</DrugIDPK>
    <LicenceNumber>PA0009/034/002</LicenceNumber>
    <ProductName>RHINOCORT AQUA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005435</DrugIDPK>
    <LicenceNumber>PA0261/024/001</LicenceNumber>
    <ProductName>CORDIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPRIDIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005436</DrugIDPK>
    <LicenceNumber>PA0261/024/002</LicenceNumber>
    <ProductName>CORDIUM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPRIDIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005437</DrugIDPK>
    <LicenceNumber>PA0261/024/003</LicenceNumber>
    <ProductName>CORDIUM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPRIDIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008874</DrugIDPK>
    <LicenceNumber>PA0261/041/001</LicenceNumber>
    <ProductName>RIMEXEL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIMEXOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008151</DrugIDPK>
    <LicenceNumber>PA0006/045/001</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008152</DrugIDPK>
    <LicenceNumber>PA0006/045/002</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008153</DrugIDPK>
    <LicenceNumber>PA0006/045/003</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008154</DrugIDPK>
    <LicenceNumber>PA0006/045/004</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008156</DrugIDPK>
    <LicenceNumber>PA0006/045/005</LicenceNumber>
    <ProductName>CEFROM POWDER</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008158</DrugIDPK>
    <LicenceNumber>PA0006/045/006</LicenceNumber>
    <ProductName>CEFROM POWDER</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005368</DrugIDPK>
    <LicenceNumber>PA0261/002/002</LicenceNumber>
    <ProductName>HUMEGON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLICLE-STIMULATING HORMONE, HUMAN</ActiveSubstance>
      <ActiveSubstance>LUTEINISING HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006753</DrugIDPK>
    <LicenceNumber>PA0581/001/001</LicenceNumber>
    <ProductName>MENTADENT P MINT FLAVOUR</ProductName>
    <Strength>.3/.8/.75</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Elida Faberge Ireland</PAHolder>
    <AuthorisedDate>1991-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>SODIUM MONOFLUORO PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>ZINC CITRATE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006615</DrugIDPK>
    <LicenceNumber>PA0914/001/001</LicenceNumber>
    <ProductName>TIMOLOL CIBA VISION</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Novartis Ophthalmics Europe Ltd</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006616</DrugIDPK>
    <LicenceNumber>PA0914/001/002</LicenceNumber>
    <ProductName>TIMOLOL CIBA VISION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Novartis Ophthalmics Europe Ltd</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000935</DrugIDPK>
    <LicenceNumber>PA0017/067/001</LicenceNumber>
    <ProductName>ANGISED</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002206</DrugIDPK>
    <LicenceNumber>PA0303/033/001</LicenceNumber>
    <ProductName>DIVINA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1994-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003630</DrugIDPK>
    <LicenceNumber>PA0100/034/001</LicenceNumber>
    <ProductName>LASMA SUSTAINED RELEASE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003370</DrugIDPK>
    <LicenceNumber>PA0077/039/001</LicenceNumber>
    <ProductName>LINGRAINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005367</DrugIDPK>
    <LicenceNumber>PA0261/002/001</LicenceNumber>
    <ProductName>HUMEGON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLICLE-STIMULATING HORMONE, HUMAN</ActiveSubstance>
      <ActiveSubstance>LUTEINISING HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006754</DrugIDPK>
    <LicenceNumber>PA0581/001/002</LicenceNumber>
    <ProductName>MENTADENT P TOOTHPASTE ORIGINAL FLAVOUR</ProductName>
    <Strength>.3/.8/.75</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Elida Faberge Ireland</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>SODIUM MONOFLUORO PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>ZINC CITRATE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000397</DrugIDPK>
    <LicenceNumber>PA0281/065/002</LicenceNumber>
    <ProductName>COTENT 100</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000396</DrugIDPK>
    <LicenceNumber>PA0281/065/001</LicenceNumber>
    <ProductName>COTENT 50</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009805</DrugIDPK>
    <LicenceNumber>PPA0465/040/001C</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009809</DrugIDPK>
    <LicenceNumber>PPA0465/040/001G</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009810</DrugIDPK>
    <LicenceNumber>PPA0465/040/001F</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013618</DrugIDPK>
    <LicenceNumber>PPA0465/038/001B</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995013619</DrugIDPK>
    <LicenceNumber>PPA0465/038/001C</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004054</DrugIDPK>
    <LicenceNumber>PPA0465/038/001A</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003472</DrugIDPK>
    <LicenceNumber>PA0086/011/001</LicenceNumber>
    <ProductName>DIMOTAPP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003476</DrugIDPK>
    <LicenceNumber>PA0086/012/001</LicenceNumber>
    <ProductName>DIMOTAPP L.A.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003555</DrugIDPK>
    <LicenceNumber>PA0090/009/005</LicenceNumber>
    <ProductName>PANCREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003553</DrugIDPK>
    <LicenceNumber>PA0090/009/004</LicenceNumber>
    <ProductName>PANCREX V</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003551</DrugIDPK>
    <LicenceNumber>PA0090/009/003</LicenceNumber>
    <ProductName>PANCREX V</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003548</DrugIDPK>
    <LicenceNumber>PA0090/009/001</LicenceNumber>
    <ProductName>PANCREX V</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003549</DrugIDPK>
    <LicenceNumber>PA0090/009/002</LicenceNumber>
    <ProductName>PANCREX V FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001917</DrugIDPK>
    <LicenceNumber>PA0040/027/004</LicenceNumber>
    <ProductName>SURMONTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1991-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMIPRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001918</DrugIDPK>
    <LicenceNumber>PA0040/027/005</LicenceNumber>
    <ProductName>SURMONTIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1991-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMIPRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002080</DrugIDPK>
    <LicenceNumber>PA0041/026/002</LicenceNumber>
    <ProductName>TRILUDAN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002123</DrugIDPK>
    <LicenceNumber>PA0776/001/003</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck ( Ireland ) Limited</PAHolder>
    <AuthorisedDate>1995-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005295</DrugIDPK>
    <LicenceNumber>PA0281/018/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005296</DrugIDPK>
    <LicenceNumber>PA0281/018/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000469</DrugIDPK>
    <LicenceNumber>PA0007/025/001</LicenceNumber>
    <ProductName>BISOLVON</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1984-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003708</DrugIDPK>
    <LicenceNumber>PA0544/028/003</LicenceNumber>
    <ProductName>VAQTA ADULT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS A VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003706</DrugIDPK>
    <LicenceNumber>PA0544/028/001</LicenceNumber>
    <ProductName>VAQTA PAEDIATRIC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS A VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006205</DrugIDPK>
    <LicenceNumber>PA0038/061/003</LicenceNumber>
    <ProductName>DOBUTAMINE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000899</DrugIDPK>
    <LicenceNumber>PA0038/061/002</LicenceNumber>
    <ProductName>DOBUTAMINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000900</DrugIDPK>
    <LicenceNumber>PA0038/061/004</LicenceNumber>
    <ProductName>DOBUTAMINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000608</DrugIDPK>
    <LicenceNumber>PA0038/061/001</LicenceNumber>
    <ProductName>STERILE DOBUTAMINE</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008209</DrugIDPK>
    <LicenceNumber>PA0748/037/002</LicenceNumber>
    <ProductName>PEVARYL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000967</DrugIDPK>
    <LicenceNumber>PA0044/090/005</LicenceNumber>
    <ProductName>ZOFRAN PLASTIC AMPOULES</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000968</DrugIDPK>
    <LicenceNumber>PA0044/090/006</LicenceNumber>
    <ProductName>ZOFRAN PLASTIC AMPOULES</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004386</DrugIDPK>
    <LicenceNumber>PA0167/065/002</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004387</DrugIDPK>
    <LicenceNumber>PA0167/065/003</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006570</DrugIDPK>
    <LicenceNumber>PA0483/007/001</LicenceNumber>
    <ProductName>STERETS NORMASOL</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Seton Prebbles Ltd</PAHolder>
    <AuthorisedDate>1991-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009150</DrugIDPK>
    <LicenceNumber>PA0051/063/002</LicenceNumber>
    <ProductName>MERONEM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1995-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEROPENEM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006427</DrugIDPK>
    <LicenceNumber>PA0437/014/001</LicenceNumber>
    <ProductName>DEXAMETHASONE SODIUM PHOSPHATE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006429</DrugIDPK>
    <LicenceNumber>PA0437/014/003</LicenceNumber>
    <ProductName>DEXAMETHASONE SODIUM PHOSPHATE</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002216</DrugIDPK>
    <LicenceNumber>PA0047/066/001</LicenceNumber>
    <ProductName>HUMULIN M 20/80</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003722</DrugIDPK>
    <LicenceNumber>PA0047/070/002</LicenceNumber>
    <ProductName>HUMULIN M4</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006333</DrugIDPK>
    <LicenceNumber>PA0436/021/003</LicenceNumber>
    <ProductName>BECLAZONE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006330</DrugIDPK>
    <LicenceNumber>PA0436/021/001</LicenceNumber>
    <ProductName>BECLAZONE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006331</DrugIDPK>
    <LicenceNumber>PA0436/021/002</LicenceNumber>
    <ProductName>BECLAZONE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006336</DrugIDPK>
    <LicenceNumber>PA0436/024/001</LicenceNumber>
    <ProductName>BECLOMETHASONE DIPROPIONATE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006337</DrugIDPK>
    <LicenceNumber>PA0436/024/002</LicenceNumber>
    <ProductName>BECLOMETHASONE DIPROPIONATE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006339</DrugIDPK>
    <LicenceNumber>PA0436/024/003</LicenceNumber>
    <ProductName>BECLOMETHASONE DIPROPIONATE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009422</DrugIDPK>
    <LicenceNumber>PA0703/001/002</LicenceNumber>
    <ProductName>ZAGAM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rhone DPC Europe</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPARFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003540</DrugIDPK>
    <LicenceNumber>PA0050/128/001</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000339</DrugIDPK>
    <LicenceNumber>PA0009/004/001</LicenceNumber>
    <ProductName>BRICANYL RESPIRATOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1976-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000480</DrugIDPK>
    <LicenceNumber>PA0007/033/002</LicenceNumber>
    <ProductName>BEROTEC</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000481</DrugIDPK>
    <LicenceNumber>PA0007/033/003</LicenceNumber>
    <ProductName>BEROTEC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005514</DrugIDPK>
    <LicenceNumber>PA0007/027/003</LicenceNumber>
    <ProductName>RINATEC NASAL</ProductName>
    <Strength>0.06</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009348</DrugIDPK>
    <LicenceNumber>PA0077/156/003</LicenceNumber>
    <ProductName>CYSTRIN CR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000415</DrugIDPK>
    <LicenceNumber>PA0007/002/005</LicenceNumber>
    <ProductName>ATROVENT AEROCAPS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003892</DrugIDPK>
    <LicenceNumber>PA0126/052/001</LicenceNumber>
    <ProductName>IMIPRAMINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006537</DrugIDPK>
    <LicenceNumber>PA0470/002/001</LicenceNumber>
    <ProductName>LANSOYL JELLY</ProductName>
    <Strength>78.23</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Parke-Davis</PAHolder>
    <AuthorisedDate>1990-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001543</DrugIDPK>
    <LicenceNumber>PA0037/031/001</LicenceNumber>
    <ProductName>LEDERSPAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE HEXACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001544</DrugIDPK>
    <LicenceNumber>PA0037/031/002</LicenceNumber>
    <ProductName>LEDERSPAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE HEXACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008274</DrugIDPK>
    <LicenceNumber>PA0130/020/003</LicenceNumber>
    <ProductName>TOREM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TORASEMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002319</DrugIDPK>
    <LicenceNumber>PA0050/080/001</LicenceNumber>
    <ProductName>VALDERMA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soap</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRICLOCARBAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006610</DrugIDPK>
    <LicenceNumber>PA0490/001/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Blackhall Pharmaceutical</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005811</DrugIDPK>
    <LicenceNumber>PA0363/004/001</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Alpharma ApS</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002299</DrugIDPK>
    <LicenceNumber>PA0048/001/009</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007691</DrugIDPK>
    <LicenceNumber>PA0009/016/021</LicenceNumber>
    <ProductName>XYLOCAINE 5% HEAVY (INTRATHECAL)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003385</DrugIDPK>
    <LicenceNumber>PA0077/069/002</LicenceNumber>
    <ProductName>HYPAQUE 45%</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1991-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006349</DrugIDPK>
    <LicenceNumber>PA0437/004/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006350</DrugIDPK>
    <LicenceNumber>PA0437/004/003</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011827</DrugIDPK>
    <LicenceNumber>PPA0465/042/001B</LicenceNumber>
    <ProductName>NIZORAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995011828</DrugIDPK>
    <LicenceNumber>PPA0465/042/001C</LicenceNumber>
    <ProductName>NIZORAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000445</DrugIDPK>
    <LicenceNumber>PA0007/014/004</LicenceNumber>
    <ProductName>CATAPRES PL PERLONGETS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1981-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLONIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004385</DrugIDPK>
    <LicenceNumber>PA0167/065/001</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008851</DrugIDPK>
    <LicenceNumber>PA0645/001/001</LicenceNumber>
    <ProductName>ACTIDOSE-AQUA</ProductName>
    <Strength>208</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Paddock Laboratories Inc. Ltd</PAHolder>
    <AuthorisedDate>1996-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHARCOAL, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008850</DrugIDPK>
    <LicenceNumber>PA0686/005/001</LicenceNumber>
    <ProductName>HEXABRIX 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GUERBET</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOXAGLATE MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>IOXAGLATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008717</DrugIDPK>
    <LicenceNumber>PA0199/003/001</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <Strength>280</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008719</DrugIDPK>
    <LicenceNumber>PA0199/004/001</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <Strength>325</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015856</DrugIDPK>
    <LicenceNumber>PA0074/047/002</LicenceNumber>
    <ProductName>CALAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008724</DrugIDPK>
    <LicenceNumber>PA0199/005/001</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <Strength>420</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008726</DrugIDPK>
    <LicenceNumber>PA0199/005/002</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <Strength>420</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003703</DrugIDPK>
    <LicenceNumber>PA0800/001/003</LicenceNumber>
    <ProductName>BIOCLATE 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>1995-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003701</DrugIDPK>
    <LicenceNumber>PA0800/001/001</LicenceNumber>
    <ProductName>BIOCLATE 250</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>1995-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003702</DrugIDPK>
    <LicenceNumber>PA0800/001/002</LicenceNumber>
    <ProductName>BIOCLATE 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>1995-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005284</DrugIDPK>
    <LicenceNumber>PA0281/010/001</LicenceNumber>
    <ProductName>TETRACYCLINE</ProductName>
    <Strength>250 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004757</DrugIDPK>
    <LicenceNumber>PA0769/018/001</LicenceNumber>
    <ProductName>AKINETON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>BIPERIDEN LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002175</DrugIDPK>
    <LicenceNumber>PA0769/002/001</LicenceNumber>
    <ProductName>BRUFEN GRANULES</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1994-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002171</DrugIDPK>
    <LicenceNumber>PA0769/004/001</LicenceNumber>
    <ProductName>FROBEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1992-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000566</DrugIDPK>
    <LicenceNumber>PA0013/004/006</LicenceNumber>
    <ProductName>MELLERIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000567</DrugIDPK>
    <LicenceNumber>PA0013/004/007</LicenceNumber>
    <ProductName>MELLERIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001185</DrugIDPK>
    <LicenceNumber>PA0022/010/002</LicenceNumber>
    <ProductName>SPARINE</ProductName>
    <Strength>50.0/0.620</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMAZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PAMOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001636</DrugIDPK>
    <LicenceNumber>PA0577/014/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002372</DrugIDPK>
    <LicenceNumber>PA0051/009/003</LicenceNumber>
    <ProductName>FULCIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002416</DrugIDPK>
    <LicenceNumber>PA0051/037/001</LicenceNumber>
    <ProductName>KETRAX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVAMISOLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006647</DrugIDPK>
    <LicenceNumber>PA0514/001/003</LicenceNumber>
    <ProductName>UPSANOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires UPSA</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006645</DrugIDPK>
    <LicenceNumber>PA0514/001/001</LicenceNumber>
    <ProductName>UPSANOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires UPSA</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006648</DrugIDPK>
    <LicenceNumber>PA0514/002/001</LicenceNumber>
    <ProductName>UPSARIN</ProductName>
    <Strength>325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires UPSA</PAHolder>
    <AuthorisedDate>1991-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006650</DrugIDPK>
    <LicenceNumber>PA0514/002/002</LicenceNumber>
    <ProductName>UPSARIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires UPSA</PAHolder>
    <AuthorisedDate>1991-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003011</DrugIDPK>
    <LicenceNumber>PA0059/039/001</LicenceNumber>
    <ProductName>ORTHO GYNE-T 380</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intrauterine Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003010</DrugIDPK>
    <LicenceNumber>PA0059/038/001</LicenceNumber>
    <ProductName>ORTHO GYNE-T INTRAUTERINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intrauterine Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005639</DrugIDPK>
    <LicenceNumber>PA0312/005/001</LicenceNumber>
    <ProductName>ORPHENADRINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORPHENADRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002907</DrugIDPK>
    <LicenceNumber>PA0057/056/003</LicenceNumber>
    <ProductName>AEROBEC 100 AUTOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1991-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002909</DrugIDPK>
    <LicenceNumber>PA0057/056/004</LicenceNumber>
    <ProductName>AEROBEC 250 INHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1991-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002905</DrugIDPK>
    <LicenceNumber>PA0057/056/001</LicenceNumber>
    <ProductName>AEROBEC 50 AUTOHALER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1991-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006706</DrugIDPK>
    <LicenceNumber>PA0565/001/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006707</DrugIDPK>
    <LicenceNumber>PA0565/001/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006704</DrugIDPK>
    <LicenceNumber>PA0565/001/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006708</DrugIDPK>
    <LicenceNumber>PA0565/002/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003509</DrugIDPK>
    <LicenceNumber>PA0086/028/002</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANFACINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000479</DrugIDPK>
    <LicenceNumber>PA0007/033/001</LicenceNumber>
    <ProductName>BEROTEC METERED DOSE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003929</DrugIDPK>
    <LicenceNumber>PA0126/072/001</LicenceNumber>
    <ProductName>CLONOFILIN SR</ProductName>
    <Strength>225</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1987-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003826</DrugIDPK>
    <LicenceNumber>PA0126/018/001</LicenceNumber>
    <ProductName>NITROFURANTOIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003903</DrugIDPK>
    <LicenceNumber>PA0126/059/002</LicenceNumber>
    <ProductName>PREDNISONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015807</DrugIDPK>
    <LicenceNumber>PA0114/077/001</LicenceNumber>
    <ProductName>ADIZEM PLUS</ProductName>
    <Strength>150/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003788</DrugIDPK>
    <LicenceNumber>PA0114/074/004</LicenceNumber>
    <ProductName>HYDOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1997-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003722</DrugIDPK>
    <LicenceNumber>PA0114/059/001</LicenceNumber>
    <ProductName>HYDROMORPHONE HYDROCHLORIDE</ProductName>
    <Strength>1.3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012823</DrugIDPK>
    <LicenceNumber>PA0114/059/002</LicenceNumber>
    <ProductName>HYDROMORPHONE HYDROCHLORIDE</ProductName>
    <Strength>2.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000531</DrugIDPK>
    <LicenceNumber>PA0114/078/001</LicenceNumber>
    <ProductName>UNILAR XL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000532</DrugIDPK>
    <LicenceNumber>PA0114/078/002</LicenceNumber>
    <ProductName>UNILAR XL</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003204</DrugIDPK>
    <LicenceNumber>PA0073/086/001</LicenceNumber>
    <ProductName>ANTRIMOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007277</DrugIDPK>
    <LicenceNumber>PA0041/026/001</LicenceNumber>
    <ProductName>TRILUDAN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007257</DrugIDPK>
    <LicenceNumber>PA0013/039/003</LicenceNumber>
    <ProductName>SANOMIGRAN ELIXIR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIZOTIFEN MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001421</DrugIDPK>
    <LicenceNumber>PA0037/008/003</LicenceNumber>
    <ProductName>MYAMBUTOL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1981-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHAMBUTOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005877</DrugIDPK>
    <LicenceNumber>PA0308/007/001</LicenceNumber>
    <ProductName>QUINODERM LOTIO-GEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Quinoderm Ltd</PAHolder>
    <AuthorisedDate>1981-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM HYDROXYQUINOLIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008519</DrugIDPK>
    <LicenceNumber>PA0013/052/001</LicenceNumber>
    <ProductName>CLIMACTOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008521</DrugIDPK>
    <LicenceNumber>PA0013/052/002</LicenceNumber>
    <ProductName>CLIMACTOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006873</DrugIDPK>
    <LicenceNumber>EU/1/98/059/004</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006874</DrugIDPK>
    <LicenceNumber>EU/1/98/059/005</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006875</DrugIDPK>
    <LicenceNumber>EU/1/98/059/006</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006876</DrugIDPK>
    <LicenceNumber>EU/1/98/059/007</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006877</DrugIDPK>
    <LicenceNumber>EU/1/98/059/008</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006878</DrugIDPK>
    <LicenceNumber>EU/1/98/059/009</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006879</DrugIDPK>
    <LicenceNumber>EU/1/98/059/010</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006881</DrugIDPK>
    <LicenceNumber>EU/1/98/059/011</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006883</DrugIDPK>
    <LicenceNumber>EU/1/98/059/012</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006871</DrugIDPK>
    <LicenceNumber>EU/1/98/059/003</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006869</DrugIDPK>
    <LicenceNumber>EU/1/98/059/002</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006867</DrugIDPK>
    <LicenceNumber>EU/1/98/059/001</LicenceNumber>
    <ProductName>TROVAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006885</DrugIDPK>
    <LicenceNumber>EU/1/98/060/001</LicenceNumber>
    <ProductName>TROVAN IV</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006886</DrugIDPK>
    <LicenceNumber>EU/1/98/060/002</LicenceNumber>
    <ProductName>TROVAN IV</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006887</DrugIDPK>
    <LicenceNumber>EU/1/98/060/003</LicenceNumber>
    <ProductName>TROVAN IV</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004692</DrugIDPK>
    <LicenceNumber>EU/1/98/061/002</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006847</DrugIDPK>
    <LicenceNumber>EU/1/98/061/001</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006848</DrugIDPK>
    <LicenceNumber>EU/1/98/061/003</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006849</DrugIDPK>
    <LicenceNumber>EU/1/98/061/004</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006850</DrugIDPK>
    <LicenceNumber>EU/1/98/061/005</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006851</DrugIDPK>
    <LicenceNumber>EU/1/98/061/006</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006852</DrugIDPK>
    <LicenceNumber>EU/1/98/061/007</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006853</DrugIDPK>
    <LicenceNumber>EU/1/98/061/008</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006855</DrugIDPK>
    <LicenceNumber>EU/1/98/061/009</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006856</DrugIDPK>
    <LicenceNumber>EU/1/98/061/010</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006857</DrugIDPK>
    <LicenceNumber>EU/1/98/061/011</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006858</DrugIDPK>
    <LicenceNumber>EU/1/98/061/012</LicenceNumber>
    <ProductName>TURVEL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006859</DrugIDPK>
    <LicenceNumber>EU/1/98/062/001</LicenceNumber>
    <ProductName>TURVEL IV</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006860</DrugIDPK>
    <LicenceNumber>EU/1/98/062/002</LicenceNumber>
    <ProductName>TURVEL IV</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006861</DrugIDPK>
    <LicenceNumber>EU/1/98/062/003</LicenceNumber>
    <ProductName>TURVEL IV</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roerig Farmaceutici Italiana</PAHolder>
    <AuthorisedDate>1998-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008268</DrugIDPK>
    <LicenceNumber>PA0130/015/004</LicenceNumber>
    <ProductName>ISMO RETARD</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1998-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006503</DrugIDPK>
    <LicenceNumber>PA0473/004/002</LicenceNumber>
    <ProductName>ALVEOLEX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1989-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006559</DrugIDPK>
    <LicenceNumber>PA0473/004/001</LicenceNumber>
    <ProductName>ALVEOLEX GRANULES</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1989-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004206</DrugIDPK>
    <LicenceNumber>EU/1/97/038/001</LicenceNumber>
    <ProductName>LIPROLOG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004207</DrugIDPK>
    <LicenceNumber>EU/1/97/038/003</LicenceNumber>
    <ProductName>LIPROLOG</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004208</DrugIDPK>
    <LicenceNumber>EU/1/97/038/002</LicenceNumber>
    <ProductName>LIPROLOG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004205</DrugIDPK>
    <LicenceNumber>PA0748/003/003</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006461</DrugIDPK>
    <LicenceNumber>PA0468/009/002</LicenceNumber>
    <ProductName>UBRETID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISTIGMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001086</DrugIDPK>
    <LicenceNumber>PA0021/002/001</LicenceNumber>
    <ProductName>ALRHEUMAT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1976-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003782</DrugIDPK>
    <LicenceNumber>PA0118/010/004</LicenceNumber>
    <ProductName>GANDA (1+0.2)</ProductName>
    <Strength>1.0/0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1981-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE MONOSULFATE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001456</DrugIDPK>
    <LicenceNumber>PA0037/021/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001457</DrugIDPK>
    <LicenceNumber>PA0037/021/002</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016518</DrugIDPK>
    <LicenceNumber>PA0303/030/001</LicenceNumber>
    <ProductName>ANDROSTAT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1997-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002204</DrugIDPK>
    <LicenceNumber>PA0047/059/004</LicenceNumber>
    <ProductName>HUMULIN TM I</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002228</DrugIDPK>
    <LicenceNumber>PA0047/069/001</LicenceNumber>
    <ProductName>HUMULIN TM M3</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003954</DrugIDPK>
    <LicenceNumber>PA0130/019/001</LicenceNumber>
    <ProductName>LORON</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLODRONATE DISODIUM TETRAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009087</DrugIDPK>
    <LicenceNumber>PA0050/081/003</LicenceNumber>
    <ProductName>MANERIX</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOCLOBEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002247</DrugIDPK>
    <LicenceNumber>PA0046/060/001</LicenceNumber>
    <ProductName>INNOHEP</ProductName>
    <Strength>3,500</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TINZAPARIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002175</DrugIDPK>
    <LicenceNumber>PA0046/025/001</LicenceNumber>
    <ProductName>MINIHEP CALCIUM</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002176</DrugIDPK>
    <LicenceNumber>PA0046/025/003</LicenceNumber>
    <ProductName>MINIHEP CALCIUM</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002219</DrugIDPK>
    <LicenceNumber>PA0046/044/001</LicenceNumber>
    <ProductName>PUMP-HEP</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005096</DrugIDPK>
    <LicenceNumber>PA0240/001/001</LicenceNumber>
    <ProductName>SCINTADREN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELENONORCHOLESTEROL (75 SE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000301</DrugIDPK>
    <LicenceNumber>PA0006/026/002</LicenceNumber>
    <ProductName>ALTACITE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000249</DrugIDPK>
    <LicenceNumber>PA0006/004/001</LicenceNumber>
    <ProductName>ALTACITE PLUS</ProductName>
    <Strength>500/250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000250</DrugIDPK>
    <LicenceNumber>PA0006/004/002</LicenceNumber>
    <ProductName>ALTACITE PLUS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009910</DrugIDPK>
    <LicenceNumber>PA0108/025/003</LicenceNumber>
    <ProductName>CREON 20000</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1998-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016512</DrugIDPK>
    <LicenceNumber>PA0077/129/001</LicenceNumber>
    <ProductName>INDAPAMIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000454</DrugIDPK>
    <LicenceNumber>PA0007/015/003</LicenceNumber>
    <ProductName>ALUPENT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002349</DrugIDPK>
    <LicenceNumber>PA0007/015/005</LicenceNumber>
    <ProductName>ALUPENT METERED AEROSOL</ProductName>
    <Strength>0.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002370</DrugIDPK>
    <LicenceNumber>PA0051/009/001</LicenceNumber>
    <ProductName>FULCIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002371</DrugIDPK>
    <LicenceNumber>PA0051/009/002</LicenceNumber>
    <ProductName>FULCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001138</DrugIDPK>
    <LicenceNumber>PA0023/008/006</LicenceNumber>
    <ProductName>LASIX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1981-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002401</DrugIDPK>
    <LicenceNumber>PA0051/025/002</LicenceNumber>
    <ProductName>MYSOLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRIMIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003627</DrugIDPK>
    <LicenceNumber>PA0748/007/001</LicenceNumber>
    <ProductName>ORTHOFORMS CONTRACEPTIVE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002994</DrugIDPK>
    <LicenceNumber>PA0059/021/001</LicenceNumber>
    <ProductName>TRINOVUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004383</DrugIDPK>
    <LicenceNumber>PA0024/005/010</LicenceNumber>
    <ProductName>BECOTIDE 100 EASI BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1997-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004384</DrugIDPK>
    <LicenceNumber>PA0024/005/011</LicenceNumber>
    <ProductName>BECOTIDE 250 EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1997-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004381</DrugIDPK>
    <LicenceNumber>PA0024/005/009</LicenceNumber>
    <ProductName>BECOTIDE 50 EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1997-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004382</DrugIDPK>
    <LicenceNumber>PA0024/001/015</LicenceNumber>
    <ProductName>VENTOLIN EASI-BREATHE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1997-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005721</DrugIDPK>
    <LicenceNumber>PA0294/013/001</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005722</DrugIDPK>
    <LicenceNumber>PA0294/013/002</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003678</DrugIDPK>
    <LicenceNumber>PA0108/015/002</LicenceNumber>
    <ProductName>DUPHALAC</ProductName>
    <Strength>95</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002724</DrugIDPK>
    <LicenceNumber>PA0050/051/002</LicenceNumber>
    <ProductName>KONAKION</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHYTOMENADIONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005838</DrugIDPK>
    <LicenceNumber>PA0303/004/002</LicenceNumber>
    <ProductName>TOILAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Landen PharmaChem NV</PAHolder>
    <AuthorisedDate>1981-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005869</DrugIDPK>
    <LicenceNumber>PA0303/001/003</LicenceNumber>
    <ProductName>VERAMIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1981-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009156</DrugIDPK>
    <LicenceNumber>PA0294/013/003</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004629</DrugIDPK>
    <LicenceNumber>PA0187/013/002</LicenceNumber>
    <ProductName>KABIKINASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006709</DrugIDPK>
    <LicenceNumber>PA0565/003/001</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006710</DrugIDPK>
    <LicenceNumber>PPA0565/003/002</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002868</DrugIDPK>
    <LicenceNumber>PA0544/025/001</LicenceNumber>
    <ProductName>MERUVAX II VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1996-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005842</DrugIDPK>
    <LicenceNumber>PA0303/005/001</LicenceNumber>
    <ProductName>GLAUPAX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1981-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETAZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005843</DrugIDPK>
    <LicenceNumber>PA0303/005/002</LicenceNumber>
    <ProductName>GLAUPAX RETARD</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1981-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETAZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006180</DrugIDPK>
    <LicenceNumber>PA0437/022/004</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006172</DrugIDPK>
    <LicenceNumber>PA0437/022/002</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003232</DrugIDPK>
    <LicenceNumber>PA0073/103/002</LicenceNumber>
    <ProductName>BUPIVACAINE &amp; ADRENALINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1989-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE, MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006597</DrugIDPK>
    <LicenceNumber>PA0488/002/001</LicenceNumber>
    <ProductName>SOMAGARD (TM DESLORELIN)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DELORELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2001-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003455</DrugIDPK>
    <LicenceNumber>PA0047/084/001</LicenceNumber>
    <ProductName>HUMAJECT M1 PEN</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003456</DrugIDPK>
    <LicenceNumber>PA0047/085/001</LicenceNumber>
    <ProductName>HUMAJECT M2 PEN</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003457</DrugIDPK>
    <LicenceNumber>PA0047/086/001</LicenceNumber>
    <ProductName>HUMAJECT M4 PEN</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003458</DrugIDPK>
    <LicenceNumber>PA0047/087/001</LicenceNumber>
    <ProductName>HUMAJECT M5 PEN</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002212</DrugIDPK>
    <LicenceNumber>PA0047/065/001</LicenceNumber>
    <ProductName>HUMULIN M 10/90</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003451</DrugIDPK>
    <LicenceNumber>PA0047/065/004</LicenceNumber>
    <ProductName>HUMULIN M1 CARTRIDGE</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005474</DrugIDPK>
    <LicenceNumber>PA0047/090/001</LicenceNumber>
    <ProductName>HUMULIN M1 PEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002218</DrugIDPK>
    <LicenceNumber>PA0047/066/002</LicenceNumber>
    <ProductName>HUMULIN M2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003453</DrugIDPK>
    <LicenceNumber>PA0047/070/004</LicenceNumber>
    <ProductName>HUMULIN M4 CARTRIDGE</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005477</DrugIDPK>
    <LicenceNumber>PA0047/093/001</LicenceNumber>
    <ProductName>HUMULIN M4 PEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003454</DrugIDPK>
    <LicenceNumber>PA0047/074/003</LicenceNumber>
    <ProductName>HUMULIN M5 CARTRIDGE</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016536</DrugIDPK>
    <LicenceNumber>PA0047/074/002</LicenceNumber>
    <ProductName>HUMULIN M5 CARTRIDGE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005478</DrugIDPK>
    <LicenceNumber>PA0047/094/001</LicenceNumber>
    <ProductName>HUMULIN M5 PEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002214</DrugIDPK>
    <LicenceNumber>PA0047/065/002</LicenceNumber>
    <ProductName>HUMULIN TM M1</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002233</DrugIDPK>
    <LicenceNumber>PA0047/070/001</LicenceNumber>
    <ProductName>HUMULIN TM M4</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002201</DrugIDPK>
    <LicenceNumber>PA0047/058/004</LicenceNumber>
    <ProductName>HUMULIN TM S</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000587</DrugIDPK>
    <LicenceNumber>PA0013/024/001</LicenceNumber>
    <ProductName>HYDERGINE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOTOXINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000588</DrugIDPK>
    <LicenceNumber>PA0013/024/002</LicenceNumber>
    <ProductName>HYDERGINE</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1980-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOTOXINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006935</DrugIDPK>
    <LicenceNumber>PA0700/009/002</LicenceNumber>
    <ProductName>TRIDIL 5 MG/ML</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006934</DrugIDPK>
    <LicenceNumber>PA0700/009/001</LicenceNumber>
    <ProductName>TRIDIL 500 MCG/ML</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016170</DrugIDPK>
    <LicenceNumber>PA0032/003/002</LicenceNumber>
    <ProductName>ASPRO CLEAR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002731</DrugIDPK>
    <LicenceNumber>PA0050/054/001</LicenceNumber>
    <ProductName>BECOSYM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002733</DrugIDPK>
    <LicenceNumber>PA0050/055/001</LicenceNumber>
    <ProductName>BENADON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002734</DrugIDPK>
    <LicenceNumber>PA0050/055/002</LicenceNumber>
    <ProductName>BENADON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002735</DrugIDPK>
    <LicenceNumber>PA0050/056/003</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002739</DrugIDPK>
    <LicenceNumber>PA0050/056/006</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005632</DrugIDPK>
    <LicenceNumber>PA0050/139/001</LicenceNumber>
    <ProductName>BIOVITAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1995-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRIC SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002756</DrugIDPK>
    <LicenceNumber>PA0050/007/007</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002758</DrugIDPK>
    <LicenceNumber>PA0050/007/009</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002757</DrugIDPK>
    <LicenceNumber>PA0050/007/008</LicenceNumber>
    <ProductName>REDOXON 200 MG</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008658</DrugIDPK>
    <LicenceNumber>PA0050/102/001</LicenceNumber>
    <ProductName>SECADERM SALVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1993-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINUS PALUSTRIS</ActiveSubstance>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
      <ActiveSubstance>MELALEUCA OIL</ActiveSubstance>
      <ActiveSubstance>TEREBENE</ActiveSubstance>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001810</DrugIDPK>
    <LicenceNumber>PA0033/020/002</LicenceNumber>
    <ProductName>STAYCEPT</ProductName>
    <Strength>96</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001807</DrugIDPK>
    <LicenceNumber>PA0033/020/001</LicenceNumber>
    <ProductName>STAYCEPT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OCTOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003905</DrugIDPK>
    <LicenceNumber>PA0050/133/001</LicenceNumber>
    <ProductName>SYNTARIS HAYFEVER NASAL</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUNISOLIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005841</DrugIDPK>
    <LicenceNumber>PA0050/104/001</LicenceNumber>
    <ProductName>ZAM BUK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>PINUS PALUSTRIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000972</DrugIDPK>
    <LicenceNumber>PA0290/071/001</LicenceNumber>
    <ProductName>DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1997-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPIVEFRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995009742</DrugIDPK>
    <LicenceNumber>PA0748/046/001</LicenceNumber>
    <ProductName>NEOCON 1/35</ProductName>
    <Strength>1000/35</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1997-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002980</DrugIDPK>
    <LicenceNumber>PA0059/009/007</LicenceNumber>
    <ProductName>PEVARYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1981-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002962</DrugIDPK>
    <LicenceNumber>PA0059/003/004</LicenceNumber>
    <ProductName>TOLECTIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1981-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLMETIN SODIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006194</DrugIDPK>
    <LicenceNumber>PA0441/002/001</LicenceNumber>
    <ProductName>VICKS VAPORUB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour, Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001289</DrugIDPK>
    <LicenceNumber>PA0023/060/002</LicenceNumber>
    <ProductName>INSUM BASAL FOR OPTIPEN CARTRIDGE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001294</DrugIDPK>
    <LicenceNumber>PA0023/061/004</LicenceNumber>
    <ProductName>INSUMAN 25/75 FOR OPTIPEN CARTRIDGE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005553</DrugIDPK>
    <LicenceNumber>EU/1/99/105/001</LicenceNumber>
    <ProductName>ROTASHIELD</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wyeth-Lederle Vaccines S.A</PAHolder>
    <AuthorisedDate>1999-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROTAVIRUS REASSORTANT SEROTYPE 1</ActiveSubstance>
      <ActiveSubstance>ROTAVIRUS REASSORTANT SEROTYPE 2</ActiveSubstance>
      <ActiveSubstance>ROTAVIRUS REASSORTANT SEROTYPE 4</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003962</DrugIDPK>
    <LicenceNumber>PA0748/008/002</LicenceNumber>
    <ProductName>EVOREL SEQUI</ProductName>
    <Strength>3.2/11.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001669</DrugIDPK>
    <LicenceNumber>PA0038/031/001</LicenceNumber>
    <ProductName>VIDAYLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005850</DrugIDPK>
    <LicenceNumber>PA0303/016/001</LicenceNumber>
    <ProductName>TEMPOROL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1985-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012672</DrugIDPK>
    <LicenceNumber>PA0468/012/002</LicenceNumber>
    <ProductName>ANANASE FORTE</ProductName>
    <Strength>44</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMELAINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003601</DrugIDPK>
    <LicenceNumber>PA0095/018/001</LicenceNumber>
    <ProductName>BENZYL BENZOATE APPLICATION B.P.</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1993-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004992</DrugIDPK>
    <LicenceNumber>PA0046/016/009</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>2000-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009212</DrugIDPK>
    <LicenceNumber>PA0126/093/001</LicenceNumber>
    <ProductName>CLONDEPRYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1996-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002154</DrugIDPK>
    <LicenceNumber>PA0046/009/005</LicenceNumber>
    <ProductName>PONDOCILLIN</ProductName>
    <Strength>175</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006450</DrugIDPK>
    <LicenceNumber>PA0468/003/002</LicenceNumber>
    <ProductName>ALGICON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008674</DrugIDPK>
    <LicenceNumber>PA0050/112/001</LicenceNumber>
    <ProductName>CORSYM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004063</DrugIDPK>
    <LicenceNumber>PA0013/048/003</LicenceNumber>
    <ProductName>NAVOBAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1999-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROPISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000666</DrugIDPK>
    <LicenceNumber>PA0013/048/002</LicenceNumber>
    <ProductName>NAVOBAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROPISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000665</DrugIDPK>
    <LicenceNumber>PA0013/048/001</LicenceNumber>
    <ProductName>NAVOBAN AMPOULES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROPISETRON HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001108</DrugIDPK>
    <LicenceNumber>PA0021/005/001</LicenceNumber>
    <ProductName>BAYCARON</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFRUSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016048</DrugIDPK>
    <LicenceNumber>PA0732/001/001</LicenceNumber>
    <ProductName>CLONTERIC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dallas Burston Healthcare Ltd</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005708</DrugIDPK>
    <LicenceNumber>PA0748/028/001</LicenceNumber>
    <ProductName>BINOVUM ORAL CONTRACEPTIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005708</DrugIDPK>
    <LicenceNumber>PA0748/028/001</LicenceNumber>
    <ProductName>BINOVUM ORAL CONTRACEPTIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006328</DrugIDPK>
    <LicenceNumber>PA0748/015/005</LicenceNumber>
    <ProductName>NIZORAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1997-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005564</DrugIDPK>
    <LicenceNumber>PA0748/024/001</LicenceNumber>
    <ProductName>ORAP</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1993-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIMOZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006352</DrugIDPK>
    <LicenceNumber>PA0748/037/001</LicenceNumber>
    <ProductName>PEVARYL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1995-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004201</DrugIDPK>
    <LicenceNumber>EU/1/98/072/001</LicenceNumber>
    <ProductName>ECHOGEN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Sonus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DODECAFLUOROPENTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002675</DrugIDPK>
    <LicenceNumber>PA0050/017/007</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006925</DrugIDPK>
    <LicenceNumber>PA0700/005/001</LicenceNumber>
    <ProductName>INTROPIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma</PAHolder>
    <AuthorisedDate>1991-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006133</DrugIDPK>
    <LicenceNumber>PA0408/035/001</LicenceNumber>
    <ProductName>RIMADOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006134</DrugIDPK>
    <LicenceNumber>PA0408/035/002</LicenceNumber>
    <ProductName>RIMADOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006138</DrugIDPK>
    <LicenceNumber>PA0408/037/003</LicenceNumber>
    <ProductName>RIMAFLOX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003886</DrugIDPK>
    <LicenceNumber>PA0126/048/001</LicenceNumber>
    <ProductName>CHLORDIAZEPOXIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006293</DrugIDPK>
    <LicenceNumber>PA0748/036/001</LicenceNumber>
    <ProductName>ORTHO-DIENOESTROL</ProductName>
    <Strength>0.01</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIENESTROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008234</DrugIDPK>
    <LicenceNumber>PA0303/026/001</LicenceNumber>
    <ProductName>TRIDESTRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1995-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>LACTOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000007</DrugIDPK>
    <LicenceNumber>PA0743/001/001</LicenceNumber>
    <ProductName>ERYCAPS ERYTHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004405</DrugIDPK>
    <LicenceNumber>PA0167/068/003</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>0.8</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004408</DrugIDPK>
    <LicenceNumber>PA0167/068/006</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>1.6</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004034</DrugIDPK>
    <LicenceNumber>PA0021/043/001</LicenceNumber>
    <ProductName>GAMIMUNE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>2000-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN IMMUMOGLOBULINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008243</DrugIDPK>
    <LicenceNumber>PA0108/023/001</LicenceNumber>
    <ProductName>TEVETEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPROSARTAN MESGLATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006933</DrugIDPK>
    <LicenceNumber>PA0700/008/004</LicenceNumber>
    <ProductName>NARCAN SYRINGE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma</PAHolder>
    <AuthorisedDate>1992-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004576</DrugIDPK>
    <LicenceNumber>PA0185/020/001</LicenceNumber>
    <ProductName>XURET</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1990-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOLAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006130</DrugIDPK>
    <LicenceNumber>PA0408/033/001</LicenceNumber>
    <ProductName>RIMACID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006131</DrugIDPK>
    <LicenceNumber>PA0408/033/002</LicenceNumber>
    <ProductName>RIMACID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006132</DrugIDPK>
    <LicenceNumber>PA0408/034/001</LicenceNumber>
    <ProductName>RIMATHROCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006135</DrugIDPK>
    <LicenceNumber>PA0408/036/001</LicenceNumber>
    <ProductName>RIMAZOLE CO-TRIMOXAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>1989-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000067</DrugIDPK>
    <LicenceNumber>PA0050/068/009</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000068</DrugIDPK>
    <LicenceNumber>PA0050/068/010</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000069</DrugIDPK>
    <LicenceNumber>PA0050/068/011</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000070</DrugIDPK>
    <LicenceNumber>PA0050/068/012</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000071</DrugIDPK>
    <LicenceNumber>PA0050/068/013</LicenceNumber>
    <ProductName>ROFERON A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1996-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002297</DrugIDPK>
    <LicenceNumber>PA0050/068/001</LicenceNumber>
    <ProductName>ROFERON-A</ProductName>
    <Strength>3000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002298</DrugIDPK>
    <LicenceNumber>PA0050/068/002</LicenceNumber>
    <ProductName>ROFERON-A</ProductName>
    <Strength>18000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002300</DrugIDPK>
    <LicenceNumber>PA0050/068/003</LicenceNumber>
    <ProductName>ROFERON-A</ProductName>
    <Strength>9000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002301</DrugIDPK>
    <LicenceNumber>PA0050/068/007</LicenceNumber>
    <ProductName>ROFERON-A</ProductName>
    <Strength>4500000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006568</DrugIDPK>
    <LicenceNumber>PA0483/005/001</LicenceNumber>
    <ProductName>STERETS AQUASOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seton Prebbles Ltd</PAHolder>
    <AuthorisedDate>1990-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008616</DrugIDPK>
    <LicenceNumber>EU/1/00/142/001</LicenceNumber>
    <ProductName>NOVOMIX 30</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2000-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010396</DrugIDPK>
    <LicenceNumber>EU/1/00/142/002</LicenceNumber>
    <ProductName>NOVOMIX 30</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2000-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006799</DrugIDPK>
    <LicenceNumber>PA0592/002/003</LicenceNumber>
    <ProductName>HUMAN ALBUMIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1994-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007890</DrugIDPK>
    <LicenceNumber>PA0592/001/001</LicenceNumber>
    <ProductName>INTRAGLOBIN F (FLUID)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007892</DrugIDPK>
    <LicenceNumber>PA0592/001/002</LicenceNumber>
    <ProductName>INTRAGLOBIN F (FLUID)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006369</DrugIDPK>
    <LicenceNumber>PPA0465/008/003</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006371</DrugIDPK>
    <LicenceNumber>PPA0465/008/004</LicenceNumber>
    <ProductName>AMOXIL FORTE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009170</DrugIDPK>
    <LicenceNumber>PA0057/064/003</LicenceNumber>
    <ProductName>BELCLOMETHASONE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009167</DrugIDPK>
    <LicenceNumber>PA0057/064/001</LicenceNumber>
    <ProductName>BECLOMETHASONE 50UG</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009168</DrugIDPK>
    <LicenceNumber>PA0057/064/002</LicenceNumber>
    <ProductName>BELCLOMETHASONE 100 UG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001726</DrugIDPK>
    <LicenceNumber>PA0040/004/002</LicenceNumber>
    <ProductName>FLAGYL COMPAK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1990-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001886</DrugIDPK>
    <LicenceNumber>PA0748/001/002</LicenceNumber>
    <ProductName>TYLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1995-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016513</DrugIDPK>
    <LicenceNumber>PA0621/005/001</LicenceNumber>
    <ProductName>STERI-DROP HYPROMELLOSE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Steripak Ltd</PAHolder>
    <AuthorisedDate>1997-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995010329</DrugIDPK>
    <LicenceNumber>PA0281/104/001</LicenceNumber>
    <ProductName>AZATHIOPRINE</ProductName>
    <Strength>50mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003915</DrugIDPK>
    <LicenceNumber>PA0277/050/013</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>6000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003925</DrugIDPK>
    <LicenceNumber>PA0277/050/014</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002889</DrugIDPK>
    <LicenceNumber>PA0060/012/001</LicenceNumber>
    <ProductName>PARSTELIN</ProductName>
    <Strength>10/1</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANYLCYPROMINE SULFATE</ActiveSubstance>
      <ActiveSubstance>TRIFLUOPERAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003932</DrugIDPK>
    <LicenceNumber>PA0277/073/008</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>6000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004503</DrugIDPK>
    <LicenceNumber>PA0013/073/001</LicenceNumber>
    <ProductName>NAVISPARE</ProductName>
    <Strength>0.25/2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005331</DrugIDPK>
    <LicenceNumber>PA0281/053/001</LicenceNumber>
    <ProductName>FERYBAR ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1989-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIVER EXTRACT</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
      <ActiveSubstance>FERRIC AMMONIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>POTASSIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005994</DrugIDPK>
    <LicenceNumber>PA0748/015/004</LicenceNumber>
    <ProductName>NIZORAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1995-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005608</DrugIDPK>
    <LicenceNumber>PA0748/001/003</LicenceNumber>
    <ProductName>TYLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005608</DrugIDPK>
    <LicenceNumber>PA0748/001/003</LicenceNumber>
    <ProductName>TYLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005609</DrugIDPK>
    <LicenceNumber>PA0748/001/004</LicenceNumber>
    <ProductName>TYLEX FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005609</DrugIDPK>
    <LicenceNumber>PA0748/001/004</LicenceNumber>
    <ProductName>TYLEX FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1996-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004817</DrugIDPK>
    <LicenceNumber>PA0212/005/001</LicenceNumber>
    <ProductName>HUMAN ALBUMIN 20%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1989-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002855</DrugIDPK>
    <LicenceNumber>PA0711/014/001</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1997-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009402</DrugIDPK>
    <LicenceNumber>PA0711/001/002</LicenceNumber>
    <ProductName>IDOMED</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1995-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003776</DrugIDPK>
    <LicenceNumber>PA0711/001/001</LicenceNumber>
    <ProductName>IDOMED</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1995-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002320</DrugIDPK>
    <LicenceNumber>PA0711/013/002</LicenceNumber>
    <ProductName>MINOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002402</DrugIDPK>
    <LicenceNumber>PA0711/005/005</LicenceNumber>
    <ProductName>ROXILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002403</DrugIDPK>
    <LicenceNumber>PA0711/005/006</LicenceNumber>
    <ProductName>ROXILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002404</DrugIDPK>
    <LicenceNumber>PA0711/005/007</LicenceNumber>
    <ProductName>ROXILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002405</DrugIDPK>
    <LicenceNumber>PA0711/005/008</LicenceNumber>
    <ProductName>ROXILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002406</DrugIDPK>
    <LicenceNumber>PA0711/005/009</LicenceNumber>
    <ProductName>ROXILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016112</DrugIDPK>
    <LicenceNumber>PA0711/005/003</LicenceNumber>
    <ProductName>ROXILLIN 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016110</DrugIDPK>
    <LicenceNumber>PA0711/005/001</LicenceNumber>
    <ProductName>ROXILLIN 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016111</DrugIDPK>
    <LicenceNumber>PA0711/005/002</LicenceNumber>
    <ProductName>ROXILLIN 750</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009041</DrugIDPK>
    <LicenceNumber>PA0365/065/001</LicenceNumber>
    <ProductName>OPV POLIOMYELITIS VACINE/LIVE BP/TRIVALENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1996-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLIOVIRUS,  TYPE 1</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 2</ActiveSubstance>
      <ActiveSubstance>POLIOVIRUS, TYPE 3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001755</DrugIDPK>
    <LicenceNumber>PA0032/031/002</LicenceNumber>
    <ProductName>PARACLEAR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1990-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007782</DrugIDPK>
    <LicenceNumber>PA0320/001/001</LicenceNumber>
    <ProductName>COLGATE FLUORIGARD (GRAPE)</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007783</DrugIDPK>
    <LicenceNumber>PA0320/001/002</LicenceNumber>
    <ProductName>COLGATE FLUORIGARD (ORANGE)</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008767</DrugIDPK>
    <LicenceNumber>PA0544/015/001</LicenceNumber>
    <ProductName>ACT-HIB DTP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008768</DrugIDPK>
    <LicenceNumber>PA0544/015/002</LicenceNumber>
    <ProductName>ACT-HIB DTP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003904</DrugIDPK>
    <LicenceNumber>PA0544/015/003</LicenceNumber>
    <ProductName>ACT-HIB DTP D.C.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003904</DrugIDPK>
    <LicenceNumber>PA0544/015/003</LicenceNumber>
    <ProductName>ACT-HIB DTP D.C.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006797</DrugIDPK>
    <LicenceNumber>PA0544/004/003</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE BP 10 DOSE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006786</DrugIDPK>
    <LicenceNumber>PA0544/001/003</LicenceNumber>
    <ProductName>ADSORBED TETANUS 10 DOSE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003345</DrugIDPK>
    <LicenceNumber>PA0769/002/007</LicenceNumber>
    <ProductName>BRUFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1995-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006825</DrugIDPK>
    <LicenceNumber>PA0544/018/003</LicenceNumber>
    <ProductName>DIFTAVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006821</DrugIDPK>
    <LicenceNumber>PA0544/018/001</LicenceNumber>
    <ProductName>DIFTAVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003473</DrugIDPK>
    <LicenceNumber>PA0086/011/003</LicenceNumber>
    <ProductName>DIMOTAPP PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1980-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006820</DrugIDPK>
    <LicenceNumber>PA0544/013/003</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS PERTUSSIS 10 DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006817</DrugIDPK>
    <LicenceNumber>PA0544/013/001</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS PERTUSSIS SINGLE DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006819</DrugIDPK>
    <LicenceNumber>PA0544/013/002</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS PERTUSSIS SINGLE DOSE SYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006798</DrugIDPK>
    <LicenceNumber>PA0544/004/004</LicenceNumber>
    <ProductName>DIP-TET VAX 20 DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006791</DrugIDPK>
    <LicenceNumber>PA0544/003/002</LicenceNumber>
    <ProductName>MEASAVAX 10 DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016265</DrugIDPK>
    <LicenceNumber>PA0544/020/002</LicenceNumber>
    <ProductName>MEASLES RUBELLA VACCINE LIVE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1995-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016264</DrugIDPK>
    <LicenceNumber>PA0544/020/001</LicenceNumber>
    <ProductName>MEASLES RUBELLA VACCINE LIVE - VIAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1995-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006788</DrugIDPK>
    <LicenceNumber>PA0544/002/002</LicenceNumber>
    <ProductName>RUBAVAX 10 DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006809</DrugIDPK>
    <LicenceNumber>PA0544/007/002</LicenceNumber>
    <ProductName>TYPHIM VI 20 DOSE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1992-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMONELLA TYPHI, VI ANTIGEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001458</DrugIDPK>
    <LicenceNumber>PA0037/021/003</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1985-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000976</DrugIDPK>
    <LicenceNumber>PA0017/087/003</LicenceNumber>
    <ProductName>CEFIZOX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIZOXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001945</DrugIDPK>
    <LicenceNumber>PA0045/030/001</LicenceNumber>
    <ProductName>LIVOSTIN EYE DROPS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1995-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCABASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001946</DrugIDPK>
    <LicenceNumber>PA0045/030/002</LicenceNumber>
    <ProductName>LIVOSTIN NASAL SPRAY</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1995-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOCABASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006485</DrugIDPK>
    <LicenceNumber>PA0468/024/001</LicenceNumber>
    <ProductName>ASCRIPTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007770</DrugIDPK>
    <LicenceNumber>PA0277/066/001</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007771</DrugIDPK>
    <LicenceNumber>PA0277/066/002</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007772</DrugIDPK>
    <LicenceNumber>PA0277/066/003</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <Strength>18</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007773</DrugIDPK>
    <LicenceNumber>PA0277/066/004</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <Strength>36</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002394</DrugIDPK>
    <LicenceNumber>PA0051/024/003</LicenceNumber>
    <ProductName>NOLVADEX FORTE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1985-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007839</DrugIDPK>
    <LicenceNumber>PA0828/003/001</LicenceNumber>
    <ProductName>HALOTHANE</ProductName>
    <Strength>0.01</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Concord Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1998-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALOTHANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003329</DrugIDPK>
    <LicenceNumber>PA0019/051/001</LicenceNumber>
    <ProductName>OZIDIA CONTROLLED RELEASE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1996-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIPIZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002747</DrugIDPK>
    <LicenceNumber>PA0019/051/002</LicenceNumber>
    <ProductName>OZIDIA CONTROLLED RELEASE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1996-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIPIZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002748</DrugIDPK>
    <LicenceNumber>PA0019/051/003</LicenceNumber>
    <ProductName>OZIDIA CONTROLLED RELEASE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1996-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIPIZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002005</DrugIDPK>
    <LicenceNumber>PA0040/078/003</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002003</DrugIDPK>
    <LicenceNumber>PA0040/078/002</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006637</DrugIDPK>
    <LicenceNumber>PA0508/004/001</LicenceNumber>
    <ProductName>CYCROMATE 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007866</DrugIDPK>
    <LicenceNumber>PA0051/070/001</LicenceNumber>
    <ProductName>SAVARINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1999-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROGUANIL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLOROQUINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000827</DrugIDPK>
    <LicenceNumber>PA0017/002/005</LicenceNumber>
    <ProductName>SEPTRIN DISPERSIBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1975-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006296</DrugIDPK>
    <LicenceNumber>PA0430/001/001</LicenceNumber>
    <ProductName>DUBLIN COUGH MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hayes, Conyngham &amp; Robinson Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUORICE LIQUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000417</DrugIDPK>
    <LicenceNumber>PA0007/004/002</LicenceNumber>
    <ProductName>TRANXENE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1980-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLORAZEPATE DIPOTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002397</DrugIDPK>
    <LicenceNumber>PA0048/037/002</LicenceNumber>
    <ProductName>COMTREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1985-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001462</DrugIDPK>
    <LicenceNumber>PA0027/035/001</LicenceNumber>
    <ProductName>DETTOL BABY</ProductName>
    <Strength>10/0.01</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001480</DrugIDPK>
    <LicenceNumber>PA0027/042/001</LicenceNumber>
    <ProductName>DETTOL CLEAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1991-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001371</DrugIDPK>
    <LicenceNumber>PA0027/014/003</LicenceNumber>
    <ProductName>DETTOL ORAL ANTISEPTIC</ProductName>
    <Strength>1.02</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouth Wash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001477</DrugIDPK>
    <LicenceNumber>PA0027/036/003</LicenceNumber>
    <ProductName>DISPROL PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001426</DrugIDPK>
    <LicenceNumber>PA0027/024/001</LicenceNumber>
    <ProductName>SENOKOT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SENNOSIDE B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001674</DrugIDPK>
    <LicenceNumber>PA0038/036/003</LicenceNumber>
    <ProductName>EPIVAL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1985-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SEMISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002408</DrugIDPK>
    <LicenceNumber>PA0051/029/001</LicenceNumber>
    <ProductName>INDERECTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1980-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007648</DrugIDPK>
    <LicenceNumber>PA0046/004/016</LicenceNumber>
    <ProductName>FUCIDIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002155</DrugIDPK>
    <LicenceNumber>PA0046/009/006</LicenceNumber>
    <ProductName>PONDOCILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007715</DrugIDPK>
    <LicenceNumber>PA0405/041/001</LicenceNumber>
    <ProductName>IOPAMIDOL 370</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007716</DrugIDPK>
    <LicenceNumber>PA0405/041/002</LicenceNumber>
    <ProductName>IOPAMIDOL 370</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007717</DrugIDPK>
    <LicenceNumber>PA0405/041/003</LicenceNumber>
    <ProductName>IOPAMIDOL 370</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007718</DrugIDPK>
    <LicenceNumber>PA0405/041/004</LicenceNumber>
    <ProductName>IOPAMIDOL 370</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007719</DrugIDPK>
    <LicenceNumber>PA0405/041/005</LicenceNumber>
    <ProductName>IOPAMIDOL 370</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007720</DrugIDPK>
    <LicenceNumber>PA0405/041/006</LicenceNumber>
    <ProductName>IOPAMIDOL 370</ProductName>
    <Strength>370</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002181</DrugIDPK>
    <LicenceNumber>PA0037/059/003</LicenceNumber>
    <ProductName>PROSTAP SR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1990-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUPRORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001606</DrugIDPK>
    <LicenceNumber>PA0037/059/004</LicenceNumber>
    <ProductName>PROSTAP SR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1990-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUPRORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010125</DrugIDPK>
    <LicenceNumber>PA0148/055/001</LicenceNumber>
    <ProductName>BOTOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1994-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOSTRIDIUM BOTULINUM TYP A-ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002305</DrugIDPK>
    <LicenceNumber>PA0050/072/002</LicenceNumber>
    <ProductName>ANEXATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1988-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUMAZENIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004851</DrugIDPK>
    <LicenceNumber>PA0277/050/015</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>6000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004852</DrugIDPK>
    <LicenceNumber>PA0277/050/016</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004853</DrugIDPK>
    <LicenceNumber>PA0277/050/017</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005184</DrugIDPK>
    <LicenceNumber>PA0277/050/001</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>1000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005185</DrugIDPK>
    <LicenceNumber>PA0277/050/002</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>3000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005187</DrugIDPK>
    <LicenceNumber>PA0277/050/003</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>5000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005189</DrugIDPK>
    <LicenceNumber>PA0277/050/004</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005334</DrugIDPK>
    <LicenceNumber>PA0277/050/018</LicenceNumber>
    <ProductName>INTRON A MULTIDOSE INJECTION PEN</ProductName>
    <Strength>15000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005335</DrugIDPK>
    <LicenceNumber>PA0277/050/019</LicenceNumber>
    <ProductName>INTRON A MULTIDOSE INJECTION PEN</ProductName>
    <Strength>25000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005336</DrugIDPK>
    <LicenceNumber>PA0277/050/020</LicenceNumber>
    <ProductName>INTRON A MULTIDOSE INJECTION PEN</ProductName>
    <Strength>50000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004854</DrugIDPK>
    <LicenceNumber>PA0277/073/010</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>6000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004855</DrugIDPK>
    <LicenceNumber>PA0277/073/011</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004856</DrugIDPK>
    <LicenceNumber>PA0277/073/012</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003933</DrugIDPK>
    <LicenceNumber>PA0277/073/009</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000369</DrugIDPK>
    <LicenceNumber>PA0277/073/006</LicenceNumber>
    <ProductName>VIRAFERON 10 MILLION IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000370</DrugIDPK>
    <LicenceNumber>PA0277/073/007</LicenceNumber>
    <ProductName>VIRAFERON 25 MILLION IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005337</DrugIDPK>
    <LicenceNumber>PA0277/073/013</LicenceNumber>
    <ProductName>VIRAFERON MULTIDOSE INJECTION PEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005338</DrugIDPK>
    <LicenceNumber>PA0277/073/014</LicenceNumber>
    <ProductName>VIRAFERON MULTIDOSE INJECTION PEN</ProductName>
    <Strength>25000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005339</DrugIDPK>
    <LicenceNumber>PA0277/073/015</LicenceNumber>
    <ProductName>VIRAFERON MULTIDOSE INJECTION PEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000365</DrugIDPK>
    <LicenceNumber>PA0277/073/002</LicenceNumber>
    <ProductName>VIRAFERON VIAL</ProductName>
    <Strength>1500000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000366</DrugIDPK>
    <LicenceNumber>PA0277/073/003</LicenceNumber>
    <ProductName>VIRAFERON VIAL</ProductName>
    <Strength>2500000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000367</DrugIDPK>
    <LicenceNumber>PA0277/073/004</LicenceNumber>
    <ProductName>VIRAFERON VIAL</ProductName>
    <Strength>5000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000368</DrugIDPK>
    <LicenceNumber>PA0277/073/005</LicenceNumber>
    <ProductName>VIRAFERON VIAL</ProductName>
    <Strength>5000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016535</DrugIDPK>
    <LicenceNumber>PA0277/073/001</LicenceNumber>
    <ProductName>VIRAFERON VIAL</ProductName>
    <Strength>500000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1995-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009004</DrugIDPK>
    <LicenceNumber>PA0365/058/002</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA TETANUS &amp; PERTUSSIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1994-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006548</DrugIDPK>
    <LicenceNumber>PA0473/001/004</LicenceNumber>
    <ProductName>DIFENE SUSTAINED</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1990-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004844</DrugIDPK>
    <LicenceNumber>PA0218/031/001</LicenceNumber>
    <ProductName>GLUCAGEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCAGON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004545</DrugIDPK>
    <LicenceNumber>PA0013/077/001</LicenceNumber>
    <ProductName>LENTARON IM DEPOT</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMESTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004518</DrugIDPK>
    <LicenceNumber>PA0013/068/001</LicenceNumber>
    <ProductName>ORIMETEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOGLUTETHIMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000558</DrugIDPK>
    <LicenceNumber>PA0013/002/002</LicenceNumber>
    <ProductName>PARLODEL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMOCRIPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004502</DrugIDPK>
    <LicenceNumber>PA0013/060/001</LicenceNumber>
    <ProductName>SLOW TRASICOR</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1996-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000586</DrugIDPK>
    <LicenceNumber>PA0013/021/002</LicenceNumber>
    <ProductName>TAVEGIL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLEMASTINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004498</DrugIDPK>
    <LicenceNumber>PA0013/057/001</LicenceNumber>
    <ProductName>TRASICOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004499</DrugIDPK>
    <LicenceNumber>PA0013/057/002</LicenceNumber>
    <ProductName>TRASICOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1995-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004500</DrugIDPK>
    <LicenceNumber>PA0013/057/003</LicenceNumber>
    <ProductName>TRASICOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004501</DrugIDPK>
    <LicenceNumber>PA0013/062/001</LicenceNumber>
    <ProductName>TRASIDREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYCLOPENTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005029</DrugIDPK>
    <LicenceNumber>EU/1/98/068/001</LicenceNumber>
    <ProductName>PYLORI-CHEK C-UREA BREATH TEST</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alimenterics B.V.</PAHolder>
    <AuthorisedDate>1998-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>13C-UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001720</DrugIDPK>
    <LicenceNumber>PA0040/003/007</LicenceNumber>
    <ProductName>FLAGYL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1981-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004576</DrugIDPK>
    <LicenceNumber>PA0013/086/003</LicenceNumber>
    <ProductName>TOFRANIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005440</DrugIDPK>
    <LicenceNumber>PA0855/024/002</LicenceNumber>
    <ProductName>INSUMAN 15/85 VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005440</DrugIDPK>
    <LicenceNumber>PA0855/024/002</LicenceNumber>
    <ProductName>INSUMAN 15/85 VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005440</DrugIDPK>
    <LicenceNumber>PA0855/024/002</LicenceNumber>
    <ProductName>INSUMAN 15/85 VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005441</DrugIDPK>
    <LicenceNumber>PA0855/024/003</LicenceNumber>
    <ProductName>INSUMAN 25/75 - VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005441</DrugIDPK>
    <LicenceNumber>PA0855/024/003</LicenceNumber>
    <ProductName>INSUMAN 25/75 - VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005441</DrugIDPK>
    <LicenceNumber>PA0855/024/003</LicenceNumber>
    <ProductName>INSUMAN 25/75 - VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005442</DrugIDPK>
    <LicenceNumber>PA0855/024/004</LicenceNumber>
    <ProductName>INSUMAN 50/50 - VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005442</DrugIDPK>
    <LicenceNumber>PA0855/024/004</LicenceNumber>
    <ProductName>INSUMAN 50/50 - VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005442</DrugIDPK>
    <LicenceNumber>PA0855/024/004</LicenceNumber>
    <ProductName>INSUMAN 50/50 - VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005432</DrugIDPK>
    <LicenceNumber>PA0855/021/002</LicenceNumber>
    <ProductName>INSUMAN RAPID - VIAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005431</DrugIDPK>
    <LicenceNumber>PA0855/021/001</LicenceNumber>
    <ProductName>INSUMAN RAPID FOR OPTIPEN - CARTRIDGE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1995-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005431</DrugIDPK>
    <LicenceNumber>PA0855/021/001</LicenceNumber>
    <ProductName>INSUMAN RAPID FOR OPTIPEN - CARTRIDGE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1995-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008270</DrugIDPK>
    <LicenceNumber>PA0130/020/001</LicenceNumber>
    <ProductName>TOREM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TORASEMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008272</DrugIDPK>
    <LicenceNumber>PA0130/020/002</LicenceNumber>
    <ProductName>TOREM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TORASEMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008276</DrugIDPK>
    <LicenceNumber>PA0130/020/004</LicenceNumber>
    <ProductName>TOREM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TORASEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008277</DrugIDPK>
    <LicenceNumber>PA0130/020/005</LicenceNumber>
    <ProductName>TOREM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TORASEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008278</DrugIDPK>
    <LicenceNumber>PA0130/020/006</LicenceNumber>
    <ProductName>TOREM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TORASEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008279</DrugIDPK>
    <LicenceNumber>PA0130/020/007</LicenceNumber>
    <ProductName>TOREM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TORASEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005474</DrugIDPK>
    <LicenceNumber>PA0282/008/001</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1980-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008500</DrugIDPK>
    <LicenceNumber>PA0012/075/001</LicenceNumber>
    <ProductName>ECHOVIST 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALACTOSE</ActiveSubstance>
      <ActiveSubstance>GALACTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004154</DrugIDPK>
    <LicenceNumber>PA0035/067/006</LicenceNumber>
    <ProductName>INNOVACE MELT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004155</DrugIDPK>
    <LicenceNumber>PA0035/067/007</LicenceNumber>
    <ProductName>INNOVACE MELT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004156</DrugIDPK>
    <LicenceNumber>PA0035/067/008</LicenceNumber>
    <ProductName>INNOVACE MELT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004157</DrugIDPK>
    <LicenceNumber>PA0035/067/009</LicenceNumber>
    <ProductName>INNOVACE MELT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1998-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001290</DrugIDPK>
    <LicenceNumber>PA0023/060/003</LicenceNumber>
    <ProductName>INSUMAN BASAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1992-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000552</DrugIDPK>
    <LicenceNumber>PA0012/068/005</LicenceNumber>
    <ProductName>ISOVIST</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1990-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROLAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001678</DrugIDPK>
    <LicenceNumber>PA0748/001/001</LicenceNumber>
    <ProductName>TYLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1995-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000142</DrugIDPK>
    <LicenceNumber>PA0224/014/003</LicenceNumber>
    <ProductName>ZOMACTON</ProductName>
    <Strength>18.0</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1995-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007692</DrugIDPK>
    <LicenceNumber>PA0405/038/001</LicenceNumber>
    <ProductName>IOPAMIDOL 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007693</DrugIDPK>
    <LicenceNumber>PA0405/038/002</LicenceNumber>
    <ProductName>IOPAMIDOL 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007694</DrugIDPK>
    <LicenceNumber>PA0405/038/003</LicenceNumber>
    <ProductName>IOPAMIDOL 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007695</DrugIDPK>
    <LicenceNumber>PA0405/038/004</LicenceNumber>
    <ProductName>IOPAMIDOL 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007699</DrugIDPK>
    <LicenceNumber>PA0405/038/005</LicenceNumber>
    <ProductName>IOPAMIDOL 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007701</DrugIDPK>
    <LicenceNumber>PA0405/038/006</LicenceNumber>
    <ProductName>IOPAMIDOL 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007703</DrugIDPK>
    <LicenceNumber>PA0405/039/001</LicenceNumber>
    <ProductName>IOPAMIDOL 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007704</DrugIDPK>
    <LicenceNumber>PA0405/039/002</LicenceNumber>
    <ProductName>IOPAMIDOL 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007705</DrugIDPK>
    <LicenceNumber>PA0405/039/003</LicenceNumber>
    <ProductName>IOPAMIDOL 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007706</DrugIDPK>
    <LicenceNumber>PA0405/039/004</LicenceNumber>
    <ProductName>IOPAMIDOL 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007707</DrugIDPK>
    <LicenceNumber>PA0405/039/005</LicenceNumber>
    <ProductName>IOPAMIDOL 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007708</DrugIDPK>
    <LicenceNumber>PA0405/039/006</LicenceNumber>
    <ProductName>IOPAMIDOL 300</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007709</DrugIDPK>
    <LicenceNumber>PA0405/040/001</LicenceNumber>
    <ProductName>IOPAMIDOL 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007710</DrugIDPK>
    <LicenceNumber>PA0405/040/002</LicenceNumber>
    <ProductName>IOPAMIDOL 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007711</DrugIDPK>
    <LicenceNumber>PA0405/040/003</LicenceNumber>
    <ProductName>IOPAMIDOL 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007712</DrugIDPK>
    <LicenceNumber>PA0405/040/004</LicenceNumber>
    <ProductName>IOPAMIDOL 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007713</DrugIDPK>
    <LicenceNumber>PA0405/040/005</LicenceNumber>
    <ProductName>IOPAMIDOL 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007714</DrugIDPK>
    <LicenceNumber>PA0405/040/006</LicenceNumber>
    <ProductName>IOPAMIDOL 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1996-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPAMIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008917</DrugIDPK>
    <LicenceNumber>PA0281/059/001</LicenceNumber>
    <ProductName>FRUPIN</ProductName>
    <Strength>5/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003665</DrugIDPK>
    <LicenceNumber>PA0677/016/001</LicenceNumber>
    <ProductName>ONCOSCINT CR 103</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>1995-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SATUMOMAB PENDETIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001860</DrugIDPK>
    <LicenceNumber>PA0035/002/001</LicenceNumber>
    <ProductName>TRYPTIZOL - 75</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1975-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009166</DrugIDPK>
    <LicenceNumber>PA0320/003/001</LicenceNumber>
    <ProductName>COLGATE SENSITIVE CARE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>1995-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM MONOFLUORO PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003367</DrugIDPK>
    <LicenceNumber>PA0077/035/003</LicenceNumber>
    <ProductName>FORTRAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003368</DrugIDPK>
    <LicenceNumber>PA0077/035/004</LicenceNumber>
    <ProductName>FORTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003365</DrugIDPK>
    <LicenceNumber>PA0077/035/001</LicenceNumber>
    <ProductName>FORTRAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003366</DrugIDPK>
    <LicenceNumber>PA0077/035/002</LicenceNumber>
    <ProductName>FORTRAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002063</DrugIDPK>
    <LicenceNumber>PA0040/092/001</LicenceNumber>
    <ProductName>CREMALGIN BALM</ProductName>
    <Strength>1/10/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1993-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008890</DrugIDPK>
    <LicenceNumber>PA0689/001/001</LicenceNumber>
    <ProductName>BETANETA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Shire Pharmaceutical Contracts Ltd</PAHolder>
    <AuthorisedDate>1995-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001526</DrugIDPK>
    <LicenceNumber>PA0037/028/001</LicenceNumber>
    <ProductName>AUREOCORT</ProductName>
    <Strength>3/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001729</DrugIDPK>
    <LicenceNumber>PA0040/006/001</LicenceNumber>
    <ProductName>NIVAQUINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001730</DrugIDPK>
    <LicenceNumber>PA0040/006/002</LicenceNumber>
    <ProductName>NIVAQUINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007774</DrugIDPK>
    <LicenceNumber>PA0126/087/001</LicenceNumber>
    <ProductName>CLONIFED SR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009206</DrugIDPK>
    <LicenceNumber>PA0126/091/004</LicenceNumber>
    <ProductName>CLONORAX COLD SORE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000430</DrugIDPK>
    <LicenceNumber>PA0007/013/001</LicenceNumber>
    <ProductName>ASASANTIN</ProductName>
    <Strength>330/75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1980-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005830</DrugIDPK>
    <LicenceNumber>PA0013/015/002</LicenceNumber>
    <ProductName>DIHYDERGOT NASAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOTAMINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008727</DrugIDPK>
    <LicenceNumber>PA0073/135/001</LicenceNumber>
    <ProductName>VANCOMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott GmbH &amp; Co KG</PAHolder>
    <AuthorisedDate>1995-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VANCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005834</DrugIDPK>
    <LicenceNumber>PA0300/005/001</LicenceNumber>
    <ProductName>LABOSEPT</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratories for Applied Biology</PAHolder>
    <AuthorisedDate>1990-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002411</DrugIDPK>
    <LicenceNumber>PA0051/032/001</LicenceNumber>
    <ProductName>FLUOTHANE</ProductName>
    <Strength>99.99</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOTHANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000942</DrugIDPK>
    <LicenceNumber>PA0017/069/002</LicenceNumber>
    <ProductName>LANOXIN - 125</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016531</DrugIDPK>
    <LicenceNumber>PA0735/004/001</LicenceNumber>
    <ProductName>ABDOSCAN</ProductName>
    <Strength>23.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRISTENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006534</DrugIDPK>
    <LicenceNumber>PA0469/008/001</LicenceNumber>
    <ProductName>PRAGMATAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1990-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004841</DrugIDPK>
    <LicenceNumber>PA0823/025/001</LicenceNumber>
    <ProductName>MUCOLEX</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003110</DrugIDPK>
    <LicenceNumber>PA0069/013/001</LicenceNumber>
    <ProductName>COLAVAGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1990-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM SULFATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003280</DrugIDPK>
    <LicenceNumber>PA0073/121/002</LicenceNumber>
    <ProductName>VASOFED 10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003279</DrugIDPK>
    <LicenceNumber>PA0073/121/001</LicenceNumber>
    <ProductName>VASOFED 5</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002128</DrugIDPK>
    <LicenceNumber>PA0043/006/002</LicenceNumber>
    <ProductName>NUROFEN SOLUBLE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016423</DrugIDPK>
    <LicenceNumber>PA0012/078/001</LicenceNumber>
    <ProductName>LEVOVIST</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>D-GALACTOSE</ActiveSubstance>
      <ActiveSubstance>PALMITIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016424</DrugIDPK>
    <LicenceNumber>PA0012/078/002</LicenceNumber>
    <ProductName>LEVOVIST</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>D-GALACTOSE</ActiveSubstance>
      <ActiveSubstance>PALMITIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003492</DrugIDPK>
    <LicenceNumber>EU/1/96/016/002</LicenceNumber>
    <ProductName>NORVIR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1996-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RITONAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001820</DrugIDPK>
    <LicenceNumber>PA0035/043/001</LicenceNumber>
    <ProductName>DEMSER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METIROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000421</DrugIDPK>
    <LicenceNumber>PA0007/034/002</LicenceNumber>
    <ProductName>DUOVENT 100 AEROCAPS</ProductName>
    <Strength>40/100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1993-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000422</DrugIDPK>
    <LicenceNumber>PA0007/034/003</LicenceNumber>
    <ProductName>DUOVENT 200 AEROCAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1993-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005707</DrugIDPK>
    <LicenceNumber>PA0748/027/001</LicenceNumber>
    <ProductName>OVYSMEN ORAL CONTRACEPTIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1995-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005707</DrugIDPK>
    <LicenceNumber>PA0748/027/001</LicenceNumber>
    <ProductName>OVYSMEN ORAL CONTRACEPTIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1995-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006697</DrugIDPK>
    <LicenceNumber>PA0516/018/001</LicenceNumber>
    <ProductName>NICONIL 22</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1990-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000491</DrugIDPK>
    <LicenceNumber>PA0012/039/006</LicenceNumber>
    <ProductName>UROGRAFIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIDOTRIZOATE MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002279</DrugIDPK>
    <LicenceNumber>PA0050/061/004</LicenceNumber>
    <ProductName>HYPNOVEL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1990-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002722</DrugIDPK>
    <LicenceNumber>PA0050/049/003</LicenceNumber>
    <ProductName>LEXOTAN ROCHE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1980-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005365</DrugIDPK>
    <LicenceNumber>PA0261/001/002</LicenceNumber>
    <ProductName>TOLVON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIANSERIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001971</DrugIDPK>
    <LicenceNumber>PA0040/065/001</LicenceNumber>
    <ProductName>BRULIDINE</ProductName>
    <Strength>0.16</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIBROMPROPAMIDINE ISETIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007907</DrugIDPK>
    <LicenceNumber>PA0592/004/001</LicenceNumber>
    <ProductName>MEGALOTECT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMA PROTEIN &gt;95% IMMUNOGLOBULINS</ActiveSubstance>
      <ActiveSubstance>IMMUNOGLOBULIN CYTOMEGALOVIRUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001925</DrugIDPK>
    <LicenceNumber>PA0040/033/002</LicenceNumber>
    <ProductName>ORUDIS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1980-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006169</DrugIDPK>
    <LicenceNumber>PA0410/001/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Products GmbH</PAHolder>
    <AuthorisedDate>1985-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009084</DrugIDPK>
    <LicenceNumber>PA0402/002/001</LicenceNumber>
    <ProductName>ULTRALIEF ANALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wallace, Cameron &amp; Company (Ire)</PAHolder>
    <AuthorisedDate>1995-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007838</DrugIDPK>
    <LicenceNumber>PA0828/002/001</LicenceNumber>
    <ProductName>M &amp; B 693</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Concord Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAPYRIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002674</DrugIDPK>
    <LicenceNumber>PA0050/017/006</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009242</DrugIDPK>
    <LicenceNumber>PPA0465/038/002</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009240</DrugIDPK>
    <LicenceNumber>PPA0465/038/003</LicenceNumber>
    <ProductName>ZOVIRAX TABLETS</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000139</DrugIDPK>
    <LicenceNumber>PA0072/002/001</LicenceNumber>
    <ProductName>CALDESENE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM UNDECYLEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000133</DrugIDPK>
    <LicenceNumber>PA0072/008/001</LicenceNumber>
    <ProductName>DESENEX OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1985-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC UNDECYLENATE</ActiveSubstance>
      <ActiveSubstance>UNDECYLENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000132</DrugIDPK>
    <LicenceNumber>PA0072/008/002</LicenceNumber>
    <ProductName>DESENEX POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1985-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC UNDECYLENATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003728</DrugIDPK>
    <LicenceNumber>PA0018/045/001</LicenceNumber>
    <ProductName>RADIAN B HEAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>AMMONIUM SALICYLATE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015962</DrugIDPK>
    <LicenceNumber>PA0018/044/001</LicenceNumber>
    <ProductName>Radian B Muscle Rub</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR OIL</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009320</DrugIDPK>
    <LicenceNumber>PA0614/003/001</LicenceNumber>
    <ProductName>GENESA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Gensia Europe Ltd</PAHolder>
    <AuthorisedDate>1995-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ARBUTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000777</DrugIDPK>
    <LicenceNumber>PA0016/031/001</LicenceNumber>
    <ProductName>PROSTIN F2 ALPHA STERILE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1980-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DINOPROST TROMETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016300</DrugIDPK>
    <LicenceNumber>PA0678/006/002</LicenceNumber>
    <ProductName>EOLARIX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1995-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005476</DrugIDPK>
    <LicenceNumber>PA0282/008/002</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1980-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007614</DrugIDPK>
    <LicenceNumber>PA0028/074/001</LicenceNumber>
    <ProductName>PRONETA</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004489</DrugIDPK>
    <LicenceNumber>PA0176/015/001</LicenceNumber>
    <ProductName>DISPERSIBLE ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004491</DrugIDPK>
    <LicenceNumber>PA0176/017/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004492</DrugIDPK>
    <LicenceNumber>PA0176/017/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006635</DrugIDPK>
    <LicenceNumber>PA0508/003/001</LicenceNumber>
    <ProductName>SALBUTAMOL 200 CYCLOCAPS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1991-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006636</DrugIDPK>
    <LicenceNumber>PA0508/003/002</LicenceNumber>
    <ProductName>SALBUTAMOL 400 CYCLOCAPS</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1991-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001638</DrugIDPK>
    <LicenceNumber>PA0037/067/001</LicenceNumber>
    <ProductName>OCUCOAT INJECTABLE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016336</DrugIDPK>
    <LicenceNumber>PA0281/064/001</LicenceNumber>
    <ProductName>CARPINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016337</DrugIDPK>
    <LicenceNumber>PA0281/064/002</LicenceNumber>
    <ProductName>CARPINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016338</DrugIDPK>
    <LicenceNumber>PA0281/064/003</LicenceNumber>
    <ProductName>CARPINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001142</DrugIDPK>
    <LicenceNumber>PA0021/025/002</LicenceNumber>
    <ProductName>DTIC DOME</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1985-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACARBAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006667</DrugIDPK>
    <LicenceNumber>PA0043/029/001</LicenceNumber>
    <ProductName>BALNEUM WITH TAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004320</DrugIDPK>
    <LicenceNumber>PA0826/001/001</LicenceNumber>
    <ProductName>PREFIL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Pierre Fabre Sante</PAHolder>
    <AuthorisedDate>1995-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STERCULIA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002859</DrugIDPK>
    <LicenceNumber>PA0057/005/001</LicenceNumber>
    <ProductName>NUELIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000905</DrugIDPK>
    <LicenceNumber>EU/1/96/019/001</LicenceNumber>
    <ProductName>TECNEMAB-K-1</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Amersham Sorin S.r.l.</PAHolder>
    <AuthorisedDate>1996-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTI-MELANOMA MAB FRAGMENTS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001135</DrugIDPK>
    <LicenceNumber>PA0021/024/001</LicenceNumber>
    <ProductName>MIGRAVESS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1989-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001137</DrugIDPK>
    <LicenceNumber>PA0021/024/002</LicenceNumber>
    <ProductName>MIGRAVESS FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1989-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001111</DrugIDPK>
    <LicenceNumber>PA0021/011/001</LicenceNumber>
    <ProductName>SECUROPEN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1981-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZLOCILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001113</DrugIDPK>
    <LicenceNumber>PA0021/011/002</LicenceNumber>
    <ProductName>SECUROPEN</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1982-01-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZLOCILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001114</DrugIDPK>
    <LicenceNumber>PA0021/011/003</LicenceNumber>
    <ProductName>SECUROPEN</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1981-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZLOCILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001115</DrugIDPK>
    <LicenceNumber>PA0021/011/004</LicenceNumber>
    <ProductName>SECUROPEN</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1981-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZLOCILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001117</DrugIDPK>
    <LicenceNumber>PA0021/011/005</LicenceNumber>
    <ProductName>SECUROPEN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1982-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZLOCILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005765</DrugIDPK>
    <LicenceNumber>PA0353/003/001</LicenceNumber>
    <ProductName>GELOX</ProductName>
    <Strength>15.8</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Beaufour Schwabe</PAHolder>
    <AuthorisedDate>1985-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SMECTITE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009435</DrugIDPK>
    <LicenceNumber>PA0723/001/001</LicenceNumber>
    <ProductName>ANTIBIOTIC SIMPLEX BONE CEMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Howmedica International IRL.</PAHolder>
    <AuthorisedDate>1993-12-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN GLUCEPTATE</ActiveSubstance>
      <ActiveSubstance>COLISTIN SULFOMETHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995008024</DrugIDPK>
    <LicenceNumber>PA0828/005/001</LicenceNumber>
    <ProductName>FLAXEDIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Concord Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALLAMINE TRIETHIODIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003266</DrugIDPK>
    <LicenceNumber>EU/1/96/028/001</LicenceNumber>
    <ProductName>EVOTOPIN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Beecham Group Plc</PAHolder>
    <AuthorisedDate>1996-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007109</DrugIDPK>
    <LicenceNumber>EU/1/96/028/002</LicenceNumber>
    <ProductName>EVOTOPIN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Beecham Group Plc</PAHolder>
    <AuthorisedDate>1996-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003145</DrugIDPK>
    <LicenceNumber>PA0062/027/002</LicenceNumber>
    <ProductName>PREFERID</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003140</DrugIDPK>
    <LicenceNumber>PA0062/027/001</LicenceNumber>
    <ProductName>PREFERID</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003193</DrugIDPK>
    <LicenceNumber>PA0073/064/001</LicenceNumber>
    <ProductName>CITRAZINE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1990-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERAZINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006611</DrugIDPK>
    <LicenceNumber>PA0492/001/001</LicenceNumber>
    <ProductName>EUPHYLONG 250</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Byk Gulden Lomberg Chemische</PAHolder>
    <AuthorisedDate>1990-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006612</DrugIDPK>
    <LicenceNumber>PA0492/001/002</LicenceNumber>
    <ProductName>EUPHYLONG 375</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Byk Gulden Lomberg Chemische</PAHolder>
    <AuthorisedDate>1990-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002209</DrugIDPK>
    <LicenceNumber>PA0047/062/001</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOHEXITAL SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002210</DrugIDPK>
    <LicenceNumber>PA0047/062/002</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006225</DrugIDPK>
    <LicenceNumber>PA0447/007/001</LicenceNumber>
    <ProductName>DISTACLOR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008385</DrugIDPK>
    <LicenceNumber>PA0447/007/008</LicenceNumber>
    <ProductName>DISTACLOR GRANULES</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1995-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009105</DrugIDPK>
    <LicenceNumber>PA0447/007/009</LicenceNumber>
    <ProductName>DISTACLOR GRANULES</ProductName>
    <Strength>187</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1995-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010114</DrugIDPK>
    <LicenceNumber>PA0047/078/003</LicenceNumber>
    <ProductName>DISTACLOR LA</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1994-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002193</DrugIDPK>
    <LicenceNumber>PA0047/046/004</LicenceNumber>
    <ProductName>ONCOVIN  (VINCRISTINE SULPHATE)</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002194</DrugIDPK>
    <LicenceNumber>PA0047/046/005</LicenceNumber>
    <ProductName>ONCOVIN  (VINCRISTINE SULPHATE)</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006216</DrugIDPK>
    <LicenceNumber>PA0447/002/001</LicenceNumber>
    <ProductName>PROGESIC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1985-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOPROFEN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005176</DrugIDPK>
    <LicenceNumber>PA0257/040/001</LicenceNumber>
    <ProductName>IRON SUPPLEMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate>1993-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLUCONATE</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000008</DrugIDPK>
    <LicenceNumber>PA0187/060/001</LicenceNumber>
    <ProductName>ALYRANE INHALATION ANAESTHETIC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005033</DrugIDPK>
    <LicenceNumber>PA0236/010/002</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005034</DrugIDPK>
    <LicenceNumber>PA0236/010/003</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005035</DrugIDPK>
    <LicenceNumber>PA0236/010/004</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005036</DrugIDPK>
    <LicenceNumber>PA0236/010/005</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1991-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000733</DrugIDPK>
    <LicenceNumber>PA0016/020/004</LicenceNumber>
    <ProductName>MEDRONE</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000735</DrugIDPK>
    <LicenceNumber>PA0016/020/005</LicenceNumber>
    <ProductName>MEDRONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1990-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000811</DrugIDPK>
    <LicenceNumber>PA0016/039/001</LicenceNumber>
    <ProductName>MOTRIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1985-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000812</DrugIDPK>
    <LicenceNumber>PA0016/039/002</LicenceNumber>
    <ProductName>MOTRIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1985-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000813</DrugIDPK>
    <LicenceNumber>PA0016/039/003</LicenceNumber>
    <ProductName>MOTRIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1985-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000779</DrugIDPK>
    <LicenceNumber>PA0016/031/002</LicenceNumber>
    <ProductName>PROSTIN F2 ALPHA STERILE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1980-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DINOPROST TROMETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000756</DrugIDPK>
    <LicenceNumber>PA0016/023/007</LicenceNumber>
    <ProductName>PROVERA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1986-12-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000321</DrugIDPK>
    <LicenceNumber>PA0002/025/001</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000322</DrugIDPK>
    <LicenceNumber>PA0002/025/002</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000351</DrugIDPK>
    <LicenceNumber>PA0002/035/001</LicenceNumber>
    <ProductName>OPHTHAINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROXYMETACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006285</DrugIDPK>
    <LicenceNumber>PA0425/002/001</LicenceNumber>
    <ProductName>DOXY KOMB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>2000-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008232</DrugIDPK>
    <LicenceNumber>PA0303/024/4</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1994-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009208</DrugIDPK>
    <LicenceNumber>PA0126/092/001</LicenceNumber>
    <ProductName>CLONOXIFEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009210</DrugIDPK>
    <LicenceNumber>PA0126/092/002</LicenceNumber>
    <ProductName>CLONOXIFEN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1995-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003827</DrugIDPK>
    <LicenceNumber>PA0126/018/002</LicenceNumber>
    <ProductName>NITROFURANTOIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003923</DrugIDPK>
    <LicenceNumber>PA0126/071/001</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003925</DrugIDPK>
    <LicenceNumber>PA0126/071/002</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003926</DrugIDPK>
    <LicenceNumber>PA0126/071/003</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008956</DrugIDPK>
    <LicenceNumber>PA0312/007/001</LicenceNumber>
    <ProductName>METHADONE ORAL DTF</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHADONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003748</DrugIDPK>
    <LicenceNumber>PA0096/008/001</LicenceNumber>
    <ProductName>BENGUES BALSAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate>1984-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002669</DrugIDPK>
    <LicenceNumber>PA0050/015/001</LicenceNumber>
    <ProductName>LIMBITROL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002670</DrugIDPK>
    <LicenceNumber>PA0050/015/002</LicenceNumber>
    <ProductName>LIMBITROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007178</DrugIDPK>
    <LicenceNumber>PA0391/004/001</LicenceNumber>
    <ProductName>PIXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Thames Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
      <ActiveSubstance>CADE OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005343</DrugIDPK>
    <LicenceNumber>PA0277/056/001</LicenceNumber>
    <ProductName>RINSTEAD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1989-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007034</DrugIDPK>
    <LicenceNumber>EU/1/97/052/007</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>0.88</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007035</DrugIDPK>
    <LicenceNumber>EU/1/97/052/008</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>0.88</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009003</DrugIDPK>
    <LicenceNumber>PA0365/058/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA TETANUS &amp; PERTUSSIS VACCINE BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1994-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008342</DrugIDPK>
    <LicenceNumber>PA0237/043/001</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008344</DrugIDPK>
    <LicenceNumber>PA0237/043/002</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008346</DrugIDPK>
    <LicenceNumber>PA0237/043/003</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008347</DrugIDPK>
    <LicenceNumber>PA0237/043/004</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008349</DrugIDPK>
    <LicenceNumber>PA0237/043/005</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005082</DrugIDPK>
    <LicenceNumber>PA0237/046/001</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005083</DrugIDPK>
    <LicenceNumber>PA0237/046/002</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005084</DrugIDPK>
    <LicenceNumber>PA0237/046/003</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005085</DrugIDPK>
    <LicenceNumber>PA0237/046/004</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005086</DrugIDPK>
    <LicenceNumber>PA0237/046/005</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005087</DrugIDPK>
    <LicenceNumber>PA0237/046/006</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005088</DrugIDPK>
    <LicenceNumber>PA0237/046/007</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005072</DrugIDPK>
    <LicenceNumber>PA0237/025/002</LicenceNumber>
    <ProductName>APS DIPYRIDAMOLE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1988-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008401</DrugIDPK>
    <LicenceNumber>PA0237/056/001</LicenceNumber>
    <ProductName>ARBRALENE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008402</DrugIDPK>
    <LicenceNumber>PA0237/056/002</LicenceNumber>
    <ProductName>ARBRALENE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005089</DrugIDPK>
    <LicenceNumber>PA0237/051/001</LicenceNumber>
    <ProductName>BERKAMIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001132</DrugIDPK>
    <LicenceNumber>PA0237/038/002</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001133</DrugIDPK>
    <LicenceNumber>PA0237/038/003</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001134</DrugIDPK>
    <LicenceNumber>PA0237/038/004</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000978</DrugIDPK>
    <LicenceNumber>PA0237/038/001</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008399</DrugIDPK>
    <LicenceNumber>PA0237/054/001</LicenceNumber>
    <ProductName>CALANIF</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008400</DrugIDPK>
    <LicenceNumber>PA0237/054/002</LicenceNumber>
    <ProductName>CALANIF</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005073</DrugIDPK>
    <LicenceNumber>PA0237/030/001</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1988-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005074</DrugIDPK>
    <LicenceNumber>PA0237/030/002</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1988-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002264</DrugIDPK>
    <LicenceNumber>PA0237/033/002</LicenceNumber>
    <ProductName>DOMICAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005079</DrugIDPK>
    <LicenceNumber>PA0237/033/001</LicenceNumber>
    <ProductName>DOMICAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005080</DrugIDPK>
    <LicenceNumber>PA0237/033/003</LicenceNumber>
    <ProductName>DOMICAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005527</DrugIDPK>
    <LicenceNumber>PA0237/034/002</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008337</DrugIDPK>
    <LicenceNumber>PA0237/034/003</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008339</DrugIDPK>
    <LicenceNumber>PA0237/034/004</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008341</DrugIDPK>
    <LicenceNumber>PA0237/034/005</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008366</DrugIDPK>
    <LicenceNumber>PA0237/047/001</LicenceNumber>
    <ProductName>ERYCEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008368</DrugIDPK>
    <LicenceNumber>PA0237/047/002</LicenceNumber>
    <ProductName>ERYCEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008391</DrugIDPK>
    <LicenceNumber>PA0237/049/003</LicenceNumber>
    <ProductName>FLOXABERK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008392</DrugIDPK>
    <LicenceNumber>PA0237/049/004</LicenceNumber>
    <ProductName>FLOXABERK</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008393</DrugIDPK>
    <LicenceNumber>PA0237/049/005</LicenceNumber>
    <ProductName>FLOXABERK</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1995-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005536</DrugIDPK>
    <LicenceNumber>PA0237/036/003</LicenceNumber>
    <ProductName>IMBRILON</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005534</DrugIDPK>
    <LicenceNumber>PA0237/036/002</LicenceNumber>
    <ProductName>IMBRILON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005090</DrugIDPK>
    <LicenceNumber>PA0237/052/001</LicenceNumber>
    <ProductName>MODAPLATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005531</DrugIDPK>
    <LicenceNumber>PA0237/035/002</LicenceNumber>
    <ProductName>PRIMPERAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005532</DrugIDPK>
    <LicenceNumber>PA0237/035/003</LicenceNumber>
    <ProductName>PRIMPERAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005528</DrugIDPK>
    <LicenceNumber>PA0237/035/001</LicenceNumber>
    <ProductName>PRIMPERAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005091</DrugIDPK>
    <LicenceNumber>PA0237/055/001</LicenceNumber>
    <ProductName>TIMPRON</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005092</DrugIDPK>
    <LicenceNumber>PA0237/055/002</LicenceNumber>
    <ProductName>TIMPRON</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006203</DrugIDPK>
    <LicenceNumber>PA0441/024/001</LicenceNumber>
    <ProductName>VICK SINEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1984-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008376</DrugIDPK>
    <LicenceNumber>PA0237/048/004</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008370</DrugIDPK>
    <LicenceNumber>PA0237/048/001</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008372</DrugIDPK>
    <LicenceNumber>PA0237/048/002</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008373</DrugIDPK>
    <LicenceNumber>PA0237/048/003</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1994-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001549</DrugIDPK>
    <LicenceNumber>PA0037/038/002</LicenceNumber>
    <ProductName>VISDERM H</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000156</DrugIDPK>
    <LicenceNumber>PA0317/001/001</LicenceNumber>
    <ProductName>ACETARD</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1990-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005644</DrugIDPK>
    <LicenceNumber>PA0317/001/002</LicenceNumber>
    <ProductName>ACETARD</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1993-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005698</DrugIDPK>
    <LicenceNumber>PA0317/007/001</LicenceNumber>
    <ProductName>FURIX RETARD</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1990-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005700</DrugIDPK>
    <LicenceNumber>PA0317/007/002</LicenceNumber>
    <ProductName>FURIX RETARD</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1990-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005702</DrugIDPK>
    <LicenceNumber>PA0317/007/003</LicenceNumber>
    <ProductName>FURIX RETARD</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1990-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005686</DrugIDPK>
    <LicenceNumber>PA0317/005/002</LicenceNumber>
    <ProductName>INDOMOD</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005839</DrugIDPK>
    <LicenceNumber>PA0317/005/001</LicenceNumber>
    <ProductName>INDOMOD</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002308</DrugIDPK>
    <LicenceNumber>PA0050/074/001</LicenceNumber>
    <ProductName>FANSIMEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1989-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFLOQUINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SULFADOXINE</ActiveSubstance>
      <ActiveSubstance>PYRIMETHAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007734</DrugIDPK>
    <LicenceNumber>PA0317/002/001</LicenceNumber>
    <ProductName>KALINORM MODIFIED RELEASE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1983-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003863</DrugIDPK>
    <LicenceNumber>PA0678/029/003</LicenceNumber>
    <ProductName>KREDEX</ProductName>
    <Strength>6.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1998-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003823</DrugIDPK>
    <LicenceNumber>PA0678/029/001</LicenceNumber>
    <ProductName>KREDEX</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1996-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003824</DrugIDPK>
    <LicenceNumber>PA0678/029/002</LicenceNumber>
    <ProductName>KREDEX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>1996-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003395</DrugIDPK>
    <LicenceNumber>PA0077/091/002</LicenceNumber>
    <ProductName>ASPRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1989-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003396</DrugIDPK>
    <LicenceNumber>PA0077/091/003</LicenceNumber>
    <ProductName>ASPRIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1989-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003394</DrugIDPK>
    <LicenceNumber>PA0077/091/001</LicenceNumber>
    <ProductName>DISPERSIBLE ASPRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1989-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001876</DrugIDPK>
    <LicenceNumber>PA0040/006/003</LicenceNumber>
    <ProductName>NIVAQUINE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1984-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROQUINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006504</DrugIDPK>
    <LicenceNumber>PA0473/005/001</LicenceNumber>
    <ProductName>RESPIJET</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008841</DrugIDPK>
    <LicenceNumber>PA0644/002/001</LicenceNumber>
    <ProductName>RONICOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Tillomed Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINYL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005200</DrugIDPK>
    <LicenceNumber>PA0277/050/011</LicenceNumber>
    <ProductName>INTRON A WITH PRESERVATIVE</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005201</DrugIDPK>
    <LicenceNumber>PA0277/050/012</LicenceNumber>
    <ProductName>INTRON A WITH PRESERVATIVE</ProductName>
    <Strength>25000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004459</DrugIDPK>
    <LicenceNumber>PA0172/005/002</LicenceNumber>
    <ProductName>DRISTAN DECONGESTANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002077</DrugIDPK>
    <LicenceNumber>PA0041/020/004</LicenceNumber>
    <ProductName>MEROCAINE SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1982-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouth Wash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002103</DrugIDPK>
    <LicenceNumber>PA0041/042/001</LicenceNumber>
    <ProductName>MEROVIT</ProductName>
    <Strength>125/1.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1990-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014828</DrugIDPK>
    <LicenceNumber>PA0011/010/001</LicenceNumber>
    <ProductName>INSIDON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OPIPRAMOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009497</DrugIDPK>
    <LicenceNumber>PA0050/090/001</LicenceNumber>
    <ProductName>CO-VASCACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004573</DrugIDPK>
    <LicenceNumber>PA0185/010/001</LicenceNumber>
    <ProductName>DIARREST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1980-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>DICYCLOVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003257</DrugIDPK>
    <LicenceNumber>PA0751/001/006</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003258</DrugIDPK>
    <LicenceNumber>PA0751/001/007</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003259</DrugIDPK>
    <LicenceNumber>PA0751/001/008</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bieffe Medital SpA</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004661</DrugIDPK>
    <LicenceNumber>PA0179/033/001</LicenceNumber>
    <ProductName>GLUCOSE/ELECTROLYTES</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004662</DrugIDPK>
    <LicenceNumber>PA0179/033/002</LicenceNumber>
    <ProductName>GLUCOSE/ELECTROLYTES</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004663</DrugIDPK>
    <LicenceNumber>PA0179/033/003</LicenceNumber>
    <ProductName>GLUCOSE/ELECTROLYTES</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004664</DrugIDPK>
    <LicenceNumber>PA0179/033/004</LicenceNumber>
    <ProductName>GLUCOSE/ELECTROLYTES</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004665</DrugIDPK>
    <LicenceNumber>PA0179/033/005</LicenceNumber>
    <ProductName>GLUCOSE/ELECTROLYTES</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004666</DrugIDPK>
    <LicenceNumber>PA0179/033/006</LicenceNumber>
    <ProductName>GLUCOSE/ELECTROLYTES</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003375</DrugIDPK>
    <LicenceNumber>PA0077/049/001</LicenceNumber>
    <ProductName>MYCARDOL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAERITHRITYL TETRANITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006725</DrugIDPK>
    <LicenceNumber>PA0521/002/005</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 20%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005801</DrugIDPK>
    <LicenceNumber>PA0810/003/001</LicenceNumber>
    <ProductName>ERECNOS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fournier Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXISYLYTE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005802</DrugIDPK>
    <LicenceNumber>PA0810/003/002</LicenceNumber>
    <ProductName>ERECNOS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fournier Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1998-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXISYLYTE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000426</DrugIDPK>
    <LicenceNumber>PA0017/092/006</LicenceNumber>
    <ProductName>RETROVIR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1995-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIDOVUDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004289</DrugIDPK>
    <LicenceNumber>PA0813/001/001</LicenceNumber>
    <ProductName>ACCUSITE INJECTABLE GEL</ProductName>
    <Strength>3.33</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Matrix Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003683</DrugIDPK>
    <LicenceNumber>PA0108/017/002</LicenceNumber>
    <ProductName>INFLUVAC INACTIVATED INFLUENZA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/SYDNEY /5/97 (H3N2)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>A/BEIJING /262/95 (H1N1)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>INFLUENZA VIRUS INACTIVATED STRAIN A/EQUI-2/MIAMI/63</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002960</DrugIDPK>
    <LicenceNumber>PA0059/003/002</LicenceNumber>
    <ProductName>TOLECTIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1980-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLMETIN SODIUM DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008590</DrugIDPK>
    <LicenceNumber>PA0114/074/001</LicenceNumber>
    <ProductName>HYDOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005898</DrugIDPK>
    <LicenceNumber>PA0372/004/001</LicenceNumber>
    <ProductName>PARMID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1989-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005899</DrugIDPK>
    <LicenceNumber>PA0372/004/002</LicenceNumber>
    <ProductName>PARMID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1989-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007023</DrugIDPK>
    <LicenceNumber>EU/1/97/050/008</LicenceNumber>
    <ProductName>SIFROL</ProductName>
    <Strength>0.88</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>1997-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003978</DrugIDPK>
    <LicenceNumber>EU/1/97/050/007</LicenceNumber>
    <ProductName>SIFROL</ProductName>
    <Strength>0.88</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>1997-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005314</DrugIDPK>
    <LicenceNumber>PA0281/031/001</LicenceNumber>
    <ProductName>FLUCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005315</DrugIDPK>
    <LicenceNumber>PA0281/031/002</LicenceNumber>
    <ProductName>FLUCILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002673</DrugIDPK>
    <LicenceNumber>PA0050/017/003</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004765</DrugIDPK>
    <LicenceNumber>PA0187/032/013</LicenceNumber>
    <ProductName>GENOTROPIN (WITH PRESERVATIVE)</ProductName>
    <Strength>36</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004758</DrugIDPK>
    <LicenceNumber>PA0187/032/009</LicenceNumber>
    <ProductName>GENOTROPIN (WITH PRESERVATIVE) KABIVIAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004754</DrugIDPK>
    <LicenceNumber>PA0187/032/007</LicenceNumber>
    <ProductName>GENOTROPIN KABIVIAL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004757</DrugIDPK>
    <LicenceNumber>PA0187/032/008</LicenceNumber>
    <ProductName>GENOTROPIN KABIVIAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002280</DrugIDPK>
    <LicenceNumber>PA0050/062/001</LicenceNumber>
    <ProductName>ROCEPHIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTRIAXONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006630</DrugIDPK>
    <LicenceNumber>PA0508/001/001</LicenceNumber>
    <ProductName>BECLOMETHASONE 100 PHARBITA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1990-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006631</DrugIDPK>
    <LicenceNumber>PA0508/001/002</LicenceNumber>
    <ProductName>BECLOMETHASONE 200 PHARBITA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1990-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006632</DrugIDPK>
    <LicenceNumber>PA0508/001/003</LicenceNumber>
    <ProductName>BECLOMETHASONE 400 PHARBITA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1990-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007126</DrugIDPK>
    <LicenceNumber>EU/1/97/051/008</LicenceNumber>
    <ProductName>MIRAPEXIN</ProductName>
    <Strength>0.88</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>1998-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006481</DrugIDPK>
    <LicenceNumber>PA0468/022/003</LicenceNumber>
    <ProductName>CALSYNAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002678</DrugIDPK>
    <LicenceNumber>PA0050/018/003</LicenceNumber>
    <ProductName>LIBRIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002679</DrugIDPK>
    <LicenceNumber>PA0050/018/004</LicenceNumber>
    <ProductName>LIBRIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002680</DrugIDPK>
    <LicenceNumber>PA0050/018/005</LicenceNumber>
    <ProductName>LIBRIUM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005682</DrugIDPK>
    <LicenceNumber>PA0317/004/003</LicenceNumber>
    <ProductName>IBUMETIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1989-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005677</DrugIDPK>
    <LicenceNumber>PA0317/004/001</LicenceNumber>
    <ProductName>IBUMETIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1989-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005679</DrugIDPK>
    <LicenceNumber>PA0317/004/002</LicenceNumber>
    <ProductName>IBUMETIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1989-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005696</DrugIDPK>
    <LicenceNumber>PA0317/006/002</LicenceNumber>
    <ProductName>NORMORIX</ProductName>
    <Strength>25 mg</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005693</DrugIDPK>
    <LicenceNumber>PA0317/006/001</LicenceNumber>
    <ProductName>NORMORIX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004193</DrugIDPK>
    <LicenceNumber>PA0167/013/001</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004248</DrugIDPK>
    <LicenceNumber>PA0167/021/001</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE BP FORMULA A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1981-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008282</DrugIDPK>
    <LicenceNumber>PA0167/021/002</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE FORMULA A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004388</DrugIDPK>
    <LicenceNumber>PA0167/066/001</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE/ADENINE-ANTICOAGULANT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004423</DrugIDPK>
    <LicenceNumber>PA0167/077/001</LicenceNumber>
    <ProductName>ADSOL RED CELL PRESERVATION</ProductName>
    <Strength>20.9</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004196</DrugIDPK>
    <LicenceNumber>PA0167/014/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE</ProductName>
    <Strength>26.3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008307</DrugIDPK>
    <LicenceNumber>PA0167/082/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE</ProductName>
    <Strength>63</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008308</DrugIDPK>
    <LicenceNumber>PA0167/083/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE</ProductName>
    <Strength>63</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004260</DrugIDPK>
    <LicenceNumber>PA0167/030/001</LicenceNumber>
    <ProductName>FENWAL-CPD ADENINE BLOOD PACK UNIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1982-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004261</DrugIDPK>
    <LicenceNumber>PA0167/031/001</LicenceNumber>
    <ProductName>FENWAL-CPD ADENINE I BLOOD PACK UNIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1982-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004250</DrugIDPK>
    <LicenceNumber>PA0167/023/001</LicenceNumber>
    <ProductName>HEPARIN ANTICOAGULANT</ProductName>
    <Strength>7500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004334</DrugIDPK>
    <LicenceNumber>PA0167/048/001</LicenceNumber>
    <ProductName>OPTIMAL ADDITIVE BLOOD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1989-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008284</DrugIDPK>
    <LicenceNumber>PA0167/048/002</LicenceNumber>
    <ProductName>OPTIMAL ADDITIVE BLOOD COLLECTION SYSTEM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001652</DrugIDPK>
    <LicenceNumber>PA0038/009/003</LicenceNumber>
    <ProductName>ERYTHROPED</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1984-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002866</DrugIDPK>
    <LicenceNumber>PA0544/023/002</LicenceNumber>
    <ProductName>H-B-VAX II</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002865</DrugIDPK>
    <LicenceNumber>PA0544/023/001</LicenceNumber>
    <ProductName>H-B-VAX II PAEDIATRIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006388</DrugIDPK>
    <LicenceNumber>PPA0465/018/001</LicenceNumber>
    <ProductName>OTOSPORIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008192</DrugIDPK>
    <LicenceNumber>PA0038/009/013</LicenceNumber>
    <ProductName>ERYTHROPED SUGAR FREE SINGLE DOSE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1985-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008868</DrugIDPK>
    <LicenceNumber>EU/1/96/025/001</LicenceNumber>
    <ProductName>INDIMACIS 125</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>1996-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IGOVOMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006931</DrugIDPK>
    <LicenceNumber>PA0551/002/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abdine Ltd.</PAHolder>
    <AuthorisedDate>1994-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008706</DrugIDPK>
    <LicenceNumber>PA0069/019/001</LicenceNumber>
    <ProductName>SENSODYNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007705</DrugIDPK>
    <LicenceNumber>PA0074/039/001</LicenceNumber>
    <ProductName>LACTULOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013458</DrugIDPK>
    <LicenceNumber>PA0013/051/001</LicenceNumber>
    <ProductName>NORPROLAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAGOLIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>QUINAGOLIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010017</DrugIDPK>
    <LicenceNumber>PA0013/051/003</LicenceNumber>
    <ProductName>NORPROLAC 150</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAGOLIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010018</DrugIDPK>
    <LicenceNumber>PA0013/051/002</LicenceNumber>
    <ProductName>NORPROLAC 75</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAGOLIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001672</DrugIDPK>
    <LicenceNumber>PA0038/036/001</LicenceNumber>
    <ProductName>EPIVAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1984-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001673</DrugIDPK>
    <LicenceNumber>PA0038/036/002</LicenceNumber>
    <ProductName>EPIVAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1984-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004316</DrugIDPK>
    <LicenceNumber>PA0818/002/001</LicenceNumber>
    <ProductName>ARDUAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Medimpex (UK) Limited</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPECURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006580</DrugIDPK>
    <LicenceNumber>PA0484/012/001</LicenceNumber>
    <ProductName>COSAL S</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001708</DrugIDPK>
    <LicenceNumber>PA0040/001/005</LicenceNumber>
    <ProductName>SECTRAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1975-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEBUTOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008231</DrugIDPK>
    <LicenceNumber>PA0303/024/002</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1994-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008233</DrugIDPK>
    <LicenceNumber>PA0303/024/004</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1994-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004981</DrugIDPK>
    <LicenceNumber>PA0303/024/003</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <Strength>200mg/ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1994-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008267</DrugIDPK>
    <LicenceNumber>PA0130/015/003</LicenceNumber>
    <ProductName>ISMO 10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1994-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000948</DrugIDPK>
    <LicenceNumber>PA0019/044/005</LicenceNumber>
    <ProductName>DIFLUCAN</ProductName>
    <Strength>25mg/5ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007437</DrugIDPK>
    <LicenceNumber>PA0711/032/001</LicenceNumber>
    <ProductName>ESTRAMON</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005443</DrugIDPK>
    <LicenceNumber>PA0855/025/001</LicenceNumber>
    <ProductName>MODIVID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFODIZIME DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005444</DrugIDPK>
    <LicenceNumber>PA0855/025/002</LicenceNumber>
    <ProductName>MODIVID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFODIZIME DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005445</DrugIDPK>
    <LicenceNumber>PA0855/025/003</LicenceNumber>
    <ProductName>MODIVID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFODIZIME DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005446</DrugIDPK>
    <LicenceNumber>PA0855/025/004</LicenceNumber>
    <ProductName>MODIVID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFODIZIME DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005505</DrugIDPK>
    <LicenceNumber>PA0855/025/005</LicenceNumber>
    <ProductName>MODIVID</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1997-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFODIZIME DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007115</DrugIDPK>
    <LicenceNumber>PA0300/006/001</LicenceNumber>
    <ProductName>MONPHYTOL PAINT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratories for Applied Biology</PAHolder>
    <AuthorisedDate>1998-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>PROPYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>PROPYL UNDECENOATE</ActiveSubstance>
      <ActiveSubstance>METHYL UNDECENOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006496</DrugIDPK>
    <LicenceNumber>PA0468/030/001</LicenceNumber>
    <ProductName>ZETAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010003</DrugIDPK>
    <LicenceNumber>PA0018/018/002</LicenceNumber>
    <ProductName>INTAL INHALER</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1981-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004820</DrugIDPK>
    <LicenceNumber>PA0212/006/001</LicenceNumber>
    <ProductName>HEPARIN 5000</ProductName>
    <Strength>16667</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1984-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001006</DrugIDPK>
    <LicenceNumber>PA0018/003/003</LicenceNumber>
    <ProductName>RYNACROM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1984-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001414</DrugIDPK>
    <LicenceNumber>PA0027/006/003</LicenceNumber>
    <ProductName>JUNIOR LEMSIP WITH PHENYLEPHRINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1984-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008776</DrugIDPK>
    <LicenceNumber>PA0549/005/003</LicenceNumber>
    <ProductName>ETHYPHARM DOXYCYCLINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006056</DrugIDPK>
    <LicenceNumber>PA0342/001/001</LicenceNumber>
    <ProductName>ROTERSEPT SPRAY</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Crookes Healthcare B.V.</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003074</DrugIDPK>
    <LicenceNumber>PA0062/023/001</LicenceNumber>
    <ProductName>DE-NOL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1984-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISMUTH SUBCITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002288</DrugIDPK>
    <LicenceNumber>EU/1/96/017/001</LicenceNumber>
    <ProductName>ECOKINASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galenus Mannheim GmbH</PAHolder>
    <AuthorisedDate>1996-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RETEPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007987</DrugIDPK>
    <LicenceNumber>EU/1/96/007/009</LicenceNumber>
    <ProductName>HUMALOG MIX50</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1998-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000570</DrugIDPK>
    <LicenceNumber>PA0013/006/001</LicenceNumber>
    <ProductName>TORECAN</ProductName>
    <Strength>6.33</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIETHYLPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000571</DrugIDPK>
    <LicenceNumber>PA0013/006/002</LicenceNumber>
    <ProductName>TORECAN</ProductName>
    <Strength>6.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIETHYLPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000572</DrugIDPK>
    <LicenceNumber>PA0013/006/003</LicenceNumber>
    <ProductName>TORECAN</ProductName>
    <Strength>6.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIETHYLPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005710</DrugIDPK>
    <LicenceNumber>PA0748/030/001</LicenceNumber>
    <ProductName>HISMANAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASTEMIZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007276</DrugIDPK>
    <LicenceNumber>PA0999/001/003</LicenceNumber>
    <ProductName>IMB TRAINING DRUG</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM MAGNESIUM SILICATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM MAGNESIUM STEARATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM MAGNESIUM SILICATE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003346</DrugIDPK>
    <LicenceNumber>PA0769/005/001</LicenceNumber>
    <ProductName>FURAMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1992-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILOXANIDE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010134</DrugIDPK>
    <LicenceNumber>PA0392/018/001</LicenceNumber>
    <ProductName>GLUCOSE (DEXTROSE MONOHYDRATE)</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate>1994-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010136</DrugIDPK>
    <LicenceNumber>PA0392/019/001</LicenceNumber>
    <ProductName>GLYCERIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate>1994-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010108</DrugIDPK>
    <LicenceNumber>PA0033/025/004</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010109</DrugIDPK>
    <LicenceNumber>PA0033/025/005</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010110</DrugIDPK>
    <LicenceNumber>PA0033/025/006</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010104</DrugIDPK>
    <LicenceNumber>PA0033/025/003</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005448</DrugIDPK>
    <LicenceNumber>PA0855/027/001</LicenceNumber>
    <ProductName>OESTROGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001643</DrugIDPK>
    <LicenceNumber>PA0037/071/001</LicenceNumber>
    <ProductName>DENTOMYCIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1994-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006199</DrugIDPK>
    <LicenceNumber>PA0441/012/001</LicenceNumber>
    <ProductName>TOPEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1979-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005308</DrugIDPK>
    <LicenceNumber>PA0281/028/001</LicenceNumber>
    <ProductName>NAPREX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005309</DrugIDPK>
    <LicenceNumber>PA0281/028/002</LicenceNumber>
    <ProductName>NAPREX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001440</DrugIDPK>
    <LicenceNumber>PA0037/012/003</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006633</DrugIDPK>
    <LicenceNumber>PA0508/002/001</LicenceNumber>
    <ProductName>TOPROMEL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1990-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006634</DrugIDPK>
    <LicenceNumber>PA0508/002/002</LicenceNumber>
    <ProductName>TOPROMEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1990-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001539</DrugIDPK>
    <LicenceNumber>PA0037/030/006</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1987-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001542</DrugIDPK>
    <LicenceNumber>PA0037/030/007</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1987-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001208</DrugIDPK>
    <LicenceNumber>PA0023/043/001</LicenceNumber>
    <ProductName>BEGRIVAC - F (PREFILLED SYRINGE)</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/WUHAN\359\95 - LIKE STRAIN - (H3N2)</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/YAMAGATA 16/88</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001209</DrugIDPK>
    <LicenceNumber>PA0023/043/003</LicenceNumber>
    <ProductName>BEGRIVAC - F AMPOULE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/WUHAN\359\95 - LIKE STRAIN - (H3N2)</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000059</DrugIDPK>
    <LicenceNumber>PA0583/008/002</LicenceNumber>
    <ProductName>DOPACARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>1994-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006762</DrugIDPK>
    <LicenceNumber>PA0583/003/003</LicenceNumber>
    <ProductName>DOPACARD</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>1994-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPEXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006763</DrugIDPK>
    <LicenceNumber>PA0583/003/002</LicenceNumber>
    <ProductName>DOPACARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>1994-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPEXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005233</DrugIDPK>
    <LicenceNumber>PA0277/072/001</LicenceNumber>
    <ProductName>TALOXA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005234</DrugIDPK>
    <LicenceNumber>PA0277/072/002</LicenceNumber>
    <ProductName>TALOXA</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005235</DrugIDPK>
    <LicenceNumber>PA0277/072/003</LicenceNumber>
    <ProductName>TALOXA</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1994-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003483</DrugIDPK>
    <LicenceNumber>PA0114/007/002</LicenceNumber>
    <ProductName>PHYLLOCONTIN CONTINUS</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005271</DrugIDPK>
    <LicenceNumber>PA0281/005/002</LicenceNumber>
    <ProductName>PAEDIATRIC CODEINE LINCTUS B.P.</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1987-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004078</DrugIDPK>
    <LicenceNumber>PA0159/005/001</LicenceNumber>
    <ProductName>PROCOL</ProductName>
    <Strength>50/2.5</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002000</DrugIDPK>
    <LicenceNumber>PA0040/077/001</LicenceNumber>
    <ProductName>PRIMALAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1985-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEQUITAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003083</DrugIDPK>
    <LicenceNumber>PA0062/025/006</LicenceNumber>
    <ProductName>UNIDOX 50 SOLUTAB</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001892</DrugIDPK>
    <LicenceNumber>PA0040/018/002</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001902</DrugIDPK>
    <LicenceNumber>PA0040/021/005</LicenceNumber>
    <ProductName>NEULACTIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERICIAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001416</DrugIDPK>
    <LicenceNumber>PA0037/007/003</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001413</DrugIDPK>
    <LicenceNumber>PA0037/007/001</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003710</DrugIDPK>
    <LicenceNumber>PA0540/009/003</LicenceNumber>
    <ProductName>KETOVAIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1996-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002030</DrugIDPK>
    <LicenceNumber>PA0040/079/004</LicenceNumber>
    <ProductName>LOMEXIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005179</DrugIDPK>
    <LicenceNumber>PA0257/043/001</LicenceNumber>
    <ProductName>CALCIUM A.C. &amp; D</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001212</DrugIDPK>
    <LicenceNumber>PA0022/026/001</LicenceNumber>
    <ProductName>NORMISON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1979-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001213</DrugIDPK>
    <LicenceNumber>PA0022/026/002</LicenceNumber>
    <ProductName>NORMISON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1980-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006913</DrugIDPK>
    <LicenceNumber>PA0668/001/001</LicenceNumber>
    <ProductName>ISOFLURANE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Rhodia Limited</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Gas</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001409</DrugIDPK>
    <LicenceNumber>PA0037/004/010</LicenceNumber>
    <ProductName>LOXAPAC IM (AMPOULE)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1984-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001410</DrugIDPK>
    <LicenceNumber>PA0037/004/011</LicenceNumber>
    <ProductName>LOXAPAC IM (VIAL)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1984-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001933</DrugIDPK>
    <LicenceNumber>PA0040/042/001</LicenceNumber>
    <ProductName>PHENERGAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006856</DrugIDPK>
    <LicenceNumber>PA0545/005/004</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000578</DrugIDPK>
    <LicenceNumber>PA0013/018/001</LicenceNumber>
    <ProductName>SYNTOCINON</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000581</DrugIDPK>
    <LicenceNumber>PA0013/018/004</LicenceNumber>
    <ProductName>SYNTOCINON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002395</DrugIDPK>
    <LicenceNumber>PA0048/035/001</LicenceNumber>
    <ProductName>ALPHA KERI BATH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
      <ActiveSubstance>LANOLIN OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001723</DrugIDPK>
    <LicenceNumber>PA0040/003/010</LicenceNumber>
    <ProductName>FLAGYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001987</DrugIDPK>
    <LicenceNumber>PA0040/070/003</LicenceNumber>
    <ProductName>ORUVAIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1990-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001988</DrugIDPK>
    <LicenceNumber>PA0040/070/004</LicenceNumber>
    <ProductName>ORUVAIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1990-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015940</DrugIDPK>
    <LicenceNumber>PA0072/007/001</LicenceNumber>
    <ProductName>CALDEASE MEDICATED</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1985-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004279</DrugIDPK>
    <LicenceNumber>PA0823/009/002</LicenceNumber>
    <ProductName>SUDAFED EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002783</DrugIDPK>
    <LicenceNumber>PA0392/020/001</LicenceNumber>
    <ProductName>GLYCERIN LEMON AND HONEY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HONEY</ActiveSubstance>
      <ActiveSubstance>CITRUS LIMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005622</DrugIDPK>
    <LicenceNumber>PA0285/004/001</LicenceNumber>
    <ProductName>METRODIN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1989-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLICLE-STIMULATING HORMONE, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005290</DrugIDPK>
    <LicenceNumber>PA0281/016/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005291</DrugIDPK>
    <LicenceNumber>PA0281/016/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005292</DrugIDPK>
    <LicenceNumber>PA0281/016/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001821</DrugIDPK>
    <LicenceNumber>PA0033/021/003</LicenceNumber>
    <ProductName>SULCOSYN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001813</DrugIDPK>
    <LicenceNumber>PA0033/021/001</LicenceNumber>
    <ProductName>SULCOSYN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001816</DrugIDPK>
    <LicenceNumber>PA0033/021/002</LicenceNumber>
    <ProductName>SULCOSYN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001893</DrugIDPK>
    <LicenceNumber>PA0040/018/003</LicenceNumber>
    <ProductName>LARGACTIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001092</DrugIDPK>
    <LicenceNumber>PA0021/003/006</LicenceNumber>
    <ProductName>ADALAT BIPHASIC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1987-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001095</DrugIDPK>
    <LicenceNumber>PA0021/003/010</LicenceNumber>
    <ProductName>ADALAT SA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001096</DrugIDPK>
    <LicenceNumber>PA0021/003/011</LicenceNumber>
    <ProductName>ADALAT SA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001097</DrugIDPK>
    <LicenceNumber>PA0021/003/012</LicenceNumber>
    <ProductName>ADALAT SA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1992-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006671</DrugIDPK>
    <LicenceNumber>PA0043/031/001</LicenceNumber>
    <ProductName>BALTAR</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1997-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001140</DrugIDPK>
    <LicenceNumber>PA0021/025/001</LicenceNumber>
    <ProductName>DTIC DOME</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1985-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACARBAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004021</DrugIDPK>
    <LicenceNumber>PA0148/032/002</LicenceNumber>
    <ProductName>P.V. CARPINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004022</DrugIDPK>
    <LicenceNumber>PA0148/032/003</LicenceNumber>
    <ProductName>P.V. CARPINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003738</DrugIDPK>
    <LicenceNumber>PA0114/074/002</LicenceNumber>
    <ProductName>HYDOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003787</DrugIDPK>
    <LicenceNumber>PA0114/074/003</LicenceNumber>
    <ProductName>HYDOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003124</DrugIDPK>
    <LicenceNumber>PA0072/027/001</LicenceNumber>
    <ProductName>CROMAIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1994-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000986</DrugIDPK>
    <LicenceNumber>PA0017/093/001</LicenceNumber>
    <ProductName>WELLFERON</ProductName>
    <Strength>3000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1994-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA - N1</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000987</DrugIDPK>
    <LicenceNumber>PA0017/093/002</LicenceNumber>
    <ProductName>WELLFERON</ProductName>
    <Strength>10000000</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1994-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA - N1</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005496</DrugIDPK>
    <LicenceNumber>PA0282/019/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001836</DrugIDPK>
    <LicenceNumber>PA0035/048/002</LicenceNumber>
    <ProductName>CARBIDOPA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002888</DrugIDPK>
    <LicenceNumber>PA0488/019/001</LicenceNumber>
    <ProductName>EMINASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANISTREPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001004</DrugIDPK>
    <LicenceNumber>PA0018/002/003</LicenceNumber>
    <ProductName>OPTICROM S.R.</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1989-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001003</DrugIDPK>
    <LicenceNumber>PA0018/002/002</LicenceNumber>
    <ProductName>OPTICROM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1984-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002389</DrugIDPK>
    <LicenceNumber>PA0051/022/001</LicenceNumber>
    <ProductName>ATROMID-S</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003064</DrugIDPK>
    <LicenceNumber>PA0062/011/001</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003065</DrugIDPK>
    <LicenceNumber>PA0062/011/002</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003066</DrugIDPK>
    <LicenceNumber>PA0062/011/003</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006463</DrugIDPK>
    <LicenceNumber>PA0468/011/001</LicenceNumber>
    <ProductName>CALCITARE</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, PORCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000419</DrugIDPK>
    <LicenceNumber>PA0007/006/001</LicenceNumber>
    <ProductName>DEXA-RHINASPRAY</ProductName>
    <Strength>20/120/100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE ISONICOTINATE</ActiveSubstance>
      <ActiveSubstance>TRAMAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005097</DrugIDPK>
    <LicenceNumber>PA0240/002/001</LicenceNumber>
    <ProductName>DICOPAC (TWO CAPSULES + ONE SOL. FOR INJ.)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYANOCOBALAMIN (57 CO)</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN (58 CO)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003062</DrugIDPK>
    <LicenceNumber>PA0062/010/001</LicenceNumber>
    <ProductName>DISIPAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORPHENADRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005972</DrugIDPK>
    <LicenceNumber>PA0392/024/001</LicenceNumber>
    <ProductName>EPSOM SALTS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004185</DrugIDPK>
    <LicenceNumber>PA0224/018/001</LicenceNumber>
    <ProductName>GONADOTRAPHON LH</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHORIONIC GONADOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003123</DrugIDPK>
    <LicenceNumber>PA0072/012/001</LicenceNumber>
    <ProductName>MICROX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1989-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOLAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001077</DrugIDPK>
    <LicenceNumber>PA0019/029/001</LicenceNumber>
    <ProductName>MITHRACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PLICAMYCIN</ActiveSubstance>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001825</DrugIDPK>
    <LicenceNumber>PA0035/045/002</LicenceNumber>
    <ProductName>PERIACTIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROHEPTADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000867</DrugIDPK>
    <LicenceNumber>PA0012/029/002</LicenceNumber>
    <ProductName>TESTOVIRON DEPOT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE ENANTHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001342</DrugIDPK>
    <LicenceNumber>PA0038/062/001</LicenceNumber>
    <ProductName>CLARITHROMYCIN GRANULES</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1994-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003484</DrugIDPK>
    <LicenceNumber>PA0086/015/001</LicenceNumber>
    <ProductName>DIMOTANE L.A.</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001800</DrugIDPK>
    <LicenceNumber>PA0035/026/002</LicenceNumber>
    <ProductName>HYDROSALURIC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010131</DrugIDPK>
    <LicenceNumber>PA0312/006/001</LicenceNumber>
    <ProductName>SENOSEC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001664</DrugIDPK>
    <LicenceNumber>PA0038/028/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1984-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001665</DrugIDPK>
    <LicenceNumber>PA0038/028/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1984-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000975</DrugIDPK>
    <LicenceNumber>PA0017/087/002</LicenceNumber>
    <ProductName>CEFIZOX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIZOXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002055</DrugIDPK>
    <LicenceNumber>PA0040/081/001</LicenceNumber>
    <ProductName>CLEXANE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXAPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002056</DrugIDPK>
    <LicenceNumber>PA0040/081/002</LicenceNumber>
    <ProductName>CLEXANE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1989-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXAPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002396</DrugIDPK>
    <LicenceNumber>PA0048/037/001</LicenceNumber>
    <ProductName>COMTREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002398</DrugIDPK>
    <LicenceNumber>PA0048/037/003</LicenceNumber>
    <ProductName>COMTREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005937</DrugIDPK>
    <LicenceNumber>PPA0384/003/002</LicenceNumber>
    <ProductName>TAGAMET 400</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1989-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003180</DrugIDPK>
    <LicenceNumber>PA0540/006/001</LicenceNumber>
    <ProductName>CIMETIDINE RHONE POULENC RORER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003181</DrugIDPK>
    <LicenceNumber>PA0540/006/002</LicenceNumber>
    <ProductName>CIMETIDINE RHONE POULENC RORER</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003713</DrugIDPK>
    <LicenceNumber>PA0540/008/001</LicenceNumber>
    <ProductName>FRUSEMEK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1993-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001035</DrugIDPK>
    <LicenceNumber>PA0018/046/001</LicenceNumber>
    <ProductName>FRUSENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1994-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>TRIAMTERENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008544</DrugIDPK>
    <LicenceNumber>PA0018/051/001</LicenceNumber>
    <ProductName>TILARIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEDOCROMIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010115</DrugIDPK>
    <LicenceNumber>PA0072/028/001</LicenceNumber>
    <ProductName>VISICROM EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1994-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000576</DrugIDPK>
    <LicenceNumber>PA0013/014/001</LicenceNumber>
    <ProductName>DESERIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYSERGIDE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000230</DrugIDPK>
    <LicenceNumber>PA0167/087/001</LicenceNumber>
    <ProductName>GLYCINE &amp;  ETHANOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008657</DrugIDPK>
    <LicenceNumber>PA0167/087/002</LicenceNumber>
    <ProductName>GLYCINE &amp; ETHANOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008665</DrugIDPK>
    <LicenceNumber>PA0167/087/003</LicenceNumber>
    <ProductName>GLYCINE &amp; ETHANOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1995-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004331</DrugIDPK>
    <LicenceNumber>PA0167/046/001</LicenceNumber>
    <ProductName>GLYCINE UROLOGICAL</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004684</DrugIDPK>
    <LicenceNumber>PA0167/046/002</LicenceNumber>
    <ProductName>GLYCINE UROLOGICAL IRRIGATION</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004185</DrugIDPK>
    <LicenceNumber>PA0167/012/004</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004189</DrugIDPK>
    <LicenceNumber>PA0167/012/007</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder &amp; Topical Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004192</DrugIDPK>
    <LicenceNumber>PA0167/012/011</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder &amp; Topical Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004191</DrugIDPK>
    <LicenceNumber>PA0167/012/008</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 3L UROMATIC</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004187</DrugIDPK>
    <LicenceNumber>PA0167/012/005</LicenceNumber>
    <ProductName>SODIUM CHLORIDE FOR IRRIGATION</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004188</DrugIDPK>
    <LicenceNumber>PA0167/012/006</LicenceNumber>
    <ProductName>SODIUM CHLORIDE FOR IRRIGATION</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004179</DrugIDPK>
    <LicenceNumber>PA0167/011/005</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004180</DrugIDPK>
    <LicenceNumber>PA0167/011/006</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004182</DrugIDPK>
    <LicenceNumber>PA0167/011/007</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004183</DrugIDPK>
    <LicenceNumber>PA0167/011/008</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004169</DrugIDPK>
    <LicenceNumber>PA0167/011/004</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000384</DrugIDPK>
    <LicenceNumber>PA0002/055/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000386</DrugIDPK>
    <LicenceNumber>PA0002/055/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000387</DrugIDPK>
    <LicenceNumber>PA0002/055/003</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000974</DrugIDPK>
    <LicenceNumber>PA0017/087/001</LicenceNumber>
    <ProductName>CEFIZOX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIZOXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005401</DrugIDPK>
    <LicenceNumber>PA0277/005/001</LicenceNumber>
    <ProductName>PALACOS R BONE CEMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1980-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYMETHYLMETHACRYLATE</ActiveSubstance>
      <ActiveSubstance>METHYLMETHACRYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005402</DrugIDPK>
    <LicenceNumber>PA0277/005/002</LicenceNumber>
    <ProductName>PALACOS R WITH GENTAMICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1980-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYMETHYLMETHACRYLATE</ActiveSubstance>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
      <ActiveSubstance>METHYLMETHACRYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005403</DrugIDPK>
    <LicenceNumber>PA0277/005/003</LicenceNumber>
    <ProductName>PALACOS R-20 WITH GENTAMICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYMETHYLMETHACRYLATE</ActiveSubstance>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
      <ActiveSubstance>METHYLMETHACRYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005191</DrugIDPK>
    <LicenceNumber>PA0277/050/005</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>30000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005193</DrugIDPK>
    <LicenceNumber>PA0277/050/006</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>50000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001513</DrugIDPK>
    <LicenceNumber>PA0355/001/001</LicenceNumber>
    <ProductName>RADIAN B LINIMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Radiol Chemicals Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006796</DrugIDPK>
    <LicenceNumber>PA0592/002/002</LicenceNumber>
    <ProductName>HUMAN ALBUMIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Biotest Pharma GmbH</PAHolder>
    <AuthorisedDate>1994-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006741</DrugIDPK>
    <LicenceNumber>PA0544/010/001</LicenceNumber>
    <ProductName>FLUZONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1994-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/SINGAPORE /6/86 (H1N1)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>A/WUHAN /359/95 (H3N2)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003349</DrugIDPK>
    <LicenceNumber>PA0769/008/001</LicenceNumber>
    <ProductName>MUSTINE HYDROCHLORIDE BP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORMETHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003002</DrugIDPK>
    <LicenceNumber>PA0059/028/001</LicenceNumber>
    <ProductName>MASSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1984-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL MONOSTEARATE</ActiveSubstance>
      <ActiveSubstance>STEARIC ACID</ActiveSubstance>
      <ActiveSubstance>SORBITAN STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002986</DrugIDPK>
    <LicenceNumber>PA0059/011/001</LicenceNumber>
    <ProductName>MICRONOR</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002987</DrugIDPK>
    <LicenceNumber>PA0059/012/001</LicenceNumber>
    <ProductName>ORTHO-NOVIN 1/50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006948</DrugIDPK>
    <LicenceNumber>PA0650/010/001</LicenceNumber>
    <ProductName>ZINC SULPHATE</ProductName>
    <Strength>14.375</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Penn Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000645</DrugIDPK>
    <LicenceNumber>PA0010/001/003</LicenceNumber>
    <ProductName>CALSYNAR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005797</DrugIDPK>
    <LicenceNumber>PA0361/007/005</LicenceNumber>
    <ProductName>METHADONE MIXTURE DTF</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHADONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007300</DrugIDPK>
    <LicenceNumber>PA0748/045/001</LicenceNumber>
    <ProductName>ORTHO-NOVIN 1/50</ProductName>
    <Strength>1.0,0.05</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995007299</DrugIDPK>
    <LicenceNumber>PA0748/010/002</LicenceNumber>
    <ProductName>MICRONOR</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>1994-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004038</DrugIDPK>
    <LicenceNumber>PA0148/054/001</LicenceNumber>
    <ProductName>LENS REFRESHER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1994-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MYRJ 52</ActiveSubstance>
      <ActiveSubstance>MACROGOL 300</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003412</DrugIDPK>
    <LicenceNumber>PA0077/112/001</LicenceNumber>
    <ProductName>PIROXICAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003413</DrugIDPK>
    <LicenceNumber>PA0077/112/002</LicenceNumber>
    <ProductName>PIROXICAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006833</DrugIDPK>
    <LicenceNumber>PA0620/002/002</LicenceNumber>
    <ProductName>FLUARIX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>A/SINGAPORE 6/86</ActiveSubstance>
      <ActiveSubstance>B/BEYING /1/87</ActiveSubstance>
      <ActiveSubstance>B/PANAMA/45/90</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002880</DrugIDPK>
    <LicenceNumber>PA0057/023/001</LicenceNumber>
    <ProductName>NORFLEX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORPHENADRINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005541</DrugIDPK>
    <LicenceNumber>PA0237/040/003</LicenceNumber>
    <ProductName>DOPAMET</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005538</DrugIDPK>
    <LicenceNumber>PA0237/040/001</LicenceNumber>
    <ProductName>DOPAMET</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005539</DrugIDPK>
    <LicenceNumber>PA0237/040/002</LicenceNumber>
    <ProductName>DOPAMET</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005989</DrugIDPK>
    <LicenceNumber>PA0398/007/001</LicenceNumber>
    <ProductName>BONOMINT</ProductName>
    <Strength>97</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Intercare Products Ltd</PAHolder>
    <AuthorisedDate>1990-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YELLOW PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005990</DrugIDPK>
    <LicenceNumber>PA0398/008/001</LicenceNumber>
    <ProductName>BROOKLAX</ProductName>
    <Strength>130</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Intercare Products Ltd</PAHolder>
    <AuthorisedDate>1990-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YELLOW PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006373</DrugIDPK>
    <LicenceNumber>PPA0465/010/001</LicenceNumber>
    <ProductName>KEFLEX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1990-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003387</DrugIDPK>
    <LicenceNumber>PA0077/076/002</LicenceNumber>
    <ProductName>CALCIUM RESONIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1994-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM POLYSTYRENE SULFONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003388</DrugIDPK>
    <LicenceNumber>PA0077/076/003</LicenceNumber>
    <ProductName>CALCIUM RESONIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1994-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM POLYSTYRENE SULFONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006329</DrugIDPK>
    <LicenceNumber>PA0461/001/001</LicenceNumber>
    <ProductName>SOLCO ALBURES</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Solco Basle (UK) Limited</PAHolder>
    <AuthorisedDate>1989-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006332</DrugIDPK>
    <LicenceNumber>PA0461/002/001</LicenceNumber>
    <ProductName>SOLCO NANOCOLL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Solco Basle (UK) Limited</PAHolder>
    <AuthorisedDate>1989-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002982</DrugIDPK>
    <LicenceNumber>PA0059/010/002</LicenceNumber>
    <ProductName>GYNO-PEVARYL VAGINAL OVULES</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1975-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002977</DrugIDPK>
    <LicenceNumber>PA0059/009/004</LicenceNumber>
    <ProductName>PEVARYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1975-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002974</DrugIDPK>
    <LicenceNumber>PA0059/009/001</LicenceNumber>
    <ProductName>PEVARYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1975-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002975</DrugIDPK>
    <LicenceNumber>PA0059/009/002</LicenceNumber>
    <ProductName>PEVARYL SPRAY</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1975-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002988</DrugIDPK>
    <LicenceNumber>PA0059/015/001</LicenceNumber>
    <ProductName>PEVISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1980-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005450</DrugIDPK>
    <LicenceNumber>PA0261/036/003</LicenceNumber>
    <ProductName>MULTILOAD CU 250 - MINI</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Square mm</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intrauterine Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005449</DrugIDPK>
    <LicenceNumber>PA0261/036/002</LicenceNumber>
    <ProductName>MULTILOAD CU 250 - SHORT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Square mm</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intrauterine Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005448</DrugIDPK>
    <LicenceNumber>PA0261/036/001</LicenceNumber>
    <ProductName>MULTILOAD CU 250 STANDARD</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Square mm</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intrauterine Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005452</DrugIDPK>
    <LicenceNumber>PA0261/037/002</LicenceNumber>
    <ProductName>MULTILOAD CU 375 - SHORT LOOP</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Square mm</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intrauterine Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005451</DrugIDPK>
    <LicenceNumber>PA0261/037/001</LicenceNumber>
    <ProductName>MULTILOAD CU 375 - STANDARD</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Square mm</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intrauterine Device</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008013</DrugIDPK>
    <LicenceNumber>PA0650/016/001</LicenceNumber>
    <ProductName>EPHEDRINE HYDROCHLORIDE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Penn Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003022</DrugIDPK>
    <LicenceNumber>PA0060/036/002</LicenceNumber>
    <ProductName>RIMEVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1984-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003023</DrugIDPK>
    <LicenceNumber>PA0060/036/003</LicenceNumber>
    <ProductName>RIMEVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1984-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1999-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002226</DrugIDPK>
    <LicenceNumber>PA0046/054/001</LicenceNumber>
    <ProductName>PINDAC</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINACIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001155</DrugIDPK>
    <LicenceNumber>PA0021/036/003</LicenceNumber>
    <ProductName>CIPROXIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1988-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005464</DrugIDPK>
    <LicenceNumber>PA0282/003/001</LicenceNumber>
    <ProductName>QUININE SULPHATE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1978-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUININE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006626</DrugIDPK>
    <LicenceNumber>PA0502/001/001</LicenceNumber>
    <ProductName>MYOSCINT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Biologics B.V.</PAHolder>
    <AuthorisedDate>1991-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMCIROMAB PENTETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005646</DrugIDPK>
    <LicenceNumber>PA0289/006/001</LicenceNumber>
    <ProductName>KELOCYANOR</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICOBALT EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004904</DrugIDPK>
    <LicenceNumber>PA0224/004/001</LicenceNumber>
    <ProductName>KLYX ENEMA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005660</DrugIDPK>
    <LicenceNumber>PA0290/047/001</LicenceNumber>
    <ProductName>OPULETS 0.4% BENOXINATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYBUPROCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005668</DrugIDPK>
    <LicenceNumber>PA0290/052/001</LicenceNumber>
    <ProductName>OPULETS 0.5% CHLORAMPHENICOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005662</DrugIDPK>
    <LicenceNumber>PA0290/049/001</LicenceNumber>
    <ProductName>OPULETS 0.5% CYCLOPENTOLATE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTOLATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005661</DrugIDPK>
    <LicenceNumber>PA0290/048/001</LicenceNumber>
    <ProductName>OPULETS 0.9% SALINE EYE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005659</DrugIDPK>
    <LicenceNumber>PA0290/046/001</LicenceNumber>
    <ProductName>OPULETS 1% ATROPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005663</DrugIDPK>
    <LicenceNumber>PA0290/049/002</LicenceNumber>
    <ProductName>OPULETS 1% CYCLOPENTOLATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTOLATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005667</DrugIDPK>
    <LicenceNumber>PA0290/051/001</LicenceNumber>
    <ProductName>OPULETS 1% FLOURESCEIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUORESCEIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005664</DrugIDPK>
    <LicenceNumber>PA0290/050/001</LicenceNumber>
    <ProductName>OPULETS 1% PILOCARPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005665</DrugIDPK>
    <LicenceNumber>PA0290/050/002</LicenceNumber>
    <ProductName>OPULETS 2% PILOCARPINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005666</DrugIDPK>
    <LicenceNumber>PA0290/050/003</LicenceNumber>
    <ProductName>OPULETS 4% PILOCARPINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003584</DrugIDPK>
    <LicenceNumber>PA0114/042/010</LicenceNumber>
    <ProductName>UNIPHYLLIN CONTINUS</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003579</DrugIDPK>
    <LicenceNumber>PA0114/042/008</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003567</DrugIDPK>
    <LicenceNumber>PA0114/042/005</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003575</DrugIDPK>
    <LicenceNumber>PA0114/042/006</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003576</DrugIDPK>
    <LicenceNumber>PA0114/042/007</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003582</DrugIDPK>
    <LicenceNumber>PA0114/042/009</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001389</DrugIDPK>
    <LicenceNumber>PA0035/069/004</LicenceNumber>
    <ProductName>PEPCID IV</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1993-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004451</DrugIDPK>
    <LicenceNumber>PA0170/014/002</LicenceNumber>
    <ProductName>DIDRONEL I.V.</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1989-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003105</DrugIDPK>
    <LicenceNumber>PA0069/009/001</LicenceNumber>
    <ProductName>EPIFOAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1984-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>PRAMOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001604</DrugIDPK>
    <LicenceNumber>PA0037/059/002</LicenceNumber>
    <ProductName>PROSTAP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1988-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUPRORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002708</DrugIDPK>
    <LicenceNumber>PA0050/041/003</LicenceNumber>
    <ProductName>PROSTIGMIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOSTIGMINE METILSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006326</DrugIDPK>
    <LicenceNumber>PA0436/020/001</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006328</DrugIDPK>
    <LicenceNumber>PA0436/020/002</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006318</DrugIDPK>
    <LicenceNumber>PA0436/016/001</LicenceNumber>
    <ProductName>PIROXICAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006319</DrugIDPK>
    <LicenceNumber>PA0436/016/002</LicenceNumber>
    <ProductName>PIROXICAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006309</DrugIDPK>
    <LicenceNumber>PA0436/008/007</LicenceNumber>
    <ProductName>SALBUTAMOL NEBULISER</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006761</DrugIDPK>
    <LicenceNumber>PA0582/011/001</LicenceNumber>
    <ProductName>HYMECEL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate>1994-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002059</DrugIDPK>
    <LicenceNumber>PA0040/084/001</LicenceNumber>
    <ProductName>ORUGESIC I.M.</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1988-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006766</DrugIDPK>
    <LicenceNumber>PA0585/003/001</LicenceNumber>
    <ProductName>PHOSPHOLINE IODIDE</ProductName>
    <Strength>0.03</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1991-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Pdr &amp; Solv for Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECOTHIOPATE IODIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006767</DrugIDPK>
    <LicenceNumber>PA0585/003/002</LicenceNumber>
    <ProductName>PHOSPHOLINE IODIDE</ProductName>
    <Strength>0.06</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1991-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Pdr &amp; Solv for Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECOTHIOPATE IODIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006768</DrugIDPK>
    <LicenceNumber>PA0585/003/003</LicenceNumber>
    <ProductName>PHOSPHOLINE IODIDE</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1991-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Pdr &amp; Solv for Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECOTHIOPATE IODIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006769</DrugIDPK>
    <LicenceNumber>PA0585/003/004</LicenceNumber>
    <ProductName>PHOSPHOLINE IODIDE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1991-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Pdr &amp; Solv for Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECOTHIOPATE IODIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002037</DrugIDPK>
    <LicenceNumber>PA0044/094/001</LicenceNumber>
    <ProductName>CUTIVATE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002039</DrugIDPK>
    <LicenceNumber>PA0044/094/002</LicenceNumber>
    <ProductName>CUTIVATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001279</DrugIDPK>
    <LicenceNumber>PA0022/059/001</LicenceNumber>
    <ProductName>MONOCORD</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001199</DrugIDPK>
    <LicenceNumber>PA0023/022/001</LicenceNumber>
    <ProductName>DANERAL ELIXIR</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006201</DrugIDPK>
    <LicenceNumber>PA0441/012/003</LicenceNumber>
    <ProductName>TOPEX TINTED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1982-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006200</DrugIDPK>
    <LicenceNumber>PA0441/012/002</LicenceNumber>
    <ProductName>TOPEX UNTINTED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1982-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005752</DrugIDPK>
    <LicenceNumber>H/C/208/00/0/0</LicenceNumber>
    <ProductName>VIPRINEX</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Knoll AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANCROD</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005070</DrugIDPK>
    <LicenceNumber>PA0237/025/001</LicenceNumber>
    <ProductName>APS DIPYRIDAMOLE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1988-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003938</DrugIDPK>
    <LicenceNumber>PA0130/015/002</LicenceNumber>
    <ProductName>ISMO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1984-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003935</DrugIDPK>
    <LicenceNumber>PA0130/015/001</LicenceNumber>
    <ProductName>ISMO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1984-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003347</DrugIDPK>
    <LicenceNumber>PA0769/006/001</LicenceNumber>
    <ProductName>GASTROZEPIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1992-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRENZEPINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006320</DrugIDPK>
    <LicenceNumber>PA0436/017/001</LicenceNumber>
    <ProductName>DILTIAZEM HYDROCHLORIDE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006317</DrugIDPK>
    <LicenceNumber>PA0436/015/002</LicenceNumber>
    <ProductName>MEFENAMIC ACID</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006323</DrugIDPK>
    <LicenceNumber>PA0436/019/001</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006325</DrugIDPK>
    <LicenceNumber>PA0436/019/002</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003348</DrugIDPK>
    <LicenceNumber>PA0769/007/001</LicenceNumber>
    <ProductName>DIMERCAPROL BP (BAL)</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMERCAPROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003994</DrugIDPK>
    <LicenceNumber>PA0144/013/001</LicenceNumber>
    <ProductName>SOLABAN</ProductName>
    <Strength>5.0 / 5.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1988-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBENZONE</ActiveSubstance>
      <ActiveSubstance>ETHYLHEXYL P-METHOXYCINNAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000553</DrugIDPK>
    <LicenceNumber>PA0012/074/001</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <Strength>105</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1993-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002081</DrugIDPK>
    <LicenceNumber>PA0041/026/003</LicenceNumber>
    <ProductName>TRILUDAN</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1989-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001772</DrugIDPK>
    <LicenceNumber>PA0107/007/003</LicenceNumber>
    <ProductName>DEBRISAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRANOMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009246</DrugIDPK>
    <LicenceNumber>PA0187/049/002</LicenceNumber>
    <ProductName>DEBRISAN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRANOMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003636</DrugIDPK>
    <LicenceNumber>PA0100/042/001</LicenceNumber>
    <ProductName>HALF-PRODUR LA</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1993-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004788</DrugIDPK>
    <LicenceNumber>PA0187/040/001</LicenceNumber>
    <ProductName>HEALONID CARTRIDGES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008693</DrugIDPK>
    <LicenceNumber>PA0187/040/003</LicenceNumber>
    <ProductName>HEALONID GV</ProductName>
    <Strength>14</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008694</DrugIDPK>
    <LicenceNumber>PA0187/040/004</LicenceNumber>
    <ProductName>HEALONID GV</ProductName>
    <Strength>14</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003637</DrugIDPK>
    <LicenceNumber>PA0100/042/002</LicenceNumber>
    <ProductName>PRODUR LA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1993-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001375</DrugIDPK>
    <LicenceNumber>PA0035/062/001</LicenceNumber>
    <ProductName>DARANIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1984-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008952</DrugIDPK>
    <LicenceNumber>PA0488/016/001</LicenceNumber>
    <ProductName>ETHMOZINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORACIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008953</DrugIDPK>
    <LicenceNumber>PA0488/016/002</LicenceNumber>
    <ProductName>ETHMOZINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORACIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008954</DrugIDPK>
    <LicenceNumber>PA0488/016/003</LicenceNumber>
    <ProductName>ETHMOZINE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORACIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003955</DrugIDPK>
    <LicenceNumber>PA0126/084/002</LicenceNumber>
    <ProductName>FENOMEL 100</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003953</DrugIDPK>
    <LicenceNumber>PA0126/084/001</LicenceNumber>
    <ProductName>FENOMEL 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002981</DrugIDPK>
    <LicenceNumber>PA0059/010/001</LicenceNumber>
    <ProductName>GYNO-PEVARYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1975-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003656</DrugIDPK>
    <LicenceNumber>PA0107/008/001</LicenceNumber>
    <ProductName>MACRODEX/DEXTROSE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 70</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003657</DrugIDPK>
    <LicenceNumber>PA0107/008/002</LicenceNumber>
    <ProductName>MACRODEX/SALINE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 70</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004854</DrugIDPK>
    <LicenceNumber>PA0236/014/007</LicenceNumber>
    <ProductName>MAXTREX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008386</DrugIDPK>
    <LicenceNumber>PA0456/003/001</LicenceNumber>
    <ProductName>MEDICOAL CHARCOAL GRANULES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Torbet Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHARCOAL, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000864</DrugIDPK>
    <LicenceNumber>PA0017/020/003</LicenceNumber>
    <ProductName>PHYSEPTONE LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHADONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005303</DrugIDPK>
    <LicenceNumber>PA0281/026/005</LicenceNumber>
    <ProductName>PRIMACINE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1994-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005304</DrugIDPK>
    <LicenceNumber>PA0281/026/006</LicenceNumber>
    <ProductName>PRIMACINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1994-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ETHYLSUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003813</DrugIDPK>
    <LicenceNumber>PA0126/007/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1978-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001375</DrugIDPK>
    <LicenceNumber>PA0764/001/001</LicenceNumber>
    <ProductName>CDP - 50 ANTICOAGULANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Parkfields Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1995-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000568</DrugIDPK>
    <LicenceNumber>PA0013/005/001</LicenceNumber>
    <ProductName>CAFERGOT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000569</DrugIDPK>
    <LicenceNumber>PA0013/005/002</LicenceNumber>
    <ProductName>CAFERGOT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000381</DrugIDPK>
    <LicenceNumber>PA0006/039/001</LicenceNumber>
    <ProductName>DIMETRIOSE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000274</DrugIDPK>
    <LicenceNumber>PA0006/019/001</LicenceNumber>
    <ProductName>EUGLUCON</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000275</DrugIDPK>
    <LicenceNumber>PA0006/019/002</LicenceNumber>
    <ProductName>EUGLUCON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000230</DrugIDPK>
    <LicenceNumber>PA0006/012/006</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000187</DrugIDPK>
    <LicenceNumber>PA0006/012/004</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000189</DrugIDPK>
    <LicenceNumber>PA0006/012/005</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000208</DrugIDPK>
    <LicenceNumber>PA0006/012/009</LicenceNumber>
    <ProductName>MOLIPAXIN CR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008159</DrugIDPK>
    <LicenceNumber>PA0006/046/001</LicenceNumber>
    <ProductName>NORPLANT</ProductName>
    <Strength>36</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000472</DrugIDPK>
    <LicenceNumber>PA0007/027/001</LicenceNumber>
    <ProductName>RINATEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002105</DrugIDPK>
    <LicenceNumber>PA0041/043/002</LicenceNumber>
    <ProductName>SABRIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1989-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VIGABATRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002106</DrugIDPK>
    <LicenceNumber>PA0041/043/003</LicenceNumber>
    <ProductName>SABRIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1989-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VIGABATRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002108</DrugIDPK>
    <LicenceNumber>PA0041/043/004</LicenceNumber>
    <ProductName>SABRIL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1989-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VIGABATRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004539</DrugIDPK>
    <LicenceNumber>PA0013/074/001</LicenceNumber>
    <ProductName>SLOW SODIUM</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000278</DrugIDPK>
    <LicenceNumber>PA0006/023/005</LicenceNumber>
    <ProductName>SURGAM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000281</DrugIDPK>
    <LicenceNumber>PA0006/023/009</LicenceNumber>
    <ProductName>SURGAM  SA</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000282</DrugIDPK>
    <LicenceNumber>PA0006/023/008</LicenceNumber>
    <ProductName>SURGAM SA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005001</DrugIDPK>
    <LicenceNumber>PA0235/008/003</LicenceNumber>
    <ProductName>ISOPAQUE CYSTO 100 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM METRIZOATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM METRIZOATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM METRIZOATE</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE METRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001210</DrugIDPK>
    <LicenceNumber>PA0235/001/003</LicenceNumber>
    <ProductName>AMIPAQUE</ProductName>
    <Strength>6.75</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRIZAMIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CALCIUM EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003275</DrugIDPK>
    <LicenceNumber>PA0073/116/001</LicenceNumber>
    <ProductName>CALCIUM LACTATE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM LACTATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000304</DrugIDPK>
    <LicenceNumber>PA0006/027/001</LicenceNumber>
    <ProductName>DORMONOCT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPRAZOLAM MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007836</DrugIDPK>
    <LicenceNumber>PA0365/024/004</LicenceNumber>
    <ProductName>FLUVIRIN INACTIVATED INFLUENZA VACCINE AMPOULE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1988-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>A/SYDNEY /5/97 (H3N2)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>A/BEIJING /262/95 (H1N1)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003174</DrugIDPK>
    <LicenceNumber>PA0073/049/003</LicenceNumber>
    <ProductName>AMYLINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002819</DrugIDPK>
    <LicenceNumber>PA0056/050/001</LicenceNumber>
    <ProductName>AGAROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
      <ActiveSubstance>GELIDIUM AMANSII</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002804</DrugIDPK>
    <LicenceNumber>PA0056/031/001</LicenceNumber>
    <ProductName>ALOPHEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALOIN</ActiveSubstance>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001432</DrugIDPK>
    <LicenceNumber>PA0504/009/001</LicenceNumber>
    <ProductName>IMMRAVAX MUMPS, MEASLES AND RUBELLA VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate>1988-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MUMPS VIRUS (URABE AM9 STRAIN)</ActiveSubstance>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000221</DrugIDPK>
    <LicenceNumber>PA0006/013/001</LicenceNumber>
    <ProductName>CORTISYL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006687</DrugIDPK>
    <LicenceNumber>PA0516/014/001</LicenceNumber>
    <ProductName>NIFELAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1989-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006689</DrugIDPK>
    <LicenceNumber>PA0516/014/002</LicenceNumber>
    <ProductName>NIFELAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1990-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008595</DrugIDPK>
    <LicenceNumber>PA0130/017/007</LicenceNumber>
    <ProductName>RECORMON 10,000 N</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003941</DrugIDPK>
    <LicenceNumber>PA0130/017/001</LicenceNumber>
    <ProductName>RECORMON 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1991-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003945</DrugIDPK>
    <LicenceNumber>PA0130/017/002</LicenceNumber>
    <ProductName>RECORMON 2000</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1991-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008594</DrugIDPK>
    <LicenceNumber>PA0130/017/006</LicenceNumber>
    <ProductName>RECORMON 5000 N</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1994-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003950</DrugIDPK>
    <LicenceNumber>PA0130/017/004</LicenceNumber>
    <ProductName>RECORMON S 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1994-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001400</DrugIDPK>
    <LicenceNumber>PA0130/017/009</LicenceNumber>
    <ProductName>RECORMON S 10000</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003952</DrugIDPK>
    <LicenceNumber>PA0130/017/005</LicenceNumber>
    <ProductName>RECORMON S 2000</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1994-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001399</DrugIDPK>
    <LicenceNumber>PA0130/017/008</LicenceNumber>
    <ProductName>RECORMON S 5000</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1996-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002038</DrugIDPK>
    <LicenceNumber>PA0040/080/003</LicenceNumber>
    <ProductName>MORPHGESIC</ProductName>
    <Strength>230</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1993-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002035</DrugIDPK>
    <LicenceNumber>PA0040/080/001</LicenceNumber>
    <ProductName>MORPHGESIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1993-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002036</DrugIDPK>
    <LicenceNumber>PA0040/080/002</LicenceNumber>
    <ProductName>MORPHGESIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1993-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005558</DrugIDPK>
    <LicenceNumber>PA0282/043/001</LicenceNumber>
    <ProductName>AMILORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005548</DrugIDPK>
    <LicenceNumber>PA0282/039/003</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005549</DrugIDPK>
    <LicenceNumber>PA0282/039/004</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005544</DrugIDPK>
    <LicenceNumber>PA0282/039/001</LicenceNumber>
    <ProductName>AMOXYCILLIN BP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005547</DrugIDPK>
    <LicenceNumber>PA0282/039/002</LicenceNumber>
    <ProductName>AMOXYCILLIN BP</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008923</DrugIDPK>
    <LicenceNumber>PA0282/047/003</LicenceNumber>
    <ProductName>ATENOLOL BP</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1996-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005587</DrugIDPK>
    <LicenceNumber>PA0282/056/001</LicenceNumber>
    <ProductName>CEPHALEXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1993-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005588</DrugIDPK>
    <LicenceNumber>PA0282/056/002</LicenceNumber>
    <ProductName>CEPHALEXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1993-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000245</DrugIDPK>
    <LicenceNumber>PA0006/003/006</LicenceNumber>
    <ProductName>CIDOMYCIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Base Grams</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005497</DrugIDPK>
    <LicenceNumber>PA0282/019/003</LicenceNumber>
    <ProductName>ERYTHROMYCIN (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1988-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005498</DrugIDPK>
    <LicenceNumber>PA0282/019/004</LicenceNumber>
    <ProductName>ERYTHROMYCIN (SUSPENSION)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001267</DrugIDPK>
    <LicenceNumber>PA0282/019/002</LicenceNumber>
    <ProductName>ERYTHROMYCIN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005516</DrugIDPK>
    <LicenceNumber>PA0282/029/001</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005517</DrugIDPK>
    <LicenceNumber>PA0282/029/002</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005518</DrugIDPK>
    <LicenceNumber>PA0282/029/003</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005519</DrugIDPK>
    <LicenceNumber>PA0282/029/004</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005479</DrugIDPK>
    <LicenceNumber>PA0282/009/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1980-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005477</DrugIDPK>
    <LicenceNumber>PA0282/009/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1980-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002874</DrugIDPK>
    <LicenceNumber>PA0282/068/001</LicenceNumber>
    <ProductName>ISOSORBIDE DINITRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1995-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005506</DrugIDPK>
    <LicenceNumber>PA0282/023/001</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005507</DrugIDPK>
    <LicenceNumber>PA0282/023/002</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005529</DrugIDPK>
    <LicenceNumber>PA0282/034/002</LicenceNumber>
    <ProductName>METFORMIN</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005524</DrugIDPK>
    <LicenceNumber>PA0282/034/001</LicenceNumber>
    <ProductName>METFORMIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005510</DrugIDPK>
    <LicenceNumber>PA0282/025/001</LicenceNumber>
    <ProductName>METOCLOPRAMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005583</DrugIDPK>
    <LicenceNumber>PA0282/053/001</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005584</DrugIDPK>
    <LicenceNumber>PA0282/053/002</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005580</DrugIDPK>
    <LicenceNumber>PA0282/051/002</LicenceNumber>
    <ProductName>PIROXICAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005579</DrugIDPK>
    <LicenceNumber>PA0282/051/001</LicenceNumber>
    <ProductName>PROXICAM USP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010176</DrugIDPK>
    <LicenceNumber>PA0382/005/001</LicenceNumber>
    <ProductName>TIMOLOL EYE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005934</DrugIDPK>
    <LicenceNumber>PA0382/005/002</LicenceNumber>
    <ProductName>TIMOLOL EYE DROPS</ProductName>
    <Strength>0.5%</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002453</DrugIDPK>
    <LicenceNumber>PA0054/016/001</LicenceNumber>
    <ProductName>UROMIRO 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002454</DrugIDPK>
    <LicenceNumber>PA0054/016/002</LicenceNumber>
    <ProductName>UROMIRO 340</ProductName>
    <Strength>340</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001311</DrugIDPK>
    <LicenceNumber>PA0024/001/006</LicenceNumber>
    <ProductName>VENTOLIN</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1983-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995006912</DrugIDPK>
    <LicenceNumber>PA0056/066/003</LicenceNumber>
    <ProductName>ACCURETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1992-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000408</DrugIDPK>
    <LicenceNumber>PA0007/001/002</LicenceNumber>
    <ProductName>MEXITIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1975-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEXILETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002955</DrugIDPK>
    <LicenceNumber>PA0058/019/001</LicenceNumber>
    <ProductName>PANZYTRAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1991-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003000</DrugIDPK>
    <LicenceNumber>PA0059/026/001</LicenceNumber>
    <ProductName>ORTHO-GYNOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1983-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lubricant Jelly</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>P-DIISOBUTYLPHENOXYPOLYETHOXYETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003108</DrugIDPK>
    <LicenceNumber>PA0069/011/001</LicenceNumber>
    <ProductName>SENSODYNE F</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1988-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM MONOFLUORO PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003869</DrugIDPK>
    <LicenceNumber>PA0126/039/001</LicenceNumber>
    <ProductName>MELACTONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005039</DrugIDPK>
    <LicenceNumber>PA0236/011/003</LicenceNumber>
    <ProductName>FARLUTAL 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1983-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005041</DrugIDPK>
    <LicenceNumber>PA0236/011/005</LicenceNumber>
    <ProductName>FARLUTAL 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1983-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000468</DrugIDPK>
    <LicenceNumber>PA0007/024/001</LicenceNumber>
    <ProductName>FINALGON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTOXYETHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>NONIVAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005560</DrugIDPK>
    <LicenceNumber>PA0282/046/001</LicenceNumber>
    <ProductName>PROCYCLIDINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCYCLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003106</DrugIDPK>
    <LicenceNumber>PA0069/010/001</LicenceNumber>
    <ProductName>SENSODYNE MINT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STRONTIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003107</DrugIDPK>
    <LicenceNumber>PA0069/010/002</LicenceNumber>
    <ProductName>SENSODYNE REG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STRONTIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002273</DrugIDPK>
    <LicenceNumber>PA0047/029/001</LicenceNumber>
    <ProductName>DOLOXENE COMPOUND</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE NAPSILATE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001444</DrugIDPK>
    <LicenceNumber>PA0037/016/001</LicenceNumber>
    <ProductName>AQUATAIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHOXYLATED STEARYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>SORBITOL SOLUTION 70 %</ActiveSubstance>
      <ActiveSubstance>ISOPROPYL PALMITATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003034</DrugIDPK>
    <LicenceNumber>PA0060/048/001</LicenceNumber>
    <ProductName>CORACTEN SPANSULE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001025</DrugIDPK>
    <LicenceNumber>PA0018/038/001</LicenceNumber>
    <ProductName>RYNACROM CO AEROSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
      <ActiveSubstance>XYLOMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005398</DrugIDPK>
    <LicenceNumber>PA0277/002/003</LicenceNumber>
    <ProductName>TINADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005399</DrugIDPK>
    <LicenceNumber>PA0277/002/004</LicenceNumber>
    <ProductName>TINADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000788</DrugIDPK>
    <LicenceNumber>PA0016/033/001</LicenceNumber>
    <ProductName>AMBAXIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1981-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BACAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000697</DrugIDPK>
    <LicenceNumber>PA0016/002/002</LicenceNumber>
    <ProductName>DALACIN C</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001846</DrugIDPK>
    <LicenceNumber>PA0016/024/007</LicenceNumber>
    <ProductName>DEPO PROVERA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1996-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000765</DrugIDPK>
    <LicenceNumber>PA0016/024/005</LicenceNumber>
    <ProductName>DEPO-PROVERA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1981-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000759</DrugIDPK>
    <LicenceNumber>PA0016/024/002</LicenceNumber>
    <ProductName>DEPO-PROVERA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004961</DrugIDPK>
    <LicenceNumber>PA0236/023/010</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004962</DrugIDPK>
    <LicenceNumber>PA0236/023/011</LicenceNumber>
    <ProductName>DOXORUBICIN SOLUTION</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1993-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004855</DrugIDPK>
    <LicenceNumber>PA0236/014/008</LicenceNumber>
    <ProductName>MAXTREX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005014</DrugIDPK>
    <LicenceNumber>PA0236/002/001</LicenceNumber>
    <ProductName>NAXOGIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1976-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIMORAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009271</DrugIDPK>
    <LicenceNumber>PA0187/055/003</LicenceNumber>
    <ProductName>OCTONATIV-M-</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1995-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004923</DrugIDPK>
    <LicenceNumber>PA0236/016/007</LicenceNumber>
    <ProductName>PHARMORUBICIN 150</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008524</DrugIDPK>
    <LicenceNumber>PA0016/045/001</LicenceNumber>
    <ProductName>PROMEDROL STERILE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE SULEPTANATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008526</DrugIDPK>
    <LicenceNumber>PA0016/045/002</LicenceNumber>
    <ProductName>PROMEDROL STERILE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1995-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE SULEPTANATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004946</DrugIDPK>
    <LicenceNumber>PA0236/022/002</LicenceNumber>
    <ProductName>SALCATONIN 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004943</DrugIDPK>
    <LicenceNumber>PA0236/022/001</LicenceNumber>
    <ProductName>SALCATONIN 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1994-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000774</DrugIDPK>
    <LicenceNumber>PA0016/028/001</LicenceNumber>
    <ProductName>TOLANASE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLAZAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000776</DrugIDPK>
    <LicenceNumber>PA0016/028/002</LicenceNumber>
    <ProductName>TOLANASE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLAZAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005050</DrugIDPK>
    <LicenceNumber>PA0236/024/003</LicenceNumber>
    <ProductName>ZAVEDOS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1993-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IDARUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006727</DrugIDPK>
    <LicenceNumber>PA0521/002/006</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 20%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>1993-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003655</DrugIDPK>
    <LicenceNumber>PA0107/005/006</LicenceNumber>
    <ProductName>SALAZOPYRIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1989-04-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001020</DrugIDPK>
    <LicenceNumber>PA0018/016/002</LicenceNumber>
    <ProductName>NALCROM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001021</DrugIDPK>
    <LicenceNumber>PA0018/016/003</LicenceNumber>
    <ProductName>NALCROM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005042</DrugIDPK>
    <LicenceNumber>PA0236/011/006</LicenceNumber>
    <ProductName>FARLUTAL 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1983-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004249</DrugIDPK>
    <LicenceNumber>PA0167/022/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE ANTICOAGULANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001604</DrugIDPK>
    <LicenceNumber>PA0365/051/001</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1993-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001405</DrugIDPK>
    <LicenceNumber>PA0037/004/005</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016194</DrugIDPK>
    <LicenceNumber>PA0037/004/004</LicenceNumber>
    <ProductName>LOXAPAC ORAL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002517</DrugIDPK>
    <LicenceNumber>PA0054/044/001</LicenceNumber>
    <ProductName>UROMIRO 300</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002518</DrugIDPK>
    <LicenceNumber>PA0054/044/002</LicenceNumber>
    <ProductName>UROMIRO 300</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005157</DrugIDPK>
    <LicenceNumber>PA0255/019/001</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE STERILE SOLUTION</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002199</DrugIDPK>
    <LicenceNumber>PA0047/056/001</LicenceNumber>
    <ProductName>CESAMET</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NABILONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001304</DrugIDPK>
    <LicenceNumber>PA0023/066/001</LicenceNumber>
    <ProductName>INTERBERIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1993-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SARGRAMOSTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001305</DrugIDPK>
    <LicenceNumber>PA0023/066/002</LicenceNumber>
    <ProductName>INTERBERIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1993-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SARGRAMOSTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000428</DrugIDPK>
    <LicenceNumber>PA0007/008/006</LicenceNumber>
    <ProductName>PERSANTIN  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1988-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005294</DrugIDPK>
    <LicenceNumber>PA0281/017/002</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007295</DrugIDPK>
    <LicenceNumber>PA0281/035/002</LicenceNumber>
    <ProductName>NEPHRO LYTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>CHLORINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007304</DrugIDPK>
    <LicenceNumber>PA0281/035/011</LicenceNumber>
    <ProductName>NEPHRO LYTE 160</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007296</DrugIDPK>
    <LicenceNumber>PA0281/035/003</LicenceNumber>
    <ProductName>NEPHRO LYTE 49</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007298</DrugIDPK>
    <LicenceNumber>PA0281/035/005</LicenceNumber>
    <ProductName>NEPHRO LYTE 53</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>CHLORINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007299</DrugIDPK>
    <LicenceNumber>PA0281/035/006</LicenceNumber>
    <ProductName>NEPHRO LYTE 61</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007294</DrugIDPK>
    <LicenceNumber>PA0281/035/001</LicenceNumber>
    <ProductName>NEPHRO LYTE 62</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007300</DrugIDPK>
    <LicenceNumber>PA0281/035/007</LicenceNumber>
    <ProductName>NEPHRO LYTE 77</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007301</DrugIDPK>
    <LicenceNumber>PA0281/035/008</LicenceNumber>
    <ProductName>NEPHRO LYTE 81</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007297</DrugIDPK>
    <LicenceNumber>PA0281/035/004</LicenceNumber>
    <ProductName>NEPHRO-LYTE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>CHLORINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008208</DrugIDPK>
    <LicenceNumber>PA0281/046/016</LicenceNumber>
    <ProductName>NEPHROLYTE  319/B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007302</DrugIDPK>
    <LicenceNumber>PA0281/035/009</LicenceNumber>
    <ProductName>NEPHRO-LYTE 115</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007303</DrugIDPK>
    <LicenceNumber>PA0281/035/010</LicenceNumber>
    <ProductName>NEPHRO-LYTE 154</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008429</DrugIDPK>
    <LicenceNumber>PA0281/035/012</LicenceNumber>
    <ProductName>NEPHROLYTE 183</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008430</DrugIDPK>
    <LicenceNumber>PA0281/035/013</LicenceNumber>
    <ProductName>NEPHROLYTE 186</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008431</DrugIDPK>
    <LicenceNumber>PA0281/035/014</LicenceNumber>
    <ProductName>NEPHROLYTE 205</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008906</DrugIDPK>
    <LicenceNumber>PA0281/046/014</LicenceNumber>
    <ProductName>NEPHROLYTE 210/B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007418</DrugIDPK>
    <LicenceNumber>PA0281/046/001</LicenceNumber>
    <ProductName>NEPHROLYTE 211/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008432</DrugIDPK>
    <LicenceNumber>PA0281/035/015</LicenceNumber>
    <ProductName>NEPHROLYTE 221</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008433</DrugIDPK>
    <LicenceNumber>PA0281/035/016</LicenceNumber>
    <ProductName>NEPHROLYTE 227</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007419</DrugIDPK>
    <LicenceNumber>PA0281/046/002</LicenceNumber>
    <ProductName>NEPHROLYTE 228/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008439</DrugIDPK>
    <LicenceNumber>PA0281/046/003</LicenceNumber>
    <ProductName>NEPHROLYTE 239/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008441</DrugIDPK>
    <LicenceNumber>PA0281/046/004</LicenceNumber>
    <ProductName>NEPHROLYTE 241/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008454</DrugIDPK>
    <LicenceNumber>PA0281/046/015</LicenceNumber>
    <ProductName>NEPHROLYTE 242/B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008434</DrugIDPK>
    <LicenceNumber>PA0281/035/017</LicenceNumber>
    <ProductName>NEPHROLYTE 244</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008442</DrugIDPK>
    <LicenceNumber>PA0281/046/005</LicenceNumber>
    <ProductName>NEPHROLYTE 246/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008443</DrugIDPK>
    <LicenceNumber>PA0281/046/006</LicenceNumber>
    <ProductName>NEPHROLYTE 303/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008444</DrugIDPK>
    <LicenceNumber>PA0281/046/007</LicenceNumber>
    <ProductName>NEPHROLYTE 318/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008445</DrugIDPK>
    <LicenceNumber>PA0281/046/008</LicenceNumber>
    <ProductName>NEPHROLYTE 330/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008446</DrugIDPK>
    <LicenceNumber>PA0281/046/009</LicenceNumber>
    <ProductName>NEPHROLYTE 331/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008447</DrugIDPK>
    <LicenceNumber>PA0281/046/010</LicenceNumber>
    <ProductName>NEPHROLYTE 332/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008435</DrugIDPK>
    <LicenceNumber>PA0281/035/018</LicenceNumber>
    <ProductName>NEPHROLYTE 357</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008449</DrugIDPK>
    <LicenceNumber>PA0281/046/011</LicenceNumber>
    <ProductName>NEPHROLYTE 358/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008451</DrugIDPK>
    <LicenceNumber>PA0281/046/012</LicenceNumber>
    <ProductName>NEPHROLYTE 366/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008452</DrugIDPK>
    <LicenceNumber>PA0281/046/013</LicenceNumber>
    <ProductName>NEPHROLYTE 370/A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-09-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001266</DrugIDPK>
    <LicenceNumber>PA0281/048/001</LicenceNumber>
    <ProductName>BICART SODIUM BICARBONATE</ProductName>
    <Strength>650</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1990-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>PDR for Soln for Haemodialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006526</DrugIDPK>
    <LicenceNumber>PA0479/002/001</LicenceNumber>
    <ProductName>BICART, SODIUM BICARBONATE COLUMN</ProductName>
    <Strength>650</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Gambro UK Limited</PAHolder>
    <AuthorisedDate>1991-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Conc For haemodialysis Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011644</DrugIDPK>
    <LicenceNumber>PA0072/010/001</LicenceNumber>
    <ProductName>CORSYM (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1986-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015958</DrugIDPK>
    <LicenceNumber>PA0018/014/002</LicenceNumber>
    <ProductName>PARACODOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009141</DrugIDPK>
    <LicenceNumber>PA0281/036/005</LicenceNumber>
    <ProductName>PINAMOX - SUGAR FREE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1996-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002847</DrugIDPK>
    <LicenceNumber>PA0060/002/001</LicenceNumber>
    <ProductName>REDEPTIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1975-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002848</DrugIDPK>
    <LicenceNumber>PA0060/002/002</LicenceNumber>
    <ProductName>REDEPTIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1975-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005874</DrugIDPK>
    <LicenceNumber>PA0018/033/001</LicenceNumber>
    <ProductName>ZAM BUK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAMPHENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004508</DrugIDPK>
    <LicenceNumber>PA0796/002/001</LicenceNumber>
    <ProductName>POSICOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIBEFRADIL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004509</DrugIDPK>
    <LicenceNumber>PA0796/002/002</LicenceNumber>
    <ProductName>POSICOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004447</DrugIDPK>
    <LicenceNumber>PA0170/010/002</LicenceNumber>
    <ProductName>PSORADRATE</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1980-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004448</DrugIDPK>
    <LicenceNumber>PA0170/010/003</LicenceNumber>
    <ProductName>PSORADRATE</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1985-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004535</DrugIDPK>
    <LicenceNumber>PA0013/071/001</LicenceNumber>
    <ProductName>ESTRAPAK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004537</DrugIDPK>
    <LicenceNumber>PA0013/071/003</LicenceNumber>
    <ProductName>ESTRAPAK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005623</DrugIDPK>
    <LicenceNumber>PA0312/002/001</LicenceNumber>
    <ProductName>ARPICOLIN</ProductName>
    <Strength>2.5/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCYCLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005043</DrugIDPK>
    <LicenceNumber>PA0236/011/007</LicenceNumber>
    <ProductName>FARLUTAL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1993-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005625</DrugIDPK>
    <LicenceNumber>PA0312/002/002</LicenceNumber>
    <ProductName>ARPICOLIN SYRUP</ProductName>
    <Strength>5/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCYCLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001270</DrugIDPK>
    <LicenceNumber>PA0022/056/001</LicenceNumber>
    <ProductName>BC 500 WITH IRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003581</DrugIDPK>
    <LicenceNumber>PA0095/008/007</LicenceNumber>
    <ProductName>RUBEX BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004446</DrugIDPK>
    <LicenceNumber>PA0170/010/001</LicenceNumber>
    <ProductName>PSORADRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1978-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006831</DrugIDPK>
    <LicenceNumber>PA0620/002/001</LicenceNumber>
    <ProductName>FLUARIX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>A/SINGAPORE 6/86</ActiveSubstance>
      <ActiveSubstance>B/BEYING /1/87</ActiveSubstance>
      <ActiveSubstance>B/PANAMA/45/90</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006835</DrugIDPK>
    <LicenceNumber>PA0620/002/003</LicenceNumber>
    <ProductName>FLUARIX VACCINE SYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>1994-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>A/SINGAPORE 6/86</ActiveSubstance>
      <ActiveSubstance>B/BEYING /1/87</ActiveSubstance>
      <ActiveSubstance>B/PANAMA/45/90</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008468</DrugIDPK>
    <LicenceNumber>PA0544/012/001</LicenceNumber>
    <ProductName>INACTIVATED INFLUENZA VACCINE BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1992-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003922</DrugIDPK>
    <LicenceNumber>PA0126/070/002</LicenceNumber>
    <ProductName>MELBETESE 2.5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003921</DrugIDPK>
    <LicenceNumber>PA0126/070/001</LicenceNumber>
    <ProductName>MELBETESE 5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001548</DrugIDPK>
    <LicenceNumber>PA0037/038/001</LicenceNumber>
    <ProductName>VISDERM H</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001667</DrugIDPK>
    <LicenceNumber>PA0038/029/002</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005635</DrugIDPK>
    <LicenceNumber>PA0289/001/001</LicenceNumber>
    <ProductName>NITROLINGUAL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006486</DrugIDPK>
    <LicenceNumber>PA0468/025/001</LicenceNumber>
    <ProductName>NIFENSAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006487</DrugIDPK>
    <LicenceNumber>PA0468/025/002</LicenceNumber>
    <ProductName>NIFENSAR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003711</DrugIDPK>
    <LicenceNumber>PA0540/009/001</LicenceNumber>
    <ProductName>KETOVAIL 100 CONTROLLED RELEASE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1993-04-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003712</DrugIDPK>
    <LicenceNumber>PA0540/009/002</LicenceNumber>
    <ProductName>KETOVAIL 200 CONTROLLED RELEASE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>1993-04-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005165</DrugIDPK>
    <LicenceNumber>PA0377/034/003</LicenceNumber>
    <ProductName>DIPROSONE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Lambert Chemicals Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006536</DrugIDPK>
    <LicenceNumber>PA0470/001/001</LicenceNumber>
    <ProductName>RECTOVALONE (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke-Davis</PAHolder>
    <AuthorisedDate>1993-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIXOCORTOL PIVALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006577</DrugIDPK>
    <LicenceNumber>PA0484/009/001</LicenceNumber>
    <ProductName>TINCTURE OF IODINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004707</DrugIDPK>
    <LicenceNumber>PA0199/001/004</LicenceNumber>
    <ProductName>OPTIRAY 240</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOVERSOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007459</DrugIDPK>
    <LicenceNumber>PA0415/003/001</LicenceNumber>
    <ProductName>VENOGLOBULIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006232</DrugIDPK>
    <LicenceNumber>PA0415/003/002</LicenceNumber>
    <ProductName>VENOGLOBULIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN HUMAN NORMAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006233</DrugIDPK>
    <LicenceNumber>PA0415/003/003</LicenceNumber>
    <ProductName>VENOGLOBULIN</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN HUMAN NORMAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006234</DrugIDPK>
    <LicenceNumber>PA0415/003/004</LicenceNumber>
    <ProductName>VENOGLOBULIN</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate>1993-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN HUMAN NORMAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000547</DrugIDPK>
    <LicenceNumber>PA0012/067/004</LicenceNumber>
    <ProductName>MAGNEVIST ENTERAL</ProductName>
    <Strength>9.38</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1993-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOPENTETATE DIMEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012564</DrugIDPK>
    <LicenceNumber>PA0436/010/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1988-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012565</DrugIDPK>
    <LicenceNumber>PA0436/010/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1988-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002729</DrugIDPK>
    <LicenceNumber>PA0050/053/003</LicenceNumber>
    <ProductName>ROACCUTANE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005161</DrugIDPK>
    <LicenceNumber>PA0255/036/002</LicenceNumber>
    <ProductName>NALOXONE HYDROCHLORIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005162</DrugIDPK>
    <LicenceNumber>PA0255/036/003</LicenceNumber>
    <ProductName>NALOXONE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009147</DrugIDPK>
    <LicenceNumber>PA0051/063/001</LicenceNumber>
    <ProductName>MERONEM</ProductName>
    <Strength>500/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1995-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEROPENEM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002668</DrugIDPK>
    <LicenceNumber>PA0050/003/001</LicenceNumber>
    <ProductName>BACTRIM ROCHE DRAPSULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002743</DrugIDPK>
    <LicenceNumber>PA0050/003/004</LicenceNumber>
    <ProductName>BACTRIM ROCHE PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006586</DrugIDPK>
    <LicenceNumber>PA0545/025/001</LicenceNumber>
    <ProductName>ERGAMISOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001227</DrugIDPK>
    <LicenceNumber>PA0022/039/002</LicenceNumber>
    <ProductName>ALUDROX PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004569</DrugIDPK>
    <LicenceNumber>PA0013/084/004</LicenceNumber>
    <ProductName>ANAFRANIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMIPRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004571</DrugIDPK>
    <LicenceNumber>PA0013/084/005</LicenceNumber>
    <ProductName>ANAFRANIL AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001527</DrugIDPK>
    <LicenceNumber>PA0037/028/002</LicenceNumber>
    <ProductName>AUREOCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002270</DrugIDPK>
    <LicenceNumber>PA0047/025/001</LicenceNumber>
    <ProductName>AVENTYL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002271</DrugIDPK>
    <LicenceNumber>PA0047/025/002</LicenceNumber>
    <ProductName>AVENTYL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000628</DrugIDPK>
    <LicenceNumber>PA0013/029/002</LicenceNumber>
    <ProductName>CALCIUM-SANDOZ</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLUBIONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM LACTOBIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003135</DrugIDPK>
    <LicenceNumber>PA0073/016/001</LicenceNumber>
    <ProductName>CETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003136</DrugIDPK>
    <LicenceNumber>PA0073/016/002</LicenceNumber>
    <ProductName>CETAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003836</DrugIDPK>
    <LicenceNumber>PA0126/024/001</LicenceNumber>
    <ProductName>CLONALIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004604</DrugIDPK>
    <LicenceNumber>PA0179/004/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004605</DrugIDPK>
    <LicenceNumber>PA0179/004/002</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001948</DrugIDPK>
    <LicenceNumber>PA0040/051/001</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <Strength>280</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001952</DrugIDPK>
    <LicenceNumber>PA0040/051/002</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <Strength>280</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001958</DrugIDPK>
    <LicenceNumber>PA0040/054/002</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <Strength>325</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001956</DrugIDPK>
    <LicenceNumber>PA0040/054/001</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <Strength>325</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001953</DrugIDPK>
    <LicenceNumber>PA0040/053/001</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <Strength>420</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001955</DrugIDPK>
    <LicenceNumber>PA0040/053/002</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <Strength>420</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000840</DrugIDPK>
    <LicenceNumber>PA0012/023/001</LicenceNumber>
    <ProductName>CYCLO PROGYNOVA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001530</DrugIDPK>
    <LicenceNumber>PA0037/029/002</LicenceNumber>
    <ProductName>DIAMOX SUSTETS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001796</DrugIDPK>
    <LicenceNumber>PA0035/024/002</LicenceNumber>
    <ProductName>EDECRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETACRYNIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006231</DrugIDPK>
    <LicenceNumber>PA0447/009/001</LicenceNumber>
    <ProductName>HAELAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDROXYCORTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006248</DrugIDPK>
    <LicenceNumber>PA0447/009/002</LicenceNumber>
    <ProductName>HAELAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDROXYCORTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008303</DrugIDPK>
    <LicenceNumber>PA0051/046/004</LicenceNumber>
    <ProductName>HIBITANE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003197</DrugIDPK>
    <LicenceNumber>PA0073/075/001</LicenceNumber>
    <ProductName>IPESIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SQUILL TINCTURE</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA TINCTURE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002074</DrugIDPK>
    <LicenceNumber>PA0041/014/001</LicenceNumber>
    <ProductName>KOLANTYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002725</DrugIDPK>
    <LicenceNumber>PA0050/051/003</LicenceNumber>
    <ProductName>KONAKION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHYTOMENADIONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002687</DrugIDPK>
    <LicenceNumber>PA0050/021/002</LicenceNumber>
    <ProductName>LAROXYL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001535</DrugIDPK>
    <LicenceNumber>PA0037/030/002</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001536</DrugIDPK>
    <LicenceNumber>PA0037/030/004</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001538</DrugIDPK>
    <LicenceNumber>PA0037/030/005</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005019</DrugIDPK>
    <LicenceNumber>PA0236/006/001</LicenceNumber>
    <ProductName>LEVIUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001960</DrugIDPK>
    <LicenceNumber>PA0040/059/001</LicenceNumber>
    <ProductName>LIPIODOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POPPY SEED OIL IODISED FATTY ACID ETHYLESTERS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000818</DrugIDPK>
    <LicenceNumber>PA0012/012/001</LicenceNumber>
    <ProductName>MICROLUT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006886</DrugIDPK>
    <LicenceNumber>PA0545/014/001</LicenceNumber>
    <ProductName>OPERIDINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003199</DrugIDPK>
    <LicenceNumber>PA0073/080/001</LicenceNumber>
    <ProductName>PAEDAVIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015957</DrugIDPK>
    <LicenceNumber>PA0018/014/001</LicenceNumber>
    <ProductName>PARACODOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001546</DrugIDPK>
    <LicenceNumber>PA0037/032/001</LicenceNumber>
    <ProductName>PARFENAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001214</DrugIDPK>
    <LicenceNumber>PA0022/027/001</LicenceNumber>
    <ProductName>PETROLAGAR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000630</DrugIDPK>
    <LicenceNumber>PA0013/030/001</LicenceNumber>
    <ProductName>PHOSPHATE-SANDOZ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000845</DrugIDPK>
    <LicenceNumber>PA0012/024/001</LicenceNumber>
    <ProductName>PROGYNOVA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003658</DrugIDPK>
    <LicenceNumber>PA0107/009/001</LicenceNumber>
    <ProductName>RHEOMACRODEX/DEXTROSE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 40</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003659</DrugIDPK>
    <LicenceNumber>PA0107/009/002</LicenceNumber>
    <ProductName>RHEOMACRODEX/SALINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN 40</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003466</DrugIDPK>
    <LicenceNumber>PA0086/007/001</LicenceNumber>
    <ProductName>ROBAXISAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>METHOCARBAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000631</DrugIDPK>
    <LicenceNumber>PA0013/031/001</LicenceNumber>
    <ProductName>SANDO-K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005021</DrugIDPK>
    <LicenceNumber>PA0236/007/001</LicenceNumber>
    <ProductName>SINTISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001365</DrugIDPK>
    <LicenceNumber>PA0027/007/001</LicenceNumber>
    <ProductName>SOLPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000868</DrugIDPK>
    <LicenceNumber>PA0012/030/001</LicenceNumber>
    <ProductName>ULTRADIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE CAPROATE</ActiveSubstance>
      <ActiveSubstance>FLUOCORTOLONE PIVALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005851</DrugIDPK>
    <LicenceNumber>PA0303/016/002</LicenceNumber>
    <ProductName>TEMPOROL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006396</DrugIDPK>
    <LicenceNumber>PA0467/003/001</LicenceNumber>
    <ProductName>METOCLOPRAMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethical Pharmaceuticals UK Ltd.</PAHolder>
    <AuthorisedDate>1988-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007137</DrugIDPK>
    <LicenceNumber>PA0467/001/001</LicenceNumber>
    <ProductName>PYRIDOXINE HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethical Pharmaceuticals UK Ltd.</PAHolder>
    <AuthorisedDate>1988-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002324</DrugIDPK>
    <LicenceNumber>PA0050/082/001</LicenceNumber>
    <ProductName>LOCERYL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1993-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOROLFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000556</DrugIDPK>
    <LicenceNumber>PA0013/001/004</LicenceNumber>
    <ProductName>VISKEN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1978-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINDOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006671</DrugIDPK>
    <LicenceNumber>PA0516/009/005</LicenceNumber>
    <ProductName>THEO NOVA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006672</DrugIDPK>
    <LicenceNumber>PA0516/009/006</LicenceNumber>
    <ProductName>THEO NOVA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006670</DrugIDPK>
    <LicenceNumber>PA0516/009/004</LicenceNumber>
    <ProductName>THEOPHYLLINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002698</DrugIDPK>
    <LicenceNumber>PA0050/029/001</LicenceNumber>
    <ProductName>REDELAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007138</DrugIDPK>
    <LicenceNumber>PA0467/002/001</LicenceNumber>
    <ProductName>GRISEODERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ethical Pharmaceuticals UK Ltd.</PAHolder>
    <AuthorisedDate>1988-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002996</DrugIDPK>
    <LicenceNumber>PA0059/023/001</LicenceNumber>
    <ProductName>DELFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1983-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009361</DrugIDPK>
    <LicenceNumber>PA0639/001/002</LicenceNumber>
    <ProductName>GRANOCYTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chugai Sanofi-Aventis</PAHolder>
    <AuthorisedDate>1996-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LENOGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006853</DrugIDPK>
    <LicenceNumber>PA0545/005/002</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006898</DrugIDPK>
    <LicenceNumber>PA0545/018/006</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002992</DrugIDPK>
    <LicenceNumber>PA0059/017/002</LicenceNumber>
    <ProductName>ORTHO-GYNEST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006582</DrugIDPK>
    <LicenceNumber>PA0484/015/001</LicenceNumber>
    <ProductName>FRIARS BALSAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1994-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006680</DrugIDPK>
    <LicenceNumber>PA0555/004/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB AEROSOL SALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006675</DrugIDPK>
    <LicenceNumber>PA0555/002/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB DAILY CLEANER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SORBIC ACID</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BORATE</ActiveSubstance>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006677</DrugIDPK>
    <LicenceNumber>PA0555/003/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB FIZZICLEAN CLEANING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006673</DrugIDPK>
    <LicenceNumber>PA0555/001/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB SALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SORBIC ACID</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BORIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BORATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006298</DrugIDPK>
    <LicenceNumber>PA0434/001/003</LicenceNumber>
    <ProductName>BEKUNIS HERBAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roha Arzneimittel GmbH &amp; Co. K.G</PAHolder>
    <AuthorisedDate>1993-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005198</DrugIDPK>
    <LicenceNumber>PA0277/050/009</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>18000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005199</DrugIDPK>
    <LicenceNumber>PA0277/050/010</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>25000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005195</DrugIDPK>
    <LicenceNumber>PA0277/050/007</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>4500000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005196</DrugIDPK>
    <LicenceNumber>PA0277/050/008</LicenceNumber>
    <ProductName>INTRON A</ProductName>
    <Strength>9000000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005114</DrugIDPK>
    <LicenceNumber>PA0255/004/001</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006947</DrugIDPK>
    <LicenceNumber>PA0650/009/001</LicenceNumber>
    <ProductName>METHYLENE BLUE</ProductName>
    <Strength>1%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Penn Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLTHIONINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006945</DrugIDPK>
    <LicenceNumber>PA0650/001/001</LicenceNumber>
    <ProductName>SODIUM BICARBONATE INFUSION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Penn Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006870</DrugIDPK>
    <LicenceNumber>PA0545/008/004</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006871</DrugIDPK>
    <LicenceNumber>PA0545/008/005</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006581</DrugIDPK>
    <LicenceNumber>PA0545/021/001</LicenceNumber>
    <ProductName>TINSET</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXATOMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005570</DrugIDPK>
    <LicenceNumber>PA0309/006/001</LicenceNumber>
    <ProductName>NOVOFILINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate>1988-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>PROXYPHYLLINE</ActiveSubstance>
      <ActiveSubstance>DIPROPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006851</DrugIDPK>
    <LicenceNumber>PA0545/005/001</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006638</DrugIDPK>
    <LicenceNumber>PA0508/005/001</LicenceNumber>
    <ProductName>PHARCETIL SUGAR-FREE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1993-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001452</DrugIDPK>
    <LicenceNumber>PA0037/020/002</LicenceNumber>
    <ProductName>ZADSTAT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001453</DrugIDPK>
    <LicenceNumber>PA0037/020/003</LicenceNumber>
    <ProductName>ZADSTAT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001454</DrugIDPK>
    <LicenceNumber>PA0037/020/004</LicenceNumber>
    <ProductName>ZADSTAT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002420</DrugIDPK>
    <LicenceNumber>PA0051/040/001</LicenceNumber>
    <ProductName>SAVLODIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002422</DrugIDPK>
    <LicenceNumber>PA0051/040/002</LicenceNumber>
    <ProductName>SAVLODIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004578</DrugIDPK>
    <LicenceNumber>PA0185/022/001</LicenceNumber>
    <ProductName>ALOMIDE OPHTHALMIC</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1991-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LODOXAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001803</DrugIDPK>
    <LicenceNumber>PA0035/029/001</LicenceNumber>
    <ProductName>MODURETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000863</DrugIDPK>
    <LicenceNumber>PA0012/029/001</LicenceNumber>
    <ProductName>TESTOVIRON DEPOT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE ENANTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000196</DrugIDPK>
    <LicenceNumber>PA0003/002/001</LicenceNumber>
    <ProductName>CAM MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000197</DrugIDPK>
    <LicenceNumber>PA0003/003/001</LicenceNumber>
    <ProductName>CYFOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLUCONATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006915</DrugIDPK>
    <LicenceNumber>PA0681/001/001</LicenceNumber>
    <ProductName>FORTUM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>St. Jamess Hospital</PAHolder>
    <AuthorisedDate>1994-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006916</DrugIDPK>
    <LicenceNumber>PA0681/001/002</LicenceNumber>
    <ProductName>FORTUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>St. Jamess Hospital</PAHolder>
    <AuthorisedDate>1994-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005065</DrugIDPK>
    <LicenceNumber>PA0237/021/001</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1983-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005066</DrugIDPK>
    <LicenceNumber>PA0237/021/002</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1983-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005067</DrugIDPK>
    <LicenceNumber>PA0237/021/003</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1983-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005068</DrugIDPK>
    <LicenceNumber>PA0237/021/004</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1983-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003114</DrugIDPK>
    <LicenceNumber>PA0069/016/002</LicenceNumber>
    <ProductName>EN-DE-KAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003115</DrugIDPK>
    <LicenceNumber>PA0069/016/003</LicenceNumber>
    <ProductName>EN-DE-KAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005329</DrugIDPK>
    <LicenceNumber>PA0281/050/001</LicenceNumber>
    <ProductName>IODINE LINIMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1990-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005330</DrugIDPK>
    <LicenceNumber>PA0281/050/002</LicenceNumber>
    <ProductName>IODINE TINCTURE BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1990-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005264</DrugIDPK>
    <LicenceNumber>PA0281/001/001</LicenceNumber>
    <ProductName>PIPERAZINE CITRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1980-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIPERAZINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005272</DrugIDPK>
    <LicenceNumber>PA0281/005/003</LicenceNumber>
    <ProductName>SYRUP CODEINE PHOSPHATE B.P.C.</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005299</DrugIDPK>
    <LicenceNumber>PA0281/022/002</LicenceNumber>
    <ProductName>TRICOMOX PAEDIATRIC (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1983-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005136</DrugIDPK>
    <LicenceNumber>PA0255/002/001</LicenceNumber>
    <ProductName>ADRENALINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005836</DrugIDPK>
    <LicenceNumber>PA0302/001/002</LicenceNumber>
    <ProductName>MEDIJEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate>1984-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>AMINOACRIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004574</DrugIDPK>
    <LicenceNumber>PA0013/086/001</LicenceNumber>
    <ProductName>TOFRANIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005058</DrugIDPK>
    <LicenceNumber>PA0237/019/001</LicenceNumber>
    <ProductName>CO TRIMOXAZOLE</ProductName>
    <Strength>100/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1983-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005059</DrugIDPK>
    <LicenceNumber>PA0237/019/002</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1983-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005060</DrugIDPK>
    <LicenceNumber>PA0237/019/003</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1983-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003850</DrugIDPK>
    <LicenceNumber>PA0126/029/002</LicenceNumber>
    <ProductName>CIDOMEL 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004040</DrugIDPK>
    <LicenceNumber>PA0148/008/002</LicenceNumber>
    <ProductName>EPIFRIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004041</DrugIDPK>
    <LicenceNumber>PA0148/008/003</LicenceNumber>
    <ProductName>EPIFRIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004922</DrugIDPK>
    <LicenceNumber>PA0224/013/001</LicenceNumber>
    <ProductName>DESMOTABS</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1993-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001363</DrugIDPK>
    <LicenceNumber>PA0429/001/001</LicenceNumber>
    <ProductName>ENTEROSAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Windsor Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004479</DrugIDPK>
    <LicenceNumber>PA0176/001/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004480</DrugIDPK>
    <LicenceNumber>PA0176/001/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004481</DrugIDPK>
    <LicenceNumber>PA0176/001/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004482</DrugIDPK>
    <LicenceNumber>PA0176/002/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006730</DrugIDPK>
    <LicenceNumber>PA0522/002/001</LicenceNumber>
    <ProductName>SURELAX LAXATIVE</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Peter Black Healthcare Ltd</PAHolder>
    <AuthorisedDate>1991-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YELLOW PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003613</DrugIDPK>
    <LicenceNumber>PA0100/001/004</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004409</DrugIDPK>
    <LicenceNumber>PA0167/068/007</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004410</DrugIDPK>
    <LicenceNumber>PA0167/068/008</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>2.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002325</DrugIDPK>
    <LicenceNumber>PA0048/010/001</LicenceNumber>
    <ProductName>BUTORPHANOL TARTRATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002328</DrugIDPK>
    <LicenceNumber>PA0048/010/002</LicenceNumber>
    <ProductName>BUTORPHANOL TARTRATE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002786</DrugIDPK>
    <LicenceNumber>PA0056/010/001</LicenceNumber>
    <ProductName>BENYLIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1975-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002839</DrugIDPK>
    <LicenceNumber>PA0056/062/001</LicenceNumber>
    <ProductName>CHOLEDYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1990-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004815</DrugIDPK>
    <LicenceNumber>PA0856/013/002</LicenceNumber>
    <ProductName>CHOLEDYL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>1995-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004816</DrugIDPK>
    <LicenceNumber>PA0856/013/003</LicenceNumber>
    <ProductName>CHOLEDYL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>1995-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003159</DrugIDPK>
    <LicenceNumber>PA0073/049/001</LicenceNumber>
    <ProductName>AMYLINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003173</DrugIDPK>
    <LicenceNumber>PA0073/049/002</LicenceNumber>
    <ProductName>AMYLINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006446</DrugIDPK>
    <LicenceNumber>PA0468/002/001</LicenceNumber>
    <ProductName>DIORALYTE EFFERVESCENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006448</DrugIDPK>
    <LicenceNumber>PA0468/002/003</LicenceNumber>
    <ProductName>DIORALYTE EFFERVESCENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000363</DrugIDPK>
    <LicenceNumber>PA0002/041/001</LicenceNumber>
    <ProductName>MODITEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000364</DrugIDPK>
    <LicenceNumber>PA0002/041/002</LicenceNumber>
    <ProductName>MODITEN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000366</DrugIDPK>
    <LicenceNumber>PA0002/041/003</LicenceNumber>
    <ProductName>MODITEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004495</DrugIDPK>
    <LicenceNumber>PA0176/022/001</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1998-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006914</DrugIDPK>
    <LicenceNumber>PA0628/002/001</LicenceNumber>
    <ProductName>10.10  CLEANING &amp; DISINFECTING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Vision (UK) Ltd</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROGEN PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006917</DrugIDPK>
    <LicenceNumber>PA0628/003/001</LicenceNumber>
    <ProductName>10.10 RINSING &amp; NEUTRALISING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Vision (UK) Ltd</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PYRUVATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>BORIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BORATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003882</DrugIDPK>
    <LicenceNumber>PA0126/046/001</LicenceNumber>
    <ProductName>CO-CODAPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003893</DrugIDPK>
    <LicenceNumber>PA0126/055/001</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016306</DrugIDPK>
    <LicenceNumber>PA0126/065/002</LicenceNumber>
    <ProductName>PAEDIATRIC PARACETAMOL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003902</DrugIDPK>
    <LicenceNumber>PA0126/059/001</LicenceNumber>
    <ProductName>PREDNISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006305</DrugIDPK>
    <LicenceNumber>PA0436/008/003</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002430</DrugIDPK>
    <LicenceNumber>PA0436/008/004</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003888</DrugIDPK>
    <LicenceNumber>PA0126/050/001</LicenceNumber>
    <ProductName>SODIUM FLORIDE</ProductName>
    <Strength>1.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003889</DrugIDPK>
    <LicenceNumber>PA0126/050/002</LicenceNumber>
    <ProductName>SODIUM FLORIDE</ProductName>
    <Strength>2.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003931</DrugIDPK>
    <LicenceNumber>PA0126/074/001</LicenceNumber>
    <ProductName>VITAMIN B6</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003917</DrugIDPK>
    <LicenceNumber>PA0126/068/001</LicenceNumber>
    <ProductName>VITAMIN C</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003862</DrugIDPK>
    <LicenceNumber>PA0126/033/001</LicenceNumber>
    <ProductName>COTRIMEL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003864</DrugIDPK>
    <LicenceNumber>PA0126/033/003</LicenceNumber>
    <ProductName>COTRIMEL FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003872</DrugIDPK>
    <LicenceNumber>PA0126/040/002</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003873</DrugIDPK>
    <LicenceNumber>PA0126/040/003</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002334</DrugIDPK>
    <LicenceNumber>PA0048/010/004</LicenceNumber>
    <ProductName>BUTORPHANOL TARTRATE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006746</DrugIDPK>
    <LicenceNumber>PA0577/003/001</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1992-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006747</DrugIDPK>
    <LicenceNumber>PA0577/003/002</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1992-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002469</DrugIDPK>
    <LicenceNumber>PA0048/010/003</LicenceNumber>
    <ProductName>BUTORPHANOL TARTRATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003113</DrugIDPK>
    <LicenceNumber>PA0069/016/001</LicenceNumber>
    <ProductName>EN-DE-KAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004870</DrugIDPK>
    <LicenceNumber>PA0218/037/001</LicenceNumber>
    <ProductName>HUMAN VELOSULIN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004871</DrugIDPK>
    <LicenceNumber>PA0218/037/003</LicenceNumber>
    <ProductName>HUMAN VELOSULIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005977</DrugIDPK>
    <LicenceNumber>PA0396/003/002</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Daniels Pharmaceutical Ltd</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001211</DrugIDPK>
    <LicenceNumber>PA0022/023/001</LicenceNumber>
    <ProductName>PETOLAGAR/PHENOLPHTHALEIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005849</DrugIDPK>
    <LicenceNumber>PA0303/015/003</LicenceNumber>
    <ProductName>DUOBACT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003600</DrugIDPK>
    <LicenceNumber>PA0095/017/001</LicenceNumber>
    <ProductName>EMULSIFYING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1994-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003602</DrugIDPK>
    <LicenceNumber>PA0095/019/001</LicenceNumber>
    <ProductName>HYDROGEN PEROXIDE 20 VOLUMES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1993-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002969</DrugIDPK>
    <LicenceNumber>PA0059/005/002</LicenceNumber>
    <ProductName>SULTRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE</ActiveSubstance>
      <ActiveSubstance>SULPHOAMINOBENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>SULFATHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001374</DrugIDPK>
    <LicenceNumber>PA0012/046/004</LicenceNumber>
    <ProductName>GYNO TRAVOGEN OVULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006620</DrugIDPK>
    <LicenceNumber>PA0495/009/001</LicenceNumber>
    <ProductName>SWARM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>J. Pickles &amp; Sons</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>DIBROMPROPAMIDINE ISETIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002064</DrugIDPK>
    <LicenceNumber>PA0040/093/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004792</DrugIDPK>
    <LicenceNumber>PA0187/040/002</LicenceNumber>
    <ProductName>HEALONID</ProductName>
    <Strength>0.75 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000927</DrugIDPK>
    <LicenceNumber>PA0017/054/005</LicenceNumber>
    <ProductName>SUGAR FREE SUDAFED ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1992-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000936</DrugIDPK>
    <LicenceNumber>PA0017/068/001</LicenceNumber>
    <ProductName>BRETYLATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRETYLIUM TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005456</DrugIDPK>
    <LicenceNumber>PA0271/001/004</LicenceNumber>
    <ProductName>ELANTAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005457</DrugIDPK>
    <LicenceNumber>PA0271/001/005</LicenceNumber>
    <ProductName>ELANTAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005463</DrugIDPK>
    <LicenceNumber>PA0271/001/006</LicenceNumber>
    <ProductName>ELANTAN 0.1%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005466</DrugIDPK>
    <LicenceNumber>PA0271/001/007</LicenceNumber>
    <ProductName>ELANTAN 0.1%</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1992-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000913</DrugIDPK>
    <LicenceNumber>PA0017/048/001</LicenceNumber>
    <ProductName>PRO-ACTIDIL T</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002576</DrugIDPK>
    <LicenceNumber>PA0294/021/001</LicenceNumber>
    <ProductName>SONI SLO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002577</DrugIDPK>
    <LicenceNumber>PA0294/021/002</LicenceNumber>
    <ProductName>SONI SLO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016302</DrugIDPK>
    <LicenceNumber>PA0187/040/005</LicenceNumber>
    <ProductName>HEALONID YELLOW</ProductName>
    <Strength>0.55</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
      <ActiveSubstance>FLUORESCEIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016303</DrugIDPK>
    <LicenceNumber>PA0187/040/006</LicenceNumber>
    <ProductName>HEALONID YELLOW</ProductName>
    <Strength>0.85</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
      <ActiveSubstance>FLUORESCEIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006748</DrugIDPK>
    <LicenceNumber>PA0577/004/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1992-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006749</DrugIDPK>
    <LicenceNumber>PA0577/004/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1992-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003971</DrugIDPK>
    <LicenceNumber>PA0141/025/001</LicenceNumber>
    <ProductName>MANNS SUPER GARLIC PILLS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1993-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>STARCH MAIZE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005716</DrugIDPK>
    <LicenceNumber>PA0294/011/001</LicenceNumber>
    <ProductName>NORGOTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>PROPYLENE GLYCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002337</DrugIDPK>
    <LicenceNumber>PA0050/086/001</LicenceNumber>
    <ProductName>ROCEPHIN 1M</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002339</DrugIDPK>
    <LicenceNumber>PA0050/087/001</LicenceNumber>
    <ProductName>ROCEPHIN 1V</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002340</DrugIDPK>
    <LicenceNumber>PA0050/087/002</LicenceNumber>
    <ProductName>ROCEPHIN 1V</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003015</DrugIDPK>
    <LicenceNumber>PA0059/042/001</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1989-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROPOIETIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003016</DrugIDPK>
    <LicenceNumber>PA0059/042/002</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>4000</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1989-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROPOIETIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003017</DrugIDPK>
    <LicenceNumber>PA0059/042/003</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1989-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROPOIETIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008689</DrugIDPK>
    <LicenceNumber>PA0059/042/009</LicenceNumber>
    <ProductName>EPREX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1995-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROPOIETIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001767</DrugIDPK>
    <LicenceNumber>PA0033/005/006</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005113</DrugIDPK>
    <LicenceNumber>PA0251/007/001</LicenceNumber>
    <ProductName>THEOPHORIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005133</DrugIDPK>
    <LicenceNumber>PA0255/011/002</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005135</DrugIDPK>
    <LicenceNumber>PA0255/011/003</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006460</DrugIDPK>
    <LicenceNumber>PA0468/009/001</LicenceNumber>
    <ProductName>UBRETID AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DISTIGMINE BROMIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005618</DrugIDPK>
    <LicenceNumber>PA0310/002/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S GEA Farmaceutisk Fabrik</PAHolder>
    <AuthorisedDate>1993-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005620</DrugIDPK>
    <LicenceNumber>PA0310/002/004</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S GEA Farmaceutisk Fabrik</PAHolder>
    <AuthorisedDate>1993-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005615</DrugIDPK>
    <LicenceNumber>PA0310/002/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A/S GEA Farmaceutisk Fabrik</PAHolder>
    <AuthorisedDate>1993-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000550</DrugIDPK>
    <LicenceNumber>PA0012/068/003</LicenceNumber>
    <ProductName>ISOVIST</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1990-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROLAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003583</DrugIDPK>
    <LicenceNumber>PA0095/008/008</LicenceNumber>
    <ProductName>RUBEX CHEWABLE BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003617</DrugIDPK>
    <LicenceNumber>PA0100/016/001</LicenceNumber>
    <ProductName>SAVENTRINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009344</DrugIDPK>
    <LicenceNumber>PA0708/004/003</LicenceNumber>
    <ProductName>SYNTHAMIX 14/1200X</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>1993-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009345</DrugIDPK>
    <LicenceNumber>PA0708/004/004</LicenceNumber>
    <ProductName>SYNTHAMIX 14/2200X</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>1993-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009342</DrugIDPK>
    <LicenceNumber>PA0708/004/002</LicenceNumber>
    <ProductName>SYNTHAMIX 9/1800X</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>1993-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003557</DrugIDPK>
    <LicenceNumber>PA0114/037/001</LicenceNumber>
    <ProductName>MORSEP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>RETINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007657</DrugIDPK>
    <LicenceNumber>PA0037/022/006</LicenceNumber>
    <ProductName>GEVRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1992-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001805</DrugIDPK>
    <LicenceNumber>PA0035/029/002</LicenceNumber>
    <ProductName>MODURETIC</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001806</DrugIDPK>
    <LicenceNumber>PA0035/029/003</LicenceNumber>
    <ProductName>MODURETIC</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006719</DrugIDPK>
    <LicenceNumber>PA0518/004/001</LicenceNumber>
    <ProductName>BACTIGRAS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005147</DrugIDPK>
    <LicenceNumber>PA0255/013/002</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005148</DrugIDPK>
    <LicenceNumber>PA0255/014/001</LicenceNumber>
    <ProductName>DIPHENHYDRAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003599</DrugIDPK>
    <LicenceNumber>PA0095/015/001</LicenceNumber>
    <ProductName>PURITAN COD LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002900</DrugIDPK>
    <LicenceNumber>PA0060/016/008</LicenceNumber>
    <ProductName>STELAZINE AMPOULE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002899</DrugIDPK>
    <LicenceNumber>PA0060/016/007</LicenceNumber>
    <ProductName>STELAZINE CONCENTRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005499</DrugIDPK>
    <LicenceNumber>PA0282/020/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001225</DrugIDPK>
    <LicenceNumber>PA0022/039/001</LicenceNumber>
    <ProductName>ALUDROX PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1987-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005298</DrugIDPK>
    <LicenceNumber>PA0281/022/001</LicenceNumber>
    <ProductName>TRICOMOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1982-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002419</DrugIDPK>
    <LicenceNumber>PA0051/039/002</LicenceNumber>
    <ProductName>HIBIDIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1982-09-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995004512</DrugIDPK>
    <LicenceNumber>PA0013/064/002</LicenceNumber>
    <ProductName>APRESOLINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1994-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004615</DrugIDPK>
    <LicenceNumber>PA0187/008/001</LicenceNumber>
    <ProductName>AMINESS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006878</DrugIDPK>
    <LicenceNumber>PA0622/012/001</LicenceNumber>
    <ProductName>STERLING HEALTHS ANSWER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sterling Health Limited</PAHolder>
    <AuthorisedDate>1992-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008994</DrugIDPK>
    <LicenceNumber>PA0365/056/001</LicenceNumber>
    <ProductName>TYPHOID VACCINE B.P. MONOVALENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1994-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TYPHOID VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003940</DrugIDPK>
    <LicenceNumber>PA0041/051/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1997-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006908</DrugIDPK>
    <LicenceNumber>PA0622/021/001</LicenceNumber>
    <ProductName>ALUMINIUM HYDROXIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sterling Health Limited</PAHolder>
    <AuthorisedDate>1993-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005909</DrugIDPK>
    <LicenceNumber>PA0379/004/003</LicenceNumber>
    <ProductName>BEECHAMS POWDERS IN TABLET FORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006256</DrugIDPK>
    <LicenceNumber>PA0449/005/001</LicenceNumber>
    <ProductName>LEMON ENO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Beecham Group Plc</PAHolder>
    <AuthorisedDate>1991-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>TARTARIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006258</DrugIDPK>
    <LicenceNumber>PA0449/005/002</LicenceNumber>
    <ProductName>ORANGE ENO FRUIT SALT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Beecham Group Plc</PAHolder>
    <AuthorisedDate>1991-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>TARTARIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005145</DrugIDPK>
    <LicenceNumber>PA0255/013/001</LicenceNumber>
    <ProductName>AMINOPHYLLINE INJ</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002906</DrugIDPK>
    <LicenceNumber>PA0060/023/001</LicenceNumber>
    <ProductName>POLIOMYELITIS VACCINE LIVE (ORAL)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1978-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLIOMYELITIS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001557</DrugIDPK>
    <LicenceNumber>PA0037/039/004</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005125</DrugIDPK>
    <LicenceNumber>PA0255/008/001</LicenceNumber>
    <ProductName>DEXTROSE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005132</DrugIDPK>
    <LicenceNumber>PA0255/011/001</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001966</DrugIDPK>
    <LicenceNumber>PA0040/064/002</LicenceNumber>
    <ProductName>HEXABRIX</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1982-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOXAGLATE SODIUM</ActiveSubstance>
      <ActiveSubstance>IOXAGLATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001964</DrugIDPK>
    <LicenceNumber>PA0040/064/001</LicenceNumber>
    <ProductName>HEXABRIX</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1982-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOXAGLATE SODIUM</ActiveSubstance>
      <ActiveSubstance>IOXAGLATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005128</DrugIDPK>
    <LicenceNumber>PA0255/009/001</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005127</DrugIDPK>
    <LicenceNumber>PA0255/001/002</LicenceNumber>
    <ProductName>SODIUM BICARBONATE INJ</ProductName>
    <Strength>4.2%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000467</DrugIDPK>
    <LicenceNumber>PA0007/019/002</LicenceNumber>
    <ProductName>VILLESCON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PROLINTANE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001174</DrugIDPK>
    <LicenceNumber>PA0022/002/002</LicenceNumber>
    <ProductName>ALUDROX S A  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMBUTONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003642</DrugIDPK>
    <LicenceNumber>PA0102/009/001</LicenceNumber>
    <ProductName>DIARPHEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENOXYLATE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004908</DrugIDPK>
    <LicenceNumber>PA0224/006/001</LicenceNumber>
    <ProductName>IDURIDIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004019</DrugIDPK>
    <LicenceNumber>PA0148/032/001</LicenceNumber>
    <ProductName>P.V. CARPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004017</DrugIDPK>
    <LicenceNumber>PA0148/029/001</LicenceNumber>
    <ProductName>PREFRIN - Z LIQUIFILM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000895</DrugIDPK>
    <LicenceNumber>PA0019/041/001</LicenceNumber>
    <ProductName>UNASYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000914</DrugIDPK>
    <LicenceNumber>PA0019/041/007</LicenceNumber>
    <ProductName>UNASYN INFUSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000912</DrugIDPK>
    <LicenceNumber>PA0019/041/006</LicenceNumber>
    <ProductName>UNASYN INFUSION</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000900</DrugIDPK>
    <LicenceNumber>PA0019/041/002</LicenceNumber>
    <ProductName>UNASYN INFUSION 750</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000906</DrugIDPK>
    <LicenceNumber>PA0019/041/004</LicenceNumber>
    <ProductName>UNASYN INJECTION</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000909</DrugIDPK>
    <LicenceNumber>PA0019/041/005</LicenceNumber>
    <ProductName>UNASYN INJECTION</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000903</DrugIDPK>
    <LicenceNumber>PA0019/041/003</LicenceNumber>
    <ProductName>UNASYN INJECTION 1500</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1987-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009347</DrugIDPK>
    <LicenceNumber>PA0708/005/002</LicenceNumber>
    <ProductName>4% BRANCHED CHAIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>1989-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006937</DrugIDPK>
    <LicenceNumber>PA0638/001/001</LicenceNumber>
    <ProductName>OPTIM EYES CONTACT LENS</ProductName>
    <Strength>0.004</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Core Technologies Limited</PAHolder>
    <AuthorisedDate>1992-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006943</DrugIDPK>
    <LicenceNumber>PA0638/001/002</LicenceNumber>
    <ProductName>OPTIM EYES TM CONTACT LENS DISINFECTING</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Core Technologies Limited</PAHolder>
    <AuthorisedDate>1992-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006874</DrugIDPK>
    <LicenceNumber>PA0622/010/001</LicenceNumber>
    <ProductName>PHILLIPS MILK OF MAGNESIA LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sterling Health Limited</PAHolder>
    <AuthorisedDate>1992-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005688</DrugIDPK>
    <LicenceNumber>PA0290/067/001</LicenceNumber>
    <ProductName>SALETTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1992-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005689</DrugIDPK>
    <LicenceNumber>PA0290/067/002</LicenceNumber>
    <ProductName>SALETTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1992-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005690</DrugIDPK>
    <LicenceNumber>PA0290/068/001</LicenceNumber>
    <ProductName>SOACLENS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1992-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004670</DrugIDPK>
    <LicenceNumber>PA0179/036/003</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004671</DrugIDPK>
    <LicenceNumber>PA0179/036/004</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004154</DrugIDPK>
    <LicenceNumber>PA0167/010/005</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004141</DrugIDPK>
    <LicenceNumber>PA0167/009/020</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS 10%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004143</DrugIDPK>
    <LicenceNumber>PA0167/009/021</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS 10%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004148</DrugIDPK>
    <LicenceNumber>PA0167/009/024</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS 5%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004149</DrugIDPK>
    <LicenceNumber>PA0167/009/025</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS 5%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001031</DrugIDPK>
    <LicenceNumber>PA0018/040/002</LicenceNumber>
    <ProductName>INTAL AUTOHALER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004403</DrugIDPK>
    <LicenceNumber>PA0167/068/001</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004404</DrugIDPK>
    <LicenceNumber>PA0167/068/002</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>0.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004406</DrugIDPK>
    <LicenceNumber>PA0167/068/004</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004407</DrugIDPK>
    <LicenceNumber>PA0167/068/005</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004291</DrugIDPK>
    <LicenceNumber>PA0167/037/003</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004292</DrugIDPK>
    <LicenceNumber>PA0167/037/004</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004296</DrugIDPK>
    <LicenceNumber>PA0167/037/007</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004297</DrugIDPK>
    <LicenceNumber>PA0167/037/008</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004300</DrugIDPK>
    <LicenceNumber>PA0167/037/011</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004301</DrugIDPK>
    <LicenceNumber>PA0167/037/012</LicenceNumber>
    <ProductName>MANNITOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002874</DrugIDPK>
    <LicenceNumber>PA0057/005/009</LicenceNumber>
    <ProductName>NUELIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002870</DrugIDPK>
    <LicenceNumber>PA0057/005/007</LicenceNumber>
    <ProductName>NUELIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002872</DrugIDPK>
    <LicenceNumber>PA0057/005/008</LicenceNumber>
    <ProductName>NUELIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004115</DrugIDPK>
    <LicenceNumber>PA0167/050/019</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000607</DrugIDPK>
    <LicenceNumber>PA0009/044/002</LicenceNumber>
    <ProductName>BETAZOK</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000608</DrugIDPK>
    <LicenceNumber>PA0009/044/003</LicenceNumber>
    <ProductName>BETAZOK</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000504</DrugIDPK>
    <LicenceNumber>PA0009/025/001</LicenceNumber>
    <ProductName>DIRYTHMIN SA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001679</DrugIDPK>
    <LicenceNumber>PA0038/039/001</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001680</DrugIDPK>
    <LicenceNumber>PA0038/039/002</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001681</DrugIDPK>
    <LicenceNumber>PA0038/039/003</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006498</DrugIDPK>
    <LicenceNumber>PA0468/033/001</LicenceNumber>
    <ProductName>CHYMAR ZON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001520</DrugIDPK>
    <LicenceNumber>PA0037/026/003</LicenceNumber>
    <ProductName>LEDERFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001524</DrugIDPK>
    <LicenceNumber>PA0037/026/006</LicenceNumber>
    <ProductName>LEDERFEN F</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1987-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003326</DrugIDPK>
    <LicenceNumber>PA0074/025/001</LicenceNumber>
    <ProductName>SUCRAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003327</DrugIDPK>
    <LicenceNumber>PA0074/025/002</LicenceNumber>
    <ProductName>SUCRAT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009346</DrugIDPK>
    <LicenceNumber>PA0708/005/001</LicenceNumber>
    <ProductName>4% BRANCHED CHAIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>1989-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007146</DrugIDPK>
    <LicenceNumber>PA0001/010/002</LicenceNumber>
    <ProductName>LOTUSSIN COUGH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1987-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004623</DrugIDPK>
    <LicenceNumber>PA0179/008/001</LicenceNumber>
    <ProductName>OSMOFUNDIN 10%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003510</DrugIDPK>
    <LicenceNumber>PA0086/026/003</LicenceNumber>
    <ProductName>GASTRESE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003512</DrugIDPK>
    <LicenceNumber>PA0086/026/004</LicenceNumber>
    <ProductName>GASTRESE LA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003508</DrugIDPK>
    <LicenceNumber>PA0086/026/002</LicenceNumber>
    <ProductName>GASTRESE PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001219</DrugIDPK>
    <LicenceNumber>PA0022/035/004</LicenceNumber>
    <ProductName>SERENID-D EXPIDET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001221</DrugIDPK>
    <LicenceNumber>PA0022/035/005</LicenceNumber>
    <ProductName>SERENID-D EXPIDET</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001600</DrugIDPK>
    <LicenceNumber>PA0037/057/001</LicenceNumber>
    <ProductName>STAPHLIPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001601</DrugIDPK>
    <LicenceNumber>PA0037/057/002</LicenceNumber>
    <ProductName>STAPHLIPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001602</DrugIDPK>
    <LicenceNumber>PA0037/057/003</LicenceNumber>
    <ProductName>STAPHLIPEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001216</DrugIDPK>
    <LicenceNumber>PA0022/031/001</LicenceNumber>
    <ProductName>WYDORA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1980-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDORAMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001217</DrugIDPK>
    <LicenceNumber>PA0022/031/002</LicenceNumber>
    <ProductName>WYDORA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1980-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDORAMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002543</DrugIDPK>
    <LicenceNumber>PA0054/068/001</LicenceNumber>
    <ProductName>INTRAFUSIN 7.5E</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1989-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002544</DrugIDPK>
    <LicenceNumber>PA0054/068/002</LicenceNumber>
    <ProductName>INTRAFUSIN 7.5E</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1989-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011340</DrugIDPK>
    <LicenceNumber>PA0054/040/001</LicenceNumber>
    <ProductName>PERIFUSIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001233</DrugIDPK>
    <LicenceNumber>PA0022/041/001</LicenceNumber>
    <ProductName>ALGIPAN  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1987-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETHYLENE GLYCOL MONOSTEARATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005960</DrugIDPK>
    <LicenceNumber>PA0387/003/001</LicenceNumber>
    <ProductName>DELPRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Delagrange Limited</PAHolder>
    <AuthorisedDate>1989-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005961</DrugIDPK>
    <LicenceNumber>PA0387/003/002</LicenceNumber>
    <ProductName>DELPRAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Delagrange Limited</PAHolder>
    <AuthorisedDate>1989-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006307</DrugIDPK>
    <LicenceNumber>PA0436/008/005</LicenceNumber>
    <ProductName>SALBUTAMOL/MICROHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006308</DrugIDPK>
    <LicenceNumber>PA0436/008/006</LicenceNumber>
    <ProductName>SALBUTAMOL/MICROHALER</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005440</DrugIDPK>
    <LicenceNumber>PA0261/027/001</LicenceNumber>
    <ProductName>CERVIPROST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DINOPROSTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003863</DrugIDPK>
    <LicenceNumber>PA0126/033/002</LicenceNumber>
    <ProductName>COTRIMEL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003887</DrugIDPK>
    <LicenceNumber>PA0126/049/001</LicenceNumber>
    <ProductName>EUROMEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003853</DrugIDPK>
    <LicenceNumber>PA0126/030/004</LicenceNumber>
    <ProductName>FERRUM HAUSMANN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003910</DrugIDPK>
    <LicenceNumber>PA0126/067/001</LicenceNumber>
    <ProductName>KEMELEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003912</DrugIDPK>
    <LicenceNumber>PA0126/067/002</LicenceNumber>
    <ProductName>KEMELEX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003879</DrugIDPK>
    <LicenceNumber>PA0126/044/004</LicenceNumber>
    <ProductName>NAPMEL E.C.</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003870</DrugIDPK>
    <LicenceNumber>PA0126/039/002</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003890</DrugIDPK>
    <LicenceNumber>PA0126/051/001</LicenceNumber>
    <ProductName>TETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003848</DrugIDPK>
    <LicenceNumber>PA0126/028/003</LicenceNumber>
    <ProductName>TIPERAL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003928</DrugIDPK>
    <LicenceNumber>PA0126/071/004</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002936</DrugIDPK>
    <LicenceNumber>PA0058/007/001</LicenceNumber>
    <ProductName>SORMODREN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1978-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BORNAPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005820</DrugIDPK>
    <LicenceNumber>PA0365/024/002</LicenceNumber>
    <ProductName>FLUVIRIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>A/SYDNEY /5/97 (H3N2)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>A/BEIJING /262/95 (H1N1)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005819</DrugIDPK>
    <LicenceNumber>PA0365/024/001</LicenceNumber>
    <ProductName>FLUVIRIN PRE-FILLED SYRINGE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>A/SYDNEY /5/97 (H3N2)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>A/BEIJING /262/95 (H1N1)-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004156</DrugIDPK>
    <LicenceNumber>PA0167/010/008</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004186</DrugIDPK>
    <LicenceNumber>PA0167/055/004</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004272</DrugIDPK>
    <LicenceNumber>PA0167/055/003</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004336</DrugIDPK>
    <LicenceNumber>PA0167/063/003</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004339</DrugIDPK>
    <LicenceNumber>PA0167/063/004</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000421</DrugIDPK>
    <LicenceNumber>PA0107/007/002</LicenceNumber>
    <ProductName>DEBRISAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1979-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRANOMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004411</DrugIDPK>
    <LicenceNumber>PA0167/068/009</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004412</DrugIDPK>
    <LicenceNumber>PA0167/068/010</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>0.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004414</DrugIDPK>
    <LicenceNumber>PA0167/068/012</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004415</DrugIDPK>
    <LicenceNumber>PA0167/068/013</LicenceNumber>
    <ProductName>ISOTONIC GENTAMICIN</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004314</DrugIDPK>
    <LicenceNumber>PA0167/039/004</LicenceNumber>
    <ProductName>PLASMALYTE M/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004312</DrugIDPK>
    <LicenceNumber>PA0167/039/003</LicenceNumber>
    <ProductName>PLASMALYTE M/GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004152</DrugIDPK>
    <LicenceNumber>PA0167/052/007</LicenceNumber>
    <ProductName>POTASSIUM/SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004144</DrugIDPK>
    <LicenceNumber>PA0167/052/004</LicenceNumber>
    <ProductName>POTASSIUM/SODIUM CHLORIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004142</DrugIDPK>
    <LicenceNumber>PA0167/052/003</LicenceNumber>
    <ProductName>POTASSIUM/SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004155</DrugIDPK>
    <LicenceNumber>PA0167/052/008</LicenceNumber>
    <ProductName>POTASSIUM/SODIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004175</DrugIDPK>
    <LicenceNumber>PA0167/054/003</LicenceNumber>
    <ProductName>RINGERS/CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004176</DrugIDPK>
    <LicenceNumber>PA0167/054/004</LicenceNumber>
    <ProductName>RINGERS/CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004129</DrugIDPK>
    <LicenceNumber>PA0167/008/011</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004130</DrugIDPK>
    <LicenceNumber>PA0167/008/012</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004123</DrugIDPK>
    <LicenceNumber>PA0167/008/007</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004124</DrugIDPK>
    <LicenceNumber>PA0167/008/008</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004090</DrugIDPK>
    <LicenceNumber>PA0167/050/008</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1993-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004096</DrugIDPK>
    <LicenceNumber>PA0167/050/012</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004112</DrugIDPK>
    <LicenceNumber>PA0167/050/018</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004109</DrugIDPK>
    <LicenceNumber>PA0167/050/017</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004093</DrugIDPK>
    <LicenceNumber>PA0167/050/011</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004089</DrugIDPK>
    <LicenceNumber>PA0167/050/007</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004085</DrugIDPK>
    <LicenceNumber>PA0167/050/003</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004086</DrugIDPK>
    <LicenceNumber>PA0167/050/004</LicenceNumber>
    <ProductName>SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003431</DrugIDPK>
    <LicenceNumber>PA0077/119/001</LicenceNumber>
    <ProductName>OSTEOFLOUR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002793</DrugIDPK>
    <LicenceNumber>PA0056/015/008</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002792</DrugIDPK>
    <LicenceNumber>PA0056/015/007</LicenceNumber>
    <ProductName>CHLOROMYCETIN OPHTHALMIC</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000155</DrugIDPK>
    <LicenceNumber>PA0365/071/001</LicenceNumber>
    <ProductName>FEFOL-VIT SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1990-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000398</DrugIDPK>
    <LicenceNumber>PA0365/072/001</LicenceNumber>
    <ProductName>FESOVIT SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1990-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003434</DrugIDPK>
    <LicenceNumber>PA0079/002/003</LicenceNumber>
    <ProductName>NYSTATIN-DOME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1977-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000477</DrugIDPK>
    <LicenceNumber>PA0007/031/001</LicenceNumber>
    <ProductName>PAVACOL-D</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002772</DrugIDPK>
    <LicenceNumber>PA0056/001/002</LicenceNumber>
    <ProductName>PONSTAN FORTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1975-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001573</DrugIDPK>
    <LicenceNumber>PA0037/051/001</LicenceNumber>
    <ProductName>VINBLASTINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005374</DrugIDPK>
    <LicenceNumber>PA0261/004/001</LicenceNumber>
    <ProductName>TETRABID ORGANON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001370</DrugIDPK>
    <LicenceNumber>PA0027/014/002</LicenceNumber>
    <ProductName>DETTOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005027</DrugIDPK>
    <LicenceNumber>PA0236/009/001</LicenceNumber>
    <ProductName>EUHYPNOS GELTHIX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1980-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005028</DrugIDPK>
    <LicenceNumber>PA0236/009/002</LicenceNumber>
    <ProductName>EUHYPNOS GELTHIX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1980-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001709</DrugIDPK>
    <LicenceNumber>PA0030/004/001</LicenceNumber>
    <ProductName>PAROVEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001712</DrugIDPK>
    <LicenceNumber>PA0030/004/002</LicenceNumber>
    <ProductName>PAROVEN 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005297</DrugIDPK>
    <LicenceNumber>PA0281/021/001</LicenceNumber>
    <ProductName>SPILAC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006314</DrugIDPK>
    <LicenceNumber>PA0436/014/001</LicenceNumber>
    <ProductName>SALOCAPS INHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006315</DrugIDPK>
    <LicenceNumber>PA0436/014/002</LicenceNumber>
    <ProductName>SALOCAPS INHALER</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1992-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005305</DrugIDPK>
    <LicenceNumber>PA0281/027/001</LicenceNumber>
    <ProductName>FLURAZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005307</DrugIDPK>
    <LicenceNumber>PA0281/027/002</LicenceNumber>
    <ProductName>FLURAZEPAM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003049</DrugIDPK>
    <LicenceNumber>PA0057/001/001</LicenceNumber>
    <ProductName>ALU-CAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006669</DrugIDPK>
    <LicenceNumber>PA0552/011/001</LicenceNumber>
    <ProductName>SILCOCKS BASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Superpac Products Limited</PAHolder>
    <AuthorisedDate>1992-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001041</DrugIDPK>
    <LicenceNumber>PA0019/007/002</LicenceNumber>
    <ProductName>TERRACORTRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003968</DrugIDPK>
    <LicenceNumber>PA0141/023/001</LicenceNumber>
    <ProductName>VIVIMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1987-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006628</DrugIDPK>
    <LicenceNumber>PA0503/002/001</LicenceNumber>
    <ProductName>PROPESS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Controlled Therapeutics (Scotland) Ltd</PAHolder>
    <AuthorisedDate>1989-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001623</DrugIDPK>
    <LicenceNumber>PA0028/061/001</LicenceNumber>
    <ProductName>PRESCAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1989-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISRADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002808</DrugIDPK>
    <LicenceNumber>PA0056/041/001</LicenceNumber>
    <ProductName>THROMBOSTAT</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THROMBIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001136</DrugIDPK>
    <LicenceNumber>PA0023/008/005</LicenceNumber>
    <ProductName>LASIX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002970</DrugIDPK>
    <LicenceNumber>PA0059/006/001</LicenceNumber>
    <ProductName>DERMONISTAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001182</DrugIDPK>
    <LicenceNumber>PA0022/009/004</LicenceNumber>
    <ProductName>PENIDURAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZATHINE BENZYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003539</DrugIDPK>
    <LicenceNumber>PA0050/127/005</LicenceNumber>
    <ProductName>CARDENE SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001724</DrugIDPK>
    <LicenceNumber>PA0040/004/001</LicenceNumber>
    <ProductName>FLAGYL COMPAK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006218</DrugIDPK>
    <LicenceNumber>PA0447/004/001</LicenceNumber>
    <ProductName>ILOSONE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1987-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ESTOLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003359</DrugIDPK>
    <LicenceNumber>PA0077/015/001</LicenceNumber>
    <ProductName>KANNASYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>KANAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005647</DrugIDPK>
    <LicenceNumber>PA0289/007/001</LicenceNumber>
    <ProductName>ALLURINOL 300</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002691</DrugIDPK>
    <LicenceNumber>PA0050/024/004</LicenceNumber>
    <ProductName>OMNOPON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIHYDROCODEINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002890</DrugIDPK>
    <LicenceNumber>PA0060/013/001</LicenceNumber>
    <ProductName>PHENOBARBITONE SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002891</DrugIDPK>
    <LicenceNumber>PA0060/013/002</LicenceNumber>
    <ProductName>PHENOBARITONE SPANSULE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006576</DrugIDPK>
    <LicenceNumber>PA0484/007/001</LicenceNumber>
    <ProductName>BONFIELDS SILCOCKS BASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EMULSIFYING WAX</ActiveSubstance>
      <ActiveSubstance>PARAFFIN SOFT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002374</DrugIDPK>
    <LicenceNumber>PA0051/011/003</LicenceNumber>
    <ProductName>IMPERACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004850</DrugIDPK>
    <LicenceNumber>PA0218/032/003</LicenceNumber>
    <ProductName>LOGIPARIN 2500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004865</DrugIDPK>
    <LicenceNumber>PA0218/032/004</LicenceNumber>
    <ProductName>LOGIPARIN 4500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001627</DrugIDPK>
    <LicenceNumber>PA0028/061/006</LicenceNumber>
    <ProductName>PRESCAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1992-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISRADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001624</DrugIDPK>
    <LicenceNumber>PA0028/061/004</LicenceNumber>
    <ProductName>PRESCAL RETARD</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISRADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001625</DrugIDPK>
    <LicenceNumber>PA0028/061/005</LicenceNumber>
    <ProductName>PRESCAL RETARD</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISRADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004926</DrugIDPK>
    <LicenceNumber>PA0228/001/001</LicenceNumber>
    <ProductName>ULSO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ulso Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISMUTH CITRATE</ActiveSubstance>
      <ActiveSubstance>STRONG AMMONIA SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006209</DrugIDPK>
    <LicenceNumber>PA0441/032/001</LicenceNumber>
    <ProductName>VICKS CHLORASEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1989-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004591</DrugIDPK>
    <LicenceNumber>PA0179/003/002</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE/DEXTROSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004602</DrugIDPK>
    <LicenceNumber>PA0179/003/014</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004556</DrugIDPK>
    <LicenceNumber>PA0179/002/003</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004558</DrugIDPK>
    <LicenceNumber>PA0179/002/004</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004560</DrugIDPK>
    <LicenceNumber>PA0179/002/005</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004561</DrugIDPK>
    <LicenceNumber>PA0179/002/006</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013005</DrugIDPK>
    <LicenceNumber>PA0037/010/002</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001435</DrugIDPK>
    <LicenceNumber>PA0037/010/007</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001516</DrugIDPK>
    <LicenceNumber>PA0037/025/003</LicenceNumber>
    <ProductName>ACHROMYCIN  V</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001429</DrugIDPK>
    <LicenceNumber>PA0037/010/004</LicenceNumber>
    <ProductName>ACHROMYCIN 1%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001432</DrugIDPK>
    <LicenceNumber>PA0037/010/005</LicenceNumber>
    <ProductName>ACHROMYCIN OPHTHALMIC OIL  (SUSPENSION)</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004641</DrugIDPK>
    <LicenceNumber>PA0179/017/001</LicenceNumber>
    <ProductName>AMINOPLASMAL L-10</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004639</DrugIDPK>
    <LicenceNumber>PA0179/016/001</LicenceNumber>
    <ProductName>AMINOPLASMAL L-5</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004643</DrugIDPK>
    <LicenceNumber>PA0179/018/001</LicenceNumber>
    <ProductName>AMINOPLASMAL PED</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004644</DrugIDPK>
    <LicenceNumber>PA0179/018/002</LicenceNumber>
    <ProductName>AMINOPLASMAL PED</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006822</DrugIDPK>
    <LicenceNumber>PA0617/002/001</LicenceNumber>
    <ProductName>C P D ANTICOAGULANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>NPBI B.V.</PAHolder>
    <AuthorisedDate>1992-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004612</DrugIDPK>
    <LicenceNumber>PA0179/004/006</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004614</DrugIDPK>
    <LicenceNumber>PA0179/004/007</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004515</DrugIDPK>
    <LicenceNumber>PA0179/001/001</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004517</DrugIDPK>
    <LicenceNumber>PA0179/001/002</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001175</DrugIDPK>
    <LicenceNumber>PA0022/004/001</LicenceNumber>
    <ProductName>EQUAGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>MEPROBAMATE</ActiveSubstance>
      <ActiveSubstance>ETHOHEPTAZINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001177</DrugIDPK>
    <LicenceNumber>PA0022/005/001</LicenceNumber>
    <ProductName>EQUANIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001178</DrugIDPK>
    <LicenceNumber>PA0022/005/002</LicenceNumber>
    <ProductName>EQUANIL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPROBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004544</DrugIDPK>
    <LicenceNumber>PA0179/001/031</LicenceNumber>
    <ProductName>GLUCOSE 20%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004545</DrugIDPK>
    <LicenceNumber>PA0179/001/032</LicenceNumber>
    <ProductName>GLUCOSE 25%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004546</DrugIDPK>
    <LicenceNumber>PA0179/001/033</LicenceNumber>
    <ProductName>GLUCOSE 25%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004547</DrugIDPK>
    <LicenceNumber>PA0179/001/034</LicenceNumber>
    <ProductName>GLUCOSE 40%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004548</DrugIDPK>
    <LicenceNumber>PA0179/001/035</LicenceNumber>
    <ProductName>GLUCOSE 40%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004538</DrugIDPK>
    <LicenceNumber>PA0179/001/025</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004539</DrugIDPK>
    <LicenceNumber>PA0179/001/026</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004550</DrugIDPK>
    <LicenceNumber>PA0179/001/037</LicenceNumber>
    <ProductName>GLUCOSE 50%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007644</DrugIDPK>
    <LicenceNumber>PA0009/005/004</LicenceNumber>
    <ProductName>HEMINEVRIN 0.8%</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMETHIAZOLE EDISILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001441</DrugIDPK>
    <LicenceNumber>PA0037/013/002</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005211</DrugIDPK>
    <LicenceNumber>PA0277/063/001</LicenceNumber>
    <ProductName>LEUCOMAX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR</ActiveSubstance>
      <ActiveSubstance>MOLGRAMOSTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005214</DrugIDPK>
    <LicenceNumber>PA0277/063/004</LicenceNumber>
    <ProductName>LEUCOMAX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR</ActiveSubstance>
      <ActiveSubstance>MOLGRAMOSTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005216</DrugIDPK>
    <LicenceNumber>PA0277/063/005</LicenceNumber>
    <ProductName>LEUCOMAX</ProductName>
    <Strength>700</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR</ActiveSubstance>
      <ActiveSubstance>MOLGRAMOSTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002623</DrugIDPK>
    <LicenceNumber>PA0049/011/001</LicenceNumber>
    <ProductName>PYOPEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBENICILLIN DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002624</DrugIDPK>
    <LicenceNumber>PA0049/011/002</LicenceNumber>
    <ProductName>PYOPEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBENICILLIN DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002655</DrugIDPK>
    <LicenceNumber>PA0049/046/003</LicenceNumber>
    <ProductName>RELIFEX DISPERSIBLE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1992-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NABUMETONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002656</DrugIDPK>
    <LicenceNumber>PA0049/046/004</LicenceNumber>
    <ProductName>RELIFEX DISPERSIBLE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1992-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NABUMETONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006818</DrugIDPK>
    <LicenceNumber>PA0617/001/001</LicenceNumber>
    <ProductName>S A G M RED CELL PRESERVATION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>NPBI B.V.</PAHolder>
    <AuthorisedDate>1992-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006282</DrugIDPK>
    <LicenceNumber>PA0455/002/001</LicenceNumber>
    <ProductName>SCHOLL WART REMOVER KIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004600</DrugIDPK>
    <LicenceNumber>PA0179/003/013</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.18%/GLUCOSE 4%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004586</DrugIDPK>
    <LicenceNumber>PA0179/002/017</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004587</DrugIDPK>
    <LicenceNumber>PA0179/002/018</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002726</DrugIDPK>
    <LicenceNumber>PA0050/052/001</LicenceNumber>
    <ProductName>TIGASON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1981-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETRETINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002727</DrugIDPK>
    <LicenceNumber>PA0050/052/002</LicenceNumber>
    <ProductName>TIGASON</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1981-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETRETINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002901</DrugIDPK>
    <LicenceNumber>PA0060/017/001</LicenceNumber>
    <ProductName>VERTIGON SPANSULE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002902</DrugIDPK>
    <LicenceNumber>PA0060/017/002</LicenceNumber>
    <ProductName>VERTIGON SPANSULE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004631</DrugIDPK>
    <LicenceNumber>PA0179/009/005</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004632</DrugIDPK>
    <LicenceNumber>PA0179/009/006</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006206</DrugIDPK>
    <LicenceNumber>PA0441/029/001</LicenceNumber>
    <ProductName>VICKS THROAT LOZENGES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1989-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006207</DrugIDPK>
    <LicenceNumber>PA0441/029/002</LicenceNumber>
    <ProductName>VICKS THROAT LOZENGES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1989-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003771</DrugIDPK>
    <LicenceNumber>PA0115/006/002</LicenceNumber>
    <ProductName>CCNU LUNDBECK CAPSULES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1980-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003482</DrugIDPK>
    <LicenceNumber>PA0086/013/007</LicenceNumber>
    <ProductName>DIMOTANE EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1987-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004589</DrugIDPK>
    <LicenceNumber>PA0179/003/001</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004195</DrugIDPK>
    <LicenceNumber>PA0167/013/003</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003515</DrugIDPK>
    <LicenceNumber>PA0086/028/001</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003516</DrugIDPK>
    <LicenceNumber>PA0086/028/003</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003518</DrugIDPK>
    <LicenceNumber>PA0086/028/004</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006430</DrugIDPK>
    <LicenceNumber>PA0437/015/001</LicenceNumber>
    <ProductName>BACTERIOSTATIC DILUENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003391</DrugIDPK>
    <LicenceNumber>PA0077/079/001</LicenceNumber>
    <ProductName>BIOGASTRONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBENOXOLONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002950</DrugIDPK>
    <LicenceNumber>PA0058/016/002</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002951</DrugIDPK>
    <LicenceNumber>PA0058/016/003</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002952</DrugIDPK>
    <LicenceNumber>PA0058/016/004</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002953</DrugIDPK>
    <LicenceNumber>PA0058/016/005</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002954</DrugIDPK>
    <LicenceNumber>PA0058/016/006</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003427</DrugIDPK>
    <LicenceNumber>PA0077/115/003</LicenceNumber>
    <ProductName>CALCIPARINE</ProductName>
    <Strength>0.8</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001945</DrugIDPK>
    <LicenceNumber>PA0044/017/002</LicenceNumber>
    <ProductName>CRYSTAPEN INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005910</DrugIDPK>
    <LicenceNumber>PA0379/006/002</LicenceNumber>
    <ProductName>DIOCALM (II)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1986-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
      <ActiveSubstance>ATTAPULGITE</ActiveSubstance>
      <ActiveSubstance>ACTIVATED ATTAPULGITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003390</DrugIDPK>
    <LicenceNumber>PA0077/078/001</LicenceNumber>
    <ProductName>DUOGASTRONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBENOXOLONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003416</DrugIDPK>
    <LicenceNumber>PA0077/113/003</LicenceNumber>
    <ProductName>EPILIM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALPROATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003378</DrugIDPK>
    <LicenceNumber>PA0077/052/001</LicenceNumber>
    <ProductName>ERADACIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003913</DrugIDPK>
    <LicenceNumber>PA0126/067/003</LicenceNumber>
    <ProductName>KEMELEX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003914</DrugIDPK>
    <LicenceNumber>PA0126/067/004</LicenceNumber>
    <ProductName>KEMELEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003930</DrugIDPK>
    <LicenceNumber>PA0126/073/001</LicenceNumber>
    <ProductName>METOCLOPRAMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003380</DrugIDPK>
    <LicenceNumber>PA0077/064/001</LicenceNumber>
    <ProductName>PHISO-MED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006813</DrugIDPK>
    <LicenceNumber>PA0544/009/001</LicenceNumber>
    <ProductName>PROHIBIT SINGLE DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1992-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003430</DrugIDPK>
    <LicenceNumber>PA0077/118/001</LicenceNumber>
    <ProductName>RETROLYTE-ORAL REHYDRATION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006304</DrugIDPK>
    <LicenceNumber>PA0436/008/002</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003392</DrugIDPK>
    <LicenceNumber>PA0077/080/001</LicenceNumber>
    <ProductName>TELEPAQUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPANOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006414</DrugIDPK>
    <LicenceNumber>PA0437/009/001</LicenceNumber>
    <ProductName>VINBLASTINE SULPHATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINBLASTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006409</DrugIDPK>
    <LicenceNumber>PA0437/008/001</LicenceNumber>
    <ProductName>VINCRISTINE SULPHATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
      <ActiveSubstance>LACTOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006410</DrugIDPK>
    <LicenceNumber>PA0437/008/002</LicenceNumber>
    <ProductName>VINCRISTINE SULPHATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
      <ActiveSubstance>LACTOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006411</DrugIDPK>
    <LicenceNumber>PA0437/008/003</LicenceNumber>
    <ProductName>VINCRISTINE SULPHATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
      <ActiveSubstance>LACTOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008105</DrugIDPK>
    <LicenceNumber>PA0552/010/001</LicenceNumber>
    <ProductName>EPSOM SALTS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Superpac Products Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004552</DrugIDPK>
    <LicenceNumber>PA0179/002/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004554</DrugIDPK>
    <LicenceNumber>PA0179/002/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002491</DrugIDPK>
    <LicenceNumber>PA0049/006/008</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002335</DrugIDPK>
    <LicenceNumber>PA0048/013/001</LicenceNumber>
    <ProductName>ANGETTES 75</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002399</DrugIDPK>
    <LicenceNumber>PA0048/039/002</LicenceNumber>
    <ProductName>ANGIERS PARACETAMOL ELIXIR</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1984-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003205</DrugIDPK>
    <LicenceNumber>PA0073/086/002</LicenceNumber>
    <ProductName>ANTRIMOX (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000377</DrugIDPK>
    <LicenceNumber>PA0002/052/005</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1985-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000378</DrugIDPK>
    <LicenceNumber>PA0002/052/006</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1985-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000375</DrugIDPK>
    <LicenceNumber>PA0002/052/004</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1985-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000359</DrugIDPK>
    <LicenceNumber>PA0002/039/003</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005791</DrugIDPK>
    <LicenceNumber>PA0360/021/007</LicenceNumber>
    <ProductName>CEDOCARD RETARD 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009421</DrugIDPK>
    <LicenceNumber>PA0715/001/001</LicenceNumber>
    <ProductName>CMW 1 - G GENTAMICIN BONE CEMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>DePuy International Ltd</PAHolder>
    <AuthorisedDate>1995-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009423</DrugIDPK>
    <LicenceNumber>PA0715/001/002</LicenceNumber>
    <ProductName>CMW 3 - G GENTAMICIN BONE CEMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>DePuy International Ltd</PAHolder>
    <AuthorisedDate>1995-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001024</DrugIDPK>
    <LicenceNumber>PA0018/036/001</LicenceNumber>
    <ProductName>COJENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE CITRATE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000368</DrugIDPK>
    <LicenceNumber>PA0002/047/001</LicenceNumber>
    <ProductName>CORGARETIC</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000369</DrugIDPK>
    <LicenceNumber>PA0002/047/002</LicenceNumber>
    <ProductName>CORGARETIC</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000450</DrugIDPK>
    <LicenceNumber>PA0007/045/004</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005829</DrugIDPK>
    <LicenceNumber>PA0299/003/001</LicenceNumber>
    <ProductName>DE WITT THROAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate>1981-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002134</DrugIDPK>
    <LicenceNumber>PA0043/014/001</LicenceNumber>
    <ProductName>DEQUACETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1992-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002135</DrugIDPK>
    <LicenceNumber>PA0043/014/002</LicenceNumber>
    <ProductName>DEQUACETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1992-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002136</DrugIDPK>
    <LicenceNumber>PA0043/014/003</LicenceNumber>
    <ProductName>DEQUACETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1992-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002130</DrugIDPK>
    <LicenceNumber>PA0043/008/001</LicenceNumber>
    <ProductName>DIJEX  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007798</DrugIDPK>
    <LicenceNumber>PA0236/023/008</LicenceNumber>
    <ProductName>DOXORUBICIN SOLUTION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1989-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000320</DrugIDPK>
    <LicenceNumber>PA0002/024/007</LicenceNumber>
    <ProductName>ECOSTATIN 1</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000319</DrugIDPK>
    <LicenceNumber>PA0002/024/006</LicenceNumber>
    <ProductName>ECOSTATIN LOTION</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000316</DrugIDPK>
    <LicenceNumber>PA0002/024/003</LicenceNumber>
    <ProductName>ECOSTATIN POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000370</DrugIDPK>
    <LicenceNumber>PA0002/051/001</LicenceNumber>
    <ProductName>ENGRAN-HP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1984-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>FERROUS CARBONATE</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001011</DrugIDPK>
    <LicenceNumber>PA0018/005/001</LicenceNumber>
    <ProductName>FEM IRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000145</DrugIDPK>
    <LicenceNumber>PA0002/005/001</LicenceNumber>
    <ProductName>FUNGILIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPHOTERICIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000146</DrugIDPK>
    <LicenceNumber>PA0002/005/002</LicenceNumber>
    <ProductName>FUNGILIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPHOTERICIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000175</DrugIDPK>
    <LicenceNumber>PA0002/005/003</LicenceNumber>
    <ProductName>FUNGILIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPHOTERICIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000176</DrugIDPK>
    <LicenceNumber>PA0002/005/004</LicenceNumber>
    <ProductName>FUNGILIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPHOTERICIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000174</DrugIDPK>
    <LicenceNumber>PA0002/020/001</LicenceNumber>
    <ProductName>HALCIDERM TOPICAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003285</DrugIDPK>
    <LicenceNumber>PA0073/124/001</LicenceNumber>
    <ProductName>HALIBUT LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALIBUT-LIVER OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004816</DrugIDPK>
    <LicenceNumber>PA0212/004/006</LicenceNumber>
    <ProductName>HUMAN ALBUMIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001400</DrugIDPK>
    <LicenceNumber>PA0037/003/001</LicenceNumber>
    <ProductName>INCREMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001401</DrugIDPK>
    <LicenceNumber>PA0037/003/002</LicenceNumber>
    <ProductName>INCREMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRIC PYROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003131</DrugIDPK>
    <LicenceNumber>PA0073/012/001</LicenceNumber>
    <ProductName>K.P.N. (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>PECTIN</ActiveSubstance>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000310</DrugIDPK>
    <LicenceNumber>PA0002/022/002</LicenceNumber>
    <ProductName>KENACORT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000308</DrugIDPK>
    <LicenceNumber>PA0002/021/001</LicenceNumber>
    <ProductName>KENACORT-A</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000309</DrugIDPK>
    <LicenceNumber>PA0002/021/002</LicenceNumber>
    <ProductName>KENACORT-A</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000313</DrugIDPK>
    <LicenceNumber>PA0002/023/003</LicenceNumber>
    <ProductName>KENALOG  INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003631</DrugIDPK>
    <LicenceNumber>PA0100/034/002</LicenceNumber>
    <ProductName>LASMA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1987-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003632</DrugIDPK>
    <LicenceNumber>PA0100/034/003</LicenceNumber>
    <ProductName>LASMA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1987-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000326</DrugIDPK>
    <LicenceNumber>PA0002/031/002</LicenceNumber>
    <ProductName>MODECATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000327</DrugIDPK>
    <LicenceNumber>PA0002/031/003</LicenceNumber>
    <ProductName>MODECATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000328</DrugIDPK>
    <LicenceNumber>PA0002/031/004</LicenceNumber>
    <ProductName>MODECATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000361</DrugIDPK>
    <LicenceNumber>PA0002/040/001</LicenceNumber>
    <ProductName>MODITEN ENANTHATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE ENANTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002683</DrugIDPK>
    <LicenceNumber>PA0050/019/002</LicenceNumber>
    <ProductName>MOGADON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000144</DrugIDPK>
    <LicenceNumber>PA0002/004/001</LicenceNumber>
    <ProductName>MOTIPRESS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1976-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NORTRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000266</DrugIDPK>
    <LicenceNumber>PA0002/007/003</LicenceNumber>
    <ProductName>MYCOSTATIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000267</DrugIDPK>
    <LicenceNumber>PA0002/007/004</LicenceNumber>
    <ProductName>MYCOSTATIN - VAGINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000293</DrugIDPK>
    <LicenceNumber>PA0002/012/001</LicenceNumber>
    <ProductName>MYSTECLIN F.</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>AMPHOTERICIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003296</DrugIDPK>
    <LicenceNumber>PA0073/131/001</LicenceNumber>
    <ProductName>NITROGLYCERIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003297</DrugIDPK>
    <LicenceNumber>PA0073/131/002</LicenceNumber>
    <ProductName>NITROGLYCERIN 0.1%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003298</DrugIDPK>
    <LicenceNumber>PA0073/131/003</LicenceNumber>
    <ProductName>NITROGLYCERIN 0.5%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002764</DrugIDPK>
    <LicenceNumber>PA0050/013/002</LicenceNumber>
    <ProductName>NOBRIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001649</DrugIDPK>
    <LicenceNumber>PA0038/008/001</LicenceNumber>
    <ProductName>PENTOTHAL RECTAL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004917</DrugIDPK>
    <LicenceNumber>PA0236/016/005</LicenceNumber>
    <ProductName>PHARMORUBICIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1991-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006639</DrugIDPK>
    <LicenceNumber>PA0508/007/001</LicenceNumber>
    <ProductName>PIROXICAM 10 PHARBITA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1992-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006640</DrugIDPK>
    <LicenceNumber>PA0508/007/002</LicenceNumber>
    <ProductName>PIROXICAM 20 PHARBITA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>1992-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002359</DrugIDPK>
    <LicenceNumber>PA0048/020/002</LicenceNumber>
    <ProductName>QUESTRAN LIGHT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1989-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COLESTYRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000324</DrugIDPK>
    <LicenceNumber>PA0002/029/001</LicenceNumber>
    <ProductName>RAUTRAX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAUWOLFIA SERPENTINA</ActiveSubstance>
      <ActiveSubstance>HYDROFLUMETHIAZIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003320</DrugIDPK>
    <LicenceNumber>PA0074/022/001</LicenceNumber>
    <ProductName>SALBUL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003321</DrugIDPK>
    <LicenceNumber>PA0074/022/002</LicenceNumber>
    <ProductName>SALBUL RETARD</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006971</DrugIDPK>
    <LicenceNumber>PA0283/001/001</LicenceNumber>
    <ProductName>SCHOLL S I</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wynlit Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005607</DrugIDPK>
    <LicenceNumber>PA0283/001/002</LicenceNumber>
    <ProductName>SCHOLL S.2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wynlit Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-01-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002282</DrugIDPK>
    <LicenceNumber>PA0048/001/001</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1975-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002302</DrugIDPK>
    <LicenceNumber>PA0048/001/010</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002286</DrugIDPK>
    <LicenceNumber>PA0048/001/002</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1975-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002296</DrugIDPK>
    <LicenceNumber>PA0048/001/008</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002290</DrugIDPK>
    <LicenceNumber>PA0048/001/003</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1975-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002291</DrugIDPK>
    <LicenceNumber>PA0048/001/005</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1976-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004184</DrugIDPK>
    <LicenceNumber>PA0167/011/011</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002349</DrugIDPK>
    <LicenceNumber>PA0048/014/006</LicenceNumber>
    <ProductName>ULTRACEF</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1982-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFADROXIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002341</DrugIDPK>
    <LicenceNumber>PA0048/014/001</LicenceNumber>
    <ProductName>ULTRACEF</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFADROXIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000299</DrugIDPK>
    <LicenceNumber>PA0002/014/011</LicenceNumber>
    <ProductName>VELOSEF  INJECTION</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002363</DrugIDPK>
    <LicenceNumber>PA0048/022/002</LicenceNumber>
    <ProductName>VEPESID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETOPOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002369</DrugIDPK>
    <LicenceNumber>PA0048/022/004</LicenceNumber>
    <ProductName>VEPESID</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002763</DrugIDPK>
    <LicenceNumber>PA0050/013/001</LicenceNumber>
    <ProductName>NOBRIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009373</DrugIDPK>
    <LicenceNumber>PA0708/008/009</LicenceNumber>
    <ProductName>GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>1992-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009375</DrugIDPK>
    <LicenceNumber>PA0708/008/010</LicenceNumber>
    <ProductName>GLUCOSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>1992-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003305</DrugIDPK>
    <LicenceNumber>PA0074/005/001</LicenceNumber>
    <ProductName>ROWACYLAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PIPOXOLAN HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORMEZANONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1997-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002137</DrugIDPK>
    <LicenceNumber>PA0043/015/001</LicenceNumber>
    <ProductName>ACRIFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1992-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006475</DrugIDPK>
    <LicenceNumber>PA0468/021/001</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006476</DrugIDPK>
    <LicenceNumber>PA0468/021/002</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003810</DrugIDPK>
    <LicenceNumber>PA0126/002/001</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003811</DrugIDPK>
    <LicenceNumber>PA0126/002/002</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003812</DrugIDPK>
    <LicenceNumber>PA0126/002/003</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002493</DrugIDPK>
    <LicenceNumber>PA0049/006/014</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005467</DrugIDPK>
    <LicenceNumber>PA0282/004/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1979-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005465</DrugIDPK>
    <LicenceNumber>PA0282/004/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1979-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002499</DrugIDPK>
    <LicenceNumber>PA0049/007/004</LicenceNumber>
    <ProductName>AMPICLOX</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002062</DrugIDPK>
    <LicenceNumber>PA0040/091/001</LicenceNumber>
    <ProductName>ASCRIPTIN A/D</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1992-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006714</DrugIDPK>
    <LicenceNumber>PA0518/001/001</LicenceNumber>
    <ProductName>BACTICLENS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005495</DrugIDPK>
    <LicenceNumber>PA0282/018/001</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001944</DrugIDPK>
    <LicenceNumber>PA0040/049/002</LicenceNumber>
    <ProductName>BREVIDIL M</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006465</DrugIDPK>
    <LicenceNumber>PA0468/013/002</LicenceNumber>
    <ProductName>CAMALOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006464</DrugIDPK>
    <LicenceNumber>PA0468/013/001</LicenceNumber>
    <ProductName>CAMALOX (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006717</DrugIDPK>
    <LicenceNumber>PA0518/003/001</LicenceNumber>
    <ProductName>CETRICLENS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006718</DrugIDPK>
    <LicenceNumber>PA0518/003/002</LicenceNumber>
    <ProductName>CETRICLENS FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005776</DrugIDPK>
    <LicenceNumber>PA0298/005/001</LicenceNumber>
    <ProductName>CHLORDIAZEPOXIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1987-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006462</DrugIDPK>
    <LicenceNumber>PA0468/010/001</LicenceNumber>
    <ProductName>CHYMAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006492</DrugIDPK>
    <LicenceNumber>PA0468/026/001</LicenceNumber>
    <ProductName>CHYMORAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006493</DrugIDPK>
    <LicenceNumber>PA0468/026/002</LicenceNumber>
    <ProductName>CHYMORAL FORTE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005576</DrugIDPK>
    <LicenceNumber>PA0282/050/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1989-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005577</DrugIDPK>
    <LicenceNumber>PA0282/050/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1989-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005578</DrugIDPK>
    <LicenceNumber>PA0282/050/003</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1989-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000500</DrugIDPK>
    <LicenceNumber>PA0009/021/007</LicenceNumber>
    <ProductName>CITANEST</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000503</DrugIDPK>
    <LicenceNumber>PA0009/022/001</LicenceNumber>
    <ProductName>CITANEST 3% WITH ADRENALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005550</DrugIDPK>
    <LicenceNumber>PA0282/040/001</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005551</DrugIDPK>
    <LicenceNumber>PA0282/040/002</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005552</DrugIDPK>
    <LicenceNumber>PA0282/040/003</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005500</DrugIDPK>
    <LicenceNumber>PA0282/020/002</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE PAEDIATRIC B.P.C.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005459</DrugIDPK>
    <LicenceNumber>PA0282/001/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1978-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005460</DrugIDPK>
    <LicenceNumber>PA0282/001/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1978-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005461</DrugIDPK>
    <LicenceNumber>PA0282/001/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1980-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006444</DrugIDPK>
    <LicenceNumber>PA0468/001/002</LicenceNumber>
    <ProductName>DIORALYTE CHERRY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006445</DrugIDPK>
    <LicenceNumber>PA0468/001/003</LicenceNumber>
    <ProductName>DIORALYTE PINEAPPLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000528</DrugIDPK>
    <LicenceNumber>PA0009/033/001</LicenceNumber>
    <ProductName>DIRYTHMIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000529</DrugIDPK>
    <LicenceNumber>PA0009/033/002</LicenceNumber>
    <ProductName>DIRYTHMIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000530</DrugIDPK>
    <LicenceNumber>PA0009/033/003</LicenceNumber>
    <ProductName>DIRYTHMIN I.V.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000531</DrugIDPK>
    <LicenceNumber>PA0009/033/004</LicenceNumber>
    <ProductName>DIRYTHMIN I.V.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002740</DrugIDPK>
    <LicenceNumber>PA0050/057/002</LicenceNumber>
    <ProductName>EPHYNAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002884</DrugIDPK>
    <LicenceNumber>PA0060/009/004</LicenceNumber>
    <ProductName>ESKACEF DRY MIX (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003488</DrugIDPK>
    <LicenceNumber>PA0114/006/001</LicenceNumber>
    <ProductName>ESODERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LINDANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003491</DrugIDPK>
    <LicenceNumber>PA0114/006/002</LicenceNumber>
    <ProductName>ESODERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LINDANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002887</DrugIDPK>
    <LicenceNumber>PA0060/011/001</LicenceNumber>
    <ProductName>EXPANSYL SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005592</DrugIDPK>
    <LicenceNumber>PA0282/058/001</LicenceNumber>
    <ProductName>FENBUFEN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1992-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005593</DrugIDPK>
    <LicenceNumber>PA0282/058/002</LicenceNumber>
    <ProductName>FENBUFEN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1992-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005594</DrugIDPK>
    <LicenceNumber>PA0282/058/003</LicenceNumber>
    <ProductName>FENBUFEN</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1992-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005462</DrugIDPK>
    <LicenceNumber>PA0282/002/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1979-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001885</DrugIDPK>
    <LicenceNumber>PA0040/015/001</LicenceNumber>
    <ProductName>GARDENAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001886</DrugIDPK>
    <LicenceNumber>PA0040/016/001</LicenceNumber>
    <ProductName>GAROIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001753</DrugIDPK>
    <LicenceNumber>PA0032/030/001</LicenceNumber>
    <ProductName>HEDAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1989-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001970</DrugIDPK>
    <LicenceNumber>PA0040/064/005</LicenceNumber>
    <ProductName>HEXABRIX 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002914</DrugIDPK>
    <LicenceNumber>PA0060/024/002</LicenceNumber>
    <ProductName>HISTRYL PAEDIATRIC SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002910</DrugIDPK>
    <LicenceNumber>PA0060/024/001</LicenceNumber>
    <ProductName>HISTRYL SPANSULE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006965</DrugIDPK>
    <LicenceNumber>PA0148/004/001</LicenceNumber>
    <ProductName>HYDROCARE PROTEIN REMOVER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1981-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005932</DrugIDPK>
    <LicenceNumber>PA0382/004/002</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1988-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005931</DrugIDPK>
    <LicenceNumber>PA0382/004/001</LicenceNumber>
    <ProductName>HYDROCORTISONE CREAM</ProductName>
    <Strength>1%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1988-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001754</DrugIDPK>
    <LicenceNumber>PA0032/031/001</LicenceNumber>
    <ProductName>JUNIOR PARACLEAR</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1988-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002681</DrugIDPK>
    <LicenceNumber>PA0050/018/006</LicenceNumber>
    <ProductName>LIBRIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006715</DrugIDPK>
    <LicenceNumber>PA0573/001/001</LicenceNumber>
    <ProductName>LITHOFALK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dr. Falk Pharma GmbH</PAHolder>
    <AuthorisedDate>1992-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>URSODEOXYCHOLIC ACID</ActiveSubstance>
      <ActiveSubstance>CHENODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004849</DrugIDPK>
    <LicenceNumber>PA0218/032/002</LicenceNumber>
    <ProductName>LOGIPARIN 20,000</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004847</DrugIDPK>
    <LicenceNumber>PA0218/032/001</LicenceNumber>
    <ProductName>LOGIPARIN 3,500</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002712</DrugIDPK>
    <LicenceNumber>PA0050/043/004</LicenceNumber>
    <ProductName>MADOPAR 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006312</DrugIDPK>
    <LicenceNumber>PA0436/011/001</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006313</DrugIDPK>
    <LicenceNumber>PA0436/011/002</LicenceNumber>
    <ProductName>NAPROXEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002851</DrugIDPK>
    <LicenceNumber>PA0060/003/001</LicenceNumber>
    <ProductName>NASOFLU MONODOSE VIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1975-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002853</DrugIDPK>
    <LicenceNumber>PA0060/003/002</LicenceNumber>
    <ProductName>NASOFLU MULTIDOSE 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1975-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002855</DrugIDPK>
    <LicenceNumber>PA0060/003/003</LicenceNumber>
    <ProductName>NASOFLU MULTIDOSE 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1975-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002689</DrugIDPK>
    <LicenceNumber>PA0050/024/002</LicenceNumber>
    <ProductName>OMNOPON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002690</DrugIDPK>
    <LicenceNumber>PA0050/024/003</LicenceNumber>
    <ProductName>OMNOPON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002693</DrugIDPK>
    <LicenceNumber>PA0050/025/001</LicenceNumber>
    <ProductName>OMNOPON-SCOPOLAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016355</DrugIDPK>
    <LicenceNumber>PA0282/011/002</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016356</DrugIDPK>
    <LicenceNumber>PA0282/011/003</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016359</DrugIDPK>
    <LicenceNumber>PA0282/011/001</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005503</DrugIDPK>
    <LicenceNumber>PA0282/022/001</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005504</DrugIDPK>
    <LicenceNumber>PA0282/022/002</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005505</DrugIDPK>
    <LicenceNumber>PA0282/022/003</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1983-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001747</DrugIDPK>
    <LicenceNumber>PA0032/008/001</LicenceNumber>
    <ProductName>PALAPRIN FORTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002612</DrugIDPK>
    <LicenceNumber>PA0049/010/012</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002605</DrugIDPK>
    <LicenceNumber>PA0049/010/005</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002606</DrugIDPK>
    <LicenceNumber>PA0049/010/006</LicenceNumber>
    <ProductName>PENBRITIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002607</DrugIDPK>
    <LicenceNumber>PA0049/010/007</LicenceNumber>
    <ProductName>PENBRITIN SYRUP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002608</DrugIDPK>
    <LicenceNumber>PA0049/010/008</LicenceNumber>
    <ProductName>PENBRITIN SYRUP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002610</DrugIDPK>
    <LicenceNumber>PA0049/010/010</LicenceNumber>
    <ProductName>PENBRITIN SYRUP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003708</DrugIDPK>
    <LicenceNumber>PA0114/053/001</LicenceNumber>
    <ProductName>POSTURE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003709</DrugIDPK>
    <LicenceNumber>PA0114/053/002</LicenceNumber>
    <ProductName>POSTURE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005514</DrugIDPK>
    <LicenceNumber>PA0282/015//00</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005515</DrugIDPK>
    <LicenceNumber>PA0282/028/002</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995005296</DrugIDPK>
    <LicenceNumber>PA0282/028/001</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004025</DrugIDPK>
    <LicenceNumber>PA0148/037/001</LicenceNumber>
    <ProductName>PROPINE-PTM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1984-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPIVEFRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005488</DrugIDPK>
    <LicenceNumber>PA0282/013/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005489</DrugIDPK>
    <LicenceNumber>PA0282/013/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005490</DrugIDPK>
    <LicenceNumber>PA0282/013/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005486</DrugIDPK>
    <LicenceNumber>PA0282/013/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003606</DrugIDPK>
    <LicenceNumber>PA0096/007/001</LicenceNumber>
    <ProductName>PULMO BAILLY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002755</DrugIDPK>
    <LicenceNumber>PA0050/007/006</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002281</DrugIDPK>
    <LicenceNumber>PA0050/062/003</LicenceNumber>
    <ProductName>ROCEPHIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTRIAXONE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005520</DrugIDPK>
    <LicenceNumber>PA0282/031/001</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005521</DrugIDPK>
    <LicenceNumber>PA0282/031/002</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006301</DrugIDPK>
    <LicenceNumber>PA0436/007/003</LicenceNumber>
    <ProductName>SALOMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1987-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006302</DrugIDPK>
    <LicenceNumber>PA0436/007/004</LicenceNumber>
    <ProductName>SALOMOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1987-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006966</DrugIDPK>
    <LicenceNumber>PA0148/005/001</LicenceNumber>
    <ProductName>SOFLENS CLEANING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1981-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001903</DrugIDPK>
    <LicenceNumber>PA0040/025/001</LicenceNumber>
    <ProductName>SONERYL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005847</DrugIDPK>
    <LicenceNumber>PA0303/009/001</LicenceNumber>
    <ProductName>SPIRIDON</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1982-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005848</DrugIDPK>
    <LicenceNumber>PA0303/009/002</LicenceNumber>
    <ProductName>SPIRIDON</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1982-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005491</DrugIDPK>
    <LicenceNumber>PA0282/014/001</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005493</DrugIDPK>
    <LicenceNumber>PA0282/014/002</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001882</DrugIDPK>
    <LicenceNumber>PA0040/008/001</LicenceNumber>
    <ProductName>STREPTOTRIAD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001883</DrugIDPK>
    <LicenceNumber>PA0040/009/001</LicenceNumber>
    <ProductName>SULPHADIAZINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001884</DrugIDPK>
    <LicenceNumber>PA0040/010/002</LicenceNumber>
    <ProductName>SULPHATRIAD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006758</DrugIDPK>
    <LicenceNumber>PA0582/008/001</LicenceNumber>
    <ProductName>TANDERIL EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate>1991-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002659</DrugIDPK>
    <LicenceNumber>PA0049/048/001</LicenceNumber>
    <ProductName>TIMENTIN</ProductName>
    <Strength>0.8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TICARCILLIN DISODIUM</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002662</DrugIDPK>
    <LicenceNumber>PA0049/048/004</LicenceNumber>
    <ProductName>TIMENTIN</ProductName>
    <Strength>3.2</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TICARCILLIN DISODIUM</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006716</DrugIDPK>
    <LicenceNumber>PA0518/002/001</LicenceNumber>
    <ProductName>TOPICLENS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002716</DrugIDPK>
    <LicenceNumber>PA0050/044/002</LicenceNumber>
    <ProductName>TRH ROCHE</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTIRELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007664</DrugIDPK>
    <LicenceNumber>PA0009/009/002</LicenceNumber>
    <ProductName>TRIGLOBE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFADIAZINE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007663</DrugIDPK>
    <LicenceNumber>PA0009/009/001</LicenceNumber>
    <ProductName>TRIGLOBE  (SUSPENSION)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFADIAZINE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000543</DrugIDPK>
    <LicenceNumber>PA0012/066/001</LicenceNumber>
    <ProductName>TRIODENE  ED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1990-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001921</DrugIDPK>
    <LicenceNumber>PA0040/030/001</LicenceNumber>
    <ProductName>VERACTIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001574</DrugIDPK>
    <LicenceNumber>PA0037/052/001</LicenceNumber>
    <ProductName>VINCRISTINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001576</DrugIDPK>
    <LicenceNumber>PA0037/052/002</LicenceNumber>
    <ProductName>VINCRISTINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001577</DrugIDPK>
    <LicenceNumber>PA0037/052/003</LicenceNumber>
    <ProductName>VINCRISTINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1982-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007688</DrugIDPK>
    <LicenceNumber>PA0009/016/020</LicenceNumber>
    <ProductName>XYLOCAINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008228</DrugIDPK>
    <LicenceNumber>PA0303/024/001</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1994-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002609</DrugIDPK>
    <LicenceNumber>PA0049/010/009</LicenceNumber>
    <ProductName>PENBRITIN SYRUP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002418</DrugIDPK>
    <LicenceNumber>PA0051/039/001</LicenceNumber>
    <ProductName>HIBIDIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1982-09-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003959</DrugIDPK>
    <LicenceNumber>PA0132/004/001</LicenceNumber>
    <ProductName>FERROCAP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Consolidated Chemicals Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003961</DrugIDPK>
    <LicenceNumber>PA0132/006/001</LicenceNumber>
    <ProductName>FERROCAP F 350</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Consolidated Chemicals Limited</PAHolder>
    <AuthorisedDate>1984-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000849</DrugIDPK>
    <LicenceNumber>PA0017/013/004</LicenceNumber>
    <ProductName>ACTIFED EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006377</DrugIDPK>
    <LicenceNumber>PPA0465/012/001</LicenceNumber>
    <ProductName>ADALAT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1991-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001255</DrugIDPK>
    <LicenceNumber>PA0022/051/001</LicenceNumber>
    <ProductName>ALREDASE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLRESTAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000292</DrugIDPK>
    <LicenceNumber>PA0006/026/001</LicenceNumber>
    <ProductName>ALTACITE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003051</DrugIDPK>
    <LicenceNumber>PA0062/004/001</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003052</DrugIDPK>
    <LicenceNumber>PA0062/004/002</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003055</DrugIDPK>
    <LicenceNumber>PA0062/004/005</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003056</DrugIDPK>
    <LicenceNumber>PA0062/004/006</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003057</DrugIDPK>
    <LicenceNumber>PA0062/004/007</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003058</DrugIDPK>
    <LicenceNumber>PA0062/004/008</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003059</DrugIDPK>
    <LicenceNumber>PA0062/004/009</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003054</DrugIDPK>
    <LicenceNumber>PA0062/004/004</LicenceNumber>
    <ProductName>AMFIPEN 250</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003060</DrugIDPK>
    <LicenceNumber>PA0062/004/010</LicenceNumber>
    <ProductName>AMFIPEN SYRUP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003053</DrugIDPK>
    <LicenceNumber>PA0062/004/003</LicenceNumber>
    <ProductName>AMFIPEN SYRUP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003061</DrugIDPK>
    <LicenceNumber>PA0062/004/011</LicenceNumber>
    <ProductName>AMFIPEN SYRUP FORTE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001226</DrugIDPK>
    <LicenceNumber>PA0023/045/001</LicenceNumber>
    <ProductName>ARELIX-K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRETANIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002078</DrugIDPK>
    <LicenceNumber>PA0041/021/001</LicenceNumber>
    <ProductName>CEPASTAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000248</DrugIDPK>
    <LicenceNumber>PA0006/003/015</LicenceNumber>
    <ProductName>CIDOMYCIN EAR</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1989-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000247</DrugIDPK>
    <LicenceNumber>PA0006/003/014</LicenceNumber>
    <ProductName>CIDOMYCIN EYE</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1989-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002096</DrugIDPK>
    <LicenceNumber>PA0041/039/001</LicenceNumber>
    <ProductName>CITRUCEL</ProductName>
    <Strength>9.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1989-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLCELLULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003594</DrugIDPK>
    <LicenceNumber>PA0095/014/001</LicenceNumber>
    <ProductName>COLOCLER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1989-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003043</DrugIDPK>
    <LicenceNumber>PA0062/001/002</LicenceNumber>
    <ProductName>CYCLOSPASMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1982-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003459</DrugIDPK>
    <LicenceNumber>PA0080/007/001</LicenceNumber>
    <ProductName>DELPHYLLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE SODIUM AMINOACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005948</DrugIDPK>
    <LicenceNumber>PA0384/012/002</LicenceNumber>
    <ProductName>FELDENE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1983-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001187</DrugIDPK>
    <LicenceNumber>PA0023/018/003</LicenceNumber>
    <ProductName>FRISIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1978-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBAZAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001180</DrugIDPK>
    <LicenceNumber>PA0023/018/001</LicenceNumber>
    <ProductName>FRISIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1978-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBAZAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001183</DrugIDPK>
    <LicenceNumber>PA0023/018/002</LicenceNumber>
    <ProductName>FRISIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1978-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBAZAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003754</DrugIDPK>
    <LicenceNumber>PA0102/001/001</LicenceNumber>
    <ProductName>FYBRANTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1977-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BRAN</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006355</DrugIDPK>
    <LicenceNumber>PPA0465/006/001</LicenceNumber>
    <ProductName>HEXOPAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1988-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006219</DrugIDPK>
    <LicenceNumber>PA0447/004/002</LicenceNumber>
    <ProductName>ILOSONE (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1987-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ESTOLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006220</DrugIDPK>
    <LicenceNumber>PA0447/004/003</LicenceNumber>
    <ProductName>ILOSONE (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1987-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ESTOLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002067</DrugIDPK>
    <LicenceNumber>PA0041/004/001</LicenceNumber>
    <ProductName>MERASYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1976-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002071</DrugIDPK>
    <LicenceNumber>PA0041/006/001</LicenceNumber>
    <ProductName>MERBENTYL DOSPAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1976-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012727</DrugIDPK>
    <LicenceNumber>PA0504/001/001</LicenceNumber>
    <ProductName>MFV-JECT MERIEUX MONO DOSE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate>1987-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003460</DrugIDPK>
    <LicenceNumber>PA0082/002/004</LicenceNumber>
    <ProductName>MUCODYNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARBOCISTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005953</DrugIDPK>
    <LicenceNumber>PA0384/016/001</LicenceNumber>
    <ProductName>NATRILIX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1990-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006345</DrugIDPK>
    <LicenceNumber>PPA0465/003/001</LicenceNumber>
    <ProductName>NEGRAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALIDIXIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002118</DrugIDPK>
    <LicenceNumber>PA0041/048/001</LicenceNumber>
    <ProductName>NICABATE PATCH</ProductName>
    <Strength>7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002119</DrugIDPK>
    <LicenceNumber>PA0041/048/002</LicenceNumber>
    <ProductName>NICABATE PATCH</ProductName>
    <Strength>14</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002120</DrugIDPK>
    <LicenceNumber>PA0041/048/003</LicenceNumber>
    <ProductName>NICABATE PATCH</ProductName>
    <Strength>21</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1993-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002121</DrugIDPK>
    <LicenceNumber>PA0041/049/001</LicenceNumber>
    <ProductName>OSCAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1992-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002097</DrugIDPK>
    <LicenceNumber>PA0041/040/001</LicenceNumber>
    <ProductName>PERFAN ENOXIMONE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1988-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002099</DrugIDPK>
    <LicenceNumber>PA0041/040/003</LicenceNumber>
    <ProductName>PERFAN ENOXIMONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1988-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003714</DrugIDPK>
    <LicenceNumber>PA0114/056/001</LicenceNumber>
    <ProductName>PHYLLODROPS ORAL LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001159</DrugIDPK>
    <LicenceNumber>PA0023/012/004</LicenceNumber>
    <ProductName>REVERIN I.V.</ProductName>
    <Strength>275</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROLITETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002084</DrugIDPK>
    <LicenceNumber>PA0041/029/001</LicenceNumber>
    <ProductName>RIFADIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002092</DrugIDPK>
    <LicenceNumber>PA0041/032/001</LicenceNumber>
    <ProductName>RIFAPRIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000184</DrugIDPK>
    <LicenceNumber>PA0006/011/007</LicenceNumber>
    <ProductName>SOFRAMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000262</DrugIDPK>
    <LicenceNumber>PA0006/011/003</LicenceNumber>
    <ProductName>SOFRAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000182</DrugIDPK>
    <LicenceNumber>PA0006/011/004</LicenceNumber>
    <ProductName>SOFRAMYCIN SKIN</ProductName>
    <Strength>1.5/0.005</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000182</DrugIDPK>
    <LicenceNumber>PA0006/011/004</LicenceNumber>
    <ProductName>SOFRAMYCIN SKIN</ProductName>
    <Strength>1.5/0.005</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000280</DrugIDPK>
    <LicenceNumber>PA0006/023/007</LicenceNumber>
    <ProductName>SURGAM DISPERSIBLE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002100</DrugIDPK>
    <LicenceNumber>PA0041/041/001</LicenceNumber>
    <ProductName>TARGOCID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1990-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEICOPLANIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001260</DrugIDPK>
    <LicenceNumber>PA0023/053/001</LicenceNumber>
    <ProductName>TARIVID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Irl Ltd.</PAHolder>
    <AuthorisedDate>1988-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002082</DrugIDPK>
    <LicenceNumber>PA0041/027/002</LicenceNumber>
    <ProductName>TENUATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMFEPRAMONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003082</DrugIDPK>
    <LicenceNumber>PA0062/025/005</LicenceNumber>
    <ProductName>UNIDOX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003081</DrugIDPK>
    <LicenceNumber>PA0062/025/004</LicenceNumber>
    <ProductName>UNIDOX SOLUTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006384</DrugIDPK>
    <LicenceNumber>PPA0465/015/001</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002072</DrugIDPK>
    <LicenceNumber>PA0041/007/001</LicenceNumber>
    <ProductName>VICKS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002065</DrugIDPK>
    <LicenceNumber>PA0041/001/001</LicenceNumber>
    <ProductName>VICKS MEDINITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1975-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006494</DrugIDPK>
    <LicenceNumber>PA0468/027/001</LicenceNumber>
    <ProductName>KLARON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1991-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006497</DrugIDPK>
    <LicenceNumber>PA0468/031/001</LicenceNumber>
    <ProductName>REZAMID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1991-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RESORCINOL</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005061</DrugIDPK>
    <LicenceNumber>PA0237/020/001</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1982-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005062</DrugIDPK>
    <LicenceNumber>PA0237/020/002</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1982-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005063</DrugIDPK>
    <LicenceNumber>PA0237/020/003</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1982-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005064</DrugIDPK>
    <LicenceNumber>PA0237/020/004</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1982-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002336</DrugIDPK>
    <LicenceNumber>PA0050/084/003</LicenceNumber>
    <ProductName>BENOXID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010178</DrugIDPK>
    <LicenceNumber>PA0050/084/001</LicenceNumber>
    <ProductName>BENOXID</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006627</DrugIDPK>
    <LicenceNumber>PA0502/002/001</LicenceNumber>
    <ProductName>CENTOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Biologics B.V.</PAHolder>
    <AuthorisedDate>1991-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006756</DrugIDPK>
    <LicenceNumber>PA0582/002/001</LicenceNumber>
    <ProductName>EFEMOLINE EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate>1991-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUOROMETHOLONE</ActiveSubstance>
      <ActiveSubstance>TETRYZOLINE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005657</DrugIDPK>
    <LicenceNumber>PA0290/018/001</LicenceNumber>
    <ProductName>FLEXCARE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1991-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>THIOMERSAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002196</DrugIDPK>
    <LicenceNumber>PA0046/036/004</LicenceNumber>
    <ProductName>HEPARIN SODIUM 1000</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003684</DrugIDPK>
    <LicenceNumber>PA0108/017/003</LicenceNumber>
    <ProductName>INFLUVAC SUB-UNIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003682</DrugIDPK>
    <LicenceNumber>PA0108/017/001</LicenceNumber>
    <ProductName>INFLUVAC SUB-UNIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1986-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002993</DrugIDPK>
    <LicenceNumber>PA0059/019/001</LicenceNumber>
    <ProductName>INTERCEPT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1981-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002927</DrugIDPK>
    <LicenceNumber>PA0058/001/001</LicenceNumber>
    <ProductName>IRUXOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLLAGENASE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016155</DrugIDPK>
    <LicenceNumber>PA0030/005/001</LicenceNumber>
    <ProductName>ISMELIN EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1981-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE MONOSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004281</DrugIDPK>
    <LicenceNumber>PA0167/036/005</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004282</DrugIDPK>
    <LicenceNumber>PA0167/036/006</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004285</DrugIDPK>
    <LicenceNumber>PA0167/036/009</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004286</DrugIDPK>
    <LicenceNumber>PA0167/036/010</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000739</DrugIDPK>
    <LicenceNumber>PA0011/011/001</LicenceNumber>
    <ProductName>LAMPRENE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOFAZIMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002935</DrugIDPK>
    <LicenceNumber>PA0058/005/001</LicenceNumber>
    <ProductName>MULTIFUNGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000800</DrugIDPK>
    <LicenceNumber>PA0011/040/001</LicenceNumber>
    <ProductName>NICOTINELL TTS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1992-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000802</DrugIDPK>
    <LicenceNumber>PA0011/040/002</LicenceNumber>
    <ProductName>NICOTINELL TTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1992-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000803</DrugIDPK>
    <LicenceNumber>PA0011/040/003</LicenceNumber>
    <ProductName>NICOTINELL TTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1992-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005880</DrugIDPK>
    <LicenceNumber>PA0290/015/001</LicenceNumber>
    <ProductName>NORMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1991-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004315</DrugIDPK>
    <LicenceNumber>PA0167/040/001</LicenceNumber>
    <ProductName>PLASMALYTE 148/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004316</DrugIDPK>
    <LicenceNumber>PA0167/040/002</LicenceNumber>
    <ProductName>PLASMALYTE 148/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004317</DrugIDPK>
    <LicenceNumber>PA0167/040/003</LicenceNumber>
    <ProductName>PLASMALYTE 148/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004318</DrugIDPK>
    <LicenceNumber>PA0167/040/004</LicenceNumber>
    <ProductName>PLASMALYTE 148/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002971</DrugIDPK>
    <LicenceNumber>PA0059/007/001</LicenceNumber>
    <ProductName>PROGRAM-20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1976-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002972</DrugIDPK>
    <LicenceNumber>PA0059/007/002</LicenceNumber>
    <ProductName>PROGRAM-40</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1976-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004484</DrugIDPK>
    <LicenceNumber>PA0176/009/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004486</DrugIDPK>
    <LicenceNumber>PA0176/009/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008845</DrugIDPK>
    <LicenceNumber>PA0644/002/002</LicenceNumber>
    <ProductName>RONICOL TIMESPAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Tillomed Laboratories Limited</PAHolder>
    <AuthorisedDate>1994-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINYL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004197</DrugIDPK>
    <LicenceNumber>PA0167/056/001</LicenceNumber>
    <ProductName>SODIUM LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004200</DrugIDPK>
    <LicenceNumber>PA0167/056/002</LicenceNumber>
    <ProductName>SODIUM LACTATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004202</DrugIDPK>
    <LicenceNumber>PA0167/056/003</LicenceNumber>
    <ProductName>SODIUM LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1982-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004205</DrugIDPK>
    <LicenceNumber>PA0167/056/004</LicenceNumber>
    <ProductName>SODIUM LACTATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002949</DrugIDPK>
    <LicenceNumber>PA0058/014/001</LicenceNumber>
    <ProductName>TALUSIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROSCILLARIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004307</DrugIDPK>
    <LicenceNumber>PA0167/038/003</LicenceNumber>
    <ProductName>TRAVERT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INVERT SUGAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004309</DrugIDPK>
    <LicenceNumber>PA0167/038/004</LicenceNumber>
    <ProductName>TRAVERT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INVERT SUGAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004304</DrugIDPK>
    <LicenceNumber>PA0167/038/001</LicenceNumber>
    <ProductName>TRAVERT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INVERT SUGAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004305</DrugIDPK>
    <LicenceNumber>PA0167/038/002</LicenceNumber>
    <ProductName>TRAVERT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INVERT SUGAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001780</DrugIDPK>
    <LicenceNumber>PA0033/008/001</LicenceNumber>
    <ProductName>URISPAS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLAVOXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002342</DrugIDPK>
    <LicenceNumber>PA0050/088/001</LicenceNumber>
    <ProductName>VALDERMA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1992-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003905</DrugIDPK>
    <LicenceNumber>PA0126/061/001</LicenceNumber>
    <ProductName>CLONURETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000965</DrugIDPK>
    <LicenceNumber>PA0017/082/001</LicenceNumber>
    <ProductName>ANTEPAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1991-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006431</DrugIDPK>
    <LicenceNumber>PA0437/015/002</LicenceNumber>
    <ProductName>BACTERIOSTATIC DILUENT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004476</DrugIDPK>
    <LicenceNumber>PA0172/022/001</LicenceNumber>
    <ProductName>BISODOL EXTRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003286</DrugIDPK>
    <LicenceNumber>PA0073/125/001</LicenceNumber>
    <ProductName>CASCARA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006164</DrugIDPK>
    <LicenceNumber>PA0409/013/001</LicenceNumber>
    <ProductName>CASMIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006165</DrugIDPK>
    <LicenceNumber>PA0409/013/002</LicenceNumber>
    <ProductName>CASMIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006166</DrugIDPK>
    <LicenceNumber>PA0409/013/003</LicenceNumber>
    <ProductName>CASMIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009028</DrugIDPK>
    <LicenceNumber>PA0365/062/001</LicenceNumber>
    <ProductName>CHOLERA VACCINE B.P.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1994-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHOLERA VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003765</DrugIDPK>
    <LicenceNumber>PA0115/005/005</LicenceNumber>
    <ProductName>CLOPIXOL INJECTION</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOPENTHIXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001661</DrugIDPK>
    <LicenceNumber>PA0038/025/001</LicenceNumber>
    <ProductName>CO-FRAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005709</DrugIDPK>
    <LicenceNumber>PA0294/008/001</LicenceNumber>
    <ProductName>CREANOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005710</DrugIDPK>
    <LicenceNumber>PA0294/008/002</LicenceNumber>
    <ProductName>CREANOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003744</DrugIDPK>
    <LicenceNumber>PA0115/001/005</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1976-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003745</DrugIDPK>
    <LicenceNumber>PA0115/001/006</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1976-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003747</DrugIDPK>
    <LicenceNumber>PA0115/001/008</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1981-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004342</DrugIDPK>
    <LicenceNumber>PA0167/064/001</LicenceNumber>
    <ProductName>DIANEAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004346</DrugIDPK>
    <LicenceNumber>PA0167/064/002</LicenceNumber>
    <ProductName>DIANEAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004349</DrugIDPK>
    <LicenceNumber>PA0167/064/003</LicenceNumber>
    <ProductName>DIANEAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002390</DrugIDPK>
    <LicenceNumber>PA0051/023/001</LicenceNumber>
    <ProductName>EPODYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETOGLUCID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000947</DrugIDPK>
    <LicenceNumber>PA0017/071/001</LicenceNumber>
    <ProductName>FERROMYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001683</DrugIDPK>
    <LicenceNumber>PA0038/042/001</LicenceNumber>
    <ProductName>GENTAMICIN</ProductName>
    <Strength>0.8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001684</DrugIDPK>
    <LicenceNumber>PA0038/042/002</LicenceNumber>
    <ProductName>GENTAMICIN</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006435</DrugIDPK>
    <LicenceNumber>PA0437/016/006</LicenceNumber>
    <ProductName>GENTAMICIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001797</DrugIDPK>
    <LicenceNumber>PA0035/025/001</LicenceNumber>
    <ProductName>HYDROMET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009299</DrugIDPK>
    <LicenceNumber>PA0218/032/006</LicenceNumber>
    <ProductName>LOGIPARIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002321</DrugIDPK>
    <LicenceNumber>PA0050/081/001</LicenceNumber>
    <ProductName>MANERIX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOCLOBEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006755</DrugIDPK>
    <LicenceNumber>PA0581/002/001</LicenceNumber>
    <ProductName>MENTADENT S TOOTHPASTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elida Faberge Ireland</PAHolder>
    <AuthorisedDate>1993-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001682</DrugIDPK>
    <LicenceNumber>PA0038/041/001</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001545</DrugIDPK>
    <LicenceNumber>PA0028/039/001</LicenceNumber>
    <ProductName>MONASPOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFSULODIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001547</DrugIDPK>
    <LicenceNumber>PA0028/039/002</LicenceNumber>
    <ProductName>MONASPOR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFSULODIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001550</DrugIDPK>
    <LicenceNumber>PA0028/039/003</LicenceNumber>
    <ProductName>MONASPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFSULODIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001552</DrugIDPK>
    <LicenceNumber>PA0028/039/004</LicenceNumber>
    <ProductName>MONASPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1983-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFSULODIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002361</DrugIDPK>
    <LicenceNumber>PA0051/005/001</LicenceNumber>
    <ProductName>RAZOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAZOXANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001808</DrugIDPK>
    <LicenceNumber>PA0035/030/001</LicenceNumber>
    <ProductName>SALURIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001663</DrugIDPK>
    <LicenceNumber>PA0038/027/001</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001778</DrugIDPK>
    <LicenceNumber>PA0033/007/002</LicenceNumber>
    <ProductName>TOPILAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1976-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOROLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001779</DrugIDPK>
    <LicenceNumber>PA0033/007/003</LicenceNumber>
    <ProductName>TOPILAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1976-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOROLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000496</DrugIDPK>
    <LicenceNumber>PA0012/046/001</LicenceNumber>
    <ProductName>TRAVOGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1981-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005718</DrugIDPK>
    <LicenceNumber>PA0330/002/002</LicenceNumber>
    <ProductName>TYLENOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005715</DrugIDPK>
    <LicenceNumber>PA0330/002/001</LicenceNumber>
    <ProductName>TYLENOL</ProductName>
    <Strength>325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000953</DrugIDPK>
    <LicenceNumber>PA0017/078/003</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-09-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000957</DrugIDPK>
    <LicenceNumber>PA0017/078/006</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1986-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000959</DrugIDPK>
    <LicenceNumber>PA0017/078/007</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1988-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000853</DrugIDPK>
    <LicenceNumber>PA0017/014/001</LicenceNumber>
    <ProductName>ACTIDIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000854</DrugIDPK>
    <LicenceNumber>PA0017/014/002</LicenceNumber>
    <ProductName>ACTIDIL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000833</DrugIDPK>
    <LicenceNumber>PA0017/003/001</LicenceNumber>
    <ProductName>AEROSPORIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000964</DrugIDPK>
    <LicenceNumber>PA0017/081/001</LicenceNumber>
    <ProductName>ALCOPAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPHENIUM HYDROXYNAPHTHOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002158</DrugIDPK>
    <LicenceNumber>PA0046/012/002</LicenceNumber>
    <ProductName>ALKASID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM ALUMINUM SILICATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002157</DrugIDPK>
    <LicenceNumber>PA0046/012/001</LicenceNumber>
    <ProductName>ALKASID (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM ALUMINUM SILICATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003977</DrugIDPK>
    <LicenceNumber>PA0143/012/002</LicenceNumber>
    <ProductName>AMINOPLEX 24</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1984-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001330</DrugIDPK>
    <LicenceNumber>PA0024/012/001</LicenceNumber>
    <ProductName>BECONASE NASAL  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003354</DrugIDPK>
    <LicenceNumber>PA0077/008/003</LicenceNumber>
    <ProductName>BENORAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1981-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001957</DrugIDPK>
    <LicenceNumber>PA0044/022/002</LicenceNumber>
    <ProductName>BETNOVATE C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002246</DrugIDPK>
    <LicenceNumber>PA0046/059/003</LicenceNumber>
    <ProductName>BURAM FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006584</DrugIDPK>
    <LicenceNumber>PA0484/016/001</LicenceNumber>
    <ProductName>CALAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001937</DrugIDPK>
    <LicenceNumber>PA0044/009/008</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004417</DrugIDPK>
    <LicenceNumber>PA0167/069/004</LicenceNumber>
    <ProductName>CHLORASEPT 5000 ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004418</DrugIDPK>
    <LicenceNumber>PA0167/069/005</LicenceNumber>
    <ProductName>CHLORASEPT 5000 ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004419</DrugIDPK>
    <LicenceNumber>PA0167/069/006</LicenceNumber>
    <ProductName>CHLORASEPT 5000 ANTISEPTIC</ProductName>
    <Strength>ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000650</DrugIDPK>
    <LicenceNumber>PA0010/007/001</LicenceNumber>
    <ProductName>CHYMOCYCLAR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004330</DrugIDPK>
    <LicenceNumber>PA0167/063/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004333</DrugIDPK>
    <LicenceNumber>PA0167/063/002</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002004</DrugIDPK>
    <LicenceNumber>PA0044/073/001</LicenceNumber>
    <ProductName>DIONOSIL OILY -  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPYLIODONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003040</DrugIDPK>
    <LicenceNumber>PA0060/052/001</LicenceNumber>
    <ProductName>DORALESE TILTAB</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1989-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000672</DrugIDPK>
    <LicenceNumber>PA0010/030/001</LicenceNumber>
    <ProductName>DRIED FACTOR VIII FRACTION B.P. HEAT TREATED</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1988-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003314</DrugIDPK>
    <LicenceNumber>PA0074/012/001</LicenceNumber>
    <ProductName>ELOTRANS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1987-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002807</DrugIDPK>
    <LicenceNumber>PA0056/040/002</LicenceNumber>
    <ProductName>ERYMAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1987-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000933</DrugIDPK>
    <LicenceNumber>PA0017/057/001</LicenceNumber>
    <ProductName>ESBATAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETANIDINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002045</DrugIDPK>
    <LicenceNumber>PA0046/004/007</LicenceNumber>
    <ProductName>FUCIDIN FOR INTRAVENOUS INFUSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FUSIDATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002191</DrugIDPK>
    <LicenceNumber>PA0047/045/001</LicenceNumber>
    <ProductName>GLUCAGON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002178</DrugIDPK>
    <LicenceNumber>PA0046/028/002</LicenceNumber>
    <ProductName>HEP RINSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002206</DrugIDPK>
    <LicenceNumber>PA0047/059/005</LicenceNumber>
    <ProductName>HUMULIN I</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002215</DrugIDPK>
    <LicenceNumber>PA0047/065/003</LicenceNumber>
    <ProductName>HUMULIN M1</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002220</DrugIDPK>
    <LicenceNumber>PA0047/066/003</LicenceNumber>
    <ProductName>HUMULIN M2</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002232</DrugIDPK>
    <LicenceNumber>PA0047/069/003</LicenceNumber>
    <ProductName>HUMULIN M3</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002235</DrugIDPK>
    <LicenceNumber>PA0047/070/003</LicenceNumber>
    <ProductName>HUMULIN M4</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1993-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000822</DrugIDPK>
    <LicenceNumber>PA0017/001/001</LicenceNumber>
    <ProductName>HYPON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1975-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000135</DrugIDPK>
    <LicenceNumber>PA0001/024/002</LicenceNumber>
    <ProductName>ICY HOT CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1992-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001827</DrugIDPK>
    <LicenceNumber>PA0033/024/001</LicenceNumber>
    <ProductName>MADECASSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001851</DrugIDPK>
    <LicenceNumber>PA0033/024/002</LicenceNumber>
    <ProductName>MADECASSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003503</DrugIDPK>
    <LicenceNumber>PA0086/022/002</LicenceNumber>
    <ProductName>MALINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALMASILATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003502</DrugIDPK>
    <LicenceNumber>PA0086/022/001</LicenceNumber>
    <ProductName>MALINAL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALMASILATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005729</DrugIDPK>
    <LicenceNumber>PA0037/058/001</LicenceNumber>
    <ProductName>MAXZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002294</DrugIDPK>
    <LicenceNumber>PA0050/067/004</LicenceNumber>
    <ProductName>MOBIFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1991-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002958</DrugIDPK>
    <LicenceNumber>PA0059/002/002</LicenceNumber>
    <ProductName>MONISTAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1976-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005163</DrugIDPK>
    <LicenceNumber>PA0256/001/001</LicenceNumber>
    <ProductName>ORALCER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Vitabiotics Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004483</DrugIDPK>
    <LicenceNumber>PA0176/003/001</LicenceNumber>
    <ProductName>OXYTETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1981-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002223</DrugIDPK>
    <LicenceNumber>PA0046/047/001</LicenceNumber>
    <ProductName>PANALEVE ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004487</DrugIDPK>
    <LicenceNumber>PA0176/011/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000846</DrugIDPK>
    <LicenceNumber>PA0017/012/001</LicenceNumber>
    <ProductName>PARAHYPON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002240</DrugIDPK>
    <LicenceNumber>PA0046/054/003</LicenceNumber>
    <ProductName>PINDAC</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINACIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001328</DrugIDPK>
    <LicenceNumber>PA0024/010/002</LicenceNumber>
    <ProductName>PIRITON</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1985-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000972</DrugIDPK>
    <LicenceNumber>PA0017/086/001</LicenceNumber>
    <ProductName>PRO-VENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002221</DrugIDPK>
    <LicenceNumber>PA0046/044/002</LicenceNumber>
    <ProductName>PUMP-HEP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004496</DrugIDPK>
    <LicenceNumber>PA0176/027/001</LicenceNumber>
    <ProductName>QUININE SULPHATE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001261</DrugIDPK>
    <LicenceNumber>PA0022/052/004</LicenceNumber>
    <ProductName>RAMODAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETODOLAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001259</DrugIDPK>
    <LicenceNumber>PA0022/052/003</LicenceNumber>
    <ProductName>RAMODAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETODOLAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002159</DrugIDPK>
    <LicenceNumber>PA0046/014/001</LicenceNumber>
    <ProductName>SELEXID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVMECILLINAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004306</DrugIDPK>
    <LicenceNumber>PA0167/058/001</LicenceNumber>
    <ProductName>SODIUM BICARBONATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004313</DrugIDPK>
    <LicenceNumber>PA0167/058/002</LicenceNumber>
    <ProductName>SODIUM BICARBONATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000839</DrugIDPK>
    <LicenceNumber>PA0017/008/001</LicenceNumber>
    <ProductName>TINEFAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZINC UNDECYLENATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000922</DrugIDPK>
    <LicenceNumber>PA0017/053/001</LicenceNumber>
    <ProductName>TUBARINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1989-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TUBOCURARINE CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001332</DrugIDPK>
    <LicenceNumber>PA0024/018/001</LicenceNumber>
    <ProductName>VENTIDE INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1990-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002794</DrugIDPK>
    <LicenceNumber>PA0056/018/002</LicenceNumber>
    <ProductName>VIRA-A (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1983-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VIDARABINE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002009</DrugIDPK>
    <LicenceNumber>PA0044/076/005</LicenceNumber>
    <ProductName>ZANTAC DISPERSIBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-09-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002034</DrugIDPK>
    <LicenceNumber>PA0044/091/002</LicenceNumber>
    <ProductName>ZIN-MET 1500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME</ActiveSubstance>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002032</DrugIDPK>
    <LicenceNumber>PA0044/091/001</LicenceNumber>
    <ProductName>ZIN-MET 750</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME</ActiveSubstance>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004037</DrugIDPK>
    <LicenceNumber>PA0148/053/001</LicenceNumber>
    <ProductName>DURACARE STORING &amp; WETTING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1991-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYVINYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001735</DrugIDPK>
    <LicenceNumber>PA0148/008/001</LicenceNumber>
    <ProductName>EPIFRIN 0.5% STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1981-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000539</DrugIDPK>
    <LicenceNumber>PA0012/050/001</LicenceNumber>
    <ProductName>LOGYNON ED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1981-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>LACTOSE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005293</DrugIDPK>
    <LicenceNumber>PA0281/017/001</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004603</DrugIDPK>
    <LicenceNumber>PA0187/002/001</LicenceNumber>
    <ProductName>ADDAMEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002320</DrugIDPK>
    <LicenceNumber>PA0048/004/005</LicenceNumber>
    <ProductName>AMIKIN VIALS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1976-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011336</DrugIDPK>
    <LicenceNumber>PA0054/036/001</LicenceNumber>
    <ProductName>AMINOFUSIN L600</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>CARBOHYDRATES NOS</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004935</DrugIDPK>
    <LicenceNumber>PA0236/018/001</LicenceNumber>
    <ProductName>AMINOGLUTETHIMI DE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003976</DrugIDPK>
    <LicenceNumber>PA0143/012/001</LicenceNumber>
    <ProductName>AMINOPLEX 24</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1984-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003352</DrugIDPK>
    <LicenceNumber>PA0077/008/001</LicenceNumber>
    <ProductName>BENORAL</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1976-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006099</DrugIDPK>
    <LicenceNumber>PA0437/019/001</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <Strength>0.25%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005253</DrugIDPK>
    <LicenceNumber>PA0278/012/001</LicenceNumber>
    <ProductName>CALLUSOLVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005786</DrugIDPK>
    <LicenceNumber>PA0360/021/005</LicenceNumber>
    <ProductName>CEDOCARD 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005789</DrugIDPK>
    <LicenceNumber>PA0360/021/006</LicenceNumber>
    <ProductName>CEDOCARD 40</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>1992-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005783</DrugIDPK>
    <LicenceNumber>PA0360/021/004</LicenceNumber>
    <ProductName>CEDOCARD 5</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>1991-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005048</DrugIDPK>
    <LicenceNumber>PA0236/013/005</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004352</DrugIDPK>
    <LicenceNumber>PA0167/064/004</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004375</DrugIDPK>
    <LicenceNumber>PA0167/064/015</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004376</DrugIDPK>
    <LicenceNumber>PA0167/064/016</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004377</DrugIDPK>
    <LicenceNumber>PA0167/064/017</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>2.27</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004379</DrugIDPK>
    <LicenceNumber>PA0167/064/019</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004380</DrugIDPK>
    <LicenceNumber>PA0167/064/020</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004381</DrugIDPK>
    <LicenceNumber>PA0167/064/021</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004382</DrugIDPK>
    <LicenceNumber>PA0167/064/022</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004384</DrugIDPK>
    <LicenceNumber>PA0167/064/024</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004357</DrugIDPK>
    <LicenceNumber>PA0167/064/005</LicenceNumber>
    <ProductName>DIANEAL PD PERITONEAL DIALYSIS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004364</DrugIDPK>
    <LicenceNumber>PA0167/064/008</LicenceNumber>
    <ProductName>DIANEAL PD2</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004367</DrugIDPK>
    <LicenceNumber>PA0167/064/009</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004370</DrugIDPK>
    <LicenceNumber>PA0167/064/010</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004371</DrugIDPK>
    <LicenceNumber>PA0167/064/011</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004372</DrugIDPK>
    <LicenceNumber>PA0167/064/012</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004373</DrugIDPK>
    <LicenceNumber>PA0167/064/013</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004374</DrugIDPK>
    <LicenceNumber>PA0167/064/014</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004383</DrugIDPK>
    <LicenceNumber>PA0167/064/023</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004378</DrugIDPK>
    <LicenceNumber>PA0167/064/018</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004360</DrugIDPK>
    <LicenceNumber>PA0167/064/006</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004363</DrugIDPK>
    <LicenceNumber>PA0167/064/007</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004361</DrugIDPK>
    <LicenceNumber>PA0167/049/019</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004362</DrugIDPK>
    <LicenceNumber>PA0167/049/020</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004358</DrugIDPK>
    <LicenceNumber>PA0167/049/017</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004353</DrugIDPK>
    <LicenceNumber>PA0167/049/013</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004354</DrugIDPK>
    <LicenceNumber>PA0167/049/014</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004355</DrugIDPK>
    <LicenceNumber>PA0167/049/015</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004356</DrugIDPK>
    <LicenceNumber>PA0167/049/016</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004350</DrugIDPK>
    <LicenceNumber>PA0167/049/011</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004351</DrugIDPK>
    <LicenceNumber>PA0167/049/012</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004347</DrugIDPK>
    <LicenceNumber>PA0167/049/009</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004348</DrugIDPK>
    <LicenceNumber>PA0167/049/010</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004343</DrugIDPK>
    <LicenceNumber>PA0167/049/006</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004335</DrugIDPK>
    <LicenceNumber>PA0167/049/001</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004345</DrugIDPK>
    <LicenceNumber>PA0167/049/008</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004368</DrugIDPK>
    <LicenceNumber>PA0167/049/023</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004369</DrugIDPK>
    <LicenceNumber>PA0167/049/024</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004365</DrugIDPK>
    <LicenceNumber>PA0167/049/021</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004366</DrugIDPK>
    <LicenceNumber>PA0167/049/022</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004340</DrugIDPK>
    <LicenceNumber>PA0167/049/004</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004341</DrugIDPK>
    <LicenceNumber>PA0167/049/005</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004337</DrugIDPK>
    <LicenceNumber>PA0167/049/002</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004338</DrugIDPK>
    <LicenceNumber>PA0167/049/003</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004344</DrugIDPK>
    <LicenceNumber>PA0167/049/007</LicenceNumber>
    <ProductName>DIANEAL PD3/GLUCOSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004359</DrugIDPK>
    <LicenceNumber>PA0167/049/018</LicenceNumber>
    <ProductName>DIANEAL PD3/GLUCOSE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004957</DrugIDPK>
    <LicenceNumber>PA0236/023/005</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002925</DrugIDPK>
    <LicenceNumber>PA0057/063/001</LicenceNumber>
    <ProductName>DUROMINE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENTERMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002926</DrugIDPK>
    <LicenceNumber>PA0057/063/002</LicenceNumber>
    <ProductName>DUROMINE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1991-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENTERMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005030</DrugIDPK>
    <LicenceNumber>PA0236/009/004</LicenceNumber>
    <ProductName>EUHYPNOS GELTHIX 15</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005031</DrugIDPK>
    <LicenceNumber>PA0236/009/005</LicenceNumber>
    <ProductName>EUHYPNOS GELTHIX 30</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005037</DrugIDPK>
    <LicenceNumber>PA0236/011/001</LicenceNumber>
    <ProductName>FARLUTAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005038</DrugIDPK>
    <LicenceNumber>PA0236/011/002</LicenceNumber>
    <ProductName>FARLUTAL</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005040</DrugIDPK>
    <LicenceNumber>PA0236/011/004</LicenceNumber>
    <ProductName>FARLUTAL 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1983-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003497</DrugIDPK>
    <LicenceNumber>PA0114/011/001</LicenceNumber>
    <ProductName>FERROCONTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLYCINE SULFATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003610</DrugIDPK>
    <LicenceNumber>PA0114/010/001</LicenceNumber>
    <ProductName>FERROCONTIN CONTINUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLYCINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003184</DrugIDPK>
    <LicenceNumber>PA0073/058/001</LicenceNumber>
    <ProductName>FERROUS GLUCONATE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004743</DrugIDPK>
    <LicenceNumber>PA0187/032/002</LicenceNumber>
    <ProductName>GENOTROPIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1989-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000134</DrugIDPK>
    <LicenceNumber>PA0001/024/001</LicenceNumber>
    <ProductName>ICY HOT BALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1992-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000706</DrugIDPK>
    <LicenceNumber>PA0016/009/002</LicenceNumber>
    <ProductName>LINCOCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000707</DrugIDPK>
    <LicenceNumber>PA0016/009/003</LicenceNumber>
    <ProductName>LINCOCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000709</DrugIDPK>
    <LicenceNumber>PA0016/009/004</LicenceNumber>
    <ProductName>LINCOCIN STERILE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LINCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000705</DrugIDPK>
    <LicenceNumber>PA0016/009/001</LicenceNumber>
    <ProductName>LINCOCIN STERILE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LINCOMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003070</DrugIDPK>
    <LicenceNumber>PA0062/016/001</LicenceNumber>
    <ProductName>LOCOBASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003071</DrugIDPK>
    <LicenceNumber>PA0062/016/002</LicenceNumber>
    <ProductName>LOCOBASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000125</DrugIDPK>
    <LicenceNumber>PA0001/005/005</LicenceNumber>
    <ProductName>LOMOTIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1981-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENOXYLATE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000785</DrugIDPK>
    <LicenceNumber>PA0016/032/004</LicenceNumber>
    <ProductName>LONITEN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1980-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOXIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000786</DrugIDPK>
    <LicenceNumber>PA0016/032/005</LicenceNumber>
    <ProductName>LONITEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1980-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOXIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004848</DrugIDPK>
    <LicenceNumber>PA0236/014/003</LicenceNumber>
    <ProductName>MAXTREX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004851</DrugIDPK>
    <LicenceNumber>PA0236/014/004</LicenceNumber>
    <ProductName>MAXTREX</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004852</DrugIDPK>
    <LicenceNumber>PA0236/014/005</LicenceNumber>
    <ProductName>MAXTREX</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004845</DrugIDPK>
    <LicenceNumber>PA0236/014/002</LicenceNumber>
    <ProductName>MAXTREX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004842</DrugIDPK>
    <LicenceNumber>PA0236/014/001</LicenceNumber>
    <ProductName>MAXTREX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004856</DrugIDPK>
    <LicenceNumber>PA0236/014/009</LicenceNumber>
    <ProductName>MAXTREX 5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004853</DrugIDPK>
    <LicenceNumber>PA0236/014/006</LicenceNumber>
    <ProductName>MAXTREX INTRATHECAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000728</DrugIDPK>
    <LicenceNumber>PA0016/019/001</LicenceNumber>
    <ProductName>MEDRONE ACNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004861</DrugIDPK>
    <LicenceNumber>PA0236/014/014</LicenceNumber>
    <ProductName>METHOTREXAATE 1000</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004989</DrugIDPK>
    <LicenceNumber>PA0236/014/010</LicenceNumber>
    <ProductName>METHOTREXATE 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004859</DrugIDPK>
    <LicenceNumber>PA0236/014/012</LicenceNumber>
    <ProductName>METHOTREXATE 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004862</DrugIDPK>
    <LicenceNumber>PA0236/014/015</LicenceNumber>
    <ProductName>METHOTREXATE 2000</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004858</DrugIDPK>
    <LicenceNumber>PA0236/014/011</LicenceNumber>
    <ProductName>METHOTREXATE 50</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004860</DrugIDPK>
    <LicenceNumber>PA0236/014/013</LicenceNumber>
    <ProductName>METHOTREXATE 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004863</DrugIDPK>
    <LicenceNumber>PA0236/014/016</LicenceNumber>
    <ProductName>METHOTREXATE 5000</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003030</DrugIDPK>
    <LicenceNumber>PA0060/045/001</LicenceNumber>
    <ProductName>MINTEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000713</DrugIDPK>
    <LicenceNumber>PA0016/011/003</LicenceNumber>
    <ProductName>MYCIGUENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000711</DrugIDPK>
    <LicenceNumber>PA0016/011/002</LicenceNumber>
    <ProductName>MYCIGUENT OPHTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000718</DrugIDPK>
    <LicenceNumber>PA0016/013/002</LicenceNumber>
    <ProductName>NEO-MEDRONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>METHYLPREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003550</DrugIDPK>
    <LicenceNumber>PA0114/029/002</LicenceNumber>
    <ProductName>NITROCONTIN CONTINUS</ProductName>
    <Strength>6.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003546</DrugIDPK>
    <LicenceNumber>PA0114/029/001</LicenceNumber>
    <ProductName>NITROCONTIN CONTINUS</ProductName>
    <Strength>2.6</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004910</DrugIDPK>
    <LicenceNumber>PA0236/016/003</LicenceNumber>
    <ProductName>PHARMORUBICIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003723</DrugIDPK>
    <LicenceNumber>PA0114/061/001</LicenceNumber>
    <ProductName>PRANOXEN CONTINUS</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003724</DrugIDPK>
    <LicenceNumber>PA0114/061/002</LicenceNumber>
    <ProductName>PRANOXEN CONTINUS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1993-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004895</DrugIDPK>
    <LicenceNumber>PA0236/015/002</LicenceNumber>
    <ProductName>REFOLINON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004899</DrugIDPK>
    <LicenceNumber>PA0236/015/003</LicenceNumber>
    <ProductName>REFOLINON</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004864</DrugIDPK>
    <LicenceNumber>PA0236/015/001</LicenceNumber>
    <ProductName>REFOLINON</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1984-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000223</DrugIDPK>
    <LicenceNumber>PA0050/048/001</LicenceNumber>
    <ProductName>RONICOL TABLETS 25MG</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000222</DrugIDPK>
    <LicenceNumber>PA0050/048/002</LicenceNumber>
    <ProductName>RONICOL TIMESPAN TABLETS 150MG</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003077</DrugIDPK>
    <LicenceNumber>PA0062/024/005</LicenceNumber>
    <ProductName>STAFOXIL</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1983-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001512</DrugIDPK>
    <LicenceNumber>PA0028/016/001</LicenceNumber>
    <ProductName>SYNACTHEN DEPOT AMPOULES</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1979-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACOSACTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004927</DrugIDPK>
    <LicenceNumber>PA0236/017/001</LicenceNumber>
    <ProductName>TAMOXIFEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004930</DrugIDPK>
    <LicenceNumber>PA0236/017/002</LicenceNumber>
    <ProductName>TAMOXIFEN 20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004932</DrugIDPK>
    <LicenceNumber>PA0236/017/003</LicenceNumber>
    <ProductName>TAMOXIFEN 40</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004938</DrugIDPK>
    <LicenceNumber>PA0236/019/002</LicenceNumber>
    <ProductName>TEMAZEPAM ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002877</DrugIDPK>
    <LicenceNumber>PA0057/010/001</LicenceNumber>
    <ProductName>TRIBIOTIC SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000720</DrugIDPK>
    <LicenceNumber>PA0016/015/001</LicenceNumber>
    <ProductName>TROBICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SPECTINOMYCIN DIHYDROCHLORIDE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003590</DrugIDPK>
    <LicenceNumber>PA0114/045/003</LicenceNumber>
    <ProductName>VIBROX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009002</DrugIDPK>
    <LicenceNumber>PA0011/027/014</LicenceNumber>
    <ProductName>VOLTAROL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009005</DrugIDPK>
    <LicenceNumber>PA0011/027/015</LicenceNumber>
    <ProductName>VOLTAROL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1996-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002123</DrugIDPK>
    <LicenceNumber>PA0043/001/001</LicenceNumber>
    <ProductName>CROOKES HALIBUT LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004064</DrugIDPK>
    <LicenceNumber>PA0145/007/001</LicenceNumber>
    <ProductName>ESSAVEN</ProductName>
    <Strength>1/10000/1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCIN</ActiveSubstance>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>PHOSPHOLIPIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002749</DrugIDPK>
    <LicenceNumber>PA0050/006/002</LicenceNumber>
    <ProductName>ALCOBON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCYTOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005069</DrugIDPK>
    <LicenceNumber>PA0237/023/001</LicenceNumber>
    <ProductName>ASMAVEN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016174</DrugIDPK>
    <LicenceNumber>PA0032/007/002</LicenceNumber>
    <ProductName>ASPRO EXTRA STRENGH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000841</DrugIDPK>
    <LicenceNumber>PA0017/009/001</LicenceNumber>
    <ProductName>CICATRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002041</DrugIDPK>
    <LicenceNumber>PA0046/004/002</LicenceNumber>
    <ProductName>FUCIDIN CAVIJECT</ProductName>
    <Strength>7</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995003705</DrugIDPK>
    <LicenceNumber>PA0294/015/002</LicenceNumber>
    <ProductName>HYDRAMIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005727</DrugIDPK>
    <LicenceNumber>PA0294/015/001</LicenceNumber>
    <ProductName>HYDRAMIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000475</DrugIDPK>
    <LicenceNumber>PA0007/029/001</LicenceNumber>
    <ProductName>METHRAZONE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEPRAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002110</DrugIDPK>
    <LicenceNumber>PA0041/045/001</LicenceNumber>
    <ProductName>ORNIDYL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EFLORNITHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002111</DrugIDPK>
    <LicenceNumber>PA0041/045/002</LicenceNumber>
    <ProductName>ORNIDYL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EFLORNITHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006764</DrugIDPK>
    <LicenceNumber>PA0585/001/001</LicenceNumber>
    <ProductName>PERCUTOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>1991-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000844</DrugIDPK>
    <LicenceNumber>PA0017/010/002</LicenceNumber>
    <ProductName>POLYBACTRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003593</DrugIDPK>
    <LicenceNumber>PA0114/047/001</LicenceNumber>
    <ProductName>PROSEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPANOL</ActiveSubstance>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002293</DrugIDPK>
    <LicenceNumber>PA0048/001/007</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005691</DrugIDPK>
    <LicenceNumber>PA0291/001/001</LicenceNumber>
    <ProductName>ASPERCREME</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Thompson Medical Co. Ltd</PAHolder>
    <AuthorisedDate>1981-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>TROLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006100</DrugIDPK>
    <LicenceNumber>PA0437/019/002</LicenceNumber>
    <ProductName>BUPIVACINE HYDROCHLORIDE INJECTION</ProductName>
    <Strength>0.5%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000380</DrugIDPK>
    <LicenceNumber>PA0002/053/001</LicenceNumber>
    <ProductName>CAPOZIDE</ProductName>
    <Strength>25/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1986-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006176</DrugIDPK>
    <LicenceNumber>PA0437/022/003</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006181</DrugIDPK>
    <LicenceNumber>PA0437/022/005</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006106</DrugIDPK>
    <LicenceNumber>PA0437/022/001</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOTATE</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1991-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005273</DrugIDPK>
    <LicenceNumber>PA0281/006/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000473</DrugIDPK>
    <LicenceNumber>PA0007/028/001</LicenceNumber>
    <ProductName>LENDORMIN</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1986-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROTIZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000474</DrugIDPK>
    <LicenceNumber>PA0007/028/002</LicenceNumber>
    <ProductName>LENDORMIN</ProductName>
    <Strength>0.250</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1986-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROTIZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008302</DrugIDPK>
    <LicenceNumber>PA0050/067/003</LicenceNumber>
    <ProductName>MOBIFLEX MILK GRANULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1990-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005613</DrugIDPK>
    <LicenceNumber>PA0310/001/004</LicenceNumber>
    <ProductName>MONOTRIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A/S GEA Farmaceutisk Fabrik</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001771</DrugIDPK>
    <LicenceNumber>PA0033/005/015</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002747</DrugIDPK>
    <LicenceNumber>PA0050/005/001</LicenceNumber>
    <ProductName>NIPRIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NITROPRUSSIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003125</DrugIDPK>
    <LicenceNumber>PA0073/002/001</LicenceNumber>
    <ProductName>PEKOLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN</ActiveSubstance>
      <ActiveSubstance>PECTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003164</DrugIDPK>
    <LicenceNumber>PA0068/006/003</LicenceNumber>
    <ProductName>PONDERAX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>1981-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENFLURAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001801</DrugIDPK>
    <LicenceNumber>PA0033/016/003</LicenceNumber>
    <ProductName>SYNFLEX FORTE</ProductName>
    <Strength>550</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1986-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000296</DrugIDPK>
    <LicenceNumber>PA0002/014/008</LicenceNumber>
    <ProductName>VELOSEF  INJECTION</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006643</DrugIDPK>
    <LicenceNumber>PA0513/001/001</LicenceNumber>
    <ProductName>VIRAZOLE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>ICN Pharmaceuticals Holland BV</PAHolder>
    <AuthorisedDate>1990-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001857</DrugIDPK>
    <LicenceNumber>PA0771/001/001</LicenceNumber>
    <ProductName>FLUTACAN  250MG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Schering Pharma Oy</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001968</DrugIDPK>
    <LicenceNumber>PA0040/064/004</LicenceNumber>
    <ProductName>HEXABRIX 200</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1986-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOXAGLATE MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>IOXAGLATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002959</DrugIDPK>
    <LicenceNumber>PA0059/002/003</LicenceNumber>
    <ProductName>MONISTAT</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1984-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005861</DrugIDPK>
    <LicenceNumber>PA0303/022/001</LicenceNumber>
    <ProductName>URINOX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1988-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005862</DrugIDPK>
    <LicenceNumber>PA0303/022/002</LicenceNumber>
    <ProductName>URINOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1988-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005863</DrugIDPK>
    <LicenceNumber>PA0303/022/003</LicenceNumber>
    <ProductName>URINOX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1988-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000789</DrugIDPK>
    <LicenceNumber>PA0016/033/003</LicenceNumber>
    <ProductName>AMBAXIN</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1981-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006912</DrugIDPK>
    <LicenceNumber>PA0628/001/001</LicenceNumber>
    <ProductName>AOSEPT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Vision (UK) Ltd</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROGEN PEROXIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006585</DrugIDPK>
    <LicenceNumber>PA0484/018/001</LicenceNumber>
    <ProductName>AQUEOUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMULSIFYING WAX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003749</DrugIDPK>
    <LicenceNumber>PA0114/058/002</LicenceNumber>
    <ProductName>ARTHRIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1989-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003720</DrugIDPK>
    <LicenceNumber>PA0114/058/001</LicenceNumber>
    <ProductName>ARTHRIN</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002989</DrugIDPK>
    <LicenceNumber>PA0059/016/001</LicenceNumber>
    <ProductName>BINOVUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1981-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006027</DrugIDPK>
    <LicenceNumber>PA0405/009/001</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006028</DrugIDPK>
    <LicenceNumber>PA0405/009/002</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006052</DrugIDPK>
    <LicenceNumber>PA0405/021/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE 800/160</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004438</DrugIDPK>
    <LicenceNumber>PA0170/002/003</LicenceNumber>
    <ProductName>DANTRIUM (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1980-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DANTROLENE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006023</DrugIDPK>
    <LicenceNumber>PA0405/006/001</LicenceNumber>
    <ProductName>DIPYRIDAMOLE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1985-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006024</DrugIDPK>
    <LicenceNumber>PA0405/006/002</LicenceNumber>
    <ProductName>DIPYRIDAMOLE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1986-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001411</DrugIDPK>
    <LicenceNumber>PA0037/005/001</LicenceNumber>
    <ProductName>GONOCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1981-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006682</DrugIDPK>
    <LicenceNumber>PA0516/013/001</LicenceNumber>
    <ProductName>ISOLAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1988-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006684</DrugIDPK>
    <LicenceNumber>PA0516/013/002</LicenceNumber>
    <ProductName>ISOLAN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1988-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006686</DrugIDPK>
    <LicenceNumber>PA0516/013/003</LicenceNumber>
    <ProductName>ISOLAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1990-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006038</DrugIDPK>
    <LicenceNumber>PA0405/013/001</LicenceNumber>
    <ProductName>LABETALOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LABETALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006039</DrugIDPK>
    <LicenceNumber>PA0405/013/002</LicenceNumber>
    <ProductName>LABETALOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LABETALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006040</DrugIDPK>
    <LicenceNumber>PA0405/013/003</LicenceNumber>
    <ProductName>LABETALOL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LABETALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000783</DrugIDPK>
    <LicenceNumber>PA0011/029/001</LicenceNumber>
    <ProductName>LOPRESORETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006065</DrugIDPK>
    <LicenceNumber>PA0405/028/001</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006066</DrugIDPK>
    <LicenceNumber>PA0405/028/002</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006067</DrugIDPK>
    <LicenceNumber>PA0405/028/003</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002180</DrugIDPK>
    <LicenceNumber>PA0046/031/001</LicenceNumber>
    <ProductName>MIRAXID FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
      <ActiveSubstance>PIVMECILLINAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006015</DrugIDPK>
    <LicenceNumber>PA0405/002/001</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1986-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006016</DrugIDPK>
    <LicenceNumber>PA0405/002/002</LicenceNumber>
    <ProductName>NIFEDIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004606</DrugIDPK>
    <LicenceNumber>PA0187/003/001</LicenceNumber>
    <ProductName>PED EL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001758</DrugIDPK>
    <LicenceNumber>PA0032/037/001</LicenceNumber>
    <ProductName>PEGALAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM SULFATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006393</DrugIDPK>
    <LicenceNumber>PPA0465/022/001</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1990-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005895</DrugIDPK>
    <LicenceNumber>PA0372/002/001</LicenceNumber>
    <ProductName>PHASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>1986-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LITHIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006034</DrugIDPK>
    <LicenceNumber>PA0405/012/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006035</DrugIDPK>
    <LicenceNumber>PA0405/012/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006036</DrugIDPK>
    <LicenceNumber>PA0405/012/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006037</DrugIDPK>
    <LicenceNumber>PA0405/012/005</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002754</DrugIDPK>
    <LicenceNumber>PA0050/007/005</LicenceNumber>
    <ProductName>REDOXON EFFERVESCENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1981-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001718</DrugIDPK>
    <LicenceNumber>PA0030/012/001</LicenceNumber>
    <ProductName>SABIDAL</ProductName>
    <Strength>135</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1982-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001725</DrugIDPK>
    <LicenceNumber>PA0030/012/002</LicenceNumber>
    <ProductName>SABIDAL SR</ProductName>
    <Strength>270</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1986-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005980</DrugIDPK>
    <LicenceNumber>PA0396/005/002</LicenceNumber>
    <ProductName>SULPHACETAMIDE EYE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Daniels Pharmaceutical Ltd</PAHolder>
    <AuthorisedDate>1990-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006043</DrugIDPK>
    <LicenceNumber>PA0405/015/001</LicenceNumber>
    <ProductName>SULPHASALAZINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1987-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000583</DrugIDPK>
    <LicenceNumber>PA0013/018/005</LicenceNumber>
    <ProductName>SYNTOCINON (SPRAY)</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYTOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009129</DrugIDPK>
    <LicenceNumber>PA0237/055/003</LicenceNumber>
    <ProductName>TIMPRON EC</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009131</DrugIDPK>
    <LicenceNumber>PA0237/055/004</LicenceNumber>
    <ProductName>TIMPRON EC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006055</DrugIDPK>
    <LicenceNumber>PA0405/023/001</LicenceNumber>
    <ProductName>TRIAZOLAM</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016369</DrugIDPK>
    <LicenceNumber>PA0044/003/007</LicenceNumber>
    <ProductName>VENTOLIN SPANDETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002843</DrugIDPK>
    <LicenceNumber>PA0056/064/002</LicenceNumber>
    <ProductName>NICONIL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1992-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002842</DrugIDPK>
    <LicenceNumber>PA0056/064/001</LicenceNumber>
    <ProductName>NICONIL 30</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1990-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006624</DrugIDPK>
    <LicenceNumber>PA0500/001/002</LicenceNumber>
    <ProductName>KALTOSTAT CAVITY DRESSING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>CV Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006623</DrugIDPK>
    <LicenceNumber>PA0500/001/001</LicenceNumber>
    <ProductName>KALTOSTAT WOUND DRESSING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>CV Laboratories Limited</PAHolder>
    <AuthorisedDate>1991-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002746</DrugIDPK>
    <LicenceNumber>PA0050/003/007</LicenceNumber>
    <ProductName>BACTRIM</ProductName>
    <Strength>Double</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006652</DrugIDPK>
    <LicenceNumber>PA0515/002/001</LicenceNumber>
    <ProductName>CLOMIPHENE CITRATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hogens Limited</PAHolder>
    <AuthorisedDate>1990-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000469</DrugIDPK>
    <LicenceNumber>PA0072/011/001</LicenceNumber>
    <ProductName>CRUEX MEDICATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM UNDECYLEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005866</DrugIDPK>
    <LicenceNumber>PA0302/007/001</LicenceNumber>
    <ProductName>DDD MEDICATED LOTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003663</DrugIDPK>
    <LicenceNumber>PA0108/001/002</LicenceNumber>
    <ProductName>DUVADILAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1981-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006217</DrugIDPK>
    <LicenceNumber>PA0447/002/002</LicenceNumber>
    <ProductName>FENOPRON</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1986-02-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002529</DrugIDPK>
    <LicenceNumber>PA0054/060/001</LicenceNumber>
    <ProductName>MICRO K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1986-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002197</DrugIDPK>
    <LicenceNumber>PA0047/050/001</LicenceNumber>
    <ProductName>PROGESIC</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000980</DrugIDPK>
    <LicenceNumber>PA0017/092/003</LicenceNumber>
    <ProductName>RETROVIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1987-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIDOVUDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004733</DrugIDPK>
    <LicenceNumber>PA0187/028/001</LicenceNumber>
    <ProductName>SOMATONORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHIONYL HUMAN SOMATOTROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003664</DrugIDPK>
    <LicenceNumber>PA0108/002/001</LicenceNumber>
    <ProductName>TACHYROL</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1976-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROTACHYSTEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001846</DrugIDPK>
    <LicenceNumber>PA0035/053/004</LicenceNumber>
    <ProductName>TIMOPTOL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1986-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004734</DrugIDPK>
    <LicenceNumber>PA0200/007/003</LicenceNumber>
    <ProductName>TRIDIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1990-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001636</DrugIDPK>
    <LicenceNumber>PA0037/064/001</LicenceNumber>
    <ProductName>VANCOSTAT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1990-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000401</DrugIDPK>
    <LicenceNumber>PA0002/057/010</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1993-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002888</DrugIDPK>
    <LicenceNumber>PA0057/054/005</LicenceNumber>
    <ProductName>AEROLIN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1986-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005985</DrugIDPK>
    <LicenceNumber>PA0398/001/002</LicenceNumber>
    <ProductName>ALLEREZE ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Intercare Products Ltd</PAHolder>
    <AuthorisedDate>1986-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005468</DrugIDPK>
    <LicenceNumber>PA0282/004/005</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007422</DrugIDPK>
    <LicenceNumber>PA0282/004/006</LicenceNumber>
    <ProductName>AMPICILLIN SYRUP B P</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1990-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002745</DrugIDPK>
    <LicenceNumber>PA0050/003/006</LicenceNumber>
    <ProductName>BACTRIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002738</DrugIDPK>
    <LicenceNumber>PA0050/003/002</LicenceNumber>
    <ProductName>BACTRIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002741</DrugIDPK>
    <LicenceNumber>PA0050/003/003</LicenceNumber>
    <ProductName>BACTRIM ADULT (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002744</DrugIDPK>
    <LicenceNumber>PA0050/003/005</LicenceNumber>
    <ProductName>BACTRIM PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005944</DrugIDPK>
    <LicenceNumber>PPA0384/010/002</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1990-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005793</DrugIDPK>
    <LicenceNumber>PA0360/023/001</LicenceNumber>
    <ProductName>CAVED-S</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEGLYCYRRHIZINIZED EXTRACT OF LIQUORICE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006588</DrugIDPK>
    <LicenceNumber>PA0484/019/001</LicenceNumber>
    <ProductName>COAL TAR OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002243</DrugIDPK>
    <LicenceNumber>PA0046/057/002</LicenceNumber>
    <ProductName>DICAPEN</ProductName>
    <Strength>0.75</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1989-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM</ActiveSubstance>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002244</DrugIDPK>
    <LicenceNumber>PA0046/057/003</LicenceNumber>
    <ProductName>DICAPEN</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1989-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM</ActiveSubstance>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006578</DrugIDPK>
    <LicenceNumber>PA0484/010/001</LicenceNumber>
    <ProductName>EUSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORINATED LIME AND BORIC ACID SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001479</DrugIDPK>
    <LicenceNumber>PA0027/041/001</LicenceNumber>
    <ProductName>GASTRITEX LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1991-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARBOMER</ActiveSubstance>
      <ActiveSubstance>CARBENOXOLONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004592</DrugIDPK>
    <LicenceNumber>PA0186/001/001</LicenceNumber>
    <ProductName>GYNATREN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Solco Basle A.G.</PAHolder>
    <AuthorisedDate>1985-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LACTOBACILLUS ACIDOPHILUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003951</DrugIDPK>
    <LicenceNumber>PA0126/083/001</LicenceNumber>
    <ProductName>HALIBUT LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003652</DrugIDPK>
    <LicenceNumber>PA0107/001/001</LicenceNumber>
    <ProductName>HYSKON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000239</DrugIDPK>
    <LicenceNumber>PA0004/049/001</LicenceNumber>
    <ProductName>JUNIFEN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1991-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004625</DrugIDPK>
    <LicenceNumber>PA0187/013/001</LicenceNumber>
    <ProductName>KABIKINASE</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-01-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004633</DrugIDPK>
    <LicenceNumber>PA0187/013/003</LicenceNumber>
    <ProductName>KABIKINASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003439</DrugIDPK>
    <LicenceNumber>PA0079/015/004</LicenceNumber>
    <ProductName>KOATE-H.T.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1985-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003440</DrugIDPK>
    <LicenceNumber>PA0079/015/005</LicenceNumber>
    <ProductName>KOATE-H.T.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1985-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003441</DrugIDPK>
    <LicenceNumber>PA0079/015/006</LicenceNumber>
    <ProductName>KOATE-H.T.</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1985-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003364</DrugIDPK>
    <LicenceNumber>PA0077/025/001</LicenceNumber>
    <ProductName>LOBAK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORMEZANONE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002957</DrugIDPK>
    <LicenceNumber>PA0059/002/001</LicenceNumber>
    <ProductName>MONISTAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1976-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002978</DrugIDPK>
    <LicenceNumber>PA0059/009/005</LicenceNumber>
    <ProductName>PEVARYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1975-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001675</DrugIDPK>
    <LicenceNumber>PA0038/037/001</LicenceNumber>
    <ProductName>PLEGISOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1986-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001731</DrugIDPK>
    <LicenceNumber>PA0030/012/004</LicenceNumber>
    <ProductName>SABIDAL RECTIOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1987-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001728</DrugIDPK>
    <LicenceNumber>PA0030/012/003</LicenceNumber>
    <ProductName>SABIDAL RECTIOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1987-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003774</DrugIDPK>
    <LicenceNumber>PA0118/001/001</LicenceNumber>
    <ProductName>SIMPLENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1976-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002355</DrugIDPK>
    <LicenceNumber>PA0048/018/001</LicenceNumber>
    <ProductName>SOTAZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000686</DrugIDPK>
    <LicenceNumber>PA0011/001/008</LicenceNumber>
    <ProductName>TEGRETOL CHEWTABS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1989-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000792</DrugIDPK>
    <LicenceNumber>PA0011/001/007</LicenceNumber>
    <ProductName>TEGRETOL CHEWTABS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1989-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003371</DrugIDPK>
    <LicenceNumber>PA0077/041/001</LicenceNumber>
    <ProductName>TRANCOPAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORMEZANONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006478</DrugIDPK>
    <LicenceNumber>PA0468/021/004</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1991-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004043</DrugIDPK>
    <LicenceNumber>PA0148/011/001</LicenceNumber>
    <ProductName>HYDROCARE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004624</DrugIDPK>
    <LicenceNumber>PA0179/008/002</LicenceNumber>
    <ProductName>OSMOFUNDIN 20%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1991-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005720</DrugIDPK>
    <LicenceNumber>PA0330/004/001</LicenceNumber>
    <ProductName>INADINE DRESSING</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>1986-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1996-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002061</DrugIDPK>
    <LicenceNumber>PA0040/089/002</LicenceNumber>
    <ProductName>10-BENZAGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1990-12-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002060</DrugIDPK>
    <LicenceNumber>PA0040/089/001</LicenceNumber>
    <ProductName>5-BENZAGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1990-12-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002313</DrugIDPK>
    <LicenceNumber>PA0048/002/002</LicenceNumber>
    <ProductName>CEFATREXYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1975-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAPIRIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005241</DrugIDPK>
    <LicenceNumber>PA0278/002/001</LicenceNumber>
    <ProductName>DITHROLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1980-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003680</DrugIDPK>
    <LicenceNumber>PA0108/016/002</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1989-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001739</DrugIDPK>
    <LicenceNumber>PA0032/004/006</LicenceNumber>
    <ProductName>GENTICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001742</DrugIDPK>
    <LicenceNumber>PA0032/004/009</LicenceNumber>
    <ProductName>GENTICIN EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001745</DrugIDPK>
    <LicenceNumber>PA0032/006/002</LicenceNumber>
    <ProductName>GENTISONE HC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001746</DrugIDPK>
    <LicenceNumber>PA0032/006/003</LicenceNumber>
    <ProductName>GENTISONE HC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1991-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001874</DrugIDPK>
    <LicenceNumber>PA0032/018/001</LicenceNumber>
    <ProductName>NICHOLAS CO2 GRANULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1982-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
      <ActiveSubstance>BETAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001939</DrugIDPK>
    <LicenceNumber>PA0040/042/005</LicenceNumber>
    <ProductName>PHENERGAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002152</DrugIDPK>
    <LicenceNumber>PA0046/009/001</LicenceNumber>
    <ProductName>PONDOCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004745</DrugIDPK>
    <LicenceNumber>PA0206/013/001</LicenceNumber>
    <ProductName>SANOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEXACHLOROPHENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002310</DrugIDPK>
    <LicenceNumber>PA0048/002/001</LicenceNumber>
    <ProductName>CEFATREXYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1975-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAPIRIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001757</DrugIDPK>
    <LicenceNumber>PA0032/035/002</LicenceNumber>
    <ProductName>PLATET CLEARTAB</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1990-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000389</DrugIDPK>
    <LicenceNumber>PA0002/056/001</LicenceNumber>
    <ProductName>STARIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOSINOPRIL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001676</DrugIDPK>
    <LicenceNumber>PA0038/038/001</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE IN 5% DEXTROSE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1985-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001677</DrugIDPK>
    <LicenceNumber>PA0038/038/002</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE IN 5% DEXTROSE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1985-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001678</DrugIDPK>
    <LicenceNumber>PA0038/038/003</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE IN 5% DEXTROSE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1985-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006213</DrugIDPK>
    <LicenceNumber>PA0441/035/001</LicenceNumber>
    <ProductName>REGULAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1990-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISPAGHULA HUSKS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005005</DrugIDPK>
    <LicenceNumber>PA0235/008/006</LicenceNumber>
    <ProductName>CEREBRAL 280 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005008</DrugIDPK>
    <LicenceNumber>PA0235/008/007</LicenceNumber>
    <ProductName>CEREBRAL 280 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005009</DrugIDPK>
    <LicenceNumber>PA0235/008/008</LicenceNumber>
    <ProductName>CORONAR 370 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003746</DrugIDPK>
    <LicenceNumber>PA0115/001/007</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1980-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004232</DrugIDPK>
    <LicenceNumber>PA0167/019/001</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004233</DrugIDPK>
    <LicenceNumber>PA0167/019/002</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004234</DrugIDPK>
    <LicenceNumber>PA0167/019/003</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004235</DrugIDPK>
    <LicenceNumber>PA0167/019/004</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004237</DrugIDPK>
    <LicenceNumber>PA0167/019/006</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004238</DrugIDPK>
    <LicenceNumber>PA0167/019/007</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004239</DrugIDPK>
    <LicenceNumber>PA0167/019/008</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004240</DrugIDPK>
    <LicenceNumber>PA0167/019/009</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004241</DrugIDPK>
    <LicenceNumber>PA0167/019/010</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004242</DrugIDPK>
    <LicenceNumber>PA0167/019/011</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004243</DrugIDPK>
    <LicenceNumber>PA0167/019/012</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004244</DrugIDPK>
    <LicenceNumber>PA0167/019/013</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004245</DrugIDPK>
    <LicenceNumber>PA0167/019/014</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004246</DrugIDPK>
    <LicenceNumber>PA0167/019/015</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004236</DrugIDPK>
    <LicenceNumber>PA0167/019/005</LicenceNumber>
    <ProductName>DIANEAL K139/GLUCOSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004999</DrugIDPK>
    <LicenceNumber>PA0235/008/001</LicenceNumber>
    <ProductName>ISOPAQUE 350 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005000</DrugIDPK>
    <LicenceNumber>PA0235/008/002</LicenceNumber>
    <ProductName>ISOPAQUE 350 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005002</DrugIDPK>
    <LicenceNumber>PA0235/008/004</LicenceNumber>
    <ProductName>ISOPAQUE AMIN 200 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005003</DrugIDPK>
    <LicenceNumber>PA0235/008/005</LicenceNumber>
    <ProductName>ISOPAQUE AMIN 200 MG</ProductName>
    <Strength>I</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001181</DrugIDPK>
    <LicenceNumber>PA0022/009/002</LicenceNumber>
    <ProductName>PENIDURAL  (SUSPENSION)</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZATHINE BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>PROCAINE PENICILLIN G</ActiveSubstance>
      <ActiveSubstance>BENZYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002961</DrugIDPK>
    <LicenceNumber>PA0059/003/003</LicenceNumber>
    <ProductName>TOLECTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1981-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLMETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005967</DrugIDPK>
    <LicenceNumber>PA0392/009/001</LicenceNumber>
    <ProductName>WHITE PETROLEUM JELLY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WHITE SOFT PARAFFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003999</DrugIDPK>
    <LicenceNumber>PA0144/017/003</LicenceNumber>
    <ProductName>ANTHRANOL 3.0</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006415</DrugIDPK>
    <LicenceNumber>PA0437/009/002</LicenceNumber>
    <ProductName>VINBLASTINE SULPHATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1990-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINBLASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005865</DrugIDPK>
    <LicenceNumber>PA0302/005/001</LicenceNumber>
    <ProductName>DDD MEDICATED CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate>1990-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004668</DrugIDPK>
    <LicenceNumber>PA0179/036/001</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1990-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004669</DrugIDPK>
    <LicenceNumber>PA0179/036/002</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1990-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001218</DrugIDPK>
    <LicenceNumber>PA0022/033/001</LicenceNumber>
    <ProductName>APISATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMFEPRAMONE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001620</DrugIDPK>
    <LicenceNumber>PA0028/060/001</LicenceNumber>
    <ProductName>AREDIA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1990-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000752</DrugIDPK>
    <LicenceNumber>PA0011/021/001</LicenceNumber>
    <ProductName>BUTACOTE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000896</DrugIDPK>
    <LicenceNumber>PA0017/028/002</LicenceNumber>
    <ProductName>DIPHTHERIA &amp; TETANUS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004909</DrugIDPK>
    <LicenceNumber>PA0224/007/004</LicenceNumber>
    <ProductName>EMTEXATE METHOTREXATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004911</DrugIDPK>
    <LicenceNumber>PA0224/007/005</LicenceNumber>
    <ProductName>EMTEXATE METHOTREXATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004912</DrugIDPK>
    <LicenceNumber>PA0224/007/006</LicenceNumber>
    <ProductName>EMTEXATE METHOTREXATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001288</DrugIDPK>
    <LicenceNumber>PA0023/060/001</LicenceNumber>
    <ProductName>INSUMAN  BASAL HOE 36H</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001291</DrugIDPK>
    <LicenceNumber>PA0023/061/001</LicenceNumber>
    <ProductName>INSUMAN COMB 15/85 32H</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001292</DrugIDPK>
    <LicenceNumber>PA0023/061/002</LicenceNumber>
    <ProductName>INSUMAN COMB 25/75 33H</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001293</DrugIDPK>
    <LicenceNumber>PA0023/061/003</LicenceNumber>
    <ProductName>INSUMAN COMB 50/50 34H</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN INSULIN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001278</DrugIDPK>
    <LicenceNumber>PA0023/057/001</LicenceNumber>
    <ProductName>INSUMAN RAPID HOE 31H</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002849</DrugIDPK>
    <LicenceNumber>PA0060/002/003</LicenceNumber>
    <ProductName>REDEPTIN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1975-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000830</DrugIDPK>
    <LicenceNumber>PA0017/002/008</LicenceNumber>
    <ProductName>SEPTRIN I.M.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000831</DrugIDPK>
    <LicenceNumber>PA0017/002/009</LicenceNumber>
    <ProductName>SEPTRIN PAEDIATRIC DISPERSIBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1989-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000787</DrugIDPK>
    <LicenceNumber>PA0011/030/001</LicenceNumber>
    <ProductName>SINTHROME</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1983-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACENOCOUMAROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005859</DrugIDPK>
    <LicenceNumber>PA0303/021/001</LicenceNumber>
    <ProductName>TOMAXEN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005860</DrugIDPK>
    <LicenceNumber>PA0303/021/002</LicenceNumber>
    <ProductName>TOMAXEN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003068</DrugIDPK>
    <LicenceNumber>PA0062/015/002</LicenceNumber>
    <ProductName>TRIMOXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003069</DrugIDPK>
    <LicenceNumber>PA0062/015/003</LicenceNumber>
    <ProductName>TRIMOXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003067</DrugIDPK>
    <LicenceNumber>PA0062/015/001</LicenceNumber>
    <ProductName>TRIMOXOL SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001716</DrugIDPK>
    <LicenceNumber>PA0030/011/001</LicenceNumber>
    <ProductName>VAREMOID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004797</DrugIDPK>
    <LicenceNumber>PA0212/001/001</LicenceNumber>
    <ProductName>KRYOBULIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1975-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004798</DrugIDPK>
    <LicenceNumber>PA0212/001/003</LicenceNumber>
    <ProductName>KRYOBULIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1975-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004799</DrugIDPK>
    <LicenceNumber>PA0212/001/002</LicenceNumber>
    <ProductName>KRYOBULIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Immuno Limited</PAHolder>
    <AuthorisedDate>1975-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001034</DrugIDPK>
    <LicenceNumber>PA0018/043/001</LicenceNumber>
    <ProductName>CYSTOPURIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1990-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004449</DrugIDPK>
    <LicenceNumber>PA0170/013/001</LicenceNumber>
    <ProductName>TOPICYCLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1990-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004659</DrugIDPK>
    <LicenceNumber>PA0179/032/001</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1990-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003531</DrugIDPK>
    <LicenceNumber>PA0088/003/001</LicenceNumber>
    <ProductName>ENDOXANA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000534</DrugIDPK>
    <LicenceNumber>PA0009/034/001</LicenceNumber>
    <ProductName>RHINOCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001388</DrugIDPK>
    <LicenceNumber>PA0035/069/003</LicenceNumber>
    <ProductName>PEPCID  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1990-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004221</DrugIDPK>
    <LicenceNumber>PA0107/017/020</LicenceNumber>
    <ProductName>DIANEAL 137/GLUCOSE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1985-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001761</DrugIDPK>
    <LicenceNumber>PA0033/001/002</LicenceNumber>
    <ProductName>SYNETEX MENOPHASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1985-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002787</DrugIDPK>
    <LicenceNumber>PA0056/012/001</LicenceNumber>
    <ProductName>BENYLIN DECONGESTANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1976-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000750</DrugIDPK>
    <LicenceNumber>PA0011/013/003</LicenceNumber>
    <ProductName>BUTAZOLIDIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000747</DrugIDPK>
    <LicenceNumber>PA0011/013/002</LicenceNumber>
    <ProductName>BUTAZOLIDIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002789</DrugIDPK>
    <LicenceNumber>PA0056/015/001</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002791</DrugIDPK>
    <LicenceNumber>PA0056/015/006</LicenceNumber>
    <ProductName>CHLOROMYCETIN OPHTHALMIC (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009282</DrugIDPK>
    <LicenceNumber>PA0549/001/007</LicenceNumber>
    <ProductName>DIACARDYNE</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1995-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000042</DrugIDPK>
    <LicenceNumber>PA0549/001/006</LicenceNumber>
    <ProductName>DIACARDYNE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1995-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000043</DrugIDPK>
    <LicenceNumber>PA0549/001/008</LicenceNumber>
    <ProductName>DIACARDYNE LA</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1995-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000044</DrugIDPK>
    <LicenceNumber>PA0549/001/009</LicenceNumber>
    <ProductName>DIACARDYNE LA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>1995-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003063</DrugIDPK>
    <LicenceNumber>PA0062/010/002</LicenceNumber>
    <ProductName>DISIPAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000181</DrugIDPK>
    <LicenceNumber>PA0060/025/001</LicenceNumber>
    <ProductName>ESKORNADE SPANSULE CAPSULES (BOTTLES)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000180</DrugIDPK>
    <LicenceNumber>PA0060/025/003</LicenceNumber>
    <ProductName>ESKORNADE SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Smith &amp; Nephew Pharmaceuticals</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002915</DrugIDPK>
    <LicenceNumber>PA0057/060/004</LicenceNumber>
    <ProductName>EXIREL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1989-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRBUTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002916</DrugIDPK>
    <LicenceNumber>PA0057/060/005</LicenceNumber>
    <ProductName>EXIREL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1989-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIRBUTEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002911</DrugIDPK>
    <LicenceNumber>PA0057/060/001</LicenceNumber>
    <ProductName>EXIREL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1989-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRBUTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002912</DrugIDPK>
    <LicenceNumber>PA0057/060/002</LicenceNumber>
    <ProductName>EXIREL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRBUTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002913</DrugIDPK>
    <LicenceNumber>PA0057/060/003</LicenceNumber>
    <ProductName>EXIREL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1989-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRBUTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002631</DrugIDPK>
    <LicenceNumber>PA0049/018/013</LicenceNumber>
    <ProductName>FLOXAPEN SYRUP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002632</DrugIDPK>
    <LicenceNumber>PA0049/018/014</LicenceNumber>
    <ProductName>FLOXAPEN SYRUP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001738</DrugIDPK>
    <LicenceNumber>PA0032/004/004</LicenceNumber>
    <ProductName>GENTIAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001741</DrugIDPK>
    <LicenceNumber>PA0032/004/008</LicenceNumber>
    <ProductName>GENTIC PURE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001740</DrugIDPK>
    <LicenceNumber>PA0032/004/007</LicenceNumber>
    <ProductName>GENTICIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001737</DrugIDPK>
    <LicenceNumber>PA0032/004/002</LicenceNumber>
    <ProductName>GENTICIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002427</DrugIDPK>
    <LicenceNumber>PA0051/046/001</LicenceNumber>
    <ProductName>HIBITANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000719</DrugIDPK>
    <LicenceNumber>PA0011/004/003</LicenceNumber>
    <ProductName>HYGROTON</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001257</DrugIDPK>
    <LicenceNumber>PA0023/050/002</LicenceNumber>
    <ProductName>LASORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1990-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005155</DrugIDPK>
    <LicenceNumber>PA0255/018/003</LicenceNumber>
    <ProductName>LIGNOCAINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001249</DrugIDPK>
    <LicenceNumber>PA0022/044/003</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1990-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001250</DrugIDPK>
    <LicenceNumber>PA0022/044/004</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1990-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003033</DrugIDPK>
    <LicenceNumber>PA0060/047/002</LicenceNumber>
    <ProductName>MESASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1990-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005158</DrugIDPK>
    <LicenceNumber>PA0255/035/001</LicenceNumber>
    <ProductName>METHYLPREDNISOLONE SODIUM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1988-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005224</DrugIDPK>
    <LicenceNumber>PA0255/035/002</LicenceNumber>
    <ProductName>METHYLPREDNISOLONE SODIUM SUCCINATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1988-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001515</DrugIDPK>
    <LicenceNumber>PA0028/022/001</LicenceNumber>
    <ProductName>NAVIDREX - K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003363</DrugIDPK>
    <LicenceNumber>PA0077/023/003</LicenceNumber>
    <ProductName>PANADOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002704</DrugIDPK>
    <LicenceNumber>PA0049/042/003</LicenceNumber>
    <ProductName>PARENTROVITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDARONE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002652</DrugIDPK>
    <LicenceNumber>PA0049/042/002</LicenceNumber>
    <ProductName>PARENTROVITE IM/HP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDARONE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002651</DrugIDPK>
    <LicenceNumber>PA0049/042/001</LicenceNumber>
    <ProductName>PARENTROVITE IV/HP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDARONE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006732</DrugIDPK>
    <LicenceNumber>PA0526/001/001</LicenceNumber>
    <ProductName>PLATEMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Numed Research &amp; Development Ltd</PAHolder>
    <AuthorisedDate>1990-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001496</DrugIDPK>
    <LicenceNumber>PA0028/002/001</LicenceNumber>
    <ProductName>RIMACTANE</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001497</DrugIDPK>
    <LicenceNumber>PA0028/002/002</LicenceNumber>
    <ProductName>RIMACTANE</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001794</DrugIDPK>
    <LicenceNumber>PA0033/016/001</LicenceNumber>
    <ProductName>SYNFLEX</ProductName>
    <Strength>275</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003028</DrugIDPK>
    <LicenceNumber>PA0060/042/002</LicenceNumber>
    <ProductName>EREVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1985-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003029</DrugIDPK>
    <LicenceNumber>PA0060/042/003</LicenceNumber>
    <ProductName>EREVAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1985-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000548</DrugIDPK>
    <LicenceNumber>PA0012/068/001</LicenceNumber>
    <ProductName>ISOVIST</ProductName>
    <Strength>190</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1990-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROLAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000549</DrugIDPK>
    <LicenceNumber>PA0012/068/002</LicenceNumber>
    <ProductName>ISOVIST</ProductName>
    <Strength>190</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1990-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROLAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000551</DrugIDPK>
    <LicenceNumber>PA0012/068/004</LicenceNumber>
    <ProductName>ISOVIST</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1990-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROLAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004031</DrugIDPK>
    <LicenceNumber>PA0148/041/001</LicenceNumber>
    <ProductName>KERECID OPHTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1985-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IDOXURIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001558</DrugIDPK>
    <LicenceNumber>PA0037/041/001</LicenceNumber>
    <ProductName>ABSTEM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1980-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBIMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007393</DrugIDPK>
    <LicenceNumber>PA0118/041/002</LicenceNumber>
    <ProductName>WELLDORM</ProductName>
    <Strength>707</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLORAL BETAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007391</DrugIDPK>
    <LicenceNumber>PA0118/041/001</LicenceNumber>
    <ProductName>WELLDORM ELIXIR</ProductName>
    <Strength>143</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1990-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAL HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002647</DrugIDPK>
    <LicenceNumber>PA0049/038/001</LicenceNumber>
    <ProductName>ASERBINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006202</DrugIDPK>
    <LicenceNumber>PA0441/022/001</LicenceNumber>
    <ProductName>BIACTOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1980-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000625</DrugIDPK>
    <LicenceNumber>PA0013/027/001</LicenceNumber>
    <ProductName>CEDILANID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANATOSIDE C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003907</DrugIDPK>
    <LicenceNumber>PA0126/064/001</LicenceNumber>
    <ProductName>CLOXCIL 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003908</DrugIDPK>
    <LicenceNumber>PA0126/064/002</LicenceNumber>
    <ProductName>CLOXCIL 500</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004794</DrugIDPK>
    <LicenceNumber>PA0208/010/001</LicenceNumber>
    <ProductName>CYCLOPROPANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>BOC Gases Ireland Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002921</DrugIDPK>
    <LicenceNumber>PA0060/030/002</LicenceNumber>
    <ProductName>DIBENYLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000317</DrugIDPK>
    <LicenceNumber>PA0002/024/004</LicenceNumber>
    <ProductName>ECOSTATIN SPRAY POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000318</DrugIDPK>
    <LicenceNumber>PA0002/024/005</LicenceNumber>
    <ProductName>ECOSTATIN SPRAY SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001191</DrugIDPK>
    <LicenceNumber>PA0023/018/004</LicenceNumber>
    <ProductName>FRISIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1980-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBAZAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001196</DrugIDPK>
    <LicenceNumber>PA0023/018/006</LicenceNumber>
    <ProductName>FRISIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1980-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBAZAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005913</DrugIDPK>
    <LicenceNumber>PA0379/009/001</LicenceNumber>
    <ProductName>GERMOLOIDS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001202</DrugIDPK>
    <LicenceNumber>PA0023/025/001</LicenceNumber>
    <ProductName>HALOTHANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003591</DrugIDPK>
    <LicenceNumber>PA0114/046/001</LicenceNumber>
    <ProductName>HEADMASTER SHAMPOO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOTHRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005988</DrugIDPK>
    <LicenceNumber>PA0398/003/002</LicenceNumber>
    <ProductName>HEMOCANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Intercare Products Ltd</PAHolder>
    <AuthorisedDate>1990-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>BISMUTH OXIDE</ActiveSubstance>
      <ActiveSubstance>BENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>CINNAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000451</DrugIDPK>
    <LicenceNumber>PA0007/046/001</LicenceNumber>
    <ProductName>IFOMIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000452</DrugIDPK>
    <LicenceNumber>PA0007/046/002</LicenceNumber>
    <ProductName>IFOMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000453</DrugIDPK>
    <LicenceNumber>PA0007/046/003</LicenceNumber>
    <ProductName>IFOMIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000455</DrugIDPK>
    <LicenceNumber>PA0007/046/004</LicenceNumber>
    <ProductName>IFOMIDE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002818</DrugIDPK>
    <LicenceNumber>PA0056/049/001</LicenceNumber>
    <ProductName>LISTERINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
      <ActiveSubstance>BENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001493</DrugIDPK>
    <LicenceNumber>PA0028/001/002</LicenceNumber>
    <ProductName>LUDIOMIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAPROTILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001494</DrugIDPK>
    <LicenceNumber>PA0028/001/003</LicenceNumber>
    <ProductName>LUDIOMIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAPROTILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001495</DrugIDPK>
    <LicenceNumber>PA0028/001/004</LicenceNumber>
    <ProductName>LUDIOMIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAPROTILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001491</DrugIDPK>
    <LicenceNumber>PA0028/001/001</LicenceNumber>
    <ProductName>LUDIOMIL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAPROTILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002451</DrugIDPK>
    <LicenceNumber>PA0054/009/004</LicenceNumber>
    <ProductName>OPTIMAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1980-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002449</DrugIDPK>
    <LicenceNumber>PA0054/009/003</LicenceNumber>
    <ProductName>OPTIMAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1980-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003706</DrugIDPK>
    <LicenceNumber>PA0114/004/001</LicenceNumber>
    <ProductName>PAVACONTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1975-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001179</DrugIDPK>
    <LicenceNumber>PA0022/009/001</LicenceNumber>
    <ProductName>PENIDURAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZATHINE BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>PROCAINE PENICILLIN G</ActiveSubstance>
      <ActiveSubstance>BENZYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002638</DrugIDPK>
    <LicenceNumber>PA0049/027/001</LicenceNumber>
    <ProductName>PREGNAVITE FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000335</DrugIDPK>
    <LicenceNumber>PA0009/001/001</LicenceNumber>
    <ProductName>PROCAINAMIDE DURULES</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1975-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROCAINAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001662</DrugIDPK>
    <LicenceNumber>PA0038/026/001</LicenceNumber>
    <ProductName>SELSUN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001537</DrugIDPK>
    <LicenceNumber>PA0028/032/001</LicenceNumber>
    <ProductName>SLOW-FE FOLIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004247</DrugIDPK>
    <LicenceNumber>PA0167/020/001</LicenceNumber>
    <ProductName>SODIUM CITRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003936</DrugIDPK>
    <LicenceNumber>PA0126/078/001</LicenceNumber>
    <ProductName>TRAIZOMEL 0.125</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003937</DrugIDPK>
    <LicenceNumber>PA0126/078/002</LicenceNumber>
    <ProductName>TRIAZOMEL  0.25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1990-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003514</DrugIDPK>
    <LicenceNumber>PA0114/023/002</LicenceNumber>
    <ProductName>TRILISATE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003511</DrugIDPK>
    <LicenceNumber>PA0114/023/001</LicenceNumber>
    <ProductName>TRILISATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004729</DrugIDPK>
    <LicenceNumber>PA0187/023/001</LicenceNumber>
    <ProductName>VAMIN INFANT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004731</DrugIDPK>
    <LicenceNumber>PA0187/023/002</LicenceNumber>
    <ProductName>VAMIN INFANT</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001702</DrugIDPK>
    <LicenceNumber>PA0030/001/002</LicenceNumber>
    <ProductName>VIBROCIL NASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIMETINDENE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001706</DrugIDPK>
    <LicenceNumber>PA0030/001/003</LicenceNumber>
    <ProductName>VIBROCIL NASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETINDENE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003588</DrugIDPK>
    <LicenceNumber>PA0114/045/001</LicenceNumber>
    <ProductName>VIBROX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003589</DrugIDPK>
    <LicenceNumber>PA0114/045/002</LicenceNumber>
    <ProductName>VIBROX SACHETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000466</DrugIDPK>
    <LicenceNumber>PA0007/019/001</LicenceNumber>
    <ProductName>VILLESCON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROLINTANE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003552</DrugIDPK>
    <LicenceNumber>PA0114/031/002</LicenceNumber>
    <ProductName>X- PREP POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007700</DrugIDPK>
    <LicenceNumber>PA0009/018/002</LicenceNumber>
    <ProductName>XYLOCARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007735</DrugIDPK>
    <LicenceNumber>PA0009/018/003</LicenceNumber>
    <ProductName>XYLOCARD</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004582</DrugIDPK>
    <LicenceNumber>PA0179/002/015</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1990-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004583</DrugIDPK>
    <LicenceNumber>PA0179/002/016</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1990-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000748</DrugIDPK>
    <LicenceNumber>PA0016/022/006</LicenceNumber>
    <ProductName>SOLU-MEDRONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1990-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001940</DrugIDPK>
    <LicenceNumber>PA0040/043/003</LicenceNumber>
    <ProductName>PHENERGAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005699</DrugIDPK>
    <LicenceNumber>PA0294/002/003</LicenceNumber>
    <ProductName>PRAXILENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAFTIDROFURYL OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007677</DrugIDPK>
    <LicenceNumber>PA0009/016/015</LicenceNumber>
    <ProductName>XYLOCAINE EPIDURAL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000796</DrugIDPK>
    <LicenceNumber>PA0011/012/002</LicenceNumber>
    <ProductName>ANTURAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFINPYRAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000741</DrugIDPK>
    <LicenceNumber>PA0011/012/001</LicenceNumber>
    <ProductName>ANTURAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFINPYRAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005137</DrugIDPK>
    <LicenceNumber>PA0255/011/004</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1987-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005144</DrugIDPK>
    <LicenceNumber>PA0255/011/006</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1987-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005143</DrugIDPK>
    <LicenceNumber>PA0255/011/005</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE STERILE POWDER</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1987-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000949</DrugIDPK>
    <LicenceNumber>PA0017/072/002</LicenceNumber>
    <ProductName>FERROMYN B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SUCCINATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005129</DrugIDPK>
    <LicenceNumber>PA0255/010/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005130</DrugIDPK>
    <LicenceNumber>PA0255/010/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000715</DrugIDPK>
    <LicenceNumber>PA0011/004/001</LicenceNumber>
    <ProductName>HYGROTON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000793</DrugIDPK>
    <LicenceNumber>PA0011/002/001</LicenceNumber>
    <ProductName>SYMMETREL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMANTADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000626</DrugIDPK>
    <LicenceNumber>PA0013/028/001</LicenceNumber>
    <ProductName>TERONAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1975-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAZINDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001505</DrugIDPK>
    <LicenceNumber>PA0028/003/004</LicenceNumber>
    <ProductName>TRASICOR</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1975-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000555</DrugIDPK>
    <LicenceNumber>PA0013/001/003</LicenceNumber>
    <ProductName>VISKEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1975-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINDOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002648</DrugIDPK>
    <LicenceNumber>PA0049/038/002</LicenceNumber>
    <ProductName>ASERBINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005908</DrugIDPK>
    <LicenceNumber>PA0379/004/002</LicenceNumber>
    <ProductName>BEECHAMS POWDERS (REFORMULATION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1985-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002699</DrugIDPK>
    <LicenceNumber>PA0050/030/001</LicenceNumber>
    <ProductName>BENEROC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005473</DrugIDPK>
    <LicenceNumber>PA0282/007/002</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1979-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005471</DrugIDPK>
    <LicenceNumber>PA0282/007/001</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1979-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003042</DrugIDPK>
    <LicenceNumber>PA0062/001/001</LicenceNumber>
    <ProductName>CYCLOSPASMOL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1974-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000446</DrugIDPK>
    <LicenceNumber>PA0007/045/001</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000447</DrugIDPK>
    <LicenceNumber>PA0007/045/002</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000448</DrugIDPK>
    <LicenceNumber>PA0007/045/003</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005920</DrugIDPK>
    <LicenceNumber>PA0379/018/002</LicenceNumber>
    <ProductName>DAY NURSE COLD REMEDY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1990-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006145</DrugIDPK>
    <LicenceNumber>PA0409/003/001</LicenceNumber>
    <ProductName>DIAZEPAM RECTAL TUBES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1985-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006146</DrugIDPK>
    <LicenceNumber>PA0409/003/002</LicenceNumber>
    <ProductName>DIAZEPAM RECTAL TUBES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1985-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002917</DrugIDPK>
    <LicenceNumber>PA0060/030/001</LicenceNumber>
    <ProductName>DIBENYLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002426</DrugIDPK>
    <LicenceNumber>PA0051/045/001</LicenceNumber>
    <ProductName>DISADINE DP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003091</DrugIDPK>
    <LicenceNumber>PA0062/026/008</LicenceNumber>
    <ProductName>FLEMOCIN</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003092</DrugIDPK>
    <LicenceNumber>PA0062/026/009</LicenceNumber>
    <ProductName>FLEMOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003093</DrugIDPK>
    <LicenceNumber>PA0062/026/010</LicenceNumber>
    <ProductName>FLEMOXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003087</DrugIDPK>
    <LicenceNumber>PA0062/026/004</LicenceNumber>
    <ProductName>FLEMOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003089</DrugIDPK>
    <LicenceNumber>PA0062/026/006</LicenceNumber>
    <ProductName>FLEMOXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003090</DrugIDPK>
    <LicenceNumber>PA0062/026/007</LicenceNumber>
    <ProductName>FLEMOXIN</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003085</DrugIDPK>
    <LicenceNumber>PA0062/026/002</LicenceNumber>
    <ProductName>FLEMOXIN  FORTE (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003084</DrugIDPK>
    <LicenceNumber>PA0062/026/001</LicenceNumber>
    <ProductName>FLEMOXIN (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003086</DrugIDPK>
    <LicenceNumber>PA0062/026/003</LicenceNumber>
    <ProductName>FLEMOXIN PAEDIATRIC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004759</DrugIDPK>
    <LicenceNumber>PA0187/032/010</LicenceNumber>
    <ProductName>GENOTROPIN</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004763</DrugIDPK>
    <LicenceNumber>PA0187/032/012</LicenceNumber>
    <ProductName>GENOTROPIN</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1992-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005153</DrugIDPK>
    <LicenceNumber>PA0255/018/001</LicenceNumber>
    <ProductName>LIGNOCAINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005154</DrugIDPK>
    <LicenceNumber>PA0255/018/002</LicenceNumber>
    <ProductName>LIGNOCAINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005118</DrugIDPK>
    <LicenceNumber>PA0255/004/007</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005119</DrugIDPK>
    <LicenceNumber>PA0255/004/008</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002413</DrugIDPK>
    <LicenceNumber>PA0051/036/001</LicenceNumber>
    <ProductName>LOREXANE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINDANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002414</DrugIDPK>
    <LicenceNumber>PA0051/036/002</LicenceNumber>
    <ProductName>LOREXANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LINDANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002415</DrugIDPK>
    <LicenceNumber>PA0051/036/003</LicenceNumber>
    <ProductName>LOREXANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LINDANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001756</DrugIDPK>
    <LicenceNumber>PA0032/033/001</LicenceNumber>
    <ProductName>NICO-2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1989-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001149</DrugIDPK>
    <LicenceNumber>PA0021/028/001</LicenceNumber>
    <ProductName>NYSTATAIN DOME ORAL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1985-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002412</DrugIDPK>
    <LicenceNumber>PA0051/035/001</LicenceNumber>
    <ProductName>PEPTAVLON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAGASTRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000609</DrugIDPK>
    <LicenceNumber>PA0009/045/001</LicenceNumber>
    <ProductName>PRAMACE</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000610</DrugIDPK>
    <LicenceNumber>PA0009/045/002</LicenceNumber>
    <ProductName>PRAMACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000611</DrugIDPK>
    <LicenceNumber>PA0009/045/003</LicenceNumber>
    <ProductName>PRAMACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000612</DrugIDPK>
    <LicenceNumber>PA0009/045/004</LicenceNumber>
    <ProductName>PRAMACE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1990-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000613</DrugIDPK>
    <LicenceNumber>PA0009/046/001</LicenceNumber>
    <ProductName>REMOXIPRIDE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMOXIPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000614</DrugIDPK>
    <LicenceNumber>PA0009/046/002</LicenceNumber>
    <ProductName>REMOXIPRIDE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMOXIPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000615</DrugIDPK>
    <LicenceNumber>PA0009/046/003</LicenceNumber>
    <ProductName>REMOXIPRIDE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMOXIPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000616</DrugIDPK>
    <LicenceNumber>PA0009/047/001</LicenceNumber>
    <ProductName>ROXIAM</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMOXIPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000617</DrugIDPK>
    <LicenceNumber>PA0009/047/002</LicenceNumber>
    <ProductName>ROXIAM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REMOXIPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005012</DrugIDPK>
    <LicenceNumber>PA0236/001/001</LicenceNumber>
    <ProductName>SINETENS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1975-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005013</DrugIDPK>
    <LicenceNumber>PA0236/001/002</LicenceNumber>
    <ProductName>SINETENS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1975-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001850</DrugIDPK>
    <LicenceNumber>PA0032/029/001</LicenceNumber>
    <ProductName>SINITOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1990-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005821</DrugIDPK>
    <LicenceNumber>PA0365/029/001</LicenceNumber>
    <ProductName>STRONG STERILE DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1990-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005882</DrugIDPK>
    <LicenceNumber>PA0365/029/002</LicenceNumber>
    <ProductName>STRONG STERILE DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1990-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002417</DrugIDPK>
    <LicenceNumber>PA0051/038/002</LicenceNumber>
    <ProductName>TETMOSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFIRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005149</DrugIDPK>
    <LicenceNumber>PA0255/016/001</LicenceNumber>
    <ProductName>THIOPENTONE SODIUM WITH DILUENT</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005150</DrugIDPK>
    <LicenceNumber>PA0255/016/002</LicenceNumber>
    <ProductName>THIOPENTONE SODIUM WITH DILUENT</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005151</DrugIDPK>
    <LicenceNumber>PA0255/016/003</LicenceNumber>
    <ProductName>THIOPENTONE SODIUM WITH DILUENT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005152</DrugIDPK>
    <LicenceNumber>PA0255/016/004</LicenceNumber>
    <ProductName>THIOPENTONE SODIUM WITH DILUENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003080</DrugIDPK>
    <LicenceNumber>PA0062/025/003</LicenceNumber>
    <ProductName>UNIDOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003078</DrugIDPK>
    <LicenceNumber>PA0062/025/001</LicenceNumber>
    <ProductName>UNIDOX (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003079</DrugIDPK>
    <LicenceNumber>PA0062/025/002</LicenceNumber>
    <ProductName>UNIDOX (SUSPENSION)</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003883</DrugIDPK>
    <LicenceNumber>PA0126/047/001</LicenceNumber>
    <ProductName>VITAMIN C</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003884</DrugIDPK>
    <LicenceNumber>PA0126/047/002</LicenceNumber>
    <ProductName>VITAMIN C</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003885</DrugIDPK>
    <LicenceNumber>PA0126/047/003</LicenceNumber>
    <ProductName>VITAMIN C</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009025</DrugIDPK>
    <LicenceNumber>PA0018/052/001</LicenceNumber>
    <ProductName>ZARENT SYNCRONER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEDOCROMIL SODIUM</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005943</DrugIDPK>
    <LicenceNumber>PPA0384/010/001</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1988-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004277</DrugIDPK>
    <LicenceNumber>PA0167/036/001</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004278</DrugIDPK>
    <LicenceNumber>PA0167/036/002</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004279</DrugIDPK>
    <LicenceNumber>PA0167/036/003</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004280</DrugIDPK>
    <LicenceNumber>PA0167/036/004</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004283</DrugIDPK>
    <LicenceNumber>PA0167/036/007</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004284</DrugIDPK>
    <LicenceNumber>PA0167/036/008</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004287</DrugIDPK>
    <LicenceNumber>PA0167/036/011</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004288</DrugIDPK>
    <LicenceNumber>PA0167/036/012</LicenceNumber>
    <ProductName>LAEVULOSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001228</DrugIDPK>
    <LicenceNumber>PA0022/040/001</LicenceNumber>
    <ProductName>MEPTAZINOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPTAZINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001229</DrugIDPK>
    <LicenceNumber>PA0022/040/002</LicenceNumber>
    <ProductName>MEPTID</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPTAZINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001231</DrugIDPK>
    <LicenceNumber>PA0022/040/003</LicenceNumber>
    <ProductName>MEPTIDOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPTAZINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006705</DrugIDPK>
    <LicenceNumber>PA0516/019/001</LicenceNumber>
    <ProductName>AZALAN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1990-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003039</DrugIDPK>
    <LicenceNumber>PA0060/051/001</LicenceNumber>
    <ProductName>MOCARD SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1990-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1995-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012339</DrugIDPK>
    <LicenceNumber>PA0401/001/001</LicenceNumber>
    <ProductName>FIBRONOCIS (HUMAN)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Amersham Health Srl</PAHolder>
    <AuthorisedDate>1985-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004081</DrugIDPK>
    <LicenceNumber>PA0159/008/001</LicenceNumber>
    <ProductName>TRISONOVIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>1984-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>RESORCINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006403</DrugIDPK>
    <LicenceNumber>PA0437/006/006</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006404</DrugIDPK>
    <LicenceNumber>PA0437/006/007</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006405</DrugIDPK>
    <LicenceNumber>PA0437/006/008</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004506</DrugIDPK>
    <LicenceNumber>PA0176/051/001</LicenceNumber>
    <ProductName>DIHYDROCODEINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006447</DrugIDPK>
    <LicenceNumber>PA0468/002/002</LicenceNumber>
    <ProductName>DIORALYTE EFFERVESCENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005427</DrugIDPK>
    <LicenceNumber>PA0261/013/003</LicenceNumber>
    <ProductName>DURABOLIN 50 MG/ML SYRINGE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005426</DrugIDPK>
    <LicenceNumber>PA0261/013/002</LicenceNumber>
    <ProductName>DURABOLIN SYRINGE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006005</DrugIDPK>
    <LicenceNumber>PPA0384/012/001</LicenceNumber>
    <ProductName>FELDENE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1989-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005942</DrugIDPK>
    <LicenceNumber>PPA0384/009/001</LicenceNumber>
    <ProductName>HALICON</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1987-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005375</DrugIDPK>
    <LicenceNumber>PA0261/005/001</LicenceNumber>
    <ProductName>HYDROCORTISONE SODIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005376</DrugIDPK>
    <LicenceNumber>PA0261/005/002</LicenceNumber>
    <ProductName>HYDROCORTISONE SODIUM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005949</DrugIDPK>
    <LicenceNumber>PPA0384/013/001</LicenceNumber>
    <ProductName>IMODIUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1990-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPERAMIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003915</DrugIDPK>
    <LicenceNumber>PA0126/067/005</LicenceNumber>
    <ProductName>KEMELEX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007660</DrugIDPK>
    <LicenceNumber>PA0047/071/001</LicenceNumber>
    <ProductName>LOVAN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003871</DrugIDPK>
    <LicenceNumber>PA0126/039/003</LicenceNumber>
    <ProductName>MELACTONE 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007120</DrugIDPK>
    <LicenceNumber>PPA0384/005/001</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005945</DrugIDPK>
    <LicenceNumber>PPA0384/011/001</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1989-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005946</DrugIDPK>
    <LicenceNumber>PPA0384/011/002</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1989-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007164</DrugIDPK>
    <LicenceNumber>PA0077/097/001</LicenceNumber>
    <ProductName>PRIMACOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MILRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007165</DrugIDPK>
    <LicenceNumber>PA0077/097/002</LicenceNumber>
    <ProductName>PRIMACOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MILRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005936</DrugIDPK>
    <LicenceNumber>PPA0384/003/001</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1990-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001333</DrugIDPK>
    <LicenceNumber>PA0024/018/002</LicenceNumber>
    <ProductName>VENTIDE ROTACAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1990-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001334</DrugIDPK>
    <LicenceNumber>PA0024/018/003</LicenceNumber>
    <ProductName>VENTIDE ROTACAPS</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1990-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004508</DrugIDPK>
    <LicenceNumber>PA0176/068/001</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004509</DrugIDPK>
    <LicenceNumber>PA0176/068/002</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004511</DrugIDPK>
    <LicenceNumber>PA0176/068/003</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004512</DrugIDPK>
    <LicenceNumber>PA0176/068/004</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005950</DrugIDPK>
    <LicenceNumber>PPA0384/014/001</LicenceNumber>
    <ProductName>ZYLORIC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1989-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005951</DrugIDPK>
    <LicenceNumber>PPA0384/014/002</LicenceNumber>
    <ProductName>ZYLORIC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1989-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000494</DrugIDPK>
    <LicenceNumber>PA0012/045/001</LicenceNumber>
    <ProductName>DIANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005178</DrugIDPK>
    <LicenceNumber>PA0277/038/002</LicenceNumber>
    <ProductName>DIPROCEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013521</DrugIDPK>
    <LicenceNumber>PA0261/013/001</LicenceNumber>
    <ProductName>DURABOLIN 25MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003398</DrugIDPK>
    <LicenceNumber>PA0077/098/001</LicenceNumber>
    <ProductName>PAEDIATRIC PARACETAMOL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1989-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007188</DrugIDPK>
    <LicenceNumber>PA0408/025/003</LicenceNumber>
    <ProductName>PROPRANOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007184</DrugIDPK>
    <LicenceNumber>PA0408/025/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007186</DrugIDPK>
    <LicenceNumber>PA0408/025/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006362</DrugIDPK>
    <LicenceNumber>PA0437/005/004</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010175</DrugIDPK>
    <LicenceNumber>PA0437/005/002</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1982-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOTREXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016197</DrugIDPK>
    <LicenceNumber>PA0185/009/001</LicenceNumber>
    <ProductName>ASEP</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUTARAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016198</DrugIDPK>
    <LicenceNumber>PA0185/009/002</LicenceNumber>
    <ProductName>ASEP</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUTARAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016199</DrugIDPK>
    <LicenceNumber>PA0185/009/003</LicenceNumber>
    <ProductName>ASEP</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008597</DrugIDPK>
    <LicenceNumber>PA0024/005/008</LicenceNumber>
    <ProductName>BECOTIDE FOR NEBULISATION  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005875</DrugIDPK>
    <LicenceNumber>PA0308/003/001</LicenceNumber>
    <ProductName>ECZEDERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Quinoderm Ltd</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001110</DrugIDPK>
    <LicenceNumber>PA0021/007/001</LicenceNumber>
    <ProductName>FABAHISTIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001868</DrugIDPK>
    <LicenceNumber>PA0035/003/003</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004905</DrugIDPK>
    <LicenceNumber>PA0224/004/002</LicenceNumber>
    <ProductName>KLYX ENEMA</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000355</DrugIDPK>
    <LicenceNumber>PA0006/035/003</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1990-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007766</DrugIDPK>
    <LicenceNumber>PA0218/037/002</LicenceNumber>
    <ProductName>VELOSULIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005938</DrugIDPK>
    <LicenceNumber>PPA0384/004/001</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1989-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005935</DrugIDPK>
    <LicenceNumber>PPA0384/001/001</LicenceNumber>
    <ProductName>ADALAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1985-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005939</DrugIDPK>
    <LicenceNumber>PPA0384/006/001</LicenceNumber>
    <ProductName>BRUFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1986-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005941</DrugIDPK>
    <LicenceNumber>PPA0384/008/001</LicenceNumber>
    <ProductName>DUVADILAN RETARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1986-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005940</DrugIDPK>
    <LicenceNumber>PPA0384/007/001</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1986-12-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005692</DrugIDPK>
    <LicenceNumber>PA0293/001/001</LicenceNumber>
    <ProductName>NAUDICELLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bio-Oil Research Limited</PAHolder>
    <AuthorisedDate>1979-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINOLEIC ACID TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>GAMOLENIC ACID TRIGLYCERIDES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005694</DrugIDPK>
    <LicenceNumber>PA0293/001/002</LicenceNumber>
    <ProductName>NAUDICELLE PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bio-Oil Research Limited</PAHolder>
    <AuthorisedDate>1983-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINOLEIC ACID TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>GAMOLENIC ACID TRIGLYCERIDES</ActiveSubstance>
      <ActiveSubstance>EICOSAPENTAENOIC ACID TRIGLYCERIDE ESTER</ActiveSubstance>
      <ActiveSubstance>DOCOSAHEXAENAIC ACID TRIGLYCERIDE ESTERS</ActiveSubstance>
      <ActiveSubstance>FATTY ACID TRIGLYCERIDE ESTER</ActiveSubstance>
      <ActiveSubstance>D-ALPHA T0COPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004011</DrugIDPK>
    <LicenceNumber>PA0144/024/002</LicenceNumber>
    <ProductName>BENOXYL 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004010</DrugIDPK>
    <LicenceNumber>PA0144/024/001</LicenceNumber>
    <ProductName>BENOXYL 5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004014</DrugIDPK>
    <LicenceNumber>PA0144/025/003</LicenceNumber>
    <ProductName>BRASIVOL COARSE</ProductName>
    <Strength>65</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004008</DrugIDPK>
    <LicenceNumber>PA0144/023/001</LicenceNumber>
    <ProductName>OILATUM SOAP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1984-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001995</DrugIDPK>
    <LicenceNumber>PA0044/041/001</LicenceNumber>
    <ProductName>EF CORTELAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003524</DrugIDPK>
    <LicenceNumber>PA0088/002/001</LicenceNumber>
    <ProductName>UROMITEXAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003525</DrugIDPK>
    <LicenceNumber>PA0088/002/002</LicenceNumber>
    <ProductName>UROMITEXAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006316</DrugIDPK>
    <LicenceNumber>PA0436/015/001</LicenceNumber>
    <ProductName>MEFENAMIC ACID</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016108</DrugIDPK>
    <LicenceNumber>PA0102/003/003</LicenceNumber>
    <ProductName>CAMCOLIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LITHIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001835</DrugIDPK>
    <LicenceNumber>PA0035/048/001</LicenceNumber>
    <ProductName>CARBIDOPA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001837</DrugIDPK>
    <LicenceNumber>PA0035/048/003</LicenceNumber>
    <ProductName>CARBIDOPA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014454</DrugIDPK>
    <LicenceNumber>PA0523/010/001</LicenceNumber>
    <ProductName>COQ10 COENZYME Q10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lifeplan Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CO ENZYM Q10</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004872</DrugIDPK>
    <LicenceNumber>PA0218/038/001</LicenceNumber>
    <ProductName>HUMAN INSULATARD</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004873</DrugIDPK>
    <LicenceNumber>PA0218/038/002</LicenceNumber>
    <ProductName>HUMAN INSULATARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004888</DrugIDPK>
    <LicenceNumber>PA0218/042/001</LicenceNumber>
    <ProductName>HUMAN MIXTARD 15/85</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008438</DrugIDPK>
    <LicenceNumber>PA0218/042/002</LicenceNumber>
    <ProductName>HUMAN MIXTARD 15/85</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004876</DrugIDPK>
    <LicenceNumber>PA0218/039/001</LicenceNumber>
    <ProductName>HUMAN MIXTARD 30/70</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004884</DrugIDPK>
    <LicenceNumber>PA0218/041/001</LicenceNumber>
    <ProductName>HUMAN MIXTARD 50/50</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004885</DrugIDPK>
    <LicenceNumber>PA0218/041/002</LicenceNumber>
    <ProductName>HUMAN MIXTARD 50/50</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008635</DrugIDPK>
    <LicenceNumber>PA0038/051/005</LicenceNumber>
    <ProductName>KLACID PAEDIATRIC  (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012070</DrugIDPK>
    <LicenceNumber>PA0059/044/001</LicenceNumber>
    <ProductName>LEUSTATIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLADRIBINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006144</DrugIDPK>
    <LicenceNumber>PA0409/002/002</LicenceNumber>
    <ProductName>METRONIDAZOLE 5 G/1</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1984-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006143</DrugIDPK>
    <LicenceNumber>PA0409/002/001</LicenceNumber>
    <ProductName>METRONIDAZOLE 5G/1</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1984-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006532</DrugIDPK>
    <LicenceNumber>PA0469/006/001</LicenceNumber>
    <ProductName>NOVARUCA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1989-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUTARAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014456</DrugIDPK>
    <LicenceNumber>PA0523/017/001</LicenceNumber>
    <ProductName>ORGANIC GERMANIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lifeplan Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PELARGONIUM ODORANTISSMUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006163</DrugIDPK>
    <LicenceNumber>PA0409/011/003</LicenceNumber>
    <ProductName>PUR-IN 15/85</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1990-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006162</DrugIDPK>
    <LicenceNumber>PA0409/011/002</LicenceNumber>
    <ProductName>PUR-IN 25/75</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1990-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006161</DrugIDPK>
    <LicenceNumber>PA0409/011/001</LicenceNumber>
    <ProductName>PUR-IN 50/50</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1990-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006160</DrugIDPK>
    <LicenceNumber>PA0409/010/001</LicenceNumber>
    <ProductName>PUR-IN ISOPHANE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1990-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006159</DrugIDPK>
    <LicenceNumber>PA0409/009/001</LicenceNumber>
    <ProductName>PUR-IN NEUTRAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1990-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008042</DrugIDPK>
    <LicenceNumber>PA0527/016/001</LicenceNumber>
    <ProductName>RHEUMATIC PAIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004937</DrugIDPK>
    <LicenceNumber>PA0236/019/001</LicenceNumber>
    <ProductName>TEMAZEPAM DRP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001843</DrugIDPK>
    <LicenceNumber>PA0035/053/001</LicenceNumber>
    <ProductName>TIMOPTOL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000870</DrugIDPK>
    <LicenceNumber>PA0012/030/002</LicenceNumber>
    <ProductName>ULTRADIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE CAPROATE</ActiveSubstance>
      <ActiveSubstance>FLUOCORTOLONE PIVALATE</ActiveSubstance>
      <ActiveSubstance>CLEMIZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000871</DrugIDPK>
    <LicenceNumber>PA0012/030/003</LicenceNumber>
    <ProductName>ULTRADIL FATTY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE CAPROATE</ActiveSubstance>
      <ActiveSubstance>FLUOCORTOLONE PIVALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001376</DrugIDPK>
    <LicenceNumber>PA0035/065/002</LicenceNumber>
    <ProductName>UTINOR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1984-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002269</DrugIDPK>
    <LicenceNumber>PA0047/022/006</LicenceNumber>
    <ProductName>V-CIL-K</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002541</DrugIDPK>
    <LicenceNumber>PA0054/067/001</LicenceNumber>
    <ProductName>INTRAFUSIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1989-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002542</DrugIDPK>
    <LicenceNumber>PA0054/067/002</LicenceNumber>
    <ProductName>INTRAFUSIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1989-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010147</DrugIDPK>
    <LicenceNumber>PA0062/024/003</LicenceNumber>
    <ProductName>STAFOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1984-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010149</DrugIDPK>
    <LicenceNumber>PA0062/024/004</LicenceNumber>
    <ProductName>STAFOXIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1984-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003004</DrugIDPK>
    <LicenceNumber>PA0059/033/001</LicenceNumber>
    <ProductName>TERAZOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003005</DrugIDPK>
    <LicenceNumber>PA0059/033/002</LicenceNumber>
    <ProductName>TERAZOL</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003006</DrugIDPK>
    <LicenceNumber>PA0059/033/003</LicenceNumber>
    <ProductName>TERAZOL</ProductName>
    <Strength>0.8</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012081</DrugIDPK>
    <LicenceNumber>PA0699/001/002</LicenceNumber>
    <ProductName>ANTRIL (ANAKINRA) 100 MG/ML</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Synergen B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012082</DrugIDPK>
    <LicenceNumber>PA0699/001/003</LicenceNumber>
    <ProductName>ANTRIL (ANAKINRA) 100 MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Synergen B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012079</DrugIDPK>
    <LicenceNumber>PA0699/001/001</LicenceNumber>
    <ProductName>ANTRIL (ANAKINRA) 100 MG/ML</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Synergen B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010898</DrugIDPK>
    <LicenceNumber>PA0251/012/001</LicenceNumber>
    <ProductName>METERFOLIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012071</DrugIDPK>
    <LicenceNumber>PA0126/089/001</LicenceNumber>
    <ProductName>SIMPLE LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014427</DrugIDPK>
    <LicenceNumber>PA0560/001/003</LicenceNumber>
    <ProductName>DYSPAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bridge Pharmaceuticals (Ire) Ltd</PAHolder>
    <AuthorisedDate>1990-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014429</DrugIDPK>
    <LicenceNumber>PA0560/001/004</LicenceNumber>
    <ProductName>DYSPAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bridge Pharmaceuticals (Ire) Ltd</PAHolder>
    <AuthorisedDate>1990-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002873</DrugIDPK>
    <LicenceNumber>PA0060/006/007</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002876</DrugIDPK>
    <LicenceNumber>PA0060/006/009</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1991-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002878</DrugIDPK>
    <LicenceNumber>PA0060/006/010</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002881</DrugIDPK>
    <LicenceNumber>PA0060/006/011</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1992-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014440</DrugIDPK>
    <LicenceNumber>PA0277/071/001</LicenceNumber>
    <ProductName>GENTACOLL IMPLANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014441</DrugIDPK>
    <LicenceNumber>PA0277/071/002</LicenceNumber>
    <ProductName>GENTACOLL IMPLANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005422</DrugIDPK>
    <LicenceNumber>PA0261/011/001</LicenceNumber>
    <ProductName>GESTANIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALLYLESTRENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002519</DrugIDPK>
    <LicenceNumber>PA0054/045/001</LicenceNumber>
    <ProductName>SODIUM UROMIRO 300</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002520</DrugIDPK>
    <LicenceNumber>PA0054/045/002</LicenceNumber>
    <ProductName>SODIUM UROMIRO 300</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003450</DrugIDPK>
    <LicenceNumber>PA0077/009/002</LicenceNumber>
    <ProductName>OXYPERTINE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sterling Drug (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPERTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014452</DrugIDPK>
    <LicenceNumber>PA0559/001/001</LicenceNumber>
    <ProductName>EVENING PRIMROSE OIL 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Beeline Healthcare</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010135</DrugIDPK>
    <LicenceNumber>PA0039/001/001</LicenceNumber>
    <ProductName>PRODOXOL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1975-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001581</DrugIDPK>
    <LicenceNumber>PA0028/051/002</LicenceNumber>
    <ProductName>ANDURSIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1984-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ANTIFOAM M</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014343</DrugIDPK>
    <LicenceNumber>PA0027/018/001</LicenceNumber>
    <ProductName>FOAM ENEMA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009824</DrugIDPK>
    <LicenceNumber>PA0011/027/008</LicenceNumber>
    <ProductName>VOLTAROL DISPERSIBLE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009748</DrugIDPK>
    <LicenceNumber>PA0010/006/006</LicenceNumber>
    <ProductName>FACTORATE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMAFRAKTION (FACTOR VIII)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009747</DrugIDPK>
    <LicenceNumber>PA0010/006/005</LicenceNumber>
    <ProductName>FACTORATE (DOUBLE-FILL)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMAFRAKTION (FACTOR VIII)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012824</DrugIDPK>
    <LicenceNumber>PA0114/071/001</LicenceNumber>
    <ProductName>J. COLLIS BROWNES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003485</DrugIDPK>
    <LicenceNumber>PA0086/016/001</LicenceNumber>
    <ProductName>DIMOTAPP P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013901</DrugIDPK>
    <LicenceNumber>PA0277/051/001</LicenceNumber>
    <ProductName>VIAFERON NASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014432</DrugIDPK>
    <LicenceNumber>PA0516/015/001</LicenceNumber>
    <ProductName>ERYTHRELAN (SUSPENSION)</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014435</DrugIDPK>
    <LicenceNumber>PA0516/015/002</LicenceNumber>
    <ProductName>ERYTHRELAN (SUSPENSION)</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002995</DrugIDPK>
    <LicenceNumber>PA0059/021/002</LicenceNumber>
    <ProductName>TRINOVUM ED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012072</DrugIDPK>
    <LicenceNumber>PA0426/001/001</LicenceNumber>
    <ProductName>CHEMOLASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmotex Inc.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHYMOPAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012073</DrugIDPK>
    <LicenceNumber>PA0468/012/001</LicenceNumber>
    <ProductName>ANANASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMELAINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010745</DrugIDPK>
    <LicenceNumber>PA0040/038/001</LicenceNumber>
    <ProductName>ANTHICAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012477</DrugIDPK>
    <LicenceNumber>PA0354/005/004</LicenceNumber>
    <ProductName>NATURAL FORM VITAMIN E</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Lifeplan Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011131</DrugIDPK>
    <LicenceNumber>PA0047/022/005</LicenceNumber>
    <ProductName>V CIL K</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011127</DrugIDPK>
    <LicenceNumber>PA0047/022/002</LicenceNumber>
    <ProductName>V CIL K</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011129</DrugIDPK>
    <LicenceNumber>PA0047/022/004</LicenceNumber>
    <ProductName>V-CIL-K</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013319</DrugIDPK>
    <LicenceNumber>PA0167/009/016</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013290</DrugIDPK>
    <LicenceNumber>PA0167/009/015</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013320</DrugIDPK>
    <LicenceNumber>PA0167/009/017</LicenceNumber>
    <ProductName>GLUCOSE INTRAVENOUS INFUSION 50%</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012591</DrugIDPK>
    <LicenceNumber>PA0437/031/001</LicenceNumber>
    <ProductName>HALOPERIDOL DECANOATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013433</DrugIDPK>
    <LicenceNumber>PA0167/078/005</LicenceNumber>
    <ProductName>SYNTHAMIX 14/1200</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013435</DrugIDPK>
    <LicenceNumber>PA0167/078/007</LicenceNumber>
    <ProductName>SYNTHAMIX 14/1800 PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001705</DrugIDPK>
    <LicenceNumber>PA0178/078/008</LicenceNumber>
    <ProductName>SYNTHAMIX 14/1800 X PARENTERAL NUTRITION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013437</DrugIDPK>
    <LicenceNumber>PA0167/078/008</LicenceNumber>
    <ProductName>SYNTHAMIX 14/1800X PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013439</DrugIDPK>
    <LicenceNumber>PA0167/078/009</LicenceNumber>
    <ProductName>SYNTHAMIX 14/2200 PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013440</DrugIDPK>
    <LicenceNumber>PA0167/078/011</LicenceNumber>
    <ProductName>SYNTHAMIX 14/2800 PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013441</DrugIDPK>
    <LicenceNumber>PA0167/078/012</LicenceNumber>
    <ProductName>SYNTHAMIX 14/2800X PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013443</DrugIDPK>
    <LicenceNumber>PA0167/078/013</LicenceNumber>
    <ProductName>SYNTHAMIX 17/1800 PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013444</DrugIDPK>
    <LicenceNumber>PA0167/078/014</LicenceNumber>
    <ProductName>SYNTHAMIX 17/1800X PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013445</DrugIDPK>
    <LicenceNumber>PA0167/078/015</LicenceNumber>
    <ProductName>SYNTHAMIX 17/2800</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013572</DrugIDPK>
    <LicenceNumber>PA0167/078/016</LicenceNumber>
    <ProductName>SYNTHAMIX 17/2800 X</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013432</DrugIDPK>
    <LicenceNumber>PA0167/078/003</LicenceNumber>
    <ProductName>SYNTHAMIX 9/1800 PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013429</DrugIDPK>
    <LicenceNumber>PA0167/078/001</LicenceNumber>
    <ProductName>SYNTHAMIX 9/1800 PARENTERAL</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009823</DrugIDPK>
    <LicenceNumber>PA0011/026/001</LicenceNumber>
    <ProductName>PERTOFRAN R</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESIPRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012077</DrugIDPK>
    <LicenceNumber>PA0481/001/009</LicenceNumber>
    <ProductName>PRIMENE 10%</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Clinique</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012078</DrugIDPK>
    <LicenceNumber>PA0481/001/010</LicenceNumber>
    <ProductName>PRIMENE 10%</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Clinique</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012075</DrugIDPK>
    <LicenceNumber>PA0481/001/002</LicenceNumber>
    <ProductName>PRIMENE 5%</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Clinique</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012076</DrugIDPK>
    <LicenceNumber>PA0481/001/003</LicenceNumber>
    <ProductName>PRIMENE 5%</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clintec Nutrition Clinique</PAHolder>
    <AuthorisedDate>1992-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013277</DrugIDPK>
    <LicenceNumber>PA0167/051/003</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE 0.3% /DEXTROSE 5.0%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013279</DrugIDPK>
    <LicenceNumber>PA0167/051/004</LicenceNumber>
    <ProductName>POTASSIUM CHLORIDE 0.3%/DEXTROSE 5.0%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012546</DrugIDPK>
    <LicenceNumber>PA0100/033/002</LicenceNumber>
    <ProductName>SUSCARD BUCCAL</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015744</DrugIDPK>
    <LicenceNumber>PA0237/019/004</LicenceNumber>
    <ProductName>DISPERSIBLE CO-TRIMOXAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012874</DrugIDPK>
    <LicenceNumber>PA0700/010/001</LicenceNumber>
    <ProductName>MANTADINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMANTADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012372</DrugIDPK>
    <LicenceNumber>PA0308/006/001</LicenceNumber>
    <ProductName>QUINODERM CREAM HYDROCORTISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Quinoderm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM HYDROXYQUINOLIN SULFATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006541</DrugIDPK>
    <LicenceNumber>PA0472/002/003</LicenceNumber>
    <ProductName>DISOGRAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Prographarm Laboratories</PAHolder>
    <AuthorisedDate>1989-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006540</DrugIDPK>
    <LicenceNumber>PA0472/002/002</LicenceNumber>
    <ProductName>DISOGRAM CR CAPSULES</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Prographarm Laboratories</PAHolder>
    <AuthorisedDate>1989-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013468</DrugIDPK>
    <LicenceNumber>PA0257/051/001</LicenceNumber>
    <ProductName>SUPERSUN EVENING PRIMROSE OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001514</DrugIDPK>
    <LicenceNumber>PA0028/021/001</LicenceNumber>
    <ProductName>NAVIDREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010220</DrugIDPK>
    <LicenceNumber>PA0028/061/002</LicenceNumber>
    <ProductName>PRESCAL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1989-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISRADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010222</DrugIDPK>
    <LicenceNumber>PA0028/061/003</LicenceNumber>
    <ProductName>PRESCAL 1.25 MT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1989-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISRADIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002352</DrugIDPK>
    <LicenceNumber>PA0048/017/001</LicenceNumber>
    <ProductName>NEOPLATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003504</DrugIDPK>
    <LicenceNumber>PA0114/021/001</LicenceNumber>
    <ProductName>BRADILAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOFURANOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005907</DrugIDPK>
    <LicenceNumber>PA0379/003/002</LicenceNumber>
    <ProductName>COLD RELIEF HOT LEMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1984-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004048</DrugIDPK>
    <LicenceNumber>PA0148/019/001</LicenceNumber>
    <ProductName>CONJUNCTIN LIQUIFILM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004047</DrugIDPK>
    <LicenceNumber>PA0148/018/001</LicenceNumber>
    <ProductName>HERPLEX-D</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IDOXURIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000899</DrugIDPK>
    <LicenceNumber>PA0017/043/001</LicenceNumber>
    <ProductName>POLIOMYELITIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000824</DrugIDPK>
    <LicenceNumber>PA0012/020/002</LicenceNumber>
    <ProductName>PRIMOLUT DEPOT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYPROGESTERONE CAPROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010487</DrugIDPK>
    <LicenceNumber>PA0028/026/001</LicenceNumber>
    <ProductName>ISMELIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010488</DrugIDPK>
    <LicenceNumber>PA0028/026/002</LicenceNumber>
    <ProductName>ISMELIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010489</DrugIDPK>
    <LicenceNumber>PA0028/026/003</LicenceNumber>
    <ProductName>ISMELIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010183</DrugIDPK>
    <LicenceNumber>PA0028/034/001</LicenceNumber>
    <ProductName>ROGITINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENTOLAMINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005724</DrugIDPK>
    <LicenceNumber>PA0294/014/001</LicenceNumber>
    <ProductName>CREFED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005725</DrugIDPK>
    <LicenceNumber>PA0294/014/002</LicenceNumber>
    <ProductName>CREFED</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011146</DrugIDPK>
    <LicenceNumber>PA0050/042/001</LicenceNumber>
    <ProductName>ALLOFERIN AMPOULES</ProductName>
    <Strength>10mg/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALCURONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011151</DrugIDPK>
    <LicenceNumber>PA0050/046/001</LicenceNumber>
    <ProductName>ARFONAD</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIMETAPHAN CAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011134</DrugIDPK>
    <LicenceNumber>PA0050/033/002</LicenceNumber>
    <ProductName>DECLINAX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEBRISOQUINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011136</DrugIDPK>
    <LicenceNumber>PA0050/036/001</LicenceNumber>
    <ProductName>LARODOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011135</DrugIDPK>
    <LicenceNumber>PA0050/034/001</LicenceNumber>
    <ProductName>NATULAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCARBAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011205</DrugIDPK>
    <LicenceNumber>PA0050/063/001</LicenceNumber>
    <ProductName>PFT- PANCREATIC FUNCTION TEST</ProductName>
    <Strength>333</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENTIROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011142</DrugIDPK>
    <LicenceNumber>PA0050/041/002</LicenceNumber>
    <ProductName>PROSTIGMIN AMPOULES</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOSTIGMINE BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011137</DrugIDPK>
    <LicenceNumber>PA0050/039/001</LicenceNumber>
    <ProductName>TENSILON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EDROPHONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010151</DrugIDPK>
    <LicenceNumber>PA0086/011/007</LicenceNumber>
    <ProductName>DIMOTAPP EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1989-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010152</DrugIDPK>
    <LicenceNumber>PA0172/016/001</LicenceNumber>
    <ProductName>BISMAG ANTACID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010153</DrugIDPK>
    <LicenceNumber>PA0172/016/002</LicenceNumber>
    <ProductName>BISMAG ANTACID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-01-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010154</DrugIDPK>
    <LicenceNumber>PA0172/019/001</LicenceNumber>
    <ProductName>SECLODIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015778</DrugIDPK>
    <LicenceNumber>PA0251/006/001</LicenceNumber>
    <ProductName>ALUHYDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012249</DrugIDPK>
    <LicenceNumber>PA0369/001/001</LicenceNumber>
    <ProductName>BISMAG-LAC</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Professor Dr. Med. Much. A.G.</PAHolder>
    <AuthorisedDate>1984-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGALDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015748</DrugIDPK>
    <LicenceNumber>PA0237/027/001</LicenceNumber>
    <ProductName>APS AMITRIPTYLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015749</DrugIDPK>
    <LicenceNumber>PA0237/027/002</LicenceNumber>
    <ProductName>APS AMITRIPTYLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010643</DrugIDPK>
    <LicenceNumber>PA0038/056/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN LACTOBIONATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1989-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011496</DrugIDPK>
    <LicenceNumber>PA0057/037/001</LicenceNumber>
    <ProductName>MEDIHALER ERGOTAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011486</DrugIDPK>
    <LicenceNumber>PA0057/028/001</LicenceNumber>
    <ProductName>MEDIHALER-ISO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011485</DrugIDPK>
    <LicenceNumber>PA0057/027/001</LicenceNumber>
    <ProductName>MEDIHALER-ISO FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011480</DrugIDPK>
    <LicenceNumber>PA0057/024/001</LicenceNumber>
    <ProductName>PULMADIL INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RIMITEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009469</DrugIDPK>
    <LicenceNumber>PA0001/015/001</LicenceNumber>
    <ProductName>CONOVA 30</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1979-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>ETYNODIOL DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012438</DrugIDPK>
    <LicenceNumber>PA0330/007/001</LicenceNumber>
    <ProductName>ORTHOSORB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010332</DrugIDPK>
    <LicenceNumber>PA0033/026/001</LicenceNumber>
    <ProductName>GARDRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENPROSTIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010312</DrugIDPK>
    <LicenceNumber>PA0033/005/005</LicenceNumber>
    <ProductName>NAPROSYN 375</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010120</DrugIDPK>
    <LicenceNumber>PA0011/004/002</LicenceNumber>
    <ProductName>HYGROTON K</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1975-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010121</DrugIDPK>
    <LicenceNumber>PA0011/030/002</LicenceNumber>
    <ProductName>SINTHROME</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1983-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACENOCOUMAROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010132</DrugIDPK>
    <LicenceNumber>PA0030/002/001</LicenceNumber>
    <ProductName>FENOSTIL RETARD</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1973-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETINDENE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003088</DrugIDPK>
    <LicenceNumber>PA0062/026/005</LicenceNumber>
    <ProductName>FLEMOXIN</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1985-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010997</DrugIDPK>
    <LicenceNumber>PA0046/041/001</LicenceNumber>
    <ProductName>LEOTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>DEXPANTHENOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>SODIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002774</DrugIDPK>
    <LicenceNumber>PA0056/001/004</LicenceNumber>
    <ProductName>PONSTAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010137</DrugIDPK>
    <LicenceNumber>PA0048/024/002</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010140</DrugIDPK>
    <LicenceNumber>PA0048/024/003</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010142</DrugIDPK>
    <LicenceNumber>PA0048/024/004</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010144</DrugIDPK>
    <LicenceNumber>PA0048/024/005</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016030</DrugIDPK>
    <LicenceNumber>PA0222/002/001</LicenceNumber>
    <ProductName>LIPOFLAVONOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lewis Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006210</DrugIDPK>
    <LicenceNumber>PA0441/032/002</LicenceNumber>
    <ProductName>VICKS CHLORASEPTIC SORETHROAT LOZENGES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1989-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001394</DrugIDPK>
    <LicenceNumber>PA0035/074/001</LicenceNumber>
    <ProductName>MODURET 25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1989-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004925</DrugIDPK>
    <LicenceNumber>PA0225/001/001</LicenceNumber>
    <ProductName>HUMAN IMMUNOGLOBULIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Irish Blood Transfusion Service</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN HUMAN NORMAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012701</DrugIDPK>
    <LicenceNumber>PA0108/006/003</LicenceNumber>
    <ProductName>DIPHTHERIA &amp; TETANUS TOXOIDS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1989-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012837</DrugIDPK>
    <LicenceNumber>PA0545/027/001</LicenceNumber>
    <ProductName>HISMADRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013375</DrugIDPK>
    <LicenceNumber>PA0255/017/002</LicenceNumber>
    <ProductName>INTERNATIONAL MEDICATION SYSTEMS LTD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013374</DrugIDPK>
    <LicenceNumber>PA0255/017/001</LicenceNumber>
    <ProductName>MAGNESIUM SULPHATE 2.5 G</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015162</DrugIDPK>
    <LicenceNumber>PA0292/001/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bodkin E.J. &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015164</DrugIDPK>
    <LicenceNumber>PA0292/001/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bodkin E.J. &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015165</DrugIDPK>
    <LicenceNumber>PA0292/001/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bodkin E.J. &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012513</DrugIDPK>
    <LicenceNumber>PA0416/013/001</LicenceNumber>
    <ProductName>BACKACHE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012512</DrugIDPK>
    <LicenceNumber>PA0416/012/001</LicenceNumber>
    <ProductName>CATARRH TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012425</DrugIDPK>
    <LicenceNumber>PA0326/002/001</LicenceNumber>
    <ProductName>FERLIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A. Nattermann &amp; CIE GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERRIC CITRATE</ActiveSubstance>
      <ActiveSubstance>COBALT GLUCONATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>CUPRIC GLYCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012521</DrugIDPK>
    <LicenceNumber>PA0416/015/001</LicenceNumber>
    <ProductName>FEVERFEW</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012520</DrugIDPK>
    <LicenceNumber>PA0416/014/001</LicenceNumber>
    <ProductName>LAXATIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PEPPERMINT OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012420</DrugIDPK>
    <LicenceNumber>PA0326/001/001</LicenceNumber>
    <ProductName>LIPOSTABIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A. Nattermann &amp; CIE GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOSPHOLIPIDS</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012423</DrugIDPK>
    <LicenceNumber>PA0326/001/002</LicenceNumber>
    <ProductName>LIPOSTABIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A. Nattermann &amp; CIE GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOSPHOLIPIDS</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012508</DrugIDPK>
    <LicenceNumber>PA0416/010/001</LicenceNumber>
    <ProductName>NERVE TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012506</DrugIDPK>
    <LicenceNumber>PA0416/008/001</LicenceNumber>
    <ProductName>RESTFUL NIGHT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012510</DrugIDPK>
    <LicenceNumber>PA0416/011/001</LicenceNumber>
    <ProductName>RHEUMATIC PAIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012960</DrugIDPK>
    <LicenceNumber>PA0137/003/001</LicenceNumber>
    <ProductName>STRESSTABS 600</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013786</DrugIDPK>
    <LicenceNumber>PA0280/002/001</LicenceNumber>
    <ProductName>BURN RELIEF  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gannet Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013789</DrugIDPK>
    <LicenceNumber>PA0280/003/001</LicenceNumber>
    <ProductName>SPRAY ON BANDAGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gannet Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013785</DrugIDPK>
    <LicenceNumber>PA0280/001/001</LicenceNumber>
    <ProductName>WOUND CLEANSING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gannet Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010494</DrugIDPK>
    <LicenceNumber>PA0028/031/001</LicenceNumber>
    <ProductName>SLOW-FE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010480</DrugIDPK>
    <LicenceNumber>PA0028/016/002</LicenceNumber>
    <ProductName>SYNACTHEN DEPOT MULTIDOSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACOSACTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001751</DrugIDPK>
    <LicenceNumber>PA0469/014/001</LicenceNumber>
    <ProductName>BIOGLAN CO2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012674</DrugIDPK>
    <LicenceNumber>PA0469/015/001</LicenceNumber>
    <ProductName>MICROPAQUE (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013875</DrugIDPK>
    <LicenceNumber>PA0288/004/001</LicenceNumber>
    <ProductName>CANTOPAL NATURTABS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013877</DrugIDPK>
    <LicenceNumber>PA0288/004/002</LicenceNumber>
    <ProductName>CANTOPAL NATURTABS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010636</DrugIDPK>
    <LicenceNumber>PA0038/053/001</LicenceNumber>
    <ProductName>MURINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015084</DrugIDPK>
    <LicenceNumber>PA0288/018/001</LicenceNumber>
    <ProductName>NICOTINIC ACID NATURTABS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013880</DrugIDPK>
    <LicenceNumber>PA0288/005/001</LicenceNumber>
    <ProductName>VITAMIN C NATURTABS</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013447</DrugIDPK>
    <LicenceNumber>PA0257/008/001</LicenceNumber>
    <ProductName>CALCIUM PANTOTHENATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012779</DrugIDPK>
    <LicenceNumber>PA0527/010/001</LicenceNumber>
    <ProductName>BECALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000492</DrugIDPK>
    <LicenceNumber>PA0012/044/001</LicenceNumber>
    <ProductName>EUGYNON 30</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012865</DrugIDPK>
    <LicenceNumber>PA0628/008/001</LicenceNumber>
    <ProductName>MIRAFLOW</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Vision (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLOXAMER</ActiveSubstance>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009949</DrugIDPK>
    <LicenceNumber>PA0013/020/001</LicenceNumber>
    <ProductName>TERMONIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013235</DrugIDPK>
    <LicenceNumber>PA0159/007/001</LicenceNumber>
    <ProductName>IRONPLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010867</DrugIDPK>
    <LicenceNumber>PA0046/014/002</LicenceNumber>
    <ProductName>SELEXID ORAL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIVMECILLINAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010168</DrugIDPK>
    <LicenceNumber>PA0255/015/006</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010160</DrugIDPK>
    <LicenceNumber>PA0255/015/001</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010162</DrugIDPK>
    <LicenceNumber>PA0255/015/002</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010163</DrugIDPK>
    <LicenceNumber>PA0255/015/003</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010164</DrugIDPK>
    <LicenceNumber>PA0255/015/004</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010166</DrugIDPK>
    <LicenceNumber>PA0255/015/005</LicenceNumber>
    <ProductName>STERILE WATER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1994-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010123</DrugIDPK>
    <LicenceNumber>PA0017/41/001</LicenceNumber>
    <ProductName>TRIVAX D T P  VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012861</DrugIDPK>
    <LicenceNumber>PA0582/012/001</LicenceNumber>
    <ProductName>METHOCEL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLHYDROXYPROPYLCELLULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013849</DrugIDPK>
    <LicenceNumber>PA0282/005/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1978-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012322</DrugIDPK>
    <LicenceNumber>PA0395/002/001</LicenceNumber>
    <ProductName>LADIES ONLY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Health &amp; Diet Food Company Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LECITHIN</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>P-AMINOBENZOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013872</DrugIDPK>
    <LicenceNumber>PA0288/003/001</LicenceNumber>
    <ProductName>NICOTINAMIDE NATURTABS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012323</DrugIDPK>
    <LicenceNumber>PA0395/004/001</LicenceNumber>
    <ProductName>VITAMIN E</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Health &amp; Diet Food Company Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012725</DrugIDPK>
    <LicenceNumber>PA0108/019/001</LicenceNumber>
    <ProductName>FEMUREST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>DYDROGESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010190</DrugIDPK>
    <LicenceNumber>PA0021/003/009</LicenceNumber>
    <ProductName>ADALAT LA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012376</DrugIDPK>
    <LicenceNumber>PA0309/002/001</LicenceNumber>
    <ProductName>BIO-STAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012445</DrugIDPK>
    <LicenceNumber>PA0337/007/001</LicenceNumber>
    <ProductName>PHARMATOVIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>IRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009732</DrugIDPK>
    <LicenceNumber>PA0016/023/004</LicenceNumber>
    <ProductName>PROVERA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1984-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012528</DrugIDPK>
    <LicenceNumber>PA0425/003/001</LicenceNumber>
    <ProductName>CARDIAGUTT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>1989-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012529</DrugIDPK>
    <LicenceNumber>PA0425/003/002</LicenceNumber>
    <ProductName>CARDIAGUTT</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>1989-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003532</DrugIDPK>
    <LicenceNumber>PA0088/004/001</LicenceNumber>
    <ProductName>HONVAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003536</DrugIDPK>
    <LicenceNumber>PA0088/004/002</LicenceNumber>
    <ProductName>HONVAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003537</DrugIDPK>
    <LicenceNumber>PA0088/005/001</LicenceNumber>
    <ProductName>MITOXANA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003539</DrugIDPK>
    <LicenceNumber>PA0088/005/002</LicenceNumber>
    <ProductName>MITOXANA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>1990-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IFOSFAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012141</DrugIDPK>
    <LicenceNumber>PA0365/024/003</LicenceNumber>
    <ProductName>FLUVIRIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011096</DrugIDPK>
    <LicenceNumber>PA0049/006/030</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010911</DrugIDPK>
    <LicenceNumber>PA0047/045/002</LicenceNumber>
    <ProductName>GLUCAGON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010576</DrugIDPK>
    <LicenceNumber>PA0037/055/001</LicenceNumber>
    <ProductName>NOLTAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1984-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010577</DrugIDPK>
    <LicenceNumber>PA0037/055/002</LicenceNumber>
    <ProductName>NOLTAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1984-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006230</DrugIDPK>
    <LicenceNumber>PA0415/002/001</LicenceNumber>
    <ProductName>PROFILATE HEAT-TREATED</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate>1988-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006179</DrugIDPK>
    <LicenceNumber>PA0415/002/002</LicenceNumber>
    <ProductName>PROFILATE HEAT-TREATED</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate>1988-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009743</DrugIDPK>
    <LicenceNumber>PA0016/024/003</LicenceNumber>
    <ProductName>DEPO-PROVERA 50 MG/ML</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009740</DrugIDPK>
    <LicenceNumber>PA0017/025/001</LicenceNumber>
    <ProductName>DEPO-PROVERA 50 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001592</DrugIDPK>
    <LicenceNumber>PA0016/024/001</LicenceNumber>
    <ProductName>DEPO-PROVERA 50 MG/ML. 1 ML.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010998</DrugIDPK>
    <LicenceNumber>PA0046/042/001</LicenceNumber>
    <ProductName>IMMUNOVIR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSINE PRANOBEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010155</DrugIDPK>
    <LicenceNumber>PA0237/024/001</LicenceNumber>
    <ProductName>APS ALLOPURINOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1988-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010156</DrugIDPK>
    <LicenceNumber>PA0237/024/002</LicenceNumber>
    <ProductName>APS ALLOPURINOL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010157</DrugIDPK>
    <LicenceNumber>PA0237/028/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1988-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010158</DrugIDPK>
    <LicenceNumber>PA0237/028/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>1988-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012035</DrugIDPK>
    <LicenceNumber>PA0088/007/001</LicenceNumber>
    <ProductName>PENDRAMINE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012036</DrugIDPK>
    <LicenceNumber>PA0088/007/002</LicenceNumber>
    <ProductName>PENDRAMINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012862</DrugIDPK>
    <LicenceNumber>PA0582/013/001</LicenceNumber>
    <ProductName>VISCOTEARS LIQUID GEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOMER</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006198</DrugIDPK>
    <LicenceNumber>PA0441/011/001</LicenceNumber>
    <ProductName>VICKS DOUBLE ACTION MEDICATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1978-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012801</DrugIDPK>
    <LicenceNumber>PA0527/036/002</LicenceNumber>
    <ProductName>ESTER-C-250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012800</DrugIDPK>
    <LicenceNumber>PA0527/036/001</LicenceNumber>
    <ProductName>ESTER-C-60</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012790</DrugIDPK>
    <LicenceNumber>PA0527/033/001</LicenceNumber>
    <ProductName>LADYCARE FOR WOMEN AFTER THE MENOPAUSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012788</DrugIDPK>
    <LicenceNumber>PA0527/032/001</LicenceNumber>
    <ProductName>LADYCARE FOR WOMEN GOING THROUGH THE MENOPAUSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012786</DrugIDPK>
    <LicenceNumber>PA0527/031/001</LicenceNumber>
    <ProductName>LADYCARE FOR WOMEN WITH MONTHLY PERIODS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012785</DrugIDPK>
    <LicenceNumber>PA0527/029/001</LicenceNumber>
    <ProductName>SCHOOLDAYS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012802</DrugIDPK>
    <LicenceNumber>PA0527/037/001</LicenceNumber>
    <ProductName>SUNSCENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012798</DrugIDPK>
    <LicenceNumber>PA0527/035/001</LicenceNumber>
    <ProductName>SUPERTED VITAMIN C</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012796</DrugIDPK>
    <LicenceNumber>PA0527/034/001</LicenceNumber>
    <ProductName>TRAVELWELL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013850</DrugIDPK>
    <LicenceNumber>PA0282/006/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE B P</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1978-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013851</DrugIDPK>
    <LicenceNumber>PA0282/006/002</LicenceNumber>
    <ProductName>AMITRIPTYLINE B P</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1978-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013883</DrugIDPK>
    <LicenceNumber>PA0288/006/001</LicenceNumber>
    <ProductName>BIOTIN NATURTABS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013885</DrugIDPK>
    <LicenceNumber>PA0288/007/001</LicenceNumber>
    <ProductName>VITAMIN B NATURTABS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012841</DrugIDPK>
    <LicenceNumber>PA0546/002/001</LicenceNumber>
    <ProductName>VICTORY V</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mynish Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003104</DrugIDPK>
    <LicenceNumber>PA0069/008/001</LicenceNumber>
    <ProductName>DILATRATE-SR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1983-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012828</DrugIDPK>
    <LicenceNumber>PA0532/001/001</LicenceNumber>
    <ProductName>HIRUDOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Panpharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011638</DrugIDPK>
    <LicenceNumber>PA0072/001/001</LicenceNumber>
    <ProductName>TUSS-IONEX (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCODONE</ActiveSubstance>
      <ActiveSubstance>PHENYLTOLOXAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012689</DrugIDPK>
    <LicenceNumber>PA0473/008/003</LicenceNumber>
    <ProductName>NIPOLEPT 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZOTEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012686</DrugIDPK>
    <LicenceNumber>PA0473/008/001</LicenceNumber>
    <ProductName>NIPOLEPT 25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZOTEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012687</DrugIDPK>
    <LicenceNumber>PA0473/008/002</LicenceNumber>
    <ProductName>NIPOLEPT 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZOTEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001942</DrugIDPK>
    <LicenceNumber>PA0044/017/001</LicenceNumber>
    <ProductName>CRYSTAPEN INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYLPENICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012437</DrugIDPK>
    <LicenceNumber>PA0330/002/006</LicenceNumber>
    <ProductName>TYLENOL JUNIOR CAPLET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010169</DrugIDPK>
    <LicenceNumber>PA0544/012/002</LicenceNumber>
    <ProductName>MFV VACCINE INACTIVATED INFLUENZA VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1992-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012490</DrugIDPK>
    <LicenceNumber>PA0360/022/001</LicenceNumber>
    <ProductName>BUFEDON 800</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012567</DrugIDPK>
    <LicenceNumber>PA0436/018/001</LicenceNumber>
    <ProductName>SODIUM CROMOGLYCATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012569</DrugIDPK>
    <LicenceNumber>PA0436/018/002</LicenceNumber>
    <ProductName>SODIUM CROMOGLYCATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1990-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012570</DrugIDPK>
    <LicenceNumber>PA0436/018/003</LicenceNumber>
    <ProductName>SODIUM CROMOGLYCATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1991-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011740</DrugIDPK>
    <LicenceNumber>PA0074/010/003</LicenceNumber>
    <ProductName>METOCYL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013177</DrugIDPK>
    <LicenceNumber>PA0144/011/007</LicenceNumber>
    <ProductName>PANOXYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015163</DrugIDPK>
    <LicenceNumber>PA0098/008/001</LicenceNumber>
    <ProductName>RAPENTON 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012679</DrugIDPK>
    <LicenceNumber>PA0473/007/001</LicenceNumber>
    <ProductName>ULCIDIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012680</DrugIDPK>
    <LicenceNumber>PA0473/007/002</LicenceNumber>
    <ProductName>ULCIDIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012682</DrugIDPK>
    <LicenceNumber>PA0473/007/004</LicenceNumber>
    <ProductName>ULCIDIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012683</DrugIDPK>
    <LicenceNumber>PA0473/007/005</LicenceNumber>
    <ProductName>ULCIDIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012684</DrugIDPK>
    <LicenceNumber>PA0473/007/006</LicenceNumber>
    <ProductName>ULCIDIN</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006208</DrugIDPK>
    <LicenceNumber>PA0441/030/001</LicenceNumber>
    <ProductName>VICKS THROAT LOZENGES LEMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1988-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001224</DrugIDPK>
    <LicenceNumber>PA0022/037/003</LicenceNumber>
    <ProductName>LORAMET</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORMETAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011369</DrugIDPK>
    <LicenceNumber>PA0054/075/001</LicenceNumber>
    <ProductName>EMFLEX</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012774</DrugIDPK>
    <LicenceNumber>PA0522/001/001</LicenceNumber>
    <ProductName>NATRACALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Peter Black Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PASSIFLORA INCARNATA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011919</DrugIDPK>
    <LicenceNumber>PA0082/064/001</LicenceNumber>
    <ProductName>NOCTZAM</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011920</DrugIDPK>
    <LicenceNumber>PA0082/064/002</LicenceNumber>
    <ProductName>NOCTZAM</ProductName>
    <Strength>0.250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003037</DrugIDPK>
    <LicenceNumber>PA0060/050/001</LicenceNumber>
    <ProductName>PLUSERIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1988-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>MUMPS VIRUS (URABE AM9 STRAIN)</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003038</DrugIDPK>
    <LicenceNumber>PA0060/050/002</LicenceNumber>
    <ProductName>PLUSERIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1988-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>MUMPS VIRUS (URABE AM9 STRAIN)</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013137</DrugIDPK>
    <LicenceNumber>PA0126/054/001</LicenceNumber>
    <ProductName>FLURZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013139</DrugIDPK>
    <LicenceNumber>PA0126/054/002</LicenceNumber>
    <ProductName>FLURZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013144</DrugIDPK>
    <LicenceNumber>PA0126/075/001</LicenceNumber>
    <ProductName>PYRIDAMEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013145</DrugIDPK>
    <LicenceNumber>PA0126/075/002</LicenceNumber>
    <ProductName>PYRIDAMEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013629</DrugIDPK>
    <LicenceNumber>PA0187/033/001</LicenceNumber>
    <ProductName>FRAGMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN-FRACTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013634</DrugIDPK>
    <LicenceNumber>PA0187/033/004</LicenceNumber>
    <ProductName>FRAGMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN-FRACTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013631</DrugIDPK>
    <LicenceNumber>PA0187/033/002</LicenceNumber>
    <ProductName>FRAGMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN-FRACTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013632</DrugIDPK>
    <LicenceNumber>PA0187/033/003</LicenceNumber>
    <ProductName>FRAGMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN-FRACTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015743</DrugIDPK>
    <LicenceNumber>PA0237/018/001</LicenceNumber>
    <ProductName>APS FRUSEMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012344</DrugIDPK>
    <LicenceNumber>PA0405/022/002</LicenceNumber>
    <ProductName>MIANSERIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIANSERIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005358</DrugIDPK>
    <LicenceNumber>PA0258/037/001</LicenceNumber>
    <ProductName>CALAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1988-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012709</DrugIDPK>
    <LicenceNumber>PA0493/004/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012711</DrugIDPK>
    <LicenceNumber>PA0493/004/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010421</DrugIDPK>
    <LicenceNumber>PA0022/060/003</LicenceNumber>
    <ProductName>EVADYNE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010416</DrugIDPK>
    <LicenceNumber>PA0022/060/001</LicenceNumber>
    <ProductName>EVADYNE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010418</DrugIDPK>
    <LicenceNumber>PA0022/060/002</LicenceNumber>
    <ProductName>EVADYNE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005917</DrugIDPK>
    <LicenceNumber>PA0379/016/001</LicenceNumber>
    <ProductName>VENOS ANTITUSSIVE FORMULA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1988-09-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012386</DrugIDPK>
    <LicenceNumber>PA0309/007/002</LicenceNumber>
    <ProductName>IBUDROS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IBUPROXAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012696</DrugIDPK>
    <LicenceNumber>PA0484/008/001</LicenceNumber>
    <ProductName>EMULSIFYING OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMULSIFYING WAX</ActiveSubstance>
      <ActiveSubstance>PARAFFIN SOFT</ActiveSubstance>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012734</DrugIDPK>
    <LicenceNumber>PA0504/009/002</LicenceNumber>
    <ProductName>MERIEUX IMMRAVAX 10 DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate>1988-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005396</DrugIDPK>
    <LicenceNumber>PA0277/002/001</LicenceNumber>
    <ProductName>TINADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1978-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013550</DrugIDPK>
    <LicenceNumber>PA0271/006/001</LicenceNumber>
    <ProductName>MENZOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011250</DrugIDPK>
    <LicenceNumber>PA0054/012/001</LicenceNumber>
    <ProductName>MERCK SKIN TESTING SOLUTIONS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012872</DrugIDPK>
    <LicenceNumber>PA0661/001/001</LicenceNumber>
    <ProductName>ZANTEC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Blackrock Clinic Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012839</DrugIDPK>
    <LicenceNumber>PA0545/032/001</LicenceNumber>
    <ProductName>FEMERON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010954</DrugIDPK>
    <LicenceNumber>PA0047/076/001</LicenceNumber>
    <ProductName>DYNABAC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIRITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010146</DrugIDPK>
    <LicenceNumber>PA0060/047/001</LicenceNumber>
    <ProductName>MESASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010291</DrugIDPK>
    <LicenceNumber>PA0022/012/002</LicenceNumber>
    <ProductName>PRONDOL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010289</DrugIDPK>
    <LicenceNumber>PA0022/012/001</LicenceNumber>
    <ProductName>PRONDOL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRINDOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015210</DrugIDPK>
    <LicenceNumber>PA0402/001/001</LicenceNumber>
    <ProductName>ULTRACACH ANALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wallace, Cameron &amp; Company (Ire)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011010</DrugIDPK>
    <LicenceNumber>PA0048/014/005</LicenceNumber>
    <ProductName>ULTRACEF (SUSPENSION)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFADROXIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011033</DrugIDPK>
    <LicenceNumber>PA0046/058/002</LicenceNumber>
    <ProductName>DICAPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULTAMICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011032</DrugIDPK>
    <LicenceNumber>PA0046/058/001</LicenceNumber>
    <ProductName>DICAPEN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULTAMICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015745</DrugIDPK>
    <LicenceNumber>PA0237/022/001</LicenceNumber>
    <ProductName>METOCLOPRAMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011386</DrugIDPK>
    <LicenceNumber>PA0056/018/001</LicenceNumber>
    <ProductName>VIRA-A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1978-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VIDARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011338</DrugIDPK>
    <LicenceNumber>PA0054/036/002</LicenceNumber>
    <ProductName>AMINOFUSIN L1000</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>CARBOHYDRATES NOS</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012838</DrugIDPK>
    <LicenceNumber>PA0545/029/001</LicenceNumber>
    <ProductName>ACNIDAZIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010055</DrugIDPK>
    <LicenceNumber>PA0019/042/001</LicenceNumber>
    <ProductName>UNASYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULTAMICILLIN TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010056</DrugIDPK>
    <LicenceNumber>PA0019/042/002</LicenceNumber>
    <ProductName>UNASYN TOSYLATE</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULTAMICILLIN TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011339</DrugIDPK>
    <LicenceNumber>PA0054/036/003</LicenceNumber>
    <ProductName>AMINOFUSIN L FORTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>CARBOHYDRATES NOS</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010516</DrugIDPK>
    <LicenceNumber>PA0023/068/001</LicenceNumber>
    <ProductName>ROXANE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROXATIDINE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010517</DrugIDPK>
    <LicenceNumber>PA0023/068/002</LicenceNumber>
    <ProductName>ROXANE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROXATIDINE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012428</DrugIDPK>
    <LicenceNumber>PA0329/004/001</LicenceNumber>
    <ProductName>THEOPLUS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012431</DrugIDPK>
    <LicenceNumber>PA0329/004/002</LicenceNumber>
    <ProductName>THEOPLUS SUSTAINED</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010379</DrugIDPK>
    <LicenceNumber>PA0035/035/001</LicenceNumber>
    <ProductName>FLUAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INFLUENZA VIRUS VACCINE MONOVALENT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010227</DrugIDPK>
    <LicenceNumber>PA0021/017/001</LicenceNumber>
    <ProductName>BAYOLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1983-07-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARINOID</ActiveSubstance>
      <ActiveSubstance>ETHYLENE GLYCOL MONOSTEARATE</ActiveSubstance>
      <ActiveSubstance>BENZYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013889</DrugIDPK>
    <LicenceNumber>PA0277/035/001</LicenceNumber>
    <ProductName>CONGESTEZE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013890</DrugIDPK>
    <LicenceNumber>PA0277/035/002</LicenceNumber>
    <ProductName>CONGESTEZE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1993-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013892</DrugIDPK>
    <LicenceNumber>PA0277/038/001</LicenceNumber>
    <ProductName>DIPROCEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-12-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008024</DrugIDPK>
    <LicenceNumber>PA0257/011/001</LicenceNumber>
    <ProductName>ROSAMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011091</DrugIDPK>
    <LicenceNumber>PA0049/006/024</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011092</DrugIDPK>
    <LicenceNumber>PA0049/006/025</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011093</DrugIDPK>
    <LicenceNumber>PA0049/006/026</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011095</DrugIDPK>
    <LicenceNumber>PA0049/006/027</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012954</DrugIDPK>
    <LicenceNumber>PA0130/016/003</LicenceNumber>
    <ProductName>SPIROCTAN 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012952</DrugIDPK>
    <LicenceNumber>PA0130/016/001</LicenceNumber>
    <ProductName>SPIROCTAN 25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012953</DrugIDPK>
    <LicenceNumber>PA0130/016/002</LicenceNumber>
    <ProductName>SPIROCTAN 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011722</DrugIDPK>
    <LicenceNumber>PA0073/094/001</LicenceNumber>
    <ProductName>INDOPON</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011723</DrugIDPK>
    <LicenceNumber>PA0073/094/002</LicenceNumber>
    <ProductName>INDOPON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1988-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012389</DrugIDPK>
    <LicenceNumber>PA0312/001/001</LicenceNumber>
    <ProductName>AMPICILLIN B.P.C.</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012390</DrugIDPK>
    <LicenceNumber>PA0312/001/003</LicenceNumber>
    <ProductName>AMPICILLIN B.P.C.</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012255</DrugIDPK>
    <LicenceNumber>PA0376/001/001</LicenceNumber>
    <ProductName>DOUBLE CHECK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Family Planning Sales Ltd</PAHolder>
    <AuthorisedDate>1983-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012256</DrugIDPK>
    <LicenceNumber>PA0376/002/001</LicenceNumber>
    <ProductName>TWOS COMPANY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Family Planning Sales Ltd</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012854</DrugIDPK>
    <LicenceNumber>PA0570/006/001</LicenceNumber>
    <ProductName>PROTECTA FEMME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Healthilife Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>LECITHINUM SOYA</ActiveSubstance>
      <ActiveSubstance>FAT EMULSIONS</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>IRON</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>ZINC</ActiveSubstance>
      <ActiveSubstance>HEAVY MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>CHROMIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011996</DrugIDPK>
    <LicenceNumber>PA0086/020/002</LicenceNumber>
    <ProductName>MALINAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALMASILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011748</DrugIDPK>
    <LicenceNumber>PA0074/022/003</LicenceNumber>
    <ProductName>SALBUL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011937</DrugIDPK>
    <LicenceNumber>PA0086/011/004</LicenceNumber>
    <ProductName>DIMOTAPP BABY DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009906</DrugIDPK>
    <LicenceNumber>PA0012/051/003</LicenceNumber>
    <ProductName>NOCTAMID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LORMETAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011538</DrugIDPK>
    <LicenceNumber>PA0058/011/001</LicenceNumber>
    <ProductName>TANNACOMP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TANNIC ACID</ActiveSubstance>
      <ActiveSubstance>ETHACRIDINE LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011048</DrugIDPK>
    <LicenceNumber>PA0048/043/001</LicenceNumber>
    <ProductName>ACETYLCYSTEINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011042</DrugIDPK>
    <LicenceNumber>PA0048/038/001</LicenceNumber>
    <ProductName>DURALIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM GLYCINATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011043</DrugIDPK>
    <LicenceNumber>PA0048/038/002</LicenceNumber>
    <ProductName>DURALIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM GLYCINATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011040</DrugIDPK>
    <LicenceNumber>PA0048/036/001</LicenceNumber>
    <ProductName>KERI CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011041</DrugIDPK>
    <LicenceNumber>PA0048/036/002</LicenceNumber>
    <ProductName>KERI LOTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005903</DrugIDPK>
    <LicenceNumber>PA0379/001/002</LicenceNumber>
    <ProductName>NIGHT NURSE COLD REMEDY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1983-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009728</DrugIDPK>
    <LicenceNumber>PA0016/018/003</LicenceNumber>
    <ProductName>DEPO-MEDRONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009729</DrugIDPK>
    <LicenceNumber>PA0016/018/004</LicenceNumber>
    <ProductName>DEPO-MEDRONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013683</DrugIDPK>
    <LicenceNumber>PA0200/006/002</LicenceNumber>
    <ProductName>INTROPIN</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1988-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013684</DrugIDPK>
    <LicenceNumber>PA0200/006/003</LicenceNumber>
    <ProductName>INTROPIN SYRINGE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1988-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013685</DrugIDPK>
    <LicenceNumber>PA0200/006/004</LicenceNumber>
    <ProductName>INTROPIN SYRINGE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1988-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013686</DrugIDPK>
    <LicenceNumber>PA0200/006/005</LicenceNumber>
    <ProductName>INTROPIN SYRINGE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1988-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010330</DrugIDPK>
    <LicenceNumber>PA0022/043/001</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010333</DrugIDPK>
    <LicenceNumber>PA0022/043/004</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010334</DrugIDPK>
    <LicenceNumber>PA0022/043/005</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1988-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013473</DrugIDPK>
    <LicenceNumber>PA0258/006/001</LicenceNumber>
    <ProductName>ASPIRIN &amp; CODEINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012781</DrugIDPK>
    <LicenceNumber>PA0114/002/010</LicenceNumber>
    <ProductName>BETADINE L M W IRRIGATING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011014</DrugIDPK>
    <LicenceNumber>PA0046/049/002</LicenceNumber>
    <ProductName>EMOFORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012171</DrugIDPK>
    <LicenceNumber>PA0365/031/007</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012166</DrugIDPK>
    <LicenceNumber>PA0365/031/004</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012168</DrugIDPK>
    <LicenceNumber>PA0365/031/005</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012169</DrugIDPK>
    <LicenceNumber>PA0365/031/006</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012161</DrugIDPK>
    <LicenceNumber>PA0365/031/001</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012163</DrugIDPK>
    <LicenceNumber>PA0365/031/002</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE 25 MG/ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012165</DrugIDPK>
    <LicenceNumber>PA0365/031/003</LicenceNumber>
    <ProductName>FLUPHENAZINE DECANOATE 25 MG/ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011024</DrugIDPK>
    <LicenceNumber>PA0046/051/002</LicenceNumber>
    <ProductName>OPAS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>HEAVY MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012797</DrugIDPK>
    <LicenceNumber>PA0114/024/002</LicenceNumber>
    <ProductName>PEPTICHEMIO</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011005</DrugIDPK>
    <LicenceNumber>PA0046/046/001</LicenceNumber>
    <ProductName>SEROTULLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013476</DrugIDPK>
    <LicenceNumber>PA0258/010/001</LicenceNumber>
    <ProductName>TOOTHACHE TINCTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013504</DrugIDPK>
    <LicenceNumber>PA0258/030/001</LicenceNumber>
    <ProductName>VITATHONE CHILBLAIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010250</DrugIDPK>
    <LicenceNumber>PA0021/034/001</LicenceNumber>
    <ProductName>ALPARE D PTERONYSSINUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010252</DrugIDPK>
    <LicenceNumber>PA0021/034/002</LicenceNumber>
    <ProductName>ALPARE D PTERONYSSINUS</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010254</DrugIDPK>
    <LicenceNumber>PA0021/034/003</LicenceNumber>
    <ProductName>ALPARE D PTERONYSSINUS</ProductName>
    <Strength>9.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010256</DrugIDPK>
    <LicenceNumber>PA0021/035/001</LicenceNumber>
    <ProductName>ALPARE TWO GRASS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010260</DrugIDPK>
    <LicenceNumber>PA0021/035/003</LicenceNumber>
    <ProductName>ALPARE TWO GRASS</ProductName>
    <Strength>9.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009682</DrugIDPK>
    <LicenceNumber>PA0007/050/002</LicenceNumber>
    <ProductName>BEROFOR</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009684</DrugIDPK>
    <LicenceNumber>PA0007/050/003</LicenceNumber>
    <ProductName>BEROFOR</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009675</DrugIDPK>
    <LicenceNumber>PA0007/050/001</LicenceNumber>
    <ProductName>BEROFOR</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013126</DrugIDPK>
    <LicenceNumber>PA0126/036/001</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013129</DrugIDPK>
    <LicenceNumber>PA0126/036/002</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009887</DrugIDPK>
    <LicenceNumber>PA0012/036/001</LicenceNumber>
    <ProductName>SOLU-BILOPTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IOPODATE CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009877</DrugIDPK>
    <LicenceNumber>PA0012/031/001</LicenceNumber>
    <ProductName>ULTRALAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009878</DrugIDPK>
    <LicenceNumber>PA0012/031/002</LicenceNumber>
    <ProductName>ULTRALAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009879</DrugIDPK>
    <LicenceNumber>PA0012/031/003</LicenceNumber>
    <ProductName>ULTRALAN FATTY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000487</DrugIDPK>
    <LicenceNumber>PA0012/039/001</LicenceNumber>
    <ProductName>UROGRAFIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009889</DrugIDPK>
    <LicenceNumber>PA0012/039/004</LicenceNumber>
    <ProductName>UROGRAFIN  76%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000488</DrugIDPK>
    <LicenceNumber>PA0012/039/003</LicenceNumber>
    <ProductName>UROGRAFIN 60%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009890</DrugIDPK>
    <LicenceNumber>PA0012/039/005</LicenceNumber>
    <ProductName>UROGRAFIN 76%</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009891</DrugIDPK>
    <LicenceNumber>PA0012/040/001</LicenceNumber>
    <ProductName>UROVISON 58%</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013160</DrugIDPK>
    <LicenceNumber>PA0143/006/001</LicenceNumber>
    <ProductName>AMINOPLEX 5 NEW</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1978-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012305</DrugIDPK>
    <LicenceNumber>PA0303/011/001</LicenceNumber>
    <ProductName>FUROMEX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012306</DrugIDPK>
    <LicenceNumber>PA0303/011/002</LicenceNumber>
    <ProductName>FUROMEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012307</DrugIDPK>
    <LicenceNumber>PA0303/012/001</LicenceNumber>
    <ProductName>ORIBUTOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHAMBUTOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012308</DrugIDPK>
    <LicenceNumber>PA0303/012/002</LicenceNumber>
    <ProductName>ORIBUTOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHAMBUTOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011750</DrugIDPK>
    <LicenceNumber>PA0074/035/001</LicenceNumber>
    <ProductName>AMILORIDE HYDROCHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011872</DrugIDPK>
    <LicenceNumber>PA0077/062/001</LicenceNumber>
    <ProductName>EBRANTIL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011873</DrugIDPK>
    <LicenceNumber>PA0077/062/002</LicenceNumber>
    <ProductName>EBRANTIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013564</DrugIDPK>
    <LicenceNumber>PA0275/008/001</LicenceNumber>
    <ProductName>FAMEL ORIGINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CODEINE</ActiveSubstance>
      <ActiveSubstance>CREOSOTE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010464</DrugIDPK>
    <LicenceNumber>PA0027/039/001</LicenceNumber>
    <ProductName>CARDIPRIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012060</DrugIDPK>
    <LicenceNumber>PA0095/011/001</LicenceNumber>
    <ProductName>DECAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012058</DrugIDPK>
    <LicenceNumber>PA0095/010/001</LicenceNumber>
    <ProductName>RIAZINE WORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010514</DrugIDPK>
    <LicenceNumber>PA0023/067/002</LicenceNumber>
    <ProductName>TRIAZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010128</DrugIDPK>
    <LicenceNumber>PA0023/054/001</LicenceNumber>
    <ProductName>FERTIRAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1988-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GONADORELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010440</DrugIDPK>
    <LicenceNumber>PA0023/006/001</LicenceNumber>
    <ProductName>LASIX + K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1978-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005919</DrugIDPK>
    <LicenceNumber>PA0379/018/001</LicenceNumber>
    <ProductName>DAY NURSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012653</DrugIDPK>
    <LicenceNumber>PA0447/005/002</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1989-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012654</DrugIDPK>
    <LicenceNumber>PA0447/005/003</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1989-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010130</DrugIDPK>
    <LicenceNumber>PA0030/001/001</LicenceNumber>
    <ProductName>VIBROCIL  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIMETINDENE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010239</DrugIDPK>
    <LicenceNumber>PA0030/001/004</LicenceNumber>
    <ProductName>VIBROCIL MICRODOSER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIMETINDENE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010042</DrugIDPK>
    <LicenceNumber>PA0019/031/004</LicenceNumber>
    <ProductName>EXIREL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRBUTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005310</DrugIDPK>
    <LicenceNumber>PA0281/030/001</LicenceNumber>
    <ProductName>VENTAMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005311</DrugIDPK>
    <LicenceNumber>PA0281/030/002</LicenceNumber>
    <ProductName>VENTAMOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000591</DrugIDPK>
    <LicenceNumber>PA0009/037/001</LicenceNumber>
    <ProductName>NEZERIL ADULT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000592</DrugIDPK>
    <LicenceNumber>PA0009/037/002</LicenceNumber>
    <ProductName>NEZERIL INFANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000593</DrugIDPK>
    <LicenceNumber>PA0009/037/003</LicenceNumber>
    <ProductName>NEZERIL JUNIOR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1988-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010145</DrugIDPK>
    <LicenceNumber>PA0054/043/003</LicenceNumber>
    <ProductName>ENDOBIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODOXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011257</DrugIDPK>
    <LicenceNumber>PA0054/017/001</LicenceNumber>
    <ProductName>UROMIRO 380</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011258</DrugIDPK>
    <LicenceNumber>PA0054/017/002</LicenceNumber>
    <ProductName>UROMIRO 380</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011259</DrugIDPK>
    <LicenceNumber>PA0054/018/001</LicenceNumber>
    <ProductName>UROMIRO 420</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011260</DrugIDPK>
    <LicenceNumber>PA0054/018/002</LicenceNumber>
    <ProductName>UROMIRO 420</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010798</DrugIDPK>
    <LicenceNumber>PA0041/037/001</LicenceNumber>
    <ProductName>LOFEXIDINE HYDROCHLORIDE</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010799</DrugIDPK>
    <LicenceNumber>PA0041/037/002</LicenceNumber>
    <ProductName>LOFEXIDINE HYDROCHLORIDE</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010800</DrugIDPK>
    <LicenceNumber>PA0041/037/003</LicenceNumber>
    <ProductName>LOFEXIDINE HYDROCHLORIDE</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010797</DrugIDPK>
    <LicenceNumber>PA0041/036/002</LicenceNumber>
    <ProductName>RIFATER 75</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
      <ActiveSubstance>PYRAZINAMIDE</ActiveSubstance>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011752</DrugIDPK>
    <LicenceNumber>PA0074/040/004</LicenceNumber>
    <ProductName>ACETYCYSTEINE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013462</DrugIDPK>
    <LicenceNumber>PA0176/050/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM CHLORIDE AND GLUCOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013737</DrugIDPK>
    <LicenceNumber>PA0176/020/001</LicenceNumber>
    <ProductName>COX PAIN RELIEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE CITRATE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013670</DrugIDPK>
    <LicenceNumber>PA0176/010/001</LicenceNumber>
    <ProductName>COX TOOTHACHE TINCTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>COMMIPHORA MOLMOL</ActiveSubstance>
      <ActiveSubstance>CLOVE OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013663</DrugIDPK>
    <LicenceNumber>PA0176/007/001</LicenceNumber>
    <ProductName>PHENOBARBITONE &amp; THEOBROMINE B.P.C.</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>THEOBROMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006539</DrugIDPK>
    <LicenceNumber>PA0472/001/001</LicenceNumber>
    <ProductName>PROGRANE LA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Prographarm Laboratories</PAHolder>
    <AuthorisedDate>1988-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011751</DrugIDPK>
    <LicenceNumber>PA0074/038/001</LicenceNumber>
    <ProductName>BECLOMETHASONE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004593</DrugIDPK>
    <LicenceNumber>PA0179/003/003</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004594</DrugIDPK>
    <LicenceNumber>PA0179/003/004</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004596</DrugIDPK>
    <LicenceNumber>PA0179/003/005</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004902</DrugIDPK>
    <LicenceNumber>PA0224/003/001</LicenceNumber>
    <ProductName>ACTH/CMC/PL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004744</DrugIDPK>
    <LicenceNumber>PA0206/012/001</LicenceNumber>
    <ProductName>BAMBINO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CASTOR OIL</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004611</DrugIDPK>
    <LicenceNumber>PA0179/004/005</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004687</DrugIDPK>
    <LicenceNumber>PA0196/008/001</LicenceNumber>
    <ProductName>CRESOPHENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
      <ActiveSubstance>PARACHLOROPHENOL, CAMPHORATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004620</DrugIDPK>
    <LicenceNumber>PA0179/007/001</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004621</DrugIDPK>
    <LicenceNumber>PA0179/007/002</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004688</DrugIDPK>
    <LicenceNumber>PA0196/010/001</LicenceNumber>
    <ProductName>ENDOMETHASONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>THYMOL IODIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004062</DrugIDPK>
    <LicenceNumber>PA0145/005/001</LicenceNumber>
    <ProductName>EPIPHYTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001461</DrugIDPK>
    <LicenceNumber>PA0037/022/001</LicenceNumber>
    <ProductName>GEVRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PHOSPHORUS</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>MANGANESE DIOXIDE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>INOSITOL</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>CHOLINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004522</DrugIDPK>
    <LicenceNumber>PA0179/001/005</LicenceNumber>
    <ProductName>GLUCOSE 10%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004523</DrugIDPK>
    <LicenceNumber>PA0179/001/006</LicenceNumber>
    <ProductName>GLUCOSE 10%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004526</DrugIDPK>
    <LicenceNumber>PA0179/001/007</LicenceNumber>
    <ProductName>GLUCOSE 20%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004530</DrugIDPK>
    <LicenceNumber>PA0179/001/010</LicenceNumber>
    <ProductName>GLUCOSE 25%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004532</DrugIDPK>
    <LicenceNumber>PA0179/001/011</LicenceNumber>
    <ProductName>GLUCOSE 40%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004535</DrugIDPK>
    <LicenceNumber>PA0179/001/013</LicenceNumber>
    <ProductName>GLUCOSE 50%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004536</DrugIDPK>
    <LicenceNumber>PA0179/001/014</LicenceNumber>
    <ProductName>GLUCOSE 50%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004061</DrugIDPK>
    <LicenceNumber>PA0145/004/001</LicenceNumber>
    <ProductName>HADENSA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICHTHAMMOL</ActiveSubstance>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004063</DrugIDPK>
    <LicenceNumber>PA0145/006/001</LicenceNumber>
    <ProductName>HADENSA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICHTHAMMOL</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CHLORCARVACROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004060</DrugIDPK>
    <LicenceNumber>PA0145/003/001</LicenceNumber>
    <ProductName>HADENSA FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ICHTHAMMOL</ActiveSubstance>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006223</DrugIDPK>
    <LicenceNumber>PA0447/006/001</LicenceNumber>
    <ProductName>HAELAN C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDROXYCORTIDE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006224</DrugIDPK>
    <LicenceNumber>PA0447/006/002</LicenceNumber>
    <ProductName>HAELAN C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1988-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDROXYCORTIDE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001023</DrugIDPK>
    <LicenceNumber>PA0018/032/001</LicenceNumber>
    <ProductName>INTAL COMPOUND SPINCAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
      <ActiveSubstance>ISOPRENALINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001975</DrugIDPK>
    <LicenceNumber>PA0040/068/001</LicenceNumber>
    <ProductName>MYOCRISIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001977</DrugIDPK>
    <LicenceNumber>PA0040/068/002</LicenceNumber>
    <ProductName>MYOCRISIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004756</DrugIDPK>
    <LicenceNumber>PA0206/016/001</LicenceNumber>
    <ProductName>OVELLE CREAM OF CALAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004327</DrugIDPK>
    <LicenceNumber>PA0167/059/004</LicenceNumber>
    <ProductName>PLASMA PROTEIN FRACTION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PLASMA PROTEIN FRACTION (HUMAN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004325</DrugIDPK>
    <LicenceNumber>PA0167/059/003</LicenceNumber>
    <ProductName>PLASMA PROTEIN FRACTION</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PLASMA PROTEIN FRACTION (HUMAN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004321</DrugIDPK>
    <LicenceNumber>PA0167/059/001</LicenceNumber>
    <ProductName>PLASMA PROTEIN FRACTION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PLASMA PROTEIN FRACTION (HUMAN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004323</DrugIDPK>
    <LicenceNumber>PA0167/059/002</LicenceNumber>
    <ProductName>PLASMA PROTEIN FRACTION</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PLASMA PROTEIN FRACTION (HUMAN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004577</DrugIDPK>
    <LicenceNumber>PA0179/002/012</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 3%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005912</DrugIDPK>
    <LicenceNumber>PA0379/008/001</LicenceNumber>
    <ProductName>YEAST VITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011251</DrugIDPK>
    <LicenceNumber>PA0054/013/001</LicenceNumber>
    <ProductName>NORISEN EXTRACTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011252</DrugIDPK>
    <LicenceNumber>PA0054/013/002</LicenceNumber>
    <ProductName>NORISEN GRASS EXTRACTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1979-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011253</DrugIDPK>
    <LicenceNumber>PA0054/013/003</LicenceNumber>
    <ProductName>NORISEN MITE M</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013314</DrugIDPK>
    <LicenceNumber>PA0167/024/001</LicenceNumber>
    <ProductName>ANTICOAGULANT 4% SODIUM CITRATE SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010887</DrugIDPK>
    <LicenceNumber>PA0047/025/003</LicenceNumber>
    <ProductName>AVENTYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010896</DrugIDPK>
    <LicenceNumber>PA0047/036/002</LicenceNumber>
    <ProductName>NU-SEALS ASPIRIN</ProductName>
    <Strength>650</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012309</DrugIDPK>
    <LicenceNumber>PA0303/013/001</LicenceNumber>
    <ProductName>DOPMIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012303</DrugIDPK>
    <LicenceNumber>PA0303/010/001</LicenceNumber>
    <ProductName>EMPERAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010106</DrugIDPK>
    <LicenceNumber>PA0018/037/001</LicenceNumber>
    <ProductName>GENISOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUCCINATE SODIUM</ActiveSubstance>
      <ActiveSubstance>UNDECYLENIC MONOETHANOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012822</DrugIDPK>
    <LicenceNumber>PA0114/050/001</LicenceNumber>
    <ProductName>NAFTIDROFURYL OXALATE CONTINUS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013628</DrugIDPK>
    <LicenceNumber>PA0172/003/001</LicenceNumber>
    <ProductName>OXIPOR VHC LOTION FOR PSORIASIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011462</DrugIDPK>
    <LicenceNumber>PA0057/013/001</LicenceNumber>
    <ProductName>PHOLTEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PHENYLTOLOXAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011133</DrugIDPK>
    <LicenceNumber>PA0050/031/001</LicenceNumber>
    <ProductName>RIMIFON</ProductName>
    <Strength>50/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010320</DrugIDPK>
    <LicenceNumber>PA0022/035/001</LicenceNumber>
    <ProductName>SERENID - D</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010323</DrugIDPK>
    <LicenceNumber>PA0022/035/002</LicenceNumber>
    <ProductName>SERENID - D</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010325</DrugIDPK>
    <LicenceNumber>PA0022/035/003</LicenceNumber>
    <ProductName>SERENID FORTE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012435</DrugIDPK>
    <LicenceNumber>PA0330/002/004</LicenceNumber>
    <ProductName>TYLENOL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012436</DrugIDPK>
    <LicenceNumber>PA0330/002/005</LicenceNumber>
    <ProductName>TYLENOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009508</DrugIDPK>
    <LicenceNumber>PA0004/050/001</LicenceNumber>
    <ProductName>MANOPLAX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLOSEQUINAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000541</DrugIDPK>
    <LicenceNumber>PA0012/064/001</LicenceNumber>
    <ProductName>FEMODENE ED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1988-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTODENE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011239</DrugIDPK>
    <LicenceNumber>PA0050/016/001</LicenceNumber>
    <ProductName>LIBRAXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
      <ActiveSubstance>CLIDINIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009771</DrugIDPK>
    <LicenceNumber>PA0017/010/001</LicenceNumber>
    <ProductName>POLYBACTRIN SOLUBLE G U</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015772</DrugIDPK>
    <LicenceNumber>PA0249/008/001</LicenceNumber>
    <ProductName>BUCCALINE BERNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015771</DrugIDPK>
    <LicenceNumber>PA0249/007/001</LicenceNumber>
    <ProductName>COLCAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015760</DrugIDPK>
    <LicenceNumber>PA0249/002/003</LicenceNumber>
    <ProductName>TUSCALMAN BERNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015761</DrugIDPK>
    <LicenceNumber>PA0249/002/004</LicenceNumber>
    <ProductName>TUSCALMAN BERNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015759</DrugIDPK>
    <LicenceNumber>PA0249/002/002</LicenceNumber>
    <ProductName>TUSCALMAN BERNA SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011271</DrugIDPK>
    <LicenceNumber>PA0054/025/001</LicenceNumber>
    <ProductName>BRONCHINOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>REPROTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011348</DrugIDPK>
    <LicenceNumber>PA0054/048/001</LicenceNumber>
    <ProductName>PAEDMIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012721</DrugIDPK>
    <LicenceNumber>PA0499/002/001</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiron B.V.</PAHolder>
    <AuthorisedDate>1991-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012726</DrugIDPK>
    <LicenceNumber>PA0499/002/003</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiron B.V.</PAHolder>
    <AuthorisedDate>1991-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011397</DrugIDPK>
    <LicenceNumber>PA0056/032/001</LicenceNumber>
    <ProductName>MYLANTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011398</DrugIDPK>
    <LicenceNumber>PA0056/032/002</LicenceNumber>
    <ProductName>MYLANTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011394</DrugIDPK>
    <LicenceNumber>PA0056/029/001</LicenceNumber>
    <ProductName>OXYCEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011712</DrugIDPK>
    <LicenceNumber>PA0073/076/001</LicenceNumber>
    <ProductName>CALRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011699</DrugIDPK>
    <LicenceNumber>PA0073/053/003</LicenceNumber>
    <ProductName>PROMETHAZINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009556</DrugIDPK>
    <LicenceNumber>PA0006/020/001</LicenceNumber>
    <ProductName>PROCTOFIBE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GRAIN FIBRE</ActiveSubstance>
      <ActiveSubstance>CITRUS FIBRE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010792</DrugIDPK>
    <LicenceNumber>PA0041/026/004</LicenceNumber>
    <ProductName>TRILUDAN PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015157</DrugIDPK>
    <LicenceNumber>PA0290/057/001</LicenceNumber>
    <ProductName>ZINCFRIN STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015158</DrugIDPK>
    <LicenceNumber>PA0290/057/002</LicenceNumber>
    <ProductName>ZINCFRIN STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011888</DrugIDPK>
    <LicenceNumber>PA0077/100/001</LicenceNumber>
    <ProductName>MODALIM CAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CIPROFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010435</DrugIDPK>
    <LicenceNumber>PA0027/003/002</LicenceNumber>
    <ProductName>TEMGESIC</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering AG</PAHolder>
    <AuthorisedDate>1978-02-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPRENORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012703</DrugIDPK>
    <LicenceNumber>PA0484/023/001</LicenceNumber>
    <ProductName>CAMOMILE AND HONEY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012868</DrugIDPK>
    <LicenceNumber>PA0650/006/001</LicenceNumber>
    <ProductName>ALUMINIUM ACETATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Penn Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
      <ActiveSubstance>L-TARTARIC ACID</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012857</DrugIDPK>
    <LicenceNumber>PA0582/003/005</LicenceNumber>
    <ProductName>SPERSACARPINE EYE OINTMENT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012858</DrugIDPK>
    <LicenceNumber>PA0582/003/006</LicenceNumber>
    <ProductName>SPERSACARPINE EYE OINTMENT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012859</DrugIDPK>
    <LicenceNumber>PA0582/003/007</LicenceNumber>
    <ProductName>SPERSACARPINE EYE OINTMENT</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012599</DrugIDPK>
    <LicenceNumber>PA0441/010/001</LicenceNumber>
    <ProductName>VICKS COUGH CALMERS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012596</DrugIDPK>
    <LicenceNumber>PA0441/008/001</LicenceNumber>
    <ProductName>VICKS FORMULA 44</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012602</DrugIDPK>
    <LicenceNumber>PA0441/024/002</LicenceNumber>
    <ProductName>VICKS SINEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1984-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012598</DrugIDPK>
    <LicenceNumber>PA0441/009/001</LicenceNumber>
    <ProductName>VICKS VAPO-LEM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>1983-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011349</DrugIDPK>
    <LicenceNumber>PA0054/049/001</LicenceNumber>
    <ProductName>TRIREXAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XIPAMIDE</ActiveSubstance>
      <ActiveSubstance>TRIAMTERENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011367</DrugIDPK>
    <LicenceNumber>PA0054/074/001</LicenceNumber>
    <ProductName>AKNE-MYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011273</DrugIDPK>
    <LicenceNumber>PA0054/025/002</LicenceNumber>
    <ProductName>BRONCHINOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>REPROTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011269</DrugIDPK>
    <LicenceNumber>PA0054/023/001</LicenceNumber>
    <ProductName>GAMANIL</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOFEPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009494</DrugIDPK>
    <LicenceNumber>PA0004/046/001</LicenceNumber>
    <ProductName>KAODENE LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1999-01-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CODEINE</ActiveSubstance>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000755</DrugIDPK>
    <LicenceNumber>PA0011/021/002</LicenceNumber>
    <ProductName>BUTACOTE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012615</DrugIDPK>
    <LicenceNumber>PA0445/001/001</LicenceNumber>
    <ProductName>COW &amp; GATE INSTANT CAROBEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012616</DrugIDPK>
    <LicenceNumber>PA0445/002/001</LicenceNumber>
    <ProductName>COW &amp; GATE LOCASOL NEW FORMULA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012618</DrugIDPK>
    <LicenceNumber>PA0445/003/001</LicenceNumber>
    <ProductName>FORTICAL APPLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012619</DrugIDPK>
    <LicenceNumber>PA0445/003/002</LicenceNumber>
    <ProductName>FORTICAL APRICOT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012620</DrugIDPK>
    <LicenceNumber>PA0445/003/003</LicenceNumber>
    <ProductName>FORTICAL BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012621</DrugIDPK>
    <LicenceNumber>PA0445/003/004</LicenceNumber>
    <ProductName>FORTICAL LEMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012622</DrugIDPK>
    <LicenceNumber>PA0445/003/005</LicenceNumber>
    <ProductName>FORTICAL NEUTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012624</DrugIDPK>
    <LicenceNumber>PA0445/003/006</LicenceNumber>
    <ProductName>FORTICAL ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012625</DrugIDPK>
    <LicenceNumber>PA0445/004/001</LicenceNumber>
    <ProductName>FORTIMEL CHOCLATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012626</DrugIDPK>
    <LicenceNumber>PA0445/004/002</LicenceNumber>
    <ProductName>FORTIMEL COFFEE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012627</DrugIDPK>
    <LicenceNumber>PA0445/004/003</LicenceNumber>
    <ProductName>FORTIMEL STRAWBERRY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012628</DrugIDPK>
    <LicenceNumber>PA0445/004/004</LicenceNumber>
    <ProductName>FORTIMEL VANILLA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012629</DrugIDPK>
    <LicenceNumber>PA0445/005/001</LicenceNumber>
    <ProductName>FORTISIP BANANA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012630</DrugIDPK>
    <LicenceNumber>PA0445/005/002</LicenceNumber>
    <ProductName>FORTISIP ENERGY PLUS NEUTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012631</DrugIDPK>
    <LicenceNumber>PA0445/005/003</LicenceNumber>
    <ProductName>FORTISIP ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012633</DrugIDPK>
    <LicenceNumber>PA0445/005/004</LicenceNumber>
    <ProductName>FORTISIP STANDARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012635</DrugIDPK>
    <LicenceNumber>PA0445/005/005</LicenceNumber>
    <ProductName>FORTISIP VANILLA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012637</DrugIDPK>
    <LicenceNumber>PA0445/006/001</LicenceNumber>
    <ProductName>FORTISON ENERGY PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012639</DrugIDPK>
    <LicenceNumber>PA0445/006/002</LicenceNumber>
    <ProductName>FORTISON LOW SODIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012642</DrugIDPK>
    <LicenceNumber>PA0445/006/004</LicenceNumber>
    <ProductName>FORTISON SOYA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012645</DrugIDPK>
    <LicenceNumber>PA0445/006/005</LicenceNumber>
    <ProductName>FORTISON STANDARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012640</DrugIDPK>
    <LicenceNumber>PA0445/006/003</LicenceNumber>
    <ProductName>PRE-FORTISON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cow &amp; Gate Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009717</DrugIDPK>
    <LicenceNumber>PA0002/052/011</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005112</DrugIDPK>
    <LicenceNumber>PA0251/004/001</LicenceNumber>
    <ProductName>FERFOLIC S.V.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013316</DrugIDPK>
    <LicenceNumber>PA0167/032/001</LicenceNumber>
    <ProductName>TRAVASEPT 100</ProductName>
    <Strength>0.015%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013317</DrugIDPK>
    <LicenceNumber>PA0167/032/002</LicenceNumber>
    <ProductName>TRAVASEPT 100</ProductName>
    <Strength>0.015%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013318</DrugIDPK>
    <LicenceNumber>PA0167/032/003</LicenceNumber>
    <ProductName>TRAVASEPT 100</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013331</DrugIDPK>
    <LicenceNumber>PA0167/032/009</LicenceNumber>
    <ProductName>TRAVASEPT 15 TOPICAL IRRIGATING</ProductName>
    <Strength>0.1%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013329</DrugIDPK>
    <LicenceNumber>PA0167/032/007</LicenceNumber>
    <ProductName>TRAVASEPT 15 TOPICAL IRRIGATING</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013330</DrugIDPK>
    <LicenceNumber>PA0167/032/008</LicenceNumber>
    <ProductName>TRAVASEPT 15 TOPICAL IRRIGATING SOLUTION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013326</DrugIDPK>
    <LicenceNumber>PA0167/032/004</LicenceNumber>
    <ProductName>TRAVASEPT 30</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013328</DrugIDPK>
    <LicenceNumber>PA0167/032/006</LicenceNumber>
    <ProductName>TRAVASEPT 30 TOPICAL IRRIGATING CETRIMIDE 0.5%</ProductName>
    <Strength>1 L</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013327</DrugIDPK>
    <LicenceNumber>PA0167/032/005</LicenceNumber>
    <ProductName>TRAVASEPT 30 TOPICAL IRRIGATION/CETRIMIDE 0.5%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011490</DrugIDPK>
    <LicenceNumber>PA0057/032/001</LicenceNumber>
    <ProductName>ALU-TAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1980-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011505</DrugIDPK>
    <LicenceNumber>PA0057/040/001</LicenceNumber>
    <ProductName>BUF ACNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1980-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011435</DrugIDPK>
    <LicenceNumber>PA0057/005/006</LicenceNumber>
    <ProductName>NUELIN SA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012187</DrugIDPK>
    <LicenceNumber>PA0365/038/001</LicenceNumber>
    <ProductName>AMILORIDE AND HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012188</DrugIDPK>
    <LicenceNumber>PA0365/038/002</LicenceNumber>
    <ProductName>AMILORIDE AND HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012142</DrugIDPK>
    <LicenceNumber>PA0365/025/001</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012143</DrugIDPK>
    <LicenceNumber>PA0365/025/002</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012145</DrugIDPK>
    <LicenceNumber>PA0365/025/003</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012146</DrugIDPK>
    <LicenceNumber>PA0365/025/004</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012094</DrugIDPK>
    <LicenceNumber>PA0365/006/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012096</DrugIDPK>
    <LicenceNumber>PA0365/006/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012098</DrugIDPK>
    <LicenceNumber>PA0365/006/003</LicenceNumber>
    <ProductName>AMPICILLIN MIXTURE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012100</DrugIDPK>
    <LicenceNumber>PA0365/006/004</LicenceNumber>
    <ProductName>AMPICILLIN MIXTURE STRONG</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012138</DrugIDPK>
    <LicenceNumber>PA0365/022/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012139</DrugIDPK>
    <LicenceNumber>PA0365/022/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012158</DrugIDPK>
    <LicenceNumber>PA0365/030/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012159</DrugIDPK>
    <LicenceNumber>PA0365/030/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012190</DrugIDPK>
    <LicenceNumber>PA0365/040/001</LicenceNumber>
    <ProductName>DANAZOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012191</DrugIDPK>
    <LicenceNumber>PA0365/040/002</LicenceNumber>
    <ProductName>DANAZOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012105</DrugIDPK>
    <LicenceNumber>PA0365/008/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012106</DrugIDPK>
    <LicenceNumber>PA0365/008/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012108</DrugIDPK>
    <LicenceNumber>PA0365/008/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012200</DrugIDPK>
    <LicenceNumber>PA0365/043/002</LicenceNumber>
    <ProductName>DICLOFENAC SODIUM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012198</DrugIDPK>
    <LicenceNumber>PA0365/043/001</LicenceNumber>
    <ProductName>DICLOFENAC SODIUM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010753</DrugIDPK>
    <LicenceNumber>PA0040/047/002</LicenceNumber>
    <ProductName>FLAXEDIL GALLAMINE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012133</DrugIDPK>
    <LicenceNumber>PA0365/015/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012155</DrugIDPK>
    <LicenceNumber>PA0365/028/001</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012156</DrugIDPK>
    <LicenceNumber>PA0365/028/002</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIBENCLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012104</DrugIDPK>
    <LicenceNumber>PA0365/007/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012102</DrugIDPK>
    <LicenceNumber>PA0365/007/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012154</DrugIDPK>
    <LicenceNumber>PA0365/027/003</LicenceNumber>
    <ProductName>ISOSORBIDE DINITRATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012152</DrugIDPK>
    <LicenceNumber>PA0365/027/002</LicenceNumber>
    <ProductName>ISOSORBIDE DINITRATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012150</DrugIDPK>
    <LicenceNumber>PA0365/027/001</LicenceNumber>
    <ProductName>ISOSORBIDE DINITRATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012179</DrugIDPK>
    <LicenceNumber>PA0365/034/001</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012181</DrugIDPK>
    <LicenceNumber>PA0365/034/002</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012149</DrugIDPK>
    <LicenceNumber>PA0365/026/002</LicenceNumber>
    <ProductName>NIFEDIPINE SOFT GELATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012147</DrugIDPK>
    <LicenceNumber>PA0365/026/001</LicenceNumber>
    <ProductName>NIFEDIPINE SOFT GELATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012131</DrugIDPK>
    <LicenceNumber>PA0365/014/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012089</DrugIDPK>
    <LicenceNumber>PA0365/005/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012090</DrugIDPK>
    <LicenceNumber>PA0365/005/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012092</DrugIDPK>
    <LicenceNumber>PA0365/005/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012093</DrugIDPK>
    <LicenceNumber>PA0365/005/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1984-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012125</DrugIDPK>
    <LicenceNumber>PA0365/011/001</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012127</DrugIDPK>
    <LicenceNumber>PA0365/011/002</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012128</DrugIDPK>
    <LicenceNumber>PA0365/012/001</LicenceNumber>
    <ProductName>TAMOXIFEN CITRATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1993-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012130</DrugIDPK>
    <LicenceNumber>PA0365/012/002</LicenceNumber>
    <ProductName>TAMOXIFEN CITRATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1993-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012174</DrugIDPK>
    <LicenceNumber>PA0365/032/002</LicenceNumber>
    <ProductName>TEMAZEPAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012172</DrugIDPK>
    <LicenceNumber>PA0365/032/001</LicenceNumber>
    <ProductName>TEMAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012140</DrugIDPK>
    <LicenceNumber>PA0365/023/001</LicenceNumber>
    <ProductName>TETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012183</DrugIDPK>
    <LicenceNumber>PA0365/037/001</LicenceNumber>
    <ProductName>TRIAZOLAM</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012185</DrugIDPK>
    <LicenceNumber>PA0365/037/002</LicenceNumber>
    <ProductName>TRIAZOLAM</ProductName>
    <Strength>0.250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012178</DrugIDPK>
    <LicenceNumber>PA0365/033/003</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012175</DrugIDPK>
    <LicenceNumber>PA0365/033/001</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012176</DrugIDPK>
    <LicenceNumber>PA0365/033/002</LicenceNumber>
    <ProductName>VERAPAMIL HYDROCHLORIDE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010993</DrugIDPK>
    <LicenceNumber>PA0046/034/001</LicenceNumber>
    <ProductName>LEO K TABLET</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010878</DrugIDPK>
    <LicenceNumber>PA0046/023/001</LicenceNumber>
    <ProductName>LEONISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM GLYCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010990</DrugIDPK>
    <LicenceNumber>PA0046/032/003</LicenceNumber>
    <ProductName>UROKINASE</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010988</DrugIDPK>
    <LicenceNumber>PA0046/032/002</LicenceNumber>
    <ProductName>UROKINASE</ProductName>
    <Strength>25,000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010985</DrugIDPK>
    <LicenceNumber>PA0046/032/001</LicenceNumber>
    <ProductName>UROKINASE</ProductName>
    <Strength>5,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013249</DrugIDPK>
    <LicenceNumber>PA0167/001/004</LicenceNumber>
    <ProductName>BUMINATE 5.0%</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013250</DrugIDPK>
    <LicenceNumber>PA0167/001/005</LicenceNumber>
    <ProductName>BUMINATE 5.0%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013248</DrugIDPK>
    <LicenceNumber>PA0167/001/003</LicenceNumber>
    <ProductName>BUNINATE 5/0%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012547</DrugIDPK>
    <LicenceNumber>PA0436/002/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011358</DrugIDPK>
    <LicenceNumber>PA0054/059/001</LicenceNumber>
    <ProductName>NUTRIZYM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
      <ActiveSubstance>OX BILE EXTRACT</ActiveSubstance>
      <ActiveSubstance>BROMELAINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013555</DrugIDPK>
    <LicenceNumber>PA0275/001/002</LicenceNumber>
    <ProductName>PANETS BABY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011789</DrugIDPK>
    <LicenceNumber>PA0080/001/002</LicenceNumber>
    <ProductName>DICYNENE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013530</DrugIDPK>
    <LicenceNumber>PA0261/022/001</LicenceNumber>
    <ProductName>COTAZYM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIPASE</ActiveSubstance>
      <ActiveSubstance>AMYLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013472</DrugIDPK>
    <LicenceNumber>PA0176/057/001</LicenceNumber>
    <ProductName>METOCLOPRAMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013438</DrugIDPK>
    <LicenceNumber>PA0255/037/002</LicenceNumber>
    <ProductName>NITROGLYCERIN U. S. P. 5MG/ML</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013436</DrugIDPK>
    <LicenceNumber>PA0255/037/001</LicenceNumber>
    <ProductName>NITROGLYCERIN U.S. P. 5 MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012383</DrugIDPK>
    <LicenceNumber>PA0309/003/001</LicenceNumber>
    <ProductName>BRONCONOVAG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate>1982-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012381</DrugIDPK>
    <LicenceNumber>PA0309/003/002</LicenceNumber>
    <ProductName>BRONCONOVAG EXTEMPORANEOUS (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate>1982-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012610</DrugIDPK>
    <LicenceNumber>PA0441/025/003</LicenceNumber>
    <ProductName>VICKS LOZENGES CHERRY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011630</DrugIDPK>
    <LicenceNumber>PA0065/014/001</LicenceNumber>
    <ProductName>ANCOLOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1984-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010936</DrugIDPK>
    <LicenceNumber>PA0047/055/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN ETHYL SUCCINATE (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010937</DrugIDPK>
    <LicenceNumber>PA0047/055/002</LicenceNumber>
    <ProductName>ERYTHROMYCIN ETHYL SUCCINATE (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010938</DrugIDPK>
    <LicenceNumber>PA0047/055/003</LicenceNumber>
    <ProductName>ERYTHROMYCIN ETHYL SUCCINATE (SUSPENSION)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013477</DrugIDPK>
    <LicenceNumber>PA0176/059/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013478</DrugIDPK>
    <LicenceNumber>PA0176/059/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013480</DrugIDPK>
    <LicenceNumber>PA0176/059/003</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013763</DrugIDPK>
    <LicenceNumber>PA0176/040/001</LicenceNumber>
    <ProductName>METFORMIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013764</DrugIDPK>
    <LicenceNumber>PA0176/040/002</LicenceNumber>
    <ProductName>METFORMIN</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013739</DrugIDPK>
    <LicenceNumber>PA0176/022/002</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013740</DrugIDPK>
    <LicenceNumber>PA0176/022/003</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013474</DrugIDPK>
    <LicenceNumber>PA0176/058/001</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013475</DrugIDPK>
    <LicenceNumber>PA0176/058/002</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013664</DrugIDPK>
    <LicenceNumber>PA0176/008/001</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013665</DrugIDPK>
    <LicenceNumber>PA0176/008/002</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013666</DrugIDPK>
    <LicenceNumber>PA0176/008/003</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013667</DrugIDPK>
    <LicenceNumber>PA0176/008/004</LicenceNumber>
    <ProductName>OXPRENOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011623</DrugIDPK>
    <LicenceNumber>PA0065/044/001</LicenceNumber>
    <ProductName>PECTAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011624</DrugIDPK>
    <LicenceNumber>PA0065/004/001</LicenceNumber>
    <ProductName>PECTAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013668</DrugIDPK>
    <LicenceNumber>PA0176/009/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013669</DrugIDPK>
    <LicenceNumber>PA0176/009/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011632</DrugIDPK>
    <LicenceNumber>PA0065/016/001</LicenceNumber>
    <ProductName>PROSPAROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011342</DrugIDPK>
    <LicenceNumber>PA0054/042/001</LicenceNumber>
    <ProductName>CISTOBIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011915</DrugIDPK>
    <LicenceNumber>PA0082/063/002</LicenceNumber>
    <ProductName>DECAZATE (PRE-FILLED SYRINGE) 25 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011917</DrugIDPK>
    <LicenceNumber>PA0082/063/004</LicenceNumber>
    <ProductName>DECAZATE 100 MG/ML</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011918</DrugIDPK>
    <LicenceNumber>PA0082/063/005</LicenceNumber>
    <ProductName>DECAZATE 100 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011914</DrugIDPK>
    <LicenceNumber>PA0082/063/001</LicenceNumber>
    <ProductName>DECAZATE 25 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011916</DrugIDPK>
    <LicenceNumber>PA0082/063/003</LicenceNumber>
    <ProductName>DECAZATE 25 MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010274</DrugIDPK>
    <LicenceNumber>PA0032/016/001</LicenceNumber>
    <ProductName>MICROPAQUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010278</DrugIDPK>
    <LicenceNumber>PA0469/015/002</LicenceNumber>
    <ProductName>MICROPAQUE HD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010276</DrugIDPK>
    <LicenceNumber>PA0032/016/002</LicenceNumber>
    <ProductName>MICROPAQUE STANDARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010279</DrugIDPK>
    <LicenceNumber>PA0032/017/001</LicenceNumber>
    <ProductName>MICROTRAST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1987-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010290</DrugIDPK>
    <LicenceNumber>PA0032/023/001</LicenceNumber>
    <ProductName>POLYCROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010292</DrugIDPK>
    <LicenceNumber>PA0032/023/002</LicenceNumber>
    <ProductName>POLYCROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010294</DrugIDPK>
    <LicenceNumber>PA0032/024/001</LicenceNumber>
    <ProductName>POLYCROL FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010296</DrugIDPK>
    <LicenceNumber>PA0032/024/002</LicenceNumber>
    <ProductName>POLYCROL FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011186</DrugIDPK>
    <LicenceNumber>PA0050/058/001</LicenceNumber>
    <ProductName>RO-A-VIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011159</DrugIDPK>
    <LicenceNumber>PA0050/050/003</LicenceNumber>
    <ProductName>SYNKAVIT</ProductName>
    <Strength>100/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010257</DrugIDPK>
    <LicenceNumber>PA0021/035/002</LicenceNumber>
    <ProductName>ALPARE TWO GRASS</ProductName>
    <Strength>4.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013286</DrugIDPK>
    <LicenceNumber>PA0167/007/010</LicenceNumber>
    <ProductName>HEMOFIL-T ANTIHAEMOPHILIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011443</DrugIDPK>
    <LicenceNumber>PA0060/020/001</LicenceNumber>
    <ProductName>DYTIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011451</DrugIDPK>
    <LicenceNumber>PA0060/037/001</LicenceNumber>
    <ProductName>ESKAMEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012762</DrugIDPK>
    <LicenceNumber>PA0109/007/001</LicenceNumber>
    <ProductName>CARBELLON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CHARCOAL, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012771</DrugIDPK>
    <LicenceNumber>PA0109/010/001</LicenceNumber>
    <ProductName>DIOCTYL MEDO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012773</DrugIDPK>
    <LicenceNumber>PA0109/010/002</LicenceNumber>
    <ProductName>DIOCTYL MEDO CONENTRATE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013537</DrugIDPK>
    <LicenceNumber>PA0263/001/001</LicenceNumber>
    <ProductName>DOANS BACKACHE PILLS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fulford Williams (International)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011284</DrugIDPK>
    <LicenceNumber>PA0054/026/008</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1985-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011287</DrugIDPK>
    <LicenceNumber>PA0054/026/010</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1985-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011285</DrugIDPK>
    <LicenceNumber>PA0054/026/009</LicenceNumber>
    <ProductName>ALORBAT - SYRINGE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1985-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011277</DrugIDPK>
    <LicenceNumber>PA0054/026/002</LicenceNumber>
    <ProductName>ALORBAT 81</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INFLUENZA VIRUS VACCINE MONOVALENT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011276</DrugIDPK>
    <LicenceNumber>PA0054/026/001</LicenceNumber>
    <ProductName>ALORBAT 81 - DISPOSABLE SYRINGE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INFLUENZA VIRUS VACCINE MONOVALENT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011278</DrugIDPK>
    <LicenceNumber>PA0054/026/003</LicenceNumber>
    <ProductName>ALORBAT 81 MULTIDOSE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INFLUENZA VIRUS VACCINE MONOVALENT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010417</DrugIDPK>
    <LicenceNumber>PA0035/066/001</LicenceNumber>
    <ProductName>INDOPTOL OPHTHALMIC  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016077</DrugIDPK>
    <LicenceNumber>PA0218/004/001</LicenceNumber>
    <ProductName>GLUCAGON NOVO</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016078</DrugIDPK>
    <LicenceNumber>PA0218/004/002</LicenceNumber>
    <ProductName>GLUCAGON NOVO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016079</DrugIDPK>
    <LicenceNumber>PA0218/004/003</LicenceNumber>
    <ProductName>GLUCAGON NOVO</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012848</DrugIDPK>
    <LicenceNumber>PA0552/013/001</LicenceNumber>
    <ProductName>PURE COD LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Superpac Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003501</DrugIDPK>
    <LicenceNumber>PA0086/020/001</LicenceNumber>
    <ProductName>ALMASILATE (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALMASILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013312</DrugIDPK>
    <LicenceNumber>PA0167/018/001</LicenceNumber>
    <ProductName>DISCASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1981-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOPAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013313</DrugIDPK>
    <LicenceNumber>PA0167/018/002</LicenceNumber>
    <ProductName>DISCASE (CHYMOPAPAIN)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOPAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011442</DrugIDPK>
    <LicenceNumber>PA0060/019/001</LicenceNumber>
    <ProductName>DYTAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013289</DrugIDPK>
    <LicenceNumber>PA0167/007/013</LicenceNumber>
    <ProductName>HEMOFIL -T ANTIHAEMOPHILIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013427</DrugIDPK>
    <LicenceNumber>PA0167/076/002</LicenceNumber>
    <ProductName>HEMOFIL-HT (HUMAN)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013425</DrugIDPK>
    <LicenceNumber>PA0167/076/001</LicenceNumber>
    <ProductName>HEMOFIL-HT (HUMAN)</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013285</DrugIDPK>
    <LicenceNumber>PA0167/007/009</LicenceNumber>
    <ProductName>HEMOFIL-T ANTIHAEMOPHILIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013287</DrugIDPK>
    <LicenceNumber>PA0167/007/011</LicenceNumber>
    <ProductName>HEMOFIL-T ANTIHAEMOPHILIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013288</DrugIDPK>
    <LicenceNumber>PA0167/007/012</LicenceNumber>
    <ProductName>HEMOFIL-T ANTIHAEMOPHILIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013284</DrugIDPK>
    <LicenceNumber>PA0167/007/008</LicenceNumber>
    <ProductName>HEMOFIL-T ANTIHAEMOPHILIC FACTOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1984-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010000</DrugIDPK>
    <LicenceNumber>PA0018/017/001</LicenceNumber>
    <ProductName>IMFERON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRIFERRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010001</DrugIDPK>
    <LicenceNumber>PA0018/017/002</LicenceNumber>
    <ProductName>IMFERON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRIFERRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010002</DrugIDPK>
    <LicenceNumber>PA0018/017/003</LicenceNumber>
    <ProductName>IMFERON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRIFERRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012978</DrugIDPK>
    <LicenceNumber>PA0118/030/001</LicenceNumber>
    <ProductName>MINIMS CASTOR OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011572</DrugIDPK>
    <LicenceNumber>PA0060/006/008</LicenceNumber>
    <ProductName>TAGAMET (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1988-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011733</DrugIDPK>
    <LicenceNumber>PA0069/005/001</LicenceNumber>
    <ProductName>TARCORTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012809</DrugIDPK>
    <LicenceNumber>PA0114/039/001</LicenceNumber>
    <ProductName>AKROTHERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HISTAMINE</ActiveSubstance>
      <ActiveSubstance>ACETYLCHOLINE CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHOLESTEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012782</DrugIDPK>
    <LicenceNumber>PA0114/002/013</LicenceNumber>
    <ProductName>BETADINE  AEROSOL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012064</DrugIDPK>
    <LicenceNumber>PA0096/003/001</LicenceNumber>
    <ProductName>CORTENEMA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012808</DrugIDPK>
    <LicenceNumber>PA0114/035/001</LicenceNumber>
    <ProductName>CRADOCAP SHAMPOO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012811</DrugIDPK>
    <LicenceNumber>PA0114/041/001</LicenceNumber>
    <ProductName>FIBRAMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012806</DrugIDPK>
    <LicenceNumber>PA0114/032/001</LicenceNumber>
    <ProductName>K CONTIN CONTINUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011557</DrugIDPK>
    <LicenceNumber>PA0062/008/001</LicenceNumber>
    <ProductName>PIMAFUCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012804</DrugIDPK>
    <LicenceNumber>PA0114/031/001</LicenceNumber>
    <ProductName>X PREP-LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011243</DrugIDPK>
    <LicenceNumber>PA0050/023/001</LicenceNumber>
    <ProductName>DROMORAN</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011244</DrugIDPK>
    <LicenceNumber>PA0050/023/002</LicenceNumber>
    <ProductName>DROMORAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LEVORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011333</DrugIDPK>
    <LicenceNumber>PA0051/059/004</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1989-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011334</DrugIDPK>
    <LicenceNumber>PA0051/059/005</LicenceNumber>
    <ProductName>ZESTRIL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1989-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010240</DrugIDPK>
    <LicenceNumber>PA0030/003/001</LicenceNumber>
    <ProductName>ZYMAFLUOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1984-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010242</DrugIDPK>
    <LicenceNumber>PA0030/003/002</LicenceNumber>
    <ProductName>ZYMAFLUOR</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011162</DrugIDPK>
    <LicenceNumber>PA0050/053/001</LicenceNumber>
    <ProductName>ROACCUTANE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOTRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013566</DrugIDPK>
    <LicenceNumber>PA0275/009/001</LicenceNumber>
    <ProductName>FAMEL EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012867</DrugIDPK>
    <LicenceNumber>PA0647/001/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>F.F.C. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011037</DrugIDPK>
    <LicenceNumber>PA0048/034/001</LicenceNumber>
    <ProductName>PLATINEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011038</DrugIDPK>
    <LicenceNumber>PA0048/034/002</LicenceNumber>
    <ProductName>PLATINEX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011039</DrugIDPK>
    <LicenceNumber>PA0048/034/003</LicenceNumber>
    <ProductName>PLATINEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011027</DrugIDPK>
    <LicenceNumber>PA0048/028/002</LicenceNumber>
    <ProductName>THERADERM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011025</DrugIDPK>
    <LicenceNumber>PA0048/028/001</LicenceNumber>
    <ProductName>THERADERM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011029</DrugIDPK>
    <LicenceNumber>PA0048/029/001</LicenceNumber>
    <ProductName>TOLERZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011022</DrugIDPK>
    <LicenceNumber>PA0048/025/001</LicenceNumber>
    <ProductName>VINCRISTINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009940</DrugIDPK>
    <LicenceNumber>PA0013/012/001</LicenceNumber>
    <ProductName>BRINALDIX K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPAMIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002688</DrugIDPK>
    <LicenceNumber>PA0050/022/001</LicenceNumber>
    <ProductName>MARPLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOCARBOXAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002694</DrugIDPK>
    <LicenceNumber>PA0050/026/001</LicenceNumber>
    <ProductName>PETHIDINE ROCHE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002686</DrugIDPK>
    <LicenceNumber>PA0050/021/001</LicenceNumber>
    <ProductName>LAROXYL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013156</DrugIDPK>
    <LicenceNumber>PA0143/005/001</LicenceNumber>
    <ProductName>AMINOPLEX 12</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1978-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013159</DrugIDPK>
    <LicenceNumber>PA0143/005/002</LicenceNumber>
    <ProductName>AMINOPLEX 12</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1978-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013165</DrugIDPK>
    <LicenceNumber>PA0143/009/002</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013166</DrugIDPK>
    <LicenceNumber>PA0143/009/003</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013167</DrugIDPK>
    <LicenceNumber>PA0143/009/004</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013163</DrugIDPK>
    <LicenceNumber>PA0143/009/001</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004074</DrugIDPK>
    <LicenceNumber>PA0158/012/001</LicenceNumber>
    <ProductName>BURNEZE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Charwell Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1988-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000425</DrugIDPK>
    <LicenceNumber>PA0007/036/001</LicenceNumber>
    <ProductName>CELEVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1988-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLCELLULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013152</DrugIDPK>
    <LicenceNumber>PA0143/002/001</LicenceNumber>
    <ProductName>GLUCOPLEX 1000</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1978-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013153</DrugIDPK>
    <LicenceNumber>PA0143/002/002</LicenceNumber>
    <ProductName>GLUCOPLEX 1000</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1978-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013154</DrugIDPK>
    <LicenceNumber>PA0143/003/001</LicenceNumber>
    <ProductName>GLUCOPLEX 1600</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1978-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013155</DrugIDPK>
    <LicenceNumber>PA0143/003/002</LicenceNumber>
    <ProductName>GLUCOPLEX 1600</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1978-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993008692</DrugIDPK>
    <LicenceNumber>PA0172/009/002</LicenceNumber>
    <ProductName>TRAMIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1988-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012585</DrugIDPK>
    <LicenceNumber>PA0437/013/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1987-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012586</DrugIDPK>
    <LicenceNumber>PA0437/013/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1987-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012583</DrugIDPK>
    <LicenceNumber>PA0437/007/001</LicenceNumber>
    <ProductName>METROVEX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015217</DrugIDPK>
    <LicenceNumber>PA0183/004/001</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011204</DrugIDPK>
    <LicenceNumber>PA0049/035/012</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011206</DrugIDPK>
    <LicenceNumber>PA0049/035/013</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009619</DrugIDPK>
    <LicenceNumber>PA0002/052/007</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009716</DrugIDPK>
    <LicenceNumber>PA0002/052/012</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009718</DrugIDPK>
    <LicenceNumber>PA0002/052/010</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009719</DrugIDPK>
    <LicenceNumber>PA0002/052/009</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009720</DrugIDPK>
    <LicenceNumber>PA0002/052/008</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015218</DrugIDPK>
    <LicenceNumber>PA0183/005/001</LicenceNumber>
    <ProductName>CERTAL LOZENGES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015230</DrugIDPK>
    <LicenceNumber>PA0183/009/001</LicenceNumber>
    <ProductName>CERTAL PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012277</DrugIDPK>
    <LicenceNumber>PA0379/006/001</LicenceNumber>
    <ProductName>DIOCALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATTAPULGITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015228</DrugIDPK>
    <LicenceNumber>PA0183/008/001</LicenceNumber>
    <ProductName>HEDCOF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015227</DrugIDPK>
    <LicenceNumber>PA0183/007/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015225</DrugIDPK>
    <LicenceNumber>PA0183/007/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015764</DrugIDPK>
    <LicenceNumber>PA0249/004/001</LicenceNumber>
    <ProductName>INFLEXAL BERNA</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010314</DrugIDPK>
    <LicenceNumber>PA0033/005/007</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010315</DrugIDPK>
    <LicenceNumber>PA0033/005/008</LicenceNumber>
    <ProductName>NAPROSYN</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010317</DrugIDPK>
    <LicenceNumber>PA0033/005/009</LicenceNumber>
    <ProductName>NAPROSYN 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015221</DrugIDPK>
    <LicenceNumber>PA0183/006/001</LicenceNumber>
    <ProductName>TAY-KA-VITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015770</DrugIDPK>
    <LicenceNumber>PA0249/006/001</LicenceNumber>
    <ProductName>TOSUMAN BERNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1993-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013578</DrugIDPK>
    <LicenceNumber>PA0167/079/002</LicenceNumber>
    <ProductName>GAMMAGARD</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GAMMA GLOBULIN</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012280</DrugIDPK>
    <LicenceNumber>PA0379/014/001</LicenceNumber>
    <ProductName>VENOS ORIGINAL WITH EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1986-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009604</DrugIDPK>
    <LicenceNumber>PA0007/011/001</LicenceNumber>
    <ProductName>ENDOXANA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009605</DrugIDPK>
    <LicenceNumber>PA0007/012/001</LicenceNumber>
    <ProductName>HONVAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009601</DrugIDPK>
    <LicenceNumber>PA0007/008/004</LicenceNumber>
    <ProductName>PERSANTIN PL PERLONGETS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009602</DrugIDPK>
    <LicenceNumber>PA0007/008/005</LicenceNumber>
    <ProductName>PERSANTIN PL PERLONGETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009624</DrugIDPK>
    <LicenceNumber>PA0003/001/001</LicenceNumber>
    <ProductName>RYBARVIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010328</DrugIDPK>
    <LicenceNumber>PA0022/038/001</LicenceNumber>
    <ProductName>TRINORDIOL 28</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010932</DrugIDPK>
    <LicenceNumber>PA0047/054/001</LicenceNumber>
    <ProductName>MOXALACTAM DISODIUM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATAMOXEF SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010933</DrugIDPK>
    <LicenceNumber>PA0047/054/002</LicenceNumber>
    <ProductName>MOXALACTAM DISODIUM</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATAMOXEF SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010934</DrugIDPK>
    <LicenceNumber>PA0047/054/003</LicenceNumber>
    <ProductName>MOXALACTAM DISODIUM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATAMOXEF SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010935</DrugIDPK>
    <LicenceNumber>PA0047/054/004</LicenceNumber>
    <ProductName>MOXALACTAM DISODIUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATAMOXEF SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012691</DrugIDPK>
    <LicenceNumber>PA0108/004/001</LicenceNumber>
    <ProductName>POLIOVIRUS VACCINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1977-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLIOVIRUS VACCINE LIVE ORAL</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010956</DrugIDPK>
    <LicenceNumber>PA0048/001/004</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012614</DrugIDPK>
    <LicenceNumber>PA0443/001/001</LicenceNumber>
    <ProductName>TAMARINE (LAXATIVE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Regina Plc</PAHolder>
    <AuthorisedDate>1986-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009681</DrugIDPK>
    <LicenceNumber>PA0009/038/001</LicenceNumber>
    <ProductName>XYLOTOX 2%</ProductName>
    <Strength>1.8</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012519</DrugIDPK>
    <LicenceNumber>PA0009/038/002</LicenceNumber>
    <ProductName>XYLOTOX 2% E80</ProductName>
    <Strength>2.2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011491</DrugIDPK>
    <LicenceNumber>PA0057/033/001</LicenceNumber>
    <ProductName>PULMADIL AUTO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RIMITEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011164</DrugIDPK>
    <LicenceNumber>PA0050/054/002</LicenceNumber>
    <ProductName>BECOSYM SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011188</DrugIDPK>
    <LicenceNumber>PA0050/059/001</LicenceNumber>
    <ProductName>BENERVA COMPOUND</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011328</DrugIDPK>
    <LicenceNumber>PA0051/051/001</LicenceNumber>
    <ProductName>CETAVLON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012847</DrugIDPK>
    <LicenceNumber>PA0552/012/001</LicenceNumber>
    <ProductName>MERCUROCHROME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Superpac Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012340</DrugIDPK>
    <LicenceNumber>PA0401/002/001</LicenceNumber>
    <ProductName>SODIUM IODIDE 1-131</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Amersham Health Srl</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IODIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013839</DrugIDPK>
    <LicenceNumber>PA0281/037/001</LicenceNumber>
    <ProductName>AMIZIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1986-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013810</DrugIDPK>
    <LicenceNumber>PA0277/010/002</LicenceNumber>
    <ProductName>ATROPINE EYE OINTMENT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013812</DrugIDPK>
    <LicenceNumber>PA0277/011/002</LicenceNumber>
    <ProductName>CHLORAMPHENICOL EYE OINTMENT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013841</DrugIDPK>
    <LicenceNumber>PA0281/039/001</LicenceNumber>
    <ProductName>HYDRALAZINE HYDROCHLORIDE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013843</DrugIDPK>
    <LicenceNumber>PA0281/039/002</LicenceNumber>
    <ProductName>HYDRALAZINE HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013846</DrugIDPK>
    <LicenceNumber>PA0281/040/001</LicenceNumber>
    <ProductName>OPRAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1986-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013838</DrugIDPK>
    <LicenceNumber>PA0281/034/001</LicenceNumber>
    <ProductName>SULFAZINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1986-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFASALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013829</DrugIDPK>
    <LicenceNumber>PA0277/019/004</LicenceNumber>
    <ProductName>SULPHACETAMIDE EYE OINTMENT</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013891</DrugIDPK>
    <LicenceNumber>PA0277/035/003</LicenceNumber>
    <ProductName>CONGESTEZE PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013777</DrugIDPK>
    <LicenceNumber>PA0278/013/001</LicenceNumber>
    <ProductName>EXOLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013575</DrugIDPK>
    <LicenceNumber>PA0167/079/001</LicenceNumber>
    <ProductName>GAMMAGARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
      <ActiveSubstance>GAMMA GLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012222</DrugIDPK>
    <LicenceNumber>PA0367/010/001</LicenceNumber>
    <ProductName>ADRENALINE ACID TARTRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012317</DrugIDPK>
    <LicenceNumber>PA0392/002/001</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011009</DrugIDPK>
    <LicenceNumber>PA0048/012/003</LicenceNumber>
    <ProductName>CEENU</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012225</DrugIDPK>
    <LicenceNumber>PA0367/013/001</LicenceNumber>
    <ProductName>DIALITE 134</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1985-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012228</DrugIDPK>
    <LicenceNumber>PA0367/013/003</LicenceNumber>
    <ProductName>DIALITE 134 WITHOUT DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012226</DrugIDPK>
    <LicenceNumber>PA0367/013/002</LicenceNumber>
    <ProductName>DIALITE 136</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1985-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007904</DrugIDPK>
    <LicenceNumber>PA0367/001/001</LicenceNumber>
    <ProductName>GLYCERIN LEMON &amp; HONEY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>HONEY</ActiveSubstance>
      <ActiveSubstance>LEMON FLAVOUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002885</DrugIDPK>
    <LicenceNumber>PA0057/047/001</LicenceNumber>
    <ProductName>HUMAN ALBUMIN MICROSPHERES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012217</DrugIDPK>
    <LicenceNumber>PA0367/008/001</LicenceNumber>
    <ProductName>KAOLIN &amp; MORPHINE MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN</ActiveSubstance>
      <ActiveSubstance>MORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012233</DrugIDPK>
    <LicenceNumber>PA0367/015/001</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012234</DrugIDPK>
    <LicenceNumber>PA0367/015/002</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012215</DrugIDPK>
    <LicenceNumber>PA0367/006/001</LicenceNumber>
    <ProductName>PAEDIATRIC PARACETAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1984-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012247</DrugIDPK>
    <LicenceNumber>PA0367/021/001</LicenceNumber>
    <ProductName>PARALDEHYDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARALDEHYDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012229</DrugIDPK>
    <LicenceNumber>PA0367/014/001</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1985-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012230</DrugIDPK>
    <LicenceNumber>PA0367/014/002</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1985-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012236</DrugIDPK>
    <LicenceNumber>PA0367/016/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012237</DrugIDPK>
    <LicenceNumber>PA0367/016/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012318</DrugIDPK>
    <LicenceNumber>PA0392/002/002</LicenceNumber>
    <ProductName>SOLUBLE ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012216</DrugIDPK>
    <LicenceNumber>PA0367/007/001</LicenceNumber>
    <ProductName>SURGICAL SPIRITS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1986-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012526</DrugIDPK>
    <LicenceNumber>PA0425/001/001</LicenceNumber>
    <ProductName>DOXY 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012527</DrugIDPK>
    <LicenceNumber>PA0425/002/002</LicenceNumber>
    <ProductName>DOXY KOMB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012531</DrugIDPK>
    <LicenceNumber>PA0425/004/001</LicenceNumber>
    <ProductName>NOVOFLUEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOCRISTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009845</DrugIDPK>
    <LicenceNumber>PA0012/002/001</LicenceNumber>
    <ProductName>NERISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1976-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUCORTOLONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009848</DrugIDPK>
    <LicenceNumber>PA0012/002/003</LicenceNumber>
    <ProductName>NERISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1976-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUCORTOLONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009847</DrugIDPK>
    <LicenceNumber>PA0012/002/002</LicenceNumber>
    <ProductName>NERISONE FATTY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1976-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUCORTOLONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011706</DrugIDPK>
    <LicenceNumber>PA0073/061/001</LicenceNumber>
    <ProductName>CHLORHEXAMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011707</DrugIDPK>
    <LicenceNumber>PA0073/061/002</LicenceNumber>
    <ProductName>CHLORHEXAMED CONCENTRATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011515</DrugIDPK>
    <LicenceNumber>PA0057/049/001</LicenceNumber>
    <ProductName>RIKOSPRAY BALSAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012661</DrugIDPK>
    <LicenceNumber>PA0457/003/001</LicenceNumber>
    <ProductName>EFAMAST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Scotia Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012370</DrugIDPK>
    <LicenceNumber>PA0308/004/001</LicenceNumber>
    <ProductName>ECZEDERM CREAM WITH HYDROCORTISONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Quinoderm Ltd</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015774</DrugIDPK>
    <LicenceNumber>PA0251/002/002</LicenceNumber>
    <ProductName>CLAIRVAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015773</DrugIDPK>
    <LicenceNumber>PA0251/002/001</LicenceNumber>
    <ProductName>CLAIRVAN ORAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011864</DrugIDPK>
    <LicenceNumber>PA0077/056/001</LicenceNumber>
    <ProductName>MEDIDERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1981-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>RESORCINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011553</DrugIDPK>
    <LicenceNumber>PA0059/033/004</LicenceNumber>
    <ProductName>TERAZOL</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1986-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013446</DrugIDPK>
    <LicenceNumber>PA0257/005/001</LicenceNumber>
    <ProductName>SYNERGISTIC 1 LECITHIN VITAMIN E &amp; SELENIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013442</DrugIDPK>
    <LicenceNumber>PA0257/004/001</LicenceNumber>
    <ProductName>SYNERGISTIC 4. VITAMIN B6 HERB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010470</DrugIDPK>
    <LicenceNumber>PA0028/005/001</LicenceNumber>
    <ProductName>CIBACALCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1976-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011222</DrugIDPK>
    <LicenceNumber>PA0050/070/001</LicenceNumber>
    <ProductName>MORPHINE SULPHATE AMPOULES</ProductName>
    <Strength>10/ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011226</DrugIDPK>
    <LicenceNumber>PA0050/070/002</LicenceNumber>
    <ProductName>MORPHINE SULPHATE AMPOULES</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011051</DrugIDPK>
    <LicenceNumber>PA0048/044/002</LicenceNumber>
    <ProductName>PARAPLATIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1986-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011052</DrugIDPK>
    <LicenceNumber>PA0048/044/003</LicenceNumber>
    <ProductName>PARAPLATIN</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1986-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011049</DrugIDPK>
    <LicenceNumber>PA0048/044/001</LicenceNumber>
    <ProductName>PARAPLATIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1986-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011229</DrugIDPK>
    <LicenceNumber>PA0050/004/001</LicenceNumber>
    <ProductName>TEMETEX</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011230</DrugIDPK>
    <LicenceNumber>PA0050/004/002</LicenceNumber>
    <ProductName>TEMETEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011231</DrugIDPK>
    <LicenceNumber>PA0050/004/003</LicenceNumber>
    <ProductName>TEMETEX (FATTY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009659</DrugIDPK>
    <LicenceNumber>PA0004/036/001</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1986-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009660</DrugIDPK>
    <LicenceNumber>PA0004/036/002</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1986-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013718</DrugIDPK>
    <LicenceNumber>PA0217/007/001</LicenceNumber>
    <ProductName>FACTOR VIII NORDISK</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013719</DrugIDPK>
    <LicenceNumber>PA0217/007/002</LicenceNumber>
    <ProductName>FACTOR VIII NORDISK</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013721</DrugIDPK>
    <LicenceNumber>PA0217/007/004</LicenceNumber>
    <ProductName>FACTOR VIII NORDISK</ProductName>
    <Strength>700</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000507</DrugIDPK>
    <LicenceNumber>PA0012/055/001</LicenceNumber>
    <ProductName>RAYVIST 180</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>IOGLICIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000509</DrugIDPK>
    <LicenceNumber>PA0012/056/001</LicenceNumber>
    <ProductName>RAYVIST 300</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOGLICIC ACID</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000510</DrugIDPK>
    <LicenceNumber>PA0012/056/002</LicenceNumber>
    <ProductName>RAYVIST 300</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOGLICIC ACID</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000512</DrugIDPK>
    <LicenceNumber>PA0012/056/003</LicenceNumber>
    <ProductName>RAYVIST 300</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOGLICIC ACID</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000513</DrugIDPK>
    <LicenceNumber>PA0012/057/010</LicenceNumber>
    <ProductName>RAYVIST 350</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009915</DrugIDPK>
    <LicenceNumber>PA0012/057/001</LicenceNumber>
    <ProductName>RAYVIST 350</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IOGLICIC ACID</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010007</DrugIDPK>
    <LicenceNumber>PA0012/057/002</LicenceNumber>
    <ProductName>RAYVIST 350</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IOGLICIC ACID</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000514</DrugIDPK>
    <LicenceNumber>PA0012/058/001</LicenceNumber>
    <ProductName>RAYVIST 370</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1987-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOGLICIC ACID</ActiveSubstance>
      <ActiveSubstance>MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013621</DrugIDPK>
    <LicenceNumber>PA0172/001/001</LicenceNumber>
    <ProductName>HAEMORRHOIDAL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011781</DrugIDPK>
    <LicenceNumber>PA0079/015/001</LicenceNumber>
    <ProductName>KOATE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1985-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011782</DrugIDPK>
    <LicenceNumber>PA0079/015/002</LicenceNumber>
    <ProductName>KOATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1985-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011783</DrugIDPK>
    <LicenceNumber>PA0079/015/003</LicenceNumber>
    <ProductName>KOATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1985-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006654</DrugIDPK>
    <LicenceNumber>PA0516/004/001</LicenceNumber>
    <ProductName>QUINELAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006655</DrugIDPK>
    <LicenceNumber>PA0516/004/002</LicenceNumber>
    <ProductName>QUINELAN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006656</DrugIDPK>
    <LicenceNumber>PA0516/004/003</LicenceNumber>
    <ProductName>QUINELAN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011070</DrugIDPK>
    <LicenceNumber>PA0047/004/001</LicenceNumber>
    <ProductName>VANCOCIN HYDROCHLORIDE</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VANCOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011045</DrugIDPK>
    <LicenceNumber>PA0048/039/003</LicenceNumber>
    <ProductName>ANGIERS JUNIOR PARACETAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1985-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011044</DrugIDPK>
    <LicenceNumber>PA0048/039/001</LicenceNumber>
    <ProductName>ANGIERS PARACETAMOL DROPS FOR CHILDREN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011354</DrugIDPK>
    <LicenceNumber>PA0054/054/004</LicenceNumber>
    <ProductName>GENTIGAN 1 ML</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-06-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011351</DrugIDPK>
    <LicenceNumber>PA0054/054/002</LicenceNumber>
    <ProductName>GENTIGAN 2 ML</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011353</DrugIDPK>
    <LicenceNumber>PA0054/054/003</LicenceNumber>
    <ProductName>GENTIGAN 2 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011355</DrugIDPK>
    <LicenceNumber>PA0054/055/001</LicenceNumber>
    <ProductName>GENTIGAN-L 2 ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011356</DrugIDPK>
    <LicenceNumber>PA0054/055/002</LicenceNumber>
    <ProductName>GENTIGAN-L 2 ML</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010967</DrugIDPK>
    <LicenceNumber>PA0046/031/002</LicenceNumber>
    <ProductName>MIRAXID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
      <ActiveSubstance>PIVMECILLINAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010974</DrugIDPK>
    <LicenceNumber>PA0046/031/003</LicenceNumber>
    <ProductName>MIRAXID PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
      <ActiveSubstance>PIVMECILLINAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012875</DrugIDPK>
    <LicenceNumber>PA0765/001/001</LicenceNumber>
    <ProductName>AMILORIDE/HYDROCHLOORTHIAZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stephin B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013534</DrugIDPK>
    <LicenceNumber>PA0261/031/001</LicenceNumber>
    <ProductName>ORGALUTREL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GONADORELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009977</DrugIDPK>
    <LicenceNumber>PA0017/077/002</LicenceNumber>
    <ProductName>SYRAPRIM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010079</DrugIDPK>
    <LicenceNumber>PA0017/077/001</LicenceNumber>
    <ProductName>SYRAPRIM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012681</DrugIDPK>
    <LicenceNumber>PA0473/007/003</LicenceNumber>
    <ProductName>ULCIDIN</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012832</DrugIDPK>
    <LicenceNumber>PA0544/006/001</LicenceNumber>
    <ProductName>MULTITEST CMI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011891</DrugIDPK>
    <LicenceNumber>PA0077/120/001</LicenceNumber>
    <ProductName>TICLID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TICLOPIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012866</DrugIDPK>
    <LicenceNumber>PA0631/001/001</LicenceNumber>
    <ProductName>ALCUSAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcusal Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>SALICYLATES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015742</DrugIDPK>
    <LicenceNumber>PA0237/017/001</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011724</DrugIDPK>
    <LicenceNumber>PA0073/095/001</LicenceNumber>
    <ProductName>MILORANT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013183</DrugIDPK>
    <LicenceNumber>PA0145/001/002</LicenceNumber>
    <ProductName>ECZENSA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013184</DrugIDPK>
    <LicenceNumber>PA0145/002/001</LicenceNumber>
    <ProductName>ECZENSA - S</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENYLPYRALINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013187</DrugIDPK>
    <LicenceNumber>PA0145/006/002</LicenceNumber>
    <ProductName>HADENSA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>ICHTHAMMOL</ActiveSubstance>
      <ActiveSubstance>CHLORCARVACROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011749</DrugIDPK>
    <LicenceNumber>PA0074/023/001</LicenceNumber>
    <ProductName>ROVAKTIVIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MELISSA EXTRACT</ActiveSubstance>
      <ActiveSubstance>EUGENOL</ActiveSubstance>
      <ActiveSubstance>LECITHINUM SOYA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002460</DrugIDPK>
    <LicenceNumber>PA0054/030/001</LicenceNumber>
    <ProductName>SYSTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013536</DrugIDPK>
    <LicenceNumber>PA0261/034/001</LicenceNumber>
    <ProductName>DEXATOPIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011903</DrugIDPK>
    <LicenceNumber>PA0082/045/001</LicenceNumber>
    <ProductName>CREMALGIN BALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013835</DrugIDPK>
    <LicenceNumber>PA0281/033/001</LicenceNumber>
    <ProductName>NEURALGON</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1985-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013837</DrugIDPK>
    <LicenceNumber>PA0281/033/002</LicenceNumber>
    <ProductName>NEURALGON</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1985-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012479</DrugIDPK>
    <LicenceNumber>PA0356/004/001</LicenceNumber>
    <ProductName>LEJ-FIBRE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Britannia Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1985-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010461</DrugIDPK>
    <LicenceNumber>PA0027/030/001</LicenceNumber>
    <ProductName>LOXENE HEAD GUARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1985-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011643</DrugIDPK>
    <LicenceNumber>PA0072/009/001</LicenceNumber>
    <ProductName>PENNCODIN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
      <ActiveSubstance>CODEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012296</DrugIDPK>
    <LicenceNumber>PA0302/010/001</LicenceNumber>
    <ProductName>SUPER WATE-ON EMULSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CORN OIL</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012295</DrugIDPK>
    <LicenceNumber>PA0302/009/001</LicenceNumber>
    <ProductName>WATE-ON EMULSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CORN OIL</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003118</DrugIDPK>
    <LicenceNumber>PA0072/002/002</LicenceNumber>
    <ProductName>CALDESENE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM UNDECYLEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013120</DrugIDPK>
    <LicenceNumber>PA0141/005/001</LicenceNumber>
    <ProductName>CORTI FLEXIOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
      <ActiveSubstance>RETINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004948</DrugIDPK>
    <LicenceNumber>PA0236/023/001</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004951</DrugIDPK>
    <LicenceNumber>PA0236/023/002</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004953</DrugIDPK>
    <LicenceNumber>PA0236/023/003</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015632</DrugIDPK>
    <LicenceNumber>PA0300/001/001</LicenceNumber>
    <ProductName>HALYCITROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratories for Applied Biology</PAHolder>
    <AuthorisedDate>1980-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013136</DrugIDPK>
    <LicenceNumber>PA0141/014/001</LicenceNumber>
    <ProductName>OTO FLEXIOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013149</DrugIDPK>
    <LicenceNumber>PA0141/022/001</LicenceNumber>
    <ProductName>RECTOSELLAN (HEMORRHOIDAL OINTMENT)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015229</DrugIDPK>
    <LicenceNumber>PA0432/003/003</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1986-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015224</DrugIDPK>
    <LicenceNumber>PA0432/002/001</LicenceNumber>
    <ProductName>CHLOROQUINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1986-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROQUINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015223</DrugIDPK>
    <LicenceNumber>PA0432/001/001</LicenceNumber>
    <ProductName>PARACETAMOL ELIXIR PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1986-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015231</DrugIDPK>
    <LicenceNumber>PA0432/004/001</LicenceNumber>
    <ProductName>TETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1985-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016035</DrugIDPK>
    <LicenceNumber>PA0222/004/001</LicenceNumber>
    <ProductName>ALEUDRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lewis Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016036</DrugIDPK>
    <LicenceNumber>PA0222/004/002</LicenceNumber>
    <ProductName>ALEUDRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lewis Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016028</DrugIDPK>
    <LicenceNumber>PA0222/001/002</LicenceNumber>
    <ProductName>LIPOTRIAD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lewis Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016033</DrugIDPK>
    <LicenceNumber>PA0222/003/001</LicenceNumber>
    <ProductName>SYMPATOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lewis Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012463</DrugIDPK>
    <LicenceNumber>PA0337/016/001</LicenceNumber>
    <ProductName>TEMPAIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012464</DrugIDPK>
    <LicenceNumber>PA0337/016/002</LicenceNumber>
    <ProductName>TEMPAIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012442</DrugIDPK>
    <LicenceNumber>PA0337/002/001</LicenceNumber>
    <ProductName>U.P.C. EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012326</DrugIDPK>
    <LicenceNumber>PA0396/001/001</LicenceNumber>
    <ProductName>VISTA METHASONE N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Daniels Pharmaceutical Ltd</PAHolder>
    <AuthorisedDate>1985-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015746</DrugIDPK>
    <LicenceNumber>PA0237/023/002</LicenceNumber>
    <ProductName>ASMAVEN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015747</DrugIDPK>
    <LicenceNumber>PA0237/023/003</LicenceNumber>
    <ProductName>ASMAVEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009511</DrugIDPK>
    <LicenceNumber>PA0005/001/001</LicenceNumber>
    <ProductName>AURALTONE EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENAZONE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009520</DrugIDPK>
    <LicenceNumber>PA0005/006/001</LicenceNumber>
    <ProductName>BRONCHOTONE MIXTURE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>SODIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009515</DrugIDPK>
    <LicenceNumber>PA0005/003/001</LicenceNumber>
    <ProductName>COPHOLCO COUGH SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-10-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>TERPIN HYDRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009521</DrugIDPK>
    <LicenceNumber>PA0005/007/001</LicenceNumber>
    <ProductName>COPHOLCOIDS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>TERPIN HYDRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013868</DrugIDPK>
    <LicenceNumber>PA0277/030/002</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013871</DrugIDPK>
    <LicenceNumber>PA0277/030/004</LicenceNumber>
    <ProductName>HYDROCORTISONE EYE DROPS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013869</DrugIDPK>
    <LicenceNumber>PA0277/030/003</LicenceNumber>
    <ProductName>HYDROCORTISONE SCALP APPLICATION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1987-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009513</DrugIDPK>
    <LicenceNumber>PA0005/002/001</LicenceNumber>
    <ProductName>NEURODYNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009519</DrugIDPK>
    <LicenceNumber>PA0005/004/002</LicenceNumber>
    <ProductName>PHYTOCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009517</DrugIDPK>
    <LicenceNumber>PA0005/004/001</LicenceNumber>
    <ProductName>PHYTOCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOXYPROPAZINE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012728</DrugIDPK>
    <LicenceNumber>PA0504/002/001</LicenceNumber>
    <ProductName>IMOTEST - TUBERCULIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012731</DrugIDPK>
    <LicenceNumber>PA0504/003/001</LicenceNumber>
    <ProductName>MERIEUX ORAL POLIOMYELITIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012732</DrugIDPK>
    <LicenceNumber>PA0504/003/002</LicenceNumber>
    <ProductName>MERIEUX ORAL POLIOMYELITIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013627</DrugIDPK>
    <LicenceNumber>PA0187/028/002</LicenceNumber>
    <ProductName>SOMATONORM</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHIONYL HUMAN SOMATOTROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011693</DrugIDPK>
    <LicenceNumber>PA0073/048/001</LicenceNumber>
    <ProductName>CHLOROPHENIRAMINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011694</DrugIDPK>
    <LicenceNumber>PA0073/048/002</LicenceNumber>
    <ProductName>CHLORPHENIRAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013641</DrugIDPK>
    <LicenceNumber>PA0196/001/001</LicenceNumber>
    <ProductName>NEOCONES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>TETRACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013644</DrugIDPK>
    <LicenceNumber>PA0196/003/001</LicenceNumber>
    <ProductName>PERIDONTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Immunetech Pharmaceuticals Inc.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>PAPAIN</ActiveSubstance>
      <ActiveSubstance>SODIUM BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013653</DrugIDPK>
    <LicenceNumber>PA0196/009/001</LicenceNumber>
    <ProductName>PULPOMIXINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE ACETATE</ActiveSubstance>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013656</DrugIDPK>
    <LicenceNumber>PA0196/011/001</LicenceNumber>
    <ProductName>SCANDONEST SPECIAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1987-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEPIVACAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013662</DrugIDPK>
    <LicenceNumber>PA0196/012/001</LicenceNumber>
    <ProductName>SCANDONEST WITHOUT VASO-CONSTRICTOR</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1987-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013643</DrugIDPK>
    <LicenceNumber>PA0196/002/001</LicenceNumber>
    <ProductName>SEPTOMIXINE FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>HALETAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015753</DrugIDPK>
    <LicenceNumber>PA0242/001/001</LicenceNumber>
    <ProductName>TERPOIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hough, Hoseason &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012334</DrugIDPK>
    <LicenceNumber>PA0399/002/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>1984-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012336</DrugIDPK>
    <LicenceNumber>PA0399/002/003</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>1984-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012337</DrugIDPK>
    <LicenceNumber>PA0399/002/004</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>1984-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012335</DrugIDPK>
    <LicenceNumber>PA0399/002/002</LicenceNumber>
    <ProductName>AMPICILLIN TRIHYDRATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>1984-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005991</DrugIDPK>
    <LicenceNumber>PA0399/003/002</LicenceNumber>
    <ProductName>BUPROFAN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fannin &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1984-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005992</DrugIDPK>
    <LicenceNumber>PA0399/004/001</LicenceNumber>
    <ProductName>COTRIFAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fannin &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1984-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COTRIMOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012338</DrugIDPK>
    <LicenceNumber>PA0399/003/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>1984-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012331</DrugIDPK>
    <LicenceNumber>PA0399/001/001</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012332</DrugIDPK>
    <LicenceNumber>PA0399/001/002</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012333</DrugIDPK>
    <LicenceNumber>PA0399/001/003</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010801</DrugIDPK>
    <LicenceNumber>PA0041/040/004</LicenceNumber>
    <ProductName>PERFAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXIMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010802</DrugIDPK>
    <LicenceNumber>PA0041/040/005</LicenceNumber>
    <ProductName>PERFAN</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXIMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010803</DrugIDPK>
    <LicenceNumber>PA0041/040/006</LicenceNumber>
    <ProductName>PERFAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXIMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010804</DrugIDPK>
    <LicenceNumber>PA0041/040/007</LicenceNumber>
    <ProductName>PERFAN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXIMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012523</DrugIDPK>
    <LicenceNumber>PA0422/003/001</LicenceNumber>
    <ProductName>NIFEREX</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYSACCHARIDE-K</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012525</DrugIDPK>
    <LicenceNumber>PA0422/003/003</LicenceNumber>
    <ProductName>NIFEREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYSACCHARIDE-K</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012524</DrugIDPK>
    <LicenceNumber>PA0422/003/002</LicenceNumber>
    <ProductName>NIFEREX ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYSACCHARIDE-K</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013801</DrugIDPK>
    <LicenceNumber>PA0277/006/002</LicenceNumber>
    <ProductName>AFRAZINE NOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013803</DrugIDPK>
    <LicenceNumber>PA0277/006/003</LicenceNumber>
    <ProductName>AFRAZINE NOSE SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013887</DrugIDPK>
    <LicenceNumber>PA0277/034/004</LicenceNumber>
    <ProductName>DIPROSONE 5 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013888</DrugIDPK>
    <LicenceNumber>PA0277/034/005</LicenceNumber>
    <ProductName>DIPROSONE 5 MG/ML</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013896</DrugIDPK>
    <LicenceNumber>PA0277/041/001</LicenceNumber>
    <ProductName>GARASONE EYE OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013897</DrugIDPK>
    <LicenceNumber>PA0277/041/002</LicenceNumber>
    <ProductName>GARASONE EYE/EAR DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013775</DrugIDPK>
    <LicenceNumber>PA0277/004/001</LicenceNumber>
    <ProductName>GEOMYCIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013788</DrugIDPK>
    <LicenceNumber>PA0277/004/008</LicenceNumber>
    <ProductName>GEOMYCIN (PAEDIATRIC) 20MG</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013782</DrugIDPK>
    <LicenceNumber>PA0277/004/005</LicenceNumber>
    <ProductName>GEOMYCIN 60 MG/1.5 ML</ProductName>
    <Strength>2.25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013778</DrugIDPK>
    <LicenceNumber>PA0277/004/002</LicenceNumber>
    <ProductName>GEOMYCIN 60 MG/1.5 ML</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013779</DrugIDPK>
    <LicenceNumber>PA0277/004/003</LicenceNumber>
    <ProductName>GEOMYCIN 80 MG/2 ML</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013784</DrugIDPK>
    <LicenceNumber>PA0277/004/006</LicenceNumber>
    <ProductName>GEOMYCIN 80 MG/2 ML</ProductName>
    <Strength>2.25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013781</DrugIDPK>
    <LicenceNumber>PA0277/004/004</LicenceNumber>
    <ProductName>GEOMYCIN 80 MG/2 ML VIAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013790</DrugIDPK>
    <LicenceNumber>PA0277/004/009</LicenceNumber>
    <ProductName>GEOMYCIN 80 MG/ML</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013792</DrugIDPK>
    <LicenceNumber>PA0277/004/010</LicenceNumber>
    <ProductName>GEOMYCIN 80 MG/ML</ProductName>
    <Strength>2.25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1979-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013793</DrugIDPK>
    <LicenceNumber>PA0277/004/011</LicenceNumber>
    <ProductName>GEOMYCIN CHAINS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1981-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013876</DrugIDPK>
    <LicenceNumber>PA0277/030/007</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013873</DrugIDPK>
    <LicenceNumber>PA0277/030/005</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013874</DrugIDPK>
    <LicenceNumber>PA0277/030/006</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013864</DrugIDPK>
    <LicenceNumber>PA0277/028/002</LicenceNumber>
    <ProductName>KADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1984-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013865</DrugIDPK>
    <LicenceNumber>PA0277/028/003</LicenceNumber>
    <ProductName>KADERM-10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013863</DrugIDPK>
    <LicenceNumber>PA0277/028/001</LicenceNumber>
    <ProductName>KADERM-3</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1985-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013832</DrugIDPK>
    <LicenceNumber>PA0277/021/001</LicenceNumber>
    <ProductName>ZINC SULPHATE WITH ADRENALINE EYE DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013886</DrugIDPK>
    <LicenceNumber>PA0277/033/003</LicenceNumber>
    <ProductName>ZYDERM 65</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013884</DrugIDPK>
    <LicenceNumber>PA0277/033/002</LicenceNumber>
    <ProductName>ZYDERM COLLAGEN IMPLANT</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016058</DrugIDPK>
    <LicenceNumber>PA0224/010/004</LicenceNumber>
    <ProductName>PLATOSIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016059</DrugIDPK>
    <LicenceNumber>PA0224/010/005</LicenceNumber>
    <ProductName>PLATOSIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferrer Internacional</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016060</DrugIDPK>
    <LicenceNumber>PA0224/010/006</LicenceNumber>
    <ProductName>PLATOSIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016056</DrugIDPK>
    <LicenceNumber>PA0224/009/001</LicenceNumber>
    <ProductName>RESCUFOLIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016052</DrugIDPK>
    <LicenceNumber>PA0224/009/002</LicenceNumber>
    <ProductName>RESCUFOLIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016053</DrugIDPK>
    <LicenceNumber>PA0224/009/003</LicenceNumber>
    <ProductName>RESCUFOLIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010387</DrugIDPK>
    <LicenceNumber>PA0035/044/004</LicenceNumber>
    <ProductName>BLOCADREN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010388</DrugIDPK>
    <LicenceNumber>PA0035/044/006</LicenceNumber>
    <ProductName>BLOCADREN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010389</DrugIDPK>
    <LicenceNumber>PA0035/044/007</LicenceNumber>
    <ProductName>BLOCADREN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009691</DrugIDPK>
    <LicenceNumber>PA0009/006/001</LicenceNumber>
    <ProductName>BRICANYL COMPOUND</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011411</DrugIDPK>
    <LicenceNumber>PA0056/042/001</LicenceNumber>
    <ProductName>COMPRECIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ENOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011412</DrugIDPK>
    <LicenceNumber>PA0056/042/002</LicenceNumber>
    <ProductName>COMPRECIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ENOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011406</DrugIDPK>
    <LicenceNumber>PA0056/037/001</LicenceNumber>
    <ProductName>PARKOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011375</DrugIDPK>
    <LicenceNumber>PA0056/007/001</LicenceNumber>
    <ProductName>VI-SIBLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1975-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISPAGHULA HUSKS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012055</DrugIDPK>
    <LicenceNumber>PA0095/001/001</LicenceNumber>
    <ProductName>ALANA BABY CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1975-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013820</DrugIDPK>
    <LicenceNumber>PA0281/023/002</LicenceNumber>
    <ProductName>AZEPAM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1983-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013818</DrugIDPK>
    <LicenceNumber>PA0281/023/001</LicenceNumber>
    <ProductName>AZEPAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1983-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013833</DrugIDPK>
    <LicenceNumber>PA0281/032/001</LicenceNumber>
    <ProductName>PERATIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1985-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013828</DrugIDPK>
    <LicenceNumber>PA0281/029/001</LicenceNumber>
    <ProductName>PERCLODIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1985-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013830</DrugIDPK>
    <LicenceNumber>PA0281/029/002</LicenceNumber>
    <ProductName>PERCLODIN DIPRIDAMOLE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013816</DrugIDPK>
    <LicenceNumber>PA0281/020/003</LicenceNumber>
    <ProductName>PRAXOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1983-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013813</DrugIDPK>
    <LicenceNumber>PA0281/020/002</LicenceNumber>
    <ProductName>PRAXOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1983-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013811</DrugIDPK>
    <LicenceNumber>PA0281/020/001</LicenceNumber>
    <ProductName>PRAXOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1983-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013804</DrugIDPK>
    <LicenceNumber>PA0281/016/005</LicenceNumber>
    <ProductName>PROPRANOLOL LA</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1984-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013807</DrugIDPK>
    <LicenceNumber>PA0281/018/003</LicenceNumber>
    <ProductName>RHEUMACID</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1987-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012491</DrugIDPK>
    <LicenceNumber>PA0361/001/001</LicenceNumber>
    <ProductName>PAMERGAN AP 100/25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012492</DrugIDPK>
    <LicenceNumber>PA0361/002/001</LicenceNumber>
    <ProductName>PAMERGAN P100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-09-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012562</DrugIDPK>
    <LicenceNumber>PA0436/008/009</LicenceNumber>
    <ProductName>SALBUTAMOL 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012560</DrugIDPK>
    <LicenceNumber>PA0436/007/007</LicenceNumber>
    <ProductName>SALOMOL 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012694</DrugIDPK>
    <LicenceNumber>PA0484/003/001</LicenceNumber>
    <ProductName>ACRIFLAVINE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACRIFLAVINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012702</DrugIDPK>
    <LicenceNumber>PA0484/020/001</LicenceNumber>
    <ProductName>ANTIPHLOGISTINE RUB A:535</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010546</DrugIDPK>
    <LicenceNumber>PA0044/025/001</LicenceNumber>
    <ProductName>BETNOVATE RECTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011440</DrugIDPK>
    <LicenceNumber>PA0060/018/001</LicenceNumber>
    <ProductName>CENDEVAX RUBELLA VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1978-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011441</DrugIDPK>
    <LicenceNumber>PA0060/018/002</LicenceNumber>
    <ProductName>CENDEVAX RUBELLA VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1978-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010828</DrugIDPK>
    <LicenceNumber>PA0044/008/004</LicenceNumber>
    <ProductName>CEPORIN (S-FORM)</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010664</DrugIDPK>
    <LicenceNumber>PA0044/051/001</LicenceNumber>
    <ProductName>ETHNINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010441</DrugIDPK>
    <LicenceNumber>PA0027/009/001</LicenceNumber>
    <ProductName>GOLDEN HONEY LEMSIP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010425</DrugIDPK>
    <LicenceNumber>PA0024/008/001</LicenceNumber>
    <ProductName>PIRIEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011449</DrugIDPK>
    <LicenceNumber>PA0060/029/001</LicenceNumber>
    <ProductName>SKEFRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010428</DrugIDPK>
    <LicenceNumber>PA0024/009/002</LicenceNumber>
    <ProductName>STERISPON NO 4</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GELATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011533</DrugIDPK>
    <LicenceNumber>PA0058/005/002</LicenceNumber>
    <ProductName>MULTIFUNGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011534</DrugIDPK>
    <LicenceNumber>PA0058/005/003</LicenceNumber>
    <ProductName>MULTIFUNGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011535</DrugIDPK>
    <LicenceNumber>PA0058/006/001</LicenceNumber>
    <ProductName>MULTIFUNGIN H</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011540</DrugIDPK>
    <LicenceNumber>PA0058/014/002</LicenceNumber>
    <ProductName>TALUSIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROSCILLARIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010426</DrugIDPK>
    <LicenceNumber>PA0024/009/001</LicenceNumber>
    <ProductName>STERISPON NO 1</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GELATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016062</DrugIDPK>
    <LicenceNumber>PA0227/002/001</LicenceNumber>
    <ProductName>ASPIRIN AND CODEINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Irish Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016064</DrugIDPK>
    <LicenceNumber>PA0227/004/001</LicenceNumber>
    <ProductName>PARACETAMOL TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Irish Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011350</DrugIDPK>
    <LicenceNumber>PA0054/054/001</LicenceNumber>
    <ProductName>GENTIGAN 2 ML</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013431</DrugIDPK>
    <LicenceNumber>PA0255/033/001</LicenceNumber>
    <ProductName>LIGNOCAINE &amp; ADRENALINE INJECTION 10 MG/ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1984-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009917</DrugIDPK>
    <LicenceNumber>PA0012/059/001</LicenceNumber>
    <ProductName>CORINDOLAN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009918</DrugIDPK>
    <LicenceNumber>PA0012/059/002</LicenceNumber>
    <ProductName>CORINDOLAN</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012319</DrugIDPK>
    <LicenceNumber>PA0392/003/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011606</DrugIDPK>
    <LicenceNumber>PA0062/033/001</LicenceNumber>
    <ProductName>FLUOCALCIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005816</DrugIDPK>
    <LicenceNumber>PA0365/016/001</LicenceNumber>
    <ProductName>MINADEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1987-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>IRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012399</DrugIDPK>
    <LicenceNumber>PA0333/001/002</LicenceNumber>
    <ProductName>NOVOTRIMOX D.S.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005854</DrugIDPK>
    <LicenceNumber>PA0303/017/003</LicenceNumber>
    <ProductName>KEFEXIN FX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1987-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005844</DrugIDPK>
    <LicenceNumber>PA0303/008/001</LicenceNumber>
    <ProductName>PRATSIOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1982-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005845</DrugIDPK>
    <LicenceNumber>PA0303/008/002</LicenceNumber>
    <ProductName>PRATSIOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1982-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005846</DrugIDPK>
    <LicenceNumber>PA0303/008/003</LicenceNumber>
    <ProductName>PRATSIOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1982-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAZOSIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013677</DrugIDPK>
    <LicenceNumber>PA0200/001/003</LicenceNumber>
    <ProductName>NARCAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1984-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012720</DrugIDPK>
    <LicenceNumber>PA0108/013/002</LicenceNumber>
    <ProductName>YOTOPAR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RITODRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012745</DrugIDPK>
    <LicenceNumber>PA0109/004/004</LicenceNumber>
    <ProductName>PHOLCOMED DIABETIC LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012747</DrugIDPK>
    <LicenceNumber>PA0109/004/005</LicenceNumber>
    <ProductName>PHOLCOMED FORTE DIABETIC LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012742</DrugIDPK>
    <LicenceNumber>PA0109/004/003</LicenceNumber>
    <ProductName>PHOLCOMED FORTE LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012740</DrugIDPK>
    <LicenceNumber>PA0109/004/002</LicenceNumber>
    <ProductName>PHOLCOMED LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012737</DrugIDPK>
    <LicenceNumber>PA0109/004/001</LicenceNumber>
    <ProductName>PHOLCOMED LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012775</DrugIDPK>
    <LicenceNumber>PA0109/011/001</LicenceNumber>
    <ProductName>TONIRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-06-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLYCINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010630</DrugIDPK>
    <LicenceNumber>PA0038/023/001</LicenceNumber>
    <ProductName>IBEROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010631</DrugIDPK>
    <LicenceNumber>PA0038/024/001</LicenceNumber>
    <ProductName>IROFOL C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010596</DrugIDPK>
    <LicenceNumber>PA0038/004/001</LicenceNumber>
    <ProductName>LIQUIFER-CR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012424</DrugIDPK>
    <LicenceNumber>PA0333/006/004</LicenceNumber>
    <ProductName>NOVAMOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012421</DrugIDPK>
    <LicenceNumber>PA0333/006/002</LicenceNumber>
    <ProductName>NOVAMOXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012422</DrugIDPK>
    <LicenceNumber>PA0333/006/003</LicenceNumber>
    <ProductName>NOVAMOXIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012419</DrugIDPK>
    <LicenceNumber>PA0333/006/001</LicenceNumber>
    <ProductName>NOVAMOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012413</DrugIDPK>
    <LicenceNumber>PA0333/005/001</LicenceNumber>
    <ProductName>NOVOAMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012414</DrugIDPK>
    <LicenceNumber>PA0333/005/002</LicenceNumber>
    <ProductName>NOVOAMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012416</DrugIDPK>
    <LicenceNumber>PA0333/005/003</LicenceNumber>
    <ProductName>NOVOAMPICILLIN (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012418</DrugIDPK>
    <LicenceNumber>PA0333/005/004</LicenceNumber>
    <ProductName>NOVOAMPICILLIN (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012401</DrugIDPK>
    <LicenceNumber>PA0333/002/001</LicenceNumber>
    <ProductName>NOVOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012402</DrugIDPK>
    <LicenceNumber>PA0333/002/002</LicenceNumber>
    <ProductName>NOVOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012410</DrugIDPK>
    <LicenceNumber>PA0333/004/002</LicenceNumber>
    <ProductName>NOVORIDAZINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012411</DrugIDPK>
    <LicenceNumber>PA0333/004/003</LicenceNumber>
    <ProductName>NOVORIDAZINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012408</DrugIDPK>
    <LicenceNumber>PA0333/004/001</LicenceNumber>
    <ProductName>NOVORIDAZINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012440</DrugIDPK>
    <LicenceNumber>PA033/001/001</LicenceNumber>
    <ProductName>NOVOTRIMOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012443</DrugIDPK>
    <LicenceNumber>PA0333/001/001</LicenceNumber>
    <ProductName>NOVOTRIMOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012407</DrugIDPK>
    <LicenceNumber>PA0333/003/003</LicenceNumber>
    <ProductName>NOVOTRIPTYN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012404</DrugIDPK>
    <LicenceNumber>PA0333/003/001</LicenceNumber>
    <ProductName>NOVOTRIPTYN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012405</DrugIDPK>
    <LicenceNumber>PA0333/003/002</LicenceNumber>
    <ProductName>NOVOTRIPTYN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McFadden Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010627</DrugIDPK>
    <LicenceNumber>PA0038/015/001</LicenceNumber>
    <ProductName>THEOGRAD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010626</DrugIDPK>
    <LicenceNumber>PA0038/014/002</LicenceNumber>
    <ProductName>TRIDIONE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012587</DrugIDPK>
    <LicenceNumber>PA0437/016/002</LicenceNumber>
    <ProductName>GENTAMICIN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012588</DrugIDPK>
    <LicenceNumber>PA0437/016/005</LicenceNumber>
    <ProductName>GENTAMICIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-08-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010512</DrugIDPK>
    <LicenceNumber>PA0023/062/001</LicenceNumber>
    <ProductName>RENEDIL EXTENDED RELEASE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010513</DrugIDPK>
    <LicenceNumber>PA0023/062/002</LicenceNumber>
    <ProductName>RENEDIL EXTENDED RELEASE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013774</DrugIDPK>
    <LicenceNumber>PA0277/058/001</LicenceNumber>
    <ProductName>RINSTEAD ORALIEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013557</DrugIDPK>
    <LicenceNumber>PA0179/003/009</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.45/GLUCOSE 2.5</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013558</DrugIDPK>
    <LicenceNumber>PA0179/003/010</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.45/GLUCOSE 2.5</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013561</DrugIDPK>
    <LicenceNumber>PA0179/003/011</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%/GLUCOSE 5%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013563</DrugIDPK>
    <LicenceNumber>PA0179/003/012</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%/GLUCOSE 5%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010581</DrugIDPK>
    <LicenceNumber>PA0037/066/001</LicenceNumber>
    <ProductName>ARTHITREX</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013169</DrugIDPK>
    <LicenceNumber>PA0144/002/001</LicenceNumber>
    <ProductName>BENOXYL 20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013171</DrugIDPK>
    <LicenceNumber>PA0144/005/001</LicenceNumber>
    <ProductName>SASTID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1978-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011522</DrugIDPK>
    <LicenceNumber>PA0057/054/001</LicenceNumber>
    <ProductName>AEROLIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011523</DrugIDPK>
    <LicenceNumber>PA0057/054/002</LicenceNumber>
    <ProductName>AEROLIN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011524</DrugIDPK>
    <LicenceNumber>PA0057/054/003</LicenceNumber>
    <ProductName>AEROLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011525</DrugIDPK>
    <LicenceNumber>PA0057/054/004</LicenceNumber>
    <ProductName>AEROLIN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011481</DrugIDPK>
    <LicenceNumber>PA0057/024/002</LicenceNumber>
    <ProductName>PULMADIL RESPIRATOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIMITEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011474</DrugIDPK>
    <LicenceNumber>PA0057/020/001</LicenceNumber>
    <ProductName>RAUWILOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAUWOLFIA SERPENTINA</ActiveSubstance>
      <ActiveSubstance>ALSEROXYLON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011925</DrugIDPK>
    <LicenceNumber>PA0086/001/001</LicenceNumber>
    <ProductName>ALLBEE WITH C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1975-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011928</DrugIDPK>
    <LicenceNumber>PA0086/005/001</LicenceNumber>
    <ProductName>FEAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1976-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013305</DrugIDPK>
    <LicenceNumber>PA0167/012/001</LicenceNumber>
    <ProductName>0.9% S/V SODIUM CHLORIDE FOR IRRIGATION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013322</DrugIDPK>
    <LicenceNumber>PA0167/010/002</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C  0.02%</ProductName>
    <Strength>1,000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013323</DrugIDPK>
    <LicenceNumber>PA0167/010/003</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C  0.05%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013324</DrugIDPK>
    <LicenceNumber>PA0167/010/004</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C 0.05%</ProductName>
    <Strength>1,000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013321</DrugIDPK>
    <LicenceNumber>PA0167/010/001</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B. P. C. 0.02%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-11-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013388</DrugIDPK>
    <LicenceNumber>PA0167/053/003</LicenceNumber>
    <ProductName>DARROWS INJECTION (LACTATED POTASSIC SALINE INJ)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013389</DrugIDPK>
    <LicenceNumber>PA0167/053/004</LicenceNumber>
    <ProductName>DARROWS INJECTION (LACTATED POTASSIC SALINE INJ)</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016100</DrugIDPK>
    <LicenceNumber>PA0218/015/003</LicenceNumber>
    <ProductName>HUMAN MONOTARD HM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013272</DrugIDPK>
    <LicenceNumber>PA0167/041/003</LicenceNumber>
    <ProductName>PLASMA-LYTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013274</DrugIDPK>
    <LicenceNumber>PA0167/041/004</LicenceNumber>
    <ProductName>PLASMA-LYTE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1985-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013306</DrugIDPK>
    <LicenceNumber>PA0167/012/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>1,000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013300</DrugIDPK>
    <LicenceNumber>PA0167/011/001</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013301</DrugIDPK>
    <LicenceNumber>PA0167/011/002</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>1,000 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012799</DrugIDPK>
    <LicenceNumber>PA0114/027/001</LicenceNumber>
    <ProductName>ANGICREM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012793</DrugIDPK>
    <LicenceNumber>PA0114/019/001</LicenceNumber>
    <ProductName>BROVON INHALANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012803</DrugIDPK>
    <LicenceNumber>PA0114/030/001</LicenceNumber>
    <ProductName>CHOLEBRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOCETAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011787</DrugIDPK>
    <LicenceNumber>PA0080/001/001</LicenceNumber>
    <ProductName>DICYNENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012821</DrugIDPK>
    <LicenceNumber>PA0114/044/001</LicenceNumber>
    <ProductName>GASTROBID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012045</DrugIDPK>
    <LicenceNumber>PA0090/006/004</LicenceNumber>
    <ProductName>HEPARIN PABYRN</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012046</DrugIDPK>
    <LicenceNumber>PA0090/006/005</LicenceNumber>
    <ProductName>HEPARIN PABYRN</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012047</DrugIDPK>
    <LicenceNumber>PA0090/006/006</LicenceNumber>
    <ProductName>HEPARIN PABYRN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012048</DrugIDPK>
    <LicenceNumber>PA0090/006/007</LicenceNumber>
    <ProductName>HEPARIN PABYRN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012049</DrugIDPK>
    <LicenceNumber>PA0090/006/008</LicenceNumber>
    <ProductName>HEPARIN PABYRN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012050</DrugIDPK>
    <LicenceNumber>PA0090/006/009</LicenceNumber>
    <ProductName>HEPARIN PABYRN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012042</DrugIDPK>
    <LicenceNumber>PA0090/006/001</LicenceNumber>
    <ProductName>HEPARIN PABYRN - 5ML</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012043</DrugIDPK>
    <LicenceNumber>PA0090/006/002</LicenceNumber>
    <ProductName>HEPARIN PABYRN - 5ML</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012044</DrugIDPK>
    <LicenceNumber>PA0090/006/003</LicenceNumber>
    <ProductName>HEPARIN PABYRN - 5ML</ProductName>
    <Strength>25000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012051</DrugIDPK>
    <LicenceNumber>PA0090/006/010</LicenceNumber>
    <ProductName>HEPARIN PABYRN (PREFILLED SYRINGES)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012807</DrugIDPK>
    <LicenceNumber>PA0114/034/001</LicenceNumber>
    <ProductName>SEDONAN EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENAZONE</ActiveSubstance>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012810</DrugIDPK>
    <LicenceNumber>PA0114/040/001</LicenceNumber>
    <ProductName>XERUMENEX EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TROLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011602</DrugIDPK>
    <LicenceNumber>PA0062/020/002</LicenceNumber>
    <ProductName>ANTRADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1982-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011603</DrugIDPK>
    <LicenceNumber>PA0062/020/003</LicenceNumber>
    <ProductName>ANTRADERM FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1982-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011599</DrugIDPK>
    <LicenceNumber>PA0062/020/001</LicenceNumber>
    <ProductName>ANTRADERM MILD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1982-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011488</DrugIDPK>
    <LicenceNumber>PA0062/005/001</LicenceNumber>
    <ProductName>ELAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012341</DrugIDPK>
    <LicenceNumber>PA0403/001/001</LicenceNumber>
    <ProductName>EXTRA STRENGTH VASELINE INTENSIVE CARE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cheseborough Pond;s (Ire)  Ltd</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011596</DrugIDPK>
    <LicenceNumber>PA0062/019/001</LicenceNumber>
    <ProductName>MEDITAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1982-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011597</DrugIDPK>
    <LicenceNumber>PA0062/019/002</LicenceNumber>
    <ProductName>MEDITAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1984-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011598</DrugIDPK>
    <LicenceNumber>PA0062/019/003</LicenceNumber>
    <ProductName>MEDITAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1984-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009993</DrugIDPK>
    <LicenceNumber>PA0018/008/001</LicenceNumber>
    <ProductName>NEOTULLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>BACITRACIN</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012601</DrugIDPK>
    <LicenceNumber>PA0102/021/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1985-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012603</DrugIDPK>
    <LicenceNumber>PA0102/021/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1985-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012605</DrugIDPK>
    <LicenceNumber>PA0102/021/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1985-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012606</DrugIDPK>
    <LicenceNumber>PA0102/021/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1985-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012566</DrugIDPK>
    <LicenceNumber>PA0102/004/001</LicenceNumber>
    <ProductName>SOMNITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1978-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012571</DrugIDPK>
    <LicenceNumber>PA0102/007/001</LicenceNumber>
    <ProductName>TAMPOVAGAN STILBOESTROL &amp; LACTIC ACID PESSARIES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIETHYLSTILBESTROL</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011827</DrugIDPK>
    <LicenceNumber>PA0077/027/001</LicenceNumber>
    <ProductName>COLDREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013597</DrugIDPK>
    <LicenceNumber>PA0185/008/001</LicenceNumber>
    <ProductName>GERIFIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1980-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013679</DrugIDPK>
    <LicenceNumber>PA0200/001/007</LicenceNumber>
    <ProductName>NARCAN SYRINGE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1989-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013680</DrugIDPK>
    <LicenceNumber>PA0200/001/008</LicenceNumber>
    <ProductName>NARCAN SYRINGE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1989-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010916</DrugIDPK>
    <LicenceNumber>PA0047/046/007</LicenceNumber>
    <ProductName>ONCOVIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1985-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013595</DrugIDPK>
    <LicenceNumber>PA0185/006/003</LicenceNumber>
    <ProductName>POLYALK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1980-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDUM LEVE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013596</DrugIDPK>
    <LicenceNumber>PA0185/006/004</LicenceNumber>
    <ProductName>POLYALK (SUSPENSION)</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1984-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011863</DrugIDPK>
    <LicenceNumber>PA0077/054/001</LicenceNumber>
    <ProductName>THROMBOLASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>UROKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011865</DrugIDPK>
    <LicenceNumber>PA0077/057/001</LicenceNumber>
    <ProductName>TRANCOPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CHLORMEZANONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010564</DrugIDPK>
    <LicenceNumber>PA0037/030/003</LicenceNumber>
    <ProductName>LEDERCORT PARENTERAL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009707</DrugIDPK>
    <LicenceNumber>PA0009/016/004</LicenceNumber>
    <ProductName>XYLOCAINE VISCOUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012554</DrugIDPK>
    <LicenceNumber>PA0100/036/002</LicenceNumber>
    <ProductName>DIOVOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1985-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003444</DrugIDPK>
    <LicenceNumber>PA0079/018/001</LicenceNumber>
    <ProductName>GAMIMUNE - N</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN NORMAL IMMUNOGLOBULIN FOR IV ADMINISTRATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003445</DrugIDPK>
    <LicenceNumber>PA0079/018/002</LicenceNumber>
    <ProductName>GAMIMUNE - N</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN NORMAL IMMUNOGLOBULIN FOR IV ADMINISTRATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003446</DrugIDPK>
    <LicenceNumber>PA0079/018/003</LicenceNumber>
    <ProductName>GAMIMUNE - N</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN NORMAL IMMUNOGLOBULIN FOR IV ADMINISTRATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003447</DrugIDPK>
    <LicenceNumber>PA0079/018/004</LicenceNumber>
    <ProductName>GAMIMUNE - N</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN NORMAL IMMUNOGLOBULIN FOR IV ADMINISTRATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002526</DrugIDPK>
    <LicenceNumber>PA0054/057/003</LicenceNumber>
    <ProductName>LIDAPRIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002527</DrugIDPK>
    <LicenceNumber>PA0054/057/004</LicenceNumber>
    <ProductName>LIDAPRIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011357</DrugIDPK>
    <LicenceNumber>PA0054/057/001</LicenceNumber>
    <ProductName>LIDAPRIM FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1984-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011197</DrugIDPK>
    <LicenceNumber>PA0049/031/006</LicenceNumber>
    <ProductName>SUPRAPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010640</DrugIDPK>
    <LicenceNumber>PA0038/054/002</LicenceNumber>
    <ProductName>TEMAFLOXACIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010641</DrugIDPK>
    <LicenceNumber>PA0038/054/003</LicenceNumber>
    <ProductName>TEMAFLOXACIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010642</DrugIDPK>
    <LicenceNumber>PA0038/054/004</LicenceNumber>
    <ProductName>TEMAFLOXACIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010638</DrugIDPK>
    <LicenceNumber>PA0038/054/001</LicenceNumber>
    <ProductName>TEMAFLOXACIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012864</DrugIDPK>
    <LicenceNumber>PA0624/001/001</LicenceNumber>
    <ProductName>SACCHAROMYCES BOULARDII</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Alax Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SACCHAROMYCES BOULARDII</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009623</DrugIDPK>
    <LicenceNumber>PA0002/057/009</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009620</DrugIDPK>
    <LicenceNumber>PA0002/057/007</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009621</DrugIDPK>
    <LicenceNumber>PA0002/057/008</LicenceNumber>
    <ProductName>VIDEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIDANOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011642</DrugIDPK>
    <LicenceNumber>PA0072/005/001</LicenceNumber>
    <ProductName>ZARENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1982-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOLAZONE</ActiveSubstance>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015160</DrugIDPK>
    <LicenceNumber>PA0290/059/001</LicenceNumber>
    <ProductName>IOCON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015111</DrugIDPK>
    <LicenceNumber>PA0290/038/001</LicenceNumber>
    <ProductName>MYDFRIN STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015096</DrugIDPK>
    <LicenceNumber>PA0290/035/002</LicenceNumber>
    <ProductName>NUTRAPLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015151</DrugIDPK>
    <LicenceNumber>PA0290/045/002</LicenceNumber>
    <ProductName>OPULETS - HOMATROPINE EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015148</DrugIDPK>
    <LicenceNumber>PA0290/045/001</LicenceNumber>
    <ProductName>OPULETS - HOMATROPINE EYE DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HOMATROPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001694</DrugIDPK>
    <LicenceNumber>PA0012/046/003</LicenceNumber>
    <ProductName>GYNO-TRAVOGEN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009490</DrugIDPK>
    <LicenceNumber>PA0001/030/005</LicenceNumber>
    <ProductName>ZYDOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009492</DrugIDPK>
    <LicenceNumber>PA0001/030/006</LicenceNumber>
    <ProductName>ZYDOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMADOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010961</DrugIDPK>
    <LicenceNumber>PA0048/004/001</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1976-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010962</DrugIDPK>
    <LicenceNumber>PA0048/004/002</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1976-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010963</DrugIDPK>
    <LicenceNumber>PA0048/004/003</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1976-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011015</DrugIDPK>
    <LicenceNumber>PA0048/019/001</LicenceNumber>
    <ProductName>CEFACIDAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011016</DrugIDPK>
    <LicenceNumber>PA0048/019/002</LicenceNumber>
    <ProductName>CEFACIDAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011017</DrugIDPK>
    <LicenceNumber>PA0048/019/003</LicenceNumber>
    <ProductName>CEFACIDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009615</DrugIDPK>
    <LicenceNumber>PA0002/047/003</LicenceNumber>
    <ProductName>CORGARETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009580</DrugIDPK>
    <LicenceNumber>PA0002/032/001</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009618</DrugIDPK>
    <LicenceNumber>PA0002/050/001</LicenceNumber>
    <ProductName>ENGRAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1984-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011053</DrugIDPK>
    <LicenceNumber>PA0048/045/001</LicenceNumber>
    <ProductName>ENKAID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENCAINIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011054</DrugIDPK>
    <LicenceNumber>PA0048/045/002</LicenceNumber>
    <ProductName>ENKAID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENCAINIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009594</DrugIDPK>
    <LicenceNumber>PA0002/036/002</LicenceNumber>
    <ProductName>IPRAL PAEDIATRIC  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011013</DrugIDPK>
    <LicenceNumber>PA0048/017/002</LicenceNumber>
    <ProductName>NEOPLATIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1981-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009496</DrugIDPK>
    <LicenceNumber>PA0002/001/001</LicenceNumber>
    <ProductName>PHOSPHOTEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1975-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PYROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>STANNOUS FLUORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011035</DrugIDPK>
    <LicenceNumber>PA0048/030/001</LicenceNumber>
    <ProductName>PRE-MED CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1983-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>POLYETHYLENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011000</DrugIDPK>
    <LicenceNumber>PA0048/010/005</LicenceNumber>
    <ProductName>STADOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011002</DrugIDPK>
    <LicenceNumber>PA0048/010/006</LicenceNumber>
    <ProductName>STADOL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009617</DrugIDPK>
    <LicenceNumber>PA0002/049/001</LicenceNumber>
    <ProductName>VERDIVITON ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1984-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009599</DrugIDPK>
    <LicenceNumber>PA0007/002/002</LicenceNumber>
    <ProductName>ATROVENT NEBULISER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009600</DrugIDPK>
    <LicenceNumber>PA0007/005/001</LicenceNumber>
    <ProductName>BISOLVOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>OXYTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015191</DrugIDPK>
    <LicenceNumber>PA0098/010/001</LicenceNumber>
    <ProductName>SPIROPENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004537</DrugIDPK>
    <LicenceNumber>PA0179/001/024</LicenceNumber>
    <ProductName>GLUCOSE 5%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011006</DrugIDPK>
    <LicenceNumber>PA0048/012/001</LicenceNumber>
    <ProductName>CEENU</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011007</DrugIDPK>
    <LicenceNumber>PA0048/012/002</LicenceNumber>
    <ProductName>CEENU</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010969</DrugIDPK>
    <LicenceNumber>PA0048/005/005</LicenceNumber>
    <ProductName>HICONCIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010970</DrugIDPK>
    <LicenceNumber>PA0048/005/006</LicenceNumber>
    <ProductName>HICONCIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010964</DrugIDPK>
    <LicenceNumber>PA0048/005/001</LicenceNumber>
    <ProductName>HICONCIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010966</DrugIDPK>
    <LicenceNumber>PA0048/005/003</LicenceNumber>
    <ProductName>HICONCIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010968</DrugIDPK>
    <LicenceNumber>PA0048/005/004</LicenceNumber>
    <ProductName>HICONCIL (SUSPENSION)</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011023</DrugIDPK>
    <LicenceNumber>PA0048/026/001</LicenceNumber>
    <ProductName>KERALYT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011003</DrugIDPK>
    <LicenceNumber>PA0048/011/001</LicenceNumber>
    <ProductName>ZIPIX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XIPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011004</DrugIDPK>
    <LicenceNumber>PA0048/011/002</LicenceNumber>
    <ProductName>ZIPIX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XIPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993006253</DrugIDPK>
    <LicenceNumber>PA0449/002/001</LicenceNumber>
    <ProductName>ELLIMANS UNIVERSAL EMBROCATION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Beecham Group Plc</PAHolder>
    <AuthorisedDate>1987-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012551</DrugIDPK>
    <LicenceNumber>PA0100/036/001</LicenceNumber>
    <ProductName>DIOVOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1985-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012325</DrugIDPK>
    <LicenceNumber>PA0395/013/001</LicenceNumber>
    <ProductName>COD LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Health &amp; Diet Food Company Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COD LIVER OIL</ActiveSubstance>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013452</DrugIDPK>
    <LicenceNumber>PA0252/032/001</LicenceNumber>
    <ProductName>REV UP CAPSULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013454</DrugIDPK>
    <LicenceNumber>PA0257/037/001</LicenceNumber>
    <ProductName>SLIPPERY ELM FOOD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012715</DrugIDPK>
    <LicenceNumber>PA0498/002/001</LicenceNumber>
    <ProductName>SUPERSUN CHILDRENS VITAMIN TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Supersun Nutrition Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012719</DrugIDPK>
    <LicenceNumber>PA0498/007/001</LicenceNumber>
    <ProductName>SUPERSUN VITAMIN B6</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Supersun Nutrition Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012717</DrugIDPK>
    <LicenceNumber>PA0498/004/001</LicenceNumber>
    <ProductName>SUPERSUN VITAMIN E</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Supersun Nutrition Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009922</DrugIDPK>
    <LicenceNumber>PA0012/069/001</LicenceNumber>
    <ProductName>ILOMEDIN IV</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ILOPROST</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012345</DrugIDPK>
    <LicenceNumber>PA0407/008/001</LicenceNumber>
    <ProductName>COPPER OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012973</DrugIDPK>
    <LicenceNumber>PA0118/015/001</LicenceNumber>
    <ProductName>MINIMS HYOSCINE HYDROBROMIDE</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011213</DrugIDPK>
    <LicenceNumber>PA0049/039/001</LicenceNumber>
    <ProductName>NACTON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1984-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLDINE METILSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011215</DrugIDPK>
    <LicenceNumber>PA0049/039/002</LicenceNumber>
    <ProductName>NACTON FORTE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1984-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLDINE METILSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011071</DrugIDPK>
    <LicenceNumber>PA0049/006/010</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011072</DrugIDPK>
    <LicenceNumber>PA0049/006/011</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002488</DrugIDPK>
    <LicenceNumber>PA0049/006/005</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002492</DrugIDPK>
    <LicenceNumber>PA0049/006/009</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011074</DrugIDPK>
    <LicenceNumber>PA0049/006/012</LicenceNumber>
    <ProductName>AMOXIL VIAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011200</DrugIDPK>
    <LicenceNumber>PA0049/035/003</LicenceNumber>
    <ProductName>AUGMENTIN JUNIOR</ProductName>
    <Strength>187</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011201</DrugIDPK>
    <LicenceNumber>PA0049/035/004</LicenceNumber>
    <ProductName>AUGMENTIN JUNIOR</ProductName>
    <Strength>187</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011203</DrugIDPK>
    <LicenceNumber>PA0049/035/008</LicenceNumber>
    <ProductName>AUGMENTIN PAEDIATRIC</ProductName>
    <Strength>78</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1983-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011165</DrugIDPK>
    <LicenceNumber>PA0049/018/009</LicenceNumber>
    <ProductName>FLOXAPEN 125 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011167</DrugIDPK>
    <LicenceNumber>PA0049/018/011</LicenceNumber>
    <ProductName>FLOXAPEN 250 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011173</DrugIDPK>
    <LicenceNumber>PA0049/024/005</LicenceNumber>
    <ProductName>MAXOLON</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012863</DrugIDPK>
    <LicenceNumber>PA0607/001/001</LicenceNumber>
    <ProductName>MENTHODEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bell, Sons &amp; Co. (Druggists)Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011148</DrugIDPK>
    <LicenceNumber>PA0049/011/003</LicenceNumber>
    <ProductName>PYOPEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARBENICILLIN DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011190</DrugIDPK>
    <LicenceNumber>PA0049/031/001</LicenceNumber>
    <ProductName>SUPRAPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011196</DrugIDPK>
    <LicenceNumber>PA0049/031/005</LicenceNumber>
    <ProductName>SUPRAPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011198</DrugIDPK>
    <LicenceNumber>PA0049/031/007</LicenceNumber>
    <ProductName>SUPRAPEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011192</DrugIDPK>
    <LicenceNumber>PA0049/031/002</LicenceNumber>
    <ProductName>SUPRAPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011193</DrugIDPK>
    <LicenceNumber>PA0049/031/003</LicenceNumber>
    <ProductName>SUPRAPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011194</DrugIDPK>
    <LicenceNumber>PA0049/031/004</LicenceNumber>
    <ProductName>SUPRAPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011182</DrugIDPK>
    <LicenceNumber>PA0049/029/005</LicenceNumber>
    <ProductName>TICAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011184</DrugIDPK>
    <LicenceNumber>PA0049/029/007</LicenceNumber>
    <ProductName>TICAR</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1985-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011180</DrugIDPK>
    <LicenceNumber>PA0049/029/004</LicenceNumber>
    <ProductName>TICAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002153</DrugIDPK>
    <LicenceNumber>PA0046/009/004</LicenceNumber>
    <ProductName>PONDOCILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009919</DrugIDPK>
    <LicenceNumber>PA0017/054/004</LicenceNumber>
    <ProductName>SUDAFED S A CAPSULES</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009978</DrugIDPK>
    <LicenceNumber>PA0017/077/003</LicenceNumber>
    <ProductName>SYRAPRIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009979</DrugIDPK>
    <LicenceNumber>PA0017/077/004</LicenceNumber>
    <ProductName>SYRAPRIM PAEDIATRIC SUSPENSION</ProductName>
    <Strength>50/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012873</DrugIDPK>
    <LicenceNumber>PA0700/003/001</LicenceNumber>
    <ProductName>ANDOZAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016040</DrugIDPK>
    <LicenceNumber>PA0224/007/002</LicenceNumber>
    <ProductName>EMTEXATE/METHOTREXATE FREEZE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016041</DrugIDPK>
    <LicenceNumber>PA0224/007/003</LicenceNumber>
    <ProductName>EMTEXATE/METHOTREXATE FREEZE</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016039</DrugIDPK>
    <LicenceNumber>PA0224/007/001</LicenceNumber>
    <ProductName>EMTHEXATE/METHOTREXATE FREEZE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011104</DrugIDPK>
    <LicenceNumber>PA0047/009/006</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011686</DrugIDPK>
    <LicenceNumber>PA0073/041/001</LicenceNumber>
    <ProductName>CALMIGEN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011687</DrugIDPK>
    <LicenceNumber>PA0073/041/002</LicenceNumber>
    <ProductName>CALMIGEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011688</DrugIDPK>
    <LicenceNumber>PA0073/041/003</LicenceNumber>
    <ProductName>CALMIGEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011697</DrugIDPK>
    <LicenceNumber>PA0073/052/001</LicenceNumber>
    <ProductName>DORMIGEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011702</DrugIDPK>
    <LicenceNumber>PA0073/059/001</LicenceNumber>
    <ProductName>FRUSEIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011703</DrugIDPK>
    <LicenceNumber>PA0073/059/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002525</DrugIDPK>
    <LicenceNumber>PA0054/057/002</LicenceNumber>
    <ProductName>LIDAPRIM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1985-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011666</DrugIDPK>
    <LicenceNumber>PA0073/011/001</LicenceNumber>
    <ProductName>NIFURAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011667</DrugIDPK>
    <LicenceNumber>PA0073/011/002</LicenceNumber>
    <ProductName>NIFURAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011668</DrugIDPK>
    <LicenceNumber>PA0073/013/001</LicenceNumber>
    <ProductName>PAEDAFER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011383</DrugIDPK>
    <LicenceNumber>PA0056/015/003</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011384</DrugIDPK>
    <LicenceNumber>PA0056/015/004</LicenceNumber>
    <ProductName>CHLOROMYCETIN OPHTHALMIC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013546</DrugIDPK>
    <LicenceNumber>PA0271/002/001</LicenceNumber>
    <ProductName>ISOKET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000365</DrugIDPK>
    <LicenceNumber>PA0006/036/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009916</DrugIDPK>
    <LicenceNumber>PA0017/044/002</LicenceNumber>
    <ProductName>ANECTINE INJECTION</ProductName>
    <Strength>500/10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009980</DrugIDPK>
    <LicenceNumber>PA0017/079/001</LicenceNumber>
    <ProductName>BANOCIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIETHYLCARBAMAZINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001614</DrugIDPK>
    <LicenceNumber>PA0017/065/001</LicenceNumber>
    <ProductName>ISOPHANE INSULIN B. P.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009984</DrugIDPK>
    <LicenceNumber>PA0017/088/001</LicenceNumber>
    <ProductName>LOASID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1984-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009498</DrugIDPK>
    <LicenceNumber>PA0004/047/001</LicenceNumber>
    <ProductName>NITRO DU 10CM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001613</DrugIDPK>
    <LicenceNumber>PA0017/064/001</LicenceNumber>
    <ProductName>PROTAMINE ZINC INSULIN B.P.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009983</DrugIDPK>
    <LicenceNumber>PA0017/086/002</LicenceNumber>
    <ProductName>PROVENT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1985-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009769</DrugIDPK>
    <LicenceNumber>PA0017/002/004</LicenceNumber>
    <ProductName>SEPTRIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1975-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009907</DrugIDPK>
    <LicenceNumber>PA0017/039/006</LicenceNumber>
    <ProductName>TETANUS ANTITOXIN B P</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009946</DrugIDPK>
    <LicenceNumber>PA0017/062/002</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN B P</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010027</DrugIDPK>
    <LicenceNumber>PA0017/065/002</LicenceNumber>
    <ProductName>WELLCOME BRAND ISOPHANE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010947</DrugIDPK>
    <LicenceNumber>PA0047/062/003</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHOHEXITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010910</DrugIDPK>
    <LicenceNumber>PA0047/044/001</LicenceNumber>
    <ProductName>DIMELOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011512</DrugIDPK>
    <LicenceNumber>PA0057/045/001</LicenceNumber>
    <ProductName>EMLAB BREWERS-YEAST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YEAST DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011513</DrugIDPK>
    <LicenceNumber>PA0057/046/001</LicenceNumber>
    <ProductName>EMLAB IRON &amp; BREWERS-YEAST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YEAST DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010915</DrugIDPK>
    <LicenceNumber>PA0047/046/006</LicenceNumber>
    <ProductName>ONCOVIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1985-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009764</DrugIDPK>
    <LicenceNumber>PA0010/017/001</LicenceNumber>
    <ProductName>PENTRAL 80</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PENTAERITHRITYL TETRANITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010704</DrugIDPK>
    <LicenceNumber>PA0040/007/001</LicenceNumber>
    <ProductName>ROVAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010918</DrugIDPK>
    <LicenceNumber>PA0047/048/001</LicenceNumber>
    <ProductName>VELBE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINBLASTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012673</DrugIDPK>
    <LicenceNumber>PA0468/029/001</LicenceNumber>
    <ProductName>RORCAL-D</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011177</DrugIDPK>
    <LicenceNumber>PA0049/029/002</LicenceNumber>
    <ProductName>TICAR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002261</DrugIDPK>
    <LicenceNumber>PA0047/009/007</LicenceNumber>
    <ProductName>AMYTAL SODIUM</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002262</DrugIDPK>
    <LicenceNumber>PA0047/009/008</LicenceNumber>
    <ProductName>AMYTAL SODIUM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015626</DrugIDPK>
    <LicenceNumber>PA0298/009/001</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015627</DrugIDPK>
    <LicenceNumber>PA0298/009/002</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015624</DrugIDPK>
    <LicenceNumber>PA0298/003/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015623</DrugIDPK>
    <LicenceNumber>PA0298/003/001</LicenceNumber>
    <ProductName>INDOMETHACIN/INDOLONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015625</DrugIDPK>
    <LicenceNumber>PA0298/006/001</LicenceNumber>
    <ProductName>PARACETAMOL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001157</DrugIDPK>
    <LicenceNumber>PA0023/012/001</LicenceNumber>
    <ProductName>REVERIN I.M.</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ROLITETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002263</DrugIDPK>
    <LicenceNumber>PA0047/011/001</LicenceNumber>
    <ProductName>SECONAL SODIUM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SECOBARBITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002264</DrugIDPK>
    <LicenceNumber>PA0047/011/002</LicenceNumber>
    <ProductName>SECONAL SODIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SECOBARBITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004613</DrugIDPK>
    <LicenceNumber>PA0187/005/001</LicenceNumber>
    <ProductName>SOLIVITO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002265</DrugIDPK>
    <LicenceNumber>PA0047/012/001</LicenceNumber>
    <ProductName>TUINAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
      <ActiveSubstance>SECOBARBITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004608</DrugIDPK>
    <LicenceNumber>PA0187/004/001</LicenceNumber>
    <ProductName>VITLIPID ADULT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SOYBEAN OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004610</DrugIDPK>
    <LicenceNumber>PA0187/004/002</LicenceNumber>
    <ProductName>VITLIPID INFANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SOYBEAN OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012754</DrugIDPK>
    <LicenceNumber>PA0508/006/001</LicenceNumber>
    <ProductName>DIPARIM 25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012756</DrugIDPK>
    <LicenceNumber>PA0508/006/002</LicenceNumber>
    <ProductName>DIPARIM 75</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012486</DrugIDPK>
    <LicenceNumber>PA0360/007/001</LicenceNumber>
    <ProductName>ASACOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>1987-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011921</DrugIDPK>
    <LicenceNumber>PA0082/065/001</LicenceNumber>
    <ProductName>DYCALIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011922</DrugIDPK>
    <LicenceNumber>PA0082/065/002</LicenceNumber>
    <ProductName>DYCALIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011923</DrugIDPK>
    <LicenceNumber>PA0082/065/003</LicenceNumber>
    <ProductName>DYCALIN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010858</DrugIDPK>
    <LicenceNumber>PA0046/007/004</LicenceNumber>
    <ProductName>CALVEPEN 333 (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PENICILLIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010857</DrugIDPK>
    <LicenceNumber>PA0046/007/001</LicenceNumber>
    <ProductName>CALVEPEN PAEDIATRIC (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010854</DrugIDPK>
    <LicenceNumber>PA0046/004/011</LicenceNumber>
    <ProductName>FUCIDIN ENTERIC COATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FUSIDATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011111</DrugIDPK>
    <LicenceNumber>PA0047/015/001</LicenceNumber>
    <ProductName>KEFLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALOTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010790</DrugIDPK>
    <LicenceNumber>PA0041/023/001</LicenceNumber>
    <ProductName>MERALEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1979-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUFENAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010994</DrugIDPK>
    <LicenceNumber>PA0046/037/001</LicenceNumber>
    <ProductName>MINIHEP DARTS</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010995</DrugIDPK>
    <LicenceNumber>PA0046/037/002</LicenceNumber>
    <ProductName>MINIHEP DARTS</ProductName>
    <Strength>5000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010786</DrugIDPK>
    <LicenceNumber>PA0041/018/002</LicenceNumber>
    <ProductName>NETHAPRIN DOSPAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAFEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BUFYLLINE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010863</DrugIDPK>
    <LicenceNumber>PA0046/009/002</LicenceNumber>
    <ProductName>PONDOCILLIN</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010864</DrugIDPK>
    <LicenceNumber>PA0046/009/003</LicenceNumber>
    <ProductName>PONDOCILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010856</DrugIDPK>
    <LicenceNumber>PA0046/006/002</LicenceNumber>
    <ProductName>PRESTIM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010787</DrugIDPK>
    <LicenceNumber>PA0041/019/001</LicenceNumber>
    <ProductName>SYNDETTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010869</DrugIDPK>
    <LicenceNumber>PA0046/015/001</LicenceNumber>
    <ProductName>TENAVOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
      <ActiveSubstance>MEPROBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010886</DrugIDPK>
    <LicenceNumber>PA0046/026/001</LicenceNumber>
    <ProductName>TENSANYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RESERPINE</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010728</DrugIDPK>
    <LicenceNumber>PA0045/022/004</LicenceNumber>
    <ProductName>NIZORAL OVULES</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1985-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>KETOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010843</DrugIDPK>
    <LicenceNumber>PA0045/029/003</LicenceNumber>
    <ProductName>SUFENTA FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUFENTANIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011001</DrugIDPK>
    <LicenceNumber>PA0046/045/001</LicenceNumber>
    <ProductName>MINIHEP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000976</DrugIDPK>
    <LicenceNumber>PA0148/033/001</LicenceNumber>
    <ProductName>HERLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IDOXURIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009536</DrugIDPK>
    <LicenceNumber>PA0002/014/006</LicenceNumber>
    <ProductName>VELOSEF   INJECTION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009534</DrugIDPK>
    <LicenceNumber>PA0002/014/005</LicenceNumber>
    <ProductName>VELOSEF  INJECTION</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009538</DrugIDPK>
    <LicenceNumber>PA0002/014/007</LicenceNumber>
    <ProductName>VELOSEF  INJECTION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011332</DrugIDPK>
    <LicenceNumber>PA0051/056/001</LicenceNumber>
    <ProductName>DIPRIVAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011319</DrugIDPK>
    <LicenceNumber>PA0051/032/002</LicenceNumber>
    <ProductName>FLUOTHANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011320</DrugIDPK>
    <LicenceNumber>PA0051/033/001</LicenceNumber>
    <ProductName>TRILENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRICHLOROETHYLENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010010</DrugIDPK>
    <LicenceNumber>PA0018/022/002</LicenceNumber>
    <ProductName>LOMODEX 40 IN DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010009</DrugIDPK>
    <LicenceNumber>PA0018/022/001</LicenceNumber>
    <ProductName>LOMODEX 40 IN SALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010012</DrugIDPK>
    <LicenceNumber>PA0018/023/002</LicenceNumber>
    <ProductName>LOMODEX 70 IN DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010011</DrugIDPK>
    <LicenceNumber>PA0018/023/001</LicenceNumber>
    <ProductName>LOMODEX 70 IN SALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009524</DrugIDPK>
    <LicenceNumber>PA0006/003/002</LicenceNumber>
    <ProductName>CIDOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICRONOMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010263</DrugIDPK>
    <LicenceNumber>PA0032/004/001</LicenceNumber>
    <ProductName>GENTICIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010807</DrugIDPK>
    <LicenceNumber>PA0041/046/001</LicenceNumber>
    <ProductName>SELDANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERFENADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012274</DrugIDPK>
    <LicenceNumber>PA0302/008/001</LicenceNumber>
    <ProductName>D.D.D.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012758</DrugIDPK>
    <LicenceNumber>PA0516/001/001</LicenceNumber>
    <ProductName>PENELAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009687</DrugIDPK>
    <LicenceNumber>PA0009/048/001</LicenceNumber>
    <ProductName>BAMBEC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BAMBUTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009689</DrugIDPK>
    <LicenceNumber>PA0009/048/002</LicenceNumber>
    <ProductName>BAMBEC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BAMBUTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010957</DrugIDPK>
    <LicenceNumber>PA0048/001/011</LicenceNumber>
    <ProductName>SOTACOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009776</DrugIDPK>
    <LicenceNumber>PA0010/022/004</LicenceNumber>
    <ProductName>ALBUMINAR 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009779</DrugIDPK>
    <LicenceNumber>PA0010/022/007</LicenceNumber>
    <ProductName>ALBUMINAR 25</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010306</DrugIDPK>
    <LicenceNumber>PA0032/040/001</LicenceNumber>
    <ProductName>PRO-PLUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009512</DrugIDPK>
    <LicenceNumber>PA0002/008/001</LicenceNumber>
    <ProductName>GRANEODIN</ProductName>
    <Strength>3.6</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010971</DrugIDPK>
    <LicenceNumber>PA0048/006/001</LicenceNumber>
    <ProductName>KANFOTREX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KANAMYCIN</ActiveSubstance>
      <ActiveSubstance>AMFOMYCIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009516</DrugIDPK>
    <LicenceNumber>PA0002/010/002</LicenceNumber>
    <ProductName>KENACORT A WITH GRANEODIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011020</DrugIDPK>
    <LicenceNumber>PA0048/024/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009510</DrugIDPK>
    <LicenceNumber>PA0002/007/008</LicenceNumber>
    <ProductName>MYCOSTATIN  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009507</DrugIDPK>
    <LicenceNumber>PA0002/007/006</LicenceNumber>
    <ProductName>MYCOSTATIN DUSTING POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009505</DrugIDPK>
    <LicenceNumber>PA0002/007/005</LicenceNumber>
    <ProductName>MYCOSTATIN E.V.T.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010975</DrugIDPK>
    <LicenceNumber>PA0048/008/001</LicenceNumber>
    <ProductName>PALITREX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010976</DrugIDPK>
    <LicenceNumber>PA0048/008/002</LicenceNumber>
    <ProductName>PALITREX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010977</DrugIDPK>
    <LicenceNumber>PA0048/008/003</LicenceNumber>
    <ProductName>PALITREX (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010978</DrugIDPK>
    <LicenceNumber>PA0048/008/004</LicenceNumber>
    <ProductName>PALITREX (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010979</DrugIDPK>
    <LicenceNumber>PA0048/008/005</LicenceNumber>
    <ProductName>PALITREX (SUSPENSION)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010981</DrugIDPK>
    <LicenceNumber>PA0048/008/006</LicenceNumber>
    <ProductName>PALITREX PAEDIATRIC DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010982</DrugIDPK>
    <LicenceNumber>PA0048/009/001</LicenceNumber>
    <ProductName>PENTREXYL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010984</DrugIDPK>
    <LicenceNumber>PA0048/009/002</LicenceNumber>
    <ProductName>PENTREXYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010986</DrugIDPK>
    <LicenceNumber>PA0048/009/003</LicenceNumber>
    <ProductName>PENTREXYL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010987</DrugIDPK>
    <LicenceNumber>PA0048/009/004</LicenceNumber>
    <ProductName>PENTREXYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010989</DrugIDPK>
    <LicenceNumber>PA0048/009/005</LicenceNumber>
    <ProductName>PENTREXYL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010991</DrugIDPK>
    <LicenceNumber>PA0048/009/006</LicenceNumber>
    <ProductName>PENTREXYL (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010992</DrugIDPK>
    <LicenceNumber>PA0048/009/007</LicenceNumber>
    <ProductName>PENTREXYL PAEDIATRIC DROPS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015631</DrugIDPK>
    <LicenceNumber>PA0299/007/001</LicenceNumber>
    <ProductName>SECRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012534</DrugIDPK>
    <LicenceNumber>PA0429/005/001</LicenceNumber>
    <ProductName>FINALGON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Windsor Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONIVAMIDE</ActiveSubstance>
      <ActiveSubstance>BUTOXYETHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013406</DrugIDPK>
    <LicenceNumber>PA0167/069/010</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013407</DrugIDPK>
    <LicenceNumber>PA0167/069/011</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013404</DrugIDPK>
    <LicenceNumber>PA0167/069/009</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1988-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013396</DrugIDPK>
    <LicenceNumber>PA0167/069/001</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013398</DrugIDPK>
    <LicenceNumber>PA0167/069/002</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013399</DrugIDPK>
    <LicenceNumber>PA0167/069/003</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012346</DrugIDPK>
    <LicenceNumber>PA0408/007/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012347</DrugIDPK>
    <LicenceNumber>PA0408/007/003</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012359</DrugIDPK>
    <LicenceNumber>PA0408/044/005</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>20.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012356</DrugIDPK>
    <LicenceNumber>PA0408/044/003</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012357</DrugIDPK>
    <LicenceNumber>PA0408/044/004</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012354</DrugIDPK>
    <LicenceNumber>PA0408/044/002</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012352</DrugIDPK>
    <LicenceNumber>PA0408/044/001</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012369</DrugIDPK>
    <LicenceNumber>PA0408/048/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012371</DrugIDPK>
    <LicenceNumber>PA0408/048/002</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013648</DrugIDPK>
    <LicenceNumber>PA0172/015/001</LicenceNumber>
    <ProductName>FIBROSINE ANALGESIC BALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>GLYCOL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>HISTAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012367</DrugIDPK>
    <LicenceNumber>PA0408/046/002</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012365</DrugIDPK>
    <LicenceNumber>PA0408/046/001</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012360</DrugIDPK>
    <LicenceNumber>PA0408/045/001</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012362</DrugIDPK>
    <LicenceNumber>PA0408/045/002</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012363</DrugIDPK>
    <LicenceNumber>PA0408/045/003</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011208</DrugIDPK>
    <LicenceNumber>PA0050/065/002</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012348</DrugIDPK>
    <LicenceNumber>PA0408/043/001</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012349</DrugIDPK>
    <LicenceNumber>PA0408/043/002</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012350</DrugIDPK>
    <LicenceNumber>PA0408/043/003</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009547</DrugIDPK>
    <LicenceNumber>PA0006/011/005</LicenceNumber>
    <ProductName>SOFRAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009971</DrugIDPK>
    <LicenceNumber>PA0016/010/001</LicenceNumber>
    <ProductName>MYCIFRADIN SULPHATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013753</DrugIDPK>
    <LicenceNumber>PA0176/032/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013754</DrugIDPK>
    <LicenceNumber>PA0176/032/002</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013755</DrugIDPK>
    <LicenceNumber>PA0176/032/003</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013517</DrugIDPK>
    <LicenceNumber>PA0176/064/002</LicenceNumber>
    <ProductName>ATEBOLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013496</DrugIDPK>
    <LicenceNumber>PA0176/064/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013467</DrugIDPK>
    <LicenceNumber>PA0176/054/001</LicenceNumber>
    <ProductName>CO-CODAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013531</DrugIDPK>
    <LicenceNumber>PA0176/069/001</LicenceNumber>
    <ProductName>METOPROLOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013532</DrugIDPK>
    <LicenceNumber>PA0176/069/002</LicenceNumber>
    <ProductName>METOPROLOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013490</DrugIDPK>
    <LicenceNumber>PA0176/062/001</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013492</DrugIDPK>
    <LicenceNumber>PA0176/062/002</LicenceNumber>
    <ProductName>OXAZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1992-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013655</DrugIDPK>
    <LicenceNumber>PA0176/004/001</LicenceNumber>
    <ProductName>TETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1981-05-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012313</DrugIDPK>
    <LicenceNumber>PA0303/015/001</LicenceNumber>
    <ProductName>DUOBACT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012301</DrugIDPK>
    <LicenceNumber>PA0303/007/001</LicenceNumber>
    <ProductName>HYPERPAX-L</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1981-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012302</DrugIDPK>
    <LicenceNumber>PA0303/007/002</LicenceNumber>
    <ProductName>HYPERPAX-L</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012314</DrugIDPK>
    <LicenceNumber>PA0303/015/002</LicenceNumber>
    <ProductName>ORIBACT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012845</DrugIDPK>
    <LicenceNumber>PA0552/007/001</LicenceNumber>
    <ProductName>DOUBLE-STRENGTH SEIDLITZ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Superpac Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009632</DrugIDPK>
    <LicenceNumber>PA0004/007/001</LicenceNumber>
    <ProductName>OCUSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011106</DrugIDPK>
    <LicenceNumber>PA0047/009/010</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013682</DrugIDPK>
    <LicenceNumber>PA0200/005/001</LicenceNumber>
    <ProductName>BRETYLOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1988-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BRETYLIUM TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012651</DrugIDPK>
    <LicenceNumber>PA0447/004/004</LicenceNumber>
    <ProductName>ILOSONE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ESTOLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011124</DrugIDPK>
    <LicenceNumber>PA0047/021/001</LicenceNumber>
    <ProductName>KEFZOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011125</DrugIDPK>
    <LicenceNumber>PA0047/021/002</LicenceNumber>
    <ProductName>KEFZOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004928</DrugIDPK>
    <LicenceNumber>PA0229/001/001</LicenceNumber>
    <ProductName>VERICAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cuxson Gerrard &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1976-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011385</DrugIDPK>
    <LicenceNumber>PA0056/017/001</LicenceNumber>
    <ProductName>BENAFED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009579</DrugIDPK>
    <LicenceNumber>PA0006/029/002</LicenceNumber>
    <ProductName>CO TRIMOXAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009581</DrugIDPK>
    <LicenceNumber>PA0006/029/003</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <Strength>100/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009584</DrugIDPK>
    <LicenceNumber>PA0006/029/004</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <Strength>800/160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009577</DrugIDPK>
    <LicenceNumber>PA0006/029/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE DISPERSIBLE TABLETS B.P.</ProductName>
    <Strength>400/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011555</DrugIDPK>
    <LicenceNumber>PA0059/037/001</LicenceNumber>
    <ProductName>IMUNOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THYMOPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011556</DrugIDPK>
    <LicenceNumber>PA0059/037/002</LicenceNumber>
    <ProductName>IMUNOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THYMOPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001797</DrugIDPK>
    <LicenceNumber>PA0116/002/003</LicenceNumber>
    <ProductName>ELANOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Corporation Plc</PAHolder>
    <AuthorisedDate>1983-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012293</DrugIDPK>
    <LicenceNumber>PPA0384/002/001</LicenceNumber>
    <ProductName>VENTOLIN METERED DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>1985-07-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012675</DrugIDPK>
    <LicenceNumber>PA0473/003/005</LicenceNumber>
    <ProductName>ZEPHOLIN GRANULATE 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012676</DrugIDPK>
    <LicenceNumber>PA0473/003/006</LicenceNumber>
    <ProductName>ZEPHOLIN GRANULATE 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012677</DrugIDPK>
    <LicenceNumber>PA0473/003/007</LicenceNumber>
    <ProductName>ZEPHOLIN GRANULATE 350</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012678</DrugIDPK>
    <LicenceNumber>PA0473/003/008</LicenceNumber>
    <ProductName>ZEPHOLIN GRANULATE 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013148</DrugIDPK>
    <LicenceNumber>PA0141/021/001</LicenceNumber>
    <ProductName>GERI-OPTIOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIGITALIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013125</DrugIDPK>
    <LicenceNumber>PA0141/008/001</LicenceNumber>
    <ProductName>TFT OPHTIOLE EYE DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1978-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010378</DrugIDPK>
    <LicenceNumber>PA0035/034/002</LicenceNumber>
    <ProductName>BIAVAX II VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1984-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RUBELLAVIRUS</ActiveSubstance>
      <ActiveSubstance>MUMPS VACCINE (LIVE ATTENUATED)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010352</DrugIDPK>
    <LicenceNumber>PA0035/004/004</LicenceNumber>
    <ProductName>CLINORIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1981-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULINDAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010353</DrugIDPK>
    <LicenceNumber>PA0035/004/005</LicenceNumber>
    <ProductName>CLINORIL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULINDAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010365</DrugIDPK>
    <LicenceNumber>PA0035/015/001</LicenceNumber>
    <ProductName>CODELSOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010409</DrugIDPK>
    <LicenceNumber>PA0035/058/004</LicenceNumber>
    <ProductName>H-B-VAX HEPATITIS B VACCINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1985-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010348</DrugIDPK>
    <LicenceNumber>PA0035/003/008</LicenceNumber>
    <ProductName>INDOCID INTRA-MUSCULAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010349</DrugIDPK>
    <LicenceNumber>PA0035/003/009</LicenceNumber>
    <ProductName>INDOCID INTRA-MUSCULAR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010347</DrugIDPK>
    <LicenceNumber>PA0035/003/007</LicenceNumber>
    <ProductName>INDOCID-R</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009509</DrugIDPK>
    <LicenceNumber>PA0004/050/002</LicenceNumber>
    <ProductName>MANOPLAX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLOSEQUINAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010383</DrugIDPK>
    <LicenceNumber>PA0035/038/001</LicenceNumber>
    <ProductName>M-M-VAX (SINGLE DOSE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>MUMPS VACCINE (LIVE ATTENUATED)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010380</DrugIDPK>
    <LicenceNumber>PA0035/036/002</LicenceNumber>
    <ProductName>M-R-VAX II VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1984-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013802</DrugIDPK>
    <LicenceNumber>PA0281/016/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010367</DrugIDPK>
    <LicenceNumber>PA0035/016/005</LicenceNumber>
    <ProductName>DECADRON EAR/EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010368</DrugIDPK>
    <LicenceNumber>PA0035/016/006</LicenceNumber>
    <ProductName>DECADRON EYE/EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010373</DrugIDPK>
    <LicenceNumber>PA0035/021/004</LicenceNumber>
    <ProductName>HYDROCORTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010526</DrugIDPK>
    <LicenceNumber>PA0023/051/001</LicenceNumber>
    <ProductName>CRYPTOCUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1987-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GONADORELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013503</DrugIDPK>
    <LicenceNumber>PA0258/028/001</LicenceNumber>
    <ProductName>BABY MELTUS LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013486</DrugIDPK>
    <LicenceNumber>PA0258/017/003</LicenceNumber>
    <ProductName>KAO-C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013481</DrugIDPK>
    <LicenceNumber>PA0258/015/002</LicenceNumber>
    <ProductName>Q-PANOL PARACETAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013483</DrugIDPK>
    <LicenceNumber>PA0258/016/001</LicenceNumber>
    <ProductName>WAX AID EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009753</DrugIDPK>
    <LicenceNumber>PA0010/008/003</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009754</DrugIDPK>
    <LicenceNumber>PA0010/008/004</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013553</DrugIDPK>
    <LicenceNumber>PA0179/001/021</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013554</DrugIDPK>
    <LicenceNumber>PA0179/001/022</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013556</DrugIDPK>
    <LicenceNumber>PA0179/001/023</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010282</DrugIDPK>
    <LicenceNumber>PA0022/010/004</LicenceNumber>
    <ProductName>SPARINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMAZINE</ActiveSubstance>
      <ActiveSubstance>PROMAZINE EMBONATE</ActiveSubstance>
      <ActiveSubstance>PROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010280</DrugIDPK>
    <LicenceNumber>PA0022/010/003</LicenceNumber>
    <ProductName>SPARINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMAZINE</ActiveSubstance>
      <ActiveSubstance>PROMAZINE EMBONATE</ActiveSubstance>
      <ActiveSubstance>PROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010284</DrugIDPK>
    <LicenceNumber>PA0022/010/005</LicenceNumber>
    <ProductName>SPARINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROMAZINE</ActiveSubstance>
      <ActiveSubstance>PROMAZINE EMBONATE</ActiveSubstance>
      <ActiveSubstance>PROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013252</DrugIDPK>
    <LicenceNumber>PA0167/002/002</LicenceNumber>
    <ProductName>SYNTHAMIN 14</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013255</DrugIDPK>
    <LicenceNumber>PA0167/002/005</LicenceNumber>
    <ProductName>SYNTHAMIN 14</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013258</DrugIDPK>
    <LicenceNumber>PA0167/002/008</LicenceNumber>
    <ProductName>SYNTHAMIN 14</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013259</DrugIDPK>
    <LicenceNumber>PA0167/002/009</LicenceNumber>
    <ProductName>SYNTHAMIN 17</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013256</DrugIDPK>
    <LicenceNumber>PA0167/002/006</LicenceNumber>
    <ProductName>SYNTHAMIN 17</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013253</DrugIDPK>
    <LicenceNumber>PA0167/002/003</LicenceNumber>
    <ProductName>SYNTHAMIN 17</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013254</DrugIDPK>
    <LicenceNumber>PA0167/002/004</LicenceNumber>
    <ProductName>SYNTHAMIN 9</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013257</DrugIDPK>
    <LicenceNumber>PA0167/002/007</LicenceNumber>
    <ProductName>SYNTHAMIN 9</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013251</DrugIDPK>
    <LicenceNumber>PA0167/002/001</LicenceNumber>
    <ProductName>SYNTHAMIN 9</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1977-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003442</DrugIDPK>
    <LicenceNumber>PA0079/017/001</LicenceNumber>
    <ProductName>KONYNE H.T.</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003443</DrugIDPK>
    <LicenceNumber>PA0079/017/002</LicenceNumber>
    <ProductName>KONYNE H.T.</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010674</DrugIDPK>
    <LicenceNumber>PA0045/002/006</LicenceNumber>
    <ProductName>GYNO-DAKTARIN</ProductName>
    <Strength>78</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010675</DrugIDPK>
    <LicenceNumber>PA0045/002/007</LicenceNumber>
    <ProductName>GYNO-DAKTARIN DISPOSABLE</ProductName>
    <Strength>78</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010689</DrugIDPK>
    <LicenceNumber>PA0045/005/008</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1979-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010729</DrugIDPK>
    <LicenceNumber>PA0045/024/001</LicenceNumber>
    <ProductName>HYPNOMIDATE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETOMIDATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010730</DrugIDPK>
    <LicenceNumber>PA0045/024/002</LicenceNumber>
    <ProductName>HYPNOMIDATE PRO-INFUSION</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETOMIDATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012111</DrugIDPK>
    <LicenceNumber>PA0365/009/002</LicenceNumber>
    <ProductName>MEVILIN - L 10 SINGLE DOSE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012112</DrugIDPK>
    <LicenceNumber>PA0365/009/003</LicenceNumber>
    <ProductName>MEVILIN - L 50 DOSE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012109</DrugIDPK>
    <LicenceNumber>PA0365/009/001</LicenceNumber>
    <ProductName>MEVILIN - L SINGLE DOSE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010515</DrugIDPK>
    <LicenceNumber>PA0023/033/001</LicenceNumber>
    <ProductName>PENICILLIN G HOECHST</ProductName>
    <Strength>500,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZYL-PENICILLINATE-OXYTITANIQUE</ActiveSubstance>
      <ActiveSubstance>NA-SALT AV 4,4-DIOXI-3,3 DIAMINO-ARSENOBENSOLDIMETHYLENDISUF.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010506</DrugIDPK>
    <LicenceNumber>PA0023/029/001</LicenceNumber>
    <ProductName>STREPTASE</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>STREPTOKINASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012877</DrugIDPK>
    <LicenceNumber>PA0100/002/001</LicenceNumber>
    <ProductName>MEGACLOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMOCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009548</DrugIDPK>
    <LicenceNumber>PA0006/011/006</LicenceNumber>
    <ProductName>SOFRAMYCIN NEBULISER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN SULFATE</ActiveSubstance>
      <ActiveSubstance>GRAMICIDIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011720</DrugIDPK>
    <LicenceNumber>PA0073/085/001</LicenceNumber>
    <ProductName>SULPHADIMIDINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1986-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000885</DrugIDPK>
    <LicenceNumber>PA0019/035/001</LicenceNumber>
    <ProductName>CARDIOVAR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1986-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000886</DrugIDPK>
    <LicenceNumber>PA0019/035/002</LicenceNumber>
    <ProductName>CARDIOVAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1986-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000887</DrugIDPK>
    <LicenceNumber>PA0019/035/003</LicenceNumber>
    <ProductName>CARDIOVAR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1982-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011721</DrugIDPK>
    <LicenceNumber>PA0073/087/001</LicenceNumber>
    <ProductName>CETRAM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1987-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001165</DrugIDPK>
    <LicenceNumber>PA0023/013/002</LicenceNumber>
    <ProductName>HOSTACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011906</DrugIDPK>
    <LicenceNumber>PA0082/047/001</LicenceNumber>
    <ProductName>PEVIDINE ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011908</DrugIDPK>
    <LicenceNumber>PA0082/047/002</LicenceNumber>
    <ProductName>PEVIDINE SURGICAL SCRUB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012312</DrugIDPK>
    <LicenceNumber>PA0303/014/003</LicenceNumber>
    <ProductName>TRICANIX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Electramed Ireland Limited</PAHolder>
    <AuthorisedDate>1987-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TINIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012842</DrugIDPK>
    <LicenceNumber>PA0548/001/002</LicenceNumber>
    <ProductName>AC-FEN-GS 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>ac-Pharma AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012843</DrugIDPK>
    <LicenceNumber>PA0548/001/003</LicenceNumber>
    <ProductName>AC-FEN-GS 400</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>ac-Pharma AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012844</DrugIDPK>
    <LicenceNumber>PA0548/001/004</LicenceNumber>
    <ProductName>AC-FEN-GS 600</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>ac-Pharma AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012290</DrugIDPK>
    <LicenceNumber>PA0382/003/001</LicenceNumber>
    <ProductName>CISPLATINUM LYOPHILISED</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012291</DrugIDPK>
    <LicenceNumber>PA0382/003/002</LicenceNumber>
    <ProductName>CISPLATINUM LYOPHILISED</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1985-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011370</DrugIDPK>
    <LicenceNumber>PA0054/077/001</LicenceNumber>
    <ProductName>EMCORETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012289</DrugIDPK>
    <LicenceNumber>PA0382/002/001</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>1985-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013603</DrugIDPK>
    <LicenceNumber>PA0167/079/004</LicenceNumber>
    <ProductName>GAMMAGARD S/D</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GAMMA GLOBULIN</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1992-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002304</DrugIDPK>
    <LicenceNumber>PA0360/005/001</LicenceNumber>
    <ProductName>CYSTRIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011509</DrugIDPK>
    <LicenceNumber>PA0060/016/012</LicenceNumber>
    <ProductName>STELAZINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013434</DrugIDPK>
    <LicenceNumber>PA0255/034/001</LicenceNumber>
    <ProductName>GENTAMICIN SULFATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003461</DrugIDPK>
    <LicenceNumber>PA0082/026/001</LicenceNumber>
    <ProductName>SILBE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012757</DrugIDPK>
    <LicenceNumber>PA0512/002/001</LicenceNumber>
    <ProductName>LIOTON 1000</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A. Menarini Industrie Farmaceutische Riunite S.r.l.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012975</DrugIDPK>
    <LicenceNumber>PA0118/021/001</LicenceNumber>
    <ProductName>MINIMS SULPHACETAMIDE SODIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013150</DrugIDPK>
    <LicenceNumber>PA0129/003/001</LicenceNumber>
    <ProductName>PARDALE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cahill-May Roberts Limited</PAHolder>
    <AuthorisedDate>1978-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011240</DrugIDPK>
    <LicenceNumber>PA0050/017/004</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011241</DrugIDPK>
    <LicenceNumber>PA0050/017/005</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011242</DrugIDPK>
    <LicenceNumber>PA0050/017/008</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012937</DrugIDPK>
    <LicenceNumber>PA0118/007/001</LicenceNumber>
    <ProductName>WELLDORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICHLORALPHENAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012938</DrugIDPK>
    <LicenceNumber>PA0118/007/002</LicenceNumber>
    <ProductName>WELLDORM ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DICHLORALPHENAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013859</DrugIDPK>
    <LicenceNumber>PA0282/044/002</LicenceNumber>
    <ProductName>BETAMETHASONE VALERATE</ProductName>
    <Strength>0.1%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013858</DrugIDPK>
    <LicenceNumber>PA0282/044/001</LicenceNumber>
    <ProductName>BETAMETHASONE VALERATE B P</ProductName>
    <Strength>0.1%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013855</DrugIDPK>
    <LicenceNumber>PA0282/031/003</LicenceNumber>
    <ProductName>SALBUTAMOL B P</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013856</DrugIDPK>
    <LicenceNumber>PA0282/031/004</LicenceNumber>
    <ProductName>SALBUTAMOL B P</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012860</DrugIDPK>
    <LicenceNumber>PA0582/009/001</LicenceNumber>
    <ProductName>TANDERIL-CHLORAMPHENICOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010645</DrugIDPK>
    <LicenceNumber>PA0044/065/002</LicenceNumber>
    <ProductName>ROTAHALER - BECOTIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010639</DrugIDPK>
    <LicenceNumber>PA0044/065/001</LicenceNumber>
    <ProductName>ROTAHALER &amp; ROTAHALER BOX VENTOLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013158</DrugIDPK>
    <LicenceNumber>PA0129/002/001</LicenceNumber>
    <ProductName>BUDALE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dales Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013783</DrugIDPK>
    <LicenceNumber>PA0279/002/001</LicenceNumber>
    <ProductName>FENNINGS GRIPE MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fenning Pharmaceuticals</PAHolder>
    <AuthorisedDate>1980-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013157</DrugIDPK>
    <LicenceNumber>PA0129/001/001</LicenceNumber>
    <ProductName>INOLAXINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dales Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012263</DrugIDPK>
    <LicenceNumber>PA0379/001/003</LicenceNumber>
    <ProductName>NIGHT NURSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1987-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011484</DrugIDPK>
    <LicenceNumber>PA0062/001/004</LicenceNumber>
    <ProductName>CYCLOSPASMOL DISPERSIBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011503</DrugIDPK>
    <LicenceNumber>PA0062/007/001</LicenceNumber>
    <ProductName>PIMAFUCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011554</DrugIDPK>
    <LicenceNumber>PA0062/007/006</LicenceNumber>
    <ProductName>PIMAFUCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011518</DrugIDPK>
    <LicenceNumber>PA0062/007/003</LicenceNumber>
    <ProductName>PIMAFUCIN (SUSPENSION)</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011519</DrugIDPK>
    <LicenceNumber>PA0062/007/004</LicenceNumber>
    <ProductName>PIMAFUCIN (SUSPENSION)</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011520</DrugIDPK>
    <LicenceNumber>PA0062/007/005</LicenceNumber>
    <ProductName>PIMAFUCIN EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011506</DrugIDPK>
    <LicenceNumber>PA0062/0007/00</LicenceNumber>
    <ProductName>PIMAFUCIN VAGINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011517</DrugIDPK>
    <LicenceNumber>PA0062/007/002</LicenceNumber>
    <ProductName>PIMAFUCIN VAGINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011494</DrugIDPK>
    <LicenceNumber>PA0062/006/002</LicenceNumber>
    <ProductName>VENDARCIN</ProductName>
    <Strength>100/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011502</DrugIDPK>
    <LicenceNumber>PA0062/006/005</LicenceNumber>
    <ProductName>VENDARCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011497</DrugIDPK>
    <LicenceNumber>PA0062/006/003</LicenceNumber>
    <ProductName>VENDARCIN</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011499</DrugIDPK>
    <LicenceNumber>PA0062/006/004</LicenceNumber>
    <ProductName>VENDARCIN</ProductName>
    <Strength>250/3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012285</DrugIDPK>
    <LicenceNumber>PA0379/027/002</LicenceNumber>
    <ProductName>AQUAFRESH MILD &amp; MINTY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012284</DrugIDPK>
    <LicenceNumber>PA0379/027/001</LicenceNumber>
    <ProductName>AQUAFRESH ORIGINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013299</DrugIDPK>
    <LicenceNumber>PA0167/010/007</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013325</DrugIDPK>
    <LicenceNumber>PA0167/010/006</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C 0.02% FOR IRRIGATION</ProductName>
    <Strength>100 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-03-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012286</DrugIDPK>
    <LicenceNumber>PA0379/028/001</LicenceNumber>
    <ProductName>MACLEANS ACTIVE MOUTHGUARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012288</DrugIDPK>
    <LicenceNumber>PA0379/029/002</LicenceNumber>
    <ProductName>MACLEANS FRESHMINT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012287</DrugIDPK>
    <LicenceNumber>PA0379/029/001</LicenceNumber>
    <ProductName>MACLEANS MILDMINT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013040</DrugIDPK>
    <LicenceNumber>PA0137/015/001</LicenceNumber>
    <ProductName>MEGACILLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLEMIZOLE PENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013041</DrugIDPK>
    <LicenceNumber>PA0137/015/002</LicenceNumber>
    <ProductName>MEGACILLIN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLEMIZOLE PENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013105</DrugIDPK>
    <LicenceNumber>PA0137/050/001</LicenceNumber>
    <ProductName>NEURO-GRUNOVIT DRAGEES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013307</DrugIDPK>
    <LicenceNumber>PA0167/012/003</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V FOR IRRIGATION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013109</DrugIDPK>
    <LicenceNumber>PA0137/052/001</LicenceNumber>
    <ProductName>ULTRA-GRUNOVIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012495</DrugIDPK>
    <LicenceNumber>PA0100/008/001</LicenceNumber>
    <ProductName>CANDEPTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012496</DrugIDPK>
    <LicenceNumber>PA0100/008/002</LicenceNumber>
    <ProductName>CANDEPTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012876</DrugIDPK>
    <LicenceNumber>PA0100/001/006</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012538</DrugIDPK>
    <LicenceNumber>PA0100/024/001</LicenceNumber>
    <ProductName>HAYMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1980-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012507</DrugIDPK>
    <LicenceNumber>PA0100/014/001</LicenceNumber>
    <ProductName>MEDI-SACHE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1978-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012558</DrugIDPK>
    <LicenceNumber>PA0100/038/002</LicenceNumber>
    <ProductName>MORFLIN</ProductName>
    <Strength>2/ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012497</DrugIDPK>
    <LicenceNumber>PA0100/009/001</LicenceNumber>
    <ProductName>RUBELIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012542</DrugIDPK>
    <LicenceNumber>PA0100/032/001</LicenceNumber>
    <ProductName>SUSTAC LA</ProductName>
    <Strength>2.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012543</DrugIDPK>
    <LicenceNumber>PA0100/032/002</LicenceNumber>
    <ProductName>SUSTAC LA</ProductName>
    <Strength>6.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012544</DrugIDPK>
    <LicenceNumber>PA0100/032/003</LicenceNumber>
    <ProductName>SUSTAC LA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011272</DrugIDPK>
    <LicenceNumber>PA0050/017/009</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011274</DrugIDPK>
    <LicenceNumber>PA0050/017/010</LicenceNumber>
    <ProductName>VALIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010431</DrugIDPK>
    <LicenceNumber>PA0024/013/001</LicenceNumber>
    <ProductName>EUDENINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013341</DrugIDPK>
    <LicenceNumber>PA0254/001/001</LicenceNumber>
    <ProductName>MAWS BABY CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013695</DrugIDPK>
    <LicenceNumber>PA0206/007/002</LicenceNumber>
    <ProductName>MERVAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALCLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013350</DrugIDPK>
    <LicenceNumber>PA0254/008/001</LicenceNumber>
    <ProductName>BRONCHIPAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013347</DrugIDPK>
    <LicenceNumber>PA0254/005/001</LicenceNumber>
    <ProductName>KRUSCHEN SALTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013351</DrugIDPK>
    <LicenceNumber>PA0254/009/001</LicenceNumber>
    <ProductName>LANTIGEN B LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013342</DrugIDPK>
    <LicenceNumber>PA0254/001/002</LicenceNumber>
    <ProductName>MAWS COLD SORE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013343</DrugIDPK>
    <LicenceNumber>PA0254/001/003</LicenceNumber>
    <ProductName>MAWS GOLDEN EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013345</DrugIDPK>
    <LicenceNumber>PA0254/003/001</LicenceNumber>
    <ProductName>PERSOMNIA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013349</DrugIDPK>
    <LicenceNumber>PA0254/007/002</LicenceNumber>
    <ProductName>TEST-SIXTY LOZENGES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate>1996-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFURIC ACID</ActiveSubstance>
      <ActiveSubstance>SULFURIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011800</DrugIDPK>
    <LicenceNumber>PA0080/005/006</LicenceNumber>
    <ProductName>ETOPHYLATE CHILDREN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011801</DrugIDPK>
    <LicenceNumber>PA0080/005/007</LicenceNumber>
    <ProductName>ETOPHYLATE FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011796</DrugIDPK>
    <LicenceNumber>PA0080/005/003</LicenceNumber>
    <ProductName>ETOPHYLATE FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011791</DrugIDPK>
    <LicenceNumber>PA0080/003/001</LicenceNumber>
    <ProductName>KIDITARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>QUINIDINE BISULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011813</DrugIDPK>
    <LicenceNumber>PA0082/007/003</LicenceNumber>
    <ProductName>BERKMYCEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011293</DrugIDPK>
    <LicenceNumber>PA0051/014/003</LicenceNumber>
    <ProductName>CEPTON CLENSING MILK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1979-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012007</DrugIDPK>
    <LicenceNumber>PA0086/026/001</LicenceNumber>
    <ProductName>GASTRESE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1987-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011910</DrugIDPK>
    <LicenceNumber>PA0082/048/001</LicenceNumber>
    <ProductName>K-SALT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010709</DrugIDPK>
    <LicenceNumber>PA0045/009/002</LicenceNumber>
    <ProductName>ORAP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1982-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIMOZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011898</DrugIDPK>
    <LicenceNumber>PA0082/037/003</LicenceNumber>
    <ProductName>OXY WASH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011896</DrugIDPK>
    <LicenceNumber>PA0082/037/002</LicenceNumber>
    <ProductName>OXY-10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011895</DrugIDPK>
    <LicenceNumber>PA0082/037/001</LicenceNumber>
    <ProductName>OXY-5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011305</DrugIDPK>
    <LicenceNumber>PA0051/017/003</LicenceNumber>
    <ProductName>SYNALAR N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010468</DrugIDPK>
    <LicenceNumber>PA0028/002/007</LicenceNumber>
    <ProductName>RIMACTANE</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1982-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010870</DrugIDPK>
    <LicenceNumber>PA0046/016/001</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010871</DrugIDPK>
    <LicenceNumber>PA0046/016/004</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010872</DrugIDPK>
    <LicenceNumber>PA0046/016/005</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012373</DrugIDPK>
    <LicenceNumber>PA0409/002/003</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1987-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012374</DrugIDPK>
    <LicenceNumber>PA0409/002/004</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>1987-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012321</DrugIDPK>
    <LicenceNumber>PA0392/023/001</LicenceNumber>
    <ProductName>FLOWERS OF SULPHUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000977</DrugIDPK>
    <LicenceNumber>PA0148/041/002</LicenceNumber>
    <ProductName>KERECID OPHTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1985-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IDOXURIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011832</DrugIDPK>
    <LicenceNumber>PA0077/032/001</LicenceNumber>
    <ProductName>MENTHACOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011862</DrugIDPK>
    <LicenceNumber>PA0077/053/001</LicenceNumber>
    <ProductName>MODRENAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1981-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRILOSTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011855</DrugIDPK>
    <LicenceNumber>PA0082/026/002</LicenceNumber>
    <ProductName>SILBE ATOMISER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010874</DrugIDPK>
    <LicenceNumber>PA0046/020/001</LicenceNumber>
    <ProductName>ALCABUTAZONE LEO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010873</DrugIDPK>
    <LicenceNumber>PA0046/016/006</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010875</DrugIDPK>
    <LicenceNumber>PA0046/021/001</LicenceNumber>
    <ProductName>DIPHEBUZOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010876</DrugIDPK>
    <LicenceNumber>PA0046/021/002</LicenceNumber>
    <ProductName>DIPHEBUZOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010892</DrugIDPK>
    <LicenceNumber>PA0046/029/002</LicenceNumber>
    <ProductName>SELEXIDIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MECILLINAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010955</DrugIDPK>
    <LicenceNumber>PA0046/029/003</LicenceNumber>
    <ProductName>SELEXIDIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MECILLINAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009833</DrugIDPK>
    <LicenceNumber>PA0017/036/001</LicenceNumber>
    <ProductName>TYPHOID PARATYPHOID A B &amp; C</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012760</DrugIDPK>
    <LicenceNumber>PA0516/002/001</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012761</DrugIDPK>
    <LicenceNumber>PA0516/002/002</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012763</DrugIDPK>
    <LicenceNumber>PA0516/002/003</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012764</DrugIDPK>
    <LicenceNumber>PA0516/002/004</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012769</DrugIDPK>
    <LicenceNumber>PA0516/005/003</LicenceNumber>
    <ProductName>ELANPRES</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012766</DrugIDPK>
    <LicenceNumber>PA0516/005/001</LicenceNumber>
    <ProductName>ELANPRES</ProductName>
    <Strength>175</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012767</DrugIDPK>
    <LicenceNumber>PA0516/005/002</LicenceNumber>
    <ProductName>ELANPRES</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>1987-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013687</DrugIDPK>
    <LicenceNumber>PA0206/001/001</LicenceNumber>
    <ProductName>KANACILLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROCAINE BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>KANAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012561</DrugIDPK>
    <LicenceNumber>PA0100/039/001</LicenceNumber>
    <ProductName>MUCOGEL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013697</DrugIDPK>
    <LicenceNumber>PA0206/009/001</LicenceNumber>
    <ProductName>VIONEURIN FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010025</DrugIDPK>
    <LicenceNumber>PA0019/018/003</LicenceNumber>
    <ProductName>CORTRIL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010026</DrugIDPK>
    <LicenceNumber>PA0019/018/004</LicenceNumber>
    <ProductName>CORTRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010023</DrugIDPK>
    <LicenceNumber>PA0019/018/001</LicenceNumber>
    <ProductName>CORTRIL  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012707</DrugIDPK>
    <LicenceNumber>PA0488/003/001</LicenceNumber>
    <ProductName>DOXOFYLLINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXOFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012246</DrugIDPK>
    <LicenceNumber>PA0367/020/001</LicenceNumber>
    <ProductName>ADRENALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012213</DrugIDPK>
    <LicenceNumber>PA0367/005/001</LicenceNumber>
    <ProductName>ATROPINE SULPHATE</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1986-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010455</DrugIDPK>
    <LicenceNumber>PA0023/011/003</LicenceNumber>
    <ProductName>CAMBISON EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNAZOLINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010456</DrugIDPK>
    <LicenceNumber>PA0023/011/004</LicenceNumber>
    <ProductName>CAMBISON SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011150</DrugIDPK>
    <LicenceNumber>PA0049/013/001</LicenceNumber>
    <ProductName>PENBRITIN KS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
      <ActiveSubstance>SULFADIMIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012210</DrugIDPK>
    <LicenceNumber>PA0367/003/003</LicenceNumber>
    <ProductName>WATER FOR INJECTION 10ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1983-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012207</DrugIDPK>
    <LicenceNumber>PA0367/003/001</LicenceNumber>
    <ProductName>WATER FOR INJECTION 2ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1983-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012208</DrugIDPK>
    <LicenceNumber>PA0367/003/002</LicenceNumber>
    <ProductName>WATER FOR INJECTION 5ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>1983-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011652</DrugIDPK>
    <LicenceNumber>PA0073/003/011</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011656</DrugIDPK>
    <LicenceNumber>PA0073/003/015</LicenceNumber>
    <ProductName>ALORBAT (DISPOSABLE SYRINGE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011657</DrugIDPK>
    <LicenceNumber>PA0073/003/016</LicenceNumber>
    <ProductName>ALORBAT MULTIDOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011998</DrugIDPK>
    <LicenceNumber>PA0086/021/001</LicenceNumber>
    <ProductName>CHAPSTICK - REGULAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>LANOLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011784</DrugIDPK>
    <LicenceNumber>PA0079/016/001</LicenceNumber>
    <ProductName>GAMIMUNE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMMUNGLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011785</DrugIDPK>
    <LicenceNumber>PA0079/016/002</LicenceNumber>
    <ProductName>GAMIMUNE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMMUNGLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013576</DrugIDPK>
    <LicenceNumber>PA0179/013/001</LicenceNumber>
    <ProductName>DEXTRAN 40 BRAUN IN DEXTROSE 5%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013577</DrugIDPK>
    <LicenceNumber>PA0179/014/001</LicenceNumber>
    <ProductName>DEXTRAN 70 BRAUN IN DEXTROSE 5%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013574</DrugIDPK>
    <LicenceNumber>PA0179/012/001</LicenceNumber>
    <ProductName>DEXTRAN 70 BRAUN IN SODIUM CHLORIDE 0.9%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010999</DrugIDPK>
    <LicenceNumber>PA0046/042/003</LicenceNumber>
    <ProductName>IMUNOVIR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INOSINE PRANOBEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015169</DrugIDPK>
    <LicenceNumber>PA0294/005/001</LicenceNumber>
    <ProductName>CUNIL SURECAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011360</DrugIDPK>
    <LicenceNumber>PA0054/060/002</LicenceNumber>
    <ProductName>MICRO K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016017</DrugIDPK>
    <LicenceNumber>PA0218/020/001</LicenceNumber>
    <ProductName>HUMAN ACTRAPHANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016018</DrugIDPK>
    <LicenceNumber>PA0218/020/002</LicenceNumber>
    <ProductName>HUMAN ACTRAPHANE PENFILL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016101</DrugIDPK>
    <LicenceNumber>PA0218/016/001</LicenceNumber>
    <ProductName>HUMAN ACTRAPID HI</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016102</DrugIDPK>
    <LicenceNumber>PA0218/016/002</LicenceNumber>
    <ProductName>HUMAN ACTRAPID HM</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016103</DrugIDPK>
    <LicenceNumber>PA0218/016/003</LicenceNumber>
    <ProductName>HUMAN ACTRAPID HM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016098</DrugIDPK>
    <LicenceNumber>PA0218/015/001</LicenceNumber>
    <ProductName>HUMAN MONOTARD HI</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016099</DrugIDPK>
    <LicenceNumber>PA0218/015/002</LicenceNumber>
    <ProductName>HUMAN MONOTARD HM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016104</DrugIDPK>
    <LicenceNumber>PA0218/017/001</LicenceNumber>
    <ProductName>HUMAN PROTAPHANE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016105</DrugIDPK>
    <LicenceNumber>PA0218/017/002</LicenceNumber>
    <ProductName>HUMAN PROTAPHANE PENFILL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016106</DrugIDPK>
    <LicenceNumber>PA0218/018/001</LicenceNumber>
    <ProductName>HUMAN ULTRATARD</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012665</DrugIDPK>
    <LicenceNumber>PA0108/003/012</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1983-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013717</DrugIDPK>
    <LicenceNumber>PA0217/006/002</LicenceNumber>
    <ProductName>NANORMON</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012907</DrugIDPK>
    <LicenceNumber>PA0117/008/001</LicenceNumber>
    <ProductName>TIZIPRAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013708</DrugIDPK>
    <LicenceNumber>PA0217/002/004</LicenceNumber>
    <ProductName>VELOSULIN 100 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1983-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013709</DrugIDPK>
    <LicenceNumber>PA0217/002/006</LicenceNumber>
    <ProductName>VELOSULIN CARTRIDGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1988-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013606</DrugIDPK>
    <LicenceNumber>PA0170/004/001</LicenceNumber>
    <ProductName>VIVONEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1977-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013573</DrugIDPK>
    <LicenceNumber>PA0170/003/001</LicenceNumber>
    <ProductName>VIVONEX HN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1977-01-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015082</DrugIDPK>
    <LicenceNumber>PA0288/017/001</LicenceNumber>
    <ProductName>VITAMIN B6 NATURTABS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012281</DrugIDPK>
    <LicenceNumber>PA0379/017/001</LicenceNumber>
    <ProductName>DAY NURSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1987-01-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009629</DrugIDPK>
    <LicenceNumber>PA0004/004/004</LicenceNumber>
    <ProductName>FROBEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1976-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009630</DrugIDPK>
    <LicenceNumber>PA0004/004/005</LicenceNumber>
    <ProductName>FROBEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1976-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009631</DrugIDPK>
    <LicenceNumber>PA0004/004/006</LicenceNumber>
    <ProductName>FROBEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1976-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLURBIPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012776</DrugIDPK>
    <LicenceNumber>PA0522/003/001</LicenceNumber>
    <ProductName>CALCIA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Peter Black Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001626</DrugIDPK>
    <LicenceNumber>PA0046/053/001</LicenceNumber>
    <ProductName>VESAGEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012919</DrugIDPK>
    <LicenceNumber>PA0117/014/001</LicenceNumber>
    <ProductName>CHLORDIAZEPOXIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012913</DrugIDPK>
    <LicenceNumber>PA0117/012/003</LicenceNumber>
    <ProductName>CILPEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1981-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012914</DrugIDPK>
    <LicenceNumber>PA0117/012/004</LicenceNumber>
    <ProductName>CILPEN SYRUP FORTE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1981-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012915</DrugIDPK>
    <LicenceNumber>PA0117/012/005</LicenceNumber>
    <ProductName>CILPEN SYRUP FORTE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1981-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012916</DrugIDPK>
    <LicenceNumber>PA0117/013/001</LicenceNumber>
    <ProductName>DIACEN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012917</DrugIDPK>
    <LicenceNumber>PA0117/013/002</LicenceNumber>
    <ProductName>DIACEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012918</DrugIDPK>
    <LicenceNumber>PA0117/013/003</LicenceNumber>
    <ProductName>DIACEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1991-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012921</DrugIDPK>
    <LicenceNumber>PA0117/016/001</LicenceNumber>
    <ProductName>DOPACEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012922</DrugIDPK>
    <LicenceNumber>PA0117/016/002</LicenceNumber>
    <ProductName>DOPACEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012923</DrugIDPK>
    <LicenceNumber>PA0117/016/003</LicenceNumber>
    <ProductName>DOPACEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012925</DrugIDPK>
    <LicenceNumber>PA0117/017/001</LicenceNumber>
    <ProductName>HISTEND</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012652</DrugIDPK>
    <LicenceNumber>PA0108/003/004</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012655</DrugIDPK>
    <LicenceNumber>PA0108/003/005</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012669</DrugIDPK>
    <LicenceNumber>PA0108/003/013</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1983-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012670</DrugIDPK>
    <LicenceNumber>PA0108/003/014</LicenceNumber>
    <ProductName>INFLUVAC MULTIDOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1983-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012920</DrugIDPK>
    <LicenceNumber>PA0117/015/001</LicenceNumber>
    <ProductName>LACEN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1979-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011202</DrugIDPK>
    <LicenceNumber>PA0050/062/006</LicenceNumber>
    <ProductName>ROCEPHIN VIALS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFTRIAXONE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011199</DrugIDPK>
    <LicenceNumber>PA0050/062/004</LicenceNumber>
    <ProductName>ROCEPHIN VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTRIAXONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012926</DrugIDPK>
    <LicenceNumber>PA0117/018/001</LicenceNumber>
    <ProductName>SOLIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1979-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012908</DrugIDPK>
    <LicenceNumber>PA0117/009/001</LicenceNumber>
    <ProductName>TASPRIN SOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012909</DrugIDPK>
    <LicenceNumber>PA0117/010/001</LicenceNumber>
    <ProductName>TIBUTAZONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012903</DrugIDPK>
    <LicenceNumber>PA0117/003/001</LicenceNumber>
    <ProductName>TICELGESIC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1983-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012905</DrugIDPK>
    <LicenceNumber>PA0117/005/001</LicenceNumber>
    <ProductName>TICILLIN VK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012927</DrugIDPK>
    <LicenceNumber>PA0117/019/001</LicenceNumber>
    <ProductName>TICIPECT COUGH EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012904</DrugIDPK>
    <LicenceNumber>PA0117/004/001</LicenceNumber>
    <ProductName>TICYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012928</DrugIDPK>
    <LicenceNumber>PA0117/020/001</LicenceNumber>
    <ProductName>TISOM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1983-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011050</DrugIDPK>
    <LicenceNumber>PA0046/059/004</LicenceNumber>
    <ProductName>BURAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015634</DrugIDPK>
    <LicenceNumber>PA0300/003/001</LicenceNumber>
    <ProductName>LABITON KOLA TONIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratories for Applied Biology</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>COLA ACUMINATA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015633</DrugIDPK>
    <LicenceNumber>PA0300/002/001</LicenceNumber>
    <ProductName>TABANO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratories for Applied Biology</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013713</DrugIDPK>
    <LicenceNumber>PA0217/004/001</LicenceNumber>
    <ProductName>INSULIN INITARD 50/50 NORDISK</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1978-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013714</DrugIDPK>
    <LicenceNumber>PA0217/004/002</LicenceNumber>
    <ProductName>INSULIN INITARD 50/50 NORDISK</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1978-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011529</DrugIDPK>
    <LicenceNumber>PA0058/001/002</LicenceNumber>
    <ProductName>IRUXOL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COLLAGENASE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012375</DrugIDPK>
    <LicenceNumber>PA0409/016/001</LicenceNumber>
    <ProductName>TOTAMOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012377</DrugIDPK>
    <LicenceNumber>PA0409/016/002</LicenceNumber>
    <ProductName>TOTAMOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005817</DrugIDPK>
    <LicenceNumber>PA0365/020/001</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005818</DrugIDPK>
    <LicenceNumber>PA0365/020/002</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1986-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013529</DrugIDPK>
    <LicenceNumber>PA0176/067/003</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013526</DrugIDPK>
    <LicenceNumber>PA0176/067/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013527</DrugIDPK>
    <LicenceNumber>PA0176/067/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012509</DrugIDPK>
    <LicenceNumber>PA0100/015/002</LicenceNumber>
    <ProductName>BALMOSA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013622</DrugIDPK>
    <LicenceNumber>PA0187/027/001</LicenceNumber>
    <ProductName>TEROLIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERODILINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013626</DrugIDPK>
    <LicenceNumber>PA0187/027/002</LicenceNumber>
    <ProductName>TEROLINE</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1986-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERODILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010681</DrugIDPK>
    <LicenceNumber>PA0045/005/005</LicenceNumber>
    <ProductName>HALDOL AMPOULE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1978-12-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011337</DrugIDPK>
    <LicenceNumber>PA0051/060/001</LicenceNumber>
    <ProductName>CORWIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XAMOTEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012353</DrugIDPK>
    <LicenceNumber>PA0303/023/001</LicenceNumber>
    <ProductName>ERASIS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ACISTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012355</DrugIDPK>
    <LicenceNumber>PA0303/023/002</LicenceNumber>
    <ProductName>ERASIS</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ACISTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009626</DrugIDPK>
    <LicenceNumber>PA0003/008/001</LicenceNumber>
    <ProductName>OPAZIMES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005268</DrugIDPK>
    <LicenceNumber>PA0281/003/001</LicenceNumber>
    <ProductName>BEXALIN EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CHLOROFORM</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012977</DrugIDPK>
    <LicenceNumber>PA0118/022/001</LicenceNumber>
    <ProductName>SNO PHENICOL MULTI- DOSE EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013771</DrugIDPK>
    <LicenceNumber>PA0176/045/001</LicenceNumber>
    <ProductName>AMILORIDE HYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1987-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013741</DrugIDPK>
    <LicenceNumber>PA0176/023/001</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013742</DrugIDPK>
    <LicenceNumber>PA0176/023/002</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013768</DrugIDPK>
    <LicenceNumber>PA0176/042/001</LicenceNumber>
    <ProductName>COSOVAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013671</DrugIDPK>
    <LicenceNumber>PA0176/012/001</LicenceNumber>
    <ProductName>COX CETRIMIDE ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013460</DrugIDPK>
    <LicenceNumber>PA0176/049/002</LicenceNumber>
    <ProductName>ERYTHROMYCIN ETHYL SUCCINATE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013461</DrugIDPK>
    <LicenceNumber>PA0176/049/003</LicenceNumber>
    <ProductName>ERYTHROMYCIN ETHYL SUCCINATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013469</DrugIDPK>
    <LicenceNumber>PA0176/056/001</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013471</DrugIDPK>
    <LicenceNumber>PA0176/056/002</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013760</DrugIDPK>
    <LicenceNumber>PA0176/037/002</LicenceNumber>
    <ProductName>HYDRALAZINE HYDROCHLORIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1987-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010980</DrugIDPK>
    <LicenceNumber>PA0046/031/004</LicenceNumber>
    <ProductName>MIRAXID (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
      <ActiveSubstance>PIVMECILLINAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010983</DrugIDPK>
    <LicenceNumber>PA0046/031/005</LicenceNumber>
    <ProductName>MIRAXID PAEDIATRIC (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN</ActiveSubstance>
      <ActiveSubstance>PIVMECILLINAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013493</DrugIDPK>
    <LicenceNumber>PA0176/063/001</LicenceNumber>
    <ProductName>PHENYTOIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013495</DrugIDPK>
    <LicenceNumber>PA0176/063/002</LicenceNumber>
    <ProductName>PHENYTOIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1988-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013482</DrugIDPK>
    <LicenceNumber>PA0176/060/001</LicenceNumber>
    <ProductName>RELCOFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1990-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012658</DrugIDPK>
    <LicenceNumber>PA0455/004/001</LicenceNumber>
    <ProductName>SCHOLL ONIXOL INGROWN TOENAIL TREATMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>UREA</ActiveSubstance>
      <ActiveSubstance>EXSICCATED SODIUM SULPHITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012646</DrugIDPK>
    <LicenceNumber>PA0447/001/003</LicenceNumber>
    <ProductName>DISTAMINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>1986-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009733</DrugIDPK>
    <LicenceNumber>PA0016/023/009</LicenceNumber>
    <ProductName>PROVERA  GRANULES</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009734</DrugIDPK>
    <LicenceNumber>PA0016/023/010</LicenceNumber>
    <ProductName>PROVERA GRANULES</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013583</DrugIDPK>
    <LicenceNumber>PA0182/008/001</LicenceNumber>
    <ProductName>HERPIDU C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IDOXURIDINE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013587</DrugIDPK>
    <LicenceNumber>PA0182/012/001</LicenceNumber>
    <ProductName>SPERSALLERG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TETRYZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013585</DrugIDPK>
    <LicenceNumber>PA0182/011/001</LicenceNumber>
    <ProductName>TRIHERPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013586</DrugIDPK>
    <LicenceNumber>PA0182/011/002</LicenceNumber>
    <ProductName>TRIHERPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012662</DrugIDPK>
    <LicenceNumber>PA0459/001/001</LicenceNumber>
    <ProductName>MORFLIN BUCCAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Zeneca Pharmaceuticals (Ire) Ltd</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015740</DrugIDPK>
    <LicenceNumber>PA0237/015/003</LicenceNumber>
    <ProductName>APS DIAZEPAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015737</DrugIDPK>
    <LicenceNumber>PA0237/015/001</LicenceNumber>
    <ProductName>APS DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015738</DrugIDPK>
    <LicenceNumber>PA0237/015/002</LicenceNumber>
    <ProductName>APS DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015734</DrugIDPK>
    <LicenceNumber>PA0237/014/001</LicenceNumber>
    <ProductName>APS NITRAZEPAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013053</DrugIDPK>
    <LicenceNumber>PA0126/010/001</LicenceNumber>
    <ProductName>ABSORBINE ARTHRITIC PAIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010852</DrugIDPK>
    <LicenceNumber>PA0046/004/001</LicenceNumber>
    <ProductName>FUCIDIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012783</DrugIDPK>
    <LicenceNumber>PA0527/027/002</LicenceNumber>
    <ProductName>H.P. VITAMIN E</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Ferrosan Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011807</DrugIDPK>
    <LicenceNumber>PA0077/020/001</LicenceNumber>
    <ProductName>SULFAMYLON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAFENIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010422</DrugIDPK>
    <LicenceNumber>PA0022/064/001</LicenceNumber>
    <ProductName>ANTACIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAPROZIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010951</DrugIDPK>
    <LicenceNumber>PA0047/067/003</LicenceNumber>
    <ProductName>AXID (100 MG NIZATIDINE)</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIZATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010952</DrugIDPK>
    <LicenceNumber>PA0047/067/004</LicenceNumber>
    <ProductName>AXID (150 MG NIZATIDINE)</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIZATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010953</DrugIDPK>
    <LicenceNumber>PA0047/067/005</LicenceNumber>
    <ProductName>AXID (300 MG NIZATIDINE)</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIZATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009981</DrugIDPK>
    <LicenceNumber>PA0017/082/002</LicenceNumber>
    <ProductName>ANTEPAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011543</DrugIDPK>
    <LicenceNumber>PA0058/016/001</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012830</DrugIDPK>
    <LicenceNumber>PA0539/001/001</LicenceNumber>
    <ProductName>REMEGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hall Brothers</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011402</DrugIDPK>
    <LicenceNumber>PA0056/036/001</LicenceNumber>
    <ProductName>MAXICAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011403</DrugIDPK>
    <LicenceNumber>PA0056/036/002</LicenceNumber>
    <ProductName>MAXICAM</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011405</DrugIDPK>
    <LicenceNumber>PA0056/036/003</LicenceNumber>
    <ProductName>MAXICAM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011415</DrugIDPK>
    <LicenceNumber>PA0056/045/004</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1989-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010336</DrugIDPK>
    <LicenceNumber>PA0022/045/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010338</DrugIDPK>
    <LicenceNumber>PA0022/045/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012533</DrugIDPK>
    <LicenceNumber>PA0429/002/001</LicenceNumber>
    <ProductName>DULCOLAX RECTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Windsor Healthcare Ltd</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010340</DrugIDPK>
    <LicenceNumber>PA0022/046/001</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010342</DrugIDPK>
    <LicenceNumber>PA0022/046/002</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010343</DrugIDPK>
    <LicenceNumber>PA0022/047/001</LicenceNumber>
    <ProductName>GLIBENCLAMIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1989-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009671</DrugIDPK>
    <LicenceNumber>PA0007/018/001</LicenceNumber>
    <ProductName>VASCULIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BAMETHAN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010888</DrugIDPK>
    <LicenceNumber>PA0046/027/001</LicenceNumber>
    <ProductName>LEOTUSS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011646</DrugIDPK>
    <LicenceNumber>PA0072/024/001</LicenceNumber>
    <ProductName>SANATOGEN ROYAL JELLY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014448</DrugIDPK>
    <LicenceNumber>PA0167/008/013</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014450</DrugIDPK>
    <LicenceNumber>PA0167/008/014</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1986-08-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012057</DrugIDPK>
    <LicenceNumber>PA0095/005/001</LicenceNumber>
    <ProductName>KIDDIPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009758</DrugIDPK>
    <LicenceNumber>PA0016/033/002</LicenceNumber>
    <ProductName>AMBAXIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1981-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011544</DrugIDPK>
    <LicenceNumber>PA0059/003/001</LicenceNumber>
    <ProductName>TOLECTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1976-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLMETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012704</DrugIDPK>
    <LicenceNumber>PA0484/027/001</LicenceNumber>
    <ProductName>BONFIELDS IPECAC &amp; SQUILL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DRIMIA MARITIMA</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>HONEY</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012700</DrugIDPK>
    <LicenceNumber>PA0484/017/001</LicenceNumber>
    <ProductName>GENTIAN VIOLET</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLROSANILINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001179</DrugIDPK>
    <LicenceNumber>PA0217/005/001</LicenceNumber>
    <ProductName>ALBUMIN NORDISK</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009989</DrugIDPK>
    <LicenceNumber>PA0017/095/001</LicenceNumber>
    <ProductName>FLUZONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1990-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012494</DrugIDPK>
    <LicenceNumber>PA0362/006/002</LicenceNumber>
    <ProductName>DILTIAZEM</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lorex Synthelabo Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009478</DrugIDPK>
    <LicenceNumber>PA0001/022/003</LicenceNumber>
    <ProductName>REHIDRAT BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013751</DrugIDPK>
    <LicenceNumber>PA0176/030/001</LicenceNumber>
    <ProductName>COBADEX</ProductName>
    <Strength>0.5%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013752</DrugIDPK>
    <LicenceNumber>PA0176/030/002</LicenceNumber>
    <ProductName>COBADEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013770</DrugIDPK>
    <LicenceNumber>PA0176/044/001</LicenceNumber>
    <ProductName>POTASSIUM EFFERVESCENT BPC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1986-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010404</DrugIDPK>
    <LicenceNumber>PA0035/055/002</LicenceNumber>
    <ProductName>MODUCREN 20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013825</DrugIDPK>
    <LicenceNumber>PA0277/019/002</LicenceNumber>
    <ProductName>SULPHACETAMIDE EYE DROPS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013827</DrugIDPK>
    <LicenceNumber>PA0277/019/003</LicenceNumber>
    <ProductName>SULPHACETAMIDE EYE DROPS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010805</DrugIDPK>
    <LicenceNumber>PA0041/044/001</LicenceNumber>
    <ProductName>ANEMET 1 MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROPISETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010806</DrugIDPK>
    <LicenceNumber>PA0041/044/002</LicenceNumber>
    <ProductName>ANEMET 1 MG/ML</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROPISETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011207</DrugIDPK>
    <LicenceNumber>PA0050/065/001</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012382</DrugIDPK>
    <LicenceNumber>PA0415/004/001</LicenceNumber>
    <ProductName>FLUOSOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PERFLUNAFENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011936</DrugIDPK>
    <LicenceNumber>PA0086/010/002</LicenceNumber>
    <ProductName>ROBAXIN 750</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOCARBAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011934</DrugIDPK>
    <LicenceNumber>PA0086/010/001</LicenceNumber>
    <ProductName>ROBAXIN 750</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOCARBAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003474</DrugIDPK>
    <LicenceNumber>PA0086/011/005</LicenceNumber>
    <ProductName>DIMOTAPP CO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1986-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013776</DrugIDPK>
    <LicenceNumber>PA0278/010/001</LicenceNumber>
    <ProductName>VARICLENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRILLIANT GREEN CI 42040</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011465</DrugIDPK>
    <LicenceNumber>PA0057/014/002</LicenceNumber>
    <ProductName>CODURAL (BLISTER PACK)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011464</DrugIDPK>
    <LicenceNumber>PA0057/014/001</LicenceNumber>
    <ProductName>CODURAL (PLASTIC TUBES)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011209</DrugIDPK>
    <LicenceNumber>PA0050/066/001</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1986-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013769</DrugIDPK>
    <LicenceNumber>PA0176/043/001</LicenceNumber>
    <ProductName>CHLORPHENIRAMINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013757</DrugIDPK>
    <LicenceNumber>PA0176/035/001</LicenceNumber>
    <ProductName>DAYOVITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013765</DrugIDPK>
    <LicenceNumber>PA0176/041/001</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1987-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013766</DrugIDPK>
    <LicenceNumber>PA0176/041/002</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1987-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013767</DrugIDPK>
    <LicenceNumber>PA0176/041/003</LicenceNumber>
    <ProductName>SPIRONOLACTONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1989-09-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009923</DrugIDPK>
    <LicenceNumber>PA0017/057/002</LicenceNumber>
    <ProductName>ESBATAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETANIDINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011546</DrugIDPK>
    <LicenceNumber>PA0059/012/003</LicenceNumber>
    <ProductName>ORTHO-NOVIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009760</DrugIDPK>
    <LicenceNumber>PA0016/034/001</LicenceNumber>
    <ProductName>FLORONE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009763</DrugIDPK>
    <LicenceNumber>PA0016/034/002</LicenceNumber>
    <ProductName>FLORONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012638</DrugIDPK>
    <LicenceNumber>PA0107/016/001</LicenceNumber>
    <ProductName>PHAZET SKIN PRICK TEST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012283</DrugIDPK>
    <LicenceNumber>PA0379/024/001</LicenceNumber>
    <ProductName>DIOCARE PRD 463</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010469</DrugIDPK>
    <LicenceNumber>PA0028/003/005</LicenceNumber>
    <ProductName>TRASICOR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1976-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012580</DrugIDPK>
    <LicenceNumber>PA0437/004/008</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012577</DrugIDPK>
    <LicenceNumber>PA0437/004/005</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012578</DrugIDPK>
    <LicenceNumber>PA0437/004/006</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012574</DrugIDPK>
    <LicenceNumber>PA0437/004/002</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012575</DrugIDPK>
    <LicenceNumber>PA0437/004/004</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012572</DrugIDPK>
    <LicenceNumber>PA0437/003/002</LicenceNumber>
    <ProductName>STRONG STERILE DOPAMINE HYDROCHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010019</DrugIDPK>
    <LicenceNumber>PA0019/013/002</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010523</DrugIDPK>
    <LicenceNumber>PA0023/042/001</LicenceNumber>
    <ProductName>CORVATON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOLSIDOMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011645</DrugIDPK>
    <LicenceNumber>PA0072/021/001</LicenceNumber>
    <ProductName>SANATOGEN VITAMIN E</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010438</DrugIDPK>
    <LicenceNumber>PA0023/005/001</LicenceNumber>
    <ProductName>TRENTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1976-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOXIFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009937</DrugIDPK>
    <LicenceNumber>PA0017/061/001</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN ZINC</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016019</DrugIDPK>
    <LicenceNumber>PA0218/021/001</LicenceNumber>
    <ProductName>ACTRAPID MC PENFILL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016107</DrugIDPK>
    <LicenceNumber>PA0218/019/001</LicenceNumber>
    <ProductName>HUMAN ACTRAPID PENFILL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012851</DrugIDPK>
    <LicenceNumber>PA0563/009/001</LicenceNumber>
    <ProductName>B-PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Natures Way (Dublin) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>PANTOTHENIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012852</DrugIDPK>
    <LicenceNumber>PA0563/012/001</LicenceNumber>
    <ProductName>CHILDRENS ONE-A-DAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Natures Way (Dublin) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>BIOTIN</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINIC ACID</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>IRON</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012850</DrugIDPK>
    <LicenceNumber>PA0563/007/001</LicenceNumber>
    <ProductName>COD LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Natures Way (Dublin) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COD LIVER OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012690</DrugIDPK>
    <LicenceNumber>PA0479/001/010</LicenceNumber>
    <ProductName>GAMBROSOL 10 X 1.5% DEXTROSE</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Gambro UK Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012692</DrugIDPK>
    <LicenceNumber>PA0479/001/015</LicenceNumber>
    <ProductName>GAMBROSOL 10 X 2.5% DEXTROSE</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Gambro UK Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012693</DrugIDPK>
    <LicenceNumber>PA0479/001/020</LicenceNumber>
    <ProductName>GAMBROSOL 10 X 4.0% DEXTROSE</ProductName>
    <Strength>3000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Gambro UK Limited</PAHolder>
    <AuthorisedDate>1989-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012853</DrugIDPK>
    <LicenceNumber>PA0563/013/001</LicenceNumber>
    <ProductName>SUPER SEA KELP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Natures Way (Dublin) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012412</DrugIDPK>
    <LicenceNumber>PA0317/008/001</LicenceNumber>
    <ProductName>DISPRIN CV</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012849</DrugIDPK>
    <LicenceNumber>PA0563/002/001</LicenceNumber>
    <ProductName>DOLOMITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Natures Way (Dublin) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010406</DrugIDPK>
    <LicenceNumber>PA0035/058/001</LicenceNumber>
    <ProductName>H-B-VAX HEPATITIS B VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010407</DrugIDPK>
    <LicenceNumber>PA0035/058/002</LicenceNumber>
    <ProductName>H-B-VAX HEPATITIS B VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010408</DrugIDPK>
    <LicenceNumber>PA0035/058/003</LicenceNumber>
    <ProductName>H-B-VAX HEPATITIS B VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010557</DrugIDPK>
    <LicenceNumber>PA0037/027/001</LicenceNumber>
    <ProductName>AUDICORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000621</DrugIDPK>
    <LicenceNumber>PA0009/004/002</LicenceNumber>
    <ProductName>BRICANYL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013652</DrugIDPK>
    <LicenceNumber>PA0176/001/004</LicenceNumber>
    <ProductName>DIAZEPAM ELIXIR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1991-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010629</DrugIDPK>
    <LicenceNumber>PA0038/019/001</LicenceNumber>
    <ProductName>IBERET 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1981-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012084</DrugIDPK>
    <LicenceNumber>PA0365/001/002</LicenceNumber>
    <ProductName>BCG VACCINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1985-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BCG VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013180</DrugIDPK>
    <LicenceNumber>PA0144/019/001</LicenceNumber>
    <ProductName>PANOXYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012590</DrugIDPK>
    <LicenceNumber>PA0437/026/003</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011418</DrugIDPK>
    <LicenceNumber>PA0056/065/001</LicenceNumber>
    <ProductName>NEW METATONE TONIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE GLYCEROPHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011514</DrugIDPK>
    <LicenceNumber>PA0057/048/001</LicenceNumber>
    <ProductName>MULCETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010224</DrugIDPK>
    <LicenceNumber>PA0028/062/001</LicenceNumber>
    <ProductName>CADRILAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CADRALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010228</DrugIDPK>
    <LicenceNumber>PA0028/062/003</LicenceNumber>
    <ProductName>CADRILAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CADRALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010226</DrugIDPK>
    <LicenceNumber>PA0028/062/002</LicenceNumber>
    <ProductName>CADRILAN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CADRALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012553</DrugIDPK>
    <LicenceNumber>PA0436/004/002</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012552</DrugIDPK>
    <LicenceNumber>PA0436/004/001</LicenceNumber>
    <ProductName>PARACETAMOL ELIXIR PAEDIATRIC BPC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012555</DrugIDPK>
    <LicenceNumber>PA0436/005/001</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012556</DrugIDPK>
    <LicenceNumber>PA0436/005/002</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012557</DrugIDPK>
    <LicenceNumber>PA0436/005/003</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012559</DrugIDPK>
    <LicenceNumber>PA0436/006/001</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012379</DrugIDPK>
    <LicenceNumber>PA0411/001/001</LicenceNumber>
    <ProductName>MACKENZIE SMELLING SALTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dr. Mackenzies Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013522</DrugIDPK>
    <LicenceNumber>PA0176/065/002</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013519</DrugIDPK>
    <LicenceNumber>PA0176/065/001</LicenceNumber>
    <ProductName>SALBUTAMOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013500</DrugIDPK>
    <LicenceNumber>PA0258/025/001</LicenceNumber>
    <ProductName>SUN N SEA COD LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013501</DrugIDPK>
    <LicenceNumber>PA0258/025/002</LicenceNumber>
    <ProductName>SUN N SEA COD LIVER OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015087</DrugIDPK>
    <LicenceNumber>PA0288/023/001</LicenceNumber>
    <ProductName>NATURAL VITAMIN E</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010304</DrugIDPK>
    <LicenceNumber>PA0032/035/001</LicenceNumber>
    <ProductName>PLATET CLEARTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010233</DrugIDPK>
    <LicenceNumber>PA0028/066/002</LicenceNumber>
    <ProductName>FORADIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010237</DrugIDPK>
    <LicenceNumber>PA0028/066/004</LicenceNumber>
    <ProductName>FORADIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010235</DrugIDPK>
    <LicenceNumber>PA0028/066/003</LicenceNumber>
    <ProductName>FORADIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010232</DrugIDPK>
    <LicenceNumber>PA0028/066/001</LicenceNumber>
    <ProductName>FORADIL PUFF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012254</DrugIDPK>
    <LicenceNumber>PA0374/002/001</LicenceNumber>
    <ProductName>ONCOTICE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Teknika Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BCG VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012833</DrugIDPK>
    <LicenceNumber>PA0545/022/001</LicenceNumber>
    <ProductName>SUFREXAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012834</DrugIDPK>
    <LicenceNumber>PA0545/022/002</LicenceNumber>
    <ProductName>SUFREXAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012835</DrugIDPK>
    <LicenceNumber>PA0545/022/003</LicenceNumber>
    <ProductName>SUFREXAL (KETANSERIN)</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012836</DrugIDPK>
    <LicenceNumber>PA0545/022/004</LicenceNumber>
    <ProductName>SUFREXAL (KETANSERIN)</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010810</DrugIDPK>
    <LicenceNumber>PA0043/010/001</LicenceNumber>
    <ProductName>FENOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010811</DrugIDPK>
    <LicenceNumber>PA0043/010/002</LicenceNumber>
    <ProductName>FENOX (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012829</DrugIDPK>
    <LicenceNumber>PA0538/004/001</LicenceNumber>
    <ProductName>HIGH IRON YEAST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wassen International Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011341</DrugIDPK>
    <LicenceNumber>PA0051/061/001</LicenceNumber>
    <ProductName>VISACOR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012666</DrugIDPK>
    <LicenceNumber>PA0462/001/001</LicenceNumber>
    <ProductName>CYCLOGEST</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>L.D. Collins &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012667</DrugIDPK>
    <LicenceNumber>PA0462/001/002</LicenceNumber>
    <ProductName>CYCLOGEST</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>L.D. Collins &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013750</DrugIDPK>
    <LicenceNumber>PA0176/029/001</LicenceNumber>
    <ProductName>NYBADEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1986-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011884</DrugIDPK>
    <LicenceNumber>PA0077/097/003</LicenceNumber>
    <ProductName>VASOTROPE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MILRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011885</DrugIDPK>
    <LicenceNumber>PA0077/097/004</LicenceNumber>
    <ProductName>VASOTROPE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MILRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011886</DrugIDPK>
    <LicenceNumber>PA0077/097/005</LicenceNumber>
    <ProductName>VASOTROPE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MILRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010443</DrugIDPK>
    <LicenceNumber>PA0027/011/002</LicenceNumber>
    <ProductName>JUNIOR DISPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-10-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003475</DrugIDPK>
    <LicenceNumber>PA0086/011/006</LicenceNumber>
    <ProductName>DIMOTAPP CO PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1985-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013860</DrugIDPK>
    <LicenceNumber>PA0282/045/001</LicenceNumber>
    <ProductName>DISOPYRAMIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013862</DrugIDPK>
    <LicenceNumber>PA0282/045/002</LicenceNumber>
    <ProductName>DISOPYRAMIDE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009452</DrugIDPK>
    <LicenceNumber>PA0001/003/001</LicenceNumber>
    <ProductName>NORPACE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1975-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009453</DrugIDPK>
    <LicenceNumber>PA0001/003/002</LicenceNumber>
    <ProductName>NORPACE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1975-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011012</DrugIDPK>
    <LicenceNumber>PA0046/049/001</LicenceNumber>
    <ProductName>EMOFORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM OXIDUM LEVE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013676</DrugIDPK>
    <LicenceNumber>PA0176/015/002</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010451</DrugIDPK>
    <LicenceNumber>PA0023/010/002</LicenceNumber>
    <ProductName>TOPISOLONE N</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1980-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DESOXIMETASONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009820</DrugIDPK>
    <LicenceNumber>PA0011/024/004</LicenceNumber>
    <ProductName>TOFRANIL R</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011527</DrugIDPK>
    <LicenceNumber>PA0057/056/002</LicenceNumber>
    <ProductName>AEROBEC INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013505</DrugIDPK>
    <LicenceNumber>PA0258/041/001</LicenceNumber>
    <ProductName>ADULT COUGH BALSAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012856</DrugIDPK>
    <LicenceNumber>PA0577/001/001</LicenceNumber>
    <ProductName>TERODILINE H.C.I.</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERODILINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010218</DrugIDPK>
    <LicenceNumber>PA0028/059/001</LicenceNumber>
    <ProductName>CORANGIN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005925</DrugIDPK>
    <LicenceNumber>PA0379/021/001</LicenceNumber>
    <ProductName>RESOLVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1988-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012593</DrugIDPK>
    <LicenceNumber>PA0441/001/001</LicenceNumber>
    <ProductName>VICKS MEDINITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011470</DrugIDPK>
    <LicenceNumber>PA0060/055/001</LicenceNumber>
    <ProductName>NEURET</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011472</DrugIDPK>
    <LicenceNumber>PA0060/055/002</LicenceNumber>
    <ProductName>NEURET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010313</DrugIDPK>
    <LicenceNumber>PA0022/030/001</LicenceNumber>
    <ProductName>OVRAN 20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1980-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013168</DrugIDPK>
    <LicenceNumber>PA0143/010/001</LicenceNumber>
    <ProductName>NOXYFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NOXYTIOLIN</ActiveSubstance>
      <ActiveSubstance>TETRACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010419</DrugIDPK>
    <LicenceNumber>PA0035/072/001</LicenceNumber>
    <ProductName>CORTISONE ACETATE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010420</DrugIDPK>
    <LicenceNumber>PA0035/072/002</LicenceNumber>
    <ProductName>CORTISONE ACETATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012736</DrugIDPK>
    <LicenceNumber>PA0506/001/001</LicenceNumber>
    <ProductName>BENZYL BENZOAT APPLICATION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012738</DrugIDPK>
    <LicenceNumber>PA0506/002/001</LicenceNumber>
    <ProductName>CODEINE LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012752</DrugIDPK>
    <LicenceNumber>PA0506/011/001</LicenceNumber>
    <ProductName>COMPOUND THYMOL GLYCERIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012739</DrugIDPK>
    <LicenceNumber>PA0506/003/001</LicenceNumber>
    <ProductName>FLEXIBLE COLLODION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012741</DrugIDPK>
    <LicenceNumber>PA0506/004/001</LicenceNumber>
    <ProductName>HAMAMELIS WATER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012744</DrugIDPK>
    <LicenceNumber>PA0506/006/001</LicenceNumber>
    <ProductName>METHYL SALICYLATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012746</DrugIDPK>
    <LicenceNumber>PA0506/007/001</LicenceNumber>
    <ProductName>PAEDIATRIC PARACETAMOL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012748</DrugIDPK>
    <LicenceNumber>PA0506/008/001</LicenceNumber>
    <ProductName>PHOLCODINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012753</DrugIDPK>
    <LicenceNumber>PA0506/012/001</LicenceNumber>
    <ProductName>RANSOMS GLYCERIN, LEMON &amp; HONEY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012750</DrugIDPK>
    <LicenceNumber>PA0506/010/001</LicenceNumber>
    <ProductName>RANSOMS PAEDIATRIC DIPHENHYDRAMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012743</DrugIDPK>
    <LicenceNumber>PA0506/005/001</LicenceNumber>
    <ProductName>WEAK IODINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>William Ransom &amp; Son Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012869</DrugIDPK>
    <LicenceNumber>PA0660/001/001</LicenceNumber>
    <ProductName>CIMENIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Foxken Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012870</DrugIDPK>
    <LicenceNumber>PA0660/001/002</LicenceNumber>
    <ProductName>CIMENIL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Foxken Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012871</DrugIDPK>
    <LicenceNumber>PA0660/001/003</LicenceNumber>
    <ProductName>CIMENIL</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Foxken Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012250</DrugIDPK>
    <LicenceNumber>PA0301/046/001</LicenceNumber>
    <ProductName>AGRIPPAL AMPOULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012134</DrugIDPK>
    <LicenceNumber>PA0301/028/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012160</DrugIDPK>
    <LicenceNumber>PA0301/030/003</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20/2ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010527</DrugIDPK>
    <LicenceNumber>PA0023/056/001</LicenceNumber>
    <ProductName>FELODIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010528</DrugIDPK>
    <LicenceNumber>PA0023/056/002</LicenceNumber>
    <ProductName>FELODIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010518</DrugIDPK>
    <LicenceNumber>PA0024/002/001</LicenceNumber>
    <ProductName>FENTAZIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001871</DrugIDPK>
    <LicenceNumber>PA0035/022/001</LicenceNumber>
    <ProductName>HYDRODERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011123</DrugIDPK>
    <LicenceNumber>PA0047/020/001</LicenceNumber>
    <ProductName>ILOTYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009987</DrugIDPK>
    <LicenceNumber>PA0017/090/002</LicenceNumber>
    <ProductName>PROVENTEX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009988</DrugIDPK>
    <LicenceNumber>PA0017/090/003</LicenceNumber>
    <ProductName>PROVENTEX</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013302</DrugIDPK>
    <LicenceNumber>PA0167/011/003</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009522</DrugIDPK>
    <LicenceNumber>PA0006/001/001</LicenceNumber>
    <ProductName>LANITOP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel - Uclaf</PAHolder>
    <AuthorisedDate>1975-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012535</DrugIDPK>
    <LicenceNumber>PA0429/006/001</LicenceNumber>
    <ProductName>WOMANKIND VITAMIN B6</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Windsor Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010318</DrugIDPK>
    <LicenceNumber>PA0022/032/001</LicenceNumber>
    <ProductName>PREGFOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE EXSICCATED</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012253</DrugIDPK>
    <LicenceNumber>PA0301/046/002</LicenceNumber>
    <ProductName>AGRIPPAL VIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012148</DrugIDPK>
    <LicenceNumber>PA0301/028/005</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012136</DrugIDPK>
    <LicenceNumber>PA0301/028/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012157</DrugIDPK>
    <LicenceNumber>PA0301/030/002</LicenceNumber>
    <ProductName>FURETIC</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1982-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012184</DrugIDPK>
    <LicenceNumber>PA0301/034/001</LicenceNumber>
    <ProductName>OPTOMYCIN CHLORAMPHENICOL EYE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015673</DrugIDPK>
    <LicenceNumber>PA0301/011/001</LicenceNumber>
    <ProductName>ATROFORD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1982-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015645</DrugIDPK>
    <LicenceNumber>PA0301/005/001</LicenceNumber>
    <ProductName>BETOPIC CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1982-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015647</DrugIDPK>
    <LicenceNumber>PA0301/006/001</LicenceNumber>
    <ProductName>CLIOTOPIC H CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012135</DrugIDPK>
    <LicenceNumber>PA0301/028/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012137</DrugIDPK>
    <LicenceNumber>PA0301/028/004</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015702</DrugIDPK>
    <LicenceNumber>PA0301/014/001</LicenceNumber>
    <ProductName>FLUOSYN</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1982-03-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012239</DrugIDPK>
    <LicenceNumber>PA0301/041/001</LicenceNumber>
    <ProductName>GUNEVAX RUBELLA VIRUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015717</DrugIDPK>
    <LicenceNumber>PA0301/016/001</LicenceNumber>
    <ProductName>HYDROTOPIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015718</DrugIDPK>
    <LicenceNumber>PA0301/016/002</LicenceNumber>
    <ProductName>HYDROTOPIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015642</DrugIDPK>
    <LicenceNumber>PA0301/004/002</LicenceNumber>
    <ProductName>PILOPTIC OPTH. SOLUTION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015643</DrugIDPK>
    <LicenceNumber>PA0301/004/003</LicenceNumber>
    <ProductName>PILOPTIC OPTH. SOLUTION</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015644</DrugIDPK>
    <LicenceNumber>PA0301/004/004</LicenceNumber>
    <ProductName>PILOPTIC OPTH. SOLUTION</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015713</DrugIDPK>
    <LicenceNumber>PA0301/015/002</LicenceNumber>
    <ProductName>TRISYN</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009685</DrugIDPK>
    <LicenceNumber>PA0009/042/002</LicenceNumber>
    <ProductName>FELODIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009683</DrugIDPK>
    <LicenceNumber>PA0009/042/001</LicenceNumber>
    <ProductName>FELODIPINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010270</DrugIDPK>
    <LicenceNumber>PA0032/013/001</LicenceNumber>
    <ProductName>MICROPAQUE D.C.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1980-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010273</DrugIDPK>
    <LicenceNumber>PA0032/015/002</LicenceNumber>
    <ProductName>VASCARDIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001773</DrugIDPK>
    <LicenceNumber>PA0148/032/004</LicenceNumber>
    <ProductName>P.V. CARPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001774</DrugIDPK>
    <LicenceNumber>PA0148/032/006</LicenceNumber>
    <ProductName>P.V. CARPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001771</DrugIDPK>
    <LicenceNumber>PA0148/032/005</LicenceNumber>
    <ProductName>P.V. CARPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013199</DrugIDPK>
    <LicenceNumber>PA0149/007/005</LicenceNumber>
    <ProductName>ISORDIL TITRADOSE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013202</DrugIDPK>
    <LicenceNumber>PA0149/007/006</LicenceNumber>
    <ProductName>ISORDIL TITRADOSE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013204</DrugIDPK>
    <LicenceNumber>PA0149/007/007</LicenceNumber>
    <ProductName>ISORDIL TITRADOSE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010930</DrugIDPK>
    <LicenceNumber>PA0047/052/001</LicenceNumber>
    <ProductName>VANCOCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011684</DrugIDPK>
    <LicenceNumber>PA0073/040/001</LicenceNumber>
    <ProductName>SUCCINYL-ASTA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUXAMETHONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011685</DrugIDPK>
    <LicenceNumber>PA0073/040/002</LicenceNumber>
    <ProductName>SUCCINYL-ASTA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011302</DrugIDPK>
    <LicenceNumber>PA0054/029/003</LicenceNumber>
    <ProductName>SUCCINYL-ASTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1985-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUXAMETHONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011299</DrugIDPK>
    <LicenceNumber>PA0054/029/001</LicenceNumber>
    <ProductName>SUCCINYL-ASTA 2%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUXAMETHONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011300</DrugIDPK>
    <LicenceNumber>PA0054/029/002</LicenceNumber>
    <ProductName>SUCCINYL-ASTA 5%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUXAMETHONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011416</DrugIDPK>
    <LicenceNumber>PA0056/048/001</LicenceNumber>
    <ProductName>BENYLIN EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009986</DrugIDPK>
    <LicenceNumber>PA0017/090/001</LicenceNumber>
    <ProductName>PROVENTEX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010192</DrugIDPK>
    <LicenceNumber>PA0028/038/002</LicenceNumber>
    <ProductName>RENGASIL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010189</DrugIDPK>
    <LicenceNumber>PA0028/038/001</LicenceNumber>
    <ProductName>RENGASIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012855</DrugIDPK>
    <LicenceNumber>PA0570/013/001</LicenceNumber>
    <ProductName>PROTEIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Healthilife Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CASEINATE</ActiveSubstance>
      <ActiveSubstance>SOYA PROTEIN</ActiveSubstance>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
      <ActiveSubstance>FLAVOUR</ActiveSubstance>
      <ActiveSubstance>PROTEIN HYDROLYSATE</ActiveSubstance>
      <ActiveSubstance>LECITHINUM SOYA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012568</DrugIDPK>
    <LicenceNumber>PA0102/005/001</LicenceNumber>
    <ProductName>CYCLOBRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1979-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLANDELATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010229</DrugIDPK>
    <LicenceNumber>PA0028/063/001</LicenceNumber>
    <ProductName>JUNIOR MU-CRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013498</DrugIDPK>
    <LicenceNumber>PA0258/023/001</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013502</DrugIDPK>
    <LicenceNumber>PA0258/027/001</LicenceNumber>
    <ProductName>CUTINEA FOOT &amp; BODY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013499</DrugIDPK>
    <LicenceNumber>PA0258/024/001</LicenceNumber>
    <ProductName>ZINC &amp; CASTOR OIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011610</DrugIDPK>
    <LicenceNumber>PA0063/005/001</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011613</DrugIDPK>
    <LicenceNumber>PA0063/008/001</LicenceNumber>
    <ProductName>ASPIRIN &amp; CODEINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011612</DrugIDPK>
    <LicenceNumber>PA0063/007/001</LicenceNumber>
    <ProductName>ASPRIN JUNIOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011611</DrugIDPK>
    <LicenceNumber>PA0063/006/001</LicenceNumber>
    <ProductName>CALMO RHEUMATIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011607</DrugIDPK>
    <LicenceNumber>PA0063/002/001</LicenceNumber>
    <ProductName>KAOLIN &amp; MORPHINE MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011609</DrugIDPK>
    <LicenceNumber>PA0063/004/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015641</DrugIDPK>
    <LicenceNumber>PA0301/004/001</LicenceNumber>
    <ProductName>PILOPTIC OPTH. SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1984-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011614</DrugIDPK>
    <LicenceNumber>PA0063/009/001</LicenceNumber>
    <ProductName>RESTWELL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>1978-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009881</DrugIDPK>
    <LicenceNumber>PA0012/031/005</LicenceNumber>
    <ProductName>ULTRALAN ORAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010771</DrugIDPK>
    <LicenceNumber>PA0040/083/001</LicenceNumber>
    <ProductName>PEFLACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010772</DrugIDPK>
    <LicenceNumber>PA0040/083/002</LicenceNumber>
    <ProductName>PEFLACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009715</DrugIDPK>
    <LicenceNumber>PA0009/021/002</LicenceNumber>
    <ProductName>CITANEST 0.5%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009713</DrugIDPK>
    <LicenceNumber>PA0009/021/001</LicenceNumber>
    <ProductName>CITANEST 0.5%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001593</DrugIDPK>
    <LicenceNumber>PA0009/021/003</LicenceNumber>
    <ProductName>CITANEST PLAIN SOLUTION 1.0% - 20 ML. VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001594</DrugIDPK>
    <LicenceNumber>PA0009/021/004</LicenceNumber>
    <ProductName>CITANEST PLAIN SOLUTION 1.0% - 50 ML. VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010665</DrugIDPK>
    <LicenceNumber>PA0044/072/001</LicenceNumber>
    <ProductName>MYODIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IOFENDYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009712</DrugIDPK>
    <LicenceNumber>PA0009/016/008</LicenceNumber>
    <ProductName>XYLOCAINE 0.5%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009692</DrugIDPK>
    <LicenceNumber>PA0009/016/012</LicenceNumber>
    <ProductName>XYLOCAINE 1.0%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009690</DrugIDPK>
    <LicenceNumber>PA0009/016/011</LicenceNumber>
    <ProductName>XYLOCAINE 1.0%</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009696</DrugIDPK>
    <LicenceNumber>PA0009/016/016</LicenceNumber>
    <ProductName>XYLOCAINE 2.0%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009709</DrugIDPK>
    <LicenceNumber>PA0009/019/004</LicenceNumber>
    <ProductName>XYLOCAINE WITH ADRENALINE 1%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009634</DrugIDPK>
    <LicenceNumber>PA0004/012/001</LicenceNumber>
    <ProductName>LIGNOSTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009635</DrugIDPK>
    <LicenceNumber>PA0004/013/001</LicenceNumber>
    <ProductName>LIGNOSTAB A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009636</DrugIDPK>
    <LicenceNumber>PA0004/014/001</LicenceNumber>
    <ProductName>LIGNOSTAB A 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009637</DrugIDPK>
    <LicenceNumber>PA0004/015/001</LicenceNumber>
    <ProductName>LIGNOSTAB N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NOREPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012220</DrugIDPK>
    <LicenceNumber>PA0367/009/002</LicenceNumber>
    <ProductName>CHLORPROMAZINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012219</DrugIDPK>
    <LicenceNumber>PA0367/009/001</LicenceNumber>
    <ProductName>CHLORPROMAZINE ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010090</DrugIDPK>
    <LicenceNumber>PA0018/027/001</LicenceNumber>
    <ProductName>CYSTOPURIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHENAMINE HIPPURATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011460</DrugIDPK>
    <LicenceNumber>PA0060/047/003</LicenceNumber>
    <ProductName>MESASAL RETENTION ENEMA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013738</DrugIDPK>
    <LicenceNumber>PA0176/021/001</LicenceNumber>
    <ProductName>DOXATET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011466</DrugIDPK>
    <LicenceNumber>PA0060/052/004</LicenceNumber>
    <ProductName>INDORAMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011463</DrugIDPK>
    <LicenceNumber>PA0060/052/003</LicenceNumber>
    <ProductName>INDORAMIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1988-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009796</DrugIDPK>
    <LicenceNumber>PA0011/003/003</LicenceNumber>
    <ProductName>LOPRESOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1981-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011790</DrugIDPK>
    <LicenceNumber>PA0080/001/005</LicenceNumber>
    <ProductName>DICYNENE 1000</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012539</DrugIDPK>
    <LicenceNumber>PA0100/024/002</LicenceNumber>
    <ProductName>HAYMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015685</DrugIDPK>
    <LicenceNumber>PA0236/021/001</LicenceNumber>
    <ProductName>LISERDOL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010773</DrugIDPK>
    <LicenceNumber>PA0040/085/001</LicenceNumber>
    <ProductName>KENOGAM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010774</DrugIDPK>
    <LicenceNumber>PA0040/085/002</LicenceNumber>
    <ProductName>KENOGAM</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009832</DrugIDPK>
    <LicenceNumber>PA0011/037/001</LicenceNumber>
    <ProductName>METOPROLOL OROS</ProductName>
    <Strength>7/95</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009834</DrugIDPK>
    <LicenceNumber>PA0011/037/002</LicenceNumber>
    <ProductName>METOPROLOL OROS</ProductName>
    <Strength>14/190</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011735</DrugIDPK>
    <LicenceNumber>PA0069/007/002</LicenceNumber>
    <ProductName>JIFFY TOOTHACHE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010634</DrugIDPK>
    <LicenceNumber>PA0038/052/001</LicenceNumber>
    <ProductName>LOFTYL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010635</DrugIDPK>
    <LicenceNumber>PA0038/052/002</LicenceNumber>
    <ProductName>LOFTYL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012831</DrugIDPK>
    <LicenceNumber>PA0542/001/001</LicenceNumber>
    <ProductName>FISHERMANS FRIEND HONEY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lofthouse of Fleetwood Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010840</DrugIDPK>
    <LicenceNumber>PA0045/025/002</LicenceNumber>
    <ProductName>HALDOL DECANOATE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011746</DrugIDPK>
    <LicenceNumber>PA0074/013/006</LicenceNumber>
    <ProductName>ROWAFENAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011747</DrugIDPK>
    <LicenceNumber>PA0074/013/007</LicenceNumber>
    <ProductName>ROWAFENAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011741</DrugIDPK>
    <LicenceNumber>PA0074/013/001</LicenceNumber>
    <ProductName>ROWAFENAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011742</DrugIDPK>
    <LicenceNumber>PA0074/013/002</LicenceNumber>
    <ProductName>ROWAFENAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011743</DrugIDPK>
    <LicenceNumber>PA0074/013/003</LicenceNumber>
    <ProductName>ROWAFENAC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011744</DrugIDPK>
    <LicenceNumber>PA0074/013/004</LicenceNumber>
    <ProductName>ROWAFENAC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011745</DrugIDPK>
    <LicenceNumber>PA0074/013/005</LicenceNumber>
    <ProductName>ROWAFENAC AMPOULES</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013672</DrugIDPK>
    <LicenceNumber>PA0176/013/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013673</DrugIDPK>
    <LicenceNumber>PA0176/013/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013674</DrugIDPK>
    <LicenceNumber>PA0176/013/003</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001967</DrugIDPK>
    <LicenceNumber>PA0040/064/003</LicenceNumber>
    <ProductName>HEXABRIX 320</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1985-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOXAGLATE SODIUM</ActiveSubstance>
      <ActiveSubstance>IOXAGLATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015132</DrugIDPK>
    <LicenceNumber>PA0290/041/001</LicenceNumber>
    <ProductName>IONAX SCRUB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
      <ActiveSubstance>POLYETHYLENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015128</DrugIDPK>
    <LicenceNumber>PA0290/040/001</LicenceNumber>
    <ProductName>IONIL T SHAMPOO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015094</DrugIDPK>
    <LicenceNumber>PA0290/035/001</LicenceNumber>
    <ProductName>NUTRAPLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015106</DrugIDPK>
    <LicenceNumber>PA0290/036/001</LicenceNumber>
    <ProductName>PSORIGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>1987-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011407</DrugIDPK>
    <LicenceNumber>PA0056/038/001</LicenceNumber>
    <ProductName>L-BUNOLOL PARKE-DAVIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011408</DrugIDPK>
    <LicenceNumber>PA0056/038/002</LicenceNumber>
    <ProductName>L-BUNOLOL PARKE-DAVIS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1985-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009485</DrugIDPK>
    <LicenceNumber>PA0001/028/001</LicenceNumber>
    <ProductName>THEO 24</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009486</DrugIDPK>
    <LicenceNumber>PA0001/028/002</LicenceNumber>
    <ProductName>THEO 24</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009488</DrugIDPK>
    <LicenceNumber>PA0001/028/003</LicenceNumber>
    <ProductName>THEO 24</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013525</DrugIDPK>
    <LicenceNumber>PA0261/014/001</LicenceNumber>
    <ProductName>MINILYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LYNESTRENOL</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011286</DrugIDPK>
    <LicenceNumber>PA0051/008/001</LicenceNumber>
    <ProductName>AVLOSULFON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DAPSONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1990-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012997</DrugIDPK>
    <LicenceNumber>PA0120/005/001</LicenceNumber>
    <ProductName>MEDOCODENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012063</DrugIDPK>
    <LicenceNumber>PA0078/013/004</LicenceNumber>
    <ProductName>PENERIN</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013099</DrugIDPK>
    <LicenceNumber>PA0137/041/001</LicenceNumber>
    <ProductName>ABSTEM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013004</DrugIDPK>
    <LicenceNumber>PA0137/010/001</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013006</DrugIDPK>
    <LicenceNumber>PA0137/010/003</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013011</DrugIDPK>
    <LicenceNumber>PA0137/010/006</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013013</DrugIDPK>
    <LicenceNumber>PA0137/010/007</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013015</DrugIDPK>
    <LicenceNumber>PA0137/010/008</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013017</DrugIDPK>
    <LicenceNumber>PA0137/010/009</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013007</DrugIDPK>
    <LicenceNumber>PA0137/010/004</LicenceNumber>
    <ProductName>ACHROMYCIN EYE/EAR OINTMENT</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013010</DrugIDPK>
    <LicenceNumber>PA0137/010/005</LicenceNumber>
    <ProductName>ACHROMYCIN OPHTH. (SUSPENSION)</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013065</DrugIDPK>
    <LicenceNumber>PA0137/025/001</LicenceNumber>
    <ProductName>ACHROMYCIN V</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013066</DrugIDPK>
    <LicenceNumber>PA0137/025/002</LicenceNumber>
    <ProductName>ACHROMYCIN V</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013633</DrugIDPK>
    <LicenceNumber>PA0172/004/002</LicenceNumber>
    <ProductName>ANADIN ANALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013636</DrugIDPK>
    <LicenceNumber>PA0172/004/003</LicenceNumber>
    <ProductName>ANADIN ANALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012958</DrugIDPK>
    <LicenceNumber>PA0137/002/001</LicenceNumber>
    <ProductName>ARISTOCORT A</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012959</DrugIDPK>
    <LicenceNumber>PA0137/002/002</LicenceNumber>
    <ProductName>ARISTOCORT A</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012970</DrugIDPK>
    <LicenceNumber>PA0118/011/002</LicenceNumber>
    <ProductName>ATROPINE SULFATE BP</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013069</DrugIDPK>
    <LicenceNumber>PA0137/027/001</LicenceNumber>
    <ProductName>AUDICORT EAR SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013070</DrugIDPK>
    <LicenceNumber>PA0137/028/001</LicenceNumber>
    <ProductName>AURECORT OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013020</DrugIDPK>
    <LicenceNumber>PA0137/012/001</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013022</DrugIDPK>
    <LicenceNumber>PA0137/012/002</LicenceNumber>
    <ProductName>AUREOMYCIN OPHTHALMIC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013101</DrugIDPK>
    <LicenceNumber>PA0137/045/001</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013067</DrugIDPK>
    <LicenceNumber>PA0137/026/001</LicenceNumber>
    <ProductName>CINOPAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013068</DrugIDPK>
    <LicenceNumber>PA0137/026/002</LicenceNumber>
    <ProductName>CINOPAL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012896</DrugIDPK>
    <LicenceNumber>PA0115/012/001</LicenceNumber>
    <ProductName>CLOPIXOL ACUPHASE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012897</DrugIDPK>
    <LicenceNumber>PA0115/012/002</LicenceNumber>
    <ProductName>CLOPIXOL ACUPHASE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013100</DrugIDPK>
    <LicenceNumber>PA0137/044/001</LicenceNumber>
    <ProductName>COPHOLCO COUGH SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1979-08-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>TERPIN HYDRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012971</DrugIDPK>
    <LicenceNumber>PA0118/012/001</LicenceNumber>
    <ProductName>CYCLOPENTOLATE HYDROCHLORIDE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013095</DrugIDPK>
    <LicenceNumber>PA0137/039/001</LicenceNumber>
    <ProductName>DEMOLOX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013096</DrugIDPK>
    <LicenceNumber>PA0137/039/002</LicenceNumber>
    <ProductName>DEMOLOX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013097</DrugIDPK>
    <LicenceNumber>PA0137/039/003</LicenceNumber>
    <ProductName>DEMOLOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012988</DrugIDPK>
    <LicenceNumber>PA0137/006/001</LicenceNumber>
    <ProductName>DETECLO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013073</DrugIDPK>
    <LicenceNumber>PA0137/029/003</LicenceNumber>
    <ProductName>DIAMOX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETAZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>PARENTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013071</DrugIDPK>
    <LicenceNumber>PA0137/029/001</LicenceNumber>
    <ProductName>DIAMOX PARENTERAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETAZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>PARENTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013072</DrugIDPK>
    <LicenceNumber>PA0137/029/002</LicenceNumber>
    <ProductName>DIAMOX SUSTETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETAZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>PARENTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013082</DrugIDPK>
    <LicenceNumber>PA0137/033/001</LicenceNumber>
    <ProductName>DISPHEX SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012023</DrugIDPK>
    <LicenceNumber>PA0078/047/002</LicenceNumber>
    <ProductName>DOXY</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012729</DrugIDPK>
    <LicenceNumber>PA0109/001/001</LicenceNumber>
    <ProductName>FENOBELLADINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012934</DrugIDPK>
    <LicenceNumber>PA0118/006/002</LicenceNumber>
    <ProductName>FLAMAZINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFADIAZINE SILVER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004667</DrugIDPK>
    <LicenceNumber>PA0179/035/001</LicenceNumber>
    <ProductName>GLYCINE 1.5% (IRRIGATION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1989-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012052</DrugIDPK>
    <LicenceNumber>PA0090/007/001</LicenceNumber>
    <ProductName>GONADOTRAPHON L.H.</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012987</DrugIDPK>
    <LicenceNumber>PA0137/005/001</LicenceNumber>
    <ProductName>GONOCIN 030</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013315</DrugIDPK>
    <LicenceNumber>PA0167/029/001</LicenceNumber>
    <ProductName>HEMOFIL ANTIHAEMOPHILIC FACTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012972</DrugIDPK>
    <LicenceNumber>PA0118/014/001</LicenceNumber>
    <ProductName>HOMATROPINE HYDROBROMIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013114</DrugIDPK>
    <LicenceNumber>PA0126/014/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013245</DrugIDPK>
    <LicenceNumber>PA0161/013/004</LicenceNumber>
    <ProductName>ISOPAQUE CYSTO 100</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Electramed Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013077</DrugIDPK>
    <LicenceNumber>PA0137/030/004</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013078</DrugIDPK>
    <LicenceNumber>PA0137/030/005</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013074</DrugIDPK>
    <LicenceNumber>PA0137/030/001</LicenceNumber>
    <ProductName>LEDERCORT ACETONIDE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013075</DrugIDPK>
    <LicenceNumber>PA0137/030/002</LicenceNumber>
    <ProductName>LEDERCORT ACETONIDE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013076</DrugIDPK>
    <LicenceNumber>PA0137/030/003</LicenceNumber>
    <ProductName>LEDERCORT DIACETATE PARENTERAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>PARENTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013019</DrugIDPK>
    <LicenceNumber>PA0137/011/001</LicenceNumber>
    <ProductName>LEDERKYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013023</DrugIDPK>
    <LicenceNumber>PA0137/013/001</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013033</DrugIDPK>
    <LicenceNumber>PA0137/013/006</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013025</DrugIDPK>
    <LicenceNumber>PA0137/013/002</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013029</DrugIDPK>
    <LicenceNumber>PA0137/013/004</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013031</DrugIDPK>
    <LicenceNumber>PA0137/013/005</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013027</DrugIDPK>
    <LicenceNumber>PA0137/013/003</LicenceNumber>
    <ProductName>LEDERMYCIN PAEDIATRIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013079</DrugIDPK>
    <LicenceNumber>PA0137/031/001</LicenceNumber>
    <ProductName>LEDERSPAN PARENTERAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013080</DrugIDPK>
    <LicenceNumber>PA0137/031/002</LicenceNumber>
    <ProductName>LEDERSPAN PARENTERAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE HEXACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012985</DrugIDPK>
    <LicenceNumber>PA0137/004/011</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012981</DrugIDPK>
    <LicenceNumber>PA0137/004/008</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012983</DrugIDPK>
    <LicenceNumber>PA0137/004/010</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012966</DrugIDPK>
    <LicenceNumber>PA0137/004/006</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012967</DrugIDPK>
    <LicenceNumber>PA0137/004/007</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012961</DrugIDPK>
    <LicenceNumber>PA0137/004/001</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012962</DrugIDPK>
    <LicenceNumber>PA0137/004/002</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012963</DrugIDPK>
    <LicenceNumber>PA0137/004/003</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012964</DrugIDPK>
    <LicenceNumber>PA0137/004/004</LicenceNumber>
    <ProductName>LOXAPAC (ORAL CONCENTRATE)</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012965</DrugIDPK>
    <LicenceNumber>PA0137/004/005</LicenceNumber>
    <ProductName>LOXAPAC (ORAL SUSPENSION)</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013218</DrugIDPK>
    <LicenceNumber>PA0149/016/001</LicenceNumber>
    <ProductName>MAGALDRATE PLUS SIMETHICONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012730</DrugIDPK>
    <LicenceNumber>PA0109/002/001</LicenceNumber>
    <ProductName>MEDOCODENE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013057</DrugIDPK>
    <LicenceNumber>PA0137/023/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013058</DrugIDPK>
    <LicenceNumber>PA0137/023/002</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013059</DrugIDPK>
    <LicenceNumber>PA0137/023/003</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013089</DrugIDPK>
    <LicenceNumber>PA0137/036/001</LicenceNumber>
    <ProductName>METHOTREXATE IT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013090</DrugIDPK>
    <LicenceNumber>PA0137/036/002</LicenceNumber>
    <ProductName>METHOTREXATE IT</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013060</DrugIDPK>
    <LicenceNumber>PA0137/023/004</LicenceNumber>
    <ProductName>METHOTREXATE PARENTERAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013061</DrugIDPK>
    <LicenceNumber>PA0137/023/005</LicenceNumber>
    <ProductName>METHOTREXATE PARENTERAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012991</DrugIDPK>
    <LicenceNumber>PA0137/007/002</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012993</DrugIDPK>
    <LicenceNumber>PA0137/007/003</LicenceNumber>
    <ProductName>MINOCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012990</DrugIDPK>
    <LicenceNumber>PA0137/007/001</LicenceNumber>
    <ProductName>MINOCIN (60 CC)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013590</DrugIDPK>
    <LicenceNumber>PA0184/005/001</LicenceNumber>
    <ProductName>MRS CULLENS SLEEP EZEE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cullen and Davison Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012995</DrugIDPK>
    <LicenceNumber>PA0137/008/001</LicenceNumber>
    <ProductName>MYAMBOTOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012996</DrugIDPK>
    <LicenceNumber>PA0137/008/002</LicenceNumber>
    <ProductName>MYAMBOTOL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012998</DrugIDPK>
    <LicenceNumber>PA0137/009/001</LicenceNumber>
    <ProductName>MYNAH</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013002</DrugIDPK>
    <LicenceNumber>PA0137/009/003</LicenceNumber>
    <ProductName>MYNAH</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013003</DrugIDPK>
    <LicenceNumber>PA0137/009/004</LicenceNumber>
    <ProductName>MYNAH</ProductName>
    <Strength>365</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013000</DrugIDPK>
    <LicenceNumber>PA0137/009/002</LicenceNumber>
    <ProductName>MYNAH</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013091</DrugIDPK>
    <LicenceNumber>PA0137/037/001</LicenceNumber>
    <ProductName>NEURODYNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013092</DrugIDPK>
    <LicenceNumber>PA0137/037/002</LicenceNumber>
    <ProductName>NEURODYNE (CELLULOSE ACETATE STRIPS)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013081</DrugIDPK>
    <LicenceNumber>PA0137/032/001</LicenceNumber>
    <ProductName>PARFENAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012755</DrugIDPK>
    <LicenceNumber>PA0109/005/002</LicenceNumber>
    <ProductName>PHOLCOMED DIABETIC FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012759</DrugIDPK>
    <LicenceNumber>PA0109/006/001</LicenceNumber>
    <ProductName>PHOLCOMED DIABETIC LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012751</DrugIDPK>
    <LicenceNumber>PA0109/005/001</LicenceNumber>
    <ProductName>PHOLCOMED FORTE LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1989-12-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012974</DrugIDPK>
    <LicenceNumber>PA0118/017/003</LicenceNumber>
    <ProductName>PILOCARPINE NITRATE BP</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013176</DrugIDPK>
    <LicenceNumber>PA0144/009/001</LicenceNumber>
    <ProductName>SALIGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>1978-08-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012735</DrugIDPK>
    <LicenceNumber>PA0109/003/001</LicenceNumber>
    <ProductName>SALIMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013772</DrugIDPK>
    <LicenceNumber>PA0176/046/001</LicenceNumber>
    <ProductName>SOOTHING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANTAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012976</DrugIDPK>
    <LicenceNumber>PA0118/021/002</LicenceNumber>
    <ProductName>STAINS SULFACETAMIDE SODIUM B P</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013094</DrugIDPK>
    <LicenceNumber>PA0137/038/002</LicenceNumber>
    <ProductName>VISDERM H (AMCINONIDE)</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013093</DrugIDPK>
    <LicenceNumber>PA0137/038/001</LicenceNumber>
    <ProductName>VISDERM H AMCINONIDE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1978-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016247</DrugIDPK>
    <LicenceNumber>PA0040/050/001</LicenceNumber>
    <ProductName>TIXYLIX LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1984-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011419</DrugIDPK>
    <LicenceNumber>PA0057/002/001</LicenceNumber>
    <ProductName>PEPTARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYOSCYAMINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012327</DrugIDPK>
    <LicenceNumber>PA0396/005/001</LicenceNumber>
    <ProductName>SULPHACETAMIDE EYE DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Daniels Pharmaceutical Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010524</DrugIDPK>
    <LicenceNumber>PA0023/043/002</LicenceNumber>
    <ProductName>BEGRIVAC - S MULTIDOSE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010208</DrugIDPK>
    <LicenceNumber>PA0028/047/001</LicenceNumber>
    <ProductName>LYPSYL COLD SORE TREATMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1985-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013732</DrugIDPK>
    <LicenceNumber>PA0176/016/003</LicenceNumber>
    <ProductName>COBUTOLIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016241</DrugIDPK>
    <LicenceNumber>PA0039/034/002</LicenceNumber>
    <ProductName>MUCOLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010841</DrugIDPK>
    <LicenceNumber>PA0045/028/002</LicenceNumber>
    <ProductName>HISMANAL  (SUSPENSION)</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ASTEMIZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013743</DrugIDPK>
    <LicenceNumber>PA0176/016/001</LicenceNumber>
    <ProductName>COBUTOLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013731</DrugIDPK>
    <LicenceNumber>PA0176/016/002</LicenceNumber>
    <ProductName>COBUTOLIN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013733</DrugIDPK>
    <LicenceNumber>PA0176/016/004</LicenceNumber>
    <ProductName>COBUTOLIN INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>1985-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013730</DrugIDPK>
    <LicenceNumber>PA0218/001/001</LicenceNumber>
    <ProductName>MONOTARD M.C. INSULIN ZINC (SUSPENSION)</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1975-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012310</DrugIDPK>
    <LicenceNumber>PA0303/014/001</LicenceNumber>
    <ProductName>TRICANIX</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TINIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012311</DrugIDPK>
    <LicenceNumber>PA0303/014/002</LicenceNumber>
    <ProductName>TRICANIX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TINIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011399</DrugIDPK>
    <LicenceNumber>PA0054/008/002</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1976-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011404</DrugIDPK>
    <LicenceNumber>PA0054/008/003</LicenceNumber>
    <ProductName>AMINOFUSIN FORTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011395</DrugIDPK>
    <LicenceNumber>PA0054/008/001</LicenceNumber>
    <ProductName>AMINOFUSIN L600</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011569</DrugIDPK>
    <LicenceNumber>PA0062/011/006</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011261</DrugIDPK>
    <LicenceNumber>PA0054/019/001</LicenceNumber>
    <ProductName>COSOME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1981-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ETHYLMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011584</DrugIDPK>
    <LicenceNumber>PA0062/014/001</LicenceNumber>
    <ProductName>CYCLOSPASMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011587</DrugIDPK>
    <LicenceNumber>PA0062/014/002</LicenceNumber>
    <ProductName>CYCLOSPASMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011590</DrugIDPK>
    <LicenceNumber>PA0062/014/003</LicenceNumber>
    <ProductName>CYCLOSPASMOL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011409</DrugIDPK>
    <LicenceNumber>PA0054/010/001</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011380</DrugIDPK>
    <LicenceNumber>PA0054/004/002</LicenceNumber>
    <ProductName>ENCEPHABOL FORTE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1977-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRITINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011324</DrugIDPK>
    <LicenceNumber>PA0051/041/001</LicenceNumber>
    <ProductName>ERALDIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRACTOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011317</DrugIDPK>
    <LicenceNumber>PA0051/031/002</LicenceNumber>
    <ProductName>HIBISCRUB</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011318</DrugIDPK>
    <LicenceNumber>PA0051/031/003</LicenceNumber>
    <ProductName>HIBISCRUB</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011730</DrugIDPK>
    <LicenceNumber>PA0068/008/001</LicenceNumber>
    <ProductName>MERIEUX ORAL POLIOMYELITIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011731</DrugIDPK>
    <LicenceNumber>PA0068/008/002</LicenceNumber>
    <ProductName>MERIEUX ORAL POLIOMYELITIS VACCINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011737</DrugIDPK>
    <LicenceNumber>PA0074/001/001</LicenceNumber>
    <ProductName>NIKEVIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1976-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011815</DrugIDPK>
    <LicenceNumber>PA0077/023/002</LicenceNumber>
    <ProductName>PANADOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011255</DrugIDPK>
    <LicenceNumber>PA0054/014/002</LicenceNumber>
    <ProductName>SEPTOPAL BEADS/CHAINS 30</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011309</DrugIDPK>
    <LicenceNumber>PA0051/018/003</LicenceNumber>
    <ProductName>SYNALAR C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011310</DrugIDPK>
    <LicenceNumber>PA0051/018/004</LicenceNumber>
    <ProductName>SYNALAR C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011307</DrugIDPK>
    <LicenceNumber>PA0051/017/004</LicenceNumber>
    <ProductName>SYNALAR N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011313</DrugIDPK>
    <LicenceNumber>PA0051/019/003</LicenceNumber>
    <ProductName>SYNANDONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011475</DrugIDPK>
    <LicenceNumber>PA0061/001/001</LicenceNumber>
    <ProductName>TOLVON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1975-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011732</DrugIDPK>
    <LicenceNumber>PA0068/012/001</LicenceNumber>
    <ProductName>TRIVASTAL 50 RETARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011315</DrugIDPK>
    <LicenceNumber>PA0054/015/002</LicenceNumber>
    <ProductName>UROMIRO 300</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011256</DrugIDPK>
    <LicenceNumber>PA0054/015/001</LicenceNumber>
    <ProductName>UROMIRO 300</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011492</DrugIDPK>
    <LicenceNumber>PA0062/006/001</LicenceNumber>
    <ProductName>VENDARCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011011</DrugIDPK>
    <LicenceNumber>PA0048/015/001</LicenceNumber>
    <ProductName>DEFENCIN CP</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1978-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013310</DrugIDPK>
    <LicenceNumber>PA0167/015/001</LicenceNumber>
    <ProductName>ELECTROLYTE 20.0% DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC ACETATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013311</DrugIDPK>
    <LicenceNumber>PA0167/016/001</LicenceNumber>
    <ProductName>ELECTROLYTE SOLUTION B</ProductName>
    <Strength>20.0%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1980-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010578</DrugIDPK>
    <LicenceNumber>PA0044/045/003</LicenceNumber>
    <ProductName>BCG INTRADERMAL 0.8 TO 2.6</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010853</DrugIDPK>
    <LicenceNumber>PA0046/004/003</LicenceNumber>
    <ProductName>FUCIDIN DISCS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010673</DrugIDPK>
    <LicenceNumber>PA0045/002/005</LicenceNumber>
    <ProductName>GYNO-DAKTARIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011291</DrugIDPK>
    <LicenceNumber>PA0051/011/001</LicenceNumber>
    <ProductName>IMPERACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010900</DrugIDPK>
    <LicenceNumber>PA0047/038/005</LicenceNumber>
    <ProductName>KEFADOL</ProductName>
    <Strength>4.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002187</DrugIDPK>
    <LicenceNumber>PA0047/038/002</LicenceNumber>
    <ProductName>KEFADOL</ProductName>
    <Strength>0.75</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFAMANDOLE NAFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010722</DrugIDPK>
    <LicenceNumber>PA0045/016/007</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010720</DrugIDPK>
    <LicenceNumber>PA0045/016/004</LicenceNumber>
    <ProductName>MOTILIUM ORAL</ProductName>
    <Strength>1 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1978-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010565</DrugIDPK>
    <LicenceNumber>PA0044/038/001</LicenceNumber>
    <ProductName>NEPENTHE INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PAPAVERETUM</ActiveSubstance>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011217</DrugIDPK>
    <LicenceNumber>PA0050/069/001</LicenceNumber>
    <ProductName>OCERAL ROCHE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011218</DrugIDPK>
    <LicenceNumber>PA0050/069/002</LicenceNumber>
    <ProductName>OCERAL ROCHE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011220</DrugIDPK>
    <LicenceNumber>PA0050/069/003</LicenceNumber>
    <ProductName>OCERAL ROCHE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010563</DrugIDPK>
    <LicenceNumber>PA0044/037/004</LicenceNumber>
    <ProductName>ZINACEF (CEFUROXINE) VIALS</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011511</DrugIDPK>
    <LicenceNumber>PA0057/043/001</LicenceNumber>
    <ProductName>CALCISORB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CELLULOSE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011438</DrugIDPK>
    <LicenceNumber>PA0057/007/002</LicenceNumber>
    <ProductName>DISALCID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALSALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011483</DrugIDPK>
    <LicenceNumber>PA0057/026/001</LicenceNumber>
    <ProductName>MEDIHALER-DUO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011482</DrugIDPK>
    <LicenceNumber>PA0057/025/001</LicenceNumber>
    <ProductName>MEDIHALER-EPI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011478</DrugIDPK>
    <LicenceNumber>PA0057/023/002</LicenceNumber>
    <ProductName>NORFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORPHENADRINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011467</DrugIDPK>
    <LicenceNumber>PA0057/015/001</LicenceNumber>
    <ProductName>NUMOTAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOETARINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011516</DrugIDPK>
    <LicenceNumber>PA0057/050/001</LicenceNumber>
    <ProductName>RIKOSPRAY SILICONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SILICONE FLUID SFD 119</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009454</DrugIDPK>
    <LicenceNumber>PA0001/003/003</LicenceNumber>
    <ProductName>NORPACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1979-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010713</DrugIDPK>
    <LicenceNumber>PA0040/017/002</LicenceNumber>
    <ProductName>INTRAVAL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010740</DrugIDPK>
    <LicenceNumber>PA0040/035/001</LicenceNumber>
    <ProductName>TIXYLIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010293</DrugIDPK>
    <LicenceNumber>PA0022/015/001</LicenceNumber>
    <ProductName>ALUDROX</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010295</DrugIDPK>
    <LicenceNumber>PA0022/015/003</LicenceNumber>
    <ProductName>ALUDROX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010300</DrugIDPK>
    <LicenceNumber>PA0022/015/004</LicenceNumber>
    <ProductName>ALUDROX</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010302</DrugIDPK>
    <LicenceNumber>PA0022/015/005</LicenceNumber>
    <ProductName>ALUDROX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010305</DrugIDPK>
    <LicenceNumber>PA0022/016/001</LicenceNumber>
    <ProductName>ALUDROX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010064</DrugIDPK>
    <LicenceNumber>PA0019/003/003</LicenceNumber>
    <ProductName>ATARAX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010028</DrugIDPK>
    <LicenceNumber>PA0019/018/005</LicenceNumber>
    <ProductName>CORTRIL 1.0%</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010501</DrugIDPK>
    <LicenceNumber>PA0023/019/003</LicenceNumber>
    <ProductName>DAONIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010459</DrugIDPK>
    <LicenceNumber>PA0023/014/001</LicenceNumber>
    <ProductName>HOSTACYCLINE P</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010490</DrugIDPK>
    <LicenceNumber>PA0028/029/001</LicenceNumber>
    <ProductName>ISMELIN - NAVIDREX K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE SULFATE</ActiveSubstance>
      <ActiveSubstance>CYCLOPENTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010439</DrugIDPK>
    <LicenceNumber>PA0027/006/001</LicenceNumber>
    <ProductName>LEMSIP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010249</DrugIDPK>
    <LicenceNumber>PA0031/001/003</LicenceNumber>
    <ProductName>POTABA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenwood Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM AMINOBENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010081</DrugIDPK>
    <LicenceNumber>PA0019/009/008</LicenceNumber>
    <ProductName>TERRAMYCIN INTRAVENOUS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012671</DrugIDPK>
    <LicenceNumber>PA0108/003/015</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012685</DrugIDPK>
    <LicenceNumber>PA0108/003/016</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012688</DrugIDPK>
    <LicenceNumber>PA0108/003/017</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010344</DrugIDPK>
    <LicenceNumber>PA0035/001/005</LicenceNumber>
    <ProductName>ALPHACILLIN</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012061</DrugIDPK>
    <LicenceNumber>PA0078/013/002</LicenceNumber>
    <ProductName>PENERIN</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012659</DrugIDPK>
    <LicenceNumber>PA0456/001/002</LicenceNumber>
    <ProductName>CALSALETTES (UNCOATED)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Torbet Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011866</DrugIDPK>
    <LicenceNumber>PA0077/058/001</LicenceNumber>
    <ProductName>GLURENORM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLIQUIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009673</DrugIDPK>
    <LicenceNumber>PA0007/025/003</LicenceNumber>
    <ProductName>BISOLVON AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1984-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010653</DrugIDPK>
    <LicenceNumber>PA0039/016/001</LicenceNumber>
    <ProductName>OPILON</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010654</DrugIDPK>
    <LicenceNumber>PA0039/016/002</LicenceNumber>
    <ProductName>OPILON FORTE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010657</DrugIDPK>
    <LicenceNumber>PA0039/019/002</LicenceNumber>
    <ProductName>PERITRATE S.A.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010690</DrugIDPK>
    <LicenceNumber>PA0039/030/001</LicenceNumber>
    <ProductName>PHOLCOLIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010679</DrugIDPK>
    <LicenceNumber>PA0039/022/003</LicenceNumber>
    <ProductName>SINUTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010662</DrugIDPK>
    <LicenceNumber>PA0039/022/001</LicenceNumber>
    <ProductName>SINUTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012258</DrugIDPK>
    <LicenceNumber>PA0377/002/001</LicenceNumber>
    <ProductName>SLOANS LINIMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lambert Chemicals Co. Ltd</PAHolder>
    <AuthorisedDate>1984-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
      <ActiveSubstance>PINE OIL</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011847</DrugIDPK>
    <LicenceNumber>PA0077/036/003</LicenceNumber>
    <ProductName>PANADEINE FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011835</DrugIDPK>
    <LicenceNumber>PA0077/033/002</LicenceNumber>
    <ProductName>SOLPADEINE FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013773</DrugIDPK>
    <LicenceNumber>PA0277/057/001</LicenceNumber>
    <ProductName>RINSTEAD PHEROL THROAT (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011625</DrugIDPK>
    <LicenceNumber>PA0065/006/001</LicenceNumber>
    <ProductName>DILOPECT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011034</DrugIDPK>
    <LicenceNumber>PA0046/059/002</LicenceNumber>
    <ProductName>BURINEX A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009646</DrugIDPK>
    <LicenceNumber>PA0004/029/001</LicenceNumber>
    <ProductName>NIROLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011325</DrugIDPK>
    <LicenceNumber>PA0051/044/001</LicenceNumber>
    <ProductName>CETAVLON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009783</DrugIDPK>
    <LicenceNumber>PA0017/022/003</LicenceNumber>
    <ProductName>ALMEVAX RUBELLA VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009745</DrugIDPK>
    <LicenceNumber>PA0016/025/002</LicenceNumber>
    <ProductName>CYTOSAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009798</DrugIDPK>
    <LicenceNumber>PA0017/025/004</LicenceNumber>
    <ProductName>DIPHTHERIA ANTITOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009793</DrugIDPK>
    <LicenceNumber>PA0017/025/002</LicenceNumber>
    <ProductName>DIPHTHERIA ANTITOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009806</DrugIDPK>
    <LicenceNumber>PA0017/026/002</LicenceNumber>
    <ProductName>DIPHTHERIA VACCINE P T A P</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009795</DrugIDPK>
    <LicenceNumber>PA0017/025/003</LicenceNumber>
    <ProductName>DIPHTHERIAL ANTITOXIN BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009813</DrugIDPK>
    <LicenceNumber>PA0017/030/001</LicenceNumber>
    <ProductName>GAZ GANGRENE ANTITOXIN B P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009723</DrugIDPK>
    <LicenceNumber>PA0016/014/001</LicenceNumber>
    <ProductName>PAMINAL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009849</DrugIDPK>
    <LicenceNumber>PA0017/039/001</LicenceNumber>
    <ProductName>TETANUS ANTITOXIN</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009852</DrugIDPK>
    <LicenceNumber>PA0017/039/002</LicenceNumber>
    <ProductName>TETANUS ANTITOXIN B P</ProductName>
    <Strength>15000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009855</DrugIDPK>
    <LicenceNumber>PA0017/039/003</LicenceNumber>
    <ProductName>TETANUS ANTITOXIN B P 10000</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009859</DrugIDPK>
    <LicenceNumber>PA0017/039/004</LicenceNumber>
    <ProductName>TETANUS ANTITOXIN B P 50,000</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009933</DrugIDPK>
    <LicenceNumber>PA0013/009/001</LicenceNumber>
    <ProductName>TRIOGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009934</DrugIDPK>
    <LicenceNumber>PA0013/009/002</LicenceNumber>
    <ProductName>TRIOGESIC ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009952</DrugIDPK>
    <LicenceNumber>PA0013/023/001</LicenceNumber>
    <ProductName>TRIOMINIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010015</DrugIDPK>
    <LicenceNumber>PA0013/023/002</LicenceNumber>
    <ProductName>TRIOMINIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009837</DrugIDPK>
    <LicenceNumber>PA0017/037/001</LicenceNumber>
    <ProductName>TYPHOID-PARATYPHOID A &amp; B AND CHOLERAVACCINE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009839</DrugIDPK>
    <LicenceNumber>PA0017/037/002</LicenceNumber>
    <ProductName>TYPHOID-PARATYPHOID A &amp; B/CHOLERA VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009840</DrugIDPK>
    <LicenceNumber>PA0017/038/001</LicenceNumber>
    <ProductName>TYPHOID-PARATYPHOID A B &amp; TETANUS VACCINE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009843</DrugIDPK>
    <LicenceNumber>PA0017/038/002</LicenceNumber>
    <ProductName>TYPHOID-PARATYPHOID A B AND TETANUS VACCINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009825</DrugIDPK>
    <LicenceNumber>PA0017/034/001</LicenceNumber>
    <ProductName>TYPHOLD-PARATYPHOID A &amp; B VACCINE</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009827</DrugIDPK>
    <LicenceNumber>PA0017/034/002</LicenceNumber>
    <ProductName>TYPHOLD-PARATYPHOID A &amp; B VACCINE B P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009608</DrugIDPK>
    <LicenceNumber>PA0007/015/006</LicenceNumber>
    <ProductName>ALUPENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009704</DrugIDPK>
    <LicenceNumber>PA0009/013/004</LicenceNumber>
    <ProductName>BUDESONIDE AEROSOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009702</DrugIDPK>
    <LicenceNumber>PA0009/013/003</LicenceNumber>
    <ProductName>BUDESONIDE AEROSOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009542</DrugIDPK>
    <LicenceNumber>PA0002/016/002</LicenceNumber>
    <ProductName>MODITEN ENANTHATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010415</DrugIDPK>
    <LicenceNumber>PA0035/065/001</LicenceNumber>
    <ProductName>NOROXIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1984-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009554</DrugIDPK>
    <LicenceNumber>PA0006/018/003</LicenceNumber>
    <ProductName>PROCTOSEDYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009611</DrugIDPK>
    <LicenceNumber>PA0002/043/001</LicenceNumber>
    <ProductName>TESULOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009676</DrugIDPK>
    <LicenceNumber>PA0009/027/005</LicenceNumber>
    <ProductName>TONOCARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCAINIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010099</DrugIDPK>
    <LicenceNumber>PA0018/030/001</LicenceNumber>
    <ProductName>SANATOGEN JUNIOR VITAMINS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1984-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010102</DrugIDPK>
    <LicenceNumber>PA0018/031/001</LicenceNumber>
    <ProductName>SANATOGEN MULTIVITAMINS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1984-08-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010089</DrugIDPK>
    <LicenceNumber>PA0018/026/001</LicenceNumber>
    <ProductName>SANATOGEN MULTIVITIMINS PLUS IRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1984-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011726</DrugIDPK>
    <LicenceNumber>PA0073/119/001</LicenceNumber>
    <ProductName>ANTYLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010686</DrugIDPK>
    <LicenceNumber>PA0045/005/006</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1977-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009680</DrugIDPK>
    <LicenceNumber>PA0009/032/001</LicenceNumber>
    <ProductName>SOLVEZINK</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009697</DrugIDPK>
    <LicenceNumber>PA0009/011/002</LicenceNumber>
    <ProductName>THEAN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1989-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROXYPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009698</DrugIDPK>
    <LicenceNumber>PA0009/011/003</LicenceNumber>
    <ProductName>THEAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROXYPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009695</DrugIDPK>
    <LicenceNumber>PA0009/011/001</LicenceNumber>
    <ProductName>THEAN AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROXYPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010525</DrugIDPK>
    <LicenceNumber>PA0023/049/001</LicenceNumber>
    <ProductName>LASILACTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011933</DrugIDPK>
    <LicenceNumber>PA0086/009/001</LicenceNumber>
    <ProductName>ROBITUSSIN AC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012292</DrugIDPK>
    <LicenceNumber>PA0383/002/001</LicenceNumber>
    <ProductName>HYPOTEARS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>CV Limited</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL</ActiveSubstance>
      <ActiveSubstance>POLYVINYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010739</DrugIDPK>
    <LicenceNumber>PA0040/034/001</LicenceNumber>
    <ProductName>PHENSEDYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011185</DrugIDPK>
    <LicenceNumber>PA0049/030/001</LicenceNumber>
    <ProductName>ANXON</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1984-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011160</DrugIDPK>
    <LicenceNumber>PA0049/018/006</LicenceNumber>
    <ProductName>FLOXAPEN 125 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011161</DrugIDPK>
    <LicenceNumber>PA0049/018/007</LicenceNumber>
    <ProductName>FLOXAPEN 125 MG/5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009956</DrugIDPK>
    <LicenceNumber>PA0013/034/001</LicenceNumber>
    <ProductName>MIRETILAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1984-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENDRALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009957</DrugIDPK>
    <LicenceNumber>PA0013/034/002</LicenceNumber>
    <ProductName>MIRETILAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1984-09-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENDRALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007566</DrugIDPK>
    <LicenceNumber>PA0544/003/003</LicenceNumber>
    <ProductName>MEASAVAX 50 DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007564</DrugIDPK>
    <LicenceNumber>PA0544/002/003</LicenceNumber>
    <ProductName>RUBAVAX 50 DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009664</DrugIDPK>
    <LicenceNumber>PA0007/015/008</LicenceNumber>
    <ProductName>ALUPENT AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013548</DrugIDPK>
    <LicenceNumber>PA0271/005/001</LicenceNumber>
    <ProductName>VASOPROST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALPROSTADIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009858</DrugIDPK>
    <LicenceNumber>PA0012/009/001</LicenceNumber>
    <ProductName>GONDAFON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYMIDINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009866</DrugIDPK>
    <LicenceNumber>PA0012/017/002</LicenceNumber>
    <ProductName>PRIMOBOLAN DEPOT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009865</DrugIDPK>
    <LicenceNumber>PA0012/017/001</LicenceNumber>
    <ProductName>PRIMOBOLAN DEPOT AMPS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METENOLONE ENANTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009870</DrugIDPK>
    <LicenceNumber>PA0012/020/003</LicenceNumber>
    <ProductName>PRIMOLUT DEPOT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYPROGESTERONE CAPROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009871</DrugIDPK>
    <LicenceNumber>PA0012/020/004</LicenceNumber>
    <ProductName>PRIMOLUT DEPOT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYPROGESTERONE CAPROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009869</DrugIDPK>
    <LicenceNumber>PA0012/020/001</LicenceNumber>
    <ProductName>PRIMOLUT DEPOT AMPS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYPROGESTERONE CAPROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009873</DrugIDPK>
    <LicenceNumber>PA0012/025/001</LicenceNumber>
    <ProductName>PROVIRONUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESTEROLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010299</DrugIDPK>
    <LicenceNumber>PA0032/027/001</LicenceNumber>
    <ProductName>HALIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXBROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010301</DrugIDPK>
    <LicenceNumber>PA0032/032/001</LicenceNumber>
    <ProductName>RENNIE PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009944</DrugIDPK>
    <LicenceNumber>PA0013/015/001</LicenceNumber>
    <ProductName>DIHYDERGOT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOTAMINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009737</DrugIDPK>
    <LicenceNumber>PA0010/005/001</LicenceNumber>
    <ProductName>CHYMAR-F</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009738</DrugIDPK>
    <LicenceNumber>PA0010/005/002</LicenceNumber>
    <ProductName>CHYMAR-F</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009780</DrugIDPK>
    <LicenceNumber>PA0010/023/001</LicenceNumber>
    <ProductName>DIALUME</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010400</DrugIDPK>
    <LicenceNumber>PA0035/054/001</LicenceNumber>
    <ProductName>PNEUMOVAX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL VACCINE</ActiveSubstance>
      <ActiveSubstance>POLYVALENT E. COLIVACCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010401</DrugIDPK>
    <LicenceNumber>PA0035/054/002</LicenceNumber>
    <ProductName>PNEUMOVAX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL VACCINE</ActiveSubstance>
      <ActiveSubstance>POLYVALENT E. COLIVACCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010402</DrugIDPK>
    <LicenceNumber>PA0035/054/003</LicenceNumber>
    <ProductName>PNEUMOVAX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL VACCINE</ActiveSubstance>
      <ActiveSubstance>POLYVALENT E. COLIVACCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010403</DrugIDPK>
    <LicenceNumber>PA0035/054/004</LicenceNumber>
    <ProductName>PNEUMOVAX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PNEUMOCOCCAL VACCINE</ActiveSubstance>
      <ActiveSubstance>POLYVALENT E. COLIVACCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010303</DrugIDPK>
    <LicenceNumber>PA0032/032/002</LicenceNumber>
    <ProductName>RENNIE PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009714</DrugIDPK>
    <LicenceNumber>PA0009/016/010</LicenceNumber>
    <ProductName>XYLOCAINE 0.5%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009694</DrugIDPK>
    <LicenceNumber>PA0009/016/014</LicenceNumber>
    <ProductName>XYLOCAINE 1.0%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009699</DrugIDPK>
    <LicenceNumber>PA0009/016/018</LicenceNumber>
    <ProductName>XYLOCAINE 2.0%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1981-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009705</DrugIDPK>
    <LicenceNumber>PA0009/019/001</LicenceNumber>
    <ProductName>XYLOCAINE WITH ADRENALINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009708</DrugIDPK>
    <LicenceNumber>PA0009/019/003</LicenceNumber>
    <ProductName>XYLOCAINE WITH ADRENALINE 1%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009711</DrugIDPK>
    <LicenceNumber>PA0009/019/006</LicenceNumber>
    <ProductName>XYLOCAINE WITH ADRENALINE 2.0%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012940</DrugIDPK>
    <LicenceNumber>PA0130/002/001</LicenceNumber>
    <ProductName>CANTIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012941</DrugIDPK>
    <LicenceNumber>PA0130/002/002</LicenceNumber>
    <ProductName>CANTIL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012942</DrugIDPK>
    <LicenceNumber>PA0130/004/001</LicenceNumber>
    <ProductName>DACTIL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012943</DrugIDPK>
    <LicenceNumber>PA0130/005/001</LicenceNumber>
    <ProductName>PIPTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012951</DrugIDPK>
    <LicenceNumber>PA0130/014/001</LicenceNumber>
    <ProductName>PIPTALIN ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012600</DrugIDPK>
    <LicenceNumber>PA0102/017/002</LicenceNumber>
    <ProductName>POSALFILIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PODOPHYLLUM RESIN</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012979</DrugIDPK>
    <LicenceNumber>PA0118/031/001</LicenceNumber>
    <ProductName>EYEZONE EYE LOTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012643</DrugIDPK>
    <LicenceNumber>PA0108/001/003</LicenceNumber>
    <ProductName>DUVADILAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011878</DrugIDPK>
    <LicenceNumber>PA0077/074/001</LicenceNumber>
    <ProductName>ALEVAIRE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TYLOXAPOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011754</DrugIDPK>
    <LicenceNumber>PA0077/005/001</LicenceNumber>
    <ProductName>BILOPAQUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1975-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM TYROPANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011528</DrugIDPK>
    <LicenceNumber>PA0057/057/001</LicenceNumber>
    <ProductName>CALCICARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1988-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011841</DrugIDPK>
    <LicenceNumber>PA0077/035/006</LicenceNumber>
    <ProductName>FORTRAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011875</DrugIDPK>
    <LicenceNumber>PA0077/070/001</LicenceNumber>
    <ProductName>HYPAQUE 65%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011876</DrugIDPK>
    <LicenceNumber>PA0077/071/001</LicenceNumber>
    <ProductName>HYPAQUE 85%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
      <ActiveSubstance>SODIUM AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011860</DrugIDPK>
    <LicenceNumber>PA0077/044/001</LicenceNumber>
    <ProductName>LEVOPHED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NOREPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011771</DrugIDPK>
    <LicenceNumber>PA0077/013/003</LicenceNumber>
    <ProductName>LUMINAL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011769</DrugIDPK>
    <LicenceNumber>PA0077/013/002</LicenceNumber>
    <ProductName>LUMINAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011767</DrugIDPK>
    <LicenceNumber>PA0077/013/001</LicenceNumber>
    <ProductName>LUMINAL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011881</DrugIDPK>
    <LicenceNumber>PA0077/084/002</LicenceNumber>
    <ProductName>NEOPHRYN NASAL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011795</DrugIDPK>
    <LicenceNumber>PA0077/018/001</LicenceNumber>
    <ProductName>PHANODORM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011874</DrugIDPK>
    <LicenceNumber>PA0077/063/001</LicenceNumber>
    <ProductName>PHISOHEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEXACHLOROPHENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011799</DrugIDPK>
    <LicenceNumber>PA0077/019/001</LicenceNumber>
    <ProductName>PROMINAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011802</DrugIDPK>
    <LicenceNumber>PA0077/019/002</LicenceNumber>
    <ProductName>PROMINAL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011804</DrugIDPK>
    <LicenceNumber>PA0077/019/003</LicenceNumber>
    <ProductName>PROMINAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010781</DrugIDPK>
    <LicenceNumber>PA0041/015/001</LicenceNumber>
    <ProductName>KOLANTYL NV</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003373</DrugIDPK>
    <LicenceNumber>PA0077/045/002</LicenceNumber>
    <ProductName>STROMBA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STANOZOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011683</DrugIDPK>
    <LicenceNumber>PA0073/038/001</LicenceNumber>
    <ProductName>EPHEDRINE HYDROCHLORIDE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010912</DrugIDPK>
    <LicenceNumber>PA0047/046/001</LicenceNumber>
    <ProductName>ONCOVIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010913</DrugIDPK>
    <LicenceNumber>PA0047/046/002</LicenceNumber>
    <ProductName>ONCOVIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010914</DrugIDPK>
    <LicenceNumber>PA0047/046/003</LicenceNumber>
    <ProductName>ONCOVIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINCRISTINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011912</DrugIDPK>
    <LicenceNumber>PA0082/049/002</LicenceNumber>
    <ProductName>FRUMIL LS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009606</DrugIDPK>
    <LicenceNumber>PA0007/015/001</LicenceNumber>
    <ProductName>ALUPENT EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE</ActiveSubstance>
      <ActiveSubstance>BROMHEXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009610</DrugIDPK>
    <LicenceNumber>PA0007/015/007</LicenceNumber>
    <ProductName>ALUPENT INHALANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009667</DrugIDPK>
    <LicenceNumber>PA0007/015/009</LicenceNumber>
    <ProductName>ALUPENT OBSTETRIC AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012282</DrugIDPK>
    <LicenceNumber>PA0379/023/001</LicenceNumber>
    <ProductName>VENOS NIGHT-TIME PRD 448</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013694</DrugIDPK>
    <LicenceNumber>PA0206/006/002</LicenceNumber>
    <ProductName>DROXARYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010433</DrugIDPK>
    <LicenceNumber>PA0024/013/002</LicenceNumber>
    <ProductName>EUDEMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013339</DrugIDPK>
    <LicenceNumber>PA0251/013/001</LicenceNumber>
    <ProductName>TOSMILEN EYE DROPS</ProductName>
    <Strength>0.25%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013340</DrugIDPK>
    <LicenceNumber>PA0251/013/002</LicenceNumber>
    <ProductName>TOSMILEN EYE DROPS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000143</DrugIDPK>
    <LicenceNumber>PA0001/013/001</LicenceNumber>
    <ProductName>OVULEN 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>ETYNODIOL DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012706</DrugIDPK>
    <LicenceNumber>PA0485/001/001</LicenceNumber>
    <ProductName>AFLOXAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Opfermann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011414</DrugIDPK>
    <LicenceNumber>PA0056/044/001</LicenceNumber>
    <ProductName>MEDIQUELL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012792</DrugIDPK>
    <LicenceNumber>PA0114/018/001</LicenceNumber>
    <ProductName>PRESSURISED BROVON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012789</DrugIDPK>
    <LicenceNumber>PA0114/017/001</LicenceNumber>
    <ProductName>PRESSURISED ISO-BROVON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012791</DrugIDPK>
    <LicenceNumber>PA0114/017/002</LicenceNumber>
    <ProductName>PRESSURISED ISO-BROVON PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010187</DrugIDPK>
    <LicenceNumber>PA0021/003/004</LicenceNumber>
    <ProductName>ADALAT 1C</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010465</DrugIDPK>
    <LicenceNumber>PA0027/040/001</LicenceNumber>
    <ProductName>TEMGESIC-NX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPRENORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010466</DrugIDPK>
    <LicenceNumber>PA0027/040/002</LicenceNumber>
    <ProductName>TEMGESIC-NX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BUPRENORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010197</DrugIDPK>
    <LicenceNumber>PA0021/008/001</LicenceNumber>
    <ProductName>OSPOLOT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULTIAME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010200</DrugIDPK>
    <LicenceNumber>PA0021/008/002</LicenceNumber>
    <ProductName>OSPOLOT</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULTIAME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010203</DrugIDPK>
    <LicenceNumber>PA0021/008/003</LicenceNumber>
    <ProductName>OSPOLOT  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULTIAME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013693</DrugIDPK>
    <LicenceNumber>PA0206/006/001</LicenceNumber>
    <ProductName>DROXARYL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010680</DrugIDPK>
    <LicenceNumber>PA0039/024/005</LicenceNumber>
    <ProductName>TEDRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010684</DrugIDPK>
    <LicenceNumber>PA0039/024/008</LicenceNumber>
    <ProductName>TEDRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010682</DrugIDPK>
    <LicenceNumber>PA0039/024/006</LicenceNumber>
    <ProductName>TEDRAL SA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013900</DrugIDPK>
    <LicenceNumber>PA0277/049/001</LicenceNumber>
    <ProductName>INDULATERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE SULFATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013899</DrugIDPK>
    <LicenceNumber>PA0277/048/001</LicenceNumber>
    <ProductName>INDULAFRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE SULFATE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010329</DrugIDPK>
    <LicenceNumber>PA0033/015/001</LicenceNumber>
    <ProductName>MASTERIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011216</DrugIDPK>
    <LicenceNumber>PA0050/068/006</LicenceNumber>
    <ProductName>ROFERON - A TELESRYINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011214</DrugIDPK>
    <LicenceNumber>PA0050/068/005</LicenceNumber>
    <ProductName>ROFERON A TELESYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011212</DrugIDPK>
    <LicenceNumber>PA0050/068/004</LicenceNumber>
    <ProductName>ROFERON A TELESYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010648</DrugIDPK>
    <LicenceNumber>PA0039/010/001</LicenceNumber>
    <ProductName>ESTROVIS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010655</DrugIDPK>
    <LicenceNumber>PA0039/018/001</LicenceNumber>
    <ProductName>PENTOVIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010685</DrugIDPK>
    <LicenceNumber>PA0039/024/009</LicenceNumber>
    <ProductName>TEDRAL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1984-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010903</DrugIDPK>
    <LicenceNumber>PA0047/039/007</LicenceNumber>
    <ProductName>DISTACLOR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010505</DrugIDPK>
    <LicenceNumber>PA0023/028/001</LicenceNumber>
    <ProductName>SYNADRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1982-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRENYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010297</DrugIDPK>
    <LicenceNumber>PA0032/025/001</LicenceNumber>
    <ProductName>CORTUCID EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011275</DrugIDPK>
    <LicenceNumber>PA0051/001/001</LicenceNumber>
    <ProductName>VIVALAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1974-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VILOXAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012014</DrugIDPK>
    <LicenceNumber>PA0078/041/001</LicenceNumber>
    <ProductName>THEOCLEAR</ProductName>
    <Strength>130</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1984-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010901</DrugIDPK>
    <LicenceNumber>PA0047/039/005</LicenceNumber>
    <ProductName>DISTACLOR (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1984-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010902</DrugIDPK>
    <LicenceNumber>PA0047/039/006</LicenceNumber>
    <ProductName>DISTACLOR (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1984-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010905</DrugIDPK>
    <LicenceNumber>PA0047/041/001</LicenceNumber>
    <ProductName>CINOBAC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010907</DrugIDPK>
    <LicenceNumber>PA0047/041/002</LicenceNumber>
    <ProductName>CINOBAC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011163</DrugIDPK>
    <LicenceNumber>PA0049/018/008</LicenceNumber>
    <ProductName>FLOXAPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010950</DrugIDPK>
    <LicenceNumber>PA0047/063/001</LicenceNumber>
    <ProductName>FOLIC ACID</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011084</DrugIDPK>
    <LicenceNumber>PA0047/008/007</LicenceNumber>
    <ProductName>KEFLEX (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011087</DrugIDPK>
    <LicenceNumber>PA0047/008/008</LicenceNumber>
    <ProductName>KEFLEX REDI-MIX ORAL (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-09-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010908</DrugIDPK>
    <LicenceNumber>PA0047/042/001</LicenceNumber>
    <ProductName>MERTHIOLATE TINCTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIOMERSAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010808</DrugIDPK>
    <LicenceNumber>PA0043/002/001</LicenceNumber>
    <ProductName>CROOKES ONE-A-DAY WITH IRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1984-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010809</DrugIDPK>
    <LicenceNumber>PA0043/005/001</LicenceNumber>
    <ProductName>CROOKES ONE-A-DAY WITHOUT IRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1984-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009639</DrugIDPK>
    <LicenceNumber>PA0004/020/001</LicenceNumber>
    <ProductName>SECRETIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SECRETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010390</DrugIDPK>
    <LicenceNumber>PA0035/044/008</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010391</DrugIDPK>
    <LicenceNumber>PA0035/044/009</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010392</DrugIDPK>
    <LicenceNumber>PA0035/044/010</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010393</DrugIDPK>
    <LicenceNumber>PA0035/044/011</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-11-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012582</DrugIDPK>
    <LicenceNumber>PA0437/006/002</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009207</DrugIDPK>
    <LicenceNumber>PA0437/006/001</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>1986-11-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009693</DrugIDPK>
    <LicenceNumber>PA0009/010/002</LicenceNumber>
    <ProductName>CO-BETALOC SA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1989-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011139</DrugIDPK>
    <LicenceNumber>PA0050/040/002</LicenceNumber>
    <ProductName>MESTINON AMPOULES</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOSTIGMINE BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011149</DrugIDPK>
    <LicenceNumber>PA0050/044/001</LicenceNumber>
    <ProductName>TRH ROCHE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTIRELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009850</DrugIDPK>
    <LicenceNumber>PA0012/002/004</LicenceNumber>
    <ProductName>NERIBAS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010319</DrugIDPK>
    <LicenceNumber>PA0033/005/010</LicenceNumber>
    <ProductName>NAPROSYN SLOW RELEASE</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010321</DrugIDPK>
    <LicenceNumber>PA0033/005/011</LicenceNumber>
    <ProductName>NAPROSYN SLOW RELEASE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009746</DrugIDPK>
    <LicenceNumber>PA0016/026/001</LicenceNumber>
    <ProductName>ORTHOXICOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009749</DrugIDPK>
    <LicenceNumber>PA0016/027/001</LicenceNumber>
    <ProductName>ORTHOXIN HYDROCHLORIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010033</DrugIDPK>
    <LicenceNumber>PA0019/022/001</LicenceNumber>
    <ProductName>TERRAMYCIN OPHTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010021</DrugIDPK>
    <LicenceNumber>PA0019/013/004</LicenceNumber>
    <ProductName>VIBRAMYCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1980-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013263</DrugIDPK>
    <LicenceNumber>PA0167/006/002</LicenceNumber>
    <ProductName>SYNTHAMIN 14</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013271</DrugIDPK>
    <LicenceNumber>PA0167/006/008</LicenceNumber>
    <ProductName>SYNTHAMIN 14</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013268</DrugIDPK>
    <LicenceNumber>PA0167/006/005</LicenceNumber>
    <ProductName>SYNTHAMIN 14</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013269</DrugIDPK>
    <LicenceNumber>PA0167/006/006</LicenceNumber>
    <ProductName>SYNTHAMIN 17</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013273</DrugIDPK>
    <LicenceNumber>PA0167/006/009</LicenceNumber>
    <ProductName>SYNTHAMIN 17</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013264</DrugIDPK>
    <LicenceNumber>PA0167/006/003</LicenceNumber>
    <ProductName>SYNTHAMIN 17</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013260</DrugIDPK>
    <LicenceNumber>PA0167/003/001</LicenceNumber>
    <ProductName>SYNTHAMIN 7S 4.0%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013261</DrugIDPK>
    <LicenceNumber>PA0167/003/002</LicenceNumber>
    <ProductName>SYNTHAMIN 7S 4.0%/AMINO ACID</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013262</DrugIDPK>
    <LicenceNumber>PA0167/006/001</LicenceNumber>
    <ProductName>SYNTHAMIN 9</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013267</DrugIDPK>
    <LicenceNumber>PA0167/006/004</LicenceNumber>
    <ProductName>SYNTHAMIN 9</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013270</DrugIDPK>
    <LicenceNumber>PA0167/006/007</LicenceNumber>
    <ProductName>SYNTHAMIN 9</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1978-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011765</DrugIDPK>
    <LicenceNumber>PA0079/010/001</LicenceNumber>
    <ProductName>ALLPYRAL ALLERGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALLERGENEXTRACT, GR\NALGER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011774</DrugIDPK>
    <LicenceNumber>PA0079/013/001</LicenceNumber>
    <ProductName>CONJUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1983-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011778</DrugIDPK>
    <LicenceNumber>PA0079/013/003</LicenceNumber>
    <ProductName>CONJUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011776</DrugIDPK>
    <LicenceNumber>PA0079/013/002</LicenceNumber>
    <ProductName>CONJUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011780</DrugIDPK>
    <LicenceNumber>PA0079/014/001</LicenceNumber>
    <ProductName>DIALYSED DIAGNOSTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1983-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011766</DrugIDPK>
    <LicenceNumber>PA0079/011/001</LicenceNumber>
    <ProductName>DOME GLYCERINATED SKIN TESTING SOLUTIONS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011768</DrugIDPK>
    <LicenceNumber>PA0079/012/001</LicenceNumber>
    <ProductName>HYMENOPTERA VENOM - HONEY BEE VENOM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1983-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011770</DrugIDPK>
    <LicenceNumber>PA0079/012/002</LicenceNumber>
    <ProductName>HYMENOPTERA VENOM - VESPID WASP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1983-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010423</DrugIDPK>
    <LicenceNumber>PA0022/064/002</LicenceNumber>
    <ProductName>ANTACIN PLUS  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011848</DrugIDPK>
    <LicenceNumber>PA0082/024/001</LicenceNumber>
    <ProductName>SILBEPHYLLINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPROPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011849</DrugIDPK>
    <LicenceNumber>PA0082/024/002</LicenceNumber>
    <ProductName>SILBEPHYLLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPROPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011851</DrugIDPK>
    <LicenceNumber>PA0082/024/003</LicenceNumber>
    <ProductName>SILBEPHYLLINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPROPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011852</DrugIDPK>
    <LicenceNumber>PA0082/024/004</LicenceNumber>
    <ProductName>SILBEPHYLLINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPROPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010749</DrugIDPK>
    <LicenceNumber>PA0040/041/001</LicenceNumber>
    <ProductName>BANISTYL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010750</DrugIDPK>
    <LicenceNumber>PA0040/043/001</LicenceNumber>
    <ProductName>PHENERGAN COMPOUND</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010751</DrugIDPK>
    <LicenceNumber>PA0040/043/002</LicenceNumber>
    <ProductName>PHENERGAN COMPOUND</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012933</DrugIDPK>
    <LicenceNumber>PA0129/004/002</LicenceNumber>
    <ProductName>MILLOPHYLINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dales Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012930</DrugIDPK>
    <LicenceNumber>PA0129/004/001</LicenceNumber>
    <ProductName>MILLOPHYLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dales Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012935</DrugIDPK>
    <LicenceNumber>PA0129/004/003</LicenceNumber>
    <ProductName>MILLOPHYLINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dales Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012936</DrugIDPK>
    <LicenceNumber>PA0129/004/004</LicenceNumber>
    <ProductName>MILLOPHYLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dales Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011228</DrugIDPK>
    <LicenceNumber>PA0050/003/008</LicenceNumber>
    <ProductName>BACTRIM ROCHE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1979-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013823</DrugIDPK>
    <LicenceNumber>PA0277/019/001</LicenceNumber>
    <ProductName>SULPHACETAMIDE EYE DROPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002521</DrugIDPK>
    <LicenceNumber>PA0054/051/001</LicenceNumber>
    <ProductName>TUTOPLAST DURA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013681</DrugIDPK>
    <LicenceNumber>PA0200/003/002</LicenceNumber>
    <ProductName>ANTADINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMANTADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012488</DrugIDPK>
    <LicenceNumber>PA0360/016/001</LicenceNumber>
    <ProductName>DIAZOXIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013699</DrugIDPK>
    <LicenceNumber>PA0206/018/001</LicenceNumber>
    <ProductName>BUFEXINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010397</DrugIDPK>
    <LicenceNumber>PA0035/051/004</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010350</DrugIDPK>
    <LicenceNumber>PA0035/003/010</LicenceNumber>
    <ProductName>INDOCID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011808</DrugIDPK>
    <LicenceNumber>PA0082/003/002</LicenceNumber>
    <ProductName>ASILONE FORTE (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009794</DrugIDPK>
    <LicenceNumber>PA0010/028/001</LicenceNumber>
    <ProductName>LYOPHILISED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012770</DrugIDPK>
    <LicenceNumber>PA0516/006/001</LicenceNumber>
    <ProductName>ELANGESIC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012772</DrugIDPK>
    <LicenceNumber>PA0516/010/001</LicenceNumber>
    <ProductName>NAPRELAN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012493</DrugIDPK>
    <LicenceNumber>PA0361/003/001</LicenceNumber>
    <ProductName>OS-CAL 500</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>OYSTER SHELL POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009476</DrugIDPK>
    <LicenceNumber>PA0001/021/001</LicenceNumber>
    <ProductName>SPIROPROP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1984-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012594</DrugIDPK>
    <LicenceNumber>PA0102/012/002</LicenceNumber>
    <ProductName>NORMACOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1984-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>STERCULIA</ActiveSubstance>
      <ActiveSubstance>FRANGULA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011345</DrugIDPK>
    <LicenceNumber>PA0054/046/001</LicenceNumber>
    <ProductName>PERIFUSIN S</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013895</DrugIDPK>
    <LicenceNumber>PA0277/040/001</LicenceNumber>
    <ProductName>PYRIFOAM SHAMPOO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PYRETHRUM EXTRACT</ActiveSubstance>
      <ActiveSubstance>PIPERONYL BUTOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011401</DrugIDPK>
    <LicenceNumber>PA0056/034/001</LicenceNumber>
    <ProductName>BENYLIN MENTHOLATED LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1983-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011550</DrugIDPK>
    <LicenceNumber>PA0059/020/001</LicenceNumber>
    <ProductName>SUPROFEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011551</DrugIDPK>
    <LicenceNumber>PA0059/020/002</LicenceNumber>
    <ProductName>SUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011894</DrugIDPK>
    <LicenceNumber>PA0082/035/001</LicenceNumber>
    <ProductName>NODILON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COTRIMOXAZOLE</ActiveSubstance>
      <ActiveSubstance>SULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012716</DrugIDPK>
    <LicenceNumber>PA0108/011/002</LicenceNumber>
    <ProductName>SERC SR</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011725</DrugIDPK>
    <LicenceNumber>PA0073/099/002</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011539</DrugIDPK>
    <LicenceNumber>PA0058/012/004</LicenceNumber>
    <ProductName>NORMORYTMIN (RYTMONORM)</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013649</DrugIDPK>
    <LicenceNumber>PA0196/005/001</LicenceNumber>
    <ProductName>TEMPOPHORE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
      <ActiveSubstance>CREOSOTE</ActiveSubstance>
      <ActiveSubstance>IODOFORM</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001618</DrugIDPK>
    <LicenceNumber>PA0378/001/002</LicenceNumber>
    <ProductName>ELASTOPLAST ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Smith &amp; Nephew-Southalls (Ire) L</PAHolder>
    <AuthorisedDate>1983-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001610</DrugIDPK>
    <LicenceNumber>PA0378/001/001</LicenceNumber>
    <ProductName>ELASTOPLAST ANTISPETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Smith &amp; Nephew-Southalls (Ire) L</PAHolder>
    <AuthorisedDate>1983-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>EDETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001812</DrugIDPK>
    <LicenceNumber>PA0035/037/004</LicenceNumber>
    <ProductName>MERUVAX II</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012668</DrugIDPK>
    <LicenceNumber>PA0467/005/001</LicenceNumber>
    <ProductName>TAZ (TRIAMCINOLONE ACENTONIDE 0.05% IN AZONE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ethical Pharmaceuticals UK Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011952</DrugIDPK>
    <LicenceNumber>PA0082/030/001</LicenceNumber>
    <ProductName>ASILONE ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010826</DrugIDPK>
    <LicenceNumber>PA0044/008/002</LicenceNumber>
    <ProductName>CEPORIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010050</DrugIDPK>
    <LicenceNumber>PA0019/037/002</LicenceNumber>
    <ProductName>FASIGYN INTRAVENOUS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TINIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010051</DrugIDPK>
    <LicenceNumber>PA0019/037/003</LicenceNumber>
    <ProductName>FASIGYN INTRAVENOUS</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009561</DrugIDPK>
    <LicenceNumber>PA0002/025/003</LicenceNumber>
    <ProductName>COGARD</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009546</DrugIDPK>
    <LicenceNumber>PA0002/019/002</LicenceNumber>
    <ProductName>FLORINEF</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009668</DrugIDPK>
    <LicenceNumber>PA0002/020/004</LicenceNumber>
    <ProductName>HALCIDERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009549</DrugIDPK>
    <LicenceNumber>PA0002/020/002</LicenceNumber>
    <ProductName>HALCIDERM  0.1%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009551</DrugIDPK>
    <LicenceNumber>PA0002/020/003</LicenceNumber>
    <ProductName>HALCIDERM 0.025%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009500</DrugIDPK>
    <LicenceNumber>PA0002/002/001</LicenceNumber>
    <ProductName>HALICOMB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALCINONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009502</DrugIDPK>
    <LicenceNumber>PA0002/002/002</LicenceNumber>
    <ProductName>HALICOMB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALCINONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009595</DrugIDPK>
    <LicenceNumber>PA0002/036/004</LicenceNumber>
    <ProductName>IPRAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011883</DrugIDPK>
    <LicenceNumber>PA0077/090/001</LicenceNumber>
    <ProductName>IZAL ANTISEPTEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMINE</ActiveSubstance>
      <ActiveSubstance>DICHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009560</DrugIDPK>
    <LicenceNumber>PA0002/022/001</LicenceNumber>
    <ProductName>KENACORT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009555</DrugIDPK>
    <LicenceNumber>PA0002/021/005</LicenceNumber>
    <ProductName>KENACORT A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009575</DrugIDPK>
    <LicenceNumber>PA0002/026/001</LicenceNumber>
    <ProductName>KINEVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1978-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SINCALIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009576</DrugIDPK>
    <LicenceNumber>PA0002/028/001</LicenceNumber>
    <ProductName>RAUDIXIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAUWOLFIA SERPENTINA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009578</DrugIDPK>
    <LicenceNumber>PA0002/030/001</LicenceNumber>
    <ProductName>RAUTRAX SINE K</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAUWOLFIA</ActiveSubstance>
      <ActiveSubstance>HYDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010837</DrugIDPK>
    <LicenceNumber>PA0044/018/001</LicenceNumber>
    <ProductName>GRISOVIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010838</DrugIDPK>
    <LicenceNumber>PA0044/018/002</LicenceNumber>
    <ProductName>GRISOVIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011622</DrugIDPK>
    <LicenceNumber>PA0065/003/001</LicenceNumber>
    <ProductName>LOCAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013579</DrugIDPK>
    <LicenceNumber>PA0179/015/001</LicenceNumber>
    <ProductName>NEOPLASMAGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GELATIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011343</DrugIDPK>
    <LicenceNumber>PA0054/043/001</LicenceNumber>
    <ProductName>ENDOBIL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODOXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011344</DrugIDPK>
    <LicenceNumber>PA0054/043/002</LicenceNumber>
    <ProductName>ENDOBIL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-07-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODOXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011691</DrugIDPK>
    <LicenceNumber>PA0073/043/001</LicenceNumber>
    <ProductName>NORMOFUNDIN MD</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011692</DrugIDPK>
    <LicenceNumber>PA0073/043/002</LicenceNumber>
    <ProductName>NORMOFUNDIN MD</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012251</DrugIDPK>
    <LicenceNumber>PA0372/005/001</LicenceNumber>
    <ProductName>DIURESAL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012252</DrugIDPK>
    <LicenceNumber>PA0372/005/002</LicenceNumber>
    <ProductName>DIURESAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010940</DrugIDPK>
    <LicenceNumber>PA0047/057/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010941</DrugIDPK>
    <LicenceNumber>PA0047/057/002</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010944</DrugIDPK>
    <LicenceNumber>PA0047/059/001</LicenceNumber>
    <ProductName>HUMULIN I (ISOPHANE INJECTION)</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010945</DrugIDPK>
    <LicenceNumber>PA0047/059/002</LicenceNumber>
    <ProductName>HUMULIN I (ISOPHANE INJECTION)</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010942</DrugIDPK>
    <LicenceNumber>PA0047/058/001</LicenceNumber>
    <ProductName>HUMULIN S (REGULAR INJECTION)</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010943</DrugIDPK>
    <LicenceNumber>PA0047/058/002</LicenceNumber>
    <ProductName>HUMULIN S (REGULAR INJECTION)</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010939</DrugIDPK>
    <LicenceNumber>PA0047/056/002</LicenceNumber>
    <ProductName>NABILONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NABILONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010286</DrugIDPK>
    <LicenceNumber>PA0032/022/001</LicenceNumber>
    <ProductName>NEUTRADONNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM SODIUM SILICATE</ActiveSubstance>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010288</DrugIDPK>
    <LicenceNumber>PA0032/022/002</LicenceNumber>
    <ProductName>NEUTRADONNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM SODIUM SILICATE</ActiveSubstance>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002448</DrugIDPK>
    <LicenceNumber>PA0054/009/001</LicenceNumber>
    <ProductName>OPTIMAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003832</DrugIDPK>
    <LicenceNumber>PA0126/020/002</LicenceNumber>
    <ProductName>PARALIEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012000</DrugIDPK>
    <LicenceNumber>PA0086/021/003</LicenceNumber>
    <ProductName>CHAPSTICK - CHERRY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012001</DrugIDPK>
    <LicenceNumber>PA0086/021/004</LicenceNumber>
    <ProductName>CHAPSTICK - GRAPE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012004</DrugIDPK>
    <LicenceNumber>PA0086/021/006</LicenceNumber>
    <ProductName>CHAPSTICK - LEMON-LIME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011999</DrugIDPK>
    <LicenceNumber>PA0086/021/002</LicenceNumber>
    <ProductName>CHAPSTICK - MINT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012003</DrugIDPK>
    <LicenceNumber>PA0086/021/005</LicenceNumber>
    <ProductName>CHAPSTICK - ORANGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002510</DrugIDPK>
    <LicenceNumber>PA0049/009/009</LicenceNumber>
    <ProductName>ORBENIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993002506</DrugIDPK>
    <LicenceNumber>PA0049/009/005</LicenceNumber>
    <ProductName>ORBENIN SYRUP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012989</DrugIDPK>
    <LicenceNumber>PA0119/014/001</LicenceNumber>
    <ProductName>EMETROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>PHOSPHORIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009875</DrugIDPK>
    <LicenceNumber>PA0012/027/001</LicenceNumber>
    <ProductName>SCHERISOLON CRYSTALLINE  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011641</DrugIDPK>
    <LicenceNumber>PA0072/003/003</LicenceNumber>
    <ProductName>ZAROXOLYN 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METOLAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015672</DrugIDPK>
    <LicenceNumber>PA0236/008/001</LicenceNumber>
    <ProductName>ADRIAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1979-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015674</DrugIDPK>
    <LicenceNumber>PA0236/008/002</LicenceNumber>
    <ProductName>ADRIAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1979-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013809</DrugIDPK>
    <LicenceNumber>PA0277/009/001</LicenceNumber>
    <ProductName>ADRENALINE 1 IN 1000 EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013800</DrugIDPK>
    <LicenceNumber>PA0277/006/001</LicenceNumber>
    <ProductName>AFRAZINE PAEDIATRIC NOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013861</DrugIDPK>
    <LicenceNumber>PA0277/027/001</LicenceNumber>
    <ProductName>ALGISPRAY  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL STEARATE</ActiveSubstance>
      <ActiveSubstance>DIETHYLAMINE SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015203</DrugIDPK>
    <LicenceNumber>PA0098/018/001</LicenceNumber>
    <ProductName>CONOTRANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012452</DrugIDPK>
    <LicenceNumber>PA0337/011/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013796</DrugIDPK>
    <LicenceNumber>PA0277/004/013</LicenceNumber>
    <ProductName>GEOMYCIN EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013794</DrugIDPK>
    <LicenceNumber>PA0277/004/012</LicenceNumber>
    <ProductName>GEOMYCIN EYE/EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013840</DrugIDPK>
    <LicenceNumber>PA0277/023/001</LicenceNumber>
    <ProductName>GOLDEN EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MERCURIC OXIDE, YELLOW</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013814</DrugIDPK>
    <LicenceNumber>PA0277/013/001</LicenceNumber>
    <ProductName>HYOSCINE EYE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYOSCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012454</DrugIDPK>
    <LicenceNumber>PA0337/012/001</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012455</DrugIDPK>
    <LicenceNumber>PA0337/012/002</LicenceNumber>
    <ProductName>IBUPROFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012456</DrugIDPK>
    <LicenceNumber>PA0337/013/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012457</DrugIDPK>
    <LicenceNumber>PA0337/013/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013815</DrugIDPK>
    <LicenceNumber>PA0277/015/001</LicenceNumber>
    <ProductName>LACHESINE EYE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012458</DrugIDPK>
    <LicenceNumber>PA0337/014/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013845</DrugIDPK>
    <LicenceNumber>PA0277/026/001</LicenceNumber>
    <ProductName>OXYMTAZOLINE HYDROCHLORIDE NASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012453</DrugIDPK>
    <LicenceNumber>PA0337/011/002</LicenceNumber>
    <ProductName>PAEDIATRIC CO-TRIMOXAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013817</DrugIDPK>
    <LicenceNumber>PA0277/016/001</LicenceNumber>
    <ProductName>PHENYLEPHRINE EYE DROPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013819</DrugIDPK>
    <LicenceNumber>PA0277/017/001</LicenceNumber>
    <ProductName>PHYSOSTIGMINE EYE DROPS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013821</DrugIDPK>
    <LicenceNumber>PA0277/017/002</LicenceNumber>
    <ProductName>PHYSOSTIGMINE EYE DROPS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015199</DrugIDPK>
    <LicenceNumber>PA0098/016/001</LicenceNumber>
    <ProductName>UVISTAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015206</DrugIDPK>
    <LicenceNumber>PA0098/016/002</LicenceNumber>
    <ProductName>UVISTAT L</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013831</DrugIDPK>
    <LicenceNumber>PA0277/020/001</LicenceNumber>
    <ProductName>ZINC SULPHATE EYE DROPS</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009884</DrugIDPK>
    <LicenceNumber>PA0012/033/002</LicenceNumber>
    <ProductName>ANGIOGRAFIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009883</DrugIDPK>
    <LicenceNumber>PA0012/033/001</LicenceNumber>
    <ProductName>ANGIOGRAFIN 65%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012446</DrugIDPK>
    <LicenceNumber>PA0337/008/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012447</DrugIDPK>
    <LicenceNumber>PA0337/008/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012448</DrugIDPK>
    <LicenceNumber>PA0337/008/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012449</DrugIDPK>
    <LicenceNumber>PA0337/009/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012450</DrugIDPK>
    <LicenceNumber>PA0337/009/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005738</DrugIDPK>
    <LicenceNumber>PA0337/017/001</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012451</DrugIDPK>
    <LicenceNumber>PA0337/010/001</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-05-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012459</DrugIDPK>
    <LicenceNumber>PA0337/015/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012460</DrugIDPK>
    <LicenceNumber>PA0337/015/002</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012461</DrugIDPK>
    <LicenceNumber>PA0337/015/003</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012462</DrugIDPK>
    <LicenceNumber>PA0337/015/004</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1984-06-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012304</DrugIDPK>
    <LicenceNumber>PA0303/010/002</LicenceNumber>
    <ProductName>EMPERAL SOLUTION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1983-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013457</DrugIDPK>
    <LicenceNumber>PA0176/048/001</LicenceNumber>
    <ProductName>ALUMINIUM HYDROXIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013143</DrugIDPK>
    <LicenceNumber>PA0126/066/002</LicenceNumber>
    <ProductName>NEUROTOL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013141</DrugIDPK>
    <LicenceNumber>PA0126/066/001</LicenceNumber>
    <ProductName>NEUROTOL SYRUP</ProductName>
    <Strength>100/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012482</DrugIDPK>
    <LicenceNumber>PA0351/001/002</LicenceNumber>
    <ProductName>SAVLON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Care Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013117</DrugIDPK>
    <LicenceNumber>PA0126/017/001</LicenceNumber>
    <ProductName>SULPHADIMIDINE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001295</DrugIDPK>
    <LicenceNumber>PA0294/007/003</LicenceNumber>
    <ProductName>THEOLAN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1983-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010883</DrugIDPK>
    <LicenceNumber>PA0047/024/001</LicenceNumber>
    <ProductName>ALLEGRON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010884</DrugIDPK>
    <LicenceNumber>PA0047/024/002</LicenceNumber>
    <ProductName>ALLEGRON</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010889</DrugIDPK>
    <LicenceNumber>PA0047/027/001</LicenceNumber>
    <ProductName>DISTALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE NAPSILATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010904</DrugIDPK>
    <LicenceNumber>PA0047/040/001</LicenceNumber>
    <ProductName>FOPANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOPROFEN</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010890</DrugIDPK>
    <LicenceNumber>PA0047/032/001</LicenceNumber>
    <ProductName>HAELAN TAPE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUDROXYCORTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010899</DrugIDPK>
    <LicenceNumber>PA0047/037/002</LicenceNumber>
    <ProductName>HAELAN X</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDROXYCORTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010897</DrugIDPK>
    <LicenceNumber>PA0047/037/001</LicenceNumber>
    <ProductName>HAELAN X</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUDROXYCORTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010895</DrugIDPK>
    <LicenceNumber>PA0047/035/001</LicenceNumber>
    <ProductName>NAPSALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE NAPSILATE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010091</DrugIDPK>
    <LicenceNumber>PA0018/028/001</LicenceNumber>
    <ProductName>SANATOGEN TONIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN-B-KOMPLEX STANDARD</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>FERROUS GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013611</DrugIDPK>
    <LicenceNumber>PA0170/007/002</LicenceNumber>
    <ProductName>FURACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NITROFURAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013609</DrugIDPK>
    <LicenceNumber>PA0170/007/001</LicenceNumber>
    <ProductName>FURACIN SOLUBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004568</DrugIDPK>
    <LicenceNumber>PA0179/002/010</LicenceNumber>
    <ProductName>0.45% SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004570</DrugIDPK>
    <LicenceNumber>PA0179/002/011</LicenceNumber>
    <ProductName>0.45% SODIUM CHLORIDE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004527</DrugIDPK>
    <LicenceNumber>PA0179/001/008</LicenceNumber>
    <ProductName>GLUCOSE 20%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004529</DrugIDPK>
    <LicenceNumber>PA0179/001/009</LicenceNumber>
    <ProductName>GLUCOSE 25%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004534</DrugIDPK>
    <LicenceNumber>PA0179/001/012</LicenceNumber>
    <ProductName>GLUCOSE 40%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009874</DrugIDPK>
    <LicenceNumber>PA0012/026/003</LicenceNumber>
    <ProductName>SCHERIPROCT</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE CAPROATE</ActiveSubstance>
      <ActiveSubstance>HEXACHLOROPHENE</ActiveSubstance>
      <ActiveSubstance>CINCHOCAINE</ActiveSubstance>
      <ActiveSubstance>CLEMIZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002796</DrugIDPK>
    <LicenceNumber>PA0379/005/001</LicenceNumber>
    <ProductName>VENOS COUGH MIXTURE ORIGINAL FORMULA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004626</DrugIDPK>
    <LicenceNumber>PA0179/009/001</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004627</DrugIDPK>
    <LicenceNumber>PA0179/009/002</LicenceNumber>
    <ProductName>WATER</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009633</DrugIDPK>
    <LicenceNumber>PA0004/008/001</LicenceNumber>
    <ProductName>DELTASTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009622</DrugIDPK>
    <LicenceNumber>PA0004/041/001</LicenceNumber>
    <ProductName>DIALAFLEX NO 61 INTRAPERITONEAL 1.36</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009625</DrugIDPK>
    <LicenceNumber>PA0004/041/002</LicenceNumber>
    <ProductName>DIALAFLEX NO 61 INTRAPERITONEAL 1.36%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009482</DrugIDPK>
    <LicenceNumber>PA0004/042/001</LicenceNumber>
    <ProductName>DIALAFLEX NO 62 INTRAPERITONEAL</ProductName>
    <Strength>6.36</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009484</DrugIDPK>
    <LicenceNumber>PA0004/042/002</LicenceNumber>
    <ProductName>DIALAFLEX NO 62 INTRAPERITONEAL 6.36%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009487</DrugIDPK>
    <LicenceNumber>PA0004/043/001</LicenceNumber>
    <ProductName>DIALAFLEX NO 63 INTRAPERITONEAL</ProductName>
    <Strength>1.36</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009489</DrugIDPK>
    <LicenceNumber>PA0004/043/002</LicenceNumber>
    <ProductName>DIALAFLEX NO 63 INTRAPERITONEAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013568</DrugIDPK>
    <LicenceNumber>PA0275/010/001</LicenceNumber>
    <ProductName>FAMEL PASTILLES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CREOSOTE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009661</DrugIDPK>
    <LicenceNumber>PA0004/037/001</LicenceNumber>
    <ProductName>HARTMANNS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009662</DrugIDPK>
    <LicenceNumber>PA0004/037/002</LicenceNumber>
    <ProductName>HARTMANNS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011817</DrugIDPK>
    <LicenceNumber>PA0077/024/001</LicenceNumber>
    <ProductName>PANASORB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011821</DrugIDPK>
    <LicenceNumber>PA0077/024/002</LicenceNumber>
    <ProductName>PANASORB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013552</DrugIDPK>
    <LicenceNumber>PA0275/001/001</LicenceNumber>
    <ProductName>PANETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009638</DrugIDPK>
    <LicenceNumber>PA0004/019/001</LicenceNumber>
    <ProductName>PROTUSSA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>TOLU SYRUP</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009657</DrugIDPK>
    <LicenceNumber>PA0004/035/001</LicenceNumber>
    <ProductName>RINGERS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1986-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009658</DrugIDPK>
    <LicenceNumber>PA0004/035/002</LicenceNumber>
    <ProductName>RINGERS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009463</DrugIDPK>
    <LicenceNumber>PA0004/038/002</LicenceNumber>
    <ProductName>STERIFLEX NO 20  LAEVULOSE</ProductName>
    <Strength>10%</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009468</DrugIDPK>
    <LicenceNumber>PA0004/039/002</LicenceNumber>
    <ProductName>STERIFLEX NO 21 LAEVULOSE  20%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009466</DrugIDPK>
    <LicenceNumber>PA0004/039/001</LicenceNumber>
    <ProductName>STERIFLEX NO 21 LAEVULOSE 20%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009472</DrugIDPK>
    <LicenceNumber>PA0004/040/002</LicenceNumber>
    <ProductName>STERIFLEX NO 22 LAEVULOSE 40%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009470</DrugIDPK>
    <LicenceNumber>PA0004/040/001</LicenceNumber>
    <ProductName>STERIFLEX NO 22 LAEVULOSE 40%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009651</DrugIDPK>
    <LicenceNumber>PA0004/032/001</LicenceNumber>
    <ProductName>STERIFLEX NO. 1</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009652</DrugIDPK>
    <LicenceNumber>PA0004/032/002</LicenceNumber>
    <ProductName>STERIFLEX NO. 1</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009655</DrugIDPK>
    <LicenceNumber>PA0004/034/001</LicenceNumber>
    <ProductName>STERIFLEX NO. 18</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009656</DrugIDPK>
    <LicenceNumber>PA0004/034/002</LicenceNumber>
    <ProductName>STERIFLEX NO. 18</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Bodkin E.J. &amp; Company</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009663</DrugIDPK>
    <LicenceNumber>PA0004/038/001</LicenceNumber>
    <ProductName>STERIFLEX NO. 20</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRUCTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009653</DrugIDPK>
    <LicenceNumber>PA0004/033/001</LicenceNumber>
    <ProductName>STERIFLEX NO. 3</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009654</DrugIDPK>
    <LicenceNumber>PA0004/033/002</LicenceNumber>
    <ProductName>STERIFLEX NO. 3</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009647</DrugIDPK>
    <LicenceNumber>PA0004/030/001</LicenceNumber>
    <ProductName>STERIFLEX NO. 6</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009648</DrugIDPK>
    <LicenceNumber>PA0004/030/002</LicenceNumber>
    <ProductName>STERIFLEX NO. 6</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009649</DrugIDPK>
    <LicenceNumber>PA0004/031/001</LicenceNumber>
    <ProductName>STERIFLEX NO. 7</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009650</DrugIDPK>
    <LicenceNumber>PA0004/031/002</LicenceNumber>
    <ProductName>STERIFLEX NO. 7</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012986</DrugIDPK>
    <LicenceNumber>PA0119/012/001</LicenceNumber>
    <ProductName>PAREPECTOLIN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rhone-Poulenc Rorer Pharms.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PECTIN</ActiveSubstance>
      <ActiveSubstance>KAOLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011047</DrugIDPK>
    <LicenceNumber>PA0048/042/001</LicenceNumber>
    <ProductName>BRAN PRODUCT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BRAN</ActiveSubstance>
      <ActiveSubstance>SUCROSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011823</DrugIDPK>
    <LicenceNumber>PA0077/026/001</LicenceNumber>
    <ProductName>BROLINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012316</DrugIDPK>
    <LicenceNumber>PA0392/001/001</LicenceNumber>
    <ProductName>RUSCO BLACKCURRANT COUGH SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rusco Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IPECACUANHA TINCTURE</ActiveSubstance>
      <ActiveSubstance>TOLU SYRUP</ActiveSubstance>
      <ActiveSubstance>SQUILL EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013206</DrugIDPK>
    <LicenceNumber>PA0149/009/001</LicenceNumber>
    <ProductName>CALTHOR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013208</DrugIDPK>
    <LicenceNumber>PA0149/009/002</LicenceNumber>
    <ProductName>CALTHOR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013209</DrugIDPK>
    <LicenceNumber>PA0149/009/003</LicenceNumber>
    <ProductName>CALTHOR (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013211</DrugIDPK>
    <LicenceNumber>PA0149/009/004</LicenceNumber>
    <ProductName>CALTHOR (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013196</DrugIDPK>
    <LicenceNumber>PA0149/005/001</LicenceNumber>
    <ProductName>PREMPAK 0.625</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013198</DrugIDPK>
    <LicenceNumber>PA0149/005/002</LicenceNumber>
    <ProductName>PREMPAK 1.25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-11-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012912</DrugIDPK>
    <LicenceNumber>PA0117/012/002</LicenceNumber>
    <ProductName>CILPEN POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012474</DrugIDPK>
    <LicenceNumber>PA0340/001/001</LicenceNumber>
    <ProductName>DEXTRO-BRONCHINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Magnamed International Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>MEPYRAMINE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010676</DrugIDPK>
    <LicenceNumber>PA0045/002/008</LicenceNumber>
    <ProductName>GYNO-DAKTARIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015668</DrugIDPK>
    <LicenceNumber>PA0301/008/001</LicenceNumber>
    <ProductName>NEOTOPIC H CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015695</DrugIDPK>
    <LicenceNumber>PA0301/013/001</LicenceNumber>
    <ProductName>OCULSUF SULFACETAMIDE SODIUM OPTH.</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015697</DrugIDPK>
    <LicenceNumber>PA0301/013/002</LicenceNumber>
    <ProductName>OCUSULF SULFACETAMIDE SODIUM OPTH.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015698</DrugIDPK>
    <LicenceNumber>PA0301/013/003</LicenceNumber>
    <ProductName>OCUSULF SULFACETAMIDE SODIUM OPTH.</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015700</DrugIDPK>
    <LicenceNumber>PA0301/013/004</LicenceNumber>
    <ProductName>OCUSULF SULFACETAMIDE SODIUM OPTH.</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012911</DrugIDPK>
    <LicenceNumber>PA0117/012/001</LicenceNumber>
    <ProductName>URINFEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1978-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011615</DrugIDPK>
    <LicenceNumber>PA0063/011/001</LicenceNumber>
    <ProductName>XYLOTOX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011616</DrugIDPK>
    <LicenceNumber>PA0063/011/002</LicenceNumber>
    <ProductName>XYLOTOX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013124</DrugIDPK>
    <LicenceNumber>PA0126/035/001</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013121</DrugIDPK>
    <LicenceNumber>PA0126/035/011</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011679</DrugIDPK>
    <LicenceNumber>PA0073/027/001</LicenceNumber>
    <ProductName>CODEINE LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011680</DrugIDPK>
    <LicenceNumber>PA0073/028/001</LicenceNumber>
    <ProductName>CODEINE PHOSPHATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011669</DrugIDPK>
    <LicenceNumber>PA0073/015/001</LicenceNumber>
    <ProductName>PETHILAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011670</DrugIDPK>
    <LicenceNumber>PA0073/015/002</LicenceNumber>
    <ProductName>PETHILAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011671</DrugIDPK>
    <LicenceNumber>PA0073/017/001</LicenceNumber>
    <ProductName>PHANTUSS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011682</DrugIDPK>
    <LicenceNumber>PA0073/032/001</LicenceNumber>
    <ProductName>PREDNISONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011714</DrugIDPK>
    <LicenceNumber>PA0073/077/002</LicenceNumber>
    <ProductName>SCORBAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011715</DrugIDPK>
    <LicenceNumber>PA0073/077/003</LicenceNumber>
    <ProductName>SCORBAN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011678</DrugIDPK>
    <LicenceNumber>PA0073/026/001</LicenceNumber>
    <ProductName>SOLUBLE ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011716</DrugIDPK>
    <LicenceNumber>PA0073/078/001</LicenceNumber>
    <ProductName>VITAMINORUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013213</DrugIDPK>
    <LicenceNumber>PA0149/013/001</LicenceNumber>
    <ProductName>FLUOR-I-STRIP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013215</DrugIDPK>
    <LicenceNumber>PA0149/013/002</LicenceNumber>
    <ProductName>FLUOR-I-STRIP AT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012597</DrugIDPK>
    <LicenceNumber>PA0102/016/001</LicenceNumber>
    <ProductName>MURIPSIN - FILM-COATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PEPSIN</ActiveSubstance>
      <ActiveSubstance>STERCULIA</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015147</DrugIDPK>
    <LicenceNumber>PA0290/044/001</LicenceNumber>
    <ProductName>FLUCON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUOROMETHOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015159</DrugIDPK>
    <LicenceNumber>PA0290/058/006</LicenceNumber>
    <ProductName>ISOPTO CARPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015120</DrugIDPK>
    <LicenceNumber>PA0290/039/001</LicenceNumber>
    <ProductName>NAPHCON-A STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPHAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015125</DrugIDPK>
    <LicenceNumber>PA0290/039/002</LicenceNumber>
    <ProductName>NAPHCON-A STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPHAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010782</DrugIDPK>
    <LicenceNumber>PA0041/016/002</LicenceNumber>
    <ProductName>KOLANTICON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM OXIDUM LEVE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
      <ActiveSubstance>DICYCLOVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010780</DrugIDPK>
    <LicenceNumber>PA0041/014/002</LicenceNumber>
    <ProductName>KOLANTYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011458</DrugIDPK>
    <LicenceNumber>PA0060/044/001</LicenceNumber>
    <ProductName>DYSPAMET</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010031</DrugIDPK>
    <LicenceNumber>PA0019/019/001</LicenceNumber>
    <ProductName>SAFAPRYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASPIRIN ALUMINIUM</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010032</DrugIDPK>
    <LicenceNumber>PA0019/020/001</LicenceNumber>
    <ProductName>SAFAPRYN CO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012657</DrugIDPK>
    <LicenceNumber>PA0450/001/001</LicenceNumber>
    <ProductName>SCOTTS EMULSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Scott &amp; Bowne Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COD LIVER OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011155</DrugIDPK>
    <LicenceNumber>PA0049/016/001</LicenceNumber>
    <ProductName>ALAVAC-P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011168</DrugIDPK>
    <LicenceNumber>PA0049/021/001</LicenceNumber>
    <ProductName>ALAVAC-S</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011171</DrugIDPK>
    <LicenceNumber>PA0049/023/001</LicenceNumber>
    <ProductName>ALLERGEN DIAGNOSTICS (INTRADERMAL TEST SOLUTIONS)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011169</DrugIDPK>
    <LicenceNumber>PA0049/022/001</LicenceNumber>
    <ProductName>ALLERGEN DIAGNOSTICS (PRICK TEST SOLUTIONS)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010632</DrugIDPK>
    <LicenceNumber>PA0038/035/002</LicenceNumber>
    <ProductName>BREMAX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011154</DrugIDPK>
    <LicenceNumber>PA0049/015/001</LicenceNumber>
    <ProductName>MIGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DERMATOPHAGOIDES PTER.</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011152</DrugIDPK>
    <LicenceNumber>PA0049/014/001</LicenceNumber>
    <ProductName>POLLINEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011156</DrugIDPK>
    <LicenceNumber>PA0049/017/001</LicenceNumber>
    <ProductName>SPECIFIC DESENSITISING VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009903</DrugIDPK>
    <LicenceNumber>PA0012/048/003</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1982-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009552</DrugIDPK>
    <LicenceNumber>PA0006/015/001</LicenceNumber>
    <ProductName>DEXACORTISYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009727</DrugIDPK>
    <LicenceNumber>PA0016/017/001</LicenceNumber>
    <ProductName>DELTA-CORTEF</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009731</DrugIDPK>
    <LicenceNumber>PA0016/020/001</LicenceNumber>
    <ProductName>MEDRONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009812</DrugIDPK>
    <LicenceNumber>PA0011/016/001</LicenceNumber>
    <ProductName>TANDALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013194</DrugIDPK>
    <LicenceNumber>PA0149/003/004</LicenceNumber>
    <ProductName>EVADYNE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009936</DrugIDPK>
    <LicenceNumber>PA0013/010/001</LicenceNumber>
    <ProductName>PARAGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013193</DrugIDPK>
    <LicenceNumber>PA0149/002/005</LicenceNumber>
    <ProductName>PREMARIN (PARENTERAL)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009893</DrugIDPK>
    <LicenceNumber>PA0012/041/001</LicenceNumber>
    <ProductName>ALBUCID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011857</DrugIDPK>
    <LicenceNumber>PA0077/040/001</LicenceNumber>
    <ProductName>EUMYDRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009860</DrugIDPK>
    <LicenceNumber>PA0012/010/001</LicenceNumber>
    <ProductName>GYNOVLAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009861</DrugIDPK>
    <LicenceNumber>PA0012/013/001</LicenceNumber>
    <ProductName>MINOVLAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009863</DrugIDPK>
    <LicenceNumber>PA0012/015/001</LicenceNumber>
    <ProductName>NEOGYNON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011954</DrugIDPK>
    <LicenceNumber>PA0078/015/001</LicenceNumber>
    <ProductName>SEDOLAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011099</DrugIDPK>
    <LicenceNumber>PA0049/007/007</LicenceNumber>
    <ProductName>AMPLICOX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012426</DrugIDPK>
    <LicenceNumber>PA0337/001/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012427</DrugIDPK>
    <LicenceNumber>PA0337/001/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012429</DrugIDPK>
    <LicenceNumber>PA0337/001/003</LicenceNumber>
    <ProductName>AMPICILLIN 125 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012430</DrugIDPK>
    <LicenceNumber>PA0337/001/004</LicenceNumber>
    <ProductName>AMPICILLIN 125 MG/5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012434</DrugIDPK>
    <LicenceNumber>PA0337/001/006</LicenceNumber>
    <ProductName>AMPICILLIN 250 MG/5 ML FORTE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012432</DrugIDPK>
    <LicenceNumber>PA0337/001/005</LicenceNumber>
    <ProductName>AMPICILLIN 250 MG/5 ML FORTE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>1983-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013600</DrugIDPK>
    <LicenceNumber>PA0185/011/003</LicenceNumber>
    <ProductName>GALENDIAZEPAM 10 OPAQUE VIOLET/PINK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1981-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013598</DrugIDPK>
    <LicenceNumber>PA0185/011/001</LicenceNumber>
    <ProductName>GALENDIAZEPAM 2 OPAQUE VIOLET/TURQUOISE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1980-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013599</DrugIDPK>
    <LicenceNumber>PA0185/011/002</LicenceNumber>
    <ProductName>GALENDIAZEPAM 5 OPAQUE VIOLET/MAUVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1981-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013651</DrugIDPK>
    <LicenceNumber>PA0196/007/001</LicenceNumber>
    <ProductName>PROTHYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>HYDROXYQUINOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010649</DrugIDPK>
    <LicenceNumber>PA0039/011/001</LicenceNumber>
    <ProductName>GELUSIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010650</DrugIDPK>
    <LicenceNumber>PA0039/011/002</LicenceNumber>
    <ProductName>GELUSIL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010499</DrugIDPK>
    <LicenceNumber>PA0023/016/001</LicenceNumber>
    <ProductName>RELEFACT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010660</DrugIDPK>
    <LicenceNumber>PA0039/021/001</LicenceNumber>
    <ProductName>SAROTEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010661</DrugIDPK>
    <LicenceNumber>PA0039/021/002</LicenceNumber>
    <ProductName>SAROTEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010663</DrugIDPK>
    <LicenceNumber>PA0039/022/002</LicenceNumber>
    <ProductName>SINUTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010757</DrugIDPK>
    <LicenceNumber>PA0040/055/001</LicenceNumber>
    <ProductName>RETRO CONRAY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013221</DrugIDPK>
    <LicenceNumber>PA0149/018/001</LicenceNumber>
    <ProductName>AURALGAN EAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012576</DrugIDPK>
    <LicenceNumber>PA0102/010/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012579</DrugIDPK>
    <LicenceNumber>PA0102/010/002</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012581</DrugIDPK>
    <LicenceNumber>PA0102/010/003</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1983-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010658</DrugIDPK>
    <LicenceNumber>PA0039/020/001</LicenceNumber>
    <ProductName>PYRIDIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010052</DrugIDPK>
    <LicenceNumber>PA0019/038/001</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010053</DrugIDPK>
    <LicenceNumber>PA0019/038/002</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013354</DrugIDPK>
    <LicenceNumber>PA0255/003/001</LicenceNumber>
    <ProductName>ISOPRENALINE HYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013355</DrugIDPK>
    <LicenceNumber>PA0255/003/002</LicenceNumber>
    <ProductName>ISOPRENALINE HYDROCHLORIDE 0.02%</ProductName>
    <Strength>10 ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011326</DrugIDPK>
    <LicenceNumber>PA0051/046/002</LicenceNumber>
    <ProductName>HIBITANE LOZENGES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013715</DrugIDPK>
    <LicenceNumber>PA0217/004/003</LicenceNumber>
    <ProductName>INITARD 50/50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1983-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013704</DrugIDPK>
    <LicenceNumber>PA0217/001/003</LicenceNumber>
    <ProductName>INSULTARD 100 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1983-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013712</DrugIDPK>
    <LicenceNumber>PA0217/003/003</LicenceNumber>
    <ProductName>MIXTARD 30/70</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1983-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015152</DrugIDPK>
    <LicenceNumber>PA0290/053/001</LicenceNumber>
    <ProductName>OPULETS SULPHACETAMIDE EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013707</DrugIDPK>
    <LicenceNumber>PA0217/002/003</LicenceNumber>
    <ProductName>VELOSULIN 100 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1983-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011028</DrugIDPK>
    <LicenceNumber>PA0046/055/001</LicenceNumber>
    <ProductName>BENODERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUSIDIC ACID</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013278</DrugIDPK>
    <LicenceNumber>PA0167/007/002</LicenceNumber>
    <ProductName>HEMOFIL ANTIHAEMOPHILIC</ProductName>
    <Strength>20/250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
      <ActiveSubstance>STANNOUS CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013280</DrugIDPK>
    <LicenceNumber>PA0167/007/003</LicenceNumber>
    <ProductName>HEMOFIL ANTIHAEMOPHILIC</ProductName>
    <Strength>30/750</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013281</DrugIDPK>
    <LicenceNumber>PA0167/007/004</LicenceNumber>
    <ProductName>HEMOFIL ANTIHAEMOPHILIC</ProductName>
    <Strength>30/1050</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013282</DrugIDPK>
    <LicenceNumber>PA0167/007/005</LicenceNumber>
    <ProductName>HEMOFIL ANTIHAEMOPHILIC</ProductName>
    <Strength>40/1050</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013283</DrugIDPK>
    <LicenceNumber>PA0167/007/006</LicenceNumber>
    <ProductName>HEMOFIL ANTIHAEMOPHILIC</ProductName>
    <Strength>50/1050</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013275</DrugIDPK>
    <LicenceNumber>PA0167/007/001</LicenceNumber>
    <ProductName>HEMOFIL ANTIHAEMOPHILIC FACTOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTIHEMOPHILIC HUMAN PLASMA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009607</DrugIDPK>
    <LicenceNumber>PA0002/041/004</LicenceNumber>
    <ProductName>MODITEN ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011530</DrugIDPK>
    <LicenceNumber>PA0058/002/001</LicenceNumber>
    <ProductName>MALIASIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011531</DrugIDPK>
    <LicenceNumber>PA0058/002/002</LicenceNumber>
    <ProductName>MALIASIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011181</DrugIDPK>
    <LicenceNumber>PA0050/057/001</LicenceNumber>
    <ProductName>EPHYNAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011245</DrugIDPK>
    <LicenceNumber>PA0050/024/001</LicenceNumber>
    <ProductName>OMNOPON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011157</DrugIDPK>
    <LicenceNumber>PA0050/050/002</LicenceNumber>
    <ProductName>SYNKAVIT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011153</DrugIDPK>
    <LicenceNumber>PA0050/050/001</LicenceNumber>
    <ProductName>SYNKAVIT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010209</DrugIDPK>
    <LicenceNumber>PA0028/048/001</LicenceNumber>
    <ProductName>OTRIVINE HAY FEVER FORMULA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010211</DrugIDPK>
    <LicenceNumber>PA0028/048/002</LicenceNumber>
    <ProductName>OTRIVINE HAY FEVER FORMULA (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016076</DrugIDPK>
    <LicenceNumber>PA0218/003/003</LicenceNumber>
    <ProductName>INSULIN ACTRAPID MC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016097</DrugIDPK>
    <LicenceNumber>PA0218/014/003</LicenceNumber>
    <ProductName>INSULIN LENTARD MC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016069</DrugIDPK>
    <LicenceNumber>PA0218/001/003</LicenceNumber>
    <ProductName>INSULIN MONOTARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016094</DrugIDPK>
    <LicenceNumber>PA0218/013/003</LicenceNumber>
    <ProductName>INSULIN RAPITARD MC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016073</DrugIDPK>
    <LicenceNumber>PA0218/002/003</LicenceNumber>
    <ProductName>INSULIN SEMITARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1988-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011170</DrugIDPK>
    <LicenceNumber>PA0050/056/002</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011166</DrugIDPK>
    <LicenceNumber>PA0050/056/001</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011172</DrugIDPK>
    <LicenceNumber>PA0050/056/007</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011178</DrugIDPK>
    <LicenceNumber>PA0050/056/008</LicenceNumber>
    <ProductName>BENERVA AMPOULES</ProductName>
    <Strength>100/ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010491</DrugIDPK>
    <LicenceNumber>PA0028/030/002</LicenceNumber>
    <ProductName>OTRIVINE - ANTISTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTAZOLINE SULFATE</ActiveSubstance>
      <ActiveSubstance>XYLOMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010493</DrugIDPK>
    <LicenceNumber>PA0028/030/003</LicenceNumber>
    <ProductName>OTRIVINE - ANTISTIN  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ANTAZOLINE SULFATE</ActiveSubstance>
      <ActiveSubstance>XYLOMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010057</DrugIDPK>
    <LicenceNumber>PA0017/074/003</LicenceNumber>
    <ProductName>NEULENTE INSULIN ZINC  (SUSPENSION)</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011306</DrugIDPK>
    <LicenceNumber>PA0054/031/001</LicenceNumber>
    <ProductName>SYSTRAL-C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010068</DrugIDPK>
    <LicenceNumber>PA0017/075/003</LicenceNumber>
    <ProductName>NEUPHANE ISOPHANE INSULIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPHANE INSULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012695</DrugIDPK>
    <LicenceNumber>PA0108/004/002</LicenceNumber>
    <ProductName>POLIOVIRUS VACCINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1977-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLIOVIRUS VACCINE LIVE ORAL</ActiveSubstance>
      <ActiveSubstance>STREPTOMYCIN</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009725</DrugIDPK>
    <LicenceNumber>PA0016/016/002</LicenceNumber>
    <ProductName>HALCION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009973</DrugIDPK>
    <LicenceNumber>PA0016/012/003</LicenceNumber>
    <ProductName>NEO-CORTEF</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009974</DrugIDPK>
    <LicenceNumber>PA0016/012/004</LicenceNumber>
    <ProductName>NEO-CORTEF</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009975</DrugIDPK>
    <LicenceNumber>PA0016/012/005</LicenceNumber>
    <ProductName>NEO-CORTEF</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009976</DrugIDPK>
    <LicenceNumber>PA0016/012/006</LicenceNumber>
    <ProductName>NEO-CORTEF</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011346</DrugIDPK>
    <LicenceNumber>PA0054/047/001</LicenceNumber>
    <ProductName>BILIMIRO</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1983-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPANOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009995</DrugIDPK>
    <LicenceNumber>PA0018/011/001</LicenceNumber>
    <ProductName>FRAMYSPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011303</DrugIDPK>
    <LicenceNumber>PA0054/030/002</LicenceNumber>
    <ProductName>SYSTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011304</DrugIDPK>
    <LicenceNumber>PA0054/030/003</LicenceNumber>
    <ProductName>SYSTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010931</DrugIDPK>
    <LicenceNumber>PA0047/053/001</LicenceNumber>
    <ProductName>ILOTYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott GmbH &amp; Co KG</PAHolder>
    <AuthorisedDate>1983-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011713</DrugIDPK>
    <LicenceNumber>PA0073/077/001</LicenceNumber>
    <ProductName>SCORBAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010259</DrugIDPK>
    <LicenceNumber>PA0032/001/001</LicenceNumber>
    <ProductName>GENETICIN INTRATHECAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1976-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013610</DrugIDPK>
    <LicenceNumber>PA0187/009/001</LicenceNumber>
    <ProductName>INTRAMIN FORTE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTRAMIN NOVUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013612</DrugIDPK>
    <LicenceNumber>PA0187/009/002</LicenceNumber>
    <ProductName>INTRAMIN FORTE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INTRAMIN NOVUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010281</DrugIDPK>
    <LicenceNumber>PA0032/018/002</LicenceNumber>
    <ProductName>NICHOLAS CO2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SUCCINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011361</DrugIDPK>
    <LicenceNumber>PA0054/061/001</LicenceNumber>
    <ProductName>TUTOLIPID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FAT EMULSIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011362</DrugIDPK>
    <LicenceNumber>PA0054/061/002</LicenceNumber>
    <ProductName>TUTOLIPID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FAT EMULSIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011363</DrugIDPK>
    <LicenceNumber>PA0054/061/003</LicenceNumber>
    <ProductName>TUTOLIPID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011364</DrugIDPK>
    <LicenceNumber>PA0054/061/004</LicenceNumber>
    <ProductName>TUTOLIPID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011365</DrugIDPK>
    <LicenceNumber>PA0054/061/005</LicenceNumber>
    <ProductName>TUTOLIPID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011366</DrugIDPK>
    <LicenceNumber>PA0054/061/006</LicenceNumber>
    <ProductName>TUTOLIPID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011717</DrugIDPK>
    <LicenceNumber>PA0073/082/001</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011718</DrugIDPK>
    <LicenceNumber>PA0073/082/002</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011719</DrugIDPK>
    <LicenceNumber>PA0073/082/003</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009777</DrugIDPK>
    <LicenceNumber>PA0017/019/001</LicenceNumber>
    <ProductName>LINCTIFED EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009778</DrugIDPK>
    <LicenceNumber>PA0017/019/002</LicenceNumber>
    <ProductName>LINCTIFED EXPECTORANT PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013119</DrugIDPK>
    <LicenceNumber>PA0126/021/001</LicenceNumber>
    <ProductName>DIGAMEL</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1983-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013216</DrugIDPK>
    <LicenceNumber>PA0149/014/001</LicenceNumber>
    <ProductName>ALPHAMIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013217</DrugIDPK>
    <LicenceNumber>PA0149/014/002</LicenceNumber>
    <ProductName>ALPHAMIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-07-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011390</DrugIDPK>
    <LicenceNumber>PA0056/024/001</LicenceNumber>
    <ProductName>EPANUTIN/PHENOBARBIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010656</DrugIDPK>
    <LicenceNumber>PA0039/019/001</LicenceNumber>
    <ProductName>PERITRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010758</DrugIDPK>
    <LicenceNumber>PA0040/056/001</LicenceNumber>
    <ProductName>CARDIO CONRAY</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010759</DrugIDPK>
    <LicenceNumber>PA0040/056/002</LicenceNumber>
    <ProductName>CARDIO CONRAY</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010756</DrugIDPK>
    <LicenceNumber>PA0040/052/001</LicenceNumber>
    <ProductName>CONRAY 480</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010763</DrugIDPK>
    <LicenceNumber>PA0040/058/001</LicenceNumber>
    <ProductName>DIAGINOL-VISCOUS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010766</DrugIDPK>
    <LicenceNumber>PA0040/067/001</LicenceNumber>
    <ProductName>M &amp; B ANTISEPTIC CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010741</DrugIDPK>
    <LicenceNumber>PA0040/036/001</LicenceNumber>
    <ProductName>NEFROLAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010742</DrugIDPK>
    <LicenceNumber>PA0040/036/002</LicenceNumber>
    <ProductName>NEFROLAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010764</DrugIDPK>
    <LicenceNumber>PA0040/060/001</LicenceNumber>
    <ProductName>PATENT BLUE V</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010765</DrugIDPK>
    <LicenceNumber>PA0040/061/001</LicenceNumber>
    <ProductName>PHYTODERMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010768</DrugIDPK>
    <LicenceNumber>PA0040/072/001</LicenceNumber>
    <ProductName>VALLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012573</DrugIDPK>
    <LicenceNumber>PA0102/008/001</LicenceNumber>
    <ProductName>ENZYPAN FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1983-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010038</DrugIDPK>
    <LicenceNumber>PA0017/071/002</LicenceNumber>
    <ProductName>FERROMYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010040</DrugIDPK>
    <LicenceNumber>PA0017/072/001</LicenceNumber>
    <ProductName>FERROMYN B ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SUCCINATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001617</DrugIDPK>
    <LicenceNumber>PA0017/073/001</LicenceNumber>
    <ProductName>FERROMYN S</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SUCCINATE</ActiveSubstance>
      <ActiveSubstance>SUCCINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013509</DrugIDPK>
    <LicenceNumber>PA0261/007/001</LicenceNumber>
    <ProductName>MIXOGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLTESTOSTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013520</DrugIDPK>
    <LicenceNumber>PA0261/010/001</LicenceNumber>
    <ProductName>TESTORAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010879</DrugIDPK>
    <LicenceNumber>PA0046/024/003</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010866</DrugIDPK>
    <LicenceNumber>PA0046/013/001</LicenceNumber>
    <ProductName>IROLENTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011296</DrugIDPK>
    <LicenceNumber>PA0051/015/004</LicenceNumber>
    <ProductName>SYNALAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010105</DrugIDPK>
    <LicenceNumber>PA0018/035/001</LicenceNumber>
    <ProductName>ACNIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RESORCINOL</ActiveSubstance>
      <ActiveSubstance>SULPHUR</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010746</DrugIDPK>
    <LicenceNumber>PA0040/039/002</LicenceNumber>
    <ProductName>ANTHISAN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010747</DrugIDPK>
    <LicenceNumber>PA0040/039/003</LicenceNumber>
    <ProductName>ANTHISAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010748</DrugIDPK>
    <LicenceNumber>PA0040/039/005</LicenceNumber>
    <ProductName>ANTHISAN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010846</DrugIDPK>
    <LicenceNumber>PA0040/039/001</LicenceNumber>
    <ProductName>ANTHISAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011854</DrugIDPK>
    <LicenceNumber>PA0082/025/001</LicenceNumber>
    <ProductName>ISO-BRONCHISAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE SULPHATE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011672</DrugIDPK>
    <LicenceNumber>PA0073/021/001</LicenceNumber>
    <ProductName>RODAVAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLOROTHEOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011673</DrugIDPK>
    <LicenceNumber>PA0073/022/001</LicenceNumber>
    <ProductName>SYSTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011674</DrugIDPK>
    <LicenceNumber>PA0073/022/002</LicenceNumber>
    <ProductName>SYSTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011675</DrugIDPK>
    <LicenceNumber>PA0073/022/003</LicenceNumber>
    <ProductName>SYSTRAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011676</DrugIDPK>
    <LicenceNumber>PA0073/023/001</LicenceNumber>
    <ProductName>SYSTRAL-C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013605</DrugIDPK>
    <LicenceNumber>PA0187/007/001</LicenceNumber>
    <ProductName>CETIPRIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013616</DrugIDPK>
    <LicenceNumber>PA0187/014/001</LicenceNumber>
    <ProductName>CETIPRIN NOVUM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013720</DrugIDPK>
    <LicenceNumber>PA0217/007/003</LicenceNumber>
    <ProductName>FACTOR VIII NORDISK</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010880</DrugIDPK>
    <LicenceNumber>PA0046/024/004</LicenceNumber>
    <ProductName>ONE-ALPHA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011030</DrugIDPK>
    <LicenceNumber>PA0046/057/001</LicenceNumber>
    <ProductName>DICAPEN</ProductName>
    <Strength>0.375</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM</ActiveSubstance>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011031</DrugIDPK>
    <LicenceNumber>PA0046/057/004</LicenceNumber>
    <ProductName>DICAPEN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM</ActiveSubstance>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009781</DrugIDPK>
    <LicenceNumber>PA0017/020/002</LicenceNumber>
    <ProductName>PHYSEPTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1987-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHADONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015144</DrugIDPK>
    <LicenceNumber>PA0290/043/001</LicenceNumber>
    <ProductName>ALCOMICIN STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010667</DrugIDPK>
    <LicenceNumber>PA0044/076/002</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012297</DrugIDPK>
    <LicenceNumber>PA0303/001/005</LicenceNumber>
    <ProductName>VERAMIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011913</DrugIDPK>
    <LicenceNumber>PA0082/054/002</LicenceNumber>
    <ProductName>UNIVER</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013580</DrugIDPK>
    <LicenceNumber>PA0179/023/001</LicenceNumber>
    <ProductName>LYODURA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013497</DrugIDPK>
    <LicenceNumber>PA0258/019/002</LicenceNumber>
    <ProductName>NOVASIL ANTACID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013494</DrugIDPK>
    <LicenceNumber>PA0258/019/001</LicenceNumber>
    <ProductName>NOVASIL ANTACID (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013798</DrugIDPK>
    <LicenceNumber>PA0277/005/005</LicenceNumber>
    <ProductName>PALACOS E WITH GENTAMICIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010217</DrugIDPK>
    <LicenceNumber>PA0028/055/001</LicenceNumber>
    <ProductName>DO-DO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011266</DrugIDPK>
    <LicenceNumber>PA0054/020/005</LicenceNumber>
    <ProductName>REFOSPOREN 1 G I.V.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZEDONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011267</DrugIDPK>
    <LicenceNumber>PA0054/020/006</LicenceNumber>
    <ProductName>REFOSPOREN 2 G I.V.</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZEDONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011268</DrugIDPK>
    <LicenceNumber>PA0054/020/007</LicenceNumber>
    <ProductName>REFOSPOREN 2 G I.V.</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFAZEDONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011263</DrugIDPK>
    <LicenceNumber>PA0054/020/002</LicenceNumber>
    <ProductName>REFOSPOREN 250 MG I.M.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZEDONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011262</DrugIDPK>
    <LicenceNumber>PA0054/020/001</LicenceNumber>
    <ProductName>REFOSPOREN 250 MG I.V.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZEDONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011265</DrugIDPK>
    <LicenceNumber>PA0054/020/004</LicenceNumber>
    <ProductName>REFOSPOREN 500 MG I.M.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZEDONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011264</DrugIDPK>
    <LicenceNumber>PA0054/020/003</LicenceNumber>
    <ProductName>REFOSPOREN 500 MG I.V.</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZEDONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011946</DrugIDPK>
    <LicenceNumber>PA0078/009/001</LicenceNumber>
    <ProductName>CATHEJELL TUBES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012080</DrugIDPK>
    <LicenceNumber>PA0078/043/001</LicenceNumber>
    <ProductName>CDCA-CEDONA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHENODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011944</DrugIDPK>
    <LicenceNumber>PA0078/007/001</LicenceNumber>
    <ProductName>CEDURAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
      <ActiveSubstance>DEGLYCYRRHIZINIZED EXTRACT OF LIQUORICE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012024</DrugIDPK>
    <LicenceNumber>PA0078/048/001</LicenceNumber>
    <ProductName>DOXY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012025</DrugIDPK>
    <LicenceNumber>PA0078/048/002</LicenceNumber>
    <ProductName>DOXY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011939</DrugIDPK>
    <LicenceNumber>PA0078/004/001</LicenceNumber>
    <ProductName>DOXYSCHEL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011943</DrugIDPK>
    <LicenceNumber>PA0078/006/001</LicenceNumber>
    <ProductName>EFFERALGAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012027</DrugIDPK>
    <LicenceNumber>PA0078/054/003</LicenceNumber>
    <ProductName>FLUOROURACIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011963</DrugIDPK>
    <LicenceNumber>PA0078/019/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011965</DrugIDPK>
    <LicenceNumber>PA0078/021/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011966</DrugIDPK>
    <LicenceNumber>PA0078/021/003</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011991</DrugIDPK>
    <LicenceNumber>PA0078/036/001</LicenceNumber>
    <ProductName>IRIMONT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012074</DrugIDPK>
    <LicenceNumber>PA0078/042/002</LicenceNumber>
    <ProductName>LARBROFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN LYSINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012019</DrugIDPK>
    <LicenceNumber>PA0078/042/001</LicenceNumber>
    <ProductName>LARBROFEN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012006</DrugIDPK>
    <LicenceNumber>PA0078/040/003</LicenceNumber>
    <ProductName>LAROLOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011997</DrugIDPK>
    <LicenceNumber>PA0078/040/001</LicenceNumber>
    <ProductName>LAROLOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012002</DrugIDPK>
    <LicenceNumber>PA0078/040/002</LicenceNumber>
    <ProductName>LAROLOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012011</DrugIDPK>
    <LicenceNumber>PA0078/040/004</LicenceNumber>
    <ProductName>LAROLOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011957</DrugIDPK>
    <LicenceNumber>PA0078/017/001</LicenceNumber>
    <ProductName>LOWTEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Central Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011958</DrugIDPK>
    <LicenceNumber>PA0078/017/002</LicenceNumber>
    <ProductName>LOWTEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Central Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011984</DrugIDPK>
    <LicenceNumber>PA0078/032/001</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011985</DrugIDPK>
    <LicenceNumber>PA0078/032/002</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011986</DrugIDPK>
    <LicenceNumber>PA0078/032/003</LicenceNumber>
    <ProductName>METHYLDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011990</DrugIDPK>
    <LicenceNumber>PA0078/035/001</LicenceNumber>
    <ProductName>NIFEREX F A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYSACCHARIDE-K</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011994</DrugIDPK>
    <LicenceNumber>PA0078/039/002</LicenceNumber>
    <ProductName>NIFLURIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFLUMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011977</DrugIDPK>
    <LicenceNumber>PA0078/027/001</LicenceNumber>
    <ProductName>NIRYLIN EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011949</DrugIDPK>
    <LicenceNumber>PA0078/013/001</LicenceNumber>
    <ProductName>PENERIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011978</DrugIDPK>
    <LicenceNumber>PA0078/029/001</LicenceNumber>
    <ProductName>PHENYKBUTAZONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012068</DrugIDPK>
    <LicenceNumber>PA0078/016/002</LicenceNumber>
    <ProductName>TENCALM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011956</DrugIDPK>
    <LicenceNumber>PA0078/016/001</LicenceNumber>
    <ProductName>TENCALM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011935</DrugIDPK>
    <LicenceNumber>PA0078/003/003</LicenceNumber>
    <ProductName>TETRACHEL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011927</DrugIDPK>
    <LicenceNumber>PA0078/003/001</LicenceNumber>
    <ProductName>TETRACHEL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012017</DrugIDPK>
    <LicenceNumber>PA0078/041/002</LicenceNumber>
    <ProductName>THEOCLEAR</ProductName>
    <Strength>260</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1984-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011962</DrugIDPK>
    <LicenceNumber>PA0078/019/001</LicenceNumber>
    <ProductName>URIFLOW</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013847</DrugIDPK>
    <LicenceNumber>PA0282/004/003</LicenceNumber>
    <ProductName>AMPICILLIN MIXTURE B.P.C.</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1980-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013848</DrugIDPK>
    <LicenceNumber>PA0282/004/004</LicenceNumber>
    <ProductName>AMPICILLIN MIXTURE B.P.C.</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1985-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013368</DrugIDPK>
    <LicenceNumber>PA0255/008/002</LicenceNumber>
    <ProductName>DEXTROSE INJECTION 50%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013356</DrugIDPK>
    <LicenceNumber>PA0255/004/003</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE 1%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013647</DrugIDPK>
    <LicenceNumber>PA0196/004/002</LicenceNumber>
    <ProductName>RACESTYPTINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>HYDROXYQUINOLINE SULFATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013646</DrugIDPK>
    <LicenceNumber>PA0196/004/001</LicenceNumber>
    <ProductName>RACESTYPTINE CORD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>HYDROXYQUINOLINE SULFATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012592</DrugIDPK>
    <LicenceNumber>PA0102/011/001</LicenceNumber>
    <ProductName>PROCYCLIDINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCYCLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015775</DrugIDPK>
    <LicenceNumber>PA0251/003/001</LicenceNumber>
    <ProductName>FERFOLIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013805</DrugIDPK>
    <LicenceNumber>PA0277/007/005</LicenceNumber>
    <ProductName>NETILLIN</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013806</DrugIDPK>
    <LicenceNumber>PA0277/007/007</LicenceNumber>
    <ProductName>NETILLIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012433</DrugIDPK>
    <LicenceNumber>PA0330/002/003</LicenceNumber>
    <ProductName>TYLENOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009672</DrugIDPK>
    <LicenceNumber>PA0007/022/001</LicenceNumber>
    <ProductName>DULCODOS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011321</DrugIDPK>
    <LicenceNumber>PA0051/034/001</LicenceNumber>
    <ProductName>DISULPHINE BLUE INTRAVENOUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPHAN BLUE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012892</DrugIDPK>
    <LicenceNumber>PA0115/009/004</LicenceNumber>
    <ProductName>TRUXAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012893</DrugIDPK>
    <LicenceNumber>PA0115/009/005</LicenceNumber>
    <ProductName>TRUXAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009880</DrugIDPK>
    <LicenceNumber>PA0012/031/004</LicenceNumber>
    <ProductName>ULTRALAN ORAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010269</DrugIDPK>
    <LicenceNumber>PA0022/006/001</LicenceNumber>
    <ProductName>HAVAPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENAMECILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010275</DrugIDPK>
    <LicenceNumber>PA0022/008/001</LicenceNumber>
    <ProductName>PENIDURAL L A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZATHINE BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>PROCAINE PENICILLIN G</ActiveSubstance>
      <ActiveSubstance>BENZYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011708</DrugIDPK>
    <LicenceNumber>PA0073/074/001</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011709</DrugIDPK>
    <LicenceNumber>PA0073/074/002</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011710</DrugIDPK>
    <LicenceNumber>PA0073/074/003</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011711</DrugIDPK>
    <LicenceNumber>PA0073/074/004</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1982-10-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010045</DrugIDPK>
    <LicenceNumber>PA0019/032/001</LicenceNumber>
    <ProductName>CEFOBID</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOPERAZONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010046</DrugIDPK>
    <LicenceNumber>PA0019/032/002</LicenceNumber>
    <ProductName>CEFOBID</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOPERAZONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010047</DrugIDPK>
    <LicenceNumber>PA0019/032/003</LicenceNumber>
    <ProductName>CEFOBID</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOPERAZONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010020</DrugIDPK>
    <LicenceNumber>PA0019/013/003</LicenceNumber>
    <ProductName>VIBRAMYCIN INTRAVENOUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012955</DrugIDPK>
    <LicenceNumber>PA0132/001/001</LicenceNumber>
    <ProductName>UROMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Consolidated Chemicals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACARBAMIDE</ActiveSubstance>
      <ActiveSubstance>PHENAZOPYRIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005405</DrugIDPK>
    <LicenceNumber>PA0277/007/002</LicenceNumber>
    <ProductName>NETILLIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NETILMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-08-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012889</DrugIDPK>
    <LicenceNumber>PA0115/009/001</LicenceNumber>
    <ProductName>TRUXAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012890</DrugIDPK>
    <LicenceNumber>PA0115/009/002</LicenceNumber>
    <ProductName>TRUXAL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012891</DrugIDPK>
    <LicenceNumber>PA0115/009/003</LicenceNumber>
    <ProductName>TRUXAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1982-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013054</DrugIDPK>
    <LicenceNumber>PA0137/021/002</LicenceNumber>
    <ProductName>PRED-MILD OPHTHALMIC (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015650</DrugIDPK>
    <LicenceNumber>PA0233/001/001</LicenceNumber>
    <ProductName>DIGANOX BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013409</DrugIDPK>
    <LicenceNumber>PA0167/069/015</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013411</DrugIDPK>
    <LicenceNumber>PA0167/069/016</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013401</DrugIDPK>
    <LicenceNumber>PA0167/069/007</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013402</DrugIDPK>
    <LicenceNumber>PA0167/069/008</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013562</DrugIDPK>
    <LicenceNumber>PA0275/007/001</LicenceNumber>
    <ProductName>OPTREX EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLANTOIN</ActiveSubstance>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013309</DrugIDPK>
    <LicenceNumber>PA0167/012/010</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V FOR IRRIGATION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder &amp; Topical Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013308</DrugIDPK>
    <LicenceNumber>PA0167/012/009</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/VFOR IRRIGATION</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Bladder &amp; Topical Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013303</DrugIDPK>
    <LicenceNumber>PA0167/011/009</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013304</DrugIDPK>
    <LicenceNumber>PA0167/011/010</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013337</DrugIDPK>
    <LicenceNumber>PA0167/032/015</LicenceNumber>
    <ProductName>TRAVASEPT 100 ANTISEPTIC SODIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013336</DrugIDPK>
    <LicenceNumber>PA0167/032/014</LicenceNumber>
    <ProductName>TRAVASEPT 100 ANTISEPTIC SOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013334</DrugIDPK>
    <LicenceNumber>PA0167/032/012</LicenceNumber>
    <ProductName>TRAVASEPT 30 ANTISEPTIC SOLUTION</ProductName>
    <Strength>0.05%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013332</DrugIDPK>
    <LicenceNumber>PA0167/032/010</LicenceNumber>
    <ProductName>TRAVESEPT 15 ANTISEPTIC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013333</DrugIDPK>
    <LicenceNumber>PA0167/032/011</LicenceNumber>
    <ProductName>TRAVESEPT 15 ANTISEPTIC SOLUTION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013335</DrugIDPK>
    <LicenceNumber>PA0167/032/013</LicenceNumber>
    <ProductName>TRAVESEPT 30 ANTISEPTIC SOLUTION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1987-02-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010611</DrugIDPK>
    <LicenceNumber>PA0044/049/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010612</DrugIDPK>
    <LicenceNumber>PA0044/049/002</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010812</DrugIDPK>
    <LicenceNumber>PA0044/002/001</LicenceNumber>
    <ProductName>BETA-CARDONE (SOTALOL)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SOTALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010613</DrugIDPK>
    <LicenceNumber>PA0044/050/001</LicenceNumber>
    <ProductName>BETA-CORLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010618</DrugIDPK>
    <LicenceNumber>PA0044/054/001</LicenceNumber>
    <ProductName>INSULIN ZINC SUSPENSION BP LENTE AB BRAND</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010620</DrugIDPK>
    <LicenceNumber>PA0044/054/002</LicenceNumber>
    <ProductName>INSULIN ZINC SUSPENSION BP LENTE AB BRAND</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010637</DrugIDPK>
    <LicenceNumber>PA0044/057/002</LicenceNumber>
    <ProductName>ISOPHANE INSULIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010633</DrugIDPK>
    <LicenceNumber>PA0044/057/001</LicenceNumber>
    <ProductName>ISOPHANE INSULIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010617</DrugIDPK>
    <LicenceNumber>PA0044/053/001</LicenceNumber>
    <ProductName>PREDNELAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010624</DrugIDPK>
    <LicenceNumber>PA0044/056/001</LicenceNumber>
    <ProductName>SOLUBLE INSULIN B P</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010625</DrugIDPK>
    <LicenceNumber>PA0044/056/002</LicenceNumber>
    <ProductName>SOLUBLE INSULIN B P</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010595</DrugIDPK>
    <LicenceNumber>PA0044/048/004</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009726</DrugIDPK>
    <LicenceNumber>PA0016/016/003</LicenceNumber>
    <ProductName>HALCION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010560</DrugIDPK>
    <LicenceNumber>PA0044/036/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA TETANUS &amp; PERTUSSIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010558</DrugIDPK>
    <LicenceNumber>PA0044/035/001</LicenceNumber>
    <ProductName>ADSORBED TETANUS VACCINE BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010559</DrugIDPK>
    <LicenceNumber>PA0044/035/002</LicenceNumber>
    <ProductName>ADSORBED TETANUS VACCINE BP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETANUS VACCINE ADSORBED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010567</DrugIDPK>
    <LicenceNumber>PA0044/042/004</LicenceNumber>
    <ProductName>BETNESOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010570</DrugIDPK>
    <LicenceNumber>PA0044/042/005</LicenceNumber>
    <ProductName>BETNESOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995000831</DrugIDPK>
    <LicenceNumber>PA0044/085/003</LicenceNumber>
    <ProductName>DINDEVAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENINDAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995002066</DrugIDPK>
    <LicenceNumber>PA0044/036/002</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010584</DrugIDPK>
    <LicenceNumber>PA0044/046/002</LicenceNumber>
    <ProductName>FLUVIRIN</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010582</DrugIDPK>
    <LicenceNumber>PA0044/046/001</LicenceNumber>
    <ProductName>FLUVIRIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010571</DrugIDPK>
    <LicenceNumber>PA0044/044/001</LicenceNumber>
    <ProductName>PREDSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010666</DrugIDPK>
    <LicenceNumber>PA0044/074/001</LicenceNumber>
    <ProductName>PROTAMINE SULPHATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTAMINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010594</DrugIDPK>
    <LicenceNumber>PA0044/048/003</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B  P</ProductName>
    <Strength>1,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010592</DrugIDPK>
    <LicenceNumber>PA0044/048/002</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010598</DrugIDPK>
    <LicenceNumber>PA0044/048/005</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010609</DrugIDPK>
    <LicenceNumber>PA0044/048/010</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010606</DrugIDPK>
    <LicenceNumber>PA0044/048/009</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010604</DrugIDPK>
    <LicenceNumber>PA0044/048/008</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength>100,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010591</DrugIDPK>
    <LicenceNumber>PA0044/048/001</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE BP</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-03-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010816</DrugIDPK>
    <LicenceNumber>PA0044/007/002</LicenceNumber>
    <ProductName>ADMUNE MULTIDOSE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010815</DrugIDPK>
    <LicenceNumber>PA0044/007/001</LicenceNumber>
    <ProductName>ADMUNE SINGLE DOSE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010829</DrugIDPK>
    <LicenceNumber>PA0044/009/001</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010541</DrugIDPK>
    <LicenceNumber>PA0044/020/001</LicenceNumber>
    <ProductName>FAZADON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FAZADINIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010671</DrugIDPK>
    <LicenceNumber>PA0045/002/003</LicenceNumber>
    <ProductName>GYNO-DAKTARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1977-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010547</DrugIDPK>
    <LicenceNumber>PA0044/028/001</LicenceNumber>
    <ProductName>PROPADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010548</DrugIDPK>
    <LicenceNumber>PA0044/028/002</LicenceNumber>
    <ProductName>PROPADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010549</DrugIDPK>
    <LicenceNumber>PA0044/028/003</LicenceNumber>
    <ProductName>PROPADERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010556</DrugIDPK>
    <LicenceNumber>PA0044/031/001</LicenceNumber>
    <ProductName>PROPADERM A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1987-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010552</DrugIDPK>
    <LicenceNumber>PA0044/029/002</LicenceNumber>
    <ProductName>PROPADERM C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010553</DrugIDPK>
    <LicenceNumber>PA0044/030/001</LicenceNumber>
    <ProductName>PROPADERN N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010835</DrugIDPK>
    <LicenceNumber>PA0044/015/003</LicenceNumber>
    <ProductName>TRIPTAFEN FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010823</DrugIDPK>
    <LicenceNumber>PA0044/007/009</LicenceNumber>
    <ProductName>ADMUNE (FLUVAC)</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010824</DrugIDPK>
    <LicenceNumber>PA0044/007/010</LicenceNumber>
    <ProductName>ADMUNE (FLUVAC)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010817</DrugIDPK>
    <LicenceNumber>PA0044/007/003</LicenceNumber>
    <ProductName>ADMUNE MULTIDOSE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010819</DrugIDPK>
    <LicenceNumber>PA0044/007/005</LicenceNumber>
    <ProductName>ADMUNE MULTIDOSE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010818</DrugIDPK>
    <LicenceNumber>PA0044/007/004</LicenceNumber>
    <ProductName>ADMUNE SINGLE DOSE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010830</DrugIDPK>
    <LicenceNumber>PA0044/009/006</LicenceNumber>
    <ProductName>CEPOREX  (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010551</DrugIDPK>
    <LicenceNumber>PA0044/029/001</LicenceNumber>
    <ProductName>PROPADERM C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015271</DrugIDPK>
    <LicenceNumber>PA0297/007/004</LicenceNumber>
    <ProductName>CAPD 2 FLUID WITH DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015605</DrugIDPK>
    <LicenceNumber>PA0297/009/004</LicenceNumber>
    <ProductName>CAPD 3 FLUID WITH 4.25% DEXTROSE</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015600</DrugIDPK>
    <LicenceNumber>PA0297/008/003</LicenceNumber>
    <ProductName>CAPD 3K WITH 4.25% DEXTROSE AND POTASSIUM</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015601</DrugIDPK>
    <LicenceNumber>PA0297/008/004</LicenceNumber>
    <ProductName>CAPD 3K WITH 4.25% DEXTROSE AND POTASSIUM</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010831</DrugIDPK>
    <LicenceNumber>PA0044/009/007</LicenceNumber>
    <ProductName>CEPOREX  (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010589</DrugIDPK>
    <LicenceNumber>PA0044/046/004</LicenceNumber>
    <ProductName>FLUVIRIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010586</DrugIDPK>
    <LicenceNumber>PA0044/046/003</LicenceNumber>
    <ProductName>FLUVIRIN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010972</DrugIDPK>
    <LicenceNumber>PA0048/006/002</LicenceNumber>
    <ProductName>KANFOTREX</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010554</DrugIDPK>
    <LicenceNumber>PA0044/032/002</LicenceNumber>
    <ProductName>MEVILIN L</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011562</DrugIDPK>
    <LicenceNumber>PA0060/003/005</LicenceNumber>
    <ProductName>NASOFLU (RIT 4040 STRAIN) MONODOSE 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1976-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011560</DrugIDPK>
    <LicenceNumber>PA0060/003/004</LicenceNumber>
    <ProductName>NASOFLU (RIT 4050 STRAIN) MONODOSE VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1976-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011563</DrugIDPK>
    <LicenceNumber>PA0060/003/006</LicenceNumber>
    <ProductName>NASOFLU (RIT 4050 STRAIN) MULTIDOSE 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1976-11-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010065</DrugIDPK>
    <LicenceNumber>PA0017/075/002</LicenceNumber>
    <ProductName>NEUPHANE</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPHANE INSULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010060</DrugIDPK>
    <LicenceNumber>PA0017/075/001</LicenceNumber>
    <ProductName>NEUPHANE ISOPHANE INSULIN INJECTION 40U/ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOPHANE INSULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015273</DrugIDPK>
    <LicenceNumber>PA0297/008/002</LicenceNumber>
    <ProductName>PERITOFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015267</DrugIDPK>
    <LicenceNumber>PA0297/006/004</LicenceNumber>
    <ProductName>PERITOFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015268</DrugIDPK>
    <LicenceNumber>PA0297/007/001</LicenceNumber>
    <ProductName>PERITOFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015269</DrugIDPK>
    <LicenceNumber>PA0297/007/002</LicenceNumber>
    <ProductName>PERITOFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015270</DrugIDPK>
    <LicenceNumber>PA0297/007/003</LicenceNumber>
    <ProductName>PERITOFLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015272</DrugIDPK>
    <LicenceNumber>PA0297/008/001</LicenceNumber>
    <ProductName>PERITOFLEX (DEXTROSE &amp; POTASSIUM)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015606</DrugIDPK>
    <LicenceNumber>PA0297/010/001</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 1</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015607</DrugIDPK>
    <LicenceNumber>PA0297/010/002</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 1</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015608</DrugIDPK>
    <LicenceNumber>PA0297/010/003</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 1</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015609</DrugIDPK>
    <LicenceNumber>PA0297/010/004</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 1</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015610</DrugIDPK>
    <LicenceNumber>PA0297/011/001</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015611</DrugIDPK>
    <LicenceNumber>PA0297/011/002</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015612</DrugIDPK>
    <LicenceNumber>PA0297/011/003</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015613</DrugIDPK>
    <LicenceNumber>PA0297/011/004</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015614</DrugIDPK>
    <LicenceNumber>PA0297/012/001</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4K</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015615</DrugIDPK>
    <LicenceNumber>PA0297/012/002</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4K</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015616</DrugIDPK>
    <LicenceNumber>PA0297/012/003</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4K</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015617</DrugIDPK>
    <LicenceNumber>PA0297/012/004</LicenceNumber>
    <ProductName>PERITOFLEX CAPD 4K</ProductName>
    <Strength>2000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009968</DrugIDPK>
    <LicenceNumber>PA0016/007/001</LicenceNumber>
    <ProductName>ALBAMYCIN T</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOVOBIOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009969</DrugIDPK>
    <LicenceNumber>PA0016/007/002</LicenceNumber>
    <ProductName>ALBAMYCIN T PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NOVOBIOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011649</DrugIDPK>
    <LicenceNumber>PA0073/003/008</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011650</DrugIDPK>
    <LicenceNumber>PA0073/003/009</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011659</DrugIDPK>
    <LicenceNumber>PA0073/003/021</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011658</DrugIDPK>
    <LicenceNumber>PA0073/003/020</LicenceNumber>
    <ProductName>ALORBAT (DISPOSABLE SYRINGE)</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011660</DrugIDPK>
    <LicenceNumber>PA0073/003/022</LicenceNumber>
    <ProductName>ALORBAT MULTIDOSE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010331</DrugIDPK>
    <LicenceNumber>PA0033/019/001</LicenceNumber>
    <ProductName>ANAPOLON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETHOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012777</DrugIDPK>
    <LicenceNumber>PA0114/002/002</LicenceNumber>
    <ProductName>BETADINE SKIN CLEANSER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1975-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011561</DrugIDPK>
    <LicenceNumber>PA0062/011/004</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011576</DrugIDPK>
    <LicenceNumber>PA0062/012/001</LicenceNumber>
    <ProductName>BRONTINA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011580</DrugIDPK>
    <LicenceNumber>PA0062/013/001</LicenceNumber>
    <ProductName>BRONTISOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010191</DrugIDPK>
    <LicenceNumber>PA0021/004/007</LicenceNumber>
    <ProductName>CANESTEN VAGINAL CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015257</DrugIDPK>
    <LicenceNumber>PA0297/003/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015258</DrugIDPK>
    <LicenceNumber>PA0297/003/002</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015178</DrugIDPK>
    <LicenceNumber>PA0297/002/001</LicenceNumber>
    <ProductName>DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015255</DrugIDPK>
    <LicenceNumber>PA0297/002/002</LicenceNumber>
    <ProductName>DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013523</DrugIDPK>
    <LicenceNumber>PA0261/013/004</LicenceNumber>
    <ProductName>DURABOLIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012641</DrugIDPK>
    <LicenceNumber>PA0108/001/001</LicenceNumber>
    <ProductName>DUVADILAN OBSTETRIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1976-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010693</DrugIDPK>
    <LicenceNumber>PA0039/032/001</LicenceNumber>
    <ProductName>ELTOFAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011760</DrugIDPK>
    <LicenceNumber>PA0077/011/001</LicenceNumber>
    <ProductName>EVIDORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEXOBARBITONE</ActiveSubstance>
      <ActiveSubstance>CYCLOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011764</DrugIDPK>
    <LicenceNumber>PA0077/012/001</LicenceNumber>
    <ProductName>GERISOM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CHLORMEZANONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009688</DrugIDPK>
    <LicenceNumber>PA0009/005/002</LicenceNumber>
    <ProductName>HEMINEVRIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMETHIAZOLE EDISILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013507</DrugIDPK>
    <LicenceNumber>PA0261/005/003</LicenceNumber>
    <ProductName>HYDROCORTISONE SODIUM SUCCINATE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011292</DrugIDPK>
    <LicenceNumber>PA0051/011/002</LicenceNumber>
    <ProductName>IMPERACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012663</DrugIDPK>
    <LicenceNumber>PA0108/003/010</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012664</DrugIDPK>
    <LicenceNumber>PA0108/003/011</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012660</DrugIDPK>
    <LicenceNumber>PA0108/003/009</LicenceNumber>
    <ProductName>INFLUVAC 0.5 ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010723</DrugIDPK>
    <LicenceNumber>PA0045/016/008</LicenceNumber>
    <ProductName>MOTILIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1978-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013589</DrugIDPK>
    <LicenceNumber>PA0184/004/001</LicenceNumber>
    <ProductName>MRS CULLENS CUTS &amp; GRAZES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cullen and Davison Limited</PAHolder>
    <AuthorisedDate>1978-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010054</DrugIDPK>
    <LicenceNumber>PA0017/074/002</LicenceNumber>
    <ProductName>NEULENTE INSULIN ZINC SUSP 80 U</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INSULIN ZINC SUSPENSION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011270</DrugIDPK>
    <LicenceNumber>PA0054/024/001</LicenceNumber>
    <ProductName>ORHEPTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIVER EXTRACT</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013594</DrugIDPK>
    <LicenceNumber>PA0185/006/002</LicenceNumber>
    <ProductName>POLYALK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1977-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013484</DrugIDPK>
    <LicenceNumber>PA0176/060/002</LicenceNumber>
    <ProductName>RELCOFEN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013528</DrugIDPK>
    <LicenceNumber>PA0261/015/001</LicenceNumber>
    <ProductName>RESTANDOL</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011634</DrugIDPK>
    <LicenceNumber>PA0070/001/001</LicenceNumber>
    <ProductName>RIFADIN</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1975-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009761</DrugIDPK>
    <LicenceNumber>PA0010/012/001</LicenceNumber>
    <ProductName>SINAXAR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>STYRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015261</DrugIDPK>
    <LicenceNumber>PA0297/005/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015263</DrugIDPK>
    <LicenceNumber>PA0297/005/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015177</DrugIDPK>
    <LicenceNumber>PA0297/001/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE &amp; DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015176</DrugIDPK>
    <LicenceNumber>PA0297/001/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE WITH DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013516</DrugIDPK>
    <LicenceNumber>PA0261/009/002</LicenceNumber>
    <ProductName>SUSTANON 100 SYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013518</DrugIDPK>
    <LicenceNumber>PA0261/009/004</LicenceNumber>
    <ProductName>SUSTANON 250 SYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010778</DrugIDPK>
    <LicenceNumber>PA0041/013/001</LicenceNumber>
    <ProductName>TACE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROTRIANISENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013592</DrugIDPK>
    <LicenceNumber>PA0185/005/001</LicenceNumber>
    <ProductName>TOTOLIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1977-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009701</DrugIDPK>
    <LicenceNumber>PA0009/016/019</LicenceNumber>
    <ProductName>XYLOCAINE 2.0%</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009706</DrugIDPK>
    <LicenceNumber>PA0009/016/001</LicenceNumber>
    <ProductName>XYLOCAINE ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009703</DrugIDPK>
    <LicenceNumber>PA0009/017/001</LicenceNumber>
    <ProductName>XYLODASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>HYALURONIDASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013689</DrugIDPK>
    <LicenceNumber>PA0206/003/001</LicenceNumber>
    <ProductName>KANAMYCIN CP</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011830</DrugIDPK>
    <LicenceNumber>PA0077/030/001</LicenceNumber>
    <ProductName>BREOPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011757</DrugIDPK>
    <LicenceNumber>PA0077/007/001</LicenceNumber>
    <ProductName>DIBOTIN SR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1976-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011758</DrugIDPK>
    <LicenceNumber>PA0077/007/002</LicenceNumber>
    <ProductName>DIBOTIN SR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1976-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010579</DrugIDPK>
    <LicenceNumber>PA0037/059/001</LicenceNumber>
    <ProductName>PROSTAP SINGLE DOSE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011100</DrugIDPK>
    <LicenceNumber>PA0047/009/002</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011101</DrugIDPK>
    <LicenceNumber>PA0047/009/003</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011102</DrugIDPK>
    <LicenceNumber>PA0047/009/004</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011103</DrugIDPK>
    <LicenceNumber>PA0047/009/005</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011098</DrugIDPK>
    <LicenceNumber>PA0047/009/001</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011105</DrugIDPK>
    <LicenceNumber>PA0047/009/009</LicenceNumber>
    <ProductName>AMYTAL SODIUM</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011119</DrugIDPK>
    <LicenceNumber>PA0047/017/001</LicenceNumber>
    <ProductName>CAPASTAT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPREOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011130</DrugIDPK>
    <LicenceNumber>PA0047/023/001</LicenceNumber>
    <ProductName>PENICILLIN V POTASSIUM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011109</DrugIDPK>
    <LicenceNumber>PA0047/012/002</LicenceNumber>
    <ProductName>TUINAL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
      <ActiveSubstance>SECOBARBITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011128</DrugIDPK>
    <LicenceNumber>PA0047/022/003</LicenceNumber>
    <ProductName>V CIL K</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011132</DrugIDPK>
    <LicenceNumber>PA0047/022/007</LicenceNumber>
    <ProductName>V CIL K PEDIPACS</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010948</DrugIDPK>
    <LicenceNumber>PA0047/062/004</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHOHEXITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010949</DrugIDPK>
    <LicenceNumber>PA0047/062/005</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHOHEXITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009585</DrugIDPK>
    <LicenceNumber>PA0006/030/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009590</DrugIDPK>
    <LicenceNumber>PA0006/035/002</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009588</DrugIDPK>
    <LicenceNumber>PA0006/035/001</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013470</DrugIDPK>
    <LicenceNumber>PA0258/002/001</LicenceNumber>
    <ProductName>MULTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011113</DrugIDPK>
    <LicenceNumber>PA0047/006/006</LicenceNumber>
    <ProductName>ILOSONE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ESTOLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011077</DrugIDPK>
    <LicenceNumber>PA0047/006/005</LicenceNumber>
    <ProductName>ILOSONE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN ESTOLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013424</DrugIDPK>
    <LicenceNumber>PA0167/075/001</LicenceNumber>
    <ProductName>TRAVENOL I.V. MULTIVITAMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015156</DrugIDPK>
    <LicenceNumber>PA0098/007/002</LicenceNumber>
    <ProductName>DIXARIT LA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-06-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001007</DrugIDPK>
    <LicenceNumber>PA0148/036/002</LicenceNumber>
    <ProductName>FML GENTOPIC TOPICAL OPHTHALMIC 15 ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001006</DrugIDPK>
    <LicenceNumber>PA0148/036/001</LicenceNumber>
    <ProductName>FML GENTOPIC TOPICAL OPTHALMIC 15 ML (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUOROMETHOLONE</ActiveSubstance>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013844</DrugIDPK>
    <LicenceNumber>PA0277/025/001</LicenceNumber>
    <ProductName>LANCE B + C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012012</DrugIDPK>
    <LicenceNumber>PA0087/002/002</LicenceNumber>
    <ProductName>RONA-PHYLLIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012013</DrugIDPK>
    <LicenceNumber>PA0087/002/003</LicenceNumber>
    <ProductName>RONA-PHYLLIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012015</DrugIDPK>
    <LicenceNumber>PA0087/003/001</LicenceNumber>
    <ProductName>RONA-PHYLLIN GG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012010</DrugIDPK>
    <LicenceNumber>PA0087/002/001</LicenceNumber>
    <ProductName>RONA-PHYLLIN-80</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011995</DrugIDPK>
    <LicenceNumber>PA0086/018/001</LicenceNumber>
    <ProductName>DIBAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYCARBOPHIL CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013703</DrugIDPK>
    <LicenceNumber>PA0217/001/002</LicenceNumber>
    <ProductName>INSULIN INSULATARD NORDISK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1977-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013710</DrugIDPK>
    <LicenceNumber>PA0217/003/001</LicenceNumber>
    <ProductName>INSULIN MIXTARD 30/70 NORDISK</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1977-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013711</DrugIDPK>
    <LicenceNumber>PA0217/003/002</LicenceNumber>
    <ProductName>INSULIN MIXTARD 30/70 NORDISK</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1977-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013706</DrugIDPK>
    <LicenceNumber>PA0217/002/002</LicenceNumber>
    <ProductName>INSULIN VELOSULIN NORDISK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1977-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012884</DrugIDPK>
    <LicenceNumber>PA0100/005/001</LicenceNumber>
    <ProductName>PAEDO-SED</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DICHLORALPHENAZONE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011381</DrugIDPK>
    <LicenceNumber>PA0054/005/001</LicenceNumber>
    <ProductName>DECODERM COMPOUND</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1977-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>FLUPREDNIDENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013083</DrugIDPK>
    <LicenceNumber>PA0137/034/001</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013084</DrugIDPK>
    <LicenceNumber>PA0137/034/002</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013086</DrugIDPK>
    <LicenceNumber>PA0137/034/004</LicenceNumber>
    <ProductName>CITOCILLIN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012062</DrugIDPK>
    <LicenceNumber>PA0096/002/001</LicenceNumber>
    <ProductName>RHINAMID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011021</DrugIDPK>
    <LicenceNumber>PA0046/051/001</LicenceNumber>
    <ProductName>OPAS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>HEAVY MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011018</DrugIDPK>
    <LicenceNumber>PA0046/050/001</LicenceNumber>
    <ProductName>GLINTEEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MYROXYLON PEREIRAE</ActiveSubstance>
      <ActiveSubstance>TANNIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011026</DrugIDPK>
    <LicenceNumber>PA0046/052/001</LicenceNumber>
    <ProductName>ULCANON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TANNIC ACID</ActiveSubstance>
      <ActiveSubstance>ETHYL PHTHALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015664</DrugIDPK>
    <LicenceNumber>PA0236/005/002</LicenceNumber>
    <ProductName>KELFIZINE W (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015667</DrugIDPK>
    <LicenceNumber>PA0236/005/003</LicenceNumber>
    <ProductName>KELFIZINE W PAEDIATRIC (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010067</DrugIDPK>
    <LicenceNumber>PA0019/005/001</LicenceNumber>
    <ProductName>RONDOMYCIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010083</DrugIDPK>
    <LicenceNumber>PA0019/011/001</LicenceNumber>
    <ProductName>TERACYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010070</DrugIDPK>
    <LicenceNumber>PA0019/006/001</LicenceNumber>
    <ProductName>TERRA-BRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
      <ActiveSubstance>IPECAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010078</DrugIDPK>
    <LicenceNumber>PA0019/009/005</LicenceNumber>
    <ProductName>TERRAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010080</DrugIDPK>
    <LicenceNumber>PA0019/009/006</LicenceNumber>
    <ProductName>TERRAMYCIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010074</DrugIDPK>
    <LicenceNumber>PA0019/009/002</LicenceNumber>
    <ProductName>TERRAMYCIN INTRAMUSCULAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010082</DrugIDPK>
    <LicenceNumber>PA0019/010/001</LicenceNumber>
    <ProductName>TERRAMYCIN SF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010085</DrugIDPK>
    <LicenceNumber>PA0019/011/004</LicenceNumber>
    <ProductName>TETEACYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010084</DrugIDPK>
    <LicenceNumber>PA0019/011/002</LicenceNumber>
    <ProductName>TETRACYN INTRAMUSCULAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010086</DrugIDPK>
    <LicenceNumber>PA0019/012/001</LicenceNumber>
    <ProductName>TETRACYN SF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001703</DrugIDPK>
    <LicenceNumber>PA0039/026/002</LicenceNumber>
    <ProductName>UROLUCOSIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013361</DrugIDPK>
    <LicenceNumber>PA0255/004/011</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE 4%</ProductName>
    <Strength>56</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012053</DrugIDPK>
    <LicenceNumber>PA0090/008/001</LicenceNumber>
    <ProductName>DISIPIDIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011585</DrugIDPK>
    <LicenceNumber>PA0060/015/001</LicenceNumber>
    <ProductName>STELABID FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011777</DrugIDPK>
    <LicenceNumber>PA0077/016/001</LicenceNumber>
    <ProductName>SULFOMYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010588</DrugIDPK>
    <LicenceNumber>PA0038/002/005</LicenceNumber>
    <ProductName>ERYTHOCIN  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010587</DrugIDPK>
    <LicenceNumber>PA0038/002/002</LicenceNumber>
    <ProductName>ERYTHROCIN I.V.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010076</DrugIDPK>
    <LicenceNumber>PA0017/076/003</LicenceNumber>
    <ProductName>NEUSULIN NEUTRAL INSULIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPHANE INSULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003480</DrugIDPK>
    <LicenceNumber>PA0114/005/001</LicenceNumber>
    <ProductName>OTOSEPTIL EAR DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011233</DrugIDPK>
    <LicenceNumber>PA0050/009/001</LicenceNumber>
    <ProductName>GANTRISIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAFURAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011234</DrugIDPK>
    <LicenceNumber>PA0050/009/002</LicenceNumber>
    <ProductName>GANTRISIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAFURAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010034</DrugIDPK>
    <LicenceNumber>PA0019/026/001</LicenceNumber>
    <ProductName>EQUIVERT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUCLIZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011191</DrugIDPK>
    <LicenceNumber>PA0050/061/003</LicenceNumber>
    <ProductName>HYPNOVEL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIDAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010194</DrugIDPK>
    <LicenceNumber>PA0028/041/001</LicenceNumber>
    <ProductName>PRISCOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLAZOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013485</DrugIDPK>
    <LicenceNumber>PA0176/061/001</LicenceNumber>
    <ProductName>TRIMETHOPRIM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013487</DrugIDPK>
    <LicenceNumber>PA0176/061/002</LicenceNumber>
    <ProductName>TRIMETHOPRIM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013489</DrugIDPK>
    <LicenceNumber>PA0176/061/003</LicenceNumber>
    <ProductName>TRIMETHOPRIM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011232</DrugIDPK>
    <LicenceNumber>PA0050/008/002</LicenceNumber>
    <ProductName>ROHYPNOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-08-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010457</DrugIDPK>
    <LicenceNumber>PA0023/012/002</LicenceNumber>
    <ProductName>REVERIN IM</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ROLITETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010555</DrugIDPK>
    <LicenceNumber>PA0037/025/002</LicenceNumber>
    <ProductName>ACHROMYCIN V</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010534</DrugIDPK>
    <LicenceNumber>PA0037/011/001</LicenceNumber>
    <ProductName>LEDERKYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010539</DrugIDPK>
    <LicenceNumber>PA0037/013/004</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010537</DrugIDPK>
    <LicenceNumber>PA0037/013/003</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013852</DrugIDPK>
    <LicenceNumber>PA0282/012/001</LicenceNumber>
    <ProductName>PHENYLBUTAZONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013853</DrugIDPK>
    <LicenceNumber>PA0282/012/002</LicenceNumber>
    <ProductName>PHENYLBUTAZONE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013601</DrugIDPK>
    <LicenceNumber>PA0185/012/001</LicenceNumber>
    <ProductName>SUREM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013602</DrugIDPK>
    <LicenceNumber>PA0185/012/002</LicenceNumber>
    <ProductName>SUREM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1982-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010600</DrugIDPK>
    <LicenceNumber>PA0038/005/002</LicenceNumber>
    <ProductName>NEMBUTAL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010529</DrugIDPK>
    <LicenceNumber>PA0037/002/001</LicenceNumber>
    <ProductName>ARISTOCORT A</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010530</DrugIDPK>
    <LicenceNumber>PA0037/002/002</LicenceNumber>
    <ProductName>ARISTOCORT A</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1983-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010562</DrugIDPK>
    <LicenceNumber>PA0037/030/001</LicenceNumber>
    <ProductName>LEDERCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010769</DrugIDPK>
    <LicenceNumber>PA0040/073/001</LicenceNumber>
    <ProductName>GARDENAL</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010770</DrugIDPK>
    <LicenceNumber>PA0040/073/002</LicenceNumber>
    <ProductName>GARDENAL</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010717</DrugIDPK>
    <LicenceNumber>PA0040/018/001</LicenceNumber>
    <ProductName>LARGACTIL 1%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010719</DrugIDPK>
    <LicenceNumber>PA0040/019/001</LicenceNumber>
    <ProductName>MAJEPTIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010721</DrugIDPK>
    <LicenceNumber>PA0040/019/002</LicenceNumber>
    <ProductName>MAJEPTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010734</DrugIDPK>
    <LicenceNumber>PA0040/021/001</LicenceNumber>
    <ProductName>NEULACTIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010735</DrugIDPK>
    <LicenceNumber>PA0040/021/002</LicenceNumber>
    <ProductName>NEULACTIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010733</DrugIDPK>
    <LicenceNumber>PA0040/020/001</LicenceNumber>
    <ProductName>NEULACTIL FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010705</DrugIDPK>
    <LicenceNumber>PA0040/010/001</LicenceNumber>
    <ProductName>SULPHATRIAD  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010707</DrugIDPK>
    <LicenceNumber>PA0040/011/001</LicenceNumber>
    <ProductName>THALAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010708</DrugIDPK>
    <LicenceNumber>PA0040/012/001</LicenceNumber>
    <ProductName>THIAZAMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010710</DrugIDPK>
    <LicenceNumber>PA0040/013/001</LicenceNumber>
    <ProductName>TRESCATYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010738</DrugIDPK>
    <LicenceNumber>PA0040/030/003</LicenceNumber>
    <ProductName>VERACTIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012636</DrugIDPK>
    <LicenceNumber>PA0107/013/001</LicenceNumber>
    <ProductName>HEALONID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013364</DrugIDPK>
    <LicenceNumber>PA0255/005/003</LicenceNumber>
    <ProductName>STRONG POTASSIUM CHLORIDE 15%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013365</DrugIDPK>
    <LicenceNumber>PA0255/005/004</LicenceNumber>
    <ProductName>STRONG POTASSIUM CHLORIDE 15%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013366</DrugIDPK>
    <LicenceNumber>PA0255/005/005</LicenceNumber>
    <ProductName>STRONG POTASSIUM CHLORIDE 15%</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011081</DrugIDPK>
    <LicenceNumber>PA0047/008/002</LicenceNumber>
    <ProductName>KELFEX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009804</DrugIDPK>
    <LicenceNumber>PA0011/008/001</LicenceNumber>
    <ProductName>STEROXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORQUINALDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010711</DrugIDPK>
    <LicenceNumber>PA0040/014/001</LicenceNumber>
    <ProductName>TREVINTIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013369</DrugIDPK>
    <LicenceNumber>PA0255/010/003</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013370</DrugIDPK>
    <LicenceNumber>PA0255/010/005</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013371</DrugIDPK>
    <LicenceNumber>PA0255/010/006</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013372</DrugIDPK>
    <LicenceNumber>PA0255/010/007</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>10 mg/ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013459</DrugIDPK>
    <LicenceNumber>PA0176/049/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013455</DrugIDPK>
    <LicenceNumber>PA0176/047/001</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013456</DrugIDPK>
    <LicenceNumber>PA0176/047/002</LicenceNumber>
    <ProductName>FLUCLOXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009894</DrugIDPK>
    <LicenceNumber>PA0012/041/002</LicenceNumber>
    <ProductName>ALBUCID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009895</DrugIDPK>
    <LicenceNumber>PA0012/041/003</LicenceNumber>
    <ProductName>ALBUCID</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009514</DrugIDPK>
    <LicenceNumber>PA0002/010/001</LicenceNumber>
    <ProductName>KENACORT A.Q.   (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>HALQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009526</DrugIDPK>
    <LicenceNumber>PA0002/012/002</LicenceNumber>
    <ProductName>MYSTECLIN F</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>AMPHOTERICIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009518</DrugIDPK>
    <LicenceNumber>PA0002/011/001</LicenceNumber>
    <ProductName>REMIDERM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>HALQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009525</DrugIDPK>
    <LicenceNumber>PA0002/011/002</LicenceNumber>
    <ProductName>REMIDERM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009528</DrugIDPK>
    <LicenceNumber>PA0002/013/001</LicenceNumber>
    <ProductName>SUMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009532</DrugIDPK>
    <LicenceNumber>PA0002/014/003</LicenceNumber>
    <ProductName>VELOSEF (SUSPENSION)</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFRADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011500</DrugIDPK>
    <LicenceNumber>PA0057/039/001</LicenceNumber>
    <ProductName>DORBANEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXALCOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011501</DrugIDPK>
    <LicenceNumber>PA0057/039/002</LicenceNumber>
    <ProductName>DORBANEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXAMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011498</DrugIDPK>
    <LicenceNumber>PA0057/038/002</LicenceNumber>
    <ProductName>DORBANEX FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011504</DrugIDPK>
    <LicenceNumber>PA0057/039/003</LicenceNumber>
    <ProductName>DORBANEX FORTE (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DANTRON</ActiveSubstance>
      <ActiveSubstance>POLOXAMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010479</DrugIDPK>
    <LicenceNumber>PA0028/015/001</LicenceNumber>
    <ProductName>VIOFORM - HYDROCORTISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009901</DrugIDPK>
    <LicenceNumber>PA0012/048/001</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009902</DrugIDPK>
    <LicenceNumber>PA0012/048/002</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1982-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009904</DrugIDPK>
    <LicenceNumber>PA0012/048/004</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1982-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009460</DrugIDPK>
    <LicenceNumber>PA0001/006/001</LicenceNumber>
    <ProductName>DARTALAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPROPAZATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009461</DrugIDPK>
    <LicenceNumber>PA0001/006/002</LicenceNumber>
    <ProductName>DARTALAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPROPAZATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013463</DrugIDPK>
    <LicenceNumber>PA0176/052/001</LicenceNumber>
    <ProductName>DIGOXIN</ProductName>
    <Strength>62.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013464</DrugIDPK>
    <LicenceNumber>PA0176/052/002</LicenceNumber>
    <ProductName>DIGOXIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013465</DrugIDPK>
    <LicenceNumber>PA0176/052/003</LicenceNumber>
    <ProductName>DIGOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009462</DrugIDPK>
    <LicenceNumber>PA0001/007/001</LicenceNumber>
    <ProductName>FLORAQUIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIIODOHYDROXYQUINOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009464</DrugIDPK>
    <LicenceNumber>PA0001/008/001</LicenceNumber>
    <ProductName>PRO-BANTHINE WITH DARTALAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPANTHELINE BROMIDE</ActiveSubstance>
      <ActiveSubstance>THIOPROPAZATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1987-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013614</DrugIDPK>
    <LicenceNumber>PA0187/012/002</LicenceNumber>
    <ProductName>EPSIKAPRON</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOCAPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013613</DrugIDPK>
    <LicenceNumber>PA0187/012/001</LicenceNumber>
    <ProductName>EPSIKAPRON 50%</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINOCAPROIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010652</DrugIDPK>
    <LicenceNumber>PA0039/014/002</LicenceNumber>
    <ProductName>MANDELAMINE HALFGRAM</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010360</DrugIDPK>
    <LicenceNumber>PA0035/011/001</LicenceNumber>
    <ProductName>CUPRIMINE (PENICILLLAMINE)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013842</DrugIDPK>
    <LicenceNumber>PA0277/024/001</LicenceNumber>
    <ProductName>OXYMATHAZOLE HYDROCHLORIDE</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001674</DrugIDPK>
    <LicenceNumber>PA0009/027/001</LicenceNumber>
    <ProductName>TONOCARD</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCAINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001675</DrugIDPK>
    <LicenceNumber>PA0009/027/002</LicenceNumber>
    <ProductName>TONOCARD</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCAINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001676</DrugIDPK>
    <LicenceNumber>PA0009/027/003</LicenceNumber>
    <ProductName>TONOCARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCAINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010646</DrugIDPK>
    <LicenceNumber>PA0039/007/001</LicenceNumber>
    <ProductName>BIOMYDRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011805</DrugIDPK>
    <LicenceNumber>PA0082/001/001</LicenceNumber>
    <ProductName>ARVIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1975-01-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011814</DrugIDPK>
    <LicenceNumber>PA0082/008/001</LicenceNumber>
    <ProductName>BERKFURIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011816</DrugIDPK>
    <LicenceNumber>PA0082/008/002</LicenceNumber>
    <ProductName>BERKFURIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010651</DrugIDPK>
    <LicenceNumber>PA0039/014/001</LicenceNumber>
    <ProductName>MANDELAMINE</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010696</DrugIDPK>
    <LicenceNumber>PA0039/035/001</LicenceNumber>
    <ProductName>SPIREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1982-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010697</DrugIDPK>
    <LicenceNumber>PA0039/035/002</LicenceNumber>
    <ProductName>SPIREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1982-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009759</DrugIDPK>
    <LicenceNumber>PA0010/011/001</LicenceNumber>
    <ProductName>SYTUSSAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010687</DrugIDPK>
    <LicenceNumber>PA0039/025/001</LicenceNumber>
    <ProductName>TYROSOLVEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009506</DrugIDPK>
    <LicenceNumber>PA0004/048/002</LicenceNumber>
    <ProductName>ARDINEX 430</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>CODEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001677</DrugIDPK>
    <LicenceNumber>PA0009/027/004</LicenceNumber>
    <ProductName>TONOCARD</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCAINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010039</DrugIDPK>
    <LicenceNumber>PA0019/030/002</LicenceNumber>
    <ProductName>TROSYL 2%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009768</DrugIDPK>
    <LicenceNumber>PA0010/019/001</LicenceNumber>
    <ProductName>THYTROPAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THYROTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012805</DrugIDPK>
    <LicenceNumber>PA0531/002/001</LicenceNumber>
    <ProductName>ENLON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Anaquest Limited</PAHolder>
    <AuthorisedDate>1986-05-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010049</DrugIDPK>
    <LicenceNumber>PA0017/074/001</LicenceNumber>
    <ProductName>NEULENTE INSULIN ZINE SUSPENSION B P 40 UNITS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INSULIN ZINC SUSPENSION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011734</DrugIDPK>
    <LicenceNumber>PA0069/007/001</LicenceNumber>
    <ProductName>JIFFY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009603</DrugIDPK>
    <LicenceNumber>PA0007/009/001</LicenceNumber>
    <ProductName>K LONGULES BIOVAIL POTASSIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1979-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012898</DrugIDPK>
    <LicenceNumber>PA0116/005/001</LicenceNumber>
    <ProductName>UNIFLAM</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Elan Corporation Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009921</DrugIDPK>
    <LicenceNumber>PA0017/056/004</LicenceNumber>
    <ProductName>IMURAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012992</DrugIDPK>
    <LicenceNumber>PA0120/002/001</LicenceNumber>
    <ProductName>NERVO FOOT EASE ANTISEPTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011904</DrugIDPK>
    <LicenceNumber>PA0082/046/001</LicenceNumber>
    <ProductName>KEST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM SULFATE</ActiveSubstance>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012968</DrugIDPK>
    <LicenceNumber>PA0118/010/001</LicenceNumber>
    <ProductName>GANDA 3.05</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1980-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012969</DrugIDPK>
    <LicenceNumber>PA0118/010/002</LicenceNumber>
    <ProductName>GANDA 5.05  EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUANETHIDINE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011700</DrugIDPK>
    <LicenceNumber>PA0073/054/001</LicenceNumber>
    <ProductName>PARACETAMOL &amp; CODEINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010922</DrugIDPK>
    <LicenceNumber>PA0047/049/004</LicenceNumber>
    <ProductName>ELDESINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1981-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010467</DrugIDPK>
    <LicenceNumber>PA0028/001/005</LicenceNumber>
    <ProductName>LUDIOMIL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAPROTILINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009797</DrugIDPK>
    <LicenceNumber>PA0011/005/002</LicenceNumber>
    <ProductName>ANAFRANIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1976-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012749</DrugIDPK>
    <LicenceNumber>PA0109/004/006</LicenceNumber>
    <ProductName>PHOLCOMED EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>METHYLEPHEDRINE HYDROCHLORIDE-DL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012778</DrugIDPK>
    <LicenceNumber>PA0114/002/009</LicenceNumber>
    <ProductName>BETADINE ANTISEPTIC LUBRICATING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012279</DrugIDPK>
    <LicenceNumber>PA0379/013/001</LicenceNumber>
    <ProductName>BEECHAMS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011056</DrugIDPK>
    <LicenceNumber>PA0049/001/001</LicenceNumber>
    <ProductName>FYNNON CALCIUM ASPIRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1975-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011211</DrugIDPK>
    <LicenceNumber>PA0049/036/001</LicenceNumber>
    <ProductName>IRON JELLOIDS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009739</DrugIDPK>
    <LicenceNumber>PA0010/006/001</LicenceNumber>
    <ProductName>FACTORATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009742</DrugIDPK>
    <LicenceNumber>PA0010/006/003</LicenceNumber>
    <ProductName>FACTORATE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1984-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009741</DrugIDPK>
    <LicenceNumber>PA0010/006/002</LicenceNumber>
    <ProductName>FACTORATE (DOUBLE-FILL)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1983-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009784</DrugIDPK>
    <LicenceNumber>PA0010/025/001</LicenceNumber>
    <ProductName>HIGH POTENCY FACTORATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009787</DrugIDPK>
    <LicenceNumber>PA0010/025/003</LicenceNumber>
    <ProductName>HIGH POTENCY FACTORATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009785</DrugIDPK>
    <LicenceNumber>PA0010/025/002</LicenceNumber>
    <ProductName>HITH POTENCY FACTORATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011396</DrugIDPK>
    <LicenceNumber>PA0056/030/001</LicenceNumber>
    <ProductName>VANQUIN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PYRVINIUM EMBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010698</DrugIDPK>
    <LicenceNumber>PA0039/036/001</LicenceNumber>
    <ProductName>GELUSIL PLUS  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012114</DrugIDPK>
    <LicenceNumber>PA0365/010/001</LicenceNumber>
    <ProductName>HEPARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012116</DrugIDPK>
    <LicenceNumber>PA0365/010/002</LicenceNumber>
    <ProductName>HEPARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012119</DrugIDPK>
    <LicenceNumber>PA0365/010/004</LicenceNumber>
    <ProductName>HEPARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012117</DrugIDPK>
    <LicenceNumber>PA0365/010/003</LicenceNumber>
    <ProductName>HEPARIN PRESERVED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012122</DrugIDPK>
    <LicenceNumber>PA0365/010/005</LicenceNumber>
    <ProductName>HEPARIN PRESERVED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012123</DrugIDPK>
    <LicenceNumber>PA0365/010/006</LicenceNumber>
    <ProductName>HEPARIN PRESERVED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015089</DrugIDPK>
    <LicenceNumber>PA0289/004/001</LicenceNumber>
    <ProductName>NYDRANE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-09-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009677</DrugIDPK>
    <LicenceNumber>PA0009/029/001</LicenceNumber>
    <ProductName>HYPERNAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRENALTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012794</DrugIDPK>
    <LicenceNumber>PA0114/022/001</LicenceNumber>
    <ProductName>UROMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFADIAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011664</DrugIDPK>
    <LicenceNumber>PA0073/009/001</LicenceNumber>
    <ProductName>PHANSPECT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010784</DrugIDPK>
    <LicenceNumber>PA0041/018/001</LicenceNumber>
    <ProductName>NETHAPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAFEDRINE</ActiveSubstance>
      <ActiveSubstance>BUFYLLINE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010087</DrugIDPK>
    <LicenceNumber>PA0018/025/001</LicenceNumber>
    <ProductName>THEO-DUR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010088</DrugIDPK>
    <LicenceNumber>PA0018/025/002</LicenceNumber>
    <ProductName>THEO-DUR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-09-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010460</DrugIDPK>
    <LicenceNumber>PA0027/022/002</LicenceNumber>
    <ProductName>GAVISCON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013565</DrugIDPK>
    <LicenceNumber>PA0179/010/001</LicenceNumber>
    <ProductName>LYOSTYPT HAEMOSTATIC FELT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COLLAGEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009991</DrugIDPK>
    <LicenceNumber>PA0018/003/002</LicenceNumber>
    <ProductName>RYNACROM NASAL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1976-10-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013716</DrugIDPK>
    <LicenceNumber>PA0217/006/001</LicenceNumber>
    <ProductName>NANORMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1981-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013749</DrugIDPK>
    <LicenceNumber>PA0176/028/002</LicenceNumber>
    <ProductName>KLOREF-S</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BETAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009481</DrugIDPK>
    <LicenceNumber>PA0001/025/001</LicenceNumber>
    <ProductName>ALDAFRUSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1985-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013870</DrugIDPK>
    <LicenceNumber>PA0288/002/001</LicenceNumber>
    <ProductName>CEMAC B 12 TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016054</DrugIDPK>
    <LicenceNumber>PA0224/010/001</LicenceNumber>
    <ProductName>PLATOSIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016055</DrugIDPK>
    <LicenceNumber>PA0224/010/002</LicenceNumber>
    <ProductName>PLATOSIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016057</DrugIDPK>
    <LicenceNumber>PA0224/010/003</LicenceNumber>
    <ProductName>PLATOSIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009857</DrugIDPK>
    <LicenceNumber>PA0012/008/001</LicenceNumber>
    <ProductName>FELICUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011755</DrugIDPK>
    <LicenceNumber>PA0077/006/001</LicenceNumber>
    <ProductName>PENICILLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011756</DrugIDPK>
    <LicenceNumber>PA0077/006/002</LicenceNumber>
    <ProductName>PENICILLIN ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009927</DrugIDPK>
    <LicenceNumber>PA0013/003/001</LicenceNumber>
    <ProductName>TRIOCOS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1976-11-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013623</DrugIDPK>
    <LicenceNumber>PA0187/025/001</LicenceNumber>
    <ProductName>GAMMONATIV</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN HUMAN NORMAL</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013624</DrugIDPK>
    <LicenceNumber>PA0187/025/002</LicenceNumber>
    <ProductName>GAMMONATIV</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN HUMAN NORMAL</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010436</DrugIDPK>
    <LicenceNumber>PA0023/004/001</LicenceNumber>
    <ProductName>ERYFER F</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1976-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009809</DrugIDPK>
    <LicenceNumber>PA0011/014/001</LicenceNumber>
    <ProductName>PARAZOLIDIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009814</DrugIDPK>
    <LicenceNumber>PA0011/017/001</LicenceNumber>
    <ProductName>TANDACOTE R</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009800</DrugIDPK>
    <LicenceNumber>PA0011/006/003</LicenceNumber>
    <ProductName>TANDERIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-07-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011371</DrugIDPK>
    <LicenceNumber>PA0055/001/001</LicenceNumber>
    <ProductName>DEPOCILLIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011372</DrugIDPK>
    <LicenceNumber>PA0055/001/002</LicenceNumber>
    <ProductName>DEPOCILLIN</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009735</DrugIDPK>
    <LicenceNumber>PA0010/003/001</LicenceNumber>
    <ProductName>ARMODIAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1976-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009982</DrugIDPK>
    <LicenceNumber>PA0017/083/001</LicenceNumber>
    <ProductName>COPARVAX-VIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CORYNEBACTERIUM PARVUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009457</DrugIDPK>
    <LicenceNumber>PA0001/005/001</LicenceNumber>
    <ProductName>LOMOTIL JUNIOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1976-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENOXYLATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010450</DrugIDPK>
    <LicenceNumber>PA0023/009/001</LicenceNumber>
    <ProductName>ERYFER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1976-08-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011060</DrugIDPK>
    <LicenceNumber>PA0049/003/001</LicenceNumber>
    <ProductName>TALPEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1976-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TALAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011061</DrugIDPK>
    <LicenceNumber>PA0049/003/002</LicenceNumber>
    <ProductName>TALPEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TALAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011063</DrugIDPK>
    <LicenceNumber>PA0049/003/003</LicenceNumber>
    <ProductName>TALPEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TALAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011065</DrugIDPK>
    <LicenceNumber>PA0049/003/004</LicenceNumber>
    <ProductName>TALPEN 125 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TALAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011066</DrugIDPK>
    <LicenceNumber>PA0049/003/005</LicenceNumber>
    <ProductName>TALPEN 125 MG/5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1976-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TALAMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009479</DrugIDPK>
    <LicenceNumber>PA0001/023/001</LicenceNumber>
    <ProductName>ANGIDISC 5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011772</DrugIDPK>
    <LicenceNumber>PA0079/012/003</LicenceNumber>
    <ProductName>ALBAY BEE VENOM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011773</DrugIDPK>
    <LicenceNumber>PA0079/012/004</LicenceNumber>
    <ProductName>ALBAY WASP VENOM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016087</DrugIDPK>
    <LicenceNumber>PA0218/010/001</LicenceNumber>
    <ProductName>ESTRIFAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016088</DrugIDPK>
    <LicenceNumber>PA0218/011/001</LicenceNumber>
    <ProductName>ESTRIFAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012900</DrugIDPK>
    <LicenceNumber>PA0116/008/002</LicenceNumber>
    <ProductName>UNIFEN 300</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Corporation Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010063</DrugIDPK>
    <LicenceNumber>PA0019/002/001</LicenceNumber>
    <ProductName>GLIBENESE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1976-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLIPIZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-05-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010850</DrugIDPK>
    <LicenceNumber>PA0046/002/002</LicenceNumber>
    <ProductName>TREOSUFLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011633</DrugIDPK>
    <LicenceNumber>PA0068/003/001</LicenceNumber>
    <ProductName>SYNERGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009480</DrugIDPK>
    <LicenceNumber>PA0001/023/002</LicenceNumber>
    <ProductName>ANGIDISC 10</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010071</DrugIDPK>
    <LicenceNumber>PA0017/076/001</LicenceNumber>
    <ProductName>NEUSULIN NEUTRAL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INSULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010073</DrugIDPK>
    <LicenceNumber>PA0017/076/002</LicenceNumber>
    <ProductName>NEUSULIN NEUTRAL INSULIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013466</DrugIDPK>
    <LicenceNumber>PA0176/053/001</LicenceNumber>
    <ProductName>CO-DYDRAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013338</DrugIDPK>
    <LicenceNumber>PA0251/008/001</LicenceNumber>
    <ProductName>RABRO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sinclair Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012648</DrugIDPK>
    <LicenceNumber>PA0447/003/001</LicenceNumber>
    <ProductName>DISTACLOR</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012649</DrugIDPK>
    <LicenceNumber>PA0447/003/002</LicenceNumber>
    <ProductName>DISTACLOR</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012812</DrugIDPK>
    <LicenceNumber>PA0114/042/003</LicenceNumber>
    <ProductName>UNIPHYLLIN UNICONTIN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012342</DrugIDPK>
    <LicenceNumber>PA0405/004/001</LicenceNumber>
    <ProductName>TEMAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012343</DrugIDPK>
    <LicenceNumber>PA0405/004/002</LicenceNumber>
    <ProductName>TEMAZEPAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012656</DrugIDPK>
    <LicenceNumber>PA0451/001/001</LicenceNumber>
    <ProductName>DISPRAY 1. QUICK PREP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stuart Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011327</DrugIDPK>
    <LicenceNumber>PA0051/050/001</LicenceNumber>
    <ProductName>TRISEP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012589</DrugIDPK>
    <LicenceNumber>PA0437/016/007</LicenceNumber>
    <ProductName>GENTAMICIN (WITH PRESERVATIVE)</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010683</DrugIDPK>
    <LicenceNumber>PA0039/024/007</LicenceNumber>
    <ProductName>TEDRAL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011617</DrugIDPK>
    <LicenceNumber>PA0063/011/003</LicenceNumber>
    <ProductName>XYLOTOX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011618</DrugIDPK>
    <LicenceNumber>PA0063/011/004</LicenceNumber>
    <ProductName>XYLOTOX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011620</DrugIDPK>
    <LicenceNumber>PA0063/011/006</LicenceNumber>
    <ProductName>XYLOTOX NORMAL PASTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011619</DrugIDPK>
    <LicenceNumber>PA0063/011/005</LicenceNumber>
    <ProductName>XYLOTOX SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009574</DrugIDPK>
    <LicenceNumber>PA0006/028/001</LicenceNumber>
    <ProductName>STEROGYL 15</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009456</DrugIDPK>
    <LicenceNumber>PA0001/003/005</LicenceNumber>
    <ProductName>NORPACE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010322</DrugIDPK>
    <LicenceNumber>PA0033/006/001</LicenceNumber>
    <ProductName>NORQUEST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010432</DrugIDPK>
    <LicenceNumber>PA0023/003/002</LicenceNumber>
    <ProductName>MERITAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOMIFENSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010429</DrugIDPK>
    <LicenceNumber>PA0023/003/001</LicenceNumber>
    <ProductName>MERITAL 25</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOMIFENSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012299</DrugIDPK>
    <LicenceNumber>PA0303/002/002</LicenceNumber>
    <ProductName>AEROPAX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1981-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012298</DrugIDPK>
    <LicenceNumber>PA0303/002/001</LicenceNumber>
    <ProductName>AEROPAX EMULSION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>1981-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011114</DrugIDPK>
    <LicenceNumber>PA0047/008/009</LicenceNumber>
    <ProductName>KEFLEX</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011115</DrugIDPK>
    <LicenceNumber>PA0047/008/010</LicenceNumber>
    <ProductName>KEFLEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010230</DrugIDPK>
    <LicenceNumber>PA0021/019/001</LicenceNumber>
    <ProductName>DOME ACNE CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RESORCINOL MONOACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010231</DrugIDPK>
    <LicenceNumber>PA0021/019/002</LicenceNumber>
    <ProductName>DOME ACNE LOTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010234</DrugIDPK>
    <LicenceNumber>PA0021/020/001</LicenceNumber>
    <ProductName>DOME ACNE MEDICATED CLEANSER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009782</DrugIDPK>
    <LicenceNumber>PA0010/024/001</LicenceNumber>
    <ProductName>KALSPARE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
      <ActiveSubstance>TRIAMTERENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009483</DrugIDPK>
    <LicenceNumber>PA0001/027/001</LicenceNumber>
    <ProductName>LOTUSSIN EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012718</DrugIDPK>
    <LicenceNumber>PA0108/013/001</LicenceNumber>
    <ProductName>YOTOPAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RITODRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012722</DrugIDPK>
    <LicenceNumber>PA0108/013/004</LicenceNumber>
    <ProductName>YUTOPAR S.R.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RITODRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009504</DrugIDPK>
    <LicenceNumber>PA0004/048/001</LicenceNumber>
    <ProductName>ARDINEX 215</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
      <ActiveSubstance>CODEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010715</DrugIDPK>
    <LicenceNumber>PA0045/013/007</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011879</DrugIDPK>
    <LicenceNumber>PA0077/075/001</LicenceNumber>
    <ProductName>HAYPHRYN NASAL SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>THENYLDIAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012584</DrugIDPK>
    <LicenceNumber>PA0437/010/004</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011880</DrugIDPK>
    <LicenceNumber>PA0077/084/001</LicenceNumber>
    <ProductName>NEOPHRYN NASAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010503</DrugIDPK>
    <LicenceNumber>PA0023/021/002</LicenceNumber>
    <ProductName>RASTINON HOECHST AMPOULES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TOLBUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010452</DrugIDPK>
    <LicenceNumber>PA0023/010/003</LicenceNumber>
    <ProductName>TOPISOLONE N</ProductName>
    <Strength>0.25%</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1981-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESOXIMETASONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015091</DrugIDPK>
    <LicenceNumber>PA0290/005/002</LicenceNumber>
    <ProductName>BSS BALANCED SALT SOLUTION</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015092</DrugIDPK>
    <LicenceNumber>PA0290/006/001</LicenceNumber>
    <ProductName>DENDRID OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IDOXURIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012009</DrugIDPK>
    <LicenceNumber>PA0087/001/002</LicenceNumber>
    <ProductName>DILORAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012008</DrugIDPK>
    <LicenceNumber>PA0087/001/001</LicenceNumber>
    <ProductName>DILORAN (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-08-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001697</DrugIDPK>
    <LicenceNumber>PA0039/026/001</LicenceNumber>
    <ProductName>UROLUCOSIL  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012397</DrugIDPK>
    <LicenceNumber>PA0315/003/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013645</DrugIDPK>
    <LicenceNumber>PA0172/008/001</LicenceNumber>
    <ProductName>DRY CLEAR ACNE LOTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1980-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011331</DrugIDPK>
    <LicenceNumber>PA0051/054/002</LicenceNumber>
    <ProductName>KALTEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015649</DrugIDPK>
    <LicenceNumber>PA0231/001/001</LicenceNumber>
    <ProductName>TCP FIRST AID GEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>1976-02-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010434</DrugIDPK>
    <LicenceNumber>PA0023/003/003</LicenceNumber>
    <ProductName>MERITAL AM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering AG</PAHolder>
    <AuthorisedDate>1983-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOMIFENSINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009972</DrugIDPK>
    <LicenceNumber>PA0016/011/001</LicenceNumber>
    <ProductName>MYCIGUENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010204</DrugIDPK>
    <LicenceNumber>PA0028/046/001</LicenceNumber>
    <ProductName>DEMI-TRASMOTIC</ProductName>
    <Strength>8/130</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010205</DrugIDPK>
    <LicenceNumber>PA0028/046/002</LicenceNumber>
    <ProductName>DEMI-TRASMOTIC</ProductName>
    <Strength>16/260</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009686</DrugIDPK>
    <LicenceNumber>PA0009/003/001</LicenceNumber>
    <ProductName>XYLOCARD</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1976-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1986-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010351</DrugIDPK>
    <LicenceNumber>PA0035/004/003</LicenceNumber>
    <ProductName>CLINGRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1976-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULINDAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012522</DrugIDPK>
    <LicenceNumber>PA0418/003/001</LicenceNumber>
    <ProductName>EXPULIN PAEDIATRIC (SUGAR FREE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gaelta Research &amp; Development Lt</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011704</DrugIDPK>
    <LicenceNumber>PA0073/059/003</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1981-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011448</DrugIDPK>
    <LicenceNumber>PA0060/028/001</LicenceNumber>
    <ProductName>LISKONUM CARBONATE</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1981-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013584</DrugIDPK>
    <LicenceNumber>PA0182/010/001</LicenceNumber>
    <ProductName>OROBRONZE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANTHAXANTHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012368</DrugIDPK>
    <LicenceNumber>PA0307/001/001</LicenceNumber>
    <ProductName>SALONPAS MEDICATED PLASTER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Salonpas (1983) Ltd</PAHolder>
    <AuthorisedDate>1980-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>GLYCOL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013569</DrugIDPK>
    <LicenceNumber>PA0275/012/001</LicenceNumber>
    <ProductName>OPTREX EYE DEW BLUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPHAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013570</DrugIDPK>
    <LicenceNumber>PA0275/012/002</LicenceNumber>
    <ProductName>OPTREX EYE DEW CLEAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPHAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016091</DrugIDPK>
    <LicenceNumber>PA0218/012/003</LicenceNumber>
    <ProductName>INSULIN ULTRATARD MC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009767</DrugIDPK>
    <LicenceNumber>PA0017/001/002</LicenceNumber>
    <ProductName>HYPON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010504</DrugIDPK>
    <LicenceNumber>PA0023/027/001</LicenceNumber>
    <ProductName>BIOFERRIN COMPLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HAEMOGLOBINUM SICC.</ActiveSubstance>
      <ActiveSubstance>LIVER EXTRACT</ActiveSubstance>
      <ActiveSubstance>IRON</ActiveSubstance>
      <ActiveSubstance>COBALT</ActiveSubstance>
      <ActiveSubstance>MANGANESE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013761</DrugIDPK>
    <LicenceNumber>PA0176/038//00</LicenceNumber>
    <ProductName>CO-FEROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009899</DrugIDPK>
    <LicenceNumber>PA0012/046/002</LicenceNumber>
    <ProductName>TRAVOGEN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1981-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOCONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009985</DrugIDPK>
    <LicenceNumber>PA0017/089/001</LicenceNumber>
    <ProductName>LOXAZOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PERMETHRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010726</DrugIDPK>
    <LicenceNumber>PA0045/018/002</LicenceNumber>
    <ProductName>ERGAMISOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVAMISOLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009790</DrugIDPK>
    <LicenceNumber>PA0010/027/001</LicenceNumber>
    <ProductName>DIORALYTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009791</DrugIDPK>
    <LicenceNumber>PA0010/027/002</LicenceNumber>
    <ProductName>DIORALYTE CHERRY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009792</DrugIDPK>
    <LicenceNumber>PA0010/027/003</LicenceNumber>
    <ProductName>DIORALYTE PINEAPPLE/GRAPEFRUIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010672</DrugIDPK>
    <LicenceNumber>PA0045/002/004</LicenceNumber>
    <ProductName>GYNO-DAKTARIN COMBI PACK</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1981-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011246</DrugIDPK>
    <LicenceNumber>PA0050/027/001</LicenceNumber>
    <ProductName>PETHILORFAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVALLORPHAN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011247</DrugIDPK>
    <LicenceNumber>PA0050/027/002</LicenceNumber>
    <ProductName>PETHILORFAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVALLORPHAN TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011844</DrugIDPK>
    <LicenceNumber>PA0077/035/007</LicenceNumber>
    <ProductName>FORTRAL N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE</ActiveSubstance>
      <ActiveSubstance>NALOXONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011845</DrugIDPK>
    <LicenceNumber>PA0077/035/008</LicenceNumber>
    <ProductName>FORTRAL N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993007891</DrugIDPK>
    <LicenceNumber>PA0359/001/001</LicenceNumber>
    <ProductName>COLLYRE BLUE LAITER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Laboratoires Laiter</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAPHAZOLINE NITRATE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011526</DrugIDPK>
    <LicenceNumber>PA0057/055/001</LicenceNumber>
    <ProductName>DORBAFIBE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016021</DrugIDPK>
    <LicenceNumber>PA0218/023/001</LicenceNumber>
    <ProductName>LYSOFIBRIN MULTIDOSE KIT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009805</DrugIDPK>
    <LicenceNumber>PA0011/009/001</LicenceNumber>
    <ProductName>STEROXIN-HYDROCORTISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORQUINALDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012612</DrugIDPK>
    <LicenceNumber>PA0441/031/001</LicenceNumber>
    <ProductName>VICKS THROAT LOZENGES LIQUORICE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011008</DrugIDPK>
    <LicenceNumber>PA0046/047/002</LicenceNumber>
    <ProductName>PANALEVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011183</DrugIDPK>
    <LicenceNumber>PA0049/029/006</LicenceNumber>
    <ProductName>TICAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011176</DrugIDPK>
    <LicenceNumber>PA0049/029/001</LicenceNumber>
    <ProductName>TICAR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TICARCILLIN DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011179</DrugIDPK>
    <LicenceNumber>PA0049/029/003</LicenceNumber>
    <ProductName>TICAR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010610</DrugIDPK>
    <LicenceNumber>PA0038/009/004</LicenceNumber>
    <ProductName>ERYTHROPED FORTE SINGLE DOSE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1984-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012902</DrugIDPK>
    <LicenceNumber>PA0117/002/001</LicenceNumber>
    <ProductName>FERRAVITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1975-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012901</DrugIDPK>
    <LicenceNumber>PA0117/001/001</LicenceNumber>
    <ProductName>VITELIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>1975-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011948</DrugIDPK>
    <LicenceNumber>PA0078/012/001</LicenceNumber>
    <ProductName>SEDERGINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013748</DrugIDPK>
    <LicenceNumber>PA0176/028/001</LicenceNumber>
    <ProductName>KLOREF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BETAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013421</DrugIDPK>
    <LicenceNumber>PA0167/074/001</LicenceNumber>
    <ProductName>CHROMIUM TRACE ELEMENT</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHROMIC CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013422</DrugIDPK>
    <LicenceNumber>PA0167/074/002</LicenceNumber>
    <ProductName>CHROMIUM TRACE ELEMENT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHROMIC CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013394</DrugIDPK>
    <LicenceNumber>PA0167/061/004</LicenceNumber>
    <ProductName>M.T.E. 4 MIXTURE ELEMENT</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE PENTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
      <ActiveSubstance>CHROMIC CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014426</DrugIDPK>
    <LicenceNumber>PA0167/061/005</LicenceNumber>
    <ProductName>M.T.E. 4 MIXTURE TRACE ELEMENT ADDITIVES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER SULFATE PENTAHYDRATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
      <ActiveSubstance>CHROMIC CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013390</DrugIDPK>
    <LicenceNumber>PA0167/061/001</LicenceNumber>
    <ProductName>MTE-4</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC</ActiveSubstance>
      <ActiveSubstance>MANGANESE</ActiveSubstance>
      <ActiveSubstance>CHROMIUM</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013391</DrugIDPK>
    <LicenceNumber>PA0167/061/002</LicenceNumber>
    <ProductName>MTE-4</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>CHROMIUM</ActiveSubstance>
      <ActiveSubstance>MANGANESE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013392</DrugIDPK>
    <LicenceNumber>PA0167/061/003</LicenceNumber>
    <ProductName>MTE-4</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013412</DrugIDPK>
    <LicenceNumber>PA0167/070/001</LicenceNumber>
    <ProductName>ZINC TRACE ELEMENT</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013413</DrugIDPK>
    <LicenceNumber>PA0167/070/002</LicenceNumber>
    <ProductName>ZINC TRACE ELEMENT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013415</DrugIDPK>
    <LicenceNumber>PA0167/072/001</LicenceNumber>
    <ProductName>COPPER TRACE ELEMENT</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COPPER SULFATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013416</DrugIDPK>
    <LicenceNumber>PA0167/072/002</LicenceNumber>
    <ProductName>COPPER TRACE ELEMENT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COPPER SULFATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013419</DrugIDPK>
    <LicenceNumber>PA0167/073/002</LicenceNumber>
    <ProductName>MANGANESE TRACE ELEMENT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013417</DrugIDPK>
    <LicenceNumber>PA0167/073/001</LicenceNumber>
    <ProductName>MANGANESE TRACE ELEMENT</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013702</DrugIDPK>
    <LicenceNumber>PA0217/001/001</LicenceNumber>
    <ProductName>INSULIN INSULATARD NORDISK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1975-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013705</DrugIDPK>
    <LicenceNumber>PA0217/002/001</LicenceNumber>
    <ProductName>INSULIN VELOSULIN NORDISK</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>1975-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011987</DrugIDPK>
    <LicenceNumber>PA0078/033/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011988</DrugIDPK>
    <LicenceNumber>PA0078/033/002</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011989</DrugIDPK>
    <LicenceNumber>PA0078/033/003</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011980</DrugIDPK>
    <LicenceNumber>PA0078/031/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011981</DrugIDPK>
    <LicenceNumber>PA0078/031/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011982</DrugIDPK>
    <LicenceNumber>PA0078/031/003</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011983</DrugIDPK>
    <LicenceNumber>PA0078/031/004</LicenceNumber>
    <ProductName>AMPICILLIN TRIHYDRATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011967</DrugIDPK>
    <LicenceNumber>PA0078/022/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011968</DrugIDPK>
    <LicenceNumber>PA0078/022/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011969</DrugIDPK>
    <LicenceNumber>PA0078/022/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011975</DrugIDPK>
    <LicenceNumber>PA0078/025/001</LicenceNumber>
    <ProductName>DOXCYCLINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011911</DrugIDPK>
    <LicenceNumber>PA0078/002/001</LicenceNumber>
    <ProductName>E MYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1976-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011976</DrugIDPK>
    <LicenceNumber>PA0078/026/001</LicenceNumber>
    <ProductName>ERYTHROMYCIN STEARATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011973</DrugIDPK>
    <LicenceNumber>PA0078/024/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011974</DrugIDPK>
    <LicenceNumber>PA0078/024/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011992</DrugIDPK>
    <LicenceNumber>PA0078/037/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011959</DrugIDPK>
    <LicenceNumber>PA0078/018/001</LicenceNumber>
    <ProductName>LEVITONE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011960</DrugIDPK>
    <LicenceNumber>PA0078/018/002</LicenceNumber>
    <ProductName>LEVITONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011961</DrugIDPK>
    <LicenceNumber>PA0078/018/003</LicenceNumber>
    <ProductName>LEVITONE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011950</DrugIDPK>
    <LicenceNumber>PA0078/014/001</LicenceNumber>
    <ProductName>MEDOPAL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011951</DrugIDPK>
    <LicenceNumber>PA0078/014/002</LicenceNumber>
    <ProductName>MEDOPAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011953</DrugIDPK>
    <LicenceNumber>PA0078/014/003</LicenceNumber>
    <ProductName>MEDOPAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012020</DrugIDPK>
    <LicenceNumber>PA0078/045/001</LicenceNumber>
    <ProductName>NIFEREX 150 FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYSACCHARIDE-K</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011979</DrugIDPK>
    <LicenceNumber>PA0078/030/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011970</DrugIDPK>
    <LicenceNumber>PA0078/023/001</LicenceNumber>
    <ProductName>TETRACYCLINE HYDROCHLORIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011971</DrugIDPK>
    <LicenceNumber>PA0078/023/002</LicenceNumber>
    <ProductName>TETRACYCLINE HYDROCHLORIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011972</DrugIDPK>
    <LicenceNumber>PA0078/023/003</LicenceNumber>
    <ProductName>TETRACYCLINE HYDROCHLORIDE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013449</DrugIDPK>
    <LicenceNumber>PA0257/023/001</LicenceNumber>
    <ProductName>CHARABS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013448</DrugIDPK>
    <LicenceNumber>PA0257/019/001</LicenceNumber>
    <ProductName>LANES P.P.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots the Chemists</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011871</DrugIDPK>
    <LicenceNumber>PA0077/061/002</LicenceNumber>
    <ProductName>INOCOR INJECTION</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013451</DrugIDPK>
    <LicenceNumber>PA0257/030/001</LicenceNumber>
    <ProductName>LUSTYS CHARCOAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013052</DrugIDPK>
    <LicenceNumber>PA0126/009/001</LicenceNumber>
    <ProductName>BARITOP G. POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1980-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009558</DrugIDPK>
    <LicenceNumber>PA0006/022/001</LicenceNumber>
    <ProductName>ANGIPLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009523</DrugIDPK>
    <LicenceNumber>PA0006/001/002</LicenceNumber>
    <ProductName>LANITOP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1975-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011457</DrugIDPK>
    <LicenceNumber>PA0060/043/002</LicenceNumber>
    <ProductName>MONOCID</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011455</DrugIDPK>
    <LicenceNumber>PA0060/043/001</LicenceNumber>
    <ProductName>MONOCID</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015678</DrugIDPK>
    <LicenceNumber>PA0236/012/001</LicenceNumber>
    <ProductName>FLOSINT</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015683</DrugIDPK>
    <LicenceNumber>PA0236/012/003</LicenceNumber>
    <ProductName>FLOSINT FOR INJECTION</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015680</DrugIDPK>
    <LicenceNumber>PA0236/012/002</LicenceNumber>
    <ProductName>FLOSINT FOR INJECTION</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011223</DrugIDPK>
    <LicenceNumber>PA0050/002/001</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1975-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011224</DrugIDPK>
    <LicenceNumber>PA0050/002/002</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1975-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011225</DrugIDPK>
    <LicenceNumber>PA0050/002/003</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1975-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011227</DrugIDPK>
    <LicenceNumber>PA0050/002/004</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1975-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011058</DrugIDPK>
    <LicenceNumber>PA0047/002/004</LicenceNumber>
    <ProductName>FENOPRON DISPERSIBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009960</DrugIDPK>
    <LicenceNumber>PA0013/035/003</LicenceNumber>
    <ProductName>SIRDALUD</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010775</DrugIDPK>
    <LicenceNumber>PA0041/003/001</LicenceNumber>
    <ProductName>PEXID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1975-11-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PERHEXILINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012212</DrugIDPK>
    <LicenceNumber>PA0367/004/001</LicenceNumber>
    <ProductName>CHILDRENS MULTIVITAMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012223</DrugIDPK>
    <LicenceNumber>PA0367/011/001</LicenceNumber>
    <ProductName>CYANOCOBALAMIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012206</DrugIDPK>
    <LicenceNumber>PA0367/002/001</LicenceNumber>
    <ProductName>SOOTHOL GRIPE MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009958</DrugIDPK>
    <LicenceNumber>PA0013/035/001</LicenceNumber>
    <ProductName>SIRDALUD</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009959</DrugIDPK>
    <LicenceNumber>PA0013/035/002</LicenceNumber>
    <ProductName>SIRDALUD</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013142</DrugIDPK>
    <LicenceNumber>PA0141/018/001</LicenceNumber>
    <ProductName>CORNERGEN IN DER OPHTHIOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013147</DrugIDPK>
    <LicenceNumber>PA0141/019/001</LicenceNumber>
    <ProductName>DEXABIOTAN OPTHIOLE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013138</DrugIDPK>
    <LicenceNumber>PA0141/016/001</LicenceNumber>
    <ProductName>GENTAMYTREX OPHTIOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013140</DrugIDPK>
    <LicenceNumber>PA0141/017/001</LicenceNumber>
    <ProductName>VIDISEPT OPHTHIOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011427</DrugIDPK>
    <LicenceNumber>PA0054/011/003</LicenceNumber>
    <ProductName>ILVICO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1980-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALICYLAMIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>QUININE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013762</DrugIDPK>
    <LicenceNumber>PA0176/039/001</LicenceNumber>
    <ProductName>TRIPLE ACTION COLD RELIEF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-07-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009786</DrugIDPK>
    <LicenceNumber>PA0017/024/002</LicenceNumber>
    <ProductName>CHOLERA VACCINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHOLERA VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009788</DrugIDPK>
    <LicenceNumber>PA0017/024/003</LicenceNumber>
    <ProductName>CHOLERA VACCINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHOLERA VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009808</DrugIDPK>
    <LicenceNumber>PA0017/027/001</LicenceNumber>
    <ProductName>DIPHTHERIA VACCINE T A B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009818</DrugIDPK>
    <LicenceNumber>PA0017/032/004</LicenceNumber>
    <ProductName>TETANUS VACCINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETANUS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009822</DrugIDPK>
    <LicenceNumber>PA0017/033/001</LicenceNumber>
    <ProductName>TETANUS VACCINE ADSORBED</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETANUS VACCINE ADSORBED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009816</DrugIDPK>
    <LicenceNumber>PA0017/032/002</LicenceNumber>
    <ProductName>TETANUS VACCINE B P</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETANUS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004077</DrugIDPK>
    <LicenceNumber>PA0159/001/001</LicenceNumber>
    <ProductName>LIFETIME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>1975-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE EXSICCATED</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005344</DrugIDPK>
    <LicenceNumber>PA0258/012/001</LicenceNumber>
    <ProductName>BON VOYAGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>1980-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015155</DrugIDPK>
    <LicenceNumber>PA0098/001/001</LicenceNumber>
    <ProductName>LAXOBERAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1975-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012328</DrugIDPK>
    <LicenceNumber>PA0397/001/001</LicenceNumber>
    <ProductName>SOLARCAINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Plough (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012329</DrugIDPK>
    <LicenceNumber>PA0397/001/002</LicenceNumber>
    <ProductName>SOLARCAINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Plough (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012330</DrugIDPK>
    <LicenceNumber>PA0397/001/003</LicenceNumber>
    <ProductName>SOLARCAINE  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Plough (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003665</DrugIDPK>
    <LicenceNumber>PA0108/003/006</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1980-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003666</DrugIDPK>
    <LicenceNumber>PA0108/003/007</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1980-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003667</DrugIDPK>
    <LicenceNumber>PA0108/003/008</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1980-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013758</DrugIDPK>
    <LicenceNumber>PA0176/036/001</LicenceNumber>
    <ProductName>DIGESTIVE MINTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROXYALUMINUM SODIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010619</DrugIDPK>
    <LicenceNumber>PA0038/012/001</LicenceNumber>
    <ProductName>ENDURONYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011237</DrugIDPK>
    <LicenceNumber>PA0050/011/001</LicenceNumber>
    <ProductName>MADRIBON</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFADIMETHOXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-06-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012439</DrugIDPK>
    <LicenceNumber>PA0331/002/001</LicenceNumber>
    <ProductName>HALOTHANE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Anaquest Limited</PAHolder>
    <AuthorisedDate>1984-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALOTHANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013510</DrugIDPK>
    <LicenceNumber>PA0261/007/002</LicenceNumber>
    <ProductName>MIXOGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL BENZOATE</ActiveSubstance>
      <ActiveSubstance>TESTOSTERONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013657</DrugIDPK>
    <LicenceNumber>PA0176/005/001</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013658</DrugIDPK>
    <LicenceNumber>PA0176/005/002</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013659</DrugIDPK>
    <LicenceNumber>PA0176/005/003</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013660</DrugIDPK>
    <LicenceNumber>PA0176/005/004</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013675</DrugIDPK>
    <LicenceNumber>PA0176/014/001</LicenceNumber>
    <ProductName>NOXACORN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>CASTOR OIL</ActiveSubstance>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010283</DrugIDPK>
    <LicenceNumber>PA0032/019/001</LicenceNumber>
    <ProductName>LIPANTIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012366</DrugIDPK>
    <LicenceNumber>PA0306/001/001</LicenceNumber>
    <ProductName>ALLCOCKS POROUS PLASTER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Richards &amp; Appleby Ltd</PAHolder>
    <AuthorisedDate>1980-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015208</DrugIDPK>
    <LicenceNumber>PA0098/019/002</LicenceNumber>
    <ProductName>PENOTRANE PESSARIES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015259</DrugIDPK>
    <LicenceNumber>PA0297/004/001</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015260</DrugIDPK>
    <LicenceNumber>PA0297/004/002</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allpharm (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-05-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013604</DrugIDPK>
    <LicenceNumber>PA0187/006/001</LicenceNumber>
    <ProductName>CRESCORMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GROWTH HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011698</DrugIDPK>
    <LicenceNumber>PA0073/052/002</LicenceNumber>
    <ProductName>DORMIGEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1980-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-04-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011221</DrugIDPK>
    <LicenceNumber>PA0050/001/001</LicenceNumber>
    <ProductName>GLUTRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1975-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013533</DrugIDPK>
    <LicenceNumber>PA0261/023/001</LicenceNumber>
    <ProductName>COTAZYM B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1984-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIPASE</ActiveSubstance>
      <ActiveSubstance>AMYLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011330</DrugIDPK>
    <LicenceNumber>PA0051/054/001</LicenceNumber>
    <ProductName>KALTEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009990</DrugIDPK>
    <LicenceNumber>PA0018/001/001</LicenceNumber>
    <ProductName>LOMUSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1975-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010463</DrugIDPK>
    <LicenceNumber>PA0027/033/001</LicenceNumber>
    <ProductName>GAVISCOLONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARBENOXOLONE</ActiveSubstance>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001211</DrugIDPK>
    <LicenceNumber>PA0235/001/004</LicenceNumber>
    <ProductName>AMIPAQUE</ProductName>
    <Strength>13.5</Strength>
    <StrengthMeasurement>Gig.bequerel</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1980-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRIZAMIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CALCIUM EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012005</DrugIDPK>
    <LicenceNumber>PA0086/025/001</LicenceNumber>
    <ProductName>H-2090</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010495</DrugIDPK>
    <LicenceNumber>PA0028/033/002</LicenceNumber>
    <ProductName>RITALIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLPHENIDATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015175</DrugIDPK>
    <LicenceNumber>PA0295/004/004</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRAGATION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015174</DrugIDPK>
    <LicenceNumber>PA0295/004/003</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012623</DrugIDPK>
    <LicenceNumber>PA0107/003/001</LicenceNumber>
    <ProductName>AMODEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013878</DrugIDPK>
    <LicenceNumber>PA0277/031/001</LicenceNumber>
    <ProductName>HALAZEPAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013879</DrugIDPK>
    <LicenceNumber>PA0277/031/002</LicenceNumber>
    <ProductName>HALAZEPAM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013881</DrugIDPK>
    <LicenceNumber>PA0277/031/003</LicenceNumber>
    <ProductName>HALAZEPAM</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010185</DrugIDPK>
    <LicenceNumber>PA0021/002/002</LicenceNumber>
    <ProductName>ALRHEUMAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1981-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010214</DrugIDPK>
    <LicenceNumber>PA0021/010/001</LicenceNumber>
    <ProductName>EPONTOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016075</DrugIDPK>
    <LicenceNumber>PA0218/003/002</LicenceNumber>
    <ProductName>ACTRAPID MC NEUTRAL INSULIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016068</DrugIDPK>
    <LicenceNumber>PA0218/001/002</LicenceNumber>
    <ProductName>MONOTARD MC INSULIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016070</DrugIDPK>
    <LicenceNumber>PA0218/002/001</LicenceNumber>
    <ProductName>SEMITARD MC INSULIN ZINC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012888</DrugIDPK>
    <LicenceNumber>PA0115/005/008</LicenceNumber>
    <ProductName>CLOPIXOL AQUEOUS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010446</DrugIDPK>
    <LicenceNumber>PA0027/017/001</LicenceNumber>
    <ProductName>LUCIDRIL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MECLOFENOXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010448</DrugIDPK>
    <LicenceNumber>PA0027/017/002</LicenceNumber>
    <ProductName>LUCIDRIL PAEDIATRIC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MECLOFENOXATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013756</DrugIDPK>
    <LicenceNumber>PA0176/033/001</LicenceNumber>
    <ProductName>MACKENZIE DECONGESTANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
      <ActiveSubstance>METHYLEPHEDRINE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015173</DrugIDPK>
    <LicenceNumber>PA0295/004/002</LicenceNumber>
    <ProductName>STERILE WATER FOR IRRIGATION</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR IRRIGATION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010677</DrugIDPK>
    <LicenceNumber>PA0045/002/009</LicenceNumber>
    <ProductName>GYNO-DAKTARIN TAMPONS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1980-12-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010724</DrugIDPK>
    <LicenceNumber>PA0045/016/009</LicenceNumber>
    <ProductName>MOTILIUM ORAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1980-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DOMPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011376</DrugIDPK>
    <LicenceNumber>PA0056/009/001</LicenceNumber>
    <ProductName>COSYLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1975-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012351</DrugIDPK>
    <LicenceNumber>PA0303/018/001</LicenceNumber>
    <ProductName>PARAMANTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMANTADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011410</DrugIDPK>
    <LicenceNumber>PA0056/039/001</LicenceNumber>
    <ProductName>BRONDECON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013085</DrugIDPK>
    <LicenceNumber>PA0137/034/003</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013780</DrugIDPK>
    <LicenceNumber>PA0279/001/001</LicenceNumber>
    <ProductName>FENNINGS SOLUBLE CHILDRENS COOLING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fenning Pharmaceuticals</PAHolder>
    <AuthorisedDate>1980-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013808</DrugIDPK>
    <LicenceNumber>PA0277/008/001</LicenceNumber>
    <ProductName>EXTRA ENERGY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013123</DrugIDPK>
    <LicenceNumber>PA0141/007/001</LicenceNumber>
    <ProductName>OTO-FLEXIOLE WITH NEOMYCIN EAR DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
      <ActiveSubstance>PHENAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012945</DrugIDPK>
    <LicenceNumber>PA0130/006/001</LicenceNumber>
    <ProductName>FE-CAP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012946</DrugIDPK>
    <LicenceNumber>PA0130/007/002</LicenceNumber>
    <ProductName>FE-CAP C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012947</DrugIDPK>
    <LicenceNumber>PA0130/008/001</LicenceNumber>
    <ProductName>FE-CAP FOLIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012948</DrugIDPK>
    <LicenceNumber>PA0130/009/001</LicenceNumber>
    <ProductName>GASTROVITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013151</DrugIDPK>
    <LicenceNumber>PA0143/001/001</LicenceNumber>
    <ProductName>HISTICAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>1975-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HISTIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012949</DrugIDPK>
    <LicenceNumber>PA0130/010/001</LicenceNumber>
    <ProductName>KELFERON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012950</DrugIDPK>
    <LicenceNumber>PA0130/011/001</LicenceNumber>
    <ProductName>KELFOLATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009961</DrugIDPK>
    <LicenceNumber>PA0013/037/001</LicenceNumber>
    <ProductName>LEPONEX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009962</DrugIDPK>
    <LicenceNumber>PA0013/037/002</LicenceNumber>
    <ProductName>LEPONEX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011175</DrugIDPK>
    <LicenceNumber>PA0049/028/001</LicenceNumber>
    <ProductName>FERRAPLEX B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011174</DrugIDPK>
    <LicenceNumber>PA0049/026/001</LicenceNumber>
    <ProductName>PREGNAVITE FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011057</DrugIDPK>
    <LicenceNumber>PA0049/002/001</LicenceNumber>
    <ProductName>UTICILLIN (BRL 3475)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1975-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARFECILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009710</DrugIDPK>
    <LicenceNumber>PA0009/016/007</LicenceNumber>
    <ProductName>XYLOCAINE EYE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010919</DrugIDPK>
    <LicenceNumber>PA0047/049/001</LicenceNumber>
    <ProductName>ELDESINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010921</DrugIDPK>
    <LicenceNumber>PA0047/049/002</LicenceNumber>
    <ProductName>ELDESINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009467</DrugIDPK>
    <LicenceNumber>PA0001/012/001</LicenceNumber>
    <ProductName>METRULEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1980-07-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
      <ActiveSubstance>ETYNODIOL DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010714</DrugIDPK>
    <LicenceNumber>PA0045/013/006</LicenceNumber>
    <ProductName>DAKTARIN TINCTURE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010694</DrugIDPK>
    <LicenceNumber>PA0045/005/009</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1979-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009928</DrugIDPK>
    <LicenceNumber>PA0013/004/008</LicenceNumber>
    <ProductName>MELLERIL RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1980-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIORIDAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009640</DrugIDPK>
    <LicenceNumber>PA0004/021/001</LicenceNumber>
    <ProductName>PANCREOZYMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PANCREOZYMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009642</DrugIDPK>
    <LicenceNumber>PA0004/023/001</LicenceNumber>
    <ProductName>VITAMIN C</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1984-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009643</DrugIDPK>
    <LicenceNumber>PA0004/023/002</LicenceNumber>
    <ProductName>VITAMIN C</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1984-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012278</DrugIDPK>
    <LicenceNumber>PA0379/011/001</LicenceNumber>
    <ProductName>DINNEFORDS GRIPE MIXTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HEAVY MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010755</DrugIDPK>
    <LicenceNumber>PA0040/049/001</LicenceNumber>
    <ProductName>BREVIDIL M</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012380</DrugIDPK>
    <LicenceNumber>PA0415/001/001</LicenceNumber>
    <ProductName>PROFILATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Grifols UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMAFRAKTION (FACTOR VIII)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009802</DrugIDPK>
    <LicenceNumber>PA0011/007/001</LicenceNumber>
    <ProductName>MEDOMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPTABARB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1985-01-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010107</DrugIDPK>
    <LicenceNumber>PA0018/039/001</LicenceNumber>
    <ProductName>BILE BEANS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTIAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016092</DrugIDPK>
    <LicenceNumber>PA0218/013/001</LicenceNumber>
    <ProductName>RAPITARD MC BIPHASIC INSULIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009924</DrugIDPK>
    <LicenceNumber>PA0013/001/001</LicenceNumber>
    <ProductName>PINDOLOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010041</DrugIDPK>
    <LicenceNumber>PA0019/030/007</LicenceNumber>
    <ProductName>TROSYL DERMAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012033</DrugIDPK>
    <LicenceNumber>PA0087/012/001</LicenceNumber>
    <ProductName>MADECASSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ASIATIC ACID</ActiveSubstance>
      <ActiveSubstance>MADECASSIC ACID</ActiveSubstance>
      <ActiveSubstance>ASIATICOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012034</DrugIDPK>
    <LicenceNumber>PA0087/012/002</LicenceNumber>
    <ProductName>MADECASSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASIATIC ACID</ActiveSubstance>
      <ActiveSubstance>MADECASSIC ACID</ActiveSubstance>
      <ActiveSubstance>ASIATICOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010702</DrugIDPK>
    <LicenceNumber>PA0045/007/001</LicenceNumber>
    <ProductName>IMAP INJECTABLE  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUSPIRILENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010699</DrugIDPK>
    <LicenceNumber>PA0045/006/001</LicenceNumber>
    <ProductName>THALAMONAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROPERIDOL</ActiveSubstance>
      <ActiveSubstance>FENTANYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011947</DrugIDPK>
    <LicenceNumber>PA0078/011/001</LicenceNumber>
    <ProductName>LARBUTAZONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011798</DrugIDPK>
    <LicenceNumber>PA0080/005/005</LicenceNumber>
    <ProductName>ETOPHYLATE ADULT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011797</DrugIDPK>
    <LicenceNumber>PA0080/005/004</LicenceNumber>
    <ProductName>ETOPHYLATE PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010298</DrugIDPK>
    <LicenceNumber>PA0032/026/001</LicenceNumber>
    <ProductName>JAAPS HEALTH SALT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM SODIUM TARTRATE</ActiveSubstance>
      <ActiveSubstance>TARTARIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015620</DrugIDPK>
    <LicenceNumber>PA0298/001/005</LicenceNumber>
    <ProductName>PENTACIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015621</DrugIDPK>
    <LicenceNumber>PA0298/001/006</LicenceNumber>
    <ProductName>PENTACIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015622</DrugIDPK>
    <LicenceNumber>PA0298/001/007</LicenceNumber>
    <ProductName>PENTACIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-11-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013747</DrugIDPK>
    <LicenceNumber>PA0176/026/001</LicenceNumber>
    <ProductName>QUININE BISULPHATE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUININE BISULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009544</DrugIDPK>
    <LicenceNumber>PA0002/017/001</LicenceNumber>
    <ProductName>SETHOTOPE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010507</DrugIDPK>
    <LicenceNumber>PA0023/030/001</LicenceNumber>
    <ProductName>FEMIPAUSIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLTESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009963</DrugIDPK>
    <LicenceNumber>PA0013/038/001</LicenceNumber>
    <ProductName>NITRISKEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PINDOLOL</ActiveSubstance>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012378</DrugIDPK>
    <LicenceNumber>PA0309/002/002</LicenceNumber>
    <ProductName>BIO-STAR VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012899</DrugIDPK>
    <LicenceNumber>PA0116/008/001</LicenceNumber>
    <ProductName>UNIFEN 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Elan Corporation Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013735</DrugIDPK>
    <LicenceNumber>PA0176/018/001</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>360</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013734</DrugIDPK>
    <LicenceNumber>PA0176/017/003</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013744</DrugIDPK>
    <LicenceNumber>PA0176/024/001</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013745</DrugIDPK>
    <LicenceNumber>PA0176/024/002</LicenceNumber>
    <ProductName>LORAZEPAM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013746</DrugIDPK>
    <LicenceNumber>PA0176/025/001</LicenceNumber>
    <ProductName>TOLBUTAMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLBUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011158</DrugIDPK>
    <LicenceNumber>PA0049/018/005</LicenceNumber>
    <ProductName>FLOXAPEN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-10-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010497</DrugIDPK>
    <LicenceNumber>PA0023/014/002</LicenceNumber>
    <ProductName>HOSTACYCLINE P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011289</DrugIDPK>
    <LicenceNumber>PA0054/027/001</LicenceNumber>
    <ProductName>AVACAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CAMYLOFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011294</DrugIDPK>
    <LicenceNumber>PA0054/027/002</LicenceNumber>
    <ProductName>AVACAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAMYLOFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013450</DrugIDPK>
    <LicenceNumber>PA0257/025/001</LicenceNumber>
    <ProductName>LUSTYS JUNABEAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011082</DrugIDPK>
    <LicenceNumber>PA0049/006/017</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011083</DrugIDPK>
    <LicenceNumber>PA0049/006/018</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011085</DrugIDPK>
    <LicenceNumber>PA0049/006/019</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011086</DrugIDPK>
    <LicenceNumber>PA0049/006/020</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011088</DrugIDPK>
    <LicenceNumber>PA0049/006/021</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011089</DrugIDPK>
    <LicenceNumber>PA0049/006/022</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011143</DrugIDPK>
    <LicenceNumber>PA0049/010/025</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011147</DrugIDPK>
    <LicenceNumber>PA0049/010/028</LicenceNumber>
    <ProductName>PENBRITIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011140</DrugIDPK>
    <LicenceNumber>PA0049/010/023</LicenceNumber>
    <ProductName>PENBRITIN (REDUCED SUGAR) 125 MG</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011141</DrugIDPK>
    <LicenceNumber>PA0049/010/024</LicenceNumber>
    <ProductName>PENBRITIN (REDUCED SUGAR) 125 MG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011144</DrugIDPK>
    <LicenceNumber>PA0049/010/026</LicenceNumber>
    <ProductName>PENBRITIN (REDUCED SUGAR) 250 MG</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011145</DrugIDPK>
    <LicenceNumber>PA0049/010/027</LicenceNumber>
    <ProductName>PENBRITIN (REDUCED SUGAR) 250 MG</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1979-01-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009592</DrugIDPK>
    <LicenceNumber>PA0002/032/007</LicenceNumber>
    <ProductName>DEXACILLIN  (SUSPENSION)</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011825</DrugIDPK>
    <LicenceNumber>PA0082/015/003</LicenceNumber>
    <ProductName>TETRACHEL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010150</DrugIDPK>
    <LicenceNumber>PA0082/015/002</LicenceNumber>
    <ProductName>TETRACHEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009582</DrugIDPK>
    <LicenceNumber>PA0002/032/002</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bridge Pharmaceuticals (Ire) Ltd</PAHolder>
    <AuthorisedDate>1979-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009583</DrugIDPK>
    <LicenceNumber>PA0002/032/003</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009586</DrugIDPK>
    <LicenceNumber>PA0002/032/004</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009587</DrugIDPK>
    <LicenceNumber>PA0002/032/005</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009589</DrugIDPK>
    <LicenceNumber>PA0002/032/006</LicenceNumber>
    <ProductName>DEXACILLIN  (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009553</DrugIDPK>
    <LicenceNumber>PA0002/020/005</LicenceNumber>
    <ProductName>HALCIDERM TOPICAL 0.025%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1979-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALCINONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010188</DrugIDPK>
    <LicenceNumber>PA0028/037/001</LicenceNumber>
    <ProductName>VARBIAN AMPOULES</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PRENALTEROL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013618</DrugIDPK>
    <LicenceNumber>PA0187/015/001</LicenceNumber>
    <ProductName>ALBUMIN HUMAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015750</DrugIDPK>
    <LicenceNumber>PA0238/002/001</LicenceNumber>
    <ProductName>VASIGIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Combe International Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012273</DrugIDPK>
    <LicenceNumber>PA0302/006/001</LicenceNumber>
    <ProductName>MAGSORBENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-08-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010243</DrugIDPK>
    <LicenceNumber>PA0021/029/001</LicenceNumber>
    <ProductName>CARBO CORT 0.25%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010248</DrugIDPK>
    <LicenceNumber>PA0021/031/001</LicenceNumber>
    <ProductName>COR-TAR-QUIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010245</DrugIDPK>
    <LicenceNumber>PA0021/030/001</LicenceNumber>
    <ProductName>DOME CORT</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>1979-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010462</DrugIDPK>
    <LicenceNumber>PA0027/031/001</LicenceNumber>
    <ProductName>PROBRONTYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCATEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012029</DrugIDPK>
    <LicenceNumber>PA0087/005/003</LicenceNumber>
    <ProductName>GLUCOPHAGE-DR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011628</DrugIDPK>
    <LicenceNumber>PA0065/012/002</LicenceNumber>
    <ProductName>DINDEVAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012825</DrugIDPK>
    <LicenceNumber>PA0115/004/001</LicenceNumber>
    <ProductName>BLEOMYCIN LUNDBECK</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>1977-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015629</DrugIDPK>
    <LicenceNumber>PA0299/002/001</LicenceNumber>
    <ProductName>DE WITTS KIDNEY &amp; BLADDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011605</DrugIDPK>
    <LicenceNumber>PA0062/028/001</LicenceNumber>
    <ProductName>TOPICYCLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010474</DrugIDPK>
    <LicenceNumber>PA0028/011/001</LicenceNumber>
    <ProductName>DORIDEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUTETHIMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011314</DrugIDPK>
    <LicenceNumber>PA0051/026/001</LicenceNumber>
    <ProductName>MYSOLINE PHENYTOIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRIMIDONE</ActiveSubstance>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011507</DrugIDPK>
    <LicenceNumber>PA0057/041/001</LicenceNumber>
    <ProductName>BISMA-REX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>BISMUTH CAMPHOCARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011508</DrugIDPK>
    <LicenceNumber>PA0057/041/002</LicenceNumber>
    <ProductName>BISMA-REX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>BISMUTH CAMPHOCARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011510</DrugIDPK>
    <LicenceNumber>PA0057/042/001</LicenceNumber>
    <ProductName>BN LINIMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
      <ActiveSubstance>STRONG AMMONIA SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011521</DrugIDPK>
    <LicenceNumber>PA0057/052/001</LicenceNumber>
    <ProductName>TITRALAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009807</DrugIDPK>
    <LicenceNumber>PA0011/013/001</LicenceNumber>
    <ProductName>BUTAZOLIDIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010444</DrugIDPK>
    <LicenceNumber>PA0027/013/001</LicenceNumber>
    <ProductName>FLENAC</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-10-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENCLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013175</DrugIDPK>
    <LicenceNumber>PA0156/004/001</LicenceNumber>
    <ProductName>ADULT TRAVEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rumon (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013173</DrugIDPK>
    <LicenceNumber>PA0156/003/001</LicenceNumber>
    <ProductName>CHILD TRAVEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rumon (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013178</DrugIDPK>
    <LicenceNumber>PA0156/005/001</LicenceNumber>
    <ProductName>MENTHOL &amp; EUCALYPTOL PASTILLES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rumon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1982-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013164</DrugIDPK>
    <LicenceNumber>PA0156/001/001</LicenceNumber>
    <ProductName>SURE SHIELD MOUTH ULCER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rumon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013179</DrugIDPK>
    <LicenceNumber>PA0156/006/001</LicenceNumber>
    <ProductName>VOCALZONES PASTILLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rumon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>PEPPERMINT OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009766</DrugIDPK>
    <LicenceNumber>PA0016/040/001</LicenceNumber>
    <ProductName>INABRIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1985-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009911</DrugIDPK>
    <LicenceNumber>PA0017/042/001</LicenceNumber>
    <ProductName>TYPHUS VACCINE B P</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012548</DrugIDPK>
    <LicenceNumber>PA0100/035/001</LicenceNumber>
    <ProductName>OVOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009815</DrugIDPK>
    <LicenceNumber>PA0011/018/001</LicenceNumber>
    <ProductName>BUTAZOLIDIN ALKA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009819</DrugIDPK>
    <LicenceNumber>PA0011/020/001</LicenceNumber>
    <ProductName>BUTAZOLIDIN R WITH XYLOCAINE R</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009799</DrugIDPK>
    <LicenceNumber>PA0011/006/002</LicenceNumber>
    <ProductName>TANDERIL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010885</DrugIDPK>
    <LicenceNumber>PA0047/024/003</LicenceNumber>
    <ProductName>ALLEGRON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010893</DrugIDPK>
    <LicenceNumber>PA0047/034/001</LicenceNumber>
    <ProductName>HISTADYL EC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHAPYRILENE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013736</DrugIDPK>
    <LicenceNumber>PA0176/019/001</LicenceNumber>
    <ProductName>PARAPAV</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012485</DrugIDPK>
    <LicenceNumber>PA0353/002/001</LicenceNumber>
    <ProductName>TRILOBAL</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Beaufour Schwabe</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GINKGO BILOBA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012487</DrugIDPK>
    <LicenceNumber>PA0353/002/002</LicenceNumber>
    <ProductName>TRILOBAL</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Beaufour Schwabe</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GINKGO BILOBA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011108</DrugIDPK>
    <LicenceNumber>PA0047/010/002</LicenceNumber>
    <ProductName>AMESEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009562</DrugIDPK>
    <LicenceNumber>PA0002/025/004</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009568</DrugIDPK>
    <LicenceNumber>PA0002/025/007</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009564</DrugIDPK>
    <LicenceNumber>PA0002/025/005</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009572</DrugIDPK>
    <LicenceNumber>PA0002/025/009</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009570</DrugIDPK>
    <LicenceNumber>PA0002/025/008</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009566</DrugIDPK>
    <LicenceNumber>PA0002/025/006</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013637</DrugIDPK>
    <LicenceNumber>PA0194/002/001</LicenceNumber>
    <ProductName>NUBAIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Endo Laboratories Incorporated</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALBUPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013638</DrugIDPK>
    <LicenceNumber>PA0194/002/002</LicenceNumber>
    <ProductName>NUBAIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Endo Laboratories Incorporated</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALBUPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013639</DrugIDPK>
    <LicenceNumber>PA0194/002/003</LicenceNumber>
    <ProductName>NUBAIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Endo Laboratories Incorporated</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALBUPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009955</DrugIDPK>
    <LicenceNumber>PA0013/027/002</LicenceNumber>
    <ProductName>CEDILANID AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DESLANOSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-05-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009455</DrugIDPK>
    <LicenceNumber>PA0001/003/004</LicenceNumber>
    <ProductName>NORPACE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1979-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-05-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010754</DrugIDPK>
    <LicenceNumber>PA0040/048/001</LicenceNumber>
    <ProductName>BREVIDIL E</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1981-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009569</DrugIDPK>
    <LicenceNumber>PA0006/025/001</LicenceNumber>
    <ProductName>BETAPRESSIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENBUTOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009571</DrugIDPK>
    <LicenceNumber>PA0006/025/002</LicenceNumber>
    <ProductName>BETAPRESSIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENBUTOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009573</DrugIDPK>
    <LicenceNumber>PA0006/025/003</LicenceNumber>
    <ProductName>BETAPRESSIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENBUTOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011567</DrugIDPK>
    <LicenceNumber>PA0060/003/009</LicenceNumber>
    <ProductName>NASOFLU (RIT 4199 STRAIN) FIFTY DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011564</DrugIDPK>
    <LicenceNumber>PA0060/003/007</LicenceNumber>
    <ProductName>NASOFLU (RIT 4199 STRAIN) MONODOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011566</DrugIDPK>
    <LicenceNumber>PA0060/003/008</LicenceNumber>
    <ProductName>NASOFLU (RIT 4199 STRAIN) TEN DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1979-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012026</DrugIDPK>
    <LicenceNumber>PA0078/053/003</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>50/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010508</DrugIDPK>
    <LicenceNumber>PA0023/031/001</LicenceNumber>
    <ProductName>FEMIPAUSIN MANOJECT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>TESTOSTERONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012021</DrugIDPK>
    <LicenceNumber>PA0078/046/001</LicenceNumber>
    <ProductName>CENADEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011489</DrugIDPK>
    <LicenceNumber>PA0057/030/001</LicenceNumber>
    <ProductName>DUO-AUTOHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011487</DrugIDPK>
    <LicenceNumber>PA0057/029/001</LicenceNumber>
    <ProductName>ISO-AUTOHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011473</DrugIDPK>
    <LicenceNumber>PA0057/019/001</LicenceNumber>
    <ProductName>RAUWILOID + VERILOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERATRUM VIRIDE</ActiveSubstance>
      <ActiveSubstance>RAUWOLFIA SERPENTINA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011471</DrugIDPK>
    <LicenceNumber>PA0057/018/001</LicenceNumber>
    <ProductName>THIAVER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERATRUM VIRIDE</ActiveSubstance>
      <ActiveSubstance>EPITIZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011468</DrugIDPK>
    <LicenceNumber>PA0057/016/001</LicenceNumber>
    <ProductName>VERILOID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERATRUM VIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012480</DrugIDPK>
    <LicenceNumber>PA0350/001/001</LicenceNumber>
    <ProductName>IDOSORB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>TIL (Medical) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CADEXOMER IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010241</DrugIDPK>
    <LicenceNumber>PA0021/023/001</LicenceNumber>
    <ProductName>ALKA MINTS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-04-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011792</DrugIDPK>
    <LicenceNumber>PA0077/017/003</LicenceNumber>
    <ProductName>FRANOL PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>THENYLDIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009451</DrugIDPK>
    <LicenceNumber>PA0001/002/003</LicenceNumber>
    <ProductName>PRO-BANTHINE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPANTHELINE BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011283</DrugIDPK>
    <LicenceNumber>PA0051/006/004</LicenceNumber>
    <ProductName>INDERAL</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010716</DrugIDPK>
    <LicenceNumber>PA0040/017/006</LicenceNumber>
    <ProductName>INTRAVAL SODIUM</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012511</DrugIDPK>
    <LicenceNumber>PA0100/018/001</LicenceNumber>
    <ProductName>OPULETS BENOXINATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYBUPROCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009755</DrugIDPK>
    <LicenceNumber>PA0016/030/001</LicenceNumber>
    <ProductName>PAMINE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009678</DrugIDPK>
    <LicenceNumber>PA0009/031/006</LicenceNumber>
    <ProductName>SENSORCAINE 0.75%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009679</DrugIDPK>
    <LicenceNumber>PA0009/031/007</LicenceNumber>
    <ProductName>SENSORCAINE 0.75%</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010103</DrugIDPK>
    <LicenceNumber>PA0018/034/001</LicenceNumber>
    <ProductName>PSOROX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1983-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009942</DrugIDPK>
    <LicenceNumber>PA0013/013/002</LicenceNumber>
    <ProductName>ZADITEN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOTIFEN FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010678</DrugIDPK>
    <LicenceNumber>PA0045/005/002</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1977-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011631</DrugIDPK>
    <LicenceNumber>PA0065/015/001</LicenceNumber>
    <ProductName>ALTHESIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1984-02-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010016</DrugIDPK>
    <LicenceNumber>PA0013/025/003</LicenceNumber>
    <ProductName>ESTULIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANFACINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009953</DrugIDPK>
    <LicenceNumber>PA0013/025/001</LicenceNumber>
    <ProductName>ESTULIC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANFACINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009954</DrugIDPK>
    <LicenceNumber>PA0013/025/002</LicenceNumber>
    <ProductName>ESTULIC</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1979-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANFACINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010917</DrugIDPK>
    <LicenceNumber>PA0047/047/001</LicenceNumber>
    <ProductName>PARATHORMONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009829</DrugIDPK>
    <LicenceNumber>PA0017/034/003</LicenceNumber>
    <ProductName>TYPHOID-PARATYPHOID A &amp; B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011793</DrugIDPK>
    <LicenceNumber>PA0080/005/001</LicenceNumber>
    <ProductName>ETOPHYLATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011794</DrugIDPK>
    <LicenceNumber>PA0080/005/002</LicenceNumber>
    <ProductName>ETOPHYLATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACEFYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011942</DrugIDPK>
    <LicenceNumber>PA0086/014/001</LicenceNumber>
    <ProductName>DIMOTANE EXPECTORANT DC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011940</DrugIDPK>
    <LicenceNumber>PA0086/013/004</LicenceNumber>
    <ProductName>DIMOTANE EXPECTORANT PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011389</DrugIDPK>
    <LicenceNumber>PA0056/020/001</LicenceNumber>
    <ProductName>PITOCIN BUCCAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010238</DrugIDPK>
    <LicenceNumber>PA0021/022/001</LicenceNumber>
    <ProductName>ACTRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010236</DrugIDPK>
    <LicenceNumber>PA0021/021/001</LicenceNumber>
    <ProductName>CARBO-DOME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009537</DrugIDPK>
    <LicenceNumber>PA0006/003/013</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <Strength>160/2</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009535</DrugIDPK>
    <LicenceNumber>PA0006/003/012</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <Strength>120/1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011877</DrugIDPK>
    <LicenceNumber>PA0077/073/001</LicenceNumber>
    <ProductName>HEDEX SOLUBLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1985-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016095</DrugIDPK>
    <LicenceNumber>PA0218/014/001</LicenceNumber>
    <ProductName>LENTARD MC INSULIN ZINC SUSPENSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016096</DrugIDPK>
    <LicenceNumber>PA0218/014/002</LicenceNumber>
    <ProductName>LENTARD MC INSULIN ZINC SUSPENSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009898</DrugIDPK>
    <LicenceNumber>PA0012/043/002</LicenceNumber>
    <ProductName>MYCANDEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HALOPROGIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009867</DrugIDPK>
    <LicenceNumber>PA0012/018/001</LicenceNumber>
    <ProductName>PRIMODIAN DEPOT AMPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE ENANTATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009872</DrugIDPK>
    <LicenceNumber>PA0012/022/001</LicenceNumber>
    <ProductName>PRIMOSTAT AMPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GESTONORONE CAPROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009876</DrugIDPK>
    <LicenceNumber>PA0012/028/001</LicenceNumber>
    <ProductName>TESTOVIRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLTESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016089</DrugIDPK>
    <LicenceNumber>PA0218/012/001</LicenceNumber>
    <ProductName>ULRATARD MC INSULIN ZINC SUSPENSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016090</DrugIDPK>
    <LicenceNumber>PA0218/012/002</LicenceNumber>
    <ProductName>ULTRATARD MC INSULIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1977-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011532</DrugIDPK>
    <LicenceNumber>PA0058/003/001</LicenceNumber>
    <ProductName>DILAUDID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009948</DrugIDPK>
    <LicenceNumber>PA0013/016/002</LicenceNumber>
    <ProductName>FERMERGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011705</DrugIDPK>
    <LicenceNumber>PA0073/060/003</LicenceNumber>
    <ProductName>ANTIMET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1983-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010072</DrugIDPK>
    <LicenceNumber>PA0019/007/003</LicenceNumber>
    <ProductName>TERRACORTRIL  (SPRAY)</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-02-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011822</DrugIDPK>
    <LicenceNumber>PA0082/011/001</LicenceNumber>
    <ProductName>LIMBRON</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010520</DrugIDPK>
    <LicenceNumber>PA0024/002/005</LicenceNumber>
    <ProductName>FENTAZIN</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011870</DrugIDPK>
    <LicenceNumber>PA0077/061/001</LicenceNumber>
    <ProductName>INOCOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013131</DrugIDPK>
    <LicenceNumber>PA0126/043/001</LicenceNumber>
    <ProductName>FLURAZEPAM</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013134</DrugIDPK>
    <LicenceNumber>PA0126/043/002</LicenceNumber>
    <ProductName>FLURAZEPAM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015153</DrugIDPK>
    <LicenceNumber>PA0290/054/001</LicenceNumber>
    <ProductName>OPULETS AMETHOCAINE EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015154</DrugIDPK>
    <LicenceNumber>PA0290/055/001</LicenceNumber>
    <ProductName>OPULETS PHYSOSTIGMINE EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHYSOSTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001450</DrugIDPK>
    <LicenceNumber>PA0037/019/003</LicenceNumber>
    <ProductName>PNU-IMUNE MULTIPLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1981-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001448</DrugIDPK>
    <LicenceNumber>PA0037/019/002</LicenceNumber>
    <ProductName>PNU-IMUNE SINGLE DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1981-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993001447</DrugIDPK>
    <LicenceNumber>PA0037/019/001</LicenceNumber>
    <ProductName>PNU-IMUNE SINGLE DOSE SYRINGES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1981-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010410</DrugIDPK>
    <LicenceNumber>PA0035/059/001</LicenceNumber>
    <ProductName>OSMOSIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1983-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011189</DrugIDPK>
    <LicenceNumber>PA0049/030/003</LicenceNumber>
    <ProductName>ANXON</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011187</DrugIDPK>
    <LicenceNumber>PA0049/030/002</LicenceNumber>
    <ProductName>ANXON</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011902</DrugIDPK>
    <LicenceNumber>PA0082/044/001</LicenceNumber>
    <ProductName>ERYCEN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012563</DrugIDPK>
    <LicenceNumber>PA0102/002/001</LicenceNumber>
    <ProductName>TAMPOVAGAN N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1984-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011323</DrugIDPK>
    <LicenceNumber>PA0051/038/001</LicenceNumber>
    <ProductName>TETMOSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soap</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFIRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013593</DrugIDPK>
    <LicenceNumber>PA0185/006/001</LicenceNumber>
    <ProductName>POLYALK (SUSPENSION)</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>1977-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-12-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011295</DrugIDPK>
    <LicenceNumber>PA0054/028/001</LicenceNumber>
    <ProductName>PERDIASTAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>BORNYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011297</DrugIDPK>
    <LicenceNumber>PA0054/028/002</LicenceNumber>
    <ProductName>PERDIASTAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENOXAMINE</ActiveSubstance>
      <ActiveSubstance>BENZYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>BORNYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010946</DrugIDPK>
    <LicenceNumber>PA0047/060/001</LicenceNumber>
    <ProductName>COLOGEL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METHYLCELLULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-12-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013560</DrugIDPK>
    <LicenceNumber>PA0275/004/001</LicenceNumber>
    <ProductName>PHARMACIN</ProductName>
    <Strength>325</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013234</DrugIDPK>
    <LicenceNumber>PA0159/004/001</LicenceNumber>
    <ProductName>SINE-OFF</ProductName>
    <Strength>.15/.18/4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011763</DrugIDPK>
    <LicenceNumber>PA0079/008/001</LicenceNumber>
    <ProductName>ALKA-SELTZER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013087</DrugIDPK>
    <LicenceNumber>PA0137/034/005</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003435</DrugIDPK>
    <LicenceNumber>PA0079/003/001</LicenceNumber>
    <ProductName>NYSTAFORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003436</DrugIDPK>
    <LicenceNumber>PA0079/003/002</LicenceNumber>
    <ProductName>NYSTAFORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1977-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011759</DrugIDPK>
    <LicenceNumber>PA0079/004/001</LicenceNumber>
    <ProductName>NYSTAFORM-HC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003433</DrugIDPK>
    <LicenceNumber>PA0079/002/002</LicenceNumber>
    <ProductName>NYSTATIN-DOME</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1977-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012067</DrugIDPK>
    <LicenceNumber>PA0096/010/001</LicenceNumber>
    <ProductName>OPOBYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001196</DrugIDPK>
    <LicenceNumber>PA0235/001/001</LicenceNumber>
    <ProductName>AMIPAQUE VIALS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1978-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METRIZAMIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CALCIUM EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001197</DrugIDPK>
    <LicenceNumber>PA0235/001/002</LicenceNumber>
    <ProductName>AMIPAQUE VIALS SOLVENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>1978-11-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011195</DrugIDPK>
    <LicenceNumber>PA0050/062/002</LicenceNumber>
    <ProductName>ROCEPHINE VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1983-11-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTRIAXONE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011036</DrugIDPK>
    <LicenceNumber>PA0048/031/001</LicenceNumber>
    <ProductName>TOPICAL SOLUTION CONTAINING 1.5% ERYTHROMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-10-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010688</DrugIDPK>
    <LicenceNumber>PA0039/028/001</LicenceNumber>
    <ProductName>VERACOLATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011430</DrugIDPK>
    <LicenceNumber>PA0054/011/004</LicenceNumber>
    <ProductName>ILVICO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE</ActiveSubstance>
      <ActiveSubstance>CALCIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010794</DrugIDPK>
    <LicenceNumber>PA0041/033/001</LicenceNumber>
    <ProductName>NETHAPRIN DOSPAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009616</DrugIDPK>
    <LicenceNumber>PA0002/048/001</LicenceNumber>
    <ProductName>THERAGRAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012697</DrugIDPK>
    <LicenceNumber>PA0108/006/001</LicenceNumber>
    <ProductName>DIPHTHERIA TOXOID &amp; TETANUS</ProductName>
    <Strength>1.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1977-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012699</DrugIDPK>
    <LicenceNumber>PA0108/006/002</LicenceNumber>
    <ProductName>DIPHTHERIA TOXOID &amp; TETANUS TOXOID</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>1977-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012016</DrugIDPK>
    <LicenceNumber>PA0087/004/001</LicenceNumber>
    <ProductName>HEPACORT PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>METHYLPARABEN E218</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012018</DrugIDPK>
    <LicenceNumber>PA0087/004/002</LicenceNumber>
    <ProductName>HEPACORT PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009540</DrugIDPK>
    <LicenceNumber>PA0006/005/004</LicenceNumber>
    <ProductName>RYTHMODAN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001582</DrugIDPK>
    <LicenceNumber>PA0009/026/003</LicenceNumber>
    <ProductName>ZELMID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIMELDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001580</DrugIDPK>
    <LicenceNumber>PA0009/026/002</LicenceNumber>
    <ProductName>ZELMID 100 MG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1982-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIMELDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001579</DrugIDPK>
    <LicenceNumber>PA0009/026/001</LicenceNumber>
    <ProductName>ZELMID 50 MG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1983-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIMELDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013162</DrugIDPK>
    <LicenceNumber>PA0143/008/001</LicenceNumber>
    <ProductName>AMINOPLEX 14</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013008</DrugIDPK>
    <LicenceNumber>PA0120/011/001</LicenceNumber>
    <ProductName>LAPIDAR HERBTABLETS NR. 2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010545</DrugIDPK>
    <LicenceNumber>PA0044/024/001</LicenceNumber>
    <ProductName>BETNOVATE A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
      <ActiveSubstance>CHLORTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010602</DrugIDPK>
    <LicenceNumber>PA0044/048/007</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010430</DrugIDPK>
    <LicenceNumber>PA0024/011/001</LicenceNumber>
    <ProductName>GUANIMYCIN FORTE  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROSTREPTOMYCIN</ActiveSubstance>
      <ActiveSubstance>SULFAGUANIDINE</ActiveSubstance>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011761</DrugIDPK>
    <LicenceNumber>PA0079/004/002</LicenceNumber>
    <ProductName>NYSTAFORM-HC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011762</DrugIDPK>
    <LicenceNumber>PA0079/004/003</LicenceNumber>
    <ProductName>NYSTAFORM-HC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NYSTATIN</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012465</DrugIDPK>
    <LicenceNumber>PA0339/001/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ross Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012467</DrugIDPK>
    <LicenceNumber>PA0339/001/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ross Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012468</DrugIDPK>
    <LicenceNumber>PA0339/001/003</LicenceNumber>
    <ProductName>AMPICILLIN 125 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ross Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012471</DrugIDPK>
    <LicenceNumber>PA0339/001/005</LicenceNumber>
    <ProductName>AMPICILLIN 250 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ross Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012473</DrugIDPK>
    <LicenceNumber>PA0339/001/006</LicenceNumber>
    <ProductName>AMPICILLIN 50 MG/5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ross Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012470</DrugIDPK>
    <LicenceNumber>PA0399/001/004</LicenceNumber>
    <ProductName>AMPICILLIN TRIHYDRATE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013001</DrugIDPK>
    <LicenceNumber>PA0120/010/001</LicenceNumber>
    <ProductName>LAPIDAR HERBTABLETS NR. 1</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013018</DrugIDPK>
    <LicenceNumber>PA0120/016/001</LicenceNumber>
    <ProductName>LAPIDAR HERBTABLETS NR. 16</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013009</DrugIDPK>
    <LicenceNumber>PA0120/012/001</LicenceNumber>
    <ProductName>LAPIDAR HERBTABLETS NR. 5</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013012</DrugIDPK>
    <LicenceNumber>PA0120/013/001</LicenceNumber>
    <ProductName>LAPIDAR HERBTABLETS NR. 6</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013016</DrugIDPK>
    <LicenceNumber>PA0120/015/001</LicenceNumber>
    <ProductName>LAPIDAR HERBTABLETS NR. 8</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013014</DrugIDPK>
    <LicenceNumber>PA0120/014/001</LicenceNumber>
    <ProductName>LAPIDAR HERBTABLETS NR.7</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013625</DrugIDPK>
    <LicenceNumber>PA0172/002/001</LicenceNumber>
    <ProductName>CODANIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1977-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010285</DrugIDPK>
    <LicenceNumber>PA0032/021/001</LicenceNumber>
    <ProductName>GLIPTIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULGLICOTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013898</DrugIDPK>
    <LicenceNumber>PA0277/043/001</LicenceNumber>
    <ProductName>DRIXORAL SUSTAINED ACTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXBROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009669</DrugIDPK>
    <LicenceNumber>PA0007/017/001</LicenceNumber>
    <ProductName>LENDORMIN</ProductName>
    <Strength>0.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROTIZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009670</DrugIDPK>
    <LicenceNumber>PA0007/017/002</LicenceNumber>
    <ProductName>LENDORMIN</ProductName>
    <Strength>0.250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROTIZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012269</DrugIDPK>
    <LicenceNumber>PA0301/054/004</LicenceNumber>
    <ProductName>AMOXICILLIN (SUSPENSION)</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013688</DrugIDPK>
    <LicenceNumber>PA0206/002/001</LicenceNumber>
    <ProductName>KANACILLIN FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROCAINE PENICILLIN G</ActiveSubstance>
      <ActiveSubstance>KANAMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010196</DrugIDPK>
    <LicenceNumber>PA0028/043/001</LicenceNumber>
    <ProductName>HALOSPOR</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOTIAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010198</DrugIDPK>
    <LicenceNumber>PA0028/043/002</LicenceNumber>
    <ProductName>HALOSPOR</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOTIAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010199</DrugIDPK>
    <LicenceNumber>PA0028/043/003</LicenceNumber>
    <ProductName>HALOSPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOTIAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010201</DrugIDPK>
    <LicenceNumber>PA0028/043/004</LicenceNumber>
    <ProductName>HALOSPOR</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOTIAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010202</DrugIDPK>
    <LicenceNumber>PA0028/043/005</LicenceNumber>
    <ProductName>HALOSPOR</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTIAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013690</DrugIDPK>
    <LicenceNumber>PA0206/003/002</LicenceNumber>
    <ProductName>KANAMYCIN CP</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010445</DrugIDPK>
    <LicenceNumber>PA0027/016/001</LicenceNumber>
    <ProductName>LLOYDS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIETHYLAMINE SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012054</DrugIDPK>
    <LicenceNumber>PA0091/001/001</LicenceNumber>
    <ProductName>OWBRIDGES COLD CONTROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chefaro Proprietaries Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012086</DrugIDPK>
    <LicenceNumber>PA0365/003/001</LicenceNumber>
    <ProductName>CALCIUM HEPARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012087</DrugIDPK>
    <LicenceNumber>PA0365/004/001</LicenceNumber>
    <ProductName>SODIUM HEPARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012088</DrugIDPK>
    <LicenceNumber>PA0365/004/002</LicenceNumber>
    <ProductName>SODIUM HEPARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015751</DrugIDPK>
    <LicenceNumber>PA0241/001/001</LicenceNumber>
    <ProductName>CLONMEL B-ALERT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hausmann Laboratories Inc.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013034</DrugIDPK>
    <LicenceNumber>PA0137/014/001</LicenceNumber>
    <ProductName>ENTERO-SEDIV</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009970</DrugIDPK>
    <LicenceNumber>PA0016/008/001</LicenceNumber>
    <ProductName>KAOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010820</DrugIDPK>
    <LicenceNumber>PA0044/007/006</LicenceNumber>
    <ProductName>ADMUNE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010821</DrugIDPK>
    <LicenceNumber>PA0044/007/007</LicenceNumber>
    <ProductName>ADMUNE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010822</DrugIDPK>
    <LicenceNumber>PA0044/007/008</LicenceNumber>
    <ProductName>ADMUNE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010791</DrugIDPK>
    <LicenceNumber>PA0041/025/001</LicenceNumber>
    <ProductName>INFACOL</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012476</DrugIDPK>
    <LicenceNumber>PA0342/001/002</LicenceNumber>
    <ProductName>ROTERSEPT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Crookes Healthcare B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011495</DrugIDPK>
    <LicenceNumber>PA0057/036/001</LicenceNumber>
    <ProductName>INTRALGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLAMIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011548</DrugIDPK>
    <LicenceNumber>PA0059/014/001</LicenceNumber>
    <ProductName>ZOMAC SODIUM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOMEPIRAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011549</DrugIDPK>
    <LicenceNumber>PA0059/014/002</LicenceNumber>
    <ProductName>ZOMAC SODIUM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOMEPIRAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011138</DrugIDPK>
    <LicenceNumber>PA0049/008/001</LicenceNumber>
    <ProductName>CELBENIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009994</DrugIDPK>
    <LicenceNumber>PA0018/010/004</LicenceNumber>
    <ProductName>FRAMYGEN STERILE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009724</DrugIDPK>
    <LicenceNumber>PA0016/014/002</LicenceNumber>
    <ProductName>PAMINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011316</DrugIDPK>
    <LicenceNumber>PA0051/029/002</LicenceNumber>
    <ProductName>INDERECTIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012818</DrugIDPK>
    <LicenceNumber>PA0114/043/006</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012819</DrugIDPK>
    <LicenceNumber>PA0114/043/007</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012820</DrugIDPK>
    <LicenceNumber>PA0114/043/008</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012814</DrugIDPK>
    <LicenceNumber>PA0114/043/002</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012815</DrugIDPK>
    <LicenceNumber>PA0114/043/003</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012816</DrugIDPK>
    <LicenceNumber>PA0114/043/004</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012887</DrugIDPK>
    <LicenceNumber>PA0114/043/047</LicenceNumber>
    <ProductName>SALBUVENT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012813</DrugIDPK>
    <LicenceNumber>PA0114/043/001</LicenceNumber>
    <ProductName>SALBUVENT AEROSOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012817</DrugIDPK>
    <LicenceNumber>PA0114/043/005</LicenceNumber>
    <ProductName>SALBUVENT RESPIRATOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010258</DrugIDPK>
    <LicenceNumber>PA0031/003/003</LicenceNumber>
    <ProductName>MYOTONINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenwood Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETHANECHOL CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010255</DrugIDPK>
    <LicenceNumber>PA0031/003/002</LicenceNumber>
    <ProductName>MYOTONINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenwood Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETHANECHOL CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009501</DrugIDPK>
    <LicenceNumber>PA0004/047/002</LicenceNumber>
    <ProductName>NITRO DUR 20 CM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010247</DrugIDPK>
    <LicenceNumber>PA0031/001/002</LicenceNumber>
    <ProductName>POTABA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenwood Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM AMINOBENZOATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010246</DrugIDPK>
    <LicenceNumber>PA0031/001/001</LicenceNumber>
    <ProductName>POTABA ENVULES</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glenwood Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM AMINOBENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010377</DrugIDPK>
    <LicenceNumber>PA0035/032/001</LicenceNumber>
    <ProductName>ADJU-FLUAX VACCINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INFLUENSA VIRUS VACCIN BIVALENT TYP A OCH B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010783</DrugIDPK>
    <LicenceNumber>PA0041/017/001</LicenceNumber>
    <ProductName>DEBENDOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>1983-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010566</DrugIDPK>
    <LicenceNumber>PA0037/036/001</LicenceNumber>
    <ProductName>METHOTREXATE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010412</DrugIDPK>
    <LicenceNumber>PA0035/063/001</LicenceNumber>
    <ProductName>MODURET</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010394</DrugIDPK>
    <LicenceNumber>PA0035/044/012</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-06-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011450</DrugIDPK>
    <LicenceNumber>PA0060/035/001</LicenceNumber>
    <ProductName>IMPROMIDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013591</DrugIDPK>
    <LicenceNumber>PA0184/006/001</LicenceNumber>
    <ProductName>MRS CULLENS LEMSOOTHE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cullen and Davison Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011681</DrugIDPK>
    <LicenceNumber>PA0073/030/001</LicenceNumber>
    <ProductName>CODEINE COMPOUND</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENACETIN</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012634</DrugIDPK>
    <LicenceNumber>PA0107/010/001</LicenceNumber>
    <ProductName>SPECTRALGEN POLLEN ALLERGEN EXTRACT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015720</DrugIDPK>
    <LicenceNumber>PA0301/017/001</LicenceNumber>
    <ProductName>ADRENALINE 1 IN 1000</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012202</DrugIDPK>
    <LicenceNumber>PA0301/037/001</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>250/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012203</DrugIDPK>
    <LicenceNumber>PA0301/037/002</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>500/10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012204</DrugIDPK>
    <LicenceNumber>PA0301/037/003</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>250/20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012205</DrugIDPK>
    <LicenceNumber>PA0301/037/004</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <Strength>500/20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012261</DrugIDPK>
    <LicenceNumber>PA0301/049/001</LicenceNumber>
    <ProductName>ANATETALL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015677</DrugIDPK>
    <LicenceNumber>PA0301/011/003</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015675</DrugIDPK>
    <LicenceNumber>PA0301/011/002</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>0.02</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015679</DrugIDPK>
    <LicenceNumber>PA0301/011/004</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015681</DrugIDPK>
    <LicenceNumber>PA0301/011/005</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015682</DrugIDPK>
    <LicenceNumber>PA0301/011/006</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015684</DrugIDPK>
    <LicenceNumber>PA0301/011/007</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>0.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015686</DrugIDPK>
    <LicenceNumber>PA0301/011/008</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>0.8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015691</DrugIDPK>
    <LicenceNumber>PA0301/011/010</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>1.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015688</DrugIDPK>
    <LicenceNumber>PA0301/011/009</LicenceNumber>
    <ProductName>ATROPINE SULPHATE EUR. P.</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010568</DrugIDPK>
    <LicenceNumber>PA0037/045/002</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012173</DrugIDPK>
    <LicenceNumber>PA0301/033/001</LicenceNumber>
    <ProductName>CHLORPROMAZINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012177</DrugIDPK>
    <LicenceNumber>PA0301/033/002</LicenceNumber>
    <ProductName>CHLORPROMAZINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012180</DrugIDPK>
    <LicenceNumber>PA0301/033/003</LicenceNumber>
    <ProductName>CHLORPROMAZINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012182</DrugIDPK>
    <LicenceNumber>PA0301/033/004</LicenceNumber>
    <ProductName>CHLORPROMAZINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012238</DrugIDPK>
    <LicenceNumber>PA0301/040/001</LicenceNumber>
    <ProductName>DEXSONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012265</DrugIDPK>
    <LicenceNumber>PA0301/052/001</LicenceNumber>
    <ProductName>DIF-PER-TET-ALL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012264</DrugIDPK>
    <LicenceNumber>PA0301/051/001</LicenceNumber>
    <ProductName>DIF-TET-ALL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012235</DrugIDPK>
    <LicenceNumber>PA0301/039/001</LicenceNumber>
    <ProductName>DIGOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015670</DrugIDPK>
    <LicenceNumber>PA0301/010/001</LicenceNumber>
    <ProductName>DOLAFEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010761</DrugIDPK>
    <LicenceNumber>PA0040/057/001</LicenceNumber>
    <ProductName>GASTRO CONRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015692</DrugIDPK>
    <LicenceNumber>PA0301/012/001</LicenceNumber>
    <ProductName>HOMATROPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HOMATROPINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012164</DrugIDPK>
    <LicenceNumber>PA0301/031/002</LicenceNumber>
    <ProductName>HYPADOPA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012162</DrugIDPK>
    <LicenceNumber>PA0301/031/001</LicenceNumber>
    <ProductName>HYPADOPA/METHYLDOPA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012167</DrugIDPK>
    <LicenceNumber>PA0301/031/003</LicenceNumber>
    <ProductName>HYPADOPA/METHYLDOPA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015669</DrugIDPK>
    <LicenceNumber>PA0301/009/001</LicenceNumber>
    <ProductName>INDOGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015723</DrugIDPK>
    <LicenceNumber>PA0301/018/002</LicenceNumber>
    <ProductName>ISOPRENALINE HYDROCHLORIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015721</DrugIDPK>
    <LicenceNumber>PA0301/018/001</LicenceNumber>
    <ProductName>ISOPRENALINE HYDROCHLORIDE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012224</DrugIDPK>
    <LicenceNumber>PA0301/038/006</LicenceNumber>
    <ProductName>JECTRAN/IRON DEXTRAN</ProductName>
    <Strength>1000/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012211</DrugIDPK>
    <LicenceNumber>PA0301/038/002</LicenceNumber>
    <ProductName>JECTRAN-50</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012218</DrugIDPK>
    <LicenceNumber>PA0301/038/004</LicenceNumber>
    <ProductName>JECTRAN-50</ProductName>
    <Strength>100/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012221</DrugIDPK>
    <LicenceNumber>PA0301/038/005</LicenceNumber>
    <ProductName>JECTRAN-50/IRON DEXTRAN</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012209</DrugIDPK>
    <LicenceNumber>PA0301/038/001</LicenceNumber>
    <ProductName>JECTRAN-50/IRON DEXTRAN</ProductName>
    <Strength>100/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012214</DrugIDPK>
    <LicenceNumber>PA0301/038/003</LicenceNumber>
    <ProductName>JECTRAN-50/IRON DEXTRAN</ProductName>
    <Strength>1000/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012227</DrugIDPK>
    <LicenceNumber>PA0301/038/007</LicenceNumber>
    <ProductName>JECTRAN-50/IRON DEXTRAN</ProductName>
    <Strength>100/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012231</DrugIDPK>
    <LicenceNumber>PA0301/038/008</LicenceNumber>
    <ProductName>JECTRAN-50/IRON DEXTRAN</ProductName>
    <Strength>250/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012232</DrugIDPK>
    <LicenceNumber>PA0301/038/009</LicenceNumber>
    <ProductName>JECTRAN-50/IRON DEXTRAN</ProductName>
    <Strength>1000/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012186</DrugIDPK>
    <LicenceNumber>PA0301/035/001</LicenceNumber>
    <ProductName>JINTAMYCIN/GENTAMICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012151</DrugIDPK>
    <LicenceNumber>PA0301/029/001</LicenceNumber>
    <ProductName>LINCOMYCETIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINCOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012260</DrugIDPK>
    <LicenceNumber>PA0301/048/001</LicenceNumber>
    <ProductName>MORBILVAX MEASLES VIRUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMMUNOGLOBULIN MEASLES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015725</DrugIDPK>
    <LicenceNumber>PA0301/019/001</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015726</DrugIDPK>
    <LicenceNumber>PA0301/019/002</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015728</DrugIDPK>
    <LicenceNumber>PA0301/019/003</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015729</DrugIDPK>
    <LicenceNumber>PA0301/019/004</LicenceNumber>
    <ProductName>MORPHINE SULPHATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015731</DrugIDPK>
    <LicenceNumber>PA0301/020/001</LicenceNumber>
    <ProductName>NALORPHINE 0.2 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015733</DrugIDPK>
    <LicenceNumber>PA0301/020/002</LicenceNumber>
    <ProductName>NALORPHINE 0.2 MG/ML</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015735</DrugIDPK>
    <LicenceNumber>PA0301/020/003</LicenceNumber>
    <ProductName>NALORPHINE 0.2 MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015736</DrugIDPK>
    <LicenceNumber>PA0301/020/004</LicenceNumber>
    <ProductName>NALORPHINE 5 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015739</DrugIDPK>
    <LicenceNumber>PA0301/020/005</LicenceNumber>
    <ProductName>NALORPHINE 5 MG/ML</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015741</DrugIDPK>
    <LicenceNumber>PA0301/020/006</LicenceNumber>
    <ProductName>NALORPHINE 5 MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012201</DrugIDPK>
    <LicenceNumber>PA0301/036/005</LicenceNumber>
    <ProductName>NEOCILLIN/AMPICILLIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012193</DrugIDPK>
    <LicenceNumber>PA0301/036/002</LicenceNumber>
    <ProductName>NEOCILLIN/AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012196</DrugIDPK>
    <LicenceNumber>PA0301/036/003</LicenceNumber>
    <ProductName>NEOCILLIN/AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012199</DrugIDPK>
    <LicenceNumber>PA0301/036/004</LicenceNumber>
    <ProductName>NEOCILLIN/AMPICILLIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012189</DrugIDPK>
    <LicenceNumber>PA0301/036/001</LicenceNumber>
    <ProductName>NEOCILLIN/AMPICILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012144</DrugIDPK>
    <LicenceNumber>PA0301/021/001</LicenceNumber>
    <ProductName>NIKETHAMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIKETHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012097</DrugIDPK>
    <LicenceNumber>PA0301/021/003</LicenceNumber>
    <ProductName>NIKETHAMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIKETHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012095</DrugIDPK>
    <LicenceNumber>PA0301/021/002</LicenceNumber>
    <ProductName>NIKETHAMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIKETHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012091</DrugIDPK>
    <LicenceNumber>PA0438/021/001</LicenceNumber>
    <ProductName>NIKETHAMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012170</DrugIDPK>
    <LicenceNumber>PA0301/032/001</LicenceNumber>
    <ProductName>NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012110</DrugIDPK>
    <LicenceNumber>PA0301/023/004</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012107</DrugIDPK>
    <LicenceNumber>PA0301/023/003</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>75/ml</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012103</DrugIDPK>
    <LicenceNumber>PA0301/023/002</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>50/1</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012101</DrugIDPK>
    <LicenceNumber>PA0301/023/001</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012113</DrugIDPK>
    <LicenceNumber>PA0301/023/005</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012115</DrugIDPK>
    <LicenceNumber>PA0301/023/006</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PETHIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012243</DrugIDPK>
    <LicenceNumber>PA0301/043/001</LicenceNumber>
    <ProductName>POLIORAL POLIOMYELITIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLIOMYELITIS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012118</DrugIDPK>
    <LicenceNumber>PA0301/024/001</LicenceNumber>
    <ProductName>PROPRANOLOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012120</DrugIDPK>
    <LicenceNumber>PA0301/025/001</LicenceNumber>
    <ProductName>PTZ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012121</DrugIDPK>
    <LicenceNumber>PA0301/025/002</LicenceNumber>
    <ProductName>PTZ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAZOCINE LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012244</DrugIDPK>
    <LicenceNumber>PA0301/044/001</LicenceNumber>
    <ProductName>SCALAVOTEST PPD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012099</DrugIDPK>
    <LicenceNumber>PA0301/022/001</LicenceNumber>
    <ProductName>STRONG STERILE NORADRENALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NOREPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012262</DrugIDPK>
    <LicenceNumber>PA0301/050/001</LicenceNumber>
    <ProductName>TETANUS ANTITOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012240</DrugIDPK>
    <LicenceNumber>PA0301/042/001</LicenceNumber>
    <ProductName>TRANQUIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012259</DrugIDPK>
    <LicenceNumber>PA0301/047/002</LicenceNumber>
    <ProductName>TRIMEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012257</DrugIDPK>
    <LicenceNumber>PA0301/047/001</LicenceNumber>
    <ProductName>TRIMEX FOR INFUSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013426</DrugIDPK>
    <LicenceNumber>PA0255/030/001</LicenceNumber>
    <ProductName>DIMENHYDRINATE 50 MG/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013619</DrugIDPK>
    <LicenceNumber>PA0187/017/001</LicenceNumber>
    <ProductName>NUTRIPHOS K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013423</DrugIDPK>
    <LicenceNumber>PA0255/029/001</LicenceNumber>
    <ProductName>PHYTOMENADOINE 1 MG/0.5 ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011775</DrugIDPK>
    <LicenceNumber>PA0077/014/001</LicenceNumber>
    <ProductName>SEOMINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>THEOBROMINE</ActiveSubstance>
      <ActiveSubstance>RESERPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011811</DrugIDPK>
    <LicenceNumber>PA0077/022/001</LicenceNumber>
    <ProductName>THEOMINAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>THEOBROMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010037</DrugIDPK>
    <LicenceNumber>PA0019/027/002</LicenceNumber>
    <ProductName>MINIZIDE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAZOSIN</ActiveSubstance>
      <ActiveSubstance>POLYTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013373</DrugIDPK>
    <LicenceNumber>PA0255/012/001</LicenceNumber>
    <ProductName>METHARAMINOL INJECTION 1%</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011853</DrugIDPK>
    <LicenceNumber>PA0077/037/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011850</DrugIDPK>
    <LicenceNumber>PA0077/037/001</LicenceNumber>
    <ProductName>AMPICILLIN MIXTURE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015214</DrugIDPK>
    <LicenceNumber>PA0211/013/001</LicenceNumber>
    <ProductName>ASPIRIN PHENACETIN AND CODEINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011856</DrugIDPK>
    <LicenceNumber>PA0077/038/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015194</DrugIDPK>
    <LicenceNumber>PA0211/007/002</LicenceNumber>
    <ProductName>IMIPRAMINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015193</DrugIDPK>
    <LicenceNumber>PA0211/007/001</LicenceNumber>
    <ProductName>IMIPRAMINE HYDROCHLORIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012030</DrugIDPK>
    <LicenceNumber>PA0087/009/001</LicenceNumber>
    <ProductName>MICRO-K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015213</DrugIDPK>
    <LicenceNumber>PA0211/012/004</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015185</DrugIDPK>
    <LicenceNumber>PA0211/003/001</LicenceNumber>
    <ProductName>SULPHAMETHIZOLE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012768</DrugIDPK>
    <LicenceNumber>PA0109/009/001</LicenceNumber>
    <ProductName>DERMACAINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINCHOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012765</DrugIDPK>
    <LicenceNumber>PA0109/008/001</LicenceNumber>
    <ProductName>KETHAMED</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PEMOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013132</DrugIDPK>
    <LicenceNumber>PA0141/011/002</LicenceNumber>
    <ProductName>SOPALAMIN-3B</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013130</DrugIDPK>
    <LicenceNumber>PA0141/011/001</LicenceNumber>
    <ProductName>SOPALAMIN-3B DRAGEES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013161</DrugIDPK>
    <LicenceNumber>PA0143/007/001</LicenceNumber>
    <ProductName>TAUROFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TAUROLIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011869</DrugIDPK>
    <LicenceNumber>PA0077/060/001</LicenceNumber>
    <ProductName>FRANOLYN EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010413</DrugIDPK>
    <LicenceNumber>PA0035/064/001</LicenceNumber>
    <ProductName>ALDORETIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010414</DrugIDPK>
    <LicenceNumber>PA0035/064/002</LicenceNumber>
    <ProductName>ALDORETIC FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
      <ActiveSubstance>AMILORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015216</DrugIDPK>
    <LicenceNumber>PA0183/003/001</LicenceNumber>
    <ProductName>MIXTURE KAOLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014990</DrugIDPK>
    <LicenceNumber>PA0183/002/001</LicenceNumber>
    <ProductName>MORPHINE B.P.C.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010213</DrugIDPK>
    <LicenceNumber>PA0028/051/001</LicenceNumber>
    <ProductName>ANDURSIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1984-05-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ANTIFOAM M</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013103</DrugIDPK>
    <LicenceNumber>PA0137/048/002</LicenceNumber>
    <ProductName>NEVIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMOXOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015166</DrugIDPK>
    <LicenceNumber>PA0294/002/002</LicenceNumber>
    <ProductName>PRAXILENE AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NAFTIDROFURYL OXALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010363</DrugIDPK>
    <LicenceNumber>PA0035/014/001</LicenceNumber>
    <ProductName>DOLOBID</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUNISAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010364</DrugIDPK>
    <LicenceNumber>PA0035/014/003</LicenceNumber>
    <ProductName>DOLOBID</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIFLUNISAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012999</DrugIDPK>
    <LicenceNumber>PA0120/006/001</LicenceNumber>
    <ProductName>SALIMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Jozeau (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011861</DrugIDPK>
    <LicenceNumber>PA0077/047/001</LicenceNumber>
    <ProductName>OXYTETRACYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013542</DrugIDPK>
    <LicenceNumber>PA0266/003/001</LicenceNumber>
    <ProductName>E P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gillespie &amp; Company Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009888</DrugIDPK>
    <LicenceNumber>PA0012/037/001</LicenceNumber>
    <ProductName>ENDOGRAFIN AMPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013230</DrugIDPK>
    <LicenceNumber>PA0157/015/001</LicenceNumber>
    <ProductName>PROPAX S.R.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Controlled Medications Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015660</DrugIDPK>
    <LicenceNumber>PA0233/007/001</LicenceNumber>
    <ProductName>EUPNINE VERNADE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015662</DrugIDPK>
    <LicenceNumber>PA0233/009/001</LicenceNumber>
    <ProductName>MYCOLACTINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015653</DrugIDPK>
    <LicenceNumber>PA0233/003/001</LicenceNumber>
    <ProductName>NATIROSE DRAGEES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
      <ActiveSubstance>ETHYLMORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015652</DrugIDPK>
    <LicenceNumber>PA0233/002/002</LicenceNumber>
    <ProductName>OUABAINE ARNAUD</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015651</DrugIDPK>
    <LicenceNumber>PA0233/002/001</LicenceNumber>
    <ProductName>OUABAINE ARNAUD AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015655</DrugIDPK>
    <LicenceNumber>PA0233/005/001</LicenceNumber>
    <ProductName>QUINICARDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINIDINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011931</DrugIDPK>
    <LicenceNumber>PA0078/003/002</LicenceNumber>
    <ProductName>TETRACHEL SYRUP</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010215</DrugIDPK>
    <LicenceNumber>PA0028/052/001</LicenceNumber>
    <ProductName>LIBROFEM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013882</DrugIDPK>
    <LicenceNumber>PA0277/033/001</LicenceNumber>
    <ProductName>ZYDERM COLLAGEN IMPLANT</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011900</DrugIDPK>
    <LicenceNumber>PA0082/040/001</LicenceNumber>
    <ProductName>METRONIDAZOLE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012826</DrugIDPK>
    <LicenceNumber>PA0115/004/003</LicenceNumber>
    <ProductName>BLEOMYCIN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BLEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010354</DrugIDPK>
    <LicenceNumber>PA0035/005/001</LicenceNumber>
    <ProductName>CREMOSTREP  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUCCINYLSULFATHIAZOLE</ActiveSubstance>
      <ActiveSubstance>STREPTOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004566</DrugIDPK>
    <LicenceNumber>PA0179/002/009</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010159</DrugIDPK>
    <LicenceNumber>PA0017/013/003</LicenceNumber>
    <ProductName>ACTIFED COMPOUND LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013698</DrugIDPK>
    <LicenceNumber>PA0206/010/001</LicenceNumber>
    <ProductName>KINEBIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013607</DrugIDPK>
    <LicenceNumber>PA0187/007/002</LicenceNumber>
    <ProductName>CEPTIPRIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011627</DrugIDPK>
    <LicenceNumber>PA0065/012/001</LicenceNumber>
    <ProductName>DINDEVAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011629</DrugIDPK>
    <LicenceNumber>PA0065/012/003</LicenceNumber>
    <ProductName>DINDEVAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011626</DrugIDPK>
    <LicenceNumber>PA0065/009/001</LicenceNumber>
    <ProductName>MEVILIN-L</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010287</DrugIDPK>
    <LicenceNumber>PA0022/011/001</LicenceNumber>
    <ProductName>SULPHAMAGNA  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>STREPTOMYCIN</ActiveSubstance>
      <ActiveSubstance>SULFADIAZINE</ActiveSubstance>
      <ActiveSubstance>PHTHALYLSULFATHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012031</DrugIDPK>
    <LicenceNumber>PA0087/011/001</LicenceNumber>
    <ProductName>ARGOTONE NASAL DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
      <ActiveSubstance>MILD SILVER PROTEIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012032</DrugIDPK>
    <LicenceNumber>PA0087/011/002</LicenceNumber>
    <ProductName>ARGOTONE SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
      <ActiveSubstance>MILD SILVER PROTEIN</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010411</DrugIDPK>
    <LicenceNumber>PA0035/061/001</LicenceNumber>
    <ProductName>B-G-PHOS ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROPHOSPHATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010361</DrugIDPK>
    <LicenceNumber>PA0035/011/002</LicenceNumber>
    <ProductName>CUPRIMINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010398</DrugIDPK>
    <LicenceNumber>PA0035/052/001</LicenceNumber>
    <ProductName>INVERSINE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010399</DrugIDPK>
    <LicenceNumber>PA0035/052/002</LicenceNumber>
    <ProductName>INVERSINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010511</DrugIDPK>
    <LicenceNumber>PA0023/032/002</LicenceNumber>
    <ProductName>PROCAINE PENICILLIN  (SUSPENSION)</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Megacurie</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001577</DrugIDPK>
    <LicenceNumber>PA0023/032/001</LicenceNumber>
    <ProductName>PROCAINE PENICILLIN - 3 MEGA SUSP.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Irl Ltd.</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009929</DrugIDPK>
    <LicenceNumber>PA0013/007/001</LicenceNumber>
    <ProductName>BELLERGAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010647</DrugIDPK>
    <LicenceNumber>PA0039/009/001</LicenceNumber>
    <ProductName>DEPRONAL S.A.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009951</DrugIDPK>
    <LicenceNumber>PA0013/022/001</LicenceNumber>
    <ProductName>MESONTOIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPHENYTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010267</DrugIDPK>
    <LicenceNumber>PA0032/009/001</LicenceNumber>
    <ProductName>CLARADIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009628</DrugIDPK>
    <LicenceNumber>PA0004/003/002</LicenceNumber>
    <ProductName>BRUFEN  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1978-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011301</DrugIDPK>
    <LicenceNumber>PA0051/016/001</LicenceNumber>
    <ProductName>SYNALAR FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011308</DrugIDPK>
    <LicenceNumber>PA0051/017/005</LicenceNumber>
    <ProductName>SYNALAR N</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011311</DrugIDPK>
    <LicenceNumber>PA0051/019/001</LicenceNumber>
    <ProductName>SYNANDON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011312</DrugIDPK>
    <LicenceNumber>PA0051/019/002</LicenceNumber>
    <ProductName>SYNANDONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009756</DrugIDPK>
    <LicenceNumber>PA0010/009/001</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009757</DrugIDPK>
    <LicenceNumber>PA0010/009/002</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009938</DrugIDPK>
    <LicenceNumber>PA0013/011/001</LicenceNumber>
    <ProductName>BRINALDIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013559</DrugIDPK>
    <LicenceNumber>PA0275/003/001</LicenceNumber>
    <ProductName>FAMEL LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010370</DrugIDPK>
    <LicenceNumber>PA0035/018/001</LicenceNumber>
    <ProductName>CODELCORTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010366</DrugIDPK>
    <LicenceNumber>PA0035/016/002</LicenceNumber>
    <ProductName>DECADRON</ProductName>
    <Strength>0.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010372</DrugIDPK>
    <LicenceNumber>PA0035/020/001</LicenceNumber>
    <ProductName>DELTACORTONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010382</DrugIDPK>
    <LicenceNumber>PA0035/037/002</LicenceNumber>
    <ProductName>MERUVAX (MULTIDOSE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010381</DrugIDPK>
    <LicenceNumber>PA0035/037/001</LicenceNumber>
    <ProductName>MERUVAX (SINGLE DOSE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>RUBELLA VIRUS VACCINE LIVE ATTENUATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012484</DrugIDPK>
    <LicenceNumber>PA0353/001/001</LicenceNumber>
    <ProductName>NERFACTOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Beaufour Schwabe</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISAXONINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001672</DrugIDPK>
    <LicenceNumber>PA0009/023/001</LicenceNumber>
    <ProductName>THEO-DUR</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001673</DrugIDPK>
    <LicenceNumber>PA0009/023/002</LicenceNumber>
    <ProductName>THEO-DUR</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011420</DrugIDPK>
    <LicenceNumber>PA0054/010/004</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1979-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011413</DrugIDPK>
    <LicenceNumber>PA0054/010/002</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011423</DrugIDPK>
    <LicenceNumber>PA0054/010/005</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011417</DrugIDPK>
    <LicenceNumber>PA0054/010/003</LicenceNumber>
    <ProductName>DECODERM LOTION</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009854</DrugIDPK>
    <LicenceNumber>PA0012/006/001</LicenceNumber>
    <ProductName>DEXA-SCHEROSON AMPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009862</DrugIDPK>
    <LicenceNumber>PA0012/014/001</LicenceNumber>
    <ProductName>MINOVLAR ED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009864</DrugIDPK>
    <LicenceNumber>PA0012/016/001</LicenceNumber>
    <ProductName>NEOGYNON ED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013630</DrugIDPK>
    <LicenceNumber>PA0172/004/001</LicenceNumber>
    <ProductName>ANADIN ANALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013640</DrugIDPK>
    <LicenceNumber>PA0172/005/001</LicenceNumber>
    <ProductName>DRISTAN DECONGESTANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>PHENINDAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013642</DrugIDPK>
    <LicenceNumber>PA0172/006/001</LicenceNumber>
    <ProductName>POWERIN ANALGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>SALICYLAMIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012441</DrugIDPK>
    <LicenceNumber>PA0332/001/001</LicenceNumber>
    <ProductName>DAPTA</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wyeth (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012417</DrugIDPK>
    <LicenceNumber>PA0322/001/001</LicenceNumber>
    <ProductName>DAPTA 12 ORAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wyeth (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014438</DrugIDPK>
    <LicenceNumber>PA0305/005/001</LicenceNumber>
    <ProductName>MEADOW CROFT EXECUTIVE B COMPLEX PLUS VITAMIN C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Kelkin Naturproducts Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014439</DrugIDPK>
    <LicenceNumber>PA0305/006/001</LicenceNumber>
    <ProductName>MEADOW CROFT EXECUTIVE B COMPLEX PLUS VITAMIN E</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Kelkin Naturproducts Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014437</DrugIDPK>
    <LicenceNumber>PA0305/007/001</LicenceNumber>
    <ProductName>MEADOW CROFT EXECUTIVE B PLUS GINSENG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Kelkin Naturproducts Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011899</DrugIDPK>
    <LicenceNumber>PA0082/038/001</LicenceNumber>
    <ProductName>DIARITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010776</DrugIDPK>
    <LicenceNumber>PA0041/004/002</LicenceNumber>
    <ProductName>MERASYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013488</DrugIDPK>
    <LicenceNumber>PA0258/018/001</LicenceNumber>
    <ProductName>ACNAID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013491</DrugIDPK>
    <LicenceNumber>PA0258/018/002</LicenceNumber>
    <ProductName>ACNAID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010752</DrugIDPK>
    <LicenceNumber>PA0040/045/001</LicenceNumber>
    <ProductName>AGIOLAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010628</DrugIDPK>
    <LicenceNumber>PA0038/017/001</LicenceNumber>
    <ProductName>ABBOKINASE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012444</DrugIDPK>
    <LicenceNumber>PA0337/003/001</LicenceNumber>
    <ProductName>HEPATIC PHARMATON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010005</DrugIDPK>
    <LicenceNumber>PA0018/020/002</LicenceNumber>
    <ProductName>DEXTRAVEN 110 IN DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010004</DrugIDPK>
    <LicenceNumber>PA0018/020/001</LicenceNumber>
    <ProductName>DEXTRAVEN 110 IN SALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010008</DrugIDPK>
    <LicenceNumber>PA0018/021/002</LicenceNumber>
    <ProductName>DEXTRAVEN 150 IN DEXTROSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010006</DrugIDPK>
    <LicenceNumber>PA0018/021/001</LicenceNumber>
    <ProductName>DEXTRAVEN 150 IN SALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTRAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013799</DrugIDPK>
    <LicenceNumber>PA0281/014/001</LicenceNumber>
    <ProductName>GRIPPON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012795</DrugIDPK>
    <LicenceNumber>PA0114/024/001</LicenceNumber>
    <ProductName>PEPTICHEMIO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013172</DrugIDPK>
    <LicenceNumber>PA0144/006/001</LicenceNumber>
    <ProductName>SASTID BAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011893</DrugIDPK>
    <LicenceNumber>PA0082/034/001</LicenceNumber>
    <ProductName>TRIMOPAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013377</DrugIDPK>
    <LicenceNumber>PA0255/020/002</LicenceNumber>
    <ProductName>HEPARIN INJECTION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013378</DrugIDPK>
    <LicenceNumber>PA0255/020/003</LicenceNumber>
    <ProductName>HEPARIN INJECTION</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013376</DrugIDPK>
    <LicenceNumber>PA0255/020/001</LicenceNumber>
    <ProductName>HEPARIN INJECTION 10 IU</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013379</DrugIDPK>
    <LicenceNumber>PA0255/020/004</LicenceNumber>
    <ProductName>HEPARIN INJECTION 500 IU/ML</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009559</DrugIDPK>
    <LicenceNumber>PA0002/021/007</LicenceNumber>
    <ProductName>KENACORT A.I.V.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE DIPOTASSIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1983-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016065</DrugIDPK>
    <LicenceNumber>PA0230/001/001</LicenceNumber>
    <ProductName>LYCAMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016066</DrugIDPK>
    <LicenceNumber>PA0230/001/002</LicenceNumber>
    <ProductName>LYCAMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ferring A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016067</DrugIDPK>
    <LicenceNumber>PA0230/001/003</LicenceNumber>
    <ProductName>LYCAMED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>UCB S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015618</DrugIDPK>
    <LicenceNumber>PA0298/001/003</LicenceNumber>
    <ProductName>ATCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015619</DrugIDPK>
    <LicenceNumber>PA0298/001/004</LicenceNumber>
    <ProductName>ATCIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011867</DrugIDPK>
    <LicenceNumber>PA0077/059/001</LicenceNumber>
    <ProductName>CIPROL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011868</DrugIDPK>
    <LicenceNumber>PA0077/059/002</LicenceNumber>
    <ProductName>CIPROL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012358</DrugIDPK>
    <LicenceNumber>PA0305/001/001</LicenceNumber>
    <ProductName>GONNE PAIN RELIEVING BALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Kelkin Naturproducts Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>MELALEUCA LEUCADENDRON</ActiveSubstance>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
      <ActiveSubstance>MUSTARD OIL</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009775</DrugIDPK>
    <LicenceNumber>PA0017/018/002</LicenceNumber>
    <ProductName>LETHIDRONE (NEONATAL) INJ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009773</DrugIDPK>
    <LicenceNumber>PA0017/018/001</LicenceNumber>
    <ProductName>LETHIDRONE INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NALORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013620</DrugIDPK>
    <LicenceNumber>PA0170/012/001</LicenceNumber>
    <ProductName>RENSAR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SARALASIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013228</DrugIDPK>
    <LicenceNumber>PA0156/002/001</LicenceNumber>
    <ProductName>SURE SHIELD DYSPEPSIA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rumon (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PEPSIN</ActiveSubstance>
      <ActiveSubstance>HEAVY MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
      <ActiveSubstance>ETHER, SOLVENT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010839</DrugIDPK>
    <LicenceNumber>PA0045/024/003</LicenceNumber>
    <ProductName>HYPNOMIDATE PRO-INFUSION</ProductName>
    <Strength>125/ml</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011547</DrugIDPK>
    <LicenceNumber>PA0059/013/001</LicenceNumber>
    <ProductName>SPOROSTACIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLODANTOIN</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009465</DrugIDPK>
    <LicenceNumber>PA0001/009/001</LicenceNumber>
    <ProductName>PRO-BANTHINE WITH PHENOBARBITONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPANTHELINE BROMIDE</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011279</DrugIDPK>
    <LicenceNumber>PA0054/026/004</LicenceNumber>
    <ProductName>ALORBAT-S</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011281</DrugIDPK>
    <LicenceNumber>PA0054/026/006</LicenceNumber>
    <ProductName>ALORBAT-S</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011282</DrugIDPK>
    <LicenceNumber>PA0054/026/007</LicenceNumber>
    <ProductName>ALORBAT-S</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011280</DrugIDPK>
    <LicenceNumber>PA0054/026/005</LicenceNumber>
    <ProductName>ALORBAT-S - DISPOSABLE SYRINGE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010814</DrugIDPK>
    <LicenceNumber>PA0044/004/001</LicenceNumber>
    <ProductName>CEPORACIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALOTIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012609</DrugIDPK>
    <LicenceNumber>PA0103/002/001</LicenceNumber>
    <ProductName>EX LAW CHOCOLATE LAXATIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ex-Lax Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012607</DrugIDPK>
    <LicenceNumber>PA0103/001/001</LicenceNumber>
    <ProductName>EX LAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ex-Lax Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012613</DrugIDPK>
    <LicenceNumber>PA0103/003/001</LicenceNumber>
    <ProductName>EX-LAX JUNIOR LAXATIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ex-Lax Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010691</DrugIDPK>
    <LicenceNumber>PA0039/031/001</LicenceNumber>
    <ProductName>MIPRALINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012364</DrugIDPK>
    <LicenceNumber>PA0305/003/001</LicenceNumber>
    <ProductName>LUSTYS PASSIFLORA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Kelkin Naturproducts Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013036</DrugIDPK>
    <LicenceNumber>PA0137/014/002</LicenceNumber>
    <ProductName>ENTERO-SEDIV</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013042</DrugIDPK>
    <LicenceNumber>PA0137/016/001</LicenceNumber>
    <ProductName>PREVECILLIN PLUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013043</DrugIDPK>
    <LicenceNumber>PA0137/017/001</LicenceNumber>
    <ProductName>PREVETHENAT INFANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013044</DrugIDPK>
    <LicenceNumber>PA0137/017/002</LicenceNumber>
    <ProductName>PREVETHENAT NORMAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013045</DrugIDPK>
    <LicenceNumber>PA0137/017/003</LicenceNumber>
    <ProductName>PREVETHENAT ULTRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012944</DrugIDPK>
    <LicenceNumber>PA0130/005/002</LicenceNumber>
    <ProductName>PIPTALIAN ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010622</DrugIDPK>
    <LicenceNumber>PA0044/055/001</LicenceNumber>
    <ProductName>PROTAMINE ZINC INSULIN B P</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013608</DrugIDPK>
    <LicenceNumber>PA0187/008/002</LicenceNumber>
    <ProductName>AMINESS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009473</DrugIDPK>
    <LicenceNumber>PA0001/019/001</LicenceNumber>
    <ProductName>NITRADISC PADS</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009474</DrugIDPK>
    <LicenceNumber>PA0001/019/002</LicenceNumber>
    <ProductName>NITRADISC PADS</ProductName>
    <Strength>32</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-11-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009752</DrugIDPK>
    <LicenceNumber>PA0016/029/001</LicenceNumber>
    <ProductName>URACIL MUSTARD</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010186</DrugIDPK>
    <LicenceNumber>PA0028/036/001</LicenceNumber>
    <ProductName>ULTANDREN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXYMESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-10-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013116</DrugIDPK>
    <LicenceNumber>PA0141/003/001</LicenceNumber>
    <ProductName>MYCETIN OPHTIOLE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010927</DrugIDPK>
    <LicenceNumber>PA0047/051/004</LicenceNumber>
    <ProductName>OPREN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENOXAPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013118</DrugIDPK>
    <LicenceNumber>PA0141/004/001</LicenceNumber>
    <ProductName>PREDNI OPHTIOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-10-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009992</DrugIDPK>
    <LicenceNumber>PA0018/006/001</LicenceNumber>
    <ProductName>ENTERFRAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015186</DrugIDPK>
    <LicenceNumber>PA0211/004/001</LicenceNumber>
    <ProductName>PREDNISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015187</DrugIDPK>
    <LicenceNumber>PA0211/004/002</LicenceNumber>
    <ProductName>PREDNISONE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010225</DrugIDPK>
    <LicenceNumber>PA0021/015/002</LicenceNumber>
    <ProductName>CLONT</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010223</DrugIDPK>
    <LicenceNumber>PA0021/015/001</LicenceNumber>
    <ProductName>CLONT INFUSION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011890</DrugIDPK>
    <LicenceNumber>PA0082/031/002</LicenceNumber>
    <ProductName>ANTIPRESSAN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010221</DrugIDPK>
    <LicenceNumber>PA0021/013/008</LicenceNumber>
    <ProductName>WATER FOR INJECTION</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010795</DrugIDPK>
    <LicenceNumber>PA0041/035/001</LicenceNumber>
    <ProductName>DESTOLIT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>URSODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010796</DrugIDPK>
    <LicenceNumber>PA0041/035/002</LicenceNumber>
    <ProductName>DESTOLIT</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>URSODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010793</DrugIDPK>
    <LicenceNumber>PA0041/027/001</LicenceNumber>
    <ProductName>TENUATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMFEPRAMONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993004559</DrugIDPK>
    <LicenceNumber>PA0184/003/001</LicenceNumber>
    <ProductName>MRS. CULLENS SLEEP-EZEE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cullen and Davison Limited</PAHolder>
    <AuthorisedDate>1991-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012300</DrugIDPK>
    <LicenceNumber>PA0303/003/001</LicenceNumber>
    <ProductName>INSOMIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011019</DrugIDPK>
    <LicenceNumber>PA0048/021/001</LicenceNumber>
    <ProductName>BUFFERIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012483</DrugIDPK>
    <LicenceNumber>PA0357/009/002</LicenceNumber>
    <ProductName>HIPREX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Carnegie Medical (3M) Incorp.</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHENAMINE HIPPURATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010262</DrugIDPK>
    <LicenceNumber>PA0022/002/001</LicenceNumber>
    <ProductName>ALUDROX S A  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SECBUTABARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010544</DrugIDPK>
    <LicenceNumber>PA0044/021/003</LicenceNumber>
    <ProductName>BETNOVATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-09-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010928</DrugIDPK>
    <LicenceNumber>PA0047/051/005</LicenceNumber>
    <ProductName>OPREN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENOXAPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010929</DrugIDPK>
    <LicenceNumber>PA0047/051/006</LicenceNumber>
    <ProductName>OPREN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENOXAPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010077</DrugIDPK>
    <LicenceNumber>PA0019/009/004</LicenceNumber>
    <ProductName>TERRAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012266</DrugIDPK>
    <LicenceNumber>PA0301/054/001</LicenceNumber>
    <ProductName>AMOXICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012267</DrugIDPK>
    <LicenceNumber>PA0301/054/002</LicenceNumber>
    <ProductName>AMOXICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012268</DrugIDPK>
    <LicenceNumber>PA0301/054/003</LicenceNumber>
    <ProductName>AMOXICILLIN (SUSPENSION)</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011388</DrugIDPK>
    <LicenceNumber>PA0056/019/002</LicenceNumber>
    <ProductName>BENYLETS CHERRY FLAVOURED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013506</DrugIDPK>
    <LicenceNumber>PA0260/001/001</LicenceNumber>
    <ProductName>NO-NICOT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>P.D.S. (Nocofin) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010036</DrugIDPK>
    <LicenceNumber>PA0019/027/001</LicenceNumber>
    <ProductName>MINIZIDE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAZOSIN</ActiveSubstance>
      <ActiveSubstance>POLYTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011378</DrugIDPK>
    <LicenceNumber>PA0056/013/001</LicenceNumber>
    <ProductName>CARBRITAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1977-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOBARBITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013102</DrugIDPK>
    <LicenceNumber>PA0137/048/001</LicenceNumber>
    <ProductName>NEVIN SYRUP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMOXOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011592</DrugIDPK>
    <LicenceNumber>PA0062/017/001</LicenceNumber>
    <ProductName>SULBENIL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011593</DrugIDPK>
    <LicenceNumber>PA0062/017/002</LicenceNumber>
    <ProductName>SULBENIL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011594</DrugIDPK>
    <LicenceNumber>PA0062/017/003</LicenceNumber>
    <ProductName>SULBENIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009770</DrugIDPK>
    <LicenceNumber>PA0010/021/001</LicenceNumber>
    <ProductName>FLOGAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009772</DrugIDPK>
    <LicenceNumber>PA0010/021/002</LicenceNumber>
    <ProductName>FLOGAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXAMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013617</DrugIDPK>
    <LicenceNumber>PA0170/008/002</LicenceNumber>
    <ProductName>FUROXONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FURAZOLIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013615</DrugIDPK>
    <LicenceNumber>PA0170/008/001</LicenceNumber>
    <ProductName>FUROXONE (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FURAZOLIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013661</DrugIDPK>
    <LicenceNumber>PA0176/006/001</LicenceNumber>
    <ProductName>ISONIAZID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISONIAZID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010727</DrugIDPK>
    <LicenceNumber>PA0045/020/002</LicenceNumber>
    <ProductName>STUGERON</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CINNARIZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009831</DrugIDPK>
    <LicenceNumber>PA0011/033/001</LicenceNumber>
    <ProductName>METOPROLOL TARTRATE + CHLORTHALIDONE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011400</DrugIDPK>
    <LicenceNumber>PA0056/033/001</LicenceNumber>
    <ProductName>PHOLCOLIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011565</DrugIDPK>
    <LicenceNumber>PA0062/011/005</LicenceNumber>
    <ProductName>BROCADOPA TEM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011112</DrugIDPK>
    <LicenceNumber>PA0047/015/002</LicenceNumber>
    <ProductName>KEFLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALOTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009931</DrugIDPK>
    <LicenceNumber>PA0013/008/001</LicenceNumber>
    <ProductName>BELLERGAL RETARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009458</DrugIDPK>
    <LicenceNumber>PA0001/005/002</LicenceNumber>
    <ProductName>LOMOTIL WITH NEOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-07-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENOXYLATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>ATROPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009459</DrugIDPK>
    <LicenceNumber>PA0001/005/003</LicenceNumber>
    <ProductName>LOMOTIL WITH NEOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENOXYLATE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013047</DrugIDPK>
    <LicenceNumber>PA0137/020/001</LicenceNumber>
    <ProductName>CHLOROPTIC OPHTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-06-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010833</DrugIDPK>
    <LicenceNumber>PA0044/012/002</LicenceNumber>
    <ProductName>FENTAZIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012398</DrugIDPK>
    <LicenceNumber>PA0315/004/001</LicenceNumber>
    <ProductName>KERFOOT NITRAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-06-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010583</DrugIDPK>
    <LicenceNumber>PA0038/001/001</LicenceNumber>
    <ProductName>CVK 250</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-06-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009530</DrugIDPK>
    <LicenceNumber>PA0002/013/002</LicenceNumber>
    <ProductName>SUMYCIN</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015115</DrugIDPK>
    <LicenceNumber>PA0290/038/002</LicenceNumber>
    <ProductName>MYDFRIN STERILE OPTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012391</DrugIDPK>
    <LicenceNumber>PA0315/001/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012394</DrugIDPK>
    <LicenceNumber>PA0315/002/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012395</DrugIDPK>
    <LicenceNumber>PA0315/002/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012396</DrugIDPK>
    <LicenceNumber>PA0315/002/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012392</DrugIDPK>
    <LicenceNumber>PA0315/001/002</LicenceNumber>
    <ProductName>KERFOOT AMITRIPTYLINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012393</DrugIDPK>
    <LicenceNumber>PA0315/001/003</LicenceNumber>
    <ProductName>KERFOOT AMITRIPTYLINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012400</DrugIDPK>
    <LicenceNumber>PA0315/005/001</LicenceNumber>
    <ProductName>KERFOOT AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012403</DrugIDPK>
    <LicenceNumber>PA0315/005/002</LicenceNumber>
    <ProductName>KERFOOT AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012406</DrugIDPK>
    <LicenceNumber>PA0315/005/003</LicenceNumber>
    <ProductName>KERFOOT AMPICILLIN</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012409</DrugIDPK>
    <LicenceNumber>PA0315/005/004</LicenceNumber>
    <ProductName>KERFOOT AMPICILLIN</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thomas Kerfoot &amp; Co. Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013367</DrugIDPK>
    <LicenceNumber>PA0255/006/001</LicenceNumber>
    <ProductName>ATROPINE SULPHATE</ProductName>
    <Strength>0.4/0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013359</DrugIDPK>
    <LicenceNumber>PA0255/004/009</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013357</DrugIDPK>
    <LicenceNumber>PA0255/004/004</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE 1%</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013358</DrugIDPK>
    <LicenceNumber>PA0255/004/006</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE 2%</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013360</DrugIDPK>
    <LicenceNumber>PA0255/004/010</LicenceNumber>
    <ProductName>LIGNOCAINE HYDROCHLORIDE 4%</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1978-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013352</DrugIDPK>
    <LicenceNumber>PA0255/001/001</LicenceNumber>
    <ProductName>SODIUM BICARBONATE INJ 4.2%</ProductName>
    <Strength>5 m</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013353</DrugIDPK>
    <LicenceNumber>PA0255/001/003</LicenceNumber>
    <ProductName>SODIUM BICARBONATE INJ 7.5%</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013362</DrugIDPK>
    <LicenceNumber>PA0255/005/001</LicenceNumber>
    <ProductName>STRONG POTASSIUM CHLORIDE 15%</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013363</DrugIDPK>
    <LicenceNumber>PA0255/005/002</LicenceNumber>
    <ProductName>STRONG POTASSIUM CHLORIDE 15%</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>1977-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010216</DrugIDPK>
    <LicenceNumber>PA0021/012/001</LicenceNumber>
    <ProductName>BINOTAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010219</DrugIDPK>
    <LicenceNumber>PA0021/012/002</LicenceNumber>
    <ProductName>BINOTAL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010271</DrugIDPK>
    <LicenceNumber>PA0022/007/001</LicenceNumber>
    <ProductName>PENIDURAL A P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZATHINE BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>PROCAINE PENICILLIN G</ActiveSubstance>
      <ActiveSubstance>BENZYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010013</DrugIDPK>
    <LicenceNumber>PA0018/024/001</LicenceNumber>
    <ProductName>SOTINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIARAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010014</DrugIDPK>
    <LicenceNumber>PA0018/024/002</LicenceNumber>
    <ProductName>SOTINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIARAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011552</DrugIDPK>
    <LicenceNumber>PA0059/022/001</LicenceNumber>
    <ProductName>MECLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MECLOCYCLINE SULFOSALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010585</DrugIDPK>
    <LicenceNumber>PA0038/002/001</LicenceNumber>
    <ProductName>ERYTHROCIN I.M.</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011452</DrugIDPK>
    <LicenceNumber>PA0060/039/001</LicenceNumber>
    <ProductName>MICRALAX MICRO ENEMA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011453</DrugIDPK>
    <LicenceNumber>PA0060/040/001</LicenceNumber>
    <ProductName>NEURO PHOSPHATES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010476</DrugIDPK>
    <LicenceNumber>PA0028/013/001</LicenceNumber>
    <ProductName>ENTERO-VIOFORM</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011290</DrugIDPK>
    <LicenceNumber>PA0051/010/002</LicenceNumber>
    <ProductName>ICIPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011288</DrugIDPK>
    <LicenceNumber>PA0051/010/001</LicenceNumber>
    <ProductName>ICIPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000804</DrugIDPK>
    <LicenceNumber>PA0012/003/001</LicenceNumber>
    <ProductName>KIRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1976-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETOXYDIAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010865</DrugIDPK>
    <LicenceNumber>PA0046/011/001</LicenceNumber>
    <ProductName>F S S (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
      <ActiveSubstance>STREPTOMYCIN</ActiveSubstance>
      <ActiveSubstance>SULFAGUANIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010861</DrugIDPK>
    <LicenceNumber>PA0046/008/001</LicenceNumber>
    <ProductName>LEOCYCLINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010862</DrugIDPK>
    <LicenceNumber>PA0046/008/002</LicenceNumber>
    <ProductName>LEOCYCLINE 333</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010825</DrugIDPK>
    <LicenceNumber>PA0044/008/001</LicenceNumber>
    <ProductName>CEPORIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010827</DrugIDPK>
    <LicenceNumber>PA0044/008/003</LicenceNumber>
    <ProductName>CEPORIN (A-FORM)</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010536</DrugIDPK>
    <LicenceNumber>PA0044/019/002</LicenceNumber>
    <ProductName>CLINIMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010538</DrugIDPK>
    <LicenceNumber>PA0044/019/003</LicenceNumber>
    <ProductName>CLINIMYCIN SYRUP</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010836</DrugIDPK>
    <LicenceNumber>PA0044/016/001</LicenceNumber>
    <ProductName>CRYSTAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>STREPTOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010066</DrugIDPK>
    <LicenceNumber>PA0019/004/001</LicenceNumber>
    <ProductName>NAVANE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOTHIXENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010832</DrugIDPK>
    <LicenceNumber>PA0044/011/001</LicenceNumber>
    <ProductName>NEOMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010069</DrugIDPK>
    <LicenceNumber>PA0019/005/002</LicenceNumber>
    <ProductName>RONDOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010075</DrugIDPK>
    <LicenceNumber>PA0019/009/003</LicenceNumber>
    <ProductName>TERRAMYCIN INTRAVENOUS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010834</DrugIDPK>
    <LicenceNumber>PA0044/013/001</LicenceNumber>
    <ProductName>TRIPLOPEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENETHAMINE PENICILLIN</ActiveSubstance>
      <ActiveSubstance>PROCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011812</DrugIDPK>
    <LicenceNumber>PA0082/007/001</LicenceNumber>
    <ProductName>BERKMYCEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012880</DrugIDPK>
    <LicenceNumber>PA0100/003/001</LicenceNumber>
    <ProductName>CHLORAMPHENICOL OPULETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012881</DrugIDPK>
    <LicenceNumber>PA0100/003/002</LicenceNumber>
    <ProductName>CHLORAMPHENICOL OPULETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001595</DrugIDPK>
    <LicenceNumber>PA0009/021/006</LicenceNumber>
    <ProductName>CITANEST 4% TOPICAL SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012883</DrugIDPK>
    <LicenceNumber>PA0100/004/002</LicenceNumber>
    <ProductName>SULPHACETAMIDE OPULETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011107</DrugIDPK>
    <LicenceNumber>PA0047/010/001</LicenceNumber>
    <ProductName>AMESEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011118</DrugIDPK>
    <LicenceNumber>PA0047/016/001</LicenceNumber>
    <ProductName>ATASORB-N (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CAPREOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011120</DrugIDPK>
    <LicenceNumber>PA0047/018/001</LicenceNumber>
    <ProductName>CYCLOSERINE</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011121</DrugIDPK>
    <LicenceNumber>PA0047/018/002</LicenceNumber>
    <ProductName>CYCLOSERINE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011110</DrugIDPK>
    <LicenceNumber>PA0047/013/001</LicenceNumber>
    <ProductName>MONOTHEAMIN &amp; AMYTAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011122</DrugIDPK>
    <LicenceNumber>PA0047/019/001</LicenceNumber>
    <ProductName>V CIL-K SULPHA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>SULFADIMIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011126</DrugIDPK>
    <LicenceNumber>PA0047/022/001</LicenceNumber>
    <ProductName>V-CIL-K</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000225</DrugIDPK>
    <LicenceNumber>PA0004/006/001</LicenceNumber>
    <ProductName>IVAX  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>KAOLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011588</DrugIDPK>
    <LicenceNumber>PA0060/016/009</LicenceNumber>
    <ProductName>STELAZINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011589</DrugIDPK>
    <LicenceNumber>PA0060/016/010</LicenceNumber>
    <ProductName>STELAZINE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009527</DrugIDPK>
    <LicenceNumber>PA0006/003/008</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <Strength>120/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009529</DrugIDPK>
    <LicenceNumber>PA0006/003/009</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <Strength>160/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-11-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010117</DrugIDPK>
    <LicenceNumber>PA0006/005/002</LicenceNumber>
    <ProductName>RYTHMODAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010736</DrugIDPK>
    <LicenceNumber>PA0040/024/001</LicenceNumber>
    <ProductName>SONERGAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010737</DrugIDPK>
    <LicenceNumber>PA0040/028/001</LicenceNumber>
    <ProductName>THEOGARDENAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010265</DrugIDPK>
    <LicenceNumber>PA0032/004/005</LicenceNumber>
    <ProductName>GENTICIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1977-06-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009896</DrugIDPK>
    <LicenceNumber>PA0012/042/001</LicenceNumber>
    <ProductName>NOVODERM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1977-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTIN BUTYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009897</DrugIDPK>
    <LicenceNumber>PA0012/042/002</LicenceNumber>
    <ProductName>NOVODERM FATTY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1977-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCORTIN BUTYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009844</DrugIDPK>
    <LicenceNumber>PA0012/001/002</LicenceNumber>
    <ProductName>SEQUILAR</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1977-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010532</DrugIDPK>
    <LicenceNumber>PA0037/010/003</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010533</DrugIDPK>
    <LicenceNumber>PA0037/010/009</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010550</DrugIDPK>
    <LicenceNumber>PA0037/025/001</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011648</DrugIDPK>
    <LicenceNumber>PA0073/003/004</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010535</DrugIDPK>
    <LicenceNumber>PA0037/013/001</LicenceNumber>
    <ProductName>LEDERMYCIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010531</DrugIDPK>
    <LicenceNumber>PA0037/004/009</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011335</DrugIDPK>
    <LicenceNumber>PA0054/032/001</LicenceNumber>
    <ProductName>TRANQUO-ADAMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>MEPROBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011379</DrugIDPK>
    <LicenceNumber>PA0056/015/002</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011373</DrugIDPK>
    <LicenceNumber>PA0056/002/002</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009750</DrugIDPK>
    <LicenceNumber>PA0010/008/001</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-03-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN PALMITATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009751</DrugIDPK>
    <LicenceNumber>PA0010/008/002</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011582</DrugIDPK>
    <LicenceNumber>PA0060/010/001</LicenceNumber>
    <ProductName>AMYLOZINE SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011570</DrugIDPK>
    <LicenceNumber>PA0060/005/002</LicenceNumber>
    <ProductName>DEVRYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011571</DrugIDPK>
    <LicenceNumber>PA0060/005/003</LicenceNumber>
    <ProductName>DEVRYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011568</DrugIDPK>
    <LicenceNumber>PA0060/005/001</LicenceNumber>
    <ProductName>DEVRYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011583</DrugIDPK>
    <LicenceNumber>PA0060/014/002</LicenceNumber>
    <ProductName>STELABID ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011573</DrugIDPK>
    <LicenceNumber>PA0060/008/001</LicenceNumber>
    <ProductName>SULFEX NASAL DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010644</DrugIDPK>
    <LicenceNumber>PA0039/001/002</LicenceNumber>
    <ProductName>PRODOXOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-05-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010593</DrugIDPK>
    <LicenceNumber>PA0038/003/002</LicenceNumber>
    <ProductName>ERYTHROPED 200 MG/5 ML</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010601</DrugIDPK>
    <LicenceNumber>PA0038/006/001</LicenceNumber>
    <ProductName>NEMBU-DONNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010597</DrugIDPK>
    <LicenceNumber>PA0038/005/001</LicenceNumber>
    <ProductName>NEMBUTAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010616</DrugIDPK>
    <LicenceNumber>PA0038/011/001</LicenceNumber>
    <ProductName>NEMBUTAL SODIUM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010603</DrugIDPK>
    <LicenceNumber>PA0038/007/001</LicenceNumber>
    <ProductName>PENTOTHAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010605</DrugIDPK>
    <LicenceNumber>PA0038/007/002</LicenceNumber>
    <ProductName>PENTOTHAL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010607</DrugIDPK>
    <LicenceNumber>PA0038/007/003</LicenceNumber>
    <ProductName>PENTOTHAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010608</DrugIDPK>
    <LicenceNumber>PA0038/007/004</LicenceNumber>
    <ProductName>PENTOTHAL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011929</DrugIDPK>
    <LicenceNumber>PA0086/006/001</LicenceNumber>
    <ProductName>DONNATAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>HYOSCYAMINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011932</DrugIDPK>
    <LicenceNumber>PA0086/006/003</LicenceNumber>
    <ProductName>DONNATAL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>HYOSCYAMINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011930</DrugIDPK>
    <LicenceNumber>PA0086/006/002</LicenceNumber>
    <ProductName>DONNATAL LA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>HYOSCYAMINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010590</DrugIDPK>
    <LicenceNumber>PA0038/003/001</LicenceNumber>
    <ProductName>ERYTHROPED 200 MG/5 ML</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010359</DrugIDPK>
    <LicenceNumber>PA0035/010/001</LicenceNumber>
    <ProductName>TETRAZETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010308</DrugIDPK>
    <LicenceNumber>PA0033/003/001</LicenceNumber>
    <ProductName>MINICORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010310</DrugIDPK>
    <LicenceNumber>PA0033/004/001</LicenceNumber>
    <ProductName>MINICORT-C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009471</DrugIDPK>
    <LicenceNumber>PA0001/016/001</LicenceNumber>
    <ProductName>DIATENS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012595</DrugIDPK>
    <LicenceNumber>PA0441/007/001</LicenceNumber>
    <ProductName>VICKS EXPECTORANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011236</DrugIDPK>
    <LicenceNumber>PA0050/010/001</LicenceNumber>
    <ProductName>GANTANOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011235</DrugIDPK>
    <LicenceNumber>PA0050/009/003</LicenceNumber>
    <ProductName>GANTRISIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFAFURAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-02-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011695</DrugIDPK>
    <LicenceNumber>PA0073/050/001</LicenceNumber>
    <ProductName>PHENYLBUTAZONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011421</DrugIDPK>
    <LicenceNumber>PA0057/003/002</LicenceNumber>
    <ProductName>ANAPAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011422</DrugIDPK>
    <LicenceNumber>PA0057/003/003</LicenceNumber>
    <ProductName>ANAPAX ADULTS COUGH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011424</DrugIDPK>
    <LicenceNumber>PA0057/003/004</LicenceNumber>
    <ProductName>ANAPAX CHILDRENS COUGH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015752</DrugIDPK>
    <LicenceNumber>PA0241/002/005</LicenceNumber>
    <ProductName>FERRUM HAUSMANN I.V.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hausmann Laboratories Inc.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012929</DrugIDPK>
    <LicenceNumber>PA0118/004/001</LicenceNumber>
    <ProductName>INAPASADE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012931</DrugIDPK>
    <LicenceNumber>PA0118/004/002</LicenceNumber>
    <ProductName>INAPASADE PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012932</DrugIDPK>
    <LicenceNumber>PA0118/005/001</LicenceNumber>
    <ProductName>INAPASADE SQ</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Chauvin Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1982-01-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010767</DrugIDPK>
    <LicenceNumber>PA0040/069/002</LicenceNumber>
    <ProductName>SECADREX 25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009644</DrugIDPK>
    <LicenceNumber>PA0004/028/001</LicenceNumber>
    <ProductName>WATER B.P.</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009645</DrugIDPK>
    <LicenceNumber>PA0004/028/002</LicenceNumber>
    <ProductName>WATER B.P.</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-12-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013115</DrugIDPK>
    <LicenceNumber>PA0126/014/002</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010048</DrugIDPK>
    <LicenceNumber>PA0019/032/004</LicenceNumber>
    <ProductName>CEFOBID</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOPERAZONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-12-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012894</DrugIDPK>
    <LicenceNumber>PA0115/009/006</LicenceNumber>
    <ProductName>TRUXAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012895</DrugIDPK>
    <LicenceNumber>PA0115/009/007</LicenceNumber>
    <ProductName>TRUXAL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009736</DrugIDPK>
    <LicenceNumber>PA0010/004/001</LicenceNumber>
    <ProductName>ARMODIAR WITH NEOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1976-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013582</DrugIDPK>
    <LicenceNumber>PA0182/002/001</LicenceNumber>
    <ProductName>IONTOFERRON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FERROUS SULFATE</ActiveSubstance>
      <ActiveSubstance>SUCCINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010326</DrugIDPK>
    <LicenceNumber>PA0033/009/001</LicenceNumber>
    <ProductName>METILAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-11-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011651</DrugIDPK>
    <LicenceNumber>PA0073/003/010</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-11-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-11-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011059</DrugIDPK>
    <LicenceNumber>PA0049/002/002</LicenceNumber>
    <ProductName>UTICILLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CARFECILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015215</DrugIDPK>
    <LicenceNumber>PA0211/017/001</LicenceNumber>
    <ProductName>NEUROPLEX</ProductName>
    <Strength>690</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011608</DrugIDPK>
    <LicenceNumber>PA0063/003/001</LicenceNumber>
    <ProductName>BENZAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011739</DrugIDPK>
    <LicenceNumber>PA0074/006/001</LicenceNumber>
    <ProductName>ERGOTROPAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011387</DrugIDPK>
    <LicenceNumber>PA0056/019/001</LicenceNumber>
    <ProductName>BENYLETS LEMON FLAVOURED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013535</DrugIDPK>
    <LicenceNumber>PA0178/001/001</LicenceNumber>
    <ProductName>BENOCTEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013538</DrugIDPK>
    <LicenceNumber>PA0178/002/001</LicenceNumber>
    <ProductName>DEXALOCAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013540</DrugIDPK>
    <LicenceNumber>PA0178/002/002</LicenceNumber>
    <ProductName>DEXALOCAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013545</DrugIDPK>
    <LicenceNumber>PA0178/004/001</LicenceNumber>
    <ProductName>DEXALOCAL - F</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013547</DrugIDPK>
    <LicenceNumber>PA0178/004/002</LicenceNumber>
    <ProductName>DEXALOCAL - F</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013543</DrugIDPK>
    <LicenceNumber>PA0178/003/001</LicenceNumber>
    <ProductName>DEXALOCAL - J</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013544</DrugIDPK>
    <LicenceNumber>PA0178/003/002</LicenceNumber>
    <ProductName>DEXALOCAL - J</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013541</DrugIDPK>
    <LicenceNumber>PA0178/002/003</LicenceNumber>
    <ProductName>DEXALOCAL (SCALP APPLICATION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013549</DrugIDPK>
    <LicenceNumber>PA0178/005/001</LicenceNumber>
    <ProductName>VAGOMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medinova GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHTHALYLSULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009565</DrugIDPK>
    <LicenceNumber>PA0006/023/002</LicenceNumber>
    <ProductName>SURGAM</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011322</DrugIDPK>
    <LicenceNumber>PA0051/037/002</LicenceNumber>
    <ProductName>KETRAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVAMISOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-09-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011897</DrugIDPK>
    <LicenceNumber>PA0078/001/001</LicenceNumber>
    <ProductName>COMPLAMEX</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-09-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010212</DrugIDPK>
    <LicenceNumber>PA0021/009/004</LicenceNumber>
    <ProductName>BAYPEN VIAL</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEZLOCILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010210</DrugIDPK>
    <LicenceNumber>PA0021/009/003</LicenceNumber>
    <ProductName>BAYPEN VIAL</ProductName>
    <Strength>2.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEZLOCILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010206</DrugIDPK>
    <LicenceNumber>PA0021/009/001</LicenceNumber>
    <ProductName>BAYPEN VIAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEZLOCILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010207</DrugIDPK>
    <LicenceNumber>PA0021/009/002</LicenceNumber>
    <ProductName>BAYPEN VIAL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEZLOCILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010703</DrugIDPK>
    <LicenceNumber>PA0040/002/001</LicenceNumber>
    <ProductName>SONALGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1976-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-08-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011661</DrugIDPK>
    <LicenceNumber>PA0073/004/001</LicenceNumber>
    <ProductName>CULANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-10-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011901</DrugIDPK>
    <LicenceNumber>PA0078/001/002</LicenceNumber>
    <ProductName>COMPLAMEX</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011907</DrugIDPK>
    <LicenceNumber>PA0078/001/004</LicenceNumber>
    <ProductName>COMPLAMEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011909</DrugIDPK>
    <LicenceNumber>PA0078/001/005</LicenceNumber>
    <ProductName>COMPLAMEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011905</DrugIDPK>
    <LicenceNumber>PA0078/001/003</LicenceNumber>
    <ProductName>COMPLAMEX RETARD</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-08-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011055</DrugIDPK>
    <LicenceNumber>PA0047/002/001</LicenceNumber>
    <ProductName>FENOPRON</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOPROFEN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011838</DrugIDPK>
    <LicenceNumber>PA0077/034/001</LicenceNumber>
    <ProductName>MENTACOUGH DEMULCENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010327</DrugIDPK>
    <LicenceNumber>PA0033/012/001</LicenceNumber>
    <ProductName>NORINYL-2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009892</DrugIDPK>
    <LicenceNumber>PA0012/040/002</LicenceNumber>
    <ProductName>UROVISON VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012956</DrugIDPK>
    <LicenceNumber>PA0132/002/001</LicenceNumber>
    <ProductName>CARDIACAP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Consolidated Chemicals Limited</PAHolder>
    <AuthorisedDate>1984-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAERITHRITYL TETRANITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012957</DrugIDPK>
    <LicenceNumber>PA0132/003/001</LicenceNumber>
    <ProductName>CARDIACAP A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Consolidated Chemicals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012910</DrugIDPK>
    <LicenceNumber>PA0117/011/001</LicenceNumber>
    <ProductName>URINFEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009913</DrugIDPK>
    <LicenceNumber>PA0012/054/002</LicenceNumber>
    <ProductName>X-EVESS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009912</DrugIDPK>
    <LicenceNumber>PA0012/054/001</LicenceNumber>
    <ProductName>X-EVESS GRANULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009910</DrugIDPK>
    <LicenceNumber>PA0012/053/001</LicenceNumber>
    <ProductName>X-FOAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009908</DrugIDPK>
    <LicenceNumber>PA0012/052/001</LicenceNumber>
    <ProductName>X-OPAQUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009909</DrugIDPK>
    <LicenceNumber>PA0012/052/002</LicenceNumber>
    <ProductName>X-OPAQUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-07-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009945</DrugIDPK>
    <LicenceNumber>PA0013/016/001</LicenceNumber>
    <ProductName>FERMERGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-06-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013854</DrugIDPK>
    <LicenceNumber>PA0282/016/001</LicenceNumber>
    <ProductName>PHENYLBUTAZONE B P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009567</DrugIDPK>
    <LicenceNumber>PA0006/024/001</LicenceNumber>
    <ProductName>CLAFORAN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1981-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013049</DrugIDPK>
    <LicenceNumber>PA0126/004/001</LicenceNumber>
    <ProductName>CLONVITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013111</DrugIDPK>
    <LicenceNumber>PA0141/001/001</LicenceNumber>
    <ProductName>EUVERNIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACARBAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015755</DrugIDPK>
    <LicenceNumber>PA0249/001/002</LicenceNumber>
    <ProductName>SOLCOSERYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015756</DrugIDPK>
    <LicenceNumber>PA0249/001/003</LicenceNumber>
    <ProductName>SOLCOSERYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015757</DrugIDPK>
    <LicenceNumber>PA0249/001/004</LicenceNumber>
    <ProductName>SOLCOSERYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015754</DrugIDPK>
    <LicenceNumber>PA0249/001/001</LicenceNumber>
    <ProductName>SOLCOSERYL AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011736</DrugIDPK>
    <LicenceNumber>PA0074/003/001</LicenceNumber>
    <ProductName>ROWAROLAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>HEXACHLOROPHENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011738</DrugIDPK>
    <LicenceNumber>PA0074/004/001</LicenceNumber>
    <ProductName>ROWATANAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISMUTH SUBGALLATE</ActiveSubstance>
      <ActiveSubstance>RESORCINOL</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010580</DrugIDPK>
    <LicenceNumber>PA0044/045/004</LicenceNumber>
    <ProductName>BCG PERCUTANEOUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-05-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012153</DrugIDPK>
    <LicenceNumber>PA0301/030/001</LicenceNumber>
    <ProductName>FURETIC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-04-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011662</DrugIDPK>
    <LicenceNumber>PA0073/006/001</LicenceNumber>
    <ProductName>B VIT C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-04-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009614</DrugIDPK>
    <LicenceNumber>PA0002/046/001</LicenceNumber>
    <ProductName>HIPPUTOPE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IODOHIPPURATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-04-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015712</DrugIDPK>
    <LicenceNumber>PA0301/015/001</LicenceNumber>
    <ProductName>TRISYN</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-04-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013024</DrugIDPK>
    <LicenceNumber>PA0126/001/002</LicenceNumber>
    <ProductName>POVISOL (DEXTROSE IN WATER 10%)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011393</DrugIDPK>
    <LicenceNumber>PA0054/007/001</LicenceNumber>
    <ProductName>REVONAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHAQUALONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010405</DrugIDPK>
    <LicenceNumber>PA0035/056/001</LicenceNumber>
    <ProductName>CALIGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CRESOL-M HEXYLATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009609</DrugIDPK>
    <LicenceNumber>PA0002/042/001</LicenceNumber>
    <ProductName>RENOTEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PENTETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016081</DrugIDPK>
    <LicenceNumber>PA0218/005/001</LicenceNumber>
    <ProductName>LENTARD INSULIN</ProductName>
    <Strength>40`</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016082</DrugIDPK>
    <LicenceNumber>PA0218/005/002</LicenceNumber>
    <ProductName>LENTARD INSULIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016083</DrugIDPK>
    <LicenceNumber>PA0218/006/001</LicenceNumber>
    <ProductName>RAPITARD INSULIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016084</DrugIDPK>
    <LicenceNumber>PA0218/006/002</LicenceNumber>
    <ProductName>RAPITARD INSULIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016085</DrugIDPK>
    <LicenceNumber>PA0218/007/001</LicenceNumber>
    <ProductName>ULTRATARD INSULIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993016086</DrugIDPK>
    <LicenceNumber>PA0218/007/002</LicenceNumber>
    <ProductName>ULTRATARD INSULIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010195</DrugIDPK>
    <LicenceNumber>PA0021/007/002</LicenceNumber>
    <ProductName>FABAHISTIN  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013028</DrugIDPK>
    <LicenceNumber>PA0126/001/004</LicenceNumber>
    <ProductName>POVISOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013032</DrugIDPK>
    <LicenceNumber>PA0126/001/006</LicenceNumber>
    <ProductName>POVISOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013030</DrugIDPK>
    <LicenceNumber>PA0126/001/005</LicenceNumber>
    <ProductName>POVISOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013026</DrugIDPK>
    <LicenceNumber>PA0126/001/003</LicenceNumber>
    <ProductName>POVISOL (DESTROSE IN WATER 20%)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013035</DrugIDPK>
    <LicenceNumber>PA0126/001/007</LicenceNumber>
    <ProductName>POVISOL (DEXTROSE 10% IN NORMAL SALIVE)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013048</DrugIDPK>
    <LicenceNumber>PA0126/001/010</LicenceNumber>
    <ProductName>POVISOL (DEXTROSE 3.3% IN SODIUM CHLORIDE 0.3%)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013039</DrugIDPK>
    <LicenceNumber>PA0126/001/009</LicenceNumber>
    <ProductName>POVISOL (DEXTROSE 4.3% IN SODIUM CHLORIDE 0.18%)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013037</DrugIDPK>
    <LicenceNumber>PA0126/001/008</LicenceNumber>
    <ProductName>POVISOL (DEXTROSE 5% )</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013021</DrugIDPK>
    <LicenceNumber>PA0126/001/001</LicenceNumber>
    <ProductName>POVISOL (DEXTROSE IN WATER 5%)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1976-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009613</DrugIDPK>
    <LicenceNumber>PA0002/045/001</LicenceNumber>
    <ProductName>MINITEC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TECHNETIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-03-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010543</DrugIDPK>
    <LicenceNumber>PA0037/017/001</LicenceNumber>
    <ProductName>STRESSTABS 600</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015646</DrugIDPK>
    <LicenceNumber>PA0301/005/002</LicenceNumber>
    <ProductName>BETOPIC OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011689</DrugIDPK>
    <LicenceNumber>PA0073/042/001</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011690</DrugIDPK>
    <LicenceNumber>PA0073/042/002</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015663</DrugIDPK>
    <LicenceNumber>PA0301/006/002</LicenceNumber>
    <ProductName>CLIOTOPIC H OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015703</DrugIDPK>
    <LicenceNumber>PA0301/014/002</LicenceNumber>
    <ProductName>FLUOSYN</ProductName>
    <Strength>0.01</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015705</DrugIDPK>
    <LicenceNumber>PA0301/014/003</LicenceNumber>
    <ProductName>FLUOSYN</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015707</DrugIDPK>
    <LicenceNumber>PA0301/014/004</LicenceNumber>
    <ProductName>FLUOSYN</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015708</DrugIDPK>
    <LicenceNumber>PA0301/014/005</LicenceNumber>
    <ProductName>FLUOSYN</ProductName>
    <Strength>0.01</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015710</DrugIDPK>
    <LicenceNumber>PA0301/014/006</LicenceNumber>
    <ProductName>FLUOSYN</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015715</DrugIDPK>
    <LicenceNumber>PA0301/015/003</LicenceNumber>
    <ProductName>TRISYN</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015716</DrugIDPK>
    <LicenceNumber>PA0301/015/004</LicenceNumber>
    <ProductName>TRISYN</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011068</DrugIDPK>
    <LicenceNumber>PA0049/005/001</LicenceNumber>
    <ProductName>OROVITE 7</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>1976-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013107</DrugIDPK>
    <LicenceNumber>PA0137/051/002</LicenceNumber>
    <ProductName>H-115 ANTI FUNGUS TINCTURE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORMIDAZOLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013106</DrugIDPK>
    <LicenceNumber>PA0137/051/001</LicenceNumber>
    <ProductName>H-115 ANTI-FUNGUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORMIDAZOLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011545</DrugIDPK>
    <LicenceNumber>PA0059/012/002</LicenceNumber>
    <ProductName>ORTHO-NOVIN 1/80</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>MESTRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010844</DrugIDPK>
    <LicenceNumber>PA0046/001/001</LicenceNumber>
    <ProductName>BETIM LEO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010845</DrugIDPK>
    <LicenceNumber>PA0046/001/003</LicenceNumber>
    <ProductName>BETIM LEO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-03-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010369</DrugIDPK>
    <LicenceNumber>PA0035/017001</LicenceNumber>
    <ProductName>DECASPRAY TOPICAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001854</DrugIDPK>
    <LicenceNumber>PA0035/017/001</LicenceNumber>
    <ProductName>DECASPRAY TOPICAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-02-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011368</DrugIDPK>
    <LicenceNumber>PA0054/004/001</LicenceNumber>
    <ProductName>ENCEPHABOL AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1976-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PYRITINOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011347</DrugIDPK>
    <LicenceNumber>PA0054/002/001</LicenceNumber>
    <ProductName>ILIACORTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1976-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXAMETHASONE ISONICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011437</DrugIDPK>
    <LicenceNumber>PA0057/007/001</LicenceNumber>
    <ProductName>DISALCID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1976-05-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993000203</DrugIDPK>
    <LicenceNumber>PA0004/002/002</LicenceNumber>
    <ProductName>CITROSAN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1974-12-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011696</DrugIDPK>
    <LicenceNumber>PA0073/050/002</LicenceNumber>
    <ProductName>PHENYLBUTAZONE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011701</DrugIDPK>
    <LicenceNumber>PA0073/055/001</LicenceNumber>
    <ProductName>TOLBUTAMIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010324</DrugIDPK>
    <LicenceNumber>PA0033/007/001</LicenceNumber>
    <ProductName>TOPILAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1976-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOROLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013233</DrugIDPK>
    <LicenceNumber>PA0159/003/001</LicenceNumber>
    <ProductName>A.R.M.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>1976-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013232</DrugIDPK>
    <LicenceNumber>PA0159/002/001</LicenceNumber>
    <ProductName>COLDPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>1976-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013514</DrugIDPK>
    <LicenceNumber>PA0261/008/004</LicenceNumber>
    <ProductName>LYNORAL</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013511</DrugIDPK>
    <LicenceNumber>PA0261/008/001</LicenceNumber>
    <ProductName>LYNORAL 0.01 MG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013512</DrugIDPK>
    <LicenceNumber>PA0261/008/002</LicenceNumber>
    <ProductName>LYNORAL 0.05 MG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013513</DrugIDPK>
    <LicenceNumber>PA0261/008/003</LicenceNumber>
    <ProductName>LYNORAL 0.1 MG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001591</DrugIDPK>
    <LicenceNumber>PA0017/063/001</LicenceNumber>
    <ProductName>WELLCOME BRAND GLOBIN ZINC INSULIN B.P. 80 IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009947</DrugIDPK>
    <LicenceNumber>PA0017/062/003</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN B P</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009943</DrugIDPK>
    <LicenceNumber>PA0017/062/001</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN B P</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009941</DrugIDPK>
    <LicenceNumber>PA0017/061/002</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN ZINC</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009935</DrugIDPK>
    <LicenceNumber>PA0017/060/002</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN ZINC  (SUSPENSION)</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009930</DrugIDPK>
    <LicenceNumber>PA0017/059/002</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN ZINC  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009932</DrugIDPK>
    <LicenceNumber>PA0017/060/001</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN ZINC 40 UNITS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010030</DrugIDPK>
    <LicenceNumber>PA0017/066/001</LicenceNumber>
    <ProductName>WELLCOME BRAND NEUTRAL INSULIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010035</DrugIDPK>
    <LicenceNumber>PA0017/066/002</LicenceNumber>
    <ProductName>WELLCOME BRAND NEUTRAL INSULIN NUSO</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001589</DrugIDPK>
    <LicenceNumber>PA0017/064/002</LicenceNumber>
    <ProductName>WELLCOME BRAND PROTAMINE ZINC INSULIN B. P. 80 IU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010272</DrugIDPK>
    <LicenceNumber>PA0032/014/001</LicenceNumber>
    <ProductName>MEGIMIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEMEGRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011454</DrugIDPK>
    <LicenceNumber>PA0057/008/001</LicenceNumber>
    <ProductName>NOVOBUTE</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1976-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011456</DrugIDPK>
    <LicenceNumber>PA0057/008/002</LicenceNumber>
    <ProductName>NOVOBUTE</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1976-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1981-01-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012066</DrugIDPK>
    <LicenceNumber>PA0096/005/001</LicenceNumber>
    <ProductName>NESTOSYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011541</DrugIDPK>
    <LicenceNumber>PA0058/015/001</LicenceNumber>
    <ProductName>CLIFT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPROSCILLARIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011542</DrugIDPK>
    <LicenceNumber>PA0058/015/002</LicenceNumber>
    <ProductName>CLIFT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPROSCILLARIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-12-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993005633</DrugIDPK>
    <LicenceNumber>PA0288/001/002</LicenceNumber>
    <ProductName>PEROIDIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009503</DrugIDPK>
    <LicenceNumber>PA0002/003/001</LicenceNumber>
    <ProductName>ROBENGATOPE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1976-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ROSE BENGAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-12-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010485</DrugIDPK>
    <LicenceNumber>PA0028/023/001</LicenceNumber>
    <ProductName>ALDOCORTEN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ALDOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010471</DrugIDPK>
    <LicenceNumber>PA0028/008/001</LicenceNumber>
    <ProductName>TACITIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOCTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012540</DrugIDPK>
    <LicenceNumber>PA0100/026/001</LicenceNumber>
    <ProductName>BEOGEX ADULT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012541</DrugIDPK>
    <LicenceNumber>PA0100/026/002</LicenceNumber>
    <ProductName>BEOGEX PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010958</DrugIDPK>
    <LicenceNumber>PA0048/003/001</LicenceNumber>
    <ProductName>LIPRINAL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1975-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010959</DrugIDPK>
    <LicenceNumber>PA0048/003/002</LicenceNumber>
    <ProductName>LIPRINAL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>1975-09-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013430</DrugIDPK>
    <LicenceNumber>PA0255/032/001</LicenceNumber>
    <ProductName>STERILE MULTIPLE VITAMIN SOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010453</DrugIDPK>
    <LicenceNumber>PA0023/011/001</LicenceNumber>
    <ProductName>CAMBISON OINTMENT</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNAZOLINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010454</DrugIDPK>
    <LicenceNumber>PA0023/011/002</LicenceNumber>
    <ProductName>CAMBISON OINTMENT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNAZOLINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010458</DrugIDPK>
    <LicenceNumber>PA0023/012/003</LicenceNumber>
    <ProductName>REVERIN I. V.</ProductName>
    <Strength>110</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ROLITETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013701</DrugIDPK>
    <LicenceNumber>PA0214/001/001</LicenceNumber>
    <ProductName>SOLASIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cuticura Laboratories Limited</PAHolder>
    <AuthorisedDate>1975-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010442</DrugIDPK>
    <LicenceNumber>PA0027/011/001</LicenceNumber>
    <ProductName>JUNIOR DISPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-11-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010855</DrugIDPK>
    <LicenceNumber>PA0046/004/013</LicenceNumber>
    <ProductName>FUCIDIN CREAM</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009550</DrugIDPK>
    <LicenceNumber>PA0006/012/001</LicenceNumber>
    <ProductName>MOLIPAXIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011447</DrugIDPK>
    <LicenceNumber>PA0060/027/001</LicenceNumber>
    <ProductName>SELACRYN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010437</DrugIDPK>
    <LicenceNumber>PA0027/005/002</LicenceNumber>
    <ProductName>DISPRIN FOILSTRIP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-10-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010621</DrugIDPK>
    <LicenceNumber>PA0038/013/001</LicenceNumber>
    <ProductName>PARADIONE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-10-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013104</DrugIDPK>
    <LicenceNumber>PA0137/049/001</LicenceNumber>
    <ProductName>ACABEL DRAGEES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BEVONIUM METILSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015205</DrugIDPK>
    <LicenceNumber>PA0211/011/001</LicenceNumber>
    <ProductName>PHENYLBUTAZONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010725</DrugIDPK>
    <LicenceNumber>PA0045/018/001</LicenceNumber>
    <ProductName>ERGAMISOL SYRUP</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LEVAMISOLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-08-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010881</DrugIDPK>
    <LicenceNumber>PA0046/025/002</LicenceNumber>
    <ProductName>MINIHEP CALCIUM HEPARIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1980-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-08-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010960</DrugIDPK>
    <LicenceNumber>PA0046/030/001</LicenceNumber>
    <ProductName>MED-E-JET INJECTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010779</DrugIDPK>
    <LicenceNumber>PA0041/013/002</LicenceNumber>
    <ProductName>TACE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-08-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012384</DrugIDPK>
    <LicenceNumber>PA0309/004/001</LicenceNumber>
    <ProductName>PSYCHO-SOMA COATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM GLUTAMATE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009885</DrugIDPK>
    <LicenceNumber>PA0012/034/001</LicenceNumber>
    <ProductName>BILIGRAM AMPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IOGLYCAMATE MEGLUMINE</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009886</DrugIDPK>
    <LicenceNumber>PA0012/034/002</LicenceNumber>
    <ProductName>BILIGRAM VIALS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010623</DrugIDPK>
    <LicenceNumber>PA0038/014/001</LicenceNumber>
    <ProductName>TRIDIONE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015637</DrugIDPK>
    <LicenceNumber>PA0301/002/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015638</DrugIDPK>
    <LicenceNumber>PA0301/002/002</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015665</DrugIDPK>
    <LicenceNumber>PA0301/007/001</LicenceNumber>
    <ProductName>DARROWS SOLUTION</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLORIC ACID</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015666</DrugIDPK>
    <LicenceNumber>PA0301/007/002</LicenceNumber>
    <ProductName>DARROWS SOLUTION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLORIC ACID</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015639</DrugIDPK>
    <LicenceNumber>PA0301/003/001</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015640</DrugIDPK>
    <LicenceNumber>PA0301/003/002</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012129</DrugIDPK>
    <LicenceNumber>PA0301/027/001</LicenceNumber>
    <ProductName>RINGERS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012132</DrugIDPK>
    <LicenceNumber>PA0301/027/002</LicenceNumber>
    <ProductName>RINGERS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012126</DrugIDPK>
    <LicenceNumber>PA0301/026/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE &amp; DEXTROSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012124</DrugIDPK>
    <LicenceNumber>PA0301/026/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE &amp; DEXTROSE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015635</DrugIDPK>
    <LicenceNumber>PA0301/001/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015636</DrugIDPK>
    <LicenceNumber>PA0301/001/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012385</DrugIDPK>
    <LicenceNumber>PA0309/004/002</LicenceNumber>
    <ProductName>PSYCHO-SOMA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM GLUTAMATE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-07-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012980</DrugIDPK>
    <LicenceNumber>PA0119/001/001</LicenceNumber>
    <ProductName>CORT-ACNE LOTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rhone-Poulenc Rorer Pharms.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>RESORCINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011444</DrugIDPK>
    <LicenceNumber>PA0060/024/003</LicenceNumber>
    <ProductName>HISTRYL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-06-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010542</DrugIDPK>
    <LicenceNumber>PA0037/015/001</LicenceNumber>
    <ProductName>AUTRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010540</DrugIDPK>
    <LicenceNumber>PA0037/014/001</LicenceNumber>
    <ProductName>FOLVITE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009557</DrugIDPK>
    <LicenceNumber>PA0002/021/006</LicenceNumber>
    <ProductName>KENACORT A</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-06-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011810</DrugIDPK>
    <LicenceNumber>PA0082/006/001</LicenceNumber>
    <ProductName>PRIMALAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1976-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MEQUITAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-05-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012361</DrugIDPK>
    <LicenceNumber>PA0305/002/001</LicenceNumber>
    <ProductName>CELABS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Kelkin Naturproducts Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-05-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011392</DrugIDPK>
    <LicenceNumber>PA0056/028/002</LicenceNumber>
    <ProductName>BENYLIN DAY &amp; NIGHT COLD - BLUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011391</DrugIDPK>
    <LicenceNumber>PA0056/028/001</LicenceNumber>
    <ProductName>BENYLIN DAY &amp; NIGHT COLD - YELLOW</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015656</DrugIDPK>
    <LicenceNumber>PA0233/006/001</LicenceNumber>
    <ProductName>DIGITALINE NATIVELLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIGITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015657</DrugIDPK>
    <LicenceNumber>PA0233/006/002</LicenceNumber>
    <ProductName>DIGITALINE NATIVELLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015658</DrugIDPK>
    <LicenceNumber>PA0233/006/003</LicenceNumber>
    <ProductName>DIGITALINE NATIVELLE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015659</DrugIDPK>
    <LicenceNumber>PA0233/006/004</LicenceNumber>
    <ProductName>DIGITALINE NATIVELLE AMPOULES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIGITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015167</DrugIDPK>
    <LicenceNumber>PA0294/004/001</LicenceNumber>
    <ProductName>CUNIL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015168</DrugIDPK>
    <LicenceNumber>PA0294/004/002</LicenceNumber>
    <ProductName>CUNIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010362</DrugIDPK>
    <LicenceNumber>PA0035/013/001</LicenceNumber>
    <ProductName>COLBENEMID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROBENECID</ActiveSubstance>
      <ActiveSubstance>COLCHICINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010355</DrugIDPK>
    <LicenceNumber>PA0035/006/001</LicenceNumber>
    <ProductName>CREMOMYCIN  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>SUCCINYLSULFATHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010356</DrugIDPK>
    <LicenceNumber>PA0035/007/001</LicenceNumber>
    <ProductName>CREMOSUXIDINE  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SUCCINYLSULFATHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013108</DrugIDPK>
    <LicenceNumber>PA0126/013/001</LicenceNumber>
    <ProductName>SILOXYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013110</DrugIDPK>
    <LicenceNumber>PA0126/013/002</LicenceNumber>
    <ProductName>SILOXYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013650</DrugIDPK>
    <LicenceNumber>PA0196/006/001</LicenceNumber>
    <ProductName>PERYLENE ULTRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015762</DrugIDPK>
    <LicenceNumber>PA0249/003/001</LicenceNumber>
    <ProductName>DI TER PER ANATOXAL BERNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015765</DrugIDPK>
    <LicenceNumber>PA0249/004/002</LicenceNumber>
    <ProductName>INFLEXAL BERNA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015767</DrugIDPK>
    <LicenceNumber>PA0249/004/004</LicenceNumber>
    <ProductName>INFLEXAL BERNA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012500</DrugIDPK>
    <LicenceNumber>PA0100/011/002</LicenceNumber>
    <ProductName>OPULETS ATROPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012514</DrugIDPK>
    <LicenceNumber>PA0100/019/001</LicenceNumber>
    <ProductName>OPULETS CYCLOPENTOLATE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTOLATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012515</DrugIDPK>
    <LicenceNumber>PA0100/019/002</LicenceNumber>
    <ProductName>OPULETS CYCLOPENTOLATE</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPENTOLATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012498</DrugIDPK>
    <LicenceNumber>PA0100/010/001</LicenceNumber>
    <ProductName>OPULETS FLUORESCEIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUORESCEIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012501</DrugIDPK>
    <LicenceNumber>PA0100/012/001</LicenceNumber>
    <ProductName>OPULETS HOMATROPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HOMATROPINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012502</DrugIDPK>
    <LicenceNumber>PA0100/012/002</LicenceNumber>
    <ProductName>OPULETS HOMATROPINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HOMATROPINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012503</DrugIDPK>
    <LicenceNumber>PA0100/013/001</LicenceNumber>
    <ProductName>OPULETS PILOCARPINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012504</DrugIDPK>
    <LicenceNumber>PA0100/013/002</LicenceNumber>
    <ProductName>OPULETS PILOCARPINE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012505</DrugIDPK>
    <LicenceNumber>PA0100/013/003</LicenceNumber>
    <ProductName>OPULETS PILOCARPINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PILOCARPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012516</DrugIDPK>
    <LicenceNumber>PA0100/020/001</LicenceNumber>
    <ProductName>OPULETS SALINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015768</DrugIDPK>
    <LicenceNumber>PA0249/005/001</LicenceNumber>
    <ProductName>TE ANATOXAL BERNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015769</DrugIDPK>
    <LicenceNumber>PA0249/005/002</LicenceNumber>
    <ProductName>TE ANATOXAL BERNA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010396</DrugIDPK>
    <LicenceNumber>PA0035/049/002</LicenceNumber>
    <ProductName>ARAMINE 10 MG/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METARAMINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009817</DrugIDPK>
    <LicenceNumber>PA0011/019/001</LicenceNumber>
    <ProductName>DELTA-BUTAZOLIDIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009450</DrugIDPK>
    <LicenceNumber>PA0001/002/001</LicenceNumber>
    <ProductName>PRO-BANTHINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1975-04-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPANTHELINE BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011426</DrugIDPK>
    <LicenceNumber>PA0054/011/002</LicenceNumber>
    <ProductName>ILVICO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>METHYLEPHEDRINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>PHENYLDIMETHYLJODPYRAZOLON</ActiveSubstance>
      <ActiveSubstance>SODIUM SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011826</DrugIDPK>
    <LicenceNumber>PA0082/018/001</LicenceNumber>
    <ProductName>CALMODEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011831</DrugIDPK>
    <LicenceNumber>PA0082/018/004</LicenceNumber>
    <ProductName>CALMODEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011828</DrugIDPK>
    <LicenceNumber>PA0082/018/002</LicenceNumber>
    <ProductName>CALMODEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011829</DrugIDPK>
    <LicenceNumber>PA0082/018/003</LicenceNumber>
    <ProductName>CALMODEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011833</DrugIDPK>
    <LicenceNumber>PA0082/018/005</LicenceNumber>
    <ProductName>CALMODEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011818</DrugIDPK>
    <LicenceNumber>PA0082/009/001</LicenceNumber>
    <ProductName>FLEXAZONE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011819</DrugIDPK>
    <LicenceNumber>PA0082/009/002</LicenceNumber>
    <ProductName>FLEXAZONE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010024</DrugIDPK>
    <LicenceNumber>PA0019/018/002</LicenceNumber>
    <ProductName>CORTRIL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012397</DrugIDPK>
    <LicenceNumber>PA0078/017/003</LicenceNumber>
    <ProductName>LOWTEN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Central Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012410</DrugIDPK>
    <LicenceNumber>PA0078/017/005</LicenceNumber>
    <ProductName>LOWTEN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Central Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011945</DrugIDPK>
    <LicenceNumber>PA0078/008/001</LicenceNumber>
    <ProductName>VAGRAN 50</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROPIZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010909</DrugIDPK>
    <LicenceNumber>PA0047/043/001</LicenceNumber>
    <ProductName>CO-PYRONIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRROBUTAMINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>METHAPYRILENE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYCLOPENTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-02-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010307</DrugIDPK>
    <LicenceNumber>PA0022/018/001</LicenceNumber>
    <ProductName>BEPLETE ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009811</DrugIDPK>
    <LicenceNumber>PA0017/028/001</LicenceNumber>
    <ProductName>DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009821</DrugIDPK>
    <LicenceNumber>PA0011/025/001</LicenceNumber>
    <ProductName>TOFRANIL R WITH PROMAZINE CAPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>IMIPRAMINE</ActiveSubstance>
      <ActiveSubstance>PROMAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009830</DrugIDPK>
    <LicenceNumber>PA0017/035/002</LicenceNumber>
    <ProductName>TYPHOID VACCINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010669</DrugIDPK>
    <LicenceNumber>PA0045/001/001</LicenceNumber>
    <ProductName>SEMAP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1975-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PENFLURIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011359</DrugIDPK>
    <LicenceNumber>PA0054/003/001</LicenceNumber>
    <ProductName>HEPABIONTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1975-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011382</DrugIDPK>
    <LicenceNumber>PA0054/006/001</LicenceNumber>
    <ProductName>NEUROBION FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>1975-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE DISULFIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010337</DrugIDPK>
    <LicenceNumber>PA0035/001/002</LicenceNumber>
    <ProductName>ALPHACILLIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1975-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010335</DrugIDPK>
    <LicenceNumber>PA0035/001/001</LicenceNumber>
    <ProductName>ALPHACILLIN 60 M</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010339</DrugIDPK>
    <LicenceNumber>PA0035/001/003</LicenceNumber>
    <ProductName>ALPHACILLIN PAEDIATRIC</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1975-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009627</DrugIDPK>
    <LicenceNumber>PA0004/002/001</LicenceNumber>
    <ProductName>CITROSAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1974-12-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011469</DrugIDPK>
    <LicenceNumber>PA0057/017/001</LicenceNumber>
    <ProductName>VERILOID VP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERATRUM VIRIDE</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1980-01-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010502</DrugIDPK>
    <LicenceNumber>PA0023/020/001</LicenceNumber>
    <ProductName>DIPAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-12-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010695</DrugIDPK>
    <LicenceNumber>PA0039/033/001</LicenceNumber>
    <ProductName>PERITRATE WITH PHENOBARBITONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-12-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011377</DrugIDPK>
    <LicenceNumber>PA0056/011/001</LicenceNumber>
    <ProductName>LOESTRIN 20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1975-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-12-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011591</DrugIDPK>
    <LicenceNumber>PA0060/016/011</LicenceNumber>
    <ProductName>STELAZINE MULTI-DOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011428</DrugIDPK>
    <LicenceNumber>PA0057/003/001</LicenceNumber>
    <ProductName>ANAPAX FAMILY COUGH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011431</DrugIDPK>
    <LicenceNumber>PA0057/004/002</LicenceNumber>
    <ProductName>FILAIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011429</DrugIDPK>
    <LicenceNumber>PA0057/004/001</LicenceNumber>
    <ProductName>FILAIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011434</DrugIDPK>
    <LicenceNumber>PA0057/004/005</LicenceNumber>
    <ProductName>FILAIR AUTO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1979-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011433</DrugIDPK>
    <LicenceNumber>PA0057/004/004</LicenceNumber>
    <ProductName>FILAIR INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012069</DrugIDPK>
    <LicenceNumber>PA0057/005/002</LicenceNumber>
    <ProductName>NUELIN PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011926</DrugIDPK>
    <LicenceNumber>PA0086/001/002</LicenceNumber>
    <ProductName>ALLBEE WITH C 550</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1978-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009842</DrugIDPK>
    <LicenceNumber>PA0012/001/001</LicenceNumber>
    <ProductName>SEQUILAR ED DRAGEES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>1975-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013479</DrugIDPK>
    <LicenceNumber>PA0258/014/001</LicenceNumber>
    <ProductName>LEMONEXA LEMON FLUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010849</DrugIDPK>
    <LicenceNumber>PA0046/001/006</LicenceNumber>
    <ProductName>BETIM EYE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010847</DrugIDPK>
    <LicenceNumber>PA0046/001/004</LicenceNumber>
    <ProductName>BETIM EYE DROPS</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010848</DrugIDPK>
    <LicenceNumber>PA0046/001/005</LicenceNumber>
    <ProductName>BETRIM EYE DROP</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-11-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010119</DrugIDPK>
    <LicenceNumber>PA0006/021/001</LicenceNumber>
    <ProductName>CLORHEXITULLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-10-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011601</DrugIDPK>
    <LicenceNumber>PA0062/009/003</LicenceNumber>
    <ProductName>MELADININE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011374</DrugIDPK>
    <LicenceNumber>PA0056/003/001</LicenceNumber>
    <ProductName>NORLESTRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>1975-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011889</DrugIDPK>
    <LicenceNumber>PA0082/031/001</LicenceNumber>
    <ProductName>ANTIPRESSAN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011892</DrugIDPK>
    <LicenceNumber>PA0082/031/003</LicenceNumber>
    <ProductName>ANTIPRESSAN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012994</DrugIDPK>
    <LicenceNumber>PA0120/003/001</LicenceNumber>
    <ProductName>POTENSAN FORTE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Medo Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>YOHIMBINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>METHYLTESTOSTERONE</ActiveSubstance>
      <ActiveSubstance>STRYCHNINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PEMOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011840</DrugIDPK>
    <LicenceNumber>PA0082/023/001</LicenceNumber>
    <ProductName>PARITANE</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011842</DrugIDPK>
    <LicenceNumber>PA0082/023/002</LicenceNumber>
    <ProductName>PARITANE</ProductName>
    <Strength>25.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013414</DrugIDPK>
    <LicenceNumber>PA0255/026/001</LicenceNumber>
    <ProductName>ATROPINE SULPHATE WITH NEOSTIGMINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013381</DrugIDPK>
    <LicenceNumber>PA0255/022/001</LicenceNumber>
    <ProductName>MULTIPLE ELECTROLYTE ADDITIVE STERILE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013428</DrugIDPK>
    <LicenceNumber>PA0255/031/001</LicenceNumber>
    <ProductName>NORADRENALINE ACID TARTRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013420</DrugIDPK>
    <LicenceNumber>PA0255/027/002</LicenceNumber>
    <ProductName>OXYTOCIN 10 I U/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013418</DrugIDPK>
    <LicenceNumber>PA0255/027/001</LicenceNumber>
    <ProductName>OXYTOCIN 10 I U/ML</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013393</DrugIDPK>
    <LicenceNumber>PA0255/025/001</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.1%</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013395</DrugIDPK>
    <LicenceNumber>PA0255/025/002</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.1% W/V</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013410</DrugIDPK>
    <LicenceNumber>PA0255/025/008</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013408</DrugIDPK>
    <LicenceNumber>PA0255/025/007</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013400</DrugIDPK>
    <LicenceNumber>PA0255/025/004</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013397</DrugIDPK>
    <LicenceNumber>PA0255/025/003</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013403</DrugIDPK>
    <LicenceNumber>PA0255/025/005</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013405</DrugIDPK>
    <LicenceNumber>PA0255/025/006</LicenceNumber>
    <ProductName>SODIUM CHLORIDE 0.9% W/V</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013382</DrugIDPK>
    <LicenceNumber>PA0255/023/001</LicenceNumber>
    <ProductName>STERILE SUXAMETHONIUM CHLORIDE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-09-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011445</DrugIDPK>
    <LicenceNumber>PA0060/025/002</LicenceNumber>
    <ProductName>ESKORADE SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-08-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011298</DrugIDPK>
    <LicenceNumber>PA0051/015/005</LicenceNumber>
    <ProductName>SYNALAR OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-08-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013508</DrugIDPK>
    <LicenceNumber>PA0261/006/003</LicenceNumber>
    <ProductName>ORADEXON-ORGANON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-07-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012271</DrugIDPK>
    <LicenceNumber>PA0302/002/001</LicenceNumber>
    <ProductName>DENTINOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012272</DrugIDPK>
    <LicenceNumber>PA0302/002/002</LicenceNumber>
    <ProductName>DENTINOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-07-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011858</DrugIDPK>
    <LicenceNumber>PA0077/042/001</LicenceNumber>
    <ProductName>DIBOTIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-07-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011820</DrugIDPK>
    <LicenceNumber>PA0082/010/001</LicenceNumber>
    <ProductName>PRINALGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALCLOFENAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-07-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010788</DrugIDPK>
    <LicenceNumber>PA0041/020/001</LicenceNumber>
    <ProductName>MEROCAINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINCHOCAINE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010789</DrugIDPK>
    <LicenceNumber>PA0041/020/002</LicenceNumber>
    <ProductName>MEROCAINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINCHOCAINE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-06-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012499</DrugIDPK>
    <LicenceNumber>PA0100/011/001</LicenceNumber>
    <ProductName>OPULETS ATROPINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012882</DrugIDPK>
    <LicenceNumber>PA0100/004/001</LicenceNumber>
    <ProductName>SULPHACETAMIDE OPULETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-29</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009810</DrugIDPK>
    <LicenceNumber>PA0011/015/001</LicenceNumber>
    <ProductName>TANDERIL ALKA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011677</DrugIDPK>
    <LicenceNumber>PA0073/024/001</LicenceNumber>
    <ProductName>COLESTERINEX</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRICARBATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010521</DrugIDPK>
    <LicenceNumber>PA0023/035/002</LicenceNumber>
    <ProductName>CHLORONASE</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010519</DrugIDPK>
    <LicenceNumber>PA0023/035/001</LicenceNumber>
    <ProductName>CHLORONASE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010498</DrugIDPK>
    <LicenceNumber>PA0023/014/003</LicenceNumber>
    <ProductName>HOSTACYCLINE P DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013062</DrugIDPK>
    <LicenceNumber>PA0137/023/006</LicenceNumber>
    <ProductName>METHOTREXATE PARENTERAL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013063</DrugIDPK>
    <LicenceNumber>PA0137/023/007</LicenceNumber>
    <ProductName>METHOTREXATE PARENTERAL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-05-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009762</DrugIDPK>
    <LicenceNumber>PA0010/014/001</LicenceNumber>
    <ProductName>TRENTADIL</ProductName>
    <Strength>520</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BAMIFYLLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-04-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009853</DrugIDPK>
    <LicenceNumber>PA0012/004/003</LicenceNumber>
    <ProductName>ALLERCUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLEMIZOLE</ActiveSubstance>
      <ActiveSubstance>CLEMIZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009851</DrugIDPK>
    <LicenceNumber>PA0012/004/002</LicenceNumber>
    <ProductName>ALLERCUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLEMIZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015689</DrugIDPK>
    <LicenceNumber>PA0237/002/001</LicenceNumber>
    <ProductName>ALUMINIUM HYDROXIDE</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015693</DrugIDPK>
    <LicenceNumber>PA0237/004/001</LicenceNumber>
    <ProductName>ASCORBIC ACID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015694</DrugIDPK>
    <LicenceNumber>PA0237/004/002</LicenceNumber>
    <ProductName>ASCORBIC ACID</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015696</DrugIDPK>
    <LicenceNumber>PA0237/004/003</LicenceNumber>
    <ProductName>ASCORBIC ACID</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015699</DrugIDPK>
    <LicenceNumber>PA0237/005/001</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015730</DrugIDPK>
    <LicenceNumber>PA0237/012/002</LicenceNumber>
    <ProductName>CASCARA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015727</DrugIDPK>
    <LicenceNumber>PA0237/012/001</LicenceNumber>
    <ProductName>CASCARA</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015724</DrugIDPK>
    <LicenceNumber>PA0237/011/001</LicenceNumber>
    <ProductName>COMPOUND CODEINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015690</DrugIDPK>
    <LicenceNumber>PA0237/003/001</LicenceNumber>
    <ProductName>DIGOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015722</DrugIDPK>
    <LicenceNumber>PA0237/010/001</LicenceNumber>
    <ProductName>FERROUS GLUCONATE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015719</DrugIDPK>
    <LicenceNumber>PA0237/009/002</LicenceNumber>
    <ProductName>IMIPRAMINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015714</DrugIDPK>
    <LicenceNumber>PA0237/009/001</LicenceNumber>
    <ProductName>IMIPRAMINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015711</DrugIDPK>
    <LicenceNumber>PA0237/008/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015709</DrugIDPK>
    <LicenceNumber>PA0237/007/001</LicenceNumber>
    <ProductName>SOLUBLE ASPIRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015706</DrugIDPK>
    <LicenceNumber>PA0237/006/003</LicenceNumber>
    <ProductName>STILBOESTROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015701</DrugIDPK>
    <LicenceNumber>PA0237/006/001</LicenceNumber>
    <ProductName>STILBOESTROL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015704</DrugIDPK>
    <LicenceNumber>PA0237/006/002</LicenceNumber>
    <ProductName>STILBOESTROL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015732</DrugIDPK>
    <LicenceNumber>PA0237/013/001</LicenceNumber>
    <ProductName>STRONG CALCIFEROL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993003760</DrugIDPK>
    <LicenceNumber>PA0114/015/001</LicenceNumber>
    <ProductName>PHYLLOCALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>HYDROXYZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011537</DrugIDPK>
    <LicenceNumber>PA0058/010/002</LicenceNumber>
    <ProductName>SOVENTOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BAMIPINE LACTATE</ActiveSubstance>
      <ActiveSubstance>BAMIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011536</DrugIDPK>
    <LicenceNumber>PA0058/010/001</LicenceNumber>
    <ProductName>SOVENTOL JELLY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BAMIPINE LACTATE</ActiveSubstance>
      <ActiveSubstance>BAMIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012065</DrugIDPK>
    <LicenceNumber>PA0096/004/001</LicenceNumber>
    <ProductName>BENURIDE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-02-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011461</DrugIDPK>
    <LicenceNumber>PA0057/012/002</LicenceNumber>
    <ProductName>NORGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013122</DrugIDPK>
    <LicenceNumber>PA0141/006/001</LicenceNumber>
    <ProductName>RHINO-FLEXIOLE C NEOMYCIN NOSE DROPS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011249</DrugIDPK>
    <LicenceNumber>PA0050/028/002</LicenceNumber>
    <ProductName>SARIDONE (ALUMINIUM SLIDE TINS)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-02-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013038</DrugIDPK>
    <LicenceNumber>PA0137/014/003</LicenceNumber>
    <ProductName>ENTERO-SEDIV</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013064</DrugIDPK>
    <LicenceNumber>PA0137/024/001</LicenceNumber>
    <ProductName>POLYCID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-02-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012517</DrugIDPK>
    <LicenceNumber>PA0100/021/001</LicenceNumber>
    <ProductName>FLAVELIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010743</DrugIDPK>
    <LicenceNumber>PA0040/037/001</LicenceNumber>
    <ProductName>PROGESTASERT (TRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012536</DrugIDPK>
    <LicenceNumber>PA0100/023/002</LicenceNumber>
    <ProductName>PYLURA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012518</DrugIDPK>
    <LicenceNumber>PA0100/023/001</LicenceNumber>
    <ProductName>PYLURA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE BITARTRATE</ActiveSubstance>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012708</DrugIDPK>
    <LicenceNumber>PA0108/008/001</LicenceNumber>
    <ProductName>INSULIN-TORONTO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012705</DrugIDPK>
    <LicenceNumber>PA0108/007/001</LicenceNumber>
    <ProductName>INSULIN-TORONTO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012714</DrugIDPK>
    <LicenceNumber>PA0108/009/002</LicenceNumber>
    <ProductName>NPH INSULIN</ProductName>
    <Strength>100 U</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012710</DrugIDPK>
    <LicenceNumber>PA0108/009/001</LicenceNumber>
    <ProductName>NPH INSULIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010376</DrugIDPK>
    <LicenceNumber>PA0035/031/001</LicenceNumber>
    <ProductName>SALUPRES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>RESERPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009841</DrugIDPK>
    <LicenceNumber>PA0012/004/001</LicenceNumber>
    <ProductName>ALLERCUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011955</DrugIDPK>
    <LicenceNumber>PA0078/015/002</LicenceNumber>
    <ProductName>SEDOLAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011446</DrugIDPK>
    <LicenceNumber>PA0060/026/001</LicenceNumber>
    <ProductName>BENZEDREX INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015161</DrugIDPK>
    <LicenceNumber>PA0291/002/001</LicenceNumber>
    <ProductName>AQUA-BAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1979-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011843</DrugIDPK>
    <LicenceNumber>PA0082/023/003</LicenceNumber>
    <ProductName>PARITANE (BLISTER PACKS)</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011846</DrugIDPK>
    <LicenceNumber>PA0082/023/004</LicenceNumber>
    <ProductName>PARITANE (BLISTER PACKS)</ProductName>
    <Strength>25.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-12-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011425</DrugIDPK>
    <LicenceNumber>PA0054/011/001</LicenceNumber>
    <ProductName>ILVICO COATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLAMIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>QUININE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-12-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011493</DrugIDPK>
    <LicenceNumber>PA0057/034/001</LicenceNumber>
    <ProductName>BENZYDAMINE TOPICAL PREPARATION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-12-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010268</DrugIDPK>
    <LicenceNumber>PA0032/010/001</LicenceNumber>
    <ProductName>ASMAPAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-12-11</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013127</DrugIDPK>
    <LicenceNumber>PA0141/009/001</LicenceNumber>
    <ProductName>CARTAGYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011655</DrugIDPK>
    <LicenceNumber>PA0073/003/014</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1978-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-11-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013787</DrugIDPK>
    <LicenceNumber>PA0277/004/007</LicenceNumber>
    <ProductName>GEOMYCIN (PAEDIATRIC) 10MG</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009700</DrugIDPK>
    <LicenceNumber>PA0009/012/001</LicenceNumber>
    <ProductName>SULOCTIDIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-11-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011477</DrugIDPK>
    <LicenceNumber>PA0057/022/001</LicenceNumber>
    <ProductName>LERGOBAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENYLPYRALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011476</DrugIDPK>
    <LicenceNumber>PA0057/021/001</LicenceNumber>
    <ProductName>THEODROX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-10-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011600</DrugIDPK>
    <LicenceNumber>PA0062/009/002</LicenceNumber>
    <ProductName>MELADINE  EMULSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011559</DrugIDPK>
    <LicenceNumber>PA0062/009/001</LicenceNumber>
    <ProductName>MELADININE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-10-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011964</DrugIDPK>
    <LicenceNumber>PA0078/021/001</LicenceNumber>
    <ProductName>INDOMETHACIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDOMETACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013214</DrugIDPK>
    <LicenceNumber>PA0157/009/001</LicenceNumber>
    <ProductName>NZYM-3</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Controlled Medications Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEHYDROCHOLIC ACID</ActiveSubstance>
      <ActiveSubstance>HYOSCYAMINE SULFATE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
      <ActiveSubstance>ENZYMES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-09-18</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015661</DrugIDPK>
    <LicenceNumber>PA0233/008/001</LicenceNumber>
    <ProductName>ELIXIR GABAIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>STRONTIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-09-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010965</DrugIDPK>
    <LicenceNumber>PA0048/005/002</LicenceNumber>
    <ProductName>HICONCIL</ProductName>
    <Strength>375</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-08-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011558</DrugIDPK>
    <LicenceNumber>PA0060/001/001</LicenceNumber>
    <ProductName>MAGNESIUM/POTASSIUM SPANSULE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-08-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012886</DrugIDPK>
    <LicenceNumber>PA0100/005/003</LicenceNumber>
    <ProductName>PAEDO-SED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-08-08</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011459</DrugIDPK>
    <LicenceNumber>PA0057/011/001</LicenceNumber>
    <ProductName>PABIREX DIARRHOEA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-08-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010374</DrugIDPK>
    <LicenceNumber>PA0035/023/001</LicenceNumber>
    <ProductName>PERIDECA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROHEPTADINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012906</DrugIDPK>
    <LicenceNumber>PA0117/006/001</LicenceNumber>
    <ProductName>TISED</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011647</DrugIDPK>
    <LicenceNumber>PA0073/001/001</LicenceNumber>
    <ProductName>SYNOGIST SHAMPOO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012056</DrugIDPK>
    <LicenceNumber>PA0095/002/001</LicenceNumber>
    <ProductName>BIOSCAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013128</DrugIDPK>
    <LicenceNumber>PA0141/010/001</LicenceNumber>
    <ProductName>OCAL EYE DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MERCURIC OXYCYANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013112</DrugIDPK>
    <LicenceNumber>PA0141/002/001</LicenceNumber>
    <ProductName>SOPACYCLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013113</DrugIDPK>
    <LicenceNumber>PA0141/002/002</LicenceNumber>
    <ProductName>SOPACYCLINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013133</DrugIDPK>
    <LicenceNumber>PA0141/012/001</LicenceNumber>
    <ProductName>SOPARON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013135</DrugIDPK>
    <LicenceNumber>PA0141/013/001</LicenceNumber>
    <ProductName>ULTRA-K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013242</DrugIDPK>
    <LicenceNumber>PA0161/003/001</LicenceNumber>
    <ProductName>ISOPTO CETAPRED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Electramed Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE ACETATE</ActiveSubstance>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013240</DrugIDPK>
    <LicenceNumber>PA0161/002/001</LicenceNumber>
    <ProductName>MAXIDEX STERILE OPHTHALMIC</ProductName>
    <Strength>5/15</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Electramed Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013236</DrugIDPK>
    <LicenceNumber>PA0161/001/001</LicenceNumber>
    <ProductName>MAXITROL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Electramed Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>POLYMYXIN B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013237</DrugIDPK>
    <LicenceNumber>PA0161/001/002</LicenceNumber>
    <ProductName>MAXITROL OINTMENT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Electramed Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-07-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010706</DrugIDPK>
    <LicenceNumber>PA0045/008/001</LicenceNumber>
    <ProductName>TRIPERIDOL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIFLUPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-06-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012644</DrugIDPK>
    <LicenceNumber>PA0108/003/001</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012650</DrugIDPK>
    <LicenceNumber>PA0108/003/003</LicenceNumber>
    <ProductName>INFLUVAC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012647</DrugIDPK>
    <LicenceNumber>PA0108/003/002</LicenceNumber>
    <ProductName>INFLUVAC SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-06-12</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010371</DrugIDPK>
    <LicenceNumber>PA0035/019/001</LicenceNumber>
    <ProductName>CODELCORTONE TRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE BUTYLACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-05-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012984</DrugIDPK>
    <LicenceNumber>PA0119/008/001</LicenceNumber>
    <ProductName>PECOMBIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Rhone-Poulenc Rorer Pharms.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>BROMELAINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-05-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013056</DrugIDPK>
    <LicenceNumber>PA0137/022/002</LicenceNumber>
    <ProductName>MILTOWN - 200</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPROBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013055</DrugIDPK>
    <LicenceNumber>PA0137/022/001</LicenceNumber>
    <ProductName>MILTOWN - 400</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPROBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010599</DrugIDPK>
    <LicenceNumber>PA0044/048/006</LicenceNumber>
    <ProductName>TUBERCULIN PURIFIED PROTEIN DERIVATIVE B P</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-05-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012784</DrugIDPK>
    <LicenceNumber>PA0114/016/001</LicenceNumber>
    <ProductName>AMM-1</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012787</DrugIDPK>
    <LicenceNumber>PA0114/016/002</LicenceNumber>
    <ProductName>AMM-2</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MORPHINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-05-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009730</DrugIDPK>
    <LicenceNumber>PA0016/019/002</LicenceNumber>
    <ProductName>MEDRONE ACNE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-04-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009856</DrugIDPK>
    <LicenceNumber>PA0012/007/001</LicenceNumber>
    <ProductName>DUOGYNON ORAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009868</DrugIDPK>
    <LicenceNumber>PA0012/019/001</LicenceNumber>
    <ProductName>PRIMOGYN DEPOT AMPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-04-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013654</DrugIDPK>
    <LicenceNumber>PA0196/010/002</LicenceNumber>
    <ProductName>ENDOMETHASONE (PINK)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>THYMOL IODIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-04-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011575</DrugIDPK>
    <LicenceNumber>PA0060/009/002</LicenceNumber>
    <ProductName>ESKACEF</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011581</DrugIDPK>
    <LicenceNumber>PA0060/009/007</LicenceNumber>
    <ProductName>ESKACEF</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011578</DrugIDPK>
    <LicenceNumber>PA0060/009/005</LicenceNumber>
    <ProductName>ESKACEF</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011579</DrugIDPK>
    <LicenceNumber>PA0060/009/006</LicenceNumber>
    <ProductName>ESKACEF</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011577</DrugIDPK>
    <LicenceNumber>PA0060/009/003</LicenceNumber>
    <ProductName>ESKACEF DRY MIX (SUSPENSION)</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009996</DrugIDPK>
    <LicenceNumber>PA0018/012/001</LicenceNumber>
    <ProductName>BARQUINOL HC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010712</DrugIDPK>
    <LicenceNumber>PA0045/012/001</LicenceNumber>
    <ProductName>DROLEPTAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010482</DrugIDPK>
    <LicenceNumber>PA0028/019/001</LicenceNumber>
    <ProductName>ESIDREX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010483</DrugIDPK>
    <LicenceNumber>PA0028/019/002</LicenceNumber>
    <ProductName>ESIDREX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010484</DrugIDPK>
    <LicenceNumber>PA0028/020/001</LicenceNumber>
    <ProductName>ESIDREX-K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010486</DrugIDPK>
    <LicenceNumber>PA0028/024/001</LicenceNumber>
    <ProductName>PERCORTEN M CRYSTULE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DESOXYCORTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010481</DrugIDPK>
    <LicenceNumber>PA0028/018/001</LicenceNumber>
    <ProductName>ULTRACORTENOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE PIVALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-03-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009998</DrugIDPK>
    <LicenceNumber>PA0018/013/002</LicenceNumber>
    <ProductName>DIMYRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009997</DrugIDPK>
    <LicenceNumber>PA0018/013/001</LicenceNumber>
    <ProductName>DIMYRIL LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009925</DrugIDPK>
    <LicenceNumber>PA0013/001/005</LicenceNumber>
    <ProductName>VISKEN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINDOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995012407</DrugIDPK>
    <LicenceNumber>PA0078/017/004</LicenceNumber>
    <ProductName>LOWTEN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Central Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-25</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011432</DrugIDPK>
    <LicenceNumber>PA0057/004/003</LicenceNumber>
    <ProductName>FILAIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>1975-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010575</DrugIDPK>
    <LicenceNumber>PA0044/045/002</LicenceNumber>
    <ProductName>BCG INTRADERMAL 0.4/1.3</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013088</DrugIDPK>
    <LicenceNumber>PA0137/035/001</LicenceNumber>
    <ProductName>PANAX GINSENG MIT BIO-EISEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-20</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009999</DrugIDPK>
    <LicenceNumber>PA0018/015/001</LicenceNumber>
    <ProductName>GENASPRIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010309</DrugIDPK>
    <LicenceNumber>PA0022/019/001</LicenceNumber>
    <ProductName>DOVENOL LINCTUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
      <ActiveSubstance>CARBINOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013791</DrugIDPK>
    <LicenceNumber>PA0280/004/001</LicenceNumber>
    <ProductName>ANALGESIC  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gannet Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SALICYLATES</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-02-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010022</DrugIDPK>
    <LicenceNumber>PA0019/016/001</LicenceNumber>
    <ProductName>NIAMID</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIALAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-01-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009905</DrugIDPK>
    <LicenceNumber>PA0017/039/005</LicenceNumber>
    <ProductName>TETANUS ANTITOXIN B P</ProductName>
    <Strength>1500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1978-01-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010718</DrugIDPK>
    <LicenceNumber>PA0045/014/001</LicenceNumber>
    <ProductName>DIPIDOLOR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIRITRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-12-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010877</DrugIDPK>
    <LicenceNumber>PA0046/022/001</LicenceNumber>
    <ProductName>HYBIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-12-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010475</DrugIDPK>
    <LicenceNumber>PA0028/012/001</LicenceNumber>
    <ProductName>LOCORTEN VIOFORM EAR DROPS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLUMETASONE PIVALATE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010472</DrugIDPK>
    <LicenceNumber>PA0028/009/001</LicenceNumber>
    <ProductName>ORISULF</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAPHENAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010473</DrugIDPK>
    <LicenceNumber>PA0028/009/002</LicenceNumber>
    <ProductName>ORISULF  (SUSPENSION)</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFAPHENAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010477</DrugIDPK>
    <LicenceNumber>PA0028/014/001</LicenceNumber>
    <ProductName>VIOFORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010478</DrugIDPK>
    <LicenceNumber>PA0028/014/002</LicenceNumber>
    <ProductName>VIOFORM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-12-01</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011248</DrugIDPK>
    <LicenceNumber>PA0050/028/001</LicenceNumber>
    <ProductName>SARIDONE (GLASS BOTTLES)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-11-28</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010375</DrugIDPK>
    <LicenceNumber>PA0035/027/001</LicenceNumber>
    <ProductName>HYDROSALURIC-K</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-11-24</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013174</DrugIDPK>
    <LicenceNumber>PA0144/008/001</LicenceNumber>
    <ProductName>STIEVAA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TRETINOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-11-16</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010973</DrugIDPK>
    <LicenceNumber>PA0048/007/001</LicenceNumber>
    <ProductName>KANTREXIL (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>KANAMYCIN</ActiveSubstance>
      <ActiveSubstance>ATTAPULGITE</ActiveSubstance>
      <ActiveSubstance>PECTIN</ActiveSubstance>
      <ActiveSubstance>BISMUTH CAMPHOCARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-11-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013539</DrugIDPK>
    <LicenceNumber>PA0266/001/001</LicenceNumber>
    <ProductName>DIUROMIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gillespie &amp; Company Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-11-14</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013691</DrugIDPK>
    <LicenceNumber>PA0206/004/001</LicenceNumber>
    <ProductName>ISOXYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOCARLIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-11-02</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010058</DrugIDPK>
    <LicenceNumber>PA0019/001/001</LicenceNumber>
    <ProductName>COPTIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLAMOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010059</DrugIDPK>
    <LicenceNumber>PA0019/001/002</LicenceNumber>
    <ProductName>COPTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLAMOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010061</DrugIDPK>
    <LicenceNumber>PA0019/001/003</LicenceNumber>
    <ProductName>COPTIN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLAMOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010062</DrugIDPK>
    <LicenceNumber>PA0019/001/004</LicenceNumber>
    <ProductName>COPTIN INTRAVENOUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TOLAMOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-10-10</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015654</DrugIDPK>
    <LicenceNumber>PA0233/004/001</LicenceNumber>
    <ProductName>NATISEDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-10-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009541</DrugIDPK>
    <LicenceNumber>PA0006/007/001</LicenceNumber>
    <ProductName>ASMACORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-10-04</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010692</DrugIDPK>
    <LicenceNumber>PA0039/031/002</LicenceNumber>
    <ProductName>MIPRALINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>1977-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-10-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010615</DrugIDPK>
    <LicenceNumber>PA0038/010/001</LicenceNumber>
    <ProductName>ENDURON</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-09-27</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010264</DrugIDPK>
    <LicenceNumber>PA0022/003/001</LicenceNumber>
    <ProductName>BEPLETE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-09-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014977</DrugIDPK>
    <LicenceNumber>PA0202/001/001</LicenceNumber>
    <ProductName>ANTIDOTE TO ANCROD B.P.C.</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lister Institute of Preventative</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SNAKE VENOM ANTISERUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-08-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010253</DrugIDPK>
    <LicenceNumber>PA0031/003/001</LicenceNumber>
    <ProductName>MYOTONINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenwood Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010277</DrugIDPK>
    <LicenceNumber>PA0022/009/003</LicenceNumber>
    <ProductName>PENIDURAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZATHINE BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>PROCAINE PENICILLIN G</ActiveSubstance>
      <ActiveSubstance>BENZYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010251</DrugIDPK>
    <LicenceNumber>PA0031/002/001</LicenceNumber>
    <ProductName>POTABA + 6</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glenwood Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM AMINOBENZOATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-07-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011941</DrugIDPK>
    <LicenceNumber>PA0078/005/001</LicenceNumber>
    <ProductName>CENTROSED</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPROBAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-06-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011436</DrugIDPK>
    <LicenceNumber>PA0057/006/001</LicenceNumber>
    <ProductName>RYNOTAB</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-05-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010891</DrugIDPK>
    <LicenceNumber>PA0047/033/001</LicenceNumber>
    <ProductName>HALDRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-05-09</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011238</DrugIDPK>
    <LicenceNumber>PA0050/011/002</LicenceNumber>
    <ProductName>MADRIBON</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFADIMETHOXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-04-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012939</DrugIDPK>
    <LicenceNumber>PA0130/001/001</LicenceNumber>
    <ProductName>NEO-CANTIL ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-03-31</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993014431</DrugIDPK>
    <LicenceNumber>PA0236/003/001</LicenceNumber>
    <ProductName>KEMICETINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-03-07</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009801</DrugIDPK>
    <LicenceNumber>PA0017/025/005</LicenceNumber>
    <ProductName>DIPHTHERIA ANTITOXIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009803</DrugIDPK>
    <LicenceNumber>PA0017/026/001</LicenceNumber>
    <ProductName>DIPHTHERIA VACCINE P T A P</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009835</DrugIDPK>
    <LicenceNumber>PA0017/036/002</LicenceNumber>
    <ProductName>TYPHOID-PARATYPHOID A B &amp; C</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009846</DrugIDPK>
    <LicenceNumber>PA0017/038/003</LicenceNumber>
    <ProductName>TYPHOID-PARATYPHOID A B/TETANUS VACCINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-02-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009543</DrugIDPK>
    <LicenceNumber>PA0006/008/001</LicenceNumber>
    <ProductName>MANDRAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHAQUALONE</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-02-17</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009965</DrugIDPK>
    <LicenceNumber>PA0016/005/001</LicenceNumber>
    <ProductName>ALBAMYCIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009966</DrugIDPK>
    <LicenceNumber>PA0016/005/002</LicenceNumber>
    <ProductName>ALBAMYCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995001696</DrugIDPK>
    <LicenceNumber>PA0016/005/003</LicenceNumber>
    <ProductName>ALBAMYCIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009967</DrugIDPK>
    <LicenceNumber>PA0016/006/001</LicenceNumber>
    <ProductName>ALBAMYCIN GU</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1977-01-13</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010357</DrugIDPK>
    <LicenceNumber>PA0035/008/001</LicenceNumber>
    <ProductName>SULFASUXIDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCCINYLSULFATHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-12-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993009545</DrugIDPK>
    <LicenceNumber>PA0006/008/002</LicenceNumber>
    <ProductName>MANDRAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHAQUALONE</ActiveSubstance>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-09-23</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993013581</DrugIDPK>
    <LicenceNumber>PA0182/001/001</LicenceNumber>
    <ProductName>DEXASALYL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate>1976-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE ACETATE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-09-21</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010341</DrugIDPK>
    <LicenceNumber>PA0035/001/004</LicenceNumber>
    <ProductName>ALPHACILLIN</ProductName>
    <Strength>175</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010345</DrugIDPK>
    <LicenceNumber>PA0035/001/006</LicenceNumber>
    <ProductName>ALPHACILLIN</ProductName>
    <Strength>350</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010346</DrugIDPK>
    <LicenceNumber>PA0035/001/007</LicenceNumber>
    <ProductName>ALPHACILLIN</ProductName>
    <Strength>700</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-09-03</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015758</DrugIDPK>
    <LicenceNumber>PA0249/002/001</LicenceNumber>
    <ProductName>TUSCALMAN BERNA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-08-05</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993015687</DrugIDPK>
    <LicenceNumber>PA0237/001/001</LicenceNumber>
    <ProductName>DIGOXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-04-15</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010851</DrugIDPK>
    <LicenceNumber>PA0046/003/001</LicenceNumber>
    <ProductName>NANORMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1976-10-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-03-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010449</DrugIDPK>
    <LicenceNumber>PA0023/007/002</LicenceNumber>
    <ProductName>LASIX RETARD</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010447</DrugIDPK>
    <LicenceNumber>PA0023/007/001</LicenceNumber>
    <ProductName>LASIX RETARD</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-01-19</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993010427</DrugIDPK>
    <LicenceNumber>PA0023/002/001</LicenceNumber>
    <ProductName>TRH -HOECHST</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1976-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROTIRELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1976-01-06</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011639</DrugIDPK>
    <LicenceNumber>PA0072/001/002</LicenceNumber>
    <ProductName>TUSS-IONEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1975-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011640</DrugIDPK>
    <LicenceNumber>PA0072/001/003</LicenceNumber>
    <ProductName>TUSS-IONEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1975-09-26</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993011574</DrugIDPK>
    <LicenceNumber>PA0060/009/001</LicenceNumber>
    <ProductName>ESKACEF</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1975-03-30</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1993012632</DrugIDPK>
    <LicenceNumber>PA0107/004/001</LicenceNumber>
    <ProductName>SECHOLEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>1975-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLIDEXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>1974-10-22</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>1995020274</DrugIDPK>
    <LicenceNumber>EU/1/06/344/1-9</LicenceNumber>
    <ProductName>ACOMPLIA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi aventis</PAHolder>
    <AuthorisedDate>2006-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIMONABANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016074</DrugIDPK>
    <LicenceNumber>PA0218/003/001</LicenceNumber>
    <ProductName>ACTRAPID MC NEUTRAL INSULIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015676</DrugIDPK>
    <LicenceNumber>PA0236/008/003</LicenceNumber>
    <ProductName>ADRIAMYCIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006795</DrugIDPK>
    <LicenceNumber>PA0544/004/002</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA AND TETANUS VACCINE BP SYRINGE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1989-09-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007413</DrugIDPK>
    <LicenceNumber>EU/1/00/148/001</LicenceNumber>
    <ProductName>AGENERASE-AMPRENAVIR</ProductName>
    <Strength>50 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2000-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPRENAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010468</DrugIDPK>
    <LicenceNumber>EU/1/00/148/002</LicenceNumber>
    <ProductName>AGENERASE-AMPRENAVIR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2000-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPRENAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010469</DrugIDPK>
    <LicenceNumber>EU/1/00/148/003</LicenceNumber>
    <ProductName>AGENERASE-AMPRENAVIR</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2000-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPRENAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010470</DrugIDPK>
    <LicenceNumber>EU/1/00/148/004</LicenceNumber>
    <ProductName>AGENERASE-AMPRENAVIR</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2000-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPRENAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013696</DrugIDPK>
    <LicenceNumber>PA0206/008/002</LicenceNumber>
    <ProductName>AIDEX</ProductName>
    <Strength>28</Strength>
    <StrengthMeasurement>g/100ml</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004045</DrugIDPK>
    <LicenceNumber>PA0148/016/001</LicenceNumber>
    <ProductName>ALBALON LIQUIFILM EYE DROPS SOLUTION</ProductName>
    <Strength>1mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPHAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005687</DrugIDPK>
    <LicenceNumber>PA0290/066/001</LicenceNumber>
    <ProductName>ALCON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008612</DrugIDPK>
    <LicenceNumber>EU/1/00/159/001</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015960</DrugIDPK>
    <LicenceNumber>EU/1/00/159/016</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015961</DrugIDPK>
    <LicenceNumber>EU/1/00/159/017</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015963</DrugIDPK>
    <LicenceNumber>EU/1/00/159/018</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015965</DrugIDPK>
    <LicenceNumber>EU/1/00/159/019</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015967</DrugIDPK>
    <LicenceNumber>EU/1/00/159/020</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015968</DrugIDPK>
    <LicenceNumber>EU/1/00/159/021</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015969</DrugIDPK>
    <LicenceNumber>EU/1/00/159/023</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015970</DrugIDPK>
    <LicenceNumber>EU/1/00/159/024</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015971</DrugIDPK>
    <LicenceNumber>EU/1/00/159/025</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015972</DrugIDPK>
    <LicenceNumber>EU/1/00/159/026</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015973</DrugIDPK>
    <LicenceNumber>EU/1/00/159/027</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015975</DrugIDPK>
    <LicenceNumber>EU/1/00/159/028</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015976</DrugIDPK>
    <LicenceNumber>EU/1/00/159/029</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015977</DrugIDPK>
    <LicenceNumber>EU/1/00/159/030</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015978</DrugIDPK>
    <LicenceNumber>EU/1/00/159/031</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015980</DrugIDPK>
    <LicenceNumber>EU/1/00/159/032</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015981</DrugIDPK>
    <LicenceNumber>EU/1/00/159/033</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015982</DrugIDPK>
    <LicenceNumber>EU/1/00/159/034</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015951</DrugIDPK>
    <LicenceNumber>EU/1/00/159/015</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011584</DrugIDPK>
    <LicenceNumber>EU/1/00/159/022</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011048</DrugIDPK>
    <LicenceNumber>EU/1/00/159/002</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011049</DrugIDPK>
    <LicenceNumber>EU/1/00/159/003</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011050</DrugIDPK>
    <LicenceNumber>EU/1/00/159/004</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011051</DrugIDPK>
    <LicenceNumber>EU/1/00/159/005</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011052</DrugIDPK>
    <LicenceNumber>EU/1/00/159/006</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011053</DrugIDPK>
    <LicenceNumber>EU/1/00/159/007</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011054</DrugIDPK>
    <LicenceNumber>EU/1/00/159/008</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011055</DrugIDPK>
    <LicenceNumber>EU/1/00/159/009</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011056</DrugIDPK>
    <LicenceNumber>EU/1/00/159/010</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011057</DrugIDPK>
    <LicenceNumber>EU/1/00/159/011</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011058</DrugIDPK>
    <LicenceNumber>EU/1/00/159/012</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011059</DrugIDPK>
    <LicenceNumber>EU/1/00/159/013</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011038</DrugIDPK>
    <LicenceNumber>EU/1/00/159/014</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <Strength>0.5mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011653</DrugIDPK>
    <LicenceNumber>PA0073/003/012</LicenceNumber>
    <ProductName>ALORBAT (DISPOSABLE SYRINGE)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011654</DrugIDPK>
    <LicenceNumber>PA0073/003/013</LicenceNumber>
    <ProductName>ALORBAT MULTIDOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1977-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016407</DrugIDPK>
    <LicenceNumber>PA0044/064/001</LicenceNumber>
    <ProductName>ALTHESIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALFADOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004646</DrugIDPK>
    <LicenceNumber>PA0179/020/001</LicenceNumber>
    <ProductName>AMINOPLASMAL 10% E WITHOUT CARBOHYDRATES SOLUTION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>ASPARGINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>ORNITHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM ACETATE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM PHOSPHATE MONOBASIC</ActiveSubstance>
      <ActiveSubstance>MALIC ACID</ActiveSubstance>
      <ActiveSubstance>N-ACETYLTYROSINE PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004645</DrugIDPK>
    <LicenceNumber>PA0179/019/001</LicenceNumber>
    <ProductName>AMINOPLASMAL 5% E WITHOUT CARBOHYDRATES SOLUTION F</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>ASPARGINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>ORNITHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM ACETATE TETRAHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MALIC ACID</ActiveSubstance>
      <ActiveSubstance>N-ACETYLTYROSINE PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019485</DrugIDPK>
    <LicenceNumber>PA1077/033/002</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2004-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014809</DrugIDPK>
    <LicenceNumber>PPA0465/008/002B</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1987-08-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016316</DrugIDPK>
    <LicenceNumber>PA1077/033/001</LicenceNumber>
    <ProductName>AMOXIL CAPSULES 250 MG</ProductName>
    <Strength>250mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016321</DrugIDPK>
    <LicenceNumber>PA1077/033/008</LicenceNumber>
    <ProductName>AMOXIL FORTE SYRUP 250 MG/ 5ML</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016317</DrugIDPK>
    <LicenceNumber>PA1077/033/007</LicenceNumber>
    <ProductName>AMOXIL SYRUP 125 MG/ 5 ML</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2002-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005769</DrugIDPK>
    <LicenceNumber>PA0298/001/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1981-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005771</DrugIDPK>
    <LicenceNumber>PA0298/001/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1981-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006297</DrugIDPK>
    <LicenceNumber>PA0432/003/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1986-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005772</DrugIDPK>
    <LicenceNumber>PA0298/002/001</LicenceNumber>
    <ProductName>AMPICILLIN ORAL SUSPENSION BP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005773</DrugIDPK>
    <LicenceNumber>PA0298/002/002</LicenceNumber>
    <ProductName>AMPICILLIN ORAL SUSPENSION BP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1986-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013795</DrugIDPK>
    <LicenceNumber>PA0281/009/004</LicenceNumber>
    <ProductName>AMPICILLIN SYRUP B P C</ProductName>
    <Strength>125mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015226</DrugIDPK>
    <LicenceNumber>PA0432/003/001</LicenceNumber>
    <ProductName>AMPICILLIN SYRUP POWDER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009721</DrugIDPK>
    <LicenceNumber>PA0002/016/007</LicenceNumber>
    <ProductName>ANATENSOL DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009539</DrugIDPK>
    <LicenceNumber>PA0002/016/001</LicenceNumber>
    <ProductName>ANATENSOL DECANOATE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010488</DrugIDPK>
    <LicenceNumber>PA0540/029/002</LicenceNumber>
    <ProductName>ANZEMET</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOLASETRON MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010492</DrugIDPK>
    <LicenceNumber>PA0540/029/003</LicenceNumber>
    <ProductName>ANZEMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOLASETRON MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010493</DrugIDPK>
    <LicenceNumber>PA0540/029/001</LicenceNumber>
    <ProductName>ANZEMET INJECTION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>2001-09-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOLASETRON MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993007911</DrugIDPK>
    <LicenceNumber>PA0374/003/001</LicenceNumber>
    <ProductName>ARDUAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon Teknika Ltd</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PIPECURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031032</DrugIDPK>
    <LicenceNumber>EU/1/10/624/001</LicenceNumber>
    <ProductName>AREPANRIX</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Biologicals S.A.</PAHolder>
    <AuthorisedDate>2010-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension and Emulsion for emulsion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1)V LIKE STRAIN (X-179A)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006711</DrugIDPK>
    <LicenceNumber>PA0568/001/001</LicenceNumber>
    <ProductName>ARTEXAL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>1988-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERTATOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015109</DrugIDPK>
    <LicenceNumber>PA0050/152/001</LicenceNumber>
    <ProductName>ASPRO TABLETS</ProductName>
    <Strength>320</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>For general sale in packs containing not more than 24 tablets. For Pharmacy only sale in packs not exceeding 50 tablets.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028478</DrugIDPK>
    <LicenceNumber>PA1501/001/001</LicenceNumber>
    <ProductName>ATRIDOX</ProductName>
    <Strength>44</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Tolmar GmbH</PAHolder>
    <AuthorisedDate>2008-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for gingival gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003045</DrugIDPK>
    <LicenceNumber>PPA0465/047/001A</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <Strength>250/125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANIC ACID (IN THE FORM OF POTASSIUM CLAVULANATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001012</DrugIDPK>
    <LicenceNumber>PA0018/007/001</LicenceNumber>
    <ProductName>AURALGICIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENAZONE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020367</DrugIDPK>
    <LicenceNumber>EU/1/06/349/06</LicenceNumber>
    <ProductName>AVAGLIM</ProductName>
    <Strength>4/1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2006-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020368</DrugIDPK>
    <LicenceNumber>EU/1/06/349/01</LicenceNumber>
    <ProductName>AVAGLIM</ProductName>
    <Strength>4/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2006-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020369</DrugIDPK>
    <LicenceNumber>EU/1/06/349/02</LicenceNumber>
    <ProductName>AVAGLIM</ProductName>
    <Strength>4/4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2006-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020370</DrugIDPK>
    <LicenceNumber>EU/1/06/349/03</LicenceNumber>
    <ProductName>AVAGLIM</ProductName>
    <Strength>8/1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2006-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020371</DrugIDPK>
    <LicenceNumber>EU/1/06/349/04</LicenceNumber>
    <ProductName>AVAGLIM</ProductName>
    <Strength>8/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2006-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020372</DrugIDPK>
    <LicenceNumber>EU/1/06/349/05</LicenceNumber>
    <ProductName>AVAGLIM</ProductName>
    <Strength>8/4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>2006-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSIGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995002030</DrugIDPK>
    <LicenceNumber>EU/1/97/033/001</LicenceNumber>
    <ProductName>AVONEX</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Biogen Idec Ltd</PAHolder>
    <AuthorisedDate>1997-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON BETA - 1A</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006103</DrugIDPK>
    <LicenceNumber>PA0437/021/001</LicenceNumber>
    <ProductName>BACTERIOSTATIC WATER</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006104</DrugIDPK>
    <LicenceNumber>PA0437/021/002</LicenceNumber>
    <ProductName>BACTERIOSTATIC WATER</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006105</DrugIDPK>
    <LicenceNumber>PA0437/021/003</LicenceNumber>
    <ProductName>BACTERIOSTATIC WATER</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for Parenteral Use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016144</DrugIDPK>
    <LicenceNumber>PA1077/041/001</LicenceNumber>
    <ProductName>BECONASE AQUEOUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016149</DrugIDPK>
    <LicenceNumber>PA1077/042/002</LicenceNumber>
    <ProductName>BECOTIDE 100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008559</DrugIDPK>
    <LicenceNumber>PPA0465/041/004C</LicenceNumber>
    <ProductName>BECOTIDE 250 INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008560</DrugIDPK>
    <LicenceNumber>PPA0465/041/004B</LicenceNumber>
    <ProductName>BECOTIDE 250 INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2000-12-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018023</DrugIDPK>
    <LicenceNumber>PPA0465/041/004D</LicenceNumber>
    <ProductName>BECOTIDE 250 INHALER</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011853</DrugIDPK>
    <LicenceNumber>PPA0465/041/002B</LicenceNumber>
    <ProductName>BECOTIDE INHALER 100MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-01-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011821</DrugIDPK>
    <LicenceNumber>PPA0465/041/001B</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011822</DrugIDPK>
    <LicenceNumber>PPA0465/041/001C</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011823</DrugIDPK>
    <LicenceNumber>PPA0465/041/001D</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011824</DrugIDPK>
    <LicenceNumber>PPA0465/041/001E</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011825</DrugIDPK>
    <LicenceNumber>PPA0465/041/001F</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011826</DrugIDPK>
    <LicenceNumber>PPA0465/041/001G</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005745</DrugIDPK>
    <LicenceNumber>PA0877/001/001</LicenceNumber>
    <ProductName>BEGRIVAC</ProductName>
    <Strength>15/15/15mc</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1) - DERIVED STRAIN USED NYMC X-181 REASS</ActiveSubstance>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1) - DERIVED STRAIN USED NYMC X-181 REASS</ActiveSubstance>
      <ActiveSubstance>B/BRISBANE/60/2008 - LIKE STRAIN (B/BRISBANE/60/2008)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005746</DrugIDPK>
    <LicenceNumber>PA0877/001/002</LicenceNumber>
    <ProductName>BEGRIVAC</ProductName>
    <Strength>15/15/15mc</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate>1998-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1) - DERIVED STRAIN USED NYMC X-181 REASS</ActiveSubstance>
      <ActiveSubstance>A/CALIFORNIA/7/2009 (H1N1) - DERIVED STRAIN USED NYMC X-181 REASS</ActiveSubstance>
      <ActiveSubstance>B/BRISBANE/60/2008</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005328</DrugIDPK>
    <LicenceNumber>PA1185/001/001</LicenceNumber>
    <ProductName>BELLFORMIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BellPharma Limited</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005329</DrugIDPK>
    <LicenceNumber>PA1185/001/002</LicenceNumber>
    <ProductName>BELLFORMIN</ProductName>
    <Strength>850</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BellPharma Limited</PAHolder>
    <AuthorisedDate>1999-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METFORMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004079</DrugIDPK>
    <LicenceNumber>EU/1/97/047/001</LicenceNumber>
    <ProductName>BENEFIX</ProductName>
    <Strength>250 IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate>1997-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004898</DrugIDPK>
    <LicenceNumber>EU/1/97/047/002</LicenceNumber>
    <ProductName>BENEFIX</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate>1997-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal  product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004899</DrugIDPK>
    <LicenceNumber>EU/1/97/047/003</LicenceNumber>
    <ProductName>BENEFIX</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate>1997-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR IX, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004823</DrugIDPK>
    <LicenceNumber>PA0823/011/001</LicenceNumber>
    <ProductName>BENYLIN WITH CODEINE</ProductName>
    <Strength>14/5.7/1.1</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1995-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>LEVOMENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995002086</DrugIDPK>
    <LicenceNumber>PA0148/040/002</LicenceNumber>
    <ProductName>BETAGAN LIQUIFILM TOPICAL OPHTHALMIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013855</DrugIDPK>
    <LicenceNumber>PA0970/032/003</LicenceNumber>
    <ProductName>BETALOC</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013856</DrugIDPK>
    <LicenceNumber>PA0970/032/002</LicenceNumber>
    <ProductName>BETALOC</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015853</DrugIDPK>
    <LicenceNumber>PA0365/066/001</LicenceNumber>
    <ProductName>BETNELAN</ProductName>
    <Strength>500mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1993-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005883</DrugIDPK>
    <LicenceNumber>PA0365/046/002</LicenceNumber>
    <ProductName>BETNESOL-N 0.01% W/W, 3500 IU/ML EYE OINTMENT</ProductName>
    <Strength>0.1/0.5%w/ %v/v</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1993-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012099</DrugIDPK>
    <LicenceNumber>EU/1/02/239/1-24</LicenceNumber>
    <ProductName>BEXTRA</ProductName>
    <Strength>10/20/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia-Pfizer EEIG</PAHolder>
    <AuthorisedDate>2003-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALDECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015219</DrugIDPK>
    <LicenceNumber>PA0211/018/001</LicenceNumber>
    <ProductName>BIDOPLEX ELIXIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1983-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015220</DrugIDPK>
    <LicenceNumber>PA0211/019/001</LicenceNumber>
    <ProductName>BIOTRAZEPAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015197</DrugIDPK>
    <LicenceNumber>PA0211/009/001</LicenceNumber>
    <ProductName>BIOZINE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Litre</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015198</DrugIDPK>
    <LicenceNumber>PA0211/009/002</LicenceNumber>
    <ProductName>BIOZINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015201</DrugIDPK>
    <LicenceNumber>PA0211/009/003</LicenceNumber>
    <ProductName>BIOZINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015202</DrugIDPK>
    <LicenceNumber>PA0211/009/004</LicenceNumber>
    <ProductName>BIOZINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004051</DrugIDPK>
    <LicenceNumber>PA0148/022/001</LicenceNumber>
    <ProductName>BLEPH-10</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013046</DrugIDPK>
    <LicenceNumber>PA0137/018/002</LicenceNumber>
    <ProductName>BLEPHAMIDE OPHTHALMIC (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007379</DrugIDPK>
    <LicenceNumber>EU/1/96/012/002</LicenceNumber>
    <ProductName>BONDRONAT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1996-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID MONOSODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007380</DrugIDPK>
    <LicenceNumber>EU/1/96/012/003</LicenceNumber>
    <ProductName>BONDRONAT</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID MONOSODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010649</DrugIDPK>
    <LicenceNumber>EU/1/96/012/005</LicenceNumber>
    <ProductName>BONDRONAT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>2000-12-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID MONOSODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004648</DrugIDPK>
    <LicenceNumber>PA0179/025/001</LicenceNumber>
    <ProductName>BRAUNODERM COLOURED</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004649</DrugIDPK>
    <LicenceNumber>PA0179/025/002</LicenceNumber>
    <ProductName>BRAUNODERM NON-COLOURED</ProductName>
    <Strength>500/10</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1987-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODINATED POVIDONE PH.EUR.</ActiveSubstance>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004651</DrugIDPK>
    <LicenceNumber>PA0179/027/001</LicenceNumber>
    <ProductName>BRAUNOL</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004650</DrugIDPK>
    <LicenceNumber>PA0179/026/002</LicenceNumber>
    <ProductName>BRAUNOSAN</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004647</DrugIDPK>
    <LicenceNumber>PA0179/024/001</LicenceNumber>
    <ProductName>BRAUNOVIDON</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1986-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012716</DrugIDPK>
    <LicenceNumber>PA0936/018/001</LicenceNumber>
    <ProductName>BREVINOR TABLETS</ProductName>
    <Strength>5/0.036mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>1997-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013098</DrugIDPK>
    <LicenceNumber>PA0137/040/001</LicenceNumber>
    <ProductName>BRONCHOTONE MIXTURE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>SODIUM IODIDE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002860</DrugIDPK>
    <LicenceNumber>PA0060/004/003</LicenceNumber>
    <ProductName>BRONSECUR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1976-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002862</DrugIDPK>
    <LicenceNumber>PA0060/004/004</LicenceNumber>
    <ProductName>BRONSECUR LIQUID CONCENTRATE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>1976-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004351</DrugIDPK>
    <LicenceNumber>PA0823/010/006</LicenceNumber>
    <ProductName>CALPOL SUGAR/COLOUR FREE INFANT</ProductName>
    <Strength>120mg/5ml</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1996-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in child resistant packs containing not more than 60ml of the 120mg/5ml unit dosage form.  The product concerned should contain paracetamol as its only active analgesic substance and only one pack should be supplied in the course of any one retail transaction.
Retail sale through pharmacies only in child resistant packs containing not more than 140 ml of the120mg/5ml unit dosage form.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.
Prescription only for any pack size exceeding 140ml content of the 120mg/5ml unit dosage form.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010859</DrugIDPK>
    <LicenceNumber>PA0046/007/006</LicenceNumber>
    <ProductName>CALVEPEN DRY POWDER (SUSPENSION)</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010860</DrugIDPK>
    <LicenceNumber>PA0046/007/007</LicenceNumber>
    <ProductName>CALVEPEN DRY POWDER (SUSPENSION)</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014737</DrugIDPK>
    <LicenceNumber>EU/1/01/196/002</LicenceNumber>
    <ProductName>CANCIDAS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>2001-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CASPOFUNGIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013617</DrugIDPK>
    <LicenceNumber>PPA0465/043/001B</LicenceNumber>
    <ProductName>CAPOZIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1996-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014849</DrugIDPK>
    <LicenceNumber>PA0002/072/006</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1997-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012530</DrugIDPK>
    <LicenceNumber>PA0425/003/003</LicenceNumber>
    <ProductName>CARDIAGUTT</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>1989-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011547</DrugIDPK>
    <LicenceNumber>PPA0465/079/001B</LicenceNumber>
    <ProductName>CATAFLAM</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015805</DrugIDPK>
    <LicenceNumber>EU/1/96/023/001</LicenceNumber>
    <ProductName>CEA-SCAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Immunomedics Inc</PAHolder>
    <AuthorisedDate>1996-10-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011621</DrugIDPK>
    <LicenceNumber>PA0063/012/001</LicenceNumber>
    <ProductName>CHLORACIN 3%</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013205</DrugIDPK>
    <LicenceNumber>PA0157/005/001</LicenceNumber>
    <ProductName>CHLORAMBID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Controlled Medications Limited</PAHolder>
    <AuthorisedDate>1977-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015196</DrugIDPK>
    <LicenceNumber>PA0211/008/001</LicenceNumber>
    <ProductName>CHLORPHENIRAMINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009789</DrugIDPK>
    <LicenceNumber>PA0010/026/001</LicenceNumber>
    <ProductName>CHYMODIACTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>CHYMOPAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009531</DrugIDPK>
    <LicenceNumber>PA0006/003/010</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <Strength>60/1.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009533</DrugIDPK>
    <LicenceNumber>PA0006/003/011</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002940</DrugIDPK>
    <LicenceNumber>PA0006/003/003</LicenceNumber>
    <ProductName>CIDOMYCIN OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003934</DrugIDPK>
    <LicenceNumber>PA0126/077/003</LicenceNumber>
    <ProductName>CIMELDINE</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1989-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006506</DrugIDPK>
    <LicenceNumber>PA0476/004/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006507</DrugIDPK>
    <LicenceNumber>PA0476/004/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>1991-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027768</DrugIDPK>
    <LicenceNumber>PA1380/049/001</LicenceNumber>
    <ProductName>CIPLOX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010241</DrugIDPK>
    <LicenceNumber>PPA0465/068/001A</LicenceNumber>
    <ProductName>CIPRAMIL 10 MG FILM-COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014532</DrugIDPK>
    <LicenceNumber>PPA0465/082/002A</LicenceNumber>
    <ProductName>CIPROXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014531</DrugIDPK>
    <LicenceNumber>PPA0465/082/001A</LicenceNumber>
    <ProductName>CIPROXIN 250 MG FILM-COATED TABLETS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014821</DrugIDPK>
    <LicenceNumber>PA1045/001/002</LicenceNumber>
    <ProductName>CITANEST 3% WITH OCTAPRESSIN SELF ASPIRATING</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Dentsply Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>FELYPRESSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014822</DrugIDPK>
    <LicenceNumber>PA1045/002/001</LicenceNumber>
    <ProductName>CITANEST 4% DENTAL INJECTION</ProductName>
    <Strength>40mg/ml</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Dentsply Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005275</DrugIDPK>
    <LicenceNumber>PA0167/098/002</LicenceNumber>
    <ProductName>CLINIMIX N9G20E</ProductName>
    <Strength>5.5/20</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1996-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>L-METHIONINE</ActiveSubstance>
      <ActiveSubstance>L-LYSINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003823</DrugIDPK>
    <LicenceNumber>PA0126/015/002</LicenceNumber>
    <ProductName>CLONAMP</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Anhyd Milligrams</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003824</DrugIDPK>
    <LicenceNumber>PA0126/015/003</LicenceNumber>
    <ProductName>CLONAMP</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Anhyd mg/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003825</DrugIDPK>
    <LicenceNumber>PA0126/015/004</LicenceNumber>
    <ProductName>CLONAMP</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Anhyd mg/5ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1981-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013181</DrugIDPK>
    <LicenceNumber>PA0157/002/001</LicenceNumber>
    <ProductName>COLSPAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Concept Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1976-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018227</DrugIDPK>
    <LicenceNumber>PPA0465/105/002A</LicenceNumber>
    <ProductName>COMBIVENT UDVS 500 MICROGRAMS/2.5MG PER 2.5ML NEBU</ProductName>
    <Strength>0.5/2.5</Strength>
    <StrengthMeasurement>Base mg/unit</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010684</DrugIDPK>
    <LicenceNumber>PA0618/043/001</LicenceNumber>
    <ProductName>COMPOUND W</ProductName>
    <Strength>17.0%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000465</DrugIDPK>
    <LicenceNumber>PA0019/028/001</LicenceNumber>
    <ProductName>COPTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1979-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000466</DrugIDPK>
    <LicenceNumber>PA0019/001/006</LicenceNumber>
    <ProductName>COPTIN  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SULFADIAZINE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995002094</DrugIDPK>
    <LicenceNumber>PA0019/028/002</LicenceNumber>
    <ProductName>COPTIN SUSPENSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005885</DrugIDPK>
    <LicenceNumber>PA0365/049/001</LicenceNumber>
    <ProductName>CORLAN</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>1993-07-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010029</DrugIDPK>
    <LicenceNumber>PA0019/018/006</LicenceNumber>
    <ProductName>CORTRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005825</DrugIDPK>
    <LicenceNumber>PA0298/011/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1989-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005826</DrugIDPK>
    <LicenceNumber>PA0298/011/002</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>1989-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006747</DrugIDPK>
    <LicenceNumber>EU/1/99/106/001</LicenceNumber>
    <ProductName>COTRONAK</ProductName>
    <Strength>200mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>1999-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBAVIRIN</ActiveSubstance>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008025</DrugIDPK>
    <LicenceNumber>EU/1/99/106/002</LicenceNumber>
    <ProductName>COTRONAK</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>1999-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBAVIRIN</ActiveSubstance>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008026</DrugIDPK>
    <LicenceNumber>EU/1/99/106/003</LicenceNumber>
    <ProductName>COTRONAK</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>1999-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBAVIRIN</ActiveSubstance>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010078</DrugIDPK>
    <LicenceNumber>PPA0465/067/001C</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>4mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010079</DrugIDPK>
    <LicenceNumber>PPA0465/067/001B</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008762</DrugIDPK>
    <LicenceNumber>PA0285/013/001</LicenceNumber>
    <ProductName>CRINONE 4% PROGESTERONE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1997-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROGESTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008060</DrugIDPK>
    <LicenceNumber>EU/1/96/024/006</LicenceNumber>
    <ProductName>CRIXIVAN</ProductName>
    <Strength>mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDINAVIR SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010975</DrugIDPK>
    <LicenceNumber>PA0043/038/001</LicenceNumber>
    <ProductName>CROOKES SPOT TREATMENT CREAM REGULAR - COLOURLESS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010976</DrugIDPK>
    <LicenceNumber>PA0043/038/002</LicenceNumber>
    <ProductName>CROOKES SPOT TREATMENT CREAM REGULAR - COVER UP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013265</DrugIDPK>
    <LicenceNumber>PA0157/004/001</LicenceNumber>
    <ProductName>CYCLABID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Controlled Medications Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000377</DrugIDPK>
    <LicenceNumber>PA0045/013/003</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1979-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000282</DrugIDPK>
    <LicenceNumber>PA0045/013/005</LicenceNumber>
    <ProductName>DAKTARIN TABLETS 250MG</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1979-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003970</DrugIDPK>
    <LicenceNumber>EU/1/97/052/001</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003971</DrugIDPK>
    <LicenceNumber>EU/1/97/052/003</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003972</DrugIDPK>
    <LicenceNumber>EU/1/97/052/005</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003974</DrugIDPK>
    <LicenceNumber>EU/1/97/052/009</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>1.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007031</DrugIDPK>
    <LicenceNumber>EU/1/97/052/002</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007032</DrugIDPK>
    <LicenceNumber>EU/1/97/052/004</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007033</DrugIDPK>
    <LicenceNumber>EU/1/97/052/006</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007036</DrugIDPK>
    <LicenceNumber>EU/1/97/052/010</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <Strength>1.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>1997-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011604</DrugIDPK>
    <LicenceNumber>PA0062/022/001</LicenceNumber>
    <ProductName>DE- NOLTAB CHEWABLE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>1983-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015630</DrugIDPK>
    <LicenceNumber>PA0299/004/001</LicenceNumber>
    <ProductName>DE WITT POWERFUL LAXATIVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
      <ActiveSubstance>ALOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005252</DrugIDPK>
    <LicenceNumber>PA0278/011/001</LicenceNumber>
    <ProductName>DERMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010522</DrugIDPK>
    <LicenceNumber>PA0023/039/001</LicenceNumber>
    <ProductName>DESOXYMETHASONE</ProductName>
    <Strength>0.05</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005691</DrugIDPK>
    <LicenceNumber>EU/1/96/013/001</LicenceNumber>
    <ProductName>DESTARA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1996-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007382</DrugIDPK>
    <LicenceNumber>EU/1/96/013/002</LicenceNumber>
    <ProductName>DESTARA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1996-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007383</DrugIDPK>
    <LicenceNumber>EU/1/96/013/003</LicenceNumber>
    <ProductName>DESTARA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007384</DrugIDPK>
    <LicenceNumber>EU/1/96/013/004</LicenceNumber>
    <ProductName>DESTARA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000556</DrugIDPK>
    <LicenceNumber>PA0179/011/001</LicenceNumber>
    <ProductName>DEXTRAN 40 BRAUN IN SODIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013551</DrugIDPK>
    <LicenceNumber>PA0179/001/016</LicenceNumber>
    <ProductName>DEXTROSE 10%</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013246</DrugIDPK>
    <LicenceNumber>PA0179/001/015</LicenceNumber>
    <ProductName>DEXTROSE 10%</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015763</DrugIDPK>
    <LicenceNumber>PA0249/003/002</LicenceNumber>
    <ProductName>DI TI PER ANATOXAL BERNA</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014608</DrugIDPK>
    <LicenceNumber>PPA0465/045/001B</LicenceNumber>
    <ProductName>DIAMICRON</ProductName>
    <Strength>80mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015182</DrugIDPK>
    <LicenceNumber>PA0211/002/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015183</DrugIDPK>
    <LicenceNumber>PA0211/002/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015184</DrugIDPK>
    <LicenceNumber>PA0211/002/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012537</DrugIDPK>
    <LicenceNumber>PA0436/002/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012545</DrugIDPK>
    <LicenceNumber>PA0436/002/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005575</DrugIDPK>
    <LicenceNumber>PA0282/049/001</LicenceNumber>
    <ProductName>DILTIAZEM HYDROCHLORIDE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1991-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010996</DrugIDPK>
    <LicenceNumber>PA0046/038/001</LicenceNumber>
    <ProductName>DILUENT FOR ONE-ALPHA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003465</DrugIDPK>
    <LicenceNumber>PA0086/004/001</LicenceNumber>
    <ProductName>DIMOTANE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>1976-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013146</DrugIDPK>
    <LicenceNumber>PA0126/086/002</LicenceNumber>
    <ProductName>DIPARIM 75</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009920</DrugIDPK>
    <LicenceNumber>PA0012/062/001</LicenceNumber>
    <ProductName>DOPERGIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012022</DrugIDPK>
    <LicenceNumber>PA0078/047/001</LicenceNumber>
    <ProductName>DOXY</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004737</DrugIDPK>
    <LicenceNumber>PA0206/006/003</LicenceNumber>
    <ProductName>DROXARYL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003451</DrugIDPK>
    <LicenceNumber>PA0007/021/001</LicenceNumber>
    <ProductName>DUOVENT INHALER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1981-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015641</DrugIDPK>
    <LicenceNumber>EU/1/02/211/007</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015642</DrugIDPK>
    <LicenceNumber>EU/1/02/211/008</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015643</DrugIDPK>
    <LicenceNumber>EU/1/02/211/009</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015623</DrugIDPK>
    <LicenceNumber>EU/1/02/211/002</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015624</DrugIDPK>
    <LicenceNumber>EU/1/02/211/003</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>0.3</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015625</DrugIDPK>
    <LicenceNumber>EU/1/02/211/004</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015626</DrugIDPK>
    <LicenceNumber>EU/1/02/211/005</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015627</DrugIDPK>
    <LicenceNumber>EU/1/02/211/006</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>ml/5ml</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010118</DrugIDPK>
    <LicenceNumber>EU/1/02/211/001</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2002-03-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN DELTA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023448</DrugIDPK>
    <LicenceNumber>EU/1/02/211/010</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>5,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2007-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN DELTA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023449</DrugIDPK>
    <LicenceNumber>EU/1/02/211/011</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>6,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2007-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN DELTA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023451</DrugIDPK>
    <LicenceNumber>EU/1/02/211/012</LicenceNumber>
    <ProductName>DYNEPO</ProductName>
    <Strength>8,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2007-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN DELTA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019929</DrugIDPK>
    <LicenceNumber>PA0583/001/002</LicenceNumber>
    <ProductName>DYSPORT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>2008-12-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOSTRIDIUM BOTULINUM TYP A-ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006596</DrugIDPK>
    <LicenceNumber>PA0547/001/001</LicenceNumber>
    <ProductName>EAREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pharmalab Limited</PAHolder>
    <AuthorisedDate>1992-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SWEET ALMOND OIL</ActiveSubstance>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013182</DrugIDPK>
    <LicenceNumber>PA0145/001/001</LicenceNumber>
    <ProductName>ECZENSA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013185</DrugIDPK>
    <LicenceNumber>PA0145/002/002</LicenceNumber>
    <ProductName>ECZENSA - S</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018354</DrugIDPK>
    <LicenceNumber>PPA0465/085/001B</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <Strength>37.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VENLAFAXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002195</DrugIDPK>
    <LicenceNumber>PA0047/049/003</LicenceNumber>
    <ProductName>ELDISINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993007132</DrugIDPK>
    <LicenceNumber>PA0329/001/001</LicenceNumber>
    <ProductName>ELUDRIL</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>1999-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouth Wash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010266</DrugIDPK>
    <LicenceNumber>PA0022/004/002</LicenceNumber>
    <ProductName>EQUAGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014606</DrugIDPK>
    <LicenceNumber>PPA0465/044/002C</LicenceNumber>
    <ProductName>ESTRADERM TTS</ProductName>
    <Strength>50mcg/day</Strength>
    <StrengthMeasurement>Microgram/day</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008425</DrugIDPK>
    <LicenceNumber>PA0061/015/001</LicenceNumber>
    <ProductName>ESTRADIOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008426</DrugIDPK>
    <LicenceNumber>PA0061/015/002</LicenceNumber>
    <ProductName>ESTRADIOL</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008427</DrugIDPK>
    <LicenceNumber>PA0061/015/003</LicenceNumber>
    <ProductName>ESTRADIOL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006369</DrugIDPK>
    <LicenceNumber>PA0908/001/001</LicenceNumber>
    <ProductName>ESTREVA</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Belpharma SA</PAHolder>
    <AuthorisedDate>1999-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017777</DrugIDPK>
    <LicenceNumber>PA0030/055/001</LicenceNumber>
    <ProductName>EX-LAX SENNA PILLS</ProductName>
    <Strength>12mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>2007-04-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CASSIA SENNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027180</DrugIDPK>
    <LicenceNumber>EU/1/08/500/1-4</LicenceNumber>
    <ProductName>FABLYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Dr. Friedrich Eberth</PAHolder>
    <AuthorisedDate>2009-02-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LASOFOXIFENE TARTRATE (00-RS-49750)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009744</DrugIDPK>
    <LicenceNumber>PA0010/006/004</LicenceNumber>
    <ProductName>FACTORATE HEAT TREATED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>1988-05-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>HUMAN PLASMAFRAKTION (FACTOR VIII)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005393</DrugIDPK>
    <LicenceNumber>PA0275/011/001</LicenceNumber>
    <ProductName>FAMEL HONEY &amp; LEMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Optrex Limited</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CREOSOTE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001068</DrugIDPK>
    <LicenceNumber>PA0019/024/004</LicenceNumber>
    <ProductName>FELDENE</ProductName>
    <Strength>10 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1984-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022911</DrugIDPK>
    <LicenceNumber>PA0822/022/001</LicenceNumber>
    <ProductName>FELDENE TOPIGEL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>2007-03-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995001001</DrugIDPK>
    <LicenceNumber>PA0032/002/001</LicenceNumber>
    <ProductName>FEMINAX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1976-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>SALICYLAMIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012152</DrugIDPK>
    <LicenceNumber>PA0549/010/002</LicenceNumber>
    <ProductName>FENOFIBRATE ETHYPHARM</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009641</DrugIDPK>
    <LicenceNumber>PA0004/022/001</LicenceNumber>
    <ProductName>FENOX  (SPRAY)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004035</DrugIDPK>
    <LicenceNumber>PA0126/030/002</LicenceNumber>
    <ProductName>FERRUM HAUSMANN INTRAMUSCULAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016150</DrugIDPK>
    <LicenceNumber>PA1077/043/001</LicenceNumber>
    <ProductName>FLIXONASE AQUEOUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003195</DrugIDPK>
    <LicenceNumber>PA0281/031/003</LicenceNumber>
    <ProductName>FLUCILLIN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1997-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004067</DrugIDPK>
    <LicenceNumber>PA0148/007/002</LicenceNumber>
    <ProductName>FML FORTE LIQUIFILM</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1986-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROMETHOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000928</DrugIDPK>
    <LicenceNumber>PA0148/020/001</LicenceNumber>
    <ProductName>FML-NEO LIQUIFILM</ProductName>
    <Strength>1/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1976-05-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>FLUOROMETHOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007605</DrugIDPK>
    <LicenceNumber>EU/1/98/093/002</LicenceNumber>
    <ProductName>FORCALTONIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Unigene UK Limited</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005722</DrugIDPK>
    <LicenceNumber>EU/1/98/093/001</LicenceNumber>
    <ProductName>FORCALTONIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Unigene UK Limited</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011753</DrugIDPK>
    <LicenceNumber>PA0077/004/002</LicenceNumber>
    <ProductName>FORTAGESIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006998</DrugIDPK>
    <LicenceNumber>EU/1/98/075/002</LicenceNumber>
    <ProductName>FORTOVASE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1998-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SAQUINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005045</DrugIDPK>
    <LicenceNumber>EU/1/98/075/001</LicenceNumber>
    <ProductName>FORTOVASE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1998-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SAQUINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001013</DrugIDPK>
    <LicenceNumber>PA0018/009/001</LicenceNumber>
    <ProductName>FRAMYCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001014</DrugIDPK>
    <LicenceNumber>PA0018/009/002</LicenceNumber>
    <ProductName>FRAMYCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001015</DrugIDPK>
    <LicenceNumber>PA0018/009/003</LicenceNumber>
    <ProductName>FRAMYCORT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001016</DrugIDPK>
    <LicenceNumber>PA0018/010/001</LicenceNumber>
    <ProductName>FRAMYGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001017</DrugIDPK>
    <LicenceNumber>PA0018/010/002</LicenceNumber>
    <ProductName>FRAMYGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001018</DrugIDPK>
    <LicenceNumber>PA0018/010/003</LicenceNumber>
    <ProductName>FRAMYGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003361</DrugIDPK>
    <LicenceNumber>PA0077/017/005</LicenceNumber>
    <ProductName>FRANOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1983-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015180</DrugIDPK>
    <LicenceNumber>PA0211/001/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1980-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015181</DrugIDPK>
    <LicenceNumber>PA0211/001/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1982-02-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012549</DrugIDPK>
    <LicenceNumber>PA0436/003/001</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012550</DrugIDPK>
    <LicenceNumber>PA0436/003/002</LicenceNumber>
    <ProductName>FRUSEMIDE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>1986-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016786</DrugIDPK>
    <LicenceNumber>PA1097/001/001</LicenceNumber>
    <ProductName>GABAPENTIN 100 MG CAPSULES</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>2005-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016787</DrugIDPK>
    <LicenceNumber>PA1097/001/002</LicenceNumber>
    <ProductName>GABAPENTIN 300MG CAPSULES</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>2005-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016788</DrugIDPK>
    <LicenceNumber>PA1097/001/003</LicenceNumber>
    <ProductName>GABAPENTIN 400MG CAPSULES</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>2005-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022894</DrugIDPK>
    <LicenceNumber>PA0711/132/004</LicenceNumber>
    <ProductName>GABIN 600 MG FILM-COATED TABLETS</ProductName>
    <Strength>600mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2007-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022895</DrugIDPK>
    <LicenceNumber>PA0711/132/005</LicenceNumber>
    <ProductName>GABIN 800 MG FILM-COATED TABLETS</ProductName>
    <Strength>800mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2007-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GABAPENTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015236</DrugIDPK>
    <LicenceNumber>PA0827/003/001</LicenceNumber>
    <ProductName>GABITRIL</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Cephalon UK Limited</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAGABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004553</DrugIDPK>
    <LicenceNumber>PA0179/038/001</LicenceNumber>
    <ProductName>GELOFUSINE</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>1992-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GELATINE POLYSUCCINATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004024</DrugIDPK>
    <LicenceNumber>PA0148/035/001</LicenceNumber>
    <ProductName>GENOPTIC LIQUIFILM</ProductName>
    <Strength>0.30</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1982-08-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006750</DrugIDPK>
    <LicenceNumber>PA0577/005/001</LicenceNumber>
    <ProductName>GERAMET</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1991-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006751</DrugIDPK>
    <LicenceNumber>PA0577/005/002</LicenceNumber>
    <ProductName>GERAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1991-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006752</DrugIDPK>
    <LicenceNumber>PA0577/005/003</LicenceNumber>
    <ProductName>GERAMET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1991-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995001640</DrugIDPK>
    <LicenceNumber>PA0577/016/001</LicenceNumber>
    <ProductName>GERIFLOX ELIXIR</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Base mg/5ml</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>1996-12-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015013</DrugIDPK>
    <LicenceNumber>PA0566/006/004</LicenceNumber>
    <ProductName>GLAMIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>2004-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>GLYCYL - GLUTAMINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLYCYL -TYROSINE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
      <ActiveSubstance>METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007920</DrugIDPK>
    <LicenceNumber>PA0566/006/001A</LicenceNumber>
    <ProductName>GLAMIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>GLYCYL - GLUTAMINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>GLYCYL -TYROSINE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE ACETATE</ActiveSubstance>
      <ActiveSubstance>METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012846</DrugIDPK>
    <LicenceNumber>PA0552/009/001</LicenceNumber>
    <ProductName>GLAUBERS SALT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Superpac Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003543</DrugIDPK>
    <LicenceNumber>PA0090/007/002</LicenceNumber>
    <ProductName>GONADOTRAPHON L.H.</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006646</DrugIDPK>
    <LicenceNumber>EU/1/95/001/013</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006647</DrugIDPK>
    <LicenceNumber>EU/1/95/001/014</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006648</DrugIDPK>
    <LicenceNumber>EU/1/95/001/015</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006764</DrugIDPK>
    <LicenceNumber>EU/1/95/001/017</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1999-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008344</DrugIDPK>
    <LicenceNumber>EU/1/95/001/018</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1999-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008372</DrugIDPK>
    <LicenceNumber>EU/1/95/001/019</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1999-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008374</DrugIDPK>
    <LicenceNumber>EU/1/95/001/020</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1999-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011719</DrugIDPK>
    <LicenceNumber>EU/1/95/001/022</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>2002-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015704</DrugIDPK>
    <LicenceNumber>EU/1/95/001/023</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>2002-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015705</DrugIDPK>
    <LicenceNumber>EU/1/95/001/024</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>2002-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015709</DrugIDPK>
    <LicenceNumber>EU/1/95/001/028</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>2002-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015710</DrugIDPK>
    <LicenceNumber>EU/1/95/001/029</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>2002-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009149</DrugIDPK>
    <LicenceNumber>EU/1/95/001/035</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>900/1.5</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009151</DrugIDPK>
    <LicenceNumber>EU/1/95/001/012</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006638</DrugIDPK>
    <LicenceNumber>EU/1/95/001/002</LicenceNumber>
    <ProductName>GONAL-F - AMPOULE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006640</DrugIDPK>
    <LicenceNumber>EU/1/95/001/004</LicenceNumber>
    <ProductName>GONAL-F - AMPOULE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006644</DrugIDPK>
    <LicenceNumber>EU/1/95/001/010</LicenceNumber>
    <ProductName>GONAL-F AMPOULE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006639</DrugIDPK>
    <LicenceNumber>EU/1/95/001/003</LicenceNumber>
    <ProductName>GONAL-F AMPOULE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006641</DrugIDPK>
    <LicenceNumber>EU/1/95/001/006</LicenceNumber>
    <ProductName>GONAL-F VIAL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006643</DrugIDPK>
    <LicenceNumber>EU/1/95/001/008</LicenceNumber>
    <ProductName>GONAL-F VIALS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006649</DrugIDPK>
    <LicenceNumber>EU/1/95/001/016</LicenceNumber>
    <ProductName>GONAL-F VIALS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016376</DrugIDPK>
    <LicenceNumber>PA0044/010/001</LicenceNumber>
    <ProductName>GUANIMYCIN FORTE  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROSTREPTOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>SULFAGUANIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003649</DrugIDPK>
    <LicenceNumber>PA0102/022/001</LicenceNumber>
    <ProductName>GUARINA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1986-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GUAR GUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013238</DrugIDPK>
    <LicenceNumber>PA0153/001/001</LicenceNumber>
    <ProductName>H.11 EXTRACT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norland Inter-Trading Co. Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYPEPTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013243</DrugIDPK>
    <LicenceNumber>PA0153/001/004</LicenceNumber>
    <ProductName>H.11 OINTMENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norland Inter-Trading Co. Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYPEPTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013241</DrugIDPK>
    <LicenceNumber>PA0153/001/003</LicenceNumber>
    <ProductName>H.11 ORAL LIQUID</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norland Inter-Trading Co. Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>POLYPEPTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013244</DrugIDPK>
    <LicenceNumber>PA0153/001/005</LicenceNumber>
    <ProductName>H.11 SUPPOSITORIES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norland Inter-Trading Co. Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYPEPTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013239</DrugIDPK>
    <LicenceNumber>PA0153/001/002</LicenceNumber>
    <ProductName>H.11 TABLETS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norland Inter-Trading Co. Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYPEPTIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006854</DrugIDPK>
    <LicenceNumber>PA0545/005/003</LicenceNumber>
    <ProductName>HALDOL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000383</DrugIDPK>
    <LicenceNumber>PA0002/053/003</LicenceNumber>
    <ProductName>HALF CAPOZIDE</ProductName>
    <Strength>25/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>1992-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006792</DrugIDPK>
    <LicenceNumber>PA0417/016/001</LicenceNumber>
    <ProductName>HALIBORANGE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006794</DrugIDPK>
    <LicenceNumber>PA0417/016/002</LicenceNumber>
    <ProductName>HALIBORANGE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1999-02-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993007636</DrugIDPK>
    <LicenceNumber>PA0027/044/002</LicenceNumber>
    <ProductName>HALIBORANGE BLACKCURRANT FLAVOURED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993007631</DrugIDPK>
    <LicenceNumber>PA0027/044/001</LicenceNumber>
    <ProductName>HALIBORANGE ORANGE FLAVOURED</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015249</DrugIDPK>
    <LicenceNumber>PA0417/016/004</LicenceNumber>
    <ProductName>HALIBORANGE VITAMIN C</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>2004-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019825</DrugIDPK>
    <LicenceNumber>PA0417/016/003</LicenceNumber>
    <ProductName>HALIBORANGE VITAMIN C ORANGE FLAVOUR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1992-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003894</DrugIDPK>
    <LicenceNumber>PA0126/055/002</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003895</DrugIDPK>
    <LicenceNumber>PA0126/055/003</LicenceNumber>
    <ProductName>HALOPERIDOL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>1985-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HALOPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011790</DrugIDPK>
    <LicenceNumber>EU/1/01/183/002</LicenceNumber>
    <ProductName>HBVAXPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011791</DrugIDPK>
    <LicenceNumber>EU/1/01/183/003</LicenceNumber>
    <ProductName>HBVAXPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011794</DrugIDPK>
    <LicenceNumber>EU/1/01/183/006</LicenceNumber>
    <ProductName>HBVAXPRO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011796</DrugIDPK>
    <LicenceNumber>EU/1/01/183/009</LicenceNumber>
    <ProductName>HBVAXPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011798</DrugIDPK>
    <LicenceNumber>EU/1/01/183/010</LicenceNumber>
    <ProductName>HBVAXPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011799</DrugIDPK>
    <LicenceNumber>EU/1/01/183/012</LicenceNumber>
    <ProductName>HBVAXPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011801</DrugIDPK>
    <LicenceNumber>EU/1/01/183/014</LicenceNumber>
    <ProductName>HBVAXPRO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>2001-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010411</DrugIDPK>
    <LicenceNumber>EU/1/00/136/002</LicenceNumber>
    <ProductName>HEPACARE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>2000-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPLE ANTIGEN HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007297</DrugIDPK>
    <LicenceNumber>EU/1/00/136/001</LicenceNumber>
    <ProductName>HEPACARE 20 UG/ML</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2000-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPLE ANTIGEN HEPATITIS B VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017643</DrugIDPK>
    <LicenceNumber>PA0022/087/001</LicenceNumber>
    <ProductName>HIBTITER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1998-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006815</DrugIDPK>
    <LicenceNumber>PA0616/002/001</LicenceNumber>
    <ProductName>HOFELS GARLIC AND PARSLEY</ProductName>
    <Strength>0.15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hofels Pure Foods Limited</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLIUM SATIVUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006812</DrugIDPK>
    <LicenceNumber>PA0616/001/001</LicenceNumber>
    <ProductName>HOFELS GARLIC PEARLES CAPSULES</ProductName>
    <Strength>0.66</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hofels Pure Foods Limited</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLIUM SATIVUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006814</DrugIDPK>
    <LicenceNumber>PA0616/001/002</LicenceNumber>
    <ProductName>HOFELS ONE-A-DAY GARLIC PEARLES</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Hofels Pure Foods Limited</PAHolder>
    <AuthorisedDate>1994-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLIUM SATIVUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001163</DrugIDPK>
    <LicenceNumber>PA0023/013/001</LicenceNumber>
    <ProductName>HOSTACYCLINE DRAGEES</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004903</DrugIDPK>
    <LicenceNumber>EU/1/97/036/001</LicenceNumber>
    <ProductName>HUMALOG - HUMAJECT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>1997-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004902</DrugIDPK>
    <LicenceNumber>EU/1/97/042/001</LicenceNumber>
    <ProductName>HUMALOG - HUMAPEN</ProductName>
    <Strength>3.0</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>1997-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010703</DrugIDPK>
    <LicenceNumber>EU/1/97/036/002</LicenceNumber>
    <ProductName>HUMALOG MIX25 - HUMAJECT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010771</DrugIDPK>
    <LicenceNumber>EU/1/97/042/002</LicenceNumber>
    <ProductName>HUMALOG MIX25 - PEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010768</DrugIDPK>
    <LicenceNumber>EU/1/97/036/003</LicenceNumber>
    <ProductName>HUMALOG MIX50 - HUMAJECT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010772</DrugIDPK>
    <LicenceNumber>EU/1/97/042/003</LicenceNumber>
    <ProductName>HUMALOG MIX50 - PEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010773</DrugIDPK>
    <LicenceNumber>EU/1/97/042/004</LicenceNumber>
    <ProductName>HUMALOG NPL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010769</DrugIDPK>
    <LicenceNumber>EU/1/97/036/004</LicenceNumber>
    <ProductName>HUMALOG NPL - HUMAJECT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN LISPRO</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004877</DrugIDPK>
    <LicenceNumber>PA0218/039/002</LicenceNumber>
    <ProductName>HUMAN MIXTARD 30/70</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1992-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003918</DrugIDPK>
    <LicenceNumber>PA0814/001/002</LicenceNumber>
    <ProductName>HYALGAN VIAL</ProductName>
    <Strength>20mg/2ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Fidia Farmaceutici S.p.A.</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYALURONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013867</DrugIDPK>
    <LicenceNumber>PA0277/030/001</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1987-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001872</DrugIDPK>
    <LicenceNumber>PA0035/021/003</LicenceNumber>
    <ProductName>HYDROCORTONE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004047</DrugIDPK>
    <LicenceNumber>PA0417/010/001</LicenceNumber>
    <ProductName>ILVICO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1994-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CALCIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.

Promotion to the general public for packs containing not more than 24 unit dosage forms.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030662</DrugIDPK>
    <LicenceNumber>EU/1/09/570/1-12</LicenceNumber>
    <ProductName>IMPRIDA HCT</ProductName>
    <Strength>5/160/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2009-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030663</DrugIDPK>
    <LicenceNumber>EU/1/09/570/13-24</LicenceNumber>
    <ProductName>IMPRIDA HCT</ProductName>
    <Strength>5/160/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2009-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030664</DrugIDPK>
    <LicenceNumber>EU/1/09/570/25-36</LicenceNumber>
    <ProductName>IMPRIDA HCT</ProductName>
    <Strength>5/160/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2009-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030665</DrugIDPK>
    <LicenceNumber>EU/1/09/570/49-60</LicenceNumber>
    <ProductName>IMPRIDA HCT</ProductName>
    <Strength>10/320/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2009-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030666</DrugIDPK>
    <LicenceNumber>EU/1/09/570/37-48</LicenceNumber>
    <ProductName>IMPRIDA HCT</ProductName>
    <Strength>10/160/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2009-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>VALSARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010316</DrugIDPK>
    <LicenceNumber>PA0022/031/003</LicenceNumber>
    <ProductName>INDORAMIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003445</DrugIDPK>
    <LicenceNumber>EU/1/97/048/001</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007048</DrugIDPK>
    <LicenceNumber>EU/1/97/048/002</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007049</DrugIDPK>
    <LicenceNumber>EU/1/97/048/003</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007050</DrugIDPK>
    <LicenceNumber>EU/1/97/048/004</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007051</DrugIDPK>
    <LicenceNumber>EU/1/97/048/005</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007052</DrugIDPK>
    <LicenceNumber>EU/1/97/048/006</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007060</DrugIDPK>
    <LicenceNumber>EU/1/97/048/010</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007063</DrugIDPK>
    <LicenceNumber>EU/1/97/048/011</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007064</DrugIDPK>
    <LicenceNumber>EU/1/97/048/012</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007056</DrugIDPK>
    <LicenceNumber>EU/1/97/048/007</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007057</DrugIDPK>
    <LicenceNumber>EU/1/97/048/008</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007058</DrugIDPK>
    <LicenceNumber>EU/1/97/048/009</LicenceNumber>
    <ProductName>INFANRIX HEPB</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>SmithKline Beecham Biologicals</PAHolder>
    <AuthorisedDate>1997-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007669</DrugIDPK>
    <LicenceNumber>EU/1/98/087/002</LicenceNumber>
    <ProductName>INFERGEN</ProductName>
    <Strength>9</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Yamanouchi Europe B.V.</PAHolder>
    <AuthorisedDate>1999-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFACON-1</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007670</DrugIDPK>
    <LicenceNumber>EU/1/98/087/003</LicenceNumber>
    <ProductName>INFERGEN</ProductName>
    <Strength>9</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Yamanouchi Europe B.V.</PAHolder>
    <AuthorisedDate>1999-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFACON-1</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005548</DrugIDPK>
    <LicenceNumber>EU/1/98/087/001</LicenceNumber>
    <ProductName>INFERGEN</ProductName>
    <Strength>9</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Yamanouchi Europe B.V.</PAHolder>
    <AuthorisedDate>1999-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFACON-1</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015766</DrugIDPK>
    <LicenceNumber>PA0249/004/003</LicenceNumber>
    <ProductName>INFLEXAL BERNA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Capital Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013726</DrugIDPK>
    <LicenceNumber>PA0217/010/001</LicenceNumber>
    <ProductName>INITARD HUMAN 40 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013727</DrugIDPK>
    <LicenceNumber>PA0217/010/002</LicenceNumber>
    <ProductName>INITARD HUMAN 80 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008582</DrugIDPK>
    <LicenceNumber>PA0577/035/001</LicenceNumber>
    <ProductName>INNOPRIL TABLETS</ProductName>
    <Strength>2.5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008583</DrugIDPK>
    <LicenceNumber>PA0577/035/002</LicenceNumber>
    <ProductName>INNOPRIL TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008584</DrugIDPK>
    <LicenceNumber>PA0577/035/003</LicenceNumber>
    <ProductName>INNOPRIL TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008585</DrugIDPK>
    <LicenceNumber>PA0577/035/004</LicenceNumber>
    <ProductName>INNOPRIL TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2000-10-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993008982</DrugIDPK>
    <LicenceNumber>PA0330/011/001</LicenceNumber>
    <ProductName>INSTAT * COLLAGEN ABSORBALBE HEMOSTAT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>COLLAGEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013725</DrugIDPK>
    <LicenceNumber>PA0217/009/002</LicenceNumber>
    <ProductName>INSULATED HUMAN 80 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013724</DrugIDPK>
    <LicenceNumber>PA0217/009/001</LicenceNumber>
    <ProductName>INSULTARD HUMAN 400 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003064</DrugIDPK>
    <LicenceNumber>EU/1/97/030/014</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003066</DrugIDPK>
    <LicenceNumber>EU/1/97/030/016</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003067</DrugIDPK>
    <LicenceNumber>EU/1/97/030/001</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003068</DrugIDPK>
    <LicenceNumber>EU/1/97/030/003</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003069</DrugIDPK>
    <LicenceNumber>EU/1/97/030/004</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003070</DrugIDPK>
    <LicenceNumber>EU/1/97/030/006</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003071</DrugIDPK>
    <LicenceNumber>EU/1/97/030/008</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003072</DrugIDPK>
    <LicenceNumber>EU/1/97/030/009</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003073</DrugIDPK>
    <LicenceNumber>EU/1/97/030/010</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003074</DrugIDPK>
    <LicenceNumber>EU/1/97/030/012</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003075</DrugIDPK>
    <LicenceNumber>EU/1/97/030/013</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003076</DrugIDPK>
    <LicenceNumber>EU/1/97/030/015</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003077</DrugIDPK>
    <LicenceNumber>EU/1/97/030/002</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003078</DrugIDPK>
    <LicenceNumber>EU/1/97/030/005</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003079</DrugIDPK>
    <LicenceNumber>EU/1/97/030/007</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003080</DrugIDPK>
    <LicenceNumber>EU/1/97/030/011</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007641</DrugIDPK>
    <LicenceNumber>EU/1/97/030/017</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007643</DrugIDPK>
    <LicenceNumber>EU/1/97/030/018</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007644</DrugIDPK>
    <LicenceNumber>EU/1/97/030/019</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007645</DrugIDPK>
    <LicenceNumber>EU/1/97/030/020</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007646</DrugIDPK>
    <LicenceNumber>EU/1/97/030/021</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007647</DrugIDPK>
    <LicenceNumber>EU/1/97/030/022</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007648</DrugIDPK>
    <LicenceNumber>EU/1/97/030/023</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007649</DrugIDPK>
    <LicenceNumber>EU/1/97/030/024</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007650</DrugIDPK>
    <LicenceNumber>EU/1/97/030/025</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007651</DrugIDPK>
    <LicenceNumber>EU/1/97/030/026</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007652</DrugIDPK>
    <LicenceNumber>EU/1/97/030/027</LicenceNumber>
    <ProductName>INSUMAN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Hoechst AG</PAHolder>
    <AuthorisedDate>1997-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019341</DrugIDPK>
    <LicenceNumber>EU/1/05/326/001</LicenceNumber>
    <ProductName>IONSYS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Units/Gram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate>2006-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013220</DrugIDPK>
    <LicenceNumber>PA0149/017/001</LicenceNumber>
    <ProductName>ISDN/PROPRANOLOL 10/20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013247</DrugIDPK>
    <LicenceNumber>PA0161/013/009</LicenceNumber>
    <ProductName>ISOPAQUE CORONAR 370</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Electramed Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009007</DrugIDPK>
    <LicenceNumber>EU/1/01/181/001</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012062</DrugIDPK>
    <LicenceNumber>EU/1/01/181/002</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012064</DrugIDPK>
    <LicenceNumber>EU/1/01/181/03</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012065</DrugIDPK>
    <LicenceNumber>EU/1/01/181/004</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012066</DrugIDPK>
    <LicenceNumber>EU/1/01/181/005</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012067</DrugIDPK>
    <LicenceNumber>EU/1/01/181/006</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012068</DrugIDPK>
    <LicenceNumber>EU/1/01/181/003</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012069</DrugIDPK>
    <LicenceNumber>EU/1/01/181/007</LicenceNumber>
    <ProductName>IXENSE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001922</DrugIDPK>
    <LicenceNumber>PA0040/031/001</LicenceNumber>
    <ProductName>LARGACTIL FORTE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE EMBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013189</DrugIDPK>
    <LicenceNumber>PA0148/025/001</LicenceNumber>
    <ProductName>LC-65 DAILY CONTACT LENS CLEANER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015301</DrugIDPK>
    <LicenceNumber>PPA0465/090/001A</LicenceNumber>
    <ProductName>LESCOL 20MG CAPSULES</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015302</DrugIDPK>
    <LicenceNumber>PPA0465/090/002A</LicenceNumber>
    <ProductName>LESCOL 40MG CAPSULES</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2002-12-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015671</DrugIDPK>
    <LicenceNumber>PA0236/006/002</LicenceNumber>
    <ProductName>LEVIUS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011859</DrugIDPK>
    <LicenceNumber>PA0077/043/001</LicenceNumber>
    <ProductName>LEVOPHED SPECIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>NOREPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015496</DrugIDPK>
    <LicenceNumber>EU/1/01/192/002</LicenceNumber>
    <ProductName>LEVVIAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2001-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015497</DrugIDPK>
    <LicenceNumber>EU/1/01/192/003</LicenceNumber>
    <ProductName>LEVVIAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2001-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015498</DrugIDPK>
    <LicenceNumber>EU/1/01/192/004</LicenceNumber>
    <ProductName>LEVVIAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2001-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009647</DrugIDPK>
    <LicenceNumber>EU/1/01/192/001</LicenceNumber>
    <ProductName>LEVVIAX</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>2001-07-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016027</DrugIDPK>
    <LicenceNumber>PA0222/001/001</LicenceNumber>
    <ProductName>LIPOTRIAD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lewis Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010308</DrugIDPK>
    <LicenceNumber>PA0819/009/004</LicenceNumber>
    <ProductName>LISINOPRIL-RATIO</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>2002-04-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000253</DrugIDPK>
    <LicenceNumber>PA0044/080/001</LicenceNumber>
    <ProductName>LOCAN CREAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995002067</DrugIDPK>
    <LicenceNumber>PA0001/001/005</LicenceNumber>
    <ProductName>LOMOTIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>1981-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHENOXYLATE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012982</DrugIDPK>
    <LicenceNumber>PA0137/004/009</LicenceNumber>
    <ProductName>LOXAPAC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>1977-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOXAPINE SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004944</DrugIDPK>
    <LicenceNumber>PA0030/030/001</LicenceNumber>
    <ProductName>LYPSYL COLD SORE</ProductName>
    <Strength>2.0/1.0/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1995-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004944</DrugIDPK>
    <LicenceNumber>PA0030/030/001</LicenceNumber>
    <ProductName>LYPSYL COLD SORE</ProductName>
    <Strength>2.0/1.0/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1995-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004944</DrugIDPK>
    <LicenceNumber>PA0030/030/001</LicenceNumber>
    <ProductName>LYPSYL COLD SORE</ProductName>
    <Strength>2.0/1.0/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1995-08-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013346</DrugIDPK>
    <LicenceNumber>PA0254/004/001</LicenceNumber>
    <ProductName>MAWS GOLDEN EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ashe Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012878</DrugIDPK>
    <LicenceNumber>PA0100/002/002</LicenceNumber>
    <ProductName>MEGACLOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMOCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012879</DrugIDPK>
    <LicenceNumber>PA0100/002/003</LicenceNumber>
    <ProductName>MEGACLOR</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010777</DrugIDPK>
    <LicenceNumber>PA0041/005/004</LicenceNumber>
    <ProductName>MERBENTYL 20</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOVERINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012733</DrugIDPK>
    <LicenceNumber>PA0504/003/003</LicenceNumber>
    <ProductName>MERIEUX ORAL POLIOMYELITIS</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015222</DrugIDPK>
    <LicenceNumber>PA0211/020/001</LicenceNumber>
    <ProductName>METOCLOPRAMIDE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011729</DrugIDPK>
    <LicenceNumber>PA0068/007/006</LicenceNumber>
    <ProductName>MFV JECT  0.5 ML</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011727</DrugIDPK>
    <LicenceNumber>PA0068/007/004</LicenceNumber>
    <ProductName>MFV JECT  5 ML MULTIDOSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006629</DrugIDPK>
    <LicenceNumber>PA0504/001/002</LicenceNumber>
    <ProductName>MFV-JECT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Merieux UK Limited</PAHolder>
    <AuthorisedDate>1987-10-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011728</DrugIDPK>
    <LicenceNumber>PA0068/007/005</LicenceNumber>
    <ProductName>MFV-JECT 25 ML MULTIDOSE VIAL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016420</DrugIDPK>
    <LicenceNumber>PA0469/017/001</LicenceNumber>
    <ProductName>MICANOL</ProductName>
    <Strength>1%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016421</DrugIDPK>
    <LicenceNumber>PA0469/017/002</LicenceNumber>
    <ProductName>MICANOL</ProductName>
    <Strength>3%w/w</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1995-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995001002</DrugIDPK>
    <LicenceNumber>PA0032/016/003</LicenceNumber>
    <ProductName>MICROPAQUE HD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>1983-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BARIUM SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000919</DrugIDPK>
    <LicenceNumber>PA0017/051/001</LicenceNumber>
    <ProductName>MIGRIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>CYCLIZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020977</DrugIDPK>
    <LicenceNumber>PA1285/003/001</LicenceNumber>
    <ProductName>MIRTAZAPINE MEDIS 15 MG FILM-COATED TABLETS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009113</DrugIDPK>
    <LicenceNumber>PA0218/033/004</LicenceNumber>
    <ProductName>MIXTARD 10 PENFILL 3ML</ProductName>
    <Strength>100IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009112</DrugIDPK>
    <LicenceNumber>PA0218/036/004</LicenceNumber>
    <ProductName>MIXTARD 50 PENFILL 3ML</ProductName>
    <Strength>100IU/ml</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>1993-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013728</DrugIDPK>
    <LicenceNumber>PA0217/011/001</LicenceNumber>
    <ProductName>MIXTARD HUMAN 40 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013729</DrugIDPK>
    <LicenceNumber>PA0217/011/002</LicenceNumber>
    <ProductName>MIXTARD HUMAN 80 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002288</DrugIDPK>
    <LicenceNumber>PA0050/067/001</LicenceNumber>
    <ProductName>MOBIFLEX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1988-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000671</DrugIDPK>
    <LicenceNumber>PA0743/003/001</LicenceNumber>
    <ProductName>MONOMAX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000673</DrugIDPK>
    <LicenceNumber>PA0743/003/002</LicenceNumber>
    <ProductName>MONOMAX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000675</DrugIDPK>
    <LicenceNumber>PA0743/003/003</LicenceNumber>
    <ProductName>MONOMAX</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>1996-05-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012391</DrugIDPK>
    <LicenceNumber>EU/1/02/235/1-4</LicenceNumber>
    <ProductName>MONOTARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2002-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007163</DrugIDPK>
    <LicenceNumber>PA0913/005/011</LicenceNumber>
    <ProductName>MST CONTINUS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007164</DrugIDPK>
    <LicenceNumber>PA0913/005/012</LicenceNumber>
    <ProductName>MST CONTINUS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1996-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012469</DrugIDPK>
    <LicenceNumber>PA0354/001/001</LicenceNumber>
    <ProductName>MULTIVITAMINS FORMULA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Lifeplan Products Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017655</DrugIDPK>
    <LicenceNumber>PA0654/014/001</LicenceNumber>
    <ProductName>NAEMIS</ProductName>
    <Strength>1.5, 3.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>2003-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NOMEGESTROL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003261</DrugIDPK>
    <LicenceNumber>PA0073/111/001</LicenceNumber>
    <ProductName>NALOXONE HYDROCHLORIDE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>anhyd mg/ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1989-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014587</DrugIDPK>
    <LicenceNumber>PPA0465/031/003B</LicenceNumber>
    <ProductName>NAPROSYN EC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1999-06-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013678</DrugIDPK>
    <LicenceNumber>PA0200/001/004</LicenceNumber>
    <ProductName>NARCAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>1989-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006863</DrugIDPK>
    <LicenceNumber>EU/1/97/031/006</LicenceNumber>
    <ProductName>NEORECORMON</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1997-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPOETIN BETA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007317</DrugIDPK>
    <LicenceNumber>EU/1/00/154/001</LicenceNumber>
    <ProductName>NEOSPECT</ProductName>
    <Strength>47</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>2000-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEPREOTIDE TRIFLUOROACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010670</DrugIDPK>
    <LicenceNumber>EU/1/00/154/002</LicenceNumber>
    <ProductName>NEOSPECT</ProductName>
    <Strength>47</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>2000-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Radio-Pharm Precursor</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEPREOTIDE TRIFLUOROACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012234</DrugIDPK>
    <LicenceNumber>EU/1/01/184/002</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012235</DrugIDPK>
    <LicenceNumber>EU/1/01/184/003</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012236</DrugIDPK>
    <LicenceNumber>EU/1/01/184/004</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012237</DrugIDPK>
    <LicenceNumber>EU/1/01/184/005</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012238</DrugIDPK>
    <LicenceNumber>EU/1/01/184/006</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012239</DrugIDPK>
    <LicenceNumber>EU/1/01/184/007</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012240</DrugIDPK>
    <LicenceNumber>EU/1/01/184/008</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012241</DrugIDPK>
    <LicenceNumber>EU/1/01/184/009</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012242</DrugIDPK>
    <LicenceNumber>EU/1/01/184/010</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012243</DrugIDPK>
    <LicenceNumber>EU/1/01/184/011</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012244</DrugIDPK>
    <LicenceNumber>EU/1/01/184/012</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012245</DrugIDPK>
    <LicenceNumber>EU/1/01/184/013</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012246</DrugIDPK>
    <LicenceNumber>EU/1/01/184/014</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012247</DrugIDPK>
    <LicenceNumber>EU/1/01/184/015</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012248</DrugIDPK>
    <LicenceNumber>EU/1/01/184/016</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012249</DrugIDPK>
    <LicenceNumber>EU/1/01/184/017</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012250</DrugIDPK>
    <LicenceNumber>EU/1/01/184/018</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012251</DrugIDPK>
    <LicenceNumber>EU/1/01/184/019</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012252</DrugIDPK>
    <LicenceNumber>EU/1/01/184/021</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012253</DrugIDPK>
    <LicenceNumber>EU/1/01/184/022</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012254</DrugIDPK>
    <LicenceNumber>EU/1/01/184/023</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012255</DrugIDPK>
    <LicenceNumber>EU/1/01/184/024</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012256</DrugIDPK>
    <LicenceNumber>EU/1/01/184/025</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012257</DrugIDPK>
    <LicenceNumber>EU/1/01/184/026</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012258</DrugIDPK>
    <LicenceNumber>EU/1/01/184/027</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012259</DrugIDPK>
    <LicenceNumber>EU/1/01/184/028</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012260</DrugIDPK>
    <LicenceNumber>EU/1/01/184/029</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012261</DrugIDPK>
    <LicenceNumber>EU/1/01/184/030</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012135</DrugIDPK>
    <LicenceNumber>EU/1/01/184/020</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009049</DrugIDPK>
    <LicenceNumber>EU/1/01/184/001</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength>10 mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2001-06-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012502</DrugIDPK>
    <LicenceNumber>PA1026/001/002</LicenceNumber>
    <ProductName>NEUPOGEN 480</ProductName>
    <Strength>30, 1.6</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>1998-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011976</DrugIDPK>
    <LicenceNumber>EU/1/02/228/001</LicenceNumber>
    <ProductName>NEUPOPEG</ProductName>
    <Strength>6mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2002-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PEGFILGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011993</DrugIDPK>
    <LicenceNumber>PA0078/039/001</LicenceNumber>
    <ProductName>NIFLURIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFLUMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995001619</DrugIDPK>
    <LicenceNumber>PA0379/001/001</LicenceNumber>
    <ProductName>NIGHT NURSE COLD REMEDY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PROMETHAZINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016255</DrugIDPK>
    <LicenceNumber>PA1077/072/002</LicenceNumber>
    <ProductName>NIMBEX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>2000-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISATRACURIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015192</DrugIDPK>
    <LicenceNumber>PA0211/006/002</LicenceNumber>
    <ProductName>NITROFURANTOIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015189</DrugIDPK>
    <LicenceNumber>PA0211/006/001</LicenceNumber>
    <ProductName>NITROFURANTOIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005965</DrugIDPK>
    <LicenceNumber>PA0891/001/001</LicenceNumber>
    <ProductName>NOOTROPIL</ProductName>
    <Strength>33.3</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>UCB (Pharma) Ireland Limited</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005966</DrugIDPK>
    <LicenceNumber>PA0891/001/002</LicenceNumber>
    <ProductName>NOOTROPIL</ProductName>
    <Strength>1200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB (Pharma) Ireland Limited</PAHolder>
    <AuthorisedDate>2002-05-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRACETAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013188</DrugIDPK>
    <LicenceNumber>PA0157/003/002</LicenceNumber>
    <ProductName>NOVAPEN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Controlled Medications Limited</PAHolder>
    <AuthorisedDate>1976-12-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010401</DrugIDPK>
    <LicenceNumber>EU/1/00/142/006</LicenceNumber>
    <ProductName>NOVOMIX 30 NOVOLET</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2000-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN ASPART</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010664</DrugIDPK>
    <LicenceNumber>PPA0465/074/001A</LicenceNumber>
    <ProductName>NU-SEALS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030496</DrugIDPK>
    <LicenceNumber>DPR1392/037/001</LicenceNumber>
    <ProductName>OILATUM EMOLLIENT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUID PARAFFIN LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007424</DrugIDPK>
    <LicenceNumber>PA0735/006/022</LicenceNumber>
    <ProductName>OMNIPAQUE</ProductName>
    <Strength>180mg</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>2000-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOHEXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036486</DrugIDPK>
    <LicenceNumber>EU/1/11/729/001</LicenceNumber>
    <ProductName>ONDUARP</ProductName>
    <Strength>40/5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2011-11-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELMISARTAN</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000283</DrugIDPK>
    <LicenceNumber>PA0045/015/001</LicenceNumber>
    <ProductName>OPERIDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1978-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOPERIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010923</DrugIDPK>
    <LicenceNumber>PA0047/051/001</LicenceNumber>
    <ProductName>OPREN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENOXAPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010925</DrugIDPK>
    <LicenceNumber>PA0047/051/002</LicenceNumber>
    <ProductName>OPREN</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENOXAPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010926</DrugIDPK>
    <LicenceNumber>PA0047/051/003</LicenceNumber>
    <ProductName>OPREN</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1980-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENOXAPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015818</DrugIDPK>
    <LicenceNumber>EU/1/00/158/015</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015819</DrugIDPK>
    <LicenceNumber>EU/1/00/158/016</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015820</DrugIDPK>
    <LicenceNumber>EU/1/00/158/017</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015821</DrugIDPK>
    <LicenceNumber>EU/1/00/158/018</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015822</DrugIDPK>
    <LicenceNumber>EU/1/00/158/019</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015823</DrugIDPK>
    <LicenceNumber>EU/1/00/158/020</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015824</DrugIDPK>
    <LicenceNumber>EU/1/00/158/021</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015841</DrugIDPK>
    <LicenceNumber>EU/1/00/158/034</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015846</DrugIDPK>
    <LicenceNumber>EU/1/00/158/032</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015827</DrugIDPK>
    <LicenceNumber>EU/1/00/158/023</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015828</DrugIDPK>
    <LicenceNumber>EU/1/00/158/024</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015829</DrugIDPK>
    <LicenceNumber>EU/1/00/158/025</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015830</DrugIDPK>
    <LicenceNumber>EU/1/00/158/026</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015832</DrugIDPK>
    <LicenceNumber>EU/1/00/158/027</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015833</DrugIDPK>
    <LicenceNumber>EU/1/00/158/028</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015834</DrugIDPK>
    <LicenceNumber>EU/1/00/158/029</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015835</DrugIDPK>
    <LicenceNumber>EU/1/00/158/030</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015836</DrugIDPK>
    <LicenceNumber>EU/1/00/158/031</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015839</DrugIDPK>
    <LicenceNumber>EU/1/00/158/033</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011037</DrugIDPK>
    <LicenceNumber>EU/1/00/158/014</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>0.5mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011067</DrugIDPK>
    <LicenceNumber>EU/1/00/158/002</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011068</DrugIDPK>
    <LicenceNumber>EU/1/00/158/003</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011069</DrugIDPK>
    <LicenceNumber>EU/1/00/158/004</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011070</DrugIDPK>
    <LicenceNumber>EU/1/00/158/005</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011071</DrugIDPK>
    <LicenceNumber>EU/1/00/158/006</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011072</DrugIDPK>
    <LicenceNumber>EU/1/00/158/007</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011073</DrugIDPK>
    <LicenceNumber>EU/1/00/158/008</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011074</DrugIDPK>
    <LicenceNumber>EU/1/00/158/009</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011075</DrugIDPK>
    <LicenceNumber>EU/1/00/158/010</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011076</DrugIDPK>
    <LicenceNumber>EU/1/00/158/011</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011077</DrugIDPK>
    <LicenceNumber>EU/1/00/158/012</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011078</DrugIDPK>
    <LicenceNumber>EU/1/00/158/013</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011583</DrugIDPK>
    <LicenceNumber>EU/1/00/158/022</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2002-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008611</DrugIDPK>
    <LicenceNumber>EU/1/00/158/001</LicenceNumber>
    <ProductName>OPULIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2001-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000443</DrugIDPK>
    <LicenceNumber>PA0007/044/008</LicenceNumber>
    <ProductName>ORAMORPH</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1992-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000444</DrugIDPK>
    <LicenceNumber>PA0007/044/009</LicenceNumber>
    <ProductName>ORAMORPH</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1992-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000442</DrugIDPK>
    <LicenceNumber>PA0007/044/007</LicenceNumber>
    <ProductName>ORAMORPH ORAL SOLUTION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>1992-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003429</DrugIDPK>
    <LicenceNumber>PA0077/117/001</LicenceNumber>
    <ProductName>OSSOPAN 800</ProductName>
    <Strength>830</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYAPETITE COLLAGEN COMPOUND</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004027</DrugIDPK>
    <LicenceNumber>PA0148/039/001</LicenceNumber>
    <ProductName>OXYLIN LIQUIFILM 0.025% W/V EYE DROPS, SOLUTION</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>1984-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003560</DrugIDPK>
    <LicenceNumber>PA0090/010/003</LicenceNumber>
    <ProductName>PABRINEX IM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>1987-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012885</DrugIDPK>
    <LicenceNumber>PA0100/005/002</LicenceNumber>
    <ProductName>PAEDO-SED</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016244</DrugIDPK>
    <LicenceNumber>PA0040/022/001</LicenceNumber>
    <ProductName>PAMERGAN AP100/25</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016245</DrugIDPK>
    <LicenceNumber>PA0040/023/001</LicenceNumber>
    <ProductName>PAMERGAN P100</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015188</DrugIDPK>
    <LicenceNumber>PA0211/005/001</LicenceNumber>
    <ProductName>PARACETAMOL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015190</DrugIDPK>
    <LicenceNumber>PA0211/005/002</LicenceNumber>
    <ProductName>PARACETAMOL ELIXIR PAEDIATRIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031462</DrugIDPK>
    <LicenceNumber>PA1138/023/001</LicenceNumber>
    <ProductName>PARACETAMOL/CAFFEINE/CODEINE AND DOXYLAMINE</ProductName>
    <Strength>450mg,10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SSL International plc</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031462</DrugIDPK>
    <LicenceNumber>PA1138/023/001</LicenceNumber>
    <ProductName>PARACETAMOL/CAFFEINE/CODEINE AND DOXYLAMINE</ProductName>
    <Strength>450mg,10mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SSL International plc</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018379</DrugIDPK>
    <LicenceNumber>EU/1/04/293/1-12</LicenceNumber>
    <ProductName>PARAREG</ProductName>
    <Strength>30mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2004-10-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINACALCET HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015561</DrugIDPK>
    <LicenceNumber>PA0126/124/001</LicenceNumber>
    <ProductName>PAROCETAN</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2005-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007264</DrugIDPK>
    <LicenceNumber>EU/1/98/078/002</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007265</DrugIDPK>
    <LicenceNumber>EU/1/98/078/003</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007266</DrugIDPK>
    <LicenceNumber>EU/1/98/078/004</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007267</DrugIDPK>
    <LicenceNumber>EU/1/98/078/006</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007268</DrugIDPK>
    <LicenceNumber>EU/1/98/078/007</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007269</DrugIDPK>
    <LicenceNumber>EU/1/98/078/008</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007270</DrugIDPK>
    <LicenceNumber>EU/1/98/078/010</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007271</DrugIDPK>
    <LicenceNumber>EU/1/98/078/011</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007272</DrugIDPK>
    <LicenceNumber>EU/1/98/078/012</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006005</DrugIDPK>
    <LicenceNumber>EU/1/98/078/001</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006006</DrugIDPK>
    <LicenceNumber>EU/1/98/078/005</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006007</DrugIDPK>
    <LicenceNumber>EU/1/98/078/009</LicenceNumber>
    <ProductName>PATREX</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1998-09-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005731</DrugIDPK>
    <LicenceNumber>EU/1/99/113/2-4</LicenceNumber>
    <ProductName>PAXENE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1999-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005720</DrugIDPK>
    <LicenceNumber>EU/1/99/113/001</LicenceNumber>
    <ProductName>PAXENE</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>1999-07-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PACLITAXEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017341</DrugIDPK>
    <LicenceNumber>PA0577/050/001</LicenceNumber>
    <ProductName>PAXT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017342</DrugIDPK>
    <LicenceNumber>PA0577/050/002</LicenceNumber>
    <ProductName>PAXT</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2004-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013866</DrugIDPK>
    <LicenceNumber>PA0288/001/001</LicenceNumber>
    <ProductName>PEROIDIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Larkhall Laboratories Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013387</DrugIDPK>
    <LicenceNumber>PA0255/024/001</LicenceNumber>
    <ProductName>PETHIDINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013635</DrugIDPK>
    <LicenceNumber>PA0189/003/001</LicenceNumber>
    <ProductName>PEVISONE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Cilag-Chemie,</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012060</DrugIDPK>
    <LicenceNumber>PA0007/061/001</LicenceNumber>
    <ProductName>PHARMATON KIDDI</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>2001-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM GLYCEROPHOSPHATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>DEXPANTHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013307</DrugIDPK>
    <LicenceNumber>PA0936/043/003</LicenceNumber>
    <ProductName>PHARMORUBICIN 10 MG SOLUTION FOR INJECTION</ProductName>
    <Strength>10mg/5ml</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013583</DrugIDPK>
    <LicenceNumber>PA0936/043/007</LicenceNumber>
    <ProductName>PHARMORUBICIN 2 MG/ML SOLUTION FOR INJECTION OR IN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013585</DrugIDPK>
    <LicenceNumber>PA0936/043/009</LicenceNumber>
    <ProductName>PHARMORUBICIN 2 MG/ML SOLUTION FOR INJECTION OR IN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-06-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013309</DrugIDPK>
    <LicenceNumber>PA0936/043/004</LicenceNumber>
    <ProductName>PHARMORUBICIN 50 MG SOLUTION FOR INJECTION</ProductName>
    <Strength>50mg/25ml</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>2001-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015209</DrugIDPK>
    <LicenceNumber>PA0211/012/001</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015211</DrugIDPK>
    <LicenceNumber>PA0211/012/002</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>1981-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015212</DrugIDPK>
    <LicenceNumber>PA0211/012/003</LicenceNumber>
    <ProductName>PHENOBARBITONE</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007681</DrugIDPK>
    <LicenceNumber>PA0417/017/001</LicenceNumber>
    <ProductName>PHENSIC 325MG/22MG TABLETS</ProductName>
    <Strength>325/22</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>1996-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments>As an item for general sale in child-resistant packages with a maximum packs size of 24 units.  As an item for retail sale through pharmacies only in child-resistant packages with a maximum pack size of 50 units.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015207</DrugIDPK>
    <LicenceNumber>PA0211/011/002</LicenceNumber>
    <ProductName>PHENYLBUTAZONE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015305</DrugIDPK>
    <LicenceNumber>EU/1/04/272/1-2</LicenceNumber>
    <ProductName>PHOTOBARR</ProductName>
    <Strength>15mg &amp; 75m</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Axcan Pharma International B.V.</PAHolder>
    <AuthorisedDate>2004-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCHLORIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003494</DrugIDPK>
    <LicenceNumber>PA0114/007/004</LicenceNumber>
    <ProductName>PHYLLOCONTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Drop</StrengthMeasurement>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>1985-09-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005608</DrugIDPK>
    <LicenceNumber>PA0283/002/001</LicenceNumber>
    <ProductName>PHYTEX PAINT</ProductName>
    <Strength>9</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Wynlit Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TANNIC ACID</ActiveSubstance>
      <ActiveSubstance>BORIC ACID</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008545</DrugIDPK>
    <LicenceNumber>PA0281/092/002</LicenceNumber>
    <ProductName>PINAMET</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>1995-10-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002229</DrugIDPK>
    <LicenceNumber>PA0046/054/002</LicenceNumber>
    <ProductName>PINDAC</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1988-01-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PINACIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015628</DrugIDPK>
    <LicenceNumber>PA0299/001/001</LicenceNumber>
    <ProductName>PLACIDEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015204</DrugIDPK>
    <LicenceNumber>PA0211/010/001</LicenceNumber>
    <ProductName>PREDNISOLONE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010504</DrugIDPK>
    <LicenceNumber>PPA0465/069/001B</LicenceNumber>
    <ProductName>PREMARIN</ProductName>
    <Strength>0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTROGENS CONJUGATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004479</DrugIDPK>
    <LicenceNumber>EU/1/97/056/001</LicenceNumber>
    <ProductName>PRIMAVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>1998-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030806</DrugIDPK>
    <LicenceNumber>PA1138/006/002</LicenceNumber>
    <ProductName>PRIODERM LOTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>SSL International plc</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003293</DrugIDPK>
    <LicenceNumber>PA0073/129/001</LicenceNumber>
    <ProductName>PROCHLORPERAZINE INJECTION BP 12.5MG/ML.</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003294</DrugIDPK>
    <LicenceNumber>PA0073/129/002</LicenceNumber>
    <ProductName>PROCHLORPERAZINE INJECTION BP 25MG IN 2ML</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1993-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCHLORPERAZINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006427</DrugIDPK>
    <LicenceNumber>EU/1/99/104/001</LicenceNumber>
    <ProductName>PROCOMVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Pasteur Merieux MSD</PAHolder>
    <AuthorisedDate>1999-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
      <ActiveSubstance>NEISSERIA MENINGITIDIS, OUTER MEMBRANE  COMPLEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015954</DrugIDPK>
    <LicenceNumber>PA0017/100/001</LicenceNumber>
    <ProductName>PROHIBIT VIAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1991-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013191</DrugIDPK>
    <LicenceNumber>PA0148/037/002</LicenceNumber>
    <ProductName>PROPINE-PTM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010083</DrugIDPK>
    <LicenceNumber>EU/1/02/202/001</LicenceNumber>
    <ProductName>PROTOPIC</ProductName>
    <Strength>0.03%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astellas Pharma GmbH</PAHolder>
    <AuthorisedDate>2002-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015502</DrugIDPK>
    <LicenceNumber>EU/1/02/202/002</LicenceNumber>
    <ProductName>PROTOPY</ProductName>
    <Strength>0.03%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astellas Pharma GmbH</PAHolder>
    <AuthorisedDate>2002-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015504</DrugIDPK>
    <LicenceNumber>EU/1/02/202/004</LicenceNumber>
    <ProductName>PROTOPY</ProductName>
    <Strength>0.1%</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astellas Pharma GmbH</PAHolder>
    <AuthorisedDate>2002-02-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021650</DrugIDPK>
    <LicenceNumber>EU/1/02/202/005</LicenceNumber>
    <ProductName>PROTOPY</ProductName>
    <Strength>0.03</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astellas Pharma GmbH</PAHolder>
    <AuthorisedDate>2003-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021651</DrugIDPK>
    <LicenceNumber>EU/1/02/202/006</LicenceNumber>
    <ProductName>PROTOPY</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Astellas Pharma GmbH</PAHolder>
    <AuthorisedDate>2003-04-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TACROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000753</DrugIDPK>
    <LicenceNumber>PA0016/023/005</LicenceNumber>
    <ProductName>PROVERA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>1988-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017912</DrugIDPK>
    <LicenceNumber>EU/1/04/301/1-5</LicenceNumber>
    <ProductName>QUINTANRIX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>GlaxoSmithKline Biologicals S.A.</PAHolder>
    <AuthorisedDate>2005-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HEPATITIS B SURFACE ANTIGEN, RECOMINANT</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018122</DrugIDPK>
    <LicenceNumber>EU/1/02/207/09-10</LicenceNumber>
    <ProductName>QUIXIDAR</ProductName>
    <Strength>5mg/0.4ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2004-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FONDAPARINUX SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017708</DrugIDPK>
    <LicenceNumber>EU/1/02/207/5-8</LicenceNumber>
    <ProductName>QUIXIDAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Sanofi aventis</PAHolder>
    <AuthorisedDate>2003-10-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FONDAPARINUX SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015544</DrugIDPK>
    <LicenceNumber>EU/1/02/207/002</LicenceNumber>
    <ProductName>QUIXIDAR</ProductName>
    <Strength>2.5/0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>2002-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FONDAPARINUX SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015545</DrugIDPK>
    <LicenceNumber>EU/1/02/207/003</LicenceNumber>
    <ProductName>QUIXIDAR</ProductName>
    <Strength>2.5/0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>2002-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FONDAPARINUX SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015546</DrugIDPK>
    <LicenceNumber>EU/1/02/207/004</LicenceNumber>
    <ProductName>QUIXIDAR</ProductName>
    <Strength>2.5/0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>2002-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FONDAPARINUX SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011256</DrugIDPK>
    <LicenceNumber>EU/1/02/207/001</LicenceNumber>
    <ProductName>QUIXIDAR</ProductName>
    <Strength>2.5/0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>2002-03-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FONDAPARINUX SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004700</DrugIDPK>
    <LicenceNumber>PA0197/001/002</LicenceNumber>
    <ProductName>RALGEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>LRC Products Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>ETHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995001258</DrugIDPK>
    <LicenceNumber>PA0266/002/003</LicenceNumber>
    <ProductName>RALGEX BALM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Gillespie &amp; Company Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993004699</DrugIDPK>
    <LicenceNumber>PA0197/001/001</LicenceNumber>
    <ProductName>RALGEX SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>LRC Products Ltd</PAHolder>
    <AuthorisedDate>1982-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>ETHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>ISOPROPANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028950</DrugIDPK>
    <LicenceNumber>PA0074/034/001-3</LicenceNumber>
    <ProductName>RANTIDINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011419</DrugIDPK>
    <LicenceNumber>EU/1/01/171/002</LicenceNumber>
    <ProductName>RAPAMUNE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2001-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SIROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011422</DrugIDPK>
    <LicenceNumber>EU/1/01/171/005</LicenceNumber>
    <ProductName>RAPAMUNE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate>2001-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SIROLIMUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017573</DrugIDPK>
    <LicenceNumber>EU/1/04/291/1-2</LicenceNumber>
    <ProductName>RAPTIVA</ProductName>
    <Strength>100 mg/ml</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Serono Europe Limited</PAHolder>
    <AuthorisedDate>2004-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EFALIZUMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033173</DrugIDPK>
    <LicenceNumber>EU/1/11/730/001-012</LicenceNumber>
    <ProductName>RASITRIO</ProductName>
    <Strength>150/5/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHOLOTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033174</DrugIDPK>
    <LicenceNumber>EU/1/11/730/013-024</LicenceNumber>
    <ProductName>RASITRIO</ProductName>
    <Strength>300/5/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHOLOTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015562</DrugIDPK>
    <LicenceNumber>EU/1/02/210/002</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015563</DrugIDPK>
    <LicenceNumber>EU/1/02/210/003</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015564</DrugIDPK>
    <LicenceNumber>EU/1/02/210/004</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015565</DrugIDPK>
    <LicenceNumber>EU/1/02/210/005</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015566</DrugIDPK>
    <LicenceNumber>EU/1/02/210/006</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015567</DrugIDPK>
    <LicenceNumber>EU/1/02/210/007</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015568</DrugIDPK>
    <LicenceNumber>EU/1/02/210/008</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010357</DrugIDPK>
    <LicenceNumber>EU/1/02/210/001</LicenceNumber>
    <ProductName>RAYZON</ProductName>
    <Strength>20mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmacia Europe EEIG</PAHolder>
    <AuthorisedDate>2002-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARECOXIB SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002750</DrugIDPK>
    <LicenceNumber>PA0050/007/001</LicenceNumber>
    <ProductName>REDOXON</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1976-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011997</DrugIDPK>
    <LicenceNumber>PA0038/075/001</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011999</DrugIDPK>
    <LicenceNumber>PA0038/075/002</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>2001-05-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011809</DrugIDPK>
    <LicenceNumber>PA0577/044/001</LicenceNumber>
    <ProductName>RELIGER</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2001-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NABUMETONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030809</DrugIDPK>
    <LicenceNumber>PA1138/022/002</LicenceNumber>
    <ProductName>REMEGEL SUMMER FRUIT</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>SSL International plc</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007399</DrugIDPK>
    <LicenceNumber>PA0618/034/001</LicenceNumber>
    <ProductName>RESOLVE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SSL International PLC</PAHolder>
    <AuthorisedDate>1994-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in packs containing not more than 5 sachets.  Retail sale through pharmacies in packs containing 10 sachets.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008978</DrugIDPK>
    <LicenceNumber>PA0111/002/002</LicenceNumber>
    <ProductName>RIMACTANE</ProductName>
    <Strength>300mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>1997-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIFAMPICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011510</DrugIDPK>
    <LicenceNumber>PPA0465/078/001A</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011511</DrugIDPK>
    <LicenceNumber>PPA0465/078/001B</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011513</DrugIDPK>
    <LicenceNumber>PPA0465/078/001C</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011519</DrugIDPK>
    <LicenceNumber>PPA0465/078/001D</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011521</DrugIDPK>
    <LicenceNumber>PPA0465/078/001E</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011528</DrugIDPK>
    <LicenceNumber>PPA0465/078/002A</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011529</DrugIDPK>
    <LicenceNumber>PPA0465/078/002B</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011530</DrugIDPK>
    <LicenceNumber>PPA0465/078/002C</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011531</DrugIDPK>
    <LicenceNumber>PPA0465/078/002D</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011532</DrugIDPK>
    <LicenceNumber>PPA0465/078/003A</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011533</DrugIDPK>
    <LicenceNumber>PPA0465/078/003B</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011534</DrugIDPK>
    <LicenceNumber>PPA0465/078/003C</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011535</DrugIDPK>
    <LicenceNumber>PPA0465/078/003D</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011536</DrugIDPK>
    <LicenceNumber>PPA0465/078/003E</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011540</DrugIDPK>
    <LicenceNumber>PPA0465/078/004A</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011541</DrugIDPK>
    <LicenceNumber>PPA0465/078/004B</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011542</DrugIDPK>
    <LicenceNumber>PPA0465/078/004C</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011543</DrugIDPK>
    <LicenceNumber>PPA0465/078/004D</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2001-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000251</DrugIDPK>
    <LicenceNumber>PA0006/005/001</LicenceNumber>
    <ProductName>RYTHMODAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005108</DrugIDPK>
    <LicenceNumber>PA0246/001/001</LicenceNumber>
    <ProductName>S.T.D.</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>STD Pharmaceutical Products Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005109</DrugIDPK>
    <LicenceNumber>PA0246/001/002</LicenceNumber>
    <ProductName>S.T.D.</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>STD Pharmaceutical Products Ltd</PAHolder>
    <AuthorisedDate>1980-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005628</DrugIDPK>
    <LicenceNumber>PA0285/005/001</LicenceNumber>
    <ProductName>SAIZEN</ProductName>
    <Strength>1.33 mg 4IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1989-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993005629</DrugIDPK>
    <LicenceNumber>PA0285/005/002</LicenceNumber>
    <ProductName>SAIZEN</ProductName>
    <Strength>3.33mg 10 IU</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1992-08-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010092</DrugIDPK>
    <LicenceNumber>PA0018/029/001</LicenceNumber>
    <ProductName>SANATOGEN NERVE TONIC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009434</DrugIDPK>
    <LicenceNumber>PA0030/046/001</LicenceNumber>
    <ProductName>SANDOCAL</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM LACTATE GLUCONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995004665</DrugIDPK>
    <LicenceNumber>PA0196/016/001</LicenceNumber>
    <ProductName>SCANDONEST</ProductName>
    <Strength>2% w/v /1:</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>1999-05-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPIVACAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010868</DrugIDPK>
    <LicenceNumber>PA0046/014/004</LicenceNumber>
    <ProductName>SELEXID</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-01-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016071</DrugIDPK>
    <LicenceNumber>PA0218/002/002</LicenceNumber>
    <ProductName>SEMITARD MC INSULIN ZINC SUSPENSION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021446</DrugIDPK>
    <LicenceNumber>PA1285/010/001</LicenceNumber>
    <ProductName>SERTRALINE MEDIS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021447</DrugIDPK>
    <LicenceNumber>PA1285/010/002</LicenceNumber>
    <ProductName>SERTRALINE MEDIS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SERTRALINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017716</DrugIDPK>
    <LicenceNumber>PA0610/016/001</LicenceNumber>
    <ProductName>SETLERS ANTACID PEPPERMINT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017721</DrugIDPK>
    <LicenceNumber>PA0610/016/002</LicenceNumber>
    <ProductName>SETLERS ANTACID SPEARMINT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>2000-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012466</DrugIDPK>
    <LicenceNumber>PA0353/004/001</LicenceNumber>
    <ProductName>SMECTA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Beaufour Schwabe</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>FLAVOXATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003242</DrugIDPK>
    <LicenceNumber>PA0073/105/005A</LicenceNumber>
    <ProductName>SODIUM CHLORIDE</ProductName>
    <Strength>0.9</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1991-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993008840</DrugIDPK>
    <LicenceNumber>PA0240/019/001</LicenceNumber>
    <ProductName>SODIUM CHROMATE (51 CR) 37 MBQ/ML RADIOPHARMACEUTI</ProductName>
    <Strength>37</Strength>
    <StrengthMeasurement>MBq/ml</StrengthMeasurement>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>1999-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHROMATE (51 CR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019148</DrugIDPK>
    <LicenceNumber>PPA0465/137/001A</LicenceNumber>
    <ProductName>SPORANOX 100MG CAPSULES</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2004-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ITRACONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015170</DrugIDPK>
    <LicenceNumber>PA0295/001/001</LicenceNumber>
    <ProductName>STERAC SODIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015171</DrugIDPK>
    <LicenceNumber>PA0295/001/002</LicenceNumber>
    <ProductName>STERAC SODIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993015172</DrugIDPK>
    <LicenceNumber>PA0295/001/005</LicenceNumber>
    <ProductName>STERISOL SODIUM CHLORIDE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007929</DrugIDPK>
    <LicenceNumber>PA0566/010/001</LicenceNumber>
    <ProductName>STRUCTOLIPID</ProductName>
    <Strength>20%</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1999-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIGLYCERIDES</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013692</DrugIDPK>
    <LicenceNumber>PA0206/005/001</LicenceNumber>
    <ProductName>SULOCTON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>1977-06-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULOCTIDIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002377</DrugIDPK>
    <LicenceNumber>PA0051/013/001</LicenceNumber>
    <ProductName>SULPHAMEZATHINE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFADIMIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009563</DrugIDPK>
    <LicenceNumber>PA0006/023/001</LicenceNumber>
    <ProductName>SURGAM</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>1982-04-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPROFENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006586</DrugIDPK>
    <LicenceNumber>PA0469/026/002</LicenceNumber>
    <ProductName>SYNALAR</ProductName>
    <Strength>0.025</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>1998-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010613</DrugIDPK>
    <LicenceNumber>EU/1/01/182/001</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012051</DrugIDPK>
    <LicenceNumber>EU/1/01/182/002</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012052</DrugIDPK>
    <LicenceNumber>EU/1/01/182/003</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012053</DrugIDPK>
    <LicenceNumber>EU/1/01/182/004</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012054</DrugIDPK>
    <LicenceNumber>EU/1/01/182/005</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012055</DrugIDPK>
    <LicenceNumber>EU/1/01/182/006</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012056</DrugIDPK>
    <LicenceNumber>EU/1/01/182/007</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012057</DrugIDPK>
    <LicenceNumber>EU/1/01/182/008</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012058</DrugIDPK>
    <LicenceNumber>EU/1/01/182/009</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012059</DrugIDPK>
    <LicenceNumber>EU/1/01/182/010</LicenceNumber>
    <ProductName>TALUVIAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott S.p.A.</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013857</DrugIDPK>
    <LicenceNumber>PA0282/032/001</LicenceNumber>
    <ProductName>TAMOXIFEN B P</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016162</DrugIDPK>
    <LicenceNumber>PA0030/008/001</LicenceNumber>
    <ProductName>TANDERIL CHLORAMPHENICOL EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016161</DrugIDPK>
    <LicenceNumber>PA0030/007/001</LicenceNumber>
    <ProductName>TANDERIL EYE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>1982-11-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYPHENBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002684</DrugIDPK>
    <LicenceNumber>PA0050/020/001</LicenceNumber>
    <ProductName>TARACTAN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002685</DrugIDPK>
    <LicenceNumber>PA0050/020/002</LicenceNumber>
    <ProductName>TARACTAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROTHIXENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021452</DrugIDPK>
    <LicenceNumber>PA1138/026/001</LicenceNumber>
    <ProductName>TEEJEL</ProductName>
    <Strength>8.7/0.01</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>SSL International plc</PAHolder>
    <AuthorisedDate>2006-04-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CETALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001235</DrugIDPK>
    <LicenceNumber>PA0022/042/001</LicenceNumber>
    <ProductName>TEMAZEPAM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1985-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001238</DrugIDPK>
    <LicenceNumber>PA0022/042/002</LicenceNumber>
    <ProductName>TEMAZEPAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>1985-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEMAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008630</DrugIDPK>
    <LicenceNumber>EU/1/00/168/001</LicenceNumber>
    <ProductName>TENECTEPLASE</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENECTEPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011302</DrugIDPK>
    <LicenceNumber>EU/1/00/168/002</LicenceNumber>
    <ProductName>TENECTEPLASE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENECTEPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011303</DrugIDPK>
    <LicenceNumber>EU/1/00/168/003</LicenceNumber>
    <ProductName>TENECTEPLASE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2001-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TENECTEPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015046</DrugIDPK>
    <LicenceNumber>PPA0465/023/002B</LicenceNumber>
    <ProductName>TENORMIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1991-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006395</DrugIDPK>
    <LicenceNumber>PPA0465/023/002A</LicenceNumber>
    <ProductName>TENORMIN 100 MG FILM-COATED TABLETS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1991-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006394</DrugIDPK>
    <LicenceNumber>PPA0465/023/001A</LicenceNumber>
    <ProductName>TENORMIN 50MG FILM-COATED TABLETS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1991-01-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011329</DrugIDPK>
    <LicenceNumber>PA0051/052/001</LicenceNumber>
    <ProductName>TENORMIN LS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021289</DrugIDPK>
    <LicenceNumber>PA1285/009/001</LicenceNumber>
    <ProductName>TERBINAFINE MEDIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-05-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBINAFINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020672</DrugIDPK>
    <LicenceNumber>EU/1/06/353/001</LicenceNumber>
    <ProductName>THELIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2006-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SITAXENTAN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020673</DrugIDPK>
    <LicenceNumber>EU/1/06/353/002</LicenceNumber>
    <ProductName>THELIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2006-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SITAXENTAN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>: Medicinal  product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020674</DrugIDPK>
    <LicenceNumber>EU/1/06/353/3-5</LicenceNumber>
    <ProductName>THELIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2006-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SITAXENTAN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013836</DrugIDPK>
    <LicenceNumber>PA0277/022/002</LicenceNumber>
    <ProductName>THEOVENT LONG ACTING</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-05-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013834</DrugIDPK>
    <LicenceNumber>PA0277/022/001</LicenceNumber>
    <ProductName>THEOVENT LONG ACTING</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>1983-04-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995014122</DrugIDPK>
    <LicenceNumber>EU/1/02/245/001</LicenceNumber>
    <ProductName>THERYTTREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>MDS Nordion S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Radio-Pharm Precursor</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YTTRIUM (90 Y)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008961</DrugIDPK>
    <LicenceNumber>EU/1/99/121/002</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>mcg</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008962</DrugIDPK>
    <LicenceNumber>EU/1/99/121/003</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008963</DrugIDPK>
    <LicenceNumber>EU/1/99/121/004</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008964</DrugIDPK>
    <LicenceNumber>EU/1/99/121/005</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008965</DrugIDPK>
    <LicenceNumber>EU/1/99/121/007</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008966</DrugIDPK>
    <LicenceNumber>EU/1/99/121/008</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008967</DrugIDPK>
    <LicenceNumber>EU/1/99/121/009</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008968</DrugIDPK>
    <LicenceNumber>EU/1/99/121/010</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008969</DrugIDPK>
    <LicenceNumber>EU/1/99/121/012</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008970</DrugIDPK>
    <LicenceNumber>EU/1/99/121/013</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008971</DrugIDPK>
    <LicenceNumber>EU/1/99/121/014</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008972</DrugIDPK>
    <LicenceNumber>EU/1/99/121/015</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006448</DrugIDPK>
    <LicenceNumber>EU/1/99/121/001</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006449</DrugIDPK>
    <LicenceNumber>EU/1/99/121/006</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006450</DrugIDPK>
    <LicenceNumber>EU/1/99/121/011</LicenceNumber>
    <ProductName>TIKOSYN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1999-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOFETILIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010384</DrugIDPK>
    <LicenceNumber>PA0035/044/001</LicenceNumber>
    <ProductName>TIMOPTOL OPHTHALMIC</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010385</DrugIDPK>
    <LicenceNumber>PA0035/044/002</LicenceNumber>
    <ProductName>TIMOPTOL OPHTHALMIC</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010386</DrugIDPK>
    <LicenceNumber>PA0035/044/003</LicenceNumber>
    <ProductName>TIMOPTOL OPHTHALMIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013571</DrugIDPK>
    <LicenceNumber>PA0277/003/003</LicenceNumber>
    <ProductName>TINADERM-M CREAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995000309</DrugIDPK>
    <LicenceNumber>PA0045/027/001</LicenceNumber>
    <ProductName>TINSET</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>1984-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXATOMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011067</DrugIDPK>
    <LicenceNumber>PA0047/003/003</LicenceNumber>
    <ProductName>TOBRAMYCIN</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011064</DrugIDPK>
    <LicenceNumber>PA0047/003/002</LicenceNumber>
    <ProductName>TOBRAMYCIN SULPHATE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993011062</DrugIDPK>
    <LicenceNumber>PA0047/003/001</LicenceNumber>
    <ProductName>TOBRAMYCIN SULPHATE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>1975-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993000762</DrugIDPK>
    <LicenceNumber>PA0028/024/002</LicenceNumber>
    <ProductName>TOFRANIL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011702</DrugIDPK>
    <LicenceNumber>EU/1/01/175/002</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011703</DrugIDPK>
    <LicenceNumber>EU/1/01/175/003</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011704</DrugIDPK>
    <LicenceNumber>EU/1/01/175/004</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011705</DrugIDPK>
    <LicenceNumber>EU/1/01/175/005</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011706</DrugIDPK>
    <LicenceNumber>EU/1/01/175/006</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011707</DrugIDPK>
    <LicenceNumber>EU/1/01/175/007</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011708</DrugIDPK>
    <LicenceNumber>EU/1/01/175/008</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011709</DrugIDPK>
    <LicenceNumber>EU/1/01/175/009</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011710</DrugIDPK>
    <LicenceNumber>EU/1/01/175/010</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011711</DrugIDPK>
    <LicenceNumber>EU/1/01/175/011</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011712</DrugIDPK>
    <LicenceNumber>EU/1/01/175/012</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011714</DrugIDPK>
    <LicenceNumber>EU/1/01/175/013</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011715</DrugIDPK>
    <LicenceNumber>EU/1/01/175/014</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011720</DrugIDPK>
    <LicenceNumber>EU/1/01/175/015</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011721</DrugIDPK>
    <LicenceNumber>EU/1/01/175/016</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011722</DrugIDPK>
    <LicenceNumber>EU/1/01/175/017</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011723</DrugIDPK>
    <LicenceNumber>EU/1/01/175/018</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011724</DrugIDPK>
    <LicenceNumber>EU/1/01/175/019</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011725</DrugIDPK>
    <LicenceNumber>EU/1/01/175/020</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011726</DrugIDPK>
    <LicenceNumber>EU/1/01/175/021</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995010650</DrugIDPK>
    <LicenceNumber>EU/1/01/175/001</LicenceNumber>
    <ProductName>TRAZEC FILM-COATED</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2001-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NATEGLINIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005554</DrugIDPK>
    <LicenceNumber>EU/1/98/088/001</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007606</DrugIDPK>
    <LicenceNumber>EU/1/98/088/002</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007607</DrugIDPK>
    <LicenceNumber>EU/1/98/088/003</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007608</DrugIDPK>
    <LicenceNumber>EU/1/98/088/004</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007609</DrugIDPK>
    <LicenceNumber>EU/1/98/088/005</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007610</DrugIDPK>
    <LicenceNumber>EU/1/98/088/006</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007611</DrugIDPK>
    <LicenceNumber>EU/1/98/088/007</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007612</DrugIDPK>
    <LicenceNumber>EU/1/98/088/008</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007613</DrugIDPK>
    <LicenceNumber>EU/1/98/088/009</LicenceNumber>
    <ProductName>TRIACELLUVAX</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>GSK Vaccines S.r.l.</PAHolder>
    <AuthorisedDate>1999-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS TOXOID</ActiveSubstance>
      <ActiveSubstance>FILAMENTOUS HAEMAGGLUTININ (FHA)</ActiveSubstance>
      <ActiveSubstance>PERTACTIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006174</DrugIDPK>
    <LicenceNumber>PA0414/001/001</LicenceNumber>
    <ProductName>TRILOBAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Intersan GmbH</PAHolder>
    <AuthorisedDate>1984-12-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GINKGO BILOBA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993016385</DrugIDPK>
    <LicenceNumber>PA0044/015/002</LicenceNumber>
    <ProductName>TRIPTAFEN DA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001326</DrugIDPK>
    <LicenceNumber>PA0024/006/002</LicenceNumber>
    <ProductName>TRIPTAFEN M</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>1984-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009025</DrugIDPK>
    <LicenceNumber>EU/1/00/156/001</LicenceNumber>
    <ProductName>TRIZIVIR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2000-12-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZIDOVUDINE</ActiveSubstance>
      <ActiveSubstance>ABACAVIR SULFATE</ActiveSubstance>
      <ActiveSubstance>LAMIVUDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015225</DrugIDPK>
    <LicenceNumber>EU/1/03/257/1-6</LicenceNumber>
    <ProductName>TRUDEXA</ProductName>
    <Strength>40 mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2003-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012395</DrugIDPK>
    <LicenceNumber>EU/1/02/236/1-4</LicenceNumber>
    <ProductName>ULTRATARD</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2002-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003650</DrugIDPK>
    <LicenceNumber>PA0102/026/001</LicenceNumber>
    <ProductName>UNIGAM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>1992-06-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>OENOTHERA BIENNIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007175</DrugIDPK>
    <LicenceNumber>PA0913/006/009</LicenceNumber>
    <ProductName>UNIPHYLLIN CONTINUS</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007168</DrugIDPK>
    <LicenceNumber>PA0913/006/004</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007169</DrugIDPK>
    <LicenceNumber>PA0913/006/005</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007170</DrugIDPK>
    <LicenceNumber>PA0913/006/006</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007171</DrugIDPK>
    <LicenceNumber>PA0913/006/007</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007172</DrugIDPK>
    <LicenceNumber>PA0913/006/008</LicenceNumber>
    <ProductName>UNIPHYLLIN SPRINKLE</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009006</DrugIDPK>
    <LicenceNumber>EU/1/01/180/001</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012041</DrugIDPK>
    <LicenceNumber>EU/1/01/180/003</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012042</DrugIDPK>
    <LicenceNumber>EU/1/01/180/004</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012043</DrugIDPK>
    <LicenceNumber>EU/1/01/180/005</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012044</DrugIDPK>
    <LicenceNumber>EU/1/01/180/006</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012045</DrugIDPK>
    <LicenceNumber>EU/1/01/180/007</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012047</DrugIDPK>
    <LicenceNumber>EU/1/01/180/009</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012048</DrugIDPK>
    <LicenceNumber>EU/1/01/180/010</LicenceNumber>
    <ProductName>UPRIMA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Abbott Laboratories Limited</PAHolder>
    <AuthorisedDate>2001-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>APOMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995012102</DrugIDPK>
    <LicenceNumber>EU/1/02/244/1-24</LicenceNumber>
    <ProductName>VALDYN</ProductName>
    <Strength>10/20/40</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Pharmacia Enterprises S.A.</PAHolder>
    <AuthorisedDate>2003-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VALDECOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019361</DrugIDPK>
    <LicenceNumber>EU/1/06/335/001</LicenceNumber>
    <ProductName>VALTROPIN (SOMATROPIN BIOPARTNERS)</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BioPartners GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOMATROPIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007937</DrugIDPK>
    <LicenceNumber>PA0566/012/004</LicenceNumber>
    <ProductName>VAMIN 9 GLUCOSE</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>1997-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>ASPARTIC ACID</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>GLUTAMIC ACID</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE</ActiveSubstance>
      <ActiveSubstance>METHIONINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006495</DrugIDPK>
    <LicenceNumber>PA0468/028/001</LicenceNumber>
    <ProductName>VANOXIDE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>1992-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993002156</DrugIDPK>
    <LicenceNumber>PA0046/010/001</LicenceNumber>
    <ProductName>VARIOTIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>1977-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PECILOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017318</DrugIDPK>
    <LicenceNumber>PA0100/044/001</LicenceNumber>
    <ProductName>VASOGEN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>2001-10-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011849</DrugIDPK>
    <LicenceNumber>EU/1/02/232/1-2</LicenceNumber>
    <ProductName>VELOSULIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2002-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013722</DrugIDPK>
    <LicenceNumber>PA0217/008/001</LicenceNumber>
    <ProductName>VELOSULIN HUMAN 40 IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013723</DrugIDPK>
    <LicenceNumber>PA0217/008/002</LicenceNumber>
    <ProductName>VELOSULIN HUMAN 80IU/ML</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016183</DrugIDPK>
    <LicenceNumber>PA1077/049/003</LicenceNumber>
    <ProductName>VENTOLIN</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993010813</DrugIDPK>
    <LicenceNumber>PA0044/003/005</LicenceNumber>
    <ProductName>VENTOLIN ROTAHALER &amp; BOX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>1979-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993001049</DrugIDPK>
    <LicenceNumber>PA0019/013/005</LicenceNumber>
    <ProductName>VIBRAMYCIN-D</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>1983-05-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012608</DrugIDPK>
    <LicenceNumber>PA0441/025/002</LicenceNumber>
    <ProductName>VICKS LOZENGES BLACKCURRANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012611</DrugIDPK>
    <LicenceNumber>PA0441/028/001</LicenceNumber>
    <ProductName>VICKS LOZENGES LEMON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012604</DrugIDPK>
    <LicenceNumber>PA0441/025/001</LicenceNumber>
    <ProductName>VICKS LOZENGES REGULAR</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013222</DrugIDPK>
    <LicenceNumber>PA0157/011/001</LicenceNumber>
    <ProductName>VIPEN POWDER (SUSPENSION)</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Millilitre</StrengthMeasurement>
    <PAHolder>Controlled Medications Limited</PAHolder>
    <AuthorisedDate>1977-07-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007800</DrugIDPK>
    <LicenceNumber>EU/1/99/128/001</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RECOMBINANT INTERFERRON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009601</DrugIDPK>
    <LicenceNumber>EU/1/99/128/003</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>3,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009602</DrugIDPK>
    <LicenceNumber>EU/1/99/128/004</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>5,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009603</DrugIDPK>
    <LicenceNumber>EU/1/99/128/005</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>5,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009604</DrugIDPK>
    <LicenceNumber>EU/1/99/128/006</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009605</DrugIDPK>
    <LicenceNumber>EU/1/99/128/007</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009606</DrugIDPK>
    <LicenceNumber>EU/1/99/128/008</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009607</DrugIDPK>
    <LicenceNumber>EU/1/99/128/009</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>3,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009608</DrugIDPK>
    <LicenceNumber>EU/1/99/128/010</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>3,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009609</DrugIDPK>
    <LicenceNumber>EU/1/99/128/011</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>3,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009610</DrugIDPK>
    <LicenceNumber>EU/1/99/128/012</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>3,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009611</DrugIDPK>
    <LicenceNumber>EU/1/99/128/013</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>5,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009612</DrugIDPK>
    <LicenceNumber>EU/1/99/128/014</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009614</DrugIDPK>
    <LicenceNumber>EU/1/99/128/016</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>5,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009615</DrugIDPK>
    <LicenceNumber>EU/1/99/128/017</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009616</DrugIDPK>
    <LicenceNumber>EU/1/99/128/018</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009617</DrugIDPK>
    <LicenceNumber>EU/1/99/128/019</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009618</DrugIDPK>
    <LicenceNumber>EU/1/99/128/020</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>10,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009619</DrugIDPK>
    <LicenceNumber>EU/1/99/128/021</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>18,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009620</DrugIDPK>
    <LicenceNumber>EU/1/99/128/022</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>18,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009621</DrugIDPK>
    <LicenceNumber>EU/1/99/128/024</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>18,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009622</DrugIDPK>
    <LicenceNumber>EU/1/99/128/023</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>18,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009627</DrugIDPK>
    <LicenceNumber>EU/1/99/128/025</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>25,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009628</DrugIDPK>
    <LicenceNumber>EU/1/99/128/026</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>25,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009629</DrugIDPK>
    <LicenceNumber>EU/1/99/128/027</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>25,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009630</DrugIDPK>
    <LicenceNumber>EU/1/99/128/028</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>25,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009631</DrugIDPK>
    <LicenceNumber>EU/1/99/128/029</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>18,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009632</DrugIDPK>
    <LicenceNumber>EU/1/99/128/030</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>18,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009633</DrugIDPK>
    <LicenceNumber>EU/1/99/128/031</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>18,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009634</DrugIDPK>
    <LicenceNumber>EU/1/99/128/032</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>30,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009635</DrugIDPK>
    <LicenceNumber>EU/1/99/128/033</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>30,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009636</DrugIDPK>
    <LicenceNumber>EU/1/99/128/034</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>30,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009637</DrugIDPK>
    <LicenceNumber>EU/1/99/128/035</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>60,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009638</DrugIDPK>
    <LicenceNumber>EU/1/99/128/036</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>60,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009639</DrugIDPK>
    <LicenceNumber>EU/1/99/128/037</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>60,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009596</DrugIDPK>
    <LicenceNumber>EU/1/99/128/002</LicenceNumber>
    <ProductName>VIRAFERON</ProductName>
    <Strength>3,000,000</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>2000-03-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006265</DrugIDPK>
    <LicenceNumber>PA0416/005/001</LicenceNumber>
    <ProductName>VITAMIN C PLUS 200 MG SOFT CAPSULE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Seven Seas Health Care Ltd</PAHolder>
    <AuthorisedDate>1991-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993012324</DrugIDPK>
    <LicenceNumber>PA0395/004/002</LicenceNumber>
    <ProductName>VITAMIN E</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Health &amp; Diet Food Company Ltd</PAHolder>
    <AuthorisedDate>1983-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003056</DrugIDPK>
    <LicenceNumber>PPA0465/013/004A</LicenceNumber>
    <ProductName>VOLTAROL RETARD 100 MG FILM-COATED PROLONGED-RELEA</ProductName>
    <Strength>100mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003055</DrugIDPK>
    <LicenceNumber>PPA0465/013/003A</LicenceNumber>
    <ProductName>VOLTAROL RETARD 75 MG FILM-COATED PROLONGED-RELEAS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>1998-11-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009926</DrugIDPK>
    <LicenceNumber>PA0017/059/001</LicenceNumber>
    <ProductName>WELLCOME BRAND INSULIN ZINC  (SUSPENSION)</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>1979-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009914</DrugIDPK>
    <LicenceNumber>PA0017/043/002</LicenceNumber>
    <ProductName>WELLCOME POLIOMYELITIS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993013700</DrugIDPK>
    <LicenceNumber>PA0208/007/001</LicenceNumber>
    <ProductName>XENON</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>BOC Gases Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011001</DrugIDPK>
    <LicenceNumber>EU/1/02/225/1-2</LicenceNumber>
    <ProductName>XIGRIS</ProductName>
    <Strength>20mg + 5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>2002-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROTRECOGIN ALFA (ACTIVATED)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995013921</DrugIDPK>
    <LicenceNumber>PA0970/054/002</LicenceNumber>
    <ProductName>XYLOCAINE ACCORDION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2000-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993006956</DrugIDPK>
    <LicenceNumber>PA0661/001/002</LicenceNumber>
    <ProductName>ZANTAC</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Blackrock Clinic Limited</PAHolder>
    <AuthorisedDate>1993-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005913</DrugIDPK>
    <LicenceNumber>EU/1/99/098/001</LicenceNumber>
    <ProductName>ZENAPAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1999-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACLIZUMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007767</DrugIDPK>
    <LicenceNumber>EU/1/99/098/002</LicenceNumber>
    <ProductName>ZENAPAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>1999-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACLIZUMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020899</DrugIDPK>
    <LicenceNumber>EU/1/06/345/01</LicenceNumber>
    <ProductName>ZIMULTI</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sanofi aventis</PAHolder>
    <AuthorisedDate>2006-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIMONABANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007331</DrugIDPK>
    <LicenceNumber>PPA0465/058/001B</LicenceNumber>
    <ProductName>ZOTON</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019273</DrugIDPK>
    <LicenceNumber>EU/1/05/313/1-9</LicenceNumber>
    <ProductName>ABLAVAR</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>mMol/ml</StrengthMeasurement>
    <PAHolder>TMC Pharma Services Ltd</PAHolder>
    <AuthorisedDate>2005-10-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GADOFOSVESET TRISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034084</DrugIDPK>
    <LicenceNumber>PPA1500/071/001</LicenceNumber>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034085</DrugIDPK>
    <LicenceNumber>PPA1500/071/002</LicenceNumber>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034086</DrugIDPK>
    <LicenceNumber>PPA1500/071/003</LicenceNumber>
    <ProductName>ACERYCAL</ProductName>
    <Strength>5/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034087</DrugIDPK>
    <LicenceNumber>PPA1500/071/004</LicenceNumber>
    <ProductName>ACERYCAL</ProductName>
    <Strength>10/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026941</DrugIDPK>
    <LicenceNumber>DPR1463/001/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027841</DrugIDPK>
    <LicenceNumber>DPR1500/005/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028518</DrugIDPK>
    <LicenceNumber>PPA1473/011/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029278</DrugIDPK>
    <LicenceNumber>DPR1392/028/001</LicenceNumber>
    <ProductName>ACTONEL ONCE A WEEK</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032669</DrugIDPK>
    <LicenceNumber>PA1635/003/002</LicenceNumber>
    <ProductName>ACTONEL PLUS CA &amp; D TABLET 35MG AND 500MG/400 IU F</ProductName>
    <Strength>35/500/400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Chilcott UK Limited</PAHolder>
    <AuthorisedDate>2010-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>CHOLECALCIFEROL CONCENTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032669</DrugIDPK>
    <LicenceNumber>PA1635/003/002</LicenceNumber>
    <ProductName>ACTONEL PLUS CA &amp; D TABLET 35MG AND 500MG/400 IU F</ProductName>
    <Strength>35/500/400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Warner Chilcott UK Limited</PAHolder>
    <AuthorisedDate>2010-04-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>CHOLECALCIFEROL CONCENTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029954</DrugIDPK>
    <LicenceNumber>DPR1328/003/001</LicenceNumber>
    <ProductName>ADCORTYL IN OROBASE</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027101</DrugIDPK>
    <LicenceNumber>DPR1473/001/001</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023069</DrugIDPK>
    <LicenceNumber>EU/1/07/401/1-6</LicenceNumber>
    <ProductName>ALLI</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>2007-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORLISTAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022976</DrugIDPK>
    <LicenceNumber>DPR1400/001/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>MIRAPHARM</PAHolder>
    <AuthorisedDate>2007-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027102</DrugIDPK>
    <LicenceNumber>DPR1473/002/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027850</DrugIDPK>
    <LicenceNumber>DPR1500/010/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>02.</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029850</DrugIDPK>
    <LicenceNumber>DPR1562/008/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030123</DrugIDPK>
    <LicenceNumber>DPR1328/020/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031284</DrugIDPK>
    <LicenceNumber>DPR1601/003/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031049</DrugIDPK>
    <LicenceNumber>DPR1592/001/001</LicenceNumber>
    <ProductName>ALPHAGAN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031138</DrugIDPK>
    <LicenceNumber>DPR1596/015/001</LicenceNumber>
    <ProductName>ALPHAGAN EYE DROPS SOLUTION</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRIMONIDINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032089</DrugIDPK>
    <LicenceNumber>PA1380/089/001</LicenceNumber>
    <ProductName>AMISULPRIDE ACTAVIS</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMISULPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028292</DrugIDPK>
    <LicenceNumber>PA1507/001/001</LicenceNumber>
    <ProductName>ANASTROZOLE PROGEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Progen s.r.l.,</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027541</DrugIDPK>
    <LicenceNumber>DPR1473/023/001</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <Strength>1g/5ml</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027542</DrugIDPK>
    <LicenceNumber>DPR1473/023/002</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024383</DrugIDPK>
    <LicenceNumber>H/C/333/X/42</LicenceNumber>
    <ProductName>ARANESP</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Amgen Europe B.V.</PAHolder>
    <AuthorisedDate>2008-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024617</DrugIDPK>
    <LicenceNumber>DPR1392/012/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024618</DrugIDPK>
    <LicenceNumber>DPR1392/012/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028933</DrugIDPK>
    <LicenceNumber>DPR1500/016/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028934</DrugIDPK>
    <LicenceNumber>DPR1500/016/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028935</DrugIDPK>
    <LicenceNumber>DPR1500/016/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029744</DrugIDPK>
    <LicenceNumber>DPR1392/012/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031328</DrugIDPK>
    <LicenceNumber>DPR1601/023/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031329</DrugIDPK>
    <LicenceNumber>DPR1601/023/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031330</DrugIDPK>
    <LicenceNumber>DPR1601/023/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031046</DrugIDPK>
    <LicenceNumber>DPR1328/026/004</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031047</DrugIDPK>
    <LicenceNumber>DPR1328/026/005</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030163</DrugIDPK>
    <LicenceNumber>DPR1328/026/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030164</DrugIDPK>
    <LicenceNumber>DPR1328/026/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030165</DrugIDPK>
    <LicenceNumber>DPR1328/026/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032160</DrugIDPK>
    <LicenceNumber>DPR1447/002/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031532</DrugIDPK>
    <LicenceNumber>DPR1328/026/006</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031153</DrugIDPK>
    <LicenceNumber>DPR1596/022/001</LicenceNumber>
    <ProductName>ARCOXIA FILM COATED TABLETS</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031154</DrugIDPK>
    <LicenceNumber>DPR1596/022/002</LicenceNumber>
    <ProductName>ARCOXIA FILM COATED TABLETS</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031155</DrugIDPK>
    <LicenceNumber>DPR1596/022/003</LicenceNumber>
    <ProductName>ARCOXIA FILM COATED TABLETS</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETORICOXIB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027325</DrugIDPK>
    <LicenceNumber>PPA1447/010/002</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027448</DrugIDPK>
    <LicenceNumber>PPA1447/010/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DONEPEZIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024168</DrugIDPK>
    <LicenceNumber>DPR1392/009/001</LicenceNumber>
    <ProductName>ARIMIDEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031529</DrugIDPK>
    <LicenceNumber>DPR1392/009/002</LicenceNumber>
    <ProductName>ARIMIDEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANASTROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024342</DrugIDPK>
    <LicenceNumber>PA0167/131/002</LicenceNumber>
    <ProductName>ARTISS POWDERS AND SOLVENT FOR SEALANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and Solvent for Sealant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN FIBRINOGEN</ActiveSubstance>
      <ActiveSubstance>APROTININ SOLUTION, BOVINE</ActiveSubstance>
      <ActiveSubstance>HUMAN THROMBIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024342</DrugIDPK>
    <LicenceNumber>PA0167/131/002</LicenceNumber>
    <ProductName>ARTISS POWDERS AND SOLVENT FOR SEALANT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and Solvent for Sealant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN FIBRINOGEN</ActiveSubstance>
      <ActiveSubstance>APROTININ SOLUTION, BOVINE</ActiveSubstance>
      <ActiveSubstance>HUMAN THROMBIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032927</DrugIDPK>
    <LicenceNumber>PPA0465/249/001</LicenceNumber>
    <ProductName>ARYTHMOL</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2011-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPAFENONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034274</DrugIDPK>
    <LicenceNumber>PPA1562/038/001</LicenceNumber>
    <ProductName>ASASANTIN RETARD</ProductName>
    <Strength>200/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022334</DrugIDPK>
    <LicenceNumber>PPA1328/069/001</LicenceNumber>
    <ProductName>ASASANTIN RETARD 200 MG /25 MG MODIFIED-RELEASE HA</ProductName>
    <Strength>200/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030428</DrugIDPK>
    <LicenceNumber>PPA1500/033/002</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030429</DrugIDPK>
    <LicenceNumber>PPA1500/033/003</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDESARTAN CILEXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032780</DrugIDPK>
    <LicenceNumber>PPA1473/046/001</LicenceNumber>
    <ProductName>AVODART</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DUTASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037875</DrugIDPK>
    <LicenceNumber>PA1380/138/002</LicenceNumber>
    <ProductName>AZITHROMYCIN ACTAVIS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2012-11-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZITHROMYCIN DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019840</DrugIDPK>
    <LicenceNumber>PA1185/003/001</LicenceNumber>
    <ProductName>BELLCALCID CALCIUM CARBONATE 1500MG AND COLECALSIF</ProductName>
    <Strength>1.5g/400</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>BellPharma Limited</PAHolder>
    <AuthorisedDate>2004-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022159</DrugIDPK>
    <LicenceNumber>PA0967/007/001</LicenceNumber>
    <ProductName>BELLPRAV</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022160</DrugIDPK>
    <LicenceNumber>PA0967/007/002</LicenceNumber>
    <ProductName>BELLPRAV</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022162</DrugIDPK>
    <LicenceNumber>PA0967/007/003</LicenceNumber>
    <ProductName>BELLPRAV</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-09-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027543</DrugIDPK>
    <LicenceNumber>DPR1473/024/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028976</DrugIDPK>
    <LicenceNumber>DPR1500/021/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035472</DrugIDPK>
    <LicenceNumber>DPR1562/019/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-04-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031282</DrugIDPK>
    <LicenceNumber>DPR1601/002/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029635</DrugIDPK>
    <LicenceNumber>DPR1328/001/001</LicenceNumber>
    <ProductName>BETAGAN UNIT DOSE EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-02-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOBUNOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026526</DrugIDPK>
    <LicenceNumber>DPR1392/019/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026942</DrugIDPK>
    <LicenceNumber>DPR1463/002/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-01-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027103</DrugIDPK>
    <LicenceNumber>DPR1473/003/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029837</DrugIDPK>
    <LicenceNumber>DPR1562/002/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027840</DrugIDPK>
    <LicenceNumber>DPR1500/004/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031283</DrugIDPK>
    <LicenceNumber>DPR1601/001/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030511</DrugIDPK>
    <LicenceNumber>DPR0465/029/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030102</DrugIDPK>
    <LicenceNumber>DPR1328/019/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034082</DrugIDPK>
    <LicenceNumber>DPR1447/010/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031131</DrugIDPK>
    <LicenceNumber>DPR1596/009/001</LicenceNumber>
    <ProductName>BETOPTIC EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAXOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029126</DrugIDPK>
    <LicenceNumber>PA1330/004/001</LicenceNumber>
    <ProductName>BICALUTAMIDE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
      <ActiveSubstance>LACTOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM STARCH GLYCOLLATE</ActiveSubstance>
      <ActiveSubstance>POVIDONE K30</ActiveSubstance>
      <ActiveSubstance>SILICA COLLOIDALIS ANHYDRICA</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029127</DrugIDPK>
    <LicenceNumber>PA1330/004/002</LicenceNumber>
    <ProductName>BICALUTAMIDE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>2008-11-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
      <ActiveSubstance>LACTOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM STARCH GLYCOLLATE</ActiveSubstance>
      <ActiveSubstance>POVIDONE K30</ActiveSubstance>
      <ActiveSubstance>SILICA COLLOIDALIS ANHYDRICA</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023238</DrugIDPK>
    <LicenceNumber>DPR1392/005/001</LicenceNumber>
    <ProductName>BONJELA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CETALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024272</DrugIDPK>
    <LicenceNumber>DPR0465/010/001</LicenceNumber>
    <ProductName>BONJELA</ProductName>
    <Strength>8.714/0.010</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CETALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027104</DrugIDPK>
    <LicenceNumber>DPR1473/004/001</LicenceNumber>
    <ProductName>BONJELA</ProductName>
    <Strength>8.714/0.010</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CETALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027450</DrugIDPK>
    <LicenceNumber>DPR1463/017/001</LicenceNumber>
    <ProductName>BONJELA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE SALICYLATE</ActiveSubstance>
      <ActiveSubstance>CETALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027083</DrugIDPK>
    <LicenceNumber>DPR1465/001/001</LicenceNumber>
    <ProductName>BREVOXYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029176</DrugIDPK>
    <LicenceNumber>DPR1465/027/001</LicenceNumber>
    <ProductName>BREVOXYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027084</DrugIDPK>
    <LicenceNumber>DPR1465/002/001</LicenceNumber>
    <ProductName>BURNEZE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029180</DrugIDPK>
    <LicenceNumber>DPR1465/028/001</LicenceNumber>
    <ProductName>BURNEZE SPRAY</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029521</DrugIDPK>
    <LicenceNumber>DPR0465/024/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029522</DrugIDPK>
    <LicenceNumber>DPR0465/024/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-01-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028586</DrugIDPK>
    <LicenceNumber>DPR1463/023/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028587</DrugIDPK>
    <LicenceNumber>DPR1463/023/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027588</DrugIDPK>
    <LicenceNumber>DPR1473/034/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027589</DrugIDPK>
    <LicenceNumber>DPR1473/034/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030032</DrugIDPK>
    <LicenceNumber>DPR1500/028/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030033</DrugIDPK>
    <LicenceNumber>DPR1500/028/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995041244</DrugIDPK>
    <LicenceNumber>PA1836/001/063</LicenceNumber>
    <ProductName>BUTTONS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>IMB Test Pharmaceutical Company</PAHolder>
    <AuthorisedDate>2013-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm xsi:nil="true" />
    <ActiveSubstances>
      <ActiveSubstance>C.PERFRINGENS TYPE B &amp; C TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031190</DrugIDPK>
    <LicenceNumber>PA0915/032/001</LicenceNumber>
    <ProductName>BYSTAT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031191</DrugIDPK>
    <LicenceNumber>PA0915/032/002</LicenceNumber>
    <ProductName>BYSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031192</DrugIDPK>
    <LicenceNumber>PA0915/032/003</LicenceNumber>
    <ProductName>BYSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030693</DrugIDPK>
    <LicenceNumber>DPR0465/001/002</LicenceNumber>
    <ProductName>CALCICHEW</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030131</DrugIDPK>
    <LicenceNumber>DPR1328/021/001</LicenceNumber>
    <ProductName>CALCICHEW D3 FORTE</ProductName>
    <Strength>500/400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022760</DrugIDPK>
    <LicenceNumber>DPR1392/003/001</LicenceNumber>
    <ProductName>CALCICHEW D3 FORTE</ProductName>
    <Strength>500mg/400IU</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>CHOLECALCIFEROL (02) 400 INTERNATION UNIT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027105</DrugIDPK>
    <LicenceNumber>DPR1473/005/001</LicenceNumber>
    <ProductName>CALCICHEW D3 FORTE</ProductName>
    <Strength>1250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026944</DrugIDPK>
    <LicenceNumber>DPR1463/004/001</LicenceNumber>
    <ProductName>CALCICHEW D3 FORTE</ProductName>
    <Strength>500/400</Strength>
    <StrengthMeasurement>mg/IU</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027839</DrugIDPK>
    <LicenceNumber>DPR1500/003/001</LicenceNumber>
    <ProductName>CALCICHEW D3 FORTE</ProductName>
    <Strength>500mg/400I</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995040087</DrugIDPK>
    <LicenceNumber>DPR1392/069/001</LicenceNumber>
    <ProductName>CALCICHEW D3 FORTE CHEWABLE TABLETS</ProductName>
    <Strength>500mg/400I</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2013-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033486</DrugIDPK>
    <LicenceNumber>DPR1633/002/001</LicenceNumber>
    <ProductName>CALCICHEW-D3 FORTE</ProductName>
    <Strength>500/400</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2010-08-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022977</DrugIDPK>
    <LicenceNumber>DPR1400/002/001</LicenceNumber>
    <ProductName>CALCICHEW-D3 FORTE</ProductName>
    <Strength>1250mg/400IU</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>MIRAPHARM</PAHolder>
    <AuthorisedDate>2007-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031285</DrugIDPK>
    <LicenceNumber>DPR1601/004/001</LicenceNumber>
    <ProductName>CALCICHEW-D3 FORTE CHEWABLE TABLETS</ProductName>
    <Strength>500mg/400IU</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030833</DrugIDPK>
    <LicenceNumber>DPR1562/011/001</LicenceNumber>
    <ProductName>CALCICHEW-D3 FORTE TABLETS</ProductName>
    <Strength>500mg/400I</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031142</DrugIDPK>
    <LicenceNumber>DPR1596/018/001</LicenceNumber>
    <ProductName>CALCICHEW-D3 FORTE TABLETS</ProductName>
    <Strength>500mg/400I</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026511</DrugIDPK>
    <LicenceNumber>PA0711/149/001</LicenceNumber>
    <ProductName>CALCIL 50 MICROGRAMS/ML CUTANEOUS SOLUTION</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-04-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027050</DrugIDPK>
    <LicenceNumber>DPR1465/023/002</LicenceNumber>
    <ProductName>CALLOUS REMOVAL PADS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029260</DrugIDPK>
    <LicenceNumber>DPR1465/039/001</LicenceNumber>
    <ProductName>CALLOUS REMOVAL PADS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022344</DrugIDPK>
    <LicenceNumber>PPA1328/073/001</LicenceNumber>
    <ProductName>CAMPRAL EC</ProductName>
    <Strength>333</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACAMPROSATE CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019555</DrugIDPK>
    <LicenceNumber>PA0019/053/001</LicenceNumber>
    <ProductName>CAMPTO</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>mg/2ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2004-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019556</DrugIDPK>
    <LicenceNumber>PA0019/053/002</LicenceNumber>
    <ProductName>CAMPTO</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>2004-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029838</DrugIDPK>
    <LicenceNumber>DPR1562/003/001</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028951</DrugIDPK>
    <LicenceNumber>DPR1463/010/004</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027824</DrugIDPK>
    <LicenceNumber>DPR1473/043/001</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027825</DrugIDPK>
    <LicenceNumber>DPR1473/043/003</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027085</DrugIDPK>
    <LicenceNumber>DPR1465/003/001</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027086</DrugIDPK>
    <LicenceNumber>DPR1465/003/002</LicenceNumber>
    <ProductName>CANESTEN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030157</DrugIDPK>
    <LicenceNumber>DPR1328/024/001</LicenceNumber>
    <ProductName>CANESTEN CREAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027407</DrugIDPK>
    <LicenceNumber>DPR1463/010/002</LicenceNumber>
    <ProductName>CANESTEN CREAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027907</DrugIDPK>
    <LicenceNumber>DPR1392/022/001</LicenceNumber>
    <ProductName>CANESTEN CREAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028936</DrugIDPK>
    <LicenceNumber>DPR1500/017/001</LicenceNumber>
    <ProductName>CANESTEN CREAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029182</DrugIDPK>
    <LicenceNumber>DPR1465/029/001</LicenceNumber>
    <ProductName>CANESTEN CREAM</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027320</DrugIDPK>
    <LicenceNumber>DPR1463/010/001</LicenceNumber>
    <ProductName>CANESTEN HC</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027208</DrugIDPK>
    <LicenceNumber>DPR1473/022/001</LicenceNumber>
    <ProductName>CANESTEN HC</ProductName>
    <Strength>1.0</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022768</DrugIDPK>
    <LicenceNumber>DPR0465/004/001</LicenceNumber>
    <ProductName>CANESTEN HC</ProductName>
    <Strength>1/1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-02-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030158</DrugIDPK>
    <LicenceNumber>DPR1328/025/001</LicenceNumber>
    <ProductName>CANESTEN HC CREAM</ProductName>
    <Strength>1/1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028938</DrugIDPK>
    <LicenceNumber>DPR1500/018/001</LicenceNumber>
    <ProductName>CANESTEN HC CREAM</ProductName>
    <Strength>1/1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029183</DrugIDPK>
    <LicenceNumber>DPR1465/029/002</LicenceNumber>
    <ProductName>CANESTEN PESSARY</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029840</DrugIDPK>
    <LicenceNumber>DPR1562/003/003</LicenceNumber>
    <ProductName>CANESTEN PESSARY</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029841</DrugIDPK>
    <LicenceNumber>DPR1562/003/004</LicenceNumber>
    <ProductName>CANESTEN PESSARY</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027908</DrugIDPK>
    <LicenceNumber>DPR1392/022/002</LicenceNumber>
    <ProductName>CANESTEN PESSARY</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031299</DrugIDPK>
    <LicenceNumber>DPR1601/014/001</LicenceNumber>
    <ProductName>CANESTEN PESSARY</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030491</DrugIDPK>
    <LicenceNumber>DPR1392/022/003</LicenceNumber>
    <ProductName>CANESTEN THRUSH</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027826</DrugIDPK>
    <LicenceNumber>DPR1473/043/002</LicenceNumber>
    <ProductName>CANESTEN THRUSH</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029184</DrugIDPK>
    <LicenceNumber>DPR1465/029/003</LicenceNumber>
    <ProductName>CANESTEN THRUSH</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027087</DrugIDPK>
    <LicenceNumber>DPR1465/003/003</LicenceNumber>
    <ProductName>CANESTEN THRUSH</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027408</DrugIDPK>
    <LicenceNumber>DPR1463/010/003</LicenceNumber>
    <ProductName>CANESTEN THRUSH</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028937</DrugIDPK>
    <LicenceNumber>DPR1500/017/002</LicenceNumber>
    <ProductName>CANESTEN THRUSH CREAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028614</DrugIDPK>
    <LicenceNumber>DPR0465/021/001</LicenceNumber>
    <ProductName>CANESTEN THRUSH VAGINAL CREAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031768</DrugIDPK>
    <LicenceNumber>DPR1447/001/001</LicenceNumber>
    <ProductName>CANESTEN THRUSH VAGINAL CREAM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-11-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021950</DrugIDPK>
    <LicenceNumber>PPA1328/056/003</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021963</DrugIDPK>
    <LicenceNumber>PPA1328/013/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021964</DrugIDPK>
    <LicenceNumber>PPA1328/013/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021965</DrugIDPK>
    <LicenceNumber>PPA1328/013/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022761</DrugIDPK>
    <LicenceNumber>DPR1392/001/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022762</DrugIDPK>
    <LicenceNumber>DPR1392/001/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022763</DrugIDPK>
    <LicenceNumber>DPR1392/001/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022764</DrugIDPK>
    <LicenceNumber>DPR1392/001/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022765</DrugIDPK>
    <LicenceNumber>DPR1392/001/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021468</DrugIDPK>
    <LicenceNumber>PPA1328/013/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029545</DrugIDPK>
    <LicenceNumber>DPR1562/001/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029546</DrugIDPK>
    <LicenceNumber>DPR1562/001/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029547</DrugIDPK>
    <LicenceNumber>DPR1562/001/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029548</DrugIDPK>
    <LicenceNumber>DPR1562/001/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-01-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027834</DrugIDPK>
    <LicenceNumber>DPR1500/002/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027835</DrugIDPK>
    <LicenceNumber>DPR1500/002/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027836</DrugIDPK>
    <LicenceNumber>DPR1500/002/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027837</DrugIDPK>
    <LicenceNumber>DPR1500/002/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027838</DrugIDPK>
    <LicenceNumber>DPR1500/002/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027106</DrugIDPK>
    <LicenceNumber>DPR1473/006/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027107</DrugIDPK>
    <LicenceNumber>DPR1473/006/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027108</DrugIDPK>
    <LicenceNumber>DPR1473/006/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027109</DrugIDPK>
    <LicenceNumber>DPR1473/006/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027110</DrugIDPK>
    <LicenceNumber>DPR1473/006/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026950</DrugIDPK>
    <LicenceNumber>DPR1463/006/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026951</DrugIDPK>
    <LicenceNumber>DPR1463/006/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026952</DrugIDPK>
    <LicenceNumber>DPR1463/006/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023043</DrugIDPK>
    <LicenceNumber>DPR0465/005/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023044</DrugIDPK>
    <LicenceNumber>DPR0465/005/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023045</DrugIDPK>
    <LicenceNumber>DPR0465/005/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023120</DrugIDPK>
    <LicenceNumber>DPR0465/005/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023245</DrugIDPK>
    <LicenceNumber>DPR0465/005/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031845</DrugIDPK>
    <LicenceNumber>PPA1328/013/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2010-03-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030458</DrugIDPK>
    <LicenceNumber>DPR1463/006/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030459</DrugIDPK>
    <LicenceNumber>DPR1463/006/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030460</DrugIDPK>
    <LicenceNumber>DPR1463/006/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029990</DrugIDPK>
    <LicenceNumber>DPR0465/005/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029950</DrugIDPK>
    <LicenceNumber>DPR1473/006/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-03-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029856</DrugIDPK>
    <LicenceNumber>DPR1562/001/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029857</DrugIDPK>
    <LicenceNumber>DPR1562/001/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031343</DrugIDPK>
    <LicenceNumber>PPA1447/047/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031344</DrugIDPK>
    <LicenceNumber>PPA1447/047/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031056</DrugIDPK>
    <LicenceNumber>DPR1596/001/001</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031057</DrugIDPK>
    <LicenceNumber>DPR1596/001/002</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031058</DrugIDPK>
    <LicenceNumber>DPR1596/001/003</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>3.75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031059</DrugIDPK>
    <LicenceNumber>DPR1596/001/004</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>5.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031060</DrugIDPK>
    <LicenceNumber>DPR1596/001/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031061</DrugIDPK>
    <LicenceNumber>DPR1596/001/006</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <Strength>10.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031305</DrugIDPK>
    <LicenceNumber>DPR1601/016/001</LicenceNumber>
    <ProductName>CARDICOR TABLETS</ProductName>
    <Strength>1.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031306</DrugIDPK>
    <LicenceNumber>DPR1601/016/002</LicenceNumber>
    <ProductName>CARDICOR TABLETS</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031307</DrugIDPK>
    <LicenceNumber>DPR1601/016/003</LicenceNumber>
    <ProductName>CARDICOR TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031308</DrugIDPK>
    <LicenceNumber>DPR1601/016/004</LicenceNumber>
    <ProductName>CARDICOR TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028441</DrugIDPK>
    <LicenceNumber>PPA1473/006/001</LicenceNumber>
    <ProductName>CARDURA XL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-02-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019808</DrugIDPK>
    <LicenceNumber>PA0749/010/001</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>3.125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019809</DrugIDPK>
    <LicenceNumber>PA0749/010/002</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>6.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019810</DrugIDPK>
    <LicenceNumber>PA0749/010/003</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019811</DrugIDPK>
    <LicenceNumber>PA0749/010/004</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2005-10-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARVEDILOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027165</DrugIDPK>
    <LicenceNumber>PPA1447/017/001</LicenceNumber>
    <ProductName>CASODEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-05-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BICALUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027370</DrugIDPK>
    <LicenceNumber>PA1380/041/001</LicenceNumber>
    <ProductName>CEFALEXIN</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027371</DrugIDPK>
    <LicenceNumber>PA1380/041/002</LicenceNumber>
    <ProductName>CEFALEXIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035448</DrugIDPK>
    <LicenceNumber>PA0361/033/004</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-06-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034318</DrugIDPK>
    <LicenceNumber>PA0361/033/001</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034319</DrugIDPK>
    <LicenceNumber>PA0361/033/002</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034320</DrugIDPK>
    <LicenceNumber>PA0361/033/003</LicenceNumber>
    <ProductName>CEFTAZIDIME</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTAZIDIME PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033835</DrugIDPK>
    <LicenceNumber>PA1675/002/001</LicenceNumber>
    <ProductName>CEFUROXIME GLOB LIMITED</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033836</DrugIDPK>
    <LicenceNumber>PA1675/002/002</LicenceNumber>
    <ProductName>CEFUROXIME GLOB LIMITED</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033837</DrugIDPK>
    <LicenceNumber>PA1675/002/003</LicenceNumber>
    <ProductName>CEFUROXIME GLOB LIMITED</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032934</DrugIDPK>
    <LicenceNumber>PA0361/030/001</LicenceNumber>
    <ProductName>CEFUROXIME MARTINDALE PHARMA</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032935</DrugIDPK>
    <LicenceNumber>PA0361/030/002</LicenceNumber>
    <ProductName>CEFUROXIME MARTINDALE PHARMA</ProductName>
    <Strength>1.5</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028217</DrugIDPK>
    <LicenceNumber>PA0749/082/002</LicenceNumber>
    <ProductName>CEFUROXIME TEVA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028218</DrugIDPK>
    <LicenceNumber>PA0749/082/003</LicenceNumber>
    <ProductName>CEFUROXIME TEVA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFUROXIME AXETIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029843</DrugIDPK>
    <LicenceNumber>DPR1562/004/001</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030636</DrugIDPK>
    <LicenceNumber>DPR1392/040/001</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032224</DrugIDPK>
    <LicenceNumber>DPR1500/031/001</LicenceNumber>
    <ProductName>CELLUVISC EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031139</DrugIDPK>
    <LicenceNumber>DPR1596/016/001</LicenceNumber>
    <ProductName>CELLUVISC EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031286</DrugIDPK>
    <LicenceNumber>DPR1601/005/001</LicenceNumber>
    <ProductName>CELLUVISC EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031159</DrugIDPK>
    <LicenceNumber>DPR1473/052/001</LicenceNumber>
    <ProductName>CELLUVISC EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-08-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARMELLOSE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027656</DrugIDPK>
    <LicenceNumber>DPR1473/025/001</LicenceNumber>
    <ProductName>CERUMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029881</DrugIDPK>
    <LicenceNumber>DPR0465/026/001</LicenceNumber>
    <ProductName>CERUMOL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROBUTANOL</ActiveSubstance>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026697</DrugIDPK>
    <LicenceNumber>PA1380/030/001</LicenceNumber>
    <ProductName>CICLOSPORIN GENFARMA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026698</DrugIDPK>
    <LicenceNumber>PA1380/030/002</LicenceNumber>
    <ProductName>CICLOSPORIN GENFARMA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026699</DrugIDPK>
    <LicenceNumber>PA1380/030/003</LicenceNumber>
    <ProductName>CICLOSPORIN GENFARMA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2008-01-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules, Soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOSPORIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029899</DrugIDPK>
    <LicenceNumber>PPA0465/217/001</LicenceNumber>
    <ProductName>CILEST 250/35 MICROGRAM TABLETS</ProductName>
    <Strength>250/35</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORGESTIMATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033903</DrugIDPK>
    <LicenceNumber>PPA1659/022/001</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032499</DrugIDPK>
    <LicenceNumber>PA0749/119/001</LicenceNumber>
    <ProductName>CISPLATIN TEVA</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020176</DrugIDPK>
    <LicenceNumber>PA0577/072/001</LicenceNumber>
    <ProductName>CITALOPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033067</DrugIDPK>
    <LicenceNumber>PA0749/125/001</LicenceNumber>
    <ProductName>CLARIE LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021516</DrugIDPK>
    <LicenceNumber>PA0408/063/003</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <Strength>125/5</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021517</DrugIDPK>
    <LicenceNumber>PA0408/063/004</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <Strength>250/5</Strength>
    <StrengthMeasurement>MG/5ml</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2006-06-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021588</DrugIDPK>
    <LicenceNumber>PA0281/131/001</LicenceNumber>
    <ProductName>CLARYL</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021589</DrugIDPK>
    <LicenceNumber>PA0281/131/002</LicenceNumber>
    <ProductName>CLARYL</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033222</DrugIDPK>
    <LicenceNumber>PA1312/012/001</LicenceNumber>
    <ProductName>CLASTEON 800MG FILM-COATED TABLETS</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Beacon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2011-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CLODRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027544</DrugIDPK>
    <LicenceNumber>DPR1473/026/001</LicenceNumber>
    <ProductName>CLOMID</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMIFENE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028639</DrugIDPK>
    <LicenceNumber>EU/1/09/542/1-7</LicenceNumber>
    <ProductName>CLOPIDOGREL 1A PHARMA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>2009-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031015</DrugIDPK>
    <LicenceNumber>EU/1/09/549/1-7</LicenceNumber>
    <ProductName>CLOPIDOGREL ACINO PHARMA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>2009-09-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031018</DrugIDPK>
    <LicenceNumber>EU/1/09/548/1-7</LicenceNumber>
    <ProductName>CLOPIDOGREL ACINO PHARMA GMBH</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>2009-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029302</DrugIDPK>
    <LicenceNumber>EU/1/08/464/15-17</LicenceNumber>
    <ProductName>CLOPIDOGREL BMS 300 MG FILM-COATED TABLETS</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2008-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027310</DrugIDPK>
    <LicenceNumber>EU/1/08/464/1-14, 18-19</LicenceNumber>
    <ProductName>CLOPIDOGREL BMS 75 MG FILM-COATED TABLETS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol-Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2008-07-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL HYDROGENSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028684</DrugIDPK>
    <LicenceNumber>PA1505/002/001</LicenceNumber>
    <ProductName>CLOPIDOGREL ESP PHARMA</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>ESP Pharma Limited</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030772</DrugIDPK>
    <LicenceNumber>EU/1/09/534/1-7</LicenceNumber>
    <ProductName>CLOPIDOGREL HEXAL</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>2009-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032610</DrugIDPK>
    <LicenceNumber>PA1369/005/001</LicenceNumber>
    <ProductName>CLOPIDOGREL NUCLEUS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>Nucleus ehf.</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031017</DrugIDPK>
    <LicenceNumber>EU/1/09/547/1-7</LicenceNumber>
    <ProductName>CLOPIDOGREL SANDOZ</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>2009-09-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021935</DrugIDPK>
    <LicenceNumber>PPA1328/058/001</LicenceNumber>
    <ProductName>CORDARONE X 200 MG TABLETS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-12-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIODARONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029261</DrugIDPK>
    <LicenceNumber>DPR1465/039/002</LicenceNumber>
    <ProductName>CORN REMOVAL PLASTERS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027088</DrugIDPK>
    <LicenceNumber>DPR1465/004/001</LicenceNumber>
    <ProductName>CORSODYL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029185</DrugIDPK>
    <LicenceNumber>DPR1465/030/001</LicenceNumber>
    <ProductName>CORSODYL DENTAL GEL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032087</DrugIDPK>
    <LicenceNumber>DPR1392/061/001</LicenceNumber>
    <ProductName>CORSODYL DENTAL GEL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027322</DrugIDPK>
    <LicenceNumber>DPR1463/012/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995025211</DrugIDPK>
    <LicenceNumber>DPR1392/018/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023093</DrugIDPK>
    <LicenceNumber>DPR1151/001/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030171</DrugIDPK>
    <LicenceNumber>DPR1328/029/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031136</DrugIDPK>
    <LicenceNumber>DPR1596/013/001</LicenceNumber>
    <ProductName>COSOPT EYE DROPS SOLUTION</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031287</DrugIDPK>
    <LicenceNumber>DPR1601/006/001</LicenceNumber>
    <ProductName>COSOPT EYE DROPS SOLUTION</ProductName>
    <Strength>20/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028939</DrugIDPK>
    <LicenceNumber>DPR1500/019/001</LicenceNumber>
    <ProductName>COSOPT EYE DROPS SOLUTION</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021527</DrugIDPK>
    <LicenceNumber>PPA1151/014/001</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021528</DrugIDPK>
    <LicenceNumber>PPA1151/014/002</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-01-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029945</DrugIDPK>
    <LicenceNumber>PPA1473/027/001</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029946</DrugIDPK>
    <LicenceNumber>PPA1473/027/002</LicenceNumber>
    <ProductName>COVERSYL ARGININE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029600</DrugIDPK>
    <LicenceNumber>PPA1473/017/002</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOSARTAN POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995025206</DrugIDPK>
    <LicenceNumber>DPR1392/017/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-11-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027295</DrugIDPK>
    <LicenceNumber>DPR1463/009/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027114</DrugIDPK>
    <LicenceNumber>DPR1473/007/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023092</DrugIDPK>
    <LicenceNumber>DPR1151/002/001</LicenceNumber>
    <ProductName>CREON 10000</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031289</DrugIDPK>
    <LicenceNumber>DPR1601/007/001</LicenceNumber>
    <ProductName>CREON 10000 CAPSULES</ProductName>
    <Strength>10000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031141</DrugIDPK>
    <LicenceNumber>DPR1596/017/001</LicenceNumber>
    <ProductName>CREON 10000 CAPSULES</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREAS POWDER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032247</DrugIDPK>
    <LicenceNumber>DPR1392/062/001</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032248</DrugIDPK>
    <LicenceNumber>DPR1392/062/002</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032249</DrugIDPK>
    <LicenceNumber>DPR1392/062/003</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032250</DrugIDPK>
    <LicenceNumber>DPR1392/062/004</LicenceNumber>
    <ProductName>CRESTOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROSUVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028249</DrugIDPK>
    <LicenceNumber>H/C/572/X/31</LicenceNumber>
    <ProductName>CYMBALTA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DULOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027089</DrugIDPK>
    <LicenceNumber>DPR1465/005/001</LicenceNumber>
    <ProductName>CYMEX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UREA</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLOROCRESOL</ActiveSubstance>
      <ActiveSubstance>DIMETHICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024758</DrugIDPK>
    <LicenceNumber>H/C/902/00/0/0</LicenceNumber>
    <ProductName>DALBAVANCIN</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DALBAVANCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033231</DrugIDPK>
    <LicenceNumber>PA0964/008/002</LicenceNumber>
    <ProductName>DECA DURABOLIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027093</DrugIDPK>
    <LicenceNumber>DPR1465/006/001</LicenceNumber>
    <ProductName>DERBAC M</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029187</DrugIDPK>
    <LicenceNumber>DPR1465/031/001</LicenceNumber>
    <ProductName>DERBAC-M LIQUID</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034662</DrugIDPK>
    <LicenceNumber>PA1380/106/001</LicenceNumber>
    <ProductName>DERINIK</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034663</DrugIDPK>
    <LicenceNumber>PA1380/106/002</LicenceNumber>
    <ProductName>DERINIK</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034664</DrugIDPK>
    <LicenceNumber>PA1380/106/003</LicenceNumber>
    <ProductName>DERINIK</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993003160</DrugIDPK>
    <LicenceNumber>PA0068/002/001</LicenceNumber>
    <ProductName>DIAMICRON 80MG TABLETS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>1976-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLICLAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023078</DrugIDPK>
    <LicenceNumber>DPR0465/006/001</LicenceNumber>
    <ProductName>DIDRONEL PMO</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-04-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027894</DrugIDPK>
    <LicenceNumber>DPR1473/044/001</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027895</DrugIDPK>
    <LicenceNumber>DPR1473/044/002</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027896</DrugIDPK>
    <LicenceNumber>DPR1473/044/003</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030026</DrugIDPK>
    <LicenceNumber>DPR1500/027/001</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030027</DrugIDPK>
    <LicenceNumber>DPR1500/027/002</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030028</DrugIDPK>
    <LicenceNumber>DPR1500/027/003</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030510</DrugIDPK>
    <LicenceNumber>DPR0465/027/006</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-05-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030218</DrugIDPK>
    <LicenceNumber>DPR0465/027/001</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030219</DrugIDPK>
    <LicenceNumber>DPR0465/027/002</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031427</DrugIDPK>
    <LicenceNumber>DPR1328/038/001</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031419</DrugIDPK>
    <LicenceNumber>DPR1392/045/001</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031420</DrugIDPK>
    <LicenceNumber>DPR1392/045/002</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>90</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031421</DrugIDPK>
    <LicenceNumber>DPR1392/045/003</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033886</DrugIDPK>
    <LicenceNumber>DPR1562/017/001</LicenceNumber>
    <ProductName>DILZEM SR</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031422</DrugIDPK>
    <LicenceNumber>DPR1392/045/004</LicenceNumber>
    <ProductName>DILZEM XL</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031423</DrugIDPK>
    <LicenceNumber>DPR1392/045/005</LicenceNumber>
    <ProductName>DILZEM XL</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031424</DrugIDPK>
    <LicenceNumber>DPR1392/045/006</LicenceNumber>
    <ProductName>DILZEM XL</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031428</DrugIDPK>
    <LicenceNumber>DPR1328/038/002</LicenceNumber>
    <ProductName>DILZEM XL</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030220</DrugIDPK>
    <LicenceNumber>DPR0465/027/003</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED RELEASE HARD CAPSULES</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030221</DrugIDPK>
    <LicenceNumber>DPR0465/027/004</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED RELEASE HARD CAPSULES</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030222</DrugIDPK>
    <LicenceNumber>DPR0465/027/005</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED RELEASE HARD CAPSULES</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030029</DrugIDPK>
    <LicenceNumber>DPR1500/027/004</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED RELEASE HARD CAPSULES</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030030</DrugIDPK>
    <LicenceNumber>DPR1500/027/005</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED RELEASE HARD CAPSULES</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030031</DrugIDPK>
    <LicenceNumber>DPR1500/027/006</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED RELEASE HARD CAPSULES</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027897</DrugIDPK>
    <LicenceNumber>DPR1473/044/004</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED-RELEASE</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027898</DrugIDPK>
    <LicenceNumber>DPR1473/044/005</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED-RELEASE</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027899</DrugIDPK>
    <LicenceNumber>DPR1473/044/006</LicenceNumber>
    <ProductName>DILZEM XL PROLONGED-RELEASE</ProductName>
    <Strength>240</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019326</DrugIDPK>
    <LicenceNumber>PA0798/003/001</LicenceNumber>
    <ProductName>DITEBOOSTER</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Statens Serum Institute</PAHolder>
    <AuthorisedDate>2005-03-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027383</DrugIDPK>
    <LicenceNumber>PA0405/052/001</LicenceNumber>
    <ProductName>DORZOLAMIDE MYLAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045968</DrugIDPK>
    <LicenceNumber>PPA1328/066/001</LicenceNumber>
    <ProductName>DOVOBET</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL HYDRATE</ActiveSubstance>
      <ActiveSubstance>BETAMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022366</DrugIDPK>
    <LicenceNumber>PPA1328/023/003</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-01-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036110</DrugIDPK>
    <LicenceNumber>PPA1562/059/001</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Micrograms/g</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2011-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035951</DrugIDPK>
    <LicenceNumber>PPA1659/045/001</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>5 Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2011-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIPOTRIOL HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019381</DrugIDPK>
    <LicenceNumber>PA1140/005/001</LicenceNumber>
    <ProductName>DOXAPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Taro Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAPRAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020413</DrugIDPK>
    <LicenceNumber>PA1140/005/002</LicenceNumber>
    <ProductName>DOXAPRAM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Taro Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>2005-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAPRAM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031221</DrugIDPK>
    <LicenceNumber>PA0361/024/001</LicenceNumber>
    <ProductName>DOXORUBICIN MARTINDALE PHARMA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027094</DrugIDPK>
    <LicenceNumber>DPR1465/007/001</LicenceNumber>
    <ProductName>DRAPOLENE</ProductName>
    <Strength>0.02/0.2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026965</DrugIDPK>
    <LicenceNumber>PA1419/001/001</LicenceNumber>
    <ProductName>DRAXMIBI</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>DRAXIMAGE (UK) Limited</PAHolder>
    <AuthorisedDate>2009-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Kit for radiopharmaceutical preparation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRAKIS (2-METHOXY ISOBUTYL ISONITRILE) COPPER (I) TETRAFLUOROLBORATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038184</DrugIDPK>
    <LicenceNumber>H/C/2314/00/0/1</LicenceNumber>
    <ProductName>DUAVIVE</ProductName>
    <Strength>20mg/0.625</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CONJUGATED ESTROGENS (CE)</ActiveSubstance>
      <ActiveSubstance>BAZEDOXIFENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029248</DrugIDPK>
    <LicenceNumber>DPR1465/032/001</LicenceNumber>
    <ProductName>DULCOLAX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027095</DrugIDPK>
    <LicenceNumber>DPR1465/008/001</LicenceNumber>
    <ProductName>DULCOLAX GASTRO RESISTANT</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027125</DrugIDPK>
    <LicenceNumber>DPR1473/011/001</LicenceNumber>
    <ProductName>DULCOLAX LIQUID 5 MG/5 ML ORAL SOLUTION</ProductName>
    <Strength>5 mg/5 ml</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PICOSULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Promotion to the public only for the short-term management of constipation in adults.

Promotion to healthcare professionals only for all other indications and age groups.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029847</DrugIDPK>
    <LicenceNumber>DPR1562/006/001</LicenceNumber>
    <ProductName>DULCOLAX PERLES</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PICOSULPHATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029849</DrugIDPK>
    <LicenceNumber>DPR1562/007/002</LicenceNumber>
    <ProductName>DULCOLAX SUPPOSITORIES</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029848</DrugIDPK>
    <LicenceNumber>DPR1562/007/001</LicenceNumber>
    <ProductName>DULCOLAX SUPPOSITORIES FOR CHILDREN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027862</DrugIDPK>
    <LicenceNumber>EU/1/08/471/1-2</LicenceNumber>
    <ProductName>DULOXETINE BOEHRINGER INGELHEIM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DULOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027863</DrugIDPK>
    <LicenceNumber>EU/1/08/471/3-5</LicenceNumber>
    <ProductName>DULOXETINE BOEHRINGER INGELHEIM</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DULOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027864</DrugIDPK>
    <LicenceNumber>EU/1/08/471/6-10</LicenceNumber>
    <ProductName>DULOXETINE BOEHRINGER INGELHEIM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DULOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027865</DrugIDPK>
    <LicenceNumber>EU/1/08/471/11-12</LicenceNumber>
    <ProductName>DULOXETINE BOEHRINGER INGELHEIM</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DULOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995042303</DrugIDPK>
    <LicenceNumber>EU/1/15/995/001</LicenceNumber>
    <ProductName>DUTREBIS</ProductName>
    <Strength>150/300</Strength>
    <StrengthMeasurement>mg/tablet</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ltd</PAHolder>
    <AuthorisedDate>2015-06-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RALTEGRAVIR</ActiveSubstance>
      <ActiveSubstance>LAMIVUDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027096</DrugIDPK>
    <LicenceNumber>DPR1465/009/001</LicenceNumber>
    <ProductName>EAREX</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SWEET ALMOND OIL</ActiveSubstance>
      <ActiveSubstance>ARACHIS OIL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032084</DrugIDPK>
    <LicenceNumber>PA1599/001/001</LicenceNumber>
    <ProductName>EBASTION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lindopharm GmbH</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EBASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032085</DrugIDPK>
    <LicenceNumber>PA1599/001/002</LicenceNumber>
    <ProductName>EBASTION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Lindopharm GmbH</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EBASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015791</DrugIDPK>
    <LicenceNumber>EU/1/02/219/004</LicenceNumber>
    <ProductName>EBIXA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>2001-12-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEMANTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021891</DrugIDPK>
    <LicenceNumber>PA0436/044/001</LicenceNumber>
    <ProductName>EFLAVEX</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021892</DrugIDPK>
    <LicenceNumber>PA0436/044/002</LicenceNumber>
    <ProductName>EFLAVEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CABERGOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027115</DrugIDPK>
    <LicenceNumber>DPR1473/008/001</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027406</DrugIDPK>
    <LicenceNumber>DPR1463/016/001</LicenceNumber>
    <ProductName>ELANTAN LA HARD</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026480</DrugIDPK>
    <LicenceNumber>H/C/932/00/0/0</LicenceNumber>
    <ProductName>ELLEFORE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESVENLAFAXINE SUCCINATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026481</DrugIDPK>
    <LicenceNumber>H/C/932/00/0/1</LicenceNumber>
    <ProductName>ELLEFORE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESVENLAFAXINE SUCCINATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026482</DrugIDPK>
    <LicenceNumber>H/C/932/00/0/2</LicenceNumber>
    <ProductName>ELLEFORE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESVENLAFAXINE SUCCINATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022758</DrugIDPK>
    <LicenceNumber>DPR1392/002/001</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022759</DrugIDPK>
    <LicenceNumber>DPR1392/002/002</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024207</DrugIDPK>
    <LicenceNumber>DPR1392/002/003</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023046</DrugIDPK>
    <LicenceNumber>EU/1/07/406/1-10</LicenceNumber>
    <ProductName>ENVIAGE</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPP100 HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023047</DrugIDPK>
    <LicenceNumber>EU/1/07/406/11-20</LicenceNumber>
    <ProductName>ENVIAGE</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPP100 HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027116</DrugIDPK>
    <LicenceNumber>DPR1473/009/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027117</DrugIDPK>
    <LicenceNumber>DPR1473/009/002</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027118</DrugIDPK>
    <LicenceNumber>DPR1473/009/003</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033244</DrugIDPK>
    <LicenceNumber>DPR1447/005/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033245</DrugIDPK>
    <LicenceNumber>DPR1447/005/002</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033246</DrugIDPK>
    <LicenceNumber>DPR1447/005/003</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033247</DrugIDPK>
    <LicenceNumber>DPR1447/005/004</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030795</DrugIDPK>
    <LicenceNumber>DPR0465/033/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030796</DrugIDPK>
    <LicenceNumber>DPR0465/033/002</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030025</DrugIDPK>
    <LicenceNumber>DPR1500/026/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030181</DrugIDPK>
    <LicenceNumber>DPR1328/031/001</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030182</DrugIDPK>
    <LicenceNumber>DPR1328/031/002</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030183</DrugIDPK>
    <LicenceNumber>DPR1328/031/003</LicenceNumber>
    <ProductName>EPANUTIN</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031194</DrugIDPK>
    <LicenceNumber>PA0361/023/001</LicenceNumber>
    <ProductName>EPIRUBICIN MARTINDALE PHARMA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2009-10-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPIRUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026993</DrugIDPK>
    <LicenceNumber>PA0711/153/001</LicenceNumber>
    <ProductName>ESCIPREX</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026994</DrugIDPK>
    <LicenceNumber>PA0711/153/004</LicenceNumber>
    <ProductName>ESCIPREX</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026995</DrugIDPK>
    <LicenceNumber>PA0711/153/003</LicenceNumber>
    <ProductName>ESCIPREX</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026996</DrugIDPK>
    <LicenceNumber>PA0711/153/002</LicenceNumber>
    <ProductName>ESCIPREX</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESCITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019870</DrugIDPK>
    <LicenceNumber>PA1201/001/001</LicenceNumber>
    <ProductName>ESTOPAUSE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Resource Medical (UK) Limited</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027494</DrugIDPK>
    <LicenceNumber>PA1474/002/001</LicenceNumber>
    <ProductName>ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA</ProductName>
    <Strength>0.02 / 3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Leon Farma, S.A.</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027495</DrugIDPK>
    <LicenceNumber>PA1474/002/002</LicenceNumber>
    <ProductName>ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA</ProductName>
    <Strength>0.03 / 3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratorios Leon Farma, S.A.</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020144</DrugIDPK>
    <LicenceNumber>PA0549/015/001</LicenceNumber>
    <ProductName>ETHIRFIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020145</DrugIDPK>
    <LicenceNumber>PA0549/015/002</LicenceNumber>
    <ProductName>ETHIRFIN</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020146</DrugIDPK>
    <LicenceNumber>PA0549/015/003</LicenceNumber>
    <ProductName>ETHIRFIN</ProductName>
    <Strength>60</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020147</DrugIDPK>
    <LicenceNumber>PA0549/015/004</LicenceNumber>
    <ProductName>ETHIRFIN</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020148</DrugIDPK>
    <LicenceNumber>PA0549/015/005</LicenceNumber>
    <ProductName>ETHIRFIN</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>2006-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027097</DrugIDPK>
    <LicenceNumber>DPR1465/010/001</LicenceNumber>
    <ProductName>EURAX HC</ProductName>
    <Strength>10/0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROTAMITON</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029249</DrugIDPK>
    <LicenceNumber>DPR1465/033/001</LicenceNumber>
    <ProductName>EURAX HC</ProductName>
    <Strength>10/0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROTAMITON</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027098</DrugIDPK>
    <LicenceNumber>DPR1465/011/001</LicenceNumber>
    <ProductName>EXOREX LOTION</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR, PREPARED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027560</DrugIDPK>
    <LicenceNumber>DPR1473/027/001</LicenceNumber>
    <ProductName>EXTEROL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UREA HYDROGEN PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018946</DrugIDPK>
    <LicenceNumber>EU/1/05/327/1-17</LicenceNumber>
    <ProductName>EXUBERA</ProductName>
    <Strength>1 &amp; 3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Aventis/Pfizer EEIG</PAHolder>
    <AuthorisedDate>2006-01-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027608</DrugIDPK>
    <LicenceNumber>DPR1473/039/001</LicenceNumber>
    <ProductName>EZETROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029552</DrugIDPK>
    <LicenceNumber>DPR1463/027/001</LicenceNumber>
    <ProductName>EZETROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-01-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027851</DrugIDPK>
    <LicenceNumber>DPR1500/011/001</LicenceNumber>
    <ProductName>EZETROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035131</DrugIDPK>
    <LicenceNumber>DPR1633/007/001</LicenceNumber>
    <ProductName>EZETROL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-02-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031145</DrugIDPK>
    <LicenceNumber>DPR1596/020/001</LicenceNumber>
    <ProductName>EZETROL TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021775</DrugIDPK>
    <LicenceNumber>PA0749/025/001</LicenceNumber>
    <ProductName>FAMCICLOVIR</ProductName>
    <Strength>125</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-02-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027564</DrugIDPK>
    <LicenceNumber>DPR1473/028/001</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027565</DrugIDPK>
    <LicenceNumber>DPR1473/028/002</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037499</DrugIDPK>
    <LicenceNumber>DPR0465/043/001</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037500</DrugIDPK>
    <LicenceNumber>DPR0465/043/002</LicenceNumber>
    <ProductName>FAVERIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2012-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVOXAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031198</DrugIDPK>
    <LicenceNumber>PPA0465/243/001</LicenceNumber>
    <ProductName>FEMARA</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-12-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LETROZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020561</DrugIDPK>
    <LicenceNumber>PA0899/029/002</LicenceNumber>
    <ProductName>FENTAZIN 4MG COATED TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2005-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERPHENAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022775</DrugIDPK>
    <LicenceNumber>PA0967/015/001</LicenceNumber>
    <ProductName>FINASTERIDE RANBAXY</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2007-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022304</DrugIDPK>
    <LicenceNumber>PA0749/035/001</LicenceNumber>
    <ProductName>FINASTERIDE TEVA</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-02-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FINASTERIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021467</DrugIDPK>
    <LicenceNumber>PPA1328/012/001</LicenceNumber>
    <ProductName>FLIXONASE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2008-01-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030275</DrugIDPK>
    <LicenceNumber>DPR1392/033/001</LicenceNumber>
    <ProductName>FLIXOTIDE EVOHALER</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033978</DrugIDPK>
    <LicenceNumber>DPR1392/063/001</LicenceNumber>
    <ProductName>FLOTROS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROSPIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034197</DrugIDPK>
    <LicenceNumber>PA1380/100/002</LicenceNumber>
    <ProductName>FLUCONAZOLE ACTAVIS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2011-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027626</DrugIDPK>
    <LicenceNumber>DPR1473/035/001</LicenceNumber>
    <ProductName>FOSAMAX</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029466</DrugIDPK>
    <LicenceNumber>PPA1328/086/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028663</DrugIDPK>
    <LicenceNumber>DPR1392/026/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027845</DrugIDPK>
    <LicenceNumber>DPR1500/007/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028060</DrugIDPK>
    <LicenceNumber>DPR1463/019/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031290</DrugIDPK>
    <LicenceNumber>DPR1601/008/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY TABLETS</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031132</DrugIDPK>
    <LicenceNumber>DPR1596/010/001</LicenceNumber>
    <ProductName>FOSAMAX ONCE WEEKLY TABLETS</ProductName>
    <Strength>70</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021286</DrugIDPK>
    <LicenceNumber>PA0577/086/001</LicenceNumber>
    <ProductName>FOSTEPOR 10MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2006-10-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995040408</DrugIDPK>
    <LicenceNumber>PA1390/049/002</LicenceNumber>
    <ProductName>FUROSEMIDE INJECTION</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Accord Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021640</DrugIDPK>
    <LicenceNumber>PA0749/022/001</LicenceNumber>
    <ProductName>GALANTAMINE TEVA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021641</DrugIDPK>
    <LicenceNumber>PA0749/022/002</LicenceNumber>
    <ProductName>GALANTAMINE TEVA</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021642</DrugIDPK>
    <LicenceNumber>PA0749/022/003</LicenceNumber>
    <ProductName>GALANTAMINE TEVA</ProductName>
    <Strength>12</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032161</DrugIDPK>
    <LicenceNumber>DPR1473/057/001</LicenceNumber>
    <ProductName>GAVISCON ADVANCE CHEWABLE TABLETS</ProductName>
    <Strength>500/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-01-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030996</DrugIDPK>
    <LicenceNumber>PA0361/022/001</LicenceNumber>
    <ProductName>GEMCITABINE MARTINDALE PHARMA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030997</DrugIDPK>
    <LicenceNumber>PA0361/022/002</LicenceNumber>
    <ProductName>GEMCITABINE MARTINDALE PHARMA</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2009-10-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030001</DrugIDPK>
    <LicenceNumber>PA0749/097/001</LicenceNumber>
    <ProductName>GEMCITABINE TEVA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030002</DrugIDPK>
    <LicenceNumber>PA0749/097/002</LicenceNumber>
    <ProductName>GEMCITABINE TEVA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030003</DrugIDPK>
    <LicenceNumber>PA0749/097/003</LicenceNumber>
    <ProductName>GEMCITABINE TEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-04-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GEMCITABINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995015708</DrugIDPK>
    <LicenceNumber>EU/1/95/01/027</LicenceNumber>
    <ProductName>GONAL-F</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Serono Europe Limited</PAHolder>
    <AuthorisedDate>2002-06-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1993009148</DrugIDPK>
    <LicenceNumber>EU/1/95/001/001</LicenceNumber>
    <ProductName>GONAL-F - AMPOULE</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>1995-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FOLLITROPIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022350</DrugIDPK>
    <LicenceNumber>PA0711/121/001</LicenceNumber>
    <ProductName>GRANISETRON</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023336</DrugIDPK>
    <LicenceNumber>PA0736/028/001</LicenceNumber>
    <ProductName>GRANISETRON B. BRAUN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRANISETRON HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GRANISETRON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030962</DrugIDPK>
    <LicenceNumber>PA0950/002/004</LicenceNumber>
    <ProductName>GRANOCYTE 13</ProductName>
    <Strength>13 million</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Chugai Pharma UK Ltd</PAHolder>
    <AuthorisedDate>2009-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for inf/inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LENOGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030963</DrugIDPK>
    <LicenceNumber>PA0950/002/003</LicenceNumber>
    <ProductName>GRANOCYTE 34</ProductName>
    <Strength>34 million</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Chugai Pharma UK Ltd</PAHolder>
    <AuthorisedDate>2009-09-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for inf/inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LENOGRASTIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027124</DrugIDPK>
    <LicenceNumber>DPR1473/010/001</LicenceNumber>
    <ProductName>HALF SINEMET CR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995044890</DrugIDPK>
    <LicenceNumber>PA2013/002/001</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Blackrock Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995044891</DrugIDPK>
    <LicenceNumber>PA2013/002/002</LicenceNumber>
    <ProductName>HYDROCORTISONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Blackrock Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028907</DrugIDPK>
    <LicenceNumber>PA1513/001/001</LicenceNumber>
    <ProductName>IBANDRONATE APOTEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>2009-12-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037702</DrugIDPK>
    <LicenceNumber>PA0749/178/001</LicenceNumber>
    <ProductName>IMATINIB TEVA PHARMA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMATINIB MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2) .</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037703</DrugIDPK>
    <LicenceNumber>PA0749/178/002</LicenceNumber>
    <ProductName>IMATINIB TEVA PHARMA</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IMATINIB MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2) .</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024085</DrugIDPK>
    <LicenceNumber>PA0167/132/001</LicenceNumber>
    <ProductName>IMMUNINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for inf/inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN COAGULATION FACTOR IX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028623</DrugIDPK>
    <LicenceNumber>EU/1/10/613/1-2</LicenceNumber>
    <ProductName>IMMUNOGAM</ProductName>
    <Strength>312</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Cangene Europe Limited</PAHolder>
    <AuthorisedDate>2010-03-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN HEPATITIS B IMMUNOGLOBULIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028443</DrugIDPK>
    <LicenceNumber>PPA1473/007/001</LicenceNumber>
    <ProductName>IMURAN</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-02-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028138</DrugIDPK>
    <LicenceNumber>DPR1392/023/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028139</DrugIDPK>
    <LicenceNumber>DPR1392/023/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-07-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027819</DrugIDPK>
    <LicenceNumber>DPR1473/042/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028940</DrugIDPK>
    <LicenceNumber>DPR1500/020/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028941</DrugIDPK>
    <LicenceNumber>DPR1500/020/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028942</DrugIDPK>
    <LicenceNumber>DPR1500/020/003</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029045</DrugIDPK>
    <LicenceNumber>DPR1392/023/003</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029929</DrugIDPK>
    <LicenceNumber>DPR1463/028/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029930</DrugIDPK>
    <LicenceNumber>DPR1463/028/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029931</DrugIDPK>
    <LicenceNumber>DPR1463/028/003</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031068</DrugIDPK>
    <LicenceNumber>DPR1596/002/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031069</DrugIDPK>
    <LicenceNumber>DPR1596/002/003</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031070</DrugIDPK>
    <LicenceNumber>DPR1596/002/002</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033239</DrugIDPK>
    <LicenceNumber>DPR1447/004/001</LicenceNumber>
    <ProductName>INEGY</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031309</DrugIDPK>
    <LicenceNumber>DPR1601/017/001</LicenceNumber>
    <ProductName>INEGY TABLETS</ProductName>
    <Strength>10/20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031310</DrugIDPK>
    <LicenceNumber>DPR1601/017/002</LicenceNumber>
    <ProductName>INEGY TABLETS</ProductName>
    <Strength>10/40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031311</DrugIDPK>
    <LicenceNumber>DPR1601/017/003</LicenceNumber>
    <ProductName>INEGY TABLETS</ProductName>
    <Strength>10/80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EZETIMIBE</ActiveSubstance>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024661</DrugIDPK>
    <LicenceNumber>DPR1392/013/001</LicenceNumber>
    <ProductName>INNOVACE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENALAPRIL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028853</DrugIDPK>
    <LicenceNumber>DPR1473/047/001</LicenceNumber>
    <ProductName>INSPRA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030098</DrugIDPK>
    <LicenceNumber>DPR1328/016/001</LicenceNumber>
    <ProductName>INSPRA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032536</DrugIDPK>
    <LicenceNumber>DPR1500/035/001</LicenceNumber>
    <ProductName>INSPRA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032537</DrugIDPK>
    <LicenceNumber>DPR1500/035/002</LicenceNumber>
    <ProductName>INSPRA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPLERENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019805</DrugIDPK>
    <LicenceNumber>EU/1/06/351/1-3</LicenceNumber>
    <ProductName>INTRINSA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Warner Chilcott Deutschland GmbH</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034281</DrugIDPK>
    <LicenceNumber>PA0408/085/001</LicenceNumber>
    <ProductName>IRBESARTAN / HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>150/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034282</DrugIDPK>
    <LicenceNumber>PA0408/085/002</LicenceNumber>
    <ProductName>IRBESARTAN / HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>300/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034283</DrugIDPK>
    <LicenceNumber>PA0408/085/003</LicenceNumber>
    <ProductName>IRBESARTAN / HYDROCHLOROTHIAZIDE</ProductName>
    <Strength>300/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2011-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022188</DrugIDPK>
    <LicenceNumber>EU/1/06/375/1-5</LicenceNumber>
    <ProductName>IRBESARTAN BMS</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022189</DrugIDPK>
    <LicenceNumber>EU/1/06/375/6-10</LicenceNumber>
    <ProductName>IRBESARTAN BMS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022190</DrugIDPK>
    <LicenceNumber>EU/1/06/375/11-15</LicenceNumber>
    <ProductName>IRBESARTAN BMS</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995025071</DrugIDPK>
    <LicenceNumber>EU/1/06/375/28-33</LicenceNumber>
    <ProductName>IRBESARTAN BMS</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995025072</DrugIDPK>
    <LicenceNumber>EU/1/06/375/22-27</LicenceNumber>
    <ProductName>IRBESARTAN BMS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022191</DrugIDPK>
    <LicenceNumber>EU/1/06/369/1-5</LicenceNumber>
    <ProductName>IRBESARTAN HCT BMS</ProductName>
    <Strength>150/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022192</DrugIDPK>
    <LicenceNumber>EU/1/06/369/6-10</LicenceNumber>
    <ProductName>IRBESARTAN HCT BMS</ProductName>
    <Strength>300/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022193</DrugIDPK>
    <LicenceNumber>EU/1/06/369/11-16</LicenceNumber>
    <ProductName>IRBESARTAN HCT BMS</ProductName>
    <Strength>150/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995025074</DrugIDPK>
    <LicenceNumber>EU/1/06/369/17-22</LicenceNumber>
    <ProductName>IRBESARTAN HYDROCHLOROTHIAZIDE BMS</ProductName>
    <Strength>300/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bristol Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>2007-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRBESARTAN</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032367</DrugIDPK>
    <LicenceNumber>PA0361/028/001</LicenceNumber>
    <ProductName>IRINOTECAN MARTINDALE PHARMA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-04-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022847</DrugIDPK>
    <LicenceNumber>PA0749/044/001</LicenceNumber>
    <ProductName>IRINOTECAN TEVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-03-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IRINOTECAN HYDROCHLORIDE TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033181</DrugIDPK>
    <LicenceNumber>PPA1447/067/001</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE AS AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033182</DrugIDPK>
    <LicenceNumber>PPA1447/067/002</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE AS AMLODIPINE BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033356</DrugIDPK>
    <LicenceNumber>PPA1659/014/001</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033357</DrugIDPK>
    <LicenceNumber>PPA1659/014/002</LicenceNumber>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029898</DrugIDPK>
    <LicenceNumber>PPA1463/010/002</LicenceNumber>
    <InterchangeableListCode>IC0045-002-008</InterchangeableListCode>
    <ProductName>ISTIN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995011618</DrugIDPK>
    <LicenceNumber>EU/1/01/172/002</LicenceNumber>
    <ProductName>KALETRA</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>AbbVie Ltd</PAHolder>
    <AuthorisedDate>2001-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RITONAVIR</ActiveSubstance>
      <ActiveSubstance>LOPINAVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031613</DrugIDPK>
    <LicenceNumber>PPA1473/040/001</LicenceNumber>
    <ProductName>KLACID LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021471</DrugIDPK>
    <LicenceNumber>PPA1328/014/001</LicenceNumber>
    <ProductName>KLACID LA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-10-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024776</DrugIDPK>
    <LicenceNumber>H/C/894/00/0/0</LicenceNumber>
    <ProductName>LACOSAMIDE PAIN SCHWARZ PHARMA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACOSAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024777</DrugIDPK>
    <LicenceNumber>H/C/894/00/0/5</LicenceNumber>
    <ProductName>LACOSAMIDE PAIN SCHWARZ PHARMA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACOSAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024778</DrugIDPK>
    <LicenceNumber>H/C/894/00/0/4</LicenceNumber>
    <ProductName>LACOSAMIDE PAIN SCHWARZ PHARMA</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACOSAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024779</DrugIDPK>
    <LicenceNumber>H/C/894/00/0/3</LicenceNumber>
    <ProductName>LACOSAMIDE PAIN SCHWARZ PHARMA</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACOSAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024780</DrugIDPK>
    <LicenceNumber>H/C/894/00/0/2</LicenceNumber>
    <ProductName>LACOSAMIDE PAIN SCHWARZ PHARMA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACOSAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024781</DrugIDPK>
    <LicenceNumber>H/C/894/00/0/1</LicenceNumber>
    <ProductName>LACOSAMIDE PAIN SCHWARZ PHARMA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>UCB Pharma GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACOSAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019455</DrugIDPK>
    <LicenceNumber>PA0997/008/001</LicenceNumber>
    <ProductName>LACTUGAL</ProductName>
    <Strength>3.4</Strength>
    <StrengthMeasurement>g/5ml</StrengthMeasurement>
    <PAHolder>Intrapharm Laboratories Limited</PAHolder>
    <AuthorisedDate>2004-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027988</DrugIDPK>
    <LicenceNumber>PA0408/071/001</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027989</DrugIDPK>
    <LicenceNumber>PA0408/071/002</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027990</DrugIDPK>
    <LicenceNumber>PA0408/071/005</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027991</DrugIDPK>
    <LicenceNumber>PA0408/071/004</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027992</DrugIDPK>
    <LicenceNumber>PA0408/071/003</LicenceNumber>
    <ProductName>LAMOTRIGINE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>2008-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersable Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LAMOTRIGINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029250</DrugIDPK>
    <LicenceNumber>DPR1465/034/001</LicenceNumber>
    <ProductName>LANACANE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027099</DrugIDPK>
    <LicenceNumber>DPR1465/012/001</LicenceNumber>
    <ProductName>LANACANE</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034134</DrugIDPK>
    <LicenceNumber>PPA0565/045/001</LicenceNumber>
    <ProductName>LANZIOP</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034135</DrugIDPK>
    <LicenceNumber>PPA0565/045/002</LicenceNumber>
    <ProductName>LANZIOP</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020117</DrugIDPK>
    <LicenceNumber>PA0436/041/001</LicenceNumber>
    <ProductName>LANZIOP</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020118</DrugIDPK>
    <LicenceNumber>PA0436/041/002</LicenceNumber>
    <ProductName>LANZIOP</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>2005-11-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANSOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035059</DrugIDPK>
    <LicenceNumber>PA1372/005/001</LicenceNumber>
    <ProductName>LATANOPROST / TIMOLOL YES</ProductName>
    <Strength>50 /5.0</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Yes Pharmaceutical Development Services GmbH</PAHolder>
    <AuthorisedDate>2011-06-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028081</DrugIDPK>
    <LicenceNumber>PA1505/001/001</LicenceNumber>
    <ProductName>LERCANIDIPINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>ESP Pharma Limited</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028082</DrugIDPK>
    <LicenceNumber>PA1505/001/002</LicenceNumber>
    <ProductName>LERCANIDIPINE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>ESP Pharma Limited</PAHolder>
    <AuthorisedDate>2011-11-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LERCANIDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022229</DrugIDPK>
    <LicenceNumber>PPA0465/090/003</LicenceNumber>
    <ProductName>LESCOL XL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-11-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030012</DrugIDPK>
    <LicenceNumber>PA1380/071/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029810</DrugIDPK>
    <LicenceNumber>PA1380/069/001</LicenceNumber>
    <ProductName>LEVOFLOXACIN ACTAVIS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029811</DrugIDPK>
    <LicenceNumber>PA1380/069/002</LicenceNumber>
    <ProductName>LEVOFLOXACIN ACTAVIS</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-05-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028420</DrugIDPK>
    <LicenceNumber>PPA1473/002/004</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030957</DrugIDPK>
    <LicenceNumber>PPA1447/044/001</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030958</DrugIDPK>
    <LicenceNumber>PPA1447/044/002</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Base Milligrams</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2009-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032145</DrugIDPK>
    <LicenceNumber>PPA1447/044/003</LicenceNumber>
    <ProductName>LIPITOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATORVASTATIN-CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028404</DrugIDPK>
    <LicenceNumber>DPR0465/018/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-07-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028547</DrugIDPK>
    <LicenceNumber>DPR1392/024/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027856</DrugIDPK>
    <LicenceNumber>DPR1500/012/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027402</DrugIDPK>
    <LicenceNumber>DPR1463/014/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027403</DrugIDPK>
    <LicenceNumber>DPR1463/014/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027594</DrugIDPK>
    <LicenceNumber>DPR1473/036/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031622</DrugIDPK>
    <LicenceNumber>DPR1562/015/001</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030582</DrugIDPK>
    <LicenceNumber>DPR0465/018/002</LicenceNumber>
    <ProductName>LIPOSTAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019804</DrugIDPK>
    <LicenceNumber>EU/1/06/351/001-003</LicenceNumber>
    <ProductName>LIVENSA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028319</DrugIDPK>
    <LicenceNumber>EU/1/00/155/007</LicenceNumber>
    <ProductName>LUVERIS</ProductName>
    <Strength>450</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>Serono Europe Limited</PAHolder>
    <AuthorisedDate>2009-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>R-HLH</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023227</DrugIDPK>
    <LicenceNumber>PA1380/005/001</LicenceNumber>
    <ProductName>LUVINSTA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023228</DrugIDPK>
    <LicenceNumber>PA1380/005/002</LicenceNumber>
    <ProductName>LUVINSTA</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023229</DrugIDPK>
    <LicenceNumber>PA1380/006/001</LicenceNumber>
    <ProductName>LUVINSTA XL</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-01-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027153</DrugIDPK>
    <LicenceNumber>DPR1465/013/001</LicenceNumber>
    <ProductName>LYCLEAR CREAM RINSE</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERMETHRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027057</DrugIDPK>
    <LicenceNumber>DPR1465/014/001</LicenceNumber>
    <ProductName>LYPSYL COLD SORE GEL</ProductName>
    <Strength>2.0/1.0/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027057</DrugIDPK>
    <LicenceNumber>DPR1465/014/001</LicenceNumber>
    <ProductName>LYPSYL COLD SORE GEL</ProductName>
    <Strength>2.0/1.0/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027057</DrugIDPK>
    <LicenceNumber>DPR1465/014/001</LicenceNumber>
    <ProductName>LYPSYL COLD SORE GEL</ProductName>
    <Strength>2.0/1.0/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027126</DrugIDPK>
    <LicenceNumber>DPR1473/012/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027127</DrugIDPK>
    <LicenceNumber>DPR1473/012/002</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027462</DrugIDPK>
    <LicenceNumber>DPR1392/021/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027463</DrugIDPK>
    <LicenceNumber>DPR1392/021/002</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027404</DrugIDPK>
    <LicenceNumber>DPR1463/015/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027405</DrugIDPK>
    <LicenceNumber>DPR1463/015/002</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028606</DrugIDPK>
    <LicenceNumber>DPR0465/020/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028607</DrugIDPK>
    <LicenceNumber>DPR0465/020/002</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2008-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035129</DrugIDPK>
    <LicenceNumber>DPR1633/006/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-04-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030100</DrugIDPK>
    <LicenceNumber>DPR1328/018/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030023</DrugIDPK>
    <LicenceNumber>DPR1500/025/001</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030024</DrugIDPK>
    <LicenceNumber>DPR1500/025/002</LicenceNumber>
    <ProductName>LYRINEL XL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031312</DrugIDPK>
    <LicenceNumber>DPR1601/018/001</LicenceNumber>
    <ProductName>LYRINEL XL PROLONGED RELEASE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031313</DrugIDPK>
    <LicenceNumber>DPR1601/018/002</LicenceNumber>
    <ProductName>LYRINEL XL PROLONGED RELEASE TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031147</DrugIDPK>
    <LicenceNumber>DPR1596/023/001</LicenceNumber>
    <ProductName>LYRINEL XL PROLONGED RELEASE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031148</DrugIDPK>
    <LicenceNumber>DPR1596/023/002</LicenceNumber>
    <ProductName>LYRINEL XL PROLONGED RELEASE TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995009519</DrugIDPK>
    <LicenceNumber>EU/1/01/193/001</LicenceNumber>
    <ProductName>MABCAMPATH</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>ILEX Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2001-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALEMTUZUMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030797</DrugIDPK>
    <LicenceNumber>DPR0465/034/001</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031100</DrugIDPK>
    <LicenceNumber>DPR1596/004/001</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031101</DrugIDPK>
    <LicenceNumber>DPR1596/004/002</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>200/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031102</DrugIDPK>
    <LicenceNumber>DPR1596/004/003</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027566</DrugIDPK>
    <LicenceNumber>DPR1473/013/003</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027128</DrugIDPK>
    <LicenceNumber>DPR1473/013/001</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027207</DrugIDPK>
    <LicenceNumber>DPR1473/013/002</LicenceNumber>
    <ProductName>MADOPAR</ProductName>
    <Strength>200/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031103</DrugIDPK>
    <LicenceNumber>DPR1596/004/004</LicenceNumber>
    <ProductName>MADOPAR CR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029999</DrugIDPK>
    <LicenceNumber>DPR1473/013/004</LicenceNumber>
    <ProductName>MADOPAR CR</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030146</DrugIDPK>
    <LicenceNumber>DPR1328/022/001</LicenceNumber>
    <ProductName>MADOPAR HARD CAPSULES</ProductName>
    <Strength>50/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030147</DrugIDPK>
    <LicenceNumber>DPR1328/022/002</LicenceNumber>
    <ProductName>MADOPAR HARD CAPSULES</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030148</DrugIDPK>
    <LicenceNumber>DPR1328/022/003</LicenceNumber>
    <ProductName>MADOPAR HARD CAPSULES</ProductName>
    <Strength>200/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENSERAZIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026368</DrugIDPK>
    <LicenceNumber>PA1419/002/001</LicenceNumber>
    <ProductName>MEDRONATE DRAXIMAGE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligrams per Ampule</StrengthMeasurement>
    <PAHolder>DRAXIMAGE (UK) Limited</PAHolder>
    <AuthorisedDate>2008-03-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Kit for radiopharmaceutical preparation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038043</DrugIDPK>
    <LicenceNumber>DPR1463/036/001</LicenceNumber>
    <ProductName>MEGACE</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEGESTROL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038025</DrugIDPK>
    <LicenceNumber>H/C/2671/00/0/2</LicenceNumber>
    <ProductName>MEMANTINE HYDROCHLORIDE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEMANTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038267</DrugIDPK>
    <LicenceNumber>H/C/2711/00/0/2</LicenceNumber>
    <ProductName>MEMANTINE MERZ</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merz Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEMANTINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>MEMANTINE (FREE BASE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038449</DrugIDPK>
    <LicenceNumber>PA0749/193/001</LicenceNumber>
    <ProductName>MEMANTINE TEVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2014-03-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEMANTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027058</DrugIDPK>
    <LicenceNumber>DPR1465/015/001</LicenceNumber>
    <ProductName>MEROCAINE</ProductName>
    <Strength>1.4/10.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027058</DrugIDPK>
    <LicenceNumber>DPR1465/015/001</LicenceNumber>
    <ProductName>MEROCAINE</ProductName>
    <Strength>1.4/10.0</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027567</DrugIDPK>
    <LicenceNumber>DPR1473/029/001</LicenceNumber>
    <ProductName>MEROCAINE</ProductName>
    <Strength>1.4/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033902</DrugIDPK>
    <LicenceNumber>DPR1562/018/001</LicenceNumber>
    <ProductName>MEROCAINE</ProductName>
    <Strength>1.4/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2010-08-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031384</DrugIDPK>
    <LicenceNumber>DPR1463/031/001</LicenceNumber>
    <ProductName>MEROCAINE</ProductName>
    <Strength>1.4/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032086</DrugIDPK>
    <LicenceNumber>DPR1392/060/001</LicenceNumber>
    <ProductName>MEROCAINE LOZENGES</ProductName>
    <Strength>1.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-12-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029251</DrugIDPK>
    <LicenceNumber>DPR1465/035/001</LicenceNumber>
    <ProductName>MEROCAINE LOZENGES</ProductName>
    <Strength>1.4mg/10.0</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028051</DrugIDPK>
    <LicenceNumber>PA1380/037/001</LicenceNumber>
    <ProductName>MEROXIMER</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028052</DrugIDPK>
    <LicenceNumber>PA1380/037/002</LicenceNumber>
    <ProductName>MEROXIMER</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028053</DrugIDPK>
    <LicenceNumber>PA1380/037/003</LicenceNumber>
    <ProductName>MEROXIMER</ProductName>
    <Strength>0.35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028054</DrugIDPK>
    <LicenceNumber>PA1380/037/004</LicenceNumber>
    <ProductName>MEROXIMER</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028055</DrugIDPK>
    <LicenceNumber>PA1380/037/005</LicenceNumber>
    <ProductName>MEROXIMER</ProductName>
    <Strength>1.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-11-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022747</DrugIDPK>
    <LicenceNumber>PA0281/134/001</LicenceNumber>
    <ProductName>MIRTAZ</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020978</DrugIDPK>
    <LicenceNumber>PA1285/003/002</LicenceNumber>
    <ProductName>MIRTAZAPINE MEDIS 30 MG FILM-COATED TABLETS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020979</DrugIDPK>
    <LicenceNumber>PA1285/003/003</LicenceNumber>
    <ProductName>MIRTAZAPINE MEDIS 45 MG FILM-COATED TABLETS</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Medis ehf</PAHolder>
    <AuthorisedDate>2006-02-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033989</DrugIDPK>
    <LicenceNumber>PA1675/001/001</LicenceNumber>
    <ProductName>MIRTAZIPINE GLOB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033990</DrugIDPK>
    <LicenceNumber>PA1675/001/002</LicenceNumber>
    <ProductName>MIRTAZIPINE GLOB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033991</DrugIDPK>
    <LicenceNumber>PA1675/001/003</LicenceNumber>
    <ProductName>MIRTAZIPINE GLOB</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>2011-09-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995043851</DrugIDPK>
    <LicenceNumber>PA0405/084/001</LicenceNumber>
    <ProductName>MITOXANTRONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>2014-12-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MITOXANTRONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021458</DrugIDPK>
    <LicenceNumber>PPA1328/003/001</LicenceNumber>
    <ProductName>MOBIC</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-09-11</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELOXICAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032227</DrugIDPK>
    <LicenceNumber>DPR1500/032/001</LicenceNumber>
    <ProductName>MOVICOL PAEDIATRIC</ProductName>
    <Strength>6.9</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030924</DrugIDPK>
    <LicenceNumber>DPR1328/037/001</LicenceNumber>
    <ProductName>MOVICOL PLAIN SACHET</ProductName>
    <Strength>13.7</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE PH.EUR.</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028964</DrugIDPK>
    <LicenceNumber>PA0979/052/001</LicenceNumber>
    <ProductName>MUCINEX</ProductName>
    <Strength>600</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN DC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029985</DrugIDPK>
    <LicenceNumber>DPR1562/009/001</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>N/A</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029859</DrugIDPK>
    <LicenceNumber>DPR1562/010/001</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength>0.12</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031497</DrugIDPK>
    <LicenceNumber>DPR1392/047/001</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength>1.0/0.25</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032082</DrugIDPK>
    <LicenceNumber>DPR1392/058/001</LicenceNumber>
    <ProductName>MYCIL</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031524</DrugIDPK>
    <LicenceNumber>DPR1392/048/001</LicenceNumber>
    <ProductName>MYCIL ATHLETE'S FOOT SPRAY</ProductName>
    <Strength>0.12</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLNAFTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028213</DrugIDPK>
    <LicenceNumber>PA0577/109/001</LicenceNumber>
    <ProductName>MYCLOVEAR</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2009-07-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMCICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019953</DrugIDPK>
    <LicenceNumber>PA0577/070/001</LicenceNumber>
    <ProductName>NAGERINE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2005-09-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINNARIZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027849</DrugIDPK>
    <LicenceNumber>DPR1500/009/001</LicenceNumber>
    <ProductName>NASACORT</ProductName>
    <Strength>55</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027140</DrugIDPK>
    <LicenceNumber>DPR1473/014/001</LicenceNumber>
    <ProductName>NASACORT</ProductName>
    <Strength>55</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034078</DrugIDPK>
    <LicenceNumber>DPR1447/009/001</LicenceNumber>
    <ProductName>NASACORT</ProductName>
    <Strength>55</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-09-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027141</DrugIDPK>
    <LicenceNumber>DPR1473/015/001</LicenceNumber>
    <ProductName>NASEPTIN NASAL</ProductName>
    <Strength>0.1/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030156</DrugIDPK>
    <LicenceNumber>DPR1328/023/001</LicenceNumber>
    <ProductName>NASEPTIN NASAL CREAM</ProductName>
    <Strength>0.1/0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022781</DrugIDPK>
    <LicenceNumber>DPR1392/004/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-02-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027883</DrugIDPK>
    <LicenceNumber>DPR1500/008/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032364</DrugIDPK>
    <LicenceNumber>DPR1447/003/001</LicenceNumber>
    <ProductName>NASONEX</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031146</DrugIDPK>
    <LicenceNumber>DPR1596/021/001</LicenceNumber>
    <ProductName>NASONEX 50 MICROGRAMS/ACTUATION NASAL SPRAY SUSPEN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030871</DrugIDPK>
    <LicenceNumber>DPR1328/036/001</LicenceNumber>
    <ProductName>NASONEX AQUEOUS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031291</DrugIDPK>
    <LicenceNumber>DPR1601/009/001</LicenceNumber>
    <ProductName>NASONEX AQUEOUS NASAL SPRAY SUSPENSION</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOMETASONE FUROATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032258</DrugIDPK>
    <LicenceNumber>PPA1473/045/001</LicenceNumber>
    <ProductName>NEBILET</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-04-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEBIVOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995039194</DrugIDPK>
    <LicenceNumber>H/C/2418/00/0/0</LicenceNumber>
    <ProductName>NEOFORDEX</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Laboratoires CTRS</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024384</DrugIDPK>
    <LicenceNumber>H/C/333/X/43</LicenceNumber>
    <ProductName>NESPO</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>DOMPE BIOTEC S.p.A.</PAHolder>
    <AuthorisedDate>2008-07-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
      <ActiveSubstance>DARBEPOETIN ALFA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022978</DrugIDPK>
    <LicenceNumber>DPR1400/003/001</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MIRAPHARM</PAHolder>
    <AuthorisedDate>2007-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022979</DrugIDPK>
    <LicenceNumber>DPR1400/003/002</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>MIRAPHARM</PAHolder>
    <AuthorisedDate>2007-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028421</DrugIDPK>
    <LicenceNumber>PPA1473/001/001</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028422</DrugIDPK>
    <LicenceNumber>PPA1473/001/002</LicenceNumber>
    <ProductName>NEXIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESOMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020284</DrugIDPK>
    <LicenceNumber>PA0823/049/013</LicenceNumber>
    <ProductName>NICORETTE</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020285</DrugIDPK>
    <LicenceNumber>PA0823/049/012</LicenceNumber>
    <ProductName>NICORETTE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020286</DrugIDPK>
    <LicenceNumber>PA0823/049/011</LicenceNumber>
    <ProductName>NICORETTE</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2005-07-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021632</DrugIDPK>
    <LicenceNumber>PA0823/049/019</LicenceNumber>
    <ProductName>NICORETTE MICROTAB LEMON SUBLINGUAL TABLETS 2MG</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE BITARTRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021633</DrugIDPK>
    <LicenceNumber>PA0823/049/020</LicenceNumber>
    <ProductName>NICORETTE MICROTAB LEMON SUBLINGUAL TABLETS 4MG</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2007-07-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Sublingual</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE BITARTRATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020552</DrugIDPK>
    <LicenceNumber>PA0823/049/017</LicenceNumber>
    <ProductName>NICORETTE SPICEMINT 2MG MEDICATED CHEWING GUM</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020282</DrugIDPK>
    <LicenceNumber>PA0823/049/018</LicenceNumber>
    <ProductName>NICORETTE SPICEMINT 4MG MEDICATED CHEWING GUM</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2006-07-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated Chewing Gum</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE RESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045738</DrugIDPK>
    <LicenceNumber>PA1186/018/002A</LicenceNumber>
    <ProductName>NIQUITIN MINI MINT</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Chefaro Ireland DAC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through general sales</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>In general sale outlets can only be sold or supplied to adults aged 18 years or above</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023450</DrugIDPK>
    <LicenceNumber>DPR1392/006/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026450</DrugIDPK>
    <LicenceNumber>DPR0465/015/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP SPRAY</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-11-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028983</DrugIDPK>
    <LicenceNumber>DPR1500/022/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP SPRAY</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-11-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028590</DrugIDPK>
    <LicenceNumber>DPR1463/022/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP SPRAY</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCEROL TRIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031628</DrugIDPK>
    <LicenceNumber>DPR1562/014/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP SPRAY</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031293</DrugIDPK>
    <LicenceNumber>DPR1601/010/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP SPRAY</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031478</DrugIDPK>
    <LicenceNumber>DPR1328/039/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP SPRAY</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031135</DrugIDPK>
    <LicenceNumber>DPR1596/012/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP SPRAY</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033269</DrugIDPK>
    <LicenceNumber>DPR1447/006/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMP STRAY</ProductName>
    <Strength>0.4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027900</DrugIDPK>
    <LicenceNumber>DPR1473/045/001</LicenceNumber>
    <ProductName>NITROLINGUAL PUMPSPRAY</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual Spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027306</DrugIDPK>
    <LicenceNumber>PA1380/033/001</LicenceNumber>
    <ProductName>NOCTISSIN</ProductName>
    <Strength>0.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027307</DrugIDPK>
    <LicenceNumber>PA1380/033/002</LicenceNumber>
    <ProductName>NOCTISSIN</ProductName>
    <Strength>0.2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045987</DrugIDPK>
    <LicenceNumber>PA0979/032/019</LicenceNumber>
    <ProductName>NUROFEN MAXIMUM STRENGTH 400MG TABLETS</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030493</DrugIDPK>
    <LicenceNumber>DPR1392/036/001</LicenceNumber>
    <ProductName>OILATUM</ProductName>
    <Strength>6/15</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-05-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUID PARAFFIN LIGHT</ActiveSubstance>
      <ActiveSubstance>WHITE SOFT PARAFFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030334</DrugIDPK>
    <LicenceNumber>DPR1473/049/001</LicenceNumber>
    <ProductName>OILATUM EMOLLIENT</ProductName>
    <Strength>63.4</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUID PARAFFIN LIGHT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027873</DrugIDPK>
    <LicenceNumber>PA1380/043/006</LicenceNumber>
    <ProductName>OLANZAPINE ACTAVIS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034004</DrugIDPK>
    <LicenceNumber>PA0047/096/001</LicenceNumber>
    <ProductName>OLANZAPINE LILLY</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034005</DrugIDPK>
    <LicenceNumber>PA0047/096/002</LicenceNumber>
    <ProductName>OLANZAPINE LILLY</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034006</DrugIDPK>
    <LicenceNumber>PA0047/096/003</LicenceNumber>
    <ProductName>OLANZAPINE LILLY</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034007</DrugIDPK>
    <LicenceNumber>PA0047/096/004</LicenceNumber>
    <ProductName>OLANZAPINE LILLY</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034008</DrugIDPK>
    <LicenceNumber>PA0047/096/005</LicenceNumber>
    <ProductName>OLANZAPINE LILLY</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034009</DrugIDPK>
    <LicenceNumber>PA0047/096/006</LicenceNumber>
    <ProductName>OLANZAPINE LILLY</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034011</DrugIDPK>
    <LicenceNumber>PA0047/096/008</LicenceNumber>
    <ProductName>OLANZAPINE LILLY 10 MG ORODISPERSIBLE TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034014</DrugIDPK>
    <LicenceNumber>PA0047/096/011</LicenceNumber>
    <ProductName>OLANZAPINE LILLY 10 MG POWDER FOR SOLUTION FOR INJ</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034012</DrugIDPK>
    <LicenceNumber>PA0047/096/009</LicenceNumber>
    <ProductName>OLANZAPINE LILLY 15 MG ORODISPERSIBLE TABLETS</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034013</DrugIDPK>
    <LicenceNumber>PA0047/096/010</LicenceNumber>
    <ProductName>OLANZAPINE LILLY 20 MG ORODISPERSIBLE TABLETS</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034010</DrugIDPK>
    <LicenceNumber>PA0047/096/007</LicenceNumber>
    <ProductName>OLANZAPINE LILLY 5 MG ORODISPERSIBLE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018822</DrugIDPK>
    <LicenceNumber>PA0074/057/001</LicenceNumber>
    <ProductName>OMEPRAZOLE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020181</DrugIDPK>
    <LicenceNumber>PA0361/019/002</LicenceNumber>
    <ProductName>ONDANSETRON</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2006-05-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022946</DrugIDPK>
    <LicenceNumber>PA0736/027/001</LicenceNumber>
    <ProductName>ONDANSETRON B.BRAUN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2009-01-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ONDANSETRON HYDROCHLORIDE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023455</DrugIDPK>
    <LicenceNumber>H/C/864/00/0/0</LicenceNumber>
    <ProductName>OPOSTAF</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Europe BV</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELAVANCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023456</DrugIDPK>
    <LicenceNumber>H/C/864/00/0/1</LicenceNumber>
    <ProductName>OPOSTAF</ProductName>
    <Strength>750</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Astellas Pharma Europe BV</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TELAVANCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045786</DrugIDPK>
    <LicenceNumber>PA1952/003/001</LicenceNumber>
    <ProductName>OPXIL-EU</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novocat Farma S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035323</DrugIDPK>
    <LicenceNumber>PA1380/117/001</LicenceNumber>
    <ProductName>OSBONELLE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2011-03-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONATE SODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028009</DrugIDPK>
    <LicenceNumber>PA1493/003/001</LicenceNumber>
    <ProductName>OSPIZAN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028010</DrugIDPK>
    <LicenceNumber>PA1493/003/002</LicenceNumber>
    <ProductName>OSPIZAN</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028011</DrugIDPK>
    <LicenceNumber>PA1493/003/003</LicenceNumber>
    <ProductName>OSPIZAN</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028012</DrugIDPK>
    <LicenceNumber>PA1493/003/004</LicenceNumber>
    <ProductName>OSPIZAN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Sigillata Ltd</PAHolder>
    <AuthorisedDate>2010-08-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OLANZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037894</DrugIDPK>
    <LicenceNumber>PA1130/036/001W</LicenceNumber>
    <ProductName>OTELUS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037895</DrugIDPK>
    <LicenceNumber>PA1130/036/003W</LicenceNumber>
    <ProductName>OTELUS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037896</DrugIDPK>
    <LicenceNumber>PA1130/036/002W</LicenceNumber>
    <ProductName>OTELUS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027059</DrugIDPK>
    <LicenceNumber>DPR1465/016/001</LicenceNumber>
    <ProductName>OTRIVINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XYLOMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ANTAZOLINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031784</DrugIDPK>
    <LicenceNumber>PA0361/026/001</LicenceNumber>
    <ProductName>OXALIPLATIN</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2009-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN (20ML)</ActiveSubstance>
      <ActiveSubstance>OXALIPLATIN (50ML)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022658</DrugIDPK>
    <LicenceNumber>PA0937/007/002</LicenceNumber>
    <ProductName>OXALIPLATIN 5 MG/ML, POWDER FOR SOLUTION FOR INFUS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>2008-06-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXALIPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027496</DrugIDPK>
    <LicenceNumber>PA0749/073/001</LicenceNumber>
    <ProductName>OXCARBAZEPINE TEVA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXCARBAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027740</DrugIDPK>
    <LicenceNumber>PA0913/015/012</LicenceNumber>
    <ProductName>PALLADONE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027741</DrugIDPK>
    <LicenceNumber>PA0913/015/013</LicenceNumber>
    <ProductName>PALLADONE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027742</DrugIDPK>
    <LicenceNumber>PA0913/015/014</LicenceNumber>
    <ProductName>PALLADONE</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027743</DrugIDPK>
    <LicenceNumber>PA0913/015/015</LicenceNumber>
    <ProductName>PALLADONE</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Micromol</StrengthMeasurement>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>2009-07-31</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022881</DrugIDPK>
    <LicenceNumber>PPA0465/158/002</LicenceNumber>
    <ProductName>PANADOL ACTIFAST TABLETS 500MG</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-07-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022842</DrugIDPK>
    <LicenceNumber>PA0967/013/002</LicenceNumber>
    <ProductName>PANTOPRAZOLE</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022839</DrugIDPK>
    <LicenceNumber>PA0967/014/001</LicenceNumber>
    <ProductName>PANTOPRAZOLE RANBAXY</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022840</DrugIDPK>
    <LicenceNumber>PA0967/014/002</LicenceNumber>
    <ProductName>PANTOPRAZOLE RANBAXY</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>2009-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995042404</DrugIDPK>
    <LicenceNumber>PA1555/002/004</LicenceNumber>
    <ProductName>PARICALCIMED</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Microgram/ML</StrengthMeasurement>
    <PAHolder>Medice Arzneimittel Putter GmbH &amp; Co. K.G</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARICALCITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031465</DrugIDPK>
    <LicenceNumber>PPA1473/035/001</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031466</DrugIDPK>
    <LicenceNumber>PPA1473/035/002</LicenceNumber>
    <ProductName>PARIET</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-01-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031684</DrugIDPK>
    <LicenceNumber>PPA1473/038/001</LicenceNumber>
    <ProductName>PENTASA</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029955</DrugIDPK>
    <LicenceNumber>DPR1328/004/001</LicenceNumber>
    <ProductName>PEPCID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030448</DrugIDPK>
    <LicenceNumber>PPA1328/117/001</LicenceNumber>
    <ProductName>PEPCID</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FAMOTIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027164</DrugIDPK>
    <LicenceNumber>PA0568/023/001</LicenceNumber>
    <ProductName>PERINDOPRIL TERT-BUTYLAMINE/INDAPAMIDE SERVIER</ProductName>
    <Strength>8/2.5</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2009-08-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995006320</DrugIDPK>
    <LicenceNumber>PA0568/009/001</LicenceNumber>
    <ProductName>PERINDOPRIL-INDAPAMIDE</ProductName>
    <Strength>2/0.625</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>2002-02-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
      <ActiveSubstance>INDAPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031388</DrugIDPK>
    <LicenceNumber>DPR1463/033/001</LicenceNumber>
    <ProductName>PERSANTIN REGARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030088</DrugIDPK>
    <LicenceNumber>DPR1328/013/001</LicenceNumber>
    <ProductName>PERSANTIN RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032538</DrugIDPK>
    <LicenceNumber>DPR1500/036/001</LicenceNumber>
    <ProductName>PERSANTIN RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-03-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031648</DrugIDPK>
    <LicenceNumber>DPR1392/051/001</LicenceNumber>
    <ProductName>PERSANTIN RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033266</DrugIDPK>
    <LicenceNumber>DPR1447/007/001</LicenceNumber>
    <ProductName>PERSANTIN RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027143</DrugIDPK>
    <LicenceNumber>DPR1473/017/001</LicenceNumber>
    <ProductName>PERSANTIN RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995025968</DrugIDPK>
    <LicenceNumber>DPR0465/014/001</LicenceNumber>
    <ProductName>PERSANTIN RETARD</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027568</DrugIDPK>
    <LicenceNumber>DPR1473/030/001</LicenceNumber>
    <ProductName>POLYFAX OINTMENT, (POLYMYXIN B SULPHATE) &amp; (BACITR</ProductName>
    <Strength>10,000/500</Strength>
    <StrengthMeasurement>International Unit</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019364</DrugIDPK>
    <LicenceNumber>EU/1/05/321/001</LicenceNumber>
    <ProductName>POSACONAZOLE SP</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>SP Europe</PAHolder>
    <AuthorisedDate>2005-10-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POSACONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027760</DrugIDPK>
    <LicenceNumber>PA1327/012/001</LicenceNumber>
    <ProductName>PRAMIPEXOLE ORION</ProductName>
    <Strength>0.088</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027761</DrugIDPK>
    <LicenceNumber>PA1327/012/002</LicenceNumber>
    <ProductName>PRAMIPEXOLE ORION</ProductName>
    <Strength>0.18</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027762</DrugIDPK>
    <LicenceNumber>PA1327/012/003</LicenceNumber>
    <ProductName>PRAMIPEXOLE ORION</ProductName>
    <Strength>0.35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027763</DrugIDPK>
    <LicenceNumber>PA1327/012/004</LicenceNumber>
    <ProductName>PRAMIPEXOLE ORION</ProductName>
    <Strength>0.7</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027764</DrugIDPK>
    <LicenceNumber>PA1327/012/005</LicenceNumber>
    <ProductName>PRAMIPEXOLE ORION</ProductName>
    <Strength>1.1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2010-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035827</DrugIDPK>
    <LicenceNumber>DPR1633/010/001</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035828</DrugIDPK>
    <LicenceNumber>DPR1633/010/002</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035829</DrugIDPK>
    <LicenceNumber>DPR1633/010/003</LicenceNumber>
    <ProductName>PRAVASTATIN SODIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown 2010 Ltd</PAHolder>
    <AuthorisedDate>2011-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAVASTATIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031922</DrugIDPK>
    <LicenceNumber>PA0711/185/001</LicenceNumber>
    <ProductName>PREVIFECT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2011-01-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029252</DrugIDPK>
    <LicenceNumber>DPR1465/036/001</LicenceNumber>
    <ProductName>PRIODERM LOTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027060</DrugIDPK>
    <LicenceNumber>DPR1465/017/001</LicenceNumber>
    <ProductName>PRIODERM LOTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MALATHION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022388</DrugIDPK>
    <LicenceNumber>H/C/794/00/0/0</LicenceNumber>
    <ProductName>PRISTIQS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESVENLAFAXINE SUCCINATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022389</DrugIDPK>
    <LicenceNumber>H/C/794/00/0/1</LicenceNumber>
    <ProductName>PRISTIQS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESVENLAFAXINE SUCCINATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022390</DrugIDPK>
    <LicenceNumber>H/C/794/00/0/2</LicenceNumber>
    <ProductName>PRISTIQS</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Wyeth Europa Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESVENLAFAXINE SUCCINATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021980</DrugIDPK>
    <LicenceNumber>PA0013/122/001</LicenceNumber>
    <ProductName>PROLEUKIN</ProductName>
    <Strength>18 million</Strength>
    <StrengthMeasurement>Units/ml</StrengthMeasurement>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>2006-09-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALDESLEUKIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037212</DrugIDPK>
    <LicenceNumber>H/C/225/X/078/G</LicenceNumber>
    <ProductName>PROMETAX</ProductName>
    <Strength>13.3</Strength>
    <StrengthMeasurement>mg/24 hours</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019187</DrugIDPK>
    <LicenceNumber>PA0754/005/001</LicenceNumber>
    <ProductName>PROPOFOL TECHNOPHARM AMPOULE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Techno-Pharm Limited</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019188</DrugIDPK>
    <LicenceNumber>PA0754/005/002</LicenceNumber>
    <ProductName>PROPOFOL TECHNOPHARM VIAL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Techno-Pharm Limited</PAHolder>
    <AuthorisedDate>2009-05-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPOFOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033550</DrugIDPK>
    <LicenceNumber>PPA0465/258/001</LicenceNumber>
    <ProductName>PROSTAP 3</ProductName>
    <Strength>11.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2010-10-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUPRORELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030064</DrugIDPK>
    <LicenceNumber>PPA1562/005/001</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030065</DrugIDPK>
    <LicenceNumber>PPA1562/005/002</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-07-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE SODIUM SESQUIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033336</DrugIDPK>
    <LicenceNumber>PPA1659/008/002</LicenceNumber>
    <ProductName>PROTIUM</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANTOPRAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030802</DrugIDPK>
    <LicenceNumber>PPA0465/233/001</LicenceNumber>
    <ProductName>PROVIGIL</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MODAFINIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030803</DrugIDPK>
    <LicenceNumber>PPA0465/233/002</LicenceNumber>
    <ProductName>PROVIGIL</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MODAFINIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030834</DrugIDPK>
    <LicenceNumber>DPR1562/012/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031294</DrugIDPK>
    <LicenceNumber>DPR1601/011/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030191</DrugIDPK>
    <LicenceNumber>DPR1328/034/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027844</DrugIDPK>
    <LicenceNumber>DPR1500/006/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027603</DrugIDPK>
    <LicenceNumber>DPR1473/037/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023920</DrugIDPK>
    <LicenceNumber>DPR1392/008/001</LicenceNumber>
    <ProductName>PROZAC</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-07-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020458</DrugIDPK>
    <LicenceNumber>PA0970/050/008</LicenceNumber>
    <ProductName>PULMICORT</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020459</DrugIDPK>
    <LicenceNumber>PA0970/050/009</LicenceNumber>
    <ProductName>PULMICORT</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>2008-04-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027921</DrugIDPK>
    <LicenceNumber>PPA1447/023/001</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027922</DrugIDPK>
    <LicenceNumber>PPA1447/023/002</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Mcg/Acutuation</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-09-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995016098</DrugIDPK>
    <LicenceNumber>PPA0465/100/003</LicenceNumber>
    <ProductName>PULMICORT TURBOHALER 400 MICROGRAMS INHALATION POW</ProductName>
    <Strength>400</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2003-02-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028037</DrugIDPK>
    <LicenceNumber>PA0749/080/001</LicenceNumber>
    <ProductName>RABEPRAZOLE SODIUM TEVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028038</DrugIDPK>
    <LicenceNumber>PA0749/080/002</LicenceNumber>
    <ProductName>RABEPRAZOLE SODIUM TEVA</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2010-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RABEPRAZOLE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027061</DrugIDPK>
    <LicenceNumber>DPR1465/018/001</LicenceNumber>
    <ProductName>RALGEX</ProductName>
    <Strength>10/1/0.12</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029846</DrugIDPK>
    <LicenceNumber>DPR1562/005/001</LicenceNumber>
    <ProductName>RALGEX</ProductName>
    <Strength>10/1/0.12</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-02-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032078</DrugIDPK>
    <LicenceNumber>DPR1392/057/001</LicenceNumber>
    <ProductName>RALGEX</ProductName>
    <Strength>6.0/1.6</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031730</DrugIDPK>
    <LicenceNumber>DPR1392/054/001</LicenceNumber>
    <ProductName>RALGEX</ProductName>
    <Strength>10/1/0.12</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-10-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029256</DrugIDPK>
    <LicenceNumber>DPR1465/037/001</LicenceNumber>
    <ProductName>RALGEX HEAT SPRAY</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027069</DrugIDPK>
    <LicenceNumber>DPR1465/019/001</LicenceNumber>
    <ProductName>RALGEX HEAT SPRAY</ProductName>
    <Strength>6.0/1.6</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023041</DrugIDPK>
    <LicenceNumber>H/C/838/00/0/0</LicenceNumber>
    <ProductName>RAMELTEON</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMELTEON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023042</DrugIDPK>
    <LicenceNumber>H/C/838/00/0/1</LicenceNumber>
    <ProductName>RAMELTEON</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RAMELTEON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030565</DrugIDPK>
    <LicenceNumber>PA1389/011/001</LicenceNumber>
    <ProductName>RANITIDINE CLARIS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Base mg/ml</StrengthMeasurement>
    <PAHolder>Claris Lifesciences (UK) Limited</PAHolder>
    <AuthorisedDate>2011-10-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032185</DrugIDPK>
    <LicenceNumber>EU/1/11/686/001-014</LicenceNumber>
    <ProductName>RASILAMLO</ProductName>
    <Strength>150/5</Strength>
    <StrengthMeasurement>mg/mg</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-04-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022201</DrugIDPK>
    <LicenceNumber>EU/1/07/405/1-10,21-30</LicenceNumber>
    <ProductName>RASILEZ</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026820</DrugIDPK>
    <LicenceNumber>EU/1/08/491/001-020</LicenceNumber>
    <ProductName>RASILEZ HCT</ProductName>
    <Strength>150/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2009-01-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033175</DrugIDPK>
    <LicenceNumber>EU/1/11/730/025-036</LicenceNumber>
    <ProductName>RASITRIO</ProductName>
    <Strength>300/5/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHOLOTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033176</DrugIDPK>
    <LicenceNumber>EU/1/11/730/037-048</LicenceNumber>
    <ProductName>RASITRIO</ProductName>
    <Strength>300/10/12.</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHOLOTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033177</DrugIDPK>
    <LicenceNumber>EU/1/11/730/049-060</LicenceNumber>
    <ProductName>RASITRIO</ProductName>
    <Strength>300/10/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-11-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>AMLODIPINE BESYLATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHOLOTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035873</DrugIDPK>
    <LicenceNumber>PA0823/041/003</LicenceNumber>
    <ProductName>REACTINE</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>2011-07-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETIRIZINE DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength: 10mg, maximum pack size: 10, maximum daily dose: 10mg</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995039551</DrugIDPK>
    <LicenceNumber>PIP1408/003/001</LicenceNumber>
    <ProductName>RECOMBINANT VARICELLA ZOSTER VIRUS (VZV) GLYCOPROT</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>GlaxoSmithKline Biologicals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038044</DrugIDPK>
    <LicenceNumber>DPR1463/037/001</LicenceNumber>
    <ProductName>RECTOGESIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022274</DrugIDPK>
    <LicenceNumber>PPA1151/019/001</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022275</DrugIDPK>
    <LicenceNumber>PPA1151/019/002</LicenceNumber>
    <ProductName>REDUCTIL</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995007076</DrugIDPK>
    <LicenceNumber>EU/1/97/035/002</LicenceNumber>
    <ProductName>REFLUDAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmion Limited</PAHolder>
    <AuthorisedDate>1997-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEPIRUDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995003241</DrugIDPK>
    <LicenceNumber>EU/1/97/035/001</LicenceNumber>
    <ProductName>REFLUDAN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pharmion Limited</PAHolder>
    <AuthorisedDate>1997-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEPIRUDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038046</DrugIDPK>
    <LicenceNumber>DPR1463/040/001</LicenceNumber>
    <ProductName>REGURIN</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2012-07-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TROSPIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030070</DrugIDPK>
    <LicenceNumber>DPR1328/008/001</LicenceNumber>
    <ProductName>RELESTAT</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINASTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027070</DrugIDPK>
    <LicenceNumber>DPR1465/020/001</LicenceNumber>
    <ProductName>REMEGEL</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027904</DrugIDPK>
    <LicenceNumber>DPR1473/046/001</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027905</DrugIDPK>
    <LicenceNumber>DPR1473/046/002</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027906</DrugIDPK>
    <LicenceNumber>DPR1473/046/003</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030074</DrugIDPK>
    <LicenceNumber>DPR1328/010/001</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030076</DrugIDPK>
    <LicenceNumber>DPR1328/010/003</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033295</DrugIDPK>
    <LicenceNumber>DPR1447/008/001</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033296</DrugIDPK>
    <LicenceNumber>DPR1447/008/002</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033297</DrugIDPK>
    <LicenceNumber>DPR1447/008/003</LicenceNumber>
    <ProductName>REMINYL XL</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-07-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032230</DrugIDPK>
    <LicenceNumber>DPR1500/033/001</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032231</DrugIDPK>
    <LicenceNumber>DPR1500/033/002</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032232</DrugIDPK>
    <LicenceNumber>DPR1500/033/003</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031314</DrugIDPK>
    <LicenceNumber>DPR1601/019/001</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031315</DrugIDPK>
    <LicenceNumber>DPR1601/019/002</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031316</DrugIDPK>
    <LicenceNumber>DPR1601/019/003</LicenceNumber>
    <ProductName>REMINYL XL PROLONGED RELEASE CAPSULES</ProductName>
    <Strength>24</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALANTAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024200</DrugIDPK>
    <LicenceNumber>PA1063/026/001</LicenceNumber>
    <ProductName>RESDAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024201</DrugIDPK>
    <LicenceNumber>PA1063/026/002</LicenceNumber>
    <ProductName>RESDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024202</DrugIDPK>
    <LicenceNumber>PA1063/026/003</LicenceNumber>
    <ProductName>RESDAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030151</DrugIDPK>
    <LicenceNumber>PA1063/026/004</LicenceNumber>
    <ProductName>RESDAL</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030152</DrugIDPK>
    <LicenceNumber>PA1063/026/005</LicenceNumber>
    <ProductName>RESDAL</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>2010-05-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030737</DrugIDPK>
    <LicenceNumber>EU/1/10/626/1-4</LicenceNumber>
    <ProductName>RIBAVIRIN BIOPARTNERS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>BioPartners GmbH</PAHolder>
    <AuthorisedDate>2010-04-06</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBAVIRIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033456</DrugIDPK>
    <LicenceNumber>EU/1/12/774/001-002</LicenceNumber>
    <ProductName>RIENSO</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>2012-06-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Temporarily Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERUMOXYTOL (USAN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026880</DrugIDPK>
    <LicenceNumber>PA1380/020/001</LicenceNumber>
    <ProductName>RILUZOLE ACTAVIS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-05-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RILUZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026609</DrugIDPK>
    <LicenceNumber>PA1410/057/001</LicenceNumber>
    <ProductName>RIMENDIA</ProductName>
    <Strength>0.020+3.00</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL (AS BETADEX-CLATHRATE)</ActiveSubstance>
      <ActiveSubstance>DROSPIRENONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022529</DrugIDPK>
    <LicenceNumber>PA0281/133/001</LicenceNumber>
    <ProductName>RINOPREX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022530</DrugIDPK>
    <LicenceNumber>PA0281/133/002</LicenceNumber>
    <ProductName>RINOPREX</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>2007-12-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021924</DrugIDPK>
    <LicenceNumber>PA1130/008/006</LicenceNumber>
    <ProductName>RISDONE 6 MG FILM-COATED TABLETS</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032143</DrugIDPK>
    <LicenceNumber>PA1399/004/002</LicenceNumber>
    <ProductName>RISESEUS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Caduceus Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM AMORPHOUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032142</DrugIDPK>
    <LicenceNumber>PA1399/004/001</LicenceNumber>
    <ProductName>RISESEUS 5 MG FILM-COATED TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Caduceus Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM AMORPHOUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032144</DrugIDPK>
    <LicenceNumber>PA1399/004/003</LicenceNumber>
    <ProductName>RISESEUS ONCE WEEKLY</ProductName>
    <Strength>35</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Caduceus Pharma Ltd</PAHolder>
    <AuthorisedDate>2011-04-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISEDRONATE SODIUM AMORPHOUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029245</DrugIDPK>
    <LicenceNumber>PPA1151/091/001</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029246</DrugIDPK>
    <LicenceNumber>PPA1151/091/002</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029247</DrugIDPK>
    <LicenceNumber>PPA1151/091/003</LicenceNumber>
    <ProductName>RISPERDAL</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>2009-04-17</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035564</DrugIDPK>
    <LicenceNumber>DPR1596/026/001</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035565</DrugIDPK>
    <LicenceNumber>DPR1596/026/002</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035566</DrugIDPK>
    <LicenceNumber>DPR1596/026/003</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2011-04-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036753</DrugIDPK>
    <LicenceNumber>DPR1463/035/001</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036754</DrugIDPK>
    <LicenceNumber>DPR1463/035/002</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>37.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036755</DrugIDPK>
    <LicenceNumber>DPR1463/035/003</LicenceNumber>
    <ProductName>RISPERDAL CONSTA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2011-10-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035211</DrugIDPK>
    <LicenceNumber>DPR1473/060/001</LicenceNumber>
    <ProductName>RISPERIDONE</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2011-03-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045579</DrugIDPK>
    <LicenceNumber>PA1469/003/001</LicenceNumber>
    <ProductName>RISPERIDONE GENTIAN</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045580</DrugIDPK>
    <LicenceNumber>PA1469/003/002</LicenceNumber>
    <ProductName>RISPERIDONE GENTIAN</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045581</DrugIDPK>
    <LicenceNumber>PA1469/003/006</LicenceNumber>
    <ProductName>RISPERIDONE GENTIAN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045582</DrugIDPK>
    <LicenceNumber>PA1469/003/005</LicenceNumber>
    <ProductName>RISPERIDONE GENTIAN</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045583</DrugIDPK>
    <LicenceNumber>PA1469/003/004</LicenceNumber>
    <ProductName>RISPERIDONE GENTIAN</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995045584</DrugIDPK>
    <LicenceNumber>PA1469/003/003</LicenceNumber>
    <ProductName>RISPERIDONE GENTIAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Gentian Generics Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022728</DrugIDPK>
    <LicenceNumber>PA0749/049/003</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022729</DrugIDPK>
    <LicenceNumber>PA0749/049/004</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022730</DrugIDPK>
    <LicenceNumber>PA0749/049/005</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022731</DrugIDPK>
    <LicenceNumber>PA0749/049/006</LicenceNumber>
    <ProductName>RISPEVA</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-08-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RISPERIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028077</DrugIDPK>
    <LicenceNumber>PA1327/013/004</LicenceNumber>
    <ProductName>RIVASTIGMINE ORION</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>2009-06-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIVASTIGMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030600</DrugIDPK>
    <LicenceNumber>PA0711/126/004</LicenceNumber>
    <ProductName>ROMEP MUT</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030601</DrugIDPK>
    <LicenceNumber>PA0711/126/005</LicenceNumber>
    <ProductName>ROMEP MUT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030602</DrugIDPK>
    <LicenceNumber>PA0711/126/006</LicenceNumber>
    <ProductName>ROMEP MUT</ProductName>
    <Strength>40</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OMEPRAZOLE MAGNESIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022049</DrugIDPK>
    <LicenceNumber>PA0711/116/001</LicenceNumber>
    <ProductName>RONI</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022050</DrugIDPK>
    <LicenceNumber>PA0711/116/002</LicenceNumber>
    <ProductName>RONI</ProductName>
    <Strength>0.50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022051</DrugIDPK>
    <LicenceNumber>PA0711/116/003</LicenceNumber>
    <ProductName>RONI</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022052</DrugIDPK>
    <LicenceNumber>PA0711/116/004</LicenceNumber>
    <ProductName>RONI</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022053</DrugIDPK>
    <LicenceNumber>PA0711/116/005</LicenceNumber>
    <ProductName>RONI</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2008-02-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022624</DrugIDPK>
    <LicenceNumber>PA0577/094/003</LicenceNumber>
    <ProductName>ROPINIROLE</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>2008-08-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029236</DrugIDPK>
    <LicenceNumber>PA1462/003/001</LicenceNumber>
    <ProductName>ROPINIROLE GLENMARK</ProductName>
    <Strength>0.25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029237</DrugIDPK>
    <LicenceNumber>PA1462/003/002</LicenceNumber>
    <ProductName>ROPINIROLE GLENMARK</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029238</DrugIDPK>
    <LicenceNumber>PA1462/003/003</LicenceNumber>
    <ProductName>ROPINIROLE GLENMARK</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029239</DrugIDPK>
    <LicenceNumber>PA1462/003/004</LicenceNumber>
    <ProductName>ROPINIROLE GLENMARK</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029240</DrugIDPK>
    <LicenceNumber>PA1462/003/005</LicenceNumber>
    <ProductName>ROPINIROLE GLENMARK</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Glenmark Pharmaceuticals Europe Limited</PAHolder>
    <AuthorisedDate>2010-11-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ROPINIROLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030629</DrugIDPK>
    <LicenceNumber>DPR1392/038/001</LicenceNumber>
    <ProductName>SALOFALK ENEMA</ProductName>
    <Strength>4.0</Strength>
    <StrengthMeasurement>Grams</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Enema</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029956</DrugIDPK>
    <LicenceNumber>DPR1328/005/001</LicenceNumber>
    <ProductName>SALOFALK GASTRO-RESISTANT</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030630</DrugIDPK>
    <LicenceNumber>DPR1392/038/002</LicenceNumber>
    <ProductName>SALOFALK GRANULES</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031161</DrugIDPK>
    <LicenceNumber>DPR1473/053/001</LicenceNumber>
    <ProductName>SALOFALK GRANULES</ProductName>
    <Strength>1000</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-08-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030631</DrugIDPK>
    <LicenceNumber>DPR1392/038/003</LicenceNumber>
    <ProductName>SALOFALK TABLETS</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-05-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027054</DrugIDPK>
    <LicenceNumber>DPR1465/021/001</LicenceNumber>
    <ProductName>SAVLON</ProductName>
    <Strength>0.5/0.1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027055</DrugIDPK>
    <LicenceNumber>DPR1465/022/001</LicenceNumber>
    <ProductName>SAVLON</ProductName>
    <Strength>1/14</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031470</DrugIDPK>
    <LicenceNumber>DPR0465/037/001</LicenceNumber>
    <ProductName>SAVLON DRY ANTISEPTIC</ProductName>
    <Strength>1.14</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029259</DrugIDPK>
    <LicenceNumber>DPR1465/038/001</LicenceNumber>
    <ProductName>SAVLON DRY ANTISEPTIC</ProductName>
    <Strength>1.14</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Spray Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995047854</DrugIDPK>
    <LicenceNumber>99999/999/992</LicenceNumber>
    <ProductName>SDFF</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>test company 2</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027355</DrugIDPK>
    <LicenceNumber>DPR1392/020/001</LicenceNumber>
    <ProductName>SERC</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-03-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031119</DrugIDPK>
    <LicenceNumber>DPR1596/007/001</LicenceNumber>
    <ProductName>SERC</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031120</DrugIDPK>
    <LicenceNumber>DPR1596/007/002</LicenceNumber>
    <ProductName>SERC</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027607</DrugIDPK>
    <LicenceNumber>DPR1473/038/002</LicenceNumber>
    <ProductName>SERC-16</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028866</DrugIDPK>
    <LicenceNumber>DPR1500/015/002</LicenceNumber>
    <ProductName>SERC-16</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028598</DrugIDPK>
    <LicenceNumber>DPR1463/025/002</LicenceNumber>
    <ProductName>SERC-16</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031320</DrugIDPK>
    <LicenceNumber>DPR1601/020/002</LicenceNumber>
    <ProductName>SERC-16 TABLETS</ProductName>
    <Strength>16</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028597</DrugIDPK>
    <LicenceNumber>DPR1463/025/001</LicenceNumber>
    <ProductName>SERC-8</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028865</DrugIDPK>
    <LicenceNumber>DPR1500/015/001</LicenceNumber>
    <ProductName>SERC-8</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029279</DrugIDPK>
    <LicenceNumber>DPR1392/020/002</LicenceNumber>
    <ProductName>SERC-8</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-12-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027606</DrugIDPK>
    <LicenceNumber>DPR1473/038/001</LicenceNumber>
    <ProductName>SERC-8</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031319</DrugIDPK>
    <LicenceNumber>DPR1601/020/001</LicenceNumber>
    <ProductName>SERC-8 TABLETS</ProductName>
    <Strength>8</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAHISTINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029652</DrugIDPK>
    <LicenceNumber>DPR1392/030/001</LicenceNumber>
    <ProductName>SERETIDE 100 DISKUS</ProductName>
    <Strength>50/100</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029653</DrugIDPK>
    <LicenceNumber>DPR1392/030/002</LicenceNumber>
    <ProductName>SERETIDE 250 DISKUS</ProductName>
    <Strength>50/250</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034023</DrugIDPK>
    <LicenceNumber>DPR1392/065/001</LicenceNumber>
    <ProductName>SEROQUEL</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2010-09-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUETIAPINE FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021611</DrugIDPK>
    <LicenceNumber>PPA1328/002/002</LicenceNumber>
    <ProductName>SEROXAT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-02-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAROXETINE HYDROCHLORIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023037</DrugIDPK>
    <LicenceNumber>PA0749/050/001</LicenceNumber>
    <ProductName>SIBUTRAMINE TEVA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HCI MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023038</DrugIDPK>
    <LicenceNumber>PA0749/050/002</LicenceNumber>
    <ProductName>SIBUTRAMINE TEVA</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2008-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIBUTRAMINE HCI MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032162</DrugIDPK>
    <LicenceNumber>DPR1473/058/001</LicenceNumber>
    <ProductName>SILKIS OINTMENT</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029220</DrugIDPK>
    <LicenceNumber>PA1380/062/004</LicenceNumber>
    <ProductName>SIMCOVAS</ProductName>
    <Strength>80</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-06-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027613</DrugIDPK>
    <LicenceNumber>DPR1473/018/002</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>62.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027614</DrugIDPK>
    <LicenceNumber>DPR1473/018/003</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>110</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027615</DrugIDPK>
    <LicenceNumber>DPR1473/018/004</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>275</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031379</DrugIDPK>
    <LicenceNumber>DPR1463/029/001</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>10/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031380</DrugIDPK>
    <LicenceNumber>DPR1463/029/002</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>25/250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031382</DrugIDPK>
    <LicenceNumber>DPR1463/029/004</LicenceNumber>
    <ProductName>SINEMET</ProductName>
    <Strength>12.5/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030021</DrugIDPK>
    <LicenceNumber>DPR1500/024/002</LicenceNumber>
    <ProductName>SINEMET 110</ProductName>
    <Strength>10/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030022</DrugIDPK>
    <LicenceNumber>DPR1500/024/003</LicenceNumber>
    <ProductName>SINEMET 275</ProductName>
    <Strength>25/250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-02-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030020</DrugIDPK>
    <LicenceNumber>DPR1500/024/001</LicenceNumber>
    <ProductName>SINEMET 62.5</ProductName>
    <Strength>12.5/50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031383</DrugIDPK>
    <LicenceNumber>DPR1463/029/005</LicenceNumber>
    <ProductName>SINEMET CR</ProductName>
    <Strength>50/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027144</DrugIDPK>
    <LicenceNumber>DPR1473/018/001</LicenceNumber>
    <ProductName>SINEMET CR</ProductName>
    <Strength>50/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged Release Capsules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023453</DrugIDPK>
    <LicenceNumber>DPR1392/007/002</LicenceNumber>
    <ProductName>SINEMET CR</ProductName>
    <Strength>50/200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-06-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031381</DrugIDPK>
    <LicenceNumber>DPR1463/029/003</LicenceNumber>
    <ProductName>SINEMET PLUS</ProductName>
    <Strength>25/100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027616</DrugIDPK>
    <LicenceNumber>DPR1473/018/005</LicenceNumber>
    <ProductName>SINEMET-PLUS</ProductName>
    <Strength>100/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027659</DrugIDPK>
    <LicenceNumber>DPR1473/040/003</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028595</DrugIDPK>
    <LicenceNumber>DPR1463/024/001</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030018</DrugIDPK>
    <LicenceNumber>DPR1500/023/002</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995040873</DrugIDPK>
    <LicenceNumber>PPA1925/001/001</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novalus Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995040874</DrugIDPK>
    <LicenceNumber>PPA1925/001/002</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novalus Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995040875</DrugIDPK>
    <LicenceNumber>PPA1925/001/003</LicenceNumber>
    <ProductName>SINGULAIR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novalus Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031324</DrugIDPK>
    <LicenceNumber>DPR1601/021/003</LicenceNumber>
    <ProductName>SINGULAIR 10 MG FILM COATED TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031110</DrugIDPK>
    <LicenceNumber>DPR1596/005/001</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031111</DrugIDPK>
    <LicenceNumber>DPR1596/005/002</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031112</DrugIDPK>
    <LicenceNumber>DPR1596/005/003</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030019</DrugIDPK>
    <LicenceNumber>DPR1500/023/003</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030017</DrugIDPK>
    <LicenceNumber>DPR1500/023/001</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029925</DrugIDPK>
    <LicenceNumber>DPR1463/024/002</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029926</DrugIDPK>
    <LicenceNumber>DPR1463/024/004</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029927</DrugIDPK>
    <LicenceNumber>DPR1463/024/003</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-03-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028856</DrugIDPK>
    <LicenceNumber>DPR1473/040/004</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027657</DrugIDPK>
    <LicenceNumber>DPR1473/040/001</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027658</DrugIDPK>
    <LicenceNumber>DPR1473/040/002</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-05-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031322</DrugIDPK>
    <LicenceNumber>DPR1601/021/001</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC 4 MG CHEWABLE TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031323</DrugIDPK>
    <LicenceNumber>DPR1601/021/002</LicenceNumber>
    <ProductName>SINGULAIR PAEDIATRIC 5 MG CHEWABLE TABLETS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MONTELUKAST SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027051</DrugIDPK>
    <LicenceNumber>DPR1465/023/001</LicenceNumber>
    <ProductName>SOFT CORN REMOVAL PADS</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995008553</DrugIDPK>
    <LicenceNumber>EU/1/01/177/001</LicenceNumber>
    <ProductName>SONOVUE</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>Bracco International B.V.</PAHolder>
    <AuthorisedDate>2001-03-26</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPHUR HEXAFLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030446</DrugIDPK>
    <LicenceNumber>DPR1473/050/001</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031377</DrugIDPK>
    <LicenceNumber>DPR1463/030/001</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-09-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032241</DrugIDPK>
    <LicenceNumber>DPR1500/034/001</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2010-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031295</DrugIDPK>
    <LicenceNumber>DPR1601/012/001</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT SOLUTION FOR INHALATION</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031144</DrugIDPK>
    <LicenceNumber>DPR1596/019/001</LicenceNumber>
    <ProductName>SPIRIVA RESPIMAT SOLUTION FOR INHALATION</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Microgram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIOTROPIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034981</DrugIDPK>
    <LicenceNumber>EU/1/11/683/001-020</LicenceNumber>
    <ProductName>SPRIMEO HCT</ProductName>
    <Strength>150/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034982</DrugIDPK>
    <LicenceNumber>EU/1/11/683/021-40</LicenceNumber>
    <ProductName>SPRIMEO HCT</ProductName>
    <Strength>150/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034983</DrugIDPK>
    <LicenceNumber>EU/1/11/683/041-060</LicenceNumber>
    <ProductName>SPRIMEO HCT</ProductName>
    <Strength>300/12.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995034984</DrugIDPK>
    <LicenceNumber>EU/1/11/683/061-80</LicenceNumber>
    <ProductName>SPRIMEO HCT</ProductName>
    <Strength>300/25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2011-06-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALISKIREN HEMIFUMARATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027056</DrugIDPK>
    <LicenceNumber>DPR1465/024/001</LicenceNumber>
    <ProductName>SUDOCREM</ProductName>
    <Strength xsi:nil="true" />
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-02-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>LANOLIN</ActiveSubstance>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
      <ActiveSubstance>BENZYL CINNAMATE</ActiveSubstance>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030866</DrugIDPK>
    <LicenceNumber>PPA1473/028/002</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>200/6</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030867</DrugIDPK>
    <LicenceNumber>PPA1473/028/003</LicenceNumber>
    <ProductName>SYMBICORT TURBOHALER</ProductName>
    <Strength>400/12</Strength>
    <StrengthMeasurement>Mcg/Dose</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUDESONIDE</ActiveSubstance>
      <ActiveSubstance>FORMOTEROL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995047729</DrugIDPK>
    <LicenceNumber>H/C/4391/00/0/1</LicenceNumber>
    <ProductName>SYMTUZA (FORMERLY DARUNAVIR COBICISTAT EMTRICITABINE TENOFOVIR ALAFENAMIDE)</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARUNAVIR ETHANOLATE</ActiveSubstance>
      <ActiveSubstance>COBICISTAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995047730</DrugIDPK>
    <LicenceNumber>H/C/4391/00/0/2</LicenceNumber>
    <ProductName>SYMTUZA (FORMERLY DARUNAVIR COBICISTAT EMTRICITABINE TENOFOVIR ALAFENAMIDE)</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARUNAVIR ETHANOLATE</ActiveSubstance>
      <ActiveSubstance>COBICISTAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995047731</DrugIDPK>
    <LicenceNumber>H/C/4391/00/0/3</LicenceNumber>
    <ProductName>SYMTUZA (FORMERLY DARUNAVIR COBICISTAT EMTRICITABINE TENOFOVIR ALAFENAMIDE)</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DARUNAVIR ETHANOLATE</ActiveSubstance>
      <ActiveSubstance>COBICISTAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005225</DrugIDPK>
    <LicenceNumber>PA0167/091/004</LicenceNumber>
    <ProductName>SYNTHAMIN 14</ProductName>
    <Strength>8.5</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1997-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005229</DrugIDPK>
    <LicenceNumber>PA0167/091/007</LicenceNumber>
    <ProductName>SYNTHAMIN 17</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1997-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995005222</DrugIDPK>
    <LicenceNumber>PA0167/091/001</LicenceNumber>
    <ProductName>SYNTHAMIN 9</ProductName>
    <Strength>5.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>1997-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>LYSINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLALANINE</ActiveSubstance>
      <ActiveSubstance>HISTIDINE</ActiveSubstance>
      <ActiveSubstance>THREONINE</ActiveSubstance>
      <ActiveSubstance>DL-METHIONINE</ActiveSubstance>
      <ActiveSubstance>TRYPTOPHAN, L-</ActiveSubstance>
      <ActiveSubstance>ALANINE</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
      <ActiveSubstance>PROLINE</ActiveSubstance>
      <ActiveSubstance>SERINE</ActiveSubstance>
      <ActiveSubstance>TYROSINE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM PHOSPHATE DIBASIC</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE HEXAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995017702</DrugIDPK>
    <LicenceNumber>PPA1071/012/002A</LicenceNumber>
    <ProductName>TAGAMET</ProductName>
    <Strength>800</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>2003-08-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027859</DrugIDPK>
    <LicenceNumber>DPR1500/013/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028859</DrugIDPK>
    <LicenceNumber>DPR1473/048/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032081</DrugIDPK>
    <LicenceNumber>DPR1392/043/002</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-12-16</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030071</DrugIDPK>
    <LicenceNumber>DPR1328/009/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031415</DrugIDPK>
    <LicenceNumber>DPR1392/043/001</LicenceNumber>
    <ProductName>TAMBOCOR</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-09-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLECAINIDE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020498</DrugIDPK>
    <LicenceNumber>EU/1/06/366/1-2</LicenceNumber>
    <ProductName>TANDEMACT</ProductName>
    <Strength>30/2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2007-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995020499</DrugIDPK>
    <LicenceNumber>EU/1/06/366/003-004</LicenceNumber>
    <ProductName>TANDEMACT</ProductName>
    <Strength>30/4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Takeda Global R&amp;D Centre Europe Limited</PAHolder>
    <AuthorisedDate>2007-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIOGLITAZONE</ActiveSubstance>
      <ActiveSubstance>GLIMEPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027569</DrugIDPK>
    <LicenceNumber>DPR1473/031/001</LicenceNumber>
    <ProductName>TAVANIC</ProductName>
    <Strength>250</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028862</DrugIDPK>
    <LicenceNumber>DPR1473/031/003</LicenceNumber>
    <ProductName>TAVANIC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-10-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030824</DrugIDPK>
    <LicenceNumber>PPA0465/237/001</LicenceNumber>
    <ProductName>TAVANIC</ProductName>
    <Strength>500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOFLOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036959</DrugIDPK>
    <LicenceNumber>PA0749/166/001</LicenceNumber>
    <ProductName>TEBONEVA</ProductName>
    <Strength>70 mg + 1 microgram</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2015-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036959</DrugIDPK>
    <LicenceNumber>PA0749/166/001</LicenceNumber>
    <ProductName>TEBONEVA</ProductName>
    <Strength>70 mg + 1 microgram</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>2015-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALENDRONIC ACID</ActiveSubstance>
      <ActiveSubstance>ALFACALCIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023064</DrugIDPK>
    <LicenceNumber>EU/1/07/408/1-10</LicenceNumber>
    <ProductName>TEKTURNA</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPP100 HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023065</DrugIDPK>
    <LicenceNumber>EU/1/07/408/11-20</LicenceNumber>
    <ProductName>TEKTURNA</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>2007-08-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPP100 HEMIFUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024668</DrugIDPK>
    <LicenceNumber>DPR1392/014/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027323</DrugIDPK>
    <LicenceNumber>DPR1463/013/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027324</DrugIDPK>
    <LicenceNumber>DPR1463/013/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027145</DrugIDPK>
    <LicenceNumber>DPR1473/019/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027146</DrugIDPK>
    <LicenceNumber>DPR1473/019/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028881</DrugIDPK>
    <LicenceNumber>DPR1392/014/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027832</DrugIDPK>
    <LicenceNumber>DPR1500/001/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027833</DrugIDPK>
    <LicenceNumber>DPR1500/001/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031326</DrugIDPK>
    <LicenceNumber>DPR1601/022/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031327</DrugIDPK>
    <LicenceNumber>DPR1601/022/002</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>180</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031157</DrugIDPK>
    <LicenceNumber>DPR1562/013/001</LicenceNumber>
    <ProductName>TELFAST</ProductName>
    <Strength>120</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>2009-08-07</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FEXOFENADINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028410</DrugIDPK>
    <LicenceNumber>PPA1447/014/001</LicenceNumber>
    <ProductName>TENORMIN</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031526</DrugIDPK>
    <LicenceNumber>PPA0465/023/003</LicenceNumber>
    <ProductName>TENORMIN 25 MG FILM-COATED TABLETS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022447</DrugIDPK>
    <LicenceNumber>PA13340/001/001</LicenceNumber>
    <ProductName>TEST PRODUCT 20</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>%v/v</StrengthMeasurement>
    <PAHolder>New Test Company LTD</PAHolder>
    <AuthorisedDate>2006-11-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TEST 29999234</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995037154</DrugIDPK>
    <LicenceNumber>DPR1392/067/001</LicenceNumber>
    <ProductName>TETRALYSAL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2012-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LYMECYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995038793</DrugIDPK>
    <LicenceNumber>DPR1463/041/001</LicenceNumber>
    <ProductName>TETRALYSAL</ProductName>
    <Strength>300</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LYMECYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026446</DrugIDPK>
    <LicenceNumber>H/C/931/00/0/0</LicenceNumber>
    <ProductName>THERALOC</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>ONCOSCIENCE AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIMOTUZUMAB</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027570</DrugIDPK>
    <LicenceNumber>DPR1473/032/001</LicenceNumber>
    <ProductName>TIMOPTOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-04-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030716</DrugIDPK>
    <LicenceNumber>DPR1328/011/002</LicenceNumber>
    <ProductName>TIMOPTOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-06-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030035</DrugIDPK>
    <LicenceNumber>DPR1500/030/001</LicenceNumber>
    <ProductName>TIMOPTOL</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031133</DrugIDPK>
    <LicenceNumber>DPR1596/011/001</LicenceNumber>
    <ProductName>TIMOPTOL EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031296</DrugIDPK>
    <LicenceNumber>DPR1601/013/001</LicenceNumber>
    <ProductName>TIMOPTOL EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-08-28</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031650</DrugIDPK>
    <LicenceNumber>DPR1392/052/001</LicenceNumber>
    <ProductName>TIMOPTOL EYE DROPS SOLUTION</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>%w/v</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-10-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030079</DrugIDPK>
    <LicenceNumber>DPR1328/011/001</LicenceNumber>
    <ProductName>TIMOPTOL LA GEL-FORMING</ProductName>
    <Strength>0.5</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027129</DrugIDPK>
    <LicenceNumber>PA0711/148/001</LicenceNumber>
    <ProductName>TIRLOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027130</DrugIDPK>
    <LicenceNumber>PA0711/148/002</LicenceNumber>
    <ProductName>TIRLOR ALLERGY 10MG TABLETS</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030248</DrugIDPK>
    <LicenceNumber>PA1380/074/001</LicenceNumber>
    <ProductName>TOPIRAMATE ACTAVIS</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030249</DrugIDPK>
    <LicenceNumber>PA1380/074/002</LicenceNumber>
    <ProductName>TOPIRAMATE ACTAVIS</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030250</DrugIDPK>
    <LicenceNumber>PA1380/074/003</LicenceNumber>
    <ProductName>TOPIRAMATE ACTAVIS</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030251</DrugIDPK>
    <LicenceNumber>PA1380/074/004</LicenceNumber>
    <ProductName>TOPIRAMATE ACTAVIS</ProductName>
    <Strength>200</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-10-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPIRAMATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033941</DrugIDPK>
    <LicenceNumber>PA0361/032/001</LicenceNumber>
    <ProductName>TOPOTECAN MARTINDALE PHARMA</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033942</DrugIDPK>
    <LicenceNumber>PA0361/032/002</LicenceNumber>
    <ProductName>TOPOTECAN MARTINDALE PHARMA</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>2010-10-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOPOTECAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029645</DrugIDPK>
    <LicenceNumber>DPR1392/029/001</LicenceNumber>
    <ProductName>TOSTRAN</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TESTOSTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995036330</DrugIDPK>
    <LicenceNumber>H/C/2279/00/0/0</LicenceNumber>
    <ProductName>TRAJENTAMET</ProductName>
    <Strength>2.5/500</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LINAGLIPTIN</ActiveSubstance>
      <ActiveSubstance>METFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027147</DrugIDPK>
    <LicenceNumber>DPR1473/020/001</LicenceNumber>
    <ProductName>TRAXAM</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027321</DrugIDPK>
    <LicenceNumber>DPR1463/011/001</LicenceNumber>
    <ProductName>TRAXAM</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2008-03-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024672</DrugIDPK>
    <LicenceNumber>DPR1392/015/001</LicenceNumber>
    <ProductName>TRAXAM</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022980</DrugIDPK>
    <LicenceNumber>DPR1400/004/001</LicenceNumber>
    <ProductName>TRAXAM</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>MIRAPHARM</PAHolder>
    <AuthorisedDate>2007-03-22</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995023248</DrugIDPK>
    <LicenceNumber>DPR0465/007/001</LicenceNumber>
    <ProductName>TRAXAM</ProductName>
    <Strength>3</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-06-01</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELBINAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030800</DrugIDPK>
    <LicenceNumber>PPA0465/232/001</LicenceNumber>
    <ProductName>TRIAPIN 5MG/5MG PROLONGED RELEASE TABLET</ProductName>
    <Strength>5mg/5mg</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-09-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FELODIPINE</ActiveSubstance>
      <ActiveSubstance>RAMIPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027148</DrugIDPK>
    <LicenceNumber>DPR1473/021/001</LicenceNumber>
    <ProductName>TRUSOPT</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Per Cent</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2008-02-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030034</DrugIDPK>
    <LicenceNumber>DPR1500/029/001</LicenceNumber>
    <ProductName>TRUSOPT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2009-03-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030095</DrugIDPK>
    <LicenceNumber>DPR1328/015/001</LicenceNumber>
    <ProductName>TRUSOPT</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031137</DrugIDPK>
    <LicenceNumber>DPR1596/014/001</LicenceNumber>
    <ProductName>TRUSOPT EYE DROPS SOLUTION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031300</DrugIDPK>
    <LicenceNumber>DPR1601/015/001</LicenceNumber>
    <ProductName>TRUSOPT EYE DROPS SOLUTION</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>2009-09-03</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DORZOLAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027052</DrugIDPK>
    <LicenceNumber>DPR1465/025/001</LicenceNumber>
    <ProductName>TYROZETS</ProductName>
    <Strength>1/5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029262</DrugIDPK>
    <LicenceNumber>DPR1465/040/001</LicenceNumber>
    <ProductName>TYROZETS</ProductName>
    <Strength>1 mg/5 mg</Strength>
    <StrengthMeasurement xsi:nil="true" />
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019674</DrugIDPK>
    <LicenceNumber>EU/1/02/232/3</LicenceNumber>
    <ProductName>VELOSULIN</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>IU/ML</StrengthMeasurement>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>2003-08-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018928</DrugIDPK>
    <LicenceNumber>PA0736/020/001</LicenceNumber>
    <ProductName>VENOFUNDIN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2006-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018929</DrugIDPK>
    <LicenceNumber>PA0736/020/002</LicenceNumber>
    <ProductName>VENOFUNDIN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2006-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995018930</DrugIDPK>
    <LicenceNumber>PA0736/020/003</LicenceNumber>
    <ProductName>VENOFUNDIN</ProductName>
    <Strength>6</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>2006-08-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLY(O-2-HYDROXYETHYL)STARCH</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029263</DrugIDPK>
    <LicenceNumber>DPR1465/041/001</LicenceNumber>
    <ProductName>VICKS INHALER</ProductName>
    <Strength>125/50/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>2008-12-18</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CINNAMOMUM CAMPHORA</ActiveSubstance>
      <ActiveSubstance>SIBERIAN FIR OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027053</DrugIDPK>
    <LicenceNumber>DPR1465/026/001</LicenceNumber>
    <ProductName>VICKS INHALER</ProductName>
    <Strength>125/50/10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
      <ActiveSubstance>SIBERIAN FIR OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033059</DrugIDPK>
    <LicenceNumber>PA1380/097/001</LicenceNumber>
    <ProductName>VILGENDRA</ProductName>
    <Strength>25</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL BASE (AS CITRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033060</DrugIDPK>
    <LicenceNumber>PA1380/097/002</LicenceNumber>
    <ProductName>VILGENDRA</ProductName>
    <Strength>50</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL BASE (AS CITRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995033061</DrugIDPK>
    <LicenceNumber>PA1380/097/003</LicenceNumber>
    <ProductName>VILGENDRA</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2010-07-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SILDENAFIL BASE (AS CITRATE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028020</DrugIDPK>
    <LicenceNumber>PA1348/016/001</LicenceNumber>
    <ProductName>VINORELBINE MARTINDALE PHARMA</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Cardinal Health UK 434 Limited</PAHolder>
    <AuthorisedDate>2009-09-25</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINORELBINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019285</DrugIDPK>
    <LicenceNumber>PA0800/004/002</LicenceNumber>
    <ProductName>VIVAGLOBIN</ProductName>
    <Strength>160</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN IMMUMOGLOBULINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021344</DrugIDPK>
    <LicenceNumber>PPA0465/013/005</LicenceNumber>
    <ProductName>VOLTAROL 1% W/W EMULGEL</ProductName>
    <Strength>1</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2006-06-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC DIETHYLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031506</DrugIDPK>
    <LicenceNumber>PPA1447/062/001</LicenceNumber>
    <ProductName>VOLTAROL RETARD</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2010-01-08</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995026608</DrugIDPK>
    <LicenceNumber>H/C/947/00/0/0</LicenceNumber>
    <ProductName>VORINOSTAT MSD</ProductName>
    <Strength>100</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VORINOSTAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030307</DrugIDPK>
    <LicenceNumber>DPR1392/034/001</LicenceNumber>
    <ProductName>WARTICON</ProductName>
    <Strength>0.15</Strength>
    <StrengthMeasurement>%w/w</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2009-04-15</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PODOPHYLLOTOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035501</DrugIDPK>
    <LicenceNumber>PA0711/201/001</LicenceNumber>
    <ProductName>YOSQIERO</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>2012-07-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030107</DrugIDPK>
    <LicenceNumber>DPR1328/017/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995030108</DrugIDPK>
    <LicenceNumber>DPR1328/017/002</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2009-04-02</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031097</DrugIDPK>
    <LicenceNumber>DPR1596/003/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031098</DrugIDPK>
    <LicenceNumber>DPR1596/003/002</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>2009-07-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029445</DrugIDPK>
    <LicenceNumber>DPR1463/026/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029446</DrugIDPK>
    <LicenceNumber>DPR1463/026/002</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>2009-01-09</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028549</DrugIDPK>
    <LicenceNumber>DPR1392/025/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995028550</DrugIDPK>
    <LicenceNumber>DPR1392/025/002</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2008-08-21</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027857</DrugIDPK>
    <LicenceNumber>DPR1500/014/001</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027858</DrugIDPK>
    <LicenceNumber>DPR1500/014/002</LicenceNumber>
    <ProductName>ZANAFLEX</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>2008-05-29</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031894</DrugIDPK>
    <LicenceNumber>DPR1473/055/001</LicenceNumber>
    <ProductName>ZANAFLEX TABLETS</ProductName>
    <Strength>2</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031895</DrugIDPK>
    <LicenceNumber>DPR1473/055/002</LicenceNumber>
    <ProductName>ZANAFLEX TABLETS</ProductName>
    <Strength>4</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-11-23</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIZANIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995032391</DrugIDPK>
    <LicenceNumber>PA0126/200/001</LicenceNumber>
    <ProductName>ZANOPRO PLUS</ProductName>
    <Strength>0.05/5</Strength>
    <StrengthMeasurement>Mg/Ml</StrengthMeasurement>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>2011-05-13</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LATANOPROST</ActiveSubstance>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995019397</DrugIDPK>
    <LicenceNumber>PPA0465/033/003</LicenceNumber>
    <ProductName>ZANTAC 75</ProductName>
    <Strength>75</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2005-05-20</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RANITIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021758</DrugIDPK>
    <LicenceNumber>PPA1328/043/001</LicenceNumber>
    <ProductName>ZIMOVANE</ProductName>
    <Strength>7.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2006-11-27</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOPICLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995025439</DrugIDPK>
    <LicenceNumber>PPA0465/207/001</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2007-12-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029528</DrugIDPK>
    <LicenceNumber>PPA0465/207/002</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>15</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029529</DrugIDPK>
    <LicenceNumber>PPA0465/207/003</LicenceNumber>
    <ProductName>ZISPIN SOLTAB</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>2009-06-05</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029661</DrugIDPK>
    <LicenceNumber>PPA1473/025/002</LicenceNumber>
    <ProductName>ZISPIN SOLTABS</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995029662</DrugIDPK>
    <LicenceNumber>PPA1473/025/003</LicenceNumber>
    <ProductName>ZISPIN SOLTABS</ProductName>
    <Strength>45</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2009-04-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MIRTAZAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027693</DrugIDPK>
    <LicenceNumber>PPA1447/024/001</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>10</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027694</DrugIDPK>
    <LicenceNumber>PPA1447/024/002</LicenceNumber>
    <ProductName>ZOCOR</ProductName>
    <Strength>20</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-07-04</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SIMVASTATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995024373</DrugIDPK>
    <LicenceNumber>DPR1392/011/001</LicenceNumber>
    <ProductName>ZOLADEX IMPLANT</ProductName>
    <Strength>3.6</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>2007-08-10</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GOSERELIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027547</DrugIDPK>
    <LicenceNumber>PA1380/035/002</LicenceNumber>
    <ProductName>ZOLMITRIPTAN ACTAVIS</ProductName>
    <Strength>5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate>2009-07-24</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995035143</DrugIDPK>
    <LicenceNumber>PA1380/114/001</LicenceNumber>
    <ProductName>ZOLMITRIPTAN ACTAVIS</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Actavis Group PTC ehf</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995027333</DrugIDPK>
    <LicenceNumber>PPA1447/009/002</LicenceNumber>
    <ProductName>ZOMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>G &amp; A Licensing Limited</PAHolder>
    <AuthorisedDate>2008-11-14</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031692</DrugIDPK>
    <LicenceNumber>PPA1473/039/001</LicenceNumber>
    <ProductName>ZOMIG</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995031693</DrugIDPK>
    <LicenceNumber>PPA1473/039/002</LicenceNumber>
    <ProductName>ZOMIG RAPIMELT</ProductName>
    <Strength>2.5</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>2010-02-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZOLMITRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995041505</DrugIDPK>
    <LicenceNumber>EU/1/14/976/001-006</LicenceNumber>
    <ProductName>ZONTIVITY</ProductName>
    <Strength>2.00</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>Merck Sharp &amp; Dohme Ltd</PAHolder>
    <AuthorisedDate>2015-01-19</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>--Unknown--</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VORAPAXAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Promotion to Healthcare Professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995022258</DrugIDPK>
    <LicenceNumber>PPA1328/067/001</LicenceNumber>
    <ProductName>ZOVIRAX</ProductName>
    <Strength>30</Strength>
    <StrengthMeasurement>mg/g</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-01-12</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>1995021946</DrugIDPK>
    <LicenceNumber>PPA1328/063/001</LicenceNumber>
    <ProductName>ZYBAN</ProductName>
    <Strength>150</Strength>
    <StrengthMeasurement>Milligram</StrengthMeasurement>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>2007-03-30</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet Prolonged Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMFEBUTAMONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
</Products>